PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Wallenborn, J; Gelbrich, G; Bulst, D; Behrends, K; Wallenborn, H; Rohrbach, A; Krause, U; Kuhnast, T; Wiegel, M; Olthoff, D				Wallenborn, Jan; Gelbrich, Goetz; Bulst, Detlef; Behrends, Katrin; Wallenborn, Hasso; Rohrbach, Andrea; Krause, Uwe; Kuehnast, Thomas; Wiegel, Martin; Olthoff, Derk			Prevention of postoperative nausea and vomiting by metoclopramide combined with dexamethasone: randomised double blind multicentre trial	BRITISH MEDICAL JOURNAL			English	Article								Objectives To determine whether 10 mg, 25 mg, or 50 mg metoclopramide combined with 8 mg dexamethasone, given intraoperatively, is more effective in preventing postoperative nausea and vomiting than 8 mg dexamethasone alone, and to assess benefit in relation to adverse drug reactions. Design Four-armed, parallel group, double blind, randomised controlled clinical trial. Setting Four clinics of a university hospital and four district hospitals in Germany. Participants 3140 patients who received balanced or regional anaesthesia during surgery. Main outcome measures Postoperative nausea and vomiting within 24 hours of surgery (primary end point); occurrence of adverse reactions. Results Cumulative incidences (95% confidence intervals) of postoperative nausea and vomiting were 23.1% (20.2% to 26.0%),20.6% (17.8% to 23.4%), 17.2% (14.6% to 19.8%), and 14.5% (12.0% to 17.0%) for 0 mg, 10 mg, 25 mg, and 50 mg metoclopramide. In the secondary analysis, 25 mg and 50 mg metoclopramide were equally effective at preventing early nausea (0-12 hours), but only 50 mg reduced late nausea and vomiting (> 12 hours). The most frequent adverse drug reactions were hypotension and tachycardia, with cumulative incidences of 8.8% (6.8% to 10.8%), 11.2% (9.0% to 13.4%), 12.9% (10.5% to 15.3%), and 17.9% (15.2% to 20.6%) for 0 mg, 10 mg, 25 mg, and 50 mg metoclopramide. Conclusion The addition of 50 mg metoclopramide to 8 mg dexamethasone (given intraoperatively) is an effective, safe, and cheap way to prevent postoperative nausea and vomiting. A reduced dose of 25 mg metoclopramide intraoperatively, With additional postoperative prophylaxis in high risk patients, may be equally effective and cause fewer adverse drug reactions.	Univ Leipzig, Coordinat Ctr Clin Trials Leipzig, D-04107 Leipzig, Germany; Univ Leipzig, Dept Anaesthesiol & Intens Care Med, D-04103 Leipzig, Germany; Bad Duben Forest Hosp, Dept Anaesthesiol, D-04849 Bad Duben, Germany; Wurzen Dist Hosp, Dept Anaesthesiol, D-04808 Wurzen, Germany; Grimma Dist Hosp, Dept Anaesthesiol, D-04668 Grimma, Germany; Weissenfels Dist Hosp, Dept Anaesthesiol, D-06667 Weissenfels, Germany	Leipzig University; Leipzig University	Gelbrich, G (corresponding author), Univ Leipzig, Coordinat Ctr Clin Trials Leipzig, D-04107 Leipzig, Germany.	goetz.gelbrich@kks.uni-1eipzig.de						Apfel CC, 2004, NEW ENGL J MED, V350, P2441, DOI 10.1056/NEJMoa032196; Apfel CC, 2002, BRIT J ANAESTH, V88, P659, DOI 10.1093/bja/88.5.659; Eberhart LHJ, 2000, CAN J ANAESTH, V47, P780, DOI 10.1007/BF03019481; Flather MD, 1997, CONTROL CLIN TRIALS, V18, P568, DOI 10.1016/S0197-2456(97)00024-X; Henzi I, 1999, BRIT J ANAESTH, V83, P761, DOI 10.1093/bja/83.5.761; OLTHOFF D, 2003, ARZNEIMITTELANWENDUN, P511; Piper SN, 2002, CAN J ANAESTH, V49, P1021, DOI 10.1007/BF03017895; Quaynor H, 2002, ACTA ANAESTH SCAND, V46, P109, DOI 10.1111/j.1399-6576.2002.aas_460120.x	8	77	81	0	6	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	AUG 12	2006	333	7563					324	327		10.1136/bmj.38903.419549.80	http://dx.doi.org/10.1136/bmj.38903.419549.80			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	073VI	16861255	Green Published, Bronze, Green Submitted			2022-12-28	WOS:000239770300014
J	Edmunds, JW; Mahadevan, LC				Edmunds, John W.; Mahadevan, Louis C.			Protein kinases seek close encounters with active genes	SCIENCE			English	Editorial Material							TRANSCRIPTIONAL RESPONSE; SACCHAROMYCES-CEREVISIAE; HISTONE H3; HOG1; YEAST; PHOSPHORYLATION; OSMOSTRESS; ACTIVATION; MEDIATE; COMPLEX		Univ Oxford, Dept Biochem, Nucl Signalling Lab, Oxford OX1 3QU, England	University of Oxford	Edmunds, JW (corresponding author), Univ Oxford, Dept Biochem, Nucl Signalling Lab, Oxford OX1 3QU, England.	louis.mahadevan@bioch.ox.ac.uk						Alepuz PM, 2003, EMBO J, V22, P2433, DOI 10.1093/emboj/cdg243; Alepuz PM, 2001, MOL CELL, V7, P767, DOI 10.1016/S1097-2765(01)00221-0; CLAYTON AL, IN PRESS MOL CELL; de Nadal E, 2004, NATURE, V427, P370, DOI 10.1038/nature02258; de Nadal E, 2002, EMBO REP, V3, P735, DOI 10.1093/embo-reports/kvf158; Deak M, 1998, EMBO J, V17, P4426, DOI 10.1093/emboj/17.15.4426; Edmunds JW, 2004, J CELL SCI, V117, P3715, DOI 10.1242/jcs.01346; O'Rourke SM, 2004, MOL BIOL CELL, V15, P532, DOI 10.1091/mbc.E03-07-0521; O'Rourke SM, 2002, TRENDS GENET, V18, P405, DOI 10.1016/S0168-9525(02)02723-3; Pokholok DK, 2006, SCIENCE, V313, P533, DOI 10.1126/science.1127677; Posas F, 2000, J BIOL CHEM, V275, P17249, DOI 10.1074/jbc.M910016199; Proft M, 2002, MOL CELL, V9, P1307, DOI 10.1016/S1097-2765(02)00557-9; Reiser V, 1999, MOL BIOL CELL, V10, P1147, DOI 10.1091/mbc.10.4.1147; Rep M, 2000, J BIOL CHEM, V275, P8290, DOI 10.1074/jbc.275.12.8290; Rep M, 1999, MOL CELL BIOL, V19, P5474; Simone C, 2004, NAT GENET, V36, P738, DOI 10.1038/ng1378; Soloaga A, 2003, EMBO J, V22, P2788, DOI 10.1093/emboj/cdg273; Wang YM, 2001, CELL, V105, P433, DOI 10.1016/S0092-8674(01)00325-7	18	37	38	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 28	2006	313	5786					449	451		10.1126/science.1131158	http://dx.doi.org/10.1126/science.1131158			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067MZ	16873633				2022-12-28	WOS:000239308600025
J	Scaglioni, PP; Yung, TM; Cai, LF; Erdjument-Bromage, H; Kaufman, AJ; Singh, B; Teruya-Feldstein, J; Tempst, P; Pandolfi, PP				Scaglioni, Pier Paolo; Yung, Thomas M.; Cai, Lu Fan; Erdjument-Bromage, Hediye; Kaufman, Andrew J.; Singh, Bhuvanesh; Teruya-Feldstein, Julie; Tempst, Paul; Pandolfi, Pier Paolo			A CK2-dependent mechanism for degradation of the PML tumor suppressor	CELL			English	Article							PROTEIN-KINASE CK2; NUCLEAR-BODY FORMATION; DNA-DAMAGE; P53; APOPTOSIS; EXPRESSION; GROWTH; ACTIVATION; SENESCENCE; CARCINOMA	The PML tumor suppressor controls key pathways for growth suppression, induction of apoptosis, and cellular senescence. PML loss occurs frequently in human tumors through unknown posttranslational mechanisms. Casein kinase 2 (CK2) is oncogenic and frequently upregulated in human tumors. Here we show that CK2 regulates PML protein levels by promoting its ubiquitin-mediated degradation dependent on direct phosphorylation at Ser517. Consequently, PML mutants that are resistant to CK2 phosphorylation display increased tumor-suppressive functions. In a faithful mouse model of lung cancer, we demonstrate that Pml inactivation leads to increased tumorigenesis. Furthermore, CK2 pharmacological inhibition enhances the PML tumor-suppressive property in vivo. Importantly, we found an inverse correlation between CK2 kinase activity and PML protein levels in human lung cancer-derived cell lines and primary specimens. These data identify a key posttranslational mechanism that controls PML protein levels and provide therapeutic means toward PML restoration through CK2 inhibition.	Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, Sloan Kettering Inst, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Program Mol Biol, Sloan Kettering Inst, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Dept Surg, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Pandolfi, PP (corresponding author), Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, Sloan Kettering Inst, 1275 York Ave, New York, NY 10021 USA.	p-pandolfi@ski.mskcc.org	Cai, Lu/AAG-9920-2019	Tempst, Paul/0000-0002-6680-3987; Scaglioni, Pier Paolo/0000-0002-6036-5138	NCI NIH HHS [R01 CA71692, K08 CA112325-01, P30 CA08748] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA008748, K08CA112325, R01CA071692] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Ahmed K, 2002, TRENDS CELL BIOL, V12, P226, DOI 10.1016/S0962-8924(02)02279-1; ALLENDE JE, 1995, FASEB J, V9, P313, DOI 10.1096/fasebj.9.5.7896000; Bernardi R, 2004, NAT CELL BIOL, V6, P665, DOI 10.1038/ncb1147; Bischof O, 2002, EMBO J, V21, P3358, DOI 10.1093/emboj/cdf341; Bruins W, 2004, MOL CELL BIOL, V24, P8884, DOI 10.1128/mcb.24.20.8884-8894.2004; Collado M, 2005, NATURE, V436, P642, DOI 10.1038/436642a; de Stanchina E, 2004, MOL CELL, V13, P523, DOI 10.1016/S1097-2765(04)00062-0; Elenitoba-Johnson KSJ, 2003, P NATL ACAD SCI USA, V100, P7259, DOI 10.1073/pnas.1137463100; Esteva FJ, 2004, CANCER-AM CANCER SOC, V100, P499, DOI 10.1002/cncr.11940; Everett RD, 2001, ONCOGENE, V20, P7266, DOI 10.1038/sj.onc.1204759; Fisher GH, 1999, ONCOGENE, V18, P5253, DOI 10.1038/sj.onc.1203087; Guo A, 2000, NAT CELL BIOL, V2, P730, DOI 10.1038/35036365; Gurrieri C, 2004, JNCI-J NATL CANCER I, V96, P269, DOI 10.1093/jnci/djh043; Hayakawa F, 2004, CANCER CELL, V5, P389, DOI 10.1016/S1535-6108(04)00082-0; Kato T, 2003, MOL CELL, V12, P829, DOI 10.1016/S1097-2765(03)00358-7; Keller DM, 2001, MOL CELL, V7, P283, DOI 10.1016/S1097-2765(01)00176-9; KOKEN MHM, 1995, ONCOGENE, V10, P1315; Lallemand-Breitenbach V, 2001, J EXP MED, V193, P1361, DOI 10.1084/jem.193.12.1361; Landesman-Bollag E, 2001, ONCOGENE, V20, P3247, DOI 10.1038/sj.onc.1204411; LAVAU C, 1995, ONCOGENE, V11, P871; Litchfield DW, 2003, BIOCHEM J, V369, P1, DOI 10.1042/BJ20021469; Meggio F, 2003, FASEB J, V17, P349, DOI 10.1096/fj.02-0473rev; MEGGIO F, 1984, J BIOL CHEM, V259, P4576; Michael D, 2002, CURR OPIN GENET DEV, V12, P53, DOI 10.1016/S0959-437X(01)00264-7; O-charoenrat P, 2004, CLIN CANCER RES, V10, P5792, DOI 10.1158/1078-0432.CCR-03-0317; Pagano M, 2003, CANCER CELL, V4, P251, DOI 10.1016/S1535-6108(03)00243-5; Piazza F, 2001, ONCOGENE, V20, P7216, DOI 10.1038/sj.onc.1204855; Pinna LA, 2002, J CELL SCI, V115, P3873, DOI 10.1242/jcs.00074; Richardson PG, 2003, NEW ENGL J MED, V348, P2609, DOI 10.1056/NEJMoa030288; Roux PP, 2004, MICROBIOL MOL BIOL R, V68, P320, DOI 10.1128/MMBR.68.2.320-344.2004; Salomoni P, 2005, BLOOD, V105, P3686, DOI 10.1182/blood-2004-09-3782; Salomoni P, 2002, CELL, V108, P165, DOI 10.1016/S0092-8674(02)00626-8; Sayed M, 2000, J BIOL CHEM, V275, P16569, DOI 10.1074/jbc.M000312200; Schuster N, 2001, J CELL BIOCHEM, V81, P172, DOI 10.1002/1097-4644(20010401)81:1<172::AID-JCB1033>3.0.CO;2-O; SELDIN DC, 1995, SCIENCE, V267, P894, DOI 10.1126/science.7846532; Tichelaar JW, 2000, J BIOL CHEM, V275, P11858, DOI 10.1074/jbc.275.16.11858; Trotman LC, 2006, NATURE, V441, P523, DOI 10.1038/nature04809; Wang ZG, 1998, SCIENCE, V279, P1547; Winkler GS, 2002, METHODS, V26, P260, DOI 10.1016/S1046-2023(02)00030-0; Wu WS, 2003, J BIOL CHEM, V278, P12294, DOI 10.1074/jbc.M211849200; Yamada M, 2005, P NATL ACAD SCI USA, V102, P7736, DOI 10.1073/pnas.0409818102; Yang ST, 2002, NAT CELL BIOL, V4, P865, DOI 10.1038/ncb869; Zhong S, 2000, BLOOD, V95, P2748, DOI 10.1182/blood.V95.9.2748.009k31a_2748_2752	43	233	251	0	16	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUL 28	2006	126	2					269	283		10.1016/j.cell.2006.05.041	http://dx.doi.org/10.1016/j.cell.2006.05.041			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	070VD	16873060	Bronze			2022-12-28	WOS:000239552600014
J	Craighead, H				Craighead, Harold			Future lab-on-a-chip technologies for interrogating individual molecules	NATURE			English	Review							SINGLE DNA-MOLECULES; MODE WAVE-GUIDES; BILAYER RECONSTITUTION; STRETCHING DNA; LIPID-BILAYERS; SPECTROSCOPY; MANIPULATION; MEMBRANE; FABRICATION; REVOLUTION	Advances in technology have allowed chemical sampling with high spatial resolution and the manipulation and measurement of individual molecules. Adaptation of these approaches to lab-on-a-chip formats is providing a new class of research tools for the investigation of biochemistry and life processes.	Cornell Univ, Ithaca, NY 14853 USA	Cornell University	Craighead, H (corresponding author), Cornell Univ, 205 Clark Hall, Ithaca, NY 14853 USA.	hgc1@cornell.edu						ASHKIN A, 1986, OPT LETT, V11, P288, DOI 10.1364/OL.11.000288; ASHKIN A, 1987, NATURE, V330, P769, DOI 10.1038/330769a0; Bakajin OB, 1998, PHYS REV LETT, V80, P2737, DOI 10.1103/PhysRevLett.80.2737; Beebe DJ, 2002, ANNU REV BIOMED ENG, V4, P261, DOI 10.1146/annurev.bioeng.4.112601.125916; Bialek W, 2005, P NATL ACAD SCI USA, V102, P10040, DOI 10.1073/pnas.0504321102; Burg TP, 2003, APPL PHYS LETT, V83, P2698, DOI 10.1063/1.1611625; BUSTAMANTE C, 1995, PHYS TODAY, V48, P32, DOI 10.1063/1.881478; Cabodi M, 2002, ANAL CHEM, V74, P5169, DOI 10.1021/ac025879a; Campbell LC, 2004, LAB CHIP, V4, P225, DOI 10.1039/b312592k; Carrion-Vazquez M, 1999, P NATL ACAD SCI USA, V96, P3694, DOI 10.1073/pnas.96.7.3694; Craighead HG, 2000, SCIENCE, V290, P1532, DOI 10.1126/science.290.5496.1532; Deamer DW, 2002, ACCOUNTS CHEM RES, V35, P817, DOI 10.1021/ar000138m; Dias AF, 2002, NANOTECHNOLOGY, V13, P285, DOI 10.1088/0957-4484/13/3/309; Dittrich PS, 2005, ANAL BIOANAL CHEM, V382, P1771, DOI 10.1007/s00216-005-3335-9; Fertig N, 2002, BIOPHYS J, V82, P3056, DOI 10.1016/S0006-3495(02)75646-4; Fertig N, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.040901; Fisher TE, 2000, NAT STRUCT BIOL, V7, P719; Foquet M, 2002, ANAL CHEM, V74, P1415, DOI 10.1021/ac011076w; Foquet ME, 1998, PROG BIOM O, V3258, P141, DOI 10.1117/12.304373; Gerton JM, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.180801; Goodwin PM, 2004, CURR PHARM BIOTECHNO, V5, P271, DOI 10.2174/1389201043376814; Grier DG, 2003, NATURE, V424, P810, DOI 10.1038/nature01935; Groves JT, 1997, SCIENCE, V275, P651, DOI 10.1126/science.275.5300.651; Hafez I, 2005, P NATL ACAD SCI USA, V102, P13879, DOI 10.1073/pnas.0504098102; Han J, 1999, PHYS REV LETT, V83, P1688, DOI 10.1103/PhysRevLett.83.1688; Han J, 2000, SCIENCE, V288, P1026, DOI 10.1126/science.288.5468.1026; HANSMA HG, 1994, ANNU REV BIOPH BIOM, V23, P115, DOI 10.1146/annurev.bb.23.060194.000555; Heng JB, 2004, BIOPHYS J, V87, P2905, DOI 10.1529/biophysj.104.041814; Ilic B, 2005, NANO LETT, V5, P925, DOI 10.1021/nl050456k; James CD, 2004, IEEE T BIO-MED ENG, V51, P1640, DOI 10.1109/TBME.2004.827252; Kasianowicz JJ, 1996, P NATL ACAD SCI USA, V93, P13770, DOI 10.1073/pnas.93.24.13770; Klemic KG, 2002, BIOSENS BIOELECTRON, V17, P597, DOI 10.1016/S0956-5663(02)00015-5; Krapf D, 2006, NANO LETT, V6, P105, DOI 10.1021/nl052163x; Kricka LJ, 1998, NAT BIOTECHNOL, V16, P513, DOI 10.1038/nbt0698-513; Kung CY, 1998, ANAL CHEM, V70, P658, DOI 10.1021/ac971107g; Levene MJ, 2003, SCIENCE, V299, P682, DOI 10.1126/science.1079700; Li JL, 2003, NAT MATER, V2, P611, DOI 10.1038/nmat965; Liu J, 2003, ANAL CHEM, V75, P4718, DOI 10.1021/ac0346407; Mannion JT, 2006, BIOPHYS J, V90, P4538, DOI 10.1529/biophysj.105.074732; MANZ A, 1990, SENSOR ACTUAT B-CHEM, V1, P244, DOI 10.1016/0925-4005(90)80209-I; Mathe J, 2004, BIOPHYS J, V87, P3205, DOI 10.1529/biophysj.104.047274; Mehta AD, 1999, SCIENCE, V283, P1689, DOI 10.1126/science.283.5408.1689; Mijatovic D, 2005, LAB CHIP, V5, P492, DOI 10.1039/b416951d; Mogensen KB, 2003, APPL OPTICS, V42, P4072, DOI 10.1364/AO.42.004072; Muller DJ, 1997, J STRUCT BIOL, V119, P172, DOI 10.1006/jsbi.1997.3875; NEHER E, 1976, NATURE, V260, P799, DOI 10.1038/260799a0; Ng JMK, 2002, ELECTROPHORESIS, V23, P3461, DOI 10.1002/1522-2683(200210)23:20<3461::AID-ELPS3461>3.0.CO;2-8; Oliva AA, 2003, NEUROCHEM RES, V28, P1639; Orth RN, 2003, LANGMUIR, V19, P1599, DOI 10.1021/la026314c; Pantoja R, 2001, BIOPHYS J, V81, P2389, DOI 10.1016/S0006-3495(01)75885-7; Patolsky F, 2005, MATER TODAY, V8, P20, DOI 10.1016/S1369-7021(05)00791-1; PERKINS TT, 1995, SCIENCE, V268, P83, DOI 10.1126/science.7701345; Quake SR, 2000, SCIENCE, V290, P1536, DOI 10.1126/science.290.5496.1536; REIF M, 1997, SCIENCE, V275, P1295; Rief M, 1997, SCIENCE, V276, P1109, DOI 10.1126/science.276.5315.1109; Riehn R, 2005, P NATL ACAD SCI USA, V102, P10012, DOI 10.1073/pnas.0503809102; Rigneault H, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.117401; Rondelez Y, 2005, NAT BIOTECHNOL, V23, P361, DOI 10.1038/nbt1072; Rosenblatt S, 2002, NANO LETT, V2, P869, DOI 10.1021/nl025639a; Samiee KT, 2006, BIOPHYS J, V90, P3288, DOI 10.1529/biophysj.105.072819; Samiee KT, 2005, BIOPHYS J, V88, P2145, DOI 10.1529/biophysj.104.052795; Sazonova V, 2004, NATURE, V431, P284, DOI 10.1038/nature02905; Schmidt C, 2000, ANGEW CHEM INT EDIT, V39, P3137, DOI 10.1002/1521-3773(20000901)39:17<3137::AID-ANIE3137>3.0.CO;2-D; Schwarz MA, 2001, LAB CHIP, V1, P1, DOI 10.1039/b103795c; Service RF, 2006, SCIENCE, V311, P1544, DOI 10.1126/science.311.5767.1544; Sischka A, 2003, REV SCI INSTRUM, V74, P4827, DOI 10.1063/1.1619545; Song S, 2004, ANAL CHEM, V76, P4589, DOI 10.1021/ac0497151; Stavis SM, 2005, J APPL PHYS, V98, DOI 10.1063/1.2005371; Stavis SM, 2005, NANOTECHNOLOGY, V16, pS314, DOI 10.1088/0957-4484/16/7/002; Stavis SM, 2005, LAB CHIP, V5, P337, DOI 10.1039/b416161k; Stipe BC, 1999, REV SCI INSTRUM, V70, P137, DOI 10.1063/1.1149555; Storm AJ, 2005, NANO LETT, V5, P1193, DOI 10.1021/nl048030d; Suzuki H, 2006, LANGMUIR, V22, P1937, DOI 10.1021/la052534p; Tegenfeldt JO, 2004, BIOPHYS J, V86, p596A; Tegenfeldt JO, 2004, P NATL ACAD SCI USA, V101, P10979, DOI 10.1073/pnas.0403849101; Tegenfeldt JO, 2004, ANAL BIOANAL CHEM, V378, P1678, DOI 10.1007/s00216-004-2526-0; Verbridge SS, 2005, J APPL PHYS, V97, DOI 10.1063/1.1924888; Wang MD, 1997, BIOPHYS J, V72, P1335, DOI 10.1016/S0006-3495(97)78780-0; Wu M, 2004, P NATL ACAD SCI USA, V101, P13798, DOI 10.1073/pnas.0403835101; Xu J, 2001, DRUG DISCOV TODAY, V6, P1278, DOI 10.1016/S1359-6446(01)02095-5; Zeck G, 2001, P NATL ACAD SCI USA, V98, P10457, DOI 10.1073/pnas.181348698; Zheng GF, 2005, NAT BIOTECHNOL, V23, P1294, DOI 10.1038/nbt1138	83	536	567	5	272	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 27	2006	442	7101					387	393		10.1038/nature05061	http://dx.doi.org/10.1038/nature05061			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067CI	16871206				2022-12-28	WOS:000239278900031
J	Parfitt, T				Parfitt, Tom			Vladimir Mendelevich: fighting for drug substitution treatment - Profile	LANCET			English	Biographical-Item												tomparfitt@hotmail.com							0	12	12	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 22	2006	368	9532					279	279		10.1016/S0140-6736(06)69060-0	http://dx.doi.org/10.1016/S0140-6736(06)69060-0			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	067PF	16860685				2022-12-28	WOS:000239314400012
J	Sokoloski, JL; Luna, GJM; Mukai, K; Kenyon, SJ				Sokoloski, J. L.; Luna, G. J. M.; Mukai, K.; Kenyon, Scott J.			An X-ray-emitting blast wave from the recurrent nova RS Ophiuchi	NATURE			English	Article							PROGENITOR SYSTEM; MODELS; EMISSION; OUTBURST; REMNANTS; ORBIT	Stellar explosions such as novae and supernovae produce most of the heavy elements in the Universe. The onset of a nova is well understood(1) as driven by runaway thermonuclear fusion reactions on the surface of a white dwarf in a binary star system; but the structure, dynamics and mass of the ejecta are not well known. In rare cases, the white dwarf is embedded in the wind nebula of a red-giant companion, and the explosion products plough through the nebula and produce X-ray emission. Here we report X-ray observations of such an event, from the eruption of the recurrent nova RS Ophiuchi(2,3). The hard X-ray emission from RS Ophiuchi early in the eruption emanates from behind a blast wave, or outward-moving shock wave, that expanded freely for less than 2 days and then decelerated owing to interaction with the nebula. The X-rays faded rapidly, suggesting that the blast wave deviates from the standard spherical shell structure(4-6). The early onset of deceleration indicates that the ejected shell had a low mass, the white dwarf has a high mass(7), and that RS Ophiuchi is therefore a progenitor of the type of supernova ( type Ia) integral to studies of the expansion of the Universe.	Smithsonian Astrophys Observ, Cambridge, MA 02138 USA; Univ Sao Paulo, Inst Astron Geofis & Ciencias Atmosfer, BR-05508900 Sao Paulo, Brazil; Univ Space Res Assoc, Greenbelt, MD 20771 USA; NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA	Harvard University; Smithsonian Institution; Universidade de Sao Paulo; Universities Space Research Association (USRA); National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center	Sokoloski, JL (corresponding author), Smithsonian Astrophys Observ, 60 Garden St, Cambridge, MA 02138 USA.	jsokoloski@cfa.harvard.edu		Kenyon, Scott/0000-0003-0214-609X; Luna, Gerardo Juan Manuel/0000-0002-2647-4373				BODE MF, 1985, MON NOT R ASTRON SOC, V217, P205, DOI 10.1093/mnras/217.1.205; BUIL C, 2006, CENT BUR ASTRON TEL, V403; CHEVALIER RA, 1980, ASTROPHYS J, V235, P186, DOI 10.1086/157623; CHEVALIER RA, 1982, ASTROPHYS J, V258, P790, DOI 10.1086/160126; DAVIS RJ, 1987, RS OPH RECURRENT NOV, P187; Fujii M, 2006, VSNET ALERT; Greiner J, 2003, ASTRON ASTROPHYS, V405, P703, DOI 10.1051/0004-6361:20030602; Hachisu I, 2001, ASTROPHYS J, V558, P323, DOI 10.1086/321601; Hamuy M, 2003, NATURE, V424, P651, DOI 10.1038/nature01854; HJELLMING RM, 1986, ASTROPHYS J, V305, pL71, DOI 10.1086/184687; IIJIMA T, 2006, 8675 IAU; Jahoda K, 1996, P SOC PHOTO-OPT INS, V2808, P59, DOI 10.1117/12.256034; Kenyon S. J., 1986, SYMBIOTIC STARS; LLOYD HM, 1993, MON NOT R ASTRON SOC, V265, P457, DOI 10.1093/mnras/265.2.457; Mason K.O., 1987, RS OPHIUCHI 1985 REC, P167; MASON KO, 1987, RS OPHIUCHI 1985 REC, P167; Mukai K, 2001, ASTROPHYS J, V551, P1024, DOI 10.1086/320220; Narumi H., 2006, 8671 IAU; OBRIEN TJ, 1987, MON NOT R ASTRON SOC, V228, P277, DOI 10.1093/mnras/228.2.277; OBRIEN TJ, 1994, MON NOT R ASTRON SOC, V271, P155, DOI 10.1093/mnras/271.1.155; ORIO M, 2004, IAU C, V194, P182; Sedov L., 1959, SIMILARITY DIMENSION, DOI [10.1016/B978-1-4832-0088-0.50005-0, DOI 10.1016/B978-1-4832-0088-0.50005-0]; Snijders M.A.J., 1987, RS OPHIUCHI 1985 REC, P51; STARRFIELD S, 1978, ASTROPHYS J, V226, P186, DOI 10.1086/156598; TAYLOR AR, 1989, MON NOT R ASTRON SOC, V237, P81, DOI 10.1093/mnras/237.1.81; Wood-Vasey WM, 2004, ASTROPHYS J, V616, P339, DOI 10.1086/424826; WOODVASEY WM, IN PRESS ASTROPHYS J; Yaron O, 2005, ASTROPHYS J, V623, P398, DOI 10.1086/428435	30	155	157	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 20	2006	442	7100					276	278		10.1038/nature04893	http://dx.doi.org/10.1038/nature04893			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064WT	16855584				2022-12-28	WOS:000239122100032
J	Edwards, P; Green, J; Roberts, I; Lutchmun, S				Edwards, Phil; Green, Judith; Roberts, Ian; Lutchmun, Suzanne			Deaths from injury in children and employment status in family: analysis of trends in class specific death rates	BMJ-BRITISH MEDICAL JOURNAL			English	Article								Objective To examine socioeconomic inequalities in rates of death from injury in children in England and Wales. Design Analysis of rates of death from injury in children by the eight class version of the Nation Statistics Socio-Economic Classification (NS-SEC and by the registrar general's social classification. Setting England and Wales during periods of four years around the 1981, 1991, and 2001 censuses. Subjects Children aged 0-15 years. Main outcome measures Death rates from injury and poisoning. Results Rates of death from injury in children fell from 11.1 deaths (95% confidence interval 10.8 to 11.5 deaths) per 100 000 children per year around the 1981 census to 4.0 deaths (3.8 to 4.2 deaths) per 100 000 children per year around the 2001 census. Socioeconomic inequalities remain: the death rate from all external causes for children of parents classified as never having worked or as long term unemployed (NS-SEC 8) was 13.1 (10.3 to 16.5) times that for children in NS-SEC I (higher managerial/professional occupations). For dead-is as pedestrians the rate in NS-SEC 8 was 20.6 (10.6 to 39.9) times higher than in NS-SEC 1; for deaths as cyclists it was 27.5 (6.4 to 118.2) times higher; for deaths due to fires it was 37.7 (11.6 to 121.9) times higher; and for deaths of undetermined intent it was 32.6 (15.8 to 67.2) times higher. Conclusions Overall rates of death from injury and poisoning in children have fallen in England and Wales over the past 20 years, except for rates in children in families in which no adult is in paid employment. Serious inequalities in injury death rates remain, particularly for pedestrians, cyclists, house fires, and deaths of undetermined intent.	Univ London London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, London WC1E 7HT, England; Univ London London Sch Hyg & Trop Med, Dept Publ Hlth & Policy, London WC1E 7HT, England; St Pancras Hosp, Camden Primary Care Trust, London NW1 0PE, England	University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine	Edwards, P (corresponding author), Univ London London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, Keppel St, London WC1E 7HT, England.	phil.edwards@LSHTM.ac.uk		Green, Judith/0000-0002-2315-5326; Edwards, Phil/0000-0003-4431-8822				Bryce C., 1995, CHILDREN RISK SAFETY; *DEP HLTH, 2002, PREV ACC INJ PRIOR A; Devis T, 1997, Popul Trends, P48; DiGuiseppi C, 1997, BRIT MED J, V314, P710, DOI 10.1136/bmj.314.7082.710; Laflamme L, 2000, Inj Prev, V6, P293, DOI 10.1136/ip.6.4.293; *NAT STAT, NAT STAT SOC CLASS; Roberts I, 1996, BRIT MED J, V313, P784; Roberts I, 1998, Inj Prev, V4, pS10; Rowan S, 2003, HLTH STAT Q, V17, P33; Smith GD, 1994, EUROPEAN J PUBLIC HL, V4, P131, DOI DOI 10.1093/EURPUB/4.2.131	10	102	105	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 15	2006	333	7559					119	121		10.1136/bmj.38875.757488.4F	http://dx.doi.org/10.1136/bmj.38875.757488.4F			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	065JK	16829537	Green Submitted, Green Accepted, Green Published, Bronze			2022-12-28	WOS:000239155900015
J	Pontes, O; Li, CF; Nunes, PC; Haag, J; Ream, T; Vitins, A; Jacobsen, SE; Pikaard, CS				Pontes, Olga; Li, Carey Fei; Nunes, Pedro Costa; Haag, Jeremy; Ream, Thomas; Vitins, Alexa; Jacobsen, Steven E.; Pikaard, Craig S.			The Arabidopsis chromatin-modifying nuclear siRNA pathway involves a nucleolar RNA processing center	CELL			English	Article							DIRECTED DNA METHYLATION; HETEROCHROMATIN FORMATION; HISTONE METHYLATION; POLYMERASE-IV; CAJAL BODIES; ARGONAUTE; TRANSCRIPTION; INTERFERENCE; LOCALIZATION; INITIATION	In Arabidopsis thaliana, small interfering RNAs (siRNAs) direct cytosine methylation at endogenous DNA repeats in a pathway involving two forms of nuclear RNA polymerase IV (Pol IVa and Pol IVb), RNA-DEPENDENT RNA POLYMERASE 2 (RDR2), DICER-LIKE 3 (DCL3), ARGONAUTE4 (AGO4), the chromatin remodeler DRD1, and the de novo cytosine methyltransferase DRM2. We show that RDR2, DCL3, AG04, and NRPD1b (the largest subunit of Pol IVb) colocalize, with siRNAs within the nucleolus. By contrast, Pol IVa and DRD1 are external to the nucleolus and colocalize with endogenous repeat loci. Mutation-induced loss of pathway proteins causes downstream proteins to mislocalize, revealing their order of action. Pol IVa acts first, and its localization is RNA dependent, suggesting an RNA template. We hypothesize that maintenance of the heterochromatic state involves locus-specific Pol IVa transcription followed by siRNA production and assembly of AGO4- and NRPD1b-containing silencing complexes within nucleolar processing centers.	Washington Univ, Dept Biol, St Louis, MO 63130 USA; Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Howard Hughes Med Inst, Los Angeles, CA 90095 USA; Inst Super Agron, Seccao Genet, Ctr Bot Aplicada Agr, P-1349017 Lisbon, Portugal	Washington University (WUSTL); University of California System; University of California Los Angeles; Howard Hughes Medical Institute; University of California System; University of California Los Angeles; Universidade de Lisboa	Pikaard, CS (corresponding author), Washington Univ, Dept Biol, 1 Brookings Dr, St Louis, MO 63130 USA.	pikaard@biology.wustl.edu	Pontes, Olga MF/F-9768-2011; Pikaard, Craig S/K-8772-2012	Pontes, Olga MF/0000-0003-3316-1145; Pikaard, Craig S/0000-0001-8204-7459	NIGMS NIH HHS [GM07185, R01GM60380, GM60398, R01 GM077590, R01GM077590] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM060398, R01GM060398, R01GM077590, R01GM060380] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Almeida R, 2005, TRENDS CELL BIOL, V15, P251, DOI 10.1016/j.tcb.2005.03.006; Aufsatz W, 2002, P NATL ACAD SCI USA, V99, P16499, DOI 10.1073/pnas.162371499; Baulcombe D, 2004, NATURE, V431, P356, DOI 10.1038/nature02874; Baumberger N, 2005, P NATL ACAD SCI USA, V102, P11928, DOI 10.1073/pnas.0505461102; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Bertrand E, 1998, GENE DEV, V12, P2463, DOI 10.1101/gad.12.16.2463; Boudonck K, 1999, MOL BIOL CELL, V10, P2297, DOI 10.1091/mbc.10.7.2297; Buhler M, 2005, MOL CELL, V18, P307, DOI 10.1016/j.molcel.2005.03.030; Cao XF, 2003, CURR BIOL, V13, P2212, DOI 10.1016/j.cub.2003.11.052; Carmell MA, 2002, GENE DEV, V16, P2733, DOI 10.1101/gad.1026102; Cioce M, 2005, ANNU REV CELL DEV BI, V21, P105, DOI 10.1146/annurev.cellbio.20.010403.103738; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Earley KW, 2006, PLANT J, V45, P616, DOI 10.1111/j.1365-313X.2005.02617.x; Filipowicz W, 2002, CURR OPIN CELL BIOL, V14, P319, DOI 10.1016/S0955-0674(02)00334-4; Gasciolli V, 2005, CURR BIOL, V15, P1494, DOI 10.1016/j.cub.2005.07.024; Grewal SIS, 2004, CURR OPIN CELL BIOL, V16, P230, DOI 10.1016/j.ceb.2004.04.002; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; HIGHETT MI, 1993, J CELL SCI, V105, P1151; Kanno T, 2005, NAT GENET, V37, P761, DOI 10.1038/ng1580; Kanno T, 2004, CURR BIOL, V14, P801, DOI 10.1016/j.cub.2004.04.037; Kiss T, 2002, CELL, V109, P145, DOI 10.1016/S0092-8674(02)00718-3; Krogh BO, 2004, ANNU REV GENET, V38, P233, DOI 10.1146/annurev.genet.38.072902.091500; Li CF, 2006, CELL, V126, P93, DOI 10.1016/j.cell.2006.05.032; Lippman Z, 2003, PLOS BIOL, V1, P420, DOI 10.1371/journal.pbio.0000067; Mette MF, 2000, EMBO J, V19, P5194, DOI 10.1093/emboj/19.19.5194; Onodera Y, 2005, CELL, V120, P613, DOI 10.1016/j.cell.2005.02.007; Pederson T, 1998, NUCLEIC ACIDS RES, V26, P3871, DOI 10.1093/nar/26.17.3871; Pendle AF, 2005, MOL BIOL CELL, V16, P260, DOI 10.1091/mbc.E04-09-0791; Pontes O, 2003, P NATL ACAD SCI USA, V100, P11418, DOI 10.1073/pnas.1932522100; Pontier D, 2005, GENE DEV, V19, P2030, DOI 10.1101/gad.348405; Rountree MR, 1997, GENE DEV, V11, P2383, DOI 10.1101/gad.11.18.2383; Song JJ, 2004, SCIENCE, V305, P1434, DOI 10.1126/science.1102514; Sontheimer EJ, 2004, SCIENCE, V305, P1409, DOI 10.1126/science.1103076; Tomari Y, 2005, GENE DEV, V19, P517, DOI 10.1101/gad.1284105; Vaucheret H, 2005, NAT GENET, V37, P659, DOI 10.1038/ng0705-659; Verdel A, 2004, SCIENCE, V303, P672, DOI 10.1126/science.1093686; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; Wassenegger M, 2006, TRENDS PLANT SCI, V11, P142, DOI 10.1016/j.tplants.2006.01.003; Wassenegger M, 2005, CELL, V122, P13, DOI 10.1016/j.cell.2005.06.034; Xie ZX, 2004, PLOS BIOL, V2, P642, DOI 10.1371/journal.pbio.0020104; Zilberman D, 2003, SCIENCE, V299, P716, DOI 10.1126/science.1079695; Zilberman D, 2004, CURR BIOL, V14, P1214, DOI 10.1016/j.cub.2004.06.055	42	333	364	1	30	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUL 14	2006	126	1					79	92		10.1016/j.cell.2006.05.031	http://dx.doi.org/10.1016/j.cell.2006.05.031			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	066JF	16839878	Bronze			2022-12-28	WOS:000239224800018
J	Slessareva, JE; Routt, SM; Temple, B; Bankaitis, VA; Dohlman, HG				Slessareva, Janna E.; Routt, Sheri M.; Temple, Brenda; Bankaitis, Vytas A.; Dohlman, Henrik G.			Activation of the phosphatidylinositol 3-kinase Vps34 by a G protein alpha subunit at the endosome	CELL			English	Article							YEAST SACCHAROMYCES-CEREVISIAE; HETEROTRIMERIC G-PROTEIN; LYSOSOME-LIKE VACUOLE; BETA-GAMMA; C-ELEGANS; PHOSPHOINOSITIDE 3-KINASES; SIGNAL-TRANSDUCTION; STRUCTURAL-ANALYSIS; CRYSTAL-STRUCTURE; PTDINS 3-KINASE	In the yeast Saccharomyces cerevisiae, the G protein beta gamma subunits are essential for pheromone signaling. The G alpha subunit Gpa1 can also promote signaling, but the effectors in this pathway are not well characterized. To identify candidate Gpa1 effectors, we expressed the constitutively active Gpa1(Q323L) mutant in each of nearly 5000 gene-deletion strains and measured mating-specific responses. Our analysis reveals a requirement for both the catalytic (Vps34) and regulatory (Vps15) subunits of the sole phosphaticlylinositol 3-kinase in yeast. We demonstrate that Gpa1 is present at endosomes, where it interacts directly with both Vps34 and Vps15 and stimulates increased production of phosphatidlylinositol 3-phosphate. Notably, Vps15 binds to GDP-bound Gpa1 and is predicted to have a seven-WID repeat structure similar to that of known G protein beta subunits. These findings reveal two new components of the pheromone signaling pathway. More remarkably, these proteins appear to comprise a preformed effector-G beta subunit assembly and function at the endosome rather than at the plasma membrane.	Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; Univ N Carolina, Dept Cell Biol, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Dohlman, HG (corresponding author), Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA.	hdohlman@med.unc.edu		Dohlman, Henrik/0000-0003-2443-0729	NIGMS NIH HHS [P01 GM065533, R01 GM44530, P01 GM65533] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM044530, P01GM065533] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Afshar K, 2004, CELL, V119, P219, DOI 10.1016/j.cell.2004.09.026; Aloy P, 2004, SCIENCE, V303, P2026, DOI 10.1126/science.1092645; Andersson J, 2004, EMBO J, V23, P2564, DOI 10.1038/sj.emboj.7600250; Apanovitch DM, 1998, BIOCHEMISTRY-US, V37, P4815, DOI 10.1021/bi9729965; AUGER KR, 1989, J BIOL CHEM, V264, P20181; BANTA LM, 1988, J CELL BIOL, V107, P1369, DOI 10.1083/jcb.107.4.1369; Blatner NR, 2004, J BIOL CHEM, V279, P53818, DOI 10.1074/jbc.M408408200; Bonangelino CJ, 2002, MOL BIOL CELL, V13, P2486, DOI 10.1091/mbc.02-01-0005; Bonangelino CJ, 2002, J CELL BIOL, V156, P1015, DOI 10.1083/jcb.200201002; Chasse SA, 2006, EUKARYOT CELL, V5, P330, DOI 10.1128/EC.5.2.330-346.2006; Chasse SA, 2004, METHOD ENZYMOL, V389, P399; Couwenbergs C, 2004, CURR BIOL, V14, P1871, DOI 10.1016/j.cub.2004.09.059; DeCamilli P, 1996, SCIENCE, V271, P1533, DOI 10.1126/science.271.5255.1533; Dohlman HG, 2001, ANNU REV BIOCHEM, V70, P703, DOI 10.1146/annurev.biochem.70.1.703; Dohlman HG, 1996, MOL CELL BIOL, V16, P5194; Dove SK, 1997, NATURE, V390, P187, DOI 10.1038/36613; FINEGOLD AA, 1990, SCIENCE, V249, P165, DOI 10.1126/science.1695391; Gillooly DJ, 2000, EMBO J, V19, P4577, DOI 10.1093/emboj/19.17.4577; Guo M, 2003, MOL CELL, V12, P517, DOI 10.1016/S1097-2765(03)00307-1; Guo SL, 1999, J BIOL CHEM, V274, P12990, DOI 10.1074/jbc.274.19.12990; HERMAN PK, 1990, MOL CELL BIOL, V10, P6742, DOI 10.1128/MCB.10.12.6742; HERMAN PK, 1991, CELL, V64, P425, DOI 10.1016/0092-8674(91)90650-N; HERMAN PK, 1991, EMBO J, V10, P4049, DOI 10.1002/j.1460-2075.1991.tb04981.x; Hess HA, 2004, CELL, V119, P209, DOI 10.1016/j.cell.2004.09.025; Hirschman JE, 1999, MOL CELL BIOL, V19, P7705; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Inouye C, 1997, SCIENCE, V278, P103, DOI 10.1126/science.278.5335.103; Jordan JD, 2000, CELL, V103, P193, DOI 10.1016/S0092-8674(00)00112-4; Kihara A, 2001, J CELL BIOL, V152, P519, DOI 10.1083/jcb.152.3.519; Lambright DG, 1996, NATURE, V379, P311, DOI 10.1038/379311a0; Lemmon MA, 2003, TRAFFIC, V4, P201, DOI 10.1034/j.1600-0854.2004.00071.x; Neves SR, 2002, SCIENCE, V296, P1636, DOI 10.1126/science.1071550; Parrish WR, 2005, J CELL SCI, V118, P5589, DOI 10.1242/jcs.02649; Parrish WR, 2004, MOL BIOL CELL, V15, P3567, DOI 10.1091/mbc.E04-03-0209; Ponting CP, 1996, PROTEIN SCI, V5, P2353, DOI 10.1002/pro.5560051122; ROBINSON JS, 1988, MOL CELL BIOL, V8, P4936, DOI 10.1128/MCB.8.11.4936; Sabbagh W, 2001, MOL CELL, V8, P683, DOI 10.1016/S1097-2765(01)00322-7; Schug S A, 1993, Pharmacoeconomics, V3, P260, DOI 10.2165/00019053-199303040-00002; Sondek J, 1996, NATURE, V379, P369, DOI 10.1038/379369a0; Sorkin A, 2002, NAT REV MOL CELL BIO, V3, P600, DOI 10.1038/nrm883; Sprang SR, 1997, ANNU REV BIOCHEM, V66, P639, DOI 10.1146/annurev.biochem.66.1.639; STACK JH, 1994, J BIOL CHEM, V269, P31552; Stack JH, 1995, COLD SPRING HARB SYM, V60, P157, DOI 10.1101/SQB.1995.060.01.019; STACK JH, 1995, J CELL BIOL, V129, P321, DOI 10.1083/jcb.129.2.321; STACK JH, 1993, EMBO J, V12, P2195, DOI 10.1002/j.1460-2075.1993.tb05867.x; Stenmark H, 1996, J BIOL CHEM, V271, P24048, DOI 10.1074/jbc.271.39.24048; STERNWEIS PC, 1986, J BIOL CHEM, V261, P631; Stols L, 2002, PROTEIN EXPRES PURIF, V25, P8, DOI 10.1006/prep.2001.1603; Takahashi T, 2001, MOL GENET GENOMICS, V265, P1112, DOI 10.1007/s004380100510; Tall GG, 2003, J BIOL CHEM, V278, P8356, DOI 10.1074/jbc.M211862200; Vanhaesebroeck B, 2001, ANNU REV BIOCHEM, V70, P535, DOI 10.1146/annurev.biochem.70.1.535; Vollert CS, 2004, MOL CELL PROTEOMICS, V3, P1053, DOI 10.1074/mcp.M400081-MCP200; WALL MA, 1995, CELL, V83, P1047, DOI 10.1016/0092-8674(95)90220-1; Wang YQ, 2005, J BIOL CHEM, V280, P284, DOI 10.1074/jbc.M411624200; Wenk MR, 2003, NAT BIOTECHNOL, V21, P813, DOI 10.1038/nbt837; Windmiller DA, 2003, J BIOL CHEM, V278, P11874, DOI 10.1074/jbc.M211787200; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Wurmser AE, 2002, J CELL BIOL, V158, P761, DOI 10.1083/jcb.200112050; Wymann MP, 1998, BBA-MOL CELL BIOL L, V1436, P127, DOI 10.1016/S0005-2760(98)00139-8; Yu JW, 2001, J BIOL CHEM, V276, P44179, DOI 10.1074/jbc.M108811200	60	173	181	0	11	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUL 14	2006	126	1					191	203		10.1016/j.cell.2006.04.045	http://dx.doi.org/10.1016/j.cell.2006.04.045			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	066JF	16839886	Bronze			2022-12-28	WOS:000239224800026
J	Barres, BA				Barres, Ben A.			Does gender matter?	NATURE			English	Editorial Material									Stanford Univ, Sch Med, Dept Neurobiol, Stanford, CA 94305 USA	Stanford University	Barres, BA (corresponding author), Stanford Univ, Sch Med, Dept Neurobiol, Fairchild Bldg Room D235,299 Campus Dr, Stanford, CA 94305 USA.	barres@stanford.edu						[Anonymous], 1997, SPEAKING SEX DENIAL; Baron -Cohen S., 2003, ESSENTIAL DIFFERENCE; Carnes M, 2005, J WOMENS HEALTH, V14, P684, DOI 10.1089/jwh.2005.14.684; Fels A., 2004, NECESSARY DREAMS; Gneezy U, 2003, Q J ECON, V118, P1049, DOI 10.1162/00335530360698496; Gould S. J., 1996, MISMEASURE MAN; Lawrence PA, 2006, PLOS BIOL, V4, P13, DOI 10.1371/journal.pbio.0040019; Leahey E, 2001, SOC FORCES, V80, P713, DOI 10.1353/sof.2001.0102; Mansfield H. C., 2006, MANLINESS; Moody J. A., 2004, FACULTY DIVERSITY PR; PETSKO GA, 2005, GENOME BIOL, V6, P1; Pinker S, 2005, NEW REPUBLIC, V232, P15; Spelke ES, 2005, AM PSYCHOL, V60, P950, DOI 10.1037/0003-066X.60.9.950; Steele CM, 1997, AM PSYCHOL, V52, P613, DOI 10.1037/0003-066X.52.6.613; SUMMERS L, COMMUNICATION; Valian, 1998, WHY SO SLOW; Wenneras C, 1997, NATURE, V387, P341, DOI 10.1038/387341a0; Xie Y., 2003, WOMEN SCI CAREER PRO; 2005, SCI GENDER SCI PINKE	19	108	109	1	51	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 13	2006	442	7099					133	136		10.1038/442133a	http://dx.doi.org/10.1038/442133a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	062XJ	16848004				2022-12-28	WOS:000238979700022
J	Currie, GP; Wedzicha, JA				Currie, Graeme P.; Wedzicha, Jadwiga A.			ABC of chronic obstructive pulmonary disease - Acute exacerbations	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Aberdeen Royal Infirm, Resp Unit, Aberdeen, Scotland; UCL, Royal Free & Univ Coll Med Sch, Acad Unit Resp Med, London, England	University of Aberdeen; University of London; University College London	Currie, GP (corresponding author), Aberdeen Royal Infirm, Resp Unit, Aberdeen, Scotland.			Currie, Graeme P/0000-0002-5711-9147				Chu CM, 2004, THORAX, V59, P1020, DOI 10.1136/thx.2004.024307; Duffy N, 2005, THORAX, V60, P713, DOI 10.1136/thx.2004.036046; MCCRORY DC, 2002, COCHRANE DB SYST REV; Wilkinson TMA, 2004, AM J RESP CRIT CARE, V169, P1298, DOI 10.1164/rccm.200310-1443OC; Wood-Baker RR, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001288.pub2	5	13	13	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 8	2006	333	7558					87	89		10.1136/bmj.333.7558.87	http://dx.doi.org/10.1136/bmj.333.7558.87			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	065BA	16825232	Green Published			2022-12-28	WOS:000239133200021
J	Bhosale, S; Sisson, AL; Talukdar, P; Furstenberg, A; Banerji, N; Vauthey, E; Bollot, G; Mareda, J; Roger, C; Wurthner, F; Sakai, N; Matile, S				Bhosale, Sheshanath; Sisson, Adam L.; Talukdar, Pinaki; Fuerstenberg, Alexandre; Banerji, Natalie; Vauthey, Eric; Bollot, Guillaume; Mareda, Jiri; Roger, Cornelia; Wuerthner, Frank; Sakai, Naomi; Matile, Stefan			Photoproduction of proton gradients with pi-stacked fluorophore scaffolds in lipid bilayers	SCIENCE			English	Article							SYNTHETIC ION CHANNELS; CHARGE SEPARATION; ELECTRON-TRANSFER; MOLECULES; ARCHITECTURE; POLYMERS; DIMERS	Rigid p-octiphenyl rods were used to create helical tetrameric p-stacks of blue, red-fluorescent naphthalene diimides that can span lipid bilayer membranes. In lipid vesicles containing quinone as electron acceptors and surrounded by ethylenediaminetetraacetic acid as hole acceptors, transmembrane proton gradients arose through quinone reduction upon excitation with visible light. Quantitative ultrafast and relatively long-lived charge separation was confirmed as the origin of photosynthetic activity by femtosecond fluorescence and transient absorption spectroscopy. Supramolecular self-organization was essential in that photoactivity was lost upon rod shortening ( from p-octiphenyl to biphenyl) and chromophore expansion ( from naphthalene diimide to perylene diimide). Ligand intercalation transformed the photoactive scaffolds into ion channels.	Univ Geneva, Dept Organ Chem, Geneva, Switzerland; Univ Geneva, Dept Chem Phys, Geneva, Switzerland; Univ Wurzburg, Inst Organ Chem, D-97074 Wurzburg, Germany	University of Geneva; University of Geneva; University of Wurzburg	Matile, S (corresponding author), Univ Geneva, Dept Organ Chem, Geneva, Switzerland.	stefan.matile@chiorg.unige.ch	Vauthey, Eric/F-9260-2016; Bhosale, Sheshanath Vishwanat/B-9158-2017; Talukdar, Pinaki/B-5966-2011; Matile, Stefan/AFL-7826-2022; Sakai, Naomi/AFN-6204-2022; Fürstenberg, Alexandre/ABF-5551-2020; Fürstenberg, Alexandre/A-4245-2010; Würthner, Frank/K-5181-2015; Banerji, Natalie/N-7142-2015	Vauthey, Eric/0000-0002-9580-9683; Bhosale, Sheshanath Vishwanat/0000-0003-0979-8250; Talukdar, Pinaki/0000-0003-3951-4335; Matile, Stefan/0000-0002-8537-8349; Sakai, Naomi/0000-0002-9460-1944; Fürstenberg, Alexandre/0000-0002-6227-3122; Würthner, Frank/0000-0001-7245-0471; Banerji, Natalie/0000-0001-9181-2642				Ahrens MJ, 2004, J AM CHEM SOC, V126, P8284, DOI 10.1021/ja039820c; BALZANI V, 2003, MOL DEVICES MACHINES, pCH6; BHOSALE S, IN PRESS CHIRALITY; DEISENHOFER J, 1989, SCIENCE, V245, P1463, DOI 10.1126/science.245.4925.1463; Giaimo JM, 2002, J AM CHEM SOC, V124, P8530, DOI 10.1021/ja026422l; GRIMALDI JJ, 1977, NATURE, V265, P229, DOI 10.1038/265229a0; Hoeben FJM, 2005, CHEM REV, V105, P1491, DOI 10.1021/cr030070z; Jordan P, 2001, NATURE, V411, P909, DOI 10.1038/35082000; Katz HE, 2000, NATURE, V404, P478, DOI 10.1038/35006603; Kerckhoffs JMCA, 2005, J AM CHEM SOC, V127, P12697, DOI 10.1021/ja0536973; LOKEY RS, 1995, NATURE, V375, P303; Matile S, 2004, TETRAHEDRON, V60, P6405, DOI 10.1016/j.tet.2004.05.052; Miller LL, 1996, ACCOUNTS CHEM RES, V29, P417, DOI 10.1021/ar9600446; Nelson N, 2004, NAT REV MOL CELL BIO, V5, P971, DOI 10.1038/nrm1525; ROBINSON JN, 1991, CHEM SOC REV, V20, P49, DOI 10.1039/cs9912000049; Schmidt-Mende L, 2001, SCIENCE, V293, P1119, DOI 10.1126/science.293.5532.1119; SteinbergYfrach G, 1997, NATURE, V385, P239, DOI 10.1038/385239a0; Talukdar P, 2005, CHEM-EUR J, V11, P6525, DOI 10.1002/chem.200500516; Talukdar P, 2005, J AM CHEM SOC, V127, P6528, DOI 10.1021/ja051260p; Wan CZ, 2000, P NATL ACAD SCI USA, V97, P14052, DOI 10.1073/pnas.250483297; Warman JM, 2004, CHEM MATER, V16, P4600, DOI 10.1021/cm049577w; Wurthner F, 2005, TOP CURR CHEM, V258, P1; Wurthner F, 2002, CHEM-EUR J, V8, P4742, DOI 10.1002/1521-3765(20021018)8:20<4742::AID-CHEM4742>3.0.CO;2-L; Zhu LY, 2006, J AM CHEM SOC, V128, P825, DOI 10.1021/ja0545620	24	348	348	4	207	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 7	2006	313	5783					84	86		10.1126/science.1126524	http://dx.doi.org/10.1126/science.1126524			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061DA	16825567	Green Published			2022-12-28	WOS:000238850200035
J	Jonkheijm, P; van der Schoot, P; Schenning, APHJ; Meijer, EW				Jonkheijm, Pascal; van der Schoot, Paul; Schenning, Albertus P. H. J.; Meijer, E. W.			Probing the solvent-assisted nucleation pathway in chemical self-assembly	SCIENCE			English	Article							SUPRAMOLECULAR ASSEMBLIES; MOLECULES; ARCHITECTURES; STACKS	Hierarchical self-assembly offers a powerful strategy for producing molecular nanostructures. Although widely used, the mechanistic details of self-assembly processes are poorly understood. We spectroscopically monitored a nucleation process in the self-assembly of pi-conjugated molecules into helical supramolecular fibrillar structures. The data support a nucleation-growth pathway that gives rise to a remarkably high degree of cooperativity. Furthermore, we characterize a helical transition in the nucleating species before growth. The self-assembly process depends strongly on solvent structure, suggesting that an organized shell of solvent molecules plays an explicit role in rigidifying the aggregates and guiding them toward further assembly into bundles and/or gels.	Eindhoven Univ Technol, Lab Macromol & Organ Chem, NL-5600 MB Eindhoven, Netherlands; Eindhoven Univ Technol, Polymer Phys Grp, NL-5600 MB Eindhoven, Netherlands	Eindhoven University of Technology; Eindhoven University of Technology	Schenning, APHJ (corresponding author), Eindhoven Univ Technol, Lab Macromol & Organ Chem, POB 513, NL-5600 MB Eindhoven, Netherlands.	a.p.h.j.schenning@tue.nl; e.w.meijer@tue.nl	Meijer, E.W./K-7632-2013; Jonkheijm, Pascal/D-3088-2013; Zhou, Yujie/G-6262-2012	Meijer, E.W./0000-0003-4126-7492; 				Aggeli A, 2001, P NATL ACAD SCI USA, V98, P11857, DOI 10.1073/pnas.191250198; Beljonne D, 2005, J PHYS CHEM B, V109, P10594, DOI 10.1021/jp050792p; CASPAR DLD, 1980, BIOPHYS J, V32, P103, DOI 10.1016/S0006-3495(80)84929-0; Cornelissen JJLM, 2001, CHEM REV, V101, P4039, DOI 10.1021/cr990126i; FLORY PJ, 1949, J CHEM PHYS, V17, P223, DOI 10.1063/1.1747230; Gesquiere A, 2004, NANO LETT, V4, P1175, DOI 10.1021/nl049842c; Herz LM, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.045203; Hoeben FJM, 2005, CHEM REV, V105, P1491, DOI 10.1021/cr030070z; Jeukens CRLPN, 2005, J AM CHEM SOC, V127, P8280, DOI 10.1021/ja051781c; Jonkheijm P, 2003, J AM CHEM SOC, V125, P15941, DOI 10.1021/ja0383118; Kentsis A, 2004, CURR PROTEIN PEPT SC, V5, P125, DOI 10.2174/1389203043486856; Klug A, 1999, PHILOS T ROY SOC B, V354, P531, DOI 10.1098/rstb.1999.0404; Krishnan R, 2005, NATURE, V435, P765, DOI 10.1038/nature03679; Lohr A, 2005, ANGEW CHEM INT EDIT, V44, P5071, DOI 10.1002/anie.200500640; Moulton B, 2001, CHEM REV, V101, P1629, DOI 10.1021/cr9900432; OOSAWA F, 1962, J MOL BIOL, V4, P10, DOI 10.1016/S0022-2836(62)80112-0; Oosawa F., 1975, THERMODYNAMICS POLYM; Peeters E, 2000, J CHEM PHYS, V112, P9445, DOI 10.1063/1.481638; Schenning APHJ, 2001, J AM CHEM SOC, V123, P409, DOI 10.1021/ja0033180; Service RF, 2005, SCIENCE, V309, P95, DOI 10.1126/science.309.5731.95; Shimizu T, 2005, CHEM REV, V105, P1401, DOI 10.1021/cr030072j; Terech P, 1997, CHEM REV, V97, P3133, DOI 10.1021/cr9700282; van der Schoot P, 2000, LANGMUIR, V16, P10076, DOI 10.1021/la000794v; van der Schoot P., 2005, SUPRAMOLECULAR POLYM; van Gestel J, 2003, LANGMUIR, V19, P1375, DOI 10.1021/la020674i; Whitesides GM, 2002, P NATL ACAD SCI USA, V99, P4769, DOI 10.1073/pnas.082065899	26	709	716	13	402	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 7	2006	313	5783					80	83		10.1126/science.1127884	http://dx.doi.org/10.1126/science.1127884			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061DA	16825566	Green Published			2022-12-28	WOS:000238850200034
J	Kinbara, K; Aida, T				Kinbara, Kazushi; Aida, Takuzo			From electron pump to proton channel	SCIENCE			English	Editorial Material							ION CHANNELS; MEMBRANE		Univ Tokyo, Sch Engn, Dept Chem & Biotechnol, Bunkyo Ku, Tokyo 1138656, Japan; Univ Tokyo, Ctr NanoBio Integrat, Bunkyo Ku, Tokyo 1138656, Japan	University of Tokyo; University of Tokyo	Kinbara, K (corresponding author), Univ Tokyo, Sch Engn, Dept Chem & Biotechnol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan.	aida@macro.t.u-tokyo.ac.jp	Aida, Takuzo/I-9117-2012; Kinbara, Kazushi/E-6347-2017	Kinbara, Kazushi/0000-0002-5945-9612				Bhosale S, 2006, SCIENCE, V313, P84, DOI 10.1126/science.1126524; FORD WE, 1978, NATURE, V274, P506; HUB HH, 1980, ANGEW CHEM INT EDIT, V19, P938, DOI 10.1002/anie.198009381; KUNITAKE T, 1977, J AM CHEM SOC, V99, P3860, DOI 10.1021/ja00453a066; Lien L, 1996, J AM CHEM SOC, V118, P12222, DOI 10.1021/ja962217s; Percec V, 2004, NATURE, V430, P764, DOI 10.1038/nature02770; Steinberg-Yfrach G, 1998, NATURE, V392, P479, DOI 10.1038/33116; SteinbergYfrach G, 1997, NATURE, V385, P239, DOI 10.1038/385239a0; TABUSHI I, 1982, TETRAHEDRON LETT, V23, P4601, DOI 10.1016/S0040-4039(00)85664-6; Talukdar P, 2005, J AM CHEM SOC, V127, P6528, DOI 10.1021/ja051260p	10	6	6	2	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 7	2006	313	5783					51	52		10.1126/science.1130124	http://dx.doi.org/10.1126/science.1130124			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061DA	16825556				2022-12-28	WOS:000238850200022
J	Poehling, KA; Edwards, KM; Weinberg, GA; Szilagyi, P; Staat, MA; Iwane, MK; Bridges, CB; Grijalva, CG; Zhu, YW; Bernstein, DI; Herrera, G; Erdman, D; Hall, CB; Seither, R; Griffin, MR				Poehling, Katherine A.; Edwards, Kathryn M.; Weinberg, Geoffrey A.; Szilagyi, Peter; Staat, Mary Allen; Iwane, Marika K.; Bridges, Carolyn B.; Grijalva, Carlos G.; Zhu, Yuwei; Bernstein, David I.; Herrera, Guillermo; Erdman, Dean; Hall, Caroline B.; Seither, Ranee; Griffin, Marie R.		New Vaccine Surveillance Netw	The underrecognized burden of influenza in young children	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							OUTPATIENT VISITS; RAPID DIAGNOSIS; HOSPITALIZATIONS; INFECTIONS; INFANTS; IMPACT; VIRUS; MANAGEMENT; EMERGENCY; RATES	Background The disease burden of influenza infection among children is not well established. We conducted a population-based surveillance of medical visits associated with laboratory-confirmed influenza. Methods Eligible children were younger than five years of age, resided in three U.S. counties, and had a medical visit for an acute respiratory tract infection or fever. Nasal and throat swabs were tested for the influenza virus by viral culture and polymerase-chain-reaction assay. Epidemiologic data were collected from parental surveys and chart reviews. Children who were hospitalized were enrolled prospectively from 2000 through 2004. Population-based rates of hospitalizations associated with influenza were calculated. Children who were seen in selected pediatric clinics and emergency departments during two influenza seasons (2002-2003 and 2003-2004) were systematically enrolled. The rates of visits to clinics and emergency departments associated with influenza were estimated. Results The average annual rate of hospitalization associated with influenza was 0.9 per 1000 children. The estimated burden of outpatient visits associated with influenza was 50 clinic visits and 6 emergency department visits per 1000 children during the 2002-2003 season and 95 clinic visits and 27 emergency department visits per 1000 children during the 2003-2004 season. Few children who had laboratory-confirmed influenza were given a diagnosis of influenza by the treating physician in the inpatient (28 percent) or outpatient (17 percent) settings. Conclusions Among young children, outpatient visits associated with influenza were 10 to 250 times as common as hospitalizations. Few influenza infections were recognized clinically.	Vanderbilt Univ, Med Ctr, Dept Pediat, Nashville, TN 37232 USA; Vanderbilt Univ, Med Ctr, Dept Prevent Med, Nashville, TN 37232 USA; Vanderbilt Univ, Med Ctr, Dept Biostat, Nashville, TN 37232 USA; Vanderbilt Univ, Med Ctr, Dept Med, Nashville, TN 37232 USA; Univ Rochester, Sch Med & Dent, Dept Pediat, Rochester, NY 14642 USA; Univ Rochester, Sch Med & Dent, Strong Childrens Res Ctr, Rochester, NY 14642 USA; Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Div Infect Dis, Cincinnati, OH USA; Ctr Dis Control & Prevent, Natl Ctr Immunizat & Resp Dis, Atlanta, GA USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; University of Rochester; University of Rochester; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Centers for Disease Control & Prevention - USA	Poehling, KA (corresponding author), Vanderbilt Univ, Med Ctr, Dept Pediat, Nashville, TN 37232 USA.		Weinberg, Geoffrey A./W-7510-2019	Weinberg, Geoffrey A./0000-0002-3900-379X; Grijalva, Carlos/0000-0002-2329-7797	NIAID NIH HHS [K23 AI065805] Funding Source: Medline; NCIRD CDC HHS [1 U01 IP000022] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K23AI065805] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCIRD CDC HHS; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ARMITAGE P, 1955, BIOMETRICS, V11, P375, DOI 10.2307/3001775; Bonner AB, 2003, PEDIATRICS, V112, P363, DOI 10.1542/peds.112.2.363; Brown LD, 2001, STAT SCI, V16, P101, DOI 10.1214/ss/1009213286; Casella G., 2002, STAT INFERENCE, V2nd; *CDCP, FLU ACT REP SURV MET; Center for Disease Control and Prevention, NAT IMM SURV NIS; Centers for Disease Control and Prevention (CDC), 2004, MMWR Morb Mortal Wkly Rep, V53, P547; COCHRAN WG, 1954, BIOMETRICS, V10, P417, DOI 10.2307/3001616; Glezen WP, 2000, JAMA-J AM MED ASSOC, V283, P499, DOI 10.1001/jama.283.4.499; Griffin Marie R, 2004, Pediatr Infect Dis J, V23, pS188, DOI 10.1097/01.inf.0000144660.53024.64; Grijalva CG, 2006, EMERG INFECT DIS, V12, P103; Hemingway CO, 2004, PEDIATRICS, V114, P948, DOI 10.1542/peds.2003-0509-F; Homer CJ, 1996, PEDIATRICS, V98, P18; Iwane MK, 2004, PEDIATRICS, V113, P1758, DOI 10.1542/peds.113.6.1758; Izurieta HS, 2000, NEW ENGL J MED, V342, P232, DOI 10.1056/NEJM200001273420402; Mac Donald R, 1999, AM J PREV MED, V16, P173, DOI 10.1016/S0749-3797(98)00159-7; Meltzer MI, 2005, VACCINE, V23, P1004, DOI 10.1016/j.vaccine.2004.07.040; MULLOOLY JP, 1982, AM J PUBLIC HEALTH, V72, P1008, DOI 10.2105/AJPH.72.9.1008; National Center for Health Statistics, NAT AMB MED CAR SURV; Neuzil KM, 2000, NEW ENGL J MED, V342, P225, DOI 10.1056/NEJM200001273420401; Neuzil KM, 2002, J INFECT DIS, V185, P147, DOI 10.1086/338363; O'Brien MA, 2004, PEDIATRICS, V113, P585, DOI 10.1542/peds.113.3.585; Perrin JM, 1996, ARCH PEDIAT ADOL MED, V150, P479, DOI 10.1001/archpedi.1996.02170300033007; Poehling KA, 2002, PEDIATRICS, V110, P83, DOI 10.1542/peds.110.1.83; Sharma V, 2002, ARCH PEDIAT ADOL MED, V156, P41, DOI 10.1001/archpedi.156.1.41; Thompson WW, 2004, JAMA-J AM MED ASSOC, V292, P1333, DOI 10.1001/jama.292.11.1333; Weinberg GA, 2004, J INFECT DIS, V189, P706, DOI 10.1086/381456; 2003, SURVEY DATA REFERENC	29	664	699	0	25	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 6	2006	355	1					31	40		10.1056/NEJMoa054869	http://dx.doi.org/10.1056/NEJMoa054869			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	060DT	16822994	Bronze			2022-12-28	WOS:000238783200005
J	Zwierlein, MW; Schunck, CH; Schirotzek, A; Ketterle, W				Zwierlein, Martin W.; Schunck, Christian H.; Schirotzek, Andre; Ketterle, Wolfgang			Direct observation of the superfluid phase transition in ultracold Fermi gases	NATURE			English	Article							BOSE-EINSTEIN CONDENSATION	Phase transitions are dramatic phenomena: water freezes into ice, atomic spins spontaneously align in a magnet, and liquid helium becomes superfluid. Sometimes, such a drastic change in behaviour is accompanied by a visible change in appearance. The hallmark of Bose-Einstein condensation and superfluidity in trapped, weakly interacting Bose gases is the sudden formation of a dense central core inside a thermal cloud(1-7). However, in strongly interacting gases-such as the recently observed fermionic superfluids(8)-there is no longer a clear separation between the superfluid and the normal parts of the cloud. The detection of fermion pair condensates has required magnetic field sweeps(9-11) into the weakly interacting regime, and the quantitative description of these sweeps presents a major theoretical challenge. Here we report the direct observation of the superfluid phase transition in a strongly interacting gas of Li-6 fermions, through sudden changes in the shape of the clouds-in complete analogy to the case of weakly interacting Bose gases. By preparing unequal mixtures of the two spin components involved in the pairing(12,13), we greatly enhance the contrast between the superfluid core and the normal component. Furthermore, the distribution of non-interacting excess atoms serves as a direct and reliable thermometer. Even in the normal state, strong interactions significantly deform the density profile of the majority spin component. We show that it is these interactions that drive the normal-to-superfluid transition at the critical population imbalance of 70 +/- 5 per cent (ref. 12).	MIT, MIT Harvard Ctr Ultracold Atoms, Dept Phys, Cambridge, MA 02139 USA; MIT, Res Lab Elect, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Zwierlein, MW (corresponding author), MIT, MIT Harvard Ctr Ultracold Atoms, Dept Phys, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	zwierlei@mit.edu	Schunck, Christian H/A-3625-2010	Schunck, Christian H/0000-0002-7917-8180; /0000-0001-8120-8548				Altman E, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.110404; ANDERSON MH, 1995, SCIENCE, V269, P198, DOI 10.1126/science.269.5221.198; Bartenstein M, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.120401; Bedaque PF, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.247002; Bourdel T, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.050401; Caldas H, 2004, PHYS REV A, V69, DOI 10.1103/PhysRevA.69.063602; Chen Q, 2006, PHYS REV A, V73, DOI 10.1103/PhysRevA.73.012303; Chevy F, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.130401; Chiofalo ML, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.090402; DAVIS KB, 1995, PHYS REV LETT, V75, P3969, DOI 10.1103/PhysRevLett.75.3969; De Silva TN, 2006, PHYS REV A, V73, DOI 10.1103/PhysRevA.73.051602; DIENER RB, 2004, PROJECTING FERMION P; Greiner M, 2003, NATURE, V426, P537, DOI 10.1038/nature02199; HAQUE M, 2006, PAIRING TRAPPED RESO; Ho TL, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.090402; Kinast J, 2005, SCIENCE, V307, P1296, DOI 10.1126/science.1109220; Kinnunen J, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.110403; Mizushima T, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.060404; Partridge GB, 2006, SCIENCE, V311, P503, DOI 10.1126/science.1122876; Partridge GB, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.020404; Perali A, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.010407; Perali A, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.220404; Pieri P, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.150404; Regal CA, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.040403; Sheehy DE, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.060401; Stajic J, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.060401; Yi W, 2006, PHYS REV A, V73, DOI 10.1103/PhysRevA.73.031604; Zwierlein MW, 2006, SCIENCE, V311, P492, DOI 10.1126/science.1122318; Zwierlein MW, 2005, NATURE, V435, P1047, DOI 10.1038/nature03858; Zwierlein MW, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.120403; Zwierlein MW, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.250401	33	290	292	0	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 6	2006	442	7098					54	58		10.1038/nature04936	http://dx.doi.org/10.1038/nature04936			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	059HS	16823447	Green Submitted			2022-12-28	WOS:000238724500034
J	Brown, DT; Herbert, M; Lamb, VK; Chinnery, PF; Taylor, RW; Lightowlers, RN; Craven, L; Cree, L; Gardner, JL; Turnbull, DM				Brown, D. T.; Herbert, M.; Lamb, V. K.; Chinnery, P. F.; Taylor, R. W.; Lightowlers, R. N.; Craven, L.; Cree, L.; Gardner, J. L.; Turnbull, D. M.			Transmission of mitochondrial DNA disorders: possibilities for the future	LANCET			English	Editorial Material							PRENATAL-DIAGNOSIS; GENOTYPE SEGREGATION; PEDIGREE ANALYSIS; PATHOGENIC MTDNA; MUTATION; FAMILIES		Newcastle Univ, Sch Med, Sch Neurol Neurobiol & Psychiat, Mitochondrial Res Grp, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; Int Ctr Life, Reprod Med Biosci Ctr, Newcastle Upon Tyne, Tyne & Wear, England	Newcastle University - UK	Turnbull, DM (corresponding author), Newcastle Univ, Sch Med, Sch Neurol Neurobiol & Psychiat, Mitochondrial Res Grp, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	d.m.turnbull@ncl.ac.uk		Chinnery, Patrick/0000-0002-7065-6617; Cree, Lynsey/0000-0003-2090-1589	Medical Research Council [G0300486] Funding Source: Medline; Wellcome Trust [074454] Funding Source: Medline; MRC [G0300486] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		BARRITT JA, 2001, REPROD BIOMED ONLINE, V3, P47; Brenner CA, 2000, FERTIL STERIL, V74, P573, DOI 10.1016/S0015-0282(00)00681-6; Chinnery PF, 2004, LANCET, V364, P592, DOI 10.1016/S0140-6736(04)16851-7; Chinnery PF, 1997, BRAIN, V120, P1713, DOI 10.1093/brain/120.10.1713; Cohen J, 1997, LANCET, V350, P186, DOI 10.1016/S0140-6736(05)62353-7; Dean NL, 2003, MOL HUM REPROD, V9, P631, DOI 10.1093/molehr/gag077; HARDING AE, 1992, AM J HUM GENET, V50, P629; HARDING AE, 1995, AM J HUM GENET, V57, P77; Hawes SM, 2002, HUM REPROD, V17, P850, DOI 10.1093/humrep/17.4.850; HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0; Jenuth JP, 1997, NAT GENET, V16, P93, DOI 10.1038/ng0597-93; Leshinsky-Silver E, 2003, PRENATAL DIAG, V23, P31, DOI 10.1002/pd.516; Lin DPC, 2004, FERTIL STERIL, V81, P73, DOI 10.1016/j.fertnstert.2003.05.005; Macmillan C, 1998, NEUROLOGY, V50, P417, DOI 10.1212/WNL.50.2.417; Meirelles FV, 1998, GENETICS, V148, P877; Meirelles FV, 1997, GENETICS, V145, P445; Moor RM, 1998, HUM REPROD UPDATE, V4, P223, DOI 10.1093/humupd/4.3.223; Poulton J, 2000, NEUROMUSCULAR DISORD, V10, P484, DOI 10.1016/S0960-8966(00)00130-9; Roberts RM, 1999, AM J MED GENET, V87, P265, DOI 10.1002/(SICI)1096-8628(19991126)87:3<265::AID-AJMG14>3.0.CO;2-S; Sato A, 2005, P NATL ACAD SCI USA, V102, P16765, DOI 10.1073/pnas.0506197102; Schaefer AM, 2004, BBA-BIOENERGETICS, V1659, P115, DOI 10.1016/j.bbabio.2004.09.005; Schwartz M, 2002, NEW ENGL J MED, V347, P576, DOI 10.1056/NEJMoa020350; Steffann J, 2006, J MED GENET, V43, P244, DOI 10.1136/jmg.2005.032326; Takeuchi T, 2005, BIOL REPROD, V72, P584, DOI 10.1095/biolreprod.104.032391; Thorburn DR, 2001, AM J MED GENET, V106, P102, DOI 10.1002/ajmg.1380; WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231; White SL, 1999, PRENATAL DIAG, V19, P1165, DOI 10.1002/(SICI)1097-0223(199912)19:12<1165::AID-PD719>3.3.CO;2-4; White SL, 1999, AM J HUM GENET, V65, P474, DOI 10.1086/302488	28	68	73	0	18	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 1	2006	368	9529					87	89		10.1016/S0140-6736(06)68972-1	http://dx.doi.org/10.1016/S0140-6736(06)68972-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	058TQ	16815383				2022-12-28	WOS:000238687900034
J	Williams, B				Williams, Bryan			Evolution of hypertensive disease: a revolution in guidelines	LANCET			English	Editorial Material							BLOOD-PRESSURE; TRIAL		Univ Leicester, Leicester Royal Infirm, Sch Med, Leicester LE2 7LX, Leics, England	University of Leicester	Williams, B (corresponding author), Univ Leicester, Leicester Royal Infirm, Sch Med, Clin Sci Bldg, Leicester LE2 7LX, Leics, England.	bw17@leicester.ac.uk		Williams, Bryan/0000-0002-8094-1841				Dahlof B, 2002, LANCET, V359, P995, DOI 10.1016/S0140-6736(02)08089-3; Dahlof B, 2005, LANCET, V366, P895, DOI 10.1016/S0140-6736(05)67185-1; de Simone G, 2006, HYPERTENSION, V47, P162, DOI 10.1161/01.HYP.0000199103.40105.b5; Deary AJ, 2002, J HYPERTENS, V20, P771, DOI 10.1097/00004872-200204000-00037; Dickerson JEC, 1999, LANCET, V353, P2008, DOI 10.1016/S0140-6736(98)07614-4; Julius S, 2006, NEW ENGL J MED, V354, P1685, DOI 10.1056/NEJMoa060838; Kearney PM, 2005, LANCET, V365, P217, DOI 10.1016/S0140-6736(05)70151-3; Lindholm LH, 2005, LANCET, V366, P1545, DOI 10.1016/S0140-6736(05)67573-3; Mason JM, 2005, J HYPERTENS, V23, P1777, DOI 10.1097/01.hjh.0000177537.91527.09; *NICE BHS, CLIN GUID, V34; Vasan RS, 2001, LANCET, V358, P1682, DOI 10.1016/S0140-6736(01)06710-1; Williams B, 2005, J AM COLL CARDIOL, V45, P813, DOI 10.1016/j.jacc.2004.10.069; WILLIAMS B, 1994, LANCET, V344, P521, DOI 10.1016/S0140-6736(94)91904-6	13	26	29	1	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 1	2006	368	9529					6	8		10.1016/S0140-6736(06)68943-5	http://dx.doi.org/10.1016/S0140-6736(06)68943-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	058TQ	16815359				2022-12-28	WOS:000238687900006
J	Maoz, E; Newman, JA; Ferrarese, L; Stetson, PB; Zepf, SE; Davis, M; Freedman, WL; Madore, BF				Maoz, E; Newman, JA; Ferrarese, L; Stetson, PB; Zepf, SE; Davis, M; Freedman, WL; Madore, BF			A distance to the galaxy NGC4258 from observations of Cepheid variable stars	NATURE			English	Article							KEY PROJECT; SCALE; DISCOVERY	Cepheid variable stars pulsate in a way that is correlated with their intrinsic luminosity, making them useful as 'standard candles' for determining distances to galaxies; the potential systematic uncertainties in the resulting distances have been estimated(1) to be only 8-10%. They have played a crucial role in establishing the extragalactic distance scale and hence the value of the Hubble constant. Here we report observations of Cepheids in the nearby galaxy NGC4258; the distance calculated from the Cepheids is 8.1 +/- 0.4 Mpc, where the uncertainty does not include possible systematic errors. There is an independently determined geometric distance to this galaxy of 7.2 +/- 0.5 Mpc, based on the observed proper motions of water masers orbiting the central black hole(2); the distances differ by 1.3 sigma. If the maser-based distance is adopted and the Cepheid distance scale revised accordingly, the derived value of the Hubble constant would increase by 12 +/- 9%, while the expansion age of the Universe would decrease by the same amount.	NASA, Ames Res Ctr, Moffett Field, CA 94035 USA; Univ Calif Berkeley, Dept Astron, Berkeley, CA 94720 USA; CALTECH, Pasadena, CA 91125 USA; Dominion Astrophys Observ, Victoria, BC V8X 4M6, Canada; Yale Univ, Dept Astron, New Haven, CT 06520 USA; Carnegie Inst Washington Observ, Pasadena, CA 91101 USA; CALTECH, Jet Prop Lab, NASA IPAC Extragalact Database, Infrared Proc & Anal Ctr, Pasadena, CA 91125 USA	National Aeronautics & Space Administration (NASA); NASA Ames Research Center; University of California System; University of California Berkeley; California Institute of Technology; National Research Council Canada; Yale University; Carnegie Institution for Science; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL)	Maoz, E (corresponding author), NASA, Ames Res Ctr, MS 245-3, Moffett Field, CA 94035 USA.	maoz@ism.arc.nasa.gov		Ferrarese, Laura/0000-0002-8224-1128				BARTEL N, 1999, B AM ASTRON SOC, V194, P6208; CARDELLI JA, 1989, ASTROPHYS J, V345, P245, DOI 10.1086/167900; Eastman RG, 1996, ASTROPHYS J, V466, P911, DOI 10.1086/177563; Ferrarese L, 1996, ASTROPHYS J, V464, P568, DOI 10.1086/177347; FERRARESE L, 1999, ASTROPH9908192; FERRARESE LF, IN PRESS ASTROPHYS J; FREEDMAN WL, 1994, ASTROPHYS J, V427, P628, DOI 10.1086/174172; FREEDMAN WL, IN PRESS PARTICLE PH; FREEDMAN WL, 1997, CRITICAL DIALOGUES C, P92; FREEDMAN WL, 1999, ASTROPH9905222; FREEDMAN WL, 1998, RELATIVISTIC ASTROPH; Gould A, 1998, ASTROPHYS J, V494, P118, DOI 10.1086/305193; GREENHILL LJ, 1995, ASTRON ASTROPHYS, V304, P21; Herrnstein JR, 1999, NATURE, V400, P539, DOI 10.1038/22972; JACOBY GH, 1992, PUBL ASTRON SOC PAC, V104, P599, DOI 10.1086/133035; Kennicutt RC, 1998, ASTROPHYS J, V498, P181, DOI 10.1086/305538; KENNICUTT RC, 1995, ASTRON J, V110, P1476, DOI 10.1086/117621; Krauss LM, 1998, ASTROPHYS J, V501, P461, DOI 10.1086/305846; MADORE BF, 1991, PUBL ASTRON SOC PAC, V103, P933, DOI 10.1086/132911; Madore BF, 1999, ASTROPHYS J, V515, P29, DOI 10.1086/307004; Maoz E, 1998, ASTROPHYS J, V494, pL181, DOI 10.1086/311194; MIYOSHI M, 1995, NATURE, V373, P127, DOI 10.1038/373127a0; MOULD JR, UNPUB ASTROPHYS J; NEWMAN JA, IN PRESS ASTROPHYS J; PANAGIA N, 1999, NEW VIEWS MAGELLANIC; SAHA A, 1994, ASTROPHYS J, V425, P14, DOI 10.1086/173957; SAKAI S, UNPUB ASTROPHYS J; SCHECHTER PL, 1993, PUBL ASTRON SOC PAC, V105, P1342, DOI 10.1086/133316; Stetson PB, 1996, PUBL ASTRON SOC PAC, V108, P851, DOI 10.1086/133808; Stetson PB, 1998, ASTROPHYS J, V508, P491, DOI 10.1086/306443; STETSON PB, 1994, PUBL ASTRON SOC PAC, V106, P250, DOI 10.1086/133378; ZARITSKY D, 1994, ASTROPHYS J, V420, P87, DOI 10.1086/173544	32	39	39	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 23	1999	401	6751					351	354		10.1038/43838	http://dx.doi.org/10.1038/43838			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	240JJ	16862105				2022-12-28	WOS:000082822600043
J	Arroll, B; Kenealy, T				Arroll, B.; Kenealy, T.			Are antibiotics effective for acute purulent rhinitis? Systematic review and meta-analysis of placebo controlled randomised trials	BMJ-BRITISH MEDICAL JOURNAL			English	Article							DOUBLE-BLIND; AMOXICILLIN; INFECTIONS; PRINCIPLES; MANAGEMENT	Objective To systematically review the evidence for the effectiveness of antibiotics in acute purulent rhinitis (many guidelines advise against their use on the basis of one study that showed no effect). Data sources Medline, Embase, Cochrane Register of Controlled Trials, and reference lists of retrieved articles. Review methods Meta-analysis of data from double blind randomised placebo controlled trials comparing antibiotics with placebo for acute purulent rhinitis (duration less than 10 days). Results Seven studies were retrieved; four contributed data on benefits of antibiotics, and four contributed data on harms of antibiotics. The pooled relative risk of benefit for persistent purulent rhinitis at five to eight days with antibiotics was 1.18 (95% confidence interval 1.05 to 1.33). The numbers needed to treat ranged from 7 to 15 when the pooled relative risk was applied to the range of control event rates. The relative risk for adverse effects with antibiotics was 1.46 (1.10 to 1.94). The numbers needed to harm for adverse effects ranged from 12 to 78. No serious harms were reported in the placebo arms. Conclusions Antibiotics arc probably effective for acute purulent rhinitis. They can cause harm, usually in the form of gastrointestinal effects. Most patients will get better without antibiotics, supporting the current "no antibiotic as first line" advice.	Univ Auckland, Dept Gen Practice & Primary Hlth Care, Auckland 1, New Zealand	University of Auckland	Arroll, B (corresponding author), Univ Auckland, Dept Gen Practice & Primary Hlth Care, Private Bag 92019, Auckland 1, New Zealand.	b.arroll@auckland.ac.nz		Kenealy, Timothy/0000-0001-6002-4766				Arroll B, 2000, NEW ZEAL MED J, V113, P493; Arroll B, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000247.pub2; De Sutter AI, 2002, J FAM PRACTICE, V51, P317; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Gonzales R, 1999, J GEN INTERN MED, V14, P151, DOI 10.1046/j.1525-1497.1999.00306.x; GWALTNEY JM, 1994, NEW ENGL J MED, V330, P25, DOI 10.1056/NEJM199401063300105; Haye R, 1998, EUR J CLIN MICROBIOL, V17, P309, DOI 10.1007/BF01709452; HERNE N, 1980, MED MALADIES INFECT, V10, P185, DOI 10.1016/S0399-077X(80)80052-7; HOWIE JGR, 1970, LANCET, V2, P1099; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Mainous AG, 1997, LANCET, V350, P1077, DOI 10.1016/S0140-6736(05)70457-8; MORRIS P, 2002, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD001094; Rosenstein N, 1998, PEDIATRICS, V101, P181; Sackett D., 2000, EVIDENCE BASED MED P, DOI DOI 10.1136/BMJ.H3089; Snow V, 2001, ANN INTERN MED, V134, P495, DOI 10.7326/0003-4819-134-6-200103200-00016; STEINWEG KK, 1983, J FAM PRACTICE, V17, P61; STOTT NCH, 1976, BRIT MED J, V2, P556, DOI 10.1136/bmj.2.6035.556; TAYLOR B, 1977, BRIT MED J, V2, P552, DOI 10.1136/bmj.2.6086.552; TODD JK, 1984, PEDIATR INFECT DIS J, V3, P226, DOI 10.1097/00006454-198405000-00009; Turnidge J, 2005, LANCET, V365, P548; VOGT FC, 1966, CLIN PEDIATR, V5, P547, DOI 10.1177/000992286600500910; WILLIAMS JW, 2003, COCHRANE DB SYST REV, V2, DOI DOI 10.1002/14651858.CD000243; WILLIAMS JW, 2000, COCHRANE DB SYST REV, V2	23	26	27	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 5	2006	333	7562					279	281		10.1136/bmj.38891.681215.AE	http://dx.doi.org/10.1136/bmj.38891.681215.AE			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	073MV	16861253	Green Published, Bronze, Green Submitted			2022-12-28	WOS:000239748200014
J	Kaufman, YJ; Koren, I				Kaufman, Yoram J.; Koren, Ilan			Smoke and pollution aerosol effect on cloud cover	SCIENCE			English	Article							CLIMATE; ATMOSPHERE; RAIN; TOP	Pollution and smoke aerosols can increase or decrease the cloud cover. This duality in the effects of aerosols forms one of the largest uncertainties in climate research. Using solar measurements from Aerosol Robotic Network sites around the globe, we show an increase in cloud cover with an increase in the aerosol column concentration and an inverse dependence on the aerosol absorption of sunlight. The emerging rule appears to be independent of geographical location or aerosol type, thus increasing our confidence in the understanding of these aerosol effects on the clouds and climate. Preliminary estimates suggest an increase of 5% in cloud cover.	Weizmann Inst Sci, Dept Environm Sci & Energy Res, IL-76100 Rehovot, Israel; NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA	Weizmann Institute of Science; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center	Koren, I (corresponding author), Weizmann Inst Sci, Dept Environm Sci & Energy Res, IL-76100 Rehovot, Israel.	ilan.koren@weizmann.ac.il	Koren, Ilan/K-1417-2012	Koren, Ilan/0000-0001-6759-6265				Ackerman AS, 2000, SCIENCE, V288, P1042, DOI 10.1126/science.288.5468.1042; ALBRECHT BA, 1989, SCIENCE, V245, P1227, DOI 10.1126/science.245.4923.1227; Andreae MO, 2004, SCIENCE, V303, P1337, DOI 10.1126/science.1092779; Chou MD, 2002, J ATMOS SCI, V59, P748, DOI 10.1175/1520-0469(2002)059<0748:ARFDFS>2.0.CO;2; Devasthale A, 2005, IEEE GEOSCI REMOTE S, V2, P333, DOI 10.1109/LGRS.2005.851736; Dubovik O, 2002, J ATMOS SCI, V59, P590, DOI 10.1175/1520-0469(2002)059<0590:VOAAOP>2.0.CO;2; Feingold G, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL021369; GUNN R, 1957, J METEOROL, V14, P272, DOI 10.1175/1520-0469(1957)014<0272:AEIOTE>2.0.CO;2; Hansen J, 1997, J GEOPHYS RES-ATMOS, V102, P6831, DOI 10.1029/96JD03436; Haywood J, 2000, REV GEOPHYS, V38, P513, DOI 10.1029/1999RG000078; Holben BN, 2001, J GEOPHYS RES-ATMOS, V106, P12067, DOI 10.1029/2001JD900014; Holben BN, 1998, REMOTE SENS ENVIRON, V66, P1, DOI 10.1016/S0034-4257(98)00031-5; Jacobson MZ, 2006, J PHYS CHEM A, V110, P6860, DOI 10.1021/jp056391r; Kaufman YJ, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL025478; Kaufman YJ, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023125; Kaufman YJ, 2005, P NATL ACAD SCI USA, V102, P11207, DOI 10.1073/pnas.0505191102; Kaufman YJ, 1998, J GEOPHYS RES-ATMOS, V103, P31783, DOI 10.1029/98JD02281; Kaufman YJ, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL014399; Kaufman YJ, 1997, SCIENCE, V277, P1636, DOI 10.1126/science.277.5332.1636; Kaufman YJ, 2001, GEOPHYS RES LETT, V28, P3251, DOI 10.1029/2001GL013312; KING MD, 1992, IEEE T GEOSCI REMOTE, V30, P2, DOI 10.1109/36.124212; Koren I, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023187; Koren I, 2004, SCIENCE, V303, P1342, DOI 10.1126/science.1089424; Kotchenruther RA, 1999, J GEOPHYS RES-ATMOS, V104, P2239, DOI 10.1029/98JD01751; Kruger O, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL014081; LAU KM, 2006, CLIM DYNAM, DOI DOI 10.1007/S00382-006-0114; Menon S, 2002, J ATMOS SCI, V59, P692, DOI 10.1175/1520-0469(2002)059<0692:GSOTAI>2.0.CO;2; Penner JE, 2001, CLIMATE CHANGE 2001: THE SCIENTIFIC BASIS, P289; Ramanathan V, 2001, SCIENCE, V294, P2119, DOI 10.1126/science.1064034; Remer LA, 2006, ATMOS CHEM PHYS, V6, P237, DOI 10.5194/acp-6-237-2006; Rosenfeld D, 2000, SCIENCE, V287, P1793, DOI 10.1126/science.287.5459.1793; Rotstayn LD, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL021922; Sekiguchi M., 2003, J GEOPHYS RES, V108; Zhang JL, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023254	34	221	228	1	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 4	2006	313	5787					655	658		10.1126/science.1126232	http://dx.doi.org/10.1126/science.1126232			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072IQ	16840661				2022-12-28	WOS:000239667500039
J	Marcus, EN				Marcus, Erin N.			The silent epidemic - The health effects of illiteracy	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							LITERACY		Univ Miami, Miller Sch Med, Div Gen Internal Med, Miami, FL 33152 USA	University of Miami	Marcus, EN (corresponding author), Univ Miami, Miller Sch Med, Div Gen Internal Med, Miami, FL 33152 USA.							DeWalt DA, 2004, J GEN INTERN MED, V19, P1228, DOI 10.1111/j.1525-1497.2004.40153.x; Howard DH, 2005, AM J MED, V118, P933, DOI 10.1016/j.amjmed.2005.07.002; Howard DH, 2005, AM J MED, V118, P371, DOI 10.1016/j.amjmed.2005.01.010; Kutner M., 2005, 1 LOOK LITERACY AM A; Parikh NS, 1996, PATIENT EDUC COUNS, V27, P33, DOI 10.1016/0738-3991(95)00787-3; Wolf MS, 2005, ARCH INTERN MED, V165, P1946, DOI 10.1001/archinte.165.17.1946	6	82	84	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 27	2006	355	4					339	341		10.1056/NEJMp058328	http://dx.doi.org/10.1056/NEJMp058328			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	067DT	16870912				2022-12-28	WOS:000239282600002
J	Myers, ML				Myers, Matthew L.			Government tobacco regulation: opportunity for change	LANCET			English	Editorial Material							CIGARETTE; LESS		Campaign Tobacco Free Kids, Washington, DC 20005 USA		Myers, ML (corresponding author), Campaign Tobacco Free Kids, Washington, DC 20005 USA.	mmyers@TobaccoFreeKids.org						Glantz S.A., 1996, CIGARETTE PAPERS; Hoffmann D, 1997, J TOXICOL ENV HEALTH, V50, P307, DOI 10.1080/009841097160393; Hoffmann D, 2001, CHEM RES TOXICOL, V14, P767, DOI 10.1021/tx000260u; O'Connor RJ, 2006, BRIT MED J, V332, P302, DOI 10.1136/bmj.332.7536.302; Siegel M, 2006, LANCET, V368, P266, DOI 10.1016/S0140-6736(06)69052-1; US Department of Health and Human Services, 2001, RISKS ASS SMOK CIG L; 1996, FED REG         0828, V21, P44396	7	0	0	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 22	2006	368	9532					268	270		10.1016/S0140-6736(06)69053-3	http://dx.doi.org/10.1016/S0140-6736(06)69053-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	067PF	16860682				2022-12-28	WOS:000239314400007
J	Straus, SE; Chesney, MA				Straus, Stephen E.; Chesney, Margaret A.			In defense of NCCAM	SCIENCE			English	Editorial Material							OSTEOARTHRITIS; KNEE		NIH, Natl Ctr Complementary & Alternat Med, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Center for Complementary & Alternative Medicine	Chesney, MA (corresponding author), NIH, Natl Ctr Complementary & Alternat Med, Bldg 10, Bethesda, MD 20892 USA.	chesneym@mail.nih.gov						BARNES PM, 2004, 343 CDCP; Berman BM, 2004, ANN INTERN MED, V141, P901, DOI 10.7326/0003-4819-141-12-200412210-00006; Clegg DO, 2006, NEW ENGL J MED, V354, P795, DOI 10.1056/NEJMoa052771; *COMM US COMPL ALT, 2005, COMPL ALT MED US; Marcus DM, 2006, SCIENCE, V313, P301, DOI 10.1126/science.1126978; Markowitz JS, 2003, JAMA-J AM MED ASSOC, V290, P1500, DOI 10.1001/jama.290.11.1500; *NCCAM US DEP HHS, 2005, EXP HOR HLTH CAR STR; Sampson W, 2005, NEW ENGL J MED, V353, P337, DOI 10.1056/NEJMp058130; Shekelle P, 2003, AHRQ PUBLICATION, V03-E023; Zubieta JK, 2006, BRAIN BEHAV IMMUN, V20, P15, DOI 10.1016/j.bbi.2005.08.006	10	10	10	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 21	2006	313	5785					303	304		10.1126/science.1131608	http://dx.doi.org/10.1126/science.1131608			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065IV	16857924	Green Submitted			2022-12-28	WOS:000239154300026
J	Szathmary, E				Szathmary, Eoers			Darwin for all seasons	SCIENCE			English	Editorial Material									Eotvos Lorand Univ, Inst Biol, H-1014 Budapest, Hungary; Coll Budapest, Inst Adv Study, H-1014 Budapest, Hungary	Eotvos Lorand University	Szathmary, E (corresponding author), Eotvos Lorand Univ, Inst Biol, 2 Szentharomsag Utca, H-1014 Budapest, Hungary.	szathmary@colbud.hu	Szathmary, Eors/AAS-1202-2021; Szathmáry, Eörs/A-5007-2011	Szathmary, Eors/0000-0001-5227-2997; 				Bryson B., 2003, SHORT HIST NEARLY EV; Christiansen M. H., 2003, LANGUAGE EVOLUTION, P1, DOI DOI 10.1093/ACPROF:OSO/9780199244843.003.0001; DARWIN C, 1969, AUTOBIOGRAPHY C DARW, P139; Dennett DC., 1996, DARWINS DANGEROUS ID; 2006, DARW 21ST CENT SCI S	5	3	3	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 21	2006	313	5785					306	307		10.1126/science.1128901	http://dx.doi.org/10.1126/science.1128901			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065IV	16857926				2022-12-28	WOS:000239154300028
J	Westra, SW; de Jager, CPC				Westra, Sjoerd W.; de Jager, Cornelis P. C.			Angioedema of the tongue	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Jeoen Bosch Ziekenhuis, Shertogenbosch, Netherlands		Westra, SW (corresponding author), Jeoen Bosch Ziekenhuis, Shertogenbosch, Netherlands.		Westra, S.W./L-4755-2015	Westra, S.W./0000-0003-0165-6151					0	3	3	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 20	2006	355	3					295	295		10.1056/NEJMicm050510	http://dx.doi.org/10.1056/NEJMicm050510			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	064NY	16855270				2022-12-28	WOS:000239097600011
J	Wright, TJ; Ebinger, C; Biggs, J; Ayele, A; Yirgu, G; Keir, D; Stork, A				Wright, Tim J.; Ebinger, Cindy; Biggs, Juliet; Ayele, Atalay; Yirgu, Gezahegn; Keir, Derek; Stork, Anna			Magma-maintained rift segmentation at continental rupture in the 2005 Afar dyking episode	NATURE			English	Article							PLATE BOUNDARY; SURFACE UPLIFT; 1960 COLLAPSE; DEFORMATION; VOLCANISM; ACCUMULATION; SUBSIDENCE; ACCRETION; STRESS; VOLUME	Seafloor spreading centres show a regular along-axis segmentation thought to be produced by a segmented magma supply in the passively upwelling mantle(1,2). On the other hand, continental rifts are segmented by large offset normal faults, and many lack magmatism. It is unclear how, when and where the ubiquitous segmented melt zones are emplaced during the continental rupture process. Between 14 September and 4 October 2005, 163 earthquakes (magnitudes greater than 3.9) and a volcanic eruption occurred within the similar to 60-km-long Dabbahu magmatic segment of the Afar rift, a nascent seafloor spreading centre in stretched continental lithosphere(3,4). Here we present a three-dimensional deformation field for the Dabbahu rifting episode derived from satellite radar data, which shows that the entire segment ruptured, making it the largest to have occurred on land in the era of satellite geodesy. Simple elastic modelling shows that the magmatic segment opened by up to 8 m, yet seismic rupture can account for only 8 per cent of the observed deformation. Magma was injected along a dyke between depths of 2 and 9 km, corresponding to a total intrusion volume of similar to 2.5 km(3). Much of the magma appears to have originated from shallow chambers beneath Dabbahu and Gabho volcanoes at the northern end of the segment, where an explosive fissural eruption occurred on 26 September 2005. Although comparable in magnitude to the ten year ( 1975 - 84) Krafla events in Iceland(5), seismic data suggest that most of the Dabbahu dyke intrusion occurred in less than a week. Thus, magma intrusion via dyking, rather than segmented normal faulting, maintains and probably initiated the along-axis segmentation along this sector of the Nubia-Arabia plate boundary.	Univ Oxford, Dept Earth Sci, Oxford OX1 3PR, England; Univ London, Royal Holloway & Bedford New Coll, Dept Geol, Egham TW20 0EX, Surrey, England; Univ Addis Ababa, Geophys Observ, Addis Ababa, Ethiopia; Univ Addis Ababa, Dept Earth Sci, Addis Ababa, Ethiopia	University of Oxford; University of London; Royal Holloway University London; Addis Ababa University; Addis Ababa University	Wright, TJ (corresponding author), Univ Leeds, Sch Earth & Environm, Leeds LS2 9JT, W Yorkshire, England.	t.wright@see.leeds.ac.uk	Wright, Tim J/A-5892-2011; NCEO, COMET+`/A-3443-2013; Keir, Derek/AAB-6110-2020; Biggs, Juliet/D-4599-2011	Wright, Tim J/0000-0001-8338-5935; Keir, Derek/0000-0001-8787-8446; Ebinger, Cynthia/0000-0002-6211-3399; Biggs, Juliet/0000-0002-4855-039X	Natural Environment Research Council [NE/D01039X/1, NE/D008611/1, NE/D01039X/2] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		ABDALLAH A, 1979, NATURE, V282, P17, DOI 10.1038/282017a0; BARBERI F, 1977, GEOL SOC AM BULL, V88, P1251, DOI 10.1130/0016-7606(1977)88<1251:VOASPT>2.0.CO;2; Cattin R, 2005, EARTH PLANET SC LETT, V239, P352, DOI 10.1016/j.epsl.2005.07.028; de Zeeuw-van Dalfsen E, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020059; DELANEY PT, 1994, B VOLCANOL, V56, P417, DOI 10.1007/BF00302823; Dugda MT, 2006, GEOL SOC SPEC PUBL, V259, P239, DOI 10.1144/GSL.SP.2006.259.01.19; FOULGER GR, 1992, NATURE, V358, P488, DOI 10.1038/358488a0; Hayward NJ, 1996, TECTONICS, V15, P244, DOI 10.1029/95TC02292; HIRN A, 1993, J GEOPHYS RES-SOL EA, V98, P11995, DOI 10.1029/93JB00373; Hofstetter R, 2003, GEOPHYS J INT, V155, P715, DOI 10.1046/j.1365-246X.2003.02080.x; Johnson DJ, 2000, B VOLCANOL, V61, P491, DOI 10.1007/s004450050006; Keir D, 2006, J GEOPHYS RES-SOL EA, V111, DOI 10.1029/2005JB003748; Kreemer C, 2003, GEOPHYS J INT, V154, P8, DOI 10.1046/j.1365-246X.2003.01917.x; LIN J, 1990, NATURE, V344, P627, DOI 10.1038/344627a0; MCTIGUE DF, 1987, J GEOPHYS RES-SOLID, V92, P12931, DOI 10.1029/JB092iB12p12931; Michel R, 1999, GEOPHYS RES LETT, V26, P875, DOI 10.1029/1999GL900138; Nishimura T, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL019810; OKADA Y, 1985, B SEISMOL SOC AM, V75, P1135; Pollitz FF, 1996, J GEOPHYS RES-SOL EA, V101, P17771, DOI 10.1029/96JB01074; RUBIN AM, 1988, GEOLOGY, V16, P413, DOI 10.1130/0091-7613(1988)016<0413:DIFIRZ>2.3.CO;2; RUEGG JC, 1993, GEOPHYS RES LETT, V20, P1899, DOI 10.1029/93GL01882; Sigmundsson F, 2006, S-P BKS GEOPHYS SCI; WHITEHEAD JA, 1984, NATURE, V312, P146, DOI 10.1038/312146a0; Wright TJ, 2004, B SEISMOL SOC AM, V94, pS175, DOI 10.1785/0120040623; Wright TJ, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2003GL018827; Wright TJ, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL018014	27	402	407	0	75	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 20	2006	442	7100					291	294		10.1038/nature04978	http://dx.doi.org/10.1038/nature04978			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064WT	16855588	Green Published			2022-12-28	WOS:000239122100036
J	Wong, TY; Klein, R; Cong, S; Mitchell, P; Couper, DJ; Hong, L; Hubbard, LD; Sharrett, AR				Wong, Tien Yin; Klein, Ronald; Cong Sun; Mitchell, Paul; Couper, David J.; Hong Lai; Hubbard, Larry D.; Sharrett, A. Richey		Atherosclerosis Risk Communities S	Age-related macular degeneration and risk for stroke	ANNALS OF INTERNAL MEDICINE			English	Article							ATHEROSCLEROSIS RISK; CARDIOVASCULAR-DISEASE; MACULOPATHY; THERAPY; HYPERTENSION; ANTIOXIDANTS; ASSOCIATION; CHOLESTEROL; INFARCTION; ASPIRIN	Background: Age-related macular degeneration (AMD) affects 7 million persons 40 years of age and older in the United States. Risk factors for the disease are similar to those for stroke. Objective: To determine what relationship, if any, exists between AMD and incident clinical stroke. Design: Prospective cohort study. Setting: The population-based Atherosclerosis Risk in Communities Study, which was conducted in Minnesota, Maryland, Mississippi, and North Carolina. Patients: 10405 persons between 49 and 73 years of age who had no history of stroke or coronary heart disease. Measurements: Participants had retinal photographs taken between 1993 and 1995. A standardized protocol was used to evaluate the photographs for the presence of drusen and other signs of AMD. Incident stroke events were identified and validated by reviewing case records. Results: There were 498 early-stage and 10 late-stage cases of AMD in the cohort (n = 508). Over a 10-year period, 241 persons had an incident stroke event. After adjusting for age, sex, ethnicity, and site, the authors found that persons with early-stage AMD had a higher cumulative incidence of stroke than those without disease (4.08% vs. 2.14%). The presence of early-stage AMD was associated with a higher adjusted risk for stroke (hazard ratio, 1.87 [95% CI, 1.21 to 2.88]). Further adjustment for systolic blood pressure, diabetes, cigarette smoking, and use of anti hypertensive medications did not substantially alter this association (hazard ratio, 1.85 [CI, 1.19 to 2.87]). The authors found that the association between early-stage AMD and stroke varied by study site and patient ethnicity. Multivariable-adjusted hazard ratios were 3.15 and 1.07 in samples of white patients in Minnesota and Maryland, respectively; 3.77 in a sample of African-American patients in Mississippi; and 0.33 in a sample of mostly white patients (91 %) in North Carolina. No site included sufficient numbers of both African-American and white patients to determine whether ethnicity contributed to the observed differences by study site. Limitations: There were few cases of late-stage AMD, and the cohort assembly method prohibited full understanding of variation by ethnicity and site. Conclusion: Middle-aged persons with signs of early-stage AMD have a higher risk for stroke independent of traditional stroke risk factors.	Univ Melbourne, Ctr Eye Res Australia, Melbourne, Vic 3002, Australia; Univ Wisconsin, Madison, WI 53706 USA; Univ Sydney, Sydney, NSW 2006, Australia; Univ N Carolina, Chapel Hill, NC 27515 USA; Johns Hopkins Univ, Baltimore, MD 21218 USA	Centre for Eye Research Australia; University of Melbourne; University of Wisconsin System; University of Wisconsin Madison; University of Sydney; University of North Carolina; University of North Carolina Chapel Hill; Johns Hopkins University	Wong, TY (corresponding author), Univ Melbourne, Ctr Eye Res Australia, 32 Gisborne St, Melbourne, Vic 3002, Australia.	twong@unimelb.edu.au	Wong, Tien Yin/AAC-9724-2020; Mitchell, Paul/P-1498-2014	Wong, Tien Yin/0000-0002-8448-1264; Couper, David/0000-0002-4313-9235	DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC055018, N01HC055020, N01HC055022, N01HC055021, N01HC055019, N01HC055016, N01HC055015] Funding Source: NIH RePORTER; NHLBI NIH HHS [N01-HC-55016, N01-HC-55022, N01-HC-55021, N01-HC-55019, N01-HC-55015, N01-HC-55018, N01-HC-55020] Funding Source: Medline	DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		*AM HEART ASS, 2004, HEART DIS STROK STAT; Curcio CA, 2001, INVEST OPHTH VIS SCI, V42, P265; Delcourt C, 2001, Ophthalmic Epidemiol, V8, P237, DOI 10.1076/opep.8.4.237.1613; Di Napoli M, 2001, STROKE, V32, P1444, DOI 10.1161/01.STR.32.6.1443-a; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; Fine SL, 2000, NEW ENGL J MED, V342, P483, DOI 10.1056/NEJM200002173420707; Folsom AR, 1999, CIRCULATION, V100, P736, DOI 10.1161/01.CIR.100.7.736; Friedman E, 2000, AM J OPHTHALMOL, V130, P658, DOI 10.1016/S0002-9394(00)00643-7; GOTO I, 1975, STROKE, V6, P263, DOI 10.1161/01.STR.6.3.263; Hyman L, 2000, ARCH OPHTHALMOL-CHIC, V118, P351, DOI 10.1001/archopht.118.3.351; HYMAN LG, 1983, AM J EPIDEMIOL, V118, P213, DOI 10.1093/oxfordjournals.aje.a113629; Jackson R, 1996, J CLIN EPIDEMIOL, V49, P1441, DOI 10.1016/0895-4356(95)00047-X; Kassoff A, 2001, ARCH OPHTHALMOL-CHIC, V119, P1417, DOI 10.1001/archopht.119.10.1417; Klaver CCW, 1998, AM J HUM GENET, V63, P200, DOI 10.1086/301901; Klaver CCW, 1999, AM J EPIDEMIOL, V150, P963; KLEIN R, 1992, OPHTHALMOLOGY, V99, P1686; Klein R, 2003, OPHTHALMOLOGY, V110, P25, DOI 10.1016/S0161-6420(02)01565-8; Klein R, 1999, ARCH OPHTHALMOL-CHIC, V117, P1203; KLEIN R, 1991, OPHTHALMOLOGY, V98, P1128; Klein R, 1999, OPHTHALMOLOGY, V106, P1056, DOI 10.1016/S0161-6420(99)90255-5; Klein Ronald, 2003, Ophthalmology, V110, P1273, DOI 10.1016/S0161-6420(03)00599-2; Lindsberg PJ, 1996, ANN NEUROL, V40, P587, DOI 10.1002/ana.410400408; McCarron MO, 1999, NEUROLOGY, V53, P1308, DOI 10.1212/WNL.53.6.1308; McGwin G, 2005, OPHTHALMOLOGY, V112, P488, DOI 10.1016/j.ophtha.2004.10.027; *NAT HEART LUNG BL, 1988, ATH RISK COMM STUD O; O'Leary DH, 1999, NEW ENGL J MED, V340, P14, DOI 10.1056/NEJM199901073400103; PAULEIKHOFF D, 1990, AM J OPHTHALMOL, V109, P211, DOI 10.1016/S0002-9394(14)75989-6; Ridker PM, 1997, NEW ENGL J MED, V336, P973, DOI 10.1056/NEJM199704033361401; Rosamond WD, 1999, STROKE, V30, P736, DOI 10.1161/01.STR.30.4.736; SCHNEIDER R, 1993, STROKE, V24, P1874, DOI 10.1161/01.STR.24.12.1874; Seddon JM, 2004, JAMA-J AM MED ASSOC, V291, P704, DOI 10.1001/jama.291.6.704; Smith W, 1998, ARCH OPHTHALMOL-CHIC, V116, P583, DOI 10.1001/archopht.116.5.583; Snow K K, 1999, Ophthalmic Epidemiol, V6, P125, DOI 10.1076/opep.6.2.125.1558; Snowdon DA, 1997, JAMA-J AM MED ASSOC, V277, P813, DOI 10.1001/jama.277.10.813; SPERDUTO RD, 1986, ARCH OPHTHALMOL-CHIC, V104, P216; van Leeuwen R, 2005, JAMA-J AM MED ASSOC, V294, P3101, DOI 10.1001/jama.294.24.3101; van Leeuwen R, 2003, INVEST OPHTH VIS SCI, V44, P3771, DOI 10.1167/iovs.03-0121; VINGERLING JR, 1995, AM J EPIDEMIOL, V142, P404, DOI 10.1093/oxfordjournals.aje.a117648; Voko Z, 2003, NEUROLOGY, V61, P1273, DOI 10.1212/01.WNL.0000090458.67821.A3; White AD, 1996, J CLIN EPIDEMIOL, V49, P223, DOI 10.1016/0895-4356(95)00041-0; White HD, 2000, NEW ENGL J MED, V343, P317, DOI 10.1056/NEJM200008033430502; WILLIAMS OD, 1989, AM J EPIDEMIOL, V129, P687, DOI 10.1093/oxfordjournals.aje.a115184; Wilson HL, 2004, AM J OPHTHALMOL, V137, P615, DOI 10.1016/j.ajo.2003.10.025; Wong TY, 2002, AM J OPHTHALMOL, V134, P828; Wong TY, 2001, LANCET, V358, P1134, DOI 10.1016/S0140-6736(01)06253-5	45	111	114	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 18	2006	145	2					98	106		10.7326/0003-4819-145-2-200607180-00007	http://dx.doi.org/10.7326/0003-4819-145-2-200607180-00007			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	063WU	16847292				2022-12-28	WOS:000239051400003
J	Dwek, E				Dwek, Eli			Astronomy - The supernova origin of interstellar dust	SCIENCE			English	Editorial Material									NASA, Goddard Space Flight Ctr, Observ Cosmol Lab, Greenbelt, MD 20771 USA	National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center	Dwek, E (corresponding author), NASA, Goddard Space Flight Ctr, Observ Cosmol Lab, Code 661, Greenbelt, MD 20771 USA.	eli.dwek@nasa.gov						CERNUSCHI F, 1965, ANN ASTROPHYS, V28, P860; Clayton DD, 2004, ANNU REV ASTRON ASTR, V42, P39, DOI 10.1146/annurev.astro.42.053102.134022; CLAYTON DD, 1975, ASTROPHYS J, V199, P765, DOI 10.1086/153750; Dwek E, 1998, ASTROPHYS J, V501, P643, DOI 10.1086/305829; HOYLE F, 1970, NATURE, V226, P62, DOI 10.1038/226062a0; Jones A. P., 2004, ASP C SER, V309, P347; KOSAZA T, 1989, ASTROPHYS J, V344, P325; LUCY LB, 1991, SUPERNOVAE //, P82; Sugerman BEK, 2006, SCIENCE, V313, P196, DOI 10.1126/science.1128131	9	7	7	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 14	2006	313	5784					178	180		10.1126/science.1130423	http://dx.doi.org/10.1126/science.1130423			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	063GZ	16840686				2022-12-28	WOS:000239008000028
J	Gill, DL; Spassova, MA; Soboloff, J				Gill, Donald L.; Spassova, Maria A.; Soboloff, Jonathan			Signal transduction - Calcium entry signals - Trickles and torrents	SCIENCE			English	Editorial Material							CA2+ SENSOR; STORE; STIM1		Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore	Gill, DL (corresponding author), Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA.	dgill@umaryland.edu	Soboloff, Jonathan/I-6995-2012	Soboloff, Jonathan/0000-0001-5192-1297				Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Dellis O, 2006, SCIENCE, V313, P229, DOI 10.1126/science.1125203; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Patterson RL, 2004, ANNU REV BIOCHEM, V73, P437, DOI 10.1146/annurev.biochem.73.071403.161303; Peinelt C, 2006, NAT CELL BIOL, V8, P771, DOI 10.1038/ncb1435; PRAKRIYA M, IN PRESS J GEN PHYSL; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; SOBOLOFF J, IN PRESS CURR BIOL; Soboloff J, 2006, J BIOL CHEM, V281, P20661, DOI 10.1074/jbc.C600126200; Spassova MA, 2006, P NATL ACAD SCI USA, V103, P4040, DOI 10.1073/pnas.0510050103; Venkatachalam K, 2002, NAT CELL BIOL, V4, pE263, DOI 10.1038/ncb1102-e263; Vig M, 2006, SCIENCE, V312, P1220, DOI 10.1126/science.1127883; Zhang SL, 2006, P NATL ACAD SCI USA, V103, P9357, DOI 10.1073/pnas.0603161103; Zhang SYL, 2005, NATURE, V437, P902, DOI 10.1038/nature04147	16	12	13	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 14	2006	313	5784					183	184		10.1126/science.1130811	http://dx.doi.org/10.1126/science.1130811			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	063GZ	16840689				2022-12-28	WOS:000239008000031
J	Nudler, E				Nudler, Evgeny			Flipping riboswitches	CELL			English	Editorial Material							GENE-EXPRESSION; MESSENGER-RNAS	Riboswitches are common cis-acting regulatory elements in bacteria. They are made of nascent RNA that changes its conformation in response to direct binding of cognate metabolites. The publication of five high-resolution crystal structures provides a comprehensive view of how riboswitches sense their ligands and points to new challenges in this emerging field.	NYU, Sch Med, Dept Biochem, New York, NY 10016 USA	New York University	Nudler, E (corresponding author), NYU, Sch Med, Dept Biochem, New York, NY 10016 USA.	evgeny.nudler@med.nyu.edu		Nudler, Evgeny/0000-0002-8811-3071				Batey RT, 2004, NATURE, V432, P411, DOI 10.1038/nature03037; Fuchs RT, 2006, NAT STRUCT MOL BIOL, V13, P226, DOI 10.1038/nsmb1059; Kubodera T, 2003, FEBS LETT, V555, P516, DOI 10.1016/S0014-5793(03)01335-8; Mandal M, 2004, NAT REV MOL CELL BIO, V5, P451, DOI 10.1038/nrm1403; Mironov AS, 2002, CELL, V111, P747, DOI 10.1016/S0092-8674(02)01134-0; MONTAGE RK, 2006, IN PRESS NATURE; Nudler E, 2004, TRENDS BIOCHEM SCI, V29, P11, DOI 10.1016/j.tibs.2003.11.004; Serganov A, 2004, CHEM BIOL, V11, P1729, DOI 10.1016/j.chembiol.2004.11.018; SERGANOV A, 2006, IN PRESS NATURE; Thore S, 2006, SCIENCE, V312, P1208, DOI 10.1126/science.1128451; Winkler W, 2002, NATURE, V419, P952, DOI 10.1038/nature01145	11	47	51	0	4	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUL 14	2006	126	1					19	22		10.1016/j.cell.2006.06.024	http://dx.doi.org/10.1016/j.cell.2006.06.024			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	066JF	16839869	Bronze			2022-12-28	WOS:000239224800009
J	Hakama, M				Hakama, M			Family history in colorectal cancer surveillance strategies	LANCET			English	Editorial Material							RISK		Univ Tampere, Sch Publ Hlth, Div Epidemiol, FIN-33014 Tampere, Finland; Finnish Canc Registry, Tampere, Finland	Tampere University; Finnish Cancer Registry	Hakama, M (corresponding author), Univ Tampere, Sch Publ Hlth, Div Epidemiol, FIN-33014 Tampere, Finland.	matti.hakama@uta.fi						Butterworth AS, 2006, EUR J CANCER, V42, P216, DOI 10.1016/j.ejca.2005.09.023; COLEMAN MP, 1993, IARC SCI PUBLICATION, V121; HAKAMA M, 1979, J EPIDEMIOL COMMUN H, V33, P257, DOI 10.1136/jech.33.4.257; LEVIN M L, 1953, Acta Unio Int Contra Cancrum, V9, P531; Makinen T, 2002, J CLIN ONCOL, V20, P2658, DOI 10.1200/JCO.2002.05.006; Salminen T, 1998, INT J CANCER, V78, P410, DOI 10.1002/(SICI)1097-0215(19981109)78:4<410::AID-IJC3>3.0.CO;2-X; Sandhu MS, 2001, J MED SCREEN, V8, P69, DOI 10.1136/jms.8.2.69	7	4	4	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 8	2006	368	9530					101	103		10.1016/S0140-6736(06)68982-4	http://dx.doi.org/10.1016/S0140-6736(06)68982-4			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	062AR	16829281				2022-12-28	WOS:000238917200007
J	Mendelson, JR; Lips, KR; Gagliardo, RW; Rabb, GB; Collins, JP; Diffendorfer, JE; Daszak, P; Ibanez, R; Zippel, KC; Lawson, DP; Wright, KM; Stuart, SN; Gascon, C; da Silva, HR; Burrowes, PA; Joglar, RL; La Marca, E; Lotters, S; du Preez, LH; Weldon, C; Hyatt, A; Rodriguez-Mahecha, JV; Hunt, S; Robertson, H; Lock, B; Raxworthy, CJ; Frost, DR; Lacy, RC; Alford, RA; Campbell, JA; Parra-Olea, G; Bolanos, F; Domingo, JJC; Halliday, T; Murphy, JB; Wake, MH; Coloma, LA; Kuzmin, SL; Price, MS; Howell, KM; Lau, M; Pethiyagoda, R; Boone, M; Lannoo, MJ; Blaustein, AR; Dobson, A; Griffiths, RA; Crump, ML; Wake, DB; Brodie, ED				Mendelson, Joseph R., III; Lips, Karen R.; Gagliardo, Ronald W.; Rabb, George B.; Collins, James P.; Diffendorfer, James E.; Daszak, Peter; Ibanez D., Roberto; Zippel, Kevin C.; Lawson, Dwight P.; Wright, Kevin M.; Stuart, Simon N.; Gascon, Claude; da Silva, Helio R.; Burrowes, Patricia A.; Joglar, Rafael L.; La Marca, Enrique; Loetters, Stefan; du Preez, Louis H.; Weldon, Che; Hyatt, Alex; Rodriguez-Mahecha, Jose Vicente; Hunt, Susan; Robertson, Helen; Lock, Brad; Raxworthy, Christopher J.; Frost, Darrel R.; Lacy, Robert C.; Alford, Ross A.; Campbell, Jonathan A.; Parra-Olea, Gabriela; Bolanos, Federico; Calvo Domingo, Jose Joaquin; Halliday, Tim; Murphy, James B.; Wake, Marvalee H.; Coloma, Luis A.; Kuzmin, Sergius L.; Price, Mark Stanley; Howell, Kim M.; Lau, Michael; Pethiyagoda, Rohan; Boone, Michelle; Lannoo, Michael J.; Blaustein, Andrew R.; Dobson, Andy; Griffiths, Richard A.; Crump, Martha L.; Wake, David B.; Brodie, Edmund D., Jr.			Biodiversity - Confronting amphibian declines and extinctions	SCIENCE			English	Editorial Material							POPULATION DECLINES; CHYTRIDIOMYCOSIS; INFECTION; DISEASE					jmendelson@zooatlanta.org	Coloma, Luis/AAO-3956-2020; Alford, Ross A/H-1577-2011; daszak, peter/U-4588-2017; Pethiyagoda, Rohan/C-2307-2009	Coloma, Luis/0000-0003-0158-2455; Alford, Ross A/0000-0002-3010-6768; daszak, peter/0000-0002-2046-5695; Lips, Karen/0000-0002-2719-1551; Pethiyagoda, Rohan/0000-0001-7215-9617; Diffendorfer, Jay/0000-0003-1093-6948; Weldon, Che/0000-0001-6716-0787; Frost, Darrel/0000-0001-9465-5734				Berger L, 1998, P NATL ACAD SCI USA, V95, P9031, DOI 10.1073/pnas.95.15.9031; Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443; Harris RN, 2006, ECOHEALTH, V3, P53, DOI 10.1007/s10393-005-0009-1; Hayes TB, 2006, ENVIRON HEALTH PERSP, V114, P40, DOI 10.1289/ehp.8051; Kiesecker JM, 2002, P NATL ACAD SCI USA, V99, P9900, DOI 10.1073/pnas.152098899; Krajick K, 2006, SCIENCE, V311, P1230, DOI 10.1126/science.311.5765.1230; La Marca E, 2005, BIOTROPICA, V37, P190, DOI 10.1111/j.1744-7429.2005.00026.x; Lips KR, 2006, P NATL ACAD SCI USA, V103, P3165, DOI 10.1073/pnas.0506889103; McCallum H, 2005, CONSERV BIOL, V19, P1421, DOI 10.1111/j.1523-1739.2005.00217.x; MENDELSON JR, 2005, IN PRESS WAZA P WORL; Pounds JA, 2006, NATURE, V439, P161, DOI 10.1038/nature04246; Pounds JA, 1999, NATURE, V398, P611, DOI 10.1038/19297; Retallick RWR, 2004, PLOS BIOL, V2, P1965, DOI 10.1371/journal.pbio.0020351; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; VanCompernolle SE, 2005, J VIROL, V79, P11598, DOI 10.1128/JVI.79.18.11598-11606.2005; Weldon C, 2004, EMERG INFECT DIS, V10, P2100, DOI 10.3201/eid1012.030804; Whiles MR, 2006, FRONT ECOL ENVIRON, V4, P27, DOI 10.1890/1540-9295(2006)004[0027:TEOAPD]2.0.CO;2; Zippel Kevin, 2002, Herpetological Review, V33, P11	18	196	223	4	137	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 7	2006	313	5783					48	48		10.1126/science.1128396	http://dx.doi.org/10.1126/science.1128396			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061DA	16825553	Green Accepted			2022-12-28	WOS:000238850200019
J	Jamrozik, K				Jamrozik, K			The epidemiology of colonialism	LANCET			English	Editorial Material							DISEASE		Univ Queensland, Sch Populat Hlth, Herston, Qld 4006, Australia	University of Queensland	Jamrozik, K (corresponding author), Univ Queensland, Sch Populat Hlth, Herston, Qld 4006, Australia.	k.jamrozik@sph.uq.edu.au						Blakely T, 2006, LANCET, V368, P44, DOI 10.1016/S0140-6736(06)68813-2; *DEP CULT MED SPOR, 2003, REP WORK GROUP HUM R; Doll R., 2004, TOBACCO PUBLIC HLTH, P3; GRANT J, 1662, NATURAL POLITICAL OB; LAST JM, 1999, DICT EPIDEMIOLOGY; MARMOT MG, 1975, AM J EPIDEMIOL, V102, P514, DOI 10.1093/oxfordjournals.aje.a112189; *NAT ARCH AUSTR, 2006, 150 NAT ARCH AUSTR; STENHOUSE NS, 1970, J CHRON DIS, V23, P423, DOI 10.1016/0021-9681(70)90026-3; Wilson N, 2005, TOB CONTROL, V14, P284, DOI 10.1136/tc.2004.010009	9	3	3	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 1	2006	368	9529					4	6		10.1016/S0140-6736(06)68814-4	http://dx.doi.org/10.1016/S0140-6736(06)68814-4			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	058TQ	16815358				2022-12-28	WOS:000238687900005
J	Tsou, MFB; Stearns, T				Tsou, Meng-Fu Bryan; Stearns, Tim			Mechanism limiting centrosome duplication to once per cell cycle	NATURE			English	Article							SISTER-CHROMATID SEPARATION; CENTRIOLE; MITOSIS; KINASE; ONCOPROTEIN; INSTABILITY; PROGRESSION; CDK2-CYCLIN; CHROMOSOME; INTERPHASE	The centrosome organizes the microtubule cytoskeleton and consists of a pair of centrioles surrounded by pericentriolar material. Cells begin the cell cycle with a single centrosome, which duplicates once before mitosis. During duplication, new centrioles grow orthogonally to existing ones and remain engaged ( tightly opposed) with those centrioles until late mitosis or early G1 phase, when they become disengaged(1). The relationship between centriole engagement/disengagement and centriole duplication potential is not understood, and the mechanisms that control these processes are not known. Here we show that centriole disengagement requires the protease separase(2) at anaphase, and that this disengagement licences centriole duplication in the next cell cycle. We describe an in vitro system using Xenopus egg extract and purified centrioles in which both centriole disengagement and centriole growth occur. Centriole disengagement at anaphase is independent of mitotic exit and Cdk2/cyclin E activity, but requires the anaphase-promoting complex and separase. In contrast to disengagement, new centriole growth occurs in interphase, is dependent on Cdk2/cyclin E, and requires previously disengaged centrioles. This suggests that re-duplication of centrioles within a cell cycle is prevented by centriole engagement itself. We propose that the 'once-only' control of centrosome duplication is achieved by temporally separating licensing in anaphase from growth of new centrioles during S phase. The involvement of separase in both centriole disengagement and sister chromatid separation would prevent premature centriole disengagement before anaphase onset, which can lead to multipolar spindles and genomic instability(3,4).	Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA	Stanford University; Stanford University	Stearns, T (corresponding author), Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA.	stearns@stanford.edu		Stearns, Tim/0000-0002-0671-6582				Bahe S, 2005, J CELL BIOL, V171, P27, DOI 10.1083/jcb.200504107; CALLAINI G, 1990, J CELL SCI, V97, P539; GARD DL, 1990, J CELL BIOL, V110, P2033, DOI 10.1083/jcb.110.6.2033; Gimenez-Abian JF, 2005, CELL CYCLE, V4, P1576, DOI 10.4161/cc.4.11.2147; Guadagno TM, 1996, CELL, V84, P73, DOI 10.1016/S0092-8674(00)80994-0; Hinchcliffe EH, 1999, SCIENCE, V283, P851, DOI 10.1126/science.283.5403.851; HOLLOWAY SL, 1993, CELL, V73, P1393, DOI 10.1016/0092-8674(93)90364-V; Hut HMJ, 2003, MOL BIOL CELL, V14, P1993, DOI 10.1091/mbc.E02-08-0510; Kumada K, 2006, J CELL BIOL, V172, P835, DOI 10.1083/jcb.200511126; KURIYAMA R, 1981, J CELL BIOL, V91, P814, DOI 10.1083/jcb.91.3.814; Lacey KR, 1999, P NATL ACAD SCI USA, V96, P2817, DOI 10.1073/pnas.96.6.2817; Liu BY, 2003, MOL CELL BIOL, V23, P5269, DOI 10.1128/MCB.23.15.5269-5281.2003; Matsumoto Y, 1999, CURR BIOL, V9, P429, DOI 10.1016/S0960-9822(99)80191-2; Mayor T, 2000, J CELL BIOL, V151, P837, DOI 10.1083/jcb.151.4.837; McDermott KM, 2006, PLOS BIOL, V4, P350, DOI 10.1371/journal.pbio.0040051; Meraldi P, 1999, NAT CELL BIOL, V1, P88, DOI 10.1038/10054; Nagao K, 2004, NATURE, V430, P1044, DOI 10.1038/nature02803; Nasmyth K, 2000, SCIENCE, V288, P1379, DOI 10.1126/science.288.5470.1379; Nigg EA, 2002, NAT REV CANCER, V2, P815, DOI 10.1038/nrc924; Nishitani H, 2002, GENES CELLS, V7, P523, DOI 10.1046/j.1365-2443.2002.00544.x; Paoletti A, 1996, J CELL SCI, V109, P3089; Peloponese JM, 2005, P NATL ACAD SCI USA, V102, P18974, DOI 10.1073/pnas.0506659103; Stemmann O, 2001, CELL, V107, P715, DOI 10.1016/S0092-8674(01)00603-1; Tsou MFB, 2006, CURR OPIN CELL BIOL, V18, P74, DOI 10.1016/j.ceb.2005.12.008; Vidwans SJ, 1999, J CELL BIOL, V147, P1371, DOI 10.1083/jcb.147.7.1371; Wirth KG, 2006, J CELL BIOL, V172, P847, DOI 10.1083/jcb.200506119; Wong C, 2003, NAT CELL BIOL, V5, P539, DOI 10.1038/ncb993; Zou H, 1999, SCIENCE, V285, P418, DOI 10.1126/science.285.5426.418	28	321	324	1	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 24	2006	442	7105					947	951		10.1038/nature04985	http://dx.doi.org/10.1038/nature04985			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	076LT	16862117				2022-12-28	WOS:000239960500044
J	Kim, Y; Sung, JY; Ceglia, I; Lee, KW; Ahn, JH; Halford, JM; Kim, AM; Kwak, SP; Park, JB; Ryu, SH; Schenck, A; Bardoni, B; Scott, JD; Nairn, AC; Greengard, P				Kim, Yong; Sung, Jee Young; Ceglia, Ilaria; Lee, Ko-Woon; Ahn, Jung-Hyuck; Halford, Jonathan M.; Kim, Amie M.; Kwak, Seung P.; Park, Jong Bae; Ryu, Sung Ho; Schenck, Annette; Bardoni, Barbara; Scott, John D.; Nairn, Angus C.; Greengard, Paul			Phosphorylation of WAVE1 regulates actin polymerization and dendritic spine morphology	NATURE			English	Article							CYCLIN-DEPENDENT KINASE-5; NUCLEUS-ACCUMBENS; FAMILY PROTEINS; ARP2/3 COMPLEX; SMALL GTPASES; CDK5; WASP; DOPAMINE; NEURONS; COCAINE	WAVE1 - the Wiskott - Aldrich syndrome protein ( WASP)- family verprolin homologous protein 1 - is a key regulator of actin-dependent morphological processes(1) in mammals, through its ability to activate the actin-related protein (Arp2/3) complex. Here we show that WAVE1 is phosphorylated at multiple sites by cyclin-dependent kinase 5 (Cdk5) both in vitro and in intact mouse neurons. Phosphorylation of WAVE1 by Cdk5 inhibits its ability to regulate Arp2/3 complex-dependent actin polymerization. Loss of WAVE1 function in vivo or in cultured neurons results in a decrease in mature dendritic spines. Expression of a dephosphorylation-mimic mutant of WAVE1 reverses this loss of WAVE1 function in spine morphology, but expression of a phosphorylation-mimic mutant does not. Cyclic AMP ( cAMP) signalling reduces phosphorylation of the Cdk5 sites in WAVE1, and increases spine density in a WAVE1-dependent manner. Our data suggest that phosphorylation/dephosphorylation of WAVE1 in neurons has an important role in the formation of the filamentous actin cytoskeleton, and thus in the regulation of dendritic spine morphology.	Rockefeller Univ, Mol & Cellular Neurosci Lab, New York, NY 10021 USA; Wyeth Res, Discovery Neurosci, Princeton, NJ 08543 USA; Pohang Univ Sci & Technol, Div Mol & Life Sci, Pohang 790784, South Korea; ULP, INSERM, CNRS, Inst Genet & Biol Mol & Cellulaire, F-67404 Illkirch Graffenstaden, France; Vollum Inst, Howard Hughes Med Inst, Portland, OR 97239 USA; Yale Univ, Sch Med, Dept Psychiat, New Haven, CT 06508 USA	Rockefeller University; Pfizer; Pohang University of Science & Technology (POSTECH); Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Howard Hughes Medical Institute; Yale University	Kim, Y (corresponding author), Rockefeller Univ, Mol & Cellular Neurosci Lab, 1230 York Ave, New York, NY 10021 USA.	kimyo@rockefeller.edu; angus.nairn@yale.edu; greengard@rockefeller.edu	Schenck, Annette/E-4514-2012; Bardoni, Barbara/F-9918-2013	Schenck, Annette/0000-0002-6918-3314; Ahn, Jung-Hyuck/0000-0001-9589-3881; Nairn, Angus/0000-0002-7075-0195; Kim, Yong/0000-0002-1387-2962; Bardoni, Barbara/0000-0001-6411-1517; Ryu, Sung Ho/0000-0003-0913-3048; Ceglia, Ilaria/0000-0003-0692-9518	NATIONAL INSTITUTE ON DRUG ABUSE [P01DA010044] Funding Source: NIH RePORTER; NIDA NIH HHS [P01 DA010044] Funding Source: Medline	NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))		Bibb JA, 1999, NATURE, V402, P669, DOI 10.1038/45251; Bibb JA, 2001, NATURE, V410, P376, DOI 10.1038/35066591; Choi J, 2005, J NEUROSCI, V25, P869, DOI 10.1523/JNEUROSCI.3212-04.2005; Cruz JC, 2004, CURR OPIN NEUROBIOL, V14, P390, DOI 10.1016/j.conb.2004.05.002; Dahl JP, 2003, J NEUROSCI, V23, P3343; Eden S, 2002, NATURE, V418, P790, DOI 10.1038/nature00859; Grove M, 2004, MOL CELL BIOL, V24, P10905, DOI 10.1128/MCB.24.24.10905-10922.2004; Innocenti M, 2004, NAT CELL BIOL, V6, P319, DOI 10.1038/ncb1105; Irie F, 2002, NAT NEUROSCI, V5, P1117, DOI 10.1038/nn964; Lee KW, 2006, P NATL ACAD SCI USA, V103, P3399, DOI 10.1073/pnas.0511244103; Luo LQ, 1996, NATURE, V379, P837, DOI 10.1038/379837a0; Machesky LM, 1999, P NATL ACAD SCI USA, V96, P3739, DOI 10.1073/pnas.96.7.3739; Matus A, 2000, SCIENCE, V290, P754, DOI 10.1126/science.290.5492.754; Miki H, 1998, EMBO J, V17, P6932, DOI 10.1093/emboj/17.23.6932; Nakayama AY, 2000, J NEUROSCI, V20, P5329, DOI 10.1523/JNEUROSCI.20-14-05329.2000; Nishi A, 1997, J NEUROSCI, V17, P8147; Norrholm SD, 2003, NEUROSCIENCE, V116, P19, DOI 10.1016/S0306-4522(02)00560-2; Patrick GN, 1999, NATURE, V402, P615, DOI 10.1038/45159; Rao A, 2000, HIPPOCAMPUS, V10, P527, DOI 10.1002/1098-1063(2000)10:5<527::AID-HIPO3>3.0.CO;2-B; Saito T, 2003, J NEUROSCI, V23, P1189, DOI 10.1523/JNEUROSCI.23-04-01189.2003; Smith DS, 2001, CELL GROWTH DIFFER, V12, P277; Soderling SH, 2003, P NATL ACAD SCI USA, V100, P1723, DOI 10.1073/pnas.0438033100; Stradal TEB, 2004, TRENDS CELL BIOL, V14, P303, DOI 10.1016/j.tcb.2004.04.007; Suetsugu S, 1999, BIOCHEM BIOPH RES CO, V260, P296, DOI 10.1006/bbrc.1999.0894; Takenawa T, 2001, J CELL SCI, V114, P1801	25	229	235	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 17	2006	442	7104					814	817		10.1038/nature04976	http://dx.doi.org/10.1038/nature04976			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	074DK	16862120				2022-12-28	WOS:000239792700046
J	Pilot, F; Philippe, JM; Lemmers, C; Lecuit, T				Pilot, Fanny; Philippe, Jean-Marc; Lemmers, Celine; Lecuit, Thomas			Spatial control of actin organization at adherens junctions by the synaptotagmin-like protein Btsz	NATURE			English	Article							DROSOPHILA E-CADHERIN; EPITHELIAL-CELLS; POLARITY; MORPHOGENESIS; ARMADILLO; ADHESION; REARRANGEMENT; NEUROBLASTS; MECHANISMS; OOGENESIS	Epithelial tissues maintain a robust architecture during development. This fundamental property relies on intercellular adhesion through the formation of adherens junctions containing E-cadherin molecules(1,2). Localization of E-cadherin is stabilized through a pathway involving the recruitment of actin filaments by E-cadherin(3-6). Here we identify an additional pathway that organizes actin filaments in the apical junctional region (AJR) where adherens junctions form in embryonic epithelia. This pathway is controlled by Bitesize (Btsz), a synaptotagmin-like protein(7,8) that is recruited in the AJR independently of E-cadherin and is required for epithelial stability in Drosophila embryos. On loss of btsz, E-cadherin is recruited normally to the AJR, but is not stabilized properly and actin filaments fail to form a stable continuous network. In the absence of E-cadherin, actin filaments are stable for a longer time than they are in btsz mutants. We identify two polarized cues that localize Btsz: phosphatidylinositol (4,5)-bisphosphate, to which Btsz binds; and Par-3. We show that Btsz binds to the Ezrin - Radixin - Moesin protein Moesin, an F-actin-binding protein that is localized apically(9) and is recruited in the AJR in a btsz-dependent manner. Expression of a dominant-negative form of Ezrin that does not bind F-actin phenocopies the loss of btsz. Thus, our data indicate that, through their interaction, Btsz and Moesin may mediate the proper organization of actin in a local domain, which in turn stabilizes E-cadherin. These results provide a mechanism for the spatial order of actin organization underlying junction stabilization in primary embryonic epithelia.	Univ Mediterrannee, CNRS, UMR 6216, Inst Biol Dev Marseille Luminy, F-13288 Marseille 09, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Lecuit, T (corresponding author), Univ Mediterrannee, CNRS, UMR 6216, Inst Biol Dev Marseille Luminy, Campus Luminy,Case 907, F-13288 Marseille 09, France.	lecuit@ibdm.univ-mrs.fr		Pilot-Storck, Fanny/0000-0001-8139-9911				Bershadsky A, 2004, TRENDS CELL BIOL, V14, P589, DOI 10.1016/j.tcb.2004.09.009; Bretscher A, 2002, NAT REV MOL CELL BIO, V3, P586, DOI 10.1038/nrm882; Cox RT, 1996, J CELL BIOL, V134, P133, DOI 10.1083/jcb.134.1.133; de Joussineau C, 2003, NATURE, V426, P555, DOI 10.1038/nature02157; Drees F, 2005, CELL, V123, P903, DOI 10.1016/j.cell.2005.09.021; Formstecher E, 2005, GENOME RES, V15, P376, DOI 10.1101/gr.2659105; Fukuda M, 2001, BIOCHEM BIOPH RES CO, V283, P513, DOI 10.1006/bbrc.2001.4803; GABEV E, 1989, BIOCHIM BIOPHYS ACTA, V979, P105, DOI 10.1016/0005-2736(89)90529-4; Gumbiner BM, 2000, J CELL BIOL, V148, P399, DOI 10.1083/jcb.148.3.399; Harris TJC, 2004, J CELL BIOL, V167, P135, DOI 10.1083/jcb.200406024; Jamora C, 2002, NAT CELL BIOL, V4, pE101, DOI 10.1038/ncb0402-e101; Knust E, 2002, SCIENCE, V298, P1955, DOI 10.1126/science.1072161; Kobielak A, 2004, NAT CELL BIOL, V6, P21, DOI 10.1038/ncb1075; Muller HAJ, 1996, J CELL BIOL, V134, P149, DOI 10.1083/jcb.134.1.149; Nelson WJ, 2003, NATURE, V422, P766, DOI 10.1038/nature01602; PEIFER M, 1993, DEVELOPMENT, V118, P1191; Petronczki M, 2001, NAT CELL BIOL, V3, P43, DOI 10.1038/35050550; Pilot F, 2006, DEVELOPMENT, V133, P711, DOI 10.1242/dev.02251; Pinal N, 2006, CURR BIOL, V16, P140, DOI 10.1016/j.cub.2005.11.068; Polesello C, 2002, NAT CELL BIOL, V4, P782, DOI 10.1038/ncb856; Serano J, 2003, P NATL ACAD SCI USA, V100, P13368, DOI 10.1073/pnas.1835727100; Speck O, 2003, NATURE, V421, P83, DOI 10.1038/nature01295; TEPASS U, 1990, CELL, V61, P787, DOI 10.1016/0092-8674(90)90189-L; Tepass U, 1996, GENE DEV, V10, P672, DOI 10.1101/gad.10.6.672; Uemura T, 1996, GENE DEV, V10, P659, DOI 10.1101/gad.10.6.659; von Stein W, 2005, DEVELOPMENT, V132, P1675, DOI 10.1242/dev.01720; Wodarz A, 2000, J CELL BIOL, V150, P1361, DOI 10.1083/jcb.150.6.1361; Yamada S, 2005, CELL, V123, P889, DOI 10.1016/j.cell.2005.09.020; Yonemura S, 2002, J CELL SCI, V115, P2569; Zelhof AC, 2004, J CELL BIOL, V164, P417, DOI 10.1083/jcb.200307048	30	94	95	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 3	2006	442	7102					580	584		10.1038/nature04935	http://dx.doi.org/10.1038/nature04935			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069NQ	16862128				2022-12-28	WOS:000239455900047
J	Selmecki, A; Forche, A; Berman, J				Selmecki, Anna; Forche, Anja; Berman, Judith			Aneuploidy and isochromosome formation in drug-resistant Candida albicans	SCIENCE			English	Article							MESSENGER-RNA LEVELS; FLUCONAZOLE RESISTANCE; EXPERIMENTAL POPULATIONS; WIDESPREAD ANEUPLOIDY; LABORATORY STRAINS; CHROMOSOME LOSS; EVOLUTION; CDR; TRANSPORTERS; SEQUENCE	Resistance to the limited number of available antifungal drugs is a serious problem in the treatment of Candida albicans. We found that aneuploidy in general and a specific segmental aneuploidy, consisting of an isochromosome composed of the two left arms of chromosome 5, were associated with azole resistance. The isochromosome forms around a single centromere flanked by an inverted repeat and was found as an independent chromosome or fused at the telomere to a full-length homolog of chromosome 5. Increases and decreases in drug resistance were strongly associated with gain and loss of this isochromosome, which bears genes expressing the enzyme in the ergosterol pathway targeted by azole drugs, efflux pumps, and a transcription factor that positively regulates a subset of efflux pump genes.	Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA; Univ Minnesota, Dept Microbiol, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Berman, J (corresponding author), Univ Minnesota, Dept Genet Cell Biol & Dev, 6-160 Jackson Hall,321 Church St SE, Minneapolis, MN 55455 USA.	jberman@umn.edu	Berman, Judith/ABA-8528-2021; Berman, Judith/AAS-5115-2021	Berman, Judith/0000-0002-8577-0084; Selmecki, Anna/0000-0003-3298-2400	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI062427] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE010641] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R29DE010641] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI062427] Funding Source: Medline; NIDCR NIH HHS [DE10641-S] Funding Source: Medline; PHS HHS [R01 AIO62427] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Anderson JB, 2003, GENETICS, V163, P1287; Bennett RJ, 2003, EMBO J, V22, P2505, DOI 10.1093/emboj/cdg235; Calvet HM, 1997, ANTIMICROB AGENTS CH, V41, P535, DOI 10.1128/AAC.41.3.535; Chen X, 2004, MOL MICROBIOL, V51, P551, DOI 10.1046/j.1365-2958.2003.03852.x; CHU WS, 1993, J BACTERIOL, V175, P6637, DOI 10.1128/jb.175.20.6637-6651.1993; Coste A, 2006, GENETICS, V172, P2139, DOI 10.1534/genetics.105.054767; Coste AT, 2004, EUKARYOT CELL, V3, P1639, DOI 10.1128/EC.3.6.1639-1652.2004; Cowen LE, 2005, SCIENCE, V309, P2185, DOI 10.1126/science.1118370; Cowen LE, 2001, J BACTERIOL, V183, P2971, DOI 10.1128/JB.183.10.2971-2978.2001; Cowen LE, 2000, J BACTERIOL, V182, P1515, DOI 10.1128/JB.182.6.1515-1522.2000; Forche A, 1999, FUNGAL GENET BIOL, V28, P107, DOI 10.1006/fgbi.1999.1164; Fraser JA, 2005, EUKARYOT CELL, V4, P401, DOI 10.1128/EC.4.2.401-406.2005; GREENFEDER SA, 1992, MOL CELL BIOL, V12, P4056, DOI 10.1128/MCB.12.9.4056; Hughes TR, 2000, NAT GENET, V25, P333, DOI 10.1038/77116; Janbon G, 1998, P NATL ACAD SCI USA, V95, P5150, DOI 10.1073/pnas.95.9.5150; Karababa M, 2004, ANTIMICROB AGENTS CH, V48, P3064, DOI 10.1128/AAC.48.8.3064-3079.2004; Lephart PR, 2005, EUKARYOT CELL, V4, P733, DOI 10.1128/EC.4.4.733-741.2005; Marr KA, 1998, ANTIMICROB AGENTS CH, V42, P2584, DOI 10.1128/AAC.42.10.2584; Marr KA, 1997, CLIN INFECT DIS, V25, P908, DOI 10.1086/515553; Sanyal K, 2004, P NATL ACAD SCI USA, V101, P11374, DOI 10.1073/pnas.0404318101; SCHONIAN G, 1993, MYCOSES, V36, P171, DOI 10.1111/j.1439-0507.1993.tb00746.x; Selmecki A, 2005, MOL MICROBIOL, V55, P1553, DOI 10.1111/j.1365-2958.2005.04492.x; Sullivan BA, 2001, NAT REV GENET, V2, P584, DOI 10.1038/35084512; Tavanti A, 2005, J CLIN MICROBIOL, V43, P5601, DOI 10.1128/JCM.43.11.5601-5613.2005; White TC, 2002, ANTIMICROB AGENTS CH, V46, P1704, DOI 10.1128/AAC.46.6.1704-1713.2002; White TC, 1997, ANTIMICROB AGENTS CH, V41, P1482, DOI 10.1128/AAC.41.7.1482	26	475	486	2	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 21	2006	313	5785					367	370		10.1126/science.1128242	http://dx.doi.org/10.1126/science.1128242			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065IV	16857942	Green Accepted			2022-12-28	WOS:000239154300049
J	Yeung, T; Terebiznik, M; Yu, LM; Silvius, J; Abidi, WM; Philips, M; Levine, T; Kapus, A; Grinstein, S				Yeung, Tony; Terebiznik, Mauricio; Yu, Liming; Silvius, John; Abidi, Wasif M.; Philips, Mark; Levine, Tim; Kapus, Andras; Grinstein, Sergio			Receptor activation alters inner surface potential during phagocytosis	SCIENCE			English	Article							PLASMA-MEMBRANE; LOCALIZATION; K-RAS4B; BINDING	The surface potential of biological membranes varies according to their lipid composition. We devised genetically encoded probes to assess surface potential in intact cells. These probes revealed marked, localized alterations in the charge of the inner surface of the plasma membrane of macrophages during the course of phagocytosis. Hydrolysis of phosphoinositides and displacement of phosphatidylserine accounted for the change in surface potential at the phagosomal cup. Signaling molecules such as K-Ras, Rac1, and c-Src that are targeted to the membrane by electrostatic interactions were rapidly released from membrane subdomains where the surface charge was altered by lipid remodeling during phagocytosis.	Hosp Sick Children, Div Cell Biol, Toronto, ON M5G 1X8, Canada; Hosp Sick Children, Gastroenterol Hepatol & Nutr Dept, Toronto, ON M5G 1X8, Canada; Univ Toronto, Inst Med Sci, Toronto, ON M5S 1A8, Canada; McGill Univ, Dept Biochem, Montreal, PQ H3G 1Y6, Canada; NYU, Sch Med, Dept Med, New York, NY 10016 USA; UCL, Div Cell Biol, London EC1V 9EL, England; St Michaels Hosp, Res Inst, Toronto, ON M5B 1W8, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; McGill University; New York University; University of London; University College London; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto	Grinstein, S (corresponding author), Hosp Sick Children, Div Cell Biol, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	sga@sickkids.ca		Mark, Philips/0000-0002-1179-8156; Yeung, Tony/0000-0002-1970-5751				Botelho RJ, 2004, CURR TOP MICROBIOL, V282, P1; HANCOCK JF, 1990, CELL, V63, P133, DOI 10.1016/0092-8674(90)90294-O; Hoppe AD, 2004, MOL BIOL CELL, V15, P3509, DOI 10.1091/mbc.E03-11-0847; Leventis R, 1998, BIOCHEMISTRY-US, V37, P7640, DOI 10.1021/bi973077h; McCabe JB, 2001, MOL BIOL CELL, V12, P3601, DOI 10.1091/mbc.12.11.3601; MCLAUGHLIN S, 1995, TRENDS BIOCHEM SCI, V20, P272, DOI 10.1016/S0968-0004(00)89042-8; Michaelson D, 2001, J CELL BIOL, V152, P111, DOI 10.1083/jcb.152.1.111; Olivotto M, 1996, BIOESSAYS, V18, P495, DOI 10.1002/bies.950180612; Roy MO, 2000, BIOCHEMISTRY-US, V39, P8298, DOI 10.1021/bi000512q	9	248	253	0	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 21	2006	313	5785					347	351		10.1126/science.1129551	http://dx.doi.org/10.1126/science.1129551			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065IV	16857939				2022-12-28	WOS:000239154300043
J	Rooney, N; McCann, K; Gellner, G; Moore, JC				Rooney, Neil; McCann, Kevin; Gellner, Gabriel; Moore, John C.			Structural asymmetry and the stability of diverse food webs	NATURE			English	Article							TROPHIC INTERACTIONS; REAL; DYNAMICS; PREDATOR; COMPARTMENTATION	Untangling the influence of human activities on food-web stability and persistence is complex given the large numbers of species and overwhelming number of interactions within ecosystems. Although biodiversity has been associated with stability, the actual structures and processes that confer stability to diverse food webs remain largely unknown. Here we show that real food webs are structured such that top predators act as couplers of distinct energy channels that differ in both productivity and turnover rate. Our theoretical analysis shows that coupled fast and slow channels convey both local and non-local stability to food webs. Alarmingly, the same human actions that have been implicated in the loss of biodiversity also directly erode the very structures and processes that we show to confer stability on food webs.	Univ Guelph, Dept Integrat Biol, Guelph, ON N1G 2W1, Canada; Univ No Colorado, Sch Biol Sci, Greeley, CO 80639 USA	University of Guelph; University of Northern Colorado	Rooney, N (corresponding author), Univ Guelph, Dept Integrat Biol, Guelph, ON N1G 2W1, Canada.	nrooney@uoguelph.ca	Moore, John/E-9802-2011	Gellner, Gabriel/0000-0001-8170-1463; Rooney, Neil/0000-0003-4360-4034				BAIRD D, 1989, ECOL MONOGR, V59, P329, DOI 10.2307/1943071; BERG MP, 1987, THESIS VRIJE U AMSTE; COHEN JE, 1978, FOOD WEBS NICHE SPAC; DERUITER PC, 1995, SCIENCE, V269, P1257, DOI 10.1126/science.269.5228.1257; DOLES J, 2000, SURVEY SOIL BIOTA AR; GOLDWASSER L, 1993, ECOLOGY, V74, P1216, DOI 10.2307/1940492; HOLT RD, 1983, AM NAT, V122, P521, DOI 10.1086/284153; HUNT HW, 1987, BIOL FERT SOILS, V3, P57, DOI 10.1007/BF00260580; Ives AR, 2002, AM NAT, V159, P388, DOI 10.1086/338994; Krause AE, 2003, NATURE, V426, P282, DOI 10.1038/nature02115; Krivan V, 1996, THEOR POPUL BIOL, V49, P265, DOI 10.1006/tpbi.1996.0014; MACARTHUR R, 1955, ECOLOGY, V36, P533, DOI 10.2307/1929601; MAY R M, 1971, Mathematical Biosciences, V12, P59, DOI 10.1016/0025-5564(71)90074-5; May R.M., 1973, STABILITY COMPLEXITY; McCann K, 1998, NATURE, V395, P794, DOI 10.1038/27427; McCann KS, 2005, ECOL LETT, V8, P513, DOI 10.1111/j.1461-0248.2005.00742.x; McCann KS, 2000, NATURE, V405, P228, DOI 10.1038/35012234; MOORE JC, 1993, SCIENCE, V261, P906, DOI 10.1126/science.261.5123.906; MOORE JC, 1989, SCIENCE, V243, P238, DOI 10.1126/science.2911739; MOORE JC, 1988, NATURE, V333, P261, DOI 10.1038/333261a0; Neira S, 2004, J EXP MAR BIOL ECOL, V312, P349, DOI 10.1016/j.jembe.2004.07.011; Neutel AM, 2002, SCIENCE, V296, P1120, DOI 10.1126/science.1068326; PAINE RT, 1992, NATURE, V355, P73, DOI 10.1038/355073a0; PIMM SL, 1979, THEOR POPUL BIOL, V16, P144, DOI 10.1016/0040-5809(79)90010-8; PIMM SL, 1980, J ANIM ECOL, V49, P879, DOI 10.2307/4233; POLIS GA, 1992, TRENDS ECOL EVOL, V7, P151, DOI 10.1016/0169-5347(92)90208-S; POLIS GA, 1991, AM NAT, V138, P123, DOI 10.1086/285208; Polis GA, 1996, AM NAT, V147, P813, DOI 10.1086/285880; Post DM, 2000, ECOLOGY, V81, P8, DOI 10.2307/177129; RAFELI DG, 1996, FOOD WEBS INTEGRATIO, P185; Sanchez F, 2004, ECOL MODEL, V172, P151, DOI 10.1016/j.ecolmodel.2003.09.005; Scheffer M, 2001, NATURE, V413, P591, DOI 10.1038/35098000; Teng J, 2004, AM NAT, V164, P85, DOI 10.1086/421723; Terborgh J, 2001, SCIENCE, V294, P1923, DOI 10.1126/science.1064397; Tilman D, 1999, ECOLOGY, V80, P1455, DOI 10.1890/0012-9658(1999)080[1455:TECOCI]2.0.CO;2; TRITES AW, 1999, FISHERIES CTR RES RE, V7; Ulanowicz RE, 1999, J MARINE SYST, V19, P159, DOI 10.1016/S0924-7963(98)90017-3; Vander Zanden MJ, 2002, ECOLOGY, V83, P2152, DOI 10.1890/0012-9658(2002)083[2152:FAIOBA]2.0.CO;2; WINEMILLER KO, 1990, ECOL MONOGR, V60, P331, DOI 10.2307/1943061; Wootton JT, 1997, ECOL MONOGR, V67, P45, DOI 10.1890/0012-9615(1997)067[0045:EATOPC]2.0.CO;2	41	602	619	11	310	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 20	2006	442	7100					265	269		10.1038/nature04887	http://dx.doi.org/10.1038/nature04887			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064WT	16855582				2022-12-28	WOS:000239122100030
J	Blencowe, BJ				Blencowe, Benjamin J.			Alternative splicing: New insights from global analyses	CELL			English	Review							MESSENGER-RNA DECAY; GENOME-WIDE SURVEY; SELECTION PRESSURE; GENE DUPLICATION; PROSTATE-CANCER; EXON; IDENTIFICATION; NONSENSE; MOUSE; MUTATIONS	Recent analyses of sequence and microarray data have suggested that alternative splicing plays a major role in the generation of proteomic and functional diversity in metazoan organisms. Efforts are now being directed at establishing the full repertoire of functionally relevant transcript variants generated by alternative splicing, the specific roles of such variants in normal and disease physiology, and how alternative splicing is coordinated on a global level to achieve cell- and tissue-specific functions. Recent progress in these areas is summarized in this review.	Univ Toronto, Banting & Best Dept Med Res, Toronto, ON M5S 3E1, Canada; Univ Toronto, Dept Mol & Med Genet, Ctr Cellular & Biomol Res, Toronto, ON M5S 3E1, Canada	University of Toronto; University of Toronto	Blencowe, BJ (corresponding author), Univ Toronto, Banting & Best Dept Med Res, Donnelly CCBR Bldg,160 Coll St,Room 1016, Toronto, ON M5S 3E1, Canada.	b.blencowe@utoronto.ca						Ars E, 2000, HUM MOL GENET, V9, P237, DOI 10.1093/hmg/9.2.237; Baek D, 2005, P NATL ACAD SCI USA, V102, P12813, DOI 10.1073/pnas.0506139102; Beffert U, 2005, NEURON, V47, P567, DOI 10.1016/j.neuron.2005.07.007; Bentley DL, 2005, CURR OPIN CELL BIOL, V17, P251, DOI 10.1016/j.ceb.2005.04.006; Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; Blanchette M, 2005, GENE DEV, V19, P1306, DOI 10.1101/gad.1314205; Boucher L, 2001, RNA, V7, P1693; Brett D, 2002, NAT GENET, V30, P29, DOI 10.1038/ng803; Brudno M, 2001, NUCLEIC ACIDS RES, V29, P2338, DOI 10.1093/nar/29.11.2338; Cartegni L, 2002, NAT REV GENET, V3, P285, DOI 10.1038/nrg775; Chen BE, 2006, CELL, V125, P607, DOI 10.1016/j.cell.2006.03.034; Chern TM, 2006, PLOS GENET, V2, P606, DOI 10.1371/journal.pgen.0020045; Davis CA, 2000, NUCLEIC ACIDS RES, V28, P1700, DOI 10.1093/nar/28.8.1700; Dulac C, 2005, CELL, V121, P664, DOI 10.1016/j.cell.2005.05.017; Dye MJ, 2006, MOL CELL, V21, P849, DOI 10.1016/j.molcel.2006.01.032; Fairbrother WG, 2002, SCIENCE, V297, P1007, DOI 10.1126/science.1073774; Forch P, 2003, Prog Mol Subcell Biol, V31, P127; Graveley BR, 2005, CELL, V123, P65, DOI 10.1016/j.cell.2005.07.028; Gromak N, 2003, EMBO J, V22, P6356, DOI 10.1093/emboj/cdg609; Hiller M, 2004, NAT GENET, V36, P1255, DOI 10.1038/ng1469; Horiuchi T, 2006, BIOL CELL, V98, P135, DOI 10.1042/BC20050002; Hughes AL, 2005, J MOL EVOL, V61, P758, DOI 10.1007/s00239-005-0037-z; Ibrahim EC, 2005, P NATL ACAD SCI USA, V102, P5002, DOI 10.1073/pnas.0500543102; Johnson JM, 2003, SCIENCE, V302, P2141, DOI 10.1126/science.1090100; Kanadia RN, 2003, SCIENCE, V302, P1978, DOI 10.1126/science.1088583; Keene JD, 2005, CHROMOSOME RES, V13, P327, DOI 10.1007/s10577-005-0848-1; Kim H, 2004, NAT GENET, V36, P915, DOI 10.1038/ng0904-915; Kopelman NM, 2005, NAT GENET, V37, P588, DOI 10.1038/ng1575; Kornblihtt AR, 2006, NAT STRUCT MOL BIOL, V13, P5, DOI 10.1038/nsmb0106-5; Kornblihtt AR, 2005, CURR OPIN CELL BIOL, V17, P262, DOI 10.1016/j.ceb.2005.04.014; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Le K, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh173; Lee C, 2003, NUCLEIC ACIDS RES, V31, P101, DOI 10.1093/nar/gkg029; Lev-Maor G, 2003, SCIENCE, V300, P1288, DOI 10.1126/science.1082588; Lewis BP, 2003, P NATL ACAD SCI USA, V100, P189, DOI 10.1073/pnas.0136770100; Li HR, 2006, CANCER RES, V66, P4079, DOI 10.1158/0008-5472.CAN-05-4264; Lipscombe D, 2005, CURR OPIN NEUROBIOL, V15, P358, DOI 10.1016/j.conb.2005.04.002; Martinez-Contreras R, 2006, PLOS BIOL, V4, P172, DOI 10.1371/journal.pbio.0040021; Matlin AJ, 2005, NAT REV MOL CELL BIO, V6, P386, DOI 10.1038/nrm1645; Miki R, 2001, P NATL ACAD SCI USA, V98, P2199, DOI 10.1073/pnas.041605498; Minovitsky S, 2005, NUCLEIC ACIDS RES, V33, P714, DOI 10.1093/nar/gki210; Modrek B, 2003, NAT GENET, V34, P177, DOI 10.1038/ng1159; Modrek B, 2002, NAT GENET, V30, P13, DOI 10.1038/ng0102-13; Modrek B, 2001, NUCLEIC ACIDS RES, V29, P2850, DOI 10.1093/nar/29.13.2850; Ohler U, 2005, PLOS COMPUT BIOL, V1, P113, DOI 10.1371/journal.pcbi.0010015; Pagani F, 2004, NAT REV GENET, V5, P389, DOI 10.1038/nrg1327; Pan Q, 2006, GENE DEV, V20, P153, DOI 10.1101/gad.1382806; Pan Q, 2005, TRENDS GENET, V21, P73, DOI 10.1016/j.tig.2004.12.004; Pan Q, 2004, MOL CELL, V16, P929, DOI 10.1016/j.molcel.2004.12.004; Philipps DL, 2004, RNA, V10, P1838, DOI 10.1261/rna.7136104; Resch A, 2004, J PROTEOME RES, V3, P76, DOI 10.1021/pr034064v; Resch A, 2004, NUCLEIC ACIDS RES, V32, P1261, DOI 10.1093/nar/gkh284; Schmucker D, 2000, CELL, V101, P671, DOI 10.1016/S0092-8674(00)80878-8; SENAPATHY P, 1990, METHOD ENZYMOL, V183, P252; Shai O, 2006, BIOINFORMATICS, V22, P606, DOI 10.1093/bioinformatics/btk028; Soergel David A. W., 2006, P175; Sorek R, 2004, TRENDS GENET, V20, P68, DOI 10.1016/j.tig.2003.12.004; Stolc V, 2004, SCIENCE, V306, P655, DOI 10.1126/science.1101312; Su ZX, 2006, GENOME RES, V16, P182, DOI 10.1101/gr.4197006; Sugnet CW, 2006, PLOS COMPUT BIOL, V2, P22, DOI 10.1371/journal.pcbi.0020004; Sun HZ, 2000, MOL CELL BIOL, V20, P6414, DOI 10.1128/MCB.20.17.6414-6425.2000; Teraoka SN, 1999, AM J HUM GENET, V64, P1617, DOI 10.1086/302418; Thanaraj TA, 2004, NUCLEIC ACIDS RES, V32, pD64, DOI 10.1093/nar/gkh030; Ule J, 2005, NAT GENET, V37, P844, DOI 10.1038/ng1610; Ule J, 2003, SCIENCE, V302, P1212, DOI 10.1126/science.1090095; Ule J, 2006, CURR OPIN NEUROBIOL, V16, P102, DOI 10.1016/j.conb.2006.01.003; Wang H, 2003, BIOINFORMATICS, V19, pi315, DOI 10.1093/bioinformatics/btg1044; Wang P, 2005, P NATL ACAD SCI USA, V102, P18920, DOI 10.1073/pnas.0506770102; Wang ZF, 2006, MOL CELL, V23, P61, DOI 10.1016/j.molcel.2006.05.018; Wang ZF, 2004, CELL, V119, P831, DOI 10.1016/j.cell.2004.11.010; Watahiki A, 2004, NAT METHODS, V1, P233, DOI 10.1038/NMETH719; Watson FL, 2005, SCIENCE, V309, P1874, DOI 10.1126/science.1116887; Wu LF, 2002, NAT GENET, V31, P255, DOI 10.1038/ng906; Xing Y, 2005, PLOS GENET, V1, P323, DOI 10.1371/journal.pgen.0010034; Xing Y, 2005, P NATL ACAD SCI USA, V102, P13526, DOI 10.1073/pnas.0501213102; Yeakley JM, 2002, NAT BIOTECHNOL, V20, P353, DOI 10.1038/nbt0402-353; Yeo G, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r74; Yeo GW, 2005, P NATL ACAD SCI USA, V102, P2850, DOI 10.1073/pnas.0409742102; Zavolan M, 2003, GENOME RES, V13, P1290, DOI 10.1101/gr.1017303; Zhang CL, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-202; Zhang Wen, 2004, J Biol, V3, P21, DOI 10.1186/jbiol16; Zhang XHF, 2004, GENE DEV, V18, P1241, DOI 10.1101/gad.1195304; Zheng CL, 2005, RNA, V11, P1767, DOI 10.1261/rna.2650905	83	798	843	3	150	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 14	2006	126	1					37	47		10.1016/j.cell.2006.06.023	http://dx.doi.org/10.1016/j.cell.2006.06.023			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	066JF	16839875	Bronze			2022-12-28	WOS:000239224800015
J	Carpick, RW				Carpick, Robert W.			Physics - Controlling friction	SCIENCE			English	Editorial Material							SURFACE; TRIBOLOGY		Univ Wisconsin, Dept Engn Phys, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Carpick, RW (corresponding author), Univ Wisconsin, Dept Engn Phys, Madison, WI 53706 USA.	carpick@engr.wisc.edu						de Boer MP, 2004, J MICROELECTROMECH S, V13, P63, DOI 10.1109/JMEMS.2003.823236; de Boer MP, 2001, MRS BULL, V26, P302, DOI 10.1557/mrs2001.65; Flater EE, 2006, WEAR, V260, P580, DOI 10.1016/j.wear.2005.02.070; JOST HP, 1990, WEAR, V136, P1, DOI 10.1016/0043-1648(90)90068-L; MATE CM, 1987, PHYS REV LETT, V59, P1942, DOI 10.1103/PhysRevLett.59.1942; Morita S., 1996, Surface Science Reports, V23, P3, DOI 10.1016/0167-5729(95)00009-7; Park JY, 2006, SCIENCE, V313, P186, DOI 10.1126/science.1125017; Prandtl L, 1928, Z ANGEW MATH MECH, V8, P85, DOI 10.1002/zamm.19280080202; Socoliuc A, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.134301; Socoliuc A, 2006, SCIENCE, V313, P207, DOI 10.1126/science.1125874; Tomlinson GA, 1929, PHILOS MAG, V7, P905, DOI 10.1080/14786440608564819; 2006, GORD RES C TRIB COLB	12	70	72	2	71	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 14	2006	313	5784					184	185		10.1126/science.1130420	http://dx.doi.org/10.1126/science.1130420			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	063GZ	16840690				2022-12-28	WOS:000239008000032
J	Sterling, TR; Haas, DW				Sterling, TR; Haas, DW			Transmission of Mycobacterium tuberculosis from health care workers	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Vanderbilt Univ, Sch Med, Dept Med, Div Infect Dis, Nashville, TN 37212 USA	Vanderbilt University	Sterling, TR (corresponding author), Vanderbilt Univ, Sch Med, Dept Med, Div Infect Dis, Nashville, TN 37212 USA.							Driver CR, 2005, AM J INFECT CONTROL, V33, P519, DOI 10.1016/j.ajic.2005.05.016; Jenssen HK, 2005, INDIANA U MATH J, V54, P1, DOI 10.1512/iumj.2005.54.2685; Mazurek Gerald H., 2005, Morbidity and Mortality Weekly Report, V54, P49; MAZUREK GH, 2005, MMWR-MORBID MORTAL W, V54, P1288; Salazar-Schicchi J, 2004, INT J TUBERC LUNG D, V8, P1443; 2005, MMWR MORB MORTAL WKL, V54, P1280	6	22	24	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 13	2006	355	2					118	121		10.1056/NEJMp068015	http://dx.doi.org/10.1056/NEJMp068015			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	062UP	16837674	Bronze			2022-12-28	WOS:000238970600002
J	Horton, R				Horton, R			Health research in the UK: the price of success	LANCET			English	Editorial Material							RANDOMIZED CONTROLLED-TRIAL; MULTICENTER		The Lancet, London NW1 7BY, England		Horton, R (corresponding author), The Lancet, London NW1 7BY, England.							Blakemore C, 2006, LANCET, V367, P1293, DOI 10.1016/S0140-6736(06)68552-8; Blakemore C, 2004, BMJ-BRIT MED J, V328, P49, DOI 10.1136/bmj.328.7430.49; Bradbury AW, 2005, LANCET, V366, P1925, DOI 10.1016/S0140-6736(05)67707-5; Chalmers I, 2003, BRIT MED J, V327, P1017, DOI 10.1136/bmj.327.7422.1017; Dennis M, 2005, LANCET, V365, P755, DOI 10.1016/S0140-6736(05)17982-3; FAZACKERLEY A, 2006, TIMES HIGHER ED 0428, P6; Glasziou P, 2006, LANCET, V367, P2057, DOI 10.1016/S0140-6736(06)68919-8; Greenhalgh RM, 2005, LANCET, V365, P2179, DOI 10.1016/S0140-6736(05)66627-5; Grilli Roberto, 2006, J Health Serv Res Policy, V11, P89, DOI 10.1258/135581906776318893; Johnston SC, 2006, LANCET, V367, P1319, DOI 10.1016/S0140-6736(06)68578-4; 2006, SCI INNOVATION INVES	11	14	14	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 8	2006	368	9530					93	97		10.1016/S0140-6736(06)68974-5	http://dx.doi.org/10.1016/S0140-6736(06)68974-5			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	062AR	16829278				2022-12-28	WOS:000238917200004
J	Webster, PJ; Moore, AM; Loschnigg, JP; Leben, RR				Webster, PJ; Moore, AM; Loschnigg, JP; Leben, RR			Coupled ocean-atmosphere dynamics in the Indian Ocean during 1997-98	NATURE			English	Article							SUMMER MONSOON RAINFALL; EL-NINO; OSCILLATION; PREDICTION	Climate variability in the Indian Ocean region seems to be, in some aspects, independent of forcing by external phenomena such as the El Nino/Southern Oscillation(1-4). But the extent to which, and how, internal coupled ocean-atmosphere dynamics determine the state of the Indian Ocean system have not been resolved. Here we present a detailed analysis of the strong seasonal anomalies in sea surface temperatures, sea surface heights, precipitation and winds that occurred in the Indian Ocean region in 1997-98, and compare the results with the record of Indian Ocean climate variability over the past 40 years. We conclude that the 1997-98 anomalies-in spite of the coincidence with the strong El Nino/Southern Oscillation event-may primarily be an expression of internal dynamics, rather than a direct response to external influences. We propose a mechanism of ocean-atmosphere interaction governing the 1997-98 event that may represent a characteristic internal mode of the Indian Ocean climate system. In the Pacific Ocean, the identification of such a mode has led to successful predictions of El Nino(5); if the proposed Indian Ocean internal mode proves to be robust, there may be a similar potential for predictability of climate in the Indian Ocean region.	Univ Colorado, Program Atmospher & Ocean Sci, Boulder, CO 80309 USA; Univ Colorado, Colorado Ctr Astrodynam Res, Dept Aerosp Engn Sci, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder	Webster, PJ (corresponding author), Univ Colorado, Program Atmospher & Ocean Sci, Campus Box 311, Boulder, CO 80309 USA.		Leben, Robert R/F-3792-2010	Leben, Robert R/0000-0003-1067-9515				ARKIN PA, 1987, MON WEATHER REV, V115, P51, DOI 10.1175/1520-0493(1987)115<0051:TRBLSC>2.0.CO;2; BARNETT TP, 1983, MON WEATHER REV, V111, P756, DOI 10.1175/1520-0493(1983)111<0756:IOTMAP>2.0.CO;2; GILL AE, 1980, Q J ROY METEOR SOC, V106, P447, DOI 10.1002/qj.49710644905; Gill AE, 1982, ATMOSPHERE OCEAN DYN; Hendricks JR, 1996, J GEOPHYS RES-OCEANS, V101, P14131, DOI 10.1029/96JC00922; Kalnay E, 1996, B AM METEOROL SOC, V77, P437, DOI 10.1175/1520-0477(1996)077<0437:TNYRP>2.0.CO;2; KAPALA A, 1994, P INT C MONS VAR PRE, P119; MEEHL G, 1994, SCIENCE, V265, P263; Meehl GA, 1997, J CLIMATE, V10, P1921, DOI 10.1175/1520-0442(1997)010<1921:TSAMAT>2.0.CO;2; NICHOLLS N, 1978, MON WEATHER REV, V106, P1505, DOI 10.1175/1520-0493(1978)106<1505:ASIATQ>2.0.CO;2; NICHOLLS N, 1995, J CLIMATE, V8, P1463, DOI 10.1175/1520-0442(1995)008<1463:AISMRA>2.0.CO;2; Nicholson SE, 1997, INT J CLIMATOL, V17, P345, DOI 10.1002/(SICI)1097-0088(19970330)17:4<345::AID-JOC127>3.0.CO;2-3; Nicholson SE, 1997, INT J CLIMATOL, V17, P117, DOI 10.1002/(SICI)1097-0088(199702)17:2<117::AID-JOC84>3.0.CO;2-O; *NOAA CLIM DIAGN C, 1997, CLIM DIAGN B NOAA, V9711; RAO KG, 1988, MON WEATHER REV, V116, P558, DOI 10.1175/1520-0493(1988)116<0558:IVOSST>2.0.CO;2; REVERDIN G, 1986, Q J ROY METEOR SOC, V112, P43, DOI 10.1002/qj.49711247104; REYNOLDS RW, 1993, J CLIMATE, V6, P114, DOI 10.1175/1520-0442(1993)006<0114:AIRTGS>2.0.CO;2; SHUKLA J, 1987, MON WEATHER REV, V115, P695, DOI 10.1175/1520-0493(1987)115<0695:EPOTSM>2.0.CO;2; Webster PJ, 1997, NATURE, V390, P562, DOI 10.1038/37499; WEBSTER PJ, 1972, MON WEATHER REV, V100, P518, DOI 10.1175/1520-0493(1972)100<0518:ROTTAT>2.3.CO;2; Webster PJ, 1998, J GEOPHYS RES-OCEANS, V103, P14451, DOI 10.1029/97JC02719; Yu LS, 1999, GEOPHYS RES LETT, V26, P735, DOI 10.1029/1999GL900072	22	1528	1659	9	139	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 23	1999	401	6751					356	360		10.1038/43848	http://dx.doi.org/10.1038/43848			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	240JJ	16862107				2022-12-28	WOS:000082822600045
J	Martini, E; Diaz, RL; Hunter, N; Keeney, S				Martini, Emmanuelle; Diaz, Robert L.; Hunter, Neil; Keeney, Scott			Crossover homeostasis in yeast meiosis	CELL			English	Article							DOUBLE-STRAND BREAKS; SACCHAROMYCES-CEREVISIAE; MEIOTIC RECOMBINATION; CROSSING-OVER; GENE CONVERSION; BUDDING YEAST; C-ELEGANS; INTERFERENCE; CHROMOSOME; INITIATION	Crossovers produced by homologous recombination promote accurate chromosome segregation in meiosis and are controlled such that at least one forms per chromosome pair and multiple crossovers are widely spaced. Recombination initiates with an excess number of double-strand breaks made by Spo11 protein. Thus, crossover control involves a decision by which some breaks give crossovers while others follow a predominantly noncrossover pathway(s). To understand this decision, we examined recombination when breaks are reduced in yeast spo11 hypomorphs. We find that crossover levels tend to be maintained at the expense of noncrossovers and that genomic loci differ in expression of this "crossover homeostasis." These findings define a previously unsuspected manifestation of crossover control, i.e., that the crossover/noncrossover ratio can change to maintain crossovers. Our results distinguish between existing models of crossover control and support the hypothesis that an obligate crossover is a genetically programmed event tied to crossover interference.	Mem Sloan Kettering Canc Ctr, Program Mol Biol, New York, NY 10021 USA; CEA, CNRS, UMR 217, DSV,SRMC,LRD, F-92265 Fontenay Aux Roses, France; Univ Calif Davis, Genet & Dev Sect, Microbiol Sect, Davis, CA 95616 USA; Univ Calif Davis, Genet & Dev Sect, Sect Mol & Cellular Biol, Davis, CA 95616 USA	Memorial Sloan Kettering Cancer Center; CEA; Centre National de la Recherche Scientifique (CNRS); University of California System; University of California Davis; University of California System; University of California Davis	Keeney, S (corresponding author), Mem Sloan Kettering Canc Ctr, Program Mol Biol, 1275 York Ave, New York, NY 10021 USA.	s-keeney@ski.mskcc.org	Keeney, Scott/GVR-8515-2022	Keeney, Scott/0000-0002-1283-6417	NIGMS NIH HHS [R01 GM058673-06A1, R01 GM058673, R01 GM074223, R01 GM74223, R01 GM058673-07, R01 GM058673-09, R01 GM058673-08, R01 GM58673] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058673, R01GM074223] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Allers T, 2001, CELL, V106, P47, DOI 10.1016/S0092-8674(01)00416-0; Bishop DK, 2004, CELL, V117, P9, DOI 10.1016/S0092-8674(04)00297-1; Borde V, 2000, SCIENCE, V290, P806, DOI 10.1126/science.290.5492.806; Borner GV, 2004, CELL, V117, P29, DOI 10.1016/S0092-8674(04)00292-2; Broman KW, 2000, AM J HUM GENET, V66, P1911, DOI 10.1086/302923; BURGOYNE PS, 1982, HUM GENET, V61, P85, DOI 10.1007/BF00274192; CAO L, 1990, CELL, V61, P1089, DOI 10.1016/0092-8674(90)90072-M; Copenhaver GP, 2002, GENETICS, V160, P1631; de los Santos T, 2003, GENETICS, V164, P81; Dernburg AF, 1998, CELL, V94, P387, DOI 10.1016/S0092-8674(00)81481-6; Diaz RL, 2002, MOL CELL BIOL, V22, P1106, DOI 10.1128/MCB.22.4.1106-1115.2002; FOSS E, 1993, GENETICS, V133, P681; Fung JC, 2004, CELL, V116, P795, DOI 10.1016/S0092-8674(04)00249-1; Henderson KA, 2004, P NATL ACAD SCI USA, V101, P4519, DOI 10.1073/pnas.0400843101; Hillers KJ, 2004, CURR BIOL, V14, pR1036, DOI 10.1016/j.cub.2004.11.038; Hillers KJ, 2003, CURR BIOL, V13, P1641, DOI 10.1016/j.cub.2003.08.026; Hoffmann ER, 2003, GENETICS, V163, P515; Hunter N, 2001, CELL, V106, P59, DOI 10.1016/S0092-8674(01)00430-5; Jones G.H., 1984, Symposia of the Society for Experimental Biology, P293; KABACK DB, 1992, SCIENCE, V256, P228, DOI 10.1126/science.1566070; Keeney S, 2001, CURR TOP DEV BIOL, V52, P1, DOI 10.1016/S0070-2153(01)52008-6; Kleckner N, 2004, P NATL ACAD SCI USA, V101, P12592, DOI 10.1073/pnas.0402724101; Malkova A, 2004, GENETICS, V168, P49, DOI 10.1534/genetics.104.027961; MCPEEK MS, 1995, GENETICS, V139, P1031; Moens PB, 2002, J CELL SCI, V115, P1611; Muller HJ, 1916, AM NAT, V50, P193, DOI 10.1086/279534; MUNZ P, 1994, GENETICS, V137, P701; NICOLAS A, 1989, NATURE, V338, P35, DOI 10.1038/338035a0; Page SL, 2003, SCIENCE, V301, P785, DOI 10.1126/science.1086605; PAPAZIAN HP, 1952, GENETICS, V37, P175; PERKINS DD, 1949, GENETICS, V34, P607; RAHN MI, 1986, CYTOGENET CELL GENET, V43, P187, DOI 10.1159/000132319; Shinohara M, 2003, GENETICS, V163, P1273; Stahl FW, 2004, GENETICS, V168, P35, DOI 10.1534/genetics.104.027789; Sturtevant A. H., 1915, Zs indukt Abstamm Berlin, V13, DOI 10.1007/BF01792906; Turney D, 2004, GENETICS, V168, P2421, DOI 10.1534/genetics.104.033555; VILLENEUVE AM, 1994, GENETICS, V136, P887	37	231	236	1	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 28	2006	126	2					285	295		10.1016/j.cell.2006.05.044	http://dx.doi.org/10.1016/j.cell.2006.05.044			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	070VD	16873061	Green Accepted, Bronze			2022-12-28	WOS:000239552600015
J	Barnard, JS; Sharp, J; Tong, JR; Midgley, PA				Barnard, J. S.; Sharp, J.; Tong, J. R.; Midgley, P. A.			High-resolution three-dimensional imaging of dislocations	SCIENCE			English	Article									Univ Cambridge, Dept Mat Sci & Met, Cambridge CB2 3QZ, England	University of Cambridge	Barnard, JS (corresponding author), Univ Cambridge, Dept Mat Sci & Met, Pembroke St, Cambridge CB2 3QZ, England.	jsb43@cam.ac.uk; pam33@cam.ac.uk		Midgley, Paul/0000-0002-6817-458X; Sharp, Joanne/0000-0001-8168-8422; Barnard, Jonathan/0000-0003-3841-4498				COCKAYNE DJ, 1969, PHILOS MAG, V20, P1265, DOI 10.1080/14786436908228210; HIRSCH PB, 1956, PHILOS MAG, V1, P677, DOI 10.1080/14786435608244003; Ludwig W, 2001, J APPL CRYSTALLOGR, V34, P602, DOI 10.1107/S002188980101086X; Midgley PA, 2003, ULTRAMICROSCOPY, V96, P413, DOI 10.1016/S0304-3991(03)00105-0; Ponce FA, 1997, NATURE, V386, P351, DOI 10.1038/386351a0	5	110	111	4	91	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 21	2006	313	5785					319	319		10.1126/science.1125783	http://dx.doi.org/10.1126/science.1125783			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065IV	16857932				2022-12-28	WOS:000239154300034
J	Alleman, M; Sidorenko, L; McGinnis, K; Seshadri, V; Dorweiler, JE; White, J; Sikkink, K; Chandler, VL				Alleman, Mary; Sidorenko, Lyudmila; McGinnis, Karen; Seshadri, Vishwas; Dorweiler, Jane E.; White, Joshua; Sikkink, Kristin; Chandler, Vicki L.			An RNA-dependent RNA polymerase is required for paramutation in maize	NATURE			English	Article							UNPAIRED DNA; METHYLATION; HETEROCHROMATIN; CHROMATIN; GENE; ARABIDOPSIS; MAINTENANCE; TRANSCRIPTION; UPSTREAM; SEQUENCE	Paramutation is an allele-dependent transfer of epigenetic information, which results in the heritable silencing of one allele by another(1). Paramutation at the b1 locus in maize is mediated by unique tandem repeats that communicate in trans to establish and maintain meiotically heritable transcriptional silencing(2). The mop1 ( mediator of paramutation1) gene is required for paramutation(3), and mop1 mutations reactivate silenced Mutator elements(4). Plants carrying mutations in the mop1 gene also stochastically exhibit pleiotropic developmental phenotypes(3). Here we report the map-based cloning of mop1, an RNA-dependent RNA polymerase gene (RDRP), most similar to the RDRP in plants that is associated with the production of short interfering RNA ( siRNA) targeting chromatin(5,6). Nuclear run-on assays reveal that the tandem repeats required for b1 paramutation are transcribed from both strands, but siRNAs were not detected. We propose that the mop1 RDRP is required to maintain a threshold level of repeat RNA, which functions in trans to establish and maintain the heritable chromatin states associated with paramutation.	Univ Arizona, Dept Plant Sci, Tucson, AZ 85721 USA	University of Arizona	Chandler, VL (corresponding author), Univ Arizona, Dept Plant Sci, 303 Forbes Hall, Tucson, AZ 85721 USA.	chandler@ag.arizona.edu	Dorweiler, Jane/K-3116-2019					Bennetzen JL, 2003, CURR OPIN PLANT BIOL, V6, P128, DOI 10.1016/S1369-5266(03)00015-3; Bernstein E, 2005, GENE DEV, V19, P1635, DOI 10.1101/gad.1324305; Brzeski J, 2003, J BIOL CHEM, V278, P823, DOI 10.1074/jbc.M209260200; Chan SWL, 2004, SCIENCE, V303, P1336, DOI 10.1126/science.1095989; Chandler VL, 2004, NAT REV GENET, V5, P532, DOI 10.1038/nrg1378; Dalmay T, 2000, CELL, V101, P543, DOI 10.1016/S0092-8674(00)80864-8; Dorweiler JE, 2000, PLANT CELL, V12, P2101, DOI 10.1105/tpc.12.11.2101; Feng Q, 2002, NATURE, V420, P316, DOI 10.1038/nature01183; Herr AJ, 2005, FEBS LETT, V579, P5879, DOI 10.1016/j.febslet.2005.08.040; Herr AJ, 2005, SCIENCE, V308, P118, DOI 10.1126/science.1106910; Hollick JB, 2001, GENETICS, V157, P369; Jeddeloh JA, 1999, NAT GENET, V22, P94, DOI 10.1038/8803; Kakutani T, 1996, P NATL ACAD SCI USA, V93, P12406, DOI 10.1073/pnas.93.22.12406; KOHALMI SE, 1988, J MOL BIOL, V204, P561, DOI 10.1016/0022-2836(88)90355-5; Lee DW, 2004, GENETICS, V167, P131, DOI 10.1534/genetics.167.1.131; Lippman Z, 2004, NATURE, V430, P471, DOI 10.1038/nature02651; Lisch D, 2002, P NATL ACAD SCI USA, V99, P6130, DOI 10.1073/pnas.052152199; Maine EM, 2005, CURR BIOL, V15, P1972, DOI 10.1016/j.cub.2005.09.049; Makeyev EV, 2002, MOL CELL, V10, P1417, DOI 10.1016/S1097-2765(02)00780-3; Martienssen RA, 2005, CHROMOSOME RES, V13, P299, DOI 10.1007/s10577-005-1507-2; Martienssen RA, 2003, NAT GENET, V35, P213, DOI 10.1038/ng1252; May BP, 2005, PLOS GENET, V1, P705, DOI 10.1371/journal.pgen.0010079; Melquist S, 2003, GENE DEV, V17, P2036, DOI 10.1101/gad.1081603; Motamedi MR, 2004, CELL, V119, P789, DOI 10.1016/j.cell.2004.11.034; PATTERSON GI, 1993, GENETICS, V135, P881; Rassoulzadegan M, 2006, NATURE, V441, P469, DOI 10.1038/nature04674; Slotkin RK, 2005, NAT GENET, V37, P641, DOI 10.1038/ng1576; Stam M, 2002, GENE DEV, V16, P1906, DOI 10.1101/gad.1006702; Sugiyama T, 2005, P NATL ACAD SCI USA, V102, P152, DOI 10.1073/pnas.0407641102; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; Xie ZX, 2004, PLOS BIOL, V2, P642, DOI 10.1371/journal.pbio.0020104	31	281	300	3	47	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 20	2006	442	7100					295	298		10.1038/nature04884	http://dx.doi.org/10.1038/nature04884			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064WT	16855589				2022-12-28	WOS:000239122100037
J	Hunt, SA				Hunt, Sharon A.			Taking heart - Cardiac transplantation past, present, and future	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Stanford Univ, Sch Med, Stanford, CA 94305 USA	Stanford University	Hunt, SA (corresponding author), Stanford Univ, Sch Med, Stanford, CA 94305 USA.							Bader FM, 2006, J HEART LUNG TRANSPL, V25, P298, DOI 10.1016/j.healun.2005.09.016; CAVES PK, 1974, LANCET, V1, P821; Mancini D, 2003, CIRCULATION, V108, P48, DOI 10.1161/01.CIR.0000070421.38604.2B; Thompson T., 1971, LIFE MAGAZINE, P56; Trulock EP, 2005, J HEART LUNG TRANSPL, V24, P956, DOI 10.1016/j.healun.2005.05.019	5	69	72	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 20	2006	355	3					231	235		10.1056/NEJMp068048	http://dx.doi.org/10.1056/NEJMp068048			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	064NY	16855261				2022-12-28	WOS:000239097600002
J	Gona, P; Van Dyke, RB; Williams, PL; Dankner, WM; Chernoff, MC; Nachman, SA; Seage, GR				Gona, Philimon; Van Dyke, Russell B.; Williams, Paige L.; Dankner, Wayne M.; Chernoff, Miriam C.; Nachman, Sharon A.; Seage, George R., III			Incidence of opportunistic and other infections in HIV-infected children in the HAART era	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; ACTIVE ANTIRETROVIRAL THERAPY; MORTALITY; RNA; INFANTS; DISEASE	Context Combination anti-retroviral therapy or highly active antiretroviral therapy (HAART) has resulted in a dramatic decline in the incidence of opportunistic and other infections in human immunodeficiency virus (HIV)-infected adults and children. Objectives To estimate the incidence of 29 targeted opportunistic and other infections occurring in the era of HAART-between January 1, 2001, and December 31, 2004-in HIV-infected infants, children, and adolescents followed up in Pediatric AIDS Clinical Trials Group (PACTG) 219C; to compare incidence rates in the HAART era to those of the pre-HAART era; and to test for linear trends over time in the HAART era. Design, Setting, and Participants Ongoing, multicenter, prospective cohort study designed to examine long-term outcomes in HIV-infected children. The study population included 2767 children enrolled between September 15, 2000, and December 31, 2004, with information entered in the database up to August 1, 2005, when data analysis was conducted. The pre-HAART era comparison population included 3331 children enrolled in 13 PACTG protocols from October 1988 to August 1998. Main Outcome Measures First occurrence of each of the 29 targeted infections. Results Seventy-five percent of the children were enrolled in 2000 and 2001, 90% acquired HIV perinatally, 52% were girls, and 59% were black. The median age was 8.2 years (range, 6-13 years). The median duration of follow-up was 3.4 years. Overall, 553 first episodes of a specific infection occurred among 395 (14%) of the study participants. The number of events for the 4 most common first-time infections and their incidence rates (IRs) per 100 person-years were 123 bacterial pneumonia (IR, 2.15; 95% confidence interval [CI], 1.79-2.56), 77 herpes zoster (IR, 1.11; 95% CI, 0.88-1.39), 57 dermatophyte infections (IR, 0.88; 0.67-1.14), and 52 oral candidiasis (IR, 0.93; 95% CI, 0.70-1.22). Incidence rates of first bacteremia, Pneumocystis jeroveci pneumonia, disseminated Mycobacterium avium complex, lymphoid interstitial pneumonitis, systemic fungal infection, cytomegalovirus retinitis, and tuberculosis were all less than 0.50 per 100 person-years. There were no statistically significant linear trends in incidence for any of the 29 infections over the 4 calendar years. However, infection rates were significantly lower than those reported in the PACTG in the pre-HAART era. The pre-HAART IRs were as follows: for bacterial pneumonia, IR, 11.1; 95% CI, 10.3-12.0; bacteremia, IR, 3.3; 95% CI, 2.9-3.8; herpes zoster, IR, 2.9; 95% CI, 2.6-3.3; disseminated M avium complex, IR, 1.8; 95% CI, 1.5-2.1; P jeroveci, IR, 1.3; 95% CI, 1.1-1.6; oral candidiasis, IR, 1.2; 95% CI, 1.0-1.5; cytomegalovirus retinitis, IR, 0.5; 95% CI, 0.3-0.6; and tuberculosis, IR, 0.2; 95% CI, 0.1-0.4. Conclusions Opportunistic infections and other related infections are uncommon in children in the HAART era, and infection rates continue to be lower than those reported in the pre-HAART era. Continued surveillance is important to assess the long-term effect of HAART on the occurrence of opportunistic and other related infections in children.	Boston Univ, Dept Math & Stat, Boston, MA 02215 USA; Harvard Univ, Sch Publ Hlth, Ctr Biostat AIDS Res, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; Boston Univ, Stat Consulting Unit, Boston, MA 02215 USA; Tulane Univ, Hlth Sci Ctr, Dept Pediat, New Orleans, LA 70118 USA; Duke Univ, Dept Pediat, Durham, NC 27706 USA; SUNY Stony Brook, Dept Pediat, Stony Brook, NY 11794 USA	Boston University; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Boston University; Tulane University; Duke University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Gona, P (corresponding author), Boston Univ, Dept Math & Stat, 111 Cummington St, Boston, MA 02215 USA.	philgona@math.bu.edu	Gona, Philimon/K-1477-2019; Abrams, William R/A-5782-2008		NIAID NIH HHS [5 U01 AI41110] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI041110] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Abrams EJ, 2000, PEDIATR CLIN N AM, V47, P79, DOI 10.1016/S0031-3955(05)70196-6; Brogly S, 2005, JAMA-J AM MED ASSOC, V293, P2213, DOI 10.1001/jama.293.18.2213; *CDCP, PED HIV AIDS SURV L2; Culnane M, 1999, JAMA-J AM MED ASSOC, V281, P151, DOI 10.1001/jama.281.2.151; Dankner WM, 2001, PEDIATR INFECT DIS J, V20, P40, DOI 10.1097/00006454-200101000-00008; Dankner WM, 2003, MED MANAGEMENT AIDS; DUNN DT, 1995, AIDS, V9, pF7, DOI 10.1097/00002030-199509000-00001; Finkelstein DM, 1996, J ACQ IMMUN DEF SYND, V12, P38, DOI 10.1097/00042560-199605010-00006; Furrer Hansjakob, 2002, J HIV Ther, V7, P2; Gortmaker SL, 2001, NEW ENGL J MED, V345, P1522, DOI 10.1056/NEJMoa011157; Ledergerber B, 1999, JAMA-J AM MED ASSOC, V282, P2220, DOI 10.1001/jama.282.23.2220; Louie JK, 2002, J INFECT DIS, V186, P1023, DOI 10.1086/343862; Mofenson LM, 1997, J INFECT DIS, V175, P1029, DOI 10.1086/516441; Nachman S, 2005, PEDIATRICS, V115, DOI 10.1542/peds.2004-1847; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Palumbo PE, 1998, JAMA-J AM MED ASSOC, V279, P756, DOI 10.1001/jama.279.10.756; Sharland M, 2004, HIV MED, V5, P61, DOI 10.1111/j.1468-1293.2004.00227.x; Shearer WT, 1997, NEW ENGL J MED, V336, P1337, DOI 10.1056/NEJM199705083361901; Steketee RW, 1997, J INFECT DIS, V175, P707, DOI 10.1093/infdis/175.3.707; YLITALO N, IN PRESS ARCH PEDIAT	20	176	182	0	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 19	2006	296	3					292	300		10.1001/jama.296.3.292	http://dx.doi.org/10.1001/jama.296.3.292			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	064LA	16849662	Bronze			2022-12-28	WOS:000239089900021
J	Dagastine, RR; Manica, R; Carnie, SL; Chan, DYC; Stevens, GW; Grieser, F				Dagastine, Raymond R.; Manica, Rogerio; Carnie, Steven L.; Chan, D. Y. C.; Stevens, Geoffrey W.; Grieser, Franz			Dynamic forces between two deformable oil droplets in water	SCIENCE			English	Article							CONSTANT APPROACH VELOCITY; COLLIDING DROPS; FILM DRAINAGE; PARTICLE; INTERFACE; SURFACE; MICROSCOPE; RUPTURE; BUBBLE	The understanding of static interactions in colloidal suspensions is well established, whereas dynamic interactions more relevant to biological and other suspended soft-matter systems are less well understood. We present the direct force measurement and quantitative theoretical description for dynamic forces for liquid droplets in another immiscible fluid. Analysis of this system demonstrates the strong link between interfacial deformation, static surface forces, and hydrodynamic drainage, which govern dynamic droplet-droplet interactions over the length scale of nanometers and over the time scales of Brownian collisions. The results and analysis have direct bearing on the control and manipulation of suspended droplets in soft-matter systems ranging from the emulsions in shampoo to cellular interactions.	Univ Melbourne, Particulate Fluids Proc Ctr, Melbourne, Vic 3010, Australia; Univ Melbourne, Dept Chem & Biomol Engn, Melbourne, Vic 3010, Australia; Univ Melbourne, Dept Math & Stat, Melbourne, Vic 3010, Australia; Univ Melbourne, Sch Chem, Melbourne, Vic 3010, Australia	University of Melbourne; University of Melbourne; University of Melbourne; University of Melbourne	Grieser, F (corresponding author), Univ Melbourne, Particulate Fluids Proc Ctr, Melbourne, Vic 3010, Australia.	franz@unimelb.edu.au	Chan, Derek Y C/N-3130-2019; Chan, Derek YC/A-4823-2010; Dagasitne, Raymond R/D-3348-2012; Manica, Rogerio/G-5033-2011	Chan, Derek Y C/0000-0002-2156-074X; Chan, Derek YC/0000-0002-2156-074X; Dagasitne, Raymond R/0000-0002-2154-4846; Manica, Rogerio/0000-0002-2247-4536; GRIESER, FRANZ/0000-0003-4331-8409; Stevens, Geoffrey/0000-0002-5788-4682				ABID S, 1994, INT J MULTIPHAS FLOW, V20, P613, DOI 10.1016/0301-9322(94)90033-7; [Anonymous], 1992, INTERMOLECULAR SURFA; Aston DE, 2002, IND ENG CHEM RES, V41, P389, DOI 10.1021/ie0101240; BAYGENTS JC, 1991, J CHEM SOC FARADAY T, V87, P1883, DOI 10.1039/ft9918701883; Bhatt D, 2001, LANGMUIR, V17, P116, DOI 10.1021/la0009691; BUTT HJ, 1994, J COLLOID INTERF SCI, V166, P109, DOI 10.1006/jcis.1994.1277; Carnie SL, 2005, LANGMUIR, V21, P2912, DOI 10.1021/la0475371; CARNIE SL, 2005, ANZIAM J E, V46, pC808; Chan DYC, 2001, J COLLOID INTERF SCI, V236, P141, DOI 10.1006/jcis.2000.7400; CHESTERS AK, 1991, CHEM ENG RES DES, V69, P259; Connor JN, 2003, FARADAY DISCUSS, V123, P193, DOI 10.1039/b204500c; Dagastine RR, 2004, J COLLOID INTERF SCI, V273, P339, DOI 10.1016/j.jcis.2003.11.001; DAGASTINE RR, 2005, 7 WORLD C CHEM ENG G; DUCKER WA, 1994, LANGMUIR, V10, P3279, DOI 10.1021/la00021a061; Goodall DG, 1998, COLLOID SURFACE A, V143, P41, DOI 10.1016/S0927-7757(98)00500-7; HUNTER RJ, 1995, FDN COLLOID SCI; Ivan I. B., 1988, THIN LIQUID FILMS, V29, P379; Klaseboer E, 2000, J COLLOID INTERF SCI, V229, P274, DOI 10.1006/jcis.2000.6987; Mulvaney P, 1996, J COLLOID INTERF SCI, V183, P614, DOI 10.1006/jcis.1996.0588; Nespolo SA, 2001, LANGMUIR, V17, P7210, DOI 10.1021/la0103968; RUSSEL WB, 1989, COLLOIDAL DISPERSION; YIANTSIOS SG, 1990, J FLUID MECH, V217, P547, DOI 10.1017/S0022112090000842	23	195	204	7	208	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 14	2006	313	5784					210	213		10.1126/science.1125527	http://dx.doi.org/10.1126/science.1125527			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	063GZ	16840696				2022-12-28	WOS:000239008000040
J	Park, JY; Ogletree, DF; Thiel, PA; Salmeron, M				Park, Jeong Young; Ogletree, D. F.; Thiel, P. A.; Salmeron, M.			Electronic control of friction in silicon pn junctions	SCIENCE			English	Article									Univ Calif Berkeley, Lawrence Berkeley Lab, Div Mat Sci, Berkeley, CA 94720 USA; Iowa State Univ, Dept Chem, Ames, IA 50011 USA; Iowa State Univ, Ames Lab, Ames, IA 50011 USA; Iowa State Univ, Dept Mat Sci & Engn, Ames, IA 50011 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Iowa State University; Iowa State University; United States Department of Energy (DOE); Ames National Laboratory; Iowa State University	Salmeron, M (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Lab, Div Mat Sci, Berkeley, CA 94720 USA.	mbsalmeron@lbl.gov	Park, Jeong Young/A-2999-2008	Park, Jeong Young/0000-0002-8132-3076; Thiel, Patricia/0000-0003-4195-0216				Dayo A, 1998, PHYS REV LETT, V80, P1690, DOI 10.1103/PhysRevLett.80.1690; Gnecco E, 2001, J PHYS-CONDENS MAT, V13, pR619, DOI 10.1088/0953-8984/13/31/202; Park JY, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1906297; Park JY, 2005, SCIENCE, V309, P1354, DOI 10.1126/science.1113239; PATEL JR, 1976, PHYS REV B, V13, P3548, DOI 10.1103/PhysRevB.13.3548; Persson B. N. J., 1998, SLIDING FRICTION PHY; Witte G, 1998, PHYS REV LETT, V80, P121, DOI 10.1103/PhysRevLett.80.121; ZHU XJ, 1989, PHYS REV B, V39, P7840, DOI 10.1103/PhysRevB.39.7840	8	149	153	7	144	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 14	2006	313	5784					186	186		10.1126/science.1125017	http://dx.doi.org/10.1126/science.1125017			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	063GZ	16840691				2022-12-28	WOS:000239008000033
J	Watts, C				Watts, Colin			Phagosome neutrality in host defense	CELL			English	Editorial Material							IN-VIVO; ANTIGEN; MACROPHAGES; MATURATION; ACTIVATION; CELLS	Activation of proteases in the phagosomes of neutrophils occurs by neutralization of the phagosomal pH by NADPH oxidase. In this issue, Savina et al. (2006) show that dendritic cell phagosomes also recruit NADPH oxidase but with different results. Here, the neutralization of phagosomal pH reduces protease activity, which preserves antigens for crosspresentation on class I MHC molecules.	Univ Dundee, Wellcome Trust Bioctr, Sch Life Sci, Dundee DD1 5EH, Scotland	University of Dundee	Watts, C (corresponding author), Univ Dundee, Wellcome Trust Bioctr, Sch Life Sci, Dundee DD1 5EH, Scotland.	c.watts@dundee.ac.uk		Watts, Colin/0000-0001-6183-2087				Ackerman AL, 2004, NAT IMMUNOL, V5, P678, DOI 10.1038/ni1082; Bevan MJ, 2006, NAT IMMUNOL, V7, P363, DOI 10.1038/ni0406-363; Delamarre L, 2005, SCIENCE, V307, P1630, DOI 10.1126/science.1108003; Henry RM, 2004, J CELL BIOL, V164, P185, DOI 10.1083/jcb.200307080; Lennon-Dumenil AM, 2002, J EXP MED, V196, P529, DOI 10.1084/jem.20020327; Moss CX, 2005, EUR J IMMUNOL, V35, P3442, DOI 10.1002/eji.200535320; Norbury CC, 1995, IMMUNITY, V3, P783, DOI 10.1016/1074-7613(95)90067-5; SAVINA A, 2006, CELL; Segal AW, 2005, ANNU REV IMMUNOL, V23, P197, DOI 10.1146/annurev.immunol.23.021704.115653; Shen LJ, 2004, IMMUNITY, V21, P155, DOI 10.1016/j.immuni.2004.07.004; Trombetta ES, 2005, ANNU REV IMMUNOL, V23, P975, DOI 10.1146/annurev.immunol.22.012703.104538; Trombetta ES, 2003, SCIENCE, V299, P1400, DOI 10.1126/science.1080106; Vulcano M, 2004, J IMMUNOL, V173, P5749, DOI 10.4049/jimmunol.173.9.5749	13	10	11	0	4	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUL 14	2006	126	1					17	19		10.1016/j.cell.2006.06.031	http://dx.doi.org/10.1016/j.cell.2006.06.031			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	066JF	16839868	Bronze			2022-12-28	WOS:000239224800008
J	Hiiragi, T; Louvet-Vallee, S; Solter, D; Maro, B				Hiiragi, T; Louvet-Vallee, S; Solter, D; Maro, B			Embryology - Does prepatterning occur in the mouse egg?	NATURE			English	Letter							BLASTOCYST AXIS; BLASTOMERES; CLEAVAGE; 2-CELL; 1ST-CLEAVAGE; BEGINS; PLANE; STAGE		Max Planck Inst Immunobiol, D-79108 Freiburg, Germany; Univ Paris 06, Lab Biol Cellulaire Dev, CNRS, UMR 7622, F-75252 Paris 05, France; Tel Aviv Univ, Sackler Fac Med, IL-69978 Ramat Aviv, Israel	Max Planck Society; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; Tel Aviv University; Sackler Faculty of Medicine	Hiiragi, T (corresponding author), Max Planck Inst Immunobiol, D-79108 Freiburg, Germany.	hiiragi@immunbio.mpg.de	Maro, Bernard/AAL-2220-2020; Solter, Davor/Q-5476-2019	Solter, Davor/0000-0002-8438-347X; Hiiragi, Takashi/0000-0003-4964-7203; Louvet, Sophie/0000-0001-7577-2329				Alarcon VB, 2005, MOL REPROD DEV, V72, P354, DOI 10.1002/mrd.20353; Alarcon VB, 2003, BIOL REPROD, V69, P1208, DOI 10.1095/biolreprod.103.018283; Chroscicka A, 2004, MOL REPROD DEV, V68, P308, DOI 10.1002/mrd.20081; Fujimori T, 2003, DEVELOPMENT, V130, P5113, DOI 10.1242/dev.00725; Gardner RL, 2001, DEVELOPMENT, V128, P839; Hiiragi T, 2004, NATURE, V430, P360, DOI 10.1038/nature02595; Louvet-Vallee S, 2005, CURR BIOL, V15, P464, DOI 10.1016/j.cub.2004.12.078; Motosugi N, 2005, GENE DEV, V19, P1081, DOI 10.1101/gad.1304805; Piotrowska K, 2001, NATURE, V409, P517, DOI 10.1038/35054069; Piotrowska-Nitsche K, 2005, MECH DEVELOP, V122, P487, DOI 10.1016/j.mod.2004.11.014; Plusa B, 2005, NATURE, V434, P391, DOI 10.1038/nature03388; Rossant J, 2004, DEV CELL, V7, P155, DOI 10.1016/j.devcel.2004.07.012; Squirrell JM, 1999, NAT BIOTECHNOL, V17, P763, DOI 10.1038/11698; Vinot S, 2005, DEV BIOL, V282, P307, DOI 10.1016/j.ydbio.2005.03.001; Zernicka-Goetz M, 2002, DEVELOPMENT, V129, P815	15	21	24	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 13	2006	442	7099					E3	E4		10.1038/nature04907	http://dx.doi.org/10.1038/nature04907			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	062XJ	16837972				2022-12-28	WOS:000238979700035
J	Brown, KA; Brain, SD; D Pearson, J; D Edgeworth, J; Lewis, SM; Treacher, DF				Brown, K. A.; Brain, S. D.; D Pearson, J.; D Edgeworth, J.; Lewis, S. M.; Treacher, D. F.			Neutrophils in development of multiple organ failure in sepsis	LANCET			English	Review							COLONY-STIMULATING FACTOR; INFLAMMATORY RESPONSE SYNDROME; RESPIRATORY-DISTRESS-SYNDROME; TUMOR-NECROSIS-FACTOR; ACTIVATED PROTEIN-C; ENDOTHELIAL-CELL-INTERACTIONS; RECEPTOR ANTAGONIST TRIAL; TOLL-LIKE RECEPTOR-2; DOUBLE-BLIND; POLYMORPHONUCLEAR LEUKOCYTES		Kings Coll London, Sch Med, Div Med Educ, London WC2R 2LS, England; Kings Coll London, Sch Med, Div Cardiovasc, London WC2R 2LS, England; Guys & St Thomas Hosp, Dept Infect, London, England; Guys & St Thomas NHS Fdn Trust, Intens Care Unit, London, England	University of London; King's College London; University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; Guy's & St Thomas' NHS Foundation Trust	Brown, KA (corresponding author), St Thomas Hosp, Rayne Inst, London SE1 7EH, England.	alun.brown@kcl.ac.uk	Brain, Susan/L-3681-2013; lewis, Sion/C-2258-2009	Brain, Susan/0000-0002-9684-8342				ABRAHAM E, 1995, JAMA-J AM MED ASSOC, V273, P934, DOI 10.1001/jama.273.12.934; Adams JM, 2001, J TRAUMA, V51, P452, DOI 10.1097/00005373-200109000-00005; Adrie C, 2000, INTENS CARE MED, V26, P364, DOI 10.1007/s001340051169; Ahmed NA, 1999, CRIT CARE MED, V27, P2459, DOI 10.1097/00003246-199911000-00023; Aird WC, 2003, BLOOD, V101, P3765, DOI 10.1182/blood-2002-06-1887; Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Annane D, 2002, JAMA-J AM MED ASSOC, V288, P862, DOI 10.1001/jama.288.7.862; Asagoe K, 1998, J IMMUNOL, V160, P4518; ASTIZ ME, 1995, CRIT CARE MED, V23, P265, DOI 10.1097/00003246-199502000-00011; ATHENS JW, 1961, J CLIN INVEST, V40, P989, DOI 10.1172/JCI104338; Azoulay E, 2003, CRIT CARE MED, V31, P157, DOI 10.1097/00003246-200301000-00025; BAKKER J, 1990, CHEST, V98, P170; Balk RA, 2000, CRIT CARE CLIN, V16, P179, DOI 10.1016/S0749-0704(05)70106-8; Barth E, 2002, CYTOKINE, V17, P275, DOI 10.1006/cyto.2002.1010; Bernard GR, 2001, NEW ENGL J MED, V344, P699, DOI 10.1056/NEJM200103083441001; Biffl WL, 1999, SURGERY, V126, P198, DOI 10.1067/msy.1999.98738; Bone RC, 1996, CRIT CARE MED, V24, P1125, DOI 10.1097/00003246-199607000-00010; Borutaite V, 2000, BBA-BIOENERGETICS, V1459, P405, DOI 10.1016/S0005-2728(00)00178-X; BOTHA AJ, 1995, J TRAUMA, V39, P411; Bouchon A, 2000, J IMMUNOL, V164, P4991, DOI 10.4049/jimmunol.164.10.4991; Bouchon A, 2001, NATURE, V410, P1103, DOI 10.1038/35074114; BRADLEY BD, 2000, CRIT CARE MED, V28, P3090; Brealey D, 2000, J ROY COLL PHYS LOND, V34, P428; BROM J, 1995, BURNS, V21, P427, DOI 10.1016/0305-4179(95)00011-Y; Brown K. Alun, 1994, P27; Brown KA, 2001, PERFUSION-UK, V16, P75, DOI 10.1177/026765910101600i111; Chishti AD, 2004, INTENS CARE MED, V30, P605, DOI 10.1007/s00134-004-2175-y; Chosay JG, 1997, AM J PHYSIOL-GASTR L, V272, pG1195, DOI 10.1152/ajpgi.1997.272.5.G1195; Cohen J, 1996, CRIT CARE MED, V24, P1431, DOI 10.1097/00003246-199609000-00002; Cohen J, 2002, NATURE, V420, P885, DOI 10.1038/nature01326; COLOTTA F, 1992, BLOOD, V80, P2012; Cristofaro P, 2003, EXPERT OPIN THER TAR, V7, P603, DOI 10.1517/14728222.7.5.603; Cummings CJ, 1999, J IMMUNOL, V162, P2341; DANIELS RH, 1992, IMMUNOLOGY, V75, P157; Dhainaut JFA, 1998, CRIT CARE MED, V26, P1963, DOI 10.1097/00003246-199812000-00021; DOERSCHUK CM, 1993, J APPL PHYSIOL, V74, P3040, DOI 10.1152/jappl.1993.74.6.3040; DOHERTY GM, 1992, J IMMUNOL, V149, P1666; DONNELLY SC, 1993, LANCET, V341, P643, DOI 10.1016/0140-6736(93)90416-E; Dunne JR, 1996, J SURG RES, V61, P348, DOI 10.1006/jsre.1996.0128; Edward SW., 1994, BIOCH PHYSL NEUTROPH; Ellis TN, 2004, IMMUNOLOGY, V112, P2, DOI 10.1111/j.1365-2567.2004.01849.x; Fadlon E, 1998, BLOOD, V91, P266, DOI 10.1182/blood.V91.1.266.266_266_274; Fan J, 2003, NAT MED, V9, P315, DOI 10.1038/nm832; Fang XM, 1999, CRIT CARE MED, V27, P1330, DOI 10.1097/00003246-199907000-00024; FASANO MB, 1991, J CLIN INVEST, V88, P1452, DOI 10.1172/JCI115454; Faxon DP, 2002, J AM COLL CARDIOL, V40, P1199, DOI 10.1016/S0735-1097(02)02136-8; Ferrante A, 1992, Immunol Ser, V57, P417; Fink MP, 2002, INTENS CARE MED, V28, P369, DOI 10.1007/s00134-001-1205-2; Fisher CJ, 1996, NEW ENGL J MED, V334, P1697, DOI 10.1056/NEJM199606273342603; Franscini N, 2004, CIRCULATION, V110, P2903, DOI 10.1161/01.CIR.0000146344.49689.BB; GALBRAITH PR, 1965, BLOOD, V25, P638; GEBB SA, 1995, J APPL PHYSIOL, V79, P493, DOI 10.1152/jappl.1995.79.2.493; Gibot S, 2005, CRIT CARE MED, V33, P792, DOI 10.1097/01.CCM.0000159089.16462.4A; Ginis I, 1997, AM J PHYSIOL-CELL PH, V272, pC295, DOI 10.1152/ajpcell.1997.272.1.C295; Gonzalez-Amaro R, 1999, CRIT REV IMMUNOL, V19, P389; GRANGER DN, 1994, J LEUKOCYTE BIOL, V55, P662, DOI 10.1002/jlb.55.5.662; Green J, 2000, J ROY COLL PHYS LOND, V34, P418; GRIMMINGER F, 1990, J IMMUNOL, V144, P1866; GUTHRIE LA, 1984, J EXP MED, V160, P1656, DOI 10.1084/jem.160.6.1656; HACK CE, 1997, ADV IMMUNOL, V66, P95; Hayashi F, 2003, BLOOD, V102, P2660, DOI 10.1182/blood-2003-04-1078; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Hoffmeyer F, 1997, IMMUNOLOGY, V92, P544, DOI 10.1046/j.1365-2567.1997.00381.x; HOLMAN JM, 1988, J LEUKOCYTE BIOL, V43, P193, DOI 10.1002/jlb.43.3.193; Hotchkiss RS, 1999, CRIT CARE MED, V27, P1230, DOI 10.1097/00003246-199907000-00002; Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333; Iba T, 2005, CRIT CARE MED, V33, P368, DOI 10.1097/01.CCM.0000153415.04995.88; Ibbotson GC, 2001, NAT MED, V7, P465, DOI 10.1038/86539; Ishikawa K, 2000, J TRAUMA, V48, P814, DOI 10.1097/00005373-200005000-00004; Jacobs S, 2003, CRIT CARE MED, V31, P1938, DOI 10.1097/01.CCM.0000074724.71242.88; Jimenez MF, 1997, ARCH SURG-CHICAGO, V132, P1263; Joyce DE, 2004, CRIT CARE MED, V32, pS280, DOI 10.1097/01.CCM.0000128037.72072.22; Kaneider NC, 2005, NAT MED, V11, P661, DOI 10.1038/nm1245; Keel M, 1997, BLOOD, V90, P3356, DOI 10.1182/blood.V90.9.3356; Keh D, 2003, AM J RESP CRIT CARE, V167, P512, DOI 10.1164/rccm.200205-446OC; KELLY FJ, 1994, REDOX REP, V1, P37, DOI 10.1080/13510002.1994.11746954; Kobold ACM, 2000, INTENS CARE MED, V26, P883, DOI 10.1007/s001340051277; Kurosawa S, 2000, J IMMUNOL, V165, P4697, DOI 10.4049/jimmunol.165.8.4697; Kurt-Jones EA, 2002, BLOOD, V100, P1860, DOI 10.1182/blood.V100.5.1860.h81702001860_1860_1868; Kyriakides C, 2001, PANCREAS, V22, P40, DOI 10.1097/00006676-200101000-00007; Laudes IJ, 2004, AM J PATHOL, V164, P1435, DOI 10.1016/S0002-9440(10)63230-0; Layseca-Espinosa E, 2002, PEDIAT ALLERG IMM-UK, V13, P319, DOI 10.1034/j.1399-3038.2002.01064.x; LEE KR, 1993, J MATER SCI-MATER EL, V4, P283; Lesur O, 2000, CRIT CARE MED, V28, P3814, DOI 10.1097/00003246-200012000-00010; Levy MM, 2003, CRIT CARE MED, V31, P1250, DOI 10.1097/01.CCM.0000050454.01978.3B; LEY K, 1993, J IMMUNOL, V151, P6347; LIESCHKE GJ, 1994, BLOOD, V84, P1737; LIN RY, 1993, CHEST, V104, P847, DOI 10.1378/chest.104.3.847; Lotz S, 2004, J LEUKOCYTE BIOL, V75, P467, DOI 10.1189/jlb.0803360; LUSCINSKAS FW, 1992, J IMMUNOL, V149, P2163; Martin C, 2003, IMMUNITY, V19, P583, DOI 10.1016/S1074-7613(03)00263-2; Martins PS, 2003, SHOCK, V20, P208, DOI 10.1097/01.shk.0000079425.52617.db; Matsukawa A, 2001, J EXP MED, V193, P679, DOI 10.1084/jem.193.6.679; MAUNDER RJ, 1986, AM REV RESPIR DIS, V133, P313; McGill SN, 1996, ARCH SURG-CHICAGO, V131, P1141; McKnight AJ, 1998, J LEUKOCYTE BIOL, V63, P271, DOI 10.1002/jlb.63.3.271; Melley DD, 2005, CLIN SCI, V108, P413, DOI 10.1042/CS20040228; Mizgerd JP, 1996, J EXP MED, V184, P639, DOI 10.1084/jem.184.2.639; Mollnes TE, 2002, BLOOD, V100, P1869; Moreland JG, 2004, J IMMUNOL, V172, P426, DOI 10.4049/jimmunol.172.1.426; Mulligan MS, 1996, P ASSOC AM PHYSICIAN, V108, P198; Nakae H, 1996, RES COMMUN MOL PATH, V91, P329; Nakamori Y, 2003, J TRAUMA, V54, P253, DOI 10.1097/01.TA.0000037096.73714.E6; NELSON S, 1994, CLIN INFECT DIS, V18, pS197, DOI 10.1093/clinids/18.Supplement_2.S197; Nelson S, 1998, J INFECT DIS, V178, P1075, DOI 10.1086/515694; Netea MG, 2003, TRENDS IMMUNOL, V24, P254, DOI 10.1016/S1471-4906(03)00079-6; Nick JA, 2004, BLOOD, V104, P3878, DOI 10.1182/blood-2004-06-2140; NUYTINCK HKS, 1988, ARCH SURG-CHICAGO, V123, P1519; OGNIBENE FP, 1986, NEW ENGL J MED, V315, P547, DOI 10.1056/NEJM198608283150904; Opal SM, 1997, CRIT CARE MED, V25, P1115, DOI 10.1097/00003246-199707000-00010; OTSUKA Y, 1990, J IMMUNOL, V145, P2639; Parsey MV, 1998, J IMMUNOL, V160, P1007; Paterson RL, 2000, J ROY COLL SURG EDIN, V45, P178; Pereira S, 2001, J IMMUNOL, V166, P4115, DOI 10.4049/jimmunol.166.6.4115; Polderman KH, 2004, LANCET, V363, P1721, DOI 10.1016/S0140-6736(04)16259-4; POLK HC, 1992, AM J SURG, V163, P191, DOI 10.1016/0002-9610(92)90099-D; Quaid GA, 1999, ARCH SURG-CHICAGO, V134, P1367, DOI 10.1001/archsurg.134.12.1367; Quezado Z, 2001, AM J PHYSIOL-REG I, V281, pR1177, DOI 10.1152/ajpregu.2001.281.4.R1177; Qureshi SS, 2001, CLIN EXP IMMUNOL, V125, P258, DOI 10.1046/j.1365-2249.2001.01596.x; Ramamoorthy C, 1997, J LEUKOCYTE BIOL, V61, P167, DOI 10.1002/jlb.61.2.167; Rees DD, 1998, BRIT J PHARMACOL, V124, P540, DOI 10.1038/sj.bjp.0701815; Rhee P, 2000, J TRAUMA, V49, P611, DOI 10.1097/00005373-200010000-00007; Rickert P, 2000, TRENDS CELL BIOL, V10, P466, DOI 10.1016/S0962-8924(00)01841-9; Root RK, 2003, CRIT CARE MED, V31, P367, DOI 10.1097/01.CCM.0000048629.32625.5D; Rosenbloom AJ, 1999, J LEUKOCYTE BIOL, V66, P83, DOI 10.1002/jlb.66.1.83; Russwurm S, 2002, SHOCK, V17, P263, DOI 10.1097/00024382-200204000-00004; Sabroe I, 2005, IMMUNOLOGY, V115, P90, DOI 10.1111/j.1365-2567.2005.02133.x; Sabroe I, 2003, J IMMUNOL, V170, P5268, DOI 10.4049/jimmunol.170.10.5268; Sakr Y, 2004, CRIT CARE MED, V32, P1825, DOI 10.1097/01.CCM.0000138558.16257.3F; SATO T, 1993, J LEUKOCYTE BIOL, V53, P144, DOI 10.1002/jlb.53.2.144; SCHLAG G, 1994, SHOCK, V2, P10, DOI 10.1097/00024382-199407000-00002; SIMMS HH, 1991, J LAB CLIN MED, V117, P241; SIMMS HH, 1994, BLOOD, V83, P1398; Singer M, 2004, LANCET, V364, P545, DOI 10.1016/S0140-6736(04)16815-3; Slofstra Sjoukje H, 2003, Hematol J, V4, P295, DOI 10.1038/sj.thj.6200263; SMITH JA, 1994, J LEUKOCYTE BIOL, V56, P672, DOI 10.1002/jlb.56.6.672; Strassheim D, 2002, INT J BIOCHEM CELL B, V34, P1527, DOI 10.1016/S1357-2725(02)00049-3; Stubner G, 1984, Immun Infekt, V12, P69; Suratt BT, 2001, AM J PHYSIOL-LUNG C, V281, pL913, DOI 10.1152/ajplung.2001.281.4.L913; Sweeney JF, 1998, J SURG RES, V74, P64, DOI 10.1006/jsre.1997.5193; Takala A, 1999, CLIN SCI, V97, P529, DOI 10.1042/CS19990073; Takeda K, 1999, IMMUNITY, V10, P39, DOI 10.1016/S1074-7613(00)80005-9; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Tanaka H, 1996, J TRAUMA, V40, P718, DOI 10.1097/00005373-199605000-00006; Taneja R, 2004, CRIT CARE MED, V32, P1460, DOI 10.1097/01.CCM.0000129975.26905.77; Tavares-Murta BM, 2002, CRIT CARE MED, V30, P1056, DOI 10.1097/00003246-200205000-00017; TELLADO JM, 1991, J LEUKOCYTE BIOL, V50, P547, DOI 10.1002/jlb.50.6.547; Thijs A, 1998, KIDNEY INT, V53, pS34; Treacher DF, 2001, PERFUSION-UK, V16, P67, DOI 10.1177/026765910101600i110; TSCHAIKOWSKY K, 1993, CLIN INVESTIGATOR, V72, P18; Tsuda Y, 2004, IMMUNITY, V21, P215, DOI 10.1016/j.immuni.2004.07.006; Tsukahara Y, 1998, WORLD J SURG, V22, P771, DOI 10.1007/s002689900468; TUCHSCHMIDT J, 1992, CHEST, V102, P216, DOI 10.1378/chest.102.1.216; Turzanski J, 1997, BRIT J HAEMATOL, V96, P46, DOI 10.1046/j.1365-2141.1997.d01-2000.x; Ulevitch RJ, 1999, CURR OPIN IMMUNOL, V11, P19, DOI 10.1016/S0952-7915(99)80004-1; van der Pol WL, 2001, J INFECT DIS, V184, P1548, DOI 10.1086/324662; van der Poll T, 2005, AM J RESP CRIT CARE, V171, P1125, DOI 10.1164/rccm.200411-1483OC; VanEeden SF, 1997, MICROCIRCULATION-LON, V4, P369, DOI 10.3109/10739689709146801; Verdant C, 2005, CURR OPIN CRIT CARE, V11, P240, DOI 10.1097/01.ccx.0000158849.94225.11; Wagner C, 2000, J MOL MED-JMM, V78, P337, DOI 10.1007/s001090000107; Wagner C, 2003, SHOCK, V19, P5, DOI 10.1097/00024382-200301000-00002; Wagner JG, 2000, PHARMACOL REV, V52, P349; WAKEFIELD CH, 1993, ARCH SURG-CHICAGO, V128, P390; Ward PA, 2004, NAT REV IMMUNOL, V4, P133, DOI 10.1038/nri1269; Weiss M, 2003, ANN NY ACAD SCI, V1010, P742, DOI 10.1196/annals.1299.134; WINDSOR ACJ, 1993, BRIT J SURG, V80, P10, DOI 10.1002/bjs.1800800106; Wyman TH, 2002, AM J PHYSIOL-CELL PH, V283, pC1592, DOI 10.1152/ajpcell.00540.2001; Xu N, 2002, AM J PHYSIOL-LUNG C, V282, pL796, DOI 10.1152/ajplung.00298.2001; Yamano M, 1998, N-S ARCH PHARMACOL, V358, P253, DOI 10.1007/PL00005250; Yang KY, 2003, AM J RESP CRIT CARE, V167, P1567, DOI 10.1164/rccm.200207-664OC; Zhang H, 2001, AM J PHYSIOL-LUNG C, V280, pL947, DOI 10.1152/ajplung.2001.280.5.L947; ZHANG P, 1994, SHOCK, V2, P133, DOI 10.1097/00024382-199408000-00009; Zhou MY, 1998, J CLIN INVEST, V101, P2427, DOI 10.1172/JCI407; 2004, INT CARE MED, V30, P536	174	387	397	4	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 8	2006	368	9530					157	169		10.1016/S0140-6736(06)69005-3	http://dx.doi.org/10.1016/S0140-6736(06)69005-3			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	062AR	16829300				2022-12-28	WOS:000238917200030
J	Gruen, RL; Bailie, RS; Wang, ZQ; Heard, S; O'Rourke, IC				Gruen, Russell L.; Bailie, Ross S.; Wang, Zhiqiang; Heard, Sam; O'Rourke, Ian C.			Specialist outreach to isolated and disadvantaged communities: a population-based study	LANCET			English	Article							GENERAL-PRACTITIONERS; REFERRALS; ACCESS; HEALTH	Background Visiting-specialist clinics (specialist outreach) have the potential to overcome some of the substantial access barriers faced by disadvantaged rural, remote, and indigenous communities, but the effectiveness of outreach clinics has not been assessed outside urban and non-disadvantaged settings. We aimed to assess the effects of outreach clinics on access, referral patterns, and care outcomes in remote communities in Australia. Methods We undertook a population-based observational study of regular surgical, ophthalmological, gynaecological, and ear, nose, and throat outreach visits, compared with hospital clinics alone, on access, referral practices, and outcomes for the populations of three remote Indigenous communities in northern Australia for 11 years. We assessed all new non-emergency potential specialist surgical cases who presented initially between Jan 1, 1990, and Jan 1, 2001. The effects of outreach clinics on the proportion of patients referred, the time from referral to initial specialist consultation, and the rates of community-based and hospital-based procedures were analysed using logic regression and Cox proportional hazard models. Findings 2339 new surgical problems presented in 2368 people between 1990 and 2001. Outreach improved the rate of referral completion (adjusted hazard ratio 1.41, 95% CI 1.07-1.86) and the risk of timely completion according to the urgency of referral (adjusted relative risk 1.30, 1.05-1.53). Outreach had no significant effect on initiation of elective referrals, but there were 156 opportunistic presentations on outreach clinic days. Specialist investigations and procedures in community clinics removed the need for many patients to travel to hospital, and outreach consultations were associated with a reduced rate of procedures that needed hospital admission (adjusted hazard ratio 0.67, 0.43-1.03). Interpretation Specialist outreach visits to remote disadvantaged Indigenous communities in Australia improve access to specialist consultations and procedures without increasing elective referrals or demands for hospital inpatient services.	Charles Darwin Univ, Inst Adv Studies, Menzies Sch Hlth Res, Casuarina, NT 0811, Australia; No Terr Univ, Sch Clin, Casuarina, NT, Australia; Univ Queensland, Sch Med, Ctr Chron Dis, Herston, Qld, Australia; Univ Cent Queensland, Rockhampton, Qld, Australia; Royal Darwin Hosp, Casuarina, NT, Australia	Charles Darwin University; Menzies School of Health Research; Charles Darwin University; University of Queensland; Central Queensland University	O'Rourke, IC (corresponding author), Charles Darwin Univ, Inst Adv Studies, Menzies Sch Hlth Res, POB 41096, Casuarina, NT 0811, Australia.	russell.gruen@menzies.edu.au	Wang, Zhiqiang/A-5835-2010; Bailie, Ross/K-8141-2013	Wang, Zhiqiang/0000-0002-5839-743X; Bailie, Ross/0000-0001-5966-3368				*AUSTR BUR STAT, 1998, EXP EST IND POP 1991; Australian Institute of Health and Welfare, 2003, HLTH WELF AUSTR AB T; Britt H, 1997, Aust Fam Physician, V26 Suppl 2, pS79; Classification Committee of the World Organization of Family Doctors, 1998, ICPC 2 INT CLASS PRI; COULTER A, 1989, BMJ-BRIT MED J, V299, P304, DOI 10.1136/bmj.299.6694.304; Gruen RL, 2005, MED J AUSTRALIA, V182, P538, DOI 10.5694/j.1326-5377.2005.tb00023.x; Gruen RL, 2004, ANZ J SURG, V74, P863, DOI 10.1111/j.1445-1433.2004.03190.x; Gruen RL, 2002, J EPIDEMIOL COMMUN H, V56, P517, DOI 10.1136/jech.56.7.517; Gruen RL, 2002, MED J AUSTRALIA, V177, P111, DOI 10.5694/j.1326-5377.2002.tb04687.x; Gruen RL, 2001, MED J AUSTRALIA, V174, P507, DOI 10.5694/j.1326-5377.2001.tb143400.x; GRUEN RL, 2004, SPECIALIST OUTREACH; GRUEN RL, 2004, SURG NOSOLOGY PRIMAR, P4; GRUEN RL, 2000, EVALUATION SPECIALIS; Hills, 1993, STAT MODELS EPIDEMIO; *HLTH DAT STAND CO, 2004, HWI73 AIHW; HOFFMANN B, 2003, HLTH HOUSING RELATED; Hoy WE, 1997, AUST NZ J PUBL HEAL, V21, P121, DOI 10.1111/j.1467-842X.1997.tb01670.x; MIRCO C, 1999, SURG OUTPATIENT DEP; PARKERSON GR, 1993, J CLIN EPIDEMIOL, V46, P379, DOI 10.1016/0895-4356(93)90153-R; *POP DIV DEP EC SO, WORLD POP PROSP 2002; ROLAND M, 1988, BRIT MED J, V297, P599, DOI 10.1136/bmj.297.6648.599; Stamp KM, 1998, AUST NZ J PUBL HEAL, V22, P673, DOI 10.1111/j.1467-842X.1998.tb01468.x; *STAT CORP, 2003, STAT STAT SOFTW REL; TAYLOR J, 1996, 1181996 AUSTR NAT U; Wallace P, 2002, LANCET, V359, P1961, DOI 10.1016/S0140-6736(02)08828-1; World Health Organization, 1995, WORLD HLTH REP 1995; Zhang J, 1998, JAMA-J AM MED ASSOC, V280, P1690, DOI 10.1001/jama.280.19.1690	27	53	53	1	12	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 8	2006	368	9530					130	138		10.1016/S0140-6736(06)68812-0	http://dx.doi.org/10.1016/S0140-6736(06)68812-0			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	062AR	16829297				2022-12-28	WOS:000238917200027
J	Wilson, SD; Dai, PC; Li, SL; Chi, SX; Kang, HJ; Lynn, JW				Wilson, Stephen D.; Dai, Pengcheng; Li, Shiliang; Chi, Songxue; Kang, H. J.; Lynn, J. W.			Resonance in the electron-doped high-transition-temperature superconductor Pr0.88LaCe0.12CuO4-delta	NATURE			English	Article							MAGNETIC EXCITATIONS; SPIN EXCITATION; CUPRATE SUPERCONDUCTORS; NEUTRON-SCATTERING; BI2SR2CACU2O8+DELTA; YBA2CU3O6+X; SPECTRUM; STRIPES; MODE	In conventional superconductors, the interaction that pairs the electrons to form the superconducting state is mediated by lattice vibrations(1) (phonons). In high-transition-temperature (high-T-c) copper oxides, it is generally believed that magnetic excitations might play a fundamental role in the superconducting mechanism because superconductivity occurs when mobile 'electrons' or 'holes' are doped into the antiferromagnetic parent compounds(2). Indeed, a sharp magnetic excitation termed 'resonance' has been observed by neutron scattering in a number of hole-doped materials(3-11). The resonance is intimately related to superconductivity(12), and its interaction with charged quasi-particles observed by photoemission(13,14), optical conductivity(15), and tunnelling(16) suggests that it might play a part similar to that of phonons in conventional superconductors. The relevance of the resonance to high-T-c superconductivity, however, has been in doubt because so far it has been found only in hole-doped materials(17). Here we report the discovery of the resonance in electron-doped superconducting Pr0.88LaCe0.12CuO4-delta (T-c = 24 K). We find that the resonance energy (E-r) is proportional to T-c via E-r approximate to 5.8k(B)T(c) for all high-T-c superconductors irrespective of electron- or hole-doping. Our results demonstrate that the resonance is a fundamental property of the superconducting copper oxides and therefore must be essential in the mechanism of superconductivity.	Univ Tennessee, Dept Phys & Astron, Knoxville, TN 37996 USA; Oak Ridge Natl Lab, Ctr Neutron Scattering, Oak Ridge, TN 37831 USA; Natl Inst Stand & Technol, NIST Ctr Neutron Res, Gaithersburg, MD 20899 USA; Univ Maryland, Dept Mat Sci & Engn, College Pk, MD 20742 USA	University of Tennessee System; University of Tennessee Knoxville; United States Department of Energy (DOE); Oak Ridge National Laboratory; National Institute of Standards & Technology (NIST) - USA; University System of Maryland; University of Maryland College Park	Dai, PC (corresponding author), Univ Tennessee, Dept Phys & Astron, Knoxville, TN 37996 USA.	daip@ornl.gov	Lynn, Jeffrey/R-4030-2019; Wilson, Stephen D/O-7001-2017; Dai, Pengcheng/C-9171-2012; Li, Shiliang/B-9379-2009; Lynn, Jeffrey/AAI-2588-2021; Chi, Songxue/A-6713-2013	Lynn, Jeffrey/0000-0003-3626-4932; Wilson, Stephen D/0000-0003-3733-930X; Dai, Pengcheng/0000-0002-6088-3170; Li, Shiliang/0000-0001-7922-3730; Chi, Songxue/0000-0002-3851-9153				Arai M, 1999, PHYS REV LETT, V83, P608, DOI 10.1103/PhysRevLett.83.608; ARONSON MC, 1995, PHYS REV LETT, V75, P725, DOI 10.1103/PhysRevLett.75.725; BARDEEN J, 1957, PHYS REV, V108, P1175, DOI 10.1103/PhysRev.108.1175; Basov DN, 2005, REV MOD PHYS, V77, P721, DOI 10.1103/RevModPhys.77.721; BOOTHROYD AT, 1992, PHYS REV B, V45, P10075, DOI 10.1103/PhysRevB.45.10075; Bourges P, 2000, SCIENCE, V288, P1234, DOI 10.1126/science.288.5469.1234; Christensen NB, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.147002; Dai PC, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.100502; Dai PC, 1999, SCIENCE, V284, P1344, DOI 10.1126/science.284.5418.1344; Dai PC, 2001, PHYS REV B, V63, DOI 10.1103/PhysRevB.63.054525; Damascelli A, 2003, REV MOD PHYS, V75, P473, DOI 10.1103/RevModPhys.75.473; Fong HF, 1999, NATURE, V398, P588, DOI 10.1038/19255; Fong HF, 2000, PHYS REV B, V61, P14773, DOI 10.1103/PhysRevB.61.14773; Fujita M, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.014514; Hayden SM, 2004, NATURE, V429, P531, DOI 10.1038/nature02576; He H, 2002, SCIENCE, V295, P1045, DOI 10.1126/science.1067877; He H, 2001, PHYS REV LETT, V86, P1610, DOI 10.1103/PhysRevLett.86.1610; Hwang J, 2004, NATURE, V427, P714, DOI 10.1038/nature02347; Kang HJ, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.214512; Matsui H, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.017003; MOOK HA, 1993, PHYS REV LETT, V70, P3490, DOI 10.1103/PhysRevLett.70.3490; Norman MR, 2003, REP PROG PHYS, V66, P1547, DOI 10.1088/0034-4885/66/10/R01; Orenstein J, 2000, SCIENCE, V288, P468, DOI 10.1126/science.288.5465.468; ROSSATMIGNOD J, 1991, PHYSICA C, V185, P86, DOI 10.1016/0921-4534(91)91955-4; Stock C, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.014502; Tranquada JM, 2004, NATURE, V429, P534, DOI 10.1038/nature02574; TRANQUADA JM, 2005, NEUTRON SCATTERING S; Yamada K, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.137004; Zasadzinski JF, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.067005	30	107	109	0	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 6	2006	442	7098					59	62		10.1038/nature04857	http://dx.doi.org/10.1038/nature04857			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	059HS	16823448	Green Submitted			2022-12-28	WOS:000238724500035
J	Knight, CL; Fihn, SD				Knight, Christopher L.; Fihn, Stephan D.			Update in general internal medicine	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							PREVENTION; METAANALYSIS; THERAPY		Univ Washington, Med Ctr, Seattle, WA 98105 USA; Vet Affairs Puget Sound Hlth Care Syst, Seattle, WA USA	University of Washington; University of Washington Seattle; US Department of Veterans Affairs; Veterans Health Administration (VHA); Vet Affairs Puget Sound Health Care System	Knight, CL (corresponding author), Univ Washington, Med Ctr, 4245 Roosevelt Way NE,Campus Box 354 760, Seattle, WA 98105 USA.	clknight@u.washington.edu	Fihn, Stephan/ABA-1040-2020	Knight, Christopher/0000-0001-6781-4007				Bischoff-Ferrari HA, 2005, JAMA-J AM MED ASSOC, V293, P2257, DOI 10.1001/jama.293.18.2257; Calonge N, 2005, ANN INTERN MED, V142, P198, DOI 10.7326/0003-4819-142-3-200502010-00011; Cannon CP, 2004, NEW ENGL J MED, V350, P1495, DOI 10.1056/NEJMoa040583; Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3; HENNEKENS CH, 1989, NEW ENGL J MED, V321, P129, DOI 10.1056/nejm198907203210301; Lai KC, 2002, NEW ENGL J MED, V346, P2033, DOI 10.1056/NEJMoa012877; Lieberman DA, 2001, NEW ENGL J MED, V345, P555, DOI 10.1056/NEJMoa010328; Lindenauer PK, 2005, NEW ENGL J MED, V353, P349, DOI 10.1056/NEJMoa041895; *NAT OST FDN, NOF PHYS GUID PHARM; Ng FH, 2003, ALIMENT PHARM THER, V18, P443, DOI 10.1046/j.1365-2036.2003.01693.x; Niewoehner DE, 2005, ANN INTERN MED, V143, P317, DOI 10.7326/0003-4819-143-5-200509060-00007; Nissen SE, 2004, JAMA-J AM MED ASSOC, V291, P1071, DOI 10.1001/jama.291.9.1071; Petersen RC, 2005, NEW ENGL J MED, V352, P2379, DOI 10.1056/NEJMoa050151; Psaty BN, 2003, JAMA-J AM MED ASSOC, V289, P2534, DOI 10.1001/jama.289.19.2534; Sanders GD, 2005, NEW ENGL J MED, V353, P1471, DOI 10.1056/NEJMsa051989; Schneider LS, 2005, JAMA-J AM MED ASSOC, V294, P1934, DOI 10.1001/jama.294.15.1934	16	4	4	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 4	2006	145	1					52	61		10.7326/0003-4819-145-1-200607040-00010	http://dx.doi.org/10.7326/0003-4819-145-1-200607040-00010			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	062IS	16818929				2022-12-28	WOS:000238938400007
J	Xu, J; Li, HD; Chen, LQ; Wang, Y; Liu, LL; He, L; Wu, WH				Xu, Jiang; Li, Hao-Dong; Chen, Li-Qing; Wang, Yi; Liu, Li-Li; He, Liu; Wu, Wei-Hua			A protein kinase, interacting with two calcineurin B-like proteins, regulates K+ transporter AKT1 in Arabidopsis	CELL			English	Article							RECTIFYING POTASSIUM CHANNEL; PLANT SALT TOLERANCE; XENOPUS OOCYTES; CALCIUM SENSORS; GUARD-CELLS; ROOT HAIRS; EXPRESSION; STRESS; NUTRITION; RESISTANT	Potassium is an essential mineral element for plant growth and development. Although it is known that plants absorb and transport K+ through membrane transporters, it remains unclear how these transporters are regulated. Here we show that the protein kinase CIPK23, encoded by the LKS1 gene, regulates K+ uptake under low-K+ conditions. Lesion of LKS1 significantly reduced K+ uptake and caused leaf chlorosis and growth inhibition, whereas overexpression of LKS1 significantly enhanced K+ uptake and tolerance to low K+. We demonstrate that CIPK23 directly phosphorylates the K+ transporter AKT1 and further find that CIPK23 is activated by the binding of two calcineurin B-like proteins, CBL1 and CBL9. We propose a model in which the CBL1/9-CIPIK23 pathway ensures activation of AKT1 and enhanced K+ uptake under low-K+ conditions.	China Agr Univ, State Key Lab Plant Physiol & Biochem, Coll Biol Sci, Natl Plant Gene Res Ctr, Beijing 100094, Peoples R China	China Agricultural University	Xu, J (corresponding author), China Agr Univ, State Key Lab Plant Physiol & Biochem, Coll Biol Sci, Natl Plant Gene Res Ctr, Beijing 100094, Peoples R China.	wuwh@public3.bta.net.cn		He, Liu/0000-0003-3951-4132				Albrecht V, 2001, EMBO J, V20, P1051, DOI 10.1093/emboj/20.5.1051; Batistic O, 2004, PLANTA, V219, P915, DOI 10.1007/s00425-004-1333-3; Bertl A, 1997, J EXP BOT, V48, P405, DOI 10.1093/jxb/48.Special_Issue.405; CAO YW, 1992, PLANT CELL, V4, P961, DOI 10.1105/tpc.4.8.961; CELENZA JL, 1986, SCIENCE, V233, P1175, DOI 10.1126/science.3526554; Cherel I, 2002, PLANT CELL, V14, P1133, DOI 10.1105/tpc.000943; Cherel I, 2004, J EXP BOT, V55, P337, DOI 10.1093/jxb/erh028; CLARKSON DT, 1980, ANNU REV PLANT PHYS, V31, P239, DOI 10.1146/annurev.pp.31.060180.001323; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; DESCAL N, 1987, CRC CRIT REV BIOCH, V22, P317; DREW MC, 1984, PLANTA, V160, P490, DOI 10.1007/BF00411136; Dreyer I, 1997, BIOPHYS J, V72, P2143, DOI 10.1016/S0006-3495(97)78857-X; EPSTEIN E, 1978, PLANT PHYSIOL, V62, P582, DOI 10.1104/pp.62.4.582; Fuchs I, 2005, PLANTA, V221, P212, DOI 10.1007/s00425-004-1437-9; Gaymard F, 1996, J BIOL CHEM, V271, P22863, DOI 10.1074/jbc.271.37.22863; Guo Y, 2001, PLANT CELL, V13, P1383, DOI 10.1105/tpc.13.6.1383; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Hartje S, 2000, PLANTA, V210, P723, DOI 10.1007/s004250050673; Hirsch RE, 1998, SCIENCE, V280, P918, DOI 10.1126/science.280.5365.918; Ichida AM, 1997, PLANT CELL, V9, P1843, DOI 10.1105/tpc.9.10.1843; Ishitani M, 2000, PLANT CELL, V12, P1667, DOI 10.1105/tpc.12.9.1667; Ivashikina N, 2001, FEBS LETT, V508, P463, DOI 10.1016/S0014-5793(01)03114-3; Jan LY, 1997, ANNU REV NEUROSCI, V20, P91, DOI 10.1146/annurev.neuro.20.1.91; Kudla J, 1999, P NATL ACAD SCI USA, V96, P4718, DOI 10.1073/pnas.96.8.4718; LEGARDE D, 1996, PLANT J, V9, P195; Li JX, 1998, PLANT PHYSIOL, V116, P785, DOI 10.1104/pp.116.2.785; Li X, 2001, MOL BREEDING, V8, P109, DOI 10.1023/A:1013316816955; Luan S, 2002, PLANT CELL, V14, pS389, DOI 10.1105/tpc.001115; Mengel, 2001, PRINCIPLES PLANT NUT, P503; Mori IC, 2000, PLANT CELL PHYSIOL, V41, P850, DOI 10.1093/pcp/pcd003; Philippar K, 1999, P NATL ACAD SCI USA, V96, P12186, DOI 10.1073/pnas.96.21.12186; Pilot G, 2003, PLANT MOL BIOL, V51, P773, DOI 10.1023/A:1022597102282; Reintanz B, 2002, P NATL ACAD SCI USA, V99, P4079, DOI 10.1073/pnas.052677799; SCHROEDER JI, 1994, ANNU REV BIOPH BIOM, V23, P441, DOI 10.1146/annurev.bb.23.060194.002301; Shi JR, 1999, PLANT CELL, V11, P2393, DOI 10.1105/tpc.11.12.2393; Spalding EP, 1999, J GEN PHYSIOL, V113, P909, DOI 10.1085/jgp.113.6.909; Very AA, 2003, ANNU REV PLANT BIOL, V54, P575, DOI 10.1146/annurev.arplant.54.031902.134831; VERY AA, 1995, PLANT J, V7, P321, DOI 10.1046/j.1365-313X.1995.7020321.x; Walter M, 2004, PLANT J, V40, P428, DOI 10.1111/j.1365-313X.2004.02219.x; Xiong LM, 2002, PLANT CELL, V14, pS165, DOI 10.1105/tpc.000596; Zimmermann S, 1998, PLANT PHYSIOL, V116, P879, DOI 10.1104/pp.116.3.879	41	682	830	15	294	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 30	2006	125	7					1347	1360		10.1016/j.cell.2006.06.011	http://dx.doi.org/10.1016/j.cell.2006.06.011			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	064QP	16814720	Green Submitted, Bronze			2022-12-28	WOS:000239104500017
J	Gore, J; Bryant, Z; Nollmann, M; Le, MU; Cozzarelli, NR; Bustamante, C				Gore, Jeff; Bryant, Zev; Noellmann, Marcelo; Le, Mai U.; Cozzarelli, Nicholas R.; Bustamante, Carlos			DNA overwinds when stretched	NATURE			English	Article							SUPERCOILED DNA; SINGLE-MOLECULE; ELASTICITY; SIMULATIONS; MECHANICS; TWEEZERS	DNA is often modelled as an isotropic rod(1-4), but its chiral structure suggests the possible importance of anisotropic mechanical properties, including coupling between twisting and stretching degrees of freedom. Simple physical intuition predicts that DNA should unwind under tension, as it is pulled towards a denatured structure(4-8). We used rotor bead tracking to directly measure twist - stretch coupling in single DNA molecules. Here we show that for small distortions, contrary to intuition, DNA overwinds under tension, reaching a maximum twist at a tension of similar to 30 pN. As tension is increased above this critical value, the DNA begins to unwind. The observed twist - stretch coupling predicts that DNA should also lengthen when overwound under constant tension, an effect that we quantitatively confirm. We present a simple model that explains these unusual mechanical properties, and also suggests a possible origin for the anomalously large torsional rigidity of DNA. Our results have implications for the action of DNA-binding proteins that must stretch and twist DNA to compensate for variability in the lengths of their binding sites(9-11). The requisite coupled DNA distortions are favoured by the intrinsic mechanical properties of the double helix reported here.	Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Phys Biosci Div, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Bustamante, C (corresponding author), Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA.	carlos@alice.berkeley.edu		Nollmann, Marcelo/0000-0003-3339-2349; Bustamante, Carlos/0000-0002-2970-0073				Baumann CG, 1997, P NATL ACAD SCI USA, V94, P6185, DOI 10.1073/pnas.94.12.6185; Bryant Z, 2003, NATURE, V424, P338, DOI 10.1038/nature01810; Bustamante C, 2000, CURR OPIN STRUC BIOL, V10, P279, DOI 10.1016/S0959-440X(00)00085-3; Cluzel P, 1996, SCIENCE, V271, P792, DOI 10.1126/science.271.5250.792; Davenport RJ, 2000, SCIENCE, V287, P2497, DOI 10.1126/science.287.5462.2497; DEPEW RE, 1975, P NATL ACAD SCI USA, V72, P4275, DOI 10.1073/pnas.72.11.4275; Feynman R. P., 1970, FEYNMAN LECT PHYS; Gore J, 2006, NATURE, V439, P100, DOI 10.1038/nature04319; Gore J, 2005, THESIS U CALIFORNIA; Gosse C, 2002, BIOPHYS J, V82, P3314, DOI 10.1016/S0006-3495(02)75672-5; HAGERMAN PJ, 1988, ANNU REV BIOPHYS BIO, V17, P265; Hegner M, 1999, P NATL ACAD SCI USA, V96, P10109, DOI 10.1073/pnas.96.18.10109; HOGAN ME, 1987, NATURE, V329, P263, DOI 10.1038/329263a0; Howard J., 2001, MECH MOTOR PROTEINS; Kamien RD, 1997, EUROPHYS LETT, V38, P237, DOI 10.1209/epl/i1997-00231-y; Kosikov KM, 1999, J MOL BIOL, V289, P1301, DOI 10.1006/jmbi.1999.2798; Lankas F, 2003, BIOPHYS J, V85, P2872, DOI 10.1016/S0006-3495(03)74710-9; Lionnet T, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.178102; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Marko JF, 1997, EUROPHYS LETT, V38, P183, DOI 10.1209/epl/i1997-00223-5; Moroz JD, 1998, MACROMOLECULES, V31, P6333, DOI 10.1021/ma971804a; Nelson P, 2003, BIOL PHYS; Olson WK, 1998, P NATL ACAD SCI USA, V95, P11163, DOI 10.1073/pnas.95.19.11163; Smith SB, 1996, SCIENCE, V271, P795, DOI 10.1126/science.271.5250.795; SMITH SB, 1992, SCIENCE, V258, P1122, DOI 10.1126/science.1439819; Strick TR, 1998, BIOPHYS J, V74, P2016, DOI 10.1016/S0006-3495(98)77908-1; Strick TR, 1996, SCIENCE, V271, P1835, DOI 10.1126/science.271.5257.1835; Travers AA, 2004, PHILOS T R SOC A, V362, P1265, DOI 10.1098/rsta.2004.1392; Wahl MC, 1997, BIOPOLYMERS, V44, P45, DOI 10.1002/(SICI)1097-0282(1997)44:1<45::AID-BIP4>3.0.CO;2-#; Wang MD, 1997, BIOPHYS J, V72, P1335, DOI 10.1016/S0006-3495(97)78780-0	30	304	309	3	79	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 17	2006	442	7104					836	839		10.1038/nature04974	http://dx.doi.org/10.1038/nature04974			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	074DK	16862122				2022-12-28	WOS:000239792700051
J	Krivtsov, AV; Twomey, D; Feng, ZH; Stubbs, MC; Wang, YZ; Faber, J; Levine, JE; Wang, J; Hahn, WC; Gilliland, DG; Golub, TR; Armstrong, SA				Krivtsov, Andrei V.; Twomey, David; Feng, Zhaohui; Stubbs, Matthew C.; Wang, Yingzi; Faber, Joerg; Levine, Jason E.; Wang, Jing; Hahn, William C.; Gilliland, D. Gary; Golub, Todd R.; Armstrong, Scott A.			Transformation from committed progenitor to leukaemia stem cell initiated by MLL-AF9	NATURE			English	Article							ACUTE MYELOID-LEUKEMIA; HEMATOPOIETIC PROGENITORS; FUSION GENE; HOXA9; MICE; IMMORTALIZATION; TRANSLOCATIONS; IDENTIFICATION; MLL-GAS7; TARGETS	Leukaemias and other cancers possess a rare population of cells capable of the limitless self-renewal necessary for cancer initiation and maintenance(1-7). Eradication of these cancer stem cells is probably a critical part of any successful anti-cancer therapy, and may explain why conventional cancer therapies are often effective in reducing tumour burden, but are only rarely curative. Given that both normal and cancer stem cells are capable of self-renewal, the extent to which cancer stem cells resemble normal tissue stem cells is a critical issue if targeted therapies are to be developed. However, it remains unclear whether cancer stem cells must be phenotypically similar to normal tissue stem cells or whether they can retain the identity of committed progenitors. Here we show that leukaemia stem cells (LSC) can maintain the global identity of the progenitor from which they arose while activating a limited stem-cell- or self-renewal-associated programme. We isolated LSC from leukaemias initiated in committed granulocyte macrophage progenitors through introduction of the MLL - AF9 fusion protein encoded by the t(9; 11)(p22; q23). The LSC were capable of transferring leukaemia to secondary recipient mice when only four cells were transferred, and possessed an immunophenotype and global gene expression profile very similar to that of normal granulocyte macrophage progenitors. However, a subset of genes highly expressed in normal haematopoietic stem cells was re-activated in LSC. LSC can thus be generated from committed progenitors without widespread reprogramming of gene expression, and a leukaemia self-renewal-associated signature is activated in the process. Our findings define progression from normal progenitor to cancer stem cell, and suggest that targeting a self-renewal programme expressed in an abnormal context may be possible.	Childrens Hosp, Div Hematol Oncol, Boston, MA 02115 USA; Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Hematol, Boston, MA 02115 USA; Harvard Univ, Broad Inst, Cambridge, MA 02142 USA; MIT, Broad Inst, Cambridge, MA 02142 USA; Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Harvard University; Boston Children's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Howard Hughes Medical Institute	Armstrong, SA (corresponding author), Childrens Hosp, Div Hematol Oncol, Boston, MA 02115 USA.	Scott.Armstrong@childrens.harvard.edu	Faber, Joerg/G-4549-2010; Krivtsov, Andrei/AAJ-9966-2021; Wang, Jenny Y./ABD-2091-2020	, Matthew/0000-0003-3771-7083; Krivtsov, Andrei/0000-0002-5511-1686; Wang, Jenny Y./0000-0002-1325-7943				Abramovich C, 2005, CURR OPIN HEMATOL, V12, P210, DOI 10.1097/01.moh.0000160737.52349.aa; Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Al-Hajj M, 2004, ONCOGENE, V23, P7274, DOI 10.1038/sj.onc.1207947; Armstrong SA, 2002, NAT GENET, V30, P41, DOI 10.1038/ng765; Ayton PM, 2003, GENE DEV, V17, P2298, DOI 10.1101/gad.1111603; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Corral J, 1996, CELL, V85, P853, DOI 10.1016/S0092-8674(00)81269-6; Cozzio A, 2003, GENE DEV, V17, P3029, DOI 10.1101/gad.1143403; Drynan LF, 2005, EMBO J, V24, P3136, DOI 10.1038/sj.emboj.7600760; Du Y, 2005, BLOOD, V106, P2498, DOI 10.1182/blood-2004-12-4840; Ernst P, 2004, CURR BIOL, V14, P2063, DOI 10.1016/j.cub.2004.11.012; Guenther MG, 2005, P NATL ACAD SCI USA, V102, P8603, DOI 10.1073/pnas.0503072102; Huntly BJP, 2004, CANCER CELL, V6, P587, DOI 10.1016/j.ccr.2004.10.015; Jamieson CHM, 2004, NEW ENGL J MED, V351, P657, DOI 10.1056/NEJMoa040258; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kolligs FT, 2002, CANCER CELL, V1, P145, DOI 10.1016/S1535-6108(02)00035-1; Kumar AR, 2004, BLOOD, V103, P1823, DOI 10.1182/blood-2003-07-2582; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; Lavau C, 1997, EMBO J, V16, P4226, DOI 10.1093/emboj/16.14.4226; Milne TA, 2005, P NATL ACAD SCI USA, V102, P14765, DOI 10.1073/pnas.0503630102; Ramalho-Santos M, 2002, SCIENCE, V298, P597, DOI 10.1126/science.1072530; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Ross ME, 2004, BLOOD, V104, P3679, DOI 10.1182/blood-2004-03-1154; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; So CW, 2004, BLOOD, V103, P3192, DOI 10.1182/blood-2003-10-3722; So CW, 2003, CANCER CELL, V3, P161, DOI 10.1016/S1535-6108(03)00019-9; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Wang J, 2005, EMBO J, V24, P368, DOI 10.1038/sj.emboj.7600521; Warner JK, 2004, ONCOGENE, V23, P7164, DOI 10.1038/sj.onc.1207933; Zeisig BB, 2004, MOL CELL BIOL, V24, P617, DOI 10.1128/MCB.24.2.617-628.2004	30	1094	1148	0	76	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 17	2006	442	7104					818	822		10.1038/nature04980	http://dx.doi.org/10.1038/nature04980			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	074DK	16862118				2022-12-28	WOS:000239792700047
J	Kuper, R; Kropelin, S				Kuper, Rudolph; Kroepelin, Stefan			Climate-controlled Holocene occupation in the Sahara: Motor of Africa's evolution	SCIENCE			English	Article							EASTERN SAHARA; ENVIRONMENTAL-CHANGE; HUMID PERIOD; ARCHAEOLOGY; RESPONSES; EGYPT	Radiocarbon data from 150 archaeological excavations in the now hyper-arid Eastern Sahara of Egypt, Sudan, Libya, and Chad reveal close links between climatic variations and prehistoric occupation during the past 12,000 years. Synoptic multiple-indicator views for major time slices demonstrate the transition from initial settlement after the sudden onset of humid conditions at 8500 B. C. E. to the exodus resulting from gradual desiccation since 5300 B. C. E. Southward shifting of the desert margin helped trigger the emergence of pharaonic civilization along the Nile, influenced the spread of pastoralism throughout the continent, and affects sub-Saharan Africa to the present day.	Univ Cologne, Inst Prehist Archaeol, Africa Res Unit, Collaborat Res Ctr 389 ACACIA, D-50823 Cologne, Germany	University of Cologne	Kropelin, S (corresponding author), Univ Cologne, Inst Prehist Archaeol, Africa Res Unit, Collaborat Res Ctr 389 ACACIA, Jennerstr 8, D-50823 Cologne, Germany.	s.kroe@uni-koeln.de						BARICH B, 1988, ORIGINI, V13, P117; Claussen M, 1999, GEOPHYS RES LETT, V26, P2037, DOI 10.1029/1999GL900494; Close A.E., 2002, AFRICA PRAEHISTORICA, P459; DANSGAARD W, 1993, NATURE, V364, P218, DOI 10.1038/364218a0; deMenocal P, 2000, QUATERNARY SCI REV, V19, P347, DOI 10.1016/S0277-3791(99)00081-5; deMenocal PB, 2001, SCIENCE, V292, P667, DOI 10.1126/science.1059827; Gasse F, 2000, QUATERNARY SCI REV, V19, P189, DOI 10.1016/S0277-3791(99)00061-X; GEHLEN B, 2002, AFRICA PRAEHISTORICA, V14, P85; HASSAN F.A., 1985, AFR ARCHAEOL REV, V3, P95; Haynes CV, 2001, GEOARCHAEOLOGY, V16, P119, DOI 10.1002/1520-6548(200101)16:1<119::AID-GEA8>3.0.CO;2-V; HENNING D, 1977, 7431 ACONF; Hoelzmann P, 2004, DEV PALEOENVIRON RES, V6, P219; Hoelzmann P, 2001, PALAEOGEOGR PALAEOCL, V169, P193, DOI 10.1016/S0031-0182(01)00211-5; JESSE F, 2003, AFRICA PRAEHISTORICA, V16, P1; Jesse F., 2004, J AFR ARCHAEOL, V2, P123, DOI [10.3213/1612-1651-10025, DOI 10.3213/1612-1651-10025]; KINDERMANN K., 2004, ARCHEO NIL, V14, P31; Kropelin S., 1999, NORDOST AFRIKA STRUK, P448; KUHLMANN KP, 2002, AFRICA PRAEHISTORICA, V14, P125; Kuper R, 2001, ANTIQUITY, V75, P801, DOI 10.1017/S0003598X00089328; KUPER R, 1995, CAHIERS RECHERCHES I, V17, P123; Kuper R., 2003, EA, V23, P25; KUPER R., 1993, ENV CHANGE HUMAN CUL, P213; KUPER R, 2003, B SOC FR EGYPTOL, V158, P12; Linstadter J, 2004, GEOARCHAEOLOGY, V19, P753, DOI 10.1002/gea.20023; McDonald MMA, 2001, OASIS PAPERS 1: THE PROCEEDINGS OF THE FIRST CONFERENCE OF THE DAKHLEH OASIS PROJECT, P26; McDonald MMA, 1998, J ANTHROPOL ARCHAEOL, V17, P124, DOI 10.1006/jaar.1998.0320; Neumann K., 1989, AFR ARCHAEOL REV, V7, P97, DOI DOI 10.1007/BF01116839; Nicoll K, 2004, QUATERNARY SCI REV, V23, P561, DOI 10.1016/j.quascirev.2003.10.004; Pachur H.-J., 1996, Palaeoecology of Africa and the Surrounding Islands, V24, P1; Pachur H.-J., 1997, PALAEOGEOGRAPHIC PAL, P111; PACHUR HJ, 1987, SCIENCE, V237, P298, DOI 10.1126/science.237.4812.298; Pinch Brock L., 2003, EGYPTOLOGY DAWN 21 C, P408; RITCHIE JC, 1985, NATURE, V314, P352, DOI 10.1038/314352a0; VERMEERSCH P.M., 2002, AFRICA PRAEHISTORICA, V14, P27; Vermeersch P.M., 1994, SAHARA, V6, P31; VERMEERSCH PM, 1978, ELKABIEN EPIPALEOLIT; von Grafenstein U, 1998, CLIM DYNAM, V14, P73, DOI 10.1007/s003820050210; Weiss H, 2001, SCIENCE, V291, P609, DOI 10.1126/science.1058775; Wendorf F., 2001, HOLOCENE SETTLEMENT; Wendorf F, 1968, PREHISTORY NUBIA, V2, P954; Wengrow D., 2003, ANCIENT EGYPT AFRICA, P121	41	535	566	8	139	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 11	2006	313	5788					803	807		10.1126/science.1130989	http://dx.doi.org/10.1126/science.1130989			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072KC	16857900				2022-12-28	WOS:000239671300050
J	Heeney, JL; Dalgleish, AG; Weiss, RA				Heeney, Jonathan L.; Dalgleish, Angus G.; Weiss, Robin A.			Origins of HIV and the evolution of resistance to AIDS	SCIENCE			English	Review							IMMUNODEFICIENCY VIRUS-INFECTION; CLASS-I; GENETIC DIVERSITY; ENZYME APOBEC3G; HLA-B; CHIMPANZEES; PROGRESSION; DISEASE; TYPE-2; CELLS	The cross-species transmission of lentiviruses from African primates to humans has selected viral adaptations which have subsequently facilitated human-to-human transmission. HIV adapts not only by positive selection through mutation but also by recombination of segments of its genome in individuals who become multiply infected. Naturally infected nonhuman primates are relatively resistant to AIDS-like disease despite high plasma viral loads and sustained viral evolution. Further understanding of host resistance factors and the mechanisms of disease in natural primate hosts may provide insight into unexplored therapeutic avenues for the prevention of AIDS.	Biomed Primate Res Ctr, Dept Virol, NL-2280 GH Rijswijk, Netherlands; Univ London St Georges Hosp, Sch Med, Dept Cellular & Mol Med, Div Oncol, London SW17 0RE, England; UCL, Wohl Vir Ctr, Div Infect & Immun, London W1T 4JF, England	St Georges University London; University of London; University College London	Heeney, JL (corresponding author), Biomed Primate Res Ctr, Dept Virol, NL-2280 GH Rijswijk, Netherlands.	heeney@bprc.nl	Dalgleish, Angus/AAZ-4450-2020	Dalgleish, Angus/0000-0003-3511-3059; Heeney, Jonathan/0000-0003-2702-1621	MRC [G8712499] Funding Source: UKRI; Medical Research Council [G8712499] Funding Source: Medline; PHS HHS [P01 A148225-01A2] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Bailes E, 2003, SCIENCE, V300, P1713, DOI 10.1126/science.1080657; Balla-Jhagjhoorsingh SS, 1999, J IMMUNOL, V162, P2308; Bogerd HP, 2004, P NATL ACAD SCI USA, V101, P3770, DOI 10.1073/pnas.0307713101; Carrington M, 2003, ANNU REV MED, V54, P535, DOI 10.1146/annurev.med.54.101601.152346; Carrington M, 1999, SCIENCE, V283, P1748, DOI 10.1126/science.283.5408.1748; Cohen GB, 1999, IMMUNITY, V10, P661, DOI 10.1016/S1074-7613(00)80065-5; Copeland KFT, 1996, MICROBIOL REV, V60, P722, DOI 10.1128/MMBR.60.4.722-742.1996; Cuevas MT, 2002, AIDS, V16, P1643, DOI 10.1097/00002030-200208160-00010; Damond F, 2004, AIDS RES HUM RETROV, V20, P666, DOI 10.1089/0889222041217392; de Groot NG, 2002, P NATL ACAD SCI USA, V99, P11748, DOI 10.1073/pnas.182420799; Drucker E, 2001, LANCET, V358, P1989, DOI 10.1016/S0140-6736(01)06967-7; Gallant JE, 2006, NEW ENGL J MED, V354, P251, DOI 10.1056/NEJMoa051871; GAO F, 1994, J VIROL, V68, P7433, DOI 10.1128/JVI.68.11.7433-7447.1994; Gonzalez E, 2005, SCIENCE, V307, P1434, DOI 10.1126/science.1101160; Gougeon ML, 1997, J IMMUNOL, V158, P2964; Goulder PJR, 2004, NAT REV IMMUNOL, V4, P630, DOI 10.1038/nri1417; Heeney JL, 2006, J VIROL, V80, P7208, DOI 10.1128/JVI.00382-06; HEENEY JL, 1995, IMMUNOL TODAY, V16, P515, DOI 10.1016/0167-5699(95)80043-3; Hendel H, 1999, J IMMUNOL, V162, P6942; John-Stewart GC, 2005, J INFECT DIS, V192, P492, DOI 10.1086/431514; Kaleebu P, 2002, J INFECT DIS, V185, P1244, DOI 10.1086/340130; Keele BF, 2006, SCIENCE, V313, P523, DOI 10.1126/science.1126531; Kellam P, 2006, CELL, V124, P695, DOI 10.1016/j.cell.2006.02.003; Kiepiela P, 2004, NATURE, V432, P769, DOI 10.1038/nature03113; Lanier LL, 2005, ANNU REV IMMUNOL, V23, P225, DOI 10.1146/annurev.immunol.23.021704.115526; Lilley BN, 2005, IMMUNOL REV, V207, P126, DOI 10.1111/j.0105-2896.2005.00318.x; Liu R, 1996, CELL, V86, P367, DOI 10.1016/S0092-8674(00)80110-5; Martin MP, 2002, NAT GENET, V31, P429, DOI 10.1038/ng934; Moore CB, 2002, SCIENCE, V296, P1439, DOI 10.1126/science.1069660; Nerrienet E, 2005, J VIROL, V79, P1312, DOI 10.1128/JVI.79.2.1312-1319.2005; O'Brien SJ, 2004, NAT GENET, V36, P565, DOI 10.1038/ng1369; Osmanov S, 2002, J ACQ IMMUN DEF SYND, V29, P184, DOI 10.1097/00042560-200202010-00013; Paxton WA, 1996, NAT MED, V2, P412, DOI 10.1038/nm0496-412; Rutjens E, 2003, FRONT BIOSCI-LANDMRK, V8, pD1134, DOI 10.2741/1125; Ryan S, 2000, J VIROL, V74, P10096, DOI 10.1128/JVI.74.21.10096-10103.2000; Santiago ML, 2005, J VIROL, V79, P12515, DOI 10.1128/JVI.79.19.12515-12527.2005; Santiago ML, 2003, J VIROL, V77, P7545, DOI 10.1128/JVI.77.13.7545-7562.2003; Sawyer SL, 2005, P NATL ACAD SCI USA, V102, P2832, DOI 10.1073/pnas.0409853102; Sawyer SL, 2004, PLOS BIOL, V2, P1278, DOI 10.1371/journal.pbio.0020275; Schmitz C, 2004, J VIROL, V78, P2006, DOI 10.1128/JVI.78.4.2006-2016.2004; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Simon V, 2005, PLOS PATHOG, V1, P20, DOI 10.1371/journal.ppat.0010006; Stremlau M, 2004, NATURE, V427, P848, DOI 10.1038/nature02343; ten Haaft P, 2001, AIDS, V15, P2085, DOI 10.1097/00002030-200111090-00003; Towers GJ, 2005, HUM GENE THER, V16, P1125, DOI 10.1089/hum.2005.16.1125; Turelli P, 2005, SCIENCE, V307, P1061, DOI 10.1126/science.1105964; Zhang JZ, 2004, HUM MOL GENET, V13, P1785, DOI 10.1093/hmg/ddh183	47	126	135	2	68	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 28	2006	313	5786					462	466		10.1126/science.1123016	http://dx.doi.org/10.1126/science.1123016			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067MZ	16873637				2022-12-28	WOS:000239308600030
J	Zhao, M; Song, B; Pu, J; Wada, T; Reid, B; Tai, GP; Wang, F; Guo, AH; Walczysko, P; Gu, Y; Sasaki, T; Suzuki, A; Forrester, JV; Bourne, HR; Devreotes, PN; McCaig, CD; Penninger, JM				Zhao, Min; Song, Bing; Pu, Jin; Wada, Teiji; Reid, Brian; Tai, Guangping; Wang, Fei; Guo, Aihua; Walczysko, Petr; Gu, Yu; Sasaki, Takehiko; Suzuki, Akira; Forrester, John V.; Bourne, Henry R.; Devreotes, Peter N.; McCaig, Colin D.; Penninger, Josef M.			Electrical signals control wound healing through phosphatidylinositol-3-OH kinase-gamma and PTEN	NATURE			English	Article							CHEMOATTRACTANT GRADIENTS; IN-VIVO; CHEMOTAXIS; FIELDS; ORIENTATION; MIGRATION; CURRENTS; CELLS; POLARIZATION; REGENERATION	Wound healing is essential for maintaining the integrity of multicellular organisms. In every species studied, disruption of an epithelial layer instantaneously generates endogenous electric fields, which have been proposed to be important in wound healing(1-3). The identity of signalling pathways that guide both cell migration to electric cues and electric-field-induced wound healing have not been elucidated at a genetic level. Here we show that electric fields, of a strength equal to those detected endogenously, direct cell migration during wound healing as a prime directional cue. Manipulation of endogenous wound electric fields affects wound healing in vivo. Electric stimulation triggers activation of Src and inositol - phospholipid signalling, which polarizes in the direction of cell migration. Notably, genetic disruption of phosphatidylinositol-3-OH kinase-gamma (PI( 3) K gamma) decreases electric-field-induced signalling and abolishes directed movements of healing epithelium in response to electric signals. Deletion of the tumour suppressor phosphatase and tensin homolog (PTEN) enhances signalling and electrotactic responses. These data identify genes essential for electrical-signal-induced wound healing and show that PI(3) K gamma and PTEN control electrotaxis.	Univ Aberdeen, Sch Med Sci, Aberdeen AB25 2ZD, Scotland; Univ Aberdeen, Dept Ophthalmol, Aberdeen AB25 2ZD, Scotland; Austrian Acad Sci, Inst Mol Biotechnol, A-1030 Vienna, Austria; Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA; Akita Univ, Sch Med, Dept Pathol & Immunol, Akita 0108543, Japan; Akita Univ, Sch Med, Dept Mol Biol, Akita 0108543, Japan; Johns Hopkins Univ, Sch Med, Dept Cell Biol, Baltimore, MD 21205 USA	University of Aberdeen; University of Aberdeen; Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA); University of California System; University of California San Francisco; Akita University; Akita University; Johns Hopkins University	Zhao, M (corresponding author), Univ Aberdeen, Sch Med Sci, Aberdeen AB25 2ZD, Scotland.	m.zhao@abdn.ac.uk; josef.penninger@imba.oeaw.ac.at	McCaig, Colin/B-1774-2010; gu, yu/GSD-4507-2022; Suzuki, Akira/GYD-6697-2022; Reid, Brian John/AFT-8587-2022; Penninger, Josef M/I-6860-2013; Wang, Fei/A-7968-2013; Song, Bing/AAB-4755-2021	Suzuki, Akira/0000-0002-5950-8808; Reid, Brian John/0000-0002-9613-979X; Penninger, Josef M/0000-0002-8194-3777; Song, Bing/0000-0001-9356-2333; Sasaki, Takehiko/0000-0003-1837-3748	NIGMS NIH HHS [R01 GM028007] Funding Source: Medline; Wellcome Trust Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM028007] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BARKER AT, 1982, AM J PHYSIOL, V242, P358; BORGENS RB, 1977, P NATL ACAD SCI USA, V74, P4528, DOI 10.1073/pnas.74.10.4528; CHIANG MC, 1992, EXP EYE RES, V54, P999, DOI 10.1016/0014-4835(92)90164-N; Denker SP, 2002, J CELL BIOL, V159, P1087, DOI 10.1083/jcb.200208050; Devreotes P, 2003, J BIOL CHEM, V278, P20445, DOI 10.1074/jbc.R300010200; Du Bois-Reymond EH, 1843, FISCHE; ERICKSON CA, 1984, J CELL BIOL, V98, P296, DOI 10.1083/jcb.98.1.296; Firtel RA, 2000, BIOESSAYS, V22, P603, DOI 10.1002/1521-1878(200007)22:7<603::AID-BIES3>3.0.CO;2-#; FOULDS IS, 1983, BRIT J DERMATOL, V109, P515, DOI 10.1111/j.1365-2133.1983.tb07673.x; Funamoto S, 2002, CELL, V109, P611, DOI 10.1016/S0092-8674(02)00755-9; Iijima M, 2002, CELL, V109, P599, DOI 10.1016/S0092-8674(02)00745-6; JAFFE LF, 1974, J CELL BIOL, V63, P614, DOI 10.1083/jcb.63.2.614; Keese CR, 2004, P NATL ACAD SCI USA, V101, P1554, DOI 10.1073/pnas.0307588100; Kimmel AR, 2003, SCIENCE, V300, P1525, DOI 10.1126/science.1085439; Masereel B, 2003, EUR J MED CHEM, V38, P547, DOI 10.1016/S0223-5234(03)00100-4; McCaig CD, 2005, PHYSIOL REV, V85, P943, DOI 10.1152/physrev.00020.2004; Reid B, 2005, FASEB J, V19, P379, DOI 10.1096/fj.04-2325com; Rickert P, 2000, TRENDS CELL BIOL, V10, P466, DOI 10.1016/S0962-8924(00)01841-9; Robinson KR, 2003, BIOESSAYS, V25, P759, DOI 10.1002/bies.10307; Sasaki T, 2000, SCIENCE, V287, P1040, DOI 10.1126/science.287.5455.1040; Servant G, 2000, SCIENCE, V287, P1037, DOI 10.1126/science.287.5455.1037; Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006; Song B, 2004, J CELL SCI, V117, P4681, DOI 10.1242/jcs.01341; Song B, 2002, P NATL ACAD SCI USA, V99, P13577, DOI 10.1073/pnas.202235299; Suzuki A, 2004, BIOCHEM SOC T, V32, P362, DOI 10.1042/BST0320362; Suzuki A, 2001, IMMUNITY, V14, P523, DOI 10.1016/S1074-7613(01)00134-0; WU LJ, 1995, J CELL BIOL, V129, P1667, DOI 10.1083/jcb.129.6.1667; Xu JS, 2003, CELL, V114, P201, DOI 10.1016/S0092-8674(03)00555-5; Zhao M, 2003, FASEB J, V17, P397, DOI 10.1096/fj.02-0610com; Zhao M, 1996, J CELL SCI, V109, P1405	30	671	711	26	251	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 27	2006	442	7101					457	460		10.1038/nature04925	http://dx.doi.org/10.1038/nature04925			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067CI	16871217				2022-12-28	WOS:000239278900044
J	Hron, G; Kollars, M; Binder, BR; Eichinger, S; Kyrle, PA				Hron, Gregor; Kollars, Marietta; Binder, Bernd R.; Eichinger, Sabine; Kyrle, Paul A.			Identification of patients at low risk for recurrent venous thromboembolism by measuring thrombin generation	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PLASMA	Context Screening of patients with venous thromboembolism (VTE) for thrombophilic risk factors is common clinical practice. Because of the large number of risk factors, assessing the risk of recurrence in an individual patient is complex. A method covering multicausal thrombophilia is therefore required. Objective To investigate the relationship between recurrence of VTE and a simple global coagulation assay measuring thrombin generation. Design, Setting, and Participants Prospective cohort study of 914 patients with first spontaneous VTE who were followed up for an average of 47 months after discontinuation of vitamin K antagonist therapy. The study was conducted at the Department of Internal Medicine I, Medical University of Vienna, Vienna, Austria, between July 1992 and July 2005. Thrombin generation was measured by a commercially available assay system. Patients with a previous or secondary VTE; antithrombin, protein C, or protein S deficiencies; presence of lupus anticoagulant; cancer; or pregnancy were excluded. Main Outcome Measure Objectively documented symptomatic recurrent VTE. Results Venous thromboembolism recurred in 100 patients (11%). Patients without recurrent VTE had lower thrombin generation than patients with recurrence ( mean [SD], 349.2 [108.0] nM vs 419.5 [110.5] nM, respectively; P <. 001). Compared with patients who had thrombin generation greater than 400 nM, the relative risk (RR) of recurrence was 0.42 (95% confidence interval [CI], 0.26- 0.67; P <. 001) in patients with values between 400 nM and 300 nM; for patients with lower values, the RR was 0.37 ( 95% CI, 0.21-0.66; P=. 001). After 4 years, the probability of recurrence was 6.5% ( 95% CI, 4.0%-8.9%) among patients with thrombin generation less than 400 nM compared with 20.0% ( 95% CI, 14.9%-25.1%) among patients with higher values ( P <. 001). Patients with thrombin generation less than 400 nM, representing two thirds of patients, had a 60% lower RR of recurrence than those with greater values ( RR, 0.40; 95% CI, 0.27-0.60; P <. 001). Conclusion Measurement of thrombin generation identifies patients at low risk for recurrent VTE.	Med Univ Vienna, Dept Internal Med 1, A-1090 Vienna, Austria; Med Univ Vienna, Dept Vasc Biol & Thrombosis Res, Ctr Biomol Med & Pharmacol, A-1090 Vienna, Austria	Medical University of Vienna; Medical University of Vienna	Kyrle, PA (corresponding author), Med Univ Vienna, Dept Internal Med 1, Wahringer Gurtel 18-20, A-1090 Vienna, Austria.	paul.kyrle@meduniwien.ac.at						BRANDT JT, 1995, THROMB HAEMOSTASIS, V74, P1185; Brummel-Ziedins KE, 2005, J THROMB HAEMOST, V3, P2497, DOI 10.1111/j.1538-7836.2005.01584.x; Curvers J, 2002, THROMB HAEMOSTASIS, V88, P5; Dargaud Y, 2005, THROMB HAEMOSTASIS, V93, P475, DOI 10.1160/TH04-10-0706; Douketis JD, 1998, JAMA-J AM MED ASSOC, V279, P458, DOI 10.1001/jama.279.6.458; DUCHEMIN J, 1994, THROMB HAEMOSTASIS, V71, P331; Eichinger S, 1999, THROMB HAEMOSTASIS, V81, P14; Eichinger S, 2002, ARCH INTERN MED, V162, P2357, DOI 10.1001/archinte.162.20.2357; Evans A, 2001, ARCH INTERN MED, V161, P1443, DOI 10.1001/archinte.161.11.1443; Kalbfleisch D., 1980, STAT ANAL FAILURE TI; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; KEARON C, 2004, RISK FACTORS RECURRE, P445; Kyrle PA, 2005, LANCET, V365, P1163, DOI 10.1016/S0140-6736(05)71880-8; Kyrle PA, 2000, NEW ENGL J MED, V343, P457, DOI 10.1056/NEJM200008173430702; Kyrle PA, 1998, ARTERIOSCL THROM VAS, V18, P1287, DOI 10.1161/01.ATV.18.8.1287; Kyrle PA, 2004, NEW ENGL J MED, V350, P2558, DOI 10.1056/NEJMoa032959; Levine MN, 2004, CHEST, V126, p287S, DOI 10.1378/chest.126.3_suppl.287S; Mann KG, 2003, CHEST, V124, p4S, DOI 10.1378/chest.124.3_suppl.4S; Prandoni P, 1996, ANN INTERN MED, V125, P1, DOI 10.7326/0003-4819-125-1-199607010-00001; Ridker PM, 2004, J THROMB HAEMOST, V2, P1034, DOI 10.1111/j.1538-7836.2004.00813.x; ROTTEVEEL RC, 1993, THROMB HAEMOSTASIS, V70, P959; VREIM CE, 1990, JAMA-J AM MED ASSOC, V263, P2753; Weltermann A, 2003, J THROMB HAEMOST, V1, P28, DOI 10.1046/j.1538-7836.2003.00038.x; Wielders S, 1997, THROMB HAEMOSTASIS, V77, P629	24	302	306	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 26	2006	296	4					397	402		10.1001/jama.296.4.397	http://dx.doi.org/10.1001/jama.296.4.397			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	066PN	16868297	Bronze			2022-12-28	WOS:000239242500025
J	Brooklyn, T; Dunnill, G; Probert, C				Brooklyn, Trevor; Dunnill, Giles; Probert, Chris			Diagnosis and treatment of pyoderma gangrenosum	BRITISH MEDICAL JOURNAL			English	Review							ULCERATIVE-COLITIS; VESICULOPUSTULAR ERUPTION; CLINICAL-FEATURES; MANAGEMENT; TACROLIMUS; INFLIXIMAB; DISEASE; TRIAL		Cheltenham Gen Hosp, Cheltenham GL53 7AN, Glos, England; Univ Bristol, Bristol Royal Infirm, Bristol BS2 8HW, Avon, England	Gloucestershire Hospitals NHS Foundation Trust; Cheltenham General Hospital; Bristol Royal Infirmary; University of Bristol	Brooklyn, T (corresponding author), Cheltenham Gen Hosp, Cheltenham GL53 7AN, Glos, England.	trevor.brooklyn@glos.nhs.uk		Probert, Christopher/0000-0003-4550-0239				Bennett ML, 2000, MEDICINE, V79, P37, DOI 10.1097/00005792-200001000-00004; Berth-Jones J., 1989, J DERMATOLOG TREAT, V1, P23; Brooklyn TN, 2006, GUT, V55, P505, DOI 10.1136/gut.2005.074815; Callen JP, 1998, LANCET, V351, P581, DOI 10.1016/S0140-6736(97)10187-8; CALLEN JP, 1985, ARCH DERMATOL, V121, P399, DOI 10.1001/archderm.121.3.399; DUGUID CM, 1993, CLIN DERMATOL, V11, P129, DOI 10.1016/0738-081X(93)90109-P; FENSKE NA, 1983, ARCH DERMATOL, V119, P664, DOI 10.1001/archderm.119.8.664; Friedman S, 2001, INFLAMM BOWEL DIS, V7, P1; Hanauer SB, 2002, LANCET, V359, P1541, DOI 10.1016/S0140-6736(02)08512-4; Harris AJ, 1998, BRIT MED J, V316, P52, DOI 10.1136/bmj.316.7124.52; HAY CRM, 1987, J CLIN PATHOL, V40, P387, DOI 10.1136/jcp.40.4.387; Hughes AP, 2000, JAMA-J AM MED ASSOC, V284, P1546, DOI 10.1001/jama.284.12.1546; JOHNSON RB, 1982, ARCH DERMATOL, V118, P76, DOI 10.1001/archderm.118.2.76; Lyon CC, 2000, J AM ACAD DERMATOL, V42, P992, DOI 10.1016/S0190-9622(00)90292-5; Lyon CC, 2000, BRIT J DERMATOL, V143, P1248, DOI 10.1046/j.1365-2133.2000.03896.x; Lyon CC, 2001, J DERMATOL TREAT, V12, P13, DOI 10.1080/095466301750163518; Lyon CC, 1999, BRIT J DERMATOL, V140, P562; McGowan Joseph Wilson 4th, 2004, J Drugs Dermatol, V3, P441; Powell FC, 2000, CLIN DERMATOL, V18, P283, DOI 10.1016/S0738-081X(99)00119-4; Regueiro M, 2003, AM J GASTROENTEROL, V98, P1821, DOI 10.1016/S0002-9270(03)00430-1; Reichrath J, 2005, J AM ACAD DERMATOL, V53, P273, DOI 10.1016/j.jaad.2004.10.006; SU WPD, 1986, J CUTAN PATHOL, V13, P323, DOI 10.1111/j.1600-0560.1986.tb00466.x; THORNTON JR, 1980, GUT, V21, P247, DOI 10.1136/gut.21.3.247; Von den Driesch P, 1997, BRIT J DERMATOL, V137, P1000, DOI 10.1046/j.1365-2133.1997.20022083.x; WILSONJONES E, 1988, J AM ACAD DERMATOL, V18, P511, DOI 10.1016/S0190-9622(88)70074-2	25	161	167	0	7	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JUL 22	2006	333	7560					181	184		10.1136/bmj.333.7560.181	http://dx.doi.org/10.1136/bmj.333.7560.181			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	068DJ	16858047	Green Published			2022-12-28	WOS:000239352100022
J	Glass, RI; Parashar, UD; Bresee, JS; Turcios, R; Fischer, TK; Widdowson, MA; Jiang, BM; Gentsch, JR				Glass, Roger I.; Parashar, Umesh D.; Bresee, Joseph S.; Turcios, Reina; Fischer, Theo K.; Widdowson, Marc-Alain; Jiang, Baoming; Gentsch, Jon R.			Rotavirus vaccines: current prospects and future challenges	LANCET			English	Review							BOVINE ROTAVIRUS; DEVELOPING-COUNTRIES; YOUNG-CHILDREN; PROTECTIVE IMMUNITY; DIARRHEAL DISEASE; MEXICAN CHILDREN; HEALTHY INFANTS; GLOBAL BURDEN; RHESUS-HUMAN; WC3 VACCINE	Rotavirus is the most common cause of severe diarrhoea in children worldwide and diarrhoeal deaths in children in developing countries. Accelerated development and introduction of rotavirus vaccines into global immunisation programmes has been a high priority for many international agencies, including WHO and the Global Alliance for Vaccines and Immunizations. Vaccines have been developed that could prevent the enormous morbidity and mortality from rotavirus and their effect should be measurable within 2-3 years. Two live oral rotavirus vaccines have been licensed in many countries; one is derived from an attenuated human strain of rotavirus and the other combines five bovine-human reassortant strains. Each vaccine has proven highly effective in preventing severe rotavirus diarrhoea in children and safe from the possible complication of intussusception. in developed countries, these vaccines could substantially reduce the number and associated costs of child hospitalisations and clinical visits for acute diarrhoea. In developing countries, they could reduce deaths from diarrhoea and improve child survival through programmes for childhood immunisations and diarrhoeal disease control. Although many scientific, programmatic, and financial challenges face the global use of rotavirus vaccines, these vaccines-and new candidates in the pipeline hold promise to make an immediate and measurable effect to improve child health and survival from this common burden affecting all children.	Ctr Dis Control & Prevent, Viral Gastroenteritis Sect, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA	Glass, RI (corresponding author), Ctr Dis Control & Prevent, Viral Gastroenteritis Sect, Atlanta, GA 30333 USA.	Rglass@cdc.gov	Al_ubaidy, Ridha/U-7286-2019; Fischer, Thea K/AAH-9892-2019	Fischer, Thea K/0000-0003-4812-980X; Widdowson, Marc-Alain/0000-0002-0682-6933				[Anonymous], 1999, MMWR Recomm Rep, V48, P1; Ball JM, 1996, SCIENCE, V272, P101, DOI 10.1126/science.272.5258.101; Barnes GL, 2002, VACCINE, V20, P2950, DOI 10.1016/S0264-410X(02)00235-9; Barnes GL, 1997, J PAEDIATR CHILD H, V33, P300, DOI 10.1111/j.1440-1754.1997.tb01604.x; BERNSTEIN DI, 1995, JAMA-J AM MED ASSOC, V273, P1191, DOI 10.1001/jama.273.15.1191; Bernstein DI, 1999, LANCET, V354, P287, DOI 10.1016/S0140-6736(98)12106-2; BERNSTEIN DI, 1990, J INFECT DIS, V162, P1055, DOI 10.1093/infdis/162.5.1055; BHAN MK, 1993, J INFECT DIS, V168, P282, DOI 10.1093/infdis/168.2.282; BISHOP RF, 1983, NEW ENGL J MED, V309, P72, DOI 10.1056/NEJM198307143090203; Black RE, 2003, LANCET, V361, P2226, DOI 10.1016/S0140-6736(03)13779-8; Blutt SE, 2003, LANCET, V362, P1445, DOI 10.1016/S0140-6736(03)14687-9; Bresee J, 2004, EMERG INFECT DIS, V10, P988, DOI 10.3201/eid1006.030519; Bresee JS, 1999, VACCINE, V17, P2207, DOI 10.1016/S0264-410X(98)00376-4; Bresee JS, 2005, J INFECT DIS, V192, pS1, DOI 10.1086/431515; CARLSON JAK, 1978, AM J DIS CHILD, V132, P477, DOI 10.1001/archpedi.1978.02120300037006; *CDCP, 1999, MMWR-MORBID MORTAL W, V48, P1007; Chang HGH, 2001, PEDIATRICS, V108, P54, DOI 10.1542/peds.108.1.54; Choi AHC, 2004, PROTEIN EXPRES PURIF, V38, P205, DOI 10.1016/j.pep.2004.08.009; Ciarlet M, 1998, J VIROL, V72, P9233, DOI 10.1128/JVI.72.11.9233-9246.1998; CICIRELLO HG, 1994, PEDIATR INFECT DIS J, V13, P720, DOI 10.1097/00006454-199408000-00008; Clark HF, 2003, PEDIATR INFECT DIS J, V22, P914, DOI 10.1097/01.inf.0000091887.48999.77; Clark HF, 1996, J INFECT DIS, V174, pS73, DOI 10.1093/infdis/174.Supplement_1.S73; Clark HF, 1996, ARCH VIROL, P187; CLARK HF, 1988, J INFECT DIS, V158, P570, DOI 10.1093/infdis/158.3.570; CLARK HF, 2004, VACCINES, P1327; Clemens J, 2005, NAT MED, V11, pS12, DOI 10.1038/nm1225; Clements-Mann ML, 1999, VACCINE, V17, P2715, DOI 10.1016/S0264-410X(98)00497-6; COFFIN SE, 1995, J INFECT DIS, V172, P874, DOI 10.1093/infdis/172.3.874; CONNER ME, 1993, J VIROL, V67, P6633, DOI 10.1128/JVI.67.11.6633-6641.1993; COOK SM, 1990, B WORLD HEALTH ORGAN, V68, P171; Cunliffe NA, 1998, B WORLD HEALTH ORGAN, V76, P525; Cunliffe NA, 2002, LANCET, V359, P640, DOI 10.1016/S0140-6736(02)07781-4; DAS BK, 1993, VIROLOGY, V197, P99, DOI 10.1006/viro.1993.1570; De Vos Beatrice, 2004, Pediatr Infect Dis J, V23, pS179, DOI 10.1097/01.inf.0000142370.16514.4a; DEMOL P, 1986, LANCET, V2, P108; Desselberger U, 2001, NOVART FDN SYMP, V238, P125; Ehresman K., 1999, Morbidity and Mortality Weekly Report, V48, P577; Estes M.K., 2001, FIELDS VIROLOGY, V2., P1747; Estes MK, 1997, ADV EXP MED BIOL, V412, P387; Fischer TK, 2005, J INFECT DIS, V192, P913, DOI 10.1086/432549; Gentsch JR, 2005, J INFECT DIS, V192, pS146, DOI 10.1086/431499; GEORGESCOURBOT MC, 1991, RES VIROLOGY, V142, P405, DOI 10.1016/0923-2516(91)90008-Q; GILGER MA, 1992, J PEDIATR-US, V120, P912, DOI 10.1016/S0022-3476(05)81959-6; Glass RI, 1999, PEDIATR INFECT DIS J, V18, P1006, DOI 10.1097/00006454-199911000-00014; Glass RI, 2005, J INFECT DIS, V192, pS160, DOI 10.1086/431504; Glass RI, 2005, J INFECT DIS, V192, pS30, DOI 10.1086/431498; GREENBERG HB, 1981, P NATL ACAD SCI-BIOL, V78, P420, DOI 10.1073/pnas.78.1.420; GRIMWOOD K, 1988, J CLIN MICROBIOL, V26, P732, DOI 10.1128/JCM.26.4.732-738.1988; HANLON P, 1987, LANCET, V1, P1342; Harnois G., 2000, MENTAL HLTH WORK IMP; Heaton PM, 2005, J INFECT DIS, V192, pS17, DOI 10.1086/431500; Herrmann JE, 1996, J INFECT DIS, V174, pS93, DOI 10.1093/infdis/174.Supplement_1.S93; Iturriza-Gomara M, 2000, J CLIN MICROBIOL, V38, P4394; J Gray, 2000, ROTAVIRUS METHODS PR; Jain Vivek, 2001, Indian Journal of Pediatrics, V68, P855, DOI 10.1007/BF02762113; Jiang BM, 1999, VACCINE, V17, P1005, DOI 10.1016/S0264-410X(98)00317-X; Jiang BM, 2002, CLIN INFECT DIS, V34, P1351, DOI 10.1086/340103; Kane EM, 2004, REV PANAM SALUD PUBL, V16, P371, DOI 10.1590/S1020-49892004001200002; Kang G, 2005, J INFECT DIS, V192, pS120, DOI 10.1086/431496; Kapikian A. Z., 2001, FIELDS VIROLOGY, V2, P1787; Kapikian AZ, 2005, J INFECT DIS, V192, pS22, DOI 10.1086/431510; Kapikian AZ, 1996, J INFECT DIS, V174, pS65, DOI 10.1093/infdis/174.Supplement_1.S65; Kilgore PE, 1996, PEDIATR INFECT DIS J, V15, P672, DOI 10.1097/00006454-199608000-00007; Kosek M, 2003, B WORLD HEALTH ORGAN, V81, P197; Koshimura Y, 2000, MICROBIOL IMMUNOL, V44, P499, DOI 10.1111/j.1348-0421.2000.tb02525.x; Lanata CF, 1996, J INFECT DIS, V174, P268, DOI 10.1093/infdis/174.2.268; Lanata CF, 1996, VACCINE, V14, P237, DOI 10.1016/0264-410X(95)00132-K; LANATA CF, 1989, J INFECT DIS, V159, P452, DOI 10.1093/infdis/159.3.452; Linhares AC, 1996, B WORLD HEALTH ORGAN, V74, P491; Linhares AC, 2006, VACCINE, V24, P3784, DOI 10.1016/j.vaccine.2005.07.027; Lynch M, 2003, CLIN INFECT DIS, V37, P1327, DOI 10.1086/379322; Lynch M, 2001, CLIN INFECT DIS, V33, P932, DOI 10.1086/322650; MACIAS M, 2005, INT C ANT AG CHEM DE; Mohan KVK, 2003, VIRUS GENES, V26, P185, DOI 10.1023/A:1023491514820; Morrison C, 2001, HUM PATHOL, V32, P216, DOI 10.1053/hupa.2001.21565; Murphy BR, 2003, J INFECT DIS, V187, P1301, DOI 10.1086/367895; Murphy TV, 2001, NEW ENGL J MED, V344, P564, DOI 10.1056/NEJM200102223440804; OMOIGBERALE AI, 1995, E AFR MED J, V72, P220; Pang XL, 1996, PEDIATR INFECT DIS J, V15, P543, DOI 10.1097/00006454-199606000-00015; Parashar UD, 2003, EMERG INFECT DIS, V9, P565, DOI 10.3201/eid0905.020562; Parashar UD, 2003, B WORLD HEALTH ORGAN, V81, P236; Parashar UD, 2006, EMERG INFECT DIS, V12, P304; Parashar UD, 2000, PEDIATRICS, V106, P1413, DOI 10.1542/peds.106.6.1413; PerezSchael I, 1997, NEW ENGL J MED, V337, P1181, DOI 10.1056/NEJM199710233371701; Peter G, 2002, PEDIATRICS, V110, DOI 10.1542/peds.110.6.e67; Phua KB, 2005, J INFECT DIS, V192, pS6, DOI 10.1086/431511; Ramachandran M, 1996, J CLIN MICROBIOL, V34, P436, DOI 10.1128/JCM.34.2.436-439.1996; Rennels MB, 1996, PEDIATRICS, V97, P7; Ruiz-Palacios GM, 2006, NEW ENGL J MED, V354, P11, DOI 10.1056/NEJMoa052434; Salinas M, 2005, PEDIATR INFECT DIS J, V24, P807, DOI 10.1097/01.inf.0000178294.13954.a1; Santos N, 2005, REV MED VIROL, V15, P29, DOI 10.1002/rmv.448; Simonsen L, 2005, J INFECT DIS, V192, pS36, DOI 10.1086/431512; Simonsen L, 2001, LANCET, V358, P1224, DOI 10.1016/S0140-6736(01)06346-2; Smith PJ, 2003, PUBLIC HEALTH REP, V118, P134, DOI 10.1016/S0033-3549(04)50228-5; Steele AD, 2003, VACCINE, V21, P354, DOI 10.1016/S0264-410X(02)00615-1; *UK GOV, 2004, INT FIN FAC PROP; United Nations, 2005, MILL DEV GOALS REP; USHIJIMA H, 1994, J CLIN MICROBIOL, V32, P2893, DOI 10.1128/JCM.32.12.2893-2897.1994; Velazquez FR, 1996, NEW ENGL J MED, V335, P1022, DOI 10.1056/NEJM199610033351404; VELAZQUEZ FR, 1993, PEDIATR INFECT DIS J, V12, P54, DOI 10.1097/00006454-199301000-00013; Vesikari T, 2006, NEW ENGL J MED, V354, P23, DOI 10.1056/NEJMoa052664; Vesikari T, 2004, VACCINE, V22, P2836, DOI 10.1016/j.vaccine.2004.01.044; Vesikari T, 2004, PEDIATR INFECT DIS J, V23, P937, DOI 10.1097/01.inf.0000141722.10130.50; VESIKARI T, 1984, LANCET, V1, P977; Vethanayagam RR, 2004, J INFECT DIS, V189, P2282, DOI 10.1086/420889; Villa S, 1999, B WORLD HEALTH ORGAN, V77, P375; WARD RL, 1995, VACCINE, V13, P1226, DOI 10.1016/0264-410X(95)00060-E; Westerman LE, 2005, P NATL ACAD SCI USA, V102, P7268, DOI 10.1073/pnas.0502437102; World Health Organization, 2002, WHO TRADITIONAL MED, P1; [No title captured]	110	344	378	1	32	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 22	2006	368	9532					323	332		10.1016/S0140-6736(06)68815-6	http://dx.doi.org/10.1016/S0140-6736(06)68815-6			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	067PF	16860702				2022-12-28	WOS:000239314400030
J	Jagsi, R; Guancial, EA; Worobey, CC; Henault, LE; Chang, YC; Starr, R; Tarbell, NJ; Hylek, EM				Jagsi, Reshma; Guancial, Elizabeth A.; Worobey, Cynthia Cooper; Henault, Lori E.; Chang, Yuchiao; Starr, Rebecca; Tarbell, Nancy J.; Hylek, Elaine M.			The "gender gap" in authorship of Academic Medical Literature - A 35-year perspective	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CONTROLLABLE LIFE-STYLE; SPECIALTY CHOICE; WOMEN PHYSICIANS; CAREER; STUDENTS; FACULTY; MEN; PUBLICATIONS; TRENDS; IMPACT	Background: Participation of women in the medical profession has increased during the past four decades, but issues of concern persist regarding disparities between the sexes in academic medicine. Advancement is largely driven by peer-reviewed original research, so we sought to determine the representation of female physician-investigators among the authors of selected publications during the past 35 years. Methods: Original articles from six prominent medical journals - the New England Journal of Medicine (NEJM), the Journal of the American Medical Association (JAMA), the Annals of Internal Medicine (Ann Intern Med), the Annals of Surgery (Ann Surg), Obstetrics & Gynecology (Obstet Gynecol), and the Journal of Pediatrics (J Pediatr) - were categorized according to the sex of both the first and the senior (last listed) author. Sex was also determined for the authors of guest editorials in NEJM and JAMA. Data were collected for the years 1970, 1980, 1990, 2000, and 2004. The analysis was restricted to authors from U.S. institutions holding M.D. degrees. Results: The sex was determined for 98.5 percent of the 7249 U.S. authors of original research with M.D. degrees. The proportion of first authors who were women increased from 5.9 percent in 1970 to 29.3 percent in 2004 (P < 0.001), and the proportion of senior authors who were women increased from 3.7 percent to 19.3 percent (P < 0.001) during the same period. The proportion of authors who were women increased most sharply in Obstet Gynecol (from 6.7 percent of first authors and 6.8 percent of senior authors in 1970 to 40.7 percent of first authors and 28.0 percent of senior authors in 2004) and J Pediatr (from 15.0 percent of first authors and 4.3 percent of senior authors in 1970 to 38.9 percent of first authors and 38.0 percent of senior authors in 2004) and remained low in Ann Surg (from 2.3 percent of first authors and 0.7 percent of senior authors in 1970 to 16.7 percent of first authors and 6.7 percent of senior authors in 2004). In 2004, 11.4 percent of the authors of guest editorials in NEJM and 18.8 percent of the authors of guest editorials in JAMA were women. Conclusions: Over the past four decades, the proportion of women among both first and senior physician-authors of original research in the United States has significantly increased. Nevertheless, women still compose a minority of the authors of original research and guest editorials in the journals studied.	Harvard Univ, Massachusetts Gen Hosp, Sch Med, Off Womens Careers, Boston, MA 02114 USA; Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Radiat Oncol, Boston, MA USA; Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Nephrol, Boston, MA USA; Harvard Univ, Massachusetts Gen Hosp, Sch Med, Div Gen Med, Boston, MA USA; Boston Univ, Sch Med, Boston Med Ctr, Sect Gen Internal Med,Res Unit, Boston, MA 02118 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Boston Medical Center; Boston University	Jagsi, R (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Off Womens Careers, Bulfinch 370,55 Fruit St, Boston, MA 02114 USA.	reshma_jagsi@post.harvard.edu		Jagsi, Reshma/0000-0001-6562-1228; Hylek, Elaine/0000-0001-8263-8304				American Medical Association, 2004, PHYS CHAR DISTR US; *ASS AM MED COLL, 1990, AAMC DAT BOOK 1990; *ASS AM MED COLL, 1995, AAMC DAT BOOK 1995; *ASS AM MED COLL, 2000, AAMC DAT BOOK 2000; *ASS AM MED COLL, 2004, AAMC DAT BOOK 2004; *ASS AM MED COLL, 2004, WOM US AC MED STAT M; Association of American Medical Colleges, 2005, WOM US AC MED STAT M; Barnett RC, 1998, ACAD MED, V73, P180, DOI 10.1097/00001888-199802000-00017; Bastuji-Garin S, 2002, ANN DERMATOL VENER, V129, P1354; Bhattacharyya N, 2000, LARYNGOSCOPE, V110, P358, DOI 10.1097/00005537-200003000-00005; Bickel J, 2002, ACAD MED, V77, P1044, DOI 10.1097/00001888-200210000-00023; BICKEL J, 1988, NEW ENGL J MED, V319, P1579, DOI 10.1056/NEJM198812153192405; BICKEL J, 1995, ACAD MED, V70, P552, DOI 10.1097/00001888-199506000-00021; Bland KI, 2002, ARCH SURG-CHICAGO, V137, P259, DOI 10.1001/archsurg.137.3.259; Buckley LM, 2000, ARCH INTERN MED, V160, P2625, DOI 10.1001/archinte.160.17.2625; CARR P, 1992, J GEN INTERN MED, V7, P418, DOI 10.1007/BF02599159; Carr PL, 1998, ANN INTERN MED, V129, P532, DOI 10.7326/0003-4819-129-7-199810010-00004; CARR PL, 1993, ANN INTERN MED, V119, P908, DOI 10.7326/0003-4819-119-9-199311010-00008; CUCA JM, 1979, J AM MED WOMEN ASSOC, V34, P425; Dickersin K, 1998, JAMA-J AM MED ASSOC, V280, P260, DOI 10.1001/jama.280.3.260; Dorsey ER, 2005, ACAD MED, V80, P791, DOI 10.1097/00001888-200509000-00002; Dorsey ER, 2003, JAMA-J AM MED ASSOC, V290, P1173, DOI 10.1001/jama.290.9.1173; Dorsey ER, 2003, JAMA-J AM MED ASSOC, V290, P2666; Garfield E, 2006, JAMA-J AM MED ASSOC, V295, P90, DOI 10.1001/jama.295.1.90; Grosz BJ., 2005, REPORT TASK FORCE WO; Lambert EM, 2005, ACAD MED, V80, P797, DOI 10.1097/00001888-200509000-00003; Nonnemaker L, 2000, NEW ENGL J MED, V342, P399, DOI 10.1056/NEJM200002103420606; RICHTEL M, 2004, NY TIMES        0107, pA19; Richtel M, 2004, NY TIMES, pA1; Schiaffino A, 2001, Gac Sanit, V15, P251; TESCH BJ, 1995, JAMA-J AM MED ASSOC, V273, P1022, DOI 10.1001/jama.273.13.1022; *THOMS I SCI INF, 2002, J CIT REP; Vydareny KH, 2000, ACAD RADIOL, V7, P493, DOI 10.1016/S1076-6332(00)80321-9; Wendel TM, 2003, SURGERY, V134, P591, DOI 10.1016/S0039-6060(03)00304-0; Yedidia MJ, 2001, ACAD MED, V76, P453, DOI 10.1097/00001888-200105000-00017; 1999, MIT FACULTY NEWS MAR	36	560	567	1	47	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 20	2006	355	3					281	287		10.1056/NEJMsa053910	http://dx.doi.org/10.1056/NEJMsa053910			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	064NY	16855268	Bronze			2022-12-28	WOS:000239097600009
J	O'Neill, GN; Gonzalez, RG; Cros, DP; Ackerman, RH; Brown, RH; Stemmer-Rachamimov, A; Harris, NL; Venna, N				O'Neill, G. N.; Gonzalez, R. Gilberto; Cros, Didier P.; Ackerman, Robert H.; Brown, Robert H., Jr.; Stemmer-Rachamimov, Anat; Harris, Nancy Lee; Venna, Nagagopal			A man with a rapidly progressive gait disorder - Amyotrophic lateral sclerosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							MOTOR-NEURON DISEASE; TRANSCRANIAL MAGNETIC STIMULATION; CEREBROSPINAL-FLUID; EL-ESCORIAL; TUNING FORK; TAU-PROTEIN; CRITERIA; ALS		Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Boston University; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	O'Neill, GN (corresponding author), Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA.							Amato AA, 1996, ANN NEUROL, V40, P581, DOI 10.1002/ana.410400407; Attarian S, 2005, CLIN NEUROPHYSIOL, V116, P35, DOI 10.1016/j.clinph.2004.07.020; BROOKS BR, 1994, J NEUROL SCI, V124, P96, DOI 10.1016/0022-510X(94)90191-0; BUNINA TL, 1962, KORSAKOV J NEUROPATH, V62, P1293; DEMICHELE G, 1991, J NEUROL SCI, V105, P155; EISEN A, 1993, CAN J NEUROL SCI, V20, P11, DOI 10.1017/S031716710004734X; Forsyth PA, 1997, ANN NEUROL, V41, P722, DOI 10.1002/ana.410410608; GUBBAY SS, 1985, J NEUROL, V232, P295, DOI 10.1007/BF00313868; HALPERIN JJ, 1990, ARCH NEUROL-CHICAGO, V47, P586, DOI 10.1001/archneur.1990.00530050110021; Halperin JJ, 2003, MUSCLE NERVE, V28, P133, DOI 10.1002/mus.10337; Jackson CE, 1998, NEUROLOGY, V50, P1795, DOI 10.1212/WNL.50.6.1795; Kato S, 2000, AMYOTROPH LATERAL SC, V1, P163, DOI 10.1080/14660820050515160; LAVRNIC D, 1995, EUR NEUROL, V35, P104, DOI 10.1159/000117102; Lomen-Hoerth C, 2002, NEUROLOGY, V59, P1077, DOI 10.1212/WNL.59.7.1077; Martina ISJ, 1998, J NEUROL NEUROSUR PS, V65, P743, DOI 10.1136/jnnp.65.5.743; MCDONALD TD, 1993, NEUROLOGY, V43, P785, DOI 10.1212/WNL.43.4.785; MITCHELL JD, 1987, NEUROL CLIN, V5, P43, DOI 10.1016/S0733-8619(18)30934-4; MITSUMOTO H, 1985, ANN NEUROL, V17, P378, DOI 10.1002/ana.410170413; Ryan A, 2003, ARCH NEUROL-CHICAGO, V60, P1001, DOI 10.1001/archneur.60.7.1001; SCHRIEFER TN, 1989, ELECTROEN CLIN NEURO, V74, P431, DOI 10.1016/0168-5597(89)90032-4; SPENCER PS, 1986, LANCET, V2, P1066, DOI 10.1016/S0140-6736(86)90468-X; Sussmuth SD, 2003, NEUROSCI LETT, V353, P57, DOI 10.1016/j.neulet.2003.09.018; Sussmuth SD, 2001, NEUROSCI LETT, V300, P95, DOI 10.1016/S0304-3940(01)01556-7; Traynor BJ, 2000, ARCH NEUROL-CHICAGO, V57, P1171, DOI 10.1001/archneur.57.8.1171; Traynor BJ, 1999, NEUROLOGY, V52, P504, DOI 10.1212/WNL.52.3.504; Traynor BJ, 2000, ARCH NEUROL-CHICAGO, V57, P109, DOI 10.1001/archneur.57.1.109; TRIGGS WJ, 1992, ANN NEUROL, V32, P345, DOI 10.1002/ana.410320307; Triggs WJ, 1999, NEUROLOGY, V53, P605, DOI 10.1212/WNL.53.3.605	28	1	1	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 20	2006	355	3					296	304		10.1056/NEJMcpc069013	http://dx.doi.org/10.1056/NEJMcpc069013			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	064NY	16855271				2022-12-28	WOS:000239097600013
J	Pan, XJ; Eathiraj, S; Munson, M; Lambright, DG				Pan, Xiaojing; Eathiraj, Sudharshan; Munson, Mary; Lambright, David G.			TBC-domain GAPs for Rab GTPases accelerate GTP hydrolysis by a dual-finger mechanism	NATURE			English	Article							TRANSITION-STATE ANALOG; ACTIVATING PROTEIN; BIOCHEMICAL-CHARACTERIZATION; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; YEAST; FAMILY; GYP1P; IDENTIFICATION; G(I-ALPHA-1)	Rab GTPases regulate membrane trafficking by cycling between inactive (GDP-bound) and active (GTP-bound) conformations(1). The duration of the active state is limited by GTPase-activating proteins ( GAPs), which accelerate the slow intrinsic rate of GTP hydrolysis. Proteins containing TBC (Tre-2, Bub2 and Cdc16) domains are broadly conserved in eukaryotic organisms and function as GAPs for Rab GTPases as well as GTPases that control cytokinesis(2). An exposed arginine residue is a critical determinant of GAP activity in vitro and in vivo(3-5). It has been expected that the catalytic mechanism of TBC domains would parallel that of Ras and Rho family GAPs. Here we report crystallographic, mutational and functional analyses of complexes between Rab GTPases and the TBC domain of Gyp1p. In the crystal structure of a TBC-domain-Rab-GTPase-aluminium fluoride complex, which approximates the transition-state intermediate for GTP hydrolysis, the TBC domain supplies two catalytic residues in trans, an arginine finger analogous to Ras/Rho family GAPs and a glutamine finger that substitutes for the glutamine in the DxxGQ motif of the GTPase. The glutamine from the Rab GTPase does not stabilize the transition state as expected but instead interacts with the TBC domain. Strong conservation of both catalytic fingers indicates that most TBC-domain GAPs may accelerate GTP hydrolysis by a similar dual-finger mechanism.	UMASS Med Sch, Program Mol Med, Worcester, MA 01605 USA; UMASS Med Sch, Dept Mol Pharmacol & Biochem, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Lambright, DG (corresponding author), UMASS Med Sch, Program Mol Med, 2 Biotech,373 Plantat St, Worcester, MA 01605 USA.	david.lambright@umassmed.edu	Munson, Mary/A-9777-2009	Munson, Mary/0000-0003-2297-8053				Albert S, 1999, EMBO J, V18, P5216, DOI 10.1093/emboj/18.19.5216; Albert S, 1999, J BIOL CHEM, V274, P33186, DOI 10.1074/jbc.274.47.33186; Bernards A, 2003, BBA-REV CANCER, V1603, P47, DOI 10.1016/S0304-419X(02)00082-3; COLEMAN DE, 1994, SCIENCE, V265, P1405, DOI 10.1126/science.8073283; Cuif MH, 1999, EMBO J, V18, P1772, DOI 10.1093/emboj/18.7.1772; Daumke O, 2004, NATURE, V429, P197, DOI 10.1038/nature02505; De Antoni A, 2002, J BIOL CHEM, V277, P41023, DOI 10.1074/jbc.M205783200; Du LL, 1998, J BIOL CHEM, V273, P3253, DOI 10.1074/jbc.273.6.3253; Du LL, 2001, MOL BIOL CELL, V12, P1215, DOI 10.1091/mbc.12.5.1215; Eathiraj S, 2005, NATURE, V436, P415, DOI 10.1038/nature03798; Gao XD, 2003, J CELL BIOL, V162, P635, DOI 10.1083/jcb.200302038; Haas AK, 2005, NAT CELL BIOL, V7, P887, DOI 10.1038/ncb1290; Lafourcade C, 2004, MOL CELL BIOL, V24, P3815, DOI 10.1128/MCB.24.9.3815-3826.2004; Lanzetti L, 2000, NATURE, V408, P374, DOI 10.1038/35042605; Miinea CP, 2005, BIOCHEM J, V391, P87, DOI 10.1042/BJ20050887; Mittal R, 1996, SCIENCE, V273, P115, DOI 10.1126/science.273.5271.115; Nassar N, 1998, NAT STRUCT BIOL, V5, P1047, DOI 10.1038/4156; Rak A, 2000, EMBO J, V19, P5105, DOI 10.1093/emboj/19.19.5105; Rittinger K, 1997, NATURE, V389, P758, DOI 10.1038/39651; SARASTE J, 1995, J CELL SCI, V108, P1541; Scheffzek K, 1997, SCIENCE, V277, P333, DOI 10.1126/science.277.5324.333; SEGEV N, 1988, CELL, V52, P915, DOI 10.1016/0092-8674(88)90433-3; Segev N, 2001, SCI STKE, pre11, DOI DOI 10.1126/STKE.2001.100.RE11; Slep KC, 2001, NATURE, V409, P1071, DOI 10.1038/35059138; SONDEK J, 1994, NATURE, V372, P276, DOI 10.1038/372276a0; STROM M, 1993, NATURE, V361, P736, DOI 10.1038/361736a0; Tesmer JJG, 1997, CELL, V89, P251, DOI 10.1016/S0092-8674(00)80204-4; Vollmer P, 1999, EUR J BIOCHEM, V260, P284, DOI 10.1046/j.1432-1327.1999.00192.x; Will E, 2001, J BIOL CHEM, V276, P12135, DOI 10.1074/jbc.M011451200; Zheng JY, 1998, J CELL SCI, V111, P1061	30	235	246	5	52	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 20	2006	442	7100					303	306		10.1038/nature04847	http://dx.doi.org/10.1038/nature04847			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064WT	16855591				2022-12-28	WOS:000239122100039
J	Hockemeyer, D; Daniels, JP; Takai, H; de Lange, T				Hockemeyer, Dirk; Daniels, Jan-Peter; Takai, Hiroyuki; de Lange, Titia			Recent expansion of the telomeric complex in rodents: Two distinct POT1 proteins protect mouse telomeres	CELL			English	Article							END-BINDING-PROTEIN; SINGLE-STRANDED-DNA; MAMMALIAN TELOMERES; LENGTH REGULATOR; DAMAGE RESPONSE; TRF2; ATM; DYSFUNCTION; CELLS; RECOMBINATION	Human telomeres are protected by shelterin, a complex that includes the POT1 single-stranded DNA binding protein. We found that mouse telomeres contain two POT1 paralogs, POT1a and POT1b, and we used conditional deletion to determine their function. Double-knockout cells showed that POT1a/b are required to prevent a DNA damage signal at chromosome ends, endoreduplication, and senescence. In contrast, POT1a/b were largely dispensable for repression of telomere fusions. Single knockouts and complementation experiments revealed that POT1a and POT1b have distinct functions. POT1a, but not POT1b, was required to repress a DNA damage signal at telomeres. Conversely, POT1b, but not POT1a, had the ability to regulate the amount of single-stranded DNA at the telomere terminus. We conclude that mouse telomeres require two distinct POT1 proteins whereas human telomeres have one. Such divergence is unprecedented in mammalian chromosome biology and has implications for modeling human telomere biology in mice.	Rockefeller Univ, Cell Biol & Genet Lab, New York, NY 10021 USA	Rockefeller University	de Lange, T (corresponding author), Rockefeller Univ, Cell Biol & Genet Lab, 1230 York Ave, New York, NY 10021 USA.	delange@mail.rockefeller.edu	Takai, Hiroyuki/B-8352-2011; de Lange, Titia/B-8263-2011	de Lange, Titia/0000-0002-9267-367X; Hockemeyer, Dirk/0000-0002-5598-5092	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM049046, R01GM049046] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG016642] Funding Source: NIH RePORTER; NIA NIH HHS [AG16642] Funding Source: Medline; NIGMS NIH HHS [GM49046] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Armanios M, 2005, P NATL ACAD SCI USA, V102, P15960, DOI 10.1073/pnas.0508124102; Artandi SE, 2000, NATURE, V406, P641, DOI 10.1038/35020592; Bailey SM, 2001, SCIENCE, V293, P2462, DOI 10.1126/science.1062560; Baumann P, 2001, SCIENCE, V292, P1171, DOI 10.1126/science.1060036; Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4; Celli GB, 2005, NAT CELL BIOL, V7, P712, DOI 10.1038/ncb1275; Chiang YJ, 2004, MOL CELL BIOL, V24, P6631, DOI 10.1128/mcb.24.15.6631-6634.2004; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; di Fagagna FD, 2003, NATURE, V426, P194, DOI 10.1038/nature02118; Erdmann N, 2004, P NATL ACAD SCI USA, V101, P6080, DOI 10.1073/pnas.0401580101; FANNING TG, 1983, NUCLEIC ACIDS RES, V11, P5073, DOI 10.1093/nar/11.15.5073; GARVIK B, 1995, MOL CELL BIOL, V15, P6128; Greenberg RA, 1999, CELL, V97, P515, DOI 10.1016/S0092-8674(00)80761-8; Griffith JD, 1999, CELL, V97, P503, DOI 10.1016/S0092-8674(00)80760-6; Herbig U, 2004, MOL CELL, V14, P501, DOI 10.1016/S1097-2765(04)00256-4; Hockemeyer D, 2005, EMBO J, V24, P2667, DOI 10.1038/sj.emboj.7600733; Horvath MP, 1998, CELL, V95, P963, DOI 10.1016/S0092-8674(00)81720-1; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Karlseder J, 1999, SCIENCE, V283, P1321, DOI 10.1126/science.283.5406.1321; Karlseder J, 2003, MOL CELL BIOL, V23, P6533, DOI 10.1128/MCB.23.18.6533-6541.2003; Laud PR, 2005, GENE DEV, V19, P2560, DOI 10.1101/gad.1321305; Lei M, 2004, NAT STRUCT MOL BIOL, V11, P1223, DOI 10.1038/nsmb867; Liu D, 2004, NAT CELL BIOL, V6, P673, DOI 10.1038/ncb1142; Loayza D, 2003, NATURE, V423, P1013, DOI 10.1038/nature01688; Maser RS, 2002, SCIENCE, V297, P565, DOI 10.1126/science.297.5581.565; Qi L, 2003, CANCER RES, V63, P8188; Silver DP, 2001, MOL CELL, V8, P233, DOI 10.1016/S1097-2765(01)00295-7; Smogorzewska A, 2002, CURR BIOL, V12, P1635, DOI 10.1016/S0960-9822(02)01179-X; Stansel RM, 2001, EMBO J, V20, P5532; Takai H, 2003, CURR BIOL, V13, P1549, DOI 10.1016/S0960-9822(03)00542-6; van Steensel B, 1998, CELL, V92, P401, DOI 10.1016/S0092-8674(00)80932-0; Veldman T, 2004, CURR BIOL, V14, P2264, DOI 10.1016/j.cub.2004.12.031; Ventura A, 2004, P NATL ACAD SCI USA, V101, P10380, DOI 10.1073/pnas.0403954101; Wang RC, 2004, CELL, V119, P355, DOI 10.1016/j.cell.2004.10.011; Wong KK, 2003, NATURE, V421, P643, DOI 10.1038/nature01385; Yang Q, 2005, MOL CELL BIOL, V25, P1070, DOI 10.1128/MCB.25.3.1070-1080.2005; Ye JZS, 2004, GENE DEV, V18, P1649, DOI 10.1101/gad.1215404; Zhu XD, 2003, MOL CELL, V12, P1489, DOI 10.1016/S1097-2765(03)00478-7; Zubko MK, 2004, GENETICS, V168, P103, DOI 10.1534/genetics.104.027904	39	300	309	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 14	2006	126	1					63	77		10.1016/j.cell.2006.04.044	http://dx.doi.org/10.1016/j.cell.2006.04.044			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	066JF	16839877	Bronze			2022-12-28	WOS:000239224800017
J	Kudo, NR; Wassmann, K; Anger, M; Schuh, M; Wirth, KG; Xu, HL; Helmhart, W; Kudo, H; Mckay, M; Maro, B; Ellenberg, J; de Boer, P; Nasmyth, K				Kudo, Nobuaki R.; Wassmann, Katja; Anger, Martin; Schuh, Melina; Wirth, Karin G.; Xu, Huiling; Helmhart, Wolfgang; Kudo, Hiromi; Mckay, Michael; Maro, Bernard; Ellenberg, Jan; de Boer, Peter; Nasmyth, Kim			Resolution of chiasmata in oocytes requires separase-mediated proteolysis	CELL			English	Article							SISTER-CHROMATID COHESION; ANAPHASE-PROMOTING COMPLEX; MEIOSIS-I DEPENDS; MOUSE OOCYTES; CHROMOSOME SEGREGATION; CAENORHABDITIS-ELEGANS; SYNAPTONEMAL COMPLEXES; MAMMALIAN OOCYTES; XENOPUS-OOCYTES; FISSION YEAST	In yeast, resolution of chiasmata in meiosis I requires proteolytic cleavage along chromosome arms of cohesin's Rec8 subunit by separase. Since activation of separase by the anaphase-promoting complex (APC/C) is supposedly not required for meiosis I in Xenopus oocytes, it has been suggested that animal cells might resolve chiasmata by a separase-independent mechanism related to the so-called "prophase pathway" that removes cohesin from chromosome arms during mitosis. By expressing Cre recombinase from a zona pellucida promoter, we have deleted a floxed allele of separase specifically in mouse oocytes. This prevents removal of Rec8 from chromosome arms and resolution of chiasmata. It also hinders extrusion of the first polar body (PBE) and causes female sterility. mRNA encoding wild-type but not catalytically inactive separase restores chiasma resolution. Both types of mRNA restore PBE. Proteolytic activity of separase is therefore essential for Rec8's removal from chromosome arms and for chiasma resolution but not for PBE.	Res Inst Mol Pathol, A-1030 Vienna, Austria; Univ Paris 06, IFR83, CNRS, UMR7622, F-75005 Paris, France; European Mol Biol Lab, Gene Express & Cell Biol Unit, D-69117 Heidelberg, Germany; European Mol Biol Lab, Biophys Unit, D-69117 Heidelberg, Germany; Peter MacCallum Canc Ctr, Melbourne, Vic, Australia; Tel Aviv Univ, Sackler Sch Med, Dept Cell & Dev Biol, IL-69978 Ramat Aviv, Israel; Radboud Univ Nijmegen Med Ctr, Dept Obstet & Gynaecol, NL-6500 HB Nijmegen, Netherlands	Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; European Molecular Biology Laboratory (EMBL); European Molecular Biology Laboratory (EMBL); Peter Maccallum Cancer Center; Tel Aviv University; Sackler Faculty of Medicine; Radboud University Nijmegen	Nasmyth, K (corresponding author), Univ Oxford, Dept Biochem, S Pks Rd, Oxford OX1 3QU, England.	kim.nasmyth@bioch.ox.ac.uk	Holt, Janet E/B-2415-2013; Maro, Bernard/AAL-2220-2020; Ellenberg, Jan/I-4688-2014; Kudo, Nobuaki/AAU-7196-2021; Anger, Martin/A-3152-2015; Anger, Martin/R-9917-2019	Ellenberg, Jan/0000-0001-5909-701X; Anger, Martin/0000-0003-0128-1054; Anger, Martin/0000-0003-0128-1054; Kudo, Nobuaki/0000-0001-8134-1242; Kudo, Hiromi/0000-0003-4313-7165; Wassmann, Katja/0000-0001-5442-5192; Nasmyth, Kim/0000-0001-7030-4403	Medical Research Council [G0901046] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Buonomo SBC, 2000, CELL, V103, P387, DOI 10.1016/S0092-8674(00)00131-8; Buonomo SBC, 2003, DEV CELL, V4, P727, DOI 10.1016/S1534-5807(03)00129-1; Ciosk R, 1998, CELL, V93, P1067, DOI 10.1016/S0092-8674(00)81211-8; CohenFix O, 1996, GENE DEV, V10, P3081, DOI 10.1101/gad.10.24.3081; Eijpe M, 2003, J CELL BIOL, V160, P657, DOI 10.1083/jcb.200212080; EPIFANO O, 1995, DEVELOPMENT, V121, P1947; Funabiki H, 1996, NATURE, V381, P438, DOI 10.1038/381438a0; Furuta T, 2000, MOL BIOL CELL, V11, P1401, DOI 10.1091/mbc.11.4.1401; Gorr IH, 2005, MOL CELL, V19, P135, DOI 10.1016/j.molcel.2005.05.022; Hassold T, 2001, NAT REV GENET, V2, P280, DOI 10.1038/35066065; Hauf S, 2005, PLOS BIOL, V3, P419, DOI 10.1371/journal.pbio.0030069; Herbert M, 2003, NAT CELL BIOL, V5, P1023, DOI 10.1038/ncb1062; Higuchi T, 2005, NATURE, V433, P171, DOI 10.1038/nature03240; Hodges CA, 2005, NAT GENET, V37, P1351, DOI 10.1038/ng1672; Hodges CA, 2002, CHROMOSOMA, V111, P165, DOI 10.1007/s00412-002-0195-3; Jaffe LA, 2004, METHOD CELL BIOL, V74, P219; Kitajima TS, 2003, EMBO J, V22, P5643, DOI 10.1093/emboj/cdg527; KUBIAK JZ, 1992, J CELL SCI, V102, P457; Kumada K, 2006, J CELL BIOL, V172, P835, DOI 10.1083/jcb.200511126; LAMMERS JHM, 1994, MOL CELL BIOL, V14, P1137, DOI 10.1128/MCB.14.2.1137; Lee J, 2003, J CELL SCI, V116, P2781, DOI 10.1242/jcs.00495; Lewandoski M, 1997, CURR BIOL, V7, P148, DOI 10.1016/S0960-9822(06)00059-5; Losada A, 1998, GENE DEV, V12, P1986, DOI 10.1101/gad.12.13.1986; MIYAZAKI WY, 1994, ANNU REV GENET, V28, P167, DOI 10.1146/annurev.ge.28.120194.001123; Nasmyth K, 2005, ANNU REV BIOCHEM, V74, P595, DOI 10.1146/annurev.biochem.74.082803.133219; Nasmyth K, 2005, CELL, V120, P739, DOI 10.1016/j.cell.2005.03.006; Pandey R, 2005, J CELL SCI, V118, P733, DOI 10.1242/jcs.01663; Peter M, 2001, NAT CELL BIOL, V3, P83, DOI 10.1038/35050607; Peters AHFM, 1997, CHROMOSOME RES, V5, P66, DOI 10.1023/A:1018445520117; Peters JM, 2002, MOL CELL, V9, P931, DOI 10.1016/S1097-2765(02)00540-3; Petronczki M, 2003, CELL, V112, P423, DOI 10.1016/S0092-8674(03)00083-7; Prieto I, 2004, CHROMOSOME RES, V12, P197, DOI 10.1023/B:CHRO.0000021945.83198.0e; Rabut G, 2004, J MICROSC-OXFORD, V216, P131, DOI 10.1111/j.0022-2720.2004.01404.x; Siomos MF, 2001, CURR BIOL, V11, P1825, DOI 10.1016/S0960-9822(01)00588-7; Stegmeier F, 2002, CELL, V108, P207, DOI 10.1016/S0092-8674(02)00618-9; Stemmann O, 2001, CELL, V107, P715, DOI 10.1016/S0092-8674(01)00603-1; Sullivan M, 2003, NAT CELL BIOL, V5, P249, DOI 10.1038/ncb940; Taieb FE, 2001, CURR BIOL, V11, P508, DOI 10.1016/S0960-9822(01)00145-2; Terret ME, 2003, CURR BIOL, V13, P1797, DOI 10.1016/j.cub.2003.09.032; Uhlmann F, 2000, CELL, V103, P375, DOI 10.1016/S0092-8674(00)00130-6; Wassmann K, 2003, CURR BIOL, V13, P1596, DOI 10.1016/j.cub.2003.08.052; Wirth KG, 2006, J CELL BIOL, V172, P847, DOI 10.1083/jcb.200506119; Xu HL, 2005, DEV CELL, V8, P949, DOI 10.1016/j.devcel.2005.03.018; Yu HG, 2005, CELL, V123, P397, DOI 10.1016/j.cell.2005.09.014	46	178	188	0	6	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUL 14	2006	126	1					135	146		10.1016/j.cell.2006.05.033	http://dx.doi.org/10.1016/j.cell.2006.05.033			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	066JF	16839882	Green Submitted, Bronze			2022-12-28	WOS:000239224800022
J	Reith, F; Rogers, SL; McPhail, DC; Webb, D				Reith, Frank; Rogers, Stephen L.; McPhail, D. C.; Webb, Daryl			Biomineralization of gold: Biofilms on bacterioform gold	SCIENCE			English	Article							THIOSULFATE COMPLEX; PRECIPITATION; METALLIDURANS	Bacterial biofilms are associated with secondary gold grains from two sites in Australia. 16S ribosomal DNA clones of the genus Ralstonia that bear 99% similarity to the bacterium Ralstonia metallidurans - shown to precipitate gold from aqueous gold(III) tetrachloride - were present on all DNA-positive gold grains but were not detected in the surrounding soils. These results provide evidence for the bacterial contribution to the authigenic formation of secondary bacterioform gold grains and nuggets.	Cooperat Res Ctr Landscape Environm & Mineral Exp, Bentley, WA 6102, Australia; Australian Natl Univ, Dept Earth & Marine Sci, Acton, ACT 0200, Australia; Australian Natl Univ, Res Sch Biol Sci, Electron Microscopy Unit, Acton, ACT 0200, Australia; CSIRO Land & Water, Glen Osmond, SA 5064, Australia	Australian National University; Australian National University; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Reith, F (corresponding author), Cooperat Res Ctr Landscape Environm & Mineral Exp, POB 1130, Bentley, WA 6102, Australia.	frank.reith@csiro.au	Reith, Frank/E-5542-2011					Bischoff G.C., 1997, NEUES JB GEOL PALAON, V6, P329, DOI [10.1127/njgpm/1997/1997/329, DOI 10.1127/NJGPM/1997/1997/329]; BISCHOFF GCO, 1994, N JB GEOL PALAONT AB, V194, P187; BOWMAN HN, 1979, 1979256 GS DEP MIN R; Boyle R.W., 1979, GEOL SURV CAN B, V280; BULTITUDE RJ, 1992, 19925 DEP RES IND QU; Erlebacher J, 2001, NATURE, V410, P450, DOI 10.1038/35068529; KARAMUSHKA V I, 1987, Prikladnaya Biokhimiya i Mikrobiologiya, V23, P697; KARAMUSHKA VI, 1990, UKR BIOKHIM ZH+, V62, P103; KARAMUSHKA VI, 1990, UKR BIOKHIM ZH+, V62, P76; Karthikeyan S, 2002, ENVIRON MICROBIOL, V4, P667, DOI 10.1046/j.1462-2920.2002.00353.x; Kashefi K, 2001, APPL ENVIRON MICROB, V67, P3275, DOI 10.1128/AEM.67.7.3275-3279.2001; KEELING JR, 1993, S AUST GEOL SURV Q G, V126, P12; Korobushkina E.D., 1983, ECOL B, V35, P325; Ledrich ML, 2005, BIOMETALS, V18, P643, DOI 10.1007/s10534-005-3858-8; Lengke MF, 2005, GEOCHIM COSMOCHIM AC, V69, P3759, DOI 10.1016/j.gca.2005.03.012; LYALIKOVA NN, 1969, MICROBIOLOGY, V38, P682; MANN S, 1992, NATURE, V357, P358, DOI 10.1038/357358b0; Mergeay M, 2003, FEMS MICROBIOL REV, V27, P385, DOI 10.1016/S0168-6445(03)00045-7; Mossman DJ, 1999, GEOSCI CAN, V26, P131; NAKJIMA A, 2003, WORLD J MICROB BIOT, V19, P369; Reith F, 2006, GEOCHIM COSMOCHIM AC, V70, P1421, DOI 10.1016/j.gca.2005.11.013; SOUTHAM G, 1994, GEOCHIM COSMOCHIM AC, V58, P4227; WATTERSON JR, 1994, GEOLOGY, V22, P1144, DOI 10.1130/0091-7613(1994)022<1144:ARBBPI>2.3.CO;2; WATTERSON JR, 1992, GEOLOGY, V20, P1147; WITKIEWICZ PL, 1981, J CHEM SOC CHEM COMM, P1111, DOI 10.1039/c39810001111	25	165	171	3	78	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 14	2006	313	5784					233	236		10.1126/science.1125878	http://dx.doi.org/10.1126/science.1125878			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	063GZ	16840703	Green Published			2022-12-28	WOS:000239008000047
J	Yamamoto, M; Stopa, M; Tokura, Y; Hirayama, Y; Tarucha, S				Yamamoto, M.; Stopa, M.; Tokura, Y.; Hirayama, Y.; Tarucha, S.			Negative Coulomb drag in a one-dimensional wire	SCIENCE			English	Article							QUANTUM; CRYSTALLIZATION; TRANSPORT; CRYSTAL	We observed negative Coulomb drag for parallel coupled quantum wires, in which electrons flow in the opposite directions between the wires. This only occurred under the conditions of strong correlation in the wires, that is, low density, high magnetic field, and low temperature, and cannot be addressed by a standard theory of momentum transfer. We propose a Coulomb drag model in which formation of a Wigner crystal state in the drag wire and a particle-like state in the drive wire is taken into account.	Univ Tokyo, Dept Appl Phys, Bunkyo Ku, Tokyo 1138656, Japan; Solut Oriented Res Sci & Technol Interacting Carr, Kawaguchi, Saitama 3310012, Japan; Harvard Univ, Ctr Nanoscale Syst, Cambridge, MA 02138 USA; NTT Basic Res Labs, Atsugi, Kanagawa 2430198, Japan; ICORP, Quantum Spin Informat Project, Atsugi, Kanagawa 2430198, Japan	University of Tokyo; Harvard University; Nippon Telegraph & Telephone Corporation; Japan Science & Technology Agency (JST)	Yamamoto, M (corresponding author), Univ Tokyo, Dept Appl Phys, Bunkyo Ku, Tokyo 1138656, Japan.		Hirayama, Yoshiro/AAE-1598-2019; Tokura, Yasuhiro/A-5550-2011; Yamamoto, Michihisa/E-6850-2017; TARUCHA, SEIGO/I-7030-2012	Tokura, Yasuhiro/0000-0001-6656-4237; Yamamoto, Michihisa/0000-0001-9113-6461; Hirayama, Yoshiro/0000-0003-2638-9133				AVERIN DV, 1992, SINGLE CHARGE TUNNEL; Debray P, 2001, J PHYS-CONDENS MAT, V13, P3389, DOI 10.1088/0953-8984/13/14/312; Feng XG, 1998, PHYS REV LETT, V81, P3219, DOI 10.1103/PhysRevLett.81.3219; Flensberg K, 1998, PHYS REV LETT, V81, P184, DOI 10.1103/PhysRevLett.81.184; GRIMES CC, 1979, PHYS REV LETT, V42, P795, DOI 10.1103/PhysRevLett.42.795; Gurevich VL, 1998, J PHYS-CONDENS MAT, V10, P2551, DOI 10.1088/0953-8984/10/11/018; Hu GY, 1998, J APPL PHYS, V84, P6713, DOI 10.1063/1.368997; Jones MD, 1996, PHYS REV LETT, V76, P4572, DOI 10.1103/PhysRevLett.76.4572; Klesse R, 2000, PHYS REV B, V62, P16912, DOI 10.1103/PhysRevB.62.16912; Lok JGS, 2001, PHYS REV B, V63, DOI 10.1103/PhysRevB.63.041305; MASLOV DL, 1992, PHYS REV B, V45, P1911, DOI 10.1103/PhysRevB.45.1911; Muraki K, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.246801; Nazarov YV, 1998, PHYS REV LETT, V81, P653, DOI 10.1103/PhysRevLett.81.653; Ponomarenko VV, 2000, PHYS REV LETT, V85, P4928, DOI 10.1103/PhysRevLett.85.4928; Raichev O, 2000, PHYS REV B, V61, P7511, DOI 10.1103/PhysRevB.61.7511; SCHULZ HJ, 1993, PHYS REV LETT, V71, P1864, DOI 10.1103/PhysRevLett.71.1864; SOLOMON PM, 1989, PHYS REV LETT, V63, P2508, DOI 10.1103/PhysRevLett.63.2508; Stopa M, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevB.64.193315; Tanatar B, 1998, PHYS REV B, V58, P9886, DOI 10.1103/PhysRevB.58.9886; von Oppen F, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.106803; Wigner E, 1934, PHYS REV, V46, P1002, DOI 10.1103/PhysRev.46.1002; Yamamoto M, 2002, PHYSICA E, V12, P726, DOI 10.1016/S1386-9477(01)00461-1	24	74	74	1	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 14	2006	313	5784					204	207		10.1126/science.1126601	http://dx.doi.org/10.1126/science.1126601			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	063GZ	16840694				2022-12-28	WOS:000239008000038
J	Eliassen, AH; Colditz, GA; Rosner, B; Willett, WC; Hankinson, SE				Eliassen, AH; Colditz, GA; Rosner, B; Willett, WC; Hankinson, SE			Adult weight change and risk of postmenopausal breast cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HORMONE REPLACEMENT THERAPY; BODY-MASS INDEX; ENDOGENOUS ESTROGEN CONCENTRATIONS; POST-MENOPAUSAL WOMEN; PROSPECTIVE COHORT; UNITED-STATES; SEX-HORMONES; COLLABORATIVE REANALYSIS; NURSES HEALTH; LIFE-STYLE	Context Endogenous hormones are a primary cause of breast cancer. Adiposity affects circulating hormones, particularly in postmenopausal women, and may be a modifiable risk factor for breast cancer. Objective To assess the associations of adult weight change since age 18 years and since menopause with the risk of breast cancer among postmenopausal women. Design, Setting, and Participants Prospective cohort study within the Nurses' Health Study. A total of 87 143 postmenopausal women, aged 30 to 55 years and free of cancer, were followed up for up to 26 years (1976-2002) to assess weight change since age 18 years. Weight change since menopause was assessed among 49 514 women who were followed up for up to 24 years. Main Outcome Measure Incidence of invasive breast cancer. Results Overall, 4393 cases of invasive breast cancer were documented. Compared with those who maintained weight, women who gained 25.0 kg or more since age 18 years were at an increased risk of breast cancer ( relative risk [RR], 1.45; 95% confidence interval [CI], 1.27- 1.66; P <. 001 for trend), with a stronger association among women who have never taken postmenopausal hormones ( RR, 1.98; 95% CI, 1.55-2.53). Compared with weight maintenance, women who gained 10.0 kg or more since menopause were at an increased risk of breast cancer ( RR, 1.18; 95% CI, 1.03- 1.35; P =. 002 for trend). Women who had never used postmenopausal hormones, lost 10.0 kg or more since menopause, and kept the weight off were at a lower risk than those who maintained weight ( RR, 0.43; 95% CI, 0.21-0.86; P=. 01 for weight loss trend). Overall, 15.0% ( 95% CI, 12.8%-17.4%) of breast cancer cases in this population may be attributable to weight gain of 2.0 kg or more since age 18 years and 4.4% ( 95% CI, 3.6%-5.5%) attributable to weight gain of 2.0 kg or more since menopause. Among those who did not use postmenopausal hormones, the population attributable risks are 24.2% ( 95% CI, 19.8%-29.1%) for a weight gain since age 18 years and 7.6% ( 95% CI, 5.9%-9.7%) for weight gain since menopause. Conclusions These data suggest that weight gain during adult life, specifically since menopause, increases the risk of breast cancer among postmenopausal women, whereas weight loss after menopause is associated with a decreased risk of breast cancer. Thus, in addition to other known benefits of healthy weight, our results provide another reason for women approaching menopause to maintain or lose weight, as appropriate.	Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA; Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health	Eliassen, AH (corresponding author), Brigham & Womens Hosp, Dept Med, Channing Lab, 181 Longwood Ave, Boston, MA 02115 USA.	heather.eliassen@channing.harvard.edu	Colditz, Graham/A-3963-2009	Colditz, Graham/0000-0002-7307-0291; Eliassen, A Heather/0000-0002-3961-6609	NATIONAL CANCER INSTITUTE [P01CA087969, R25CA098566] Funding Source: NIH RePORTER; NCI NIH HHS [CA87969, R25 CA098566-02] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Baer HJ, 2005, BREAST CANCER RES, V7, pR314, DOI 10.1186/bcr998; BARNESJOSIAH D, 1995, CANCER CAUSE CONTROL, V6, P112, DOI 10.1007/BF00052771; BELANGER CF, 1978, AM J NURS, V78, P1039, DOI 10.2307/3462013; Beral V, 2002, BRIT J CANCER, V87, P1234, DOI 10.1038/sj.bjc.6600596; Beral V, 1997, LANCET, V350, P1047, DOI 10.1016/S0140-6736(97)08233-0; Berg AO, 2003, ANN INTERN MED, V139, P930, DOI 10.7326/0003-4819-139-11-200312020-00012; Berkey CS, 1999, CANCER-AM CANCER SOC, V85, P2400, DOI 10.1002/(SICI)1097-0142(19990601)85:11<2400::AID-CNCR15>3.0.CO;2-O; Brinton L A, 1992, Ann Epidemiol, V2, P597, DOI 10.1016/1047-2797(92)90004-A; BRUZZI P, 1985, AM J EPIDEMIOL, V122, P904, DOI 10.1093/oxfordjournals.aje.a114174; Calle EE, 2004, NAT REV CANCER, V4, P579, DOI 10.1038/nrc1408; Chen WY, 2004, CANCER, V101, P1490, DOI 10.1002/cncr.20499; CHETKOWSKI RJ, 1986, NEW ENGL J MED, V314, P1615, DOI 10.1056/NEJM198606193142505; Chlebowski RT, 2003, JAMA-J AM MED ASSOC, V289, P3243, DOI 10.1001/jama.289.24.3243; CHU SY, 1991, J CLIN EPIDEMIOL, V44, P1197, DOI 10.1016/0895-4356(91)90152-Y; COLDITZ GA, 1987, AM J EPIDEMIOL, V126, P319, DOI 10.1093/aje/126.2.319; Colditz GA, 2005, NAT REV CANCER, V5, P388, DOI 10.1038/nrc1608; Dansinger ML, 2005, JAMA-J AM MED ASSOC, V293, P43, DOI 10.1001/jama.293.1.43; DEWAARD F, 1982, MATURITAS, V4, P155, DOI 10.1016/0378-5122(82)90042-1; Dorgan JF, 2002, JNCI-J NATL CANCER I, V94, P606; Eng SM, 2005, AM J EPIDEMIOL, V162, P229, DOI 10.1093/aje/kwi195; ENRIORI CL, 1986, GYNECOL ONCOL, V23, P77, DOI 10.1016/0090-8258(86)90118-6; Feigelson HS, 2004, CANCER EPIDEM BIOMAR, V13, P220, DOI 10.1158/1055-9965.EPI-03-0301; Friedenreich CM, 2002, INT J CANCER, V99, P445, DOI 10.1002/ijc.10389; GRODIN JM, 1973, J CLIN ENDOCR METAB, V36, P207, DOI 10.1210/jcem-36-2-207; HANKINSON SE, 1995, J NATL CANCER I, V87, P1297, DOI 10.1093/jnci/87.17.1297; Harvie M, 2005, CANCER EPIDEM BIOMAR, V14, P656, DOI 10.1158/1055-9965.EPI-04-0001; Hirose K, 1999, INT J CANCER, V80, P349, DOI 10.1002/(SICI)1097-0215(19990129)80:3&lt;349::AID-IJC3&gt;3.0.CO;2-8; Huang ZP, 1997, JAMA-J AM MED ASSOC, V278, P1407, DOI 10.1001/jama.278.17.1407; International Agency for Research on Cancer, 2002, IARC HDB CANC PREV W; JUDD HL, 1982, OBSTET GYNECOL, V59, P680; JURGENS RW, 1992, AM J OBSTET GYNECOL, V167, P459, DOI 10.1016/S0002-9378(11)91429-X; Key TJ, 2003, J NATL CANCER I, V95, P1218, DOI 10.1093/jnci/djg022; Lahmann PH, 2005, BRIT J CANCER, V93, P582, DOI 10.1038/sj.bjc.6602763; Lahmann PH, 2003, INT J CANCER, V103, P246, DOI 10.1002/ijc.10799; Li CI, 2000, INT J EPIDEMIOL, V29, P208, DOI 10.1093/ije/29.2.208; Magnusson C, 1999, INT J CANCER, V81, P339, DOI 10.1002/(SICI)1097-0215(19990505)81:3<339::AID-IJC5>3.3.CO;2-Y; Magnusson C, 1998, INT J CANCER, V76, P29, DOI 10.1002/(SICI)1097-0215(19980330)76:1<29::AID-IJC6>3.3.CO;2-1; MARSHALL RJ, 1985, STAT MED, V4, P337, DOI 10.1002/sim.4780040313; Missmer SA, 2004, JNCI-J NATL CANCER I, V96, P1856, DOI 10.1093/jnci/djh336; Morimoto LM, 2002, CANCER CAUSE CONTROL, V13, P741, DOI 10.1023/A:1020239211145; *NAT CANC I, 1973, SEER CANC STAT REV; NEWCOMB PA, 1995, EPIDEMIOLOGY, V6, P318, DOI 10.1097/00001648-199505000-00022; Parker ED, 2003, INT J OBESITY, V27, P1447, DOI 10.1038/sj.ijo.0802437; Potischman N, 1996, JNCI-J NATL CANCER I, V88, P756, DOI 10.1093/jnci/88.11.756; Prentice RL, 2006, JAMA-J AM MED ASSOC, V295, P629, DOI 10.1001/jama.295.6.629; RICHEDWARDS JW, 1994, AM J OBSTET GYNECOL, V171, P171, DOI 10.1016/0002-9378(94)90465-0; Rimm E B, 1990, Epidemiology, V1, P466, DOI 10.1097/00001648-199011000-00009; Shoff SM, 2000, CANCER EPIDEM BIOMAR, V9, P591; Shu XO, 2001, INT J CANCER, V94, P449, DOI 10.1002/ijc.1487; SIITERI PK, 1987, AM J CLIN NUTR, V45, P277, DOI 10.1093/ajcn/45.1.277; SPIEGELMAN D, IN PRESS CANC CAUSES; Stein CJ, 2004, J CLIN ENDOCR METAB, V89, P2522, DOI 10.1210/jc.2004-0288; Thomas HV, 1997, J NATL CANCER I, V89, P396, DOI 10.1093/jnci/89.5.396; Trentham-Dietz A, 2000, CANCER CAUSE CONTROL, V11, P533, DOI 10.1023/A:1008961931534; TrenthamDietz A, 1997, AM J EPIDEMIOL, V145, P1011, DOI 10.1093/oxfordjournals.aje.a009057; TROY LM, 1995, INT J OBESITY, V19, P570; van den Brandt PA, 2000, AM J EPIDEMIOL, V152, P514, DOI 10.1093/aje/152.6.514; vandenBrandt PA, 1997, CANCER CAUSE CONTROL, V8, P39, DOI 10.1023/A:1018479020716; Wenten M, 2002, ANN EPIDEMIOL, V12, P435, DOI 10.1016/S1047-2797(01)00293-9; Ziegler RG, 1996, J NATL CANCER I, V88, P650, DOI 10.1093/jnci/88.10.650	60	418	422	1	18	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 12	2006	296	2					193	201		10.1001/jama.296.2.193	http://dx.doi.org/10.1001/jama.296.2.193			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	062LP	16835425				2022-12-28	WOS:000238946500025
J	Manini, TM; Everhart, JE; Patel, KV; Schoeller, DA; Colbert, LH; Visser, M; Tylavsky, F; Bauer, DC; Goodpaster, BH; Harris, TB				Manini, Todd M.; Everhart, James E.; Patel, Kushang V.; Schoeller, Dale A.; Colbert, Lisa H.; Visser, Marjolein; Tylavsky, Frances; Bauer, Douglas C.; Goodpaster, Bret H.; Harris, Tamara B.			Daily activity energy expenditure and mortality among older adults	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PHYSICAL-ACTIVITY; WOMEN; MEN; EXERCISE; DISEASE; LIFE; OBESITY; HUMANS; MODEL	Context Exercise is associated with mortality benefits but simply expending energy through any activity in an individual's free-living environment may confer survival advantages. Objective To determine whether free-living activity energy expenditure is associated with all-cause mortality among older adults. Design, Setting, and Participants Free-living activity energy expenditure was assessed in 302 high-functioning, community-dwelling older adults ( aged 70-82 years). Total energy expenditure was assessed over 2 weeks using doubly labeled water. Resting metabolic rate was measured using indirect calorimetry and the thermic effect of meals was estimated at 10% of total energy expenditure. Free-living activity energy expenditure was calculated as: ( total energy expenditure x 0.90) resting metabolic rate. Participants were followed up over a mean of 6.15 years (1998-2006). Main Outcome Measures Free-living activity energy expenditure ( 3 tertiles: low, < 521 kcal/d; middle, 521- 770 kcal/d; high, > 770 kcal/d) and all-cause mortality. Results Fifty-five participants (18.2%) died during follow-up. As a continuous risk factor, an SD increase in free-living activity energy expenditure ( 287 kcal/d) was associated with a 32% lower risk of mortality after adjusting for age, sex, race, study site, weight, height, percentage of body fat, and sleep duration ( hazard ratio, 0.68; 95% confidence interval, 0.48-0.96). Using the same adjustments, individuals in the highest tertile of free-living activity energy expenditure were at a significantly lower mortality risk compared with the lowest tertile ( hazard ratio, 0.31; 95% confidence interval, 0.14-0.69). Absolute risk of death was 12.1% in the highest tertile of activity energy expenditure vs 24.7% in the lowest tertile; absolute risks were similar to these for tertiles of physical activity level. The effect of free-living activity energy expenditure changed little after further adjustment for self-rated health, education, prevalent health conditions, and smoking behavior. According to self-reports, individuals expending higher levels of free-living activity energy were more likely to work for pay ( P=. 004) and climb stairs ( P=. 01) but self-reported high-intensity exercise, walking for exercise, walking other than for exercise, volunteering, and caregiving did not differ significantly across the activity energy expenditure tertiles. Conclusions Objectively measured free-living activity energy expenditure was strongly associated with lower risk of mortality in healthy older adults. Simply expending energy through any activity may influence survival in older adults.	NIA, Lab Epidemiol Demog & Biometry, Bethesda, MD 20892 USA; NIDDKD, Bethesda, MD 20892 USA; Univ Wisconsin, Dept Nutr Sci, Madison, WI 53706 USA; Univ Wisconsin, Dept Kinesiol, Madison, WI 53706 USA; Vrije Univ Amsterdam Med Ctr, Fac Earth & Life Sci, Inst Hlth Sci, Amsterdam, Netherlands; Vrije Univ Amsterdam Med Ctr, Inst Res Extramural Med, Amsterdam, Netherlands; Univ Tennessee, Dept Biostat & Epidemiol, Memphis, TN USA; Univ Calif San Francisco, Dept Med, San Francisco, CA USA; Univ Pittsburgh, Med Ctr, Div Endocrinol & Metab, Pittsburgh, PA USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; University of Tennessee System; University of Tennessee Health Science Center; University of California System; University of California San Francisco; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Manini, TM (corresponding author), NIA, Lab Epidemiol Demog & Biometry, 7201 Wisconsin Ave Gateway Bldg,Suite 3C309, Bethesda, MD 20892 USA.	maninit@mail.nih.gov	Visser, Marjolein/AAP-3224-2020	Visser, Marjolein/0000-0002-5136-298X	Intramural NIH HHS Funding Source: Medline; NIA NIH HHS [N01-AG-6-2106, N01-AG-6-2103, N01-AG-6-2101] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [N01AG062106, Z01AG007390, N01AG062103, N01AG062101] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		AINSWORTH BE, 1993, MED SCI SPORT EXER, V25, P71, DOI 10.1249/00005768-199301000-00011; Bijnen FCH, 1998, ARCH INTERN MED, V158, P1499, DOI 10.1001/archinte.158.14.1499; Bijnen FCH, 1999, AM J EPIDEMIOL, V150, P1289, DOI 10.1093/oxfordjournals.aje.a009960; Black AE, 1996, EUR J CLIN NUTR, V50, P72; Blair SN, 1996, JAMA-J AM MED ASSOC, V276, P205, DOI 10.1001/jama.276.3.205; Blair SN, 1999, MED SCI SPORT EXER, V31, pS646, DOI 10.1097/00005768-199911001-00025; Blanc S, 2004, AM J CLIN NUTR, V79, P303; Blanc S, 2002, J APPL PHYSIOL, V92, P1036, DOI 10.1152/japplphysiol.00743.2001; BLOESCH D, 1988, J AM COLL NUTR, V7, P471; Chung HY, 2001, ANN NY ACAD SCI, V928, P327; COWARD WA, 1990, DOUBLY LABELED WATER; Durante R, 1996, MED SCI SPORT EXER, V28, P1282, DOI 10.1097/00005768-199610000-00012; Elia M, 2000, EUR J CLIN NUTR, V54, pS92, DOI 10.1038/sj.ejcn.1601030; Ferrucci L, 1999, AM J EPIDEMIOL, V149, P645, DOI 10.1093/oxfordjournals.aje.a009865; Goto S, 2004, ANN NY ACAD SCI, V1019, P471, DOI 10.1196/annals.1297.085; Gregg EW, 2000, J AM GERIATR SOC, V48, P883, DOI 10.1111/j.1532-5415.2000.tb06884.x; Gregg EW, 2003, JAMA-J AM MED ASSOC, V289, P2379, DOI 10.1001/jama.289.18.2379; Hakim AA, 1998, NEW ENGL J MED, V338, P94, DOI 10.1056/NEJM199801083380204; KAPLAN GA, 1987, AM J PUBLIC HEALTH, V77, P307, DOI 10.2105/AJPH.77.3.307; Kushi LH, 1997, JAMA-J AM MED ASSOC, V277, P1287, DOI 10.1001/jama.277.16.1287; Lamonte MJ, 2001, MED SCI SPORT EXER, V33, pS370, DOI 10.1097/00005768-200106001-00006; Levin S, 1999, ANN EPIDEMIOL, V9, P481, DOI 10.1016/S1047-2797(99)00022-8; LICHTMAN SW, 1992, NEW ENGL J MED, V327, P1893, DOI 10.1056/NEJM199212313272701; Morgan K, 1997, J EPIDEMIOL COMMUN H, V51, P490, DOI 10.1136/jech.51.5.490; PATE RR, 1995, JAMA-J AM MED ASSOC, V273, P402, DOI 10.1001/jama.273.5.402; Pedersen BK, 2000, INT J SPORTS MED, V21, pS4, DOI 10.1055/s-2000-1444; PRENTICE AM, 1986, BRIT MED J, V292, P983, DOI 10.1136/bmj.292.6526.983; Prentice AM, 1996, INT J OBESITY, V20, P688; Rice DP, 2004, ANNU REV PUBL HEALTH, V25, P457, DOI 10.1146/annurev.publhealth.25.101802.123054; Sallis JF, 2000, RES Q EXERCISE SPORT, V71, pS1, DOI 10.1080/02701367.2000.11082780; SCHOELLER DA, 1986, AM J PHYSIOL, V250, pR823, DOI 10.1152/ajpregu.1986.250.5.R823; SCHOELLER DA, 1982, J APPL PHYSIOL, V53, P955, DOI 10.1152/jappl.1982.53.4.955; SCHOENFELD D, 1982, BIOMETRIKA, V69, P239, DOI 10.1093/biomet/69.1.239; Schutz Y, 2001, OBES RES, V9, P368, DOI 10.1038/oby.2001.48; SERIES WTR, 1985, ENERGY PROTEIN REQUI; Stessman J, 2000, J AM GERIATR SOC, V48, P499, DOI 10.1111/j.1532-5415.2000.tb04995.x; Wannamethee SG, 1998, LANCET, V351, P1603, DOI 10.1016/S0140-6736(97)12355-8; WEIR JBD, 1949, J PHYSIOL-LONDON, V109, P1, DOI 10.1113/jphysiol.1949.sp004363; Weller I, 1998, EPIDEMIOLOGY, V9, P632, DOI 10.1097/00001648-199811000-00012	39	407	417	0	40	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 12	2006	296	2					171	179		10.1001/jama.296.2.171	http://dx.doi.org/10.1001/jama.296.2.171			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	062LP	16835422	Bronze			2022-12-28	WOS:000238946500022
J	Meylan, E; Tschopp, J; Karin, M				Meylan, Etienne; Tschopp, Juerg; Karin, Michael			Intracellular pattern recognition receptors in the host response	NATURE			English	Review							NF-KAPPA-B; HEPATITIS-C-VIRUS; TOLL-LIKE RECEPTOR-3; LEGIONELLA-PNEUMOPHILA INFECTION; COLD AUTOINFLAMMATORY SYNDROME; ANTIVIRAL SIGNALING PROTEIN; BACTERIAL MURAMYL DIPEPTIDE; INFLAMMATORY-BOWEL-DISEASE; MUCKLE-WELLS-SYNDROME; DOUBLE-STRANDED-RNA	The innate immune system relies on its capacity to rapidly detect invading pathogenic microbes as foreign and eliminate them. Indeed, Toll-like receptors are a class of membrane receptors that sense extracellular microbes and trigger anti-pathogen signalling cascades. Recently, intracellular microbial sensors have also been identified, including NOD-like receptors and the helicase-domain-containing antiviral proteins RIG-I and MDA5. Some of these cytoplasmic molecules sense microbial, as well as non-microbial, danger signals, but the mechanisms of recognition used by these sensors remain poorly understood. Nonetheless, it is apparent that these proteins are likely to have critical roles in health and disease.	Univ Lausanne, Dept Biochem, CH-1066 Epalinges, Switzerland; Univ Calif San Diego, Sch Med, Dept Pharmacol, Lab Gene Regulat & Signal Transduct, La Jolla, CA 92093 USA	University of Lausanne; University of California System; University of California San Diego	Tschopp, J (corresponding author), Univ Lausanne, Dept Biochem, Chemin Boveresses 155, CH-1066 Epalinges, Switzerland.	jurg.tschopp@unil.ch; Karinoffice@ucsd.edu		Meylan, Etienne/0000-0002-0899-2230				Agostini L, 2004, IMMUNITY, V20, P319, DOI 10.1016/S1074-7613(04)00046-9; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Andrejeva J, 2004, P NATL ACAD SCI USA, V101, P17264, DOI 10.1073/pnas.0407639101; Braat H, 2005, J MOL MED, V83, P601, DOI 10.1007/s00109-005-0685-x; Chamaillard M, 2003, NAT IMMUNOL, V4, P702, DOI 10.1038/ni945; Cheneval D, 1998, J BIOL CHEM, V273, P17846, DOI 10.1074/jbc.273.28.17846; Dinarello CA, 1996, BLOOD, V87, P2095, DOI 10.1182/blood.V87.6.2095.bloodjournal8762095; Dinarello CA, 2005, J EXP MED, V201, P1355, DOI 10.1084/jem.20050640; Eckmann L, 2005, IMMUNITY, V22, P661, DOI 10.1016/j.immuni.2005.06.004; Edelmann KH, 2004, VIROLOGY, V322, P231, DOI 10.1016/j.virol.2004.01.033; Ferwerda G, 2005, PLOS PATHOG, V1, P279, DOI 10.1371/journal.ppat.0010034; Fortier A, 2005, TRENDS MICROBIOL, V13, P328, DOI 10.1016/j.tim.2005.05.007; Franchi L, 2006, NAT IMMUNOL, V7, P576, DOI 10.1038/ni1346; Girardin SE, 2003, J BIOL CHEM, V278, P8869, DOI 10.1074/jbc.C200651200; Hacker H, 2006, NATURE, V439, P204, DOI 10.1038/nature04369; Hawkins PN, 2004, ARTHRITIS RHEUM-US, V50, P607, DOI 10.1002/art.20033; Hawkins PN, 2003, NEW ENGL J MED, V348, P2583, DOI 10.1056/NEJM200306193482523; Hoffman HM, 2004, LANCET, V364, P1779, DOI 10.1016/S0140-6736(04)17401-1; Hoffman HM, 2001, NAT GENET, V29, P301, DOI 10.1038/ng756; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Inohara N, 2003, J BIOL CHEM, V278, P5509, DOI 10.1074/jbc.C200673200; Inohara N, 2005, ANNU REV BIOCHEM, V74, P355, DOI 10.1146/annurev.biochem.74.082803.133347; Inohara N, 1999, J BIOL CHEM, V274, P14560, DOI 10.1074/jbc.274.21.14560; Jones DA, 2004, CURR OPIN IMMUNOL, V16, P48, DOI 10.1016/j.coi.2003.11.016; Kanazawa N, 2005, BLOOD, V105, P1195, DOI 10.1182/blood-2004-07-2972; Kanneganti TD, 2006, NATURE, V440, P233, DOI 10.1038/nature04517; Karin M, 2006, CELL, V124, P823, DOI 10.1016/j.cell.2006.02.016; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kato H, 2005, IMMUNITY, V23, P19, DOI 10.1016/j.immuni.2005.04.010; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Kawamura H, 2006, J IMMUNOL, V176, P2152, DOI 10.4049/jimmunol.176.4.2152; Kobayashi KS, 2005, SCIENCE, V307, P731, DOI 10.1126/science.1104911; Lamarre D, 2003, NATURE, V426, P186, DOI 10.1038/nature02099; Li J, 2004, HUM MOL GENET, V13, P1715, DOI 10.1093/hmg/ddh182; Li K, 2005, P NATL ACAD SCI USA, V102, P2992, DOI 10.1073/pnas.0408824102; Li XD, 2005, P NATL ACAD SCI USA, V102, P17717, DOI 10.1073/pnas.0508531102; Maeda S, 2005, SCIENCE, V307, P734, DOI 10.1126/science.1103685; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Martinon F, 2005, TRENDS IMMUNOL, V26, P447, DOI 10.1016/j.it.2005.06.004; Martinon F, 2004, CURR BIOL, V14, P1929, DOI 10.1016/j.cub.2004.10.027; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Martinon F, 2004, CELL, V117, P561, DOI 10.1016/j.cell.2004.05.004; MATZINGER P, 1994, ANNU REV IMMUNOL, V12, P991, DOI 10.1146/annurev.iy.12.040194.005015; McAlindon ME, 1998, GUT, V42, P214, DOI 10.1136/gut.42.2.214; McDermott MF, 2002, TRENDS MOL MED, V8, P550, DOI 10.1016/S1471-4914(02)02425-5; Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Miao EA, 2006, NAT IMMUNOL, V7, P569, DOI 10.1038/ni1344; Molofsky AB, 2006, J EXP MED, V203, P1093, DOI 10.1084/jem.20051659; Oganesyan G, 2006, NATURE, V439, P208, DOI 10.1038/nature04374; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Ogura Y, 2001, J BIOL CHEM, V276, P4812, DOI 10.1074/jbc.M008072200; Opitz B, 2004, J BIOL CHEM, V279, P36426, DOI 10.1074/jbc.M403861200; PERREGAUX D, 1994, J BIOL CHEM, V269, P15195; Podolsky DK, 2002, NEW ENGL J MED, V347, P417, DOI 10.1056/NEJMra0804647; Ren T, 2006, PLOS PATHOG, V2, P175, DOI 10.1371/journal.ppat.0020018; Riedl SJ, 2005, NATURE, V434, P926, DOI 10.1038/nature03465; Rothenfusser S, 2005, J IMMUNOL, V175, P5260, DOI 10.4049/jimmunol.175.8.5260; Samuel CE, 2001, CLIN MICROBIOL REV, V14, P778, DOI 10.1128/CMR.14.4.778-809.2001; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Shi Y, 2003, NATURE, V425, P516, DOI 10.1038/nature01991; Sun QM, 2006, IMMUNITY, V24, P633, DOI 10.1016/j.immuni.2006.04.004; Sutterwala FS, 2006, IMMUNITY, V24, P317, DOI 10.1016/j.immuni.2006.02.004; Tanabe T, 2004, EMBO J, V23, P1587, DOI 10.1038/sj.emboj.7600175; Ting JPY, 2005, ANNU REV IMMUNOL, V23, P387, DOI 10.1146/annurev.immunol.23.021704.115616; Travassos LH, 2004, EMBO REP, V5, P1000, DOI 10.1038/sj.embor.7400248; Vavricka SR, 2004, GASTROENTEROLOGY, V127, P1401, DOI 10.1053/j.gastro.2004.07.024; Viala J, 2004, NAT IMMUNOL, V5, P1166, DOI 10.1038/ni1131; WALEV I, 1995, EMBO J, V14, P1607, DOI 10.1002/j.1460-2075.1995.tb07149.x; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Yamamoto M, 2004, GENES CELLS, V9, P1055, DOI 10.1111/j.1365-2443.2004.00789.x; Yoneyama M, 2005, J IMMUNOL, V175, P2851, DOI 10.4049/jimmunol.175.5.2851; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Zamboni DS, 2006, NAT IMMUNOL, V7, P318, DOI 10.1038/ni1305	78	873	964	2	101	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 6	2006	442	7098					39	44		10.1038/nature04946	http://dx.doi.org/10.1038/nature04946			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	059HS	16823444	Green Published			2022-12-28	WOS:000238724500031
J	Scharf, HP; Mansmann, U; Streitberger, K; Witte, S; Kramer, J; Maier, C; Trampisch, HJ; Victor, N				Scharf, Hanns-Peter; Mansmann, Ulrich; Streitberger, Konrad; Witte, Steffen; Kraemer, Juergen; Maier, Christoph; Trampisch, Hans-Joachim; Victor, Norbert			Acupuncture and knee osteoarthritis - A three-armed randomized trial	ANNALS OF INTERNAL MEDICINE			English	Article							ADJUNCTIVE THERAPY; ARTHRITIS; CRITERIA; VALIDATION; OUTCOMES; PATIENT; WOMAC; HIP	Background: Despite the popularity of acupuncture, evidence of its efficacy for reducing pain remains equivocal. Objective: To assess the efficacy and safety of traditional Chinese acupuncture (TCA) compared with sham acupuncture (needling at defined nonacupuncture points) and conservative therapy in patients with chronic pain due to osteoarthritis of the knee. Design: Randomized, controlled trial. Setting: 315 primary care practices staffed by 320 practitioners with at least 2 years' experience in acupuncture. Patients: 1007 patients who had had chronic pain for at least 6 months due to osteoarthritis of the knee (American College of Rheumatology [ACR] criteria and Kellgren-Lawrence score of 2 or 3). Interventions: Up to 6 physiotherapy sessions and as-needed anti-inflammatory drugs plus 10 sessions of TCA, 10 sessions of sham acupuncture, or 10 physician visits within 6 weeks. Patients could request up to 5 additional sessions or visits if the initial treatment was viewed as being partially successful. Measurements: Success rate, as defined by at least 36% improvement in Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) score at 26 weeks. Additional end points were WOMAC score and global patient assessment. Results: Success rates were 53.1% for TCA, 51.0% for sham acupuncture, and 29.1% for conservative therapy. Acupuncture groups had higher success rates than conservative therapy groups (relative risk for TCA compared with conservative therapy, 1.75 [95% Cl, 1.43 to 2.13]; relative risk for sham acupuncture compared with conservative therapy, 1.73 [CI, 1.42 to 2.11]). There was no difference between TCA and sham acupuncture (relative risk, 1.01 [Cl, 0.87 to 1.171). Limitations: There was no blinding between acupuncture and traditional therapy and no monitoring of acupuncture compliance with study protocol. In general, practitioner-patient contacts were less intense in the conservative therapy group than in the TCA and sham acupuncture groups. Conclusions: Compared with physiotherapy and as-needed antiinflammatory drugs, addition of either TCA or sham acupuncture led to greater improvement in WOMAC score at 26 weeks. No statistically significant difference was observed between TCA and sham acupuncture, suggesting that the observed differences could be due to placebo effects, differences in intensity of provider contact, or a physiologic effect of needling regardless of whether it is done according to TCA principles.	Heidelberg Univ, Heidelberg, Germany; Ruhr Univ Bochum, D-4630 Bochum, Germany	Ruprecht Karls University Heidelberg; Ruhr University Bochum	Victor, N (corresponding author), Heidelberg Univ, Bergheimer Str 58, Heidelberg, Germany.			Hans, Trampisch/0000-0001-9136-1079				ALTMAN R, 1986, ARTHRITIS RHEUM, V29, P1039, DOI 10.1002/art.1780290816; Angst F, 2001, ARTHRIT RHEUM-ARTHR, V45, P384, DOI 10.1002/1529-0131(200108)45:4<384::AID-ART352>3.0.CO;2-0; BELLAMY N, 1988, J RHEUMATOL, V15, P1833; Berman BM, 1999, RHEUMATOLOGY, V38, P346, DOI 10.1093/rheumatology/38.4.346; Berman BM, 2004, ANN INTERN MED, V141, P901, DOI 10.7326/0003-4819-141-12-200412210-00006; CHRISTENSEN BV, 1992, ACTA ANAESTH SCAND, V36, P519, DOI 10.1111/j.1399-6576.1992.tb03511.x; Collins SL, 2001, PAIN, V91, P189, DOI 10.1016/S0304-3959(00)00435-8; Ezzo J, 2001, ARTHRITIS RHEUM, V44, P819, DOI 10.1002/1529-0131(200104)44:4<819::AID-ANR138>3.0.CO;2-P; FELSON DT, 1988, EPIDEMIOL REV, V10, P1; Felson DT, 1998, ARTHRITIS RHEUM, V41, P1564, DOI 10.1002/1529-0131(199809)41:9<1564::AID-ART6>3.0.CO;2-M; Felson DT, 2000, ANN INTERN MED, V133, P726, DOI 10.7326/0003-4819-133-9-200011070-00015; GOLDSMITH CH, 1993, J RHEUMATOL, V20, P561; *INT C HARM, 1998, CPMPICH36396 INT C H; Kaptchuk TJ, 2002, ANN INTERN MED, V136, P817, DOI 10.7326/0003-4819-136-11-200206040-00011; KELLGREN JH, 1957, ANN RHEUM DIS, V16, P494, DOI 10.1136/ard.16.4.494; KNUTSON K, 1994, ACTA ORTHOP SCAND, V65, P375, DOI 10.3109/17453679408995475; LACHIN JM, 1977, BIOMETRICS, V33, P315, DOI 10.2307/2529781; MARCUS R, 1976, BIOMETRIKA, V63, P655, DOI 10.1093/biomet/63.3.655; Melchart D, 2004, ARCH INTERN MED, V164, P104, DOI 10.1001/archinte.164.1.104; Moerman DE, 2002, ANN INTERN MED, V136, P471, DOI 10.7326/0003-4819-136-6-200203190-00011; MOLSBERGER A, 1994, DER SCHMERZ, V8, P37; MOLSBERGER A, 2002, DTSCH ARZTEBLATT, V99, P1819; Puhl W, 2000, Z ORTHOP GRENZGEB, V138, P85, DOI 10.1055/s-2000-10120; Ramsay DJ, 1998, JAMA-J AM MED ASSOC, V280, P1518; SHAFFER JP, 1995, ANNU REV PSYCHOL, V46, P561, DOI 10.1146/annurev.ps.46.020195.003021; Streitberger K, 1998, LANCET, V352, P364, DOI 10.1016/S0140-6736(97)10471-8; Streitberger Konrad, 2004, BMC Complement Altern Med, V4, P6; Stucki G, 1996, Z RHEUMATOL, V55, P40; STUCKI G, 1995, CLIN EXP RHEUMATOL, V13, P349; STUX G, 2001, CLIN ACUPUNCTURE SCI, P171; Vas J, 2004, BMJ-BRIT MED J, V329, P1216, DOI 10.1136/bmj.38238.601447.3A; VONKORFF M, 1992, PAIN, V50, P133, DOI 10.1016/0304-3959(92)90154-4; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; Witt C, 2005, LANCET, V366, P136, DOI 10.1016/S0140-6736(05)66871-7	34	255	289	0	38	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 4	2006	145	1					12	20		10.7326/0003-4819-145-1-200607040-00005	http://dx.doi.org/10.7326/0003-4819-145-1-200607040-00005			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	062IS	16818924				2022-12-28	WOS:000238938400002
J	Wohrle, J				Woehrle, Jochen			Closure of patent foramen ovale after cryptogenic stroke	LANCET			English	Editorial Material							ATRIAL SEPTAL ANEURYSM; RECURRENT CEREBROVASCULAR EVENTS; PARADOXICAL EMBOLISM; TRANSCATHETER CLOSURE; PERCUTANEOUS CLOSURE; THROMBUS FORMATION; MEDICAL-TREATMENT; DEVICE CLOSURE; DEFECT; PREVENTION		Univ Ulm, Dept Internal Med 2, D-89081 Ulm, Germany	Ulm University	Wohrle, J (corresponding author), Univ Ulm, Dept Internal Med 2, D-89081 Ulm, Germany.	jochen.woehrle@uniklinik-ulm.de						Anzai H, 2004, AM J CARDIOL, V93, P426, DOI 10.1016/j.amjcard.2003.10.036; Beitzke A, 2002, Z KARDIOL, V91, P693, DOI 10.1007/s00392-002-0835-x; Bogousslavsky J, 1996, NEUROLOGY, V46, P1301, DOI 10.1212/WNL.46.5.1301; Braun M, 2004, EUR HEART J, V25, P424, DOI 10.1016/j.ehj.2003.10.021; Cujec B, 1999, CAN J CARDIOL, V15, P57; De Castro S, 2000, STROKE, V31, P2407, DOI 10.1161/01.STR.31.10.2407; El Said HG, 2005, PEDIATR CARDIOL, V26, P62, DOI 10.1007/s00246-004-0686-5; Herrmann HC, 2005, CATHETER CARDIO INTE, V64, P197, DOI 10.1002/ccd.20260; Homma S, 2002, CIRCULATION, V105, P2625, DOI 10.1161/01.CIR.0000017498.88393.44; Hung J, 2000, J AM COLL CARDIOL, V35, P1311, DOI 10.1016/S0735-1097(00)00514-3; Khositseth A, 2004, MAYO CLIN PROC, V79, P35, DOI 10.4065/79.1.35; Krumsdorf U, 2004, J AM COLL CARDIOL, V43, P302, DOI 10.1016/j.jacc.2003.10.030; Martin F, 2002, CIRCULATION, V106, P1121, DOI 10.1161/01.CIR.0000027819.19722.EE; Mas JL, 2001, NEW ENGL J MED, V345, P1740, DOI 10.1056/NEJMoa011503; MAS JL, 1995, AM HEART J, V130, P1083, DOI 10.1016/0002-8703(95)90212-0; Onorato Eustaquio, 2003, J Interv Cardiol, V16, P43; SCHLUCHLENZ HW, 2005, INT J CARDIOL, V101, P77; Wahl A, 2005, J AM COLL CARDIOL, V45, P377, DOI 10.1016/j.jacc.2004.10.043; Wahl A, 2001, NEUROLOGY, V57, P1330, DOI 10.1212/WNL.57.7.1330; Windecker S, 2004, J AM COLL CARDIOL, V44, P750, DOI 10.1016/j.jacc.2004.05.044	20	46	48	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL-AUG	2006	368	9533					350	352		10.1016/S0140-6736(06)69087-9	http://dx.doi.org/10.1016/S0140-6736(06)69087-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	069JJ	16876648	Bronze			2022-12-28	WOS:000239441900009
J	Henderson, KA; Kee, K; Maleki, S; Santini, PA; Keeney, S				Henderson, Kiersten A.; Kee, Kehkooi; Maleki, Shohreh; Santini, Paul A.; Keeney, Scott			Cyclin-dependent kinase directly regulates initiation of meiotic recombination	CELL			English	Article							SYNAPTONEMAL COMPLEX-FORMATION; PREMEIOTIC DNA-REPLICATION; B-TYPE CYCLINS; CHROMOSOME SYNAPSIS; S-PHASE; YEAST; MEIOSIS; GENE; EXPRESSION; PACHYTENE	Meiosis is a specialized cell division that halves the genome complement, producing haploid gametes/spores from diploid cells. Proper separation of homologous chromosomes at the first meiotic division requires the production of physical connections (chiasmata) between homologs through recombinational exchange of chromosome arms after sister-chromatid cohesion is established but before chromosome segregation takes place. The events of meiotic prophase must thus occur in a strictly temporal order, but the molecular controls coordinating these events have not been well elucidated. Here, we demonstrate that the budding yeast cyclin-dependent kinase Cdc28 directly regulates the formation of the DNA double-strand breaks that initiate recombination by phosphorylating the Mer2/Rec107 protein and thereby modulating interactions of Mer2 with other proteins required for break formation. We propose that this function of Cdc28 helps to coordinate the events of meiotic prophase with each other and with progression through prophase.	Mem Sloan Kettering Canc Ctr, Program Mol Biol, New York, NY 10021 USA; Cornell Univ, Weill Grad Sch Med Sci, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Cornell University	Henderson, KA (corresponding author), Mem Sloan Kettering Canc Ctr, Program Mol Biol, 1275 York Ave, New York, NY 10021 USA.	s-keeney@ski.mskcc.org	Keeney, Scott/GVR-8515-2022	Keeney, Scott/0000-0002-1283-6417; KEE, KEHKOOI/0000-0001-6926-7203	NIGMS NIH HHS [R01 GM058673-06A1, R01 GM058673-07, R01 GM58673, R01 GM058673-08, R01 GM058673-09, R01 GM058673] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058673] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Arora C, 2004, MOL CELL, V13, P549, DOI 10.1016/S1097-2765(04)00063-2; Baudat F, 2001, CURR BIOL, V11, pR45, DOI 10.1016/S0960-9822(01)00013-6; Bell SP, 2002, ANNU REV BIOCHEM, V71, P333, DOI 10.1146/annurev.biochem.71.110601.135425; Benjamin KR, 2003, GENE DEV, V17, P1524, DOI 10.1101/gad.1101503; Bishop AC, 2000, NATURE, V407, P395, DOI 10.1038/35030148; Borde V, 2000, SCIENCE, V290, P806, DOI 10.1126/science.290.5492.806; Cha RS, 2000, GENE DEV, V14, P493; Chu S, 1998, MOL CELL, V1, P685, DOI 10.1016/S1097-2765(00)80068-4; Diaz RL, 2002, MOL CELL BIOL, V22, P1106, DOI 10.1128/MCB.22.4.1106-1115.2002; ENGEBRECHT J, 1990, CELL, V62, P927, DOI 10.1016/0092-8674(90)90267-I; ENGEBRECHT J, 1991, CELL, V66, P1257, DOI 10.1016/0092-8674(91)90047-3; Gasior SL, 1998, GENE DEV, V12, P2208, DOI 10.1101/gad.12.14.2208; Gerton JL, 2005, NAT REV GENET, V6, P477, DOI 10.1038/nrg1614; GRANDIN N, 1993, MOL CELL BIOL, V13, P2113, DOI 10.1128/MCB.13.4.2113; Hepworth SR, 1998, MOL CELL BIOL, V18, P5750, DOI 10.1128/MCB.18.10.5750; Hochwagen A, 2006, CURR BIOL, V16, pR217, DOI 10.1016/j.cub.2006.03.009; Hochwagen A, 2005, CELL, V122, P861, DOI 10.1016/j.cell.2005.07.010; JONES G H, 1987, P213; KANE SM, 1974, J BACTERIOL, V118, P8, DOI 10.1128/JB.118.1.8-14.1974; Kassir Y, 2003, INT REV CYTOL, V224, P111, DOI 10.1016/S0074-7696(05)24004-4; Kee K, 2002, GENETICS, V160, P111; Kee K, 2004, EMBO J, V23, P1815, DOI 10.1038/sj.emboj.7600184; Keeney S, 2001, CURR TOP DEV BIOL, V52, P1, DOI 10.1016/S0070-2153(01)52008-6; Lamb TM, 2001, GENETICS, V157, P545; Larochelle S, 2006, NAT STRUCT MOL BIOL, V13, P55, DOI 10.1038/nsmb1028; MALONE RE, 1991, GENETICS, V128, P79; Murakami H, 2003, NUCLEIC ACIDS RES, V31, P4085, DOI 10.1093/nar/gkg441; Murakami H, 2001, NAT GENET, V28, P290, DOI 10.1038/90142; NANDABALAN K, 1995, MOL CELL BIOL, V15, P1953; Nigg Erich A., 1993, Trends in Cell Biology, V3, P296, DOI 10.1016/0962-8924(93)90011-O; Ogino K, 2006, J BIOL CHEM, V281, P1338, DOI 10.1074/jbc.M505767200; PADMORE R, 1991, CELL, V66, P1239, DOI 10.1016/0092-8674(91)90046-2; Page SL, 2003, SCIENCE, V301, P785, DOI 10.1126/science.1086605; Petronczki M, 2003, CELL, V112, P423, DOI 10.1016/S0092-8674(03)00083-7; Prieler S, 2005, GENE DEV, V19, P255, DOI 10.1101/gad.321105; ROCKMILL B, 1995, GENETICS, V141, P49; SHUSTER EO, 1989, GENETICS, V123, P29; SIKORSKI RS, 1989, GENETICS, V122, P19; SIMCHEN G, 1976, MOL GEN GENET, V144, P21, DOI 10.1007/BF00277299; Smith AV, 1997, J CELL BIOL, V136, P957, DOI 10.1083/jcb.136.5.957; Smith KN, 2001, CURR BIOL, V11, P88, DOI 10.1016/S0960-9822(01)00026-4; Stuart D, 1998, GENE DEV, V12, P2698, DOI 10.1101/gad.12.17.2698; SYM M, 1993, CELL, V72, P365, DOI 10.1016/0092-8674(93)90114-6; Tonami Y, 2005, P NATL ACAD SCI USA, V102, P5797, DOI 10.1073/pnas.0407236102; Ubersax JA, 2003, NATURE, V425, P859, DOI 10.1038/nature02062; XU LZ, 1995, MOL CELL BIOL, V15, P6572; Zickler D, 1999, ANNU REV GENET, V33, P603, DOI 10.1146/annurev.genet.33.1.603	47	103	106	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 30	2006	125	7					1321	1332		10.1016/j.cell.2006.04.039	http://dx.doi.org/10.1016/j.cell.2006.04.039			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	064QP	16814718	Green Accepted, Bronze			2022-12-28	WOS:000239104500015
J	Zhang, JZ; Harbottle, G; Wang, CS; Kong, ZC				Zhang, JZ; Harbottle, G; Wang, CS; Kong, ZC			Oldest playable musical instruments found at Jiahu early Neolithic site in China	NATURE			English	Article								Excavations at the early Neolithic site of Jiahu(1,2) in Henan Province, China have produced what may be the earliest complete, playable, tightly-dated multinote musical instruments. Jiahu was occupied from 7000 BC to 5700 BC, considerably antedating the well known Peiligang culture(3-5). Here we describe six exquisitely made complete flutes which were found in radiocarbon-dated excavation layers, along with fragments of perhaps 30 more. The flutes are made from the ulnae of the red-crowned crane (Grus japonensis Millen) and have 5, 6, 7 and 8 holes. The best preserved flute has been played and tonally analysed. In addition to early musical artefacts, the archaeological record at Jiahu(1,2) contains important information on the very foundations of Chinese society. We describe the archaeological characteristics of the Jiahu site, details concerning its dating, its place in the prehistory of the Chinese Neolithic, the ethnicity of its population and the results of a tonal analysis of a nearly 9,000-year-old musical instrument found there.	Univ Sci & Technol China, Archaeometry Lab, Hefei 230026, Anhui, Peoples R China; Inst Cultural Rel & Archaeol Henan Province, Zhengzhou 450000, Henan, Peoples R China; Brookhaven Natl Lab, Dept Chem, Upton, NY 11973 USA; Acad Sinica, Inst Bot, Paleobot Lab, Beijing 100080, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; United States Department of Energy (DOE); Brookhaven National Laboratory; Chinese Academy of Sciences; Institute of Botany, CAS	Harbottle, G (corresponding author), Univ Sci & Technol China, Archaeometry Lab, Hefei 230026, Anhui, Peoples R China.							AN Z, 1991, WORLD ARCHAEOL, V23, P193; BARNARD N, 1983, ORIGINS CHINESE CIVI; Blackwell Bonnie A. B., 1997, GEOARCHAEOLOGY, V12, P507, DOI DOI 10.1002/(SICI)1520-6548(199709)12:6<507::AID-GEA2>3.0.CO;2-2; BROWN HM, 1987, NEW GROVES DICT MUSI, P664; HOWELLS W, 1983, ORIGINS CHINESE CIVI; *I CULT REL, 1989, WENWU, V1, P1; LINDLEY M, 1987, NEW GROVES DICT MUSI, P277; Marcuse S, 1975, SURVEY MUSICAL INSTR; *NAT BUR CULT REL, 1991, COMP CULT AR CHIN; Needham N., 1962, SCI CIVILIZATION CHI, V4.1, P126; PIAN RC, 1987, NEW GROVES DICT MUSI, P245; Underhill AP, 1997, J WORLD PREHIST, V11, P103, DOI 10.1007/BF02221203; Zhang JZ, 1998, ANTIQUITY, V72, P897; 1997, SCIENCE, V276, P205	14	56	62	1	47	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 23	1999	401	6751					366	368		10.1038/43865	http://dx.doi.org/10.1038/43865			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	240JJ	16862110	Bronze			2022-12-28	WOS:000082822600048
J	Martick, M; Scott, WG				Martick, Monika; Scott, William G.			Tertiary contacts distant from the active site prime a ribozyme for catalysis	CELL			English	Article							DIVALENT METAL-IONS; HAMMERHEAD RIBOZYME; CRYSTAL-STRUCTURE; SELF-CLEAVAGE; MECHANISTIC CHARACTERIZATION; CONFORMATIONAL-CHANGE; SATELLITE RNA; PHOSPHOROTHIOATE; CRYSTALLOGRAPHY; MONOVALENT	Minimal hammerhead ribozymes have been characterized extensively by static and time-resolved crystallography as well as numerous biochemical analyses, leading to mutually contradictory mechanistic explanations for catalysis. We present the 2.2 A resolution crystal structure of a full-length Schistosoma mansoni hammerhead ribozyme that permits us to explain the structural basis for its 1000-fold catalytic enhancement. The full-length hammerhead structure reveals how tertiary interactions occurring remotely from the active site prime this ribozyme for catalysis. G-12 and G-8 are positioned consistent with their previously suggested roles in acid-base catalysis, the nucleophile is aligned with a scissile phosphate positioned proximal to the A-9 phosphate, and previously unexplained roles of other conserved nucleotides become apparent within the context of a distinctly new fold that nonetheless accommodates the previous structural studies. These interactions permit us to explain the previously irreconcilable sets of experimental results in a unified, consistent, and unambiguous manner.	Univ Calif Santa Cruz, Ctr Mol Biol RNA, Santa Cruz, CA 95064 USA; Univ Calif Santa Cruz, Dept Mol Cellular & Dev Biol, Santa Cruz, CA 95064 USA; Univ Calif Santa Cruz, Dept Chem & Biochem, Robert L Sinsheimer Labs, Santa Cruz, CA 95064 USA	University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz	Scott, WG (corresponding author), Univ Calif Santa Cruz, Ctr Mol Biol RNA, Santa Cruz, CA 95064 USA.	wgscott@chemistry.ucsc.edu		Scott, William/0000-0002-9273-3564	NIAID NIH HHS [R01 AI043393] Funding Source: Medline; NIGMS NIH HHS [R01 GM087721] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI043393] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Blount KE, 2005, ANNU REV BIOPH BIOM, V34, P415, DOI 10.1146/annurev.biophys.34.122004.184428; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Canny MD, 2004, J AM CHEM SOC, V126, P10848, DOI 10.1021/ja046848v; ClouetdOrval B, 1997, BIOCHEMISTRY-US, V36, P9087, DOI 10.1021/bi9710941; Curtis EA, 2001, RNA, V7, P546, DOI 10.1017/S1355838201002357; DAHM SC, 1993, BIOCHEMISTRY-US, V32, P13040, DOI 10.1021/bi00211a013; DAHM SC, 1991, BIOCHEMISTRY-US, V30, P9464, DOI 10.1021/bi00103a011; De la Pena M, 2003, EMBO J, V22, P5561, DOI 10.1093/emboj/cdg530; Dunham CM, 2003, J MOL BIOL, V332, P327, DOI 10.1016/S0022-2836(03)00843-X; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ferbeyre G, 1998, MOL CELL BIOL, V18, P3880, DOI 10.1128/MCB.18.7.3880; Ferre-D'Amare AR, 1998, NATURE, V395, P567, DOI 10.1038/26912; FORSTER AC, 1987, CELL, V50, P9, DOI 10.1016/0092-8674(87)90657-X; Han J, 2005, BIOCHEMISTRY-US, V44, P7864, DOI 10.1021/bi047941z; HASELOFF J, 1989, GENE, V82, P43, DOI 10.1016/0378-1119(89)90028-0; Heckman JE, 2005, BIOCHEMISTRY-US, V44, P4148, DOI 10.1021/bi047858b; Horton TE, 1998, BIOCHEMISTRY-US, V37, P18094, DOI 10.1021/bi981425p; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Ke AL, 2004, NATURE, V429, P201, DOI 10.1038/nature02522; Khvorova A, 2003, NAT STRUCT BIOL, V10, P708, DOI 10.1038/nsb959; Kim NK, 2005, J AM CHEM SOC, V127, P14134, DOI 10.1021/ja0541027; KOIZUMI M, 1991, BIOCHEMISTRY-US, V30, P5145, DOI 10.1021/bi00235a005; Lott WB, 1998, P NATL ACAD SCI USA, V95, P542, DOI 10.1073/pnas.95.2.542; Mathews DH, 2004, P NATL ACAD SCI USA, V101, P7287, DOI 10.1073/pnas.0401799101; Mathews DH, 1999, J MOL BIOL, V288, P911, DOI 10.1006/jmbi.1999.2700; McKay DB, 1996, RNA, V2, P395; Murray JB, 2000, MOL CELL, V5, P279, DOI 10.1016/S1097-2765(00)80423-2; Murray JB, 1998, CHEM BIOL, V5, P587, DOI 10.1016/S1074-5521(98)90116-8; Murray JB, 2002, J MOL BIOL, V315, P121, DOI 10.1006/jmbi.2001.5145; Murray JB, 1998, CELL, V92, P665, DOI 10.1016/S0092-8674(00)81134-4; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakano S, 2003, BIOCHEMISTRY-US, V42, P2982, DOI 10.1021/bi026815x; Nakano S, 2001, BIOCHEMISTRY-US, V40, P12022, DOI 10.1021/bi011253n; O'Rear JL, 2001, RNA, V7, P537, DOI 10.1017/S1355838201002461; Osborne EM, 2005, RNA, V11, P187, DOI 10.1261/rna.7950605; Penedo JC, 2004, RNA, V10, P880, DOI 10.1261/rna.5268404; PLEY HW, 1994, NATURE, V372, P68, DOI 10.1038/372068a0; PRODY GA, 1986, SCIENCE, V231, P1577, DOI 10.1126/science.231.4745.1577; PYLE AM, 1993, SCIENCE, V261, P709, DOI 10.1126/science.7688142; RUFFNER DE, 1990, BIOCHEMISTRY-US, V29, P10695, DOI 10.1021/bi00499a018; Rupert PB, 2002, SCIENCE, V298, P1421, DOI 10.1126/science.1076093; Rupert PB, 2001, NATURE, V410, P780, DOI 10.1038/35071009; Scott WG, 1999, CURR OPIN CHEM BIOL, V3, P705, DOI 10.1016/S1367-5931(99)00029-0; Scott WG, 1996, SCIENCE, V274, P2065, DOI 10.1126/science.274.5295.2065; Scott WG, 1999, Q REV BIOPHYS, V32, P241, DOI 10.1017/S003358350000353X; SCOTT WG, 1995, CELL, V81, P991, DOI 10.1016/S0092-8674(05)80004-2; Simorre JP, 1997, BIOCHEMISTRY-US, V36, P518, DOI 10.1021/bi9620520; SLIM G, 1991, NUCLEIC ACIDS RES, V19, P1183, DOI 10.1093/nar/19.6.1183; SOMOZA JR, 1995, ACTA CRYSTALLOGR A, V51, P691, DOI 10.1107/S0108767395002315; Suzumura K, 2000, FEBS LETT, V473, P106, DOI 10.1016/S0014-5793(00)01499-X; Symons RH, 1997, NUCLEIC ACIDS RES, V25, P2683, DOI 10.1093/nar/25.14.2683; UHLENBECK OC, 1987, NATURE, V328, P596, DOI 10.1038/328596a0; VANTOL H, 1990, NUCLEIC ACIDS RES, V18, P1971, DOI 10.1093/nar/18.8.1971; Wang SL, 1999, BIOCHEMISTRY-US, V38, P14363, DOI 10.1021/bi9913202; Wedekind JE, 1998, ANNU REV BIOPH BIOM, V27, P475, DOI 10.1146/annurev.biophys.27.1.475; Winn MD, 2003, J SYNCHROTRON RADIAT, V10, P23, DOI 10.1107/S0909049502017235; Yang HW, 2003, NUCLEIC ACIDS RES, V31, P3450, DOI 10.1093/nar/gkg529; YARUS M, 1993, FASEB J, V7, P31, DOI 10.1096/fasebj.7.1.8422972	59	361	375	0	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 28	2006	126	2					309	320		10.1016/j.cell.2006.06.036	http://dx.doi.org/10.1016/j.cell.2006.06.036			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	070VD	16859740	Green Accepted, Green Submitted, Bronze			2022-12-28	WOS:000239552600017
J	Wu, YQ; Borde, M; Heissmeyer, V; Feuerer, M; Lapan, AD; Stroud, JC; Bates, DL; Guo, L; Han, AD; Ziegler, SF; Mathis, D; Benoist, C; Chen, L; Rao, A				Wu, Yongqing; Borde, Madhuri; Heissmeyer, Vigo; Feuerer, Markus; Lapan, Ariya D.; Stroud, James C.; Bates, Darren L.; Guo, Liang; Han, Aidong; Ziegler, Steven F.; Mathis, Diane; Benoist, Christophe; Chen, Lin; Rao, Anjana			FOXP3 controls regulatory T cell function through cooperation with NFAT	CELL			English	Article							TRANSCRIPTION FACTOR FOXP3; NUCLEAR FACTOR; KAPPA-B; FORKHEAD-DOMAIN; GENE-EXPRESSION; DNA; SCURFIN; ANTIGEN; CALCINEURIN; MECHANISMS	Antigen stimulation of immune cells activates the transcription factor NFAT, a key regulator of T cell activation and anergy. NFAT forms cooperative complexes with the AP-1 family of transcription factors and regulates T cell activation-associated genes. Here we show that regulatory T cell (Treg) function is mediated by an analogous cooperative complex of NFAT with the forkhead transcription factor FOXP3, a lineage specification factor for Tregs. The crystal structure of an NFAT:FOXP2:DNA complex reveals an extensive protein-protein interaction interface between NFAT and FOXP2. Structure-guided mutations of FOXP3, predicted to progressively disrupt its interaction with NFAT, interfere in a graded manner with the ability of FOXP3 to repress expression of the cytokine IL2, upregulate expression of the Treg markers CTLA4 and CD25, and confer suppressor function in a murine model of autoimmune diabetes. Thus by switching transcriptional partners, NFAT converts the acute T cell activation program into the suppressor program of Tregs.	Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Sch Med, CBR Inst Biomed Res, Boston, MA 02115 USA; Harvard Univ, Sch Med, Joslin Diabet Ctr, Brigham & Womens Hosp,Sect Immunol & Immunogenet, Boston, MA 02115 USA; Univ Colorado, Dept Chem & Biochem, Boulder, CO 80309 USA; Univ Washington, Dept Immunol, Seattle, WA 98195 USA; Univ Washington, Benaroya Res Inst Virginia Mason, Seattle, WA 98195 USA	Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Joslin Diabetes Center, Inc.; University of Colorado System; University of Colorado Boulder; University of Washington; University of Washington Seattle; Benaroya Research Institute; University of Washington; University of Washington Seattle; Virginia Mason Medical Center	Chen, L (corresponding author), Univ So Calif, 1050 Childs Way, Los Angeles, CA 90089 USA.	linchen@usc.edu; arao@cbr.med.harvard.edu	Stroud, James C/B-3230-2012; chen, Lin/A-3392-2008	Stroud, James C/0000-0003-0850-4812; chen, Lin/0000-0003-4798-6199; Heissmeyer, Vigo/0000-0002-2263-8545	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077320, T32GM008759] Funding Source: NIH RePORTER; NIGMS NIH HHS [T32 GM142607, T32 GM008759, R01 GM077320] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Andre I, 1996, P NATL ACAD SCI USA, V93, P2260, DOI 10.1073/pnas.93.6.2260; Ansel KM, 2004, NAT IMMUNOL, V5, P1251, DOI 10.1038/ni1135; Ansel KM, 2003, NAT IMMUNOL, V4, P616, DOI 10.1038/ni0703-616; Apostolou I, 2004, J EXP MED, V199, P1401, DOI 10.1084/jem.20040249; Avni O, 2002, NAT IMMUNOL, V3, P643, DOI 10.1038/ni808; Bennett CL, 2001, NAT GENET, V27, P20, DOI 10.1038/83713; Bettelli E, 2005, P NATL ACAD SCI USA, V102, P5138, DOI 10.1073/pnas.0501675102; Bluestone JA, 2003, NAT REV IMMUNOL, V3, P253, DOI 10.1038/nri1032; Bopp T, 2005, J EXP MED, V201, P181, DOI 10.1084/jem.20041538; Brunkow ME, 2001, NAT GENET, V27, P68, DOI 10.1038/83784; Carlsson P, 2002, DEV BIOL, V250, P1, DOI 10.1006/dbio.2002.0780; Chen L, 1998, NATURE, V392, P42, DOI 10.1038/32100; Coffer PJ, 2004, NAT REV IMMUNOL, V4, P889, DOI 10.1038/nri1488; Crabtree GR, 2002, CELL, V109, pS67, DOI 10.1016/S0092-8674(02)00699-2; Finn PW, 1997, J IMMUNOL, V158, P4074; Fontenot JD, 2005, NAT IMMUNOL, V6, P331, DOI 10.1038/ni1179; Fontenot JD, 2003, NAT IMMUNOL, V4, P330, DOI 10.1038/ni904; Giffin MJ, 2003, NAT STRUCT BIOL, V10, P800, DOI 10.1038/nsb981; Heissmeyer V, 2004, NAT IMMUNOL, V5, P255, DOI 10.1038/ni1047; HEISSMEYER V, 2004, SCI STKE, pPE29; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Jaeckel E, 2005, DIABETES, V54, P306, DOI 10.2337/diabetes.54.2.306; JAIN JN, 1993, NATURE, V365, P352, DOI 10.1038/365352a0; Jin L, 2003, NAT STRUCT BIOL, V10, P807, DOI 10.1038/nsb975; KATZ JD, 1995, SCIENCE, V268, P1185, DOI 10.1126/science.7761837; Khattri R, 2003, NAT IMMUNOL, V4, P337, DOI 10.1038/ni909; Khattri R, 2001, J IMMUNOL, V167, P6312, DOI 10.4049/jimmunol.167.11.6312; Knoechel B, 2005, J EXP MED, V202, P1375, DOI 10.1084/jem.20050855; Kretschmer K, 2005, NAT IMMUNOL, V6, P1219, DOI 10.1038/ni1265; Lai CSL, 2001, NATURE, V413, P519, DOI 10.1038/35097076; Lee DU, 2004, J BIOL CHEM, V279, P4802, DOI 10.1074/jbc.M307904200; Levine M, 2003, NATURE, V424, P147, DOI 10.1038/nature01763; LI C, 1993, P NATL ACAD SCI USA, V90, P11583, DOI 10.1073/pnas.90.24.11583; Luo C, 1996, J EXP MED, V184, P141, DOI 10.1084/jem.184.1.141; Macian F, 2000, EMBO J, V19, P4783, DOI 10.1093/emboj/19.17.4783; Macian F, 2002, CELL, V109, P719, DOI 10.1016/S0092-8674(02)00767-5; Masteller EL, 2005, J IMMUNOL, V175, P3053, DOI 10.4049/jimmunol.175.5.3053; MCCAFFREY PG, 1994, J BIOL CHEM, V269, P30445; MINER JN, 1991, TRENDS BIOCHEM SCI, V16, P423, DOI 10.1016/0968-0004(91)90168-U; Okamura H, 2000, MOL CELL, V6, P539, DOI 10.1016/S1097-2765(00)00053-8; Ranger AM, 1998, IMMUNITY, V9, P627, DOI 10.1016/S1074-7613(00)80660-3; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; Schubert LA, 2001, J BIOL CHEM, V276, P37672, DOI 10.1074/jbc.M104521200; Stroud JC, 2006, STRUCTURE, V14, P159, DOI 10.1016/j.str.2005.10.005; Stroud JC, 2003, J MOL BIOL, V334, P1009, DOI 10.1016/j.jmb.2003.09.065; Su L, 2004, J IMMUNOL, V173, P4994, DOI 10.4049/jimmunol.173.8.4994; Wang B, 2003, J BIOL CHEM, V278, P24259, DOI 10.1074/jbc.M207174200; Wildin RS, 2001, NAT GENET, V27, P18, DOI 10.1038/83707; Williams LD, 2000, ANNU REV BIOPH BIOM, V29, P497, DOI 10.1146/annurev.biophys.29.1.497; Ziegler SF, 2006, ANNU REV IMMUNOL, V24, P209, DOI 10.1146/annurev.immunol.24.021605.090547	51	865	927	4	50	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 28	2006	126	2					375	387		10.1016/j.cell.2006.05.042	http://dx.doi.org/10.1016/j.cell.2006.05.042			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	070VD	16873067	Bronze			2022-12-28	WOS:000239552600022
J	Rothwell, PM				Rothwell, Peter M.			Funding for practice-oriented clinical research	LANCET			English	Editorial Material							FOCAL CEREBRAL-ISCHEMIA; STROKE; TRIALS; HEALTH		Univ Oxford, Radcliffe Infirm, Stroke Prevent Res Unit, Oxford OX2 6HE, England	Radcliffe Infirmary; University of Oxford	Rothwell, PM (corresponding author), Univ Oxford, Radcliffe Infirm, Stroke Prevent Res Unit, Oxford OX2 6HE, England.	peter.rothwell@clneuro.ox.ac.uk	Rothwell, Peter/ABE-5913-2020	Rothwell, Peter/0000-0001-9739-9211				*AC MED SCI, 2003, STRENGTH CLIN RES; Bath PMW, 2005, BRIT MED J, V330, P342, DOI 10.1136/bmj.38331.655347.8F; Chalmers I, 2003, BRIT MED J, V327, P1017, DOI 10.1136/bmj.327.7422.1017; Cochrane A. L, 1972, PUBLIC HEALTH, DOI DOI 10.1016/S0033-3506(73)80082-4; Gardner J. W., 1995, EXCELLENCE CAN WE BE; Horn J, 2001, STROKE, V32, P2433, DOI 10.1161/hs1001.096009; Horton R, 2006, LANCET, V368, P93, DOI 10.1016/S0140-6736(06)68974-5; Johnston SC, 2006, LANCET, V367, P1319, DOI 10.1016/S0140-6736(06)68578-4; MACLEOD M, 2006, CEREBROVASC DIS, V21, P42; Macleod MR, 2004, STROKE, V35, P1203, DOI 10.1161/01.STR.0000125719.25853.20; National Collaborating Centre for Chronic Conditions, 2006, PARK DIS NAT CLIN GU; POLLACK A, 2002, NY TIMES        0419, pC1; Rees J, 2004, PERSPECT BIOL MED, V47, P597, DOI 10.1353/pbm.2004.0068; Rees J, 2002, SCIENCE, V296, P698, DOI 10.1126/science.296.5568.698; Rothwell PM, 2006, BRIT MED J, V332, P863, DOI 10.1136/bmj.332.7546.863; *UK CLIN RES COLL, 2006, UK HLTH RES AN 1 NAT; van der Worp HB, 2005, J NEUROL, V252, P1108, DOI 10.1007/s00415-005-0802-3; Worrall BB, 2006, STROKE, V37, P1955, DOI 10.1161/01.STR.0000234048.04053.39; 1999, NAT GENET, V22, P1	20	32	32	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 22	2006	368	9532					262	266		10.1016/S0140-6736(06)69010-7	http://dx.doi.org/10.1016/S0140-6736(06)69010-7			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	067PF	16860680				2022-12-28	WOS:000239314400005
J	Douglas, K; O'Malley, PG; Jackson, JL				Douglas, Kevin; O'Malley, Patrick G.; Jackson, Jeffrey L.			Meta-analysis: The effect of statins on albuminuria	ANNALS OF INTERNAL MEDICINE			English	Review							ISOLATED SYSTOLIC HYPERTENSION; IMPROVES ENDOTHELIAL FUNCTION; CHOLESTEROL-LOWERING THERAPY; COA REDUCTASE INHIBITORS; TYPE-2 DIABETIC-PATIENTS; SIMVASTATIN TREATMENT; RENAL-FUNCTION; HYPERCHOLESTEROLEMIC PATIENTS; CARDIOVASCULAR EVENTS; BLOOD-PRESSURE	Background: Albuminuria is an independent risk factor for cardiovascular and renal disease with limited therapeutic options. Data on the effects of statins on albuminuria are conflicting. Purpose: To determine whether and to what degree statins affect albuminuria. Data Sources: English-language and non-English-language studies found in PubMed, MEDLINE, EMBASE, BIOSIS, SciSearch, PASCAL, and International Pharmaceutical Abstracts (IPA) databases and the Cochrane Central Register of Controlled Trials that were published between January 1974 and November 2005. Study Selection: Randomized, placebo-controlled trials of statins reporting baseline and follow-up measurements of albuminuria or proteinuria measured by 24-hour urine collection or the urinary albumin-to-creatinine ratio. Data Extraction: Two investigators independently abstracted study quality, characteristics, and outcomes. Data Synthesis: Fifteen studies involving a total of 1384 patients and averaging 24 weeks in duration were included. Meta-analysis of the proportional reduction in proteinuria showed that statins reduced albuminuria (11 studies) and proteinuria (4 studies) in 13 of 15 studies. The reduction in excretion was greater among studies with greater baseline albuminuria or proteinuria: change of 2% (95% Cl, -32% to 35%) for those with excretion less than 30 mg/d, -48% (Cl, -71 % to -25%) for those with excretion of 30 to 300 mg/d, and -47% (Cl, -67% to -26%) for those with excretion more than 300 mg/d. Statistical heterogeneity was evident only in the group with excretion greater than 300 mg/d (excretion < 30 mg/d, I-2 = 23% [P = 0.27]; excretion of 30 to 299 mg/d, I-2 = 0% [P = 0.64]; excretion >= 300 mg/d, I-2 = 63% [P = 0.020]). Limitations: Published studies were not of high quality on average and varied markedly in effect size, as well as in characteristics of the cohorts. Unpublished studies showing no effect could impact these results. Conclusion: Statins may have a beneficial effect on pathologic albuminuria. The validity of this finding, and whether this effect translates into reduction of cardiovascular or end-stage renal disease, requires larger studies.	Walter Reed Army Med Ctr, Washington, DC 20307 USA; Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA	United States Department of Defense; United States Army; Walter Reed National Military Medical Center; Uniformed Services University of the Health Sciences - USA	Douglas, K (corresponding author), Walter Reed Army Med Ctr, 6900 Georgia Ave NW, Washington, DC 20307 USA.		Jackson, Jeffrey/AAA-3519-2019	Jackson, Jeffrey/0000-0002-9820-5834				Asselbergs FW, 2004, CIRCULATION, V110, P2809, DOI 10.1161/01.CIR.0000146378.65439.7A; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Buemi M, 2000, CLIN PHARMACOL THER, V67, P427, DOI 10.1067/mcp.2000.105330; COOK DJ, 1993, JAMA-J AM MED ASSOC, V269, P2749, DOI 10.1001/jama.269.21.2749; Dalla Nora E, 2003, J ENDOCRINOL INVEST, V26, P73, DOI 10.1007/BF03345126; Davignon J, 2004, CIRCULATION, V109, P39, DOI 10.1161/01.CIR.0000131517.20177.5a; De Leeuw PW, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000027871.86296.92; Dupuis J, 1999, CIRCULATION, V99, P3227, DOI 10.1161/01.CIR.99.25.3227; EGASHIRA K, 1994, CIRCULATION, V89, P2519, DOI 10.1161/01.CIR.89.6.2519; Ferrier KE, 2002, J AM COLL CARDIOL, V39, P1020, DOI 10.1016/S0735-1097(02)01717-5; Fried LF, 2001, KIDNEY INT, V59, P260, DOI 10.1046/j.1523-1755.2001.00487.x; Fried LF, 2001, J DIABETES COMPLICAT, V15, P113, DOI 10.1016/S1056-8727(01)00140-4; Gaw A, 1996, ATHEROSCLEROSIS, V125, P267; Gerstein HC, 2001, JAMA-J AM MED ASSOC, V286, P421, DOI 10.1001/jama.286.4.421; Glorioso N, 1999, HYPERTENSION, V34, P1281, DOI 10.1161/01.HYP.34.6.1281; Hernandez-Perera O, 1998, J CLIN INVEST, V101, P2711, DOI 10.1172/JCI1500; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hillege HL, 2002, CIRCULATION, V106, P1777, DOI 10.1161/01.CIR.0000031732.78052.81; HOMMEL E, 1992, DIABETOLOGIA, V35, P447, DOI 10.1007/BF02342442; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; John S, 1998, CIRCULATION, V98, P211, DOI 10.1161/01.CIR.98.3.211; LAM KSL, 1995, DIABETOLOGIA, V38, P604, DOI 10.1007/s001250050326; Lee TM, 2005, KIDNEY INT, V68, P779, DOI 10.1111/j.1523-1755.2005.00457.x; Lee TM, 2002, HYPERTENSION, V40, P67, DOI 10.1161/01.HYP.0000022805.11288.7F; LINTOTT CJ, 1995, AM J CARDIOL, V76, pA97, DOI 10.1016/S0002-9149(05)80027-X; Maron DJ, 2000, CIRCULATION, V101, P207, DOI 10.1161/01.CIR.101.2.207; Moher D, 1999, LANCET, V354, P1896, DOI 10.1016/S0140-6736(99)04149-5; Nakamura T, 2001, AM J NEPHROL, V21, P449, DOI 10.1159/000046648; Nakamura T, 2002, NEPHROL DIAL TRANSPL, V17, P798, DOI 10.1093/ndt/17.5.798; NIELSEN S, 1993, DIABETOLOGIA, V36, P1079, DOI 10.1007/BF02374502; PEDERSEN TR, 1994, LANCET, V344, P1383; SACKS FM, 1995, AM J CARDIOL, V76, pC78, DOI 10.1016/S0002-9149(99)80475-5; THOMAS ME, 1993, KIDNEY INT, V44, P1124, DOI 10.1038/ki.1993.358; Thompson SG, 1999, STAT MED, V18, P2693, DOI 10.1002/(SICI)1097-0258(19991030)18:20<2693::AID-SIM235>3.0.CO;2-V; Tonolo G, 1997, DIABETES CARE, V20, P1891, DOI 10.2337/diacare.20.12.1891; TREASURE CB, 1995, NEW ENGL J MED, V332, P481, DOI 10.1056/NEJM199502233320801; Tsunekawa T, 2001, CIRCULATION, V104, P376, DOI 10.1161/hc2901.094094; Vaughan CJ, 2000, J AM COLL CARDIOL, V35, P1, DOI 10.1016/S0735-1097(99)00525-2; Wachtell K, 2003, ANN INTERN MED, V139, P901, DOI 10.7326/0003-4819-139-11-200312020-00008; ZHANG A, 1995, DIABETES RES CLIN PR, V29, P189, DOI 10.1016/0168-8227(95)01138-2	40	171	186	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 18	2006	145	2					117	124		10.7326/0003-4819-145-2-200607180-00009	http://dx.doi.org/10.7326/0003-4819-145-2-200607180-00009			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	063WU	16847294				2022-12-28	WOS:000239051400005
J	Baird, G; Simonoff, E; Pickles, A; Chandler, S; Loucas, T; Meldrum, D; Charman, T				Baird, Gillian; Simonoff, Emily; Pickles, Andrew; Chandler, Susie; Loucas, Tom; Meldrum, David; Charman, Tony			Prevalence of disorders of the autism spectrum in a population cohort of children in South Thames: the Special Needs and Autism Project (SNAP)	LANCET			English	Article							PERVASIVE DEVELOPMENTAL DISORDERS; PRESCHOOL-CHILDREN; EPIDEMIOLOGY	Background Recent reports have suggested that the prevalence of autism and related spectrum disorders (ASDs) is substantially higher than previously recognised. We sought to quantify prevalence of ASDs in children in South Thames, UK. Methods Within a total population cohort of 56946 children aged 9-10 years, we screened all those with a current clinical diagnosis of ASD (n=255) or those judged to be at risk for being an undetected case (n=1515). A stratified subsample (n=255) received a comprehensive diagnostic assessment, including standardised clinical observation, and parent interview assessments of autistic symptoms, language, and intelligence quotient (IQ). Clinical consensus diagnoses of childhood autism and other ASDs were derived. We used a sample weighting procedure to estimate prevalence. Findings The prevalence of childhood autism was 38.9 per 10000 (95% CI 29.9-47.8) and that of other ASDs was 77.2 per 10000 (52.1-102.3), making the total prevalence of all AS Ds 116.1 per 10000 (90.4-141.8). A narrower definition of childhood autism, which combined clinical consensus with instrument criteria for past and current presentation, provided a prevalence of 24.8 per 10 000 (17.6-32.0). The rate of previous local identification was lowest for children of less educated parents. Interpretation Prevalence of autism and related ASDs is substantially greater than previously recognised. Whether the increase is due to better ascertainment, broadening diagnostic criteria, or increased incidence is unclear. Services in health, education, and social care will need to recognise the needs of children with some form of ASD, who constitute 1% of the child population.	Guys & St Thomas NHS Fdn, Newcomen Ctr, London, England; Kings Coll London, Inst Psychiat, Dept Child & Adolescent Psychiat, London WC2R 2LS, England; Univ Manchester, Div Epidemiol & Hlth Sci, Biostat Grp, Manchester, Lancs, England; Univ Reading, Sch Psychol & Clin Language Sci, Reading, Berks, England; Chatswood Assessment Ctr, Sydney, NSW, Australia; UCL, Inst Child Hlth, Behav & Brain Sci Unit, London, England	University of London; King's College London; University of Manchester; University of Reading; University of London; University College London	Baird, G (corresponding author), Guys Hosp, Newcomen Ctr, London SE1 9RT, England.	gillian.baird@gstt.nhs.uk	Simonoff, Emily A/B-7593-2011; Charman, Tony/A-2085-2014; Pickles, Andrew/A-9625-2011	Charman, Tony/0000-0003-1993-6549; Pickles, Andrew/0000-0003-1283-0346; Simonoff, Emily/0000-0002-5450-0823; Chandler, Susie/0000-0002-5543-8638	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Baird G, 2000, J AM ACAD CHILD PSY, V39, P694, DOI 10.1097/00004583-200006000-00007; Bertrand J, 2001, PEDIATRICS, V108, P1155, DOI 10.1542/peds.108.5.1155; Berument SK, 1999, BRIT J PSYCHIAT, V175, P444, DOI 10.1192/bjp.175.5.444; Chakrabarti S, 2001, JAMA-J AM MED ASSOC, V285, P3093, DOI 10.1001/jama.285.24.3093; Chakrabarti S, 2005, AM J PSYCHIAT, V162, P1133, DOI 10.1176/appi.ajp.162.6.1133; *DEP ED SKILLS, 2005, SPEC ED NEEDS ENGL; Dunn L. M., 1997, BRIT PICTURE VOCABUL; *ESRC JISC CENS PR, OR DAT DEP CENS 2001; Fombonne E, 2005, J APPL RES INTELLECT, V18, P281, DOI 10.1111/j.1468-3148.2005.00266.x; Goodman R., 2005, MENTAL HLTH CHILDREN; Honda H, 2005, J CHILD PSYCHOL PSYC, V46, P572, DOI 10.1111/j.1469-7610.2005.01425.x; Howlin P, 2004, J CHILD PSYCHOL PSYC, V45, P212, DOI 10.1111/j.1469-7610.2004.00215.x; Jarbrink K, 2001, AUTISM, V5, P7, DOI 10.1177/1362361301005001002; Lord C, 2000, J AUTISM DEV DISORD, V30, P205, DOI 10.1023/A:1005592401947; LORD C, 1994, J AUTISM DEV DISORD, V24, P659, DOI 10.1007/BF02172145; Macintyre S, 1998, J EPIDEMIOL COMMUN H, V52, P657, DOI 10.1136/jech.52.10.657; MORRIS R, 1991, J PUBLIC HEALTH MED, V13, P318; Raven J. C., 1990, COLOURED PROGR MATRI; Raven J. C., 1990, STANDARD PROGR MATRI; Rutter M, 2005, J INTELL DISABIL RES, V49, P231, DOI 10.1111/j.1365-2788.2005.00676.x; Rutter M., 2003, SOCIAL COMMUNICATION; Sparrow S.S., 2005, VINELAND 2 ADAPTIVE; *STAT CORP, 2005, STAT STAT SOFTW REL; Wechsler D., 1992, WECHSLER INTELLIGENC; Williams JG, 2006, ARCH DIS CHILD, V91, P8, DOI 10.1136/adc.2004.062083; WING L, 1979, J AUTISM DEV DISORD, V9, P11, DOI 10.1007/BF01531288; World Health Organisation, 1993, MENT DIS GLOSS GUID; Yeargin-Allsopp M, 2003, JAMA-J AM MED ASSOC, V289, P49, DOI 10.1001/jama.289.1.49	29	1301	1333	3	301	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL 15	2006	368	9531					210	215		10.1016/S0140-6736(06)69041-7	http://dx.doi.org/10.1016/S0140-6736(06)69041-7			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	064MY	16844490				2022-12-28	WOS:000239095000032
J	Pincock, S				Pincock, Stephen			Brian Oliver Lyndhurst Duke - Obituary	LANCET			English	Biographical-Item												stephenpincock@gmail.com		Pincock, Stephen/0000-0003-1655-2902					0	0	0	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 15	2006	368	9531					196	196		10.1016/S0140-6736(06)69026-0	http://dx.doi.org/10.1016/S0140-6736(06)69026-0			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	064MY	16874900	Bronze			2022-12-28	WOS:000239095000016
J	Rohrer, F; Berresheim, H				Rohrer, Franz; Berresheim, Harald			Strong correlation between levels of tropospheric hydroxyl radicals and solar ultraviolet radiation	NATURE			English	Article							LASER-INDUCED FLUORESCENCE; ATMOSPHERIC CHEMISTRY; BOUNDARY-LAYER; OH; HO2; OZONE	The most important chemical cleaning agent of the atmosphere is the hydroxyl radical(1,2), OH. It determines the oxidizing power of the atmosphere, and thereby controls the removal of nearly all gaseous atmospheric pollutants(3,4). The atmospheric supply of OH is limited, however, and could be overcome by consumption due to increasing pollution and climate change(4-6), with detrimental feedback effects. To date, the high variability of OH concentrations has prevented the use of local observations to monitor possible trends in the concentration of this species. Here we present and analyse long-term measurements of atmospheric OH concentrations, which were taken between 1999 and 2003 at the Meteorological Observatory Hohenpeissenberg in southern Germany. We find that the concentration of OH can be described by a surprisingly linear dependence on solar ultraviolet radiation throughout the measurement period, despite the fact that OH concentrations are influenced by thousands of reactants. A detailed numerical model of atmospheric reactions and measured trace gas concentrations indicates that the observed correlation results from compensations between individual processes affecting OH, but that a full understanding of these interactions may not be possible on the basis of our current knowledge of atmospheric chemistry. As a consequence of the stable relationship between OH concentrations and ultraviolet radiation that we observe, we infer that there is no long-term trend in the level of OH in the Hohenpeissenberg data set.	Forschungszentrum Julich, Inst ICG Troposphare 2, D-52425 Julich, Germany; German Natl Meteorol Serv, DWD, MOHp, D-82383 Hohenpeissenberg, Germany	Helmholtz Association; Research Center Julich	Rohrer, F (corresponding author), Forschungszentrum Julich, Inst ICG Troposphare 2, Postfach 1913, D-52425 Julich, Germany.	f.rohrer@fz-juelich.de; harald.berresheim@dwd.de	Rohrer, Franz/I-2052-2012; Berresheim, Harald/F-9670-2011	Rohrer, Franz/0000-0003-3436-3419; Berresheim, Harald/0000-0003-3095-0800				Berresheim H, 2000, INT J MASS SPECTROM, V202, P91, DOI 10.1016/S1387-3806(00)00233-5; Berresheim H, 2003, ATMOS CHEM PHYS, V3, P639, DOI 10.5194/acp-3-639-2003; Bohn B, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2003JD004319; Brauers T, 2001, J GEOPHYS RES-ATMOS, V106, P7399, DOI 10.1029/2000JD900679; BRUNE WH, 1995, J ATMOS SCI, V52, P3328, DOI 10.1175/1520-0469(1995)052<3328:MOAHIT>2.0.CO;2; CROSLEY DR, 1995, J ATMOS SCI, V52, P3299, DOI 10.1175/1520-0469(1995)052<3299:TMOOAH>2.0.CO;2; DORN H-P, 1988, Tellus Series B Chemical and Physical Meteorology, V40, P437; *DTSCH WETT, GLOB ATM WATCH; Ehhalt DH, 2000, J GEOPHYS RES-ATMOS, V105, P3565, DOI 10.1029/1999JD901070; Ehhalt DH, 1998, SCIENCE, V279, P1002, DOI 10.1126/science.279.5353.1002; EHHALT DH, 1990, P ROY SOC EDINB B, V97, P17, DOI 10.1017/S0269727000005273; EISELE FL, 1991, J GEOPHYS RES-ATMOS, V96, P9295, DOI 10.1029/91JD00198; Faloona I, 2001, J GEOPHYS RES-ATMOS, V106, P24315, DOI 10.1029/2000JD900691; Geiger H, 2003, ATMOS ENVIRON, V37, P1503, DOI 10.1016/S1352-2310(02)01047-6; Hanisco TF, 2001, J PHYS CHEM A, V105, P1543, DOI 10.1021/jp002334g; Heard DE, 2003, CHEM REV, V103, P5163, DOI 10.1021/cr020522s; Holland F, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2001JD001393; Holland F, 1998, J ATMOS CHEM, V31, P205, DOI 10.1023/A:1005868520002; Jacob DJ, 2002, HANDBOOK OF WEATHER, CLIMATE, AND WATER: ATMOSPHERIC CHEMISTRY, HYDROLOGY, AND SOCIETAL IMPACTS, P29; Lelieveld J, 2004, ATMOS CHEM PHYS, V4, P2337, DOI 10.5194/acp-4-2337-2004; LEVY H, 1971, SCIENCE, V173, P141, DOI 10.1126/science.173.3992.141; Manning MR, 2005, NATURE, V436, P1001, DOI 10.1038/nature03900; PERNER D, 1987, J ATMOS CHEM, V5, P185, DOI 10.1007/BF00048859; PLATT U, 1988, J GEOPHYS RES-ATMOS, V93, P5159, DOI 10.1029/JD093iD05p05159; Prinn RG, 2001, SCIENCE, V292, P1882, DOI 10.1126/science.1058673; SILLMAN S, 1990, J GEOPHYS RES-ATMOS, V95, P1837, DOI 10.1029/JD095iD02p01837; Stockwell WR, 1997, J GEOPHYS RES-ATMOS, V102, P25847, DOI 10.1029/97JD00849; WENNBERG PO, 1995, J ATMOS SCI, V52, P3413, DOI 10.1175/1520-0469(1995)052<3413:ISMOOA>2.0.CO;2; *WORLD MET ORG, 2001, 142 GAW WORLD MET OR	29	243	251	10	165	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 13	2006	442	7099					184	187		10.1038/nature04924	http://dx.doi.org/10.1038/nature04924			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	062XJ	16838018				2022-12-28	WOS:000238979700043
J	Deen, JL; Harris, E; Wills, B; Balmaseda, A; Hammond, SN; Rocha, C; Dung, NM; Hung, NT; Hien, TT; Farrar, JJ				Deen, Jacqueline L.; Harris, Eva; Wills, Bridget; Balmaseda, Angel; Hammond, Samantha Nadia; Rocha, Crisanta; Dung, Nguyen Minh; Hung, Nguyen Thanh; Hien, Tran Tinh; Farrar, Jeremy J.			The WHO dengue classification and case definitions: time for a reassessment	LANCET			English	Editorial Material							HEMORRHAGIC-FEVER; RISK-FACTORS; VIETNAMESE CHILDREN; INFECTIONS; SEVERITY; EPIDEMIC; DIAGNOSIS; FEATURES; INFANTS; ADULTS		Int Vaccine Inst, Seoul, South Korea; Univ Calif Berkeley, Sch Publ Hlth, Div Infect Dis, Berkeley, CA 94720 USA; Univ Oxford, Clin Res Unit, Hosp Trop Dis, Ho Chi Minh City, Vietnam; Minist Hlth, Dept Virol, Managua, Nicaragua; Hosp Infantil Manuel de Jesus Rivera, Infect Dis Unit, Managua, Nicaragua; Childrens Hosp 1, Ho Chi Minh City, Vietnam; London Sch Hyg & Trop Med, London WC1, England	International Vaccine Institute; University of California System; University of California Berkeley; University of Oxford; University of London; London School of Hygiene & Tropical Medicine	Deen, JL (corresponding author), Int Vaccine Inst, Kwanak POB 14, Seoul, South Korea.	jdeen@ivi.int	Farrar, Jeremy J./HGA-7610-2022	Wills, Bridget/0000-0001-9086-8804; Farrar, Jeremy/0000-0002-2700-623X				[Anonymous], 1994, DENG DENG HEM FEV AM; Balmaseda A, 2005, AM J TROP MED HYG, V73, P1059, DOI 10.4269/ajtmh.2005.73.1059; BURKE DS, 1988, AM J TROP MED HYG, V38, P172, DOI 10.4269/ajtmh.1988.38.172; COHEN SN, 1964, J PEDIATR, V68, P448, DOI DOI 10.1016/S0022-3476(66)80249-4; DIETZ VJ, 1990, AM J EPIDEMIOL, V131, P693; Endy TP, 2002, AM J EPIDEMIOL, V156, P40, DOI 10.1093/aje/kwf005; Garcia-Rivera EJ, 2003, PAN AM J PUBLIC HLTH, V13, P362; Graham RR, 1999, AM J TROP MED HYG, V61, P412, DOI 10.4269/ajtmh.1999.61.412; Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480; Guha P, 2005, INT J GEOM METHODS M, V2, P1, DOI 10.1142/S0219887805000429; Halstead S.B., 1980, TOGAVIRUSES BIOL STR, p107e173; HALSTEAD SB, 1989, REV INFECT DIS, V11, pS830; Hammond SN, 2005, AM J TROP MED HYG, V73, P1063; Harris E, 2000, AM J TROP MED HYG, V63, P5, DOI 10.4269/ajtmh.2000.63.5; HAYES CG, 1988, AM J TROP MED HYG, V39, P110, DOI 10.4269/ajtmh.1988.39.110; Hung NT, 2004, J INFECT DIS, V189, P221, DOI 10.1086/380762; Kalayanarooj S., 2002, Dengue Bulletin, V26, P33; Kalayanarooj S, 1997, J INFECT DIS, V176, P313, DOI 10.1086/514047; Kalayanarooj S., 1999, Dengue Bulletin, V23, P10; Kalaycioglu E, 1999, TURK J CHEM, V23, P1; Lum LCS, 1996, AM J TROP MED HYG, V54, P256, DOI 10.4269/ajtmh.1996.54.256; Phuong CXT, 2002, TROP MED INT HEALTH, V7, P125, DOI 10.1046/j.1365-3156.2002.00841.x; Phuong CXT, 2004, AM J TROP MED HYG, V70, P172, DOI 10.4269/ajtmh.2004.70.172; PONGPANICH B, 1973, J PEDIATR-US, V83, P1073, DOI 10.1016/S0022-3476(73)80553-0; Rahman M, 2002, EMERG INFECT DIS, V8, P738, DOI 10.3201/eid0807.010398; SANGKAWIBHA N, 1984, AM J EPIDEMIOL, V120, P653, DOI 10.1093/oxfordjournals.aje.a113932; Solomon T, 2000, LANCET, V355, P1053, DOI 10.1016/S0140-6736(00)02036-5; SRICHIKUL T, 1977, AM J TROP MED HYG, V18, P954; SUMARMO, 1983, B WORLD HEALTH ORGAN, V61, P693; Thein S, 1997, AM J TROP MED HYG, V56, P566, DOI 10.4269/ajtmh.1997.56.566; *WHO REG OFF SE AS, 1999, GUID TREATM DENG FEV; Wichmann O, 2004, TROP MED INT HEALTH, V9, P1022, DOI 10.1111/j.1365-3156.2004.01295.x; Wills BA, 2005, NEW ENGL J MED, V353, P877, DOI 10.1056/NEJMoa044057; Wills BA, 2002, CLIN INFECT DIS, V35, P277, DOI 10.1086/341410; World Health Organization, 1997, DENG HEM FEV DIAGN T, V2nd	35	264	279	0	24	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 8	2006	368	9530					170	173		10.1016/S0140-6736(06)69006-5	http://dx.doi.org/10.1016/S0140-6736(06)69006-5			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	062AR	16829301				2022-12-28	WOS:000238917200031
J	Pratt, D; Piper, M; Appleby, L; Webb, R; Shaw, J				Pratt, Daniel; Piper, Mary; Appleby, Louis; Webb, Roger; Shaw, Jenny			Suicide in recently released prisoners: a population-based cohort study	LANCET			English	Article							FINNISH PRISONERS; MENTAL DISORDER; WATTU PROJECT; ENGLAND; WALES; MORTALITY	Background Several studies have been undertaken on suicide in custody, but few on suicide after the release from prison. We undertook a population-based cohort study to investigate suicide rates in recently released prisoners in England and Wales. Methods We used the database of the National Confidential Inquiry into Suicide and Homicide by People with Mental Illness for England and Wales to identify all individuals who died by suicide or who received an open verdict at the coroner's inquest between 2000 and 2002. These records were linked to a Home Office register to identify all such deaths in people within 1 year of release from prison in England and Wales. We compared suicide rates per 100000 person-years in these released prisoners with rates in the general population by using the indirectly age-standardised mortality ratio. Findings We identified 382 suicides occurring in 244988 individuals within 1 year of release from prison; a suicide rate of 156 per 100 000 person-years. 79 (21%) suicides occurred within the first 28 days after release. In all age groups, suicide rates were higher in recently released prisoners than in the general population. The overall age-standardised mortality ratio for recently released prisoners was 8.3 (95% Cl 7.5-9.3) for men and 35.8 (25.4-50.2) for women. Interpretation Recently released prisoners are at a much greater risk of suicide than the general population, especially in the first few weeks after release. The risk of suicide in recently released prisoners is approaching that seen in discharged psychiatric patients. A shared responsibility ties with the prison, probation, health, and social services to develop more collaborative practices in providing services for this high-risk group.	Univ Manchester, Ctr Suicide Prevent, Manchester M13 9PL, Lancs, England; Dept Hlth, London SE1 6TE, England	University of Manchester	Shaw, J (corresponding author), Univ Manchester, Ctr Suicide Prevent, Manchester M13 9PL, Lancs, England.	jennifer.j.shaw@manchester.ac.uk	Pratt, Daniel/O-9490-2015	Pratt, Daniel/0000-0001-8843-1224; shaw, jennifer/0000-0003-2569-7687; Webb, Roger/0000-0001-8532-2647				Appleby L., 2001, SAFETY 1 5 YEAR REPO; Baxter D, 1999, BRIT J PSYCHIAT, V175, P322, DOI 10.1192/bjp.175.4.322; Bland RC, 1998, INT J LAW PSYCHIAT, V21, P273, DOI 10.1016/S0160-2527(98)00005-3; Breslow NE., 1987, STAT METHODS CANC RE, P81; Brooke D, 1996, BRIT MED J, V313, P1524, DOI 10.1136/bmj.313.7071.1524; DOOLEY E, 1990, BRIT J PSYCHIAT, V156, P40, DOI 10.1192/bjp.156.1.40; Fazel S, 2005, LANCET, V366, P1301, DOI 10.1016/S0140-6736(05)67325-4; Fazel S, 2002, LANCET, V359, P545, DOI 10.1016/S0140-6736(02)07740-1; FOX A, 2005, HOME OFFICE ON LINE; Fruehwald S, 2004, BRIT J PSYCHIAT, V185, P494, DOI 10.1192/bjp.185.6.494; GOLDACRE M, 1993, LANCET, V342, P283, DOI 10.1016/0140-6736(93)91822-4; HARDINGPINK D, 1990, MED SCI LAW, V30, P12, DOI 10.1177/002580249003000104; Home Office, 2003, PRIS STAT ENGL WAL 2; JOUKAMAA M, 1995, FORENSIC SCI INT, V73, P85, DOI 10.1016/0379-0738(95)01713-S; Joukamaa M, 1998, FORENSIC SCI INT, V96, P11, DOI 10.1016/S0379-0738(98)00098-X; King EA, 2001, BRIT J PSYCHIAT, V178, P531, DOI 10.1192/bjp.178.6.531; Neeleman J, 1997, PSYCHOL MED, V27, P467, DOI 10.1017/S0033291796004631; Rooney C., 1998, POPUL TRENDS, V93, P29; Rothman K, 1986, MODERN EPIDEMIOLOGY; Sattar Ghazala, 2003, Crisis, V24, P17, DOI 10.1027//0227-5910.24.1.17; Shaw J, 2004, BRIT J PSYCHIAT, V184, P263, DOI 10.1192/bjp.184.3.263; Shaw J., 2003, SAFER PRISONS NATL S; Singleton N., 1998, PSYCHIAT MORBIDITY P; SINGLETON N, 2002, DRUG RELATED MORTALI; Social Exclusion Unit, 2002, RED REOFF EXPR; Sohlman B, 1999, ACTA PSYCHIAT SCAND, V99, P102, DOI 10.1111/j.1600-0447.1999.tb07207.x; Towl G.J., 2002, SUICIDE PRISONS; Visher CA, 2003, ANNU REV SOCIOL, V29, P89, DOI 10.1146/annurev.soc.29.010202.095931	28	167	172	1	15	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 8	2006	368	9530					119	123		10.1016/S0140-6736(06)69002-8	http://dx.doi.org/10.1016/S0140-6736(06)69002-8			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	062AR	16829295	Green Submitted			2022-12-28	WOS:000238917200025
J	Thompson, JK; Simon, J; Loh, H; Vuletic, V				Thompson, James K.; Simon, Jonathan; Loh, Huanqian; Vuletic, Vladan			A high-brightness source of narrowband, identical-photon pairs	SCIENCE			English	Article							ATOMIC ENSEMBLES; QUANTUM COMMUNICATION; LINEAR OPTICS; LIGHT; INTERFERENCE; ENTANGLEMENT; VIOLATION; STORAGE	We generated narrowband pairs of nearly identical photons at a rate of 5 X 10(4) pairs per second from a laser-cooled atomic ensemble inside an optical cavity. A two-photon interference experiment demonstrated that the photons could be made 90% indistinguishable, a key requirement for quantum information-processing protocols. Used as a conditional single-photon source, the system operated near the fundamental limits on recovery efficiency (57%), Fourier transform - limited bandwidth, and pair-generation-rate - limited suppression of two-photon events ( factor of 33 below the Poisson limit). Each photon had a spectral width of 1.1 megahertz, ideal for interacting with atomic ensembles that form the basis of proposed quantum memories and logic.	MIT, Dept Phys, MIT Harvard Ctr Ultracold Atoms, Elect Res Lab, Cambridge, MA 02139 USA; Harvard Univ, MIT Harvard Ctr Ultracold Atoms, Dept Phys, Cambridge, MA 02138 USA	Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT)	Thompson, JK (corresponding author), MIT, Dept Phys, MIT Harvard Ctr Ultracold Atoms, Elect Res Lab, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	jkthomps@mit.edu	Loh, Huanqian/K-6811-2015; Vuletic, Vladan/M-8736-2019	Loh, Huanqian/0000-0002-7325-0815; Thompson, James/0000-0003-1160-5112; Simon, Jonathan/0000-0001-7854-4647				Andre A, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.243602; ASPECT A, 1982, PHYS REV LETT, V49, P91, DOI 10.1103/PhysRevLett.49.91; Balic V, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.183601; Black AT, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.133601; Chaneliere T, 2005, NATURE, V438, P833, DOI 10.1038/nature04315; Chou CW, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.213601; CLAUSER JF, 1974, PHYS REV D, V9, P853, DOI 10.1103/PhysRevD.9.853; Duan LM, 2001, NATURE, V414, P413, DOI 10.1038/35106500; Eisaman MD, 2005, NATURE, V438, P837, DOI 10.1038/nature04327; Eisaman MD, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.233602; Fattal D, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.037903; HONG CK, 1987, PHYS REV LETT, V59, P2044, DOI 10.1103/PhysRevLett.59.2044; Julsgaard B, 2001, NATURE, V413, P400, DOI 10.1038/35096524; Knill E, 2001, NATURE, V409, P46, DOI 10.1038/35051009; Konig F, 2005, PHYS REV A, V71, DOI 10.1103/PhysRevA.71.033805; Kuzmich A, 2003, NATURE, V423, P731, DOI 10.1038/nature01714; Legero T, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.070503; Legero T, 2003, APPL PHYS B-LASERS O, V77, P797, DOI 10.1007/s00340-003-1337-x; Matsukevich DN, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.030405; Matsukevich DN, 2004, SCIENCE, V306, P663, DOI 10.1126/science.1103346; OU ZY, 1988, PHYS REV LETT, V61, P50, DOI 10.1103/PhysRevLett.61.50; Phillips DF, 2001, PHYS REV LETT, V86, P783, DOI 10.1103/PhysRevLett.86.783; Polyakov SV, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.263601; SHIH YH, 1988, PHYS REV LETT, V61, P2921, DOI 10.1103/PhysRevLett.61.2921; TURCHETTE QA, 1995, PHYS REV LETT, V75, P4710, DOI 10.1103/PhysRevLett.75.4710; van der Wal CH, 2003, SCIENCE, V301, P196, DOI 10.1126/science.1085946	29	160	161	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 7	2006	313	5783					74	77		10.1126/science.1127676	http://dx.doi.org/10.1126/science.1127676			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061DA	16825564	Green Submitted			2022-12-28	WOS:000238850200032
J	Pfeifer, MA; Williams, GJ; Vartanyants, IA; Harder, R; Robinson, IK				Pfeifer, Mark A.; Williams, Garth J.; Vartanyants, Ivan A.; Harder, Ross; Robinson, Ian K.			Three-dimensional mapping of a deformation field inside a nanocrystal	NATURE			English	Article							FOURIER-TRANSFORM; PHASE RETRIEVAL; MICROSCOPY; RECONSTRUCTION; DIFFRACTION; RESOLUTION; MAGNITUDE	Coherent X-ray diffraction imaging is a rapidly advancing form of microscopy: diffraction patterns, measured using the latest third-generation synchrotron radiation sources, can be inverted to obtain full three-dimensional images of the interior density within nanocrystals(1-3). Diffraction from an ideal crystal lattice results in an identical copy of this continuous diffraction pattern at every Bragg peak. This symmetry is broken by the presence of strain fields, which arise from the epitaxial contact forces that are inevitable whenever nanocrystals are prepared on a substrate(4). When strain is present, the diffraction copies at different Bragg peaks are no longer identical and contain additional information, appearing as broken local inversion symmetry about each Bragg point. Here we show that one such pattern can nevertheless be inverted to obtain a 'complex' crystal density, whose phase encodes a projection of the lattice deformation. A lead nanocrystal was crystallized in ultrahigh vacuum from a droplet on a silica substrate and equilibrated close to its melting point. A three-dimensional image of the density, obtained by inversion of the coherent X-ray diffraction, shows the expected facetted morphology, but in addition reveals a real-space phase that is consistent with the three-dimensional evolution of a deformation field arising from interfacial contact forces. Quantitative three-dimensional imaging of lattice strain on the nanometre scale will have profound consequences for our fundamental understanding of grain interactions and defects in crystalline materials(4). Our method of measuring and inverting diffraction patterns from nanocrystals represents a vital step towards the ultimate goal of atomic resolution single-molecule imaging that is a prominent justification for development of X-ray free-electron lasers(5-7).	Univ Illinois, Dept Phys, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign	Robinson, IK (corresponding author), Univ Oregon, Dept Phys, Eugene, OR 97403 USA.	i.robinson@ucl.ac.uk	Pfeifer, Mark/C-4132-2011; Williams, Garth/H-1606-2012; Robinson, Ian/A-4906-2010	Robinson, Ian/0000-0003-4897-5221	EPSRC [EP/D052939/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/D052939/1] Funding Source: researchfish	EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))		BATES RHT, 1982, OPTIK, V61, P247; CAHN RW, 1995, NATURE, V375, P363, DOI 10.1038/375363a0; Eisebitt S, 2004, NATURE, V432, P885, DOI 10.1038/nature03139; FIENUP JR, 1982, APPL OPTICS, V21, P2758, DOI 10.1364/AO.21.002758; FIENUP JR, 1987, J OPT SOC AM A, V4, P118, DOI 10.1364/JOSAA.4.000118; HAYES MH, 1982, IEEE T ACOUST SPEECH, V30, P140, DOI 10.1109/TASSP.1982.1163863; HENDERSON R, 1995, Q REV BIOPHYS, V28, P171, DOI 10.1017/S003358350000305X; HEYRAUD JC, 1983, SURF SCI, V128, P334, DOI 10.1016/S0039-6028(83)80036-3; Huldt G, 2003, J STRUCT BIOL, V144, P219, DOI 10.1016/j.jsb.2003.09.025; Jacobsen C, 1998, NAT STRUCT BIOL, V5, P650, DOI 10.1038/1341; Larson BC, 2002, NATURE, V415, P887, DOI 10.1038/415887a; Marchesini S, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.140101; McBride W, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.233902; METZGER H, 1978, J PHYS F MET PHYS, V8, P391, DOI 10.1088/0305-4608/8/3/009; Miao J, 1998, J OPT SOC AM A, V15, P1662, DOI 10.1364/JOSAA.15.001662; Miao JW, 1999, NATURE, V400, P342, DOI 10.1038/22498; Neutze R, 2000, NATURE, V406, P752, DOI 10.1038/35021099; Patel N, 2002, NATURE, V415, P110, DOI 10.1038/415110a; PFEIFER MA, 2004, THESIS U ILLINOIS; SAYRE D, 1952, ACTA CRYSTALLOGR, V5, P843, DOI 10.1107/S0365110X52002276; Vartanyants IA, 2001, J PHYS-CONDENS MAT, V13, P10593, DOI 10.1088/0953-8984/13/47/305; Williams GJ, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.175501; WILLIAMS GJ, 2004, THESIS U ILLINOIS; WORTIS M, 1988, CHEM PHYSICS SOLID S, V7, P367	24	515	524	4	205	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 6	2006	442	7098					63	66		10.1038/nature04867	http://dx.doi.org/10.1038/nature04867			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	059HS	16823449	Green Published			2022-12-28	WOS:000238724500036
J	Schapira, AHV				Schapira, Anthony H. V.			Mitochondrial disease	LANCET			English	Review							CYTOCHROME-C-OXIDASE; HEREDITARY OPTIC NEUROPATHY; PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; RESPIRATORY-CHAIN DISORDERS; INTRACYTOPLASMIC SPERM INJECTION; ELECTRON-TRANSPORT CHAIN; AMYLOID-BETA PEPTIDE; GAMMA-GENE POLG; PARKINSONS-DISEASE; ALZHEIMERS-DISEASE	Defects of mitochondrial metabolism cause a wide range of human diseases that include examples from all medical subspecialties. This review updates the topic of mitochondrial diseases by reviewing the most important recent advances in this area. The factors influencing inheritance, maintenance and replication of mtDNA are reviewed and the genotype-phenotype of mtDNA disorders has been expanded, with new insights into epidemiology, pathogenesis and its role in ageing. Recently identified nuclear gene mutations of mitochondrial proteins include mutations of frataxin causing Friedreich's ataxia, PINK1, DJ1 causing Parkinson's disease and POLG causing infantile mtDNA depletion syndrome, ophthalmoplegia, parkinsonism, male subfertility and, in a transgenic mouse model, premature senescence. Mitochondrial defects in neurodegenerative diseases include Parkinson's, Alzheimer's and Huntington's disease. Improved understanding of mtDNA inheritance and mutation penetrance patterns, and novel techniques for mtDNA modification offer significant prospects for more accurate genetic counselling and effective future therapies.	UCL, Inst Neurol, London NW3 2PF, England; Royal Free & Univ Coll Med Sch, Univ Dept Clin Neurosci, London NW3 2PF, England	University of London; University College London; University of London; University College London	Schapira, AHV (corresponding author), Royal Free & Univ Coll Med Sch, Univ Dept Clin Neurosci, London NW3 2PF, England.	a.schapira@medasch.ucl.ac.uk	Schapira, Anthony/A-1245-2010	Schapira, Anthony/0000-0002-3018-3966	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Antonicka H, 2003, AM J HUM GENET, V72, P101, DOI 10.1086/345489; Barrientos A, 2002, GENE, V286, P53, DOI 10.1016/S0378-1119(01)00803-4; Beilina A, 2005, P NATL ACAD SCI USA, V102, P5703, DOI 10.1073/pnas.0500617102; Beretta S, 2004, BRAIN, V127, P2183, DOI 10.1093/brain/awh258; BOHNERT B, 1974, ARCH PSYCHIAT NERVEN, V218, P353, DOI 10.1007/BF00342578; Busciglio J, 2002, NEURON, V33, P677, DOI 10.1016/S0896-6273(02)00604-9; Canet-Aviles RM, 2004, P NATL ACAD SCI USA, V101, P9103, DOI 10.1073/pnas.0402959101; Casley CS, 2002, J NEUROCHEM, V80, P91, DOI 10.1046/j.0022-3042.2001.00681.x; Chandrasekaran K, 1997, MOL BRAIN RES, V44, P99, DOI 10.1016/S0169-328X(96)00191-X; Chinnery PE, 1998, BRAIN, V121, P1889, DOI 10.1093/brain/121.10.1889; Chinnery PF, 2000, ANN NEUROL, V48, P188, DOI 10.1002/1531-8249(200008)48:2<188::AID-ANA8>3.0.CO;2-P; Chinnery PF, 2003, J NEUROL NEUROSUR PS, V74, P1188, DOI 10.1136/jnnp.74.9.1188; Chinnery PF, 2004, LANCET, V364, P592, DOI 10.1016/S0140-6736(04)16851-7; Chinnery PF, 2002, LANCET, V360, P1323, DOI 10.1016/S0140-6736(02)11310-9; Clark KM, 1997, NAT GENET, V16, P222, DOI 10.1038/ng0797-222; COCK HR, 1995, NEUROLOGY, V45, pA294; Coenen MJH, 2004, ANN NEUROL, V56, P560, DOI 10.1002/ana.20229; COOPER JM, 1993, LANCET, V341, P969, DOI 10.1016/0140-6736(93)91269-R; CORRALDEBRINSKI M, 1994, GENOMICS, V23, P471, DOI 10.1006/geno.1994.1525; Coskun PE, 2004, P NATL ACAD SCI USA, V101, P10726, DOI 10.1073/pnas.0403649101; D'Aurelio M, 2004, HUM MOL GENET, V13, P3171, DOI 10.1093/hmg/ddh326; Danan C, 1999, AM J HUM GENET, V65, P463, DOI 10.1086/302484; Darin N, 2001, ANN NEUROL, V49, P377, DOI 10.1002/ana.75; Darios F, 2003, HUM MOL GENET, V12, P517, DOI 10.1093/hmg/ddg044; Davis RE, 1997, P NATL ACAD SCI USA, V94, P4526, DOI 10.1073/pnas.94.9.4526; de Lonlay P, 2001, NAT GENET, V29, P57, DOI 10.1038/ng706; De Meirleir L, 2004, J MED GENET, V41, P120, DOI 10.1136/jmg.2003.012047; DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567; Du Yan S, 1999, J BIOL CHEM, V274, P2145, DOI 10.1074/jbc.274.4.2145; Entelis NS, 2001, J BIOL CHEM, V276, P45642, DOI 10.1074/jbc.M103906200; Ezquerra M, 2005, ARCH NEUROL-CHICAGO, V62, P306, DOI 10.1001/archneur.62.2.306; Ferrari G, 2005, BRAIN, V128, P723, DOI 10.1093/brain/awh410; Filosto M, 2003, ANN NEUROL, V54, P524, DOI 10.1002/ana.10709; Filosto M, 2003, ARCH NEUROL-CHICAGO, V60, P1279, DOI 10.1001/archneur.60.9.1279; Fish J, 2004, SCIENCE, V306, P2098, DOI 10.1126/science.1102077; Greene JC, 2003, P NATL ACAD SCI USA, V100, P4078, DOI 10.1073/pnas.0737556100; Gu M, 1998, ANN NEUROL, V44, P177, DOI 10.1002/ana.410440207; HARDING AE, 1995, AM J HUM GENET, V57, P77; HARDING BN, 1995, J NEUROL NEUROSUR PS, V58, P320, DOI 10.1136/jnnp.58.3.320; Hart PE, 2005, ARCH NEUROL-CHICAGO, V62, P621, DOI 10.1001/archneur.62.4.621; Hausse AO, 2002, HEART, V87, P346, DOI 10.1136/heart.87.4.346; Hoglinger GU, 2003, J NEUROCHEM, V86, P1297, DOI 10.1046/j.1471-4159.2003.01952.x; HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0; Holt IJ, 1997, HUM MOL GENET, V6, P1251, DOI 10.1093/hmg/6.8.1251; Houshmand M, 1997, J ASSIST REPROD GEN, V14, P223, DOI 10.1007/BF02766114; Hsu LJ, 2000, AM J PATHOL, V157, P401, DOI 10.1016/S0002-9440(10)64553-1; Hudson G, 2005, NEUROLOGY, V64, P371, DOI 10.1212/01.WNL.0000149767.51152.83; Jensen M, 2004, HUM REPROD, V19, P65, DOI 10.1093/humrep/deh038; Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782; Kiechl S, 2004, J NEUROL NEUROSUR PS, V75, P1125, DOI 10.1136/jnnp.2003.025890; KISH SJ, 1992, J NEUROCHEM, V59, P776, DOI 10.1111/j.1471-4159.1992.tb09439.x; Kolesnikova OA, 2004, HUM MOL GENET, V13, P2519, DOI 10.1093/hmg/ddh267; Korhonen JA, 2003, J BIOL CHEM, V278, P48627, DOI 10.1074/jbc.M306981200; Krausz C, 2004, J CLIN ENDOCR METAB, V89, P4292, DOI 10.1210/jc.2004-0008; KRIGE D, 1992, ANN NEUROL, V32, P782, DOI 10.1002/ana.410320612; Lalani SR, 2005, ARCH NEUROL-CHICAGO, V62, P317, DOI 10.1001/archneur.62.2.317; Lamperti C, 2003, NEUROLOGY, V60, P1206, DOI 10.1212/01.WNL.0000055089.39373.FC; Lee SJ, 2003, ANTIOXID REDOX SIGN, V5, P337, DOI 10.1089/152308603322110904; Leonard JV, 2000, LANCET, V355, P389, DOI 10.1016/S0140-6736(99)05226-5; Leonard JV, 2000, LANCET, V355, P299, DOI 10.1016/S0140-6736(99)05225-3; Lodi R, 2001, ANN NEUROL, V49, P590; Luoma P, 2004, LANCET, V364, P875, DOI 10.1016/S0140-6736(04)16983-3; Lustbader JW, 2004, SCIENCE, V304, P448, DOI 10.1126/science.1091230; Majamaa K, 1998, AM J HUM GENET, V63, P447, DOI 10.1086/301959; Man PYW, 2003, AM J HUM GENET, V72, P333, DOI 10.1016/j.ajhg.2016.05.015; Mancuso M, 2004, ARCH NEUROL-CHICAGO, V61, P1777, DOI 10.1001/archneur.61.11.1777; Mancuso M, 2004, NEUROLOGY, V62, P316, DOI 10.1212/WNL.62.2.316; Mandel H, 2001, NAT GENET, V29, P337, DOI 10.1038/ng746; Marchington DR, 2002, MOL HUM REPROD, V8, P1046, DOI 10.1093/molehr/8.11.1046; Mattiazzi M, 2004, HUM MOL GENET, V13, P869, DOI 10.1093/hmg/ddh103; McFarland R, 2004, ANN NEUROL, V55, P478, DOI 10.1002/ana.20004; Mootha VK, 2005, P NATL ACAD SCI USA, V102, P10405, DOI 10.1073/pnas.0505194102; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Mootha VK, 2003, P NATL ACAD SCI USA, V100, P605, DOI 10.1073/pnas.242716699; Muftuoglu M, 2004, MOVEMENT DISORD, V19, P544, DOI 10.1002/mds.10695; Musumeci O, 2001, NEUROLOGY, V56, P849, DOI 10.1212/WNL.56.7.849; Naviaux RK, 2004, ANN NEUROL, V55, P706, DOI 10.1002/ana.20079; OGASAHARA S, 1989, P NATL ACAD SCI USA, V86, P2379, DOI 10.1073/pnas.86.7.2379; Ojaimi J, 1999, ANN NEUROL, V46, P656, DOI 10.1002/1531-8249(199910)46:4<656::AID-ANA16>3.3.CO;2-H; Okado-Matsumoto A, 2002, P NATL ACAD SCI USA, V99, P9010, DOI 10.1073/pnas.132260399; Palacino JJ, 2004, J BIOL CHEM, V279, P18614, DOI 10.1074/jbc.M401135200; Papadopoulou LC, 1999, NAT GENET, V23, P333; PARKER WD, 1994, NEUROLOGY, V44, P1090, DOI 10.1212/WNL.44.6.1090; PARKER WD, 1989, ANN NEUROL, V26, P719, DOI 10.1002/ana.410260606; PARKER WD, 1990, NEUROLOGY, V40, P1302, DOI 10.1212/WNL.40.8.1302; PARKER WD, 1995, NEUROLOGY, V45, P482, DOI 10.1212/WNL.45.3.482; Petersen KF, 2004, NEW ENGL J MED, V350, P664, DOI 10.1056/NEJMoa031314; Petros JA, 2005, P NATL ACAD SCI USA, V102, P719, DOI 10.1073/pnas.0408894102; Polyak K, 1998, NAT GENET, V20, P291, DOI 10.1038/3108; Pyle A, 2005, ANN NEUROL, V57, P564, DOI 10.1002/ana.20417; Qi XP, 2004, ANN NEUROL, V56, P182, DOI 10.1002/ana.20175; Qi XP, 2003, INVEST OPHTH VIS SCI, V44, P1088, DOI 10.1167/iovs.02-0864; Qi XP, 2003, ANN NEUROL, V53, P198, DOI 10.1002/ana.10426; REICHMANN H, 1993, J NEUROL, V240, P377, DOI 10.1007/BF00839971; Ross OA, 2003, EXP GERONTOL, V38, P397, DOI 10.1016/S0531-5565(02)00266-8; Rovio AT, 2001, NAT GENET, V29, P261, DOI 10.1038/ng759; Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751; SCHAPIRA AHV, 1989, LANCET, V1, P1269, DOI 10.1016/S0140-6736(89)92366-0; Schapira AHV, 2002, J NEUROL NEUROSUR PS, V72, P144, DOI 10.1136/jnnp.72.2.144; Schon EA, 2003, J CLIN INVEST, V111, P303, DOI 10.1172/JCI200317741; Schriner SE, 2005, SCIENCE, V308, P1909, DOI 10.1126/science.1106653; Schwartz M, 2002, NEW ENGL J MED, V347, P576, DOI 10.1056/NEJMoa020350; Servidei Serenella, 2004, Neuromuscul Disord, V14, P107; Seznec H, 2005, HUM MOL GENET, V14, P463, DOI 10.1093/hmg/ddi042; Seznec H, 2004, HUM MOL GENET, V13, P1017, DOI 10.1093/hmg/ddh114; Shults CW, 2002, ARCH NEUROL-CHICAGO, V59, P1541, DOI 10.1001/archneur.59.10.1541; Skladal D, 2003, BRAIN, V126, P1905, DOI 10.1093/brain/awg170; Smith PM, 2004, BBA-BIOENERGETICS, V1659, P232, DOI 10.1016/j.bbabio.2004.09.003; Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058; St John J, 2000, LANCET, V355, P200, DOI 10.1016/S0140-6736(99)03842-8; Sutovsky P, 2004, REPROD BIOMED ONLINE, V8, P24, DOI 10.1016/S1472-6483(10)60495-6; Sutovsky P, 1999, NATURE, V402, P371, DOI 10.1038/46466; Taanman JW, 2005, NEUROSCI LETT, V376, P56, DOI 10.1016/j.neulet.2004.11.023; Taanman JW, 2003, HUM MOL GENET, V12, P1839, DOI 10.1093/hmg/ddg192; Tan EK, 2000, NEUROLOGY, V55, P533, DOI 10.1212/WNL.55.4.533; Tanaka M, 2002, J BIOMED SCI, V9, P534, DOI 10.1007/BF02254980; Tang YY, 2000, MOL BIOL CELL, V11, P2349, DOI 10.1091/mbc.11.7.2349; Tay SKH, 2004, ARCH NEUROL-CHICAGO, V61, P1935, DOI 10.1001/archneur.61.12.1935; Taylor RW, 2003, ANN NEUROL, V54, P521, DOI 10.1002/ana.10673; Thyagarajan D, 2000, ANN NEUROL, V48, P730, DOI 10.1002/1531-8249(200011)48:5<730::AID-ANA6>3.0.CO;2-0; Tiranti V, 1998, AM J HUM GENET, V63, P1609, DOI 10.1086/302150; Torroja L, 1998, J CELL BIOL, V141, P1009, DOI 10.1083/jcb.141.4.1009; Torroni A, 1997, AM J HUM GENET, V60, P1107; TRANEBJAERG L, 1995, J MED GENET, V32, P257, DOI 10.1136/jmg.32.4.257; Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517; Tyynismaa H, 2004, HUM MOL GENET, V13, P3219, DOI 10.1093/hmg/ddh342; Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284; Valentino ML, 2004, ANN NEUROL, V56, P631, DOI 10.1002/ana.20236; Valentino ML, 2002, ANN NEUROL, V51, P774, DOI 10.1002/ana.10193; Valnot I, 2000, HUM MOL GENET, V9, P1245, DOI 10.1093/hmg/9.8.1245; van der Walt JM, 2003, AM J HUM GENET, V72, P804, DOI 10.1086/373937; Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034; Van Goethem G, 2002, ACTA NEUROL BELG, V102, P39; Visapaa I, 2002, AM J HUM GENET, V71, P863, DOI 10.1086/342773; WALLACE DC, 1992, ANN NEUROL, V32, P113, DOI 10.1002/ana.410320123; Wallace DC, 1999, GENE, V238, P211, DOI 10.1016/S0378-1119(99)00295-4; Wilson FH, 2004, SCIENCE, V306, P1190, DOI 10.1126/science.1102521; Yan SD, 1997, NATURE, V389, P689; Zhu ZQ, 1998, NAT GENET, V20, P337, DOI 10.1038/3804	139	466	504	0	69	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 1	2006	368	9529					70	82		10.1016/S0140-6736(06)68970-8	http://dx.doi.org/10.1016/S0140-6736(06)68970-8			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	058TQ	16815381				2022-12-28	WOS:000238687900032
J	Haber, JE; Debatisse, M				Haber, James E.; Debatisse, Michelle			Gene amplification: Yeast takes a turn	CELL			English	Review							BREAK-INDUCED REPLICATION; LARGE DNA PALINDROME; INSTABILITY; REPAIR	The origins of gene amplifications in mammalian cells has been difficult to analyze because of secondary genome arrangements. Recent studies in budding yeast, including Narayanan et al. (2006) in this issue of Cell, have provided new insights in the role of palindromic sequences in gene amplification.	Brandeis Univ, Rosenstiel Ctr, Waltham, MA 02254 USA; Brandeis Univ, Dept Biol, Waltham, MA 02254 USA; Univ Paris 06, Inst Curie, CNRS, UMR 7147,Sect Rech, F-75248 Paris 05, France	Brandeis University; Brandeis University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Sorbonne Universite	Haber, JE (corresponding author), Brandeis Univ, Rosenstiel Ctr, Waltham, MA 02254 USA.	haber@brandeis.edu; michelle.debatisse@curie.fr		Haber, James/0000-0002-1878-0610				Admire A, 2006, GENE DEV, V20, P159, DOI 10.1101/gad.1392506; Butler DK, 1996, CELL, V87, P1115, DOI 10.1016/S0092-8674(00)81805-X; Debatisse M, 1998, RECENT RES CANCER, V154, P216; Glover TW, 2005, HUM MOL GENET, V14, pR197, DOI 10.1093/hmg/ddi265; Koszul R, 2004, EMBO J, V23, P234, DOI 10.1038/sj.emboj.7600024; Lemoine FJ, 2005, CELL, V120, P587, DOI 10.1016/j.cell.2004.12.039; Lobachev KS, 2002, CELL, V108, P183, DOI 10.1016/S0092-8674(02)00614-1; Malkova A, 2001, GENE DEV, V15, P1055, DOI 10.1101/gad.875901; Maringele L, 2004, GENE DEV, V18, P2663, DOI 10.1101/gad.316504; McEachern MJ, 2006, ANNU REV BIOCHEM, V75, P111, DOI 10.1146/annurev.biochem.74.082803.133234; Mills KD, 2003, IMMUNOL REV, V194, P77, DOI 10.1034/j.1600-065X.2003.00060.x; Mondello C, 2001, CANCER RES, V61, P4520; NARAYANAN V, 2006, CELL; Pipiras E, 1998, EMBO J, V17, P325, DOI 10.1093/emboj/17.1.325; Rattray AJ, 2005, GENE DEV, V19, P1390, DOI 10.1101/gad.1315805; Schwartz M, 2006, CANCER LETT, V232, P13, DOI 10.1016/j.canlet.2005.07.039; Tanaka H, 2005, NAT GENET, V37, P320, DOI 10.1038/ng1515; Tanaka H, 2002, P NATL ACAD SCI USA, V99, P8772, DOI 10.1073/pnas.132275999; Umezu K, 2002, GENETICS, V160, P97; Watanabe T, 2005, EMBO J, V24, P190, DOI 10.1038/sj.emboj.7600503	20	30	31	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 30	2006	125	7					1237	1240		10.1016/j.cell.2006.06.012	http://dx.doi.org/10.1016/j.cell.2006.06.012			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	064QP	16814711	Bronze			2022-12-28	WOS:000239104500008
J	Bramwell, R; West, H; Salmon, P				Bramwell, Ros; West, Helen; Salmon, Peter			Health professionals' and service users' interpretation of screening test results: experimental study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							RISKS; DECISIONS; FALLACY	Objective To investigate the accuracy of interpretation of probabilistic screening information by different stakeholder groups and whether presentation as frequencies improves accuracy Design Between participants experimental design; participants responded to screening information embedded in a scenario. Setting Regional maternity set-vice and national conferences and training days. Participants 43 pregnant women attending their first antenatal appointment in a regional maternity service; 40 companions accompanying the women to their appointments; 42 midwives; 41 obstetricians. Participation rates were 56%, 48%, 89%, and 71% respectively. Measures Participants estimated the probability that a positive screening test result meant that a baby actually had Down's syndrome on the basis of all the relevant information, which was presented in a scenario. They were randomly assigned to scenarios that presented the information in percentage (n = 86) or frequency (n = 83) format. They also gave basic demographic information and rated their confidence, in their estimate. Results Most responses (86%) were incorrect. Obstetricians gave significantly more correct answers (although still only 43%) than either midwives (0%) or pregnant,women (9%). Overall, die proportion of correct answers was higher for presentation as frequencies (24%) than for presentation as percentages (6%), but further analysis showed that this difference occurred only in responses from obstetricians. Many health professionals were confident in their incorrect responses. Conclusions Most stakeholders in pregnancy screening draw incorrect inferences from probabilistic information, and health professionals need to be aware of the difficulties that both they and their patients have with such information. Moreover, they should be aware that different people make different mistakes and that ways of conveying information that help some people will not help others.	Univ Liverpool, Div Clin Psychol, Liverpool L69 3GB, Merseyside, England	University of Liverpool	Bramwell, R (corresponding author), Univ Liverpool, Div Clin Psychol, Liverpool L69 3GB, Merseyside, England.	rosb@liv.ac.uk	Salmon, Peter/H-5289-2018	Salmon, Peter/0000-0001-6450-5209				BRAMWELL R, 1999, GENETIC INFORMATION, P183; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; Edwards A, 2002, BMJ-BRIT MED J, V324, P827, DOI 10.1136/bmj.324.7341.827; FLEISS JL, 1973, EDUC PSYCHOL MEAS, V33, P613, DOI 10.1177/001316447303300309; Gigerenzer G, 2003, BMJ-BRIT MED J, V327, P741, DOI 10.1136/bmj.327.7417.741; GIGERENZER G, 1995, PSYCHOL REV, V102, P684, DOI 10.1037/0033-295X.102.4.684; HAMMERTON M, 1973, J EXP PSYCHOL, V101, P252, DOI 10.1037/h0035224; Klein JG, 2005, BMJ-BRIT MED J, V330, P781, DOI 10.1136/bmj.330.7494.781; Koehler JJ, 1996, BEHAV BRAIN SCI, V19, P1, DOI 10.1017/S0140525X00041157; Marteau TM, 2001, BRIT MED J, V322, P526, DOI 10.1136/bmj.322.7285.526; Steurer J, 2002, BRIT MED J, V324, P824, DOI 10.1136/bmj.324.7341.824; Taylor P, 2005, BRIT MED J, V330, P915, DOI 10.1136/bmj.330.7497.915; *UK NAT SCREEN COM, 2004, TEST DOWNS SYNDR PRE; Villejoubert G, 2002, MEM COGNITION, V30, P171, DOI 10.3758/BF03195278	14	79	80	0	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 5	2006	333	7562					284	286A		10.1136/bmj.38884.663102.AE	http://dx.doi.org/10.1136/bmj.38884.663102.AE			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	073MV	16840441	Green Submitted, Bronze, Green Published			2022-12-28	WOS:000239748200016
J	Jayaraman, KS				Jayaraman, K. S.			Break with tradition	NATURE			English	News Item																			0	3	4	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 27	2006	442	7101					342	343		10.1038/442342a	http://dx.doi.org/10.1038/442342a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067CI	16871181				2022-12-28	WOS:000239278900010
J	Kinsella, JP; Cutter, GR; Walsh, WF; Gerstmann, DR; Bose, CL; Hart, C; Sekar, KC; Auten, RL; Bhutani, VK; Gerdes, JS; George, TN; Southgate, WM; Carriedo, H; Couser, RJ; Mammel, MC; Hall, DC; Pappagallo, M; Sardesai, S; Strain, JD; Baier, M; Abman, SH				Kinsella, John P.; Cutter, Gary R.; Walsh, William F.; Gerstmann, Dale R.; Bose, Carl L.; Hart, Claudia; Sekar, Kris C.; Auten, Richard L.; Bhutani, Vinod K.; Gerdes, Jeffrey S.; George, Thomas N.; Southgate, W. Michael; Carriedo, Heather; Couser, Robert J.; Mammel, Mark C.; Hall, David C.; Pappagallo, Mariann; Sardesai, Smeeta; Strain, John D.; Baier, Monika; Abman, Steven H.			Early inhaled nitric oxide therapy in premature newborns with respiratory failure	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PERSISTENT PULMONARY-HYPERTENSION; HYALINE-MEMBRANE DISEASE; CHRONIC LUNG-DISEASE; BRONCHOPULMONARY DYSPLASIA; DISTRESS-SYNDROME; NEUTROPHIL INFLUX; PRETERM INFANTS; BLEEDING-TIME; BLOOD; ACTIVATION	Background: The safety and efficacy of early, low-dose, prolonged therapy with inhaled nitric oxide in premature newborns with respiratory failure are uncertain. Methods: We performed a multicenter, randomized trial involving 793 newborns who were 34 weeks of gestational age or less and had respiratory failure requiring mechanical ventilation. Newborns were randomly assigned to receive either inhaled nitric oxide (5 ppm) or placebo gas for 21 days or until extubation, with stratification according to birth weight (500 to 749 g, 750 to 999 g, or 1000 to 1250 g). The primary efficacy outcome was a composite of death or bronchopulmonary dysplasia at 36 weeks of postmenstrual age. Secondary safety outcomes included severe intracranial hemorrhage, periventricular leukomalacia, and ventriculomegaly. Results: Overall, there was no significant difference in the incidence of death or bronchopulmonary dysplasia between patients receiving inhaled nitric oxide and those receiving placebo (71.6 percent vs. 75.3 percent, P=0.24). However, for infants with a birth weight between 1000 and 1250 g, as compared with placebo, inhaled nitric oxide therapy reduced the incidence of bronchopulmonary dysplasia (29.8 percent vs. 59.6 percent); for the cohort overall, such treatment reduced the combined end point of intracranial hemorrhage, periventricular leukomalacia, or ventriculomegaly (17.5 percent vs. 23.9 percent, P=0.03) and of periventricular leukomalacia alone (5.2 percent vs. 9.0 percent, P=0.048). Inhaled nitric oxide therapy did not increase the incidence of pulmonary hemorrhage or other adverse events. Conclusions: Among premature newborns with respiratory failure, low-dose inhaled nitric oxide did not reduce the overall incidence of bronchopulmonary dysplasia, except among infants with a birth weight of at least 1000 g, but it did reduce the overall risk of brain injury. (ClinicalTrials.gov number, NCT00006401.)	Childrens Hosp, Div Neonatol, Denver, CO 80218 USA; Univ Colorado, Sch Med, Pediat Heart Lung Ctr, Denver, CO USA; Univ Alabama, Birmingham, AL USA; Vanderbilt Univ, Med Ctr, Nashville, TN USA; Utah Valley Reg Med Ctr, Provo, UT USA; Univ N Carolina, Chapel Hill, NC USA; Univ Pittsburgh, Magee Womens Hosp, Pittsburgh, PA 15213 USA; Univ Oklahoma, Oklahoma City, OK USA; Duke Univ, Durham, NC USA; Univ Penn Hlth Syst, Penn Hosp, Philadelphia, PA USA; Univ Iowa, Iowa City, IA USA; Med Univ S Carolina, Charleston, SC 29425 USA; Loma Linda Univ, Loma Linda, CA 92350 USA; Childrens Hosp, Minneapolis, MN USA; Childrens Hosp, St Paul, MN USA; St Josephs Hosp, Phoenix, AZ USA; Univ Connecticut, Farmington, CT USA; Univ So Calif, Los Angeles, CA USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Alabama System; University of Alabama Birmingham; Vanderbilt University; University of North Carolina; University of North Carolina Chapel Hill; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Oklahoma System; University of Oklahoma Health Sciences Center; Duke University; University of Pennsylvania; Pennsylvania Medicine; University of Iowa; Medical University of South Carolina; Loma Linda University; Children's Hospitals & Clinics of Minnesota; Children's Hospitals & Clinics of Minnesota; St. Joseph's Hospital and Medical Center; University of Connecticut; University of Southern California	Kinsella, JP (corresponding author), Childrens Hosp, Div Neonatol, Box B-070,1056 E 19th Ave, Denver, CO 80218 USA.	john.kinsella@uchsc.edu	Cutter, Gary/AAY-5392-2021	Cutter, Gary/0000-0002-8455-980X; Mammel, Mark/0000-0002-2256-4574	NCRR NIH HHS [M01-RR00069] Funding Source: Medline; PHS HHS [P50-57144, UO1-64857] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000069] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		ABMAN SH, 1993, PEDIATRICS, V92, P606; [Anonymous], 1997, NEW ENGL J MED, V337, P434; Auten RL, 2003, PEDIATR PULM, V35, P335, DOI 10.1002/ppul.10275; Ballard RA, 2006, NEW ENGL J MED, V355, P343, DOI 10.1056/NEJMoa061088; Bland RD, 2005, AM J RESP CRIT CARE, V172, P899, DOI 10.1164/rccm.200503-384OC; Brus F, 1996, PEDIATR RES, V39, P958, DOI 10.1203/00006450-199606000-00006; Cannon RO, 2001, J CLIN INVEST, V108, P279, DOI 10.1172/JCI12761; Clark RH, 2000, NEW ENGL J MED, V342, P469, DOI 10.1056/NEJM200002173420704; George TN, 1998, J PEDIATR-US, V132, P731, DOI 10.1016/S0022-3476(98)70370-1; Gutierrez HH, 1996, FREE RADICAL BIO MED, V21, P43, DOI 10.1016/0891-5849(95)02226-0; Haynes RL, 2005, BRAIN PATHOL, V15, P225; HOGMAN M, 1993, LANCET, V341, P1664, DOI 10.1016/0140-6736(93)90802-N; Issa A, 1999, PEDIATR RES, V45, P247, DOI 10.1203/00006450-199902000-00016; Kinsella JP, 1997, PEDIATR RES, V41, P457, DOI 10.1203/00006450-199704000-00002; KINSELLA JP, 1992, LANCET, V340, P819, DOI 10.1016/0140-6736(92)92687-B; KINSELLA JP, 1994, PEDIATR RES, V36, P402, DOI 10.1203/00006450-199409000-00022; Kinsella JP, 1999, LANCET, V354, P1061, DOI 10.1016/S0140-6736(99)03558-8; Lin YJ, 2005, PEDIATR RES, V58, P22, DOI 10.1203/01.PDR.0000163378.94837.3E; McCurnin DC, 2005, AM J PHYSIOL-LUNG C, V288, pL450, DOI 10.1152/ajplung.00347.2004; MERRITT TA, 1983, J CLIN INVEST, V72, P656, DOI 10.1172/JCI111015; Mestan KKL, 2005, NEW ENGL J MED, V353, P23, DOI 10.1056/NEJMoa043514; NORTHWAY WH, 1967, NEW ENGL J MED, V276, P357, DOI 10.1056/NEJM196702162760701; OGDEN BE, 1983, CHEST, V83, pS31, DOI 10.1378/chest.83.5.31S; PAPILE LA, 1978, J PEDIATR-US, V92, P529, DOI 10.1016/S0022-3476(78)80282-0; Pawloski JR, 2001, NATURE, V409, P622, DOI 10.1038/35054560; PELIOWSKI A, 1995, J PEDIATR-US, V126, P450, DOI 10.1016/S0022-3476(95)70467-1; ROBERTS JD, 1992, LANCET, V340, P818, DOI 10.1016/0140-6736(92)92686-A; Schreiber MD, 2003, NEW ENGL J MED, V349, P2099, DOI 10.1056/NEJMoa031154; SPEER CP, 1993, PEDIATRICS, V91, P794; Stork E, 1997, NEW ENGL J MED, V336, P597; Subhedar NV, 1997, ARCH DIS CHILD-FETAL, V77, pF191, DOI 10.1136/fn.77.3.F191; SUGIURA M, 1994, J APPL PHYSIOL, V77, P1355, DOI 10.1152/jappl.1994.77.3.1355; TOCE SS, 1984, AM J DIS CHILD, V138, P581, DOI 10.1001/archpedi.1984.02140440065017; Van Meurs KP, 2005, NEW ENGL J MED, V353, P13, DOI 10.1056/NEJMoa043927; Viscardi RM, 2004, PEDIATR RES, V55, P1009, DOI 10.1203/01.pdr.0000127015.60185.8a	35	239	251	1	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 27	2006	355	4					354	364		10.1056/NEJMoa060442	http://dx.doi.org/10.1056/NEJMoa060442			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	067DT	16870914				2022-12-28	WOS:000239282600004
J	Siegel, M; Blum, A				Siegel, Michael; Blum, Alan			FDA regulation of tobacco: reprieve for the Marlboro man?	LANCET			English	Editorial Material									Boston Univ, Sch Publ Hlth, Dept Social & Behav Sci, Boston, MA 02118 USA; Univ Alabama, Ctr Study Tobacco & Soc, Tuscaloosa, AL USA	Boston University; University of Alabama System; University of Alabama Tuscaloosa	Siegel, M (corresponding author), Boston Univ, Sch Publ Hlth, Dept Social & Behav Sci, Boston, MA 02118 USA.	mbsiegel@bu.edu		Siegel, Michael/0000-0002-2573-9616				*ALTR GROUP, 2005, OUR POS FDA REG TOB; BLUM A, 1991, NEW ENGL J MED, V324, P913, DOI 10.1056/NEJM199103283241310; *CAMP TOB FREE KID, 2005, PUBL HLTH GROUPS CAL; *CAMP TOB FREE KID, 2005, BROK PROM OUT CHILDR; MULLINS B, 2004, ROLL CALL       1005, P1; *NAT CTR TOB FREE, 2000, CAMP PROV STAT US SU; Siegel M, 2001, AM J PUBLIC HEALTH, V91, P1100, DOI 10.2105/AJPH.91.7.1100; 1996, FED REG         0828, V21, P44396	8	4	4	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 22	2006	368	9532					266	268		10.1016/S0140-6736(06)69052-1	http://dx.doi.org/10.1016/S0140-6736(06)69052-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	067PF	16860681				2022-12-28	WOS:000239314400006
J	Florez, JC; Jablonski, KA; Bayley, N; Pollin, TI; de Bakker, PIW; Shuldiner, AR; Knowler, WC; Nathan, DM; Altshuler, D				Florez, Jose C.; Jablonski, Kathleen A.; Bayley, Nick; Pollin, Toni I.; de Bakker, Paul I. W.; Shuldiner, Alan R.; Knowler, William C.; Nathan, David M.; Altshuler, David		Diabet Prevention Program Res Grp	TCF7L2 polymorphisms and progression to diabetes in the Diabetes Prevention Program	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							INSULIN-RESISTANCE; GLUCOSE-TOLERANCE; VARIANT; RISK	Background: Common polymorphisms of the transcription factor 7-like 2 gene (TCF7L2) have recently been associated with type 2 diabetes. We examined whether the two most strongly associated variants (rs12255372 and rs7903146) predict the progression to diabetes in persons with impaired glucose tolerance who were enrolled in the Diabetes Prevention Program, in which lifestyle intervention or treatment with metformin was compared with placebo. Methods: We genotyped these variants in 3548 participants and performed Cox regression analysis using genotype, intervention, and their interactions as predictors. We assessed the effect of genotype on measures of insulin secretion and insulin sensitivity at baseline and at one year. Results: Over an average period of three years, participants with the risk-conferring TT genotype at rs7903146 were more likely to have progression from impaired glucose tolerance to diabetes than were CC homozygotes (hazard ratio, 1.55; 95 percent confidence interval, 1.20 to 2.01; P < 0.001). The effect of genotype was stronger in the placebo group (hazard ratio, 1.81; 95 percent confidence interval, 1.21 to 2.70; P=0.004) than in the metformin and lifestyle-intervention groups (hazard ratios, 1.62 and 1.15, respectively; P for the interaction between genotype and intervention not significant). The TT genotype was associated with decreased insulin secretion but not increased insulin resistance at baseline. Similar results were obtained for rs12255372. Conclusions: Common variants in TCF7L2 seem to be associated with an increased risk of diabetes among persons with impaired glucose tolerance. The risk-conferring genotypes in TCF7L2 are associated with impaired beta-cell function but not with insulin resistance. (ClinicalTrials.gov number, NTC00004992.)	George Washington Univ, Diabet Prevent Program Outcomes Study Coordinatin, Rockville, MD USA	George Washington University	Florez, JC (corresponding author), George Washington Univ, Ctr Biostat, Diabet Prevent Program Coordinating Ctr, 6110 Execut Blvd,Suite 750, Rockville, MD 20852 USA.	dppmail@biostat.bsc.gwu.edu	de Bakker, Paul IW/B-8730-2009; Altshuler, David M/A-4476-2009	de Bakker, Paul IW/0000-0001-7735-7858; Altshuler, David M/0000-0002-7250-4107; Shuldiner, Alan/0000-0001-9921-4305	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK048489, Z01DK069051, Z01DK069000, R01DK072041, K23DK065978] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline; NIDDK NIH HHS [K23 DK65978-03, R01DK072041-01, U01 DK048489, K23 DK065978, R01 DK072041] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		[Anonymous], 1999, NAT GENET, V22, P1; Barroso I, 2005, DIABETIC MED, V22, P517, DOI 10.1111/j.1464-5491.2005.01550.x; Bray GA, 1999, DIABETES CARE, V22, P623; *DIAB PREV PROGR, 1999, DIABETES CARE, V22, P1389; Diabetes Prevention Progam, 2005, DIABETES, V54, P1150; Fajans SS, 2001, NEW ENGL J MED, V345, P971, DOI 10.1056/NEJMra002168; Florez JC, 2004, DIABETES, V53, P1360, DOI 10.2337/diabetes.53.5.1360; Florez JC, 2003, ANNU REV GENOM HUM G, V4, P257, DOI 10.1146/annurev.genom.4.070802.110436; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Grant SFA, 2006, NAT GENET, V38, P320, DOI 10.1038/ng1732; GREENBERG RS, 1985, ANNU REV PUBL HEALTH, V6, P223; Hanson RL, 2000, AM J EPIDEMIOL, V151, P190; Hattersley AT, 2005, LANCET, V366, P1315, DOI 10.1016/S0140-6736(05)67531-9; Hirschhorn JN, 2002, GENET MED, V4, P45, DOI 10.1097/00125817-200203000-00002; HOLM S, 1979, SCAND J STAT, V6, P65; Ioannidis JPA, 2001, NAT GENET, V29, P306, DOI 10.1038/ng749; Kitabchi AE, 2005, DIABETES, V54, P2404, DOI 10.2337/diabetes.54.8.2404; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Lohmueller KE, 2003, NAT GENET, V33, P177, DOI 10.1038/ng1071; Lyssenko V, 2005, PLOS MED, V2, P1299, DOI 10.1371/journal.pmed.0020345; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Nielsen EMD, 2003, DIABETES, V52, P573, DOI 10.2337/diabetes.52.2.573; O'Rahilly S, 2005, SCIENCE, V307, P370, DOI 10.1126/science.1104346; PHILLIPS DIW, 1994, DIABETIC MED, V11, P286, DOI 10.1111/j.1464-5491.1994.tb00273.x; SLUITER WJ, 1976, DIABETES, V25, P241, DOI 10.2337/diabetes.25.4.241; Tang K, 1999, P NATL ACAD SCI USA, V96, P10016, DOI 10.1073/pnas.96.18.10016; Yi FH, 2005, J BIOL CHEM, V280, P1457, DOI 10.1074/jbc.M411487200	27	645	726	1	44	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 20	2006	355	3					241	250		10.1056/NEJMoa062418	http://dx.doi.org/10.1056/NEJMoa062418			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	064NY	16855264	Green Accepted			2022-12-28	WOS:000239097600005
J	Montoya, JM; Pimm, SL; Sole, RV				Montoya, Jose M.; Pimm, Stuart L.; Sole, Ricard V.			Ecological networks and their fragility	NATURE			English	Review							FOOD-WEB PATTERNS; BODY-SIZE; COEVOLUTIONARY NETWORKS; TROPHIC INTERACTIONS; SPECIES ABUNDANCE; COMPLEXITY; STABILITY; COMPARTMENTS; SPECIALIZATION; CONNECTANCE	Darwin used the metaphor of a 'tangled bank' to describe the complex interactions between species. Those interactions are varied: they can be antagonistic ones involving predation, herbivory and parasitism, or mutualistic ones, such as those involving the pollination of flowers by insects. Moreover, the metaphor hints that the interactions may be complex to the point of being impossible to understand. All interactions can be visualized as ecological networks, in which species are linked together, either directly or indirectly through intermediate species. Ecological networks, although complex, have well defined patterns that both illuminate the ecological mechanisms underlying them and promise a better understanding of the relationship between complexity and ecological stability.	Duke Univ, Nicholas Sch Environm & Earth Sci, Durham, NC 27708 USA; IMIM UPF, ICREA Complex Syst Lab, Barcelona 08003, Spain; Queen Mary Univ London, Sch Biol & Chem Sci, London E1 4NS, England; Santa Fe Inst, Santa Fe, NM 87501 USA	Duke University; ICREA; Pompeu Fabra University; University of London; Queen Mary University London; The Santa Fe Institute	Pimm, SL (corresponding author), Duke Univ, Nicholas Sch Environm & Earth Sci, Durham, NC 27708 USA.	stuartpimm@aol.com	Montoya, Jose/AAH-2369-2019; pimm, stuart/ABF-1082-2020; Solé, Ricard/I-3379-2015; Montoya, Jose M/E-3605-2010	Montoya, Jose M./0000-0002-6676-7592; Sole, Ricard/0000-0001-6974-1008	Natural Environment Research Council [NE/C002105/1] Funding Source: researchfish; ICREA Funding Source: Custom	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); ICREA(ICREA)		Abrams Peter A., 1996, P371; Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; Amaral LAN, 2000, P NATL ACAD SCI USA, V97, P11149, DOI 10.1073/pnas.200327197; Askew R. R., 1961, Transactions of the Society for British Entomology, V14, P237; Bascompte J, 2006, SCIENCE, V312, P431, DOI 10.1126/science.1123412; Bascompte J, 2003, P NATL ACAD SCI USA, V100, P9383, DOI 10.1073/pnas.1633576100; Berlow EL, 1999, NATURE, V398, P330, DOI 10.1038/18672; Berlow EL, 2004, J ANIM ECOL, V73, P585, DOI 10.1111/j.0021-8790.2004.00833.x; Cattin MF, 2004, NATURE, V427, P835, DOI 10.1038/nature02327; Cohen J.E., 1990, COMMUNITY FOOD WEBS; COHEN JE, 1993, ECOLOGY, V74, P252, DOI 10.2307/1939520; Cohen JE, 2003, P NATL ACAD SCI USA, V100, P1781, DOI 10.1073/pnas.232715699; Dunne JA, 2002, P NATL ACAD SCI USA, V99, P12917, DOI 10.1073/pnas.192407699; Dunne JA, 2002, ECOL LETT, V5, P558, DOI 10.1046/j.1461-0248.2002.00354.x; Emmerson MC, 2004, J ANIM ECOL, V73, P399, DOI 10.1111/j.0021-8790.2004.00818.x; Fonseca CR, 1996, J ANIM ECOL, V65, P339, DOI 10.2307/5880; Froese R, 2005, FISHBASE; Garlaschelli D, 2003, NATURE, V423, P165, DOI 10.1038/nature01604; HALL SJ, 1991, J ANIM ECOL, V60, P823, DOI 10.2307/5416; Hawkins B. A., 1994, PATTERN PROCESS HOST; INOUE T, 1990, Contributions from the Biological Laboratory Kyoto University, V27, P377; Jonsson T, 2005, ADV ECOL RES, V36, P1, DOI 10.1016/S0065-2504(05)36001-6; JORDANO P, 1987, AM NAT, V129, P657, DOI 10.1086/284665; Jordano P, 2003, ECOL LETT, V6, P69, DOI 10.1046/j.1461-0248.2003.00403.x; JORDANO P, 2005, PLANT POLLINATOR INT; Kitching R.L., 1983, P205; Kitching R.L., 2000, FOOD WEBS CONTAINER, DOI [10.1017/CBO9780511542107, DOI 10.1017/CBO9780511542107]; Krause AE, 2003, NATURE, V426, P282, DOI 10.1038/nature02115; MACARTHUR R, 1955, ECOLOGY, V36, P533, DOI 10.2307/1929601; May R.M., 1974, STABILITY COMPLEXITY; McCann K, 1998, NATURE, V395, P794, DOI 10.1038/27427; McCann KS, 2000, NATURE, V405, P228, DOI 10.1038/35012234; Melian CJ, 2004, ECOLOGY, V85, P352, DOI 10.1890/02-0638; MEMMOTT J, 1994, J ANIM ECOL, V63, P521, DOI 10.2307/5219; Memmott J, 2004, P ROY SOC B-BIOL SCI, V271, P2605, DOI 10.1098/rspb.2004.2909; MENGE BA, 1995, ECOL MONOGR, V65, P21, DOI 10.2307/2937158; Montoya JM, 2003, OIKOS, V102, P614, DOI 10.1034/j.1600-0706.2003.12031.x; Montoya JM, 2002, J THEOR BIOL, V214, P405, DOI 10.1006/jtbi.2001.2460; Neutel AM, 2002, SCIENCE, V296, P1120, DOI 10.1126/science.1068326; PAINE RT, 1969, AM NAT, V103, P91, DOI 10.1086/282586; PIMM SL, 1984, NATURE, V307, P321, DOI 10.1038/307321a0; PIMM SL, 1987, THEOR POPUL BIOL, V32, P303, DOI 10.1016/0040-5809(87)90052-9; PIMM SL, 1991, NATURE, V350, P669, DOI 10.1038/350669a0; PIMM SL, 1980, J ANIM ECOL, V49, P879, DOI 10.2307/4233; PIMM SL, 2003, FOOD WEBS; Pimm SL, 1991, BALANCE NATURE ECOLO; Pimm SL, 2001, WORLD ACCORDING PIMM; POLIS GA, 1991, AM NAT, V138, P123, DOI 10.1086/285208; Polis GA, 1996, AM NAT, V147, P813, DOI 10.1086/285880; RAFFAELLI D, 1992, J ANIM ECOL, V61, P551, DOI 10.2307/5610; Raffaelli David G., 1996, P185; Rana JS, 2002, J ANIM ECOL, V71, P15, DOI 10.1046/j.0021-8790.2001.00574.x; Reagan D.P., 1996, FOOD WEB TROPICAL RA; ROOT RB, 1967, ECOL MONOGR, V37, P317, DOI 10.2307/1942327; Sanderson JG, 2000, AM SCI, V88, P332, DOI 10.1511/2000.4.332; Sih A, 1998, TRENDS ECOL EVOL, V13, P350, DOI 10.1016/S0169-5347(98)01437-2; Sole R. V., 2002, Complexity, V8, P20, DOI 10.1002/cplx.10055; Sole RV, 2001, P ROY SOC B-BIOL SCI, V268, P2039, DOI 10.1098/rspb.2001.1767; SOLE RV, 2006, SELF ORG COMPLEX ECO; Stouffer DB, 2005, ECOLOGY, V86, P1301, DOI 10.1890/04-0957; Strogatz SH, 2001, NATURE, V410, P268, DOI 10.1038/35065725; STRONG DR, 1984, INSECTS PLANTS; Sugihara G, 2003, P NATL ACAD SCI USA, V100, P5246, DOI 10.1073/pnas.0831096100; Temeles EJ, 2003, SCIENCE, V300, P630, DOI 10.1126/science.1080003; Thomas J.D., 1990, Advances in Ecological Research, V20, P125, DOI 10.1016/S0065-2504(08)60054-9; Thompson JD., 1994, COEVOLUTIONARY PROCE; Vazquez DP, 2003, ECOLOGY, V84, P2493, DOI 10.1890/02-0587; Warren Philip H., 1996, P142; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; WHEELWRIGHT NT, 1984, BIOTROPICA, V16, P173, DOI 10.2307/2388051; Williams RJ, 2004, AM NAT, V163, P458, DOI 10.1086/381964; Williams RJ, 2002, P NATL ACAD SCI USA, V99, P12913, DOI 10.1073/pnas.192448799; Williams RJ, 2000, NATURE, V404, P180, DOI 10.1038/35004572; Woodward G, 2005, TRENDS ECOL EVOL, V20, P402, DOI 10.1016/j.tree.2005.04.005; Woodward Guy, 2005, P179; Wootton JT, 2002, J SEA RES, V48, P157, DOI 10.1016/S1385-1101(02)00149-1; Yodzis P, 1998, J ANIM ECOL, V67, P635, DOI 10.1046/j.1365-2656.1998.00224.x	78	773	808	39	580	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 20	2006	442	7100					259	264		10.1038/nature04927	http://dx.doi.org/10.1038/nature04927			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064WT	16855581				2022-12-28	WOS:000239122100029
J	Sawyers, CL				Sawyers, Charles L.			Will kinase inhibitors have a dark side?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							INVASION; AKT		Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90024 USA; Univ Calif Los Angeles, Dept Mol Pharmacol, Los Angeles, CA USA; Univ Calif Los Angeles, Dept Urol, Los Angeles, CA USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Sawyers, CL (corresponding author), Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90024 USA.		Sawyers, Charles/G-5327-2016					Arteaga CL, 2006, CURR OPIN GENET DEV, V16, P30, DOI 10.1016/j.gde.2005.12.009; Hutchinson JN, 2004, CANCER RES, V64, P3171, DOI 10.1158/0008-5472.CAN-03-3465; Neshat MS, 2001, P NATL ACAD SCI USA, V98, P10314, DOI 10.1073/pnas.171076798; O'Reilly KE, 2006, CANCER RES, V66, P1500, DOI 10.1158/0008-5472.CAN-05-2925; Yoeli-Lerner M, 2005, MOL CELL, V20, P539, DOI 10.1016/j.molcel.2005.10.033	5	32	32	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 20	2006	355	3					313	315		10.1056/NEJMcibr062354	http://dx.doi.org/10.1056/NEJMcibr062354			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	064NY	16855275				2022-12-28	WOS:000239097600017
J	Mangione, CM; Gerzoff, RB; Williamson, DF; Steers, WN; Kerr, EA; Brown, AF; Waitzfelder, BE; Marrero, DG; Dudley, RA; Kim, C; Herman, W; Thompson, TJ; Safford, MM; Selby, JV				Mangione, Carol M.; Gerzoff, Robert B.; Williamson, David F.; Steers, W. Neil; Kerr, Eve A.; Brown, Arleen F.; Waitzfelder, Beth E.; Marrero, David G.; Dudley, R. Adams; Kim, Catherine; Herman, William; Thompson, Theodore J.; Safford, Monika M.; Selby, Joe V.		TRIAD Study Grp	The association between quality of care and the intensity of diabetes disease management programs	ANNALS OF INTERNAL MEDICINE			English	Article							HEALTH MAINTENANCE ORGANIZATION; CHRONIC ILLNESS; IMPROVE; SYSTEM; INTERVENTIONS; SERVICES; VISITS; ADULTS; RISK	Background: Although disease management programs are widely implemented, little is known about their effectiveness. Objective: To determine whether disease management by physician groups is associated with diabetes care processes, control of intermediate outcomes, or the amount of medication used when intermediate outcomes are above target levels. Design: Cross-sectional study. Setting: Patients were randomly sampled from 63 physician groups nested in 7 health plans sponsored by Translating Research into Action for Diabetes (87%) and from 4 health plans with individual physician contracts (13%). Patients: 8661 adults with diabetes who completed a survey (2000-2001) and had medical record data. Measurements: Physician group and health plan directors described their organizations' use of physician reminders, performance feedback, and structured care management on a survey; their responses were used to determine measures of intensity of disease management. The current study measured 8 processes of care, including most recent hemoglobin A, level, systolic blood pressure, serum low-density lipoprotein cholesterol level, and several measures of medication use. Results: Increased use of any of 3 disease management strategies was significantly associated with higher adjusted rates of retinal screening, nephropathy screening, foot examinations, and measurement of hemoglobin Aye levels. Serum lipid level testing and influenza vaccine administration were associated with greater use of structured care management and performance feedback. Greater use of performance feedback correlated with an increased rate of foot examinations (difference, 5 percentage points [95% Cl, 1 to 8 percentage points]), and greater use of physician reminders was associated with an increased rate of nephropathy screening (difference, 15 percentage points [Cl, 6 to 23 percentage points]). No strategies were associated with intermediate outcome levels or level of medication management. Limitations: Physician groups were not randomly sampled from population-based listings, and disease management strategies were not randomly allocated across groups. Conclusions: Disease management strategies were associated with better processes of diabetes care but not with improved intermediate outcomes or level of medication management. A greater focus on direct measurement, feedback, and reporting of intermediate outcome levels or of level of medication management may enhance the effectiveness of these programs.	Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA; Ctr Dis Control & Prevent, Atlanta, GA USA; Vet Affiars Ann Arbor Healthcare Syst, Ann Arbor, MI USA; Univ Michigan, Sch Med, Ann Arbor, MI 48109 USA; Univ Med & Dent New Jersey, Newark, NJ 07103 USA; Pacific Healthcare Inst, Honolulu, HI USA; Indiana Univ, Sch Med, Bloomington, IN 47405 USA; Univ Med & Dent New Jersey, Newark, NJ 07103 USA; Pacific Hlth Res Inst, Honolulu, HI USA; Indiana Univ, Sch Med, Indianapolis, IN 46204 USA; Univ Calif San Francisco, Inst Hlth Policy Studies, San Francisco, CA 94143 USA; Kaiser Permanente, Oakland, CA USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Centers for Disease Control & Prevention - USA; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System; University of Michigan System; University of Michigan; Rutgers State University New Brunswick; Rutgers State University Medical Center; Indiana University System; Indiana University Bloomington; Rutgers State University New Brunswick; Rutgers State University Medical Center; Pacific Health Research & Education Institute; Indiana University System; Indiana University-Purdue University Indianapolis; University of California System; University of California San Francisco; Kaiser Permanente	Mangione, CM (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, 911 Broxton Pl,Room 119, Los Angeles, CA 90095 USA.	cmangione@mednet.ucla.edu		Brown, Arleen/0000-0001-9948-8955				*AM DIAB ASS, INTR; [Anonymous], IMPROVING DATA QUALI; Aubert RE, 1998, ANN INTERN MED, V129, P605, DOI 10.7326/0003-4819-129-8-199810150-00004; Beckles GLA, 1998, DIABETES CARE, V21, P1432, DOI 10.2337/diacare.21.9.1432; Casalino L, 2003, JAMA-J AM MED ASSOC, V289, P434, DOI 10.1001/jama.289.4.434; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Curb JD, 2002, DIABETES CARE, V25, P386; Ellrodt G, 1997, JAMA-J AM MED ASSOC, V278, P1687, DOI 10.1001/jama.278.20.1687; Engelgau MM, 1998, DIABETES CARE, V21, P2062, DOI 10.2337/diacare.21.12.2062; Epstein RS, 1996, ANN INTERN MED, V124, P832, DOI 10.7326/0003-4819-124-9-199605010-00008; Fleming B, 2004, AM J MANAG CARE, V10, P934; *HEDIS, 1999, HLTH PLAN EMPL DAT I; Ilag LL, 2003, DIABETES CARE, V26, P2722, DOI 10.2337/diacare.26.10.2722; Ivers N, 2012, COCHRANE DB SYST REV, V6, DOI DOI 10.1002/14651858.CD000259.PUB3; Katz JN, 1996, MED CARE, V34, P73, DOI 10.1097/00005650-199601000-00006; Keating NL, 2004, MED CARE, V42, P829, DOI 10.1097/01.mlr.0000135829.73795.a7; Kerr EA, 2004, ANN INTERN MED, V141, P272, DOI 10.7326/0003-4819-141-4-200408170-00007; Kerr EA, 2003, MED CARE, V41, P1173, DOI 10.1097/01.MLR.0000088453.57269.29; Kerr EA, 2001, AM J MANAG CARE, V7, P1033; Krein SL, 2000, MED CARE, V38, pS38; Leatherman S, 2003, HEALTH AFFAIR, V22, P17, DOI 10.1377/hlthaff.22.2.17; Montori VM, 2002, DIABETES CARE, V25, P1952, DOI 10.2337/diacare.25.11.1952; National Committee for Quality Assurance, STAT HLTH CAR QUAL R; Norris SL, 2002, AM J PREV MED, V22, P15, DOI 10.1016/S0749-3797(02)00423-3; ORNSTEIN SM, 1991, J FAM PRACTICE, V32, P82; Ornstein SM, 1999, AM J MANAG CARE, V5, P621; Petitti DB, 2000, DIABETES CARE, V23, P192, DOI 10.2337/diacare.23.2.192; Renders CM, 2001, DIABETES CARE, V24, P1821, DOI 10.2337/diacare.24.10.1821; Saaddine JB, 2002, ANN INTERN MED, V136, P565, DOI 10.7326/0003-4819-136-8-200204160-00005; Sadur CN, 1999, DIABETES CARE, V22, P2011, DOI 10.2337/diacare.22.12.2011; Saydah SH, 2004, JAMA-J AM MED ASSOC, V291, P335, DOI 10.1001/jama.291.3.335; Simon LP, 1999, DIABETES CARE, V22, P208, DOI 10.2337/diacare.22.2.208; Sperl-Hillen J, 2000, Jt Comm J Qual Improv, V26, P615; Trento M, 2001, DIABETES CARE, V24, P995, DOI 10.2337/diacare.24.6.995; Wagner EH, 2001, HEALTH AFFAIR, V20, P64, DOI 10.1377/hlthaff.20.6.64; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; Weingarten SR, 2002, BRIT MED J, V325, P925, DOI 10.1136/bmj.325.7370.925	37	129	132	0	8	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 18	2006	145	2					107	116		10.7326/0003-4819-145-2-200607180-00008	http://dx.doi.org/10.7326/0003-4819-145-2-200607180-00008			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	063WU	16847293	Green Submitted			2022-12-28	WOS:000239051400004
J	Steven, AC; Spear, PG				Steven, Alasdair C.; Spear, Patricia G.			Biochemistry - Viral glycoproteins and an evolutionary conundrum	SCIENCE			English	Editorial Material							MEMBRANE-FUSION; VIRUS; MECHANISM; ENTRY		NIAMSD, Struct Biol Lab, Bethesda, MD 20892 USA; Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); Northwestern University; Feinberg School of Medicine	Steven, AC (corresponding author), NIAMSD, Struct Biol Lab, 50 South Dr, Bethesda, MD 20892 USA.	stevena@mail.nih.gov; p-spear@northwestern.edu			NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [ZIAAR027002, Z01AR027002] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Baker ML, 2005, J VIROL, V79, P14967, DOI 10.1128/JVI.79.23.14967-14970.2005; DINITTO JP, 2003, SCI STKE, pRE16, DOI DOI 10.1126/STKE.2132003RE16; Harrison SC, 2005, ADV VIRUS RES, V64, P231, DOI 10.1016/S0065-3527(05)64007-9; Heldwein EE, 2006, SCIENCE, V313, P217, DOI 10.1126/science.1126548; McGeoch DJ, 2006, VIRUS RES, V117, P90, DOI 10.1016/j.virusres.2006.01.002; Roche S, 2002, VIROLOGY, V297, P128, DOI 10.1006/viro.2002.1429; Roche S, 2006, SCIENCE, V313, P187, DOI 10.1126/science.1127683; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; Spear PG, 2004, CELL MICROBIOL, V6, P401, DOI 10.1111/j.1462-5822.2004.00389.x; Steven AC, 2005, CURR OPIN STRUC BIOL, V15, P227, DOI 10.1016/j.sbi.2005.03.008; STEVEN AC, 1997, STRUCTURAL BIOL VIRU, P312; Wikoff WR, 2000, SCIENCE, V289, P2129, DOI 10.1126/science.289.5487.2129	12	34	36	1	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 14	2006	313	5784					177	178		10.1126/science.1129761	http://dx.doi.org/10.1126/science.1129761			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	063GZ	16840685				2022-12-28	WOS:000239008000027
J	Neale, MJ; Keeney, S				Neale, Matthew J.; Keeney, Scott			Clarifying the mechanics of DNA strand exchange in meiotic recombination	NATURE			English	Review							RECA HOMOLOGS RAD51; HUMAN DMC1 PROTEIN; SACCHAROMYCES-CEREVISIAE; SCHIZOSACCHAROMYCES-POMBE; CROSSOVER INTERFERENCE; SYNAPTONEMAL COMPLEX; CHROMOSOME SYNAPSIS; CHIASMA FORMATION; ATPASE ACTIVITY; OCTAMERIC RING	During meiosis, accurate separation of maternal and paternal chromosomes requires that they first be connected to one another through homologous recombination. Meiotic recombination has many intriguing but poorly understood features that distinguish it from recombination in mitotically dividing cells, and several of these features depend on the meiosis-specific DNA strand exchange protein Dmc1 ( disrupted meiotic cDNA1). Many questions about this protein have arisen since its discovery more than a decade ago, but recent genetic and biochemical breakthroughs promise to shed light on the unique behaviours and functions of this central player in the remarkable chromosome dynamics of meiosis.	Mem Sloan Kettering Canc Ctr, Program Mol Biol, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center	Keeney, S (corresponding author), Mem Sloan Kettering Canc Ctr, Program Mol Biol, 1275 York Ave, New York, NY 10021 USA.	keeneys@mskcc.org	Keeney, Scott/GVR-8515-2022	Neale, Matthew/0000-0002-6453-1877; Keeney, Scott/0000-0002-1283-6417	NIGMS NIH HHS [R01 GM058673] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058673] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABOUSSEKHRA A, 1992, MOL CELL BIOL, V12, P3224, DOI 10.1128/MCB.12.7.3224; Akamatsu Y, 2003, P NATL ACAD SCI USA, V100, P15770, DOI 10.1073/pnas.2632890100; Alexeev A, 2003, NAT STRUCT BIOL, V10, P182, DOI 10.1038/nsb901; Bianco P. R., 1998, FRONT BIOSCI, V3, pD570; Bishop DK, 1999, GENES CELLS, V4, P425, DOI 10.1046/j.1365-2443.1999.00273.x; BISHOP DK, 1994, CELL, V79, P1081, DOI 10.1016/0092-8674(94)90038-8; BISHOP DK, 1992, CELL, V69, P439, DOI 10.1016/0092-8674(92)90446-J; Blat Y, 2002, CELL, V111, P791, DOI 10.1016/S0092-8674(02)01167-4; Bugreev DV, 2005, J BIOL CHEM, V280, P26886, DOI 10.1074/jbc.M502248200; Bugreev DV, 2004, P NATL ACAD SCI USA, V101, P9988, DOI 10.1073/pnas.0402105101; Catlett MG, 2003, MOL BIOL CELL, V14, P4707, DOI 10.1091/mbc.E03-05-0288; Chang YC, 2005, BIOCHEMISTRY-US, V44, P6052, DOI 10.1021/bi048897q; Chen YK, 2004, P NATL ACAD SCI USA, V101, P10572, DOI 10.1073/pnas.0404195101; Di Giacomo M, 2005, P NATL ACAD SCI USA, V102, P737, DOI 10.1073/pnas.0406212102; Dray E, 2006, PLANT PHYSIOL, V140, P1059, DOI 10.1104/pp.105.075838; Dresser ME, 1997, GENETICS, V147, P533; Ellermeier C, 2004, GENETICS, V168, P1891, DOI 10.1534/genetics.104.034280; Enomoto R, 2006, J BIOL CHEM, V281, P5575, DOI 10.1074/jbc.M506506200; Enomoto R, 2004, J BIOL CHEM, V279, P35263, DOI 10.1074/jbc.M402481200; Gerton JL, 2002, P NATL ACAD SCI USA, V99, P6895, DOI 10.1073/pnas.102167899; Grushcow JM, 1999, GENETICS, V153, P607; Gupta RC, 2001, P NATL ACAD SCI USA, V98, P8433, DOI 10.1073/pnas.121005298; Hayase A, 2004, CELL, V119, P927, DOI 10.1016/j.cell.2004.10.031; Henry JM, 2006, MOL CELL BIOL, V26, P2913, DOI 10.1128/MCB.26.8.2913-2923.2006; Hong ERL, 2001, J BIOL CHEM, V276, P41906, DOI 10.1074/jbc.M105563200; Hunter N, 2001, CELL, V106, P59, DOI 10.1016/S0092-8674(01)00430-5; Jaskelioff M, 2003, J BIOL CHEM, V278, P9212, DOI 10.1074/jbc.M211545200; Johnson RD, 2001, BIOCHEM SOC T, V29, P196, DOI 10.1042/BST0290196; Keeney S, 2001, CURR TOP DEV BIOL, V52, P1, DOI 10.1016/S0070-2153(01)52008-6; Kinebuchi T, 2005, J BIOL CHEM, V280, P28382, DOI 10.1074/jbc.M503372200; Kinebuchi T, 2004, MOL CELL, V14, P363, DOI 10.1016/S1097-2765(04)00218-7; Kleckner N, 2006, CHROMOSOMA, V115, P175, DOI 10.1007/s00412-006-0055-7; Klein F, 1999, CELL, V98, P91, DOI 10.1016/S0092-8674(00)80609-1; Kojic M, 2002, MOL CELL, V10, P683, DOI 10.1016/S1097-2765(02)00632-9; Krogh BO, 2004, ANNU REV GENET, V38, P233, DOI 10.1146/annurev.genet.38.072902.091500; Lee MH, 2005, J BIOL CHEM, V280, P40980, DOI 10.1074/jbc.M505896200; Leu JY, 1998, CELL, V94, P375, DOI 10.1016/S0092-8674(00)81480-4; Li ZF, 1997, P NATL ACAD SCI USA, V94, P11221, DOI 10.1073/pnas.94.21.11221; Martin JS, 2005, MOL CELL BIOL, V25, P3127, DOI 10.1128/MCB.25.8.3127-3139.2005; Masson JY, 1999, EMBO J, V18, P6552, DOI 10.1093/emboj/18.22.6552; Nara T, 2001, BIOCHEM BIOPH RES CO, V285, P92, DOI 10.1006/bbrc.2001.5095; Neale MJ, 2005, NATURE, V436, P1053, DOI 10.1038/nature03872; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; Passy SI, 1999, P NATL ACAD SCI USA, V96, P10684, DOI 10.1073/pnas.96.19.10684; Petronczki M, 2003, CELL, V112, P423, DOI 10.1016/S0092-8674(03)00083-7; Petukhova G, 1998, NATURE, V393, P91, DOI 10.1038/30037; Petukhova G, 2000, GENE DEV, V14, P2206, DOI 10.1101/gad.826100; Petukhova GV, 2005, NAT STRUCT MOL BIOL, V12, P449, DOI 10.1038/nsmb923; Petukhova GV, 2003, DEV CELL, V5, P927, DOI 10.1016/S1534-5807(03)00369-1; Ristic D, 2001, P NATL ACAD SCI USA, V98, P8454, DOI 10.1073/pnas.151056798; ROCKMILL B, 1995, GENE DEV, V9, P2684, DOI 10.1101/gad.9.21.2684; Sauvageau S, 2005, MOL CELL BIOL, V25, P4377, DOI 10.1128/MCB.25.11.4377-4387.2005; Schwacha A, 1997, CELL, V90, P1123, DOI 10.1016/S0092-8674(00)80378-5; Sehorn MG, 2004, NATURE, V429, P433, DOI 10.1038/nature02563; Sharan SK, 2004, DEVELOPMENT, V131, P131, DOI 10.1242/dev.00888; Shinohara A, 2004, CYTOGENET GENOME RES, V107, P201, DOI 10.1159/000080598; Shinohara A, 1997, GENES CELLS, V2, P615, DOI 10.1046/j.1365-2443.1997.1480347.x; SHINOHARA A, 1992, CELL, V69, P457, DOI 10.1016/0092-8674(92)90447-K; Shinohara M, 2000, P NATL ACAD SCI USA, V97, P10814, DOI 10.1073/pnas.97.20.10814; Shinohara M, 1997, GENETICS, V147, P1545; Shinohara M, 2003, GENETICS, V163, P1273; Siaud N, 2004, EMBO J, V23, P1392, DOI 10.1038/sj.emboj.7600146; Smith AV, 1997, J CELL BIOL, V136, P957, DOI 10.1083/jcb.136.5.957; Solinger JA, 2002, MOL CELL, V10, P1175, DOI 10.1016/S1097-2765(02)00743-8; Stahl FW, 2004, GENETICS, V168, P35, DOI 10.1534/genetics.104.027789; Sung P, 2003, J BIOL CHEM, V278, P42729, DOI 10.1074/jbc.R300027200; Tarsounas M, 1999, J CELL BIOL, V147, P207, DOI 10.1083/jcb.147.2.207; Tsubouchi H, 2004, GENETICS, V168, P1219, DOI 10.1534/genetics.103.025700; Tsubouchi H, 2003, DEV CELL, V5, P915, DOI 10.1016/S1534-5807(03)00357-5; Tsubouchi H, 2002, MOL CELL BIOL, V22, P3078, DOI 10.1128/MCB.22.9.3078-3088.2002; Van Komen S, 2000, MOL CELL, V6, P563, DOI 10.1016/S1097-2765(00)00055-1; Wesoly J, 2006, MOL CELL BIOL, V26, P976, DOI 10.1128/MCB.26.3.976-989.2006; Xu HL, 2005, DEV CELL, V8, P949, DOI 10.1016/j.devcel.2005.03.018; Yang HJ, 2005, NATURE, V433, P653, DOI 10.1038/nature03234; Young JA, 2004, GENETICS, V167, P593, DOI 10.1534/genetics.103.023762; Zickler D, 1999, ANNU REV GENET, V33, P603, DOI 10.1146/annurev.genet.33.1.603; Zierhut C, 2004, CURR BIOL, V14, P752, DOI 10.1016/j.cub.2004.04.030	77	284	291	2	47	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 13	2006	442	7099					153	158		10.1038/nature04885	http://dx.doi.org/10.1038/nature04885			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	062XJ	16838012	Green Accepted			2022-12-28	WOS:000238979700037
J	Tymoczko, D				Tymoczko, Dmitri			The geometry of musical chords	SCIENCE			English	Article							VOICE; PITCH	A musical chord can be represented as a point in a geometrical space called an orbifold. Line segments represent mappings from the notes of one chord to those of another. Composers in a wide range of styles have exploited the non-Euclidean geometry of these spaces, typically by using short line segments between structurally similar chords. Such line segments exist only when chords are nearly symmetrical under translation, reflection, or permutation. Paradigmatically consonant and dissonant chords possess different near-symmetries and suggest different musical uses.	Princeton Univ, Dept Mus, Princeton, NJ 08544 USA; Radcliffe Inst Adv Study, Cambridge, MA 02138 USA	Princeton University	Tymoczko, D (corresponding author), Princeton Univ, Dept Mus, Princeton, NJ 08544 USA.	dmitri@princeton.edu						Agmon E., 1991, MUSIKOMETRIKA, V3, P15; ATTNEAVE F, 1971, AM J PSYCHOL, V84, P147, DOI 10.2307/1421351; Boretz Benjamin., 1972, PERSPECT NEW MUSIC, V11, P146; Callender C., 2004, MUS THEORY ONLINE, V10; CALLENDER C, 2005, J CLOUGH MEM C U CHI; COHN R, 1991, J MUSIC THEORY, V35, P1, DOI 10.2307/843808; Cohn R, 1997, J MUSIC THEORY, V41, P1, DOI 10.2307/843761; COHN R, 1996, MUSIC ANAL, V15, P9, DOI 10.2307/854168; Cohn RL, 1999, NINETEEN CENT MUSIC, V22, P213; Douthett J, 1998, J MUSIC THEORY, V42, P241, DOI 10.2307/843877; Heinichen J.D., 1969, GEN BASS COMPOSITION; Hostinsky Otakar., 1879, LEHRE MUSIKALISCHEN; Huron D, 2001, MUSIC PERCEPT, V19, P1, DOI 10.1525/mp.2001.19.1.1; MASSON C, 1967, NOUVEAU TRAITE REGLE; Mazzola G., 2002, TOPOS MUSIC; Morris RD, 1998, MUSIC THEOR SPECTRUM, V20, P175, DOI 10.1525/mts.1998.20.2.02a00010; ROEDER J, 1984, THESIS YALE U; SATAKE I, 1956, P NATL ACAD SCI USA, V42, P359, DOI 10.1073/pnas.42.6.359; Sethares W., 2005, TUNING TIMBRE SPECTR, DOI 10.1007/b138848; SHEPARD RN, 1982, PSYCHOL REV, V89, P305, DOI 10.1037/0033-295X.89.4.305; Straus JN, 2003, MUSIC THEOR SPECTRUM, V25, P305, DOI 10.1525/mts.2003.25.2.305; Thurston W., GEOMETRY TOPOLOGY 3; CHORDGEOMETRIES 1 1	23	119	119	1	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 7	2006	313	5783					72	74		10.1126/science.1126287	http://dx.doi.org/10.1126/science.1126287			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	061DA	16825563				2022-12-28	WOS:000238850200031
J	Chandra, D; Bratton, SB; Person, MD; Tian, YA; Martin, AG; Ayres, M; Fearnhead, HO; Gandhi, V; Tang, DG				Chandra, Dhyan; Bratton, Shawn B.; Person, Maria D.; Tian, Yanan; Martin, Angel G.; Ayres, Mary; Fearnhead, Howard O.; Gandhi, Varsha; Tang, Dean G.			Intracellular nucleotides act as critical prosurvival factors by binding to cyctochrome c and inhibiting apoptosome	CELL			English	Article							CYTOCHROME-C; DEPENDENT FORMATION; CELL-DEATH; ACTIVATION; APAF-1; DATP; REQUIREMENT; CASPASE-9; DEPLETION; SURVIVAL	Cytochromec(CC)-initiated Apaf-1 apoptosome formation represents a key initiating event in apoptosis. This process can be reconstituted in vitro with the addition of CC and ATP or dATP to cell lysates. How physiological levels of nucleotides, normally at high mM concentrations, affect apoptosome activation remains unclear. Here we show that physiological levels of nucleotides inhibit the CC-initiated apoptosome formation and caspase-9 activation by directly binding to CC on several key lysine residues and thus preventing CC interaction with Apaf-1. We show that in various apoptotic systems caspase activation is preceded or accompanied by decreases in overall intracellular NTP pools. Microinjection of nucleotides inhibits whereas experimentally reducing NTP pools enhances both CC and apoptotic stimuli-induced cell death. Our results thus suggest that the intracellular nucleotides represent critical prosurvival factors by functioning as natural inhibitors of apoptosome formation and a barrier that cells must overcome the nucleotide barrier to undergo apoptosis cell death.	Univ Texas, MD Anderson Canc Ctr, Dept Carcinogenesis, Div Res, Smithville, TX 78957 USA; Univ Texas, Coll Pharm, Div Pharmacol & Toxicol, Austin, TX 78712 USA; Texas A&M Univ, Dept Vet Physiol & Pharmacol, College Stn, TX 77843 USA; NCI, Apoptosis Sect, Lab Prot Dynam & Signaling, Frederick, MD 21702 USA; Univ Texas, MD Anderson Canc Ctr, Program Mol Carcinogenesis, Grad Sch Biomed Sci, Houston, TX 77030 USA; Univ Texas, MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Austin; Texas A&M University System; Texas A&M University College Station; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Chandra, D (corresponding author), Univ Texas, MD Anderson Canc Ctr, Dept Carcinogenesis, Div Res, Sci Pk, Smithville, TX 78957 USA.	dhchandra@mdanderson.org; dtang@mdanderson.org	Fearnhead, Howard O/D-4826-2012; Tang, Dean/AAI-3457-2020	Tang, Dean/0000-0001-5029-1174; Garcia Martin, Angel/0000-0002-3831-2769; Chandra, Dhyan/0000-0001-7272-9384; Fearnhead, Howard/0000-0002-8054-9794; Bratton, Shawn/0000-0003-2895-5020	NATIONAL CANCER INSTITUTE [R01CA090297, R01CA057629] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES007784, R01ES009859] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG023374] Funding Source: NIH RePORTER; NCI NIH HHS [CA90297, CA57629] Funding Source: Medline; NIA NIH HHS [AG023374] Funding Source: Medline; NIEHS NIH HHS [ES009859, ES07784] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Benedict MA, 2000, J BIOL CHEM, V275, P8461, DOI 10.1074/jbc.275.12.8461; Boatright KM, 2003, MOL CELL, V11, P529, DOI 10.1016/S1097-2765(03)00051-0; Bratton SB, 2001, EMBO J, V20, P998, DOI 10.1093/emboj/20.5.998; Cain K, 2001, J BIOL CHEM, V276, P41985, DOI 10.1074/jbc.M107419200; Cain K, 2000, J BIOL CHEM, V275, P6067, DOI 10.1074/jbc.275.9.6067; Chabes A, 2003, CELL, V112, P391, DOI 10.1016/S0092-8674(03)00075-8; Chandra D, 2003, J BIOL CHEM, V278, P17408, DOI 10.1074/jbc.M300750200; Chandra D, 2002, J BIOL CHEM, V277, P50842, DOI 10.1074/jbc.M207622200; Chereau D, 2005, BIOCHEMISTRY-US, V44, P4971, DOI 10.1021/bi047360+; CRAIG DB, 1991, BIOCHEM J, V279, P781, DOI 10.1042/bj2790781; Dagher PC, 2000, AM J PHYSIOL-CELL PH, V279, pC1270, DOI 10.1152/ajpcell.2000.279.4.C1270; Grusch M, 2001, EXP HEMATOL, V29, P623, DOI 10.1016/S0301-472X(01)00624-5; Hao ZY, 2005, CELL, V121, P579, DOI 10.1016/j.cell.2005.03.016; Jiang XJ, 2004, ANNU REV BIOCHEM, V73, P87, DOI 10.1146/annurev.biochem.73.011303.073706; Jiang XJ, 2000, J BIOL CHEM, V275, P31199, DOI 10.1074/jbc.C000405200; Kelly KJ, 2001, J CLIN INVEST, V108, P1291, DOI 10.1172/JCI13018; Kim HE, 2005, P NATL ACAD SCI USA, V102, P17545, DOI 10.1073/pnas.0507900102; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; Mesner PW, 1999, J BIOL CHEM, V274, P22635, DOI 10.1074/jbc.274.32.22635; MILLER DS, 1986, J BIOL CHEM, V261, P13911; Nutt LK, 2005, CELL, V123, P89, DOI 10.1016/j.cell.2005.07.032; Oliver FJ, 1997, J BIOL CHEM, V272, P10624; Paschen W, 2000, J NEUROCHEM, V75, P1675, DOI 10.1046/j.1471-4159.2000.0751675.x; Purring-Koch C, 2000, P NATL ACAD SCI USA, V97, P11928, DOI 10.1073/pnas.220416197; Quemeneur L, 2003, J IMMUNOL, V170, P4986, DOI 10.4049/jimmunol.170.10.4986; Riedl SJ, 2005, NATURE, V434, P926, DOI 10.1038/nature03465; SETO S, 1985, J CLIN INVEST, V75, P377, DOI 10.1172/JCI111710; Shi YG, 2004, CELL, V117, P855, DOI 10.1016/j.cell.2004.06.007; Srinivasula SM, 1998, MOL CELL, V1, P949, DOI 10.1016/S1097-2765(00)80095-7; Wang A, 2005, CANCER RES, V65, P7809, DOI 10.1158/0008-5472.CAN-05-0888; Waterhouse NJ, 2001, J CELL BIOL, V153, P319, DOI 10.1083/jcb.153.2.319; Yu TN, 2001, J BIOL CHEM, V276, P13034, DOI 10.1074/jbc.M009773200; Yu XC, 2005, STRUCTURE, V13, P1725, DOI 10.1016/j.str.2005.09.006; Zhou HL, 2000, J CELL BIOL, V151, P483, DOI 10.1083/jcb.151.3.483; Zou H, 1999, J BIOL CHEM, V274, P11549, DOI 10.1074/jbc.274.17.11549	36	96	98	1	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 30	2006	125	7					1333	1346		10.1016/j.cell.2006.05.026	http://dx.doi.org/10.1016/j.cell.2006.05.026			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	064QP	16814719	Bronze			2022-12-28	WOS:000239104500016
J	Zender, L; Spector, MS; Xue, W; Flemming, P; Cordon-Cardo, C; Silke, J; Fan, ST; Luk, JM; Wigler, M; Hannon, GJ; Mu, D; Lucito, R; Powers, S; Lowe, SW				Zender, Lars; Spector, Mona S.; Xue, Wen; Flemming, Peer; Cordon-Cardo, Carlos; Silke, John; Fan, Sheung-Tat; Luk, John M.; Wigler, Michael; Hannon, Gregory J.; Mu, David; Lucito, Robert; Powers, Scott; Lowe, Scott W.			Identification and validation of oncogenes in liver cancer using an integrative oncogenomic approach	CELL			English	Article							YES-ASSOCIATED PROTEIN; COMPARATIVE GENOMIC HYBRIDIZATION; TUMOR-SUPPRESSOR; HOMOZYGOUS DELETIONS; CELL-PROLIFERATION; DNA AMPLIFICATION; DOWN-REGULATION; LUNG-CANCER; APOPTOSIS; GENE	The heterogeneity and instability of human tumors hamper straightforward identification of cancer-causing mutations through genomic approaches alone. Herein we describe a mouse model of liver cancer initiated from progenitor cells harboring defined cancer-predisposing lesions. Genome-wide analyses of tumors in this mouse model and in human hepatocellular carcinomas revealed a recurrent amplification at mouse chromosome 9qA1, the syntenic region of human chromosome 11q22. Gene-expression analyses delineated cIAP1, a known inhibitor of apoptosis, and Yap, a transcription factor, as candidate oncogenes in the amplicon. In the genetic context of their amplification, both cIAP1 and Yap accelerated tumorigenesis and were required to sustain rapid growth of amplicon-containing tumors. Furthermore, cIAP1 and Yap cooperated to promote tumorigenesis. Our results establish a tractable model of liver cancer, identify two oncogenes that cooperate by virtue of their coamplification in the same genomic locus, and suggest an efficient strategy for the annotation of human cancer genes.	Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; Hannover Med Sch, Dept Pathol, D-30625 Hannover, Germany; Mem Sloan Kettering Canc Ctr, Div Mol Pathol, New York, NY 10021 USA; Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia; Univ Hong Kong, Dept Surg, Hong Kong, Hong Kong, Peoples R China; Howard Hughes Med Inst, Cold Spring Harbor, NY 11724 USA	Cold Spring Harbor Laboratory; Hannover Medical School; Memorial Sloan Kettering Cancer Center; Walter & Eliza Hall Institute; University of Hong Kong; Howard Hughes Medical Institute	Zender, L (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.	lowe@cshl.edu	Luk, John/A-4085-2008; Lucito, Robert/AID-7159-2022; Mu, David/E-8933-2011; Silke, John/B-7622-2008; Hannon, Gregory/AAB-3568-2019; Fan, Sheung Tat/C-4138-2009	Luk, John/0000-0002-6323-7940; Mu, David/0000-0002-7762-0182; Silke, John/0000-0002-7611-5774; Powers, Scott/0000-0003-2769-1932; Wigler, Michael/0000-0003-4396-1971	NATIONAL CANCER INSTITUTE [P01CA087497, P01CA013106, U01CA105388, P30CA008748, R01CA078544] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NCI NIH HHS [P01 CA087497, P30 CA008748, CA13106, CA078544, R01 CA078544, CA87497, CA105388, P01 CA013106, U01 CA105388] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AGUILAR F, 1994, SCIENCE, V264, P1317, DOI 10.1126/science.8191284; Alison MR, 2005, CELL PROLIFERAT, V38, P407, DOI 10.1111/j.1365-2184.2005.00354.x; Artandi SE, 2000, NAT MED, V6, P852, DOI 10.1038/78595; Bashyam MD, 2005, NEOPLASIA, V7, P556, DOI 10.1593/neo.04586; Basu S, 2003, MOL CELL, V11, P11, DOI 10.1016/S1097-2765(02)00776-1; Block GD, 1996, J CELL BIOL, V132, P1133, DOI 10.1083/jcb.132.6.1133; Chan EH, 2005, ONCOGENE, V24, P2076, DOI 10.1038/sj.onc.1208445; Collins C, 2001, GENOME RES, V11, P1034, DOI 10.1101/gr.GR1743R; Conze DB, 2005, MOL CELL BIOL, V25, P3348, DOI 10.1128/MCB.25.8.3348-3356.2005; Cox C, 2005, P NATL ACAD SCI USA, V102, P4542, DOI 10.1073/pnas.0408593102; CROOK NE, 1993, J VIROL, V67, P2168, DOI 10.1128/JVI.67.4.2168-2174.1993; Dai ZY, 2003, HUM MOL GENET, V12, P791, DOI 10.1093/hmg/ddg083; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Deveraux QL, 1998, EMBO J, V17, P2215, DOI 10.1093/emboj/17.8.2215; Edgar BA, 2006, CELL, V124, P267, DOI 10.1016/j.cell.2006.01.005; Feitelson MA, 2002, ONCOGENE, V21, P2593, DOI 10.1038/sj.onc.1205434; Futreal PA, 2005, COLD SH Q B, V70, P43, DOI 10.1101/sqb.2005.70.015; Garber K, 2005, J NATL CANCER I, V97, P1322, DOI 10.1093/jnci/dji324; Goyal L, 2000, EMBO J, V19, P589, DOI 10.1093/emboj/19.4.589; Gu DQ, 2002, TRANSPLANTATION, V73, P1818, DOI 10.1097/00007890-200206150-00020; Hamaratoglu F, 2006, NAT CELL BIOL, V8, P27, DOI 10.1038/ncb1339; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hu L, 2004, ONCOGENE, V23, P298, DOI 10.1038/sj.onc.1206483; Huang JB, 2005, CELL, V122, P421, DOI 10.1016/j.cell.2005.06.007; Imoto I, 2001, CANCER RES, V61, P6629; KALLIONIEMI OP, 1993, SEMIN CANCER BIOL, V4, P41; Kim M, 2006, CELL, V125, P1269, DOI 10.1016/j.cell.2006.06.008; LaCasse EC, 1998, ONCOGENE, V17, P3247, DOI 10.1038/sj.onc.1202569; Laconi E, 1998, AM J PATHOL, V153, P319, DOI 10.1016/S0002-9440(10)65574-5; Lee JW, 2005, ONCOGENE, V24, P1477, DOI 10.1038/sj.onc.1208304; Liston P, 2003, ONCOGENE, V22, P8568, DOI 10.1038/sj.onc.1207101; Llovet JM, 2003, LANCET, V362, P1907, DOI 10.1016/S0140-6736(03)14964-1; Lowe SW, 2004, NATURE, V432, P307, DOI 10.1038/nature03098; Lucito R, 2003, GENOME RES, V13, P2291, DOI 10.1101/gr.1349003; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Ma FR, 2001, P NATL ACAD SCI USA, V98, P9778, DOI 10.1073/pnas.171322898; McClatchey AI, 2005, GENE DEV, V19, P2265, DOI 10.1101/gad.1335605; MURAKAMI H, 1993, CANCER RES, V53, P1719; Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X; Nitou M, 2002, EXP CELL RES, V279, P330, DOI 10.1006/excr.2002.5615; Parkin DM, 2001, INT J CANCER, V94, P153, DOI 10.1002/ijc.1440; Peng Shian-Yang, 1993, Journal of the Formosan Medical Association, V92, P866; Salvesen GS, 2002, NAT REV MOL CELL BIO, V3, P401, DOI 10.1038/nrm830; SANDGREN EP, 1989, ONCOGENE, V4, P715; Schmitt CA, 2002, CANCER CELL, V1, P289, DOI 10.1016/S1535-6108(02)00047-8; Segal E, 2005, NAT GENET, V37, pS38, DOI 10.1038/ng1561; Silke J, 2005, P NATL ACAD SCI USA, V102, P16182, DOI 10.1073/pnas.0502828102; Snijders AM, 2005, ONCOGENE, V24, P4232, DOI 10.1038/sj.onc.1208601; St John MAR, 1999, NAT GENET, V21, P182, DOI 10.1038/5965; Strano S, 2001, J BIOL CHEM, V276, P15164, DOI 10.1074/jbc.M010484200; SUDOL M, 1994, ONCOGENE, V9, P2145; SUZUKI K, 1994, HEPATOLOGY, V20, P1231; Takahashi Y, 2005, CLIN CANCER RES, V11, P1380, DOI 10.1158/1078-0432.CCR-04-1773; Tamaskovic R, 2003, FEBS LETT, V546, P73, DOI 10.1016/S0014-5793(03)00474-5; WANG XW, 1994, P NATL ACAD SCI USA, V91, P2230, DOI 10.1073/pnas.91.6.2230; Wright CW, 2005, J CLIN INVEST, V115, P2673, DOI 10.1172/JCI26251; Yagi R, 1999, EMBO J, V18, P2551, DOI 10.1093/emboj/18.9.2551; ZENDER L, 2006, IN PRESS COLD SPRING	58	869	907	1	76	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 30	2006	125	7					1253	1267		10.1016/j.cell.2006.05.030	http://dx.doi.org/10.1016/j.cell.2006.05.030			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	064QP	16814713	Green Accepted, Bronze			2022-12-28	WOS:000239104500010
J	Hirano, N; Takahashi, E; Yamamoto, J; Abe, N; Ingle, SP; Kaneoka, I; Hirata, T; Kimura, JI; Ishii, T; Ogawa, Y; Machida, S; Suyehiro, K				Hirano, Naoto; Takahashi, Eiichi; Yamamoto, Junji; Abe, Natsue; Ingle, Stephanie P.; Kaneoka, Ichiro; Hirata, Takafumi; Kimura, Jun-Ichi; Ishii, Teruaki; Ogawa, Yujiro; Machida, Shiki; Suyehiro, Kiyoshi			Volcanism in response to plate flexure	SCIENCE			English	Article							UPPER-MANTLE; JAPAN TRENCH; BASALTS; PACIFIC; TEMPERATURE; VELOCITIES; OCEANWARD; MODEL; YOUNG	Volcanism on Earth is known to occur in three tectonic settings: divergent plate boundaries ( such as mid-ocean ridges), convergent plate boundaries ( such as island arcs), and hot spots. We report volcanism on the 135 million-year-old Pacific Plate not belonging to any of these categories. Small alkalic volcanoes form from small percent melts and originate in the asthenosphere, as implied by their trace element geochemistry and noble gas isotopic compositions. We propose that these small volcanoes erupt along lithospheric fractures in response to plate flexure during subduction. Minor extents of asthenospheric melting and the volcanoes' tectonic alignment and age progression in the direction opposite to that of plate motion provide evidence for the presence of a small percent melt in the asthenosphere.	Tokyo Inst Technol, Dept Earth & Planetary Sci, Meguro Ku, Tokyo 1528551, Japan; Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; Japan Agcy Marine Earth Sci & Technol, Yokosuka, Kanagawa 2370061, Japan; Kyoto Univ, Inst Geothermal Sci, Beppu, Oita 8740903, Japan; Univ Hawaii, Sch Ocean & Earth Sci & Technol, Honolulu, HI 96822 USA; Univ Tokyo, Earthquake Res Inst, Bunkyo Ku, Tokyo 1130032, Japan; Shimane Univ, Fac Sci & Engn, Matsue, Shimane 6908504, Japan; Univ Tokyo, Ocean Res Inst, Nakano Ku, Tokyo 1648639, Japan; Univ Tsukuba, Inst Geosci, Tsukuba, Ibaraki 3058571, Japan	Tokyo Institute of Technology; University of California System; University of California San Diego; Scripps Institution of Oceanography; Japan Agency for Marine-Earth Science & Technology (JAMSTEC); Kyoto University; University of Hawaii System; University of Tokyo; Shimane University; University of Tokyo; University of Tsukuba	Hirano, N (corresponding author), Tokyo Inst Technol, Dept Earth & Planetary Sci, Meguro Ku, 2-12-1 Ookayama, Tokyo 1528551, Japan.	nhirano@ucsd.edu	HIRANO, NAOTO/F-6009-2016; Abe, Natsue/AAP-7388-2021; Yamamoto, Junji/F-8821-2012; Takahashi, Eiichi/B-4883-2017	HIRANO, NAOTO/0000-0003-3491-0312; Abe, Natsue/0000-0002-2734-0035; Takahashi, Eiichi/0000-0002-6500-1827; Machida, Shiki/0000-0002-1069-7214; Hirano, Naoto/0000-0003-0980-3929; Kimura, Jun-Ichi/0000-0002-2677-515X				ARTH JG, 1976, J RES US GEOL SURV, V4, P41; CLAGUE DA, 1990, EARTH PLANET SC LETT, V98, P175, DOI 10.1016/0012-821X(90)90058-6; Dixon JE, 1997, AM MINERAL, V82, P368; Faul UH, 2005, EARTH PLANET SC LETT, V234, P119, DOI 10.1016/j.epsl.2005.02.008; GRIPP AE, 1990, GEOPHYS RES LETT, V17, P1109, DOI 10.1029/GL017i008p01109; Hirano N, 2004, CONTRIB MINERAL PETR, V148, P47, DOI 10.1007/s00410-004-0593-z; Hirano N, 2001, GEOPHYS RES LETT, V28, P2719, DOI 10.1029/2000GL012426; Hirschmann MM, 2000, GEOCHEM GEOPHY GEOSY, V1, DOI 10.1029/2000GC000070; HONDA M, 1991, NATURE, V349, P149, DOI 10.1038/349149a0; Hopp J, 2005, EARTH PLANET SC LETT, V240, P573, DOI 10.1016/j.epsl.2005.09.036; Karato S, 1998, EARTH PLANET SC LETT, V157, P193, DOI 10.1016/S0012-821X(98)00034-X; Koppers AAP, 2003, GEOCHEM GEOPHY GEOSY, V4, DOI 10.1029/2003GC000574; Mofjeld H., 2004, OCEANOGRAPHY, V17, P34, DOI [10.5670/oceanog.2004.65, DOI 10.5670/OCEANOG.2004.65]; Moore JG., 1985, GEOL SURV BULL, V1663, P1, DOI [10.3133/b1663, DOI 10.3133/B1663]; MORGAN WJ, 1968, J GEOPHYS RES, V73, P1959, DOI 10.1029/JB073i006p01959; NAKANISHI M, 1989, J GEOPHYS RES-SOLID, V94, P15437, DOI 10.1029/JB094iB11p15437; NATLAND JH, 1980, AM J SCI, V280, P709; Obayashi M, 2006, EARTH PLANET SC LETT, V243, P149, DOI 10.1016/j.epsl.2005.12.032; Owens WB, 2001, DEEP-SEA RES PT I, V48, P959, DOI 10.1016/S0967-0637(00)00076-5; Priestley K, 2006, EARTH PLANET SC LETT, V244, P285, DOI 10.1016/j.epsl.2006.01.008; Sandwell DT, 1997, J GEOPHYS RES-SOL EA, V102, P10039, DOI 10.1029/96JB03223; STAUDACHER T, 1982, EARTH PLANET SC LETT, V60, P389, DOI 10.1016/0012-821X(82)90075-9; STEIN CA, 1992, NATURE, V359, P123, DOI 10.1038/359123a0; SUYEHIRO K, 1994, J GEOPHYS RES-SOL EA, V99, P22331, DOI 10.1029/94JB01337; Watts A.B., 2001, ISOSTASY FLEXURE LIT; WYLLIE PJ, 1995, J GEODYN, V20, P429, DOI 10.1016/0264-3707(95)00023-3; WYLLIE PJ, 1988, REV GEOPHYS, V26, P370, DOI 10.1029/RG026i003p00370	28	217	225	4	68	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 8	2006	313	5792					1426	1428		10.1126/science.1128235	http://dx.doi.org/10.1126/science.1128235			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	081WQ	16873612				2022-12-28	WOS:000240348700039
J	Segal, E; Fondufe-Mittendorf, Y; Chen, LY; Thastrom, A; Field, Y; Moore, IK; Wang, JPZ; Widom, J				Segal, Eran; Fondufe-Mittendorf, Yvonne; Chen, Lingyi; Thastroem, AnnChristine; Field, Yair; Moore, Irene K.; Wang, Ji-Ping Z.; Widom, Jonathan			A genomic code for nucleosome positioning	NATURE			English	Article							SACCHAROMYCES-CEREVISIAE; DNA-SEQUENCE; EXPRESSION PROFILES; GENE-EXPRESSION; YEAST; CHROMATIN; PROMOTER; HISTONE; IDENTIFICATION; BINDING	Eukaryotic genomes are packaged into nucleosome particles that occlude the DNA from interacting with most DNA binding proteins. Nucleosomes have higher affinity for particular DNA sequences, reflecting the ability of the sequence to bend sharply, as required by the nucleosome structure. However, it is not known whether these sequence preferences have a significant influence on nucleosome position in vivo, and thus regulate the access of other proteins to DNA. Here we isolated nucleosome-bound sequences at high resolution from yeast and used these sequences in a new computational approach to construct and validate experimentally a nucleosome - DNA interaction model, and to predict the genome-wide organization of nucleosomes. Our results demonstrate that genomes encode an intrinsic nucleosome organization and that this intrinsic organization can explain similar to 50% of the in vivo nucleosome positions. This nucleosome positioning code may facilitate specific chromosome functions including transcription factor binding, transcription initiation, and even remodelling of the nucleosomes themselves.	Weizmann Inst Sci, Dept Comp Sci & Appl Math, IL-76100 Rehovot, Israel; Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, Evanston, IL 60208 USA; Northwestern Univ, Dept Stat, Evanston, IL 60208 USA	Weizmann Institute of Science; Northwestern University; Northwestern University	Segal, E (corresponding author), Weizmann Inst Sci, Dept Comp Sci & Appl Math, IL-76100 Rehovot, Israel.	eran.segal@weizmann.ac.il; j-widom@northwestern.edu	Segal, Eran/AAF-4855-2019; Chen, Lingyi/G-6309-2013	Segal, Eran/0000-0002-6859-1164	NCI NIH HHS [R01 CA119176, R01 CA119176-01] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA119176] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ALMER A, 1986, EMBO J, V5, P2689, DOI 10.1002/j.1460-2075.1986.tb04552.x; Anderson JD, 2001, MOL CELL BIOL, V21, P3830, DOI 10.1128/MCB.21.11.3830-3839.2001; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Basehoar AD, 2004, CELL, V116, P699, DOI 10.1016/S0092-8674(04)00205-3; Bernstein BE, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r62; Cairns BR, 2005, CURR OPIN GENET DEV, V15, P185, DOI 10.1016/j.gde.2005.01.003; Casolari JM, 2004, CELL, V117, P427, DOI 10.1016/S0092-8674(04)00448-9; Cui Y, 2000, P NATL ACAD SCI USA, V97, P127, DOI 10.1073/pnas.97.1.127; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Guillemette B, 2005, PLOS BIOL, V3, P2100, DOI 10.1371/journal.pbio.0030384; Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; Ideker T, 2001, SCIENCE, V292, P929, DOI 10.1126/science.292.5518.929; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; KENT NA, 1994, MOL CELL BIOL, V14, P5229, DOI 10.1128/MCB.14.8.5229; Kim JW, 2004, MOL CELL BIOL, V24, P8104, DOI 10.1128/MCB.24.18.8104-8112.2004; Kornberg RD, 1999, CELL, V98, P285, DOI 10.1016/S0092-8674(00)81958-3; Lee CK, 2004, NAT GENET, V36, P900, DOI 10.1038/ng1400; Li H, 2002, P NATL ACAD SCI USA, V99, P11772, DOI 10.1073/pnas.112341999; Li SS, 2002, J BIOL CHEM, V277, P44651, DOI 10.1074/jbc.M206623200; Lowary PT, 1998, J MOL BIOL, V276, P19, DOI 10.1006/jmbi.1997.1494; Moreira JMA, 1998, EMBO J, V17, P6028, DOI 10.1093/emboj/17.20.6028; Olson WK, 1998, P NATL ACAD SCI USA, V95, P11163, DOI 10.1073/pnas.95.19.11163; RABINER LR, 1989, P IEEE, V77, P257, DOI 10.1109/5.18626; Richmond TJ, 2003, NATURE, V423, P145, DOI 10.1038/nature01595; Robert F, 2004, MOL CELL, V16, P199, DOI 10.1016/j.molcel.2004.09.021; SATCHWELL SC, 1986, J MOL BIOL, V191, P659, DOI 10.1016/0022-2836(86)90452-3; Sekinger EA, 2005, MOL CELL, V18, P735, DOI 10.1016/j.molcel.2005.05.003; SHIMIZU M, 1991, EMBO J, V10, P3033, DOI 10.1002/j.1460-2075.1991.tb07854.x; Sudarsanam P, 2000, P NATL ACAD SCI USA, V97, P3364, DOI 10.1073/pnas.050407197; Thastrom A, 2004, J MOL BIOL, V338, P695, DOI 10.1016/j.jmb.2004.03.032; Thastrom A, 1999, J MOL BIOL, V288, P213, DOI 10.1006/jmbi.1999.2686; TRIFONOV EN, 1980, NUCLEIC ACIDS RES, V8, P4041, DOI 10.1093/nar/8.17.4041; van Holde KE., 1989, SPRINGER SERIES MOL; Verdone L, 1996, MOL CELL BIOL, V16, P1978; Wang JPZ, 2005, NUCLEIC ACIDS RES, V33, P6743, DOI 10.1093/nar/gki977; Weiss K, 1997, EMBO J, V16, P4352, DOI 10.1093/emboj/16.14.4352; Weiss K, 1998, MOL CELL BIOL, V18, P5392, DOI 10.1128/MCB.18.9.5392; Widlund HR, 1997, J MOL BIOL, V267, P807, DOI 10.1006/jmbi.1997.0916; Widom J, 2001, Q REV BIOPHYS, V34, P269, DOI 10.1017/S0033583501003699; Wyrick JJ, 1999, NATURE, V402, P418, DOI 10.1038/46567; Yuan GC, 2005, SCIENCE, V309, P626, DOI 10.1126/science.1112178	44	1145	1176	0	170	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 17	2006	442	7104					772	778		10.1038/nature04979	http://dx.doi.org/10.1038/nature04979			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	074DK	16862119	Green Accepted			2022-12-28	WOS:000239792700037
J	Carvalho, P; Goder, V; Rapoport, TA				Carvalho, Pedro; Goder, Veit; Rapoport, Tom A.			Distinct ubiquitin-ligase complexes define convergent pathways for the degradation of ER proteins	CELL			English	Article							ENDOPLASMIC-RETICULUM MEMBRANE; QUALITY-CONTROL; MISFOLDED GLYCOPROTEINS; RETRO-TRANSLOCATION; IDENTIFIES YOS9P; DOMAIN PROTEIN; YEAST; CYTOSOL; RETROTRANSLOCATION; TRANSPORT	Many misfolded endoplasmic reticulum (ER) proteins are eliminated by ERAD, a process in which substrates are polyubiquitylated and moved into the cytosol for proteasomal degradation. We have identified in S. cerevisiae distinct ubiquitin-ligase complexes that define different ERAD pathways. Proteins with misfolded ER-luminal domains use the ERAD-L pathway, in which the Hrd1p/Hrd3p ligase forms a near stoichiometric membrane core complex by binding to Der1p via the linker protein Usa1p. This core complex associates through Hrd3p with Yos9p, a substrate recognition protein in the ER lumen. Substrates with misfolded intra-membrane domains define a pathway (ERAD-M) that differs from ERAD-L by being independent of Usa1p and Der1p. Membrane proteins with misfolded cytosolic domains use the ERAD-C pathway and are directly targeted to the Doa10p ubiquitin ligase. All three pathways converge at the Cdc48p ATPase complex. These results lead to a unifying concept for ERAD that may also apply to mammalian cells.	Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Harvard Medical School	Rapoport, TA (corresponding author), Harvard Univ, Sch Med, Howard Hughes Med Inst, 240 Longwood Ave, Boston, MA 02115 USA.	tom_rapoport@hms.harvard.edu	Carvalho, Pedro/HHN-1424-2022; Goder, Veit/F-8092-2016	Carvalho, Pedro/0000-0002-9691-5277; Goder, Veit/0000-0003-0854-4873	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052586] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM052586] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Akiyama Y, 2003, J BIOL CHEM, V278, P18146, DOI 10.1074/jbc.M302152200; Awasthi S, 2001, J BIOL CHEM, V276, P31004, DOI 10.1074/jbc.M100022200; Bays NW, 2001, NAT CELL BIOL, V3, P24, DOI 10.1038/35050524; Bhamidipati A, 2005, MOL CELL, V19, P741, DOI 10.1016/j.molcel.2005.07.027; Biederer T, 1997, SCIENCE, V278, P1806, DOI 10.1126/science.278.5344.1806; Bordallo J, 1998, MOL BIOL CELL, V9, P209, DOI 10.1091/mbc.9.1.209; Brodsky JL, 1999, SEMIN CELL DEV BIOL, V10, P507, DOI 10.1006/scdb.1999.0321; Buschhorn BA, 2004, FEBS LETT, V577, P422, DOI 10.1016/j.febslet.2004.10.039; Caldwell SR, 2001, J BIOL CHEM, V276, P23296, DOI 10.1074/jbc.M102962200; Flierman D, 2003, J BIOL CHEM, V278, P34774, DOI 10.1074/jbc.M303360200; Flury I, 2005, EMBO J, V24, P3917, DOI 10.1038/sj.emboj.7600855; Gardner RG, 2001, MOL CELL BIOL, V21, P4276, DOI 10.1128/MCB.21.13.4276-4291.2001; Gardner RG, 2000, J CELL BIOL, V151, P69, DOI 10.1083/jcb.151.1.69; Gauss R, 2006, EMBO J, V25, P1827, DOI 10.1038/sj.emboj.7601088; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Gillece P, 1999, J CELL BIOL, V147, P1443, DOI 10.1083/jcb.147.7.1443; Hampton RY, 1996, MOL BIOL CELL, V7, P2029, DOI 10.1091/mbc.7.12.2029; Haynes CM, 2002, J CELL BIOL, V158, P91, DOI 10.1083/jcb.200201053; Huyer G, 2004, J BIOL CHEM, V279, P38369, DOI 10.1074/jbc.M402468200; Jakob CA, 2001, EMBO REP, V2, P423; Kikkert M, 2004, J BIOL CHEM, V279, P3525, DOI 10.1074/jbc.M307453200; Kim W, 2005, MOL CELL, V19, P753, DOI 10.1016/j.molcel.2005.08.010; Knop M, 1996, EMBO J, V15, P753, DOI 10.1002/j.1460-2075.1996.tb00411.x; Kokame K, 2000, J BIOL CHEM, V275, P32846, DOI 10.1074/jbc.M002063200; Lilley BN, 2005, P NATL ACAD SCI USA, V102, P14296, DOI 10.1073/pnas.0505014102; Lilley BN, 2004, NATURE, V429, P834, DOI 10.1038/nature02592; Meusser B, 2004, MOL CELL, V14, P247, DOI 10.1016/S1097-2765(04)00212-6; Meusser B, 2005, NAT CELL BIOL, V7, P766, DOI 10.1038/ncb0805-766; Neuber O, 2005, NAT CELL BIOL, V7, P993, DOI 10.1038/ncb1298; Ng DTW, 2000, J CELL BIOL, V150, P77, DOI 10.1083/jcb.150.1.77; Oda Y, 2006, J CELL BIOL, V172, P383, DOI 10.1083/jcb.200507057; Plemper RK, 1999, J CELL SCI, V112, P4123; Ravid T, 2006, EMBO J, V25, P533, DOI 10.1038/sj.emboj.7600946; Richly H, 2005, CELL, V120, P73, DOI 10.1016/j.cell.2004.11.013; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Schuberth C, 2005, NAT CELL BIOL, V7, P999, DOI 10.1038/ncb1299; Schulze A, 2005, J MOL BIOL, V354, P1021, DOI 10.1016/j.jmb.2005.10.020; Shearer AG, 2005, EMBO J, V24, P149, DOI 10.1038/sj.emboj.7600498; Song BL, 2005, MOL CELL, V19, P829, DOI 10.1016/j.molcel.2005.08.009; Spear ED, 2003, MOL BIOL CELL, V14, P2756, DOI 10.1091/mbc.E02-11-0717; Swanson R, 2001, GENE DEV, V15, P2660, DOI 10.1101/gad.933301; Szathmary R, 2005, MOL CELL, V19, P765, DOI 10.1016/j.molcel.2005.08.015; Taxis C, 2003, J BIOL CHEM, V278, P35903, DOI 10.1074/jbc.M301080200; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; Tsai B, 2002, NAT REV MOL CELL BIO, V3, P246, DOI 10.1038/nrm780; van den Berg B, 2004, NATURE, V427, P36, DOI 10.1038/nature02218; Vashist S, 2001, J CELL BIOL, V155, P355, DOI 10.1083/jcb.200106123; Vashist S, 2004, J CELL BIOL, V165, P41, DOI 10.1083/jcb.200309132; Ye YH, 2003, J CELL BIOL, V162, P71, DOI 10.1083/jcb.200302169; Ye YH, 2005, P NATL ACAD SCI USA, V102, P14132, DOI 10.1073/pnas.0505006102; Ye YH, 2004, NATURE, V429, P841, DOI 10.1038/nature02656	51	544	561	5	35	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUL 28	2006	126	2					361	373		10.1016/j.cell.2006.05.043	http://dx.doi.org/10.1016/j.cell.2006.05.043			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	070VD	16873066	Bronze			2022-12-28	WOS:000239552600021
J	Cottrell, GW				Cottrell, Garrison W.			New life for neural networks	SCIENCE			English	Editorial Material							DIMENSIONALITY		Univ Calif San Diego, Dept Comp Sci & Engn, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Cottrell, GW (corresponding author), Univ Calif San Diego, Dept Comp Sci & Engn, La Jolla, CA 92093 USA.	gary@cs.ucsd.edu		Cottrell, Garrison/0000-0001-7538-1715				COTTRELL GW, 1989, MODELS COGNITION REV, V1, P208; DeMers D., 1993, ADV NEURAL INFORM PR, P580; Hinton GE, 2006, SCIENCE, V313, P504, DOI 10.1126/science.1127647; Hinton GE, 2002, NEURAL COMPUT, V14, P1771, DOI 10.1162/089976602760128018; Roweis ST, 2000, SCIENCE, V290, P2323, DOI 10.1126/science.290.5500.2323; RUMELHART DE, 1986, NATURE, V323, P533, DOI 10.1038/323533a0; Smolensky P., 1986, PARALLEL DISTRIBUTED, V1, P194; Tenenbaum JB, 2000, SCIENCE, V290, P2319, DOI 10.1126/science.290.5500.2319	8	21	31	1	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 28	2006	313	5786					454	455		10.1126/science.1129813	http://dx.doi.org/10.1126/science.1129813			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067MZ	16873635				2022-12-28	WOS:000239308600028
J	Pokholok, DK; Zeitlinger, J; Hannett, NM; Reynolds, DB; Young, RA				Pokholok, Dmitry K.; Zeitlinger, Julia; Hannett, Nancy M.; Reynolds, David B.; Young, Richard A.			Activated signal transduction kinases frequently occupy target genes	SCIENCE			English	Article							TRANSCRIPTIONAL REGULATION; YEAST; MAP; PROTEIN; EXPRESSION; HOG1; GENOME; LOCALIZATION; ORGANIZATION; RECRUITMENT	Cellular signal transduction pathways modify gene expression programs in response to changes in the environment, but the mechanisms by which these pathways regulate populations of genes under their control are not entirely understood. We present evidence that most mitogen-activated protein kinases and protein kinase A subunits become physically associated with the genes that they regulate in the yeast ( Saccharomyces cerevisiae) genome. The ability to detect this interaction of signaling kinases with target genes can be used to more precisely and comprehensively map the regulatory circuitry that eukaryotic cells use to respond to their environment.	Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; MIT, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT)	Young, RA (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	young@wi.mit.edu	Young, Richard A/F-6495-2012	Young, Richard A/0000-0001-8855-8647	NHGRI NIH HHS [HG002668] Funding Source: Medline; NIGMS NIH HHS [GM069676] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002668] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069676] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alepuz PM, 2003, EMBO J, V22, P2433, DOI 10.1093/emboj/cdg243; Alepuz PM, 2001, MOL CELL, V7, P767, DOI 10.1016/S1097-2765(01)00221-0; Casolari JM, 2005, GENE DEV, V19, P1188, DOI 10.1101/gad.1307205; Casolari JM, 2004, CELL, V117, P427, DOI 10.1016/S0092-8674(04)00448-9; Chang YW, 2004, MOL CELL, V15, P107, DOI 10.1016/j.molcel.2004.05.021; Clayton AL, 2003, FEBS LETT, V546, P51, DOI 10.1016/S0014-5793(03)00451-4; de Nadal E, 2004, NATURE, V427, P370, DOI 10.1038/nature02258; Edmunds JW, 2004, J CELL SCI, V117, P3715, DOI 10.1242/jcs.01346; Ferrigno P, 1998, EMBO J, V17, P5606, DOI 10.1093/emboj/17.19.5606; HILL CS, 1995, CELL, V80, P199, DOI 10.1016/0092-8674(95)90403-4; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Jorgensen P, 2004, GENE DEV, V18, P2491, DOI 10.1101/gad.1228804; KARIN M, 1995, CURR BIOL, V5, P747, DOI 10.1016/S0960-9822(95)00151-5; KLEIN C, 1994, MOL CELL BIOL, V14, P1920, DOI 10.1128/MCB.14.3.1920; Mahanty SK, 1999, CELL, V98, P501, DOI 10.1016/S0092-8674(00)81978-9; Martin DE, 2004, CELL, V119, P969, DOI 10.1016/j.cell.2004.11.047; O'Rourke SM, 2002, TRENDS GENET, V18, P405, DOI 10.1016/S0168-9525(02)02723-3; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; Proft M, 2002, MOL CELL, V9, P1307, DOI 10.1016/S1097-2765(02)00557-9; Roberts CJ, 2000, SCIENCE, V287, P873, DOI 10.1126/science.287.5454.873; Schmid M, 2006, MOL CELL, V21, P379, DOI 10.1016/j.molcel.2005.12.012; Schneper L, 2004, CURR OPIN MICROBIOL, V7, P624, DOI 10.1016/j.mib.2004.10.002; Schwartz MA, 2004, ANNU REV GENET, V38, P725, DOI 10.1146/annurev.genet.39.073003.112634; Simone C, 2004, NAT GENET, V36, P738, DOI 10.1038/ng1378; Tomas-Cobos L, 2004, J BIOL CHEM, V279, P22010, DOI 10.1074/jbc.M400609200; Yang SH, 2003, GENE, V320, P3, DOI 10.1016/S0378-1119(03)00816-3	27	203	211	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 28	2006	313	5786					533	536		10.1126/science.1127677	http://dx.doi.org/10.1126/science.1127677			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067MZ	16873666				2022-12-28	WOS:000239308600066
J	Marcus, DM; Grollman, AP				Marcus, Donald M.; Grollman, Arthur P.			Review for NCCAM is overdue	SCIENCE			English	Editorial Material							ALTERNATIVE MEDICINE; CHELATION-THERAPY; HERBAL REMEDIES; HEART-DISEASE; HEALTH		Baylor Coll Med, Dept Med, Houston, TX 77030 USA; SUNY Stony Brook, Dept Pharmacol Sci, Stony Brook, NY 11794 USA	Baylor College of Medicine; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Marcus, DM (corresponding author), Baylor Coll Med, Dept Med, Houston, TX 77030 USA.	dmarcus@bcm.tmc.edu						*AM HEART ASS, QUEST ANSW CHEL THER; Bent S, 2006, NEW ENGL J MED, V354, P557, DOI 10.1056/NEJMoa053085; Berman JD, 2004, ANNU REV MED, V55, P239, DOI 10.1146/annurev.med.55.091902.103657; Blendon RJ, 2001, ARCH INTERN MED, V161, P805, DOI 10.1001/archinte.161.6.805; BUDIANSKY S, 1995, US NEWS WORLD R 0717, P48; *COMM US COMPL ALT, 2005, COMPL ALT MED US, pCH9; Couzin J, 1998, SCIENCE, V282, P2175, DOI 10.1126/science.282.5397.2175; De Smet PAGM, 2004, CLIN PHARMACOL THER, V76, P1, DOI 10.1016/j.clpt.2004.03.005; Elvin-Lewis Memory, 2005, Adv Food Nutr Res, V50, P219, DOI 10.1016/S1043-4526(05)50007-X; Ernst E, 2000, AM HEART J, V140, P139, DOI 10.1067/mhj.2000.107548; Knudtson ML, 2002, JAMA-J AM MED ASSOC, V287, P481, DOI 10.1001/jama.287.4.481; KOLATA G, 2005, NY TIMES        0728; Markowitz JS, 2003, JAMA-J AM MED ASSOC, V290, P1500, DOI 10.1001/jama.290.11.1500; MARSHALL E, 1994, SCIENCE, V265, P2000, DOI 10.1126/science.8091220; Mervis J, 2006, SCIENCE, V311, P28, DOI 10.1126/science.311.5757.28; *NCCAM US DEP HHS, 2005, EXP HOR HLTH CAR STR; Sampson W, 2005, NEW ENGL J MED, V353, P337, DOI 10.1056/NEJMp058130; Seely Dugald M R, 2005, BMC Cardiovasc Disord, V5, P32, DOI 10.1186/1471-2261-5-32; Stokstad E, 2000, SCIENCE, V288, P1568, DOI 10.1126/science.288.5471.1568; Turner RB, 2005, NEW ENGL J MED, V353, P341, DOI 10.1056/NEJMoa044441; Villarruz MV, 2002, COCHRANE DB SYST REV, V4, DOI [10.1002/14651858.CD002785, DOI 10.1002/14651858.CD002785, DOI 10.1002/14651858]; Vogel G, 1997, SCIENCE, V278, P378, DOI 10.1126/science.278.5337.378; Young JH, 1998, B HIST MED, V72, P279, DOI 10.1353/bhm.1998.0110; 1992, WORKSH ALT MED CHANT	24	10	10	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 21	2006	313	5785					301	302		10.1126/science.1126978	http://dx.doi.org/10.1126/science.1126978			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065IV	16857923				2022-12-28	WOS:000239154300025
J	Machado, RF; Anthi, A; Steinberg, MH; Bonds, D; Sachdev, V; Kato, GJ; Taveira-DaSilva, AM; Ballas, SK; Blackwelder, W; Xu, XL; Hunter, L; Barton, B; Waclawiw, M; Castro, O; Gladwin, MT				Machado, Roberto F.; Anthi, Anastasia; Steinberg, Martin H.; Bonds, Duane; Sachdev, Vandana; Kato, Gregory J.; Taveira-DaSilva, Angelo M.; Ballas, Samir K.; Blackwelder, William; Xu, Xiuli; Hunter, Lori; Barton, Bruce; Waclawiw, Myron; Castro, Oswaldo; Gladwin, Mark T.		MSH Investigators	N-terminal pro-brain natriuretic peptide levels and risk of death in sickle cell disease	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CORONARY-ARTERY-DISEASE; PRIMARY PULMONARY-HYPERTENSION; NITRIC-OXIDE BIOAVAILABILITY; VENTRICULAR DYSFUNCTION; MYOCARDIAL-INFARCTION; VASCULAR ENDOTHELIUM; ARGININE METABOLISM; PRACTICE GUIDELINES; PLATELET-ADHESION; PROGNOSTIC VALUE	Context Thirty percent of patients with sickle cell disease (SCD) develop pulmonary hypertension, a major risk factor for death in this population. A validated blood biomarker of pulmonary hypertension in SCD could provide important prognostic and diagnostic information and allow the exploration of the prevalence of pulmonary hypertension in participants in the 1996 Multicenter Study of Hydroxyurea in Sickle Cell Anemia (MSH) Patients' Follow-up Study. Levels of N-terminal pro-brain natriuretic peptide (NT-proBNP) provide such information in patients with idiopathic pulmonary arterial hypertension. Objective To determine the relationship between NT-proBNP levels and severity of pulmonary hypertension and prospective mortality in patients with SCD. Design, Setting, and Participants NT-proBNP levels were measured in 230 participants in the National Institutes of Health (NIH) Sickle Cell Disease-Pulmonary Hypertension Screening Study (enrollment between February 2001 and March 2005) and in 121 samples from patients enrolled starting in 1996 in the MSH Patients' Follow-up Study. A threshold level predictive of high pulmonary artery pressure and mortality was identified in the NIH Sickle Cell Disease-Pulmonary Hypertension Screening Study and used to define an a priori analytical plan to determine the prevalence and associated mortality of pulmonary hypertension in the MSH follow-up study. Main Outcome Measures Severity of pulmonary hypertension and risk of all-cause mortality. Results NT-proBNP levels were higher in patients with sickle cell pulmonary hypertension and correlated directly with tricuspid regurgitant jet velocity in the NIH cohort (R = 0.50, P<.001). An NT-proBNP level of 160 pg/mL or greater had a 78% positive predictive value for the diagnosis of pulmonary hypertension and was an independent predictor of mortality (21 deaths at 31 months' median follow-up; risk ratio, 5.1; 95% confidence interval, 2.1-12.5; P<.001; 19.5% absolute increase in risk of death). In the MSH cohort, 30% of patients had an NT-proBNP level of 160 pg/mL or greater. An NT-proBNP level of 160 pg/mL or greater in the MSH cohort was independently associated with mortality by Cox proportional hazards regression analysis (24 deaths at 47 months' median follow-up; risk ratio, 2.87; 95% confidence interval, 1.2-6.6; P=.02; 11.9% absolute increase in risk of death). Conclusions Pulmonary hypertension, as indicated by an NT-proBNP level of 160 pg/mL or greater, was very common in patients in the NIH study and in the MSH cohort. The MSH analysis suggests that rates of vaso-occlusive pain episodes in these patients were unrelated to risk of death; this risk was largely determined by occult hemolytic anemia-associated pulmonary hypertension.	NHLBI, Vasc Med Branch, Ctr Clin, NIH, Bethesda, MD 20892 USA; NHLBI, Div Blood Dis & Resources, Bethesda, MD 20892 USA; NHLBI, Cardiovasc Branch, Bethesda, MD 20892 USA; NHLBI, Pulm & Crit Care Med Branch, Bethesda, MD 20892 USA; NHLBI, Off Biostat Res, Bethesda, MD 20892 USA; NIH, Dept Crit Care Med, Ctr Clin, Bethesda, MD 20892 USA; Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA; Thomas Jefferson Univ, Jefferson Med Coll, Dept Med, Cardeza Fdn, Philadelphia, PA 19107 USA; Maryland Med Res Inst, Baltimore, MD USA; Howard Univ, Ctr Sickle Cell Dis, Washington, DC 20059 USA	National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); Boston University; Jefferson University; Howard University	Machado, RF (corresponding author), NHLBI, Vasc Med Branch, Ctr Clin, NIH, 10 Ctr Dr,Bldg 10-CRC,Room 5-5130, Bethesda, MD 20892 USA.	robertom@nhlbi.nih.gov	Kato, Gregory J/I-7615-2014	Kato, Gregory J/0000-0003-4465-3217; Steinberg, Martin/0000-0001-8800-8020; Barton, Bruce/0000-0001-7878-8895; Machado, Roberto/0000-0002-3722-5954	CLINICAL CENTER [Z01CL001174, Z01CL008070] Funding Source: NIH RePORTER; Intramural NIH HHS [ZIA HL006012-01, Z99 HL999999] Funding Source: Medline	CLINICAL CENTER; Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Aessopos A, 2001, BLOOD, V97, P3411, DOI 10.1182/blood.V97.11.3411; Aslan M, 2001, P NATL ACAD SCI USA, V98, P15215, DOI 10.1073/pnas.221292098; Aslan M, 2003, J BIOL CHEM, V278, P4194, DOI 10.1074/jbc.M208916200; Ataga KI, 2004, AM J MED, V117, P665, DOI 10.1016/j.amjmed.2004.03.034; Ballas SK, 1999, BRIT J HAEMATOL, V105, P491, DOI 10.1111/j.1365-2141.1999.01339.x; Castro O, 2003, BLOOD, V101, P1257, DOI 10.1182/blood-2002-03-0948; CHARACHE S, 1995, NEW ENGL J MED, V332, P1317, DOI 10.1056/NEJM199505183322001; Cox DR., 1989, ANAL BINARY DATA; Crapo RO, 2002, AM J RESP CRIT CARE, V166, P111, DOI 10.1164/rccm.166/1/111; De Castro LM, 2004, BLOOD, V104, p462A, DOI 10.1182/blood.V104.11.1663.1663; Gladwin MT, 2004, NEW ENGL J MED, V350, P886, DOI 10.1056/NEJMoa035477; Gladwin MT, 2003, CIRCULATION, V107, P271, DOI 10.1161/01.CIR.0000044943.12533.A8; HAGGER D, 1995, BLOOD COAGUL FIBRIN, V6, P93, DOI 10.1097/00001721-199504000-00001; Hall C, 2004, EUR J HEART FAIL, V6, P257, DOI 10.1016/j.ejheart.2003.12.015; Harrison A, 2002, ANN EMERG MED, V39, P131, DOI 10.1067/mem.2002.121483; HEBBEL RP, 1982, J CLIN INVEST, V70, P1253, DOI 10.1172/JCI110724; Hosmer D. W., 1999, APPL SURVIVAL ANAL; HOSMER DW, 1989, APPL LOGISTIC REGRES; James SK, 2003, CIRCULATION, V108, P275, DOI 10.1161/01.CIR.0000079170.10579.DC; Kato GJ, 2006, BLOOD, V107, P2279, DOI 10.1182/blood-2005-06-2373; Kaul DK, 2004, J CLIN INVEST, V114, P1136, DOI 10.1172/JCI200421633; Keh D, 1996, INT J ARTIF ORGANS, V19, P291, DOI 10.1177/039139889601900506; Kragelund C, 2005, NEW ENGL J MED, V352, P666, DOI 10.1056/NEJMoa042330; KURANTSINMILLS J, 1992, BRIT J HAEMATOL, V81, P539, DOI 10.1111/j.1365-2141.1992.tb02989.x; Leuchte HH, 2004, AM J RESP CRIT CARE, V170, P360, DOI 10.1164/rccm.200308-1142OC; Leuchte HH, 2004, J AM COLL CARDIOL, V43, P764, DOI 10.1016/j.jacc.2003.09.051; Levey AS, 2003, ANN INTERN MED, V139, P137, DOI 10.7326/0003-4819-139-2-200307150-00013; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Levin ER, 1998, NEW ENGL J MED, V339, P321; MAGEE L, 1990, AM STAT, V44, P250, DOI 10.2307/2685352; McGoon M, 2004, CHEST, V126, p14S, DOI 10.1378/chest.126.1_suppl.14S; Michelson AD, 1996, AM J PHYSIOL-HEART C, V270, pH1640, DOI 10.1152/ajpheart.1996.270.5.H1640; Minneci PC, 2005, J CLIN INVEST, V115, P3409, DOI 10.1172/JCI25040; Morris CR, 2005, JAMA-J AM MED ASSOC, V294, P81, DOI 10.1001/jama.294.1.81; Morrow DA, 2005, JAMA-J AM MED ASSOC, V294, P2866, DOI 10.1001/jama.294.22.2866; Nagaya N, 1998, J AM COLL CARDIOL, V31, P202, DOI 10.1016/S0735-1097(97)00452-X; Nagaya N, 2000, CIRCULATION, V102, P865; Nagaya N, 1998, AM HEART J, V136, P297, DOI 10.1053/hj.1998.v136.89729; NAGELKERKE NJD, 1991, BIOMETRIKA, V78, P691, DOI 10.1093/biomet/78.3.691; Nath KA, 2004, MICROCIRCULATION, V11, P179, DOI 10.1080/10739680490278592; Nolan VG, 2005, BLOOD, V106, P3264, DOI 10.1182/blood-2005-04-1594; Omland T, 2002, CIRCULATION, V106, P2913, DOI 10.1161/01.CIR.0000041661.63285.AE; Omland T, 2005, AM J CARDIOL, V95, P24, DOI 10.1016/j.amjcard.2004.08.058; Omland T, 1996, CIRCULATION, V93, P1963, DOI 10.1161/01.CIR.93.11.1963; Omland T, 2002, AM J CARDIOL, V89, P463, DOI 10.1016/S0002-9149(01)02271-8; PETERS M, 1994, THROMB HAEMOSTASIS, V71, P169; PLATT OS, 1994, NEW ENGL J MED, V330, P1639, DOI 10.1056/NEJM199406093302303; RADOMSKI MW, 1987, LANCET, V2, P1057, DOI 10.1016/S0140-6736(87)91481-4; RADOMSKI MW, 1993, CARDIOVASC RES, V27, P1380, DOI 10.1093/cvr/27.7.1380; Reiter CD, 2002, NAT MED, V8, P1383, DOI 10.1038/nm799; Rother RP, 2005, JAMA-J AM MED ASSOC, V293, P1653, DOI 10.1001/jama.293.13.1653; Schnog JJB, 2004, ANN HEMATOL, V83, P371, DOI 10.1007/s00277-004-0856-9; Steinberg MH, 2003, JAMA-J AM MED ASSOC, V289, P1645, DOI 10.1001/jama.289.13.1645; Studt JD, 2005, BLOOD, V105, P542, DOI 10.1182/blood-2004-06-2096; Taveira-DaSilva AM, 2003, AM J RESP CRIT CARE, V168, P1427, DOI 10.1164/rccm.200206-593OC; Tsutamoto T, 1997, CIRCULATION, V96, P509; von Lukowicz T, 2005, EUR J HEART FAIL, V7, P525, DOI 10.1016/j.ejheart.2004.12.010; Wang TJ, 2004, NEW ENGL J MED, V350, P655, DOI 10.1056/NEJMoa031994; Wang XD, 2004, P NATL ACAD SCI USA, V101, P11477, DOI 10.1073/pnas.0402201101; Weatherall DJ, 2001, B WORLD HEALTH ORGAN, V79, P704	60	138	142	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 19	2006	296	3					310	318		10.1001/jama.296.3.310	http://dx.doi.org/10.1001/jama.296.3.310			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	064LA	16849664				2022-12-28	WOS:000239089900023
J	Allen, D; Vasavada, A				Allen, David; Vasavada, Abhay			Cataract and surgery for cataract	BMJ-BRITISH MEDICAL JOURNAL			English	Review							INTRAOCULAR-LENS SURGERY; RURAL EYE CAMP; EXTRACTION; PHACOEMULSIFICATION		Sunderland Eye Infirm, Sunderland SR2 9HP, England; Raghudeep Eye Clin, Iladevi Cataract & IOL Res Ctr, Ahmadabad 380052, Gujarat, India		Allen, D (corresponding author), Sunderland Eye Infirm, Sunderland SR2 9HP, England.	David.allen@chs.northy.nhs.uk						Allen David, 2005, Clin Evid, P762; Asbell PA, 2005, LANCET, V365, P599; Balent LC, 2001, OPHTHALMIC SURG LAS, V32, P446; Barry P, 2006, J CATARACT REFR SURG, V32, P407, DOI 10.1016/j.jcrs.2006.02.021; Civerchia L, 1996, OPHTHALMIC SURG LAS, V27, P200; Foster A, 2001, BRIT J OPHTHALMOL, V85, P635, DOI 10.1136/bjo.85.6.635; Gillies M, 1998, ARCH OPHTHALMOL-CHIC, V116, P90, DOI 10.1001/archopht.116.1.90; Kelly SP, 2005, J CATARACT REFR SURG, V31, P2395, DOI 10.1016/j.jcrs.2005.06.039; Minassian DC, 2001, BRIT J OPHTHALMOL, V85, P822, DOI 10.1136/bjo.85.7.822; Osborne SA, 2006, BRIT J OPHTHALMOL, V90, P333, DOI 10.1136/bjo.2005.080754; Prajna  NV, 1998, AM J OPHTHALMOL, V125, P14, DOI 10.1016/S0002-9394(99)80230-X; Riaz Y, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001323.pub2; *ROYAL COLL OPHTH, 2004, CAT SURG GUID, P39; Ruit S, 2000, CLIN EXP OPHTHALMOL, V28, P274, DOI 10.1046/j.1442-9071.2000.00316.x; Ruit S, 1999, OPHTHALMOLOGY, V106, P1887, DOI 10.1016/S0161-6420(99)90397-4; TAYLOR HR, 1988, NEW ENGL J MED, V319, P1429, DOI 10.1056/NEJM198812013192201; THYLEFORS B, 1995, B WORLD HEALTH ORGAN, V73, P115; Vasavada AR, 2005, LANCET, V365, P550; Zodpey S P, 1999, J Indian Med Assoc, V97, P13; ZODPEY SP, 1999, J INDIAN MED ASSOC, V97, P24	20	115	116	3	19	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 15	2006	333	7559					128	132		10.1136/bmj.333.7559.128	http://dx.doi.org/10.1136/bmj.333.7559.128			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	065JK	16840470	Green Published			2022-12-28	WOS:000239155900018
J	Mourya, DT; Mishra, AC				Mourya, D. T.; Mishra, A. C.			Chikungunya fever	LANCET			English	Editorial Material							EPIDEMIC		Natl Inst Virol, Pune 411021, Maharashtra, India	Indian Council of Medical Research (ICMR); ICMR - National Institute of Virology (NIV)	Mourya, DT (corresponding author), Natl Inst Virol, Microbial Containment Complex, Pune 411021, Maharashtra, India.	mouryadt@icmr.org.in						Bodenmann P, 2006, LANCET, V368, P258, DOI 10.1016/S0140-6736(06)69046-6; BRIGHTON SW, 1983, S AFR MED J, V63, P313; *CDCP, 2006, OUTBR NOT CHIK FEV I; Jupp P. G., 1988, The arboviruses: epidemiology and ecology. Volume II., P137; MASON P. J., 1957, TRANS ROY SOC TROP MED AND HYG, V51, P238; Mourya DT, 2002, ACTA VIROL, V46, P51; ROBINSON M C, 1955, Trans R Soc Trop Med Hyg, V49, P28, DOI [10.1016/0035-9203(57)90022-6, 10.1016/0035-9203(55)90080-8]; RODRIGUE.FM, 1972, B WORLD HEALTH ORGAN, V46, P173; Schuffenecker I, 2006, PLOS MED, V3, P1058, DOI 10.1371/journal.pmed.0030263; WHO, 2006, DIS OUTBR NEWS CHIK	10	40	41	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 15	2006	368	9531					186	187		10.1016/S0140-6736(06)69017-X	http://dx.doi.org/10.1016/S0140-6736(06)69017-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	064MY	16844472				2022-12-28	WOS:000239095000009
J	Erickson, GM; Currie, PJ; Inouye, BD; Winn, AA				Erickson, Gregory M.; Currie, Philip J.; Inouye, Brian D.; Winn, Alice A.			Tyrannosaur life tables: An example of nonavian dinosaur population biology	SCIENCE			English	Article							NATURAL-POPULATIONS; GROWTH-PATTERNS; MORTALITY	The size and age structures for four assemblages of North American tyrannosaurs-Albertosaurus, Tyrannosaurus, Gorgosaurus, and Daspletosaurus - reveal a pronounced, bootstrap-supported pattern of age-specific mortality characterized by relatively high juvenile survivorship and increased mortality at midlife and near the maximum life span. Such patterns are common today in wild populations of long-lived birds and mammals. Factors such as predation and entrance into the breeding population may have influenced tyrannosaur survivorship. This survivorship pattern can explain the rarity of juvenile specimens in museum collections.	Florida State Univ, Dept Biol Sci, Tallahassee, FL 32306 USA; Univ Alberta, Dept Biol Sci, Calgary, AB T6G 2E, Canada	State University System of Florida; Florida State University; University of Alberta	Erickson, GM (corresponding author), Florida State Univ, Dept Biol Sci, B-157, Tallahassee, FL 32306 USA.	gerickson@bio.fsu.edu	Currie, Philip J/A-2628-2014	Currie, Philip J/0000-0001-6857-3161				Abercrombie CL, 2001, CROCODILIAN BIOLOGY AND EVOLUTION, P409; ANDREWS RM, 1982, BIOL REPTILIA PHYS D, V13; Brochu CA, 2003, J VERTEBR PALEONTOL, V22; Carr TD, 1999, J VERTEBR PALEONTOL, V19, P497, DOI 10.1080/02724634.1999.10011161; Chinsamy-Turan A., 2005, MICROSTRUCTURE DINOS; Currie Philip J., 2000, Gaia (Lisboa), V15, P271; DEEVEY ES, 1947, Q REV BIOL, V22, P283, DOI 10.1086/395888; Ebert T.A., 1999, PLANT ANIMAL POPULAT; Erickson GM, 2004, NATURE, V430, P772, DOI 10.1038/nature02699; Erickson GM, 2005, TRENDS ECOL EVOL, V20, P677, DOI 10.1016/j.tree.2005.08.012; Erickson GM, 2001, NATURE, V412, P429, DOI 10.1038/35086558; ESTES RD, 1991, BEHAV GUIDE AFRICAN; FLOWERDUE JR, 1987, MAMMALS THEIR REPROD; IVERSON JB, 1991, CAN J ZOOL, V69, P385, DOI 10.1139/z91-060; Jacobsen Aase Roland, 1998, Historical Biology, V13, P17; Kurten B., 1988, EVOLUTION FOSSIL MAM; MADSEN JH, 1976, B UTAH GEOLOGICAL MI, V109, P1; Newton I, 1989, LIFETIME REPROD BIRD; Pearl R, 1935, Q REV BIOL, V10, P60, DOI 10.1086/394476; Postupalsky S., 1989, P297; PROMISLOW DEL, 1991, EVOLUTION, V45, P1869, DOI 10.1111/j.1558-5646.1991.tb02693.x; Ricklefs RE, 2001, EXP GERONTOL, V36, P845, DOI 10.1016/S0531-5565(00)00245-X; Rogers RR, 2003, NATURE, V422, P515, DOI 10.1038/nature01532; SANDER PM, 1990, ANN SCI NAT ZOOL, V11, P213; Schweitzer MH, 2005, SCIENCE, V308, P1456, DOI 10.1126/science.1112158; SPINAGE CA, 1972, ECOLOGY, V53, P645, DOI 10.2307/1934778; Tanke Darren H., 2000, Gaia (Lisboa), V15, P167; Webb G., 1989, CROCODILES AUSTR; WELLS JW, 1963, NATURE, V197, P948, DOI 10.1038/197948a0; [No title captured]	30	85	87	0	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 14	2006	313	5784					213	217		10.1126/science.1125721	http://dx.doi.org/10.1126/science.1125721			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	063GZ	16840697				2022-12-28	WOS:000239008000041
J	Blumenthal, D				Blumenthal, D			Employer-sponsored insurance - Riding the health care tiger	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							DISEASE MANAGEMENT; SAVINGS ACCOUNTS; QUALITY; PLAN		Massachusetts Gen Hosp, Partners Hlth Care Syst, Inst Hlth Policy, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Partners Healthcare System	Blumenthal, D (corresponding author), Massachusetts Gen Hosp, Partners Hlth Care Syst, Inst Hlth Policy, Boston, MA 02114 USA.							Abelson Reed, 2005, N Y Times Web, pC4; APPLEBY J, 2005, US TODAY        0623, pB1; BAKER CS, 2005, THESIS HARVARD U CAM; Blumenthal D, 1997, NEW ENGL J MED, V337, P1550, DOI 10.1056/NEJM199711203372113; Blumenthal D, 2006, NEW ENGL J MED, V355, P82, DOI 10.1056/NEJMhpr060703; CLAXTON G, 2005, HIGH DEDUCTIBLE PLAN; COLLINS SR, 2005, SHARED RESPONSIBILIT; *COMM FUND, 2005, EBRI COMM FUND CONS; Cowan C. A., 2005, FINANCING HLTH CARE; DAVIS K, 2004, CONSUMER DIRECTED HL; ENTHOVEN AC, 2003, HLTH AFF MILLWOOD S; Epstein AM, 2004, NEW ENGL J MED, V350, P406, DOI 10.1056/NEJMsb035374; Feldman R, 2005, HEALTH AFFAIR, V24, P1582, DOI 10.1377/hlthaff.24.6.1582; Fireman B, 2004, HEALTH AFFAIR, V23, P63, DOI 10.1377/hlthaff.23.6.63; FRONSTIN P, 2004, 273 EMPL BEN RES I; Fuchs VR, 2002, NEW ENGL J MED, V346, P1822, DOI 10.1056/NEJM200206063462314; Galvin RS, 2005, HEALTH AFFAIR, V24, P228, DOI 10.1377/hlthaff.24.1.228; Goetzel RZ, 2005, HEALTH CARE FINANC R, V26, P1; *KAIS FAM FDN, 2005, EMPL HLTH BEN 2005 S; Lave JR, 1999, HEALTH AFFAIR, V18, P112, DOI 10.1377/hlthaff.18.4.112; *NAT BUS GROUP HLT, 2004, CORP HLTH CAR COMM G; NEWHOUSE J, 2005, BOSTON GLOBE    1111, pA23; NEWHOUSE JR, 1993, FREE ALL LESSONS RAN, P372; Robinson JC, 2005, NEW ENGL J MED, V353, P1199, DOI 10.1056/NEJMp058097; ROBINSON JC, 2002, HLTH AFF MILLWOOD S, pW139; Rosenthal M, 2005, HEALTH AFFAIR, V24, P1592, DOI 10.1377/hlthaff.24.6.1592; Rosenthal MB, 2005, JAMA-J AM MED ASSOC, V294, P1788, DOI 10.1001/jama.294.14.1788; Rosenthal MB, 2004, HEALTH AFFAIR, V23, P127, DOI 10.1377/hlthaff.23.2.127; Tollen LA, 2004, HEALTH SERV RES, V39, P1167, DOI 10.1111/j.1475-6773.2004.00281.x; *WATS WYATT WORLDW, 2005, MAN HLTH CAR COSTS N; ZIMMERMAN A, 2005, WALL STREET J   1027, P1	31	20	20	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 13	2006	355	2					195	202		10.1056/NEJMhpr060704	http://dx.doi.org/10.1056/NEJMhpr060704			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	062UP	16837686				2022-12-28	WOS:000238970600015
J	Bhutta, ZA				Bhutta, Zulfiqar A.			Current concepts in the diagnosis and treatment of typhoid fever	BMJ-BRITISH MEDICAL JOURNAL			English	Review							ANTIMICROBIAL RESISTANCE; DEVELOPING-COUNTRIES; SALMONELLA-TYPHI; CHILDREN; PARATYPHI; DRUG; CHLORAMPHENICOL; IDENTIFICATION; BACTEREMIA; OFLOXACIN		Aga Khan Univ, Dept Paediat & Child Hlth, Karachi, Pakistan	Aga Khan University	Bhutta, ZA (corresponding author), Aga Khan Univ, Dept Paediat & Child Hlth, Karachi, Pakistan.	zulfiqar.bhutta@aku.edu						Abdel Fadeel M, 2004, AM J TROP MED HYG, V70, P323, DOI 10.4269/ajtmh.2004.70.323; Berkley JA, 2005, NEW ENGL J MED, V352, P39, DOI 10.1056/NEJMoa040275; Bhan MK, 2005, LANCET, V366, P749, DOI 10.1016/S0140-6736(05)67181-4; Bhutta ZA, 1999, AM J TROP MED HYG, V61, P654, DOI 10.4269/ajtmh.1999.61.654; Bhutta ZA, 1996, ARCH DIS CHILD, V75, P214, DOI 10.1136/adc.75.3.214; Bhutta ZA, 2000, ANTIMICROB AGENTS CH, V44, P450, DOI 10.1128/AAC.44.2.450-452.2000; Bhutta ZA, 2006, CONNS CURRENT THERAP, P215; Brooks WA, 2005, EMERG INFECT DIS, V11, P326, DOI 10.3201/eid1102.040422; Chandel DS, 2000, EMERG INFECT DIS, V6, P420, DOI 10.3201/eid0604.000420; Crump JA, 2004, B WORLD HEALTH ORGAN, V82, P346; FERRECCIO C, 1984, J PEDIATR-US, V104, P899, DOI 10.1016/S0022-3476(84)80492-8; Frenck RW, 2004, CLIN INFECT DIS, V38, P951, DOI 10.1086/382359; Graham SM, 2002, CURR OPIN INFECT DIS, V15, P507, DOI 10.1097/00001432-200210000-00009; Hathout S el-D, 1970, J Egypt Public Health Assoc, V45, P145; Hirose K, 2002, J CLIN MICROBIOL, V40, P633, DOI 10.1128/JCM.40.02.633-636.2002; House D, 2001, J CLIN MICROBIOL, V39, P1002, DOI 10.1128/JCM.39.3.1002-1007.2001; *I MED, 1986, NEW VACC DEV EST PRI; KHURIBULOS N, 1981, CLIN PEDIATR, V20, P448, DOI 10.1177/000992288102000704; Lim PL, 1998, J CLIN MICROBIOL, V36, P2271, DOI 10.1128/JCM.36.8.2271-2278.1998; Nsutebu EF, 2003, TROP MED INT HEALTH, V8, P575, DOI 10.1046/j.1365-3156.2003.01012.x; Nsutebu EF, 2002, T ROY SOC TROP MED H, V96, P64, DOI 10.1016/S0035-9203(02)90243-9; Ochiai RL, 2005, EMERG INFECT DIS, V11, P1764, DOI 10.3201/eid1111.050168; Okeke IN, 2005, LANCET INFECT DIS, V5, P568, DOI 10.1016/S1473-3099(05)70217-6; Okeke IN, 2005, LANCET INFECT DIS, V5, P481, DOI 10.1016/S1473-3099(05)70189-4; Olopoenia LA, 2000, POSTGRAD MED J, V76, P80, DOI 10.1136/pmj.76.892.80; Olsen SJ, 2004, J CLIN MICROBIOL, V42, P1885, DOI 10.1128/JCM.42.5.1885-1889.2004; Phongmany S, 2005, T ROY SOC TROP MED H, V99, P451, DOI 10.1016/j.trstmh.2004.08.007; Prakash P, 2005, J CLIN MICROBIOL, V43, P431, DOI 10.1128/JCM.43.1.431-432.2005; PUNJABI NH, 1988, PEDIATR INFECT DIS J, V7, P598, DOI 10.1097/00006454-198808000-00002; Renuka K, 2005, J MED MICROBIOL, V54, P999, DOI 10.1099/jmm.0.45966-0; Rowe B, 1997, CLIN INFECT DIS, V24, pS106, DOI 10.1093/clinids/24.Supplement_1.S106; ROWE B, 1987, EPIDEMIOL INFECT, V98, P379, DOI 10.1017/S0950268800062142; Shirakawa T, 2006, DIAGN MICR INFEC DIS, V54, P299, DOI 10.1016/j.diagmicrobio.2005.10.016; Siddiqui FJ, 2006, INT J INFECT DIS, V10, P215, DOI 10.1016/j.ijid.2005.03.010; Sinha A, 1999, LANCET, V354, P734, DOI 10.1016/S0140-6736(98)09001-1; Thaver D, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD.000179.pub2; Thomas MG, 2003, INTERN MED J, V33, P472, DOI 10.1046/j.1445-5994.2003.00454.x; TOPLEY JM, 1986, ARCH DIS CHILD, V61, P164, DOI 10.1136/adc.61.2.164; van den Bergh ETAM, 1999, TROP MED INT HEALTH, V4, P211; Vinh H, 2005, ANN TROP PAEDIATR, V25, P17, DOI 10.1179/146532805X23308; Vollaard AM, 2005, T ROY SOC TROP MED H, V99, P440, DOI 10.1016/j.trstmh.2004.09.012; Wain J, 1998, J CLIN MICROBIOL, V36, P1683, DOI 10.1128/JCM.36.6.1683-1687.1998; Watt G, 2005, AM J TROP MED HYG, V72, P10, DOI 10.4269/ajtmh.2005.72.10; *WHO, 2003, BACKGR DOC DIAGN TRE, P19	44	181	184	0	11	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 8	2006	333	7558					78	82B		10.1136/bmj.333.7558.78	http://dx.doi.org/10.1136/bmj.333.7558.78			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	065BA	16825230	Green Published, Green Submitted			2022-12-28	WOS:000239133200018
J	Rossignol, JF; Abu-Zekry, M; Hussein, A; Santoro, MG				Rossignol, JF; Abu-Zekry, M; Hussein, A; Santoro, MG			Effect of nitazoxanide for treatment of severe rotavirus diarrhoea: randomised double-blind placebo-controlled trial	LANCET			English	Article							KAPPA-B KINASE; PERSISTENT DIARRHEA; CHILDREN; DISEASE; REPLICATION; INHIBITION; BANGLADESH; INFECTION; AGE	Background Rotavirus is a leading cause of morbidity and mortality in children younger than 5 years, but there is no effective treatment. We assessed the activity of nitazoxanide, a broad-spectrum anti-infective drug, against rotavirus in cell culture and in a clinical trial in paediatric patients hospitalised with severe rotavirus diarrhoea. Methods We did a randomised double-blind placebo-controlled trial in 50 children admitted to the Cairo University Children's Hospital between June 15 and Aug 23, 2005, with severe rotavirus diarrhoea. 38 children aged 5 months to 7 years (median age 11 months) with rotavirus as the sole identified cause of gastroenteritis were enrolled in the clinical study. Patients were randomly assigned either 7.5 mg/kg nitazoxanide as an oral suspension or placebo twice a day for 3 days, and all remained in hospital for 7 days after start of treatment. The primary endpoint was time from first dose to resolution of illness, and analysis was by modified intention-to-treat. This study is registered with ClinicalTrials.gov, number NCT00302640. Findings Survival analysis showed that the median time to resolution of illness was 31 h (IQR 22-73) for the nitazoxanide-treated group compared with 75 h (51-124) for the placebo group (p=0.0137). No significant adverse events were reported. Interpretation A 3-day course of nitazoxanide significantly reduced the duration of rotavirus disease in hospitalised paediatric patients. These results are encouraging, and might lead us to think about new approaches to managing rotavirus disease in children.	Romark Inst Med Res, Tampa, FL 33607 USA; Cairo Univ, Childrens Hosp, Dept Pediat Gastroenterol, Cairo, Egypt; Univ Roma Tor Vergata, Dept Biol, Rome, Italy	Egyptian Knowledge Bank (EKB); Cairo University; University of Rome Tor Vergata	Rossignol, JF (corresponding author), Romark Inst Med Res, Tampa, FL 33607 USA.	jrossignol@romark.com	Pham, Van/ABB-4933-2020	Santoro, Maria Gabriella/0000-0003-1432-4949				Albert MJ, 1999, J CLIN MICROBIOL, V37, P3458, DOI 10.1128/JCM.37.11.3458-3464.1999; Amadi B, 2002, LANCET, V360, P1375, DOI 10.1016/S0140-6736(02)11401-2; Amici C, 2004, AIDS, V18, P1271, DOI 10.1097/00002030-200406180-00005; Azim T, 1999, CLIN DIAGN LAB IMMUN, V6, P690, DOI 10.1128/CDLI.6.5.690-695.1999; Bellemare S, 2004, BMC MED, V2, DOI 10.1186/1741-7015-2-11; Bernasconi D, 2005, J BIOL CHEM, V280, P24127, DOI 10.1074/jbc.M413726200; Fox LM, 2005, CLIN INFECT DIS, V40, P1173, DOI 10.1086/428839; Guandalini S., 1997, NESTLE NUTR WORKSHOP, V38, P153; Infante RM, 2004, CLIN GASTROENTEROL H, V2, P135, DOI 10.1016/S1542-3565(03)00322-7; Kosek M, 2003, B WORLD HEALTH ORGAN, V81, P197; Leung AKC, 2005, ADV THER, V22, P476, DOI 10.1007/BF02849868; MING ZF, 1991, T ROY SOC TROP MED H, V85, P667, DOI 10.1016/0035-9203(91)90389-G; MITRA AK, 1995, ACTA PAEDIATR, V84, P996, DOI 10.1111/j.1651-2227.1995.tb13814.x; MUSHER DM, IN PRESS CLIN INFECT; Nguyen TV, 2004, J CLIN MICROBIOL, V42, P5745, DOI 10.1128/JCM.42.12.5745-5750.2004; Parashar UD, 2003, EMERG INFECT DIS, V9, P565, DOI 10.3201/eid0905.020562; Richardson S, 1998, LANCET, V351, P1844, DOI 10.1016/S0140-6736(97)11257-0; Rossignol JF, 2006, CLIN GASTROENTEROL H, V4, P320, DOI 10.1016/j.cgh.2005.12.020; Rossignol JF, 2005, CLIN GASTROENTEROL H, V3, P987, DOI 10.1016/S1542-3565(05)00427-1; Rossignol JF, 2001, J INFECT DIS, V184, P381, DOI 10.1086/322038; ROSSIGNOL JF, 2006, DIGESTIVE DIS W 0520; Salazar-Lindo E, 2000, NEW ENGL J MED, V343, P463, DOI 10.1056/NEJM200008173430703; Sarker SA, 2005, PEDIATRICS, V116, pE221, DOI 10.1542/peds.2004-2334; Sood M, 1999, ARCH DIS CHILD, V80, P309, DOI 10.1136/adc.80.4.309; Superti F, 1998, J INFECT DIS, V178, P564, DOI 10.1086/517475; Van Niel CW, 2002, PEDIATRICS, V109, P678, DOI 10.1542/peds.109.4.678; [WHO] World Health Organisation, 1988, WHO M; Widdowson MA, 2005, CURR OPIN GASTROEN, V21, P26	28	129	138	0	6	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 8	2006	368	9530					124	129		10.1016/S0140-6736(06)68852-1	http://dx.doi.org/10.1016/S0140-6736(06)68852-1			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	062AR	16829296				2022-12-28	WOS:000238917200026
J	McTigue, K; Larson, JC; Valoski, A; Burke, G; Kotchen, J; Lewis, CE; Stefanick, ML; Van Horn, L; Kuller, L				McTigue, Kathleen; Larson, Joseph C.; Valoski, Alice; Burke, Greg; Kotchen, Jane; Lewis, Cora E.; Stefanick, Marcia L.; Van Horn, Linda; Kuller, Lewis			Mortality and cardiac and vascular outcomes in extremely obese women	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BODY-MASS INDEX; GASTRIC BYPASS; UNITED-STATES; WEIGHT; LIFE; ASSOCIATION; OVERWEIGHT; RISK	Context Obesity, typically measured as body mass index of 30 or higher, has 3 subclasses: obesity 1 (30-34.9); obesity 2 (35-39.9); and extreme obesity (>= 40). Extreme obesity is increasing particularly rapidly in the United States, yet its health risks are not well characterized. Objective To determine how cardiovascular and mortality risks differ across clinical weight categories in women, with a focus on extreme obesity. Design, Setting, and Participants We examined incident mortality and cardiovascular outcomes by weight status in 90 185 women recruited from 40 US centers for the Women's Health Initiative Observational Study and followed up for an average of 7.0 years (October 1, 1993 to August 31, 2004). Main Outcome Measures Incidence of mortality, coronary heart disease, diabetes, and hypertension. Results Extreme obesity prevalence differed with race/ethnicity, from 1% among Asian and Pacific Islanders to 10% among black women. All-cause mortality rates per 10 000 person-years were 68.39 (95% confidence interval [CI], 65.26-71.68) for normal body mass index, 71.16 (95% CI, 67.68-74.82) for overweight, 84.47 (95% CI, 78.90-90.42) for obesity 1, 102.85 (95% CI, 92.90-113.86) for obesity 2, and 116.85 (95% CI, 103.36-132.11) for extreme obesity. Analyses adjusted for age, smoking, educational achievement, US region, and physical activity levels showed that weight-related risk for all-cause mortality, coronary heart disease mortality, and coronary heart disease incidence did not differ by race/ethnicity. Adjusted analyses among white and black participants showed positive trends in all-cause mortality and coronary heart disease incidence with increasing weight category. Much of the obesity-related mortality and coronary heart disease risk was mediated by diabetes, hypertension, and hyperlipidemia. In white women, weight-related all-cause mortality risk was modified by age, with obesity conferring less risk among older women. Conclusions Considering obesity as a body mass index of 30 or higher may lead to misinterpretation of individual and population risks. Escalating extreme obesity may exacerbate health effects and costs of the obesity epidemic.	Univ Pittsburgh, Dept Med, Div Gen Internal Med, Pittsburgh, PA 15213 USA; Univ Pittsburgh, Dept Epidemiol, Pittsburgh, PA 15213 USA; Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98104 USA; Wake Forest Univ, Dept Publ Hlth Sci, Winston Salem, NC 27109 USA; Med Coll Wisconsin, Hlth Policy Inst, Div Epidemiol, Milwaukee, WI 53226 USA; Univ Alabama Birmingham, Dept Med, Div Prevent Med, Birmingham, AL 35294 USA; Stanford Univ, Sch Med, Dept Med, Stanford Prevent Res Ctr, Stanford, CA 94305 USA; Northwestern Univ, Feinberg Sch Med, Dept Prevent Med, Chicago, IL 60611 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Fred Hutchinson Cancer Center; Wake Forest University; Medical College of Wisconsin; University of Alabama System; University of Alabama Birmingham; Stanford University; Northwestern University; Feinberg School of Medicine	McTigue, K (corresponding author), Univ Pittsburgh, Dept Med, Div Gen Internal Med, 230 McKee Pl,Suite 600, Pittsburgh, PA 15213 USA.	mctiguem@upmc.edu			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK067192] Funding Source: NIH RePORTER; NIDDK NIH HHS [1 K08 DK067192-01] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AINSWORTH BE, 1993, MED SCI SPORT EXER, V25, P71, DOI 10.1249/00005768-199301000-00011; Allison DB, 1999, JAMA-J AM MED ASSOC, V282, P1530, DOI 10.1001/jama.282.16.1530; Arterburn DE, 2005, INT J OBESITY, V29, P334, DOI 10.1038/sj.ijo.0802896; Arterburn DE, 2004, AM J MED, V117, P738, DOI 10.1016/j.amjmed.2004.06.031; Blair Steven N, 2003, Clin J Sport Med, V13, P319, DOI 10.1097/00042752-200309000-00008; Calle EE, 1999, NEW ENGL J MED, V341, P1097, DOI 10.1056/NEJM199910073411501; COLDITZ GA, 1995, ANN INTERN MED, V122, P481, DOI 10.7326/0003-4819-122-7-199504010-00001; Curb JD, 2003, ANN EPIDEMIOL, V13, pS122, DOI 10.1016/S1047-2797(03)00048-6; Durazo-Arvizu RA, 1998, AM J EPIDEMIOL, V147, P739, DOI 10.1093/oxfordjournals.aje.a009518; DurazoArvizu R, 1997, ANN EPIDEMIOL, V7, P383, DOI 10.1016/S1047-2797(97)00044-6; Ferraro KF, 2003, J GERONTOL B-PSYCHOL, V58, pS110, DOI 10.1093/geronb/58.2.S110; Folsom AR, 2000, ARCH INTERN MED, V160, P2117, DOI 10.1001/archinte.160.14.2117; Fontaine KR, 2003, JAMA-J AM MED ASSOC, V289, P187, DOI 10.1001/jama.289.2.187; Freedman DS, 2002, JAMA-J AM MED ASSOC, V288, P1758, DOI 10.1001/jama.288.14.1758; Huang ZP, 1998, ANN INTERN MED, V128, P81, DOI 10.7326/0003-4819-128-2-199801150-00001; Kim KS, 2000, ANN EPIDEMIOL, V10, P424, DOI 10.1016/S1047-2797(00)00065-X; Kuczmarski RJ, 2000, AM J CLIN NUTR, V72, P1074; Laara E, 1996, J EPIDEMIOL COMMUN H, V50, P408, DOI 10.1136/jech.50.4.408; Langer RD, 2003, ANN EPIDEMIOL, V13, pS107, DOI 10.1016/S1047-2797(03)00047-4; MANSON JE, 2001, CLIN J WOMENS HLTH, V1, P225; Mcgee DL, 2005, ANN EPIDEMIOL, V15, P87, DOI 10.1016/j.annepidem.2004.05.012; *NHLBI OB ED IN, 1998, CLIN GUID IND EV TRE; Schauer PR, 2003, ANN SURG, V238, P467, DOI 10.1097/01.sla.0000089851.41115.1b; SJOSTROM L, 1992, INT J OBESITY, V16, P465; Stevens J, 1998, NEW ENGL J MED, V338, P1, DOI 10.1056/NEJM199801013380101; Stevens J, 2000, NUTR REV, V58, P346, DOI 10.1111/j.1753-4887.2000.tb01832.x; Sturm R, 2003, ARCH INTERN MED, V163, P2146, DOI 10.1001/archinte.163.18.2146; Sugerman HJ, 2001, ANN SURG, V234, P41, DOI 10.1097/00000658-200107000-00007; *US DEP HHS, PHYS ACT HLTH REP SU	29	237	241	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 5	2006	296	1					79	86		10.1001/jama.296.1.79	http://dx.doi.org/10.1001/jama.296.1.79			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	058RU	16820550	Bronze			2022-12-28	WOS:000238683100025
J	Basto, R; Lau, J; Vinogradova, T; Gardiol, A; Woods, CG; Khodjakov, A; Raff, JW				Basto, Renata; Lau, Joyce; Vinogradova, Tatiana; Gardiol, Alejandra; Woods, C. Geoffrey; Khodjakov, Alexey; Raff, Jordan W.			Flies without centrioles	CELL			English	Article							DROSOPHILA ASYMMETRIC DIVISIONS; CELL-CYCLE PROGRESSION; C-ELEGANS; CENTROSOME DUPLICATION; D-TACC; CORTICAL POLARITY; PRIMARY CILIUM; PROTEIN SPD-2; VERTEBRATES; NEUROBLASTS	Centrioles and centrosomes have an important role in animal cell organization, but it is uncertain to what extent they are essential for animal development. The Drosophila protein DSas-4 is related to the human microcephaly protein CenpJ and the C. elegans centriolar protein Sas-4. We show that DSas-4 is essential for centriole replication in flies. DSas-4 mutants start to lose centrioles during embryonic development, and, by third-instar larval stages, no centrioles or centrosomes are detectable. Mitotic spindle assembly is slow in mutant cells, and similar to 30% of the asymmetric divisions of larval neuroblasts are abnormal. Nevertheless, mutant flies develop with near normal timing into morphologically normal adults. These flies, however, have no cilia or flagella and die shortly after birth because their sensory neurons lack cilia. Thus, centrioles are essential for the formation of centrosomes, cilia, and flagella, but, remarkably, they are not essential for most aspects of Drosophila development.	Gurdon Inst, Cambridge CB2 1QN, England; New York State Dept Hlth, Wadsworth Ctr, Albany, NY 12201 USA; SUNY Albany, Dept Biomed Sci, Albany, NY 12222 USA; Cambridge Inst Med Res, Dept Med Genet, Cambridge CB2 2XY, England	State University of New York (SUNY) System; Wadsworth Center; State University of New York (SUNY) System; State University of New York (SUNY) Albany; University of Cambridge	Basto, R (corresponding author), Gurdon Inst, Tennis Court Rd, Cambridge CB2 1QN, England.	j.raff@gurdon.cam.ac.uk	woods, christopher g/A-1361-2010; Vinogradova, Tatiana/AAU-5793-2020		NIGMS NIH HHS [R01 GM059363, R01 GM059363-08, GM59363] Funding Source: Medline; Wellcome Trust Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059363] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Badano JL, 2005, NAT REV GENET, V6, P194, DOI 10.1038/nrg1557; Barros TP, 2005, J CELL BIOL, V170, P1039, DOI 10.1083/jcb.200504097; Bast RC, 2000, INT J GYNECOL CANCER, V10, P2, DOI 10.1046/j.1525-1438.2000.99502.x; Betschinger J, 2004, CURR BIOL, V14, pR674, DOI 10.1016/j.cub.2004.08.017; Bettencourt-Dias M, 2005, CURR BIOL, V15, P2199, DOI 10.1016/j.cub.2005.11.042; Bonaccorsi S, 2000, NAT CELL BIOL, V2, P54, DOI 10.1038/71378; Bond J, 2005, NAT GENET, V37, P353, DOI 10.1038/ng1539; Buffin E, 2005, CURR BIOL, V15, P856, DOI 10.1016/j.cub.2005.03.052; Corbit KC, 2005, NATURE, V437, P1018, DOI 10.1038/nature04117; Cowan CR, 2004, ANNU REV CELL DEV BI, V20, P427, DOI 10.1146/annurev.cellbio.19.111301.113823; de Anda FC, 2005, NATURE, V436, P704, DOI 10.1038/nature03811; DEBEC A, 1989, BIOL CELL, V67, P307, DOI 10.1016/0248-4900(89)90068-3; Delattre M, 2004, NAT CELL BIOL, V6, P656, DOI 10.1038/ncb1146; Doxsey S, 2005, ANNU REV CELL DEV BI, V21, P411, DOI 10.1146/annurev.cellbio.21.122303.120418; Dubruille R, 2002, DEVELOPMENT, V129, P5487, DOI 10.1242/dev.00148; Eley L, 2005, CURR OPIN GENET DEV, V15, P308, DOI 10.1016/j.gde.2005.04.008; Gergely F, 2000, EMBO J, V19, P241, DOI 10.1093/emboj/19.2.241; Giansanti MG, 2001, DEVELOPMENT, V128, P1137; Gonczy P, 2002, TRENDS CELL BIOL, V12, P332, DOI 10.1016/S0962-8924(02)02306-1; Grieder NC, 2000, DEVELOPMENT, V127, P4253; Habedanck R, 2005, NAT CELL BIOL, V7, P1140, DOI 10.1038/ncb1320; Hinchcliffe EH, 2001, SCIENCE, V291, P1547, DOI 10.1126/science.1056866; Huang JY, 1999, EMBO J, V18, P2184, DOI 10.1093/emboj/18.8.2184; Huangfu D, 2005, P NATL ACAD SCI USA, V102, P11325, DOI 10.1073/pnas.0505328102; IkeshimaKataoka H, 1997, NATURE, V390, P625, DOI 10.1038/37641; KELLOGG DR, 1994, ANNU REV BIOCHEM, V63, P639, DOI 10.1146/annurev.bi.63.070194.003231; KELLOGG DR, 1992, MOL BIOL CELL, V3, P1, DOI 10.1091/mbc.3.1.1; Kemp CA, 2004, DEV CELL, V6, P511, DOI 10.1016/S1534-5807(04)00066-8; KERNAN M, 1994, NEURON, V12, P1195, DOI 10.1016/0896-6273(94)90437-5; Khodjakov A, 2000, CURR BIOL, V10, P59, DOI 10.1016/S0960-9822(99)00276-6; Khodjakov A, 2001, J CELL BIOL, V153, P237, DOI 10.1083/jcb.153.1.237; Kirkham M, 2003, CELL, V112, P575, DOI 10.1016/S0092-8674(03)00117-X; Kouprina N, 2005, HUM MOL GENET, V14, P2155, DOI 10.1093/hmg/ddi220; Lee MJ, 2001, NAT CELL BIOL, V3, P643, DOI 10.1038/35083033; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Leidel S, 2005, NAT CELL BIOL, V7, P115, DOI 10.1038/ncb1220; Leidel S, 2003, DEV CELL, V4, P431, DOI 10.1016/S1534-5807(03)00062-5; Martinez-Campos M, 2004, J CELL BIOL, V165, P673, DOI 10.1083/jcb.200402130; Megraw TL, 2001, CURR BIOL, V11, P116, DOI 10.1016/S0960-9822(01)00017-3; Nigg EA, 2002, NAT REV CANCER, V2, P815, DOI 10.1038/nrc924; O'Connell KF, 2001, CELL, V105, P547, DOI 10.1016/S0092-8674(01)00338-5; Pazour GJ, 2002, TRENDS CELL BIOL, V12, P551, DOI 10.1016/S0962-8924(02)02410-8; Pelletier L, 2004, CURR BIOL, V14, P863, DOI 10.1016/j.cub.2004.04.012; Phalle BD, 1998, J CELL BIOL, V141, P1383, DOI 10.1083/jcb.141.6.1383; Piel M, 2001, SCIENCE, V291, P1550, DOI 10.1126/science.1057330; Raff JW, 2002, J CELL BIOL, V157, P1139, DOI 10.1083/jcb.200203035; Raff JW, 2001, CURR BIOL, V11, pR159, DOI 10.1016/S0960-9822(01)00082-3; Rieder CL, 2001, TRENDS CELL BIOL, V11, P413, DOI 10.1016/S0962-8924(01)02085-2; Schneider L, 2005, CURR BIOL, V15, P1861, DOI 10.1016/j.cub.2005.09.012; Siegrist SE, 2005, CELL, V123, P1323, DOI 10.1016/j.cell.2005.09.043; Woods CG, 2005, AM J HUM GENET, V76, P717, DOI 10.1086/429930; Yu FW, 2000, CELL, V100, P399, DOI 10.1016/S0092-8674(00)80676-5	52	516	524	0	30	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUN 30	2006	125	7					1375	1386		10.1016/j.cell.2006.05.025	http://dx.doi.org/10.1016/j.cell.2006.05.025			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	064QP	16814722	Bronze			2022-12-28	WOS:000239104500019
J	Billings, J; Dixon, J; Mijanovich, T; Wennberg, D				Billings, John; Dixon, Jennifer; Mijanovich, Tod; Wennberg, David			Case finding for patients at risk of readmission to hospital: development of algorithm to identify high risk patients	BRITISH MEDICAL JOURNAL			English	Article							FOLLOW-UP	Objective To develop a method of identifying patients at high risk of readmission to hospital in the next 12 months for practical use by primary care trusts and general practices in the NHS in England. Data sources Data from hospital episode statistics showing all admissions in NHS trusts in England over five years, 1999-2000 to 2003-4; data from die 2001 census for England. Population All residents in England admitted to hospital in the previous four years with a subset of "reference" conditions for which improved management may help to prevent future admissions. Design Multivariate statistical analysis of routinely collected data to develop an algorithm to predict patients at highest risk of readmission in the next 12 months. The algorithm was developed by using a 10% sample of hospital episode statistics data for all of England for the period indicated. The coefficients for 21 most powerful (and statistically significant) variables were then applied against a second 10% test sample to validate the findings of the algorithm from the first sample. Results The key factors predicting subsequent admission included age, sex, ethnicity, number of previous admissions, and clinical condition. The algorithm produces a risk score (from 0 to 100) for each patient admitted with a reference condition. At a risk score threshold of 50, the algorithm identified 54.3% of patients admitted with a reference condition who would have an admission in the next 12 months; 34.7% of patients were "flagged" incorrectly (they would not have a subsequent admission). At risk score threshold levels of 70 and 80, the rate of incorrectly "flagged" patients dropped to 22.6% and 15.7%, but the algorithm found a lower percentage of patients who would be readmitted. The algorithm is made freely available to primary care trusts via a website. Conclusions A method of predicting individual patients at highest risk of readmission to hospital in the next 12 months has been developed, which has a reasonable level of sensitivity and specificity. Using various assumptions a "business case" has been modelled to demonstrate to primary care trusts and practices the potential costs and impact of an intervention using the algorithm to reduce hospital admissions.	NYU, Ctr Hlth & Publ Serv Res, New York, NY 10012 USA; Kings Fund, London W1G 0AN, England; Hlth Dialog Analyt Solut, Hlth Dialog Corp Headquarters, Boston, MA USA	New York University	Billings, J (corresponding author), NYU, Ctr Hlth & Publ Serv Res, 295 Lafayette St, New York, NY 10012 USA.	john.billings@nyu.edu						Department of Health, 2005, SUPP PEOPL LONG TERM; Naylor MD, 1999, JAMA-J AM MED ASSOC, V281, P613, DOI 10.1001/jama.281.7.613; Phillips CO, 2004, JAMA-J AM MED ASSOC, V291, P1358, DOI 10.1001/jama.291.11.1358; Roland M, 2005, BRIT MED J, V330, P289, DOI 10.1136/bmj.330.7486.289	4	257	260	0	25	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	AUG 12	2006	333	7563					327	330		10.1136/bmj.38870.657917.AE	http://dx.doi.org/10.1136/bmj.38870.657917.AE			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	073VI	16815882	Green Published, Bronze, Green Submitted			2022-12-28	WOS:000239770300015
J	Kok, NFM; Lind, MY; Hansson, BME; Pilzecker, D; zur Borg, IRAMM; Knipscheer, BC; Hazebroek, EJ; Dooper, IM; Weimar, W; Hop, WCJ; Adang, EMM; van der Wilt, GJ; Bonjer, HJ; van der Vliet, JA; IJzermans, JNM				Kok, Niels F. M.; Lind, May Y.; Hansson, Birgitta M. E.; Pilzecker, Desiree; zur Borg, Irigrid R. A. M. Mertens; Knipscheer, Ben C.; Hazebroek, Eric J.; Dooper, Ine M.; Weimar, Willem; Hop, Wim C. J.; Adang, Eddy M. M.; van der Wilt, Gert Jan; Bonjer, Hendrik J.; van der Vliet, Jordanus A.; IJzermans, Jan N. M.			Comparison of laparoscopic and mini incision open donor nephrectomy: single blind, randomised controlled clinical trial	BRITISH MEDICAL JOURNAL			English	Article							QUALITY-OF-LIFE; LIVING-DONOR; RETURN; PAIN	Objectives To determine the best approach for live donor nephrectomy to minimise discomfort to the donor and to provide good graft function. Design Single blind, randomised controlled trial. Setting Two university medical centres, the Netherlands. Participants 100 living kidney donors. Interventions Participants were randomly assigned to either laparoscopic donor nephrectomy or to mini incision muscle splitting open donor nephrectomy. Main outcome measures The primary outcome was physical fatigue using the multidimensional fatigue inventory 20 (MFI-20). Secondary outcomes were physical function using the SF-36, hospital stay after surgery, pain, operating times, recipient graft function, and graft survival. Results Compared with mini incision open donor nephrectomy, laparoscopic donor nephrectomy resulted in longer skin to skin time (median 221 v 164 minutes, P < 0.001), longer warm ischaemia time (6 v 3 minutes, P < 0.001), less blood loss (100 v 240 ml, P < 0.001), and a similar number of complications (intraoperatively 12% v 6%, P = 0.49, postoperatively both 6%). After laparoscopic nephrectomy, donors required less morphine (16 v 25 mg, P = 0.005) and shorter hospital stay (3 v 4 days, P = 0.003). During one year's follow-up mean physical fatigue was less (difference - 1.3, 95% confidence interval - 2.4 to - 0.1) and physical function was better (difference 6.2, 2.0 to 10.3) after laparoscopic nephrectomy. Function of the graft and graft survival rate of the recipient at one year censored for death did not differ (100% after laparoscopic nephrectomy and 98% after open nephrectomy). Conclusions Laparoscopic donor nephrectomy results in a better quality of life compared with mini incision open donor nephrectomy but equal safety and graft function.	Erasmus MC, Dept Surg, NL-3000 CA Rotterdam, Netherlands; Radboud Univ Med Ctr, Dept Surg, Nijmegen, Netherlands; Radboud Univ Med Ctr, Dept Nephrol, Nijmegen, Netherlands; Radboud Univ Med Ctr, Dept Urol, Nijmegen, Netherlands; Erasmus MC, Dept Anaesthesiol, NL-3000 CA Rotterdam, Netherlands; Erasmus MC, Dept Nephrol, NL-3000 CA Rotterdam, Netherlands; Erasmus MC, Dept Epidemiol & Biostat, NL-3000 CA Rotterdam, Netherlands; Radboud Univ Med Ctr, Dept Med Technol Assessment, Nijmegen, Netherlands	Erasmus University Rotterdam; Erasmus MC; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Radboud University Nijmegen	IJzermans, JNM (corresponding author), Erasmus MC, Dept Surg, POB 2040, NL-3000 CA Rotterdam, Netherlands.	j.ijzermans@erasmusmc.nl	van der Wilt, G.J./H-8120-2014; Adang, E.M.M./L-4169-2015; van der Vliet, J. Adam/L-4721-2015	van der Wilt, G.J./0000-0002-5856-762X; 				Berends FJ, 2002, SURG ENDOSC, V16, P893, DOI 10.1007/s004640090078; Buell JF, 2005, CLIN TRANSPLANT, V19, P102, DOI 10.1111/j.1399-0012.2004.00308.x; Dunker MS, 2001, DIS COLON RECTUM, V44, P1800, DOI 10.1007/BF02234458; Ingelfinger JR, 2005, NEW ENGL J MED, V353, P447, DOI 10.1056/NEJMp058156; Kok NFM, 2006, TRANSPLANTATION, V81, P881, DOI 10.1097/01.tp.0000203320.74256.fd; Lewis GRR, 2004, TRANSPL INT, V17, P589, DOI 10.1007/s00147-004-0770-z; Lind MY, 2003, SURG ENDOSC, V17, P591, DOI 10.1007/s00464-002-9118-x; Oyen O, 2005, TRANSPLANTATION, V79, P1236, DOI 10.1097/01.TP.0000161669.49416.BA; Perry KT, 2003, J UROLOGY, V169, P2018, DOI 10.1097/01.ju.0000067975.59772.b6; Simforoosh N, 2005, BJU INT, V95, P851, DOI 10.1111/j.1464-410X.2005.05415.x; Smets EMA, 1996, BRIT J CANCER, V73, P241, DOI 10.1038/bjc.1996.42; Srivastava A, 2003, J UROLOGY, V170, P738, DOI 10.1097/01.ju.0000081649.53247.2d; Wadstrom J, 2005, TRANSPLANTATION, V80, P1060, DOI 10.1097/01.tp.0000176477.81591.6f; Ware JE, 1993, SF36 HLTH SURVEY MAN; Wolf JS, 2001, TRANSPLANTATION, V72, P284, DOI 10.1097/00007890-200107270-00021; Yang SL, 2002, UROLOGY, V59, P673, DOI 10.1016/S0090-4295(02)01516-9	16	144	144	0	6	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JUL 29	2006	333	7561					221	224		10.1136/bmj.38886.618947.7C	http://dx.doi.org/10.1136/bmj.38886.618947.7C			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	070CC	16847014	Green Published, Green Submitted, Bronze			2022-12-28	WOS:000239496900017
J	Kadyrov, FA; Dzantiev, L; Constantin, N; Modrich, P				Kadyrov, Farid A.; Dzantiev, Leonid; Constantin, Nicoleta; Modrich, Paul			Endonucleolytic function of MutL alpha in human mismatch repair	CELL			English	Article							DNA MISMATCH; RNA-POLYMERASE; COMPLEXES; INITIATION; EXCISION; PCNA; RECONSTITUTION; HETERODIMER; MECHANISM; PROTEINS	Half of hereditary nonpolyposis colon cancer kindreds harbor mutations that inactivate MutlL alpha (MLH1 circle PMS2 heterodimer). MutL alpha is required for mismatch repair, but its function in this process is unclear. We show that human MutL alpha is a latent endonuclease that is activated in a mismatch-, MutS alpha-, RFC-, PCNA-, and ATP-dependent manner. Incision of a nicked mismatch-containing DNA heteroduplex by this four-protein system is strongly biased to the nicked strand. A mismatch-containing DNA segment spanned by two strand breaks is removed by the 5'-to-3' activity of MutS alpha-activated exonuclease I. The probable endonuclease active site has been localized to a PMS2 DQHA(X)(2)E(X)(4)E motif. This motif is conserved in eukaryotic PMS2 homologs and in MutL proteins from a number of bacterial species but is lacking in MutL proteins from bacteria that rely on d(GATC) methylation for strand discrimination in mismatch repair. Therefore, the mode of excision initiation may differ in these organisms.	Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA; Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA	Duke University; Duke University; Howard Hughes Medical Institute	Modrich, P (corresponding author), Duke Univ, Med Ctr, Dept Biochem, Box 3711, Durham, NC 27710 USA.	modrich@biochem.duke.edu		Modrich, Paul/0000-0001-8708-9885	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045190] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM45190] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ASH DE, 1982, J BIOL CHEM, V257, P9261; AU KG, 1992, J BIOL CHEM, V267, P12142; Blackwell LJ, 2001, J BIOL CHEM, V276, P33233, DOI 10.1074/jbc.M105076200; Bowers J, 2001, J MOL BIOL, V306, P957, DOI 10.1006/jmbi.2001.4467; Cannavo E, 2005, CANCER RES, V65, P10759, DOI 10.1158/0008-5472.CAN-05-2528; Constantin N, 2005, J BIOL CHEM, V280, P39752, DOI 10.1074/jbc.M509701200; Dao V, 1998, J BIOL CHEM, V273, P9202, DOI 10.1074/jbc.273.15.9202; Dzantiev L, 2004, MOL CELL, V15, P31, DOI 10.1016/j.molcel.2004.06.016; FANG WH, 1993, J BIOL CHEM, V268, P11838; Finkelstein J, 2003, ANAL BIOCHEM, V319, P78, DOI 10.1016/S0003-2697(03)00273-2; Galburt EA, 2002, BIOCHEMISTRY-US, V41, P13851, DOI 10.1021/bi020467h; Genschel J, 2003, MOL CELL, V12, P1077, DOI 10.1016/S1097-2765(03)00428-3; Genschel J, 2002, J BIOL CHEM, V277, P13302, DOI 10.1074/jbc.M111854200; GRACHEV MA, 1989, EUR J BIOCHEM, V180, P577, DOI 10.1111/j.1432-1033.1989.tb14684.x; Gu LY, 1998, NUCLEIC ACIDS RES, V26, P1173, DOI 10.1093/nar/26.5.1173; Guo SL, 2004, J BIOL CHEM, V279, P16912, DOI 10.1074/jbc.M313213200; Habraken Y, 1998, J BIOL CHEM, V273, P9837, DOI 10.1074/jbc.273.16.9837; Iyer RR, 2006, CHEM REV, V106, P302, DOI 10.1021/cr0404794; Kunkel TA, 2005, ANNU REV BIOCHEM, V74, P681, DOI 10.1146/annurev.biochem.74.082803.133243; Lee B, 2002, NUCLEIC ACIDS RES, V30, P942, DOI 10.1093/nar/30.4.942; Lee SD, 2006, J MOL BIOL, V355, P175, DOI 10.1016/j.jmb.2005.10.059; LI GM, 1995, P NATL ACAD SCI USA, V92, P1950, DOI 10.1073/pnas.92.6.1950; Miyaki M, 1997, ONCOGENE, V15, P2877, DOI 10.1038/sj.onc.1201668; Peltomaki P, 2005, FAM CANCER, V4, P227, DOI 10.1007/s10689-004-7993-0; PROLLA TA, 1994, SCIENCE, V265, P1091, DOI 10.1126/science.8066446; Raschle M, 2002, J BIOL CHEM, V277, P21810, DOI 10.1074/jbc.M108787200; Raschle M, 1999, J BIOL CHEM, V274, P32368, DOI 10.1074/jbc.274.45.32368; Stojic L, 2004, DNA REPAIR, V3, P1091, DOI 10.1016/j.dnarep.2004.06.006; SU SS, 1988, J BIOL CHEM, V263, P6829; Surtees JA, 2004, CYTOGENET GENOME RES, V107, P146, DOI 10.1159/000080593; Tomer G, 2002, J BIOL CHEM, V277, P21801, DOI 10.1074/jbc.M111342200; Wei KC, 2003, GENE DEV, V17, P603, DOI 10.1101/gad.1060603; Zaychikov E, 1996, SCIENCE, V273, P107, DOI 10.1126/science.273.5271.107; Zhang YB, 2005, CELL, V122, P693, DOI 10.1016/j.cell.2005.06.027	34	448	464	2	54	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUL 28	2006	126	2					297	308		10.1016/j.cell.2006.05.039	http://dx.doi.org/10.1016/j.cell.2006.05.039			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	070VD	16873062	Bronze			2022-12-28	WOS:000239552600016
J	Metz, M; Piliponsky, AM; Chen, CC; Lammel, V; Abrink, M; Pejler, G; Tsai, M; Galli, SJ				Metz, Martin; Piliponsky, Adrian M.; Chen, Ching-Cheng; Lammel, Verena; Abrink, Magnus; Pejler, Gunnar; Tsai, Mindy; Galli, Stephen J.			Mast cells can enhance resistance to snake and honeybee venoms	SCIENCE			English	Article							PEPTIDE; MICE; PROTEASES; TOXICITY; IMMUNITY; TISSUE; BITES; APIS	Snake or honeybee envenomation can cause substantial morbidity and mortality, and it has been proposed that the activation of mast cells by snake or insect venoms can contribute to these effects. We show, in contrast, that mast cells can significantly reduce snake-venom - induced pathology in mice, at least in part by releasing carboxypeptidase A and possibly other proteases, which can degrade venom components. Mast cells also significantly reduced the morbidity and mortality induced by honeybee venom. These findings identify a new biological function for mast cells in enhancing resistance to the morbidity and mortality induced by animal venoms.	Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA; Swedish Univ Agr Sci, Dept Mol Biosci, Biomed Ctr, Uppsala, Sweden	Stanford University; Swedish University of Agricultural Sciences	Galli, SJ (corresponding author), Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA.	sgalli@stanford.edu	Chen, Ching-Cheng/C-1259-2009; Maurer, Marcus/ABG-2174-2020; Metz, Martin/B-8799-2009; Metz, Martin/M-5237-2013; Åbrink, Magnus/AAK-8346-2020	Maurer, Marcus/0000-0002-4121-481X; Metz, Martin/0000-0002-4070-9976; Metz, Martin/0000-0002-4070-9976; Tsai, Mindy/0000-0002-8421-4721; Abrink, Magnus/0000-0002-1335-3927	NCI NIH HHS [R01 CA72074, R01 CA072074] Funding Source: Medline; NHLBI NIH HHS [P50 HL067674, P50 HL67674] Funding Source: Medline; NIAID NIH HHS [R37 AI23990, R01 AI023990] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA072074] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL067674] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI023990, R37AI023990] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Calixto MC, 2003, INFLAMM RES, V52, P132, DOI 10.1007/s000110300026; Caughey GH, 2002, MOL IMMUNOL, V38, P1353, DOI 10.1016/S0161-5890(02)00087-1; Chippaux JP, 1998, B WORLD HEALTH ORGAN, V76, P515; Clair JMS, 2004, J CLIN INVEST, V113, P628, DOI 10.1172/JCI200419062; DUTTA NK, 1952, NATURE, V169, P1064, DOI 10.1038/1691064b0; Echtenacher B, 1996, NATURE, V381, P75, DOI 10.1038/381075a0; Finkelman FD, 2005, J ALLERGY CLIN IMMUN, V115, P449, DOI 10.1016/j.jaci.2004.12.1125; Fry BG, 2006, NATURE, V439, P584, DOI 10.1038/nature04328; Gurish MF, 2001, J EXP MED, V194, pF1, DOI 10.1084/jem.194.1.F1; Harrison RA, 2003, TOXICON, V41, P441, DOI 10.1016/S0041-0101(02)00360-4; HIGGINBOTHAM RD, 1965, J IMMUNOL, V95, P867; Huang CF, 1998, J CLIN IMMUNOL, V18, P169, DOI 10.1023/A:1020574820797; KLOOG Y, 1988, SCIENCE, V242, P268, DOI 10.1126/science.2845579; Kochva E, 1998, Public Health Rev, V26, P209; Malaviya R, 1996, NATURE, V381, P77, DOI 10.1038/381077a0; Maurer M, 1998, J EXP MED, V188, P2343, DOI 10.1084/jem.188.12.2343; Maurer M, 2004, NATURE, V432, P512, DOI 10.1038/nature03085; McNamee D, 2001, LANCET, V357, P1680, DOI 10.1016/S0140-6736(00)04868-6; Metcalfe DD, 1997, PHYSIOL REV, V77, P1033, DOI 10.1152/physrev.1997.77.4.1033; Metsarinne KP, 2002, ARTERIOSCL THROM VAS, V22, P268, DOI 10.1161/hq0202.103994; NAKANO T, 1985, J EXP MED, V162, P1025, DOI 10.1084/jem.162.3.1025; Prodeus AP, 1997, NATURE, V390, P172, DOI 10.1038/36586; Rucavado A, 2004, TOXICON, V43, P417, DOI 10.1016/j.toxicon.2004.01.016; SCHMIDT JO, 1995, TOXICON, V33, P917, DOI 10.1016/0041-0101(95)00011-A; Tchougounova E, 2003, J EXP MED, V198, P423, DOI 10.1084/jem.20030671; Tsai M, 2000, P NATL ACAD SCI USA, V97, P9186, DOI 10.1073/pnas.160254997; Turner H, 1999, NATURE, V402, pB24, DOI 10.1038/35037021; Weisel-Eichler A, 2004, J COMP PHYSIOL A, V190, P683, DOI 10.1007/s00359-004-0526-3; White J, 2005, TOXICON, V45, P951, DOI 10.1016/j.toxicon.2005.02.030; ZIAI MR, 1990, J PHARM PHARMACOL, V42, P457, DOI 10.1111/j.2042-7158.1990.tb06595.x	30	265	274	1	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 28	2006	313	5786					526	530		10.1126/science.1128877	http://dx.doi.org/10.1126/science.1128877			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067MZ	16873664				2022-12-28	WOS:000239308600064
J	Numata, T; Ikeuchi, Y; Fukai, S; Suzuki, T; Nureki, O				Numata, Tomoyuki; Ikeuchi, Yoshiho; Fukai, Shuya; Suzuki, Tsutomu; Nureki, Osamu			Snapshots of tRNA sulphuration via an adenylated intermediate	NATURE			English	Article							CRYSTAL-STRUCTURE; MOLECULAR-MECHANISM; BIOSYNTHESIS; 4-THIOURIDINE; SYNTHETASE; INITIATION; COMPLEX; MNMA; LOOP; THII		Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Dept Biol Informat, Midori Ku, Kanagawa 2268501, Japan; Univ Tokyo, Grad Sch Engn, Dept Chem & Biotechnol, Bunkyo Ku, Tokyo 1138656, Japan; PRESTO, JST, Kawaguchi, Saitama 3320012, Japan; RIKEN, Genom Sci Ctr, Yokohama, Kanagawa 2300045, Japan	Tokyo Institute of Technology; University of Tokyo; Japan Science & Technology Agency (JST); RIKEN	Nureki, O (corresponding author), Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Dept Biol Informat, Midori Ku, 4259 Nagatsuta Cho, Kanagawa 2268501, Japan.	nureki@bio.titech.ac.jp	Numata, Tomoyuki/L-6952-2018; Suzuki, Tsutomu/J-1776-2015; NUREKI, OSAMU/G-4960-2014; ikeuchi, yoshiho/C-1713-2014; Ikeuchi, Yoshiho/N-1057-2019; Fukai, Shuya/X-4838-2018	Numata, Tomoyuki/0000-0002-4244-8829; Suzuki, Tsutomu/0000-0002-9731-1731; ikeuchi, yoshiho/0000-0002-2829-3840; Fukai, Shuya/0000-0002-1241-1443				Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; Ashraf SS, 1999, RNA, V5, P188, DOI 10.1017/S1355838299981529; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bjork Glenn R., 1995, P165; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; DeLano W.L, PYMOL MOL GRAPHICS S; Ikeuchi Y, 2006, MOL CELL, V21, P97, DOI 10.1016/j.molcel.2005.11.001; Ikeuchi Y, 2005, MOL CELL, V19, P235, DOI 10.1016/j.molcel.2005.06.007; ISEL C, 1993, J BIOL CHEM, V268, P25269; Isel C, 1999, EMBO J, V18, P1038, DOI 10.1093/emboj/18.4.1038; ISHITANI R, 2006, CUEMOL MOL VISUALIZA; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kambampati R, 2003, BIOCHEMISTRY-US, V42, P1109, DOI 10.1021/bi026536+; Kruger MK, 1998, J MOL BIOL, V284, P621, DOI 10.1006/jmbi.1998.2196; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Mueller EG, 2001, J BIOL CHEM, V276, P33588, DOI 10.1074/jbc.M104067200; NISSEN P, 1995, SCIENCE, V270, P1464, DOI 10.1126/science.270.5241.1464; Numata T, 2006, ACTA CRYSTALLOGR F, V62, P368, DOI 10.1107/S174430910600738X; Palenchar PM, 2000, J BIOL CHEM, V275, P8283, DOI 10.1074/jbc.275.12.8283; Rizzi M, 1996, EMBO J, V15, P5125, DOI 10.1002/j.1460-2075.1996.tb00896.x; Shigi N, 2006, J BIOL CHEM, V281, P2104, DOI 10.1074/jbc.M510771200; Shigi N, 2002, J BIOL CHEM, V277, P39128, DOI 10.1074/jbc.M207323200; SULLIVAN MA, 1985, J BACTERIOL, V161, P368, DOI 10.1128/JB.161.1.368-376.1985; SYLVERS LA, 1993, BIOCHEMISTRY-US, V32, P3836, DOI 10.1021/bi00066a002; Tesmer JG, 1996, NAT STRUCT BIOL, V3, P74, DOI 10.1038/nsb0196-74; Urbonavicius J, 2001, EMBO J, V20, P4863, DOI 10.1093/emboj/20.17.4863; Weeks CM, 1999, J APPL CRYSTALLOGR, V32, P120, DOI 10.1107/S0021889898010504; YOKOYAMA S, 1985, P NATL ACAD SCI USA, V82, P4905, DOI 10.1073/pnas.82.15.4905; Yokoyama Shigeyuki, 1995, P207	30	105	108	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 27	2006	442	7101					419	424		10.1038/nature04896	http://dx.doi.org/10.1038/nature04896			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067CI	16871210				2022-12-28	WOS:000239278900035
J	Blaser, HU				Blaser, Hans-Ulrich			A golden boost to an old reaction	SCIENCE			English	Editorial Material							HYDROGENATION		Solvias AG, CH-4002 Basel, Switzerland	Solvias	Blaser, HU (corresponding author), Solvias AG, CH-4002 Basel, Switzerland.	hans-ulrich.blaser@solvias.com						BAUMEISTER P, 1997, HDB HETEROGENEOUS CA, P2186; Blaser H. U., 2001, FINE CHEM HETEROGENE, P389; Chen YY, 2005, CHEM COMMUN, P5298, DOI 10.1039/b509595f; Claus P, 2005, APPL CATAL A-GEN, V291, P222, DOI 10.1016/j.apcata.2004.12.048; Corma A, 2006, SCIENCE, V313, P332, DOI 10.1126/science.1128383; Leipzig B., 1898, Z ELEKTROCHEM, V4, P506, DOI DOI 10.1002/BBPC; Siegrist U, 1998, CHEM INDUST, V75, P207	7	199	203	4	113	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 21	2006	313	5785					312	313		10.1126/science.1131574	http://dx.doi.org/10.1126/science.1131574			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065IV	16857930				2022-12-28	WOS:000239154300032
J	Sridhar, V; Loope, DB; Swinehart, JB; Mason, JA; Oglesby, RJ; Rowe, CM				Sridhar, Venkataramana; Loope, David B.; Swinehart, James B.; Mason, Joseph A.; Oglesby, Robert J.; Rowe, Clinton M.			Large wind shift on the Great Plains during the Medieval Warm Period	SCIENCE			English	Article							HOLOCENE DUNE ACTIVITY; NEBRASKA SAND HILLS; STRATIGRAPHIC EVIDENCE; LONGITUDINAL DUNES; FIRE HISTORY; DROUGHT; CLIMATE; PRECIPITATION; CALIFORNIA; FREQUENCY	Spring-summer winds from the south move moist air from the Gulf of Mexico to the Great Plains. Rainfall in the growing season sustains prairie grasses that keep large dunes in the Nebraska Sand Hills immobile. Longitudinal dunes built during the Medieval Warm Period ( 800 to 1000 years before the present) record the last major period of sand mobility. These dunes are oriented NW-SE and are composed of cross-strata with bipolar dip directions. The trend and structure of the dunes record a drought that was initiated and sustained by a historically unprecedented shift of spring-summer atmospheric circulation over the Plains: Moist southerly flow was replaced by dry southwesterly flow.	Univ Nebraska, Dept Geosci, Lincoln, NE 68588 USA; Univ Nebraska, Sch Nat Resources, Lincoln, NE 68583 USA; Univ Wisconsin, Dept Geog, Madison, WI 53706 USA	University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln; University of Wisconsin System; University of Wisconsin Madison	Loope, DB (corresponding author), Univ Nebraska, Dept Geosci, Lincoln, NE 68588 USA.	dloope1@unl.edu	Sridhar, Venkat/AAT-6676-2020	Sridhar, Venkat/0000-0002-1003-2247; Mason, Joseph/0000-0003-2287-8247				Arbogast AF, 1996, J ARID ENVIRON, V34, P403, DOI 10.1006/jare.1996.0120; Bradley RS, 2003, SCIENCE, V302, P404, DOI 10.1126/science.1090372; Brown KJ, 2005, P NATL ACAD SCI USA, V102, P8865, DOI 10.1073/pnas.0503621102; CARLSON TN, 1991, MIDLATITUDE WEATHER, P448; Cook ER, 2004, SCIENCE, V306, P1015, DOI 10.1126/science.1102586; Daniels JM, 2005, HOLOCENE, V15, P736, DOI 10.1191/0959683605hl847rp; Forman SL, 2001, GLOBAL PLANET CHANGE, V29, P1, DOI 10.1016/S0921-8181(00)00092-8; FRYBERGER SG, 1979, US GEOLOGICAL SURVEY, V1052, P137; Goble RJ, 2004, QUATERNARY SCI REV, V23, P1173, DOI 10.1016/j.quascirev.2003.09.009; Kocurek G, 1996, SEDIMENTARY ENV PROC, P125; Koster RD, 2000, J HYDROMETEOROL, V1, P26, DOI 10.1175/1525-7541(2000)001<0026:VAPOPA>2.0.CO;2; Laird KR, 1996, NATURE, V384, P552, DOI 10.1038/384552a0; LANCASTER N, 1992, SEDIMENTOLOGY, V39, P631, DOI 10.1111/j.1365-3091.1992.tb02141.x; Lancaster N, 2002, GEOLOGY, V30, P991, DOI 10.1130/0091-7613(2002)030<0991:LPAHDA>2.0.CO;2; Loope D.B., 2000, GREAT PLAINS RES, V10, P5; LOOPE DB, 1995, GEOL SOC AM BULL, V107, P396, DOI 10.1130/0016-7606(1995)107<0396:DDPOTN>2.3.CO;2; MADOLE RF, 1994, GEOLOGY, V22, P483, DOI 10.1130/0091-7613(1994)022<0483:SEODIT>2.3.CO;2; MADOLE RF, 1995, QUATERNARY SCI REV, V14, P155, DOI 10.1016/0277-3791(95)00005-A; Mason JA, 2004, HOLOCENE, V14, P209, DOI 10.1191/0959683604hl677rp; Millspaugh SH, 2000, GEOLOGY, V28, P211, DOI 10.1130/0091-7613(2000)28<211:VIFFAC>2.0.CO;2; Mohr JA, 2000, HOLOCENE, V10, P587, DOI 10.1191/095968300675837671; MUHS DR, 1995, QUATERNARY RES, V43, P198, DOI 10.1006/qres.1995.1020; MUHS DR, 1993, J ARID ENVIRON, V25, P351, DOI 10.1006/jare.1993.1068; Osborn TJ, 2006, SCIENCE, V311, P841, DOI 10.1126/science.1120514; RUBIN DM, 1990, SEDIMENTOLOGY, V37, P673, DOI 10.1111/j.1365-3091.1990.tb00628.x; RUBIN DM, 1985, SEDIMENTOLOGY, V32, P147, DOI 10.1111/j.1365-3091.1985.tb00498.x; Schubert SD, 2004, SCIENCE, V303, P1855, DOI 10.1126/science.1095048; Schubert SD, 2004, J CLIMATE, V17, P485, DOI [10.1175/1520-0442(2004)017<0485:COLDIT>2.0.CO;2, 10.1175/1520-0442(2004)017&lt;0485:COLDIT&gt;2.0.CO;2]; Shin SI, 2006, J CLIMATE, V19, P2801, DOI 10.1175/JCLI3733.1; STINE S, 1994, NATURE, V369, P546, DOI 10.1038/369546a0; SWETNAM TW, 1993, SCIENCE, V262, P885, DOI 10.1126/science.262.5135.885; THOMAS DSG, 1986, Z GEOMORPHOL, V30, P231; Wilhite DA, 1990, ATLAS SAND HILLS A, P17; Woodhouse CA, 1998, B AM METEOROL SOC, V79, P2693, DOI 10.1175/1520-0477(1998)079<2693:YODVIT>2.0.CO;2	34	61	63	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 21	2006	313	5785					345	347		10.1126/science.1128941	http://dx.doi.org/10.1126/science.1128941			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065IV	16857938	Green Published			2022-12-28	WOS:000239154300042
J	Misch, DA				Misch, Donald A.			The physician's counsel	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												dmisch@northwestern.edu	Misch, Donald/B-1289-2009						0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 19	2006	296	3					259	260		10.1001/jama.296.3.259	http://dx.doi.org/10.1001/jama.296.3.259			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	064LA	16849651				2022-12-28	WOS:000239089900001
J	Carosella, ED; Pradeu, T				Carosella, Edgardo D.; Pradeu, Thomas			Transplantation and identity: a dangerous split?	LANCET			English	Editorial Material							HAND TRANSPLANTATION; FACE		Univ Paris 04, Dept Philosophy, IHPST, F-75006 Paris, France; Hop St Louis, CEA, DRM, DSV,Serv Rech Hematoimmunol, Paris, France	UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; CEA; UDICE-French Research Universities; Universite Paris Cite	Pradeu, T (corresponding author), Univ Paris 04, Dept Philosophy, IHPST, F-75006 Paris, France.	thomas.pradeu@ens.fr						Devauchelle B, 2006, LANCET, V368, P203, DOI 10.1016/S0140-6736(06)68935-6; Dubernard JM, 1999, LANCET, V353, P1315, DOI 10.1016/S0140-6736(99)02062-0; Hovius SER, 2001, J HAND SURG-BRIT EUR, V26, P519, DOI 10.1054/jhsb.2001.0673; Huxtable R, 2005, BIOETHICS, V19, P505, DOI 10.1111/j.1467-8519.2005.00461.x; Meyer VE, 2001, J HAND SURG-BRIT EUR, V26, P509, DOI 10.1054/jhsb.2001.0670; Okie S, 2006, NEW ENGL J MED, V354, P889, DOI 10.1056/NEJMp068005; 2005, LANCET, V366, P1984	7	21	23	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 15	2006	368	9531					183	184		10.1016/S0140-6736(06)68938-1	http://dx.doi.org/10.1016/S0140-6736(06)68938-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	064MY	16844470	Green Submitted			2022-12-28	WOS:000239095000007
J	Steures, P; van der Steeg, JW; Hompes, PGA; Habbema, JDF; Eijkemans, MJC; Broekmans, F; Verhoeve, HR; Bossuyt, PMM; van der Veen, F; Mol, BWJ				Steures, Pieternel; van der Steeg, Jan Willem; Hompes, Peter G. A.; Habbema, J. Dik F.; Eijkemans, Marinus J. C.; Broekmans, Frank J.; Verhoeve, Harold R.; Bossuyt, Patrick M. M.; van der Veen, Fulco; Mol, Ben W. J.		Collaborative Effort Clin Evaluat	Intrauterine insemination with controlled ovarian hyperstimulation versus expectant management for couples with unexplained subfertility and an intermediate prognosis: a randomised clinical trial	LANCET			English	Article							INFERTILITY; GONADOTROPIN; PREGNANCY; BIRTH	Background Intrauterine insemination with controlled ovarian hyperstimulation is commonly used as first-line treatment for couples with unexplained subfertility. Since such treatment increases the risk of multiple pregnancy, a couple's chances of achieving an ongoing pregnancy without it should be considered to identify those most likely to benefit from treatment. We aimed to assess the incremental effectiveness of intrauterine insemination with controlled ovarian hyperstimulation compared with expectant management in couples with unexplained subfertility and an intermediate prognosis of a spontaneous ongoing pregnancy. Methods 253 couples with unexplained subfertility and a 30-40% probability of a spontaneous ongoing pregnancy within 12 months were randomly assigned either intrauterine insemination with controlled ovarian hyperstimulation for 6 months or expectant management for G months. The primary endpoint of this hospital-based study was ongoing pregnancy within 6 months. Analysis was by intention to treat. This trial is registered with the Dutch Trial Register and as an International Standard Randomised Clinical Trial, number ISRCTN72675518. Findings Of the 253 couples enrolled, 127 were assigned intrauterine insemination with controlled ovarian hyperstimulation and 126 expectant management. In the intervention group, 42 (33%) women conceived and 29 (23%) pregnancies were ongoing. In the expectant management group, 40 (32%) women conceived and 34 (27%) pregnancies were ongoing (relative risk 0.85, 95% CI 0.63-1.1). There was one twin pregnancy in each study group, and one woman in the intervention group conceived triplets. Interpretation A large beneficial effect of intrauterine insemination with controlled ovarian hyperstimulation in couples with unexplained subfertility and an intermediate prognosis can be excluded. Expectant management for 6 months is therefore justified in these couples.	Univ Amsterdam, Acad Med Ctr, Ctr Reprod Med, Dept Obstet & Gynaecol, NL-1105 AZ Amsterdam, Netherlands; Vrije Univ Amsterdam, Med Ctr, Dept Obstet & Gynaecol, Amsterdam, Netherlands; Univ Med Ctr, Erasmus Med Ctr, Dept Publ Hlth, Rotterdam, Netherlands; Univ Med Ctr Utrecht, Dept Obstet & Gynaecol, Utrecht, Netherlands; Onze Lieve Vrouw Hosp, Dept Obstet & Gynaecol, Amsterdam, Netherlands; Univ Amsterdam, Acad Med Ctr, Dept Biostat & Epidemiol, NL-1105 AZ Amsterdam, Netherlands; Maxima Med Ctr, Dept Obstet & Gynaecol, Veldhoven, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; Erasmus University Rotterdam; Erasmus MC; Utrecht University; Utrecht University Medical Center; Onze Lieve Vrouwe Gasthuis Hospital; University of Amsterdam; Academic Medical Center Amsterdam; Maxima Medical Center	Steures, P (corresponding author), Univ Amsterdam, Acad Med Ctr, Ctr Reprod Med, Dept Obstet & Gynaecol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	pn.steures@amc.uva.nl	Bossuyt, Patrick M/AAR-1183-2021; Eijkemans, Marinus J/D-8214-2013; Bossuyt, Patrick M./B-4557-2016; Mol, Ben/I-4526-2012	Bossuyt, Patrick M/0000-0003-4427-0128; Bossuyt, Patrick M./0000-0003-4427-0128; 				[Anonymous], COCHRANE DATABASE SY; ARICI A, 1994, FERTIL STERIL, V61, P314; Cohlen BJ, 2005, GYNECOL OBSTET INVES, V59, P3, DOI 10.1159/000080492; Collins JA, 2004, HUM REPROD UPDATE, V10, P309, DOI 10.1093/humupd/dmh029; Dutch Society of Obstetrics and Gynaecology, 2004, NED VERENIG OBSTET G, V1, P1; Fauser BCJM, 2005, LANCET, V365, P1807, DOI 10.1016/S0140-6736(05)66478-1; Gerris J, 2000, HUM REPROD, V15, P27; Goverde AJ, 2000, LANCET, V355, P13, DOI 10.1016/S0140-6736(99)04002-7; Guzick DS, 1999, NEW ENGL J MED, V340, P177, DOI 10.1056/NEJM199901213400302; Habbema JDF, 2004, HUM REPROD, V19, P1497, DOI 10.1093/humrep/deh303; Hunault CC, 2004, HUM REPROD, V19, P2019, DOI 10.1093/humrep/deh365; KIRBY CA, 1991, FERTIL STERIL, V56, P102; MURDOCH AP, 1991, BRIT J OBSTET GYNAEC, V98, P1107, DOI 10.1111/j.1471-0528.1991.tb15362.x; National Collaborating Centre for Women's and Children's Health, 2004, FERT GUID ASS TREATM; NULSEN JC, 1993, OBSTET GYNECOL, V82, P780; *SPEC INT GROUP SA, 2005, PREV MULT PREGN NONI; Taylor A, 2003, BRIT MED J, V327, P434, DOI 10.1136/bmj.327.7412.434	17	134	136	0	10	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 15	2006	368	9531					216	221		10.1016/S0140-6736(06)69042-9	http://dx.doi.org/10.1016/S0140-6736(06)69042-9			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	064MY	16844491				2022-12-28	WOS:000239095000033
J	Gottlieb, E				Gottlieb, Eyal			OPA1 and PARL keep a lid on apoptosis	CELL			English	Editorial Material							MITOCHONDRIAL FISSION; CRISTAE	A change in the shape of mitochondrial cristae must take place to attain rapid and complete release of cytochrome c during apoptosis. In this issue of Cell, Cipolat et al. (2006) and Frezza et al. (2006) show that a rhomboid intramembrane protease PARL and a dynamin-related protein OPA1 are critical regulators of cristae remodeling.	Beatson Inst Canc Res, Canc Res UK, Apoptosis & Tumour Physiol Lab, Glasgow G61 1BD, Lanark, Scotland	Beatson Institute; Cancer Research UK	Gottlieb, E (corresponding author), Beatson Inst Canc Res, Canc Res UK, Apoptosis & Tumour Physiol Lab, Garscube Estate, Glasgow G61 1BD, Lanark, Scotland.	e.gottlieb@beatson.gla.ac.uk	Gottlieb, Eyal/G-6450-2010	Gottlieb, Eyal/0000-0002-9770-0956				Danino D, 2001, CURR OPIN CELL BIOL, V13, P454, DOI 10.1016/S0955-0674(00)00236-2; Frank S, 2001, DEV CELL, V1, P515, DOI 10.1016/S1534-5807(01)00055-7; Frey TG, 2000, TRENDS BIOCHEM SCI, V25, P319, DOI 10.1016/S0968-0004(00)01609-1; Germain M, 2005, EMBO J, V24, P1546, DOI 10.1038/sj.emboj.7600592; McQuibban GA, 2003, NATURE, V423, P537, DOI 10.1038/nature01633; Scorrano L, 2002, DEV CELL, V2, P55, DOI 10.1016/S1534-5807(01)00116-2; Youle RJ, 2005, NAT REV MOL CELL BIO, V6, P657, DOI 10.1038/nrm1697	7	41	44	0	10	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUL 14	2006	126	1					27	29		10.1016/j.cell.2006.06.030	http://dx.doi.org/10.1016/j.cell.2006.06.030			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	066JF	16839872	Bronze			2022-12-28	WOS:000239224800012
J	Suydam, IT; Snow, CD; Pande, VS; Boxer, SG				Suydam, Ian T.; Snow, Christopher D.; Pande, Vijay S.; Boxer, Steven G.			Electric fields at the active site of an enzyme: Direct comparison of experiment with theory	SCIENCE			English	Article							VIBRATIONAL STARK SPECTROSCOPY; HUMAN ALDOSE REDUCTASE; CHEMICAL-SHIFTS; AMINO-ACIDS; DRUG DESIGN; PROTEINS; ELECTROSTATICS; CHEMISTRY; SENSITIVITY; DYNAMICS	The electric fields produced in folded proteins influence nearly every aspect of protein function. We present a vibrational spectroscopy technique that measures changes in electric field at a specific site of a protein as shifts in frequency ( Stark shifts) of a calibrated nitrile vibration. A nitrile-containing inhibitor is used to deliver a unique probe vibration to the active site of human aldose reductase, and the response of the nitrile stretch frequency is measured for a series of mutations in the enzyme active site. These shifts yield quantitative information on electric fields that can be directly compared with electrostatics calculations. We show that extensive molecular dynamics simulations and ensemble averaging are required to reproduce the observed changes in field.	Stanford Univ, Dept Chem, Stanford, CA 94305 USA	Stanford University	Boxer, SG (corresponding author), Stanford Univ, Dept Chem, Stanford, CA 94305 USA.	sboxer@stanford.edu	Pande, Vijay/ABE-8145-2020; Snow, Christopher/L-5624-2013	Snow, Christopher/0000-0002-7690-3519; Boxer, Steven/0000-0001-9167-4286				Andrews SS, 2002, J PHYS CHEM A, V106, P469, DOI 10.1021/jp011724f; Andrews SS, 2000, J PHYS CHEM A, V104, P11853, DOI 10.1021/jp002242r; Bublitz GU, 1997, ANNU REV PHYS CHEM, V48, P213, DOI 10.1146/annurev.physchem.48.1.213; Georgescu RE, 2002, BIOPHYS J, V83, P1731, DOI 10.1016/S0006-3495(02)73940-4; Getahun Z, 2003, J AM CHEM SOC, V125, P405, DOI 10.1021/ja0285262; GILSON MK, 1986, BIOPOLYMERS, V25, P2097, DOI 10.1002/bip.360251106; HONIG B, 1995, SCIENCE, V268, P1144, DOI 10.1126/science.7761829; Howard EI, 2004, PROTEINS, V55, P792, DOI 10.1002/prot.20015; Kirshenbaum K, 2002, CHEMBIOCHEM, V3, P235, DOI 10.1002/1439-7633(20020301)3:2/3<235::AID-CBIC235>3.0.CO;2-7; Lamour V, 1999, ACTA CRYSTALLOGR D, V55, P721, DOI 10.1107/S0907444998013365; Lehle H, 2005, BIOPHYS J, V88, P1978, DOI 10.1529/biophysj.104.048140; Muzet N, 2003, P NATL ACAD SCI USA, V100, P8742, DOI 10.1073/pnas.1432955100; Oldfield E, 2002, ANNU REV PHYS CHEM, V53, P349, DOI 10.1146/annurev.physchem.53.082201.124235; Park ES, 1999, J PHYS CHEM B, V103, P9813, DOI 10.1021/jp992329g; Park ES, 2002, J PHYS CHEM B, V106, P5800, DOI 10.1021/jp0203043; PEARSON JG, 1993, J AM CHEM SOC, V115, P6851, DOI 10.1021/ja00068a049; Podjarny A, 2004, CELL MOL LIFE SCI, V61, P763, DOI 10.1007/s00018-003-3404-1; Reimers JR, 1996, J PHYS CHEM-US, V100, P1498, DOI 10.1021/jp9523985; Schutz CN, 2001, PROTEINS, V44, P400, DOI 10.1002/prot.1106; Simonson T, 2001, CURR OPIN STRUC BIOL, V11, P243, DOI 10.1016/S0959-440X(00)00197-4; Snow CD, 2005, ANNU REV BIOPH BIOM, V34, P43, DOI 10.1146/annurev.biophys.34.040204.144447; Srivastava SK, 2005, ENDOCR REV, V26, P380, DOI 10.1210/er.2004-0028; Suydam IT, 2003, BIOCHEMISTRY-US, V42, P12050, DOI 10.1021/bi0352926; Van Zandt MC, 2004, BIOORGAN MED CHEM, V12, P5661, DOI 10.1016/j.bmc.2004.07.062; Villa J, 2001, J PHYS CHEM B, V105, P7887, DOI 10.1021/jp011048h; Warshel A, 1998, CURR OPIN STRUC BIOL, V8, P211, DOI 10.1016/S0959-440X(98)80041-9	26	259	259	0	90	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 14	2006	313	5784					200	204		10.1126/science.1127159	http://dx.doi.org/10.1126/science.1127159			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	063GZ	16840693				2022-12-28	WOS:000239008000037
J	Distel, JR				Distel, JR			Raymond Davis Jr (1914-2006) - Obituary	NATURE			English	Biographical-Item									Los Alamos Natl Lab, Los Alamos, NM 87545 USA	United States Department of Energy (DOE); Los Alamos National Laboratory	Distel, JR (corresponding author), Los Alamos Natl Lab, POB 1663, Los Alamos, NM 87545 USA.	jdistel@lanl.gov							0	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 13	2006	442	7099					150	150		10.1038/442150a	http://dx.doi.org/10.1038/442150a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	062XJ	16838010	Bronze			2022-12-28	WOS:000238979700033
J	Shelly, DR; Beroza, GC; Ide, S; Nakamula, S				Shelly, David R.; Beroza, Gregory C.; Ide, Satoshi; Nakamula, Sho			Low-frequency earthquakes in Shikoku, Japan, and their relationship to episodic tremor and slip	NATURE			English	Article							1946 NANKAI EARTHQUAKE; BUNGO CHANNEL; SILENT SLIP; SUBDUCTION; SOUTHWEST; BENEATH; PRESSURE; EVENTS; REGION	Non-volcanic seismic tremor was discovered in the Nankai trough subduction zone in southwest Japan(1) and subsequently identified in the Cascadia subduction zone(2). In both locations, tremor is observed to coincide temporally with large, slow slip events on the plate interface downdip of the seismogenic zone(2-7). The relationship between tremor and aseismic slip remains uncertain, however, largely owing to difficulty in constraining the source depth of tremor. In southwest Japan, a high quality borehole seismic network allows identification of coherent S-wave ( and sometimes P-wave) arrivals within the tremor, whose sources are classified as low-frequency earthquakes. As low-frequency earthquakes comprise at least a portion of tremor, understanding their mechanism is critical to understanding tremor as a whole. Here, we provide strong evidence that these earthquakes occur on the plate interface, coincident with the inferred zone of slow slip. The locations and characteristics of these events suggest that they are generated by shear slip during otherwise aseismic transients, rather than by fluid flow. High pore-fluid pressure in the immediate vicinity, as implied by our estimates of seismic P- and S-wave speeds, may act to promote this transient mode of failure. Low-frequency earthquakes could potentially contribute to seismic hazard forecasting by providing a new means to monitor slow slip at depth.	Stanford Univ, Dept Geophys, Stanford, CA 94305 USA; Univ Tokyo, Dept Earth & Planetary Sci, Bunkyo Ku, Tokyo 1130033, Japan; Univ Tokyo, Earthquake Res Inst, Bunkyo Ku, Tokyo 1130032, Japan	Stanford University; University of Tokyo; University of Tokyo	Shelly, DR (corresponding author), Stanford Univ, Dept Geophys, 397 Panama Mall, Stanford, CA 94305 USA.	dshelly@pangea.stanford.edu	IDE, SATOSHI/G-4887-2014	IDE, SATOSHI/0000-0003-0063-548X; Shelly, David/0000-0003-2783-5158				Baba T, 2002, PHYS EARTH PLANET IN, V132, P59, DOI 10.1016/S0031-9201(02)00044-4; BIRD P, 2003, GEOCHEM GEOPHY GEOSY, V4, DOI DOI 10.1029/2001GC00252; CHOUET B, 1988, J GEOPHYS RES-SOLID, V93, P4375, DOI 10.1029/JB093iB05p04375; CHRISTENSEN NI, 1984, GEOPHYS J ROY ASTR S, V79, P411, DOI 10.1111/j.1365-246X.1984.tb02232.x; Dragert H, 2001, SCIENCE, V292, P1525, DOI 10.1126/science.1060152; HACKER BR, 2003, J GEOPHYS RES-SOL EA, V108, DOI DOI 10.1029/2001JB001129; Hirose H, 2005, EARTH PLANETS SPACE, V57, P961, DOI 10.1186/BF03351875; Hirose H, 1999, GEOPHYS RES LETT, V26, P3237, DOI 10.1029/1999GL010999; Iwabuchi T, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002214; JULIAN BR, 1994, J GEOPHYS RES-SOL EA, V99, P11859, DOI 10.1029/93JB03129; Kao H, 2005, NATURE, V436, P841, DOI 10.1038/nature03903; Katsumata A, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL015981; KIRBY S, 1995, REV GEOPHYS, V33, P287, DOI 10.1029/95RG00353; Kodaira S, 2004, SCIENCE, V304, P1295, DOI 10.1126/science.1096535; Miller MM, 2002, SCIENCE, V295, P2423, DOI 10.1126/science.1071193; MIYAZAWA M, 2005, GEOPHYS RES LETT, V32, DOI DOI 10.1029/2005GL002539; Nadeau RM, 2005, SCIENCE, V307, P389, DOI 10.1126/science.1107142; Obara K, 2006, TECTONOPHYSICS, V417, P33, DOI 10.1016/j.tecto.2005.04.013; Obara K, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020848; Obara K, 2002, SCIENCE, V296, P1679, DOI 10.1126/science.1070378; Obara K, 2005, REV SCI INSTRUM, V76, DOI 10.1063/1.1854197; Ozawa S, 2002, SCIENCE, V298, P1009, DOI 10.1126/science.1076780; Peacock SM, 1999, SCIENCE, V286, P937, DOI 10.1126/science.286.5441.937; RALEIGH CB, 1965, J GEOPHYS RES, V70, P3965, DOI 10.1029/JZ070i016p03965; Rogers G, 2003, SCIENCE, V300, P1942, DOI 10.1126/science.1084783; Seno T, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL018349; Shiomi K, 2004, J GEOPHYS RES-SOL EA, V109, DOI 10.1029/2003JB002774; Tanioka Y, 2001, EARTH PLANETS SPACE, V53, P235, DOI 10.1186/BF03352380; Zhang HJ, 2004, GEOLOGY, V32, P361, DOI 10.1130/G20261.2; Zhang HJ, 2003, B SEISMOL SOC AM, V93, P1875, DOI 10.1785/0120020190	30	594	605	4	117	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 13	2006	442	7099					188	191		10.1038/nature04931	http://dx.doi.org/10.1038/nature04931			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	062XJ	16838019				2022-12-28	WOS:000238979700044
J	Finch, A; Beiner, M; Lubinski, J; Lynch, HT; Moller, P; Rosen, B; Murphy, J; Ghadirian, P; Friedman, E; Foulkes, WD; Kim-Sing, C; Wagner, T; Tung, N; Couch, F; Stoppa-Lyonnet, D; Ainsworth, P; Daly, M; Pasini, B; Gershoni-Baruch, R; Eng, C; Olopade, OI; McLennan, J; Karlan, B; Weitzel, J; Sun, P; Narod, SA				Finch, Amy; Beiner, Mario; Lubinski, Jan; Lynch, Henry T.; Moller, Pal; Rosen, Barry; Murphy, Joan; Ghadirian, Parviz; Friedman, Eitan; Foulkes, William D.; Kim-Sing, Charmaine; Wagner, Teresa; Tung, Nadine; Couch, Fergus; Stoppa-Lyonnet, Dominique; Ainsworth, Peter; Daly, Mary; Pasini, Babara; Gershoni-Baruch, Ruth; Eng, Charis; Olopade, Olufunmilayo I.; McLennan, Jane; Karlan, Beth; Weitzel, Jeffrey; Sun, Ping; Narod, Steven A.		Hereditary Ovarian Canc Clin Study	Salpingo-oophorectomy and the risk of ovarian, fallopian tube, and peritoneal cancers in women with a BRCA1 or BRCA2 mutation	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PROPHYLACTIC OOPHORECTOMY; BREAST-CANCER; FAMILY-HISTORY; CARRIERS; POPULATION; CARCINOMATOSIS; PENETRANCE; SERIES	Context Women with BRCA1 or BRCA2 mutation are often advised to undergo preventive oophorectomy. The effectiveness of this intervention has not been prospectively evaluated in a large cohort. Objectives To estimate the incidence of ovarian, fallopian tube, and primary peritoneal cancer in women who carry a deleterious mutation in BRCA1 or BRCA2. To estimate the reduction in risk of these cancers associated with a bilateral prophylactic salpingo-oophorectomy. Design, Setting, and Participants Women known to carry a BRCA1 or BRCA2 mutation were identified from an international registry between 1992 and 2003. A total of 1828 carriers at 1 of 32 centers in Canada, the United States, Europe, and Israel completed questionnaires at baseline and follow-up. Participants were observed from the date of study entry until: diagnosis of ovarian, fallopian tube, or peritoneal cancer; death; or the date of the most recent follow-up. Intervention Participants were divided into women who had undergone bilateral prophylactic oophorectomy and those who had not. Main Outcome Measure The incidence of ovarian, peritoneal, and fallopian tube cancer was determined by survival analysis. The risk reduction associated with prophylactic salpingo-oophorectomy was evaluated by a time-dependent survival analysis, adjusting for covariates. Results After a mean follow-up of 3.5 years, 50 incident ovarian, fallopian tube, and peritoneal cancer cases were reported in the cohort. Of the 1828 women, 555 (30%) underwent a bilateral prophylactic salpingo-oophorectomy prior to study entry, 490 (27%) underwent the procedure after entering the study, and 783 (43%) did not undergo the procedure. There were 32 incident cancers diagnosed in women with intact ovaries (1015/100 000 per year). Eleven cancer cases were identified at the time of prophylactic oophorectomy and 7 were diagnosed following prophylactic oophorectomy (217/100 000 per year). The estimated cumulative incidence of peritoneal cancer is 4.3% at 20 years after oophorectomy. The overall ( adjusted) reduction in cancer risk associated with bilateral oophorectomy is 80% (multivariate hazard ratio = 0.20; 95% confidence interval, 0.07-0.58; P=.003). Conclusion Oophorectomy is associated with reduced risk of ovarian and fallopian tube cancer in high-risk women, although there is a substantial residual risk for peritoneal cancer in BRCA1 and BRCA2 mutation carriers following prophylactic salpingooophorectomy.	Toronto Sunnybrook Reg Canc Ctr, Ctr Res Womens Hlth, Toronto, ON M5G 1N8, Canada; Pomeranian Med Univ, Szczecin, Poland; Creighton Univ, Sch Med, Dept Prevent Med & Publ Hlth, Omaha, NE USA; Norwegian Radium Hosp, Oslo, Norway; Univ Toronto, Dept Gynecol Oncol, Univ Hlth Network, Toronto, ON, Canada; Univ Montreal, CHUM Hotel Dieu, Dept Med, Epidemiol Res Unit, Montreal, PQ, Canada; Univ Montreal, CHUM Hotel Dieu, Dept Genet, Epidemiol Res Unit, Montreal, PQ, Canada; Chaim Sheba Med Ctr, IL-52621 Tel Hashomer, Israel; McGill Univ, Dept Oncol & Human Genet, Program Canc Genet, Montreal, PQ, Canada; British Columbia Canc Agcy, Vancouver, BC V5Z 4E6, Canada; Med Univ Vienna, Div Senol, Vienna, Austria; Private Trust Breast Hlth, Vienna, Austria; Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; Mayo Clin Coll Med, Rochester, MN USA; Inst Marie Curie, Paris, France; London Reg Canc Program, London, ON, Canada; Fox Chase Canc Ctr, Philadelphia, PA 19111 USA; Univ Turin, I-10124 Turin, Italy; Rambam Med Ctr, Haifa, Israel; Ohio State Univ, Columbus, OH 43210 USA; Cleveland Clin, Genome Med Inst, Cleveland, OH 44106 USA; Univ Chicago, Chicago, IL 60637 USA; Canc Risk Program, San Francisco, CA USA; Cedars Sinai Med Ctr, Div Gynecol Oncol, Los Angeles, CA 90048 USA; City Hope Med Ctr, Duarte, CA USA	University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; Pomeranian Medical University; Creighton University; University of Oslo; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Universite de Montreal; Universite de Montreal; Chaim Sheba Medical Center; McGill University; British Columbia Cancer Agency; Medical University of Vienna; Harvard University; Beth Israel Deaconess Medical Center; Mayo Clinic; Western University (University of Western Ontario); Fox Chase Cancer Center; University of Turin; Rambam Health Care Campus; Technion Israel Institute of Technology; University System of Ohio; Ohio State University; Cleveland Clinic Foundation; University of Chicago; Cedars Sinai Medical Center; City of Hope	Narod, SA (corresponding author), Toronto Sunnybrook Reg Canc Ctr, Ctr Res Womens Hlth, 790 Bay St, Toronto, ON M5G 1N8, Canada.	steven.narod@wchospital.ca	Pasini, Barbara/AHI-2004-2022; Narod, Steven A/AAA-6112-2022; Foulkes, William D./AAR-9586-2021	Pasini, Barbara/0000-0002-4373-1212; Foulkes, William D./0000-0001-7427-4651; Finch, Amy PM/0000-0003-0096-0178	NATIONAL CANCER INSTITUTE [R01CA063678] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA63678] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Antoniou A, 2003, AM J HUM GENET, V72, P1117, DOI 10.1086/375033; CHEN KTK, 1985, OBSTET GYNECOL, V66, pS93; Colgan TJ, 2002, GYNECOL ONCOL, V85, P397, DOI 10.1006/gyno.2002.6638; Eisen A, 2005, J CLIN ONCOL, V23, P7491, DOI 10.1200/JCO.2004.00.7138; Finch A, 2006, GYNECOL ONCOL, V100, P58, DOI 10.1016/j.ygyno.2005.06.065; Ford D, 1998, AM J HUM GENET, V62, P676, DOI 10.1086/301749; Greene FL, 2002, AJCC CANC STAGING MA, DOI DOI 10.1007/978-1-4757-3656-4; Gronwald J, 2006, J MED GENET, V43, P424, DOI 10.1136/jmg.2005.036921; Kauff ND, 2002, NEW ENGL J MED, V346, P1609, DOI 10.1056/NEJMoa020119; King MC, 2003, SCIENCE, V302, P643, DOI 10.1126/science.1088759; Liede A, 2002, J CLIN ONCOL, V20, P1570, DOI 10.1200/JCO.20.6.1570; Metcalfe KA, 2005, GYNECOL ONCOL, V96, P222, DOI 10.1016/j.ygyno.2004.09.039; Narod SA, 2005, J CLIN ONCOL, V23, P1656, DOI 10.1200/JCO.2005.10.035; Olivier RI, 2004, BRIT J CANCER, V90, P1492, DOI 10.1038/sj.bjc.6601692; Paley PJ, 2001, GYNECOL ONCOL, V80, P176, DOI 10.1006/gyno.2000.6071; PARKIN DM, 2004, CANC INCIDENCE 5 CON, V7; PIVER MS, 1993, CANCER-AM CANCER SOC, V71, P2751, DOI 10.1002/1097-0142(19930501)71:9<2751::AID-CNCR2820710911>3.0.CO;2-J; Powell CB, 2005, J CLIN ONCOL, V23, P127, DOI 10.1200/JCO.2005.04.109; Rebbeck TR, 2002, NEW ENGL J MED, V346, P1616, DOI 10.1056/NEJMoa012158; Risch HA, 2001, AM J HUM GENET, V68, P700, DOI 10.1086/318787; Rutter JL, 2003, JNCI-J NATL CANCER I, V95, P1072, DOI 10.1093/jnci/95.14.1072; SHEPHERD JH, 1989, BRIT J OBSTET GYNAEC, V96, P889, DOI 10.1111/j.1471-0528.1989.tb03341.x; Struewing JP, 1997, NEW ENGL J MED, V336, P1401, DOI 10.1056/NEJM199705153362001; TOBACMAN JK, 1982, LANCET, V2, P795	24	434	454	0	14	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 12	2006	296	2					185	192		10.1001/jama.296.2.185	http://dx.doi.org/10.1001/jama.296.2.185			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	062LP	16835424	Green Published			2022-12-28	WOS:000238946500024
J	Lerner, RA				Lerner, RA			R. Bruce Merrifield (1921-2006)	SCIENCE			English	Biographical-Item									Scripps Res Inst, La Jolla, CA 92037 USA	Scripps Research Institute	Lerner, RA (corresponding author), Scripps Res Inst, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	rlerner@scripps.edu							0	2	3	1	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 7	2006	313	5783					57	57		10.1126/science.1130957	http://dx.doi.org/10.1126/science.1130957			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061DA	16825560				2022-12-28	WOS:000238850200026
J	Kerr, B; Neuhauser, C; Bohannan, BJM; Dean, AM				Kerr, B; Neuhauser, C; Bohannan, BJM; Dean, AM			Local migration promotes competitive restraint in a host-pathogen 'tragedy of the commons'	NATURE			English	Article							POPULATION-STRUCTURE; VIRULENCE; EVOLUTION; METAPOPULATION; PERSISTENCE; PREY; PARASITE; BACTERIOPHAGE; TRANSMISSION; EXTINCTION	Fragmented populations possess an intriguing duplicity: even if subpopulations are reliably extinction-prone, asynchrony in local extinctions and recolonizations makes global persistence possible(1-8). Migration is a double-edged sword in such cases: too little migration prevents recolonization of extinct patches, whereas too much synchronizes subpopulations, raising the likelihood of global extinction. Both edges of this proverbial sword have been explored by manipulating the rate of migration within experimental populations(1,3-6,8). However, few experiments have examined how the evolutionary ecology of fragmented populations depends on the pattern of migration(5). Here, we show that the migration pattern affects both coexistence and evolution within a community of bacterial hosts (Escherichia coli) and viral pathogens (T4 coliphage) distributed across a large network of subpopulations. In particular, different patterns of migration select for distinct pathogen strategies, which we term 'rapacious' and 'prudent'. These strategies define a 'tragedy of the commons'(9): rapacious phage displace prudent variants for shared host resources, but prudent phage are more productive when alone. We find that prudent phage dominate when migration is spatially restricted, while rapacious phage evolve under unrestricted migration. Thus, migration pattern alone can determine whether a de novo tragedy of the commons is resolved in favour of restraint.	Univ Washington, Dept Biol, Seattle, WA 98195 USA; Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA; Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA	University of Washington; University of Washington Seattle; University of Minnesota System; University of Minnesota Twin Cities; Stanford University	Kerr, B (corresponding author), Univ Washington, Dept Biol, Box 351800, Seattle, WA 98195 USA.	kerrb@u.washington.edu	Bohannan, Brendan J. M./R-1582-2017	Bohannan, Brendan J. M./0000-0003-2907-1016; Neuhauser, Claudia/0000-0001-8932-675X				Abedon ST, 2003, APPL ENVIRON MICROB, V69, P7499, DOI 10.1128/AEM.69.12.7499-7506.2003; Antonovics J., 2004, ECOLOGY GENETICS EVO, P471, DOI DOI 10.1016/B978-012323448-3/50021-0; Bergstrom CT, 1999, P NATL ACAD SCI USA, V96, P5095, DOI 10.1073/pnas.96.9.5095; Bohannan BJM, 2000, ECOL LETT, V3, P362, DOI 10.1046/j.1461-0248.2000.00161.x; Bonsall MB, 2002, J ANIM ECOL, V71, P1075, DOI 10.1046/j.1365-2656.2002.00670.x; Boots M, 1999, P ROY SOC B-BIOL SCI, V266, P1933, DOI 10.1098/rspb.1999.0869; Briggs CJ, 2004, THEOR POPUL BIOL, V65, P299, DOI 10.1016/j.tpb.2003.11.001; BULL JJ, 1991, EVOLUTION, V45, P875, DOI [10.1111/j.1558-5646.1991.tb04356.x, 10.2307/2409695]; Cooper VS, 2002, P ROY SOC B-BIOL SCI, V269, P1161, DOI 10.1098/rspb.2002.1976; EBERT D, 1994, SCIENCE, V265, P1084, DOI 10.1126/science.265.5175.1084; Ellner SP, 2001, NATURE, V412, P538, DOI 10.1038/35087580; Galvani AP, 2003, TRENDS ECOL EVOL, V18, P132, DOI 10.1016/S0169-5347(02)00050-2; Grenfell BT, 2001, NATURE, V414, P716, DOI 10.1038/414716a; HARDIN G, 1968, SCIENCE, V162, P1248; HERRE EA, 1993, SCIENCE, V259, P1442, DOI 10.1126/science.259.5100.1442; Holyoak M, 2000, AM NAT, V156, P378, DOI 10.1086/303395; Holyoak M, 1996, ECOLOGY, V77, P1867, DOI 10.2307/2265790; HUFFAKER C. B., 1958, HILGARDIA, V27, P343; Johst K, 2003, BIOL CONSERV, V109, P57, DOI 10.1016/S0006-3207(02)00133-7; Keeling M, 2000, P ROY SOC B-BIOL SCI, V267, P385, DOI 10.1098/rspb.2000.1013; Keeling MJ, 2004, ECOLOGY GENETICS EVO, P415, DOI [10.1016/B978-012323448-3/50019-2, DOI 10.1016/B978-012323448-3/50019-2]; Kreft JU, 2004, MICROBIOL-SGM, V150, P2751, DOI 10.1099/mic.0.26829-0; LENSKI RE, 1985, AM NAT, V125, P585, DOI 10.1086/284364; LIPSITCH M, 1995, EVOLUTION, V49, P743, DOI 10.1111/j.1558-5646.1995.tb02310.x; Mouquet N., 2005, METACOMMUNITIES SPAT, P237; NOWAK MA, 1994, P ROY SOC B-BIOL SCI, V255, P81, DOI 10.1098/rspb.1994.0012; O'Keefe KJ, 2002, AM NAT, V159, P597, DOI 10.1086/339990; Paddison P, 1998, GENETICS, V148, P1539; Thrall PH, 2003, PLANT PATHOL, V52, P350, DOI 10.1046/j.1365-3059.2003.00863.x; Thrall PH, 2003, SCIENCE, V299, P1735, DOI 10.1126/science.1080070	30	265	270	2	93	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 6	2006	442	7098					75	78		10.1038/nature04864	http://dx.doi.org/10.1038/nature04864			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	059HS	16823452				2022-12-28	WOS:000238724500039
J	McNutt, MK				McNutt, Marcia K.			Another nail in the plume coffin?	SCIENCE			English	Editorial Material							MANTLE; EXPLAIN		Monterey Bay Aquarium Res Inst, Moss Landing, CA 95039 USA	Monterey Bay Aquarium Research Institute	McNutt, MK (corresponding author), Monterey Bay Aquarium Res Inst, 7700 Sandholdt Rd, Moss Landing, CA 95039 USA.	mcnutt@mbari.org		McNutt, Marcia/0000-0003-0117-7716				Anderson DL, 1998, P NATL ACAD SCI USA, V95, P9087, DOI 10.1073/pnas.95.16.9087; Hirano N, 2006, SCIENCE, V313, P1426, DOI 10.1126/science.1128235; McNutt MK, 1997, NATURE, V389, P479, DOI 10.1038/39013; Montelli R, 2004, SCIENCE, V303, P338, DOI 10.1126/science.1092485; MORGAN WJ, 1968, J GEOPHYS RES, V73, P1959, DOI 10.1029/JB073i006p01959; OConnell R.J., 2000, GEOPHYSICAL MONOGRAP, P377; ZINDLER A, 1982, NATURE, V298, P519, DOI 10.1038/298519a0	7	11	11	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 8	2006	313	5792					1394	1395		10.1126/science.1131298	http://dx.doi.org/10.1126/science.1131298			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	081WQ	16873610				2022-12-28	WOS:000240348700026
J	Gillam, S				Gillam, Stephen			Health policy - NHS authority may not fix what isn't really broken	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Liverpool Rd Hlth Ctr, Lea Vale Med Grp, Luton LU1 1HH, Beds, England		Gillam, S (corresponding author), Liverpool Rd Hlth Ctr, Lea Vale Med Grp, Luton LU1 1HH, Beds, England.	sjg67@medschl.cam.ac.uk	Ashraf, Muhammad/I-6800-2015; Ashraf, Muhammad Yasin/G-7225-2015; Ahmad, Muhammad Sajid Aqeel/J-2209-2015; Ashraf, M. Yasin/F-7227-2011	Ashraf, M. Yasin/0000-0001-8221-4771				DEWAR S, 2003, GOVT NHS TIME NEW RE; Hart JT, 2006, BRIT J GEN PRACT, V56, P303; LANGLANDS A, 2003, SYNCHRONISING HIGHER	3	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 29	2006	333	7561					253	254		10.1136/bmj.333.7561.253	http://dx.doi.org/10.1136/bmj.333.7561.253			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	070CC	16873865	Green Published			2022-12-28	WOS:000239496900026
J	Tiihonen, J; Wahlbeck, K; Lonnqvist, J; Klaukka, T; Ioannidis, JPA; Volavka, J; Haukka, J				Tiihonen, Jari; Wahlbeck, Kristian; Lonnqvist, Jouko; Klaukka, Timo; Ioannidis, John P. A.; Volavka, Jan; Haukka, Jari			Effectiveness of antipsychotic treatments in a nationwide cohort of patients in community care after first hospitalisation due to schizophrenia and schizoaffective disorder: observational follow-up study	BRITISH MEDICAL JOURNAL			English	Article								Objective To study the association between prescribed antipsychotic drugs and outcome in schizophrenia or schizoaffective disorder in the community. Design Prospective cohort study using national central registers. Setting Community care in Finland. Participants Nationwide cohort of 2230 consecutive adults hospitalised in Finland for the first time because of schizophrenia or schizoaffective disorder, January 1995 to December 2001. Main outcome measures Rates of discontinuation of drugs (all causes), rates of rehospitalisation, and mortality associated with monotherapy with the 10 most commonly used antipsychotic drugs. Multivariate models and propensity score methods were used to adjust estimates of effectiveness. Results Initial use of clozapine (adjusted relative risk 0.17, 95% confidence interval 0.10 to 0.29), perphenazine depot (0.24, 0.13 to 0.47), and olanzapine (0.35, 0.18 to 0.71) were associated with the lowest rates of discontinuation for any reason when compared with oral haloperidol. During an average follow-up of 3.6 years, 4640 cases of rehospitalisation were recorded. Current use of perphenazine depot (0.32, 0.22 to 0.49), olanzapine (0.54, 0.41 to 0.71), and clozapine (0.64, 0.48 to 0.85) were associated with the lowest risk of rehospitalisation. Use of haloperidol was associated with a poor outcome among women. Mortality was markedly raised in patients not taking antipsychotics (12.3, 6.0 to 24.1) and the risk of suicide was high (37.4, 5.1 to 276). Conclusions The effectiveness of first and second generation antipsychotics varies greatly in the community. Patients treated with perphenazine depot, clozapine, or olanzapine have a substantially lower risk of rehospitalisation or discontinuation (for any reason) of their initial treatment than do patients treated with haloperidol. Excess mortality is seen mostly in patients not using antipsychotic drugs.	Univ Kuopio, Niuvanniemi Hosp, Dept Forens Psychiat, FIN-70240 Kuopio, Finland; Natl Res & Dev Ctr Welf & Hlth STAKES, Helsinki, Finland; Natl Publ Hlth Inst, Dept Mental Hlth & Alcohol Res, Helsinki, Finland; Social Insurance Inst, Helsinki, Finland; Univ Ioannina, Sch Med, Dept Hyg & Epidemiol, Clin Trials & Evidence Based Med Unit, GR-45110 Ioannina, Greece; NYU, New York, NY USA	University of Eastern Finland; Finland National Institute for Health & Welfare; Finland National Institute for Health & Welfare; University of Ioannina; New York University	Tiihonen, J (corresponding author), Univ Kuopio, Niuvanniemi Hosp, Dept Forens Psychiat, FIN-70240 Kuopio, Finland.	jari.tiihonen@niuva.fi	Wahlbeck, Kristian/F-8394-2011; Tiihonen, Jari/G-3078-2012; Haukka, Jari/G-1484-2014; Volavka, Jan/E-9529-2019; Young, Alexander/A-1523-2009; Ioannidis, John P. A./G-9836-2011	Wahlbeck, Kristian/0000-0003-3754-3933; Tiihonen, Jari/0000-0002-0400-6798; Haukka, Jari/0000-0003-1450-6208; Volavka, Jan/0000-0002-4178-8207; Young, Alexander/0000-0002-9367-9213; 				Davis JM, 2003, ARCH GEN PSYCHIAT, V60, P553, DOI 10.1001/archpsyc.60.6.553; Geddes J, 2000, BRIT MED J, V321, P1371, DOI 10.1136/bmj.321.7273.1371; Geddes J, 2002, NEW ENGL J MED, V346, P56, DOI 10.1056/NEJM200201033460112; Isohanni M, 1997, SOC PSYCH PSYCH EPID, V32, P303, DOI 10.1007/BF00789044; Leucht S, 2003, LANCET, V361, P1581, DOI 10.1016/S0140-6736(03)13306-5; Lieberman JA, 2005, NEW ENGL J MED, V353, P1209, DOI 10.1056/NEJMoa051688; Suvisaari JM, 1999, ARCH GEN PSYCHIAT, V56, P733, DOI 10.1001/archpsyc.56.8.733; Thornley B, 1998, BRIT MED J, V317, P1181, DOI 10.1136/bmj.317.7167.1181	8	281	298	0	23	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JUL 29	2006	333	7561					224	227		10.1136/bmj.38881.382755.2F	http://dx.doi.org/10.1136/bmj.38881.382755.2F			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	070CC	16825203	Green Published, Green Submitted, Bronze			2022-12-28	WOS:000239496900018
J	deMello, AJ				deMello, Andrew J.			Control and detection of chemical reactions in microfluidic systems	NATURE			English	Review							POLYMERASE-CHAIN-REACTION; MICROCHIP-BASED SYNTHESIS; ELEMENTAL FLUORINE; REACTION AMPLIFICATION; NANOPARTICLE FORMATION; REACTION OPTIMIZATION; GLASS MICROCHIP; GENERATION; DNA; MICROREACTOR	Recent years have seen considerable progress in the development of microfabricated systems for use in the chemical and biological sciences. Much development has been driven by a need to perform rapid measurements on small sample volumes. However, at a more primary level, interest in miniaturized analytical systems has been stimulated by the fact that physical processes can be more easily controlled and harnessed when instrumental dimensions are reduced to the micrometre scale. Such systems define new operational paradigms and provide predictions about how molecular synthesis might be revolutionized in the fields of high-throughput synthesis and chemical production.	Imperial Coll London, Dept Chem, Elect Mat Grp, London SW7 2AZ, England	Imperial College London	deMello, AJ (corresponding author), Imperial Coll London, Dept Chem, Elect Mat Grp, Exhibit Rd,S Kensington, London SW7 2AZ, England.	a.demello@imperial.ac.uk						Alivisatos AP, 1996, SCIENCE, V271, P933, DOI 10.1126/science.271.5251.933; [Anonymous], 2005, ANGEW CHEM; Auroux PA, 2004, LAB CHIP, V4, P534, DOI 10.1039/b408850f; Beebe DJ, 2002, ANNU REV BIOMED ENG, V4, P261, DOI 10.1146/annurev.bioeng.4.112601.125916; Besser RS, 2003, CHEM ENG SCI, V58, P19, DOI 10.1016/S0009-2509(02)00398-6; Biddiss E, 2004, ANAL CHEM, V76, P3208, DOI 10.1021/ac035451r; Blazej RG, 2006, P NATL ACAD SCI USA, V103, P7240, DOI 10.1073/pnas.0602476103; Bringer MR, 2004, PHILOS T R SOC A, V362, P1087, DOI 10.1098/rsta.2003.1364; Brivio M, 2006, LAB CHIP, V6, P329, DOI 10.1039/b510856j; Burns MA, 1998, SCIENCE, V282, P484, DOI 10.1126/science.282.5388.484; Cabrera CR, 2001, ANAL CHEM, V73, P658, DOI 10.1021/ac000495a; Chambers RD, 2005, LAB CHIP, V5, P1132, DOI 10.1039/b504675k; Chambers RD, 2005, LAB CHIP, V5, P191, DOI 10.1039/b416400h; Chambers RD, 2001, LAB CHIP, V1, P132, DOI 10.1039/b108841f; Chambers RD, 1999, CHEM COMMUN, P883, DOI 10.1039/a901473j; Chan EM, 2005, J AM CHEM SOC, V127, P13854, DOI 10.1021/ja051381p; Chen H, 2004, APPL PHYS LETT, V84, P2193, DOI 10.1063/1.1686895; DeMello J, 2004, LAB CHIP, V4, p11N, DOI 10.1039/b403638g; Dertinger SKW, 2001, ANAL CHEM, V73, P1240, DOI 10.1021/ac001132d; Dittrich PS, 2005, ANAL BIOANAL CHEM, V382, P1771, DOI 10.1007/s00216-005-3335-9; Dittrich PS, 2006, NAT REV DRUG DISCOV, V5, P210, DOI 10.1038/nrd1985; Edel JB, 2002, CHEM COMMUN, P1136, DOI 10.1039/b202998g; Fermer C, 2003, EUR J PHARM SCI, V18, P129, DOI 10.1016/S0928-0987(02)00252-X; Fernandez-Suarez M, 2002, LAB CHIP, V2, P170, DOI 10.1039/b202324e; Fredrickson CK, 2004, LAB CHIP, V4, P526, DOI 10.1039/b410720a; Garcia-Egido E, 2003, LAB CHIP, V3, P73, DOI 10.1039/b302381h; Garcia-Egido E, 2002, LAB CHIP, V2, P31, DOI 10.1039/b109360f; Geysen HM, 2003, NAT REV DRUG DISCOV, V2, P222, DOI 10.1038/nrd10335; Greenway GM, 2000, SENSOR ACTUAT B-CHEM, V63, P153, DOI 10.1016/S0925-4005(00)00352-X; Hatakeyama T, 2006, J AM CHEM SOC, V128, P2518, DOI 10.1021/ja057720w; He ST, 2005, CHEM LETT, V34, P748, DOI 10.1246/cl.2005.748; Hu GQ, 2006, ANAL CHIM ACTA, V557, P146, DOI 10.1016/j.aca.2005.10.021; Hung LH, 2006, LAB CHIP, V6, P174, DOI 10.1039/b513908b; Iles A, 2005, LAB CHIP, V5, P540, DOI 10.1039/b419081e; Jahnisch K, 2004, ANGEW CHEM INT EDIT, V43, P406, DOI 10.1002/anie.200300577; Jakeway SC, 2000, FRESEN J ANAL CHEM, V366, P525, DOI 10.1007/s002160051548; Jensen KF, 2001, CHEM ENG SCI, V56, P293, DOI 10.1016/S0009-2509(00)00230-X; Jeon NL, 2002, NAT BIOTECHNOL, V20, P826, DOI 10.1038/nbt712; Kawaguchi T, 2005, ANGEW CHEM INT EDIT, V44, P2413, DOI 10.1002/anie.200462466; Kikutani Y, 2002, LAB CHIP, V2, P188, DOI 10.1039/b208382p; Kikutani Y, 2002, LAB CHIP, V2, P193, DOI 10.1039/b208383n; Knight JB, 1998, PHYS REV LETT, V80, P3863, DOI 10.1103/PhysRevLett.80.3863; Kobayashi J, 2004, SCIENCE, V304, P1305, DOI 10.1126/science.1096956; Kopp MU, 1998, SCIENCE, V280, P1046, DOI 10.1126/science.280.5366.1046; Krishnadasan S, 2004, J MATER CHEM, V14, P2655, DOI 10.1039/b401559b; Krishnan M, 2002, SCIENCE, V298, P793, DOI 10.1126/science.298.5594.793; Lagally ET, 2004, J PHYS D APPL PHYS, V37, pR245, DOI 10.1088/0022-3727/37/23/R01; Lagally ET, 2004, ANAL CHEM, V76, P3162, DOI 10.1021/ac035310p; LAMER VK, 1950, J AM CHEM SOC, V72, P4847, DOI 10.1021/ja01167a001; Lee CC, 2005, SCIENCE, V310, P1793, DOI 10.1126/science.1118919; Leung SA, 2005, ANALYST, V130, P46, DOI 10.1039/b412069h; Levenspiel O., 1999, CHEM REACTION ENG, V3rd ed.; Lin X.Z., 2004, NANO LETT, V4, P2227; Liu RH, 2004, ANAL CHEM, V76, P1824, DOI 10.1021/ac0353029; Liu RH, 2000, J MICROELECTROMECH S, V9, P190, DOI 10.1109/84.846699; Lu H, 2001, LAB CHIP, V1, P22, DOI 10.1039/b104037p; Mao HB, 2002, J AM CHEM SOC, V124, P4432, DOI 10.1021/ja017625x; Marcus JS, 2006, ANAL CHEM, V78, P956, DOI 10.1021/ac0513865; Mengeaud V, 2002, ANAL CHEM, V74, P4279, DOI 10.1021/ac025642e; Miller PW, 2006, CHEM COMMUN, P546, DOI 10.1039/b515710b; Millman JR, 2005, NAT MATER, V4, P98, DOI 10.1038/nmat1270; Mitchell MC, 2001, J CHEM SOC PERK T 1, P514, DOI 10.1039/b009037i; Mitchell MC, 2001, ANALYST, V126, P24, DOI 10.1039/b007397k; MULLIS K, 1986, COLD SPRING HARB SYM, V51, P263, DOI 10.1101/SQB.1986.051.01.032; Murray CB, 2000, ANNU REV MATER SCI, V30, P545, DOI 10.1146/annurev.matsci.30.1.545; Nguyen NT, 2005, J MICROMECH MICROENG, V15, pR1, DOI 10.1088/0960-1317/15/2/R01; Obeid PJ, 2003, ANAL CHEM, V75, P288, DOI 10.1021/ac0260239; Oda RP, 1998, ANAL CHEM, V70, P4361, DOI 10.1021/ac980452i; Ottino JM, 2004, PHILOS T R SOC A, V362, P923, DOI 10.1098/rsta.2003.1355; OTTINO JM, 1990, ANNU REV FLUID MECH, V22, P207, DOI 10.1146/annurev.fl.22.010190.001231; OTTINO JM, 1989, SCI AM, V260, P56, DOI 10.1038/scientificamerican0189-56; Pennemann H, 2004, ORG PROCESS RES DEV, V8, P422, DOI 10.1021/op0341770; Ratner DM, 2005, CHEM COMMUN, P578, DOI 10.1039/b414503h; SalimiMoosavi H, 1997, J AM CHEM SOC, V119, P8716, DOI 10.1021/ja971735f; Schwarz MA, 2001, LAB CHIP, V1, P1, DOI 10.1039/b103795c; SCHWESINGER N, 2001, Patent No. 0170387; Shastry MCR, 1998, BIOPHYS J, V74, P2714, DOI 10.1016/S0006-3495(98)77977-9; Shestopalov I, 2004, LAB CHIP, V4, P316, DOI 10.1039/b403378g; Song H, 2003, ANGEW CHEM INT EDIT, V42, P768, DOI 10.1002/anie.200390203; Song H, 2003, J AM CHEM SOC, V125, P14613, DOI 10.1021/ja0354566; Song YJ, 2005, J PHYS CHEM B, V109, P9330, DOI 10.1021/JP044777G; Song YJ, 2004, J NANOSCI NANOTECHNO, V4, P788, DOI 10.1166/jnn.2004.111; Stroock AD, 2002, SCIENCE, V295, P647, DOI 10.1126/science.1066238; Taniguchi T, 2002, LAB CHIP, V2, P19, DOI 10.1039/b108739h; Tice JD, 2003, LANGMUIR, V19, P9127, DOI 10.1021/la030090w; Wagner J, 2004, CHEM ENG J, V101, P251, DOI 10.1016/j.cej.2003.11.021; Wang HZ, 2004, CHEM COMMUN, P48, DOI 10.1039/b310644f; Wang HZ, 2002, CHEM COMMUN, P1462, DOI 10.1039/b203478f; Watts P, 2005, CHEM ENG TECHNOL, V28, P290, DOI 10.1002/ceat.200407124; Watts P, 2003, DRUG DISCOV TODAY, V8, P586, DOI 10.1016/S1359-6446(03)02732-6; WOHLER F, 1848, GRUNDRISS ORG CHEM; Woolley AT, 1996, ANAL CHEM, V68, P4081, DOI 10.1021/ac960718q; Wootton RCR, 2002, ORG PROCESS RES DEV, V6, P187, DOI 10.1021/op0155155; Wootton RCR, 2002, LAB CHIP, V2, P5, DOI 10.1039/b111286d; Yen BKH, 2003, ADV MATER, V15, P1858, DOI 10.1002/adma.200305162; Yen BKH, 2005, ANGEW CHEM INT EDIT, V44, P5447, DOI 10.1002/anie.200500792	96	1129	1180	19	757	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 27	2006	442	7101					394	402		10.1038/nature05062	http://dx.doi.org/10.1038/nature05062			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067CI	16871207				2022-12-28	WOS:000239278900032
J	Hogerzeil, HV; Samson, M; Casanovas, JV; Rahmani-Ocora, L				Hogerzeil, Hans V.; Samson, Melanie; Casanovas, Jaurne Vidal; Rahmani-Ocora, Ladan			Is access to essential medicines as part of the fulfilment of the right to health enforceable through the courts?	LANCET			English	Article								Background Most countries in the world have become States parties to one or more international human rights treaties, thus creating an obligation by the State to its people towards the realisation of the right to health, which includes access to essential medicines. But whether such access is enforceable in practice is unknown. Methods We did a systematic search to identify completed court cases in low-income and middle-income countries in which individuals or groups had claimed access to essential medicines with reference to the right to health in general, or to specific human rights treaties ratified by the government. We identified and analysed 71 court cases from 12 countries in which access to essential medicines was claimed with reference to the right to health. Findings In 59 cases, access to essential medicines as part of the fulfilment of the right to health could indeed be enforced through the courts, with most coming from Central and Latin America. Success was mainly linked to constitutional provisions on the right to health, supported by the human rights treaties. Other success factors were a link between the right to health and the right to life, and support by public-interest non-government organisations. individual cases have generated entitlements across a population group, the right to health was not restricted by limitations in social security coverage, and government policies have successfully been challenged in court. Interpretation Skilful litigation can help to ensure that governments fulfil their constitutional and international treaty obligations. Such assurances are especially valuable in countries in which social security systems are still being developed. However, redress mechanisms through the courts should be used as a last resort. Rather, policymakers should ensure that human rights standards guide their health policies and programmes from the outset.	WHO, Dept Med Policy & Stand, CH-1211 Geneva, Switzerland	World Health Organization	Hogerzeil, HV (corresponding author), WHO, Dept Med Policy & Stand, CH-1211 Geneva, Switzerland.	hogerzeilh@who.int						[Anonymous], 1965, INT CONV EL ALL FORM; Messeder Ana Márcia, 2005, Cad. Saúde Pública, V21, P525, DOI 10.1590/S0102-311X2005000200019; *WHO, 2003, WHO TECHN REP SER, V920, P54; 1979, CONV EL ALL FORMS DI	4	122	126	1	9	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 22	2006	368	9532					305	311		10.1016/S0140-6736(06)69076-4	http://dx.doi.org/10.1016/S0140-6736(06)69076-4			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	067PF	16860700				2022-12-28	WOS:000239314400028
J	Taylor, R				Taylor, Rosie			Revenge of the hymenoptera	LANCET			English	Editorial Material									The Lancet, London NW1 7BY, England		Taylor, R (corresponding author), The Lancet, London NW1 7BY, England.							Goetz J., 2003, P 12 IEEE INT WORKSH; POPPLE S, 1999, ACTA HORTIC, V495, P491; *UK PARL HOUS COMM, 2006, HANS UK PARL HOUS CO	3	0	1	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 22	2006	368	9532					272	272		10.1016/S0140-6736(06)69055-7	http://dx.doi.org/10.1016/S0140-6736(06)69055-7			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	067PF	16860684				2022-12-28	WOS:000239314400009
J	Chen, K; Cole, J; Conger, C; Draskovic, J; Lohr, M; Klein, K; Scheidemantel, T; Schiffer, P				Chen, K.; Cole, J.; Conger, C.; Draskovic, J.; Lohr, M.; Klein, K.; Scheidemantel, T.; Schiffer, P.			Granular materials: Packing grains by thermal cycling	NATURE			English	Article							COMPACTION; DENSITY		Penn State Univ, Dept Phys, University Pk, PA 16802 USA; Penn State Univ, Mat Res Inst, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Chen, K (corresponding author), Penn State Univ, Dept Phys, University Pk, PA 16802 USA.	schiffer@phys.psu.edu	Schiffer, Peter/F-3227-2011	Schiffer, Peter/0000-0002-6430-6549				BARKER GC, 1993, PHYS REV E, V47, P184, DOI 10.1103/PhysRevE.47.184; Blight G. E., 1985, International Journal of Bulk Solids Storage in Silos, V1, P1; Donev A, 2004, SCIENCE, V303, P990, DOI 10.1126/science.1093010; LIU CH, 1994, PHYS REV B, V50, P782, DOI 10.1103/PhysRevB.50.782; Nowak ER, 1998, PHYS REV E, V57, P1971, DOI 10.1103/PhysRevE.57.1971; Philippe P, 2002, EUROPHYS LETT, V60, P677, DOI 10.1209/epl/i2002-00362-7; Puri V. M., 1986, International Journal of Bulk Solids Storage in Silos, V2, P1; Richard P, 2005, NAT MATER, V4, P121, DOI 10.1038/nmat1300; VIKLANDER P, 1997, COLD REGION SCI TECH, V27, P141; 2001, FLOW SOLIDS      FAL, P1	10	72	73	2	43	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 20	2006	442	7100					257	257		10.1038/442257a	http://dx.doi.org/10.1038/442257a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064WT	16855580	Bronze, Green Submitted			2022-12-28	WOS:000239122100025
J	Cipolat, S; Rudka, T; Hartmann, D; Costa, V; Serneels, L; Craessaerts, K; Metzger, K; Frezza, C; Annaert, W; D'Adamio, L; Derks, C; Dejaegere, T; Pellegrini, L; D'Hooge, R; Scorrano, L; De Strooper, B				Cipolat, Sara; Rudka, Tomasz; Hartmann, Dieter; Costa, Veronica; Serneels, Lutgarde; Craessaerts, Katleen; Metzger, Kristine; Frezza, Christian; Annaert, Wim; D'Adamio, Luciano; Derks, Carmen; Dejaegere, Tim; Pellegrini, Luca; D'Hooge, Rudi; Scorrano, Luca; De Strooper, Bart			Mitochondrial rhomboid PARL regulates cytochrome c release during apoptosis via OPA1-dependent cristae remodeling	CELL			English	Article							DYNAMIN-RELATED PROTEIN; DOMINANT OPTIC ATROPHY; INTRAMEMBRANE PROTEOLYSIS; ALZHEIMERS-DISEASE; GAMMA-SECRETASE; OPA1; MEMBRANE; MECHANISM; FISSION; FUSION	Rhomboids, evolutionarily conserved integral membrane proteases, participate in crucial signaling pathways. Presenilin-associated rhomboid-like (PARL) is an inner mitochondrial membrane rhomboid of unknown function, whose yeast ortholog is involved in mitochondrial fusion. Parl(-/-) mice display normal intrauterine development but from the fourth postnatal week undergo progressive multisystemic atrophy leading to cachectic death. Atrophy is sustained by increased apoptosis, both in and ex vivo. Parl(-/-) cells display normal mitochondrial morphology and function but are no longer protected against intrinsic apoptotic death stimuli by the dynamin-related mitochondrial protein OPA1. Parl(-/-) mitochondria display reduced levels of a soluble, intermembrane space (IMS) form of OPA1, and OPA1 specifically targeted to IMS complements Parl(-/-) cells, substantiating the importance of PARL in OPA1 processing. Parl(-/-) mitochondria. undergo faster apoptotic cristae remodeling and cytochrome c release. These findings implicate regulated intramembrane proteolysis in controlling apoptosis.	Venetian Inst Mol Med, Dulbecco Telethon Inst, Padua, Italy; Flanders Interuniv Inst Biotechnol, VIB4, Neuronal Cell Biol & Gene Transfer Lab, Louvain, Belgium; Flanders Interuniv Inst Biotechnol, VIB4, Membrane Trafficking Lab, Louvain, Belgium; Flanders Interuniv Inst Biotechnol, VIB4, Ctr Human Genet, Louvain, Belgium; Katholieke Univ Leuven, Lab Biol Psychol, Louvain, Belgium; Albert Einstein Coll Med, Bronx, NY 10461 USA	Fondazione Telethon; Dulbecco Telethon Institute (DTI); Veneto Institute Molecular Medicine; KU Leuven; Yeshiva University; Albert Einstein College of Medicine	Scorrano, L (corresponding author), Venetian Inst Mol Med, Dulbecco Telethon Inst, Padua, Italy.	luca.scorrano@unipd.it; bart.destrooper@med.kuleuven.be	Scorrano, Luca/K-3967-2019; Frezza, Christian/G-2174-2010; de+Strooper, Bart/Z-1638-2019; De Strooper, Bart/F-6507-2012; Scorrano, Luca/A-6652-2008	Scorrano, Luca/0000-0002-8515-8928; Frezza, Christian/0000-0002-3293-7397; De Strooper, Bart/0000-0001-5455-5819; Scorrano, Luca/0000-0002-8515-8928; D'Adamio, Luciano/0000-0002-9820-4882; D'Adamio, Luciano/0000-0002-2204-9441; Pellegrini, Luca/0000-0002-4235-7708	Telethon [TCP02016] Funding Source: Medline	Telethon(Fondazione Telethon)		Alexander C, 2000, NAT GENET, V26, P211, DOI 10.1038/79944; Annaert W, 2002, ANNU REV CELL DEV BI, V18, P25, DOI 10.1146/annurev.cellbio.18.020402.142302; Arnoult D, 2005, J BIOL CHEM, V280, P35742, DOI 10.1074/jbc.M505970200; BERNARDI P, 1981, J BIOL CHEM, V256, P7187; Brossier F, 2005, P NATL ACAD SCI USA, V102, P4146, DOI 10.1073/pnas.0407918102; Brown MS, 2000, CELL, V100, P391, DOI 10.1016/S0092-8674(00)80675-3; Cipolat S, 2004, P NATL ACAD SCI USA, V101, P15927, DOI 10.1073/pnas.0407043101; Danial NN, 2003, NATURE, V424, P952, DOI 10.1038/nature01825; Delettre C, 2000, NAT GENET, V26, P207, DOI 10.1038/79936; Delettre C, 2001, HUM GENET, V109, P584, DOI 10.1007/s00439-001-0633-y; Esser K, 2002, J MOL BIOL, V323, P835, DOI 10.1016/S0022-2836(02)01000-8; Freeman M, 2004, NAT REV MOL CELL BIO, V5, P188, DOI 10.1038/nrm1334; Frezza C, 2006, CELL, V126, P177, DOI 10.1016/j.cell.2006.06.025; Gallio M, 2002, P NATL ACAD SCI USA, V99, P12208, DOI 10.1073/pnas.192138799; Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320; Hao ZY, 2005, CELL, V121, P579, DOI 10.1016/j.cell.2005.03.016; Herlan M, 2003, J BIOL CHEM, V278, P27781, DOI 10.1074/jbc.M211311200; Irwin WA, 2003, NAT GENET, V35, P367, DOI 10.1038/ng1270; JACOBS EE, 1960, J BIOL CHEM, V235, P531; James DI, 2003, J BIOL CHEM, V278, P36373, DOI 10.1074/jbc.M303758200; Koonin EV, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-3-r19; Kopan R, 2004, NAT REV MOL CELL BIO, V5, P499, DOI 10.1038/nrm1406; Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125; Lee YJ, 2004, MOL BIOL CELL, V15, P5001, DOI 10.1091/mbc.E04-04-0294; Lemberg MK, 2005, EMBO J, V24, P464, DOI 10.1038/sj.emboj.7600537; Marjaux E, 2004, NEURON, V42, P189, DOI 10.1016/S0896-6273(04)00218-1; McQuibban GA, 2003, NATURE, V423, P537, DOI 10.1038/nature01633; Mumm JS, 2000, MOL CELL, V5, P197, DOI 10.1016/S1097-2765(00)80416-5; Olichon A, 2002, FEBS LETT, V523, P171, DOI 10.1016/S0014-5793(02)02985-X; Otera H, 2005, EMBO J, V24, P1375, DOI 10.1038/sj.emboj.7600614; Pellegrini L, 2001, J ALZHEIMERS DIS, V3, P181; PEROTTI ME, 1983, J HISTOCHEM CYTOCHEM, V31, P351, DOI 10.1177/31.3.6186730; Rizzuto R, 2000, J PHYSIOL-LONDON, V529, P37, DOI 10.1111/j.1469-7793.2000.00037.x; Sandri M, 1999, INT J BIOCHEM CELL B, V31, P1373, DOI 10.1016/S1357-2725(99)00063-1; Scaffidi C, 1998, EMBO J, V17, P1675, DOI 10.1093/emboj/17.6.1675; Scorrano L, 2002, DEV CELL, V2, P55, DOI 10.1016/S1534-5807(01)00116-2; Sesaki H, 2003, BIOCHEM BIOPH RES CO, V308, P276, DOI 10.1016/S0006-291X(03)01348-2; Sik A, 2004, J BIOL CHEM, V279, P15323, DOI 10.1074/jbc.M313756200; Smirnova E, 2001, MOL BIOL CELL, V12, P2245, DOI 10.1091/mbc.12.8.2245; SOTTOCASA GL, 1967, J CELL BIOL, V32, P415, DOI 10.1083/jcb.32.2.415; VEIS DJ, 1993, CELL, V75, P229, DOI 10.1016/0092-8674(93)80065-M; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Wei MC, 2000, GENE DEV, V14, P2060; Yoon Y, 2003, MOL CELL BIOL, V23, P5409, DOI 10.1128/MCB.23.15.5409-5420.2003; Youle RJ, 2005, NAT REV MOL CELL BIO, V6, P657, DOI 10.1038/nrm1697	45	562	579	2	35	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUL 14	2006	126	1					163	175		10.1016/j.cell.2006.06.021	http://dx.doi.org/10.1016/j.cell.2006.06.021			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	066JF	16839884	Bronze			2022-12-28	WOS:000239224800024
J	Tsymbal, EY; Kohlstedt, H				Tsymbal, Evgeny Y.; Kohlstedt, Hermann			Applied physics - Tunneling across a ferroelectric	SCIENCE			English	Editorial Material							ROOM-TEMPERATURE; SPIN POLARIZATION; PEROVSKITE FILMS; JUNCTIONS; MAGNETORESISTANCE; SUPERCONDUCTORS		Univ Nebraska, Dept Phys & Astron, Nebraska Ctr Mat & Nanosci, Lincoln, NE 68588 USA; Forschungszentrum Julich, Inst Festkorperforsch, D-52425 Julich, Germany; Univ Calif Berkeley, Dept Mat Sci & Engn, Berkeley, CA 94720 USA	University of Nebraska System; University of Nebraska Lincoln; Helmholtz Association; Research Center Julich; University of California System; University of California Berkeley	Tsymbal, EY (corresponding author), Univ Nebraska, Dept Phys & Astron, Nebraska Ctr Mat & Nanosci, Lincoln, NE 68588 USA.	tsymbal@unl.edu	Tsymbal, Evgeny/G-3493-2013	Tsymbal, Evgeny/0000-0002-6728-5480				Bea H, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2170432; Binek C, 2005, J PHYS-CONDENS MAT, V17, pL39, DOI 10.1088/0953-8984/17/2/L06; Borisov P, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.117203; Bune AV, 1998, NATURE, V391, P874, DOI 10.1038/36069; Dawber M, 2005, REV MOD PHYS, V77, P1083, DOI 10.1103/RevModPhys.77.1083; De Teresa JM, 1999, SCIENCE, V286, P507, DOI 10.1126/science.286.5439.507; Esaki L., 1971, IBM TECH DISCL B, V13, P2161; Fong DD, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.144112; Frenkel J, 1930, PHYS REV, V36, P1604, DOI 10.1103/PhysRev.36.1604; Gajek M, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.020406; Gerra G, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.107603; GIAEVER I, 1960, PHYS REV LETT, V5, P147, DOI 10.1103/PhysRevLett.5.147; GIAEVER I, 1960, PHYS REV LETT, V5, P464, DOI 10.1103/PhysRevLett.5.464; JULLIERE M, 1975, PHYS LETT A, V54, P225, DOI 10.1016/0375-9601(75)90174-7; Junquera J, 2003, NATURE, V422, P506, DOI 10.1038/nature01501; Kohlstedt H, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.125341; MOODERA JS, 1995, PHYS REV LETT, V74, P3273, DOI 10.1103/PhysRevLett.74.3273; Parkin SSP, 2004, NAT MATER, V3, P862, DOI 10.1038/nmat1256; Smolenskii G. A., 1982, Soviet Physics - Uspekhi, V25, P475, DOI 10.1070/PU1982v025n07ABEH004570; Spaldin NA, 2005, SCIENCE, V309, P391, DOI 10.1126/science.1113357; TEDROW PM, 1971, PHYS REV LETT, V26, P192, DOI 10.1103/PhysRevLett.26.192; TEDROW PM, 1973, PHYS REV B, V7, P318, DOI 10.1103/PhysRevB.7.318; Tybell T, 1999, APPL PHYS LETT, V75, P856, DOI 10.1063/1.124536; Valasek J, 1921, PHYS REV, V17, P475, DOI 10.1103/PhysRev.17.475; Yuasa S, 2004, NAT MATER, V3, P868, DOI 10.1038/nmat1257; Zheng H, 2004, SCIENCE, V303, P661, DOI 10.1126/science.1094207; Zhuravlev MY, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.246802	28	665	675	15	348	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 14	2006	313	5784					181	183		10.1126/science.1126230	http://dx.doi.org/10.1126/science.1126230			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	063GZ	16840688	Green Published			2022-12-28	WOS:000239008000030
J	Hall-Stoodley, L; Hu, FZ; Gieseke, A; Nistico, L; Nguyen, D; Hayes, J; Forbes, M; Greenberg, DP; Dice, B; Burrows, A; Wackym, PA; Stoodley, P; Post, JC; Ehrlich, GD; Kerschner, JE				Hall-Stoodley, Luanne; Hu, Fen Ze; Gieseke, Armin; Nistico, Laura; Nguyen, Duc; Hayes, Jay; Forbes, Michael; Greenberg, David P.; Dice, Bethany; Burrows, Amy; Wackym, P. Ashley; Stoodley, Paul; Post, J. Christopher; Ehrlich, Garth D.; Kerschner, Joseph E.			Direct detection of bacterial Biofilms on the middle-ear mucosa of children with chronic otitis media	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							NONTYPABLE HAEMOPHILUS-INFLUENZAE; IN-SITU HYBRIDIZATION; ANTIBIOTIC-RESISTANCE; STREPTOCOCCUS-PNEUMONIAE; PSEUDOMONAS-AERUGINOSA; EFFUSION; MODEL; MICROORGANISMS; IDENTIFICATION; INFECTIONS	Context Chronic otitis media ( OM) is a common pediatric infectious disease. Previous studies demonstrating that metabolically active bacteria exist in culture-negative pediatric middle-ear effusions and that experimental infection with Haemophilus influenzae in the chinchilla model of otitis media results in the formation of adherent mucosal biofilms suggest that chronic OM may result from a mucosal biofilm infection. Objective To test the hypothesis that chronic OM in humans is biofilm-related. Design, Setting, and Patients Middle-ear mucosa (MEM) biopsy specimens were obtained from 26 children ( mean age, 2.5 [ range, 0.5-14] years) undergoing tympanostomy tube placement for treatment of otitis media with effusion (OME) and recurrent OM and were analyzed using microbiological culture, polymerase chain reaction (PCR)based diagnostics, direct microscopic examination, fluorescence in situ hybridization, and immunostaining. Uninfected ( control) MEM specimens were obtained from 3 children and 5 adults undergoing cochlear implantation. Patients were enrolled between February 2004 and April 2005 from a single US tertiary referral otolaryngology practice. Main Outcome Measures Confocal laser scanning microscopic (CLSM) images were obtained from MEM biopsy specimens and were evaluated for biofilm morphology using generic stains and species-specific probes for H influenzae, Streptococcus pneumoniae, and Moraxella catarrhalis. Effusions, when present, were evaluated by PCR and culture for evidence of pathogen-specific nucleic acid sequences and bacterial growth, respectively. Results Of the 26 children undergoing tympanostomy tube placement, 13 (50%) had OME, 20 (77%) had recurrent OM, and 7 (27%) had both diagnoses; 27 of 52 (52%) of the ears had effusions, 24 of 24 effusions were PCR-positive for at least 1 OM pathogen, and 6 (22%) of 27 effusions were culture-positive for any pathogen. Mucosal biofilms were visualized by CLSM on 46 (92%) of 50 MEM specimens from children with OME and recurrent OM using generic and pathogen-specific probes. Biofilms were not observed on 8 control MEM specimens obtained from the patients undergoing cochlear implantation. Conclusion Direct detection of biofilms on MEM biopsy specimens from children with OME and recurrent OM supports the hypothesis that these chronic middle-ear disorders are biofilm-related.	Allegheny Singer Res Inst, Ctr Genom Sci, Pittsburgh, PA 15212 USA; Drexel Univ, Coll Med, Dept Microbiol & Immunol, Pittsburgh, PA USA; Max Planck Inst Marine Microbiol, Dept Mol Ecol, Bremen, Germany; Childrens Hosp Pittsburgh, Pittsburgh, PA 15213 USA; Med Coll Wisconsin, Childrens Hosp Wisconsin, Dept Otolaryngol, Milwaukee, WI 53226 USA	Drexel University; Max Planck Society; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Children's Hospital of Wisconsin; Medical College of Wisconsin	Ehrlich, GD (corresponding author), Allegheny Singer Res Inst, Ctr Genom Sci, 320 E North Ave, Pittsburgh, PA 15212 USA.	gehrlich@wpahs.org	Hall-Stoodley, Luanne/AAF-1925-2020; Stoodley, Paul/E-5079-2013; Nguyen, Duc/AAX-1819-2021	Stoodley, Paul/0000-0001-6069-273X; Nguyen, Duc/0000-0002-5059-4404; Wackym, P. Ashley/0000-0002-2904-5072; Ehrlich, Garth/0000-0003-1140-6594	NIDCD NIH HHS [DC 04173, DC 05659, F32 DC000192, R01 DC004173, DC 00192, R01 DC007903, DC 007903, R01 DC002148, DC 02148, R01 DC007903-01A1, K08 DC000192, R01 DC005659] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004173, K08DC000192, R01DC007903, F32DC000192, R01DC005659, R01DC002148] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Allegrucci M, 2006, J BACTERIOL, V188, P2325, DOI 10.1128/JB.188.7.2325-2335.2006; AMANN RI, 1990, APPL ENVIRON MICROB, V56, P1919, DOI 10.1128/AEM.56.6.1919-1925.1990; Anderl JN, 2003, ANTIMICROB AGENTS CH, V47, P1251, DOI 10.1128/AAC.47.4.1251-1256.2003; Aul JJ, 1998, ANN OTO RHINOL LARYN, V107, P508; Bennett KE, 2001, ARCH DIS CHILD, V85, P91, DOI 10.1136/adc.85.2.91; Borriello G, 2004, ANTIMICROB AGENTS CH, V48, P2659, DOI 10.1128/AAC.48.7.2659-2664.2004; Christensen BB, 1998, APPL ENVIRON MICROB, V64, P2247; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Costerton W, 2003, J CLIN INVEST, V112, P1466, DOI 10.1172/JCI200320365; Dingman JR, 1998, J CLIN MICROBIOL, V36, P3417, DOI 10.1128/JCM.36.11.3417-3419.1998; Donlan RM, 2002, CLIN MICROBIOL REV, V15, P167, DOI 10.1128/CMR.15.2.167-193.2002; Drenkard E, 2002, NATURE, V416, P740, DOI 10.1038/416740a; Ehrlich GD, 2002, JAMA-J AM MED ASSOC, V287, P1710, DOI 10.1001/jama.287.13.1710; Fux CA, 2004, J BACTERIOL, V186, P4486, DOI 10.1128/JB.186.14.4486-4491.2004; Fux Christoph A, 2003, Expert Rev Anti Infect Ther, V1, P667, DOI 10.1586/14787210.1.4.667; Gok U, 2001, INT J PEDIATR OTORHI, V60, P49, DOI 10.1016/S0165-5876(01)00510-9; Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821; HARABUCHI Y, 1994, J INFECT DIS, V170, P862, DOI 10.1093/infdis/170.4.862; Hogardt M, 2000, J CLIN MICROBIOL, V38, P818, DOI 10.1128/JCM.38.2.818-825.2000; Kempf VAJ, 2000, J CLIN MICROBIOL, V38, P830, DOI 10.1128/JCM.38.2.830-838.2000; Leibovitz E, 2003, PEDIATR INFECT DIS J, V22, P209, DOI 10.1097/00006454-200303000-00002; MANZ W, 1992, SYST APPL MICROBIOL, V15, P593, DOI 10.1016/S0723-2020(11)80121-9; Parsek MR, 2003, ANNU REV MICROBIOL, V57, P677, DOI 10.1146/annurev.micro.57.030502.090720; POST JC, 1995, JAMA-J AM MED ASSOC, V273, P1598, DOI 10.1001/jama.273.20.1598; Rayner MG, 1998, JAMA-J AM MED ASSOC, V279, P296, DOI 10.1001/jama.279.4.296; Roberts ME, 2005, MICROBIOL-SGM, V151, P75, DOI 10.1099/mic.0.27385-0; Shen K, 2006, INFECT IMMUN, V74, P321, DOI 10.1128/IAI.74.1.321-330.2006; Shen K, 2005, INFECT IMMUN, V73, P3479, DOI 10.1128/IAI.73.6.3479-3491.2005; Stewart PS, 2001, LANCET, V358, P135, DOI 10.1016/S0140-6736(01)05321-1; Stoodley P, 2002, ANNU REV MICROBIOL, V56, P187, DOI 10.1146/annurev.micro.56.012302.160705	31	657	712	0	85	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 12	2006	296	2					202	211		10.1001/jama.296.2.202	http://dx.doi.org/10.1001/jama.296.2.202			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	062LP	16835426	Green Accepted, Green Submitted			2022-12-28	WOS:000238946500026
J	Kohane, IS; Masys, DR; Altman, RB				Kohane, IS; Masys, DR; Altman, RB			The incidentalome - A threat to genomic medicine	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							MANAGED CARE ORGANIZATION; BREAST-CANCER; GENE-EXPRESSION; DISEASE; INFORMATION; MICROARRAYS; DISCOVERY; WOMEN; RISK		Harvard Univ, Sch Med, Ctr Biomed Informat, Boston, MA 02115 USA; Harvard Univ, Sch Med, Div Hlth Sci Technol, Boston, MA 02115 USA; Vanderbilt Univ, Sch Med, Dept Biomed Informat, Nashville, TN 37212 USA; Stanford Univ, Dept Genet, Stanford, CA 94305 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Vanderbilt University; Stanford University	Kohane, IS (corresponding author), Harvard Univ, Sch Med, Ctr Biomed Informat, 10 Shattuck St, Boston, MA 02115 USA.	isaac_kohane@harvard.edu	Kohane, Isaac Kohane/K-3716-2012	Kohane, Isaac Kohane/0000-0003-2192-5160	NATIONAL LIBRARY OF MEDICINE [U54LM008748] Funding Source: NIH RePORTER; NLM NIH HHS [5U54LM008748-02] Funding Source: Medline	NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NLM NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))		Allison DB, 2006, NAT REV GENET, V7, P55, DOI 10.1038/nrg1749; Csillag C, 2005, SCAND J GASTROENTERO, V40, P369, DOI 10.1080/00365520510012226; ELIAS S, 1994, NEW ENGL J MED, V330, P1611, DOI 10.1056/NEJM199406023302213; Ermak G, 2002, DRUG TODAY, V38, P509, DOI 10.1358/dot.2002.38.7.704681; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Heller RA, 1997, P NATL ACAD SCI USA, V94, P2150, DOI 10.1073/pnas.94.6.2150; Hugosson J, 2000, BJU INT, V85, P1078, DOI 10.1046/j.1464-410x.2000.00679.x; Illes J, 2006, SCIENCE, V311, P783, DOI 10.1126/science.1124665; James PA, 2006, J CLIN ONCOL, V24, P707, DOI 10.1200/JCO.2005.01.9737; Javitt GH, 2006, ADV CHRONIC KIDNEY D, V13, P178, DOI 10.1053/j.ackd.2006.01.003; Kohane IS, 2005, NEW ENGL J MED, V353, P2074, DOI 10.1056/NEJMsb051220; Kruglyak L, 2005, NAT GENET, V37, P1299, DOI 10.1038/ng1205-1299; Miller RM, 2005, NEUROSCIENTIST, V11, P539, DOI 10.1177/1073858405278330; Miller SM, 2005, J HEALTH COMMUN, V10, P119, DOI 10.1080/07366290500265335; Mouchawar J, 2005, AM J MANAG CARE, V11, P601; Mouchawar J, 2005, GENET MED, V7, P191, DOI 10.1097/01.GIM.0000156526.16967.7A; Mullighan CG, 2005, CANCER J, V11, P268, DOI 10.1097/00130404-200507000-00003; Ogino S, 2004, J MOL DIAGN, V6, P1, DOI 10.1016/S1525-1578(10)60484-9; Rock MJ, 2005, J PEDIATR-US, V147, pS73, DOI 10.1016/j.jpeds.2005.08.004; TERAMOTO A, 1994, RADIOLOGY, V193, P161, DOI 10.1148/radiology.193.1.8090885; van 't Veer LJ, 2003, BREAST CANCER RES, V5, P57, DOI 10.1186/bcr562	21	229	233	0	9	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 12	2006	296	2					212	215		10.1001/jama.296.2.212	http://dx.doi.org/10.1001/jama.296.2.212			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	062LP	16835427				2022-12-28	WOS:000238946500027
J	Shpyrko, OG; Streitel, R; Balagurusamy, VSK; Grigoriev, AY; Deutsch, M; Ocko, BM; Meron, M; Lin, BH; Pershan, PS				Shpyrko, OG; Streitel, R; Balagurusamy, VSK; Grigoriev, AY; Deutsch, M; Ocko, BM; Meron, M; Lin, BH; Pershan, PS			Surface crystallization in a liquid AuSi alloy	SCIENCE			English	Article							X-RAY REFLECTIVITY; METALLIC GLASSES; VAPOR INTERFACE; RANGE ORDER; GA ALLOY; GOLD; SILICIDE	X-ray measurements reveal a crystalline monolayer at the surface of the eutectic liquid Au82Si18, at temperatures above the alloy's melting point. Surface-induced atomic layering, the hallmark of liquid metals, is also found below the crystalline monolayer. The layering depth, however, is threefold greater than that of all liquid metals studied to date. The crystallinity of the surface monolayer is notable, considering that AuSi does not form stable bulk crystalline phases at any concentration and temperature and that no crystalline surface phase has been detected thus far in any pure liquid metal or nondilute alloy. These results are discussed in relation to recently suggested models of amorphous alloys.	Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; Harvard Univ, Div Engn & Appl Sci, Cambridge, MA 02138 USA; Argonne Natl Lab, Ctr Nanoscale Mat, Argonne, IL 60439 USA; Bar Ilan Univ, Dept Phys, IL-52900 Ramat Gan, Israel; Brookhaven Natl Lab, Condensed Matter Phys & Mat Sci Dept, Upton, NY 11973 USA; Univ Chicago, Ctr Adv Radiat Sources, Chicago, IL 60637 USA	Harvard University; Harvard University; United States Department of Energy (DOE); Argonne National Laboratory; Bar Ilan University; United States Department of Energy (DOE); Brookhaven National Laboratory; University of Chicago	Shpyrko, OG (corresponding author), Harvard Univ, Dept Phys, Cambridge, MA 02138 USA.	oshpyrko@anl.gov	Shpyrko, Oleg/J-3970-2012	Balagurusamy, Venkat/0000-0002-1994-2634				Bischoff L, 2000, J PHYS D APPL PHYS, V33, P692, DOI 10.1088/0022-3727/33/6/316; Chang JF, 2004, MATER CHEM PHYS, V83, P199, DOI 10.1016/S0254-0584(03)00240-2; CHEN HS, 1967, J APPL PHYS, V38, P3646, DOI 10.1063/1.1710186; Cheng YT, 2000, J MICROELECTROMECH S, V9, P3, DOI 10.1109/84.825770; DASH JG, 1985, PHYS TODAY, V38, P26, DOI 10.1063/1.880994; Dogic Z, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.165701; Donnelly SE, 2002, SCIENCE, V296, P507, DOI 10.1126/science.1068521; FILONENKO VA, 1969, RUSS J PHYS CHEM+, V43, P874; FRENKEN JWM, 1985, PHYS REV LETT, V54, P134, DOI 10.1103/PhysRevLett.54.134; GREEN AK, 1976, J APPL PHYS, V47, P1284, DOI 10.1063/1.322827; Hannon JB, 2006, NATURE, V440, P69, DOI 10.1038/nature04574; Huisman WJ, 1997, NATURE, V390, P379, DOI 10.1038/37069; KLEMENT W, 1960, NATURE, V187, P869, DOI 10.1038/187869b0; MAGNUSSEN OM, 1995, PHYS REV LETT, V74, P4444, DOI 10.1103/PhysRevLett.74.4444; Miracle DB, 2004, NAT MATER, V3, P697, DOI 10.1038/nmat1219; MOLODTSOV SL, 1991, PHYS REV B, V44, P8850, DOI 10.1103/PhysRevB.44.8850; Oh SH, 2005, SCIENCE, V310, P661, DOI 10.1126/science.1118611; REGAN MJ, 1995, PHYS REV LETT, V75, P2498, DOI 10.1103/PhysRevLett.75.2498; Sheng HW, 2006, NATURE, V439, P419, DOI 10.1038/nature04421; Shpyrko OG, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.106103; SINHA SK, 1988, PHYS REV B, V38, P2297, DOI 10.1103/PhysRevB.38.2297; Tkachenko AV, 1996, PHYS REV LETT, V76, P2527, DOI 10.1103/PhysRevLett.76.2527; WEISSMULLER J, 1992, J NON-CRYST SOLIDS, V142, P70, DOI 10.1016/S0022-3093(05)80008-0; WU XZ, 1993, SCIENCE, V261, P1018, DOI 10.1126/science.261.5124.1018; Yang B, 1999, P NATL ACAD SCI USA, V96, P13009, DOI 10.1073/pnas.96.23.13009; Yang B, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.212103	26	163	165	6	149	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 7	2006	313	5783					77	80		10.1126/science.1128314	http://dx.doi.org/10.1126/science.1128314			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061DA	16825565	Green Submitted			2022-12-28	WOS:000238850200033
J	Miller, AJ; Mihm, MC				Miller, Arlo J.; Mihm, Martin C., Jr.			Mechanisms of disease - Melanoma	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							MICROPHTHALMIA TRANSCRIPTION FACTOR; CUTANEOUS MALIGNANT-MELANOMA; TUMOR-SUPPRESSOR GENE; CELL-CYCLE ARREST; BETA-CATENIN; BRAF MUTATIONS; INTEGRIN ALPHA(V)BETA(3); MELANOCORTIN-1 RECEPTOR; ULTRAVIOLET-RADIATION; METASTATIC MELANOMA		Massachusetts Gen Hosp, Dept Dermatopathol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Mihm, MC (corresponding author), Massachusetts Gen Hosp, Dept Dermatopathol, 55 Fruit St,Warren 827, Boston, MA 02114 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER; NIGMS NIH HHS [T32-GM07753, T32 GM007753] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aitken J, 1999, JNCI-J NATL CANCER I, V91, P446, DOI 10.1093/jnci/91.5.446; ALBINO AP, 1989, ONCOGENE, V4, P1363; Alonso SR, 2004, AM J PATHOL, V164, P193, DOI 10.1016/S0002-9440(10)63110-0; *AM CANC SOC, 2003, CANC FACTS FIG 2003; Balch CM, 2001, J CLIN ONCOL, V19, P3622, DOI 10.1200/JCO.2001.19.16.3622; Banerjee D, 2001, Curr Opin Investig Drugs, V2, P574; Baxter LL, 2003, GENE EXPR PATTERNS, V3, P703, DOI 10.1016/j.modgep.2003.07.002; Bienz M, 2005, CURR BIOL, V15, pR64, DOI 10.1016/j.cub.2004.12.058; Braig M, 2006, CANCER RES, V66, P2881, DOI 10.1158/0008-5472.CAN-05-4006; Brembeck FH, 2004, GENE DEV, V18, P2225, DOI 10.1101/gad.317604; Brooks PC, 1996, CELL, V85, P683, DOI 10.1016/S0092-8674(00)81235-0; Brunet A, 1999, EMBO J, V18, P664, DOI 10.1093/emboj/18.3.664; Cantley LC, 1999, P NATL ACAD SCI USA, V96, P4240, DOI 10.1073/pnas.96.8.4240; Chin L, 1997, GENE DEV, V11, P2822, DOI 10.1101/gad.11.21.2822; Chudnovsky Y, 2005, NAT GENET, V37, P745, DOI 10.1038/ng1586; CLARK WH, 1984, HUM PATHOL, V15, P1147, DOI 10.1016/S0046-8177(84)80310-X; Cowley GP, 1996, J PATHOL, V179, P183, DOI 10.1002/(SICI)1096-9896(199606)179:2<183::AID-PATH554>3.0.CO;2-W; Curtin JA, 2005, NEW ENGL J MED, V353, P2135, DOI 10.1056/NEJMoa050092; Danen EHJ, 1996, MELANOMA RES, V6, P127, DOI 10.1097/00008390-199604000-00007; DANEN EHJ, 1994, HISTOPATHOLOGY, V24, P249, DOI 10.1111/j.1365-2559.1994.tb00517.x; Daniotti M, 2004, ONCOGENE, V23, P5968, DOI 10.1038/sj.onc.1207780; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Dechantsreiter MA, 1999, J MED CHEM, V42, P3033, DOI 10.1021/jm970832g; Du JY, 2003, AM J PATHOL, V163, P333, DOI 10.1016/S0002-9440(10)63657-7; Duncan LM, 1998, CANCER RES, V58, P1515; Eskandarpour M, 2005, INT J CANCER, V115, P65, DOI 10.1002/ijc.20873; Felding-Habermann B, 2002, CLIN EXP METASTAS, V19, P427, DOI 10.1023/A:1016377114119; Flores JF, 1996, CANCER RES, V56, P5023; Frandberg PA, 1998, BIOCHEM BIOPH RES CO, V245, P490, DOI 10.1006/bbrc.1998.8459; Garraway LA, 2005, NATURE, V436, P117, DOI 10.1038/nature03664; Gilchrest BA, 1999, NEW ENGL J MED, V340, P1341, DOI 10.1056/NEJM199904293401707; Goding CR, 2000, GENE DEV, V14, P1712; Gottardi CJ, 2001, CURR BIOL, V11, pR792, DOI 10.1016/S0960-9822(01)00473-0; Gottardi CJ, 2001, J CELL BIOL, V153, P1049, DOI 10.1083/jcb.153.5.1049; Granter SR, 2002, APPL IMMUNOHISTO M M, V10, P47, DOI 10.1097/00022744-200203000-00008; Guldberg P, 1997, CANCER RES, V57, P3660; Haass NK, 2005, PIGM CELL RES, V18, P150, DOI 10.1111/j.1600-0749.2005.00235.x; Harris SL, 2005, ONCOGENE, V24, P2899, DOI 10.1038/sj.onc.1208615; Hingorani SR, 2003, CANCER RES, V63, P5198; HODGKINSON CA, 1993, CELL, V74, P395, DOI 10.1016/0092-8674(93)90429-T; Hoeflich MP, 2006, CANCER RES, V66, P999, DOI 10.1158/0008-5472.CAN-05-2720; Hofbauer GFL, 1998, MELANOMA RES, V8, P337, DOI 10.1097/00008390-199808000-00007; Hofmann UB, 2000, J INVEST DERMATOL, V115, P625, DOI 10.1046/j.1523-1747.2000.00114.x; Hsu MY, 2000, J CELL SCI, V113, P1535; Hsu MY, 1996, JOURNAL OF INVESTIGATIVE DERMATOLOGY SYMPOSIUM PROCEEDINGS, VOL 1, NO 2, APRIL 1996, P188; HUSSUSSIAN CJ, 1994, NAT GENET, V8, P15, DOI 10.1038/ng0994-15; Johnson JP, 1999, CANCER METAST REV, V18, P345, DOI 10.1023/A:1006304806799; KAMB A, 1994, NAT GENET, V8, P22, DOI 10.1038/ng0994-22; KAMB A, 1994, SCIENCE, V264, P436, DOI 10.1126/science.8153634; Kamijo T, 1997, CELL, V91, P649, DOI 10.1016/S0092-8674(00)80452-3; Kennedy C, 2001, J INVEST DERMATOL, V117, P294, DOI 10.1046/j.0022-202x.2001.01421.x; King R, 1999, AM J PATHOL, V155, P731, DOI 10.1016/S0002-9440(10)65172-3; Kuphal S, 2005, CANCER METAST REV, V24, P195, DOI 10.1007/s10555-005-1572-1; LERNER AB, 1986, J INVEST DERMATOL, V87, P299, DOI 10.1111/1523-1747.ep12524353; Li G, 2001, CANCER RES, V61, P3819; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Li XW, 2001, J CELL SCI, V114, P2665; Lin AW, 1998, GENE DEV, V12, P3008, DOI 10.1101/gad.12.19.3008; Loercher AE, 2005, J CELL BIOL, V168, P35, DOI 10.1083/jcb.200410115; Lyons JF, 2001, ENDOCR-RELAT CANCER, V8, P219, DOI 10.1677/erc.0.0080219; MacKie RM, 2002, DERMATOL CLIN, V20, P597, DOI 10.1016/S0733-8635(02)00028-1; Maldonado JL, 2003, J NATL CANCER I, V95, P1878, DOI 10.1093/jnci/djg123; Marks R, 2000, CLIN EXP DERMATOL, V25, P459, DOI 10.1046/j.1365-2230.2000.00693.x; McGill GG, 2002, CELL, V109, P707, DOI 10.1016/S0092-8674(02)00762-6; Michaloglou C, 2005, NATURE, V436, P720, DOI 10.1038/nature03890; Miettinen M, 2001, AM J SURG PATHOL, V25, P205, DOI 10.1097/00000478-200102000-00008; Miller AJ, 2004, CANCER RES, V64, P509, DOI 10.1158/0008-5472.CAN-03-2440; Naysmith L, 2004, J INVEST DERMATOL, V122, P423, DOI 10.1046/j.0022-202X.2004.22221.x; Nishimura EK, 2005, SCIENCE, V307, P720, DOI 10.1126/science.1099593; NOBORI T, 1994, NATURE, V368, P753, DOI 10.1038/368753a0; Omholt K, 2003, CLIN CANCER RES, V9, P6483; Patton EE, 2005, CURR BIOL, V15, P249, DOI 10.1016/j.cub.2005.01.031; Petitclerc E, 1999, CANCER RES, V59, P2724; Pollock PM, 2003, NAT GENET, V33, P19, DOI 10.1038/ng1054; Pollock PM, 2000, CLIN LAB MED, V20, P667; Pomerantz J, 1998, CELL, V92, P713, DOI 10.1016/S0092-8674(00)81400-2; Qi JF, 2005, MOL BIOL CELL, V16, P4386, DOI 10.1091/mbc.E05-03-0186; Recio JA, 2002, CANCER RES, V62, P6724; Rimm DL, 1999, AM J PATHOL, V154, P325, DOI 10.1016/S0002-9440(10)65278-9; Rubinfeld B, 1997, SCIENCE, V275, P1790, DOI 10.1126/science.275.5307.1790; Salti GI, 2000, CANCER RES, V60, P5012; Sanders DSA, 1999, J CLIN PATHOL-MOL PA, V52, P151, DOI 10.1136/mp.52.3.151; Sauter ER, 2002, CANCER RES, V62, P3200; Scott RAH, 1997, EYE, V11, P607, DOI 10.1038/eye.1997.163; Seiter S, 2002, J IMMUNOTHER, V25, P252, DOI 10.1097/00002371-200205000-00008; Serrano M, 1996, CELL, V85, P27, DOI 10.1016/S0092-8674(00)81079-X; Sharpless NE, 2004, ONCOGENE, V23, P379, DOI 10.1038/sj.onc.1207074; Sharpless NE, 2003, ONCOGENE, V22, P3092, DOI 10.1038/sj.onc.1206461; Shtutman M, 1999, P NATL ACAD SCI USA, V96, P5522, DOI 10.1073/pnas.96.10.5522; Solit DB, 2006, NATURE, V439, P358, DOI 10.1038/nature04304; Sotillo R, 2001, P NATL ACAD SCI USA, V98, P13312, DOI 10.1073/pnas.241338598; Stahl JM, 2004, CANCER RES, V64, P7002, DOI 10.1158/0008-5472.CAN-04-1399; Stahl JM, 2003, CANCER RES, V63, P2881; Steck PA, 1997, NAT GENET, V15, P356, DOI 10.1038/ng0497-356; STEINGRIMSSON E, 1994, NAT GENET, V8, P256, DOI 10.1038/ng1194-256; Takeuchi H, 2003, CANCER RES, V63, P441; Thompson JF, 2005, LANCET, V365, P687, DOI 10.1016/S0140-6736(05)17951-3; Tsao H, 2004, J INVEST DERMATOL, V122, P337, DOI 10.1046/j.0022-202X.2004.22243.x; Tsao H, 2000, CANCER RES, V60, P1800; VALVERDE P, 1995, NAT GENET, V11, P328, DOI 10.1038/ng1195-328; VALYINAGY IT, 1993, LAB INVEST, V69, P152; Welsh CF, 2001, NAT CELL BIOL, V3, P950, DOI 10.1038/ncb1101-950; Widlund HR, 2002, J CELL BIOL, V158, P1079, DOI 10.1083/jcb.200202049; Widlund HR, 2003, ONCOGENE, V22, P3035, DOI 10.1038/sj.onc.1206443; Wu H, 2003, ONCOGENE, V22, P3113, DOI 10.1038/sj.onc.1206451; You MJ, 2002, P NATL ACAD SCI USA, V99, P1455, DOI 10.1073/pnas.022632099; Zuo L, 1996, NAT GENET, V12, P97, DOI 10.1038/ng0196-97	107	1069	1120	4	164	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 6	2006	355	1					51	65		10.1056/NEJMra052166	http://dx.doi.org/10.1056/NEJMra052166			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	060DT	16822996				2022-12-28	WOS:000238783200007
J	Cook, NR; Buring, JE; Ridker, PM				Cook, Nancy R.; Buring, Julie E.; Ridker, Paul M.			The effect of including C-reactive protein in cardiovascular risk prediction models for women	ANNALS OF INTERNAL MEDICINE			English	Article							CORONARY-HEART-DISEASE; DENSITY-LIPOPROTEIN CHOLESTEROL; MIDDLE-AGED MEN; PRIMARY PREVENTION; METABOLIC SYNDROME; STATIN THERAPY; INFLAMMATION; MARKERS; ATHEROSCLEROSIS; SENSITIVITY	Background: While high-sensitivity C-reactive protein (hsCRP) is an independent predictor of cardiovascular risk, global risk prediction models incorporating hsCRP have not been developed for clinical use. Objective: To develop and compare global cardiovascular risk prediction models with and without hsCRP. Design: Observational cohort study. Setting: U.S. female health professionals. Participants: Initially healthy nondiabetic women age 45 years and older participating in the Women's Health Study and followed an average of 10 years. Measurements: Incident cardiovascular events (myocardial infarction, stroke, coronary revascularization, and cardiovascular death). Results: High-sensitivity CRP made a relative contribution to global risk at least as large as that provided by total, high-density lipoprotein (HDL), and low-density lipoprotein (LDL) cholesterol individually, but less than that provided by age, smoking, and blood pressure. All global measures of fit improved when hsCRP was included, with likelihood-based measures demonstrating strong preference for models that include hsCRP. With use of 10-year risk categories of 0% to less than 5%, 5% to less than 10%, 10% to less than 20%, and 20% or greater, risk prediction was more accurate in models that included hsCRP, particularly for risk between 5% and 20%. Among women initially classified with risks of 5% to less than 10% and 10% to less than 20% according to the Adult Treatment Panel III covariables, 21% and 19%, respectively, were reclassified into more accurate risk categories. Although addition of hsCRP had minimal effect on the c-statistic (a measure of model discrimination) once age, smoking, and blood pressure were accounted for, the effect was nonetheless greater than that of total, LDL, or HDL cholesterol, suggesting that the c-statistic may be insensitive in evaluating risk prediction models. Limitations: Data were available only for women. Conclusions: A global risk prediction model that includes hsCRP improves cardiovascular risk classification in women, particularly among those with a 10-year risk of 5% to 20%. In models that include age, blood pressure, and smoking status, hsCRP improves prediction at least as much as do lipid measures.	Harvard Univ, Div Prevent Med, Brigham & Womens Hosp, Sch Med, Boston, MA 02215 USA; Harvard Univ, Sch Publ Hlth, Boston, MA 02215 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health	Cook, NR (corresponding author), Harvard Univ, Div Prevent Med, Brigham & Womens Hosp, Sch Med, 900 Commonwealth Ave E, Boston, MA 02215 USA.	ncook@rics.bwh.harvard.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL043851] Funding Source: NIH RePORTER; NCI NIH HHS [CA-47988] Funding Source: Medline; NHLBI NIH HHS [HL-43851] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Ash A, 1999, STAT MED, V18, P375, DOI 10.1002/(SICI)1097-0258(19990228)18:4<375::AID-SIM20>3.0.CO;2-J; Ballantyne CM, 2004, CIRCULATION, V109, P837, DOI 10.1161/01.CIR.0000116763.91992.F1; BOEKHOLDT SM, 2005, ATHEROSCLEROSIS; Buring JE, 1992, J MYOCARDIAL ISCHEMI, V4, P27; Burnham KP., 2004, MODEL SELECTION MULT, V2, DOI 10.1007/b97636; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; COX DR, 1972, J R STAT SOC B, V34, P187; Cushman M, 2005, CIRCULATION, V112, P25, DOI 10.1161/CIRCULATIONAHA.104.504159; D'Agostino RB, 2001, JAMA-J AM MED ASSOC, V286, P180, DOI 10.1001/jama.286.2.180; Danesh J, 2004, NEW ENGL J MED, V350, P1387, DOI 10.1056/NEJMoa032804; Efron B., 1994, MONOGRAPHS STAT APPL; Festa A, 2002, DIABETES, V51, P1131, DOI 10.2337/diabetes.51.4.1131; Festa A, 2000, CIRCULATION, V102, P42, DOI 10.1161/01.CIR.102.1.42; Fleiss J. L., 1981, STAT METHODS RATES P, V2; Gail MH, 2005, BIOSTATISTICS, V6, P227, DOI 10.1093/biostatistics/kxi005; Greenland P, 2003, JAMA-J AM MED ASSOC, V290, P891, DOI 10.1001/jama.290.7.891; Greenland P, 2001, CIRCULATION, V104, P1863, DOI 10.1161/hc4201.097189; Grundy SM, 2005, J AM COLL CARDIOL, V46, P173, DOI 10.1016/j.jacc.2005.05.007; HAINLINE A, 1982, MANUAL LAB OPERATION; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Harrell F.E., 2015, REGRESSION MODELING, DOI [10.1007/978-3-319-19425-7, DOI 10.1007/978-3-319-19425-7, 10.1007/978-1-4757-3462-1]; Hastie T., 2009, ELEMENTS STAT LEARNI, DOI 10.1007/978-0-387-84858-7_7; Hosmer DW, 1997, STAT MED, V16, P965; Kent SM, 2003, AM J CARDIOL, V92, P1224, DOI 10.1016/j.amjcard.2003.07.040; Khot UN, 2003, JAMA-J AM MED ASSOC, V290, P898, DOI 10.1001/jama.290.7.898; Koenig W, 2004, CIRCULATION, V109, P1349, DOI 10.1161/01.CIR.0000120707.98922.E3; Laaksonen DE, 2005, EUR HEART J, V26, P1783, DOI 10.1093/eurheartj/ehi237; Moons KGM, 2003, ACAD RADIOL, V10, P670, DOI 10.1016/S1076-6332(03)80087-9; NAGELKERKE NJD, 1991, BIOMETRIKA, V78, P691, DOI 10.1093/biomet/78.3.691; Nissen SE, 2005, NEW ENGL J MED, V352, P29, DOI 10.1056/NEJMoa042000; Pai JK, 2004, NEW ENGL J MED, V351, P2599, DOI 10.1056/NEJMoa040967; Pearson TA, 2003, CIRCULATION, V107, P499, DOI 10.1161/01.CIR.0000052939.59093.45; Pradhan AD, 2001, JAMA-J AM MED ASSOC, V286, P327, DOI 10.1001/jama.286.3.327; Rexrode KM, 2000, J WOMEN HEALTH GEN-B, V9, P19, DOI 10.1089/152460900318911; Ridker PM, 2003, CIRCULATION, V107, P391, DOI 10.1161/01.CIR.0000055014.62083.05; Ridker PM, 2005, JAMA-J AM MED ASSOC, V294, P326, DOI 10.1001/jama.294.3.326; Ridker PM, 2004, CIRCULATION, V109, P2818, DOI 10.1161/01.CIR.0000132467.45278.59; Ridker PM, 2004, CIRCULATION, V109, P6, DOI 10.1161/01.CIR.0000133444.17867.56; Ridker PM, 1998, CIRCULATION, V98, P839, DOI 10.1161/01.CIR.98.9.839; Ridker PM, 2001, NEW ENGL J MED, V344, P1959, DOI 10.1056/NEJM200106283442601; Ridker PM, 2005, NEW ENGL J MED, V352, P20, DOI 10.1056/NEJMoa042378; Ridker PM, 1997, NEW ENGL J MED, V336, P973, DOI 10.1056/NEJM199704033361401; Ridker PM, 2002, NEW ENGL J MED, V347, P1557, DOI 10.1056/NEJMoa021993; Ridker PM, 2005, NEW ENGL J MED, V352, P1293, DOI 10.1056/NEJMoa050613; Royston P, 2004, STAT MED, V23, P723, DOI 10.1002/sim.1621; Sullivan LM, 2004, STAT MED, V23, P1631, DOI 10.1002/sim.1742; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837	47	392	407	0	13	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 4	2006	145	1					21	29		10.7326/0003-4819-145-1-200607040-00128	http://dx.doi.org/10.7326/0003-4819-145-1-200607040-00128			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	062IS	16818925				2022-12-28	WOS:000238938400003
J	Aita, K; Kai, I				Aita, K; Kai, I			Withdrawal of care in Japan	LANCET			English	Editorial Material									Univ Tokyo, Sch Hlth Sci & Nursing, Dept Social Gerontol, Bunkyo Ku, Tokyo 1130033, Japan	University of Tokyo	Aita, K (corresponding author), Univ Tokyo, Sch Hlth Sci & Nursing, Dept Social Gerontol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	aitak-tky@umin.ac.jp	Kai, Ichiro/AAF-1970-2021	Kai, Ichiro/0000-0002-7883-7383				Akabayashi A, 2002, SOC SCI MED, V55, P517, DOI 10.1016/S0277-9536(01)00184-8; KAI I, 1993, SOC SCI MED, V36, P1151, DOI 10.1016/0277-9536(93)90235-V; KAI K, 2004, SEIBUNDO, P284; NAGAO N, 2005, SEIMEI RINRI, V15, P101; NAKAYAMA K, 2000, ANRAKUSHI SONGENSHI, P83; Otomo Eiichi, 2004, Nihon Ronen Igakkai Zasshi, V41, P483; Schreiner Andrea S, 2004, Int J Palliat Nurs, V10, P185; 2005, YOMIURI SHIMBUN 0519, P35; 2006, YOMIURI SHIMBUN 0325, P1; 2006, MAINICHI SHIMBU 0329, P1; 2005, CHUNICHI SHIMBU 0103, P1; 2006, MAINICHI SHIMBU 0325, P1; 2006, ASAHI SHIMBUN   0427, P22; 2005, ASAHI SHIMBUN   0326, P39; 2004, YOMIURI SHIMBUN 0514, P1; 2006, ASAHI SHIMBUN   0423, P34; 2006, ASAHI SHIMBUN   0325, P1; 2006, ASAHI SHIMBUN   0330, P39	18	8	8	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 1	2006	368	9529					12	14		10.1016/S0140-6736(06)68946-0	http://dx.doi.org/10.1016/S0140-6736(06)68946-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	058TQ	16815362				2022-12-28	WOS:000238687900009
J	Saji, NH; Goswami, BN; Vinayachandran, PN; Yamagata, T				Saji, NH; Goswami, BN; Vinayachandran, PN; Yamagata, T			A dipole mode in the tropical Indian Ocean	NATURE			English	Article							EQUATORIAL; PACIFIC; THROUGHFLOW; DYNAMICS; MONSOON	For the tropical Pacific and Atlantic oceans, internal modes of variability that lead to climatic oscillations have been recognized(1,2), but in the Indian Ocean region a similar ocean-atmosphere interaction causing interannual climate variability has not yet been found(3). Here we report an analysis of observational data over the past 40 years, showing a dipole mode in the Indian Ocean: a pattern of internal variability with anomalously low sea surface temperatures off Sumatra and high sea surface temperatures in the western Indian Ocean, with accompanying wind and precipitation anomalies. The spatio-temporal links between sea surface temperatures and winds reveal a strong coupling through the precipitation field and ocean dynamics. This air-sea interaction process is unique and inherent in the Indian Ocean, and is shown to be independent of the El Nino/Southern Oscillation. The discovery of this dipole mode that accounts for about 12% of the sea surface temperature variability in the Indian Ocean-and, in its active years, also causes severe rainfall in eastern Africa and droughts in Indonesia-brightens the prospects for a long-term forecast of rainfall anomalies in the affected countries.	Inst Global Change Res, SEAVANS N7F, Minato Ku, Tokyo 1056791, Japan; Indian Inst Sci, Ctr Atmospher & Ocean Sci, Bangalore 560012, Karnataka, India; Univ Tokyo, Grad Sch Sci, Dept Earth & Planetary Phys, Tokyo 1130033, Japan	Japan Agency for Marine-Earth Science & Technology (JAMSTEC); Indian Institute of Science (IISC) - Bangalore; University of Tokyo	Yamagata, T (corresponding author), Inst Global Change Res, SEAVANS N7F, Minato Ku, 1-2-1 Shibaura, Tokyo 1056791, Japan.		Yamagata, Toshio/A-1807-2009; Vinayachandran, P/E-1102-2012; Hameed, Saji N/B-9188-2009	Vinayachandran, P/0000-0002-4915-5455; Hameed, Saji N/0000-0002-6199-9853				BARNETT TP, 1983, MON WEATHER REV, V111, P756, DOI 10.1175/1520-0493(1983)111<0756:IOTMAP>2.0.CO;2; BEHERA SK, IN PRESS GEOPHYS RES; CLARKE AJ, 1993, J PHYS OCEANOGR, V23, P386, DOI 10.1175/1520-0485(1993)023<0386:OADOSA>2.0.CO;2; Flohn H., 1987, PALAEOECOL AFR, V18, P3; GODDARD L, IN PRESS J GEOPHYS R; GOSWAMI BN, 1995, J CLIMATE, V8, P524, DOI 10.1175/1520-0442(1995)008<0524:AMIMFT>2.0.CO;2; Goswami BN, 1999, Q J ROY METEOR SOC, V125, P611, DOI 10.1002/qj.49712555412; HASTENRATH S, 1993, J GEOPHYS RES-OCEANS, V98, P20219, DOI 10.1029/93JC02330; Kalnay E, 1996, B AM METEOROL SOC, V77, P437, DOI 10.1175/1520-0477(1996)077<0437:TNYRP>2.0.CO;2; KAPALA A, 1994, P INT C MONS VAR PRE, P119; Kawamura R, 1998, J METEOROL SOC JPN, V76, P597, DOI 10.2151/jmsj1965.76.4_597; LATIF M, IN PRESS J CLIM; LEVINE P, 1994, DEFENCE PEACE ECON, V5, P1, DOI 10.1080/10430719408404776; Meyers G, 1996, J GEOPHYS RES-OCEANS, V101, P12255, DOI 10.1029/95JC03729; MURTUGUDDE R, IN PRESS J GEOPHYS R; Neelin JD, 1998, J GEOPHYS RES-OCEANS, V103, P14261, DOI 10.1029/97JC03424; NITTA T, 1996, WEATHER SERVICE B JM, V63, P178; Potemra JT, 1999, GEOPHYS RES LETT, V26, P365, DOI 10.1029/1998GL900280; RAYNER NA, 1996, 74 UK MET OFF; REPPIN J, IN PRESS J GEOPHYS R; REVERDIN G, 1986, Q J ROY METEOR SOC, V112, P43, DOI 10.1002/qj.49711247104; STOUT JE, 1983, MON WEATHER REV, V111, P774, DOI 10.1175/1520-0493(1983)111<0774:LLMDDF>2.0.CO;2; Vinayachandran PN, 1999, GEOPHYS RES LETT, V26, P1613, DOI 10.1029/1999GL900179; Wallace JM, 1998, J GEOPHYS RES-OCEANS, V103, P14241, DOI 10.1029/97JC02905; Wyrtki K, 1973, Science, V181, P262, DOI 10.1126/science.181.4096.262; Xie PP, 1996, J CLIMATE, V9, P840, DOI 10.1175/1520-0442(1996)009<0840:AOGMPU>2.0.CO;2; XIE SP, 1994, TELLUS A, V46, P340, DOI 10.1034/j.1600-0870.1994.t01-1-00001.x; Yamagata T, 1996, J GEOPHYS RES-OCEANS, V101, P12465, DOI 10.1029/95JC03623; Yu LS, 1999, GEOPHYS RES LETT, V26, P735, DOI 10.1029/1999GL900072; ZEBIAK SE, 1993, J CLIMATE, V6, P1567, DOI 10.1175/1520-0442(1993)006<1567:AIITEA>2.0.CO;2	30	3443	3714	11	446	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 23	1999	401	6751					360	363		10.1038/43854	http://dx.doi.org/10.1038/43854			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	240JJ	16862108				2022-12-28	WOS:000082822600046
J	Ho, KM; Sheridan, D				Ho, Kwok M.; Sheridan, Davidj			Meta-analysis of frusemide to prevent or treat acute renal failure	BMJ-BRITISH MEDICAL JOURNAL			English	Article							HIGH-DOSE FRUSEMIDE; CARDIAC-SURGERY; LOOP DIURETICS; DOUBLE-BLIND; FUROSEMIDE; DOPAMINE; MULTICENTER; MORTALITY; OLIGURIA; MANNITOL	Objective To investigate the potential beneficial and adverse effects of frusemide to prevent or treat acute renal failure in adults. Design Meta-analysis of randomised controlled trials. Data sources Cochrane controlled trials register (2005 issue 4), Embase, and Medline (1966 to 1 February 2006), without language restrictions. Review methods Two reviewers checked the quality of the studies and independently extracted data. Results Nine randomised controlled trials totalling 849 patients with or at risk of acute renal failure were included. Outcome measures not significantly different after frusemide treatment were in-hospital mortality (relative risk 1.11, 95% confidence interval 0.92 to 1.33), risk for requiring renal replacement therapy or dialysis (0.99, 0.80 to 1.22), number of dialysis sessions required (weight mean difference -0.48 sessions, -1.45 to 0.50), and proportion of patients with persistent oliguria (urine output <500 ml/day: 0.54, 0.18 to 1.61). Stratifying studies that used frusemide to prevent or treat acute renal failure did not change the results on mortality (relative risk ratio 2.10,95% confidence interval 0.67 to 6.63) and the risk for requiring dialysis (4.12, 0.46 to 37.2). Evidence suggested an increased risk of temporary deafness and tinnitus in patients treated with high doses of frusemide (relative risk 3.97, 95% confidence interval 1.00 to 15.78). Conclusions Frusemide is not associated with any significant clinical benefits in the prevention and treatment of acute renal failure in adults. High doses may be associated with an increased risk of ototoxicity.	Royal Perth Hosp, Intens Care Unit, Perth, WA 6000, Australia	Royal Perth Hospital; University of Western Australia	Ho, KM (corresponding author), Royal Perth Hosp, Intens Care Unit, Perth, WA 6000, Australia.	kwok.ho@health.wa.gov.au	Ho, Kwok M./E-3546-2010	Ho, Kwok M./0000-0002-6705-6004				Altman DG, 2003, BMJ-BRIT MED J, V326, P219, DOI 10.1136/bmj.326.7382.219; BORIRAKCHANYAVAT V, 1978, POSTGRAD MED J, V54, P30, DOI 10.1136/pgmj.54.627.30; BREZIS M, 1994, AM J PHYSIOL-RENAL, V267, pF1059, DOI 10.1152/ajprenal.1994.267.6.F1059; Brown J, 1998, PC WEEK, V15, P90; CANEVAL D, 1974, BRIT MED J, V290, P244; Cantarovich F, 2004, AM J KIDNEY DIS, V44, P402, DOI 10.1053/j.ajkd.2004.05.021; CANTAROVICH F, 1971, POSTGRAD MED J, V47, P13; CANTAROVICH F, 1973, BMJ-BRIT MED J, V4, P449, DOI 10.1136/bmj.4.5890.449; FRANKEL MC, 1983, CLIN EXP DIAL A, V7, P145, DOI 10.3109/08860228309076045; FRIES D, 1971, POSTGRAD MED J, V47, P18; GANCVAL D, 1974, BRIT MED J, V290, P244; GRAZIANI G, 1984, NEPHRON, V37, P39, DOI 10.1159/000183205; Hager B, 1996, SCHWEIZ MED WSCHR, V126, P666; Hein OV, 2005, RENAL FAILURE, V27, P385, DOI 10.1081/JDI-200065298; HEYMAN SN, 1994, KIDNEY INT, V45, P981, DOI 10.1038/ki.1994.132; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Ho K M, 2003, Crit Care Resusc, V5, P97; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; KARAYANNOPOULOS S, 1974, BMJ-BRIT MED J, V2, P278; KLEINKNECHT D, 1976, NEPHRON, V17, P51, DOI 10.1159/000180710; LACHANCE SL, 1985, J UROLOGY, V133, P950, DOI 10.1016/S0022-5347(17)49326-8; Lassnigg A, 2000, J AM SOC NEPHROL, V11, P97, DOI 10.1681/ASN.V11197; Lombardi R, 2003, RENAL FAILURE, V25, P775, DOI 10.1081/JDI-120024293; LUMLERTGUL D, 1989, NEPHRON, V52, P40, DOI 10.1159/000185580; Mehta RL, 2002, JAMA-J AM MED ASSOC, V288, P2547, DOI 10.1001/jama.288.20.2547; MIYAZAKI H, 1990, JPN J VET SCI, V52, P265; MONTOREANO R, 1971, POSTGRAD MED J, V47, P7; NUUTINEN L, 1976, ANN CHIR GYNAECOL FE, V65, P258; Shilliday IR, 1997, NEPHROL DIAL TRANSPL, V12, P2592, DOI 10.1093/ndt/12.12.2592; Sirivella S, 2000, ANN THORAC SURG, V69, P501, DOI 10.1016/S0003-4975(99)01298-9; SOLOMON R, 1994, NEW ENGL J MED, V331, P1416, DOI 10.1056/NEJM199411243312104; SULLIVAN JF, 1971, POSTGRAD MED J, V47, P26; Terrin N, 2005, J CLIN EPIDEMIOL, V58, P894, DOI 10.1016/j.jclinepi.2005.01.006; Uchino S, 2005, JAMA-J AM MED ASSOC, V294, P813, DOI 10.1001/jama.294.7.813; Uchino S, 2004, CRIT CARE MED, V32, P1669, DOI 10.1097/01.CCM.0000132892.51063.2F; WEINSTEIN JM, 1992, NEPHRON, V62, P413, DOI 10.1159/000187090; Witt U, 2001, J EVOL ECON, V11, P1, DOI 10.1007/PL00003854; Wittner M, 1991, Drugs, V41 Suppl 3, P1	38	182	195	1	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 26	2006	333	7565					420	423		10.1136/bmj.38902.605347.7C	http://dx.doi.org/10.1136/bmj.38902.605347.7C			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	081AO	16861256	Green Published, Green Submitted, Bronze			2022-12-28	WOS:000240289800020
J	Shlyk-Kerner, O; Samish, I; Kaftan, D; Holland, N; Sai, PSM; Kless, H; Scherz, A				Shlyk-Kerner, Oksana; Samish, Ilan; Kaftan, David; Holland, Neta; Sai, P. S. Maruthi; Kless, Hadar; Scherz, Avigdor			Protein flexibility acclimatizes photosynthetic energy conversion to the ambient temperature	NATURE			English	Article							HELICAL MEMBRANE-PROTEINS; THERMOPHILIC ALCOHOL-DEHYDROGENASE; OXYGEN-EVOLVING CENTER; ELECTRON-TRANSFER; REACTION CENTERS; PHOTOSYSTEM-II; RHODOBACTER-SPHAEROIDES; PROTON; FLUORESCENCE; ARCHITECTURE	Adjustment of catalytic activity in response to diverse ambient temperatures is fundamental to life on Earth. A crucial example of this is photosynthesis, where solar energy is converted into electrochemical potential that drives oxygen and biomass generation at temperatures ranging from those of frigid Antarctica to those of scalding hot springs. The energy conversion proceeds by concerted mobilization of electrons and protons on photoexcitation of reaction centre protein complexes(1-3). Following physicochemical paradigms, the rates of imperative steps in this process were predicted to increase exponentially with rising temperatures, resulting in different yields of solar energy conversion at the distinct growth temperatures of photosynthetic mesophiles and extremophiles. In contrast, here we show a meticulous adjustment of energy conversion rate, resulting in similar yields from mesophiles and thermophiles. The key molecular players in the temperature adjustment process consist of a cluster of hitherto unrecognized protein cavities and an adjacent packing motif that jointly impart local flexibility crucial to the reaction centre proteins. Mutations within the packing motif of mesophiles that increase the bulkiness of the amino-acid side chains, and thus reduce the size of the cavities, promote thermophilic behaviour. This novel biomechanical mechanism accounts for the slowing of the catalytic reaction above physiological temperatures in contradiction to the classical Arrhenius paradigm. The mechanism provides new guidelines for manipulating the acclimatization of enzymes to the ambient temperatures of diverse habitats. More generally, it reveals novel protein elements that are of potential significance for modulating structure - activity relationships in membrane and globular proteins alike.	Weizmann Inst Sci, Dept Plant Sci, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Scherz, A (corresponding author), Weizmann Inst Sci, Dept Plant Sci, IL-76100 Rehovot, Israel.	Avigdor.Scherz@weizmann.ac.il	samish, ilan/B-7980-2016; Kaftan, David/N-6799-2019; Kaftan, David/J-5790-2017	samish, ilan/0000-0002-0299-9124; Kaftan, David/0000-0003-0932-0986				Bower MJ, 1997, J MOL BIOL, V267, P1268, DOI 10.1006/jmbi.1997.0926; Curran AR, 2003, CURR OPIN STRUC BIOL, V13, P412, DOI 10.1016/S0959-440X(03)00102-7; DEISENHOFER J, 1995, J MOL BIOL, V246, P429, DOI 10.1006/jmbi.1994.0097; Eilers M, 2000, P NATL ACAD SCI USA, V97, P5796, DOI 10.1073/pnas.97.11.5796; Ferreira KN, 2004, SCIENCE, V303, P1831, DOI 10.1126/science.1093087; Friedman R, 2003, BIOPHYS J, V85, P886, DOI 10.1016/S0006-3495(03)74528-7; Garbers A, 1998, BIOCHEMISTRY-US, V37, P11399, DOI 10.1021/bi980296+; GOLDBERG E, 2004, THESIS WEIZMANN I SC; Hammes-Schiffer S, 2004, BBA-BIOENERGETICS, V1655, P29, DOI 10.1016/j.bbabio.2003.07.009; Iwata S, 2004, CURR OPIN STRUC BIOL, V14, P447, DOI 10.1016/j.sbi.2004.07.002; Joshi M, 1999, Z NATURFORSCH C, V54, P35; Knapp MJ, 2002, J AM CHEM SOC, V124, P3865, DOI 10.1021/ja012205t; Kohen A, 1999, NATURE, V399, P496, DOI 10.1038/20981; Kohen A, 1998, ACCOUNTS CHEM RES, V31, P397, DOI 10.1021/ar9701225; Li JL, 1998, BIOCHEMISTRY-US, V37, P2818, DOI 10.1021/bi971699x; Liang J, 1998, PROTEINS, V33, P18, DOI 10.1002/(SICI)1097-0134(19981001)33:1<18::AID-PROT2>3.3.CO;2-X; Liang ZX, 2004, P NATL ACAD SCI USA, V101, P9556, DOI 10.1073/pnas.0403337101; Loll B, 2005, NATURE, V438, P1040, DOI 10.1038/nature04224; Moser CC, 2003, ADV PROTEIN CHEM, V63, P71; Nedbal L, 1999, J PHOTOCH PHOTOBIO B, V48, P154, DOI 10.1016/S1011-1344(99)00032-9; Okamura MY, 2000, BBA-BIOENERGETICS, V1458, P148, DOI 10.1016/S0005-2728(00)00065-7; Remy A, 2003, NAT STRUCT BIOL, V10, P637, DOI 10.1038/nsb954; Senes A, 2004, CURR OPIN STRUC BIOL, V14, P465, DOI 10.1016/j.sbi.2004.07.007; Senes A, 2001, P NATL ACAD SCI USA, V98, P9056, DOI 10.1073/pnas.161280798; Somero GN, 2003, COMP BIOCHEM PHYS B, V136, P577, DOI 10.1016/S1096-4959(03)00215-X; Wong KF, 2005, P NATL ACAD SCI USA, V102, P6807, DOI 10.1073/pnas.0408343102; Word JM, 1999, J MOL BIOL, V285, P1711, DOI 10.1006/jmbi.1998.2400; Wraight CA, 2004, FRONT BIOSCI-LANDMRK, V9, P309, DOI 10.2741/1236; Xu Q, 2002, BIOCHEMISTRY-US, V41, P2694, DOI 10.1021/bi011834c; Zavodszky P, 1998, P NATL ACAD SCI USA, V95, P7406, DOI 10.1073/pnas.95.13.7406	30	39	40	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 17	2006	442	7104					827	830		10.1038/nature04947	http://dx.doi.org/10.1038/nature04947			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	074DK	16862124				2022-12-28	WOS:000239792700049
J	Verhamme, KMC; Mosis, G; Dieleman, JP; Stricker, BHC; Sturkenboom, MCJM				Verhamme, Katia M. C.; Mosis, Georgio; Dieleman, Jeanne P.; Stricker, Bruno H. Ch; Sturkenboom, Miriam C. J. M.			Spironolactone and risk of upper gastrointestinal events: population based case-control study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ULCERATION	Objective To confirm and quantify any association between spironolactone and upper gastrointestinal bleeding and ulcers. Design Population based case-control study. Setting A primary care information database in the Netherlands. Participants All people on the database who were aged 18 or more between 1 January 1996 and 30 September 2003. Patients with a history of alcoholism or gastrointestinal cancer were excluded. Ten controls were matched to each case of gastroduodenal ulcer or upper gastrointestinal bleeding by age (year of birth), sex, and index date. Main outcome measures The occurrence of an upper gastrointestinal event (bleeding or ulcers) adjusted for potential confounders with conditional logistic regression analysis. Results Within the source population of 306 645 patients, 523 cases of gastric or duodenal ulcer or upper gastrointestinal bleeding were identified and matched to 5230 controls. Current use of spironolactone was associated with a 2.7-fold (95% confidence interval 1.2 to 6.0) increased risk of a gastrointestinal event. Conclusion The risk of gastroduodenal ulcers or upper gastrointestinal bleeding is significantly increased in patients using spironolactone.	Erasmus MC, Dept Med Informat, NL-3000 Rotterdam, Netherlands; Erasmus MC, Dept Epidemiol & Biostat, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Verhamme, KMC (corresponding author), Erasmus MC, Dept Med Informat, POB 1738, NL-3000 Rotterdam, Netherlands.	k.verhamme@erasmusmc.nl	Chin, Shui Hao/V-9070-2019	Chin, Shui Hao/0000-0001-5620-0798; Verhamme, Katia/0000-0001-8162-4904				DOLL R, 1968, GUT, V9, P42, DOI 10.1136/gut.9.1.42; Juurlink DN, 2004, NEW ENGL J MED, V351, P543, DOI 10.1056/NEJMoa040135; Kato K, 1999, J CLIN ENDOCR METAB, V84, P2568, DOI 10.1210/jc.84.7.2568; KREMER D, 1973, BMJ-BRIT MED J, V2, P216, DOI 10.1136/bmj.2.5860.216; Lijnen P, 2000, J MOL CELL CARDIOL, V32, P865, DOI 10.1006/jmcc.2000.1129; MACKAY A, 1977, LANCET, V1, P481; REED PI, 1980, SCAND J GASTROENTERO, V15, P51; Slight SH, 1998, MOL CELL BIOCHEM, V189, P47, DOI 10.1023/A:1006844010371; Weil J, 2000, GUT, V46, P27, DOI 10.1136/gut.46.1.27	9	29	29	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 12	2006	333	7563					330	333		10.1136/bmj.38883.479549.2F	http://dx.doi.org/10.1136/bmj.38883.479549.2F			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	073VI	16840442	Green Published, Bronze, Green Submitted			2022-12-28	WOS:000239770300016
J	Weisstaub, NV; Zhou, MM; Lira, A; Lambe, E; Gonzalez-Maeso, J; Hornung, JP; Sibille, E; Underwood, M; Itohara, S; Dauer, WT; Ansorge, MS; Morelli, E; Mann, JJ; Toth, M; Aghajanian, G; Sealfon, SC; Hen, R; Gingrich, JA				Weisstaub, Noelia V.; Zhou, Mingming; Lira, Alena; Lambe, Evelyn; Gonzalez-Maeso, Javier; Hornung, Jean-Pierre; Sibille, Etienne; Underwood, Mark; Itohara, Shigeyoshi; Dauer, William T.; Ansorge, Mark S.; Morelli, Emanuela; Mann, J. John; Toth, Miklos; Aghajanian, George; Sealfon, Stuart C.; Hen, Rene; Gingrich, Jay A.			Cortical 5-HT2A receptor signaling modulates anxiety-like behaviors in mice	SCIENCE			English	Article							ELEVATED T-MAZE; SEROTONIN; AMYGDALA; MODELS; TRANSPORTER; ANTAGONISTS; MECHANISMS; DISORDER; ADULT; BRAIN	Serotonin [5-hydroxytryptamine (5-HT)] neurotransmission in the central nervous system modulates depression and anxiety-related behaviors in humans and rodents, but the responsible downstream receptors remain poorly understood. We demonstrate that global disruption of 5-HT2A receptor (5HT2AR) signaling in mice reduces inhibition in conflict anxiety paradigms without affecting fear-conditioned and depression-related behaviors. Selective restoration of 5HT2AR signaling to the cortex normalized conflict anxiety behaviors. These findings indicate a specific role for cortical 5HT2AR function in the modulation of conflict anxiety, consistent with models of cortical, "top-down'' influences on risk assessment.	Columbia Univ, Dept Psychiat, New York, NY 10032 USA; Columbia Univ, Dept Biol, New York, NY 10032 USA; Columbia Univ, Sackler Inst Labs, New York, NY 10032 USA; Columbia Univ, Ctr Neurobiol & Behav, New York, NY 10032 USA; Columbia Univ, Dept Neurol, New York, NY 10032 USA; New York State Psychiat Inst & Hosp, New York, NY 10032 USA; Yale Univ, Dept Psychiat, New Haven, CT 06520 USA; CUNY Mt Sinai Sch Med, Dept Neurol, New York, NY 10029 USA; Univ Lausanne, Inst Biol Cellulaire & Morphol, Lausanne, Switzerland; RIKEN, Lab Behav Genet, Brain Sci Inst, Wako, Saitama 35101, Japan; Cornell Univ, Med Ctr, Dept Pharmacol, New York, NY 10021 USA	Columbia University; Columbia University; Columbia University; Columbia University; Columbia University; New York State Psychiatry Institute; Yale University; City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; University of Lausanne; RIKEN; Cornell University	Gingrich, JA (corresponding author), Columbia Univ, Dept Psychiat, New York, NY 10032 USA.	jag46@columbia.edu	Weisstaub, Noelia/ABA-1706-2021; Itohara, Shigeyoshi/I-8769-2012; Lambe, Evelyn K/K-3699-2015; Hornung, Jean-Pierre/O-7505-2015; ansorge, mark s/L-1360-2014; Morelli, Emanuela/J-4546-2012; Toth, Miklos/O-3343-2017	Itohara, Shigeyoshi/0000-0002-2410-9989; Lambe, Evelyn K/0000-0002-5994-6090; Hornung, Jean-Pierre/0000-0002-9229-7520; SEALFON, Stuart/0000-0001-5791-1217; Morelli, Emanuela/0000-0001-8704-9330; Dauer, William/0000-0003-1775-7504	NIDA NIH HHS [P01 DA12923] Funding Source: Medline; NIMH NIH HHS [KO8 MH01711] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [K08MH001711] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P01DA012923] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Ansorge MS, 2004, SCIENCE, V306, P879, DOI 10.1126/science.1101678; Artaiz I, 1998, BEHAV PHARMACOL, V9, P103; Bai F, 2001, PHARMACOL BIOCHEM BE, V70, P187, DOI 10.1016/S0091-3057(01)00599-8; BALLENGER JC, 1979, ARCH GEN PSYCHIAT, V36, P224; Bishop S, 2004, NAT NEUROSCI, V7, P184, DOI 10.1038/nn1173; BJORNTORP P, 1995, METABOLISM, V44, P38, DOI 10.1016/0026-0495(95)90208-2; BONCINELLI E, 1993, J NEUROBIOL, V24, P1356, DOI 10.1002/neu.480241008; Booij L, 2003, MOL PSYCHIATR, V8, P951, DOI 10.1038/sj.mp.4001423; BRIDGES PK, 1976, PSYCHOL MED, V6, P399, DOI 10.1017/S003329170001583X; Cohen H, 2005, DEPRESS ANXIETY, V22, P84, DOI 10.1002/da.20087; GOODWIN FV, 1983, BR J CLIN PHARM, V15, P393; Graeff FG, 2002, PSYCHOPHARMACOLOGY, V163, P467, DOI 10.1007/s00213-002-1112-4; Griebel G, 1997, NEUROPHARMACOLOGY, V36, P793, DOI 10.1016/S0028-3908(97)00034-8; Gross C, 2002, NATURE, V416, P396, DOI 10.1038/416396a; HANDLEY SL, 1993, BEHAV BRAIN RES, V58, P203, DOI 10.1016/0166-4328(93)90104-X; Heinz A, 2005, NAT NEUROSCI, V8, P20, DOI 10.1038/nn1366; Iwasato T, 2000, NATURE, V406, P726, DOI 10.1038/35021059; Kent JM, 2005, AM J PSYCHIAT, V162, P1379, DOI 10.1176/appi.ajp.162.7.1379; Luciana M, 2001, J PSYCHOPHARMACOL, V15, P219, DOI 10.1177/026988110101500410; MCFARLAIN RA, 1972, PSYCHOPHARMACOLOGIA, V27, P85, DOI 10.1007/BF00421958; Millan MJ, 2003, PROG NEUROBIOL, V70, P83, DOI 10.1016/s0301-0082(03)00087-X; Miyashita T, 2005, NEUROSCIENCE, V136, P487, DOI 10.1016/j.neuroscience.2005.08.025; Mora PO, 1997, PHARMACOL BIOCHEM BE, V58, P1051, DOI 10.1016/S0091-3057(97)00057-9; PORSOLT RD, 1978, EUR J PHARMACOL, V47, P379, DOI 10.1016/0014-2999(78)90118-8; Ressler KJ, 2000, DEPRESS ANXIETY, V12, P2, DOI 10.1002/1520-6394(2000)12:1+<2::AID-DA2>3.3.CO;2-W; SELDEN NRW, 1991, NEUROSCIENCE, V42, P335, DOI 10.1016/0306-4522(91)90379-3; SHIBATA S, 1989, PSYCHOPHARMACOLOGY, V98, P38, DOI 10.1007/BF00442003; Soares VD, 2004, BRAIN RES BULL, V64, P181, DOI 10.1016/j.brainresbull.2004.06.007; STERU L, 1985, PSYCHOPHARMACOLOGY, V85, P367, DOI 10.1007/BF00428203; TECOTT LH, 1995, NATURE, V374, P542, DOI 10.1038/374542a0; Wood MD, 2003, CNS NEUROL DISORD-DR, V2, P383, DOI 10.2174/1568007033482698	31	315	339	0	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 28	2006	313	5786					536	540		10.1126/science.1123432	http://dx.doi.org/10.1126/science.1123432			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067MZ	16873667				2022-12-28	WOS:000239308600067
J	Ballard, RA; Truog, WE; Cnaan, A; Martin, RJ; Ballard, PL; Merrill, JD; Walsh, MC; Durand, DJ; Mayock, DE; Eichenwald, EC; Null, DR; Hudak, ML; Puri, AR; Golombek, SG; Courtney, SE; Stewart, DL; Welty, SE; Phibbs, RH; Hibbs, AM; Luan, XQ; Wadlinger, SR; Asselin, JM; Coburn, CE				Ballard, Roberta A.; Truog, William E.; Cnaan, Avital; Martin, Richard J.; Ballard, Philip L.; Merrill, Jeffrey D.; Walsh, Michele C.; Durand, David J.; Mayock, Dennis E.; Eichenwald, Eric C.; Null, Donald R.; Hudak, Mark L.; Puri, Asha R.; Golombek, Sergio G.; Courtney, Sherry E.; Stewart, Dan L.; Welty, Stephen E.; Phibbs, Roderic H.; Hibbs, Anna Maria; Luan, Xianqun; Wadlinger, Sandra R.; Asselin, Jeanette M.; Coburn, Christine E.		NO CLD Study Grp	Inhaled nitric oxide in preterm infants undergoing mechanical ventilation	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PERSISTENT PULMONARY-HYPERTENSION; PREMATURE-INFANTS; LUNG GROWTH; NEURODEVELOPMENTAL OUTCOMES; RESPIRATORY-FAILURE; THERAPY; DISEASE; EFFICACY; SAFETY; MODEL	Background: Bronchopulmonary dysplasia in premature infants is associated with prolonged hospitalization, as well as abnormal pulmonary and neurodevelopmental outcome. In animal models, inhaled nitric oxide improves both gas exchange and lung structural development, but the use of this therapy in infants at risk for bronchopulmonary dysplasia is controversial. Methods: We conducted a randomized, stratified, double-blind, placebo-controlled trial of inhaled nitric oxide at 21 centers involving infants with a birth weight of 1250 g or less who required ventilatory support between 7 and 21 days of age. Treated infants received decreasing concentrations of nitric oxide, beginning at 20 ppm, for a minimum of 24 days. The primary outcome was survival without bronchopulmonary dysplasia at 36 weeks of postmenstrual age. Results: Among 294 infants receiving nitric oxide and 288 receiving placebo birth weight (766 g and 759 g, respectively), gestational age (26 weeks in both groups), and other characteristics were similar. The rate of survival without bronchopulmonary dysplasia at 36 weeks of postmenstrual age was 43.9 percent in the group receiving nitric oxide and 36.8 percent in the placebo group (P=0.042). The infants who received inhaled nitric oxide were discharged sooner (P=0.04) and received supplemental oxygen therapy for a shorter time (P=0.006). There were no short-term safety concerns. Conclusions: Inhaled nitric oxide therapy improves the pulmonary outcome for premature infants who are at risk for bronchopulmonary dysplasia when it is started between 7 and 21 days of age and has no apparent short-term adverse effects. (ClinicalTrials.gov number, NCT00000548.)	Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Philadelphia, PA 19104 USA; Univ Missouri, Kansas City, MO 64110 USA; Case Western Reserve Univ, Cleveland, OH 44106 USA; Childrens Hosp & Res Ctr, Oakland, CA USA; Univ Washington, Sch Med, Seattle, WA USA; Harvard Univ, Sch Med, Boston, MA USA; Univ Utah, Med Ctr, Salt Lake City, UT USA; Univ Florida, Hlth Sci Ctr, Jacksonville, FL 32209 USA; Univ Calif Los Angeles, Sch Med, Los Angeles, CA USA; New York Med Coll, Valhalla, NY 10595 USA; Long Isl Jewish Hlth Syst, New Hyde Pk, NY USA; Univ Louisville, Sch Med, Louisville, KY 40292 USA; Ohio State Univ, Sch Med & Publ Hlth, Columbus, OH 43210 USA; Univ Calif San Francisco, San Francisco, CA 94143 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; University of Missouri System; University of Missouri Kansas City; Case Western Reserve University; University of Washington; University of Washington Seattle; Harvard University; Harvard Medical School; Utah System of Higher Education; University of Utah; State University System of Florida; University of Florida; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; New York Medical College; Northwell Health; University of Louisville; University System of Ohio; Ohio State University; University of California System; University of California San Francisco	Ballard, RA (corresponding author), Childrens Hosp Philadelphia, 3535 Market St,Suite 1584, Philadelphia, PA 19104 USA.	ballard@email.chop.edu	Kavyrshina, Viktoria/N-1770-2018; Щербак, Геннадий/B-5738-2018; Truog, William/R-5576-2019; Welty, Stephen/AAZ-4307-2021; Golombek, Sergio G/A-7697-2008; Welty, Stephen/AGS-7454-2022; Stewart, Dan/R-7130-2019; Vorobev, Alexander/C-1918-2016; Ioda, Julia/P-1722-2015	Kavyrshina, Viktoria/0000-0002-1762-2477; Щербак, Геннадий/0000-0001-8462-6147; Welty, Stephen/0000-0002-6321-8440; Vorobev, Alexander/0000-0002-7324-428X; Ioda, Julia/0000-0002-7320-0666; Durand, David/0000-0003-1181-0941	NCRR NIH HHS [M01-RR00064, M01-RR00080, M01-RR00084, M01-RR001271, M01-RR00425, M01-RR00240] Funding Source: Medline; NHLBI NIH HHS [P50-HL56401, U01-HL62514] Funding Source: Medline; NICHD NIH HHS [HD26979, P30-HD26979] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD026979] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000084, M01RR000425, M01RR000064, M01RR001271, M01RR000240, M01RR000080] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL062514, P50HL056401] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		[Anonymous], 2004, PEDIATRICS, V114, P1377; [Anonymous], 1997, NEW ENGL J MED, V337, P434; Ballard PL, 2006, PEDIATR RES, V59, P157, DOI 10.1203/01.pdr.0000190664.69081.f1; Ballard RA, 1998, NEW ENGL J MED, V338, P493, DOI 10.1056/NEJM199802193380802; Banks BA, 1999, PEDIATRICS, V103, P610, DOI 10.1542/peds.103.3.610; BERMAN W, 1986, J PEDIATR-US, V109, P45, DOI 10.1016/S0022-3476(86)80570-4; Bland RD, 2005, AM J RESP CRIT CARE, V172, P899, DOI 10.1164/rccm.200503-384OC; Bloche MG, 2004, NEW ENGL J MED, V351, P2035, DOI 10.1056/NEJMp048271; Clark PL, 2002, ARCH DIS CHILD-FETAL, V86, pF41, DOI 10.1136/fn.86.1.F41; Clark RH, 2000, NEW ENGL J MED, V342, P469, DOI 10.1056/NEJM200002173420704; Coalson Jacqueline J, 2003, Semin Neonatol, V8, P73, DOI 10.1016/S1084-2756(02)00193-8; Cotton RB, 2006, PEDIATR RES, V59, P142, DOI 10.1203/01.pdr.0000191815.60293.cc; *CYT, 2005, STATXACT 7 STAT SOFT; *CYT STAT SOFTW SE, 2003, EAST VERS 3 0 SOFTW; Field D, 2005, PEDIATRICS, V115, P926, DOI 10.1542/peds.2004-1209; Follmann D, 2003, BIOMETRICS, V59, P420, DOI 10.1111/1541-0420.00049; Hascoet JM, 2005, J PEDIATR-US, V146, P318, DOI 10.1016/j.jpeds.2004.10.019; Jennison C, 2000, GROUP SEQUENTIAL MET; Jobe Alan H., 2001, American Journal of Respiratory and Critical Care Medicine, V163, P1723; Kinsella JP, 2006, NEW ENGL J MED, V355, P354, DOI 10.1056/NEJMoa060442; Kinsella JP, 1999, LANCET, V354, P1061, DOI 10.1016/S0140-6736(99)03558-8; Laptook AR, 2005, PEDIATRICS, V115, P673, DOI 10.1542/peds.2004-0667; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; Lin YJ, 2005, PEDIATR RES, V58, P22, DOI 10.1203/01.PDR.0000163378.94837.3E; Marlow N, 2005, NEW ENGL J MED, V352, P9, DOI 10.1056/NEJMoa041367; Martin RJ, 2005, NEW ENGL J MED, V353, P82, DOI 10.1056/NEJMe058124; Martin RJ, 2002, SEMIN PERINATOL, V26, P432, DOI 10.1053/sper.2002.37311; McCurnin DC, 2005, AM J PHYSIOL-LUNG C, V288, pL450, DOI 10.1152/ajplung.00347.2004; Mestan KKL, 2005, NEW ENGL J MED, V353, P23, DOI 10.1056/NEJMoa043514; NORTHWAY WH, 1967, NEW ENGL J MED, V276, P357, DOI 10.1056/NEJM196702162760701; Roberts JD, 1997, NEW ENGL J MED, V336, P605, DOI 10.1056/NEJM199702273360902; Schreiber MD, 2003, NEW ENGL J MED, V349, P2099, DOI 10.1056/NEJMoa031154; Stork E, 1997, NEW ENGL J MED, V336, P597; Tang JR, 2004, AM J PHYSIOL-LUNG C, V287, pL344, DOI 10.1152/ajplung.00291.2003; Van Meurs KP, 2005, NEW ENGL J MED, V353, P13, DOI 10.1056/NEJMoa043927; Walsh MC, 2004, PEDIATRICS, V114, P1305, DOI 10.1542/peds.2004-0204	36	334	350	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 27	2006	355	4					343	353		10.1056/NEJMoa061088	http://dx.doi.org/10.1056/NEJMoa061088			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	067DT	16870913				2022-12-28	WOS:000239282600003
J	Woodhouse, WM				Woodhouse, William M.			Easy love	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												wdhouse@fmed.isu.edu							0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 26	2006	296	4					372	372		10.1001/jama.296.4.372	http://dx.doi.org/10.1001/jama.296.4.372			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	066PN	16868283				2022-12-28	WOS:000239242500001
J	Wang, JF; Cortina, G; Wu, SV; Tran, R; Cho, JH; Tsai, MJ; Bailey, TJ; Jamrich, M; Ament, ME; Treem, WR; Hill, ID; Vargas, JH; Gershman, G; Farmer, DG; Reyen, L; Martin, MG				Wang, Jiafang; Cortina, Galen; Wu, S. Vincent; Tran, Robert; Cho, Jang-Hyeon; Tsai, Ming-Jer; Bailey, Travis J.; Jamrich, Milan; Ament, Marvin E.; Treem, William R.; Hill, Ivor D.; Vargas, Jorge H.; Gershman, George; Farmer, Douglas G.; Reyen, Laurie; Martin, Martin G.			Mutant Neurogenin-3 in congenital malabsorptive diarrhea	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							IRRITABLE-BOWEL-SYNDROME; PEPTIDE YY; CELL FATE; GENE; DIFFERENTIATION; MICE; SPECIFICATION; MORPHOGENESIS; INHIBITION; DEFICIENCY	Background: Neurogenin-3 (NEUROG3) is expressed in endocrine progenitor cells and is required for endocrine-cell development in the pancreas and intestine. The NEUROG3 gene (NEUROG3) is therefore a candidate for the cause of a newly discovered autosomal recessive disorder characterized by generalized malabsorption and a paucity of enteroendocrine cells. Methods: We screened genomic DNA from three unrelated patients with sparse enteroendocrine cells for mutations of NEUROG3. We then tested the ability of the observed mutations to alter NEUROG3 function, using in vitro and in vivo assays. Results: The patients had few intestinal enteroendocrine cells positive for chromogranin A, but they had normal numbers of Paneth's, goblet, and absorptive cells. We identified two homozygous mutations in NEUROG3, both of which rendered the NEUROG3 protein unable to activate NEUROD1, a downstream target of NEUROG3, and compromised the ability of NEUROG3 to bind to an E-box element in the NEUROD1 promoter. The injection of wild-type but not mutant NEUROG3 messenger RNA into xenopus embryos induced NEUROD1 expression. Conclusions: A newly discovered disorder characterized by malabsorptive diarrhea and a lack of intestinal enteroendocrine cells is caused by loss-of-function mutations in NEUROG3.	Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA USA; Univ Calif Los Angeles, David Geffen Sch Med, Ctr Ulcer Res & Educ, Dept Med,Div Digest Dis, Los Angeles, CA USA; Univ Calif Los Angeles, David Geffen Sch Med, Dept Surg, Los Angeles, CA USA; Univ Calif Los Angeles, David Geffen Sch Med, Dept Nursing, Los Angeles, CA USA; Mattel Childrens Hosp, Dept Pediat, Div Gastroenterol & Nutr, Los Angeles, CA USA; Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA; SUNY Downstate Coll Med, Dept Pediat, Div Gastroenterol Hepatol & Nutr, Brooklyn, NY USA; Wake Forest Univ, Sch Med, Div Gastroenterol, Dept Pediat, Winston Salem, NC 27109 USA; Univ Calif Los Angeles, Harbor Med Ctr, David Geffen Sch Med, Dept Pediat,Div Gastroenterol, Torrance, CA 90509 USA; Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Baylor College of Medicine; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; Wake Forest University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Baylor College of Medicine	Martin, MG (corresponding author), Univ Calif Los Angeles, Dept Pediat Gastroenterol & Nutr, David Geffen Sch Med, 10833 Le Conte Ave,12-383 MDCC, Los Angeles, CA 90095 USA.	mmartin@mednet.ucla.edu	Martín, María/HDL-9512-2022	Bailey, Travis/0000-0002-0472-7886	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007512] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD017379, R01HD034706, R37HD017379, R03HD041034] Funding Source: NIH RePORTER; NICHD NIH HHS [T32 HD07512, HD-34706, HD17379, HD-41034] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Ahlgren U, 1996, DEVELOPMENT, V122, P1409; del Bosque-Plata L, 2001, DIABETES, V50, P694, DOI 10.2337/diabetes.50.3.694; Diez-Sampedro A, 2003, P NATL ACAD SCI USA, V100, P11753, DOI 10.1073/pnas.1733027100; Drossman DA, 2002, GASTROENTEROLOGY, V123, P2108, DOI 10.1053/gast.2002.37095; Fajans SS, 2001, NEW ENGL J MED, V345, P971, DOI 10.1056/NEJMra002168; Fre S, 2005, NATURE, V435, P964, DOI 10.1038/nature03589; Gershon MD, 2005, J CLIN GASTROENTEROL, V39, pS184, DOI 10.1097/01.mcg.0000156403.37240.30; Gradwohl G, 2000, P NATL ACAD SCI USA, V97, P1607, DOI 10.1073/pnas.97.4.1607; Hirasawa A, 2005, NAT MED, V11, P90, DOI 10.1038/nm1168; Hogenauer C, 2001, NEW ENGL J MED, V344, P270, DOI 10.1056/NEJM200101253440405; Huang HP, 2000, MOL CELL BIOL, V20, P3292, DOI 10.1128/MCB.20.9.3292-3307.2000; Jackson RS, 2003, J CLIN INVEST, V112, P1550, DOI 10.1172/JCI18784; Jackson RS, 1997, NAT GENET, V16, P303, DOI 10.1038/ng0797-303; Jenny M, 2002, EMBO J, V21, P6338, DOI 10.1093/emboj/cdf649; Jensen J, 2000, NAT GENET, V24, P36, DOI 10.1038/71657; Lai EC, 2004, DEVELOPMENT, V131, P965, DOI 10.1242/dev.01074; Lee CS, 2002, GENE DEV, V16, P1488, DOI 10.1101/gad.985002; Lin HC, 1996, GASTROENTEROLOGY, V110, P1491, DOI 10.1053/gast.1996.v110.pm8613054; Ma QF, 1996, CELL, V87, P43, DOI 10.1016/S0092-8674(00)81321-5; Martin MG, 2000, AM J PHYSIOL-GASTR L, V278, pG591, DOI 10.1152/ajpgi.2000.278.4.G591; Martin MG, 1996, NAT GENET, V12, P216, DOI 10.1038/ng0296-216; Martin MG, 2004, PEDIAT GASTROINTESTI, P898; MEI N, 1985, PHYSIOL REV, V65, P211, DOI 10.1152/physrev.1985.65.2.211; Naya FJ, 1997, GENE DEV, V11, P2323, DOI 10.1101/gad.11.18.2323; Schonhoff S, 2005, MOL CELL BIOL, V25, P4189, DOI 10.1128/MCB.25.10.4189-4199.2005; Schonhoff SE, 2004, ENDOCRINOLOGY, V145, P2639, DOI 10.1210/en.2004-0051; Scrocchi LA, 1996, NAT MED, V2, P1254, DOI 10.1038/nm1196-1254; Smith SB, 2003, J BIOL CHEM, V278, P38254, DOI 10.1074/jbc.M302229200; STERNBERG PW, 1988, NATURE, V335, P551, DOI 10.1038/335551a0; van Es JH, 2005, NATURE, V435, P959, DOI 10.1038/nature03659; Wu SV, 2002, P NATL ACAD SCI USA, V99, P2392, DOI 10.1073/pnas.042617699; Yang Q, 2001, SCIENCE, V294, P2155, DOI 10.1126/science.1065718	32	204	209	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 20	2006	355	3					270	280		10.1056/NEJMoa054288	http://dx.doi.org/10.1056/NEJMoa054288			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	064NY	16855267	Bronze			2022-12-28	WOS:000239097600008
J	Bodenmann, P; Genton, B				Bodenmann, Patrick; Genton, Blaise			Chikungunya: an epidemic in real time	LANCET			English	Editorial Material									Univ Lausanne, Med Outpatient Clin, Dept Community Med & Publ Hlth, CH-1011 Lausanne, Switzerland; Univ Lausanne, Travel Clin, CH-1011 Lausanne, Switzerland; Swiss Trop Inst, CH-4002 Basel, Switzerland	University of Lausanne; University of Lausanne; University of Basel; Swiss Tropical & Public Health Institute	Bodenmann, P (corresponding author), Univ Lausanne, Med Outpatient Clin, Dept Community Med & Publ Hlth, Bugnon 44, CH-1011 Lausanne, Switzerland.	patrick.bodenmann@hospvd.ch		Bodenmann, Patrick/0000-0002-1058-1035				BRIGHTON SW, 1983, S AFR MED J, V63, P313; D'Acremont V, 2003, J TRAVEL MED, V10, pS25; *ED, MED VOYAG; ROBINSON M C, 1955, Trans R Soc Trop Med Hyg, V49, P28, DOI [10.1016/0035-9203(57)90022-6, 10.1016/0035-9203(55)90080-8]	4	52	53	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 15	2006	368	9531					258	258		10.1016/S0140-6736(06)69046-6	http://dx.doi.org/10.1016/S0140-6736(06)69046-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	064MY	16844497				2022-12-28	WOS:000239095000039
J	Roche, S; Bressanelli, S; Rey, FA; Gaudin, Y				Roche, Stephane; Bressanelli, Stephane; Rey, Felix A.; Gaudin, Yves			Crystal structure of the low-pH form of the vesicular stomatitis virus glycoprotein G	SCIENCE			English	Article							FUSION-INACTIVE CONFORMATION; SEMLIKI-FOREST-VIRUS; MEMBRANE-FUSION; ENVELOPE GLYCOPROTEIN; ANGSTROM RESOLUTION; AMINO-ACIDS; PROTEIN; RABIES; MUTATIONS; DOMAIN	The vesicular stomatitis virus has an atypical membrane fusion glycoprotein (G) exhibiting a pH-dependent equilibrium between two forms at the virus surface. Membrane fusion is triggered during the transition from the high- to low-pH form. The structure of G in its low-pH form shows the classic hairpin conformation observed in all other fusion proteins in their postfusion conformation, in spite of a novel fold combining features of fusion proteins from classes I and II. The structure provides a framework for understanding the reversibility of the G conformational change. Unexpectedly, G is homologous to gB of herpesviruses, which raises important questions on viral evolution.	CNRS, UMR 2472, IFR 115, F-91198 Gif Sur Yvette, France; INRA, UMR1157, F-91198 Gif Sur Yvette, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; INRAE	Gaudin, Y (corresponding author), CNRS, UMR 2472, IFR 115, F-91198 Gif Sur Yvette, France.	gaudin@vms.cnrs-gif.fr	Rey, Felix/B-6497-2012	Bressanelli, Stephane/0000-0002-0921-6727; Rey, Felix/0000-0002-9953-7988; Gaudin, Yves/0000-0002-0122-2954				Bressanelli S, 2004, EMBO J, V23, P728, DOI 10.1038/sj.emboj.7600064; BULLOUGH PA, 1994, NATURE, V371, P37, DOI 10.1038/371037a0; Carneiro FA, 2001, J BIOL CHEM, V276, P62, DOI 10.1074/jbc.M008753200; Chen L, 2001, STRUCTURE, V9, P255, DOI 10.1016/S0969-2126(01)00581-0; CLAGUE MJ, 1990, BIOCHEMISTRY-US, V29, P1303, DOI 10.1021/bi00457a028; DeLano W.L, PYMOL MOL GRAPHICS S; DOMS RW, 1987, J CELL BIOL, V105, P1957, DOI 10.1083/jcb.105.5.1957; DURRER P, 1995, J BIOL CHEM, V270, P17575, DOI 10.1074/jbc.270.29.17575; Fass D, 1996, NAT STRUCT BIOL, V3, P465, DOI 10.1038/nsb0596-465; Fredericksen BL, 1996, VIROLOGY, V217, P49, DOI 10.1006/viro.1996.0092; FREDERICKSEN BL, 1995, J VIROL, V69, P1435, DOI 10.1128/JVI.69.3.1435-1443.1995; Gaudin Y, 1999, J GEN VIROL, V80, P1221, DOI 10.1099/0022-1317-80-5-1221; GAUDIN Y, 1995, J VIROL, V69, P5528, DOI 10.1128/JVI.69.9.5528-5534.1995; GAUDIN Y, 1991, J VIROL, V65, P4853, DOI 10.1128/JVI.65.9.4853-4859.1991; Gaudin Y, 1996, J VIROL, V70, P7371, DOI 10.1128/JVI.70.11.7371-7378.1996; Gaudin Y, 2000, Subcell Biochem, V34, P379; GAUDIN Y, 1993, J VIROL, V67, P1365, DOI 10.1128/JVI.67.3.1365-1372.1993; Gibbons DL, 2004, NATURE, V427, P320, DOI 10.1038/nature02239; Heldwein EE, 2006, SCIENCE, V313, P217, DOI 10.1126/science.1126548; Holm L, 2000, BIOINFORMATICS, V16, P566, DOI 10.1093/bioinformatics/16.6.566; Lescar J, 2001, CELL, V105, P137, DOI 10.1016/S0092-8674(01)00303-8; Martinez I, 2005, J VIROL, V79, P3578, DOI 10.1128/JVI.79.6.3578-3585.2005; Modis Y, 2003, P NATL ACAD SCI USA, V100, P6986, DOI 10.1073/pnas.0832193100; Modis Y, 2004, NATURE, V427, P313, DOI 10.1038/nature02165; Pak CC, 1997, BIOCHEMISTRY-US, V36, P8890, DOI 10.1021/bi9702851; REY FA, 1995, NATURE, V375, P291, DOI 10.1038/375291a0; Roche S, 2002, VIROLOGY, V297, P128, DOI 10.1006/viro.2002.1429; Skehel JJ, 1998, CELL, V95, P871, DOI 10.1016/S0092-8674(00)81710-9; VANDEPOL SB, 1986, VIROLOGY, V148, P312, DOI 10.1016/0042-6822(86)90328-4; Weissenhorn W, 1998, MOL CELL, V2, P605, DOI 10.1016/S1097-2765(00)80159-8; WILSON IA, 1981, NATURE, V289, P366, DOI 10.1038/289366a0; WIMLEY WC, 1992, BIOCHEMISTRY-US, V31, P12813, DOI 10.1021/bi00166a015; Xu YH, 2004, J BIOL CHEM, V279, P30514, DOI 10.1074/jbc.M403760200; Yao Y, 2003, VIROLOGY, V310, P319, DOI 10.1016/S0042-6822(03)00146-6; Yin HS, 2006, NATURE, V439, P38, DOI 10.1038/nature04322; Yin HS, 2005, P NATL ACAD SCI USA, V102, P9288, DOI 10.1073/pnas.0503989102; ZHANG L, 1994, J VIROL, V68, P2186, DOI 10.1128/JVI.68.4.2186-2193.1994	37	342	358	3	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 14	2006	313	5784					187	191		10.1126/science.1127683	http://dx.doi.org/10.1126/science.1127683			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	063GZ	16840692				2022-12-28	WOS:000239008000034
J	Caron, JB; Scheltema, A; Schander, C; Rudkin, D				Caron, Jean-Bernard; Scheltema, Amelie; Schander, Christoffer; Rudkin, David			A soft-bodied mollusc with radula from the Middle Cambrian Burgess Shale	NATURE			English	Article							WIWAXIA-CORRUGATA MATTHEW; ARTICULATED HALKIERIIDS; FOSSIL RECORD; LIFE-STYLES; ORIGIN; POLYPLACOPHORAN; APLACOPHORA; EVOLUTION	Odontogriphus omalus was originally described as a problematic non-biomineralized lophophorate organism. Here we re-interpret Odontogriphus based on 189 new specimens including numerous exceptionally well preserved individuals from the Burgess Shale collections of the Royal Ontario Museum. This additional material provides compelling evidence that the feeding apparatus in Odontogriphus is a radula of molluscan architecture comprising two primary bipartite tooth rows attached to a radular membrane and showing replacement by posterior addition. Further characters supporting molluscan affinity include a broad foot bordered by numerous ctenidia located in a mantle groove and a stiffened cuticular dorsum. Odontogriphus has a radula similar to Wiwaxia corrugata but lacks a scleritome. We interpret these animals to be members of an early stem-group mollusc lineage that probably originated in the Neoproterozoic Ediacaran Period, providing support for the retention of a biomat-based grazing community from the late Precambrian Period until at least the Middle Cambrian.	Royal Ontario Museum, Dept Nat Hist Palaeobiol, Toronto, ON M5S 2C6, Canada; Woods Hole Oceanog Inst, Woods Hole, MA 02543 USA; Univ Bergen, Dept Biol, N-5020 Bergen, Norway	Royal Ontario Museum; Woods Hole Oceanographic Institution; University of Bergen	Caron, JB (corresponding author), Royal Ontario Museum, Dept Nat Hist Palaeobiol, 100 Queens Pk, Toronto, ON M5S 2C6, Canada.	jcaron@rom.on.ca		Caron, Jean-Bernard/0000-0002-1670-5502				ALLISON PA, 1988, LETHAIA, V21, P403, DOI 10.1111/j.1502-3931.1988.tb01769.x; Balavoine G, 2003, INTEGR COMP BIOL, V43, P137, DOI 10.1093/icb/43.1.137; BENGTSON S, 1992, LETHAIA, V25, P401, DOI 10.1111/j.1502-3931.1992.tb01644.x; Bengtson Stefan, 2002, Paleontological Society Papers, V8, P289; Bottjer D.J., 2000, GSA TODAY, V10, P1; Budd GE, 2000, BIOL REV, V75, P253, DOI 10.1017/S000632310000548X; Budd GE, 2003, INTEGR COMP BIOL, V43, P157, DOI 10.1093/icb/43.1.157; BUTTERFIELD NJ, 1990, PALEOBIOLOGY, V16, P287, DOI 10.1017/S0094837300010009; CARON JB, 2005, THESIS U TORONTO; CARON JB, IN PRESS PALAIOS, V21; CONWAY MS, 1993, PALAEONTOLOGY, V36, P593; Dornbos SQ, 2005, PALAEOGEOGR PALAEOCL, V220, P47, DOI 10.1016/j.palaeo.2003.11.016; Dornbos SQ, 2004, LETHAIA, V37, P127, DOI 10.1080/00241160410004764; Douzery EJP, 2004, P NATL ACAD SCI USA, V101, P15386, DOI 10.1073/pnas.0403984101; Dzik Jerzy, 1995, Acta Palaeontologica Polonica, V40, P341; Eibye-Jacobsen D, 2004, LETHAIA, V37, P317, DOI 10.1080/00241160410002027; Erwin DH, 2002, DEVELOPMENT, V129, P3021; Fedonkin MA, 1997, NATURE, V388, P868, DOI 10.1038/42242; FISCHER FP, 1980, ZOOMORPHOLOGIE, V94, P121, DOI 10.1007/BF01081929; HAAS W, 1981, MALACOLOGIA, V21, P403; Hagadorn JW, 2000, J PALEONTOL, V74, P731, DOI 10.1666/0022-3360(2000)074<0731:ECETFF>2.0.CO;2; Henry JQ, 2004, DEV BIOL, V272, P145, DOI 10.1016/j.ydbio.2004.04.027; Jensen S, 1998, NATURE, V393, P567, DOI 10.1038/31215; MORRIS S C, 1976, Palaeontology (Oxford), V19, P199; MORRIS SC, 1995, PHILOS T ROY SOC B, V347, P305, DOI 10.1098/rstb.1995.0029; MORRIS SC, 1990, NATURE, V345, P802, DOI 10.1038/345802a0; MORRIS SC, 1985, PHILOS T R SOC B, V307, P507, DOI 10.1098/rstb.1985.0005; Narbonne GM, 2005, ANNU REV EARTH PL SC, V33, P421, DOI 10.1146/annurev.earth.33.092203.122519; Orr PJ, 2002, PALAIOS, V17, P110, DOI 10.1669/0883-1351(2002)017<0110:BEIOFE>2.0.CO;2; Peterson KJ, 2004, P NATL ACAD SCI USA, V101, P6536, DOI 10.1073/pnas.0401670101; Ritchie A, 2001, PALAEONTOLOGY, V44, P861, DOI 10.1111/1475-4983.00205; RUNNEGAR B, 1979, J PALEONTOL, V53, P1374; Runnegar Bruce, 1996, P77; SATTERTHWAIT DF, 1976, PALEOBIOLOGY PALEOEC; SCHELTEMA AH, 1993, BIOL BULL, V184, P57, DOI 10.2307/1542380; Scheltema AH, 2003, J MORPHOL, V257, P219, DOI 10.1002/jmor.10121; Scheltema AH, 2002, INVERTEBR BIOL, V121, P1; Scheltema Amelie H., 1994, P13; Seilacher A, 2005, PALAEOGEOGR PALAEOCL, V227, P323, DOI 10.1016/j.palaeo.2005.06.003; Seilacher A, 1999, PALAIOS, V14, P86, DOI 10.2307/3515363; Seilacher A., 1994, BIOSTABILIZATION SED, P97; VALENTINE JW, 2004, ORIGIN PHYLA; Vendrasco MJ, 2004, NATURE, V429, P288, DOI 10.1038/nature02548; Vinther J, 2005, ZOOL SCR, V34, P81, DOI 10.1111/j.1463-6409.2005.00177.x; [No title captured]	45	105	109	1	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 13	2006	442	7099					159	163		10.1038/nature04894	http://dx.doi.org/10.1038/nature04894			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	062XJ	16838013	Green Accepted			2022-12-28	WOS:000238979700038
J	Habif, TP				Habif, TP			Doxycycline-induced phototoxicity	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Dartmouth Coll Sch Med, Hanover, NH 03755 USA	Dartmouth College	Habif, TP (corresponding author), Dartmouth Coll Sch Med, Hanover, NH 03755 USA.								0	8	8	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 13	2006	355	2					182	182		10.1056/NEJMicm050829	http://dx.doi.org/10.1056/NEJMicm050829			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	062UP	16837682				2022-12-28	WOS:000238970600010
J	Lee, DS; Pencina, MJ; Benjamin, EJ; Wang, TJ; Levy, D; O'Donnell, CJ; Nam, B; Larson, MG; D'Agostino, RB; Vasan, RS				Lee, Douglas S.; Pencina, Michael J.; Benjamin, Emelia J.; Wang, Thomas J.; Levy, Daniel; O'Donnell, Christopher J.; Nam, Byung-Ho; Larson, Martin G.; D'Agostino, Ralph B.; Vasan, Ramachandran S.			Association of parental heart failure with risk of heart failure in offspring	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							LEFT-VENTRICULAR MASS; FAMILIAL DILATED CARDIOMYOPATHY; CARDIOVASCULAR-DISEASE; BLOOD-PRESSURE; MYOCARDIAL-INFARCTION; FRAMINGHAM; GENE; HISTORY; POLYMORPHISM; HYPERTROPHY	BACKGROUND: The association between heart failure in parents and the prevalence of left ventricular systolic dysfunction and the risk of heart failure in their offspring has not been investigated in a community-based setting. METHODS: We examined the cross-sectional association of heart failure in parents with the prevalence of left ventricular systolic dysfunction, as well as left ventricular mass, internal dimensions, and wall thickness, in 1497 participants of the Framingham Offspring Study (mean age, 57 years; 819 women) who underwent routine echocardiography. We also investigated prospectively whether heart failure in parents increased the risk of heart failure in 2214 offspring (mean age, 44 years; 1150 women). RESULTS: As compared with the 1039 participants whose parents did not have heart failure, the 458 participants in the cross-sectional cohort who had at least one parent with heart failure were more likely to have increased left ventricular mass (17.0 percent vs. 26.9 percent), left ventricular internal dimensions (18.6 percent vs. 23.4 percent), and left ventricular systolic dysfunction (3.1 percent vs. 5.7 percent); the multivariable-adjusted odds ratios were 1.35 (95 percent confidence interval, 0.99 to 1.84), 1.29 (95 percent confidence interval, 0.96 to 1.72), and 2.37 (95 percent confidence interval, 1.22 to 4.61), respectively. In the longitudinal cohort, heart failure developed in 90 offspring during follow-up (mean length of follow-up, 20 years). The age- and sex-adjusted 10-year incidence rates of heart failure were 2.72 percent among offspring with a parent with heart failure, as compared with 1.62 percent among those without a parent with heart failure. This increase in risk persisted after multivariable adjustment (hazard ratio, 1.70; 95 percent confidence interval, 1.11 to 2.60). CONCLUSIONS: Heart failure in parents is associated with an increased prevalence of left ventricular systolic dysfunction cross-sectionally and an elevated risk of heart failure longitudinally. Our data emphasize the contribution of familial factors to the heart-failure burden in the community.	NHLBI, Framingham Heart Study, Framingham, MA 01702 USA; NHLBI, Bethesda, MD 20892 USA; Massachusetts Gen Hosp, Div Cardiol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA USA; Boston Univ, Dept Math, Boston, MA 02215 USA; Boston Univ, Sch Med, Dept Epidemiol & Prevent Med, Boston, MA 02118 USA; Boston Univ, Sch Med, Cardiol Sect, Boston, MA 02118 USA	Framingham Heart Study; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Boston University; Boston University; Boston University	Vasan, RS (corresponding author), NHLBI, Framingham Heart Study, 73 Mt Wayte Ave,Suite 2, Framingham, MA 01702 USA.	vasan@bu.edu	Ramachandran, Vasan/Y-2527-2019; Levy, Daniel/ABB-2752-2021; Levy, Daniel/ABF-6873-2021; Benjamin, Emelia/E-7103-2011	Ramachandran, Vasan/0000-0001-7357-5970; Levy, Daniel/0000-0003-1843-8724; Pencina, Michael/0000-0001-5798-8855; Benjamin, Emelia/0000-0003-4076-2336; Larson, Martin/0000-0002-9631-1254; Lee, Douglas/0000-0001-7078-745X	DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC025195] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL066582, K24HL004334, K23HL074077] Funding Source: NIH RePORTER; NHLBI NIH HHS [U01 HL 66582, N01-HC-25195, K24HL04334, K23 HL074077] Funding Source: Medline	DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		American Heart Association, 2005, HEART DIS STROKE STA; Arnett DK, 2001, AM J HYPERTENS, V14, P1226, DOI 10.1016/S0895-7061(01)02200-2; Baig MK, 1998, J AM COLL CARDIOL, V31, P195, DOI 10.1016/S0735-1097(97)00433-6; Bell CG, 2004, DIABETES, V53, P1857, DOI 10.2337/diabetes.53.7.1857; DAWBER TR, 1963, ANN NY ACAD SCI, V107, P539, DOI 10.1111/j.1749-6632.1963.tb13299.x; DEVEREUX RB, 1986, AM J CARDIOL, V57, P450, DOI 10.1016/0002-9149(86)90771-X; Dong YB, 2004, HYPERTENSION, V44, P884, DOI 10.1161/01.HYP.0000147824.08621.a6; Drazner MH, 2004, J AM COLL CARDIOL, V43, P2207, DOI 10.1016/j.jacc.2003.11.064; Fatkin D, 1999, NEW ENGL J MED, V341, P1715, DOI 10.1056/NEJM199912023412302; Grunig E, 1998, J AM COLL CARDIOL, V31, P186, DOI 10.1016/S0735-1097(97)00434-8; Hunt SA, 2001, CIRCULATION, V104, P2996, DOI 10.1161/hc4901.102568; Kamisago M, 2000, NEW ENGL J MED, V343, P1688, DOI 10.1056/NEJM200012073432304; KANNEL WB, 1979, AM J EPIDEMIOL, V110, P281, DOI 10.1093/oxfordjournals.aje.a112813; Kannell WB, 1999, ARCH INTERN MED, V159, P1197, DOI 10.1001/archinte.159.11.1197; Karvonen J, 2002, J HYPERTENS, V20, P2371, DOI 10.1097/00004872-200212000-00015; KEE F, 1993, BRIT MED J, V307, P1528, DOI 10.1136/bmj.307.6918.1528; Levy D, 2000, HYPERTENSION, V36, P477, DOI 10.1161/01.HYP.36.4.477; Lloyd-Jones DM, 2004, JAMA-J AM MED ASSOC, V291, P2204, DOI 10.1001/jama.291.18.2204; MCKEE PA, 1971, NEW ENGL J MED, V285, P1441, DOI 10.1056/NEJM197112232852601; MICHELS VV, 1992, NEW ENGL J MED, V326, P77, DOI 10.1056/NEJM199201093260201; Murabito JM, 2004, ANN INTERN MED, V140, P434, DOI 10.7326/0003-4819-140-6-200403160-00010; Pasotti M, 2004, MED CLIN N AM, V88, P1173, DOI 10.1016/j.mcna.2004.02.004; Pettersson-Fernholm K, 2003, DIABETES, V52, P891, DOI 10.2337/diabetes.52.3.891; Post WS, 1997, HYPERTENSION, V30, P1025, DOI 10.1161/01.HYP.30.5.1025; Rakar S, 1997, EUR HEART J, V18, P117; Rockhill B, 1998, AM J PUBLIC HEALTH, V88, P15, DOI 10.2105/AJPH.88.1.15; Sundstroma J, 2004, EUR HEART J, V25, P523, DOI 10.1016/j.ehj.2004.01.008; Swan L, 2003, EUR HEART J, V24, P579, DOI 10.1016/S0195-668X(02)00524-9; Thomas DC, 2004, STAT METHODS GENETIC; Vasan RS, 1997, NEW ENGL J MED, V336, P1350, DOI 10.1056/NEJM199705083361903; Vasan RS, 2002, JAMA-J AM MED ASSOC, V288, P1252, DOI 10.1001/jama.288.10.1252; Vuagnat A, 2001, J MOL MED-JMM, V79, P175, DOI 10.1007/s001090100205; Wang TJ, 2003, CIRCULATION, V108, P572, DOI 10.1161/01.CIR.0000081764.35431.DE; 2004, MMWR MORB MORTAL WKL, V53, P1044	34	125	128	1	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 13	2006	355	2					138	147		10.1056/NEJMoa052948	http://dx.doi.org/10.1056/NEJMoa052948			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	062UP	16837677				2022-12-28	WOS:000238970600005
J	Miroshnychenko, Y; Alt, W; Dotsenko, I; Forster, L; Khudaverdyan, M; Meschede, D; Schrader, D; Rauschenbeutel, A				Miroshnychenko, Yevhen; Alt, Wolfgang; Dotsenko, Igor; Foerster, Leonid; Khudaverdyan, Mkrtych; Meschede, Dieter; Schrader, Dominik; Rauschenbeutel, Arno			An atom-sorting machine	NATURE			English	Article							SCANNING TUNNELING MICROSCOPE; CONTROLLED COLLISIONS; SINGLE ATOMS; ENTANGLEMENT; MANIPULATION		Univ Bonn, Inst Angew Phys, D-53115 Bonn, Germany	University of Bonn	Miroshnychenko, Y (corresponding author), Univ Bonn, Inst Angew Phys, D-53115 Bonn, Germany.	arno.rauschenbeutel@iap.uni-bonn.de	Rauschenbeutel, Arno/C-1472-2013	Rauschenbeutel, Arno/0000-0003-2467-4029; Dotsenko, Igor/0000-0002-5074-6447				Bartels L, 1997, PHYS REV LETT, V79, P697, DOI 10.1103/PhysRevLett.79.697; Dotsenko I, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.033002; EIGLER DM, 1990, NATURE, V344, P524, DOI 10.1038/344524a0; Grier DG, 2003, NATURE, V424, P810, DOI 10.1038/nature01935; Hensinger WK, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2164910; Jaksch D, 1999, PHYS REV LETT, V82, P1975, DOI 10.1103/PhysRevLett.82.1975; Kuhr S, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.213002; Kuhr S, 2001, SCIENCE, V293, P278, DOI 10.1126/science.1062725; Mandel O, 2003, NATURE, V425, P937, DOI 10.1038/nature02008; Metcalf HJ., 1999, LASER COOLING TRAPPI; Miroshnychenko Y, 2003, OPT EXPRESS, V11, P3498, DOI 10.1364/OE.11.003498; Schrader D, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.150501; You L, 2003, PHYS REV A, V67, DOI 10.1103/PhysRevA.67.032308	13	101	102	1	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 13	2006	442	7099					151	151		10.1038/442151a	http://dx.doi.org/10.1038/442151a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	062XJ	16838011				2022-12-28	WOS:000238979700034
J	Gee, RE				Gee, Rebekah E.			Plan B, reproductive rights, and physician activism.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Penn, Philadelphia, PA 19104 USA	University of Pennsylvania	Gee, RE (corresponding author), Univ Penn, Philadelphia, PA 19104 USA.							Finer LB, 2006, PERSPECT SEX REPRO H, V38, P90, DOI 10.1363/3809006; Finer Lawrence B., 2005, ESTIMATES US ABORTIO; *PHARM ACC PARTN, STAT PROF	3	10	10	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 6	2006	355	1					4	5		10.1056/NEJMp068135	http://dx.doi.org/10.1056/NEJMp068135			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	060DT	16822991				2022-12-28	WOS:000238783200002
J	Gonzales, D; Rennard, SI; Nides, M; Oncken, C; Azoulay, S; Billing, CB; Watsky, EJ; Gong, J; Williams, KE; Reeves, KR				Gonzales, David; Rennard, Stephen I.; Nides, Mitchell; Oncken, Cheryl; Azoulay, Salomon; Billing, Clare B.; Watsky, Eric J.; Gong, Jason; Williams, Kathryn E.; Reeves, Karen R.		Varenicline Phase 3 Study Grp	Varenicline, an alpha 4 beta 2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation - A randomized controlled trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							QUESTIONNAIRE; WITHDRAWAL; ADDICTION; TOLERANCE; SR	Context The alpha 4 beta 2 nicotinic acetylcholine receptors (nAChRs) are linked to the reinforcing effects of nicotine and maintaining smoking behavior. Varenicline, a novel alpha 4 beta 2 nAChR partial agonist, may be beneficial for smoking cessation. Objective To assess efficacy and safety of varenicline for smoking cessation compared with sustained-release bupropion (bupropion SR) and placebo. Design, Setting, and Participants Randomized, double-blind, parallel-group, placebo- and active-treatment-controlled, phase 3 clinical trial conducted at 19 US centers from June 19, 2003, to April 22, 2005. Participants were 1025 generally healthy smokers (>= 10 cigarettes/d) with fewer than 3 months of smoking abstinence in the past year, 18 to 75 years old, recruited via advertising. Intervention Participants were randomly assigned in a 1:1:1 ratio to receive brief counseling and varenicline titrated to 1 mg twice per day (n = 352), bupropion SR titrated to 150 mg twice per day (n = 329), or placebo (n = 344) orally for 12 weeks, with 40 weeks of nondrug follow-up. Main Outcome Measures Primary outcome was the exhaled carbon monoxide confirmed 4-week rate of continuous abstinence from smoking for weeks 9 through 12. A secondary outcome was the continuous abstinence rate for weeks 9 through 24 and weeks 9 through 52. Results For weeks 9 through 12, the 4-week continuous abstinence rates were 44.0% for varenicline vs 17.7% for placebo (odds ratio [OR], 3.85; 95% confidence interval [CI], 2.70-5.50; P<.001) and vs 29.5% for bupropion SR (OR, 1.93; 95% CI, 1.40-2.68; P<.001). Bupropion SR was also significantly more efficacious than placebo (OR, 2.00; 95% CI, 1.38-2.89; P<.001). For weeks 9 through 52, the continuous abstinence rates were 21.9% for varenicline vs 8.4% for placebo (OR, 3.09; 95% CI, 1.95-4.91; P<.001) and vs 16.1% for bupropion SR (OR, 1.46; 95% CI, 0.99-2.17; P=.057). Varenicline reduced craving and withdrawal and, for those who smoked while receiving study drug, smoking satisfaction. No sex differences in efficacy for varenicline were observed. Varenicline was safe and generally well tolerated, with study drug discontinuation rates similar to those for placebo. The most common adverse events for participants receiving active-drug treatment were nausea (98 participants receiving varenicline [28.1%]) and insomnia (72 receiving bupropion SR [21.9%]). Conclusion Varenicline was significantly more efficacious than placebo for smoking cessation at all time points and significantly more efficacious than bupropion SR at the end of 12 weeks of drug treatment and at 24 weeks.	Oregon Hlth & Sci Univ, Dept Med, Smoking Cessat Ctr, Portland, OR 97239 USA; Univ Nebraska Med Ctr, Div Pulm, Omaha, NE USA; Los Angeles Clin Trials, Los Angeles, CA USA; Univ Connecticut, Ctr Hlth, Dept Med, Farmington, CT USA; Pfizer Global Res & Dev, Groton, CT USA	Oregon Health & Science University; University of Nebraska System; University of Nebraska Medical Center; University of Connecticut; Pfizer	Gonzales, D (corresponding author), Oregon Hlth & Sci Univ, Dept Med, Smoking Cessat Ctr, 3181 SW Sam Jackson Pk Rd,CR 115, Portland, OR 97239 USA.	gonzales@ohsu.edu		Gonzales, David/0000-0002-4323-198X				American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Brauer L H, 2001, Nicotine Tob Res, V3, P101; Cappelleri JC, 2005, VALUE HEALTH, V8, P333, DOI 10.1016/S1098-3015(10)62876-8; Cappelleri JC, 2005, VALUE HEALTH, V8, P334, DOI 10.1016/S1098-3015(10)62877-X; Centers for Disease Control and Prevention, 2004, MMWR-MORBID MORTAL W, V53, P427; Coe JW, 2005, BIOORG MED CHEM LETT, V15, P4889, DOI 10.1016/j.bmcl.2005.08.035; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd; Cox L S, 2001, Nicotine Tob Res, V3, P7, DOI 10.1080/14622200020032051; Di Chiara G, 2000, EUR J PHARMACOL, V393, P295, DOI 10.1016/S0014-2999(00)00122-9; Fiore M C, 2000, Respir Care, V45, P1196; FIORE MC, 2000, TREATING TOBACCO USE; Gonzales DH, 2001, CLIN PHARMACOL THER, V69, P438, DOI 10.1067/mcp.2001.115750; HEATHERTON TF, 1991, BRIT J ADDICT, V86, P1119; HUGHES JR, 1986, ARCH GEN PSYCHIAT, V43, P289; JASINSKI DR, 1978, ARCH GEN PSYCHIAT, V35, P501; Jorenby DE, 1999, NEW ENGL J MED, V340, P685, DOI 10.1056/NEJM199903043400903; Jorenby DE, 2006, JAMA-J AM MED ASSOC, V296, P56, DOI 10.1001/jama.296.1.56; Joseph CC, 2005, CURR MED RES OPIN, V21, P749, DOI 10.1185/030079905X43712; Maskos U, 2005, NATURE, V436, P103, DOI 10.1038/nature03694; *NAT C I, 2003, NIH PUBL; NIDES M, IN PRESS ARCH INTERN; PAPKE RL, 1994, MOL PHARMACOL, V45, P142; Pontieri FE, 1996, NATURE, V382, P255, DOI 10.1038/382255a0; Rose JE, 1998, EXP CLIN PSYCHOPHARM, V6, P331, DOI 10.1037/1064-1297.6.3.331; Scharfenberg G, 1971, Dtsch Gesundheitsw, V26, P463; Shiffman S, 2004, NICOTINE TOB RES, V6, P599, DOI 10.1080/14622200410001734067; Tapper AR, 2004, SCIENCE, V306, P1029, DOI 10.1126/science.1099420; Tonnesen P, 2003, J INTERN MED, V254, P184, DOI 10.1046/j.1365-2796.2003.01185.x; Tonstad S, 2006, JAMA-J AM MED ASSOC, V296, P64, DOI 10.1001/jama.296.1.64; Vocci FJ, 2005, AM J PSYCHIAT, V162, P1432, DOI 10.1176/appi.ajp.162.8.1432	30	1053	1095	0	81	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 5	2006	296	1					47	55		10.1001/jama.296.1.47	http://dx.doi.org/10.1001/jama.296.1.47			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	058RU	16820546	Bronze			2022-12-28	WOS:000238683100021
J	Kaul, S; Diamond, GA				Kaul, Sanjay; Diamond, George A.			Good enough: A primer on the analysis and interpretation of noninferiority trials	ANNALS OF INTERNAL MEDICINE			English	Article							PLACEBO-CONTROLLED TRIALS; ACUTE CORONARY SYNDROMES; ACTIVE-CONTROL TRIALS; NON-INFERIORITY; UNFRACTIONATED HEPARIN; MYOCARDIAL-INFARCTION; EQUIVALENCE; DESIGN; ISSUES; XIMELAGATRAN	Active-control noninferiority trials are being performed with increasing frequency when standard placebo-controlled trials are considered unethical. Three attributes are optimally required to establish noninferiority: 1) The treatment under consideration exhibits therapeutic noninferiority to the active control; 2) the treatment would exhibit therapeutic efficacy in a placebo-controlled trial if such a trial were to be performed; and 3) the treatment offers ancillary advantages in safety, tolerability, cost, or convenience. Trials designed to show noninferiority require an appropriate reference population, a proven active control and dose, a high level of adherence to treatment, and adequate statistical power. However, the formal analysis of such trials is founded on several assumptions that cannot be validated explicitly. These assumptions are evaluated in the context of 8 recently published noninferiority trials. The analyses in this paper confirm the establishment of noninferiority in only 4 of the 8 trials. The authors conclude that if noninferiority trials are to be applied to clinical and regulatory decisions about the marketing and use of new treatments, these assumptions must be made explicit and their influence on the resultant conclusions assessed rigorously.	Univ Calif Los Angeles, Div Cardiol, Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA; Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90048 USA	Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Kaul, S (corresponding author), Univ Calif Los Angeles, Div Cardiol, Cedars Sinai Med Ctr, 5536 S Tower,8700 Beverly Blvd, Los Angeles, CA 90048 USA.	kaul@cshs.org						Albers GW, 2005, JAMA-J AM MED ASSOC, V293, P690; BLACKWELDER WC, 1982, CONTROL CLIN TRIALS, V3, P345, DOI 10.1016/0197-2456(82)90024-1; Blazing MA, 2004, JAMA-J AM MED ASSOC, V292, P55, DOI 10.1001/jama.292.1.55; *COMM PROPR MED PR, 2004, POINTS CONS CHOIC NO; D'Agostino RB, 2003, STAT MED, V22, P169, DOI 10.1002/sim.1425; Diamond GA, 2004, J AM COLL CARDIOL, V43, P1929, DOI 10.1016/j.jacc.2004.01.035; Dundar Y, 2003, QJM-INT J MED, V96, P103, DOI 10.1093/qjmed/hcg016; Ellenberg SS, 2000, ANN INTERN MED, V133, P464, DOI 10.7326/0003-4819-133-6-200009190-00015; Ferguson JJ, 2004, JAMA-J AM MED ASSOC, V292, P45; Gotzsche PC, 2006, JAMA-J AM MED ASSOC, V295, P1172, DOI 10.1001/jama.295.10.1172; Greene WL, 2000, ANN INTERN MED, V132, P715, DOI 10.7326/0003-4819-132-9-200005020-00006; Hasselblad V, 2001, DRUG INF J, V35, P435, DOI 10.1177/009286150103500212; Holmgren E B, 1999, J Biopharm Stat, V9, P651, DOI 10.1081/BIP-100101201; HUGHES S, 2005, HEARTWIRE NEWS  0616; Hung HMJ, 2005, BIOMETRICAL J, V47, P28, DOI 10.1002/bimj.200410084; Hung HMJ, 2003, STAT MED, V22, P213, DOI 10.1002/sim.1315; Kaul S, 2005, J AM COLL CARDIOL, V46, P1986, DOI 10.1016/j.jacc.2005.07.062; Le Henanff A, 2006, JAMA-J AM MED ASSOC, V295, P1147, DOI 10.1001/jama.295.10.1147; Lincoff AM, 2003, JAMA-J AM MED ASSOC, V289, P853, DOI 10.1001/jama.289.7.853; Pfeffer MA, 2003, NEW ENGL J MED, V349, P1893, DOI 10.1056/NEJMoa032292; Piaggio G, 2006, JAMA-J AM MED ASSOC, V295, P1152, DOI 10.1001/jama.295.10.1152; Rothmann M, 2003, STAT MED, V22, P239, DOI 10.1002/sim.1400; Siegel JP, 2000, AM HEART J, V139, pS166, DOI 10.1016/S0002-8703(00)90066-8; Simon R, 1999, BIOMETRICS, V55, P484, DOI 10.1111/j.0006-341X.1999.00484.x; Snapinn Steven M, 2004, J Biopharm Stat, V14, P263, DOI 10.1081/BIP-120037178; Temple R, 2002, STAT MED, V21, P2939, DOI 10.1002/sim.1298; Temple R, 2000, ANN INTERN MED, V133, P455, DOI 10.7326/0003-4819-133-6-200009190-00014; Topol E, 1997, NEW ENGL J MED, V337, P1118; TOPOL E, 1993, NEW ENGL J MED, V329, P673, DOI 10.1056/nejm199309023291001; Topol EJ, 2001, NEW ENGL J MED, V344, P1888, DOI 10.1056/NEJM200106213442502; VandeWerf F, 1997, NEW ENGL J MED, V337, P1124; Ware JH, 1997, NEW ENGL J MED, V337, P1159, DOI 10.1056/NEJM199710163371610; 2001, FED REG, V66, P24390	33	184	189	0	10	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 4	2006	145	1					62	69		10.7326/0003-4819-145-1-200607040-00011	http://dx.doi.org/10.7326/0003-4819-145-1-200607040-00011			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	062IS	16818930				2022-12-28	WOS:000238938400008
J	Gupton, SL; Waterman-Storer, CM				Gupton, Stephanie L.; Waterman-Storer, Clare M.			Spatiotemporal feedback between actomyosin and focal-adhesion systems optimizes rapid cell migration	CELL			English	Article							FLUORESCENT SPECKLE MICROSCOPY; INTEGRIN-LIGAND BINDING; EARLY MOLECULAR EVENTS; ACTIN-FILAMENTS; SMOOTH-MUSCLE; LEADING-EDGE; LIVING CELLS; MICROTUBULE; TURNOVER; CONTRACTILITY	Cells exhibit a biphasic migration-velocity response to increasing adhesion strength, with fast migration occurring at intermediate extracellular matrix (ECM) concentration and slow migration occurring at low and high ECM concentration. A simple mechanical model has been proposed to explain this observation, in which too little adhesion does not provide sufficient traction whereas too much adhesion renders cells immobile. Here we characterize a phenotype for rapid cell migration, which in contrast to the previous model reveals a complex interdependence of subcellular systems that mediates optimal cell migration in response to increasing adhesion strength. The organization and activity of actin, myosin II, and focal adhesions (FAs) are spatially and temporally highly variable and do not exhibit a simple correlation with optimal motility rates. Furthermore, we can recapitulate rapid migration at a nonoptimal ECM concentration by manipulating myosin II activity. Thus, the interplay between actomyosin and FA dynamics results in a specific balance between adhesion and contraction, which induces maximal migration velocity.	Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA	Scripps Research Institute	Gupton, SL (corresponding author), Scripps Res Inst, Dept Cell Biol, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	waterman@scripps.edu		Waterman, Clare/0000-0001-6142-6775	NIGMS NIH HHS [GM67230] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067230, U01GM067230] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adams MC, 2003, METHODS, V29, P29, DOI 10.1016/S1046-2023(02)00282-7; ADELSTEIN RS, 1975, NATURE, V256, P597, DOI 10.1038/256597a0; Asthagiri AR, 1999, J BIOL CHEM, V274, P27119, DOI 10.1074/jbc.274.38.27119; Bailly M, 1998, EXP CELL RES, V241, P285, DOI 10.1006/excr.1998.4031; Brunton VG, 2004, BBA-MOL CELL RES, V1692, P121, DOI 10.1016/j.bbamcr.2004.04.010; Bulinski JC, 2001, J CELL SCI, V114, P3885; Burridge K, 1996, ANNU REV CELL DEV BI, V12, P463, DOI 10.1146/annurev.cellbio.12.1.463; ChrzanowskaWodnicka M, 1996, J CELL BIOL, V133, P1403, DOI 10.1083/jcb.133.6.1403; Cox EA, 2001, MOL BIOL CELL, V12, P265, DOI 10.1091/mbc.12.2.265; Critchley DR, 1999, BIOCHEM SOC SYMP, V65, P79; Danuser G, 2003, J MICROSC-OXFORD, V211, P191, DOI 10.1046/j.1365-2818.2003.01222.x; de Rooij J, 2005, J CELL BIOL, V171, P153, DOI 10.1083/jcb.200506152; del Pozo MA, 2003, J IMMUNOL, V170, P41, DOI 10.4049/jimmunol.170.1.41; Delanoe-Ayari H, 2004, P NATL ACAD SCI USA, V101, P2229, DOI 10.1073/pnas.0304297101; DIMILLA PA, 1993, J CELL BIOL, V122, P729, DOI 10.1083/jcb.122.3.729; DIMILLA PA, 1991, BIOPHYS J, V60, P15, DOI 10.1016/S0006-3495(91)82027-6; FORSCHER P, 1988, J CELL BIOL, V107, P1505, DOI 10.1083/jcb.107.4.1505; FRANGOS JA, 1985, SCIENCE, V227, P1477, DOI 10.1126/science.3883488; Gupton SL, 2002, CURR BIOL, V12, P1891, DOI 10.1016/S0960-9822(02)01276-9; GUTPON SL, 2005, J CELL BIOL, V168, P619; Hamill OP, 2001, PHYSIOL REV, V81, P685, DOI 10.1152/physrev.2001.81.2.685; Holub A, 2003, J LEUKOCYTE BIOL, V73, P657, DOI 10.1189/jlb.0502264; Huttenlocher A, 1996, J CELL BIOL, V134, P1551, DOI 10.1083/jcb.134.6.1551; ISHIHARA H, 1989, J PHARMACOL EXP THER, V250, P388; Katsumi A, 2002, J CELL BIOL, V158, P153, DOI 10.1083/jcb.200201105; Kaverina I, 2002, INT J BIOCHEM CELL B, V34, P746, DOI 10.1016/S1357-2725(01)00171-6; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Palecek SP, 1997, NATURE, V385, P537, DOI 10.1038/385537a0; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Ponti A, 2004, SCIENCE, V305, P1782, DOI 10.1126/science.1100533; Ponti A, 2003, BIOPHYS J, V84, P3336, DOI 10.1016/S0006-3495(03)70058-7; Salmon WC, 2002, J CELL BIOL, V158, P31, DOI 10.1083/jcb.200203022; SCHMIDT CE, 1993, J CELL BIOL, V123, P977, DOI 10.1083/jcb.123.4.977; Straight AF, 2003, SCIENCE, V299, P1743, DOI 10.1126/science.1081412; Svitkina TM, 1999, J CELL BIOL, V145, P1009, DOI 10.1083/jcb.145.5.1009; Tamada M, 2004, DEV CELL, V7, P709, DOI 10.1016/j.devcel.2004.08.021; TAYLOR DL, 1982, PHILOS T ROY SOC B, V299, P185, DOI 10.1098/rstb.1982.0125; Vallotton P, 2004, P NATL ACAD SCI USA, V101, P9660, DOI 10.1073/pnas.0300552101; Vallotton P, 2003, BIOPHYS J, V85, P1289, DOI 10.1016/S0006-3495(03)74564-0; Verkhovsky AB, 1999, BIOCHEM SOC SYMP, V65, P207; Watanabe N, 2002, SCIENCE, V295, P1083, DOI 10.1126/science.1067470; Webb DJ, 2002, NAT CELL BIOL, V4, pE97, DOI 10.1038/ncb0402-e97; Webb DJ, 2004, NAT CELL BIOL, V6, P154, DOI 10.1038/ncb1094; Wittmann T, 2003, J CELL BIOL, V161, P845, DOI 10.1083/jcb.200303082; Wozniak MA, 2004, BBA-MOL CELL RES, V1692, P103, DOI 10.1016/j.bbamcr.2004.04.007; Yamada K. M., 2002, CURRENT PROTOCOLS CE; Zaidel-Bar R, 2003, J CELL SCI, V116, P4605, DOI 10.1242/jcs.00792; Zimerman B, 2004, CELL MOTIL CYTOSKEL, V58, P143, DOI 10.1002/cm.20005	48	439	444	0	49	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 30	2006	125	7					1361	1374		10.1016/j.cell.2006.05.029	http://dx.doi.org/10.1016/j.cell.2006.05.029			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	064QP	16814721	Bronze			2022-12-28	WOS:000239104500018
J	Lorenz, IC; Marcotrigiano, J; Dentzer, TG; Rice, CM				Lorenz, Ivo C.; Marcotrigiano, Joseph; Dentzer, Thomas G.; Rice, Charles M.			Structure of the catalytic domain of the hepatitis C virus NS2-3 protease	NATURE			English	Article							CRYSTAL-STRUCTURE; NS3 PROTEASE	Hepatitis C virus is a major global health problem affecting an estimated 170 million people worldwide(1). Chronic infection is common and can lead to cirrhosis and liver cancer. There is no vaccine available and current therapies have met with limited success(2). The viral RNA genome encodes a polyprotein that includes two proteases essential for virus replication(3,4). The NS2-3 protease mediates a single cleavage at the NS2/NS3 junction, whereas the NS3-4A protease cleaves at four downstream sites in the polyprotein. NS3-4A is characterized as a serine protease with a chymotrypsin-like fold(5,6), but the enzymatic mechanism of the NS2-3 protease remains unresolved(7-9). Here we report the crystal structure of the catalytic domain of the NS2-3 protease at 2.3 angstrom resolution. The structure reveals a dimeric cysteine protease with two composite active sites. For each active site, the catalytic histidine and glutamate residues are contributed by one monomer, and the nucleophilic cysteine by the other. The carboxy-terminal residues remain coordinated in the two active sites, predicting an inactive post-cleavage form. Proteolysis through formation of a composite active site occurs in the context of the viral polyprotein expressed in mammalian cells. These features offer unexpected insights into polyprotein processing by hepatitis C virus and new opportunities for antiviral drug design.	Rockefeller Univ, Ctr Study Hepatitis C, Lab Virol & Infect Dis, New York, NY 10021 USA	Rockefeller University	Rice, CM (corresponding author), Rockefeller Univ, Ctr Study Hepatitis C, Lab Virol & Infect Dis, 1230 York Ave, New York, NY 10021 USA.	marcotj@rockefeller.edu; ricec@rockefeller.edu	Marcotrigiano, Joseph/K-6697-2016	Marcotrigiano, Joseph/0000-0003-0346-3353				Alter HJ, 2000, SEMIN LIVER DIS, V20, P17, DOI 10.1055/s-2000-9505; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bartenschlager R, 2004, ADV VIRUS RES, V63, P71, DOI 10.1016/S0065-3527(04)63002-8; Boatright KM, 2003, CURR OPIN CELL BIOL, V15, P725, DOI 10.1016/j.ceb.2003.10.009; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Gale M, 2005, NATURE, V436, P939, DOI 10.1038/nature04078; GRAKOUI A, 1993, P NATL ACAD SCI USA, V90, P10583, DOI 10.1073/pnas.90.22.10583; HIJIKATA M, 1993, J VIROL, V67, P4665, DOI 10.1128/JVI.67.8.4665-4675.1993; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Hoofnagle JH, 2002, HEPATOLOGY, V36, pS21, DOI 10.1053/jhep.2002.36227; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kim JL, 1996, CELL, V87, P343, DOI 10.1016/S0092-8674(00)81351-3; LINDENBACH BD, 2001, FIELDS VIROLOGY, P991; Love RA, 1996, CELL, V87, P331, DOI 10.1016/S0092-8674(00)81350-1; MALCOLM BA, 1995, PROTEIN SCI, V4, P1439, DOI 10.1002/pro.5560040801; MCPHALEN CA, 1988, BIOCHEMISTRY-US, V27, P6582, DOI 10.1021/bi00417a058; Mosimann SC, 1997, J MOL BIOL, V273, P1032, DOI 10.1006/jmbi.1997.1306; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pallaoro M, 2001, J VIROL, V75, P9939, DOI 10.1128/JVI.75.20.9939-9946.2001; PICKERSGILL RW, 1992, ACTA CRYSTALLOGR B, V48, P49; Pietschmann T, 2006, P NATL ACAD SCI USA, V103, P7408, DOI 10.1073/pnas.0504877103; SANTOLINI E, 1995, J VIROL, V69, P7461, DOI 10.1128/JVI.69.12.7461-7471.1995; Thibeault D, 2001, J BIOL CHEM, V276, P46678, DOI 10.1074/jbc.M108266200; TONG L, 1993, J MOL BIOL, V230, P228, DOI 10.1006/jmbi.1993.1139; Urbani A, 1998, J BIOL CHEM, V273, P18760, DOI 10.1074/jbc.273.30.18760; Weeks CM, 1999, J APPL CRYSTALLOGR, V32, P120, DOI 10.1107/S0021889898010504; Wlodawer A, 2000, BBA-PROTEIN STRUCT M, V1477, P16, DOI 10.1016/S0167-4838(99)00267-8; Wu Z, 1998, TRENDS BIOCHEM SCI, V23, P92, DOI 10.1016/S0968-0004(98)01180-3; Yamaga AK, 2002, J BIOL CHEM, V277, P33228, DOI 10.1074/jbc.M202304200	29	144	152	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 17	2006	442	7104					831	835		10.1038/nature04975	http://dx.doi.org/10.1038/nature04975			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	074DK	16862121				2022-12-28	WOS:000239792700050
J	Esposito, JJ; Sammons, SA; Frace, AM; Osborne, JD; Olsen-Rasmussen, M; Zhang, M; Govil, D; Damon, IK; Kline, R; Laker, M; Li, Y; Smith, GL; Meyer, H; LeDuc, JW; Wohlhueter, RM				Esposito, Joseph J.; Sammons, Scott A.; Frace, A. Michael; Osborne, John D.; Olsen-Rasmussen, Melissa; Zhang, Ming; Govil, Dhwani; Damon, Inger K.; Kline, Richard; Laker, Miriam; Li, Yu; Smith, Geoffrey L.; Meyer, Hermann; LeDuc, James W.; Wohlhueter, Robert M.			Genome sequence diversity and clues to the evolution of variola (smallpox) virus	SCIENCE			English	Article							NUCLEOTIDE-SEQUENCE; ESCHERICHIA-COLI; DNA; VIRULENCE; TRANSPOSITION	Comparative genomics of 45 epidemiologically varied variola virus isolates from the past 30 years of the smallpox era indicate low sequence diversity, suggesting that there is probably little difference in the isolates' functional gene content. Phylogenetic clustering inferred three clades coincident with their geographical origin and case-fatality rate; the latter implicated putative proteins that mediate viral virulence differences. Analysis of the viral linear DNA genome suggests that its evolution involved direct descent and DNA end-region recombination events. Knowing the sequences will help understand the viral proteome and improve diagnostic test precision, therapeutics, and systems for their assessment.	Ctr Dis Control & Prevent, Biotech Core Facil Branch, Div Sci Resources, Natl Ctr Preparedness Detect & Control Infect Dis, Atlanta, GA 30329 USA; Ctr Dis Control & Prevent, Poxvirus & Rabies Branch, Div Viral & Rickettsial Dis, Natl Ctr Zoonot Vector Borne & Enter Dis, Atlanta, GA 30329 USA; Ctr Dis Control & Prevent, Coordinating Ctr Infect Dis, Atlanta, GA 30329 USA; Univ London Imperial Coll Sci Technol & Med, London W2 1PG, England; Bundeswehr Inst Microbiol, D-80937 Munich, Germany	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Imperial College London; Bundeswehr Institute of Microbiology (IMB)	Esposito, JJ (corresponding author), Ctr Dis Control & Prevent, Biotech Core Facil Branch, Div Sci Resources, Natl Ctr Preparedness Detect & Control Infect Dis, Atlanta, GA 30329 USA.	jesposito@cdc.gov	Smith, Geoffrey L/G-2894-2012; Osborne, John/F-3445-2016	Smith, Geoffrey L/0000-0002-3730-9955; Osborne, John/0000-0002-0851-1150	Medical Research Council [G0501257] Funding Source: Medline; MRC [G0501257] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Alcami A, 1996, P NATL ACAD SCI USA, V93, P11029, DOI 10.1073/pnas.93.20.11029; Balbas P, 2001, MOL BIOTECHNOL, V19, P1, DOI 10.1385/MB:19:1:001; BANHAM AH, 1993, J GEN VIROL, V74, P2807, DOI 10.1099/0022-1317-74-12-2807; BEDSON HS, 1964, J HYG-CAMBRIDGE, V62, P147, DOI 10.1017/S0022172400039887; Camus-Bouclainville C, 2004, J VIROL, V78, P2510, DOI 10.1128/JVI.78.5.2510-2516.2004; de Miranda MP, 2003, J GEN VIROL, V84, P2459, DOI 10.1099/vir.0.19292-0; Domi A, 2002, P NATL ACAD SCI USA, V99, P12415, DOI 10.1073/pnas.192420599; Dumbell KR, 1999, EPIDEMIOL INFECT, V122, P287, DOI 10.1017/S0950268899002150; DUMBELL KR, 1986, AM J EPIDEMIOL, V123, P403, DOI 10.1093/oxfordjournals.aje.a114255; DUMBELL KR, 1975, T ROY SOC TROP MED H, V69, P303, DOI 10.1016/0035-9203(75)90123-6; ESPOSITO JJ, 1985, VIROLOGY, V143, P230, DOI 10.1016/0042-6822(85)90111-4; ESPOSITO JJ, 1981, VIROLOGY, V109, P231, DOI 10.1016/0042-6822(81)90495-5; Hamilton MD, 2005, NUCLEIC ACIDS RES, V33, P2259, DOI 10.1093/nar/gki525; Henderson DA, 1999, JAMA-J AM MED ASSOC, V281, P2127, DOI 10.1001/jama.281.22.2127; Huq F, 2003, T ROY SOC TROP MED H, V97, P97, DOI 10.1016/S0035-9203(03)90036-8; Institute of Medicine, 1999, ASS FUT SCI NEEDS LI; Jezek Z, 1988, HUMAN MONKEYPOX; MASSUNG RF, 1995, VIROLOGY, V211, P350, DOI 10.1006/viro.1995.1416; Massung RF, 1996, VIROLOGY, V221, P291, DOI 10.1006/viro.1996.0378; MASSUNG RF, 1993, NATURE, V366, P748, DOI 10.1038/366748a0; MASSUNG RF, 1994, VIROLOGY, V201, P215, DOI 10.1006/viro.1994.1288; Meyer H, 2002, J VET MED B, V49, P17, DOI 10.1046/j.1439-0450.2002.00532.x; MOSS B, 2001, POXVIRIDAE VIRUSES T, V2, P2849; MOYER RW, 1980, CELL, V22, P545, DOI 10.1016/0092-8674(80)90364-5; National Research Council, 2004, BIOT RES AG TERR; NIZAMUDDIN M, 1961, LANCET, V1, P68; PICKUP DJ, 1984, P NATL ACAD SCI-BIOL, V81, P6817, DOI 10.1073/pnas.81.21.6817; Salemi M., 2003, PHYLOGENETIC HDB PRA; SHAFA E, 1972, WHOSE7235; SHCHELKUNOV SN, 1993, VIRUS RES, V30, P239, DOI 10.1016/0168-1702(93)90093-3; Shchelkunov SN, 2000, VIROLOGY, V266, P361, DOI 10.1006/viro.1999.0086; SHCHELKUNOV SN, 1994, VIRUS RES, V32, P37, DOI 10.1016/0168-1702(94)90060-4; SHCHELKUNOV SN, 1993, DOKL AKAD NAUK+, V328, P629; SHCHELKUNOV SN, 1995, VIRUS RES, V36, P107, DOI 10.1016/0168-1702(94)00113-Q; SHCHELKUNOV SN, 1993, VIRUS RES, V27, P25, DOI 10.1016/0168-1702(93)90110-9; Snel B, 2002, GENOME RES, V12, P17, DOI 10.1101/gr.176501; Tian JD, 2004, NATURE, V432, P1050, DOI 10.1038/nature03151; *WHO, 1999, WEEKLY EPIDEMIOL REC, V74, P188; *WHO, 2002, WKLY EPIDEMIOL REC, V77, P34; *WORLD HLTH ASS, 2002, 5515 WHA	40	139	143	1	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 11	2006	313	5788					807	812		10.1126/science.1125134	http://dx.doi.org/10.1126/science.1125134			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072KC	16873609	Green Published			2022-12-28	WOS:000239671300051
J	Jones, GH; Franklin, FCH				Jones, Gareth H.; Franklin, F. Chris H.			Meiotic crossing-over: Obligation and interference	CELL			English	Editorial Material							RECOMBINATION; MEIOSIS		Univ Birmingham, Sch Biosci, Birmingham B15 2TT, W Midlands, England	University of Birmingham	Jones, GH (corresponding author), Univ Birmingham, Sch Biosci, Birmingham B15 2TT, W Midlands, England.	g.h.jones@bham.ac.uk		Franklin, F. Chris H./0000-0003-3507-722X	Biotechnology and Biological Sciences Research Council [BB/C512810/1] Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		BAKER BS, 1976, ANNU REV GENET, V10, P53, DOI 10.1146/annurev.ge.10.120176.000413; Borner GV, 2004, CELL, V117, P29, DOI 10.1016/S0092-8674(04)00292-2; Broman KW, 2000, AM J HUM GENET, V66, P1911, DOI 10.1086/302923; de Boer E, 2006, P NATL ACAD SCI USA, V103, P9607, DOI 10.1073/pnas.0600418103; Hillers KJ, 2003, CURR BIOL, V13, P1641, DOI 10.1016/j.cub.2003.08.026; Keeney S, 2001, CURR TOP DEV BIOL, V52, P1, DOI 10.1016/S0070-2153(01)52008-6; Kleckner N, 2004, P NATL ACAD SCI USA, V101, P12592, DOI 10.1073/pnas.0402724101; PARKER JS, 1982, CHROMOSOMA, V85, P673, DOI 10.1007/BF00330780	8	129	135	1	18	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUL 28	2006	126	2					246	248		10.1016/j.cell.2006.07.010	http://dx.doi.org/10.1016/j.cell.2006.07.010			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	070VD	16873056	Bronze			2022-12-28	WOS:000239552600010
J	Maret, S; Bergin, EA; Lada, CJ				Maret, S.; Bergin, E. A.; Lada, C. J.			A low fraction of nitrogen in molecular form in a dark cloud	NATURE			English	Article							DENSE INTERSTELLAR CLOUDS; O1 HALE-BOPP; STARLESS CORES; DEPLETION; COMETS; N2H+; DESORPTION; ABUNDANCE; CHEMISTRY	Nitrogen is the fifth most abundant element in the Universe. In the interstellar medium, it has been thought to be mostly molecular (N-2)(1). However, N-2 has no observable rotational or vibrational transitions, so its abundance in the interstellar medium remains poorly known. In comets, the N-2 abundance is very low(2,3), while the elemental nitrogen abundance is deficient with respect to the solar value. Moreover, large nitrogen isotopic anomalies are observed in meteorites and interstellar dust particles(4). Here we report the N2H+ (and by inference the N-2) abundance inside a cold dark molecular cloud. We find that only a small fraction of nitrogen in the gas phase is molecular, with most of it being atomic. Because the compositions of comets probably reflect those of dark clouds(5), this result explains the low N-2 abundance in comets. We argue that the elemental nitrogen abundance deficiency in comets can be understood if the atomic oxygen abundance is lower than predicted by present chemical models. Furthermore, the lack of molecular nitrogen in molecular clouds explains the nitrogen anomalies in meteorites and interstellar dust particles, as nitrogen fractionation is enhanced if gaseous nitrogen is atomic(6).	Univ Michigan, Dept Astron, Ann Arbor, MI 48109 USA; Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA	University of Michigan System; University of Michigan; Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution	Maret, S (corresponding author), Univ Michigan, Dept Astron, 500 Church St, Ann Arbor, MI 48109 USA.	smaret@umich.edu		Maret, Sebastien/0000-0003-1104-4554				Alves JF, 2001, NATURE, V409, P159, DOI 10.1038/35051509; BERGIN EA, 1995, ASTROPHYS J, V441, P222, DOI 10.1086/175351; Bergin EA, 2002, ASTROPHYS J, V570, pL101, DOI 10.1086/340950; BERGIN EA, IN PRESS ASTROPHYS J; CASELLI P, 1995, ASTROPHYS J, V455, pL77, DOI 10.1086/309805; Caselli P, 2002, ASTROPHYS J, V565, P344, DOI 10.1086/324302; Caselli P, 1998, ASTROPHYS J, V499, P234, DOI 10.1086/305624; Charnley SB, 2002, ASTROPHYS J, V569, pL133, DOI 10.1086/340484; Cochran AL, 2000, ICARUS, V146, P583, DOI 10.1006/icar.2000.6413; Geppert WD, 2004, ASTROPHYS J, V609, P459, DOI 10.1086/420733; Gibb EL, 2004, ASTROPHYS J SUPPL S, V151, P35, DOI 10.1086/381182; HERBST E, 1973, ASTROPHYS J, V185, P505, DOI 10.1086/152436; Iro N, 2003, ICARUS, V161, P511, DOI 10.1016/S0019-1035(02)00038-6; Irvine W. M., 2000, Protostars and planets 4, P1159; Keto E, 2004, ASTROPHYS J, V613, P355, DOI 10.1086/422987; Knauth DC, 2004, NATURE, V429, P636, DOI 10.1038/nature02614; LINKE RA, 1983, ASTROPHYS J, V271, pL85, DOI 10.1086/184100; MESSENGER S, 1996, METEORIT PLANET SCI, V31, pA88; Oberg KI, 2005, ASTROPHYS J, V621, pL33, DOI 10.1086/428901; Pagani L, 2005, ASTRON ASTROPHYS, V429, P181, DOI 10.1051/0004-6361:20041044; Tafalla M, 2002, ASTROPHYS J, V569, P815, DOI 10.1086/339321; Terzieva R, 2000, MON NOT R ASTRON SOC, V317, P563, DOI 10.1046/j.1365-8711.2000.03618.x; WOMACK M, 1992, ASTROPHYS J, V393, P188, DOI 10.1086/171496; WYCKOFF S, 1991, ASTROPHYS J, V367, P641, DOI 10.1086/169659	25	87	87	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 27	2006	442	7101					425	427		10.1038/nature04919	http://dx.doi.org/10.1038/nature04919			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067CI	16871211	Green Published			2022-12-28	WOS:000239278900036
J	Andersen, LB; Harro, M; Sardinha, LB; Froberg, K; Ekelund, U; Brage, S; Anderssen, SA				Andersen, Lars Bo; Harro, Maarike; Sardinha, Luis B.; Froberg, Karsten; Ekelund, Ulf; Brage, Soren; Anderssen, Sigmund Alfred			Physical activity and clustered cardiovascular risk in children: a cross-sectional study (The European Youth Heart Study)	LANCET			English	Article							METABOLIC SYNDROME; COMPUTER-SCIENCE; ACTIVITY MONITOR; ACCELEROMETER; ADOLESCENTS; VALIDATION; VALIDITY; HEALTH	Background Atherosclerosis develops from early childhood; physical activity could positively affect this process. This study's aim was to assess the associations of objectively measured physical activity with clustering of cardiovascular disease risk factors in children and derive guidelines on the basis of this analysis. Methods We did a cross-sectional study of 1732 randomly selected 9-year-old and 15-year-old school children from Denmark, Estonia, and Portugal. Risk factors included in the composite risk factor score (mean of Z scores) were systolic blood pressure, triglyceride, total cholesterol/HDL ratio, insulin resistance, sum of four skinfolds, and aerobic fitness. Individuals with a risk score above 1 SD of the composite variable were defined as being at risk. Physical activity was assessed by accelerometry. Findings Odds ratios for having clustered risk for ascending quintiles of physical activity (counts per min; cpm) were 3.29 (95% Cl 1.96-5.52), 3.13 (1.87-5.25), 2.51 (1.47-4.26), and 2.03 (1.18-3.50), respectively, compared with the most active quintile. The first to the third quintile of physical activity had a raised risk in all analyses. The mean time spent above 2000 cpm in the fourth quintile was 116 min per day in 9-year-old and 88 min per day in 15-year-old children. Interpretation Physical activity levels should be higher than the current international guidelines of at least 1 h per day of physical activity of at least moderate intensity to prevent clustering of cardiovascular disease risk factors.	Norwegian Sch Sports Sci, Dept Sports Med, N-0806 Oslo, Norway; Estonian Ctr Behav & Hlth Sci, Natl Inst Hlth Dev, Tartu, Estonia; Univ Tecn Lisboa, Fac Human Movement, P-1100 Lisbon, Portugal; Univ So Denmark, Inst Sport Sci & Clin Biomech, Odense, Denmark; MRC, Epidemiol Unit, Cambridge, England	Norwegian School of Sport Sciences; Universidade de Lisboa; University of Southern Denmark	Andersen, LB (corresponding author), Norwegian Sch Sports Sci, Dept Sports Med, Box 4014 Ullevaal Stad, N-0806 Oslo, Norway.	lars.bo.andersen@nih.no	Sardinha, Luís Bettencourt/F-2641-2013; Brage, Soren/C-6415-2013; Ekelund, Ulf/A-1046-2008; Fahimifar, Sepideh/M-5303-2019; Sardinha, Luís B./ABG-5389-2020	Sardinha, Luís Bettencourt/0000-0002-6230-6027; Brage, Soren/0000-0002-1265-7355; Sardinha, Luís B./0000-0002-6230-6027	Medical Research Council [MC_U106179473] Funding Source: Medline; MRC [MC_U106179473] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		ALTMAN DG, 1991, THEORETICAL DISTRIBU, P68; American College of Sports Medicine, 1988, MED SCI SPORTS EXERC, V20, P422, DOI DOI 10.1249/00005768-198808000-00022; Andersen Lars Bo, 2004, Int J Behav Nutr Phys Act, V1, P6, DOI 10.1186/1479-5868-1-6; Andersen LB, 2003, PREV MED, V37, P363, DOI 10.1016/S0091-7435(03)00145-2; BIDDLE S, 1999, YOUNG ACTIVE YOUNG P, P1; Boreham C, 2001, J SPORT SCI, V19, P915, DOI 10.1080/026404101317108426; Brage S, 2003, MED SCI SPORT EXER, V35, P1447, DOI 10.1249/01.MSS.0000079078.62035.EC; Brage S, 2003, PEDIATR EXERC SCI, V15, P277, DOI 10.1123/pes.15.3.277; Cook S, 2003, ARCH PEDIAT ADOL MED, V157, P821, DOI 10.1001/archpedi.157.8.821; Ekelund U, 2003, OBES RES, V11, P793, DOI 10.1038/oby.2003.110; Ekelund U, 2000, INT J SPORTS MED, V21, P586, DOI 10.1055/s-2000-8487; Ford ES, 2005, DIABETES CARE, V28, P878, DOI 10.2337/diacare.28.4.878; Grundy SM, 2004, CIRCULATION, V109, P433, DOI 10.1161/01.CIR.0000111245.75752.C6; Lawlor DA, 2005, ARCH DIS CHILD, V90, P582, DOI 10.1136/adc.2004.055335; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Puyau MR, 2002, OBES RES, V10, P150, DOI 10.1038/oby.2002.24; Riddoch C, 2005, J PHYS ACT HEALTH, V2, P115, DOI DOI 10.1123/JPAH.2.1.115; SALLIS JF, 1994, PEDIATR EXERC SCI, V6, P302; Strong WB, 2005, J PEDIATR-US, V146, P732, DOI 10.1016/j.jpeds.2005.01.055; Tanner JM, 1962, GROWTH ADOLESCENCE, V2nd; Treuth MS, 2004, MED SCI SPORT EXER, V36, P198, DOI 10.1249/01.MSS.0000113666.98463.B0; Trost SG, 1998, MED SCI SPORT EXER, V30, P629, DOI 10.1097/00005768-199804000-00023; Ward DS, 2005, MED SCI SPORT EXER, V37, pS582, DOI 10.1249/01.mss.0000185292.71933.91	23	1055	1090	4	188	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 22	2006	368	9532					299	304		10.1016/S0140-6736(06)69075-2	http://dx.doi.org/10.1016/S0140-6736(06)69075-2			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	067PF	16860699				2022-12-28	WOS:000239314400027
J	Watts, G				Watts, Geoff			Knowing me, knowing ewe	LANCET			English	Editorial Material												geoff@scileg.freeserve.co.uk						Darwin Charles, 1871, DESCENT MAN; Goetz J., 2003, P 12 IEEE INT WORKSH; Goodall J., 2000, SHADOW MAN; Gosling SD, 2001, PSYCHOL BULL, V127, P45, DOI 10.1037//0033-2909.127.1.45; HOYLE F, 1957, BLACK CLOUD; Rivas Jesus A., 2001, Animal Behaviour Forum, V62, pF1, DOI 10.1006/anbe.2001.1755	6	1	1	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 22	2006	368	9532					270	272		10.1016/S0140-6736(06)69054-5	http://dx.doi.org/10.1016/S0140-6736(06)69054-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	067PF	16860683				2022-12-28	WOS:000239314400008
J	Eshaghi, S; Niegowski, D; Kohl, A; Molina, DM; Lesley, SA; Nordlund, P				Eshaghi, Said; Niegowski, Damian; Kohl, Andreas; Molina, Daniel Martinez; Lesley, Scott A.; Nordlund, Par			Crystal structure of a divalent metal ion transporter CorA at 2.9 angstrom resolution	SCIENCE			English	Article							ENTERICA SEROVAR TYPHIMURIUM; MAGNESIUM TRANSPORT; SALMONELLA-TYPHIMURIUM; ESCHERICHIA-COLI; CONSERVED RESIDUES; MG2+ TRANSPORTER; MEMBRANE DOMAIN; PROTEIN; TOPOLOGY; MUTAGENESIS	CorA family members are ubiquitously distributed transporters of divalent metal cations and are considered to be the primary Mg2+ transporter of Bacteria and Archaea. We have determined a 2.9 angstrom resolution structure of CorA from Thermotoga maritima that reveals a pentameric cone shaped protein. Two potential regulatory metal binding sites are found in the N-terminal domain that bind both Mg2+ and Co2+. The structure of CorA supports an efflux system involving dehydration and rehydration of divalent metal ions potentially mediated by a ring of conserved aspartate residues at the cytoplasmic entrance and a carbonyl funnel at the periplasmic side of the pore.	Karolinska Inst, Dept Med Biochem & Biophys, Div Biophys, SE-17177 Stockholm, Sweden; Stockholm Univ, Dept Biochem & Biophys, S-10691 Stockholm, Sweden; Novartis Res Fdn, Joint Ctr Struct Genom, San Diego, CA 92121 USA; Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA	Karolinska Institutet; Stockholm University; Novartis; Novartis	Eshaghi, S (corresponding author), Karolinska Inst, Dept Med Biochem & Biophys, Div Biophys, SE-17177 Stockholm, Sweden.	Said.Eshaghi@ki.se; Par.Nordlund@ki.se						Andersen C, 2002, MOL MICROBIOL, V44, P1131, DOI 10.1046/j.1365-2958.2002.02898.x; Bui DM, 1999, J BIOL CHEM, V274, P20438, DOI 10.1074/jbc.274.29.20438; Caldwell AM, 2003, J BACTERIOL, V185, P374, DOI 10.1128/JB.185.1.374-376.2003; Daley DO, 2005, SCIENCE, V308, P1321, DOI 10.1126/science.1109730; DIEBLER H, 1969, Pure and Applied Chemistry, V20, P93, DOI 10.1351/pac196920010093; Doyle DA, 2004, EUR BIOPHYS J BIOPHY, V33, P175, DOI 10.1007/s00249-003-0382-z; Doyle DA, 2004, TRENDS NEUROSCI, V27, P298, DOI 10.1016/j.tins.2004.04.004; Gardner RC, 2003, CURR OPIN PLANT BIOL, V6, P263, DOI 10.1016/S1369-5266(03)00032-3; Grass G, 2005, J BACTERIOL, V187, P1604, DOI 10.1128/JB.187.5.1604-1611.2005; Higgins MK, 2004, J MOL BIOL, V342, P697, DOI 10.1016/j.jmb.2004.07.088; HMIEL SP, 1986, J BACTERIOL, V168, P1444, DOI 10.1128/jb.168.3.1444-1450.1986; Kehres DG, 2002, BIOMETALS, V15, P261, DOI 10.1023/A:1016078832697; Knoop V, 2005, MOL GENET GENOMICS, V274, P205, DOI 10.1007/s00438-005-0011-x; Kucharski LM, 2000, J BIOL CHEM, V275, P16767, DOI 10.1074/jbc.M001507200; Lunin VV, 2006, NATURE, V440, P833, DOI 10.1038/nature04642; Maguire ME, 2002, BIOMETALS, V15, P203, DOI 10.1023/A:1016058229972; Miyazawa A, 2003, NATURE, V423, P949, DOI 10.1038/nature01748; Schock I, 2000, PLANT J, V24, P489, DOI 10.1046/j.1365-313x.2000.00895.x; Smith RL, 1998, J BACTERIOL, V180, P2788, DOI 10.1128/JB.180.10.2788-2791.1998; SMITH RL, 1993, J BIOL CHEM, V268, P14071; Smith RL, 1998, J BIOL CHEM, V273, P28663, DOI 10.1074/jbc.273.44.28663; SNAVELY MD, 1989, J BACTERIOL, V171, P4761, DOI 10.1128/jb.171.9.4761-4766.1989; Szegedy MA, 1999, J BIOL CHEM, V274, P36973, DOI 10.1074/jbc.274.52.36973; VONHEIJNE G, 1992, J MOL BIOL, V225, P487, DOI 10.1016/0022-2836(92)90934-C; Warren MA, 2004, J BACTERIOL, V186, P4605, DOI 10.1128/JB.186.14.4605-4612.2004; Worlock AJ, 2002, J BACTERIOL, V184, P4369, DOI 10.1128/JB.184.16.4369-4373.2002; [No title captured]	27	149	154	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 21	2006	313	5785					354	357		10.1126/science.1127121	http://dx.doi.org/10.1126/science.1127121			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065IV	16857941				2022-12-28	WOS:000239154300045
J	Loreau, M; Oteng-Yeboah, A; Arroyo, MTK; Babin, D; Barbault, R; Donoghue, M; Gadgil, M; Hauser, C; Heip, C; Larigauderie, A; Ma, K; Mace, G; Mooney, HA; Perrings, C; Raven, P; Sarukhan, J; Schei, P; Scholes, RJ; Watson, RT				Loreau, Michel; Oteng-Yeboah, Alfred; Arroyo, M. T. K.; Babin, D.; Barbault, R.; Donoghue, M.; Gadgil, M.; Hauser, C.; Heip, C.; Larigauderie, A.; Ma, K.; Mace, G.; Mooney, H. A.; Perrings, C.; Raven, P.; Sarukhan, J.; Schei, P.; Scholes, R. J.; Watson, R. T.			Diversity without representation	NATURE			English	Editorial Material									McGill Univ, Dept Biol, Montreal, PQ H3A 1B1, Canada; CSIR, Accra, Ghana	McGill University	Loreau, M (corresponding author), McGill Univ, Dept Biol, 1205 Doctor Penfield Ave, Montreal, PQ H3A 1B1, Canada.	executive-secretariat@imoseb.net	Heip, Carlo/C-2446-2009; Mace, Georgina M/I-3072-2016	Mace, Georgina M/0000-0001-8965-5211; Scholes, Robert/0000-0001-5537-6935				[Anonymous], 2005, MILLENNIUM ECOSYSTEM; Baillie J. E. M., 2004, 2004 IUCN RED LIST T; Dirzo R, 2005, SCIENCE, V310, P943, DOI 10.1126/science.1119958; Hendriks IE, 2006, SCIENCE, V312, P1715, DOI 10.1126/science.1128548; Mooney H, 2005, NATURE, V434, P561, DOI 10.1038/434561a; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121	6	92	100	0	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 20	2006	442	7100					245	246		10.1038/442245a	http://dx.doi.org/10.1038/442245a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064WT	16855567				2022-12-28	WOS:000239122100016
J	Mittleman, MA; Reynolds, EE				Mittleman, Murray A.; Reynolds, E. E.			A 39-year-old woman with hypercholesterolemia	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CORONARY-HEART-DISEASE; C-REACTIVE PROTEIN; DENSITY-LIPOPROTEIN CHOLESTEROL; CARDIOVASCULAR-DISEASE; PRIMARY-PREVENTION; RISK-FACTORS; MYOCARDIAL-INFARCTION; RANDOMIZED-TRIALS; CLINICAL-PRACTICE; NATIONAL-HEALTH	Ms T, a 39-year-old woman, has a total cholesterol level of 277 mg/dL (7.17 mmol/L) and well-controlled hypertension; her brother had a stroke in his 30s. She is primarily concerned with her mother's history of breast cancer, but she would like to know if she can take a dietary supplement or if she needs to take cholesterol-lowering medication, and if so, whether she will need to continue it as well as adhere to her diet for the rest of her life. Her estimated 10-year risk of developing coronary heart disease (CHD) is 1% to 2% using the Framingham Risk Score, but that may underestimate her true risk as an African American woman with a family history of CHD. Recommendations for her, her longer-term risk for CHD, and evidence for lipid-lowering therapies are discussed.	Harvard Univ, Sch Med, Boston, MA USA; Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health	Mittleman, MA (corresponding author), Beth Israel Deaconess Med Ctr, 185 Pilgrim Rd,Deac-301, Boston, MA 02215 USA.	mmittlem@bidmc.harvard.edu		Mittleman, Murray/0000-0001-9788-7274				Albert CM, 2002, CIRCULATION, V105, P2595, DOI 10.1161/01.CIR.0000017493.03108.1C; *ALLHAT OFF COORD, 2002, JAMA-J AM MED ASSOC, V288, P2998, DOI DOI 10.1016/S1062-1458(03)00049-7; American Heart Association, 2003, HEART DIS STROK STAT; [Anonymous], 1975, JAMA-J AM MED ASSOC, V231, P360; Arnett DK, 2002, AM J EPIDEMIOL, V156, P929, DOI 10.1093/aje/kwf133; Austin MA, 1998, AM J CARDIOL, V81, p7B, DOI 10.1016/S0002-9149(98)00031-9; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Ballantyne CM, 2003, CIRCULATION, V107, P2409, DOI 10.1161/01.CIR.0000068312.21969.C8; Bellosta S, 2004, CIRCULATION, V109, P50, DOI 10.1161/01.CIR.0000131519.15067.1f; Brookes ST, 2004, J CLIN EPIDEMIOL, V57, P229, DOI 10.1016/j.jclinepi.2003.08.009; Cannon CP, 2004, NEW ENGL J MED, V350, P1495, DOI 10.1056/NEJMoa040583; Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3; D'Agostino RB, 2001, JAMA-J AM MED ASSOC, V286, P180, DOI 10.1001/jama.286.2.180; Dale KM, 2006, JAMA-J AM MED ASSOC, V295, P74, DOI 10.1001/jama.295.1.74; Danesh J, 2000, CIRCULATION, V102, P1082, DOI 10.1161/01.CIR.102.10.1082; Danesh J, 2000, BMJ-BRIT MED J, V321, P199, DOI 10.1136/bmj.321.7255.199; Danesh J, 2004, NEW ENGL J MED, V350, P1387, DOI 10.1056/NEJMoa032804; De Backer G, 2003, EUR HEART J, V24, P1601, DOI 10.1016/S0195-668X(03)00347-6; de Lorgeril M, 1999, CIRCULATION, V99, P779, DOI 10.1161/01.CIR.99.6.779; Downs JR, 1998, JAMA-J AM MED ASSOC, V279, P1615, DOI 10.1001/jama.279.20.1615; FALK E, 1995, CIRCULATION, V92, P657, DOI 10.1161/01.CIR.92.3.657; Folsom AR, 2002, AM HEART J, V144, P233, DOI 10.1067/mhj.2002.124054; Ford ES, 2003, CIRCULATION, V107, P2185, DOI 10.1161/01.CIR.0000066320.27195.B4; FRICK MH, 1987, NEW ENGL J MED, V317, P1237, DOI 10.1056/NEJM198711123172001; FUSTER V, 1994, CIRCULATION, V90, P2126, DOI 10.1161/01.CIR.90.4.2126; Gotto A. M., 2003, MANUAL LIPID DISORDE; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Grundy SM, 2001, CIRCULATION, V104, P491, DOI 10.1161/01.CIR.104.4.491; Grundy SM, 2004, CIRCULATION, V110, P227, DOI 10.1161/01.CIR.0000133317.49796.0E; Haffner Steven M, 2003, Diabetes Care, V26 Suppl 1, pS83; Howard BV, 2006, JAMA-J AM MED ASSOC, V295, P655, DOI 10.1001/jama.295.6.655; JOHNSON CL, 1993, JAMA-J AM MED ASSOC, V269, P3002, DOI 10.1001/jama.269.23.3002; Ko DT, 2004, JAMA-J AM MED ASSOC, V291, P1864, DOI 10.1001/jama.291.15.1864; Kraus WE, 2002, NEW ENGL J MED, V347, P1483, DOI 10.1056/NEJMoa020194; LaRosa JC, 2005, NEW ENGL J MED, V352, P1425, DOI 10.1056/NEJMoa050461; LaRosa JC, 1999, JAMA-J AM MED ASSOC, V282, P2340, DOI 10.1001/jama.282.24.2340; Law MR, 2002, BMJ-BRIT MED J, V324, P1570, DOI 10.1136/bmj.324.7353.1570; Law MR, 2003, BRIT MED J, V326, P1423, DOI 10.1136/bmj.326.7404.1423; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Linfante A, 2004, CIRCULATION, V110, P664; Lloyd-Lones DM, 2003, ARCH INTERN MED, V163, P1966, DOI 10.1001/archinte.163.16.1966; Mitka M, 2003, JAMA-J AM MED ASSOC, V290, P2243, DOI 10.1001/jama.290.17.2243; Mozaffarian D, 2005, JAMA-J AM MED ASSOC, V294, P2897, DOI 10.1001/jama.294.22.2897; Pasternak RC, 2002, CIRCULATION, V106, P1024, DOI 10.1161/01.CIR.0000032466.44170.44; Pearson TA, 2003, CIRCULATION, V107, P499, DOI 10.1161/01.CIR.0000052939.59093.45; Pelkman CL, 2004, AM J CLIN NUTR, V79, P204; Pradhan AD, 2002, JAMA-J AM MED ASSOC, V288, P980, DOI 10.1001/jama.288.8.980; Ridker PM, 1998, CIRCULATION, V97, P2007, DOI 10.1161/01.CIR.97.20.2007; Ridker PM, 2003, CIRCULATION, V107, P391, DOI 10.1161/01.CIR.0000055014.62083.05; Ridker PM, 2004, CIRCULATION, V109, P6, DOI 10.1161/01.CIR.0000133444.17867.56; Ridker PM, 2001, NEW ENGL J MED, V344, P1959, DOI 10.1056/NEJM200106283442601; Ridker PM, 1997, NEW ENGL J MED, V336, P973, DOI 10.1056/NEJM199704033361401; Ridker PM, 2002, NEW ENGL J MED, V347, P1557, DOI 10.1056/NEJMoa021993; RIFKIND BM, 1984, JAMA-J AM MED ASSOC, V251, P365; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Rubins HB, 1999, NEW ENGL J MED, V341, P410, DOI 10.1056/NEJM199908053410604; Sacks FM, 1996, NEW ENGL J MED, V335, P1001, DOI 10.1056/NEJM199610033351401; Schlesinger Z, 2000, CIRCULATION, V102, P21, DOI 10.1161/01.CIR.102.1.21; Sever PS, 2003, LANCET, V361, P1149, DOI 10.1016/S0140-6736(03)12948-0; Shepherd J, 2002, LANCET, V360, P1623, DOI 10.1016/S0140-6736(02)11600-X; Snow V, 2004, ANN INTERN MED, V140, P644, DOI 10.7326/0003-4819-140-8-200404200-00012; Stampfer MJ, 2000, NEW ENGL J MED, V343, P16, DOI 10.1056/NEJM200007063430103; Taylor RS, 2004, AM J MED, V116, P682, DOI 10.1016/j.amjmed.2004.01.009; Thompson PD, 2003, JAMA-J AM MED ASSOC, V289, P1681, DOI 10.1001/jama.289.13.1681; Topol EJ, 2004, NEW ENGL J MED, V350, P1562, DOI 10.1056/NEJMe048061; Wald DS, 2002, BMJ-BRIT MED J, V325, P1202, DOI 10.1136/bmj.325.7374.1202; Walsh JME, 2004, JAMA-J AM MED ASSOC, V291, P2243, DOI 10.1001/jama.291.18.2243; Waters DD, 2005, AM J CARDIOL, V96, p69F, DOI 10.1016/j.amjcard.2005.06.028; Welch GN, 1998, NEW ENGL J MED, V338, P1042, DOI 10.1056/NEJM199804093381507; Willerson JT, 2004, CIRCULATION, V109, P2, DOI 10.1161/01.CIR.0000129535.04194.38; Wilson PWF, 2002, JAMA-J AM MED ASSOC, V288, P2042, DOI 10.1001/jama.288.16.2042; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837	72	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 19	2006	296	3					319	326		10.1001/jama.296.3.319	http://dx.doi.org/10.1001/jama.296.3.319			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	064LA	16849665				2022-12-28	WOS:000239089900024
J	Socoliuc, A; Gnecco, E; Maier, S; Pfeiffer, O; Baratoff, A; Bennewitz, R; Meyer, E				Socoliuc, Anisoara; Gnecco, Enrico; Maier, Sabine; Pfeiffer, Oliver; Baratoff, Alexis; Bennewitz, Roland; Meyer, Ernst			Atomic-scale control of friction by actuation of nanometer-sized contacts	SCIENCE			English	Article							MICROSCOPE; INTERFACE	Stiction and wear are demanding problems in nanoelectromechanical devices, because of their large surface-to-volume ratios and the inapplicability of traditional liquid lubricants. An efficient way to switch friction on and off at the atomic scale is achieved by exciting the mechanical resonances of the sliding system perpendicular to the contact plane. The resulting variations of the interaction energy reduce friction below 10 piconewtons in a finite range of excitation and load, without any noticeable wear. Without actuation, atomic stick-slip motion, which leads to dissipation, is observed in the same range. Even if the normal oscillations require energy to actuate, our technique represents a valuable way to minimize energy dissipation in nanocontacts.	Univ Basel, Dept Phys & Astron, CH-4003 Basel, Switzerland; McGill Univ, Dept Phys, Montreal, PQ, Canada	University of Basel; McGill University	Socoliuc, A (corresponding author), Univ Basel, Dept Phys & Astron, CH-4003 Basel, Switzerland.	a.socoliuc@unibas.ch	Gnecco, Enrico/H-5419-2013; Bennewitz, Roland/P-9657-2016; Meyer, Ernst/L-3873-2016; Maier, Sabine/B-5917-2008	Gnecco, Enrico/0000-0002-3053-923X; Bennewitz, Roland/0000-0002-5464-8190; Meyer, Ernst/0000-0001-6385-3412; Maier, Sabine/0000-0001-9589-6855				AUBRY S, 1983, PHYSICA D, V7, P240, DOI 10.1016/0167-2789(83)90129-X; Bureau L, 2000, PHYS REV E, V62, P6810, DOI 10.1103/PhysRevE.62.6810; Dienwiebel M, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.126101; Dinelli F, 1997, APPL PHYS LETT, V71, P1177, DOI 10.1063/1.120417; Gao JP, 1998, J PHYS CHEM B, V102, P5033, DOI 10.1021/jp982150q; Gnecco E, 2001, J PHYS-CONDENS MAT, V13, pR619, DOI 10.1088/0953-8984/13/31/202; Heuberger M, 1998, J PHYS CHEM B, V102, P5038, DOI 10.1021/jp9823143; HIRANO M, 1990, PHYS REV B, V41, P11837, DOI 10.1103/PhysRevB.41.11837; HOWALD L, 1993, APPL PHYS LETT, V63, P117, DOI 10.1063/1.109732; Hu YZ, 1998, TRIBOL LETT, V5, P81, DOI 10.1023/A:1019121103687; Kerssemakers J, 1998, SURF SCI, V417, P281, DOI 10.1016/S0039-6028(98)00672-4; Krylov SY, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.065101; Maier S, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.245418; NADAI A, 1950, THEORY FLOW FRACTURE, pCH7; Rabe U, 1996, REV SCI INSTRUM, V67, P3281, DOI 10.1063/1.1147409; Riedo E, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.084502; Rozman MG, 1998, PHYS REV E, V57, P7340, DOI 10.1103/PhysRevE.57.7340; SCHIMMEL T, 1995, N ATLANTIC TREATY OR; Socoliuc A, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.134301; Urbakh M, 2004, NATURE, V430, P525, DOI 10.1038/nature02750; WEAVER JMR, 1991, J VAC SCI TECHNOL B, V9, P1559, DOI 10.1116/1.585423; Zaloj V, 1999, PHYS REV LETT, V82, P4823, DOI 10.1103/PhysRevLett.82.4823	22	266	274	6	192	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 14	2006	313	5784					207	210		10.1126/science.1125874	http://dx.doi.org/10.1126/science.1125874			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	063GZ	16840695				2022-12-28	WOS:000239008000039
J	Harigaya, Y; Tanaka, H; Yamanaka, S; Tanaka, K; Watanabe, Y; Tsutsumi, C; Chikashige, Y; Hiraoka, Y; Yamashita, A; Yamamoto, M				Harigaya, Yuriko; Tanaka, Hirotsugu; Yamanaka, Soichiro; Tanaka, Kayoko; Watanabe, Yoshinori; Tsutsumi, Chihiro; Chikashige, Yuji; Hiraoka, Yasushi; Yamashita, Akira; Yamamoto, Masayuki			Selective elimination of messenger RNA prevents an incidence of untimely meiosis	NATURE			English	Article							MEIOTIC REGULATOR MEI2P; FISSION YEAST; SCHIZOSACCHAROMYCES-POMBE; SEXUAL DEVELOPMENT; TRANSCRIPTION FACTOR; SACCHAROMYCES-CEREVISIAE; PROTEIN; ENCODES; PHOSPHORYLATION; SPORULATION	Much remains unknown about the molecular regulation of meiosis. Here we show that meiosis-specific transcripts are selectively removed if expressed during vegetative growth in fission yeast. These messenger RNAs contain a cis-acting region-which we call the DSR-that confers this removal via binding to a YTH-family protein Mmi1. Loss of Mmi1 function severely impairs cell growth owing to the untimely expression of meiotic transcripts. Microarray analysis reveals that at least a dozen such meiosis-specific transcripts are eliminated by the DSR-Mmi1 system. Mmi1 remains in the form of multiple nuclear foci during vegetative growth. At meiotic prophase these foci precipitate to a single focus, which coincides with the dot formed by the master meiosis-regulator Mei2. A meiotic arrest due to the loss of the Mei2 dot is released by a reduction in Mmi1 activity. We propose that Mei2 turns off the DSR-Mmi1 system by sequestering Mmi1 to the dot and thereby secures stable expression of meiosis-specific transcripts.	Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Tokyo 1130033, Japan; Univ Tokyo, Mol Genet Res Lab, Tokyo 1130033, Japan; Natl Inst Informat & Commun Technol, Kansai Adv Res Ctr, Kobe, Hyogo 6512492, Japan	University of Tokyo; University of Tokyo; National Institute of Information & Communications Technology (NICT) - Japan	Yamamoto, M (corresponding author), Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Tokyo 1130033, Japan.	yamamoto@biochem.s.u-tokyo.ac.jp	Yamashita, Akira/A-5278-2015; Hiraoka, Yasushi/B-5111-2009	Yamashita, Akira/0000-0002-1805-1434; Hiraoka, Yasushi/0000-0001-9407-8228; Watanabe, Yoshinori/0000-0002-5488-4812; HARIGAYA, YURIKO/0000-0002-1879-5214; Tanaka, Kayoko/0000-0002-2905-3603				Allmang C, 1999, GENE DEV, V13, P2148, DOI 10.1101/gad.13.16.2148; BASI G, 1993, GENE, V123, P131, DOI 10.1016/0378-1119(93)90552-E; Cam HP, 2005, NAT GENET, V37, P809, DOI 10.1038/ng1602; Chu S, 1998, SCIENCE, V282, P699, DOI 10.1126/science.282.5389.699; Glynn JM, 2001, CURR BIOL, V11, P836, DOI 10.1016/S0960-9822(01)00235-4; Hansen KR, 2005, MOL CELL BIOL, V25, P590, DOI 10.1128/MCB.25.2.590-601.2005; HARTMANN AM, 1999, MOL BIOL CELL, V11, P3909; Higuchi T, 2002, MOL CELL BIOL, V22, P1, DOI 10.1128/MCB.22.1.1-11.2002; Horie S, 1998, MOL CELL BIOL, V18, P2118, DOI 10.1128/MCB.18.4.2118; IINO Y, 1985, MOL GEN GENET, V198, P416, DOI 10.1007/BF00332932; IINO Y, 1991, EMBO J, V10, P221, DOI 10.1002/j.1460-2075.1991.tb07939.x; Jensen TH, 2005, CELL, V121, P660, DOI 10.1016/j.cell.2005.05.018; Kitajima TS, 2003, EMBO J, V22, P5643, DOI 10.1093/emboj/cdg527; Kunitomo H, 2000, MOL BIOL CELL, V11, P3205, DOI 10.1091/mbc.11.9.3205; KUPEIC M, 1997, MOL CELLULAR BIOL YE, P889; Mata J, 2002, NAT GENET, V32, P143, DOI 10.1038/ng951; MAUNDRELL K, 1993, GENE, V123, P127, DOI 10.1016/0378-1119(93)90551-D; MCLEOD M, 1988, NATURE, V332, P509, DOI 10.1038/332509a0; Mendell JT, 2000, MOL CELL BIOL, V20, P8944, DOI 10.1128/MCB.20.23.8944-8957.2000; Milligan L, 2005, MOL CELL BIOL, V25, P9996, DOI 10.1128/MCB.25.22.9996-10004.2005; Nayler O, 2000, J CELL BIOL, V150, P949, DOI 10.1083/jcb.150.5.949; Niccoli T, 2004, J CELL SCI, V117, P5543, DOI 10.1242/jcs.01475; NURSE P, 1985, MOL GEN GENET, V198, P497, DOI 10.1007/BF00332946; Parisi S, 1999, MOL CELL BIOL, V19, P3515; Primig M, 2000, NAT GENET, V26, P415, DOI 10.1038/82539; Rafalska I, 2004, HUM MOL GENET, V13, P1535, DOI 10.1093/hmg/ddh167; Sato M, 2001, FEBS LETT, V499, P251, DOI 10.1016/S0014-5793(01)02567-4; Shimada T, 2003, MOL BIOL CELL, V14, P2461, DOI 10.1091/mbc.E02-11-0738; Stoilov P, 2002, TRENDS BIOCHEM SCI, V27, P495, DOI 10.1016/S0968-0004(02)02189-8; SUGIMOTO A, 1991, GENE DEV, V5, P1990, DOI 10.1101/gad.5.11.1990; SUROSKY RT, 1992, MOL CELL BIOL, V12, P3948, DOI 10.1128/MCB.12.9.3948; Szankasi P, 1996, CURR GENET, V30, P284, DOI 10.1007/s002940050134; Watanabe T, 2001, NUCLEIC ACIDS RES, V29, P2327, DOI 10.1093/nar/29.11.2327; WATANABE Y, 1994, CELL, V78, P487, DOI 10.1016/0092-8674(94)90426-X; Watanabe Y, 1997, NATURE, V386, P187, DOI 10.1038/386187a0; Watanabe Y, 1999, NATURE, V400, P461, DOI 10.1038/22774; YAMAMOTO M, 1997, MOL CELLULAR BIOL YE, P889; Yamashita A, 1997, GENES CELLS, V2, P155, DOI 10.1046/j.1365-2443.1997.1100307.x; Yamashita A, 1998, CELL, V95, P115, DOI 10.1016/S0092-8674(00)81787-0; Zhao SL, 2003, METH MOL B, V236, P365	40	235	242	1	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 6	2006	442	7098					45	50		10.1038/nature04881	http://dx.doi.org/10.1038/nature04881			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	059HS	16823445				2022-12-28	WOS:000238724500032
J	Tournoy, J; Dapper, I; Spitz, B; Meersseman, W; Van Wijngaerden, E; Lagrou, K; Blockmans, D				Tournoy, Jos; Dapper, Ilse; Spitz, Bernard; Meersseman, Wouter; Van Wijngaerden, Eric; Lagrou, Katrien; Blockmans, Daniel			Haemolysis, elevated liver enzymes, and thrombocytopenia in a 34-year-old pregnant woman	LANCET			English	Editorial Material							HELLP-SYNDROME		Univ Hosp Gasthuisberg, Dept Gen Internal Med, B-3000 Louvain, Belgium; Univ Hosp Gasthuisberg, Dept Obstet, B-3000 Louvain, Belgium; Univ Hosp Gasthuisberg, Dept Microbiol, B-3000 Louvain, Belgium	KU Leuven; University Hospital Leuven; KU Leuven; University Hospital Leuven; KU Leuven; University Hospital Leuven	Blockmans, D (corresponding author), Univ Hosp Gasthuisberg, Dept Gen Internal Med, B-3000 Louvain, Belgium.	daniel.blockmans@uz.kuleuven.ac.de	tournoy, jos/AAR-1965-2020; Van Wijngaerden, Eric/AAB-9187-2021	tournoy, jos/0000-0002-0265-9154; Van Wijngaerden, Eric/0000-0001-8926-099X				GIACOMINI T, 1995, B ACAD NAT MED PARIS, V179, P335; REUBINOFF BE, 1991, INT J GYNECOL OBSTET, V36, P95, DOI 10.1016/0020-7292(91)90762-T; SIBAI BM, 1993, AM J OBSTET GYNECOL, V169, P1000, DOI 10.1016/0002-9378(93)90043-I	3	6	6	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 1	2006	368	9529					90	90		10.1016/S0140-6736(06)68973-3	http://dx.doi.org/10.1016/S0140-6736(06)68973-3			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	058TQ	16815384				2022-12-28	WOS:000238687900035
J	Westerling, AL; Hidalgo, HG; Cayan, DR; Swetnam, TW				Westerling, A. L.; Hidalgo, H. G.; Cayan, D. R.; Swetnam, T. W.			Warming and earlier spring increase western US forest wildfire activity	SCIENCE			English	Article							VEGETATION DISTRIBUTION; CLIMATE-CHANGE; UNITED-STATES; FIRE REGIMES; VARIABILITY; FLUXES; MODEL; WATER; ENSO	Western United States forest wildfire activity is widely thought to have increased in recent decades, yet neither the extent of recent changes nor the degree to which climate may be driving regional changes in wildfire has been systematically documented. Much of the public and scientific discussion of changes in western United States wildfire has focused instead on the effects of 19th- and 20th-century land-use history. We compiled a comprehensive database of large wildfires in western United States forests since 1970 and compared it with hydroclimatic and land-surface data. Here, we show that large wildfire activity increased suddenly and markedly in the mid-1980s, with higher large-wildfire frequency, longer wildfire durations, and longer wildfire seasons. The greatest increases occurred in mid-elevation, Northern Rockies forests, where land-use histories have relatively little effect on fire risks and are strongly associated with increased spring and summer temperatures and an earlier spring snowmelt.	Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; Univ Calif, Merced, CA 95344 USA; US Geol Survey, La Jolla, CA 92093 USA; Univ Arizona, Tree Ring Res Lab, Tucson, AZ 85721 USA	University of California System; University of California San Diego; Scripps Institution of Oceanography; University of California System; University of California Merced; United States Department of the Interior; United States Geological Survey; University of Arizona	Westerling, AL (corresponding author), Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA.	awesterling@ucmerced.edu	Dolk, Shaun/B-5656-2012; Hidalgo, Hugo G./I-7170-2019	Hidalgo, Hugo G./0000-0003-4638-0742				Allen CD, 2002, ECOL APPL, V12, P1418; BALLING RC, 1992, AGR FOREST METEOROL, V60, P285, DOI 10.1016/0168-1923(92)90043-4; Belsky AJ, 1997, CONSERV BIOL, V11, P315, DOI 10.1046/j.1523-1739.1997.95405.x; Cayan DR, 2001, B AM METEOROL SOC, V82, P399, DOI 10.1175/1520-0477(2001)082<0399:CITOOS>2.3.CO;2; Covington WW, 2000, NATURE, V408, P135; COVINGTON WW, 1994, J FOREST, V92, P39; GERHSUNOV A, 1999, EOS, V80, P25; Gershunov A, 1998, J CLIMATE, V11, P1575, DOI 10.1175/1520-0442(1998)011<1575:EIOIER>2.0.CO;2; GRUEL GE, 2001, FIRE SIERRA NEVADA F; Hamlet AF, 2005, J HYDROMETEOROL, V6, P330, DOI 10.1175/JHM420.1; Heyerdahl EK, 2002, HOLOCENE, V12, P597, DOI 10.1191/0959683602hl570rp; Houghton J.T., 2001, IPCC CLIMATE CHANGE; Kipfmueller KF, 2000, US FOR SERV RMRS-P, V5, P270; Liang X, 1994, J GEOPHYS RES-ATMOS, V99, P14415, DOI 10.1029/94JD00483; Maurer EP, 2002, J CLIMATE, V15, P3237, DOI [10.1175/1520-0442(2002)015<3237:ALTHBD>2.0.CO;2, 10.1175/1520-0442(2002)015&lt;3237:ALTHBD&gt;2.0.CO;2]; MCKELVEY KS, 1996, SIERRA NEVADA ECOSYS, V2, pCH37; Mitchell KE, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2003JD003823; National Assessment Synthesis Team, 2000, CLIM CHANG IMP US PO; *NCDC, 1994, TD9640 DBMB NCDC NOA; Pacala SW, 2001, SCIENCE, V292, P2316, DOI 10.1126/science.1057320; Pierce JL, 2004, NATURE, V432, P87, DOI 10.1038/nature03058; Pyne S.J., 1996, INTRO WILDLAND FIRE; SACKS W, IN PRESS OECOLOGIA; SAVAGE M, 1990, ECOLOGY, V71, P2374, DOI 10.2307/1938649; Schimel D, 2005, ADV GLOB CHANGE RES, P449; Schoennagel T, 2004, BIOSCIENCE, V54, P661, DOI 10.1641/0006-3568(2004)054[0661:TIOFFA]2.0.CO;2; Schoennagel T, 2005, ECOL APPL, V15, P2000, DOI 10.1890/04-1579; Sheffield J, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2004JD005182; Slack J.R., 1992, 92129 US GEOL SURV; Stephenson NL, 1998, J BIOGEOGR, V25, P855, DOI 10.1046/j.1365-2699.1998.00233.x; STEPHENSON NL, 1990, AM NAT, V135, P649, DOI 10.1086/285067; Stewart IT, 2005, J CLIMATE, V18, P1136, DOI 10.1175/JCLI3321.1; SWETNAM TW, 1990, SCIENCE, V249, P1017, DOI 10.1126/science.249.4972.1017; Swetnam TW, 1998, J CLIMATE, V11, P3128, DOI 10.1175/1520-0442(1998)011<3128:MDAERT>2.0.CO;2; SWETNAM TW, 1993, SCIENCE, V262, P885, DOI 10.1126/science.262.5135.885; Veblen TT, 2000, ECOL APPL, V10, P1178, DOI 10.1890/1051-0761(2000)010[1178:CAHIOF]2.0.CO;2; Westerling A.L., 2003, EOS T AM GEOPHYS UN, V84, P545, DOI [10.1029/2003EO490001, DOI 10.1029/2003EO490001, 10.1029/2003eo490001]; Westerling AL, 2003, B AM METEOROL SOC, V84, P595, DOI 10.1175/BAMS-84-5-595; Whitlock C, 2004, NATURE, V432, P28, DOI 10.1038/432028a	39	3377	3475	44	1261	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 18	2006	313	5789					940	943		10.1126/science.1128834	http://dx.doi.org/10.1126/science.1128834			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	074MR	16825536				2022-12-28	WOS:000239817000035
J	Haerizadeh, F; Singh, MB; Bhalla, PL				Haerizadeh, Farzad; Singh, Mohan B.; Bhalla, Prem L.			Transcriptional repression distinguishes somatic from germ cell lineages in a plant	SCIENCE			English	Article							FLOWERING PLANTS; IDENTIFICATION; SPERM; ARABIDOPSIS; EXPRESSION; PROMOTER; FAMILY; GENES	In flowering plants, the male germline begins with an asymmetric division, after which one of the resulting cells, the generative cell, divides symmetrically to produce two sperm cells. We show here that the male germline is initiated by transcriptional control. We identify GRSF, germline-restrictive silencing factor, from the lily. GRSF is ubiquitous in nongerm cells and is absent from male germ cells. GRSF recognizes silencer sequences in promoters of genes specific to the germline, stably repressing these genes in cells that are not destined to become germ cells.	Univ Melbourne, Plant Mol Biol & Biotechnol Lab, Australian Res Council,Fac land & Food Resources, Ctr Excellence Integrat Legume Res, Parkville, Vic 3010, Australia	University of Melbourne	Bhalla, PL (corresponding author), Univ Melbourne, Plant Mol Biol & Biotechnol Lab, Australian Res Council,Fac land & Food Resources, Ctr Excellence Integrat Legume Res, Parkville, Vic 3010, Australia.	premlb@unimelb.edu.au		Bhalla, Prem/0000-0002-2910-0393; Singh, Mohan/0000-0001-9427-8975				Boyle B, 2001, PLANT CELL, V13, P2525, DOI 10.1105/tpc.13.11.2525; Burkhard P, 2001, TRENDS CELL BIOL, V11, P82, DOI 10.1016/S0962-8924(00)01898-5; Buttinelli M, 1999, GENETICA, V106, P117, DOI 10.1023/A:1003745315540; COOK WB, 1992, NUCLEIC ACIDS RES, V20, P359, DOI 10.1093/nar/20.2.359; Engel ML, 2005, PLANT PHYSIOL, V138, P2124, DOI 10.1104/pp.104.054213; Imin N, 2006, MOL CELL PROTEOMICS, V5, P274, DOI 10.1074/mcp.M500242-MCP200; Lunyak VV, 2005, CELL, V121, P499, DOI 10.1016/j.cell.2005.05.003; MASCARENHAS JP, 1989, PLANT CELL, V1, P657, DOI 10.1105/tpc.1.7.657; Mori T, 2006, NAT CELL BIOL, V8, P64, DOI 10.1038/ncb1345; Okada T, 2005, PLANT J, V44, P557, DOI 10.1111/j.1365-313X.2005.02554.x; Okada T, 2005, PLANT CELL PHYSIOL, V46, P797, DOI 10.1093/pcp/pci075; Rotman N, 2005, CURR BIOL, V15, P244, DOI 10.1016/j.cub.2005.01.013; Shidlovskii YV, 2005, EMBO J, V24, P97, DOI 10.1038/sj.emboj.7600508; Siddiqa A, 2001, NATURE, V410, P383, DOI 10.1038/35066602; Singh M, 2003, FEBS LETT, V542, P47, DOI 10.1016/S0014-5793(03)00335-1; STRADER CD, 1994, ANNU REV BIOCHEM, V63, P101, DOI 10.1146/annurev.bi.63.070194.000533; Sun CT, 2001, J BIOL CHEM, V276, P24059, DOI 10.1074/jbc.M101330200; Xu HL, 1999, PLANT MOL BIOL, V39, P607, DOI 10.1023/A:1006162120037; Xu HL, 1999, P NATL ACAD SCI USA, V96, P2554, DOI 10.1073/pnas.96.5.2554	19	37	39	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 28	2006	313	5786					496	499		10.1126/science.1125526	http://dx.doi.org/10.1126/science.1125526			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067MZ	16873660				2022-12-28	WOS:000239308600054
J	Lallemand-Breitenbach, V; de The, H				Lallemand-Breitenbach, Valerie; de The, Hugues			CK2 and PML: Regulating the regulator	CELL			English	Editorial Material									Univ Paris 07, CNRS, UMR 7151, Hop St Louis, F-75475 Paris 10, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite	de The, H (corresponding author), Univ Paris 07, CNRS, UMR 7151, Hop St Louis, F-75475 Paris 10, France.	dethe@paris7.jussieu.fr		Lallemand, Valerie/0000-0001-9852-204X				Bischof O, 2002, EMBO J, V21, P3358, DOI 10.1093/emboj/cdf341; Condemine W, 2006, CANCER RES, V66, P6192, DOI 10.1158/0008-5472.CAN-05-3792; Hecker CM, 2006, J BIOL CHEM, V281, P16117, DOI 10.1074/jbc.M512757200; Lin HK, 2004, NATURE, V431, P205, DOI 10.1038/nature02783; Meroni G, 2005, BIOESSAYS, V27, P1147, DOI 10.1002/bies.20304; Negorev D, 2001, ONCOGENE, V20, P7234, DOI 10.1038/sj.onc.1204764; Trotman LC, 2006, NATURE, V441, P523, DOI 10.1038/nature04809; Wei XL, 2003, J BIOL CHEM, V278, P29288, DOI 10.1074/jbc.M212215200; Zhu J, 2005, CANCER CELL, V7, P143, DOI 10.1016/j.ccr.2005.01.005	9	8	8	0	1	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUL 28	2006	126	2					244	245		10.1016/j.cell.2006.07.004	http://dx.doi.org/10.1016/j.cell.2006.07.004			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	070VD	16873055	Bronze			2022-12-28	WOS:000239552600009
J	Winckler, G; Fischer, H				Winckler, Gisela; Fischer, Hubertus			30,000 years of cosmic dust in Antarctic ice	SCIENCE			English	Article							INTERPLANETARY DUST; GLACIAL CYCLES		Columbia Univ, Lamont Doherty Earth Observ, Earth Inst, Palisades, NY 10964 USA; Alfred Wegener Inst Polar & Marine Res, D-27568 Bremerhaven, Germany	Columbia University; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research	Winckler, G (corresponding author), Columbia Univ, Lamont Doherty Earth Observ, Earth Inst, Palisades, NY 10964 USA.	winckler@ldeo.columbia.edu	Fischer, Hubertus/A-1211-2014	Fischer, Hubertus/0000-0002-2787-4221				Augustin L, 2004, NATURE, V429, P623, DOI 10.1038/nature02599; Brook EJ, 2000, GEOPHYS RES LETT, V27, P3145, DOI 10.1029/2000GL011813; Gabrielli P, 2004, NATURE, V432, P1011, DOI 10.1038/nature03137; Marcantonio F, 2001, PALEOCEANOGRAPHY, V16, P260, DOI 10.1029/2000PA000540; MULLER RA, 1995, NATURE, V377, P107, DOI 10.1038/377107b0; NIER AO, 1992, METEORITICS, V27, P166, DOI 10.1111/j.1945-5100.1992.tb00744.x; Winckler G, 2004, QUATERNARY SCI REV, V23, P1873, DOI 10.1016/j.quascirev.2004.05.007	7	40	40	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 28	2006	313	5786					491	491		10.1126/science.1127469	http://dx.doi.org/10.1126/science.1127469			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067MZ	16873659	Green Submitted			2022-12-28	WOS:000239308600052
J	Despriet, DDG; Klaver, CCW; Witteman, JCM; Bergen, AAB; Kardys, I; de Maat, MPM; Boekhoorn, SS; Vingerling, JR; Hofman, A; Oostra, BA; Uitterlinden, AG; Stijnen, T; van Duijn, CM; de Jong, PTVM				Despriet, Dominiek D. G.; Klaver, Caroline C. W.; Witteman, Jacqueline C. M.; Bergen, Arthur A. B.; Kardys, Isabella; de Maat, Moniek P. M.; Boekhoorn, Sharmila S.; Vingerling, Johannes R.; Hofman, Albert; Oostra, Ben A.; Uitterlinden, Andre G.; Stijnen, Theo; van Duijn, Cornelia M.; de Jong, Paulus T. V. M.			Complement factor H polymorphism, complement activators, and risk of age-related macular degeneration	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							C-REACTIVE PROTEIN; CORONARY-HEART-DISEASE; GENOMEWIDE-SCAN; FAMILIAL AGGREGATION; SUSCEPTIBILITY LOCI; EXTENDED FAMILIES; CRP LEVELS; MACULOPATHY; POPULATION; GENE	Context The evidence that inflammation is an important pathway in age-related macular degeneration (AMD) is growing. Recent case-control studies demonstrated an association between the complement factor H (CFH) gene, a regulator of complement, and AMD. Objectives To assess the associations between the CFH gene and AMD in the general population and to investigate the modifying effect of smoking, serum inflammatory markers, and genetic variation of C-reactive protein (CRP). Design, Setting, and Participants Population-based, prospective cohort study of individuals aged 55 years or older (enrollment between March 20, 1990, and July 31, 1993, and 3 follow-up examinations that were performed between September 1, 1993, and December 31, 2004) in Rotterdam, the Netherlands. The CFH Y402H polymorphism was determined in a total of 5681 individuals. Information on smoking, erythrocyte sedimentation rate, CRP serum levels, and haplotypes of the CRP gene were assessed at baseline. Main Outcome Measures All severity stages of prevalent and incident AMD, graded according to the international classification and grading system for AMD. Results The frequency of CFH Y402H was 36.2% (4116/11 362 alleles). At baseline, there were 2062 persons (36.3%) with any type of AMD (prevalent cases), including 78 (1.4%) with late AMD (stage 4). During follow-up (mean, 8 years; median, 10 years), 1649 (35.5%) of 4642 participants progressed to a higher stage of AMD (incident cases), including 93 (5.6%) who developed late AMD. The odds ratio (OR) of AMD increased in an allele-dose manner with 2.00 (95% confidence interval [CI], 1.56-2.55) for stage 2 AMD, 4.58 (95% CI, 2.82-7.44) for stage 3 AMD, and 11.02 (95% CI, 6.82-11.81) for stage 4 (late, vision threatening) AMD for homozygous persons. Cumulative risks calculated by Kaplan-Meier analysis of late AMD by age 95 years were 48.3% for homozygotes, 42.6% for heterozygotes, and 21.9% for noncarriers. The population-attributable risk for CFH Y402H was 54.0%. Elevated erythrocyte sedimentation rates further increased the OR to 20.2 (95% CI, 9.5-43.0), elevated serum CRP levels to 27.7 (95% CI, 10.7-72.0), and smoking to 34.0 (95% CI, 13.0-88.6) for homozygotes compared with noncarriers without these determinants. The CRP haplotypes conferring high levels of CRP significantly increased the effect of CFH Y402H (P<.01). Conclusions The CFH Y402H polymorphism may account for a substantial proportion of AMD in individuals similar to those in the Rotterdam Study and may confer particular risk in the presence of environmental and genetic stimulators of the complement cascade.	Netherlands Inst Neurosci, Dept Mol & Clin Ophthalmogenet, NL-1105 BA Amsterdam, Netherlands; Erasmus MC, Dept Epidemiol & Biostat, Rotterdam, Netherlands; Erasmus MC, Dept Ophthalmol, Rotterdam, Netherlands; Erasmus MC, Dept Hematol, Rotterdam, Netherlands; Erasmus MC, Dept Clin Genet, Rotterdam, Netherlands; Erasmus MC, Dept Internal Med, Rotterdam, Netherlands; Univ Amsterdam, Acad Med Ctr, Dept Clin Genet, NL-1105 AZ Amsterdam, Netherlands; Univ Amsterdam, Acad Med Ctr, Dept Ophthalmol, NL-1105 AZ Amsterdam, Netherlands	Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW); Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	de Jong, PTVM (corresponding author), Netherlands Inst Neurosci, Dept Mol & Clin Ophthalmogenet, Meibergdreef 47, NL-1105 BA Amsterdam, Netherlands.	p.dejong@nin.knaw.nl	Bergen, Arthur/J-3637-2013; Klaver, Caroline C.W./A-2013-2016	Klaver, Caroline/0000-0002-2355-5258; Bergen, Arthur/0000-0002-6333-9576; Van Duijn, Cornelia/0000-0002-2374-9204				Abecasis GR, 2004, AM J HUM GENET, V74, P482, DOI 10.1086/382786; Ambati J, 2003, NAT MED, V9, P1390, DOI 10.1038/nm950; BIRD AEC, 1995, SURV OPHTHALMOL, V39, P367, DOI 10.1016/S0039-6257(05)80092-X; Black S, 2004, J BIOL CHEM, V279, P48487, DOI 10.1074/jbc.R400025200; Brull DJ, 2003, ARTERIOSCL THROM VAS, V23, P2063, DOI 10.1161/01.ATV.0000084640.21712.9C; Carlson CS, 2005, AM J HUM GENET, V77, P64, DOI 10.1086/431366; de Cordoba SR, 2004, MOL IMMUNOL, V41, P355, DOI 10.1016/j.molimm.2004.02.005; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; Friedman DS, 2004, ARCH OPHTHALMOL-CHIC, V122, P564; Giannakis E, 2001, INT IMMUNOPHARMACOL, V1, P433, DOI 10.1016/S1567-5769(00)00040-0; Hageman GS, 2001, PROG RETIN EYE RES, V20, P705, DOI 10.1016/S1350-9462(01)00010-6; Hageman GS, 2005, P NATL ACAD SCI USA, V102, P7227, DOI 10.1073/pnas.0501536102; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; HEIBA IM, 1994, GENET EPIDEMIOL, V11, P51, DOI 10.1002/gepi.1370110106; HOFMAN A, 1991, EUR J EPIDEMIOL, V7, P403, DOI 10.1007/BF00145007; Iyengar SK, 2004, AM J HUM GENET, V74, P20, DOI 10.1086/380912; Kardys I, 2006, EUR HEART J, V27, P1331, DOI 10.1093/eurheartj/ehl018; KEW RR, 1985, J CLIN INVEST, V75, P1000, DOI 10.1172/JCI111760; Klaver CCW, 1998, ARCH OPHTHALMOL-CHIC, V116, P1646, DOI 10.1001/archopht.116.12.1646; Klein ML, 1998, ARCH OPHTHALMOL-CHIC, V116, P1082, DOI 10.1001/archopht.116.8.1082; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Magnusson KP, 2006, PLOS MED, V3, P109, DOI 10.1371/journal.pmed.0030005; Majewski J, 2003, AM J HUM GENET, V73, P540, DOI 10.1086/377701; Rivera A, 2005, HUM MOL GENET, V14, P3227, DOI 10.1093/hmg/ddi353; Rothman K., 1998, MODERN EPIDEMIOLOGY; Seddon JM, 2005, ARCH OPHTHALMOL-CHIC, V123, P774, DOI 10.1001/archopht.123.6.774; Seddon JM, 2003, AM J HUM GENET, V73, P780, DOI 10.1086/378505; Seddon JM, 1997, AM J OPHTHALMOL, V123, P199, DOI 10.1016/S0002-9394(14)71036-0; Souied EH, 2005, MOL VIS, V11, P1135; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; van der Vaart H, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-22; van Leeuwen R, 2003, ARCH OPHTHALMOL-CHIC, V121, P519, DOI 10.1001/archopht.121.4.519; Weber JL, 2001, ADV GENET, V42, P77, DOI 10.1016/S0065-2660(01)42016-5; Weeks DE, 2004, AM J HUM GENET, V75, P174, DOI 10.1086/422476; Zareparsi S, 2005, AM J HUM GENET, V77, P149, DOI 10.1086/431426	35	262	285	0	17	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 19	2006	296	3					301	309		10.1001/jama.296.3.301	http://dx.doi.org/10.1001/jama.296.3.301			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	064LA	16849663	Bronze			2022-12-28	WOS:000239089900022
J	Kessler, DP; Summerton, N; Graham, JR				Kessler, Daniel P.; Summerton, Nicholas; Graham, John R.			Effects of the medical liability system in Australia, the UK, and the USA	LANCET			English	Review							CLINICAL-PRACTICE GUIDELINES; DEFENSIVE MEDICINE; MALPRACTICE REFORMS; CARE; NEGLIGENCE; PHYSICIANS; IMPACT; LAW; HEALTH; POLICY	Although the direct costs of the medical liability system account for a small fraction of total health spending, the system's indirect effects on cost and quality of care can be much more important. Here, we summarise findings of existing research on the effects of the medical liability systems of Australia, the UK, and the USA. We find systematic evidence of defensive medicine-medical practice based on fear of legal liability rather than on patients' best interests. We conclude with discussion of four avenues for reform of traditional tort compensation for medical injury and several suggestions for future research.	Stanford Univ, Hoover Inst, Stanford, CA 94305 USA; Natl Bur Econ Res, Stanford, CA 94305 USA; Univ Hull, Welton HU15 1PN, Brough, England; Sydney Hosp, Dept Med, Sydney, NSW 2000, Australia	Stanford University; National Bureau of Economic Research; University of Hull	Kessler, DP (corresponding author), Stanford Univ, Hoover Inst, Stanford, CA 94305 USA.	fkessler@stanford.edu						*ACCC, 2005, 4 ACCC; *AHMAC LEG PROC RE, REV LAW NEGL FIN REP; Better Regulation Task Force, 2004, BETT ROUT REDR; Brazier M, 2000, MED LAW REV, V8, P85; *C BUDG OFF, 2004, EC BUDG ISS BRIEF LI; Cabana MD, 1999, JAMA-J AM MED ASSOC, V282, P1458, DOI 10.1001/jama.282.15.1458; Conde Caspar, 2004, POLICY, V20, P28; CROFTS P, 2003, AUST HLTH L B, V10, P113; DANZON PM, 2000, HDB HLTH EC, P1339; *DISTR COURT NSW, ANN REV 2002, P23; DRABSCH T, MED NEGLIGENCE UPDAT; Dubay L, 2001, J HEALTH ECON, V20, P591, DOI 10.1016/S0167-6296(01)00082-0; Dubay L, 1999, J HEALTH ECON, V18, P491, DOI 10.1016/S0167-6296(99)00004-1; Dwyer P, 1998, MED J AUSTRALIA, V169, P292, DOI 10.5694/j.1326-5377.1998.tb140275.x; Encinosa W. E., 2005, HAVE STATE CAPS MALP; Fenn P, 2004, ECON J, V114, pF272, DOI 10.1111/j.1468-0297.2004.00222.x; FENN P, 2002, EVALUATING POLICY AL; FENN P, LIABILITY INSURANCE; Fenn P., 2002, IMPACT CONDITIONAL F; FURROW BR, 2004, LIABILITY QUALITY IS; *GOV ACC OFF, 2003, GAO037022003; *GOV ACC OFF, 2003, GAO038362003; Graham JR, 2003, LANCET, V362, P836, DOI 10.1016/S0140-6736(03)14267-5; GRAHAM JR, 2005, AUSTR FINANCIAL 0923, P71; *HARV MED PRACT ST, 1990, PAT DOCT LAW MED INJ; HAVIGHURST CC, 1995, HLTH CARE CHOICES PR; HOBBS M, 2002, TECHNOLOGICAL CHANGE, P112; HUGHES JW, 1989, J BUS ECON STAT, V7, P423, DOI 10.2307/1391643; Hurwitz B, 2004, BMJ-BRIT MED J, V329, P1024, DOI 10.1136/bmj.329.7473.1024; KEHL D, 2001, LIABILITY INSURANCE; Kessler D, 1996, Q J ECON, V111, P353, DOI 10.2307/2946682; Kessler D, 2002, J PUBLIC ECON, V84, P175, DOI 10.1016/S0047-2727(01)00124-4; Kessler DP, 2005, JAMA-J AM MED ASSOC, V293, P2618, DOI 10.1001/jama.293.21.2618; Kessler DP, 2002, J HEALTH ECON, V21, P931, DOI 10.1016/S0167-6296(02)00076-0; Kessler DP, 1997, LAW CONTEMP PROBL, V60, P81, DOI 10.2307/1191996; KESSLER DP, IN PRESS MED MALPRAC; *MED IND POL REV P, 2003, REP PRIM MIN AFF SEC; *MED LIAB MON, 2001, TRENDS 2001 RAT PHYS; Mello MM, 2002, TEX LAW REV, V80, P1595; MICELI TJ, 1991, J LEGAL STUD, V20, P381, DOI 10.1086/467892; Morris Julian, 2002, POLICY, V18, P10; PARKER M, 2003, TORTS LAW J, V11, P1; Pelly JE, 1998, MED J AUSTRALIA, V169, P330, DOI 10.5694/j.1326-5377.1998.tb140288.x; Richardson J, 2002, TECHNOLOGICAL CHANGE, P121; RUBINFELD DL, IN PRESS HDB LAW EC; SLOAN FA, 1990, AM ECON REV, V80, P128; SPIEGELMAN JJ, 2005, 14 COMM LAW C NEGL I; Studdert DM, 2005, JAMA-J AM MED ASSOC, V293, P2609, DOI 10.1001/jama.293.21.2609; Studdert DM, 2000, MED CARE, V38, P250, DOI 10.1097/00005650-200003000-00002; STUDDERT DM, 1997, LAW CONTEMP PROBL, V60, P1; SUMMERTON N, 1995, BRIT MED J, V310, P27, DOI 10.1136/bmj.310.6971.27; *TILL TOW PERR, 2002, US TORT COSTS 2000 T; United Kingdom Department of Health Chief Medical Officer (Sir Liam Donaldson), 2003, MAK AM CONS PAP SETT; *US C OFF TECHN AS, 1994, OTAH602 US C; *US DEP HHS, 2002, CONFR NEW HLTH CAR C; 1992, COMMONWEALTH LAW REP, V175, P479; 2001, COMMONWEALTH LAW REP, V205, P434	57	91	93	1	21	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 15	2006	368	9531					240	246		10.1016/S0140-6736(06)69045-4	http://dx.doi.org/10.1016/S0140-6736(06)69045-4			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	064MY	16844494				2022-12-28	WOS:000239095000036
J	Frezza, C; Cipolat, S; de Brito, OM; Micaroni, M; Beznoussenko, GV; Rudka, T; Bartoli, D; Polishuck, RS; Danial, NN; De Strooper, B; Scorrano, L				Frezza, Christian; Cipolat, Sara; de Brito, Olga Martins; Micaroni, Massimo; Beznoussenko, Galina V.; Rudka, Tomasz; Bartoli, Davide; Polishuck, Roman S.; Danial, Nika N.; De Strooper, Bart; Scorrano, Luca			OPA1 controls apoptotic cristae remodeling independently from mitochondrial fusion	CELL			English	Article							CYTOCHROME-C RELEASE; CELL-DEATH; PROTEIN; FISSION; MITOFUSIN-1; BAX; MORPHOLOGY; MEDIATOR; REQUIRES; GTPASE	Mitochondria amplify activation of caspases during apoptosis by releasing cytochrome c and other cofactors. This is accompanied by fragmentation of the organelle and remodeling of the cristae. Here we provide evidence that Optic Atrophy 1 (OPA1), a profusion dynamin-related protein of the inner mitochondrial membrane mutated in dominant optic atrophy, protects from apoptosis by preventing cytochrome c release independently from mitochondrial fusion. OPA1 does not interfere with activation of the mitochondrial "gatekeepers" BAX and BAK, but it controls the shape of mitochondrial cristae, keeping their junctions; tight during apoptosis. Tightness of cristae junctions correlates with oligomerization of two forms of OPA1, a soluble, intermembrane space and an integral inner membrane one. The proapoptotic BCL-2 family member BID, which widens cristae junctions, also disrupts OPA1 oligomers. Thus, OPA1 has genetically and molecularly distinct functions in mitochondrial fusion and in cristae remodeling during apoptosis.	Venetian Inst Mol Med, Dulbecco Telethon Inst, Padua, Italy; Ist Ric Farmacol Mario Negri, Consorzio Mario Negri Sud, Dept Cell Biol & Oncol, I-66030 Santa Maria Imbaro, Italy; Flanders Interuniv Inst Biotechnol, VIB4, Ctr Human Genet, Neuronal Cell Biol & Gene Transfer Lab, Louvain, Belgium; Katholieke Univ Leuven, Louvain, Belgium; Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA	Fondazione Telethon; Dulbecco Telethon Institute (DTI); Veneto Institute Molecular Medicine; Consorzio Mario Negri Sud; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; KU Leuven; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Scorrano, L (corresponding author), Venetian Inst Mol Med, Dulbecco Telethon Inst, Padua, Italy.	luca.scorrano@unipd.it	de+Strooper, Bart/Z-1638-2019; Scorrano, Luca/K-3967-2019; Scorrano, Luca/A-6652-2008; De Strooper, Bart/F-6507-2012; Frezza, Christian/G-2174-2010	Scorrano, Luca/0000-0002-8515-8928; Scorrano, Luca/0000-0002-8515-8928; De Strooper, Bart/0000-0001-5455-5819; Frezza, Christian/0000-0002-3293-7397; Micaroni, Massimo/0000-0001-6405-0451	Telethon [TCP02016] Funding Source: Medline	Telethon(Fondazione Telethon)		Adams JM, 2001, TRENDS BIOCHEM SCI, V26, P61, DOI 10.1016/S0968-0004(00)01740-0; Amutha B, 2004, BIOCHEM J, V381, P19, DOI 10.1042/BJ20040566; Arnoult D, 2005, J BIOL CHEM, V280, P35742, DOI 10.1074/jbc.M505970200; Chen HC, 2005, J BIOL CHEM, V280, P26185, DOI 10.1074/jbc.M503062200; Chen HC, 2003, J CELL BIOL, V160, P189, DOI 10.1083/jcb.200211046; Cipolat S, 2004, P NATL ACAD SCI USA, V101, P15927, DOI 10.1073/pnas.0407043101; Cipolat S, 2006, CELL, V126, P163, DOI 10.1016/j.cell.2006.06.021; Danial NN, 2003, NATURE, V424, P952, DOI 10.1038/nature01825; Danino D, 2001, CURR OPIN CELL BIOL, V13, P454, DOI 10.1016/S0955-0674(00)00236-2; Delettre C, 2001, HUM GENET, V109, P584, DOI 10.1007/s00439-001-0633-y; Fannjiang Y, 2004, GENE DEV, V18, P2785, DOI 10.1101/gad.1247904; Fiala JC, 2005, J MICROSC-OXFORD, V218, P52, DOI 10.1111/j.1365-2818.2005.01466.x; Frank S, 2001, DEV CELL, V1, P515, DOI 10.1016/S1534-5807(01)00055-7; Germain M, 2005, EMBO J, V24, P1546, DOI 10.1038/sj.emboj.7600592; Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320; Griparic L, 2004, J BIOL CHEM, V279, P18792, DOI 10.1074/jbc.M400920200; Griparic L, 2001, TRAFFIC, V2, P235, DOI 10.1034/j.1600-0854.2001.1r008.x; Herlan M, 2003, J BIOL CHEM, V278, P27781, DOI 10.1074/jbc.M211311200; Ishihara N, 2004, J CELL SCI, V117, P6535, DOI 10.1242/jcs.01565; Jagasia R, 2005, NATURE, V433, P754, DOI 10.1038/nature03316; James DI, 2003, J BIOL CHEM, V278, P36373, DOI 10.1074/jbc.M303758200; Karbowski M, 2004, J CELL BIOL, V164, P493, DOI 10.1083/jcb.200309082; Koshiba T, 2004, SCIENCE, V305, P858, DOI 10.1126/science.1099793; Lee YJ, 2004, MOL BIOL CELL, V15, P5001, DOI 10.1091/mbc.E04-04-0294; Legros F, 2002, MOL BIOL CELL, V13, P4343, DOI 10.1091/mbc.E02-06-0330; McQuibban GA, 2003, NATURE, V423, P537, DOI 10.1038/nature01633; Mironov AA, 2001, J CELL BIOL, V155, P1225, DOI 10.1083/jcb.200108073; Neuspiel M, 2005, J BIOL CHEM, V280, P25060, DOI 10.1074/jbc.M501599200; NICHOLLS P, 1980, CAN J BIOCHEM CELL B, V58, P969, DOI 10.1139/o80-132; Olichon A, 2003, J BIOL CHEM, V278, P7743, DOI 10.1074/jbc.C200677200; Otera H, 2005, EMBO J, V24, P1375, DOI 10.1038/sj.emboj.7600614; Petronilli V, 2001, J BIOL CHEM, V276, P12030, DOI 10.1074/jbc.M010604200; Santel A, 2003, J CELL SCI, V116, P2763, DOI 10.1242/jcs.00479; Santel A, 2001, J CELL SCI, V114, P867; Satoh M, 2003, BIOCHEM BIOPH RES CO, V300, P482, DOI 10.1016/S0006-291X(02)02874-7; Scaffidi C, 1998, EMBO J, V17, P1675, DOI 10.1093/emboj/17.6.1675; Scorrano L, 2003, BIOCHEM BIOPH RES CO, V304, P437, DOI 10.1016/S0006-291X(03)00615-6; Scorrano L, 2003, SCIENCE, V300, P135, DOI 10.1126/science.1081208; Scorrano L, 2002, DEV CELL, V2, P55, DOI 10.1016/S1534-5807(01)00116-2; Smirnova E, 2001, MOL BIOL CELL, V12, P2245, DOI 10.1091/mbc.12.8.2245; Sugioka R, 2004, J BIOL CHEM, V279, P52726, DOI 10.1074/jbc.M408910200; Sweitzer SM, 1998, CELL, V93, P1021, DOI 10.1016/S0092-8674(00)81207-6; Wang XD, 2001, GENE DEV, V15, P2922; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Wei MC, 2000, GENE DEV, V14, P2060; Yoon Y, 2003, MOL CELL BIOL, V23, P5409, DOI 10.1128/MCB.23.15.5409-5420.2003; Youle RJ, 2005, NAT REV MOL CELL BIO, V6, P657, DOI 10.1038/nrm1697	47	1131	1161	4	73	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 14	2006	126	1					177	189		10.1016/j.cell.2006.06.025	http://dx.doi.org/10.1016/j.cell.2006.06.025			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	066JF	16839885	Green Accepted, Bronze			2022-12-28	WOS:000239224800025
J	Enwonwu, CO; Falkler, WA; Phillips, RS				Enwonwu, Cyril O.; Falkler, William A., Jr.; Phillips, Reshma S.			Noma (cancrum oris)	LANCET			English	Review							NECROTIZING ULCERATIVE GINGIVITIS; HUMAN-IMMUNODEFICIENCY-VIRUS; MALNOURISHED NIGERIAN CHILDREN; PROTEIN-ENERGY MALNUTRITION; LINEAR GROWTH-RETARDATION; ORAL EPITHELIAL-CELLS; SUB-SAHARAN AFRICA; FULL-TERM NEONATE; FUSOBACTERIUM-NECROPHORUM; ACTINOBACILLUS-ACTINOMYCETEMCOMITANS		Univ Maryland, Dept Biomed Sci, Sch Dent, Baltimore, MD 21201 USA; Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Enwonwu, CO (corresponding author), Univ Maryland, Dept Biomed Sci, Sch Dent, 666 W Baltimore St, Baltimore, MD 21201 USA.	cenwonwu@umaryland.edu			NIDCR NIH HHS [DE43TW00907A] Funding Source: Medline	NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Adedoja D, 2002, East Afr Med J, V79, P499; Adelekan DA, 2003, NUTRITION, V19, P179, DOI 10.1016/S0899-9007(02)01101-2; Adelsberger L., 1945, LANCET, V1, P317; Adolph HP, 1996, ANN PLAS SURG, V37, P657, DOI 10.1097/00000637-199612000-00017; Albertsson-Wikland K, 1998, HORM RES, V49, P7, DOI 10.1159/000053080; ALKALAY A, 1985, CLIN PEDIATR, V24, P528, DOI 10.1177/000992288502400911; ALLEN LH, 1994, EUR J CLIN NUTR, V48, pS75; ALVERDY J, 1991, ANN SURG, V214, P719, DOI 10.1097/00000658-199112000-00012; Asamoah-Odei E, 2004, LANCET, V364, P35, DOI 10.1016/S0140-6736(04)16587-2; ASIEDU K, 2000, AFRICA HLTH      MAR, P19; Atiyeh BS, 1998, SCAND J PLAST RECONS, V32, P343; Baratti-Mayer D, 2003, LANCET INFECT DIS, V3, P419, DOI 10.1016/S1473-3099(03)00670-4; Barmes DE, 1997, TROP MED INT HEALTH, V2, P1111, DOI 10.1046/j.1365-3156.1997.d01-220.x; Beck MA, 1998, NUTR REV, V56, pS140; Beisel WR, 1996, J NUTR, V126, pS2611, DOI 10.1093/jn/126.suppl_10.2611S; Berthold Peter, 2003, Dent Clin North Am, V47, P559, DOI 10.1016/S0011-8532(03)00020-X; Bickler SW, 2000, B WORLD HEALTH ORGAN, V78, P1330; BIRKEDALHANSEN H, 1993, J PERIODONTAL RES, V28, P500, DOI 10.1111/j.1600-0765.1993.tb02113.x; Bourgeois DM, 1999, ORAL DIS, V5, P172; Bourgeois DM, 1999, AM J TROP MED HYG, V61, P909, DOI 10.4269/ajtmh.1999.61.909; Campbell DI, 2003, PEDIATR RES, V54, P306, DOI 10.1203/01.PDR.0000076666.16021.5E; Chandra RK, 2000, NUTRITION AND IMMUNOLOGY, pV; CHANDRA RK, 1991, AM J CLIN NUTR, V53, P1087, DOI 10.1093/ajcn/53.5.1087; Chidzonga MM, 1996, J ORAL MAXIL SURG, V54, P1056, DOI 10.1016/S0278-2391(96)90159-7; Chidzonga MM, 2003, ORAL DIS, V9, P317, DOI 10.1034/j.1601-0825.2003.00962.x; Chindia M L, 1997, Quintessence Int, V28, P277; CLERICI M, 1993, IMMUNOL TODAY, V14, P107, DOI 10.1016/0167-5699(93)90208-3; Contreras A, 1997, ORAL MICROBIOL IMMUN, V12, P259, DOI 10.1111/j.1399-302X.1997.tb00389.x; Costini B, 1995, Med Trop (Mars), V55, P263; DaviesAdetugbo AA, 1996, J DIARRHOEAL DIS RES, V14, P5; Dawson J., 1945, BRIT DENTAL JOUR, V79, P151; de Onis M, 2003, INT J EPIDEMIOL, V32, P518, DOI 10.1093/ije/dyg099; DEONIS M, 1993, B WORLD HEALTH ORGAN, V71, P703; DUNCAN B, 1993, PEDIATRICS, V91, P867; EISELE D W, 1990, Ear Nose and Throat Journal, V69, P119; Enwere GC, 1999, ANN TROP MED PARASIT, V93, P669, DOI 10.1080/00034989957907; Enwonwu CO, 2006, NEW ENGL J MED, V354, P221, DOI 10.1056/NEJMp058193; Enwonwu CO, 2004, INT DENT J, V54, P344; Enwonwu CO, 2005, EUR CYTOKINE NETW, V16, P240; Enwonwu CO, 2005, INT J DERMATOL, V44, P707, DOI 10.1111/j.1365-4632.2004.02510.x; Enwonwu CO, 2005, TROP MED INT HEALTH, V10, P65, DOI 10.1111/j.1365-3156.2004.01351.x; Enwonwu CO, 1999, AM J TROP MED HYG, V60, P223, DOI 10.4269/ajtmh.1999.60.223; ENWONWU CO, 1972, ARCH ORAL BIOL, V17, P1357, DOI 10.1016/0003-9969(72)90169-0; Enwonwu CO, 1999, ORAL DIS, V5, P144; ENWONWU CO, 1995, B WORLD HEALTH ORGAN, V73, P541; Enwonwu CO, 2000, CRIT REV ORAL BIOL M, V11, P159, DOI 10.1177/10454411000110020201; Falkler WA, 1999, ORAL DIS, V5, P150; Falkler WA, 1999, AM J TROP MED HYG, V60, P150, DOI 10.4269/ajtmh.1999.60.150; Falkler WW, 2000, ORAL DIS, V6, P103, DOI 10.1111/j.1601-0825.2000.tb00109.x; FERGUSON AC, 1978, J PEDIATR-US, V93, P52, DOI 10.1016/S0022-3476(78)80599-X; Fieger A, 2003, TROP MED INT HEALTH, V8, P402, DOI 10.1046/j.1365-3156.2003.01036.x; Flaitz CM, 1996, ORAL SURG ORAL MED O, V81, P433, DOI 10.1016/S1079-2104(96)80019-9; Fraker P, 2000, NUTRITION AND IMMUNOLOGY, P147; Freeman AF, 2002, PEDIATR INFECT DIS J, V21, P83, DOI 10.1097/00006454-200201000-00025; Gazi MI, 1997, ORAL MICROBIOL IMMUN, V12, P240, DOI 10.1111/j.1399-302X.1997.tb00386.x; GHARBIA SE, 1994, J PERIODONTOL, V65, P56, DOI 10.1902/jop.1994.65.1.56; GHOSAL SP, 1978, LANCET, V2, P289; Hanson LA, 2004, ACTA PAEDIATR, V93, P154, DOI 10.1080/08035250310022586; Hartman EHM, 2006, J PLAST RECONSTR AES, V59, P337, DOI 10.1016/j.bjps.2005.10.005; Hasselbalch H, 1999, EUR J PEDIATR, V158, P964, DOI 10.1007/s004310051258; Hicken NF, 1935, AM J DIS CHILD, V50, P1455; Idigbe EO, 1999, ORAL DIS, V5, P156; IEVEN M, 1993, EUR J CLIN MICROBIOL, V12, P705, DOI 10.1007/BF02009385; JELLIFFE DB, 1985, COMMUNITY DENT ORAL, V13, P342, DOI 10.1111/j.1600-0528.1985.tb00469.x; JELLIFFE DB, 1952, PEDIATRICS, V9, P544; JUSTERREICHER A, 1993, AM J PERINAT, V10, P409; KARLBERG J, 1994, EUR J CLIN NUTR, V48, pS25; Karp CL, 1999, IMMUNOL REV, V168, P91, DOI 10.1111/j.1600-065X.1999.tb01285.x; KORMAN KS, 1993, PERIODONTOL 2000, V2, P83; KOZMINSKAKUBARSKA A, 1982, INT J DERMATOL, V21, P465, DOI 10.1111/j.1365-4362.1982.tb03184.x; LIMONGELLI WA, 1976, ORAL SURG ORAL MED O, V41, P40, DOI 10.1016/0030-4220(76)90250-4; LIN JY, 1992, ACTA PAEDIATR, V81, P720, DOI 10.1111/j.1651-2227.1992.tb12345.x; LISTGARTEN MA, 1967, J PERIODONTOL, V38, P379, DOI 10.1902/jop.1967.38.5.379; Liu YX, 2000, PEDIATR RES, V47, P475, DOI 10.1203/00006450-200004000-00011; LOESCHE WJ, 1982, J PERIODONTOL, V53, P223, DOI 10.1902/jop.1982.53.4.223; LUNN PG, 1991, LANCET, V338, P907, DOI 10.1016/0140-6736(91)91772-M; Macdonald J B, 1962, Ann R Coll Surg Engl, V31, P361; MALBERGER E, 1967, J PERIOD RES, V2, P154, DOI 10.1111/j.1600-0765.1967.tb01883.x; Marck KW, 1998, EUR J PLAST SURG, V21, P277, DOI 10.1007/s002380050094; Marck KW, 2003, PLAST RECONSTR SURG, V111, P1702, DOI 10.1097/01.PRS.0000055445.84307.3C; Marck KW, 2003, NOMA FACE POVERTY, P53; MEIS JFGM, 1993, INFECTION, V21, P174, DOI 10.1007/BF01710542; MONTANDON D, 1991, PLAST RECONSTR SURG, V87, P76, DOI 10.1097/00006534-199101000-00013; Moore SE, 1999, INT J EPIDEMIOL, V28, P1088, DOI 10.1093/ije/28.6.1088; MORLEY D, 1969, BMJ-BRIT MED J, V1, P297, DOI 10.1136/bmj.1.5639.297; Nath S, 1998, PLAST RECONSTR SURG, V102, P350, DOI 10.1097/00006534-199808000-00008; Ngom PT, 2004, AM J CLIN NUTR, V80, P722; OBIECHINA AE, 2002, ODATO STOMATOLOGIE T, V90, P11; OLIPHANT JC, 1984, RES VET SCI, V36, P382, DOI 10.1016/S0034-5288(18)31965-9; OTUYEMI O, 1998, PEDIAT DENT J, V8, P133; PASS RF, 1985, J INFECT DIS, V152, P243, DOI 10.1093/infdis/152.2.243; Paster BJ, 2002, J CLIN MICROBIOL, V40, P2187, DOI 10.1128/JCM.40.6.2187-2191.2002; Patton LL, 2002, ORAL DIS, V8, P98, DOI 10.1034/j.1601-0825.2002.00020.x; Pena M, 2002, ANNU REV NUTR, V22, P241, DOI 10.1146/annurev.nutr.22.120701.141104; Phillips RS, 2004, J NUTR BIOCHEM, V15, P281, DOI 10.1016/j.jnutbio.2003.11.006; PINDBORG JJ, 1966, J PERIODONTOL, V37, P14, DOI 10.1902/jop.1966.37.1.14; Pittet B, 2001, J CRANIOFAC SURG, V12, P273, DOI 10.1097/00001665-200105000-00014; Ranganathan K, 2006, Adv Dent Res, V19, P63; RANSOMEKUTI O, 1985, ACTA PAEDIATR SCAND, P95; REHAN N E, 1981, Nigerian Journal of Paediatrics, V8, P35; Rice AL, 2000, B WORLD HEALTH ORGAN, V78, P1207; ROTBART HA, 1986, J PEDIATR-US, V109, P596, DOI 10.1016/S0022-3476(86)80219-0; Rouabhia M, 2002, INFECT IMMUN, V70, P7073, DOI 10.1128/IAI.70.12.7073-7080.2002; SABISTON CB, 1986, J CLIN PERIODONTOL, V13, P727, DOI 10.1111/j.1600-051X.1986.tb00873.x; Sandros J, 2000, J DENT RES, V79, P1808, DOI 10.1177/00220345000790101301; Sauerwein RW, 1997, AM J CLIN NUTR, V65, P1534, DOI 10.1093/ajcn/65.5.1534; SAWYER DR, 1986, J DENT CHILD     NOV, P439; SKERRY TM, 1994, EUR J CLIN NUTR, V48, pS190; SLOTS J, 1986, J CLIN PERIODONTOL, V13, P570, DOI 10.1111/j.1600-051X.1986.tb00849.x; SMITH GR, 1986, VET REC, V118, P691, DOI 10.1136/vr.118.25.691; SMITH LD, 1975, PATHOGENIC ANAEROBIC; Solomons NW, 2003, J NUTR, V133, P1237; SOLOMONS NW, 1993, NUTR REV, V51, P327, DOI 10.1111/j.1753-4887.1993.tb03758.x; TAIWO JO, 1993, J PERIODONTOL, V64, P1071, DOI 10.1902/jop.1993.64.11.1071; TEMPEST MN, 1966, BRIT J SURG, V53, P949, DOI 10.1002/bjs.1800531109; Thiery G, 2002, Med Trop (Mars), V62, P193; TOURDES J, 1848, THESIS STRASBOURG; Van Damme PA, 2004, LANCET INFECT DIS, V4, P73, DOI 10.1016/S1473-3099(04)00924-7; Vetter KM, 1996, PEDIATR INFECT DIS J, V15, P438, DOI 10.1097/00006454-199605000-00011; Weaver GH, 1907, J INFECT DIS, V4, P8, DOI 10.1093/infdis/4.1.8; WHITTLE HC, 1979, T ROY SOC TROP MED H, V73, P66, DOI 10.1016/0035-9203(79)90132-9; *WHO, 1996, 116 WHO OMS; WHO (World Health Organization), 1998, WORLD HLTH REP 1998; [No title captured]	125	102	103	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 8	2006	368	9530					147	156		10.1016/S0140-6736(06)69004-1	http://dx.doi.org/10.1016/S0140-6736(06)69004-1			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	062AR	16829299				2022-12-28	WOS:000238917200029
J	Hook, J				Hook, J			Exploring musical space	SCIENCE			English	Editorial Material							TRANSFORMATIONS; SCALES; SETS		Indiana Univ, Jacobs Sch Mus, Bloomington, IN 47405 USA	Indiana University System; Indiana University Bloomington	Hook, J (corresponding author), Indiana Univ, Jacobs Sch Mus, Bloomington, IN 47405 USA.	juhook@indiana.edu						CALLENDER C, 2005, J CLOUGH MEM C U CHI; CAREY N, 1989, MUSIC THEOR SPECTRUM, V11, P187, DOI 10.1525/mts.1989.11.2.02a00030; CLOUGH J, 1991, J MUSIC THEORY, V35, P93, DOI 10.2307/843811; Clough J, 1999, MUSIC THEOR SPECTRUM, V21, P74, DOI 10.1525/mts.1999.21.1.02a00040; CLOUGH J, 1985, J MUSIC THEORY, V29, P249, DOI 10.2307/843615; Cohn R, 1997, J MUSIC THEORY, V41, P1, DOI 10.2307/843761; Cohn R, 1998, J MUSIC THEORY, V42, P167, DOI 10.2307/843871; Douthett J, 1998, J MUSIC THEORY, V42, P241, DOI 10.2307/843877; Forte Allen, 1973, STRUCTURE ATONAL MUS; Hook J, 2002, J MUSIC THEORY, V46, P57, DOI 10.1215/00222909-46-1-2-57; Lewin David, 1987, GEN MUSICAL INTERVAL; Tymoczko D, 2006, SCIENCE, V313, P72, DOI 10.1126/science.1126287	12	3	3	1	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 7	2006	313	5783					49	50		10.1126/science.1129300	http://dx.doi.org/10.1126/science.1129300			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061DA	16825554				2022-12-28	WOS:000238850200020
J	Irwing, P; Lynn, R				Irwing, P; Lynn, R			Is there a sex difference in IQ scores?	NATURE			English	Letter							STANDARD PROGRESSIVE MATRICES; UNIVERSITY-STUDENTS; INTELLIGENCE; METAANALYSIS		Univ Manchester, Manchester Business Sch, Manchester M15 6PB, Lancs, England; Univ Ulster, Sch Psychol, Coleraine BT52 1SA, Londonderry, North Ireland	University of Manchester; Ulster University	Irwing, P (corresponding author), Univ Manchester, Manchester Business Sch, Booth St W, Manchester M15 6PB, Lancs, England.	paul.irwing@man.ac.uk	Irwing, Paul/A-8740-2008	Irwing, Paul/0000-0002-4751-2156				Abad FJ, 2004, PERS INDIV DIFFER, V36, P1459, DOI 10.1016/S0191-8869(03)00241-1; BackhoffEscudero E, 1996, REV MEX PSICOL, V13, P21; Blinkhorn S, 2005, NATURE, V438, P31, DOI 10.1038/438031a; Colom R, 2000, INTELLIGENCE, V28, P57, DOI 10.1016/S0160-2896(99)00035-5; Colom R, 2002, SPAN J PSYCHOL, V5, P29, DOI 10.1017/S1138741600005801; Hunter J.E., 2004, METHODS META ANAL CO; Irwing P, 2005, BRIT J PSYCHOL, V96, P505, DOI 10.1348/000712605X53542; JACKSON DN, IN PRESS INTELLIGENC; Lynn R, 2004, INTELLIGENCE, V32, P481, DOI 10.1016/j.intell.2004.06.008; Lynn R, 2004, INTELLIGENCE, V32, P411, DOI 10.1016/j.intell.2004.06.007; Nyborg H, 2003, SCIENTIFIC STUDY OF GENERAL INTELLIGENCE: TRIBUTE TO ARTHUR R. J ENSEN, P187, DOI 10.1016/B978-008043793-4/50047-7; ROSENTHAL R, 1995, PSYCHOL BULL, V118, P183, DOI 10.1037/0033-2909.118.2.183	12	21	21	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 6	2006	442	7098					E1	E1		10.1038/nature04966	http://dx.doi.org/10.1038/nature04966			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	059HS	16823409	Bronze			2022-12-28	WOS:000238724500029
J	Dresler, CM; Leon, ME; Straif, K; Baan, R; Secretan, B				Dresler, Carolyn M.; Leon, Maria E.; Straif, Kurt; Baan, Robert; Secretan, Beatrice			Reversal of risk upon quitting smoking	LANCET			English	Editorial Material							MALE BRITISH DOCTORS; LUNG-FUNCTION; CESSATION; MORTALITY; CANCER; HEALTH; DISEASE; WOMEN		Int Agcy Res Canc, F-69008 Lyon, France	World Health Organization; International Agency for Research on Cancer (IARC)	Dresler, CM (corresponding author), Int Agcy Res Canc, 150 Cours Albert Thomas, F-69008 Lyon, France.	dresler@iarc.fr		Lauby-Secretan, Beatrice/0000-0001-6559-3351				Anthonisen NR, 2002, AM J RESP CRIT CARE, V166, P675, DOI 10.1164/rccm.2112096; Anthonisen NR, 2005, ANN INTERN MED, V142, P233, DOI 10.7326/0003-4819-142-4-200502150-00005; BROWN CA, 1991, THORAX, V46, P112, DOI 10.1136/thx.46.2.112; BURCHFIEL CM, 1995, AM J RESP CRIT CARE, V151, P1778, DOI 10.1164/ajrccm.151.6.7767520; DOLL R, 1994, BRIT MED J, V309, P901, DOI 10.1136/bmj.309.6959.901; DOLL R, 1976, BRIT MED J, V2, P1525, DOI 10.1136/bmj.2.6051.1525; Doll R, 2004, BMJ-BRIT MED J, V328, P1519, DOI 10.1136/bmj.38142.554479.AE; GARFINKEL L, 1988, CANCER RES, V48, P6951; Hooi JD, 2001, AM J EPIDEMIOL, V153, P666, DOI 10.1093/aje/153.7.666; International Agency of Research on Cancer, 2004, IARC MON EV CARC RIS; Mai SK, 2007, HLTH CONS SMOK REP S, V2, P30; Peto R, 2000, BRIT MED J, V321, P323, DOI 10.1136/bmj.321.7257.323; Rajkumar T, 2006, INT J CANCER, V118, P1481; Scanlon PD, 2000, AM J RESP CRIT CARE, V161, P381, DOI 10.1164/ajrccm.161.2.9901044	14	38	41	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL-AUG	2006	368	9533					348	349		10.1016/S0140-6736(06)69086-7	http://dx.doi.org/10.1016/S0140-6736(06)69086-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	069JJ	16876647				2022-12-28	WOS:000239441900008
J	Kachur, SP; Slutsker, L				Kachur, SP; Slutsker, L			Measuring malaria drug efficacy and transmission intensity	LANCET			English	Editorial Material							MARKERS; TRENDS		Ctr Dis Control & Prevent, Malaria Branch, Atlanta, GA 30341 USA	Centers for Disease Control & Prevention - USA	Kachur, SP (corresponding author), Ctr Dis Control & Prevent, Malaria Branch, Atlanta, GA 30341 USA.	spk0@cdc.gov	Kachur, Patrick/ABE-7220-2021					[Anonymous], 2003, ASS MON ANT DRUG EFF; Bloland PB, 2003, J EXP BIOL, V206, P3761, DOI 10.1242/jeb.00637; Drakeley CJ, 2005, P NATL ACAD SCI USA, V102, P5108, DOI 10.1073/pnas.0408725102; Francis D, 2006, J INFECT DIS, V193, P978, DOI 10.1086/500951	4	3	3	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 1	2006	368	9529					10	12		10.1016/S0140-6736(06)68945-9	http://dx.doi.org/10.1016/S0140-6736(06)68945-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	058TQ	16815361				2022-12-28	WOS:000238687900008
J	Badano, JL; Katsanis, N				Badano, Jose L.; Katsanis, Nicholas			Life without centrioles: Cilia in the spotlight	CELL			English	Editorial Material							CELL-CYCLE PROGRESSION; DUPLICATION; CENTROSOME	Centrioles are critical cellular components that form the architectural core of both Centrosomes and basal bodies, the nucleating structures of cilia. New, work, including a study in this issue (Basto et al., 2006), highlights the unexpected finding that lack of centrioles does not impede development in the fruit fly. Rather, flies reach maturity but then die because their sensory neurons lack cilia.	Johns Hopkins Univ, McKusich Nathans Inst Genet Med, Baltimore, MD 21205 USA	Johns Hopkins University	Badano, JL (corresponding author), Johns Hopkins Univ, McKusich Nathans Inst Genet Med, Baltimore, MD 21205 USA.	katsanis@jhmi.edu	Katsanis, Nicholas/E-1837-2012	Katsanis, Nicholas/0000-0002-2480-0171; Badano, Jose/0000-0002-0706-8652				BADANO JL, 2006, ANN REV GENOMICS HUM; BASTO R, 2006, CELL; Bettencourt-Dias M, 2005, CURR BIOL, V15, P2199, DOI 10.1016/j.cub.2005.11.042; Bond J, 2005, NAT GENET, V37, P353, DOI 10.1038/ng1539; Hinchcliffe EH, 2001, SCIENCE, V291, P1547, DOI 10.1126/science.1056866; Hudson JW, 2001, CURR BIOL, V11, P441, DOI 10.1016/S0960-9822(01)00117-8; La Terra S, 2005, J CELL BIOL, V168, P713, DOI 10.1083/jcb.200411126; Leidel S, 2003, DEV CELL, V4, P431, DOI 10.1016/S1534-5807(03)00062-5; Pazour GJ, 2003, CURR OPIN CELL BIOL, V15, P105, DOI 10.1016/S0955-0674(02)00012-1; Rieder CL, 2001, TRENDS CELL BIOL, V11, P413, DOI 10.1016/S0962-8924(01)02085-2	10	13	14	0	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUN 30	2006	125	7					1228	1230		10.1016/j.cell.2006.06.013	http://dx.doi.org/10.1016/j.cell.2006.06.013			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	064QP	16814708	Bronze			2022-12-28	WOS:000239104500005
J	De Luca, A; Caraveo, PA; Mereghetti, S; Tiengo, A; Bignami, GF				De Luca, A.; Caraveo, P. A.; Mereghetti, S.; Tiengo, A.; Bignami, G. F.			A long-period, violently variable X-ray source in a young supernova remnant	SCIENCE			English	Article							ACCRETION; MAGNETARS; STARS; MODEL	Observations with the Newton X-ray Multimirror Mission satellite show a strong periodic modulation at 6.67 +/- 0.03 hours of the x-ray source at the center of the 2000-year-old supernova remnant RCW 103. No fast pulsations are visible. If genetically tied to the supernova remnant, the source could either be an x-ray binary, composed of a compact object and a low-mass star in an eccentric orbit, or an isolated neutron star. In the latter case, the combination of its age and period would indicate that it is a peculiar magnetar, dramatically slowed down, possibly by a supernova debris disc. Both scenarios require nonstandard assumptions about the formation and evolution of compact objects in supernova explosions.	Ist Nazl Astrofis, Ist Astrofis Spaziale & fis Cosm, I-20133 Milan, Italy; UPS, CNRS, Ctr Etud Spatiale Rayonnements, F-31028 Toulouse 4, France; Univ Pavia, Dipartimento Fis Nucl & Teor, I-27100 Pavia, Italy	Istituto Nazionale Astrofisica (INAF); Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; University of Pavia	De Luca, A (corresponding author), Ist Nazl Astrofis, Ist Astrofis Spaziale & fis Cosm, Via Bassini 15, I-20133 Milan, Italy.	deluca@iasf-milano.inaf.it	Caraveo, Patrizia/AAL-5708-2020	Caraveo, Patrizia/0000-0003-2478-8018; De Luca, Andrea/0000-0001-6739-687X; Tiengo, Andrea/0000-0002-6038-1090; Bignami, Giovanni/0000-0001-9582-2450; MEREGHETTI, SANDRO/0000-0003-3259-7801				BECKER W, 2002, P 270 WE HER SEM NEU, P64; Carter LM, 1997, PUBL ASTRON SOC PAC, V109, P990, DOI 10.1086/133971; Chatterjee P, 2000, ASTROPHYS J, V534, P373, DOI 10.1086/308748; DAVIDSON K, 1973, ASTROPHYS J, V179, P585, DOI 10.1086/151897; DAVIES RE, 1981, MON NOT R ASTRON SOC, V196, P209, DOI 10.1093/mnras/196.2.209; DUNCAN RC, 1992, ASTROPHYS J, V392, pL9, DOI 10.1086/186413; Ferrario L, 2006, MON NOT R ASTRON SOC, V367, P1323, DOI 10.1111/j.1365-2966.2006.10058.x; Francischelli GJ, 2002, ASTROPHYS J, V565, P471, DOI 10.1086/323223; Garmire G. P., 2000, BAAS, V32, P1237; GARMIRE GP, 2000, 7350 IAU; Gotthelf EV, 1999, ASTROPHYS J, V514, pL107, DOI 10.1086/311948; Gotthelf EV, 1997, ASTROPHYS J, V487, pL175, DOI 10.1086/310900; Heyl JS, 2002, ASTROPHYS J, V567, P510, DOI 10.1086/338547; ILLARIONOV AF, 1975, ASTRON ASTROPHYS, V39, P185; Kalogera V, 1996, ASTROPHYS J, V471, P352, DOI 10.1086/177974; King AR, 2006, MON NOT R ASTRON SOC, V366, pL31, DOI 10.1111/J.1745-3933.2005.00126.X; Kuulkers E., 2006, COMPACT STELLAR XRAY, P421; Li XD, 1999, ASTROPHYS J, V513, pL45, DOI 10.1086/311904; Narayan R, 2005, ASTROPHYS SPACE SCI, V300, P177, DOI 10.1007/s10509-005-1178-7; Pavlov GG, 2004, IAU SYMP, P239; Possenti A, 2002, ASTRON ASTROPHYS, V387, P993, DOI 10.1051/0004-6361:20020472; Reynoso EM, 2004, PUBL ASTRON SOC AUST, V21, P82, DOI 10.1071/AS03053; Sanwal D., 2002, BAAS, V34, P764; Struder L, 2001, ASTRON ASTROPHYS, V365, pL18, DOI 10.1051/0004-6361:20000066; TUOHY I, 1980, APJ, V239, P107; Turner MJL, 2001, ASTRON ASTROPHYS, V365, pL27, DOI 10.1051/0004-6361:20000087; Vink J, 2006, MON NOT R ASTRON SOC, V370, pL14, DOI 10.1111/j.1745-3933.2006.00178.x; Wang ZX, 2006, NATURE, V440, P772, DOI 10.1038/nature04669; Wang ZX, 2002, ASTR SOC P, V271, P297; WOODS PM, 2006, COMPACT STELLAR XRAY, P547, DOI DOI 10.1017/CBO9780511536281	30	77	77	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 11	2006	313	5788					814	817		10.1126/science.1129185	http://dx.doi.org/10.1126/science.1129185			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072KC	16825535				2022-12-28	WOS:000239671300053
J	Zenkin, N; Yuzenkova, Y; Severinov, K				Zenkin, Nikolay; Yuzenkova, Yulia; Severinov, Konstantin			Transcript-assisted transcriptional proofreading	SCIENCE			English	Article							RNA-POLYMERASE-II; STRUCTURAL BASIS; MECHANISM; ELONGATION; CLEAVAGE; FIDELITY; RESOLUTION; CATALYSIS; COMPLEXES; TFIIS	Fidelity of template-dependent nucleic acid synthesis is the main determinant of stable heredity and error-free gene expression. The mechanism ( or mechanisms) ensuring fidelity of transcription by DNA-dependent RNA polymerases (RNAPs) is not fully understood. Here, we show that the 3' end - proximal nucleotide of the nascent transcript stimulates hydrolysis of the penultimate phosphodiester bond by providing active groups and coordination bonds to the RNAP active center. This stimulation is much higher in the case of misincorporated nucleotide. We show that during transcription elongation, the hydrolytic reaction stimulated by misincorporated nucleotides proofreads most of the misincorporation events and thus serves as an intrinsic mechanism of transcription fidelity.	Rutgers State Univ, Waksman Inst, Piscataway, NJ 08854 USA; Rutgers State Univ, Dept Mol Biol & Biochem, Piscataway, NJ 08854 USA; Russian Acad Sci, Inst Mol Genet, Moscow 123182, Russia	Rutgers State University New Brunswick; Rutgers State University New Brunswick; Russian Academy of Sciences	Zenkin, N (corresponding author), Rutgers State Univ, Waksman Inst, 190 Frelinghuysen Rd, Piscataway, NJ 08854 USA.	nicserzen@mail.ru; severik@waksman.rutgers.edu	Severinov, Konstantin/C-8545-2016	Zenkin, Nikolay/0000-0003-2212-9545; yuzenkova, yulia/0000-0003-4036-9235				Bar-Nahum G, 2005, CELL, V120, P183, DOI 10.1016/j.cell.2004.11.045; CARTER P, 1987, SCIENCE, V237, P394, DOI 10.1126/science.3299704; Cramer Patrick, 2001, Science (Washington D C), V292, P1863, DOI 10.1126/science.1059493; Dall'Acqua W, 2000, PROTEIN SCI, V9, P1; ERIE DA, 1993, SCIENCE, V262, P867, DOI 10.1126/science.8235608; Foster JE, 2001, CELL, V106, P243, DOI 10.1016/S0092-8674(01)00420-2; GUO HL, 1993, J BIOL CHEM, V268, P18762; IZBAN MG, 1993, J BIOL CHEM, V268, P12864; Jeon C, 1996, P NATL ACAD SCI USA, V93, P13677, DOI 10.1073/pnas.93.24.13677; Kettenberger H, 2004, MOL CELL, V16, P955, DOI 10.1016/j.molcel.2004.11.040; Lange U, 2004, MOL MICROBIOL, V52, P1133, DOI 10.1111/j.1365-2958.2004.04039.x; Laptenko O, 2003, EMBO J, V22, P6322, DOI 10.1093/emboj/cdg610; LAZCANO A, 1988, J MOL EVOL, V27, P365, DOI 10.1007/BF02101199; MATSUZAKI H, 1994, J MOL BIOL, V235, P1173, DOI 10.1006/jmbi.1994.1072; ORLOVA M, 1995, P NATL ACAD SCI USA, V92, P4596, DOI 10.1073/pnas.92.10.4596; Poole AM, 2005, MOL BIOL EVOL, V22, P1444, DOI 10.1093/molbev/msi132; Sosunov V, 2003, EMBO J, V22, P2234, DOI 10.1093/emboj/cdg193; Steitz TA, 1998, NATURE, V391, P231, DOI 10.1038/34542; STEITZ TA, 1993, P NATL ACAD SCI USA, V90, P6498, DOI 10.1073/pnas.90.14.6498; Temiakov D, 2005, MOL CELL, V19, P655, DOI 10.1016/j.molcel.2005.07.020; Thomas MJ, 1998, CELL, V93, P627, DOI 10.1016/S0092-8674(00)81191-5; Vassylyev DG, 2002, NATURE, V417, P712, DOI 10.1038/nature752; Westover KD, 2004, CELL, V119, P481, DOI 10.1016/j.cell.2004.10.016; WHITEHALL SK, 1994, J BIOL CHEM, V269, P2299	24	114	121	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 28	2006	313	5786					518	520		10.1126/science.1127422	http://dx.doi.org/10.1126/science.1127422			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067MZ	16873663				2022-12-28	WOS:000239308600061
J	Corma, A; Serna, P				Corma, Avelino; Serna, Pedro			Chemoselective hydrogenation of nitro compounds with supported gold catalysts	SCIENCE			English	Article							NANOPARTICLES	The selective reduction of a nitro group when other reducible functions are present is a difficult process that often requires stoichiometric amounts of reducing agents or, if H 2 is used, the addition of soluble metals. Gold nanoparticles supported on TiO2 or Fe2O3 catalyzed the chemoselective hydrogenation of functionalized nitroarenes with H-2 under mild reaction conditions that avoided the accumulation of hydroxylamines and their potential exothermic decomposition. These chemoselective hydrogenation gold catalysts also provide a previously unknown route for the synthesis of the industrially relevant cyclohexanone oxime from 1-nitro-1-cyclohexene.	Univ Politecn Valencia, Consejo Super Invest Cient, Inst Tecnol Quim, Valencia 46022, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Universitat Politecnica de Valencia; CSIC-UPV - Instituto de Tecnologia Quimica (ITQ)	Corma, A (corresponding author), Univ Politecn Valencia, Consejo Super Invest Cient, Inst Tecnol Quim, Ave Naranjos S-N, Valencia 46022, Spain.	acorma@itq.upv.es	CANOS, AVELINO CORMA/A-3040-2013; Serna Merino, Pedro/ABD-2612-2021	CANOS, AVELINO CORMA/0000-0002-2232-3527; 				Abad A, 2005, ANGEW CHEM INT EDIT, V44, P4066, DOI 10.1002/anie.200500382; Bailie JE, 1999, CHEM COMMUN, P2151, DOI 10.1039/a906538e; BLANKENSHIP SA, 2003, Patent No. 2003232719; Blaser H-U., 2001, AROMATIC NITRO COMPO, P389; Braden R., 1977, US patent, Patent No. [4,002,673, 4002673]; Braden R., 1977, [No title captured], Patent No. [4,051,177, 4051177]; BURAWOY A, 1959, TETRAHEDRON, V5, P340, DOI 10.1016/0040-4020(59)80025-9; Butera J., 1991, World (WO) Patent, Patent No. [91/09023, 9109023]; Claus P, 2005, APPL CATAL A-GEN, V291, P222, DOI 10.1016/j.apcata.2004.12.048; Concepcion P, 2004, J AM CHEM SOC, V126, P5523, DOI 10.1021/ja031768x; Corma A, 2005, CHEM COMMUN, P4042, DOI 10.1039/b506685a; Daniel MC, 2004, CHEM REV, V104, P293, DOI 10.1021/cr030698+; Downing RS, 1997, CATAL TODAY, V37, P121, DOI 10.1016/S0920-5861(97)00005-9; Gonzalez-Arellano C, 2005, CHEM COMMUN, P3451, DOI 10.1039/b505271h; Janin E, 2003, J CATAL, V215, P245, DOI 10.1016/S0021-9517(03)00016-2; Kovar RF, 1976, US Patent, Patent No. [3,975,444, 3975444]; Lu X, 1999, J PHYS CHEM A, V103, P10969, DOI 10.1021/jp9909053; Milone C, 2005, J CATAL, V236, P80, DOI 10.1016/j.jcat.2005.09.023; NAITO S, 1988, J CHEM SOC CHEM COMM, P832, DOI 10.1039/c39880000832; NARENDRA MA, 2005, Patent No. 2005070869; Rylander P., 1979, CATALYTIC HYDROGENAT, P122; Sepulveda-Escribano A, 1998, J CATAL, V178, P649, DOI 10.1006/jcat.1998.2199; SIEGRIST U, 1998, CHEM IND, V75; Suchy M., 1991, WO patent, Patent No. [91/00278, 9100278]; Wegener G., 2002, US Patent, Patent No. [6,395,934, 6395934]	25	1249	1275	33	816	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 21	2006	313	5785					332	334		10.1126/science.1128383	http://dx.doi.org/10.1126/science.1128383			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Current Chemical Reactions (CCR-EXPANDED)	Science & Technology - Other Topics	065IV	16857934				2022-12-28	WOS:000239154300038
J	Erkel, C; Kube, M; Reinhardt, R; Liesack, W				Erkel, Christoph; Kube, Michael; Reinhardt, Richard; Liesack, Werner			Genome of Rice Cluster I archaea - the key methane producers in the rice rhizosphere	SCIENCE			English	Article							DEPENDENT PHOSPHOFRUCTOKINASE; ACETATE; ASSIMILATION; SULFATE	Rice fields are a global source of the greenhouse gas methane, which is produced by methanogenic archaea, and by methanogens of Rice Cluster I (RC-I) in particular. RC-I methanogens are not yet available in pure culture, and the mechanistic reasons for their prevalence in rice fields are unknown. We reconstructed a complete RC-I genome (3.18 megabases) using a metagenomic approach. Sequence analysis demonstrated an aerotolerant, H-2/CO2-dependent lifestyle and enzymatic capacities for carbohydrate metabolism and assimilatory sulfate reduction, hitherto unknown among methanogens. These capacities and a unique set of antioxidant enzymes and DNA repair mechanisms as well as oxygen-insensitive enzymes provide RC-I with a selective advantage over other methanogens in its habitats, thereby explaining the prevalence of RC-I methanogens in the rice rhizosphere.	Max Planck Inst Terr Microbiol, D-35043 Marburg, Germany; Max Planck Inst Mol Genet, D-14195 Berlin, Germany	Max Planck Society; Max Planck Society	Liesack, W (corresponding author), Max Planck Inst Terr Microbiol, Karl von Frisch Str, D-35043 Marburg, Germany.	liesack@mpi-marburg.mpg.de		Kuba, Michael J/0000-0003-2688-736X; Liesack, Werner/0000-0002-9533-1552	Direct For Biological Sciences [0946430] Funding Source: National Science Foundation; Directorate For Geosciences [1204254] Funding Source: National Science Foundation; Division Of Earth Sciences [1614855] Funding Source: National Science Foundation; Division Of Integrative Organismal Systems [1456778] Funding Source: National Science Foundation	Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Division Of Earth Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))		Baumer Sebastian, 2002, Archaea, V1, P1, DOI 10.1155/2002/371325; Chelikani P, 2004, CELL MOL LIFE SCI, V61, P192, DOI 10.1007/s00018-003-3206-5; DANIELS L, 1986, APPL ENVIRON MICROB, V51, P703, DOI 10.1128/AEM.51.4.703-709.1986; DEMPLE B, 1994, ANNU REV BIOCHEM, V63, P915, DOI 10.1146/annurev.biochem.63.1.915; Donovan SE, 2004, APPL ENVIRON MICROB, V70, P3884, DOI 10.1128/AEM.70.7.3884-3892.2004; Erkel C, 2005, FEMS MICROBIOL ECOL, V53, P187, DOI 10.1016/j.femsec.2004.12.004; Fournier M, 2003, J BACTERIOL, V185, P71, DOI 10.1128/JB.185.1.71-79.2003; Galand PE, 2005, MICROB ECOL, V49, P209, DOI 10.1007/s00248-003-0229-2; Hansen T, 2001, ARCH MICROBIOL, V177, P62, DOI 10.1007/s00203-001-0359-1; Jenney FE, 1999, SCIENCE, V286, P306, DOI 10.1126/science.286.5438.306; Lu YH, 2005, SCIENCE, V309, P1088, DOI 10.1126/science.1113435; Lu YH, 2005, ENVIRON MICROBIOL, V7, P326, DOI 10.1111/j.1462-2920.2005.00697.x; NEUE HU, 1993, BIOSCIENCE, V43, P466, DOI 10.2307/1311906; NOUCHI I, 1990, PLANT PHYSIOL, V94, P59, DOI 10.1104/pp.94.1.59; OBERLIES G, 1980, ARCH MICROBIOL, V128, P248, DOI 10.1007/BF00406167; Ramakrishnan B, 2001, FEMS MICROBIOL ECOL, V37, P175, DOI 10.1111/j.1574-6941.2001.tb00865.x; SCHAFER T, 1993, ARCH MICROBIOL, V159, P72, DOI 10.1007/BF00244267; SHIEH J, 1988, J BACTERIOL, V170, P3072, DOI 10.1128/jb.170.7.3072-3079.1988; SHIEH JS, 1987, J BACTERIOL, V169, P5327, DOI 10.1128/jb.169.11.5327-5329.1987; Siebers B, 1998, J BACTERIOL, V180, P2137, DOI 10.1128/JB.180.8.2137-2143.1998; Sizova MV, 2003, FEMS MICROBIOL ECOL, V45, P301, DOI 10.1016/S0168-6496(03)00165-X; Thauer RK, 1998, MICROBIOL-UK, V144, P2377, DOI 10.1099/00221287-144-9-2377; Tuininga JE, 1999, J BIOL CHEM, V274, P21023, DOI 10.1074/jbc.274.30.21023; Verhees CH, 2001, J BACTERIOL, V183, P7145, DOI 10.1128/JB.183.24.7145-7153.2001; Watanabe A, 1999, J GEOPHYS RES-ATMOS, V104, P23623, DOI 10.1029/1999JD900467; ZEIKUS JG, 1977, J BACTERIOL, V132, P604, DOI 10.1128/JB.132.2.604-613.1977	26	138	331	2	91	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 21	2006	313	5785					370	372		10.1126/science.1127062	http://dx.doi.org/10.1126/science.1127062			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065IV	16857943				2022-12-28	WOS:000239154300050
J	Hochberg, LR; Serruya, MD; Friehs, GM; Mukand, JA; Saleh, M; Caplan, AH; Branner, A; Chen, D; Penn, RD; Donoghue, JP				Hochberg, Leigh R.; Serruya, Mijail D.; Friehs, Gerhard M.; Mukand, Jon A.; Saleh, Maryam; Caplan, Abraham H.; Branner, Almut; Chen, David; Penn, Richard D.; Donoghue, John P.			Neuronal ensemble control of prosthetic devices by a human with tetraplegia	NATURE			English	Article							BRAIN-COMPUTER INTERFACE; MOTOR-CORTICAL ACTIVITY; SPINAL-CORD-INJURY; ELECTRODE ARRAY; DIRECTION; PATTERNS; CORTEX; DISCHARGE; SIGNALS; SYSTEM	Neuromotor prostheses ( NMPs) aim to replace or restore lost motor functions in paralysed humans by routeing movement-related signals from the brain, around damaged parts of the nervous system, to external effectors. To translate preclinical results from intact animals to a clinically useful NMP, movement signals must persist in cortex after spinal cord injury and be engaged by movement intent when sensory inputs and limb movement are long absent. Furthermore, NMPs would require that intention-driven neuronal activity be converted into a control signal that enables useful tasks. Here we show initial results for a tetraplegic human (MN) using a pilot NMP. Neuronal ensemble activity recorded through a 96-microelectrode array implanted in primary motor cortex demonstrated that intended hand motion modulates cortical spiking patterns three years after spinal cord injury. Decoders were created, providing a 'neural cursor' with which MN opened simulated e-mail and operated devices such as a television, even while conversing. Furthermore, MN used neural control to open and close a prosthetic hand, and perform rudimentary actions with a multi-jointed robotic arm. These early results suggest that NMPs based upon intracortical neuronal ensemble spiking activity could provide a valuable new neurotechnology to restore independence for humans with paralysis.	Brown Univ, Dept Neurosci, Providence, RI 02912 USA; Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Brigham & Womens Hosp, Boston, MA 02114 USA; Harvard Univ, Sch Med, Spaulding Rehabil Hosp, Boston, MA 02114 USA; Brown Univ, Brain Sci Program, Providence, RI 02912 USA; Brown Univ, Dept Engn, Providence, RI 02912 USA; Vet Hlth Adm, Dept Vet Affairs, Rehabil Res & Dev Serv, Ctr Restorat & Regenerat Med, Providence, RI 02908 USA; Brown Univ, Dept Clin Neurosci Neurosurg, Providence, RI 02905 USA; Rhode Isl Hosp, Dept Neurosurg, Providence, RI 02905 USA; Brown Univ, Dept Rehabil Med, Providence, RI 02903 USA; Sargent Rehabil Ctr, Warwick, RI 02818 USA; Cyberkinet Neurotechnol Syst Inc, Foxboro, MA 02035 USA; Cyberkinet Neurotechnol Syst Inc, Salt Lake City, UT 84108 USA; Rehabil Inst Chicago, Dept Phys Med & Rehabil, Chicago, IL 60611 USA; Univ Chicago Hosp, Dept Neurosurg, Chicago, IL 60637 USA	Brown University; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Spaulding Rehabilitation Hospital; Brown University; Brown University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Brown University; Lifespan Health Rhode Island; Rhode Island Hospital; Brown University; Shirley Ryan AbilityLab; University of Chicago; University of Illinois System	Donoghue, JP (corresponding author), Brown Univ, Dept Neurosci, POB 1953, Providence, RI 02912 USA.	john_donoghue@brown.edu	Hochberg, Leigh/R-6872-2019	Hochberg, Leigh/0000-0003-0261-2273				Baker JT, 1999, J NEUROSCI, V19, P10044; Birbaumer N, 1999, NATURE, V398, P297, DOI 10.1038/18581; Carmena JM, 2003, PLOS BIOL, V1, P193, DOI 10.1371/journal.pbio.0000042; Donoghue JP, 1998, J NEUROPHYSIOL, V79, P159, DOI 10.1152/jn.1998.79.1.159; EVARTS EV, 1981, HDB PHYSL, P1083; FETZ EB, 1971, SCIENCE, V174, P431, DOI 10.1126/science.174.4007.431; FETZ EE, 1973, J NEUROPHYSIOL, V36, P179, DOI 10.1152/jn.1973.36.2.179; Gandolfo F, 2000, P NATL ACAD SCI USA, V97, P2259, DOI 10.1073/pnas.040567097; GEORGOPOULOS AP, 1982, J NEUROSCI, V2, P1527; Graimann B, 2004, IEEE T BIO-MED ENG, V51, P954, DOI 10.1109/TBME.2004.826671; Guillory KS, 1999, J NEUROSCI METH, V91, P21, DOI 10.1016/S0165-0270(99)00076-X; HOCHBERG LR, IN PRESS IEEE ENG ME; HUMPHREY DR, 1970, SCIENCE, V170, P758, DOI 10.1126/science.170.3959.758; HUMPHREY DR, 1991, LIFE SCI R, V50, P413; Jackson AB, 2004, ARCH PHYS MED REHAB, V85, P1740, DOI 10.1016/j.apmr.2004.04.035; JACOBS KM, 1991, SCIENCE, V251, P944, DOI 10.1126/science.2000496; Kennedy P, 2004, J NEURAL ENG, V1, P72, DOI 10.1088/1741-2560/1/2/002; Kennedy PR, 2000, IEEE T REHABIL ENG, V8, P198, DOI 10.1109/86.847815; Kennedy PR, 2004, IEEE T NEUR SYS REH, V12, P339, DOI 10.1109/TNSRE.2004.834629; Kennedy PR, 1998, NEUROREPORT, V9, P1707, DOI 10.1097/00001756-199806010-00007; Lal TN, 2005, ADV NEURAL INFORM PR; Leuthardt EC, 2004, J NEURAL ENG, V1, P63, DOI 10.1088/1741-2560/1/2/001; Lotze M, 1999, RESTOR NEUROL NEUROS, V14, P183; Mason SG, 2004, J CLIN NEUROPHYSIOL, V21, P404, DOI 10.1097/01.WNP.0000146840.78749.79; Maynard EM, 1997, ELECTROEN CLIN NEURO, V102, P228, DOI 10.1016/S0013-4694(96)95176-0; Maynard FM, 1997, SPINAL CORD, V35, P266, DOI 10.1038/sj.sc.3100432; Mikulis DJ, 2002, NEUROLOGY, V58, P794, DOI 10.1212/WNL.58.5.794; Muller-Putz GR, 2005, NEUROSCI LETT, V382, P169, DOI 10.1016/j.neulet.2005.03.021; Olson BP, 2005, IEEE T NEUR SYS REH, V13, P72, DOI 10.1109/TNSRE.2004.843174; Paninski L, 2004, J NEUROPHYSIOL, V91, P515, DOI 10.1152/jn.00587.2002; ROUSCHE PJ, 1992, ANN BIOMED ENG, V20, P413, DOI 10.1007/BF02368133; Sabbah P, 2002, J NEUROTRAUM, V19, P53, DOI 10.1089/089771502753460231; Sanes JN, 2000, ANNU REV NEUROSCI, V23, P393, DOI 10.1146/annurev.neuro.23.1.393; Schwartz AB, 2004, ANNU REV NEUROSCI, V27, P487, DOI 10.1146/annurev.neuro.27.070203.144233; Schwartz AB, 2001, CURR OPIN NEUROBIOL, V11, P701, DOI 10.1016/S0959-4388(01)00272-0; Serruya MD, 2002, NATURE, V416, P141, DOI 10.1038/416141a; Shoham S, 2001, NATURE, V413, P793, DOI 10.1038/35101651; Suner S, 2005, IEEE T NEUR SYS REH, V13, P524, DOI 10.1109/TNSRE.2005.857687; Taylor DM, 2002, SCIENCE, V296, P1829, DOI 10.1126/science.1070291; Thoumie P, 1998, SPINAL CORD, V36, P104, DOI 10.1038/sj.sc.3100496; Vaughan TM, 2003, IEEE T NEUR SYS REH, V11, P94, DOI 10.1109/TNSRE.2003.814799; Wolpaw JR, 2004, P NATL ACAD SCI USA, V101, P17849, DOI 10.1073/pnas.0403504101; Wu W, 2004, IEEE T BIO-MED ENG, V51, P933, DOI 10.1109/TBME.2004.826666; Yousry TA, 1997, BRAIN, V120, P141, DOI 10.1093/brain/120.1.141	44	2117	2212	38	711	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 13	2006	442	7099					164	171		10.1038/nature04970	http://dx.doi.org/10.1038/nature04970			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	062XJ	16838014				2022-12-28	WOS:000238979700039
J	Lanata, CF; Franco, M				Lanata, CF; Franco, M			Nitazoxanide for rotavirus diarrhoea?	LANCET			English	Editorial Material							CHILDREN		Inst Invest Nutr, Lima 12, Peru; Pontificia Univ Javeriana, Inst Genet Humana, Bogota, Colombia	Pontificia Universidad Javeriana	Lanata, CF (corresponding author), Inst Invest Nutr, Lima 12, Peru.	clanata@iin.sld.pe	Lanata, Claudio F./N-7997-2018; CORTES, Manuel Antonio FRANCO/M-7517-2014	Lanata, Claudio F./0000-0002-6994-7425; CORTES, Manuel Antonio FRANCO/0000-0002-0265-0563				Esposito M, 2005, ANTIMICROB AGENTS CH, V49, P3715, DOI 10.1128/AAC.49.9.3715-3723.2005; Fox LM, 2005, CLIN INFECT DIS, V40, P1173, DOI 10.1086/428839; Rossen JWA, 2004, J VIROL, V78, P9721, DOI 10.1128/JVI.78.18.9721-9730.2004; Rossignol JF, 2006, LANCET, V368, P124, DOI 10.1016/S0140-6736(06)68852-1; Salazar-Lindo E, 2000, NEW ENGL J MED, V343, P463, DOI 10.1056/NEJM200008173430703; Sarker SA, 1998, PEDIATR INFECT DIS J, V17, P1149, DOI 10.1097/00006454-199812000-00010; Szymanski H, 2006, ALIMENT PHARM THER, V23, P247, DOI 10.1111/j.1365-2036.2006.02740.x	7	4	4	0	5	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 8	2006	368	9530					100	101		10.1016/S0140-6736(06)68981-2	http://dx.doi.org/10.1016/S0140-6736(06)68981-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	062AR	16829280				2022-12-28	WOS:000238917200006
J	Regenauer-Lieb, K; Weinberg, RF; Rosenbaum, G				Regenauer-Lieb, Klaus; Weinberg, Roberto F.; Rosenbaum, Gideon			The effect of energy feedbacks on continental strength	NATURE			English	Article							CORE COMPLEXES; LOCALIZATION; THRUST; DEFORMATION; LITHOSPHERE; EXTENSION; TECTONICS; FAULTS	The classical strength profile of continents(1,2) is derived from a quasi-static view of their rheological response to stress-one that does not consider dynamic interactions between brittle and ductile layers. Such interactions result in complexities of failure in the brittle-ductile transition and the need to couple energy to understand strain localization. Here we investigate continental deformation by solving the fully coupled energy, momentum and continuum equations. We show that this approach produces unexpected feedback processes, leading to a significantly weaker dynamic strength evolution. In our model, stress localization focused on the brittle-ductile transition leads to the spontaneous development of mid-crustal detachment faults immediately above the strongest crustal layer. We also find that an additional decoupling layer forms between the lower crust and mantle. Our results explain the development of decoupling layers that are observed to accommodate hundreds of kilometres of horizontal motions during continental deformation.	Johannes Gutenberg Univ Mainz, Inst Geowissensch, D-55099 Mainz, Germany; Univ Western Australia, Sch Earth & Geog Sci, Perth, WA 6009, Australia; CSIRO Explorat & Min, Kensington, WA 6151, Australia; Monash Univ, Sch Geosci, Clayton, Vic 3800, Australia; Univ Queensland, Sch Phys Sci, Brisbane, Qld 4072, Australia	Johannes Gutenberg University of Mainz; University of Western Australia; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Monash University; University of Queensland	Regenauer-Lieb, K (corresponding author), Johannes Gutenberg Univ Mainz, Inst Geowissensch, D-55099 Mainz, Germany.	klaus@cyllene.uwa.edu.au	Regenauer-Lieb, Klaus/F-9560-2011; Regenauer-Lieb, Klaus/H-5706-2014; Rosenbaum, Gideon/G-4686-2012	Regenauer-Lieb, Klaus/0000-0002-2198-5895; Rosenbaum, Gideon/0000-0002-2544-093X; weinberg, roberto/0000-0001-9420-8918				ANDERSON JL, 1987, METAMORPHISM CRUSTAL, P502; BRACE WF, 1980, J GEOPHYS RES, V85, P6248, DOI 10.1029/JB085iB11p06248; Buck WR, 1998, NATURE, V392, P272, DOI 10.1038/32636; BUROV EB, 1995, J GEOPHYS RES-SOL EA, V100, P3905, DOI 10.1029/94JB02770; BUTLER RWH, 1986, J GEOL SOC LONDON, V143, P857, DOI 10.1144/gsjgs.143.6.0857; COOK FA, 1992, TECTONICS, V11, P12, DOI 10.1029/91TC02332; DAVIS GH, 1979, GEOLOGY, V7, P120, DOI 10.1130/0091-7613(1979)7<120:GDOTCM>2.0.CO;2; Ellis S, 2004, J GEOPHYS RES-SOL EA, V109, DOI 10.1029/2003JB002744; GOETZE C, 1979, GEOPHYS J ROY ASTR S, V59, P463, DOI 10.1111/j.1365-246X.1979.tb02567.x; Gueydan F, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2001JB000611; *HIBB KARLSS SOR I, 2000, ABAQUS STAND THEOR M; Jackson J. A., 2002, GSA TODAY, V12, P4, DOI [DOI 10.1130/1052-5173(2002)0122.0.CO;2, DOI 10.1130/1052-5173(2002)012<0004:S0TCLT>2.0.C0;2]; Jolivet L, 1998, J GEOPHYS RES-SOL EA, V103, P12123, DOI 10.1029/97JB03616; LAUBSCHER HP, 1983, GEOL SOC AM MEM, V158, P191; LISTER GS, 1984, GEOLOGY, V12, P221, DOI 10.1130/0091-7613(1984)12<221:MCCOCT>2.0.CO;2; Meissner R, 1998, TECTONOPHYSICS, V296, P47, DOI 10.1016/S0040-1951(98)00136-X; MILLER EL, 1983, TECTONICS, V2, P239, DOI 10.1029/TC002i003p00239; Needleman A., 1992, APPL MECH REV, V45, P3; RAMSAY JG, 1981, SPEC PUBLS GEOL SOC, V9, P293; RANALLI G, 1987, TECTONOPHYSICS, V132, P281, DOI 10.1016/0040-1951(87)90348-9; Regenauer-Lieb K, 2004, PHYS EARTH PLANET IN, V142, P113, DOI 10.1016/j.pepi.2004.01.003; REGENAUERLIEB K, 2005, EOS S, V86; RICE JR, 1977, THEORETICAL APPL MEC, P207; Rosenbaum G, 2005, GEOLOGY, V33, P609, DOI 10.1130/G21477.1; Royden LH, 1997, SCIENCE, V276, P788, DOI 10.1126/science.276.5313.788; RUDNICKI JW, 1975, J MECH PHYS SOLIDS, V23, P371, DOI 10.1016/0022-5096(75)90001-0; SHAWKI TG, 1994, J APPL MECH-T ASME, V61, P538, DOI 10.1115/1.2901493; WERNICKE B, 1981, NATURE, V291, P645, DOI 10.1038/291645a0; Wernicke B., 1992, CORDILLERAN OROGEN C, P553, DOI DOI 10.1130/DNAG-GNA-G3.553; Wobus C, 2005, NATURE, V434, P1008, DOI 10.1038/nature03499	30	121	121	0	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 6	2006	442	7098					67	70		10.1038/nature04868	http://dx.doi.org/10.1038/nature04868			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	059HS	16823450				2022-12-28	WOS:000238724500037
J	Tonstad, S; Tonnesen, P; Hajek, P; Williams, KE; Billing, CB; Reeves, KR				Tonstad, Serena; Tonnesen, Philip; Hajek, Peter; Williams, Kathryn E.; Billing, Clare B.; Reeves, Karen R.		Varenicline Phase 3 Study Grp	Effect of maintenance therapy with varenicline on smoking cessation - A randomized controlled trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SUSTAINED-RELEASE BUPROPION; RECEPTOR PARTIAL AGONIST; TREATMENT SERVICES; PREVENTION; RELAPSE; SYMPTOMS; PLACEBO	Context The majority of cigarette smokers who achieve abstinence relapse within the first year and require many attempts before achieving permanent abstinence. Evidence to support pharmacological treatment for relapse prevention is insufficient. Objective To determine whether smokers who quit after 12 weeks of treatment with varenicline, a selective alpha 4 beta 2 nicotinic acetylcholine receptor partial agonist, maintain greater continuous abstinence rates (defined as not a single "puff" of a cigarette) than placebo controls during an additional 12 weeks of treatment and until 52 weeks after treatment initiation. Design, Setting, and Participants Randomized controlled trial conducted at multiple medical clinics in 7 countries with follow-up to 52 weeks after study baseline. Of 1927 cigarette smokers recruited between April 2003 and February 2004 and treated for 12 weeks with open-label varenicline titrated to 1 mg twice per day, 1236 (64.1%) did not smoke, use tobacco, or use nicotine replacement therapy during the last week of treatment and 62.8% (n=1210) were randomized to additional treatment or placebo. Intervention Participants were randomly assigned to receive either double-blind varenicline, 1 mg twice per day (n=603), or placebo (n=607) for an additional 12 weeks. Main Outcome Measures Carbon monoxide-confirmed continued abstinence during weeks 13 to 24 and weeks 13 to 52 of the study. Results The carbon monoxide-confirmed continuous abstinence rate was significantly higher for the varenicline group than for the placebo group for weeks 13 to 24 (70.5% vs 49.6%; odds ratio [OR], 2.48; 95% confidence interval [CI], 1.95-3.16; P<.001) as well as for weeks 13 to 52 (43.6% vs 36.9%; OR, 1.34; 95% CI, 1.06-1.69; P=.02). Adverse events reported in the open-label period were mostly mild; no difference in adverse events between varenicline and placebo was observed during the double-blind period. Conclusions Smokers who achieved abstinence for at least 7 days at the end of 12 weeks of open-label varenicline treatment and were randomized to receive an additional 12 weeks of varenicline treatment showed significantly greater continuous abstinence in weeks 13 to 24 compared with placebo. This advantage was maintained through the nontreatment follow-up to week 52. Varenicline may be an efficacious, safe, and well-tolerated agent for maintaining abstinence from smoking.	Ullevaal Univ Hosp, Dept Prevent Cardiol, N-0407 Oslo, Norway; Univ Oslo, Oslo, Norway; Univ Copenhagen, Dept Pulm Med, Copenhagen, Denmark; Gentofte Univ Hosp, Copenhagen, Denmark; Univ London, Queen Mary, Wolfson Inst Prevent Med, London, England; Pfizer Global Res & Dev, Groton, CT USA	University of Oslo; University of Oslo; University of Copenhagen; University of Copenhagen; Herlev & Gentofte Hospital; University of London; Queen Mary University London; Pfizer	Tonstad, S (corresponding author), Ullevaal Univ Hosp, Dept Prevent Cardiol, N-0407 Oslo, Norway.	serena.tonstad@uus.no						Ferguson J, 2005, ADDICTION, V100, P59, DOI 10.1111/j.1360-0443.2005.01028.x; Fiore MC, 2000, JAMA-J AM MED ASSOC, V283, P3244; Gonzales D, 2006, JAMA-J AM MED ASSOC, V296, P47, DOI 10.1001/jama.296.1.47; Hajek P, 2009, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD003999.pub3, 10.1002/14651858.CD003999.pub4]; Hays JT, 2001, ANN INTERN MED, V135, P423, DOI 10.7326/0003-4819-135-6-200109180-00011; Hughes JR, 2003, NICOTINE TOB RES, V5, P13, DOI 10.1080/1462220031000070552; HUGHES JR, 1986, ARCH GEN PSYCHIAT, V43, P289; HUGHES JR, 1991, ARCH GEN PSYCHIAT, V48, P52; HUGHES JR, 2006, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000031.PUB3; Hurt RD, 2003, J CLIN ONCOL, V21, P914, DOI 10.1200/JCO.2003.08.160; Jorenby DE, 2006, JAMA-J AM MED ASSOC, V296, P56, DOI 10.1001/jama.296.1.56; Joseph CC, 2005, CURR MED RES OPIN, V21, P749, DOI 10.1185/030079905X43712; Judge K, 2005, ADDICTION, V100, P46, DOI 10.1111/j.1360-0443.2005.01027.x; Lancaster T, 2006, ARCH INTERN MED, V166, P828, DOI 10.1001/archinte.166.8.828; Marlatt A., 1985, RELAPSE PREVENTION M; *NAT I CLIN EXC, 2004, 0082 NAT I CLIN EXC; Stead LF, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000146.pub3; West R, 2005, ADDICTION, V100, P299, DOI 10.1111/j.1360-0443.2004.00995.x	18	463	482	0	25	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 5	2006	296	1					64	71		10.1001/jama.296.1.64	http://dx.doi.org/10.1001/jama.296.1.64			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	058RU	16820548	Bronze			2022-12-28	WOS:000238683100023
J	Watkins, PB; Kaplowitz, N; Slattery, JT; Colonese, CR; Colucci, SV; Stewart, PW; Harris, SC				Watkins, Paul B.; Kaplowitz, Neil; Slattery, John T.; Colonese, Connie R.; Colucci, Salvatore V.; Stewart, Paul W.; Harris, Stephen C.			Aminotransferase elevations in healthy adults receiving 4 grams of acetaminophen daily - A randomized controlled trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							UNITED-STATES; RISK-FACTORS; PARACETAMOL; OSTEOARTHRITIS; PREVALENCE; KNEE; PHARMACOKINETICS; IBUPROFEN; NAPROXEN; INJURY	Context During a clinical trial of a novel hydrocodone/acetaminophen combination, a high incidence of serum alanine aminotransferase (ALT) elevations was observed. Objective To characterize the incidence and magnitude of ALT elevations in healthy participants receiving 4 g of acetaminophen daily, either alone or in combination with selected opioids, as compared with participants treated with placebo. Design, Setting, and Participants A randomized, single-blind, placebo-controlled, 5-treatment, parallel-group, inpatient, diet-controlled (meals provided), longitudinal study of 145 healthy adults in 2 US inpatient clinical pharmacology units. Intervention Each participant received either placebo (n=39), 1 of 3 acetaminophen/opioid combinations (n=80), or acetaminophen alone (n=26). Each active treatment included 4 g of acetaminophen daily, the maximum recommended daily dosage. The intended treatment duration was 14 days. Main Outcomes Serum liver chemistries and trough acetaminophen concentrations measured daily through 8 days, and at 1- or 2-day intervals thereafter. Results None of the 39 participants assigned to placebo had a maximum ALT of more than 3 times the upper limit of normal. In contrast, the incidence of maximum ALT of more than 3 times the upper limits of normal was 31% to 44% in the 4 treatment groups receiving acetaminophen, including those participants treated with acetaminophen alone. Compared with placebo, treatment with acetaminophen was associated with a markedly higher median maximum ALT (ratio of medians, 2.78; 95% confidence interval, 1.47-4.09; P<.001). Trough acetaminophen concentrations did not exceed therapeutic limits in any participant and, after active treatment was discontinued, often decreased to undetectable levels before ALT elevations resolved. Conclusions Initiation of recurrent daily intake of 4 g of acetaminophen in healthy adults is associated with ALT elevations and concomitant treatment with opioids does not seem to increase this effect. History of acetaminophen ingestion should be considered in the differential diagnosis of serum aminotransferase elevations, even in the absence of measurable serum acetaminophen concentrations.	Univ N Carolina, Gen Clin Res Ctr, Dept Med, Chapel Hill, NC 27599 USA; Univ So Calif, Keck Sch Med, Dept Med, Los Angeles, CA USA; Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA; Univ Washington, Dept Med, Seattle, WA 98195 USA; Boehringer Ingelheim Pharmaceut Inc, Ridgefield, CT 06877 USA; Purdue Pharma LP, Dept Clin Pharmacol & Clin Pharmacokinet, Stamford, CT USA; Univ N Carolina, Dept Biostat, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of Southern California; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Boehringer Ingelheim; Purdue Pharma L.P.; University of North Carolina; University of North Carolina Chapel Hill	Watkins, PB (corresponding author), Univ N Carolina, Gen Clin Res Ctr, Dept Med, Campus Box 7600,Rm 3005 APCF, Chapel Hill, NC 27599 USA.	pbwatkins@med.unc.edu			NCRR NIH HHS [RR-000046] Funding Source: Medline	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		BRADLEY JD, 1991, NEW ENGL J MED, V325, P87, DOI 10.1056/NEJM199107113250203; Browning JD, 2004, HEPATOLOGY, V40, P1387, DOI 10.1002/hep.20466; CRITCHLEY JAJH, 1986, BRIT J CLIN PHARMACO, V22, P649, DOI 10.1111/j.1365-2125.1986.tb02953.x; FALLOON I, 1978, PSYCHOL MED, V8, P495, DOI 10.1017/S0033291700016196; Geba GP, 2002, JAMA-J AM MED ASSOC, V287, P64, DOI 10.1001/jama.287.1.64; Ioannou GN, 2006, AM J GASTROENTEROL, V101, P76, DOI 10.1111/j.1572-0241.2005.00341.x; Koennecke HC, 2001, NEUROLOGY, V57, P2301, DOI 10.1212/WNL.57.12.2301; Kwan D, 1999, J CLIN PHARMACOL, V39, P68, DOI 10.1177/00912709922007570; KWAN D, 1995, DIGEST DIS SCI, V40, P1951, DOI 10.1007/BF02208663; LANZA FL, 1986, GUT, V27, P440, DOI 10.1136/gut.27.4.440; Mortensen ME, 2002, ANN PHARMACOTHER, V36, P1481; Nikles C Jane, 2005, Am J Ther, V12, P80, DOI 10.1097/00045391-200501000-00011; Prescott L F, 2000, Am J Ther, V7, P143, DOI 10.1097/00045391-200007020-00011; Purkins L, 2004, BRIT J CLIN PHARMACO, V57, P199, DOI 10.1046/j.1365-2125.2003.01969.x; Rosenzweig P, 1999, BRIT J CLIN PHARMACO, V48, P19; SEIDEMAN P, 1988, BRIT J RHEUMATOL, V27, P117; SEIDEMAN P, 1993, ACTA ORTHOP SCAND, V64, P285, DOI 10.3109/17453679308993626; Watkins PB, 2006, HEPATOLOGY, V43, P618, DOI 10.1002/hep.21095; WATKINS PB, 1994, JAMA-J AM MED ASSOC, V271, P992, DOI 10.1001/jama.271.13.992; WILLIAMS HJ, 1993, ARTHRITIS RHEUM-US, V36, P1196, DOI 10.1002/art.1780360904; Yin OQP, 2001, INT J PHARM, V222, P305, DOI 10.1016/S0378-5173(01)00712-8	21	430	440	0	16	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 5	2006	296	1					87	93		10.1001/jama.296.1.87	http://dx.doi.org/10.1001/jama.296.1.87			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	058RU	16820551	Bronze			2022-12-28	WOS:000238683100026
J	Kim, M; Gans, JD; Nogueira, C; Wang, A; Paik, JH; Feng, B; Brennan, C; Hahn, WC; Cordon-Cardo, C; Wagner, SN; Flotte, TJ; Duncan, LM; Granter, SR; Chin, L				Kim, Minjung; Gans, Joseph D.; Nogueira, Cristina; Wang, Audrey; Paik, Ji-Hye; Feng, Bin; Brennan, Cameron; Hahn, William C.; Cordon-Cardo, Carlos; Wagner, Stephan N.; Flotte, Thomas J.; Duncan, Lyn M.; Granter, Scott R.; Chin, Lynda			Comparative oncogenomics identifies NEDD9 as a melanoma metastasis gene	CELL			English	Article							FOCAL-ADHESION KINASE; RESOLUTION GENOMIC PROFILES; CANCER METASTASIS; DOCKING PROTEIN; HEF1; HYBRIDIZATION; MELANOCYTES; PROGRESSION; CARCINOMAS; EXPRESSION	Genomes of human cancer cells are characterized by numerous chromosomal aberrations of uncertain pathogenetic significance. Here, in an inducible mouse model of melanoma, we characterized metastatic variants with an acquired focal chromosomal amplification that corresponds to a much larger amplification in human metastatic melanomas. Further analyses identified Nedd9, an adaptor protein related to p130CAS, as the only gene within the minimal common region that exhibited amplification-associated overexpression. A series of functional, biochemical, and clinical studies established NEDD9 as a bona fide melanoma metastasis gene. NEDD9 enhanced invasion in vitro and metastasis in vivo of both normal and transformed melanocytes, functionally interacted with focal adhesion kinase and modulated focal contact formation, and exhibited frequent robust overexpression in human metastatic melanoma relative to primary melanoma. Thus, comparative oncogenomics has enabled the identification and facilitated the validation of a highly relevant cancer gene governing metastatic potential in human melanoma.	Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; Univ Porto, Inst Mol Pathol & Immunol, Fac Med, P-4100 Oporto, Portugal; Dana Farber Canc Inst, Ctr Appl Canc Sci, Boston, MA 02115 USA; Mem Sloan Kettering Canc Ctr, Dept Surg, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA; MIT, Cambridge, MA 02142 USA; Harvard Univ, Broad Inst, Cambridge, MA 02142 USA; Austrian Acad Sci, Ctr Mol Med, A-1090 Vienna, Austria; Med Univ Vienna, Dept Dermatol, DIAID, A-1090 Vienna, Austria; Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Pathol,Dermatopathol Unit, Boston, MA 02114 USA; Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Dermatol, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Universidade do Porto; Harvard University; Dana-Farber Cancer Institute; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Austrian Academy of Sciences; Medical University of Vienna; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Kim, M (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA.	lynda_chin@dfci.harvard.edu	Brennan, Cameron/R-7082-2019; Nogueira, Cristina/N-4574-2015	Brennan, Cameron/0000-0003-4064-8891; Nogueira, Cristina/0000-0002-0853-5304; Wagner, Stephan/0000-0003-4941-7029; Kim, Minjung/0000-0002-5682-6640	NCI NIH HHS [P50 CA093683, U01 CA105423, U01 CA84313, P50 CA93683, P50 CA112962, R01 CA93947] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA093947, P50CA093683, U01CA084313, U01CA105423] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Aguirre AJ, 2004, P NATL ACAD SCI USA, V101, P9067, DOI 10.1073/pnas.0402932101; Bastian BC, 2003, AM J PATHOL, V163, P1765, DOI 10.1016/S0002-9440(10)63536-5; Bastian BC, 1998, CANCER RES, V58, P2170; Bernards R, 2002, NATURE, V418, P823, DOI 10.1038/418823a; Boukerche H, 2005, CANCER RES, V65, P10901, DOI 10.1158/0008-5472.CAN-05-1614; Brennan C, 2004, CANCER RES, V64, P4744, DOI 10.1158/0008-5472.CAN-04-1241; Carrasco DR, 2006, CANCER CELL, V9, P313, DOI 10.1016/j.ccr.2006.03.019; Chin L, 1999, NATURE, V400, P468, DOI 10.1038/22788; Chin L, 2003, NAT REV CANCER, V3, P559, DOI 10.1038/nrc1145; Chudnovsky Y, 2005, J CLIN INVEST, V115, P813, DOI 10.1172/JCI200524808; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Disatnik MH, 1999, J BIOL CHEM, V274, P32486, DOI 10.1074/jbc.274.45.32486; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Garraway LA, 2005, NATURE, V436, P117, DOI 10.1038/nature03664; Gupta PB, 2005, NAT GENET, V37, P1047, DOI 10.1038/ng1634; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hess AR, 2006, CELL CYCLE, V5, P478, DOI 10.4161/cc.5.5.2518; Hess AR, 2005, CANCER RES, V65, P9851, DOI 10.1158/0008-5472.CAN-05-2172; Hoek K, 2004, CANCER RES, V64, P5270, DOI 10.1158/0008-5472.CAN-04-0731; Kinsella TM, 1996, HUM GENE THER, V7, P1405, DOI 10.1089/hum.1996.7.12-1405; KUMAR S, 1992, BIOCHEM BIOPH RES CO, V185, P1155, DOI 10.1016/0006-291X(92)91747-E; Law SF, 1996, MOL CELL BIOL, V16, P3327; Lillington DM, 2003, GENE CHROMOSOME CANC, V36, P121, DOI 10.1002/gcc.10149; Lucito R, 2003, GENOME RES, V13, P2291, DOI 10.1101/gr.1349003; McLean GW, 2005, NAT REV CANCER, V5, P505, DOI 10.1038/nrc1647; Meierjohann S, 2006, CANCER RES, V66, P3145, DOI 10.1158/0008-5472.CAN-05-2667; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Namiki T, 2005, CANCER GENET CYTOGEN, V157, P1, DOI 10.1016/j.cancergencyto.2004.06.004; O'Hagan RC, 2002, CANCER CELL, V2, P149, DOI 10.1016/S1535-6108(02)00094-6; O'Neill GM, 2000, TRENDS CELL BIOL, V10, P111, DOI 10.1016/S0962-8924(99)01714-6; O'Neill GM, 2001, MOL CELL BIOL, V21, P5094, DOI 10.1128/MCB.21.15.5094-5108.2001; Pugacheva EN, 2005, NAT CELL BIOL, V7, P937, DOI 10.1038/ncb1309; Singh-Gasson S, 1999, NAT BIOTECHNOL, V17, P974, DOI 10.1038/13664; Stokke T, 2001, BRIT J CANCER, V85, P1900, DOI 10.1054/bjoc.2001.2164; Storchova Z, 2004, NAT REV MOL CELL BIO, V5, P45, DOI 10.1038/nrm1276; THOMPSON F, 1993, GENE CHROMOSOME CANC, V7, P185, DOI 10.1002/gcc.2870070402; Tonon G, 2005, P NATL ACAD SCI USA, V102, P9625, DOI 10.1073/pnas.0504126102; Tsao H, 2004, J INVEST DERMATOL, V122, P337, DOI 10.1046/j.0022-202X.2004.22243.x; van Nimwegen MJ, 2005, CANCER RES, V65, P4698, DOI 10.1158/0008-5472.CAN-04-4126; van Seventer GA, 2001, EUR J IMMUNOL, V31, P1417, DOI 10.1002/1521-4141(200105)31:5<1417::AID-IMMU1417>3.0.CO;2-C; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Zhang XA, 2003, J BIOL CHEM, V278, P27319, DOI 10.1074/jbc.M303039200; Zhao XJ, 2005, CANCER RES, V65, P5561, DOI 10.1158/0008-5472.CAN-04-4603; Zielke H R, 1974, Methods Cell Biol, V8, P107, DOI 10.1016/S0091-679X(08)60447-1	44	327	341	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 30	2006	125	7					1269	1281		10.1016/j.cell.2006.06.008	http://dx.doi.org/10.1016/j.cell.2006.06.008			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	064QP	16814714	Bronze			2022-12-28	WOS:000239104500011
J	Chang, SR; Young, BD; Li, SJ; Qi, XX; Richardson, JA; Olson, EN				Chang, Shurong; Young, Bryan D.; Li, Shijie; Qi, Xiaoxia; Richardson, James A.; Olson, Eric N.			Histone deacetylase 7 maintains vascular integrity by repressing matrix metalloproteinase 10	CELL			English	Article							SERUM RESPONSE FACTOR; HISTONE DEACETYLASE INHIBITOR; MATRIX METALLOPROTEINASES; TRANSCRIPTION FACTOR; MYOCARDIAL-INFARCTION; NUCLEAR EXPORT; CLASS-I; METASTASIS; ACTIVATION; EXPRESSION	Development and homeostasis of the cardiovascular system require intimate interactions between endothelial and smooth muscle cells, which form a seamless circulatory network. We show that histone deacetylase 7 (HDAC7) is specifically expressed in the vascular endothelium during early embryogenesis, where it maintains vascular integrity by repressing the expression of matrix metalloproteinase (MMP) 10, a secreted endoproteinase that degrades the extracellular matrix. Disruption of the HDAC7 gene in mice results in embryonic lethality due to a failure in endothelial cell-cell adhesion and consequent dilatation and rupture of blood vessels. HDAC7 represses MMP10 gene transcription by associating with myocyte enhancer factor-2 (MEF2), a direct activator of MMP10 transcription and essential regulator of blood vessel development. These findings reveal an unexpected and specific role for HDAC7 in the maintenance of vascular integrity and have important implications for understanding the processes of angiogenesis and vascular remodeling during cardiovascular development and disease.	Univ Texas, SW Med Ctr, Dept Mol Biol, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Pathol, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Olson, EN (corresponding author), Univ Texas, SW Med Ctr, Dept Mol Biol, 6000 Harry Hines Blvd, Dallas, TX 75390 USA.	eric.olson@utsouthwestern.edu		Young, Bryan/0000-0002-8264-5421				Ailenberg M, 2002, BIOCHEM BIOPH RES CO, V298, P110, DOI 10.1016/S0006-291X(02)02420-8; Chakraborti S, 2003, MOL CELL BIOCHEM, V253, P269, DOI 10.1023/A:1026028303196; Chang HC, 2004, CELL SIGNAL, V16, P675, DOI 10.1016/j.cellsig.2003.11.001; Chang PS, 2001, J BIOL CHEM, V276, P17206, DOI 10.1074/jbc.M010983200; Chang SR, 2005, P NATL ACAD SCI USA, V102, P8120, DOI 10.1073/pnas.0503275102; Chang SR, 2004, MOL CELL BIOL, V24, P8467, DOI 10.1128/MCB.24.19.8467-8476.2004; CHENG TC, 1993, SCIENCE, V261, P215, DOI 10.1126/science.8392225; Cleaver O., 1999, HEART DEV, P221; Cleutjens JPM, 2002, J CARD FAIL, V8, pS344, DOI 10.1054/jcaf.2002.129261; Creemers EEJM, 2003, AM J PHYSIOL-HEART C, V284, pH364, DOI 10.1152/ajpheart.00511.2002; Creemers EEJM, 2001, CIRC RES, V89, P201, DOI 10.1161/hh1501.094396; Dressel U, 2001, J BIOL CHEM, V276, P17007, DOI 10.1074/jbc.M101508200; GOSSETT LA, 1989, MOL CELL BIOL, V9, P5022, DOI 10.1128/MCB.9.11.5022; Grozinger CM, 2002, CHEM BIOL, V9, P3, DOI 10.1016/S1074-5521(02)00092-3; Handsley MM, 2005, INT J CANCER, V115, P849, DOI 10.1002/ijc.20945; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kao HY, 2000, GENE DEV, V14, P55; Kim MS, 2000, CANCER LETT, V157, P23, DOI 10.1016/S0304-3835(00)00465-1; Kisanuki YY, 2001, DEV BIOL, V230, P230, DOI 10.1006/dbio.2000.0106; Li SJ, 2005, P NATL ACAD SCI USA, V102, P1082, DOI 10.1073/pnas.0409103102; Li SJ, 2003, P NATL ACAD SCI USA, V100, P9366, DOI 10.1073/pnas.1233635100; Lin Q, 1998, DEVELOPMENT, V125, P4565; Lin Q, 1997, SCIENCE, V276, P1404, DOI 10.1126/science.276.5317.1404; Liu J, 2003, LUNG CANCER, V42, P335, DOI 10.1016/S0169-5002(03)00355-6; Liu LT, 2003, CANCER RES, V63, P3069; London CA, 2003, CANCER GENE THER, V10, P823, DOI 10.1038/sj.cgt.7700642; McKinsey TA, 2000, NATURE, V408, P106, DOI 10.1038/35040593; McKinsey TA, 2000, P NATL ACAD SCI USA, V97, P14400, DOI 10.1073/pnas.260501497; Ogata T, 2005, J VASC SURG, V41, P1036, DOI 10.1016/j.jvs.2005.02.020; Ogata Y, 2006, INT J CANCER, V118, P215, DOI 10.1002/ijc.21285; Phan D, 2005, DEVELOPMENT, V132, P2669, DOI 10.1242/dev.01849; Rundhaug JE, 2005, J CELL MOL MED, V9, P267, DOI 10.1111/j.1582-4934.2005.tb00355.x; Saunders WB, 2005, J CELL SCI, V118, P2325, DOI 10.1242/jcs.02360; Shelton JM, 2000, J LIPID RES, V41, P532; Spinale FG, 2002, CIRC RES, V90, P520, DOI 10.1161/01.RES.0000013290.12884.A3; Thurston G, 2003, CELL TISSUE RES, V314, P61, DOI 10.1007/s00441-003-0749-6; Vega RB, 2004, CELL, V119, P555, DOI 10.1016/j.cell.2004.10.024; Vega RB, 2004, MOL CELL BIOL, V24, P8374, DOI 10.1128/MCB.24.19.8374-8385.2004; Verdin E, 2003, TRENDS GENET, V19, P286, DOI 10.1016/S0168-9525(03)00073-8; Whetstine JR, 2005, MOL CELL, V18, P483, DOI 10.1016/j.molcel.2005.04.006; Yoon SO, 2003, J BIOCHEM MOL BIOL, V36, P128; Youn HD, 2000, EMBO J, V19, P4323, DOI 10.1093/emboj/19.16.4323; Youn HD, 2000, IMMUNITY, V13, P85, DOI 10.1016/S1074-7613(00)00010-8; Zhang CL, 2002, CELL, V110, P479, DOI 10.1016/S0092-8674(02)00861-9	44	356	375	0	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 28	2006	126	2					321	334		10.1016/j.cell.2006.05.040	http://dx.doi.org/10.1016/j.cell.2006.05.040			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	070VD	16873063	Bronze			2022-12-28	WOS:000239552600018
J	Wang, KH; Majewska, A; Schummers, J; Farley, B; Hu, CC; Sur, M; Tonegawa, S				Wang, Kuan Hong; Majewska, Ania; Schummers, James; Farley, Brandon; Hu, Chengcheng; Sur, Mriganka; Tonegawa, Susumu			In vivo two-photon imaging reveals a role of arc in enhancing orientation specificity in visual cortex	CELL			English	Article							IMMEDIATE-EARLY GENE; CYTOSKELETON-ASSOCIATED PROTEIN; CORTICAL PLASTICITY; RECEPTIVE FIELDS; MESSENGER-RNAS; ADULT CORTEX; EXPERIENCE; NEURONS; EXPRESSION; MEMORY	Cortical representations of visual information are modified by an animal's visual experience. To investigate the mechanisms in mice, we replaced the coding part of the neural activity-regulated immediate early gene Arc with a GFP gene and repeatedly monitored visual experience-induced GFP expression in adult primary visual cortex by in vivo two-photon microscopy. In Arc-positive GFP heterozygous mice, the pattern of GFP-positive cells exhibited orientation specificity. Daily presentations of the same stimulus led to the reactivation of a progressively smaller population with greater reactivation reliability. This adaptation process was not affected by the lack of Arc in GFP homozygous mice. However, the number of GFP-positive cells with low orientation specificity was greater, and the average spike tuning curve was broader in the adult homozygous compared to heterozygous or wild-type mice. These results suggest a physiological function of Arc in enhancing the overall orientation specificity of visual cortical neurons during the post-eye-opening life of an animal.	MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA; MIT, Picower Inst Learning & Memory, Cambridge, MA 02139 USA; MIT, RIKEN MIT Neurosci Res Ctr, Cambridge, MA 02139 USA; MIT, Dept Biol, Cambridge, MA 02139 USA; MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA	Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Northwell Health; Massachusetts Institute of Technology (MIT); RIKEN; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Harvard T.H. Chan School of Public Health	Tonegawa, S (corresponding author), MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA.	tonegawa@mit.edu	Wang, Kuan Hong/J-1150-2016; Hu, Chengcheng/A-8391-2017	Wang, Kuan Hong/0000-0002-2249-5417; Schummers, James/0000-0002-1030-824X; Hu, Chengcheng/0000-0001-8525-0356; Farley, Brandon/0000-0002-9451-3653; Majewska, Ania/0000-0002-2167-6849	NIAID NIH HHS [AI24643, AI51164] Funding Source: Medline; NIMH NIH HHS [P50-MH58880] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI051164, R37AI024643, R01AI024643] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH058880] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Bao SW, 2001, NATURE, V412, P79, DOI 10.1038/35083586; Barth AL, 2004, J NEUROSCI, V24, P6466, DOI 10.1523/JNEUROSCI.4737-03.2004; Boehm U, 2005, CELL, V123, P683, DOI 10.1016/j.cell.2005.09.027; Chapman B, 1999, J NEUROBIOL, V41, P18, DOI 10.1002/(SICI)1097-4695(199910)41:1<18::AID-NEU4>3.0.CO;2-V; Choi GB, 2005, NEURON, V46, P647, DOI 10.1016/j.neuron.2005.04.011; Crair MC, 1998, SCIENCE, V279, P566, DOI 10.1126/science.279.5350.566; Dragoi V, 2000, NEURON, V28, P287, DOI 10.1016/S0896-6273(00)00103-3; Emondi AA, 2004, J NEUROSCI METH, V135, P95, DOI 10.1016/j.jneumeth.2003.12.022; Fagiolini M, 2003, P NATL ACAD SCI USA, V100, P2854, DOI 10.1073/pnas.0536089100; Ferguson JN, 2001, J NEUROSCI, V21, P8278; Frankland PW, 2004, SCIENCE, V304, P881, DOI 10.1126/science.1094804; Gordon JA, 1996, J NEUROSCI, V16, P3274; Grutzendler J, 2002, NATURE, V420, P812, DOI 10.1038/nature01276; Guzowski JF, 2006, P NATL ACAD SCI USA, V103, P1077, DOI 10.1073/pnas.0505519103; Guzowski JF, 1999, NAT NEUROSCI, V2, P1120, DOI 10.1038/16046; Guzowski JF, 2000, J NEUROSCI, V20, P3993; HUBEL DH, 1963, J NEUROPHYSIOL, V26, P994, DOI 10.1152/jn.1963.26.6.994; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Huber P. H., 1981, ROBUST STAT; Jahne B., 2002, DIGITAL IMAGE PROCES; Li XQ, 1998, J BIOL CHEM, V273, P34970, DOI 10.1074/jbc.273.52.34970; LINK W, 1995, P NATL ACAD SCI USA, V92, P5734, DOI 10.1073/pnas.92.12.5734; Liu D, 2000, MECH DEVELOP, V92, P207, DOI 10.1016/S0925-4773(99)00340-8; LYFORD GL, 1995, NEURON, V14, P433, DOI 10.1016/0896-6273(95)90299-6; Majewska A, 2000, PFLUG ARCH EUR J PHY, V441, P398, DOI 10.1007/s004240000435; Majewska A, 2003, P NATL ACAD SCI USA, V100, P16024, DOI 10.1073/pnas.2636949100; MARR D, 1980, PROC R SOC SER B-BIO, V207, P187, DOI 10.1098/rspb.1980.0020; Moga DE, 2004, NEUROSCIENCE, V125, P7, DOI 10.1016/j.neuroscience.2004.02.004; Schoups A, 2001, NATURE, V412, P549, DOI 10.1038/35087601; Sengpiel F, 1999, NAT NEUROSCI, V2, P727, DOI 10.1038/11192; Steward O, 2001, NEURON, V30, P227, DOI 10.1016/S0896-6273(01)00275-6; Steward O, 2001, P NATL ACAD SCI USA, V98, P7062, DOI 10.1073/pnas.131146398; Sutton MA, 2004, SCIENCE, V304, P1979, DOI 10.1126/science.1096202; Tagawa Y, 2005, NAT NEUROSCI, V8, P380, DOI 10.1038/nn1410; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; Tsodyks M, 2004, NATURE, V431, P775, DOI 10.1038/nature03013; Wallace CS, 1998, J NEUROSCI, V18, P26; Weinberger NM, 2003, NEUROBIOL LEARN MEM, V80, P268, DOI 10.1016/S1074-7427(03)00072-8; White LE, 2001, NATURE, V411, P1049, DOI 10.1038/35082568; WORSLEY KJ, 1992, J CEREBR BLOOD F MET, V12, P900, DOI 10.1038/jcbfm.1992.127	40	165	171	1	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 28	2006	126	2					389	402		10.1016/j.cell.2006.06.038	http://dx.doi.org/10.1016/j.cell.2006.06.038			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	070VD	16873068	Bronze, Green Submitted			2022-12-28	WOS:000239552600023
J	Smellie, WSA; Spickett, GP				Smellie, W. Stuart A.; Spickett, Gavin P.			Cases in primary care laboratory medicine - Paraprotein management	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							GUIDELINES		Gen Hosp, Clin Lab, Bishop Auckland DL14 6AD, England; Royal Victoria Infirm, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England	Newcastle University - UK	Smellie, WSA (corresponding author), Gen Hosp, Clin Lab, Bishop Auckland DL14 6AD, England.	info@smellie.com						Alexanian R, 1999, ARCH PATHOL LAB MED, V123, P108; Beetham R, 2000, ANN CLIN BIOCHEM, V37, P563, DOI 10.1258/0004563001899690; Graziani M, 2003, CLIN CHEM LAB MED, V41, P338, DOI 10.1515/CCLM.2003.054; Keren DF, 1999, ARCH PATHOL LAB MED, V123, P126; Keren DF, 1999, ARCH PATHOL LAB MED, V123, P106; Kyle RA, 1997, HEMATOL ONCOL CLIN N, V11, P71, DOI 10.1016/S0889-8588(05)70416-0; RICHES P, 1995, CLIN BIOCHEM, P493; Smellie WSA, 2005, J CLIN PATHOL, V58, P1016, DOI 10.1136/jcp.2004.025049; Smith A, 2001, BRIT J HAEMATOL, V115, P522	9	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 22	2006	333	7560					185	187		10.1136/bmj.333.7560.185	http://dx.doi.org/10.1136/bmj.333.7560.185			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	068DJ	16858048	Green Published			2022-12-28	WOS:000239352100023
J	Greilich, A; Yakovlev, DR; Shabaev, A; Efros, AL; Yugova, IA; Oulton, R; Stavarache, V; Reuter, D; Wieck, A; Bayer, M				Greilich, A.; Yakovlev, D. R.; Shabaev, A.; Efros, Al. L.; Yugova, I. A.; Oulton, R.; Stavarache, V.; Reuter, D.; Wieck, A.; Bayer, M.			Mode locking of electron spin coherences in singly charged quantum dots	SCIENCE			English	Article								The fast dephasing of electron spins in an ensemble of quantum dots is detrimental for applications in quantum information processing. We show here that dephasing can be overcome by using a periodic train of light pulses to synchronize the phases of the precessing spins, and we demonstrate this effect in an ensemble of singly charged ( In, Ga) As/GaAs quantum dots. This mode locking leads to constructive interference of contributions to Faraday rotation and presents potential applications based on robust quantum coherence within an ensemble of dots.	Univ Dortmund, D-44221 Dortmund, Germany; AF Ioffe Phys Tech Inst, St Petersburg 194021, Russia; USN, Res Lab, Washington, DC 20375 USA; George Mason Univ, Sch Computat Sci, Fairfax, VA 22030 USA; St Petersburg State Univ, Inst Phys, St Petersburg 198504, Russia; Ruhr Univ Bochum, D-44780 Bochum, Germany	Dortmund University of Technology; Russian Academy of Sciences; St. Petersburg Scientific Centre of the Russian Academy of Sciences; Ioffe Physical Technical Institute; United States Department of Defense; United States Navy; Naval Research Laboratory; George Mason University; Saint Petersburg State University; Ruhr University Bochum	Yakovlev, DR (corresponding author), Univ Dortmund, D-44221 Dortmund, Germany.	efros@dave.nrl.navy.mil; manfred.bayer@physik.unidortmund.de	Bayer, Manfred/I-7947-2013; Greilich, Alex/A-8927-2009; Yugova, Irina/F-6823-2011; Yakovlev, Dmitri R./AAO-7408-2020; Wieck, Andreas Dirk/C-5129-2009	Greilich, Alex/0000-0001-7813-682X; Yugova, Irina/0000-0003-0020-3679; Yakovlev, Dmitri R./0000-0001-7349-2745; Bayer, Manfred/0000-0002-0893-5949; Wieck, Andreas Dirk/0000-0001-9776-2922				Awschalom DD, 2002, NANOSCI TECHNOL, P147; Bracker AS, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.047402; Braun PF, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.116601; Coish WA, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.195340; Dutt MVG, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.227403; Elzerman JM, 2004, NATURE, V430, P431, DOI 10.1039/nature02693; Greilich A, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.045323; Greilich A, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.227401; Imamoglu A, 1999, PHYS REV LETT, V83, P4204, DOI 10.1103/PhysRevLett.83.4204; Kennedy TA, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.045307; Khaetskii AV, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.186802; Kroutvar M, 2004, NATURE, V432, P81, DOI 10.1038/nature03008; Loss D, 1998, PHYS REV A, V57, P120, DOI 10.1103/PhysRevA.57.120; Merkulov IA, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.205309; Petta JR, 2005, SCIENCE, V309, P2180, DOI 10.1126/science.1116955; Shabaev A, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.201305; Slichter C. P., 1996, PRINCIPLES MAGNETIC; Wolf SA, 2001, SCIENCE, V294, P1488, DOI 10.1126/science.1065389	18	384	385	2	60	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 21	2006	313	5785					341	345		10.1126/science.1128215	http://dx.doi.org/10.1126/science.1128215			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065IV	16857937				2022-12-28	WOS:000239154300041
J	Vitetta, ES; Ghetie, VF				Vitetta, Ellen S.; Ghetie, Victor F.			Considering therapeutic antibodies	SCIENCE			English	Editorial Material									Univ Texas, SW Med Ctr, Ctr Canc Immunobiol, Dallas, TX 75235 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Vitetta, ES (corresponding author), Univ Texas, SW Med Ctr, Ctr Canc Immunobiol, 6000 Harry Hines Blvd, Dallas, TX 75235 USA.	ellen.vitetta@utsouthwestern.edu						Beyersdorf N, 2005, ANN RHEUM DIS, V64, P91, DOI 10.1136/ard.2005.042564; Brekke OH, 2003, NAT REV DRUG DISCOV, V2, P52, DOI 10.1038/nrd984; Holliger P, 2005, NAT BIOTECHNOL, V23, P1126, DOI 10.1038/nbt1142; Liu XY, 2006, INT IMMUNOPHARMACOL, V6, P791, DOI 10.1016/j.intimp.2005.11.022; Luhder F, 2003, J EXP MED, V197, P955, DOI 10.1084/jem.20021024; Marshall E, 2006, SCIENCE, V311, P1688, DOI 10.1126/science.311.5768.1688; Waldmann TA, 2006, ADV IMMUNOL, V90, P83, DOI 10.1016/S0065-2776(06)90003-0	7	26	98	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 21	2006	313	5785					308	309		10.1126/science.1130482	http://dx.doi.org/10.1126/science.1130482			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065IV	16857927				2022-12-28	WOS:000239154300029
J	Riikonen, R				Riikonen, Raili			Childhood convulsive status epilepticus	LANCET			English	Editorial Material									Univ Kuopio, Childrens Hosp, Dept Child Neurol, FIN-70211 Kuopio, Finland	University of Eastern Finland	Riikonen, R (corresponding author), Univ Kuopio, Childrens Hosp, Dept Child Neurol, FIN-70211 Kuopio, Finland.	raili.riikonen@uku.fi						Chin RFM, 2006, LANCET, V368, P222, DOI 10.1016/S0140-6736(06)69043-0; Coeytaux A, 2000, NEUROLOGY, V55, P693, DOI 10.1212/WNL.55.5.693; DELORENZO RJ, 1995, J CLIN NEUROPHYSIOL, V12, P316; DeLorenzo RJ, 1996, NEUROLOGY, V46, P1029, DOI 10.1212/WNL.46.4.1029; Hesdorffer DC, 1998, NEUROLOGY, V50, P735, DOI 10.1212/WNL.50.3.735; Knake S, 2001, EPILEPSIA, V42, P714, DOI 10.1046/j.1528-1157.2001.01101.x; Metsaranta P, 2004, DEV MED CHILD NEUROL, V46, P4, DOI 10.1017/S0012162204000027; Treiman DM, 1998, NEW ENGL J MED, V339, P792, DOI 10.1056/NEJM199809173391202	8	1	1	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 15	2006	368	9531					184	185		10.1016/S0140-6736(06)69016-8	http://dx.doi.org/10.1016/S0140-6736(06)69016-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	064MY	16844471				2022-12-28	WOS:000239095000008
J	Heldwein, EE; Lou, H; Bender, FC; Cohen, GH; Eisenberg, RJ; Harrison, SC				Heldwein, Ekaterina E.; Lou, Huan; Bender, Florent C.; Cohen, Gary H.; Eisenberg, Roselyn J.; Harrison, Stephen C.			Crystal structure of glycoprotein B from herpes simplex virus 1	SCIENCE			English	Article							PROTEIN-STRUCTURE; FUSION DOMAIN; CELL-FUSION; TYPE-1; ENTRY; MUTATIONS; GB; EPITOPES; MUTANT; IDENTIFICATION	Glycoprotein B (gB) is the most conserved component of the complex cell-entry machinery of herpes viruses. A crystal structure of the gB ectodomain from herpes simplex virus type 1 reveals a multidomain trimer with unexpected homology to glycoprotein G from vesicular stomatitis virus (VSV G). An alpha-helical coiled-coil core relates gB to class I viral membrane fusion glycoproteins; two extended beta hairpins with hydrophobic tips, homologous to fusion peptides in VSV G, relate gB to class II fusion proteins. Members of both classes accomplish fusion through a large-scale conformational change, triggered by a signal from a receptor-binding component. The domain connectivity within a gB monomer would permit such a rearrangement, including long-range translocations linked to viral and cellular membranes.	Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; Childrens Hosp, Mol Med Lab, Boston, MA 02115 USA; Childrens Hosp, Howard Hughes Med Inst, Boston, MA 02115 USA; Univ Penn, Sch Dent Med, Dept Microbiol, Philadelphia, PA 19104 USA; Univ Penn, Sch Vet Med, Dept Pathobiol, Philadelphia, PA 19104 USA	Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute; University of Pennsylvania; University of Pennsylvania	Heldwein, EE (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, 320 Longwood Ave, Boston, MA 02115 USA.	heldwein@crystal.harvard.edu		Heldwein, Ekaterina/0000-0003-3113-6958	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI056045, R01AI049980, R21AI065886, R21AI056045] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036731] Funding Source: NIH RePORTER; NIAID NIH HHS [AI065886, AI056045, R21 AI065886, AI049980] Funding Source: Medline; NINDS NIH HHS [NS36731] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Blomberg N, 1999, TRENDS BIOCHEM SCI, V24, P441, DOI 10.1016/S0968-0004(99)01472-3; Britt WJ, 2005, J VIROL, V79, P4066, DOI 10.1128/JVI.79.7.4066-4079.2005; BZIK DJ, 1984, VIROLOGY, V137, P185, DOI 10.1016/0042-6822(84)90022-9; CAL WH, 1988, J VIROL, V62, P2596, DOI 10.1128/JVI.62.8.2596-2604.1988; Carfi A, 2001, MOL CELL, V8, P169, DOI 10.1016/S1097-2765(01)00298-2; Cocchi F, 2004, P NATL ACAD SCI USA, V101, P7445, DOI 10.1073/pnas.0401883101; DURRER P, 1995, J BIOL CHEM, V270, P17575, DOI 10.1074/jbc.270.29.17575; FORRESTER A, 1992, J VIROL, V66, P341, DOI 10.1128/JVI.66.1.341-348.1992; Foster TF, 2001, VIROLOGY, V287, P18, DOI 10.1006/viro.2001.1004; GAGE PJ, 1993, J VIROL, V67, P2191, DOI 10.1128/JVI.67.4.2191-2201.1993; Harrison SC, 2005, ADV VIRUS RES, V64, P231, DOI 10.1016/S0065-3527(05)64007-9; HIGHLANDER SL, 1989, J VIROL, V63, P730, DOI 10.1128/JVI.63.2.730-738.1989; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; Jones NA, 2004, VIROLOGY, V324, P213, DOI 10.1016/j.virol.2004.03.024; Kleywegt GJ, 1996, ACTA CRYSTALLOGR D, V52, P826, DOI 10.1107/S0907444995014983; KOUSOULAS KG, 1988, VIROLOGY, V166, P423, DOI 10.1016/0042-6822(88)90513-2; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Krummenacher C, 2005, EMBO J, V24, P4144, DOI 10.1038/sj.emboj.7600875; Laquerre S, 1998, J VIROL, V72, P6119, DOI 10.1128/JVI.72.7.6119-6130.1998; Lemmon MA, 2000, BIOCHEM J, V350, P1, DOI 10.1042/0264-6021:3500001; LIGAS MW, 1988, J VIROL, V62, P1486, DOI 10.1128/JVI.62.5.1486-1494.1988; Norais N, 1996, J VIROL, V70, P7379, DOI 10.1128/JVI.70.11.7379-7387.1996; OHLIN M, 1993, J VIROL, V67, P703, DOI 10.1128/JVI.67.2.703-710.1993; PELLETT PE, 1985, J VIROL, V53, P243, DOI 10.1128/JVI.53.1.243-253.1985; PEREIRA L, 1989, VIROLOGY, V172, P11, DOI 10.1016/0042-6822(89)90102-5; Roche S, 2006, SCIENCE, V313, P187, DOI 10.1126/science.1127683; ROOP C, 1993, J VIROL, V67, P2285, DOI 10.1128/JVI.67.4.2285-2297.1993; Spear PG, 2004, CELL MICROBIOL, V6, P401, DOI 10.1111/j.1462-5822.2004.00389.x; Spear PG, 2003, J VIROL, V77, P10179, DOI 10.1128/JVI.77.19.10179-10185.2003; UTZ U, 1989, J VIROL, V63, P1995, DOI 10.1128/JVI.63.5.1995-2001.1989; VEY M, 1995, VIROLOGY, V206, P746, DOI 10.1016/S0042-6822(95)80002-6	31	459	484	1	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 14	2006	313	5784					217	220		10.1126/science.1126548	http://dx.doi.org/10.1126/science.1126548			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	063GZ	16840698				2022-12-28	WOS:000239008000042
J	Santhanam, G; Ryu, SI; Yu, BM; Afshar, A; Shenoy, KV				Santhanam, Gopal; Ryu, Stephen I.; Yu, Byron M.; Afshar, Afsheen; Shenoy, Krishna V.			A high-performance brain-computer interface	NATURE			English	Article							CONTROL SIGNALS; PREMOTOR CORTEX	Recent studies have demonstrated that monkeys(1-4) and humans(5-9) can use signals from the brain to guide computer cursors. Brain computer interfaces (BCIs) may one day assist patients suffering from neurological injury or disease, but relatively low system performance remains a major obstacle. In fact, the speed and accuracy with which keys can be selected using BCIs is still far lower than for systems relying on eye movements. This is true whether BCIs use recordings from populations of individual neurons using invasive electrode techniques(1-5,7,8) or electroencephalogram recordings using less-(6) or non-invasive(9) techniques. Here we present the design and demonstration, using electrode arrays implanted in monkey dorsal premotor cortex, of a manyfold higher performance BCI than previously reported(9,10). These results indicate that a fast and accurate key selection system, capable of operating with a range of keyboard sizes, is possible ( up to 6.5 bits per second, or similar to 15 words per minute, with 96 electrodes). The highest information throughput is achieved with unprecedentedly brief neural recordings, even as recording quality degrades over time. These performance results and their implications for system design should substantially increase the clinical viability of BCIs in humans.	Stanford Univ, Dept Elect Engn, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Neurosurg, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Med Scientist Training Program, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Neurosci Program, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Stanford University	Shenoy, KV (corresponding author), Stanford Univ, Dept Elect Engn, 330 Serra Mall,319 Paul G Allen Ctr Integrated Sy, Stanford, CA 94305 USA.	shenoy@stanford.edu	Ramli, Roziana/E-7157-2010					BATISTA A, 2005, HETEROGENEOUS COORDI; Carmena JM, 2003, PLOS BIOL, V1, P193, DOI 10.1371/journal.pbio.0000042; Churchland MM, 2006, J NEUROSCI, V26, P3697, DOI 10.1523/JNEUROSCI.3762-05.2006; Cisek P, 2004, NATURE, V431, P993, DOI 10.1038/nature03005; Cisek P, 2002, J NEUROPHYSIOL, V88, P1064, DOI 10.1152/jn.00995.2001; Cover T. M., 1990, ELEMENTS INFORM THEO; Dayan P, 2001, COMPUTATIONAL NEUROS; HOCHBERG LR, 2005, BRAINGATE NEUROMOTOR; Kennedy PR, 2000, IEEE T REHABIL ENG, V8, P198, DOI 10.1109/86.847815; Leuthardt EC, 2004, J NEURAL ENG, V1, P63, DOI 10.1088/1741-2560/1/2/001; Messier J, 2000, J NEUROPHYSIOL, V84, P152, DOI 10.1152/jn.2000.84.1.152; Musallam S, 2004, SCIENCE, V305, P258, DOI 10.1126/science.1097938; Patil PG, 2004, NEUROSURGERY, V55, P27, DOI 10.1227/01.NEU.0000126872.23715.E5; Polikov VS, 2005, J NEUROSCI METH, V148, P1, DOI 10.1016/j.jneumeth.2005.08.015; Santhanam G, 2004, P ANN INT IEEE EMBS, V26, P4380; Serruya MD, 2002, NATURE, V416, P141, DOI 10.1038/416141a; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x; Shenoy KV, 2003, NEUROREPORT, V14, P591, DOI 10.1097/00001756-200303240-00013; Taylor DM, 2002, SCIENCE, V296, P1829, DOI 10.1126/science.1070291; Taylor DM, 2003, IEEE T NEUR SYS REH, V11, P195, DOI 10.1109/TNSRE.2003.814451; Wolpaw JR, 2004, P NATL ACAD SCI USA, V101, P17849, DOI 10.1073/pnas.0403504101; Yu B. M., 2006, ADV NEURAL INFORM PR, V18; YU BM, 2004, P 26 ANN INT C IEEE, P4516	24	465	484	8	135	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 13	2006	442	7099					195	198		10.1038/nature04968	http://dx.doi.org/10.1038/nature04968			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	062XJ	16838020	Green Submitted			2022-12-28	WOS:000238979700046
J	Vestrand, WT; Wren, JA; Wozniak, PR; Aptekar, R; Golentskii, S; Pal'shin, V; Sakamoto, T; White, RR; Evans, S; Casperson, D; Fenimore, E				Vestrand, W. T.; Wren, J. A.; Wozniak, P. R.; Aptekar, R.; Golentskii, S.; Pal'shin, V.; Sakamoto, T.; White, R. R.; Evans, S.; Casperson, D.; Fenimore, E.			Energy input and response from prompt and early optical afterglow emission in gamma-ray bursts	NATURE			English	Article							RAPTOR OBSERVATIONS	The taxonomy of optical emission detected during the critical first few minutes after the onset of a gamma-ray burst (GRB) defines two broad classes: prompt optical emission correlated with prompt gamma-ray emission(1), and early optical afterglow emission uncorrelated with the gamma-ray emission(2). The standard theoretical interpretation attributes prompt emission to internal shocks in the ultrarelativistic outflow generated by the internal engine(3-5); early afterglow emission is attributed to shocks generated by interaction with the surrounding medium(6-8). Here we report on observations of a bright GRB that, for the first time, clearly show the temporal relationship and relative strength of the two optical components. The observations indicate that early afterglow emission can be understood as reverberation of the energy input measured by prompt emission. Measurements of the early afterglow reverberations therefore probe the structure of the environment around the burst, whereas the subsequent response to late-time impulsive energy releases reveals how earlier flaring episodes have altered the jet and environment parameters. Many GRBs are generated by the death of massive stars that were born and died before the Universe was ten per cent of its current age(9,10), so GRB afterglow reverberations provide clues about the environments around some of the first stars.	Los Alamos Natl Lab, Space Sci & Applicat Grp, Los Alamos, NM 87545 USA; AF Ioffe Phys Tech Inst, St Petersburg 194021, Russia; NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA	United States Department of Energy (DOE); Los Alamos National Laboratory; Russian Academy of Sciences; St. Petersburg Scientific Centre of the Russian Academy of Sciences; Ioffe Physical Technical Institute; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center	Vestrand, WT (corresponding author), Los Alamos Natl Lab, Space Sci & Applicat Grp, ISR-1,MS-D466, Los Alamos, NM 87545 USA.	vestrand@lanl.gov	Evans, Stuart/ABG-6915-2021; Pal'shin, Valentin/F-3973-2014; Aptekar, Raphail/B-3456-2015	Evans, Stuart/0000-0002-1873-0752; Wozniak, Przemyslaw/0000-0002-9919-3310				Akerlof C, 1999, NATURE, V398, P400, DOI 10.1038/18837; CHESTER M, 2005, 3838 GRB; Ciardi B, 2000, ASTROPHYS J, V540, P687, DOI 10.1086/309384; Falcone AD, 2006, ASTROPHYS J, V641, P1010, DOI 10.1086/500655; Fenimore EE, 1996, ASTROPHYS J, V473, P998, DOI 10.1086/178210; FOX DB, 2005, 3829 GRB; Fox DW, 2003, NATURE, V422, P284, DOI 10.1038/nature01504; GOLENETSKII S, 2005, 3852 GRB; KATZ JI, 1994, ASTROPHYS J, V432, pL107, DOI 10.1086/187523; Lazzati D, 2006, ASTROPHYS J, V641, P972, DOI 10.1086/500502; LEDOUX C, 2005, 3869 GRB; Li WD, 2003, ASTROPHYS J, V586, pL9, DOI 10.1086/374684; Meszaros P, 1997, ASTROPHYS J, V476, P232, DOI 10.1086/303625; Meszaros P, 1999, MON NOT R ASTRON SOC, V306, pL39, DOI 10.1046/j.1365-8711.1999.02800.x; PAGE KL, 2005, 3837 GRB; PAGE M, 2005, 3830 GRB; Panaitescu A, 2004, MON NOT R ASTRON SOC, V353, P511, DOI 10.1111/j.1365-2966.2004.08083.x; PROCHASKA JX, 2005, 3833 GRB; Quimby RM, 2006, ASTROPHYS J, V640, P402, DOI 10.1086/499803; Rykoff ES, 2004, ASTROPHYS J, V601, P1013, DOI 10.1086/380777; Sari R, 1999, ASTROPHYS J, V520, P641, DOI 10.1086/307508; van Paradijs J, 2000, ANNU REV ASTRON ASTR, V38, P379, DOI 10.1146/annurev.astro.38.1.379; Vestrand WT, 2005, NATURE, V435, P178, DOI 10.1038/nature03515; Vestrand WT, 2002, PROC SPIE, V4845, P126, DOI 10.1117/12.459515; Wozniak PR, 2006, ASTROPHYS J, V642, pL99, DOI 10.1086/504796; Wozniak PR, 2005, ASTROPHYS J, V627, pL13, DOI 10.1086/431975; WREN J, 2005, 3836 GRB	29	103	104	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 13	2006	442	7099					172	175		10.1038/nature04913	http://dx.doi.org/10.1038/nature04913			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	062XJ	16838015				2022-12-28	WOS:000238979700040
J	Hollien, J; Weissman, JS				Hollien, Julie; Weissman, Jonathan S.			Decay of endoplasmic reticulum-localized mRNAs during the unfolded protein response	SCIENCE			English	Article							TRANSCRIPTION FACTOR XBP-1; ENDONUCLEOLYTIC CLEAVAGE; TRANSMEMBRANE PROTEIN; TRANSLATIONAL CONTROL; CELL-SURVIVAL; ER STRESS; IRE1; GENES; KINASE; PERK	The unfolded protein response (UPR) allows the endoplasmic reticulum ( ER) to recover from the accumulation of misfolded proteins, in part by increasing its folding capacity. Inositol-requiring enzyme -1 (IRE1) promotes this remodeling by detecting misfolded ER proteins and activating a transcription factor, X-box-binding protein 1, through endonucleolytic cleavage of its messenger RNA ( mRNA). Here, we report that IRE1 independently mediates the rapid degradation of a specific subset of mRNAs, based both on their localization to the ER membrane and on the amino acid sequence they encode. This response is well suited to complement other UPR mechanisms because it could selectively halt production of proteins that challenge the ER and clear the translocation and folding machinery for the subsequent remodeling process.	Univ Calif San Francisco, Howard Hughes Med Inst, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Calif Inst Quantitat Biomed Res, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Weissman, JS (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA.	weissman@cmp.ucsf.edu	Longo, Kenneth A/A-5631-2010	Weissman, Jonathan/0000-0003-2445-670X; Hollien, Julie/0000-0003-0649-1261				Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; COX JS, 1993, CELL, V73, P1197, DOI 10.1016/0092-8674(93)90648-A; Credle JJ, 2005, P NATL ACAD SCI USA, V102, P18773, DOI 10.1073/pnas.0509487102; Doma MK, 2006, NATURE, V440, P561, DOI 10.1038/nature04530; Dong BH, 2001, RNA, V7, P361, DOI 10.1017/S1355838201002230; Drysdale RA, 2005, NUCLEIC ACIDS RES, V33, pD390, DOI 10.1093/nar/gki046; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Gatfield D, 2004, NATURE, V429, P575, DOI 10.1038/nature02559; Gerber AP, 2004, PLOS BIOL, V2, P342, DOI 10.1371/journal.pbio.0020079; Harding HP, 2001, MOL CELL, V7, P1153, DOI 10.1016/S1097-2765(01)00264-7; Harding HP, 2000, MOL CELL, V5, P897, DOI 10.1016/S1097-2765(00)80330-5; Iwakoshi NN, 2003, NAT IMMUNOL, V4, P321, DOI 10.1038/ni907; Iwawaki T, 2001, NAT CELL BIOL, V3, P158, DOI 10.1038/35055065; Kimata Y, 2006, GENES CELLS, V11, P59, DOI 10.1111/j.1365-2443.2005.00921.x; Lee AH, 2003, MOL CELL BIOL, V23, P7448, DOI 10.1128/MCB.23.21.7448-7459.2003; MORI K, 1993, CELL, V74, P743; Niwa M, 2005, GENOME BIOL, V6; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Reimold AM, 2000, GENE DEV, V14, P152; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Shen XH, 2005, PLOS GENET, V1, P355, DOI 10.1371/journal.pgen.0010037; Shen XH, 2001, CELL, V107, P893, DOI 10.1016/S0092-8674(01)00612-2; Tirasophon W, 2000, GENE DEV, V14, P2725, DOI 10.1101/gad.839400; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; Urano F, 2002, J CELL BIOL, V158, P639, DOI 10.1083/jcb.200203086; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Zhang KZ, 2005, J CLIN INVEST, V115, P268, DOI 10.1172/JCI200521848; Zhang PC, 2002, MOL CELL BIOL, V22, P3864, DOI 10.1128/MCB.22.11.3864-3874.2002	28	863	890	2	64	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 7	2006	313	5783					104	107		10.1126/science.1129631	http://dx.doi.org/10.1126/science.1129631			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061DA	16825573				2022-12-28	WOS:000238850200042
J	Bradley, EH; Herrin, J; Elbel, B; McNamara, RL; Magid, DJ; Nallamothu, BK; Wang, YF; Normand, SLT; Spertus, JA; Krumholz, HM				Bradley, Elizabeth H.; Herrin, Jeph; Elbel, Brian; McNamara, Robert L.; Magid, David J.; Nallamothu, Brahmajee K.; Wang, Yongfei; Normand, Sharon-Lise T.; Spertus, John A.; Krumholz, Harlan M.			Hospital quality for acute myocardial infarction - Correlation among process measures and relationship with short-term mortality	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PERFORMANCE; CARE	Context The Centers for Medicare & Medicaid Services (CMS) and the Joint Commission on Accreditation of Healthcare Organizations (JCAHO) measure and report quality process measures for acute myocardial infarction (AMI), but little is known about how these measures are correlated with each other and the degree to which inferences about a hospital's outcomes can be made from its performance on publicly reported processes. Objective To determine correlations among AMI core process measures and the degree to which they explain the variation in hospital-specific, risk-standardized, 30-day mortality rates. Design, Setting, and Participants We assessed hospital performance in the CMS/JCAHO AMI core process measures using 2002-2003 data from 962 hospitals participating in the National Registry of Myocardial Infarction (NRMI) and correlated these measures with each other and with hospital-level, risk-standardized, 30-day mortality rates derived from Medicare claims data. Main Outcome Measures Hospital performance on AMI core measures; hospital-specific, risk-standardized, 30-day mortality rates for AMI patients aged 66 years or older. Results We found moderately strong correlations (correlation coefficients >= 0.40; P values <.001) for all pairwise comparisons between beta-blocker use at admission and discharge, aspirin use at admission and discharge, and angiotensin-converting enzyme inhibitor use, and weaker, but statistically significant, correlations between these medication measures and smoking cessation counseling and time to reperfusion therapy measures (correlation coefficients <0.40; P values <.001). Some process measures were significantly correlated with risk-standardized, 30-day mortality rates (P values <.001) but together explained only 6.0% of hospital-level variation in risk-standardized, 30-day mortality rates for patients with AMI. Conclusions The publicly reported AMI process measures capture a small proportion of the variation in hospitals' risk-standardized short-term mortality rates. Multiple measures that reflect a variety of processes and also outcomes, such as risk-standardized mortality rates, are needed to more fully characterize hospital performance.	Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Med, Sect Cardiovasc Med, New Haven, CT 06520 USA; Yale Univ, Sch Med, Robert Wood Johnson Clin Scholars Program, New Haven, CT 06520 USA; Yale New Haven Med Ctr, Ctr Outcomes Res & Evaluat, New Haven, CT 06504 USA; Kaiser Permanente Clin Res Unit, Aurora, CO USA; Univ Colorado, Hlth Sci Ctr, Dept Prevent Med & Biometr, Denver, CO 80262 USA; Univ Colorado, Hlth Sci Ctr, Div Emergency Med, Denver, CO 80262 USA; Univ Michigan, Sch Med, Dept Internal Med, Div Cardiovasc Dis, Ann Arbor, MI USA; Ann Arbor Vet Affairs Med Ctr, Hlth Serv Res & Dev Ctr Excellence, Ann Arbor, MI USA; Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; Univ Missouri, Kansas City, MO 64110 USA; Mid Amer Heart Inst, Kansas City, MO USA	Yale University; Yale University; Yale University; Yale University; Kaiser Permanente; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Michigan System; University of Michigan; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; University of Missouri System; University of Missouri Kansas City; Saint Luke's Mid America Heart Institute	Krumholz, HM (corresponding author), Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, 333 Cedar St,POB 208088, New Haven, CT 06520 USA.	harlan.krumholz@yale.edu	Spertus, John/ABD-3075-2021; , Harlan/AAI-2875-2020	Elbel, Brian/0000-0003-1615-9430; Normand, Sharon-Lise/0000-0001-7027-4769	NHLBI NIH HHS [R01HL072575] Funding Source: Medline; NIA NIH HHS [P30AG21342] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL072575] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG021342] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Adams RJ, 2004, CIRCULATION, V110, P2512, DOI 10.1161/01.CIR.0000134791.68010.FA; Bradley EH, 2006, CIRCULATION, V113, P1079, DOI 10.1161/CIRCULATIONAHA.105.590133; Cronbach LJ, 1951, PSYCHOMETRIKA, V16, P297; Granger CB, 2005, AM J MED, V118, P858, DOI 10.1016/j.amjmed.2005.01.070; Jacobs R, 2005, MED CARE, V43, P1177, DOI 10.1097/01.mlr.0000185692.72905.4a; JENCKS SF, 1988, JAMA-J AM MED ASSOC, V260, P2240, DOI 10.1001/jama.260.15.2240; Jha AK, 2005, NEW ENGL J MED, V353, P265, DOI 10.1056/NEJMsa051249; *JOINT COMM ACCR H, PERF MEAS IN CURR SP; Kerr EA, 2001, AM J MANAG CARE, V7, P1033; Krumholz HM, 2006, CIRCULATION, V113, P1683, DOI 10.1161/CIRCULATIONAHA.105.611186; Landrum MB, 2000, HLTH SERVICES OUTCOM, V1, P23, DOI [10.1023/A:1010093701870, DOI 10.1023/A:1010093701870]; McGlynn EA, 2003, MED CARE, V41, pI39; Mehta RH, 1999, AM HEART J, V138, P688, DOI 10.1016/S0002-8703(99)70184-5; Normand SLT, 1997, J AM STAT ASSOC, V92, P803, DOI 10.2307/2965545; Nunnelly J., 1994, PSYCHOMETRIC THEORY; Peterson ED, 2006, JAMA-J AM MED ASSOC, V295, P1912, DOI 10.1001/jama.295.16.1912; SIDAK Z, 1967, J AM STAT ASSOC, V62, P626, DOI 10.2307/2283989; Spertus John A., 2003, Circulation, V107, P1681, DOI 10.1161/01.CIR.0000062026.90014.63	18	291	296	0	20	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 5	2006	296	1					72	78		10.1001/jama.296.1.72	http://dx.doi.org/10.1001/jama.296.1.72			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	058RU	16820549				2022-12-28	WOS:000238683100024
J	Del Brutto, OH; Roos, KL; Coffey, CS; Garcia, HH				Del Brutto, Oscar H.; Roos, Karen L.; Coffey, Christopher S.; Garcia, Hector H.			Meta-analysis: Cysticidal drugs for neurocysticercosis: Albendazole and praziquantel	ANNALS OF INTERNAL MEDICINE			English	Review							COMPUTED TOMOGRAPHIC LESIONS; SINGLE-DAY PRAZIQUANTEL; DOUBLE-BLIND; CEREBRAL CYSTICERCOSIS; BRAIN CYSTICERCOSIS; SEIZURE RECURRENCE; PROGNOSTIC-FACTORS; FOCAL SEIZURES; THERAPY; CHILDREN	Background: Conflicting reports have caused controversy on whether cysticidal drugs modify the natural course of neurocysticercosis. Purpose:To perform a meta-analysis of randomized trials assessing the effect of cysticidal drugs on neuroimaging and clinical outcomes of patients with neurocysticercosis. Data Sources: Search of MEDLINE, Cochrane Database of Systematic Reviews, and Literatura Latino-Americana y del Caribe en Ciencias de la Salud (LILACS) between 1979 and 2005. There were no language restrictions. Study Selection: Randomized trials of cysticidal drug therapy for neurocysticercosis that met predefined criteria designed to allow characterization of the disease and objective evaluation of therapy. Data Abstraction: The authors independently reviewed articles. Abstracted data included study design, number of randomly assigned patients and withdrawals, intervention, adverse events, timing of neuroimaging studies, and outcomes. Data Synthesis: Eleven studies met the inclusion criteria. Six trials randomly assigned 464 patients with cystic lesions (vesicular cysticerci), and 5 trials randomly assigned 478 patients with enhancing lesions (colloidal cysticerd). Parasites were located in the brain parenchyma or subarachnoid space at the convexity of the cerebral hemispheres. Cysticidal drug therapy was associated with complete resolution of cystic lesions (44% vs. 19%; P = 0.025). Trials on enhancing lesions showed a trend toward lesion resolution favoring the use of cysticidal drugs (72% vs. 63%; P = 0.38) that became statistically significant when an outlier trial was excluded from the analysis (69% vs. 55%; P = 0.006). Risk for seizure recurrence was lower after cysticidal treatment in patients with enhancing lesions (14% vs. 37%; P < 0.001). The single trial evaluating the frequency of seizures in patients with cystic lesions showed a 67% reduction in the rate of generalized seizures with treatment (P = 0.006). Limitations: Not all studies focused on the control of seizures as an outcome. Conclusions: Cysticidal drug therapy results in better resolution of colloidal and vesicular cysticerci, lower risk for recurrence of seizures in patients with colloidal cysticerci, and a reduction in the rate of generalized seizures in patients with vesicular cysticerci.	Hosp Clin Kennedy, Guayaquil, Ecuador; Indiana Univ, Sch Med, Indianapolis, IN 46204 USA; Univ Alabama Birmingham, Birmingham, AL USA; Inst Ciencias Neurol, Lima, Peru; Univ Peruana Cayetano Heredia, Lima, Peru	Indiana University System; Indiana University-Purdue University Indianapolis; University of Alabama System; University of Alabama Birmingham; Universidad Peruana Cayetano Heredia	Del Brutto, OH (corresponding author), Air Ctr 3542, POB 522970, Miami, FL 33152 USA.	odb@gye.satnet.net						Alarcon F, 2001, REV ECUAT NEUROL, V10, P1; ALARCON F, 1989, ARCH NEUROL-CHICAGO, V46, P1231, DOI 10.1001/archneur.1989.00520470099034; Baranwal AK, 1998, PEDIATR INFECT DIS J, V17, P696, DOI 10.1097/00006454-199808000-00007; Baranwal AK, 2002, J TROP PEDIATRICS, V48, P219, DOI 10.1093/tropej/48.4.219; Baranwal AK, 2001, J CHILD NEUROL, V16, P443, DOI 10.2310/7010.2001.7057; CARPIO A, 1988, ANN NEUROL, V24, P144; CARPIO A, 1995, ARCH INTERN MED, V155, P1982, DOI 10.1001/archinte.155.18.1982; CARPIO A, 1991, ACT 8 C PAN NEUR MON, P469; CRUZ I, 1995, J NEUROL SCI, V133, P152, DOI 10.1016/0022-510X(95)00181-Z; CRUZ M, 1991, T ROY SOC TROP MED H, V85, P244, DOI 10.1016/0035-9203(91)90041-V; Del Brutto OH, 1999, NEUROLOGY, V52, P1079, DOI 10.1212/WNL.52.5.1079; DELBRUTTO OH, 1995, J NEUROL NEUROSUR PS, V58, P247, DOI 10.1136/jnnp.58.2.247; DELBRUTTO OH, 1992, NEUROLOGY, V42, P389, DOI 10.1212/WNL.42.2.389; DELBRUTTO OH, 1994, NEUROLOGY, V44, P1706, DOI 10.1212/WNL.44.9.1706; ESCOBEDO F, 1987, ARCH INTERN MED, V147, P738, DOI 10.1001/archinte.147.4.738; ESCOBEDO F, 1989, Acta Leidensia, V57, P247; Garcia HH, 1997, J INFECT DIS, V175, P486, DOI 10.1093/infdis/175.2.486; Garcia HH, 2004, NEW ENGL J MED, V350, P249, DOI 10.1056/NEJMoa031294; Garcia HH, 1997, NEUROLOGY, V48, P1421, DOI 10.1212/WNL.48.5.1421; Garcia HH, 2003, LANCET, V362, P547, DOI 10.1016/S0140-6736(03)14117-7; Gogia S, 2003, T ROY SOC TROP MED H, V97, P416, DOI 10.1016/S0035-9203(03)90075-7; Guo Dong-mei, 2003, Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi, V21, P187; Hardy RJ, 1998, STAT MED, V17, P841, DOI 10.1002/(SICI)1097-0258(19980430)17:8<841::AID-SIM781>3.0.CO;2-D; Harris RP, 2001, AM J PREV MED, V20, P21, DOI 10.1016/S0749-3797(01)00261-6; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Kalra V, 2003, J PEDIATR-US, V143, P111, DOI 10.1016/S0022-3476(03)00211-7; KRAMER LD, 1995, ARCH NEUROL-CHICAGO, V52, P101, DOI 10.1001/archneur.1995.00540250109020; KRAMER LD, 1989, RADIOLOGY, V171, P459, DOI 10.1148/radiology.171.2.2704811; Lopez-Gomez M, 2001, NEUROLOGY, V57, P1929, DOI 10.1212/WNL.57.10.1929; MITCHELL WG, 1988, PEDIATRICS, V82, P76; MOODLEY M, 1989, LANCET, V1, P262, DOI 10.1016/S0140-6736(89)91268-3; Nash TE, 2004, NEUROLOGY, V62, P1934, DOI 10.1212/01.WNL.0000129481.12067.06; Padma M. V., 1995, National Medical Journal of India, V8, P255; PADMA MV, 1994, NEUROLOGY, V44, P1344, DOI 10.1212/WNL.44.7.1344; Petitti D, 1994, DECISION ANAL COST E; Pretell EJ, 2000, CLIN NEUROL NEUROSUR, V102, P215, DOI 10.1016/S0303-8467(00)00110-4; Rajshekhar V, 2004, NEUROLOGY, V62, P2236, DOI 10.1212/01.WNL.0000130471.19171.D8; Robles C, 1979, Salud Publica Mex, V21, P603; Salinas R, 1999, TROP MED INT HEALTH, V4, P713, DOI 10.1046/j.1365-3156.1999.00477.x; Shadish W. R., 1994, HDB RES SYNTHESIS; Singhi P, 2004, J CHILD NEUROL, V19, P323, DOI 10.1177/088307380401900503; Singhi P, 2003, PEDIATR INFECT DIS J, V22, P268, DOI 10.1097/00006454-200303000-00013; Sotelo J, 2004, NEW ENGL J MED, V350, P280, DOI 10.1056/NEJMe038218; SOTELO J, 1990, J NEUROL, V237, P69, DOI 10.1007/BF00314663; SOTELO J, 1985, NEUROLOGY, V35, P752, DOI 10.1212/WNL.35.5.752; SOTELO J, 1988, ARCH NEUROL-CHICAGO, V45, P532, DOI 10.1001/archneur.1988.00520290064015; SOTELO J, 1988, ARCH NEUROL-CHICAGO, V45, P1130, DOI 10.1001/archneur.1988.00520340084017; SOTELO J, 1984, NEW ENGL J MED, V310, P1001, DOI 10.1056/NEJM198404193101601; Sweeting MJ, 2004, STAT MED, V23, P1351, DOI 10.1002/sim.1761; TAKAYANAGUI OM, 1992, ARCH NEUROL-CHICAGO, V49, P290, DOI 10.1001/archneur.1992.00530270106026; VAZQUEZ V, 1992, NEW ENGL J MED, V327, P696, DOI 10.1056/NEJM199209033271005; WANG MC, 1999, INTEGRATING RESULTS; WHITE AC, 1992, NEW ENGL J MED, V327, P1955	53	144	145	0	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 4	2006	145	1					43	51		10.7326/0003-4819-145-1-200607040-00009	http://dx.doi.org/10.7326/0003-4819-145-1-200607040-00009			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	062IS	16818928				2022-12-28	WOS:000238938400006
J	Oransky, I				Oransky, I			Peter J Scheuer - Obituary	LANCET			English	Biographical-Item												ivan-oransky@erols.com						SCHEUER PJ, PUBLICATION LIST	1	0	0	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 24	2006	367	9528					2054	2054		10.1016/S0140-6736(06)68912-5	http://dx.doi.org/10.1016/S0140-6736(06)68912-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	058HZ	16832894				2022-12-28	WOS:000238657400014
J	Lomvardas, S; Barnea, G; Pisapia, DJ; Mendelsohn, M; Kirkland, J; Axel, R				Lomvardas, Stavros; Barnea, Gilad; Pisapia, David J.; Mendelsohn, Monica; Kirkland, Jennifer; Axel, Richard			Interchromosornal interactions and olfactory receptor choice	CELL			English	Article							ODORANT RECEPTORS; GENE-EXPRESSION; DROSOPHILA; MOUSE; CHROMOSOME; NEURONS; TISSUE; TRANS; MAP	The expression of a single odorant receptor (OR) gene from a large gene family in individual sensory neurons is an essential feature of the organization and function of the olfactory system. We have used chromosome conformation capture to demonstrate the specific association of an enhancer element, H, on chromosome 14 with multiple OR gene promoters on different chromosomes. DNA and RNA fluorescence in situ hybridization (FISH) experiments allow us to visualize the colocalization of the H enhancer with the single OR allele, that is transcribed in a sensory neuron. In transgenic mice bearing additional H elements, sensory neurons that express OR pseudogenes also express a second functional receptor. These data suggest a model of receptor choice in which a single trans-acting enhancer element may allow the stochastic activation of only one OR allele in an olfactory sensory neuron.	Columbia Univ, Coll Phys & Surg, Dept Biochem & Mol Biophys, New York, NY 10032 USA; Columbia Univ, Coll Phys & Surg, Howard Hughes Med Inst, New York, NY 10032 USA	Columbia University; Columbia University; Howard Hughes Medical Institute	Axel, R (corresponding author), Columbia Univ, Coll Phys & Surg, Dept Biochem & Mol Biophys, New York, NY 10032 USA.	ra27@columbia.edu		Lomvardas, Stavros/0000-0002-7668-3026; Axel, Richard/0000-0002-3141-4076	NATIONAL CANCER INSTITUTE [P01CA023767] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004209] Funding Source: NIH RePORTER; NCI NIH HHS [5P01 CA023767] Funding Source: Medline; NIDCD NIH HHS [5R01 DC004209-08] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Barnea G, 2004, SCIENCE, V304, P1468, DOI 10.1126/science.1096146; Carter D, 2002, NAT GENET, V32, P623, DOI 10.1038/ng1051; CHESS A, 1994, CELL, V78, P823, DOI 10.1016/S0092-8674(94)90562-2; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Dillon N, 1997, MOL CELL, V1, P131, DOI 10.1016/S1097-2765(00)80014-3; Eggan E, 2004, NATURE, V428, P44, DOI 10.1038/nature02375; Feinstein P, 2004, CELL, V117, P817, DOI 10.1016/j.cell.2004.05.011; GELBART WM, 1982, P NATL ACAD SCI-BIOL, V79, P2636, DOI 10.1073/pnas.79.8.2636; GEYER PK, 1990, EMBO J, V9, P2247, DOI 10.1002/j.1460-2075.1990.tb07395.x; HOZUMI N, 1976, P NATL ACAD SCI USA, V73, P3628, DOI 10.1073/pnas.73.10.3628; Kravchenko E, 2005, MOL CELL BIOL, V25, P9283, DOI 10.1128/MCB.25.21.9283-9291.2005; Lewcock JW, 2004, P NATL ACAD SCI USA, V101, P1069, DOI 10.1073/pnas.0307986100; LEWIS EB, 1954, AM NAT, V88, P225, DOI 10.1086/281833; Li JS, 2004, NATURE, V428, P393, DOI 10.1038/nature02433; Ling JQ, 2006, SCIENCE, V312, P269, DOI 10.1126/science.1123191; MacDonald JL, 2005, DEV BIOL, V288, P461, DOI 10.1016/j.ydbio.2005.09.048; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Navarro M, 2001, NATURE, V414, P759, DOI 10.1038/414759a; Qasba P, 1998, J NEUROSCI, V18, P227; Ramsahoye BH, 2000, P NATL ACAD SCI USA, V97, P5237, DOI 10.1073/pnas.97.10.5237; Rothman A, 2005, MOL CELL NEUROSCI, V28, P535, DOI 10.1016/j.mcn.2004.11.006; Serizawa S, 2003, SCIENCE, V302, P2088, DOI 10.1126/science.1089122; Serizawa S, 2000, NAT NEUROSCI, V3, P687, DOI 10.1038/76641; Shykind BM, 2005, HUM MOL GENET, V14, pR33, DOI 10.1093/hmg/ddi105; Shykind BM, 2004, CELL, V117, P801, DOI 10.1016/j.cell.2004.05.015; Spilianakis CG, 2005, NATURE, V435, P637, DOI 10.1038/nature03574; Tanimoto K, 1999, NATURE, V398, P344, DOI 10.1038/18698; VANDERPLOEG LHT, 1991, NEW BIOL, V3, P324; Vassalli A, 2002, NEURON, V35, P681, DOI 10.1016/S0896-6273(02)00793-6; Wang F, 1998, CELL, V93, P47, DOI 10.1016/S0092-8674(00)81145-9; Wes PD, 2001, NATURE, V410, P698, DOI 10.1038/35070581; West AG, 2005, HUM MOL GENET, V14, pR101, DOI 10.1093/hmg/ddi104; Young JM, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-11-r71; Zhao GQ, 2003, CELL, V115, P255, DOI 10.1016/S0092-8674(03)00844-4; Zimmerman JE, 2000, GENETICS, V154, P237	36	451	469	0	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 28	2006	126	2					403	413		10.1016/j.cell.2006.06.035	http://dx.doi.org/10.1016/j.cell.2006.06.035			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	070VD	16873069	Green Submitted, Bronze			2022-12-28	WOS:000239552600024
J	Ricciardi, A; Ward, JM				Ricciardi, Anthony; Ward, Jessica M.			Comment on "Opposing effects of native and exotic herbivores on plant invasions"	SCIENCE			English	Editorial Material							METAANALYSIS; HYPOTHESIS; INVADERS		McGill Univ, Redpath Museum, Montreal, PQ H3A 2K6, Canada	McGill University	Ricciardi, A (corresponding author), McGill Univ, Redpath Museum, 859 Sherbrooke St W, Montreal, PQ H3A 2K6, Canada.	tony.ricciardi@mcgill.ca	Ricciardi, Anthony/A-8536-2010	Ricciardi, Anthony/0000-0003-1492-0054				Adams DC, 1997, ECOLOGY, V78, P1277, DOI 10.1890/0012-9658(1997)078[1277:RTFMAO]2.0.CO;2; BERENBAUM M, 1981, ECOLOGY, V62, P1254, DOI 10.2307/1937290; Colautti RI, 2004, ECOL LETT, V7, P721, DOI 10.1111/j.1461-0248.2004.00616.x; Darwin C., 1877, ORIGIN SPECIES; Harborne J. B., 1993, INTRO ECOLOGICAL BIO, V4th; Kolar CS, 2001, TRENDS ECOL EVOL, V16, P199, DOI 10.1016/S0169-5347(01)02101-2; Levine JM, 2004, ECOL LETT, V7, P975, DOI 10.1111/j.1461-0248.2004.00657.x; Parker JD, 2006, SCIENCE, V311, P1459, DOI 10.1126/science.1121407; Rejmanek M, 1996, BIOL CONSERV, V78, P171, DOI 10.1016/0006-3207(96)00026-2; Ricciardi A, 2004, ECOL LETT, V7, P781, DOI 10.1111/j.1461-0248.2004.00642.x; Rosenberg MS, 2000, METAWIN STAT SOFTWAR; THORPE JP, 1982, ANNU REV ECOL SYST, V13, P139, DOI 10.1146/annurev.es.13.110182.001035; Webb CO, 2002, ANNU REV ECOL SYST, V33, P475, DOI 10.1146/annurev.ecolsys.33.010802.150448	13	26	27	1	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 21	2006	313	5785								10.1126/science.1128946	http://dx.doi.org/10.1126/science.1128946			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065IV	16857922				2022-12-28	WOS:000239154300021
J	Attaran, A; Barnes, KI; Bate, R; Binka, F; d'Alessandro, U; Fanello, CI; Garrett, L; Mutabingwa, TK; Roberts, D; Sibley, CH; Talisuna, A; Van Geertruyden, JP; Watkins, WM				Attaran, Amir; Barnes, Karen I.; Bate, Roger; Binka, Fred; d'Alessandro, Umberto; Fanello, Caterina I.; Garrett, Laurie; Mutabingwa, Theonest K.; Roberts, Donald; Sibley, Carol Hopkins; Talisuna, Ambrose; Van Geertruyden, Jean-Pierre; Watkins, William M.			The World Bank: false financial and statistical accounts and medical malpractice in malaria treatment	LANCET			English	Editorial Material							PLASMODIUM-FALCIPARUM MALARIA; GLOBAL FUND; CHLOROQUINE; RESISTANCE; INDIA		Univ Ottawa, Inst Populat Hlth, Ottawa, ON K1N 6N5, Canada; Univ Ottawa, Fac Law, Ottawa, ON K1N 6N5, Canada; Univ Cape Town, ZA-7925 Cape Town, South Africa; Amer Enterprise Inst Publ Policy Res, Washington, DC USA; Univ Ghana, Dept Epidemiol, Accra, Ghana; Inst Trop Med Prince Leopold, B-2000 Antwerp, Belgium; London Sch Hyg & Trop Med, London WC1, England; Council Foreign Relat, New York, NY USA; E African Network Monitoring Antimalarial Treatme, Muheza, Tanzania; Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA; Univ Washington, Seattle, WA 98195 USA; Univ Oxford, Oxford, England	University of Ottawa; University of Ottawa; University of Cape Town; American Enterprise Institute for Public Policy Research; University of Ghana; Institute of Tropical Medicine (ITM); University of London; London School of Hygiene & Tropical Medicine; Uniformed Services University of the Health Sciences - USA; University of Washington; University of Washington Seattle; University of Oxford	Attaran, A (corresponding author), Univ Ottawa, Inst Populat Hlth, Ottawa, ON K1N 6N5, Canada.	aattaran@uottawa.ca	Fanello, Caterina/AAT-9679-2021; Van geertruyden, Jean-Pierre/S-3254-2019; D'Alessandro, Umberto/D-3457-2015; Van geertruyden, Jean-Pierre/K-6425-2014	Fanello, Caterina/0000-0003-1932-9562; Van geertruyden, Jean-Pierre/0000-0001-5006-6364; D'Alessandro, Umberto/0000-0001-6341-5009; Van geertruyden, Jean-Pierre/0000-0001-5006-6364				ADEYI S, 2005, COMMUNICATION   0110; Akhavan D, 1999, SOC SCI MED, V49, P1385, DOI 10.1016/S0277-9536(99)00214-2; [Anonymous], 2003, ASS MON ANT DRUG EFF; Attaran A, 2004, NATURE, V430, P932, DOI 10.1038/430932a; Attaran A, 2004, LANCET, V363, P237, DOI 10.1016/S0140-6736(03)15330-5; ATTARAN A, 2005, E COMMUNICATION 0431; ATTARAN A, 2005, E COMMUNICATION 0603; ATTARAN A, 2005, E COMMUNICATION 0430; ATTARAN A, 2004, E COMMUNICATION 0525; Bell C, 2004, MACROECONOMICS HIV A; Butler D, 2004, NATURE, V429, P588, DOI 10.1038/429588a; *DIR NAT VECT BORN, 2002, IND EP SIT REP 1997; Einhorn J, 2001, FOREIGN AFF, V80, P22, DOI 10.2307/20050248; *IND NAT ANT PROGR, 2002, MAL DRUG POL; Kshirsagar NA, 2000, AM J TROP MED HYG, V62, P402, DOI 10.4269/ajtmh.2000.62.402; MALLABY S, 2004, WORLDS BANKER STORY; MCCARTHY FD, MALARIA GROWTH; *NAT ANT PROGR, 2003, STAT ENH MAL CONTR P; *ROLL BACK MAL MON, 2005, BRAZ COUNTR PROF; *SECR VIG SAUD, BRAZ REG CAS MAL 196; Singh N, 2004, VECTOR-BORNE ZOONOT, V4, P239, DOI 10.1089/1530366042162506; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; Trape JF, 2001, AM J TROP MED HYG, V64, P12, DOI 10.4269/ajtmh.2001.64.12; White NJ, 2004, J CLIN INVEST, V113, P1084, DOI [10.1172/JCI21682, 10.1172/JCI200421682]; *WHO, POS WHOS ROLL BACK M; World Bank, 2005, WORLD BANK COUNTRY, P1, DOI 10.1596/978-0-8213-6226-6; *WORLD BANK, 2005, ROLL BACK MAL WORLD; *WORLD BANK, 2002, WORLD BANK POL DISCL; *WORLD BANK, 2005, PRESS BRIEF WORLD BA; *WORLD BANK, 2004, WORLD BANK DRAFT DEC; *WORLD BANK, 2002, PUBL HLTH; *WORLD BANK, 2001, PARTN FIGHT MAL HUG; *WORLD BANK, CONTR AW DAT SEARCH; *WORLD BANK OP EV, 2005, COMM RES IMPR EFF HI; Yamey G, 2001, BMJ-BRIT MED J, V322, P1191, DOI 10.1136/bmj.322.7296.1191; 2002, ACHIEVING IMPACT ROL	36	16	17	0	8	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL 15	2006	368	9531					247	252		10.1016/S0140-6736(06)68545-0	http://dx.doi.org/10.1016/S0140-6736(06)68545-0			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	064MY	16844495				2022-12-28	WOS:000239095000037
J	Christie, G; Currie, GP; Plant, P				Christie, Gordon; Currie, Graeme P.; Plant, Paul			ABC of chronic obstructive pulmonary disease - Ventilatory support	BRITISH MEDICAL JOURNAL			English	Editorial Material							NONINVASIVE VENTILATION; RESPIRATORY-FAILURE; EXACERBATIONS		Aberdeen Royal Infirm, Resp Unit, Aberdeen, Scotland; St James Univ Hosp, Dept Resp Med, Leeds LS9 7TF, W Yorkshire, England	University of Aberdeen; Saint James's University Hospital	Christie, G (corresponding author), Aberdeen Royal Infirm, Resp Unit, Aberdeen, Scotland.			Currie, Graeme P/0000-0002-5711-9147				Baudouin S, 2002, THORAX, V57, P192; Lightowler JV, 2003, BMJ-BRIT MED J, V326, P185, DOI 10.1136/bmj.326.7382.185; Plant PK, 2000, LANCET, V355, P1931, DOI 10.1016/S0140-6736(00)02323-0	3	3	3	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JUL 15	2006	333	7559					138	140		10.1136/bmj.333.7559.138	http://dx.doi.org/10.1136/bmj.333.7559.138			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	065JK	16840478	Green Published			2022-12-28	WOS:000239155900030
J	Kurita, H				Kurita, Hiroshi			Disorders of the autism spectrum	LANCET			English	Editorial Material							PERVASIVE DEVELOPMENTAL DISORDERS; INFANTILE-AUTISM; TOTAL POPULATION; PREVALENCE; JAPAN; AREA		Zenkoku Ryoiku Sodan Ctr, Shinjuku Ku, Tokyo 1620051, Japan		Kurita, H (corresponding author), Zenkoku Ryoiku Sodan Ctr, Shinjuku Ku, 2-2-8 Nishiwaseda, Tokyo 1620051, Japan.	hkurita@mvf.biglobe.ne.jp						APA, 1994, DIAGN STAT MAN MENT; Baird G, 2000, J AM ACAD CHILD PSY, V39, P694, DOI 10.1097/00004583-200006000-00007; Baird G, 2006, LANCET, V368, P210, DOI 10.1016/S0140-6736(06)69041-7; Bertrand J, 2001, PEDIATRICS, V108, P1155, DOI 10.1542/peds.108.5.1155; Chakrabarti S, 2001, JAMA-J AM MED ASSOC, V285, P3093, DOI 10.1001/jama.285.24.3093; Gillberg C, 2006, J AUTISM DEV DISORD, V36, P429, DOI 10.1007/s10803-006-0081-6; Honda H, 2005, J CHILD PSYCHOL PSYC, V46, P572, DOI 10.1111/j.1469-7610.2005.01425.x; LORD C, 1994, J AUTISM DEV DISORD, V24, P659, DOI 10.1007/BF02172145; Madsen KM, 2003, PEDIATRICS, V112, P604, DOI 10.1542/peds.112.3.604; MATSUISHI T, 1987, J CHILD NEUROL, V2, P268, DOI 10.1177/088307388700200406; SUGIYAMA T, 1989, J AUTISM DEV DISORD, V19, P87, DOI 10.1007/BF02212720; TANOUE Y, 1988, J AUTISM DEV DISORD, V18, P155, DOI 10.1007/BF02211943; WHO, 2012, ICD 10 CLASS MENT BE; Yeargin-Allsopp M, 2003, JAMA-J AM MED ASSOC, V289, P49, DOI 10.1001/jama.289.1.49	14	9	10	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 15	2006	368	9531					179	181		10.1016/S0140-6736(06)69015-6	http://dx.doi.org/10.1016/S0140-6736(06)69015-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	064MY	16844468				2022-12-28	WOS:000239095000005
J	Bensaad, K; Tsuruta, A; Selak, MA; Vidal, MNC; Nakano, K; Bartrons, R; Gottlieb, E; Vousden, KH				Bensaad, Karim; Tsuruta, Atsushi; Selak, Mary A.; Calvo Vidal, M. Nieves; Nakano, Katsunori; Bartrons, Ramon; Gottlieb, Eyal; Vousden, Karen H.			TIGAR, a p53-inducible regulator of glycolysis and apoptosis	CELL			English	Article							PENTOSE-PHOSPHATE PATHWAY; OXIDATIVE STRESS; GLUCOSE-METABOLISM; CANCER-CELLS; P53; GLUCOSE-6-PHOSPHATE-DEHYDROGENASE; ACTIVATION; GENE; FRUCTOSE-2,6-BISPHOSPHATASE; ARREST	The, p53 tumor-suppressor protein prevents cancer development through various mechanisms, including the induction of cell-cycle arrest, apoptosis, and the maintenance of genome stability. We have identified a p53-inducible gene named TIGAR (TP53-induced glycolysis and apoptosis regulator). TIGAR expression lowered fructose-2,6-bisphosphate levels in cells, resulting in an inhibition of glycolysis and an overall decrease in intracellular reactive oxygen species (ROS) levels. These functions of TIGAR correlated with an ability to protect cells from ROS-associated apoptosis, and consequently, knockdown of endogenous TIGAR expression sensitized cells to p53-induced death. Expression of TIGAR may therefore modulate the apoptotic response to p53, allowing survival in the face of mild or transient stress signals that may be reversed or repaired. The decrease of intracellular ROS levels in response to TIGAR may also play a role in the ability of p53 to protect from the accumulation of genomic damage.	Beatson Inst Canc Res, Glasgow G61 1BD, Lanark, Scotland; Univ Barcelona, IDIBELL, Dept Ciencies Fisiol 2, Unitat Bioquim & Biol Mol, Lhospitalet De Llobregat 08907, Spain	Beatson Institute; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Barcelona	Vousden, KH (corresponding author), Beatson Inst Canc Res, Switchback Rd, Glasgow G61 1BD, Lanark, Scotland.	k.vousden@beatson.gla.ac.uk	Gottlieb, Eyal/G-6450-2010	Gottlieb, Eyal/0000-0002-9770-0956; Bartrons, Ramon/0000-0001-9349-5847				BAZAN JF, 1989, P NATL ACAD SCI USA, V86, P9642, DOI 10.1073/pnas.86.24.9642; Boada J, 2000, FEBS LETT, V480, P261, DOI 10.1016/S0014-5793(00)01950-5; Budanov AV, 2004, SCIENCE, V304, P596, DOI 10.1126/science.1095569; Chen K, 2003, J BIOL CHEM, V278, P39527, DOI 10.1074/jbc.M304423200; Chesney J, 1999, P NATL ACAD SCI USA, V96, P3047, DOI 10.1073/pnas.96.6.3047; Fico A, 2004, CELL DEATH DIFFER, V11, P823, DOI 10.1038/sj.cdd.4401420; Hollstein M, 1999, MUTAT RES-FUND MOL M, V431, P199, DOI 10.1016/S0027-5107(99)00162-1; Hsiao CH, 2006, EXP HEMATOL, V34, P264, DOI 10.1016/j.exphem.2005.12.009; Huang HL, 2003, ONCOGENE, V22, P8168, DOI 10.1038/sj.onc.1206979; Jeffers JR, 2003, CANCER CELL, V4, P321, DOI 10.1016/S1535-6108(03)00244-7; Jen KY, 2005, CANCER RES, V65, P7666, DOI 10.1158/0008-5472.CAN-05-1039; Johnson TM, 1996, P NATL ACAD SCI USA, V93, P11848, DOI 10.1073/pnas.93.21.11848; KLETZIEN RF, 1994, FASEB J, V8, P174, DOI 10.1096/fasebj.8.2.8119488; Lain S, 2003, EUR J CANCER, V39, P1053, DOI 10.1016/S0959-8049(03)00063-7; Le Goffe C, 2002, BIOCHEM J, V364, P349, DOI 10.1042/BJ20011856; Li PF, 1999, EMBO J, V18, P6027, DOI 10.1093/emboj/18.21.6027; Liang Y, 1997, DIABETOLOGIA, V40, P1018, DOI 10.1007/s001250050783; LIN K, 1992, J BIOL CHEM, V267, P6556; Ludwig RL, 1996, MOL CELL BIOL, V16, P4952; Macip S, 2003, MOL CELL BIOL, V23, P8576, DOI 10.1128/MCB.23.23.8576-8585.2003; Martindale JL, 2002, J CELL PHYSIOL, V192, P1, DOI 10.1002/jcp.10119; Nakano K, 2000, ONCOGENE, V19, P4283, DOI 10.1038/sj.onc.1203774; NISSLER K, 1995, J CANCER RES CLIN, V121, P739, DOI 10.1007/BF01213320; Okar DO, 2001, TRENDS BIOCHEM SCI, V26, P30, DOI 10.1016/S0968-0004(00)01699-6; Ozer N, 2001, INT J BIOCHEM CELL B, V33, P221, DOI 10.1016/S1357-2725(01)00011-5; Perez JX, 2000, AM J PHYSIOL-CELL PH, V279, pC1359, DOI 10.1152/ajpcell.2000.279.5.C1359; Polyak K, 1997, NATURE, V389, P300, DOI 10.1038/38525; Polyak K, 1996, GENE DEV, V10, P1945, DOI 10.1101/gad.10.15.1945; Rowan S, 1996, EMBO J, V15, P827, DOI 10.1002/j.1460-2075.1996.tb00418.x; Sablina AA, 2005, NAT MED, V11, P1306, DOI 10.1038/nm1320; Sengupta S, 2005, NAT REV MOL CELL BIO, V6, P44, DOI 10.1038/nrm1546; Tian WN, 1999, AM J PHYSIOL-CELL PH, V276, pC1121, DOI 10.1152/ajpcell.1999.276.5.C1121; Tsang WP, 2003, LIFE SCI, V73, P2047, DOI 10.1016/S0024-3205(03)00566-6; Vander Heiden MG, 2001, MOL CELL BIOL, V21, P5899, DOI 10.1128/MCB.21.17.5899-5912.2001; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Villunger A, 2003, SCIENCE, V302, P1036, DOI 10.1126/science.1090072; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Vousden KH, 2000, CELL, V103, P691, DOI 10.1016/S0092-8674(00)00171-9; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; WALDMAN T, 1995, CANCER RES, V55, P5187; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Yoon KA, 2004, J HUM GENET, V49, P134, DOI 10.1007/s10038-003-0122-3; Zhang YM, 2003, MOL MICROBIOL, V48, P1317, DOI 10.1046/j.1365-2958.2003.03486.x	43	1400	1466	11	162	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUL 14	2006	126	1					107	120		10.1016/j.cell.2006.05.036	http://dx.doi.org/10.1016/j.cell.2006.05.036			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	066JF	16839880	Bronze			2022-12-28	WOS:000239224800020
J	Scully, C				Scully, Crispian			Aphthous ulceration	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RECURRENT ORAL ULCERATION; DOUBLE-BLIND; PERIODIC FEVER; STOMATITIS; ULCERS; THALIDOMIDE; MANAGEMENT; DISEASE; PLACEBO; CHLORHEXIDINE		UCL, Eastman Dent Inst, London WC1X 8LD, England	University of London; University College London	Scully, C (corresponding author), UCL, Eastman Dent Inst, 256 Grays Inn Rd, London WC1X 8LD, England.	c.scully@eastman.ucl.ac.uk						Akintoye Sunday O, 2005, Dent Clin North Am, V49, P31, DOI 10.1016/j.cden.2004.08.001; Barouky R, 2003, EUR J DERMATOL, V13, P207; BITTOUN R, 1991, MED J AUSTRALIA, V154, P471, DOI 10.5694/j.1326-5377.1991.tb121180.x; Boulinguez S, 1997, PRESSE MED, V26, P558; CRIVELLI MR, 1988, COMMUNITY DENT ORAL, V16, P58, DOI 10.1111/j.1600-0528.1988.tb00556.x; de Wazieres B, 1999, REV MED INTERNE, V20, P567, DOI 10.1016/S0248-8663(99)80105-2; Femiano F, 2005, J ORAL PATHOL MED, V34, P508, DOI 10.1111/j.1600-0714.2005.00348.x; Field E A, 1992, Int J Paediatr Dent, V2, P1; FIELD EA, 1987, BRIT DENT J, V163, P19, DOI 10.1038/sj.bdj.4806174; Gonzalez-Moles MA, 2000, J ORAL PATHOL MED, V29, P514, DOI 10.1034/j.1600-0714.2000.291006.x; GREER RO, 1993, J ORAL MAXIL SURG, V51, P243, DOI 10.1016/S0278-2391(10)80164-8; Haisraeli-Shalish M, 1996, ORAL SURG ORAL MED O, V82, P634, DOI 10.1016/S1079-2104(96)80437-9; Hasan A, 2002, CLIN EXP IMMUNOL, V128, P318, DOI 10.1046/j.1365-2249.2002.01757.x; Healy CM, 1999, ORAL DIS, V5, P39; HUNTER IP, 1993, ORAL SURG ORAL MED O, V75, P595, DOI 10.1016/0030-4220(93)90232-S; HUNTER L, 1987, BRIT DENT J, V162, P106, DOI 10.1038/sj.bdj.4806042; Jacobson JM, 1997, NEW ENGL J MED, V336, P1487, DOI 10.1056/NEJM199705223362103; Letsinger JA, 2005, J AM ACAD DERMATOL, V52, P500, DOI 10.1016/j.jaad.2004.10.863; Liao Chiang-Hua, 2004, Journal of Microbiology Immunology and Infection, V37, P379; Ludlow JB, 2000, ORAL SURG ORAL MED O, V89, P425, DOI 10.1016/S1079-2104(00)70123-5; MacPhail L A, 1997, Oral Dis, V3 Suppl 1, pS190; McCartan BE, 1996, J ORAL PATHOL MED, V25, P357, DOI 10.1111/j.1600-0714.1996.tb00278.x; MCCARTAN BE, 1992, OBSTET GYNECOL, V80, P455; MEILLER TF, 1991, ORAL SURG ORAL MED O, V72, P425, DOI 10.1016/0030-4220(91)90553-O; MILES DA, 1993, ORAL SURG ORAL MED O, V75, P397, DOI 10.1016/0030-4220(93)90158-Z; MILLER MF, 1977, ORAL SURG ORAL MED O, V43, P886, DOI 10.1016/0030-4220(77)90081-0; Murray B, 2005, J ORAL PATHOL MED, V34, P413, DOI 10.1111/j.1600-0714.2005.00334.x; Natah SS, 2004, INT J ORAL MAX SURG, V33, P221, DOI 10.1006/ijom.2002.0446; NOLAN A, 1991, J ORAL PATHOL MED, V20, P389, DOI 10.1111/j.1600-0714.1991.tb00950.x; Notani K, 2000, ORAL SURG ORAL MED O, V89, P477, DOI 10.1016/S1079-2104(00)70128-4; OLSON JA, 1982, ORAL SURG ORAL MED O, V54, P517, DOI 10.1016/0030-4220(82)90189-X; Padeh S, 2005, PEDIATR CLIN N AM, V52, P577, DOI 10.1016/j.pcl.2005.01.005; PIMLOTT SJ, 1983, BRIT DENT J, V154, P174, DOI 10.1038/sj.bdj.4805025; Piskin S, 2002, J EUR ACAD DERMATOL, V16, P66, DOI 10.1046/j.1468-3083.2002.00369.x; Porter S, 1992, Ann Dent, V51, P14; PORTER S, 2005, CLIN EVID, V13, P1687; PORTER SR, 1993, ORAL SURG ORAL MED O, V76, P449, DOI 10.1016/0030-4220(93)90011-R; Rehberger A, 1998, EUR J DERMATOL, V8, P274; REVUZ J, 1990, ARCH DERMATOL, V126, P923, DOI 10.1001/archderm.126.7.923; Rivera-Hidalgo F, 2004, ORAL DIS, V10, P335, DOI 10.1111/j.1601-0825.2004.01049.x; Saulsbury FT, 2005, J PEDIATR-US, V146, P283, DOI 10.1016/j.jpeds.2004.09.006; Scully C, 2005, BRIT DENT J, V199, P259, DOI 10.1038/sj.bdj.4812649; Scully C, 2003, J AM DENT ASSOC, V134, P200, DOI 10.14219/jada.archive.2003.0134; Sedghizadeh PP, 2002, ORAL SURG ORAL MED O, V94, P474, DOI 10.1067/moe.2002.127581; Shotts RH, 1999, ORAL SURG ORAL MED O, V87, P706, DOI 10.1016/S1079-2104(99)70165-4; Shulman JD, 2004, J ORAL PATHOL MED, V33, P558, DOI 10.1111/j.1600-0714.2004.00241.x; Skaare AB, 1996, J CLIN PERIODONTOL, V23, P778, DOI 10.1111/j.1600-051X.1996.tb00609.x; Ussher M, 2003, TOB CONTROL, V12, P86, DOI 10.1136/tc.12.1.86; Verpilleux MP, 1999, DERMATOLOGY, V198, P247, DOI 10.1159/000018123; YEOMAN CM, 1978, BRIT DENT J, V144, P114, DOI 10.1038/sj.bdj.4804043	50	147	164	0	13	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 13	2006	355	2					165	172		10.1056/NEJMcp054630	http://dx.doi.org/10.1056/NEJMcp054630			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	062UP	16837680				2022-12-28	WOS:000238970600008
J	Oransky, I				Oransky, I			Ronald E Cranford - Obituary	LANCET			English	Biographical-Item												ivan-oransky@erols.com						CRANFORD RE, PUBLICATION LIST	1	1	1	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 8	2006	368	9530					112	112		10.1016/S0140-6736(06)68990-3	http://dx.doi.org/10.1016/S0140-6736(06)68990-3			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	062AR	16858764				2022-12-28	WOS:000238917200013
J	Mcrae, S; Tran, H; Schulman, S; Ginsberg, J; Kearon, C				McRae, Simon; Tran, Huyen; Schulman, Sam; Ginsberg, Jeff; Kearon, Clive			Effect of patient's sex on risk of recurrent venous thromboembolism: a meta-analysis	LANCET			English	Article							ORAL ANTICOAGULANT-THERAPY; DEEP-VEIN THROMBOSIS; LONG-TERM; PULMONARY-EMBOLISM; PREDICTIVE-VALUE; 1ST EPISODE; DURATION; COMPLICATIONS; PREVENTION; WARFARIN	Background Individual risk of recurrent venous thromboembolism affects patient management and might differ between men and women. We did a meta-analysis to assess from available evidence whether men and women have the same risk of recurrent venous thromboembolism after stopping anticoagulant treatment. Methods Eligible articles were identified by searches of MEDLINE (source PubMed, 1966 to February 2005), EMBase (1980 to February 2005), and the Cochrane database 2005, issue 1. Prospective cohort studies and randomised trials were eligible if they included patients with objectively diagnosed venous thromboembolism treated for a minimum of 1 month and followed up for recurrence after anticoagulant treatment was stopped. Data were extracted for study design, study quality and the number, sex, and age of enrolled patients, risk factors for venous thromboembolism, treatment given, duration of follow-up, and the number of episodes of recurrent venous thrombosis. Findings 15 studies (nine randomised controlled trials and six prospective observational studies) enrolling a total of 5416 individuals (2729 men), of whom 816 (523 men) had recurrent venous thromboembolism after stopping treatment, were eligible for inclusion. The pooled estimate of the relative risk (RR) of recurrent venous thromboembolism for men compared with for women was 1.6 (95% Cl 1.2-2.0). Significant heterogeneity was shown among individual study findings; however, the higher risk of recurrent venous thromboembolism in men than in women was consistent across predefined subgroups. The relative risk for recurrence in men from randomised trials (RR 1.3; 95% CI 1.0-1.8) was lower than that from observational studies (2.1; 1.5-2.9). The lower risk of recurrent venous thromboembolism in women did not seem to be accounted for by a reduced rate of recurrence after venous thromboembolism associated with oestrogen treatment or pregnancy. Interpretation Men seem to have a 50% higher risk than women of recurrent venous thromboembolism after stopping anticoagulant treatment. If confirmed by further prospective studies, this difference in risk of recurrence should be considered when duration of anticoagulant treatment is determined in individual patients.	Queen Elizabeth Hosp, Dept Haematol & Oncol, Woodville, SA 5011, Australia; McMaster Univ, Med Ctr, Dept Med, Hamilton, ON L8N 3Z5, Canada; Henderson Res Ctr, Hamilton, ON, Canada; Gen Hosp, Hamilton Hlth Sci, Hamilton, ON, Canada	McMaster University; McMaster University	Mcrae, S (corresponding author), Queen Elizabeth Hosp, Dept Haematol & Oncol, Woodville, SA 5011, Australia.	Simon.Mcrae@imvs.sa.gov.au	ginsberg, jeffrey s/ABC-1065-2020; Schulman, Sam/I-7559-2019	Schulman, Sam/0000-0002-8512-9043				AbuRahma AF, 1998, J VASC SURG, V28, P630, DOI 10.1016/S0741-5214(98)70087-4; Agnelli G, 2004, NEW ENGL J MED, V351, P2015; Baglin T, 2004, J THROMB HAEMOST, V2, P2152, DOI 10.1111/j.1538-7836.2004.01050.x; Baglin T, 2003, LANCET, V362, P523, DOI 10.1016/S0140-6736(03)14111-6; Berkowitz DE, 2003, CIRCULATION, V108, P2000, DOI 10.1161/01.CIR.0000092948.04444.C7; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Douketis JD, 1998, JAMA-J AM MED ASSOC, V279, P458, DOI 10.1001/jama.279.6.458; *EV BAS MED WORK G, 2002, US GUID MED LIT MAN; FIHN SD, 1993, ANN INTERN MED, V118, P511, DOI 10.7326/0003-4819-118-7-199304010-00005; Franzeck UK, 1996, CIRCULATION, V93, P74, DOI 10.1161/01.CIR.93.1.74; Hansson PO, 2000, ARCH INTERN MED, V160, P769, DOI 10.1001/archinte.160.6.769; Heit JA, 2000, ARCH INTERN MED, V160, P761, DOI 10.1001/archinte.160.6.761; Kahn SR, 2002, BLOOD REV, V16, P155, DOI 10.1016/S0268-960X(02)00008-5; Kearon C, 2004, J THROMB HAEMOST, V2, P743, DOI 10.1046/j.1538-7836.2004.00698.x; Kearon C, 1999, NEW ENGL J MED, V340, P901, DOI 10.1056/NEJM199903253401201; Koopman MMW, 1996, NEW ENGL J MED, V334, P682, DOI 10.1056/NEJM199603143341102; Kyrle PA, 2004, NEW ENGL J MED, V350, P2558, DOI 10.1056/NEJMoa032959; LAGERSTEDT CI, 1985, LANCET, V2, P515; LEVINE MN, 1995, THROMB HAEMOSTASIS, V74, P606; Linkins LA, 2003, ANN INTERN MED, V139, P893, DOI 10.7326/0003-4819-139-11-200312020-00007; Ost D, 2005, JAMA-J AM MED ASSOC, V294, P706, DOI 10.1001/jama.294.6.706; Palareti G, 2005, J THROMB HAEMOST, V3, P955, DOI 10.1111/j.1538-7836.2005.01330.x; Palareti G, 2003, CIRCULATION, V108, P313, DOI 10.1161/01.CIR.0000079162.69615.0F; Palareti G, 2002, THROMB HAEMOSTASIS, V87, P7; Pengo V, 2004, NEW ENGL J MED, V350, P2257, DOI 10.1056/NEJMoa032274; Piovella F, 2002, HAEMATOLOGICA, V87, P515; Poli D, 2004, BLOOD COAGUL FIBRIN, V15, P221, DOI 10.1097/00001721-200404000-00004; Prandoni P, 2002, BLOOD, V100, P3484, DOI 10.1182/blood-2002-01-0108; Prandoni P, 1996, ANN INTERN MED, V125, P1, DOI 10.7326/0003-4819-125-1-199607010-00001; Ridker PM, 2003, NEW ENGL J MED, V348, P1425, DOI 10.1056/NEJMoa035029; Schulman S, 2003, NEW ENGL J MED, V349, P1713, DOI 10.1056/NEJMoa030104; Schulman S, 1997, NEW ENGL J MED, V336, P393, DOI 10.1056/NEJM199702063360601; SCHULMAN S, 1995, NEW ENGL J MED, V332, P1661, DOI 10.1056/NEJM199506223322501; SUDLOW MF, 1992, LANCET, V340, P873	34	233	237	0	9	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL-AUG	2006	368	9533					371	378		10.1016/S0140-6736(06)69110-1	http://dx.doi.org/10.1016/S0140-6736(06)69110-1			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	069JJ	16876665				2022-12-28	WOS:000239441900030
J	Pengo, V; Prandoni, P				Pengo, Vittorio; Prandoni, Paolo			Sex and anticoagulation in patients with idiopathic venous thromboembolism	LANCET			English	Editorial Material							RISK		Univ Padua, Dept Cardiothorac & Vasc Sci, I-35128 Padua, Italy; Univ Padua, Dept Med & Surg Sci, I-35128 Padua, Italy	University of Padua; University of Padua	Pengo, V (corresponding author), Univ Padua, Dept Cardiothorac & Vasc Sci, I-35128 Padua, Italy.	vittorio.pengo@unipd.it	Pengo, Vittorio/GSE-5972-2022; Pengo, Vittorio/AAV-9491-2020	Pengo, Vittorio/0000-0003-2064-6071; Pengo, Vittorio/0000-0003-2064-6071				Buller HR, 2004, CHEST, V126, p401S, DOI 10.1378/chest.126.3_suppl.401S; Eichinger S, 2004, ARCH INTERN MED, V164, P92, DOI 10.1001/archinte.164.1.92; Mcrae S, 2006, LANCET, V368, P371, DOI 10.1016/S0140-6736(06)69110-1; O WK, 2006, ARCH INTERN MED, V166, P729; Palareti G, 2003, CIRCULATION, V108, P313, DOI 10.1161/01.CIR.0000079162.69615.0F; Prandoni P, 2002, ANN INTERN MED, V137, P955, DOI 10.7326/0003-4819-137-12-200212170-00008; PRANDONI P, 2005, J THROMB HAEMOST, V3, pP1647	7	5	5	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL-AUG	2006	368	9533					342	343		10.1016/S0140-6736(06)69083-1	http://dx.doi.org/10.1016/S0140-6736(06)69083-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	069JJ	16876644				2022-12-28	WOS:000239441900005
J	Fairhead, JF; Rothwell, PM				Fairhead, Jack F.; Rothwell, Peter M.			Underinvestigation and undertreatment of carotid disease in elderly patients with transient ischaemic attack and stroke: comparative population based study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CASE-FATALITY; AGE; MORTALITY; RISK; SEX	Objective To identify any underinvestigation of older patients with transient ischaemic attack (TIA) and stroke. Design Comparative population based studies. Setting Routine clinical practice in all secondary care services in Oxfordshire and a nested population based study of incidence of transient ischaemic attack and stroke (the Oxford vascular study-OXVASC). Participants/population All patients undergoing carotid imaging for ischaemic retinal or cerebral transient ischaemic attack or stroke from 1 April 2002 to 31 March 2005 in the Oxford vascular study (n = 91 105) and from 1 April 2002 to 31 March 2003. in routine clinical practice (n = 589 899). Main outcome measures Age specific rates of carotid imaging, diagnosed >= 50% symptomatic carotid stenosis, and subsequent endarterectomy, in patients with recent transient ischaemic attack or stroke. Results Of patients with recent carotid territory transient ischaemic attack or ischaemic stroke, 575 in routine clinical practice and 402 in the Oxford vascular study had carotid imaging, with similar rates up to the age of 80. The incidence of >= 50% symptomatic stenosis increased steeply with age, particularly in those aged ! 80. Compared with investigations in patients in the Oxford vascular study, the rates of carotid imaging (relative rate 0.36, 95% confidence interval 0.28 to 0.46, P < 0.0001), diagnosis of >= 50% symptomatic stenosis (0.33, 0.16 to 0.69, P = 0.004), and carotid endarterectomy (0.19, 0.06 to 0.63, P = 0.007) in this age group in routine clinical practice were all substantially lower. Conclusions Incidence of symptomatic carotid stenosis increases steeply with age, but, despite good evidence of major benefit from endarterectomy in elderly patients and a willingness to have surgery, there is substantial underinvestigation in routine clinical practice in patients aged >= 80 with transient ischaemic attack or ischaemic stroke.	Radcliffe Infirm, Dept Clin Neurol, Stroke Prevent Res Unit, Oxford OX2 6HE, England	Radcliffe Infirmary	Rothwell, PM (corresponding author), Radcliffe Infirm, Dept Clin Neurol, Stroke Prevent Res Unit, Oxford OX2 6HE, England.	peter.rothwell@clneuro.ox.ac.uk	Rothwell, Peter/ABE-5913-2020	Rothwell, Peter/0000-0001-9739-9211	MRC [G0500987] Funding Source: UKRI; Medical Research Council [G0500987] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Bond R, 2005, CEREBROVASC DIS, V20, P69, DOI 10.1159/000086509; Brass LM, 1998, ARCH INTERN MED, V158, P2093, DOI 10.1001/archinte.158.19.2093; BUNGEJA G, 1997, BMJ-BRIT MED J, V315, P1059; Coull AJ, 2004, STROKE, V35, P2041, DOI 10.1161/01.STR.0000137605.48864.2f; Dharma-Wardene MW, 2002, J GASTROINTEST CANC, V32, P129, DOI 10.1385/IJGC:32:2-3:129; Dudley NJ, 2002, AGE AGEING, V31, P37, DOI 10.1093/ageing/31.1.37; Fairhead JF, 2005, NEUROLOGY, V65, P371, DOI 10.1212/01.WNL.0000170368.82460.b4; Feigin V, 2004, LANCET, V363, P1920, DOI 10.1016/S0140-6736(04)16436-2; Gaw A, 2004, INT J CLIN PRACT, V58, P777, DOI 10.1111/j.1368-5031.2004.00300.x; GREENBERG G, 1985, BMJ-BRIT MED J, V291, P97; GURWITZ JH, 1992, JAMA-J AM MED ASSOC, V268, P1417, DOI 10.1001/jama.1992.03490110055029; Heflin MT, 2002, J AM GERIATR SOC, V50, P1651, DOI 10.1046/j.1532-5415.2002.50456.x; *INT STROK WORK PA, 2004, NAT CLIN GUID STROK; Regueiro CR, 2003, J THROMB THROMBOLYS, V15, P119, DOI 10.1023/B:THRO.0000003326.00180.60; Rothwell PM, 2004, LANCET, V363, P915, DOI 10.1016/S0140-6736(04)15785-1; Rothwell PM, 2005, LANCET, V366, P1773, DOI 10.1016/S0140-6736(05)67702-1; Rothwell PM, 2004, LANCET, V363, P1925, DOI 10.1016/S0140-6736(04)16405-2; Rudd AG, 2004, AGE AGEING, V33, P280, DOI 10.1093/ageing/afh107; SUDLOW C, 2004, CLIN EVIDENCE, P36; Tonks A, 1999, BRIT MED J, V319, P1450, DOI 10.1136/bmj.319.7223.1450; Wolf PA, 1999, STROKE, V30, P1991, DOI 10.1161/01.STR.30.9.1991	21	58	59	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 9	2006	333	7567					525	527		10.1136/bmj.38895.646898.55	http://dx.doi.org/10.1136/bmj.38895.646898.55			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	084LD	16849366	Green Submitted, Green Published, Bronze			2022-12-28	WOS:000240533500016
J	Wang, XL; Chory, J				Wang, Xuelu; Chory, Joanne			Brassinosteroids regulate dissociation of BKI1, a negative regulator of BRI1 signaling, from the plasma membrane	SCIENCE			English	Article							RECEPTOR KINASE; GENE-EXPRESSION; ARABIDOPSIS; PROTEIN; GROWTH; BIOSYNTHESIS; HOMEOSTASIS; ACTIVATION; STEROIDS; BZR1	Brassinosteroids, the steroid hormones of plants, are perceived at the plasma membrane by a leucine-rich repeat receptor serine/threonine kinase called BRI1. We report a BRI1-interacting protein, BKI1, which is a negative regulator of brassinosteroid signaling. Brassinosteroids cause the rapid dissociation of BKI1 - yellow fluorescent protein from the plasma membrane in a process that is dependent on BRI1-kinase. BKI1 is a substrate of BRI1 kinase and limits the interaction of BRI1 with its proposed coreceptor, BAK1, suggesting that BKI1 prevents the activation of BRI1.	Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA; Salk Inst Biol Studies, Plant Biol Lab, La Jolla, CA 92037 USA	Howard Hughes Medical Institute; Salk Institute; Salk Institute	Chory, J (corresponding author), Salk Inst Biol Studies, Howard Hughes Med Inst, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	chory@salk.edu						Altmann T, 1998, CURR OPIN PLANT BIOL, V1, P378, DOI 10.1016/S1369-5266(98)80259-8; Cano-Delgado A, 2004, DEVELOPMENT, V131, P5341, DOI 10.1242/dev.01403; Clouse SD, 1996, PLANT PHYSIOL, V111, P671, DOI 10.1104/pp.111.3.671; Friedrichsen DM, 2000, PLANT PHYSIOL, V123, P1247, DOI 10.1104/pp.123.4.1247; Guy GR, 2002, CELL SIGNAL, V14, P11, DOI 10.1016/S0898-6568(01)00227-3; He JX, 2005, SCIENCE, V307, P1634, DOI 10.1126/science.1107580; Hirabayashi S., 2004, PLANT BIOTECHNOL, V21, P35, DOI 10.5511/plantbiotechnology.21.35; Holt LJ, 2005, BIOCHEM J, V388, P393, DOI 10.1042/BJ20050216; Kinoshita T, 2005, NATURE, V433, P167, DOI 10.1038/nature03227; Kouhara H, 1997, CELL, V89, P693, DOI 10.1016/S0092-8674(00)80252-4; Li J, 2002, CELL, V110, P213, DOI 10.1016/S0092-8674(02)00812-7; Li JM, 1997, CELL, V90, P929, DOI 10.1016/S0092-8674(00)80357-8; Li JM, 2002, SCIENCE, V295, P1299; Mora-Garcia S, 2004, GENE DEV, V18, P448, DOI 10.1101/gad.1174204; Nam KH, 2004, PLANT CELL, V16, P2406, DOI 10.1105/tpc.104.023903; Nam KH, 2002, CELL, V110, P203, DOI 10.1016/S0092-8674(02)00814-0; Sekimata K, 2002, TETRAHEDRON-ASYMMETR, V13, P1875, DOI 10.1016/S0957-4166(02)00475-5; Shiu SH, 2001, P NATL ACAD SCI USA, V98, P10763, DOI 10.1073/pnas.181141598; Tanaka K, 2005, PLANT PHYSIOL, V138, P1117, DOI 10.1104/pp.104.058040; Vert G, 2006, NATURE, V441, P96, DOI 10.1038/nature04681; Vert G, 2005, ANNU REV CELL DEV BI, V21, P177, DOI 10.1146/annurev.cellbio.21.090704.151241; Wang XF, 2005, PLANT CELL, V17, P1685, DOI 10.1105/tpc.105.031393; Wang XL, 2005, DEV CELL, V8, P855, DOI 10.1016/j.devcel.2005.05.001; Wang ZY, 2002, DEV CELL, V2, P505, DOI 10.1016/S1534-5807(02)00153-3; Wang ZY, 2001, NATURE, V410, P380, DOI 10.1038/35066597; Yin YH, 2005, CELL, V120, P249, DOI 10.1016/j.cell.2004.11.044; Yin YH, 2002, CELL, V109, P181, DOI 10.1016/S0092-8674(02)00721-3	27	338	375	13	124	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 25	2006	313	5790					1118	1122		10.1126/science.1127593	http://dx.doi.org/10.1126/science.1127593			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	076ZT	16857903				2022-12-28	WOS:000239998200046
J	Hinton, GE; Salakhutdinov, RR				Hinton, G. E.; Salakhutdinov, R. R.			Reducing the dimensionality of data with neural networks	SCIENCE			English	Article							REDUCTION	High-dimensional data can be converted to low-dimensional codes by training a multilayer neural network with a small central layer to reconstruct high-dimensional input vectors. Gradient descent can be used for fine-tuning the weights in such "autoencoder'' networks, but this works well only if the initial weights are close to a good solution. We describe an effective way of initializing the weights that allows deep autoencoder networks to learn low-dimensional codes that work much better than principal components analysis as a tool to reduce the dimensionality of data.	Univ Toronto, Dept Comp Sci, Toronto, ON M5S 3G4, Canada	University of Toronto	Hinton, GE (corresponding author), Univ Toronto, Dept Comp Sci, 6 Kings Coll Rd, Toronto, ON M5S 3G4, Canada.	hinton@cs.toronto.edu	DASK, JHONSON/AAF-4199-2021					[Anonymous], 1987, COMPUT SPEECH LANG, DOI DOI 10.1016/0885-2308(87)90026-X; DEERWESTER S, 1990, J AM SOC INFORM SCI, V41, P391, DOI 10.1002/(SICI)1097-4571(199009)41:6<391::AID-ASI1>3.0.CO;2-9; DeMers D., 1993, ADV NEURAL INFORM PR, P580; HECHTNIELSEN R, 1995, SCIENCE, V269, P1860, DOI 10.1126/science.269.5232.1860; Hinton GE, 2002, NEURAL COMPUT, V14, P1771, DOI 10.1162/089976602760128018; Hinton GE, 2006, NEURAL COMPUT, V18, P1527, DOI 10.1162/neco.2006.18.7.1527; HOPFIELD JJ, 1982, P NATL ACAD SCI-BIOL, V79, P2554, DOI 10.1073/pnas.79.8.2554; Roweis ST, 2000, SCIENCE, V290, P2323, DOI 10.1126/science.290.5500.2323; Smolensky P., 1986, PARALLEL DISTRIBUTED, V1, P194; Tenenbaum JB, 2000, SCIENCE, V290, P2319, DOI 10.1126/science.290.5500.2319; Welling M., 2005, ADV NEURAL INF PROCE, V17, P1481	12	10572	11945	285	3435	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 28	2006	313	5786					504	507		10.1126/science.1127647	http://dx.doi.org/10.1126/science.1127647			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067MZ	16873662				2022-12-28	WOS:000239308600057
J	Ismail, N; Ng, DTW				Ismail, Nurzian; Ng, Davis T. W.			Have you HRD? Understanding ERAD is DOAble!	CELL			English	Editorial Material							ENDOPLASMIC-RETICULUM DEGRADATION; PROTEINS; YEAST		Natl Univ Singapore, Temasek Life Sci Lab, Singapore 117604, Singapore; Natl Univ Singapore, Dept Biol Sci, Singapore 117604, Singapore	National University of Singapore; National University of Singapore	Ng, DTW (corresponding author), Natl Univ Singapore, Temasek Life Sci Lab, Singapore 117604, Singapore.	davis@tll.org.sg						Cormier JH, 2005, MOL CELL, V19, P717, DOI 10.1016/j.molcel.2005.08.029; Gardner RG, 2000, J CELL BIOL, V151, P69, DOI 10.1083/jcb.151.1.69; Gauss R, 2006, EMBO J, V25, P1827, DOI 10.1038/sj.emboj.7601088; Jakob CA, 1998, J CELL BIOL, V142, P1223, DOI 10.1083/jcb.142.5.1223; Knop M, 1996, EMBO J, V15, P753, DOI 10.1002/j.1460-2075.1996.tb00411.x; Nishikawa S, 2001, J CELL BIOL, V153, P1061, DOI 10.1083/jcb.153.5.1061; Romisch K, 2005, ANNU REV CELL DEV BI, V21, P435, DOI 10.1146/annurev.cellbio.21.012704.133250; Vashist S, 2004, J CELL BIOL, V165, P41, DOI 10.1083/jcb.200309132	8	48	49	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 28	2006	126	2					237	239		10.1016/j.cell.2006.07.001	http://dx.doi.org/10.1016/j.cell.2006.07.001			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	070VD	16873052	Bronze			2022-12-28	WOS:000239552600006
J	Jiricny, J				Jiricny, Josef			MutL alpha: At the cutting edge of mismatch repair	CELL			English	Editorial Material							SYSTEM; MICE; SUSCEPTIBILITY; RECONSTITUTION		Univ Zurich, Inst Mol Canc Res, CH-8006 Zurich, Switzerland; ETH, Dept Biol, CH-8092 Zurich, Switzerland	University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich	Jiricny, J (corresponding author), Univ Zurich, Inst Mol Canc Res, CH-8006 Zurich, Switzerland.	jiricny@imcr.unizh.ch						Constantin N, 2005, J BIOL CHEM, V280, P39752, DOI 10.1074/jbc.M509701200; Dzantiev L, 2004, MOL CELL, V15, P31, DOI 10.1016/j.molcel.2004.06.016; HOLMES J, 1990, P NATL ACAD SCI USA, V87, P5837, DOI 10.1073/pnas.87.15.5837; Jiricny J, 2006, NAT REV MOL CELL BIO, V7, P335, DOI 10.1038/nrm1907; Lipkin SM, 2002, NAT GENET, V31, P385, DOI 10.1038/ng931; Modrich P, 1996, ANNU REV BIOCHEM, V65, P101, DOI 10.1146/annurev.bi.65.070196.000533; Prolla TA, 1998, NAT GENET, V18, P276, DOI 10.1038/ng0398-276; Wei KC, 2003, GENE DEV, V17, P603, DOI 10.1101/gad.1060603; Zhang YB, 2005, CELL, V122, P693, DOI 10.1016/j.cell.2005.06.027	9	30	37	0	4	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUL 28	2006	126	2					239	241		10.1016/j.cell.2006.07.003	http://dx.doi.org/10.1016/j.cell.2006.07.003			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	070VD	16873053	Bronze			2022-12-28	WOS:000239552600007
J	Spudich, JA				Spudich, James A.			Molecular motors take tension in stride	CELL			English	Editorial Material							MYOSIN-V; CYTOPLASMIC DYNEIN; LOAD; COORDINATION; PROCESSIVITY; MECHANISM; HEAD		Stanford Univ, Dept Biochem, Sch Med, Stanford, CA 94305 USA	Stanford University	Spudich, JA (corresponding author), Stanford Univ, Dept Biochem, Sch Med, Stanford, CA 94305 USA.	jspudich@stanford.edu			NIGMS NIH HHS [R01 GM033289] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM033289] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Altman D, 2004, CELL, V116, P737, DOI 10.1016/S0092-8674(04)00211-9; Baker JE, 2004, P NATL ACAD SCI USA, V101, P5542, DOI 10.1073/pnas.0307247101; Guydosh NR, 2006, P NATL ACAD SCI USA, V103, P8054, DOI 10.1073/pnas.0600931103; Mallik R, 2004, NATURE, V427, P649, DOI 10.1038/nature02293; Purcell TJ, 2005, P NATL ACAD SCI USA, V102, P13873, DOI 10.1073/pnas.0506441102; Toba S, 2006, P NATL ACAD SCI USA, V103, P5741, DOI 10.1073/pnas.0508511103; Vale RD, 2000, SCIENCE, V288, P88, DOI 10.1126/science.288.5463.88; Veigel C, 2005, NAT CELL BIOL, V7, P861, DOI 10.1038/ncb1287	8	16	16	0	1	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUL 28	2006	126	2					242	244		10.1016/j.cell.2006.07.009	http://dx.doi.org/10.1016/j.cell.2006.07.009			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	070VD	16873054	Bronze			2022-12-28	WOS:000239552600008
J	Amin, MS; Matchar, DB; Wood, MA; Ellenbogen, KA				Amin, Mitesh S.; Matchar, David B.; Wood, Mark A.; Ellenbogen, Kenneth A.			Management of recalled pacemakers and implantable cardioverter-defibrillators - A decision analysis model	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							EARLY COMPLICATIONS; THERAPY; CHAMBER	Context Limited information exists to direct clinical management after an implantable device has been put under advisory. A better understanding of the risks and benefits of device replacement compared with continued clinical follow-up would be helpful to clinicians. Objective Using the tools of decision analysis, to determine the best management approach ( immediate device replacement vs continued monitoring) in the setting of a device advisory. Design A decision model was constructed to evaluate the risks and benefits associated with immediate device replacement compared with continued monitoring. Main Outcome Measures Variables considered included indications for device implantation, anticipated course following device failure, device failure rates from the advisory ranging from 0.0001% to 1.0% per year, and device replacement mortality rates ranging from 0.10% to 1.00% per procedure. Device replacement was preferred to continued follow-up when replacement led to greater patient survival. Results The decision to replace a recalled device depends primarily on the advisory's estimated device failure rate and the likely effects of device failure on mortality. Procedural mortality is an important secondary factor, while patient age and remaining generator life have the least influence on the decision. For pacemaker-dependent patients, advisory device failure rates exceeding 0.3% warrant device replacement in most situations. In patients with implantable cardioverter-defibrillators for primary or secondary prevention, a failure rate associated with an advisory of 3.0% is needed to favor replacement in most cases, decreasing to close to 1.0% as procedural mortality rates decrease to 0.1% or risk of fatal arrhythmias increase to near 20% per year. In cases of pacemaker implantation for non-life-threatening situations (eg, carotid sinus hypersensitivity), most device advisories do not warrant device replacement. Conclusions The decision to replace a device under advisory is determined primarily by the incidence of device malfunction and the likely effects of device failure. This analysis provides a framework for managing recalled devices in the context of device, patient, and institutional characteristics.	Virginia Commonwealth Univ, Med Coll Virginia, Dept Internal Med, Med Ctr, Richmond, VA 23298 USA; Virginia Commonwealth Univ, Med Coll Virginia, Div Cardiol, Med Ctr, Richmond, VA 23298 USA; Duke Univ, Dept Med, Durham, NC 27706 USA; Duke Univ, Ctr Clin Hlth Policy Res, Durham, NC 27706 USA; Durham Dept Vet Affairs Med Ctr, Durham, NC USA	Virginia Commonwealth University; Virginia Commonwealth University; Duke University; Duke University	Ellenbogen, KA (corresponding author), Virginia Commonwealth Univ, Med Coll Virginia, Dept Internal Med, Med Ctr, POB 980053, Richmond, VA 23298 USA.	kellenbogen@pol.net	Ellenbogen, Kenneth/AAJ-3992-2021; Matchar, David/M-3951-2019	Matchar, David/0000-0003-3020-2108				AGGARWAL RK, 1995, BRIT HEART J, V73, P571; Alter P, 2005, PACE, V28, P926, DOI 10.1111/j.1540-8159.2005.00195.x; Auricchio A, 2006, EUROPACE, V8, P313, DOI 10.1093/europace/eul043; Bardy GH, 2005, NEW ENGL J MED, V352, P225, DOI 10.1056/NEJMoa043399; BECK JR, 1982, AM J MED, V73, P889, DOI 10.1016/0002-9343(82)90787-2; Bristow MR, 2004, NEW ENGL J MED, V350, P2140, DOI 10.1056/NEJMoa032423; CHAUHAN A, 1994, PACE, V17, P2012, DOI 10.1111/j.1540-8159.1994.tb03791.x; Ellenbogen KA, 2003, AM J CARDIOL, V92, P740, DOI 10.1016/S0002-9149(03)00844-0; Gold MR, 1996, J AM COLL CARDIOL, V28, P1278, DOI 10.1016/S0735-1097(96)00314-2; GOULD PA, 2006, JAMA-J AM MED ASSOC, V295, P1907, DOI DOI 10.1001/JAMA.295.16.1907; *GUID, 2005, GUID ADV UPD CONT RE; Harcombe AA, 1998, HEART, V80, P240, DOI 10.1136/hrt.80.3.240; Kay GN, 1999, CIRCULATION, V100, P2344, DOI 10.1161/01.CIR.100.23.2344; Kochanek Kenneth D, 2004, Natl Vital Stat Rep, V53, P1; Maisel WH, 2006, JAMA-J AM MED ASSOC, V295, P1929, DOI 10.1001/jama.295.16.1929; Maisel WH, 2006, JAMA-J AM MED ASSOC, V295, P1901, DOI 10.1001/jama.295.16.1901; Maisel WH, 2005, JAMA-J AM MED ASSOC, V294, P955, DOI 10.1001/jama.294.8.955; Maisel WH, 2004, PACE, V27, P437, DOI 10.1111/j.1540-8159.2004.00460.x; McAnulty J, 1997, NEW ENGL J MED, V337, P1576; *MEDTR, 2005, MARQ PAT MAN INF; Mela T, 2001, AM J CARDIOL, V88, P750, DOI 10.1016/S0002-9149(01)01845-8; MIROWSKI M, 1980, NEW ENGL J MED, V303, P322, DOI 10.1056/NEJM198008073030607; Moss AJ, 2002, NEW ENGL J MED, V346, P877, DOI 10.1056/NEJMoa013474; Smith PN, 1998, PACE, V21, P42, DOI 10.1111/j.1540-8159.1998.tb01060.x; SONNENBERG FA, 1993, MED DECIS MAKING, V13, P322, DOI 10.1177/0272989X9301300409; THOMAS AC, 1988, PACE, V11, P2053, DOI 10.1111/j.1540-8159.1988.tb06349.x; Tobin K, 2000, AM J CARDIOL, V85, P774, DOI 10.1016/S0002-9149(99)00861-9; Undavia M, 2006, HEART RHYTHM, V3, P971, DOI 10.1016/j.hrthm.2006.04.010; WEINSTEIN MC, 1980, CLIN DECISION ANAL, P131; Wiegand UKH, 2004, CHEST, V126, P1177, DOI 10.1378/chest.126.4.1177; Wild DM, 2004, PACE, V27, P1526, DOI 10.1111/j.1540-8159.2004.00671.x; ZAIM S, 1994, AM J MED SCI, V307, P185, DOI 10.1097/00000441-199403000-00005	32	40	41	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 26	2006	296	4					412	420		10.1001/jama.296.4.412	http://dx.doi.org/10.1001/jama.296.4.412			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	066PN	16868299	Bronze			2022-12-28	WOS:000239242500027
J	Garcia, MJ; Lessick, J; Hoffmann, MHK				Garcia, Mario J.; Lessick, Jonathan; Hoffmann, Martin H. K.		CATSCAN Study Investigators	Accuracy of 16-row multidetector computed tomography for the assessment of coronary artery stenosis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PRACTICE GUIDELINES COMMITTEE; ASSOCIATION TASK-FORCE; MS TEMPORAL RESOLUTION; DIAGNOSTIC-ACCURACY; ANGIOGRAPHY; QUANTIFICATION; RECONSTRUCTION; TECHNOLOGY; LESIONS	Context Multidetector computed tomography (MDCT) has been proposed as a non-invasive method to evaluate coronary anatomy. Objective To determine the diagnostic accuracy of 16-row MDCT for the detection of obstructive coronary disease based exclusively on quantitative analysis and performed in a multicenter study. Design, Setting, and Patients Eleven participating sites prospectively enrolled 238 patients who were clinically referred for nonemergency coronary angiography from June 2004 through March 2005. Following a low-dose MDCT scan to evaluate coronary artery calcium, 187 patients with an Agatston score of less than 600 underwent contrast-enhanced MDCT. Conventional angiography was performed 1 to 14 days after MDCT. Conventional angiographic and MDCT studies were analyzed by independent core laboratories. Main Outcome Measures Segment-based and patient-based sensitivities and specificities for the detection of luminal stenosis of more than 50% ( of luminal diameter) and more than 70% ( of luminal diameter) based on quantitative coronary angiography. Results Of 1629 nonstented segments larger than 2 mm in diameter, there were 89 (5.5%) in 59 (32%) of 187 patients with stenosis of more than 50% by conventional angiography. Of the 1629 segments, 71% were evaluable on MDCT. After censoring all nonevaluable segments as positive, the sensitivity for detecting more than 50% luminal stenoses was 89%; specificity, 65%; positive predictive value, 13%; and negative predictive value, 99%. In a patient-based analysis, the sensitivity for detecting patients with at least 1 positive segment was 98%; specificity, 54%; positive predictive value, 50%; and negative predictive value, 99%. After censoring all nonevaluable segments as positive, the sensitivity for detecting more than 70% luminal stenoses was 94%; specificity, 67%; positive predictive value, 6%; and negative predictive value, 99%. In a patient-based analysis, the sensitivity for detecting patients with at least 1 positive segment was 94%; specificity, 51%; positive predictive value, 28%; and negative predictive value, 98%. Conclusions The results of this study indicate that MDCT coronary angiography performed with 16-row scanners is limited by a high number of nonevaluable cases and a high false-positive rate. Thus, its routine implementation in clinical practice is not justified. Nevertheless, given its high sensitivity and negative predictive value, 16-row MDCT may be useful in excluding coronary disease in selected patients in whom a false-positive or inconclusive stress test result is suspected.	Cleveland Clin Fdn, Dept Cardiol, Cleveland, OH 44195 USA; Rambam Med Ctr, Haifa, Israel; Philips Med Syst, Highland Hts, OH USA; Univ Ulm, Ulm, Germany	Cleveland Clinic Foundation; Rambam Health Care Campus; Technion Israel Institute of Technology; Philips; Philips Healthcare; Ulm University	Garcia, MJ (corresponding author), Cleveland Clin Fdn, Dept Cardiol, 9500 Euclid Ave, Cleveland, OH 44195 USA.	garciam@ccf.org		Lessick, Jonathan/0000-0003-4430-712X				Achenbach S, 2005, EUR HEART J, V26, P1978, DOI 10.1093/eurheartj/ehi326; AGATSTON AS, 1990, J AM COLL CARDIOL, V15, P827, DOI 10.1016/0735-1097(90)90282-T; Austen W G, 1975, Circulation, V51, P5; Bashore TM, 2001, J AM COLL CARDIOL, V37, P2170, DOI 10.1016/S0735-1097(01)01346-8; Dewey M, 2004, INVEST RADIOL, V39, P223, DOI 10.1097/01.rli.0000115201.27096.6e; *EUR COMM, 2000, EUR GUID QUAL CRIT C; Gibbons RJ, 1997, J AM COLL CARDIOL, V30, P260; Hausleiter J, 2006, CIRCULATION, V113, P1305, DOI 10.1161/CIRCULATIONAHA.105.602490; Hoffmann MHK, 2005, JAMA-J AM MED ASSOC, V293, P2471, DOI 10.1001/jama.293.20.2471; Kaiser C, 2005, EUR HEART J, V26, P1987, DOI 10.1093/eurheartj/ehi384; Kuettner A, 2005, HEART, V91, P938, DOI 10.1136/hrt.2004.044735; Kuettner A, 2005, J AM COLL CARDIOL, V45, P123, DOI 10.1016/j.jacc.2004.10.050; Kuettner A, 2004, J AM COLL CARDIOL, V44, P1230, DOI 10.1016/j.jacc.2004.05.079; Leber AW, 2005, J AM COLL CARDIOL, V46, P147, DOI 10.1016/j.jacc.2005.03.071; Leschka S, 2005, EUR HEART J, V26, P1482, DOI 10.1093/eurheartj/ehi261; Martuscelli E, 2004, EUR HEART J, V25, P1043, DOI 10.1016/j.ehj.2004.03.024; Mollet NR, 2005, J AM COLL CARDIOL, V45, P128, DOI 10.1016/j.jacc.2004.09.074; Mollet NR, 2005, CIRCULATION, V112, P2318, DOI 10.1161/CIRCULATIONAHA.105.533471; Nieman K, 2002, CIRCULATION, V106, P2051, DOI 10.1161/01.CIR.0000037222.58317.3D; Obuchowski NA, 2005, AM J ROENTGENOL, V184, P364, DOI 10.2214/ajr.184.2.01840364; Raff GL, 2005, J AM COLL CARDIOL, V46, P552, DOI 10.1016/j.jacc.2005.05.056; Rius T, 2006, EUR HEART J, V27, P637, DOI 10.1093/eurheartj/ehi534; Ropers D, 2003, CIRCULATION, V107, P664, DOI 10.1161/01.CIR.0000055738.31551.A9; Scanlon PJ, 1999, J AM COLL CARDIOL, V33, P1756, DOI 10.1016/S0735-1097(99)00126-6; UEHATA A, 1993, CIRCULATION, V88, P1724, DOI 10.1161/01.CIR.88.4.1724	26	208	220	0	6	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 26	2006	296	4					403	411		10.1001/jama.296.4.403	http://dx.doi.org/10.1001/jama.296.4.403			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	066PN	16868298	Bronze			2022-12-28	WOS:000239242500026
J	Pavkov, ME; Bennett, PH; Knowler, WC; Krakoff, J; Sievers, ML; Nelson, RG				Pavkov, Meda E.; Bennett, Peter H.; Knowler, William C.; Krakoff, Jonathan; Sievers, Maurice L.; Nelson, Robert G.			Effect of youth-onset type 2 diabetes mellitus on incidence of end-stage renal disease and mortality in young and middle-aged Pima Indians	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							VASCULAR-DISEASE; HEART-DISEASE; CHILDREN; COMPLICATIONS; PREVALENCE; ANTIBODIES; RISK	Context The long-term outcome of persons with youth-onset type 2 diabetes mellitus has not been well described. Objective To compare incidence of diabetic end-stage renal disease ( ESRD) and mortality in Pima Indians with youth- and older-onset type 2 diabetes mellitus. Design, Setting, and Participants Longitudinal population-based study conducted between 1965 and 2002 in Pima Indians from the state of Arizona. Participants were divided into 2 groups: ( 1) youth- onset type 2 diabetes mellitus ( onset < 20 years of age) and ( 2) older-onset type 2 diabetes mellitus ( onset >= 20 - < 55 years of age). Events and person-years of follow-up were stratified in a time-dependent fashion by decades of age. End-stage renal disease was defined as dialysis attributed to diabetic nephropathy or death from diabetic nephropathy. Main Outcome Measures Incidence rate of diabetic ESRD and mortality between 25 and 55 years of age, according to age at onset of type 2 diabetes mellitus. Results Among the 1856 diabetic participants, 96 had youth- onset type 2 diabetes mellitus. The age-sex - adjusted incidence of diabetic ESRD was 25.0 cases per 1000 person-years (95% confidence interval [CI], 6.7-43.1) in youth- onset diabetes mellitus and 5.4 cases per 1000 person-years ( 95% CI, 4.4-6.4) in older-onset diabetes mellitus ( incidence rate ratio, 4.6; 95% CI, 2.2-9.8). Age-specific incidence rates were higher in participants with youth- onset diabetes mellitus at all ages. Between 25 and 55 years of age, the age-sex - adjusted death rate from natural causes was 15.4 deaths per 1000 person-years ( 95% CI, 0.2-30.5) in participants with youth- onset diabetes mellitus and 7.3 deaths per 1000 person-years ( 95% CI, 5.9-8.7) in individuals with older-onset diabetes mellitus ( death rate ratio, 2.1; 95% CI, 0.8-5.7). Compared with nondiabetic participants, the death rate was 3.0 times as high in individuals with youth- onset diabetes mellitus ( 95% CI, 1.1-8.0) and 1.4 times as high in individuals with older-onset diabetes mellitus ( 95% CI, 1.1-1.8). In a subset of 1386 participants with complete data for all covariates who were observed from the onset of diabetes mellitus, the age at onset of diabetes mellitus was not associated with the incidence of ESRD ( hazard ratio, 1.0; 95% CI, 0.9-1.2) after adjusting for sex, mean arterial pressure, body mass index ( calculated as weight in kilograms divided by height in meters squared), plasma glucose concentration, smoking, hypoglycemic medicines, and blood pressure medicines in a Cox proportional-hazards model. Conclusions Early-onset type 2 diabetes mellitus is associated with substantially increased incidence of ESRD and mortality in middle age. The longer duration of diabetes mellitus by middle age in individuals diagnosed younger than age 20 years largely accounts for these outcomes.	NIH, Phoenix Epidemiol & Clin Res Branch, NIDDKD, Phoenix, AZ 85014 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Pavkov, ME (corresponding author), NIH, Phoenix Epidemiol & Clin Res Branch, NIDDKD, 1550 E Indian Sch Rd, Phoenix, AZ 85014 USA.	mpavkov@phx.niddk.nih.gov	Nelson, Robert G/B-1470-2012; Bennett, Peter/AAH-9605-2021		NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [Z01DK069063, Z01DK069036, ZIADK069036, ZIADK069063] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Alberti G, 2004, DIABETES CARE, V27, P1798, DOI 10.2337/diacare.27.7.1798; Dabelea D, 1999, DIABETOLOGIA, V42, P1265; Dabelea D, 1998, DIABETOLOGIA, V41, P904, DOI 10.1007/s001250051006; Fagot-Campagna A, 2000, J PEDIATR-US, V136, P664, DOI 10.1067/mpd.2000.105141; Franks PW, 2006, DIABETES, V55, P460, DOI 10.2337/diabetes.55.02.06.db05-0823; HANSON RL, 1997, DIABETES S1, V46, P51; Hillier TA, 2003, DIABETES CARE, V26, P2999, DOI 10.2337/diacare.26.11.2999; JANSSEN RC, 1994, DIABETES, V43, P558, DOI 10.2337/diabetes.43.4.558; KNOWLER WC, 1990, DIABETES METAB REV, V6, P1, DOI 10.1002/dmr.5610060101; KNOWLER WC, 1979, DIABETOLOGIA, V17, P161, DOI 10.1007/BF01219743; Krakoff J, 2003, DIABETES CARE, V26, P76, DOI 10.2337/diacare.26.1.76; Lee ET, 2001, DIABETOLOGIA, V44, pS78, DOI 10.1007/PL00002943; Lee ET, 2001, DIABETOLOGIA, V44, pS3, DOI 10.1007/PL00002936; MANTEL N, 1959, J NATL CANCER I, V22, P719; MANTEL N, 1963, J AM STAT ASSOC, V58, P690; Muller YHL, 2005, DIABETES, V54, P3035, DOI 10.2337/diabetes.54.10.3035; NELSON RG, 1990, CIRCULATION, V81, P987, DOI 10.1161/01.CIR.81.3.987; NELSON RG, 1988, DIABETOLOGIA, V31, P730, DOI 10.1007/BF00274774; Pavkov ME, 2005, KIDNEY INT, V68, P1267, DOI 10.1111/j.1523-1755.2005.00523.x; Pavkov ME, 2004, DIABETES CARE, V27, P1132, DOI 10.2337/diacare.27.5.1132; ROTHMAN KJ, 1979, NIH791649 PUBL, P11; Singh R, 2004, PEDIATR DIABETES, V5, P154, DOI 10.1111/j.1399-543X.2004.00060.x; Uchigata Y, 2003, TYPE 2 DIABETES CHIL, P187; US Renal Data System, 2005, USRDS 2005 ANN DAT R; *WHO, 1985, WHO TECH REP SER, V727; Yokoyama H, 1997, DIABETES CARE, V20, P844, DOI 10.2337/diacare.20.5.844	26	207	213	0	9	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 26	2006	296	4					421	426		10.1001/jama.296.4.421	http://dx.doi.org/10.1001/jama.296.4.421			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	066PN	16868300	Bronze			2022-12-28	WOS:000239242500028
J	Yeni, P; Cooper, DA; Aboulker, JP; Babiker, AG; Carey, D; Darbyshire, JH; Floridia, M; Girard, PM; Goodall, L; Hooker, MH; Mijch, A; Meiffredy, V; Salzberger, B; Cooper, DA; Yeni, P; Aboulker, JP; Antunes, F; Babiker, A; Becker, M; Boukli, N; Brun-Vezinet, F; Carey, D; Churchill, D; Conway, B; Chazallon, C; Darbyshire, J; De Wit, S; Dusak, B; Emery, S; Flepp, M; Gatell, J; Girard, PM; Goodall, RL; Hemmer, R; Hooker, M; Law, M; Loveday, C; Lundgren, J; Manion, D; Meiffredy, V; Mijch, A; Mulcahy, F; Orani, A; Pharo, C; Ristola, M; Salzberger, B; Sandstrom, E; Schechter, M; Schnittman, S; Seligmann, M; Staszewski, S; Stek, M; Verbiest, W; Weber, J; Withnall, R				Yeni, P.; Cooper, D. A.; Aboulker, J-P; Babiker, A. G.; Carey, D.; Darbyshire, J. H.; Floridia, M.; Girard, P-M; Goodall, L.; Hooker, M. H.; Mijch, A.; Meiffredy, V.; Salzberger, B.; Cooper, D. A.; Yeni, P.; Aboulker, J-P; Antunes, F.; Babiker, A.; Becker, M.; Boukli, N.; Brun-Vezinet, F.; Carey, D.; Churchill, D.; Conway, B.; Chazallon, C.; Darbyshire, J.; De Wit, S.; Dusak, B.; Emery, S.; Flepp, M.; Gatell, J.; Girard, P-M; Goodall, R. L.; Hemmer, R.; Hooker, M.; Law, M.; Loveday, C.; Lundgren, J.; Manion, D.; Meiffredy, V.; Mijch, A.; Mulcahy, F.; Orani, A.; Pharo, C.; Ristola, M.; Salzberger, B.; Sandstrom, E.; Schechter, M.; Schnittman, S.; Seligmann, M.; Staszewski, S.; Stek, M.; Verbiest, W.; Weber, J.; Withnall, R.		INITIO Trial Int Co-ordinating	Virological and immunological outcomes at 3 years after starting antiretroviral therapy with regimens containing non-nucleoside reverse transcriptase inhibitor, protease inhibitor, or both in INITIO: open-label randomised trial	LANCET			English	Article							SEQUENTIAL 3-DRUG REGIMENS	Background Antiretroviral therapy has greatly reduced HIV mortality and morbidity. However, the best sequence Of regimens and implications of initial regimen for long-term therapeutic success are not well defined. Methods In INITIO, a large international randomised trial, we compared antiretroviral therapy with two nucleoside analogue reverse transcriptase inhibitors (didanosine+stavudine) plus either a non-nucleoside reverse transcriptase inhibitor (efavirenz, EFV) or a protease inhibitor (nelfinavir, NFV), or both (EFV/NFV), in patients with HIV-1 infection who had not previously received antiretroviral drugs. Primary outcomes were proportion with undetectable HIV RNA in plasma, and change in CD4 count from baseline at 3 years. Analyses were by intention-to-treat. This study is registered as an International Standard Randomised Controlled Trial, number ISRCTN44582462. Findings We followed up 911 participants (297 EFV, 311 NFV, 303 EFV/NFV). At 3 years, the proportion with HIV RNA less than 50 copies per mL was highest in the EFV group (188 [74%] EFV, 162 [62%] NFV, 155 [62%] EFV/NFV, p=0.004). Mean (95% CI) increases in CD4 count were 316X10(6) cells per L (288-343) for EFV, 289X10(6) cells per L (262-316) for NFV, and 274X10(6) cells per L (231-291) for EFV/NFV (p=0.1). Fewer participants in the EFV group than in the other groups stopped adequate antiretroviral therapy for more than 30 days (p=0.005). Participants in the EFV/NFV group had shorter time to stopping the initial regimen (p<0.0001) and to a treatment modifying adverse event (p=0.04) than those in the other groups. Interpretation Starting antiretroviral therapy with a three-drug/two-class regimen including efavirenz was better than starting with regimens including nelfinavir or efavirenz plus nelfinavir in terms of virological suppression and durability of the initial regimen. The shorter time on adequate antiretroviral therapy or to a treatment-modifying adverse event might explain the absence of additional benefit for the four-drug regimen.	MRC, Clin Trials Unit, London NW1 2DA, England; NCHECR, Sydney, NSW, Australia; Grp Hosp Bichat, Paris, France; INSERM, SC10, F-75654 Paris 13, France; ISS, Rome, Italy	Medical Research Council Clinical Trials Unit; University of New South Wales Sydney; Kirby Institute; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); Istituto Superiore di Sanita (ISS)	Babiker, AG (corresponding author), MRC, Clin Trials Unit, London NW1 2DA, England.	a.babiker@ctu.mrc.ac.uk	Schechter, Mauro/AAG-7445-2020; Lundgren, Jens/AAE-6876-2019; Emery, Sean/O-9122-2019; Floridia, Marco/Q-6571-2017; Emery, Sean/J-3825-2017; Ristola, Matti/AAD-5092-2022	Emery, Sean/0000-0001-6072-8309; Floridia, Marco/0000-0003-3971-0141; Emery, Sean/0000-0001-6072-8309; Ristola, Matti/0000-0001-5115-2811				[Anonymous], 1998, MMWR Recomm Rep, V47, P1; Babiker AG, 2001, CONTROL CLIN TRIALS, V22, P160; Division of AIDS, 1992, DIV AIDS GRAD SEV AD; *EUR AG EV MED PRO, 2003, E2D EUR AG EV MED PR; Gazzard B, 2005, HIV MED, V6, P1, DOI 10.1111/j.1468-1293.2005.0311b.x; Gazzard B, 1998, LANCET, V352, P314, DOI 10.1016/S0140-6736(98)04084-7; Johnson Victoria A, 2005, Top HIV Med, V13, P125; MacArthur RD, 2001, CONTROL CLIN TRIALS, V22, P176, DOI 10.1016/S0197-2456(01)00111-8; Marschner IC, 1999, J ACQ IMMUN DEF SYND, V20, P220, DOI 10.1097/00042560-199903010-00002; Moyle Graeme J, 2003, AIDS Read, V13, P223; POLLARD R, 1996, 11 INT AIDS C; Robbins GK, 2003, NEW ENGL J MED, V349, P2293, DOI 10.1056/NEJMoa030264; Shafer RW, 2003, NEW ENGL J MED, V349, P2304, DOI 10.1056/NEJMoa030265; *US CDCP, 1992, MMWR-MORBID MORTAL W, V41, P1; *US DEP HHS, 2005, GUID US ANT AG HIV 1; Walmsley S, 2002, NEW ENGL J MED, V346, P2039, DOI 10.1056/NEJMoa012354; Whitby L, 2002, CYTOMETRY, V50, P102, DOI 10.1002/cyto.10094; Yeni PG, 2004, JAMA-J AM MED ASSOC, V292, P251, DOI 10.1001/jama.292.2.251	18	75	75	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 22	2006	368	9532					287	298						12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	067PF	16860698				2022-12-28	WOS:000239314400026
J	Sarbib, JL; Nankani, G; Patel, P				Sarbib, Jean-Louis; Nankani, Gobind; Patel, Praful			The Booster Program for Malaria Control: putting knowledge and money to work	LANCET			English	Editorial Material									World Bank Grp, Human Dev Network, Washington, DC 20433 USA; World Bank Grp, Africa Reg, Washington, DC 20433 USA; World Bank Grp, S Asia Reg, Washington, DC 20433 USA	The World Bank; The World Bank; The World Bank	Sarbib, JL (corresponding author), World Bank Grp, Human Dev Network, 1818 H St NW, Washington, DC 20433 USA.	jsarbib@worldbank.org						ATTARAN A, 2006, LANCET          0425; *B M GAT FFDN, 2005, GLOB HLTH PARTN ASS; *BANQ MOND, 2005, DOC FORM PROJ CRED P; *GLOB FUND FIGHT A, TUB MAL FUND WORKS; High Level Forum on the Health MDGs, 2005, BEST PRACT PRINC GLO; Institute of Medicine (US) Committee on the Economics of Antimalarial Drugs, 2004, SAVING LIVES BUYING; *PROGR APPR TECHN, 2005, NEW PARTN LAUNCH ACC; RAMANA GNV, COMMUNICATION; Sachs J, 2002, NATURE, V415, P680, DOI 10.1038/415680a; Shakow A., 2006, GLOBAL FUND WORLD BA; *UNICEF WHO, WORLD MAL REP 2005; *US PRES MAL IN, OV; *WHO, 2005, GUID TREATM MAL, pCH9; World Bank, 2005, PROJ APPR DOC PROP G; *WORLD BANK, 2005, PROJ APPR DOC PROP C; *WORLD BANK, 2006, MAL WORLD BANK GLOB; *WORLD BANK, 2005, IND VECT BORN DIS CO; World Bank, 1997, PROJ APPR DOC PROP C	18	6	6	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 15	2006	368	9531					253	257		10.1016/S0140-6736(06)68437-7	http://dx.doi.org/10.1016/S0140-6736(06)68437-7			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	064MY	16844496				2022-12-28	WOS:000239095000038
J	Mellor, J				Mellor, Jane			It takes a PHD to read the histone code	CELL			English	Editorial Material							METHYLATION; CHROMODOMAINS; TUDOR	The pattern of histone modifications, called the histone code, influences transitions between chromatin states and the regulation of transcriptional activity. Four recent papers describe how plant homeodomain (PHD) finger proteins read part of this code. The PHD finger may promote both gene expression and repression through interactions with trimethylated lysine 4 on histone 3 (H3K4), a universal modification at the beginning of active genes.	Univ Oxford, Dept Biochem, Oxford OX1 3QU, England	University of Oxford	Mellor, J (corresponding author), Univ Oxford, Dept Biochem, S Parks Rd, Oxford OX1 3QU, England.	jane.mellor@bioch.ox.ac.uk						Fischle W, 2003, GENE DEV, V17, P1870, DOI 10.1101/gad.1110503; Flanagan JF, 2005, NATURE, V438, P1181, DOI 10.1038/nature04290; Huang Y, 2006, SCIENCE, V312, P748, DOI 10.1126/science.1125162; Kim J, 2006, EMBO REP, V7, P397, DOI 10.1038/sj.embor.7400625; LI H, 2006, NATURE          0521; PENA PV, 2003, NATURE          0521; SHI X, 2003, NATURE          0521; Wysocka J, 2005, CELL, V121, P859, DOI 10.1016/j.cell.2005.03.036; WYSOCKA J, 2006, NATURE          0521	9	157	165	0	21	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUL 14	2006	126	1					22	24		10.1016/j.cell.2006.06.028	http://dx.doi.org/10.1016/j.cell.2006.06.028			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	066JF	16839870	Bronze			2022-12-28	WOS:000239224800010
J	Wu, L; Multani, AS; He, H; Cosme-Blanco, W; Deng, Y; Deng, JM; Bachilo, O; Pathak, S; Tahara, H; Bailey, SM; Deng, YB; Behringer, RR; Chang, S				Wu, Ling; Multani, Asha S.; He, Hua; Cosme-Blanco, Wilfredo; Deng, Yu; Deng, Jian Min; Bachilo, Olga; Pathak, Sen; Tahara, Hedioshi; Bailey, Susan M.; Deng, Yibin; Behringer, Richard R.; Chang, Sandy			Pot1 deficiency initiates DNA damage checkpoint activation and aberrant homologous recombination at telomeres	CELL			English	Article							SINGLE-STRANDED-DNA; LENGTH HOMEOSTASIS; PROTEIN; CELLS; END; COMPLEX; TRF1; REGULATOR; WRN; PHOSPHORYLATION	The terminal t-loop structure adopted by mammalian telomeres is thought to prevent telomeres from being recognized as double-stranded DNA breaks by sequestering the 3' single-stranded G-rich overhang from exposure to the DNA damage machinery. The POT1 (protection of telomeres) protein binds the single-stranded overhang and is required for both chromosomal end protection and telomere length regulation. The mouse genome contains two POT1 orthologs, Pot1a and Pot1b. Here we show that conditional deletion of Pot1a elicits a DNA damage response at telomeres, resulting in p53-dependent replicative senescence. Pot1a-deficient cells exhibit overall telomere length and 3' overhang elongation as well as aberrant homologous recombination (HR) at telomeres, manifested as increased telomere sister chromatid exchanges and formation of telomere circles. Telomeric HR following Pot1a loss requires NBS1. Pot1a deletion also results in chromosomal instability. Our results suggest that POT1a is crucial for the maintenance of both telomere integrity and overall genomic stability.	Univ Texas, MD Anderson Canc Ctr, Dept Mol Genet, Houston, TX 77030 USA; Univ Texas, MD Anderson Canc Ctr, Dept Hematopathol, Houston, TX 77030 USA; Rice Univ, Dept Bioengn, Houston, TX 77251 USA; Hiroshima Univ, Grad Sch Biomed Sci, Program Biomed Res, Dept Cellular & Mol Bio,Minami Ku, Hiroshima 734, Japan; Colorado State Univ, Dept Environm & Radiol Hlth Sci, Ft Collins, CO 80523 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Rice University; Hiroshima University; Colorado State University	Chang, S (corresponding author), Univ Texas, MD Anderson Canc Ctr, Dept Mol Genet, 1515 Holcombe Blvd,Box 1006, Houston, TX 77030 USA.	schang@mdanderson.org		Deng, Yibin/0000-0001-5711-3565	NCI NIH HHS [CA016672, R01 CA129037] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA129037, P30CA016672] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Arango NA, 1999, CELL, V99, P409, DOI 10.1016/S0092-8674(00)81527-5; Artandi SE, 2000, NATURE, V406, P641, DOI 10.1038/35020592; Bailey SM, 2004, NUCLEIC ACIDS RES, V32, P3743, DOI 10.1093/nar/gkh691; Bailey SM, 2001, SCIENCE, V293, P2462, DOI 10.1126/science.1062560; Banin S, 1998, SCIENCE, V281, P1674, DOI 10.1126/science.281.5383.1674; Baumann P, 2002, MOL CELL BIOL, V22, P8079, DOI 10.1128/MCB.22.22.8079-8087.2002; Baumann P, 2001, SCIENCE, V292, P1171, DOI 10.1126/science.1060036; Bechter OE, 2004, CANCER RES, V64, P3444, DOI 10.1158/0008-5472.CAN-04-0323; Blackburn EH, 2001, CELL, V106, P661, DOI 10.1016/S0092-8674(01)00492-5; Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4; Canman CE, 1998, SCIENCE, V281, P1677, DOI 10.1126/science.281.5383.1677; Celli GB, 2005, NAT CELL BIOL, V7, P712, DOI 10.1038/ncb1275; Cesare AJ, 2004, MOL CELL BIOL, V24, P9948, DOI 10.1128/MCB.24.22.9948-9957.2004; Crabbe L, 2004, SCIENCE, V306, P1951, DOI 10.1126/science.1103619; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; di Fagagna FD, 2003, NATURE, V426, P194, DOI 10.1038/nature02118; GARVIK B, 1995, MOL CELL BIOL, V15, P6128; Griffith JD, 1999, CELL, V97, P503, DOI 10.1016/S0092-8674(00)80760-6; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; Hemann MT, 1999, NUCLEIC ACIDS RES, V27, P3964, DOI 10.1093/nar/27.20.3964; Hockemeyer D, 2005, EMBO J, V24, P2667, DOI 10.1038/sj.emboj.7600733; Hockemeyer D, 2006, CELL, V126, P63, DOI 10.1016/j.cell.2006.04.044; Houghtaling BR, 2004, CURR BIOL, V14, P1621, DOI 10.1016/j.cub.2004.08.052; Karlseder J, 1999, SCIENCE, V283, P1321, DOI 10.1126/science.283.5406.1321; Kelleher C, 2005, MOL CELL BIOL, V25, P808, DOI 10.1128/MCB.25.2.808-818.2005; Kim WJ, 2004, INT J CONTROL AUTOM, V2, P279; Kondo T, 2004, CANCER RES, V64, P523, DOI 10.1158/0008-5472.CAN-03-1196; Laud PR, 2005, GENE DEV, V19, P2560, DOI 10.1101/gad.1321305; Lei M, 2004, NAT STRUCT MOL BIOL, V11, P1223, DOI 10.1038/nsmb867; Lei M, 2003, NATURE, V426, P198, DOI 10.1038/nature02092; Lei M, 2005, J BIOL CHEM, V280, P20449, DOI 10.1074/jbc.M502212200; Li BB, 2000, CELL, V101, P471, DOI 10.1016/S0092-8674(00)80858-2; Liu D, 2004, J BIOL CHEM, V279, P51338, DOI 10.1074/jbc.M409293200; Liu D, 2004, NAT CELL BIOL, V6, P673, DOI 10.1038/ncb1142; Loayza D, 2003, NATURE, V423, P1013, DOI 10.1038/nature01688; Londono-Vallejo JA, 2004, CANCER RES, V64, P2324, DOI 10.1158/0008-5472.CAN-03-4035; Lustig AJ, 2003, NAT REV GENET, V4, P916, DOI 10.1038/nrg1207; Maser RS, 2004, DNA REPAIR, V3, P979, DOI 10.1016/j.dnarep.2004.05.009; Mohaghegh P, 2001, NUCLEIC ACIDS RES, V29, P2843, DOI 10.1093/nar/29.13.2843; Murti KG, 1999, P NATL ACAD SCI USA, V96, P14436, DOI 10.1073/pnas.96.25.14436; Nikitina T, 2004, J CELL BIOL, V166, P161, DOI 10.1083/jcb.200403118; Opresko PL, 2004, MOL CELL, V14, P763, DOI 10.1016/j.molcel.2004.05.023; Opresko PL, 2005, J BIOL CHEM, V280, P32069, DOI 10.1074/jbc.M505211200; Parrinello S, 2003, NAT CELL BIOL, V5, P741, DOI 10.1038/ncb1024; Rudolph KL, 1999, CELL, V96, P701, DOI 10.1016/S0092-8674(00)80580-2; Shakirov EV, 2005, MOL CELL BIOL, V25, P7725, DOI 10.1128/MCB.25.17.7725-7733.2005; Smogorzewska A, 2004, ANNU REV BIOCHEM, V73, P177, DOI 10.1146/annurev.biochem.73.071403.160049; Tahara H, 2005, NAT METHODS, V2, P829, DOI 10.1038/NMETH797; Takai H, 2003, CURR BIOL, V13, P1549, DOI 10.1016/S0960-9822(03)00542-6; Tarsounas M, 2004, CELL, V117, P337, DOI 10.1016/S0092-8674(04)00337-X; Teixeira MT, 2004, CELL, V117, P323, DOI 10.1016/S0092-8674(04)00334-4; Tsukuda T, 2005, NATURE, V438, P379, DOI 10.1038/nature04148; vanSteensel B, 1997, NATURE, V385, P740, DOI 10.1038/385740a0; Veldman T, 2004, CURR BIOL, V14, P2264, DOI 10.1016/j.cub.2004.12.031; Verdun RE, 2005, MOL CELL, V20, P551, DOI 10.1016/j.molcel.2005.09.024; Wang RC, 2004, CELL, V119, P355, DOI 10.1016/j.cell.2004.10.011; Wei C, 2004, MOL CELL BIOL, V24, P2091, DOI 10.1128/MCB.24.5.2091-2102.2004; Yang Q, 2005, MOL CELL BIOL, V25, P1070, DOI 10.1128/MCB.25.3.1070-1080.2005; Ye JZS, 2004, J BIOL CHEM, V279, P47264, DOI 10.1074/jbc.M409047200; Ye JZS, 2004, GENE DEV, V18, P1649, DOI 10.1101/gad.1215404; Zaug AJ, 2005, P NATL ACAD SCI USA, V102, P10864, DOI 10.1073/pnas.0504744102; Zhu SY, 2000, IUBMB LIFE, V50, P57, DOI 10.1080/15216540050176601; Zhu XD, 2003, MOL CELL, V12, P1489, DOI 10.1016/S1097-2765(03)00478-7	63	318	330	1	28	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 14	2006	126	1					49	62		10.1016/j.cell.2006.05.037	http://dx.doi.org/10.1016/j.cell.2006.05.037			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	066JF	16839876	Bronze			2022-12-28	WOS:000239224800016
J	Prudhomme, M; Attaiech, L; Sanchez, G; Martin, B; Claverys, JP				Prudhomme, Marc; Attaiech, Laetitia; Sanchez, Guillaume; Martin, Bernard; Claverys, Jean-Pierre			Antibiotic stress induces genetic transformability in the human pathogen Streptococcus pneumoniae	SCIENCE			English	Article							SOS RESPONSE; TOPOISOMERASE-IV; DNA GYRASE; COMPETENCE; RECOMBINATION; INDUCTION; PHEROMONE; IDENTIFICATION; RECA	Natural transformation is a widespread mechanism for genetic exchange in bacteria. Aminoglycoside and fluoroquinolone antibiotics, as well as mitomycin C, a DNA-damaging agent, induced transformation in Streptococcus pneumoniae. This induction required an intact competence regulatory cascade. Furthermore, mitomycin C induction of recA was strictly dependent on the development of competence. In response to antibiotic stress, S. pneumoniae, which lacks an SOS-like system, exhibited genetic transformation. The design of antibiotherapy should take into consideration this potential of a major human pathogen to increase its rate of genetic exchange in response to antibiotics.	Univ Toulouse 3, CNRS, UMR 5100, Lab Microbiol & Genet Mol, F-31062 Toulouse 9, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Claverys, JP (corresponding author), Univ Toulouse 3, CNRS, UMR 5100, Lab Microbiol & Genet Mol, 118 Route Narbonne, F-31062 Toulouse 9, France.	claverys@ibcg.biotoul.fr	Attaiech, Laetitia/M-6593-2014	Attaiech, Laetitia/0000-0002-6188-1839; Prudhomme, Marc/0000-0001-8144-0777				Beaber JW, 2004, NATURE, V427, P72, DOI 10.1038/nature02241; Cashel M., 1996, ESCHERICHIA COLI SAL, P1458; Claverys JP, 2000, MOL MICROBIOL, V35, P251, DOI 10.1046/j.1365-2958.2000.01718.x; Claverys JP, 2002, FRONT BIOSCI-LANDMRK, V7, pD1798, DOI 10.2741/claverys; CLAVERYS JP, 2006, ANN REV MICROBIOL; Dagkessamanskaia A, 2004, MOL MICROBIOL, V51, P1071, DOI 10.1111/j.1365-2958.2003.03892.x; Drlica K, 1997, MICROBIOL MOL BIOL R, V61, P377, DOI 10.1128/.61.3.377-392.1997; Griffith F, 1928, J HYG-CAMBRIDGE, V27, P113, DOI 10.1017/S0022172400031879; Grove DE, 2005, J BIOL CHEM, V280, P11067, DOI 10.1074/jbc.M414057200; Guiral S, 2005, P NATL ACAD SCI USA, V102, P8710, DOI 10.1073/pnas.0500879102; Havarstein LS, 2006, MOL MICROBIOL, V59, P1297, DOI 10.1111/j.1365-2958.2005.05021.x; KOWALCZYKOWSKI SC, 1991, ANNU REV BIOPHYS BIO, V20, P539, DOI 10.1146/annurev.bb.20.060191.002543; Levine C, 1998, BBA-GENE STRUCT EXPR, V1400, P29, DOI 10.1016/S0167-4781(98)00126-2; LITTLE JW, 1984, P NATL ACAD SCI-BIOL, V81, P1375, DOI 10.1073/pnas.81.5.1375; Luo P, 2003, J BACTERIOL, V185, P349, DOI 10.1128/JB.185.1.349-358.2003; MARTIN B, 1995, MOL MICROBIOL, V15, P367, DOI 10.1111/j.1365-2958.1995.tb02250.x; Martin B, 2000, MOL MICROBIOL, V38, P867, DOI 10.1046/j.1365-2958.2000.02187.x; Miller C, 2004, SCIENCE, V305, P1629, DOI 10.1126/science.1101630; Mortier-Barriere I, 1998, MOL MICROBIOL, V27, P159, DOI 10.1046/j.1365-2958.1998.00668.x; Pestova EV, 1996, MOL MICROBIOL, V21, P853, DOI 10.1046/j.1365-2958.1996.501417.x; Peterson SN, 2004, MOL MICROBIOL, V51, P1051, DOI 10.1046/j.1365-2958.2003.03907.x; PHILLIPS I, 1987, J ANTIMICROB CHEMOTH, V20, P631, DOI 10.1093/jac/20.5.631; SMITH JM, 1991, NATURE, V349, P29, DOI 10.1038/349029a0; VANBOGELEN RA, 1990, P NATL ACAD SCI USA, V87, P5589, DOI 10.1073/pnas.87.15.5589	24	307	328	7	73	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 7	2006	313	5783					89	92		10.1126/science.1127912	http://dx.doi.org/10.1126/science.1127912			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061DA	16825569				2022-12-28	WOS:000238850200037
J	Stern, DL				Stern, DL			Morphing into shape	SCIENCE			English	Editorial Material							INSECTS; GENES		Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA	Princeton University	Stern, DL (corresponding author), Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA.	dstern@princeton.edu		Stern, David/0000-0002-1847-6483	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063622] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM063622, R01 GM063622-01] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abzhanov A, 2004, SCIENCE, V305, P1462, DOI 10.1126/science.1098095; Crickmore MA, 2006, SCIENCE, V313, P63, DOI 10.1126/science.1128650; Huxley J., 1932, PROBLEMS RELATIVE GR; LEWIS EB, 1963, AM ZOOL, V3, P33; Nijhout H, 2003, DEV BIOL, V261, P1, DOI 10.1016/S0012-1606(03)00276-8; Thompson D.W, 1917, GROWTH FORM; Truman JW, 2006, SCIENCE, V312, P1385, DOI 10.1126/science.1123652; Weatherbee SD, 1998, GENE DEV, V12, P1474, DOI 10.1101/gad.12.10.1474	8	4	4	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 7	2006	313	5783					50	51		10.1126/science.1130785	http://dx.doi.org/10.1126/science.1130785			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061DA	16825555	Green Accepted			2022-12-28	WOS:000238850200021
J	Chan, DC				Chan, David C.			Mitochondria: Dynamic organelles in disease, aging, and development	CELL			English	Review							DOMINANT OPTIC ATROPHY; RESPIRATORY-CHAIN FUNCTION; SUBSTANTIA-NIGRA NEURONS; HUMAN SKELETAL-MUSCLE; CYTOCHROME-C RELEASE; AXONAL-TRANSPORT; DNA MUTATIONS; HUMAN-CELLS; DEGENERATIVE DISEASES; MISSENSE MUTATION	Mitochondria are the primary energy-generating system in most eukaryotic cells. Additionally, they participate in intermediary metabolism, calcium signaling, and apoptosis. Given these well-established functions, it might be expected that mitochondrial dysfunction would give rise to a simple and predictable set of defects in all tissues. However, mitochondrial dysfunction has pleiotropic effects in multicellular organisms. Clearly, much about the basic biology of mitochondria remains to be understood. Here we discuss recent work that suggests that the dynamics (fusion and fission) of these organelles is important in development and disease.	CALTECH, Div Biol, Pasadena, CA 91125 USA	California Institute of Technology	Chan, DC (corresponding author), CALTECH, Div Biol, Pasadena, CA 91125 USA.	dchan@caltech.edu	Chan, Doris/O-1227-2014	Chan, Doris/0000-0002-4990-986X				Alexander C, 2000, NAT GENET, V26, P211, DOI 10.1038/79944; Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769; Bleazard W, 1999, NAT CELL BIOL, V1, P298, DOI 10.1038/13014; BOFFOLI D, 1994, BBA-MOL BASIS DIS, V1226, P73, DOI 10.1016/0925-4439(94)90061-2; Breckenridge DG, 2003, J CELL BIOL, V160, P1115, DOI 10.1083/jcb.200212059; Brierley EJ, 1997, MOL CELL BIOCHEM, V174, P325, DOI 10.1023/A:1006847319162; Carelli V, 2004, PROG RETIN EYE RES, V23, P53, DOI 10.1016/j.preteyeres.2003.10.003; Chen HC, 2005, J BIOL CHEM, V280, P26185, DOI 10.1074/jbc.M503062200; Chen HC, 2003, J CELL BIOL, V160, P189, DOI 10.1083/jcb.200211046; Chomyn A, 2003, BIOCHEM BIOPH RES CO, V304, P519, DOI 10.1016/S0006-291X(03)00625-9; Cipolat S, 2004, P NATL ACAD SCI USA, V101, P15927, DOI 10.1073/pnas.0407043101; COOPER JM, 1992, J NEUROL SCI, V113, P91, DOI 10.1016/0022-510X(92)90270-U; D'Aurelio M, 2004, HUM MOL GENET, V13, P3171, DOI 10.1093/hmg/ddh326; Delettre C, 2000, NAT GENET, V26, P207, DOI 10.1038/79936; Delettre C, 2002, MOL GENET METAB, V75, P97, DOI 10.1006/mgme.2001.3278; DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567; Dimauro S, 2005, ANN MED, V37, P222, DOI 10.1080/07853890510007368; Frank S, 2001, DEV CELL, V1, P515, DOI 10.1016/S1534-5807(01)00055-7; Fransson A, 2003, J BIOL CHEM, V278, P6495, DOI 10.1074/jbc.M208609200; Frederick RL, 2004, J CELL BIOL, V167, P87, DOI 10.1083/jcb.200405100; Garrido N, 2003, MOL BIOL CELL, V14, P1583, DOI 10.1091/mbc.E02-07-0399; Griffin EE, 2005, J CELL BIOL, V170, P237, DOI 10.1083/jcb.200503148; Griparic L, 2004, J BIOL CHEM, V279, P18792, DOI 10.1074/jbc.M400920200; Guo XF, 2005, NEURON, V47, P379, DOI 10.1016/j.neuron.2005.06.027; HARMAN D, 1972, J AM GERIATR SOC, V20, P145, DOI 10.1111/j.1532-5415.1972.tb00787.x; HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298; HAYASHI JI, 1991, P NATL ACAD SCI USA, V88, P10614, DOI 10.1073/pnas.88.23.10614; Hermann GJ, 1998, J CELL BIOL, V143, P359, DOI 10.1083/jcb.143.2.359; HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0; Iborra FJ, 2004, BMC BIOL, V2, DOI 10.1186/1741-7007-2-9; Ingerman E, 2005, J CELL BIOL, V170, P1021, DOI 10.1083/jcb.200506078; Inoue K, 2000, NAT GENET, V26, P176, DOI 10.1038/82826; Jagasia R, 2005, NATURE, V433, P754, DOI 10.1038/nature03316; Kamei S, 2005, INVEST OPHTH VIS SCI, V46, P4288, DOI 10.1167/iovs.03-1407; Kasahara A, 2006, HUM MOL GENET, V15, P871, DOI 10.1093/hmg/ddl005; Kim JY, 2005, NEUROLOGY, V64, P966, DOI 10.1212/01.WNL.0000157282.76715.B1; Kirkwood TBL, 2005, CELL, V120, P437, DOI 10.1016/j.cell.2005.01.027; Koshiba T, 2004, SCIENCE, V305, P858, DOI 10.1126/science.1099793; Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778; Kraytsberg Y, 2004, SCIENCE, V304, P981, DOI 10.1126/science.1096342; Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125; Labrousse AM, 1999, MOL CELL, V4, P815, DOI 10.1016/S1097-2765(00)80391-3; Larsen NB, 2005, MITOCHONDRION, V5, P89, DOI 10.1016/j.mito.2005.02.002; Larsson NG, 1998, NAT GENET, V18, P231, DOI 10.1038/ng0398-231; Lee YJ, 2004, MOL BIOL CELL, V15, P5001, DOI 10.1091/mbc.E04-04-0294; Legros F, 2004, J CELL SCI, V117, P2653, DOI 10.1242/jcs.01134; Legros F, 2002, MOL BIOL CELL, V13, P4343, DOI 10.1091/mbc.E02-06-0330; Li Z, 2004, CELL, V119, P873, DOI 10.1016/j.cell.2004.11.003; LINNANE AW, 1989, LANCET, V1, P642, DOI 10.1016/S0140-6736(89)92145-4; Lodi R, 2004, ANN NEUROL, V56, P719, DOI 10.1002/ana.20278; Lowell BB, 2005, SCIENCE, V307, P384, DOI 10.1126/science.1104343; Maassen JA, 2004, DIABETES, V53, pS103, DOI 10.2337/diabetes.53.2007.S103; Maechler P, 2001, NATURE, V414, P807, DOI 10.1038/414807a; Mattenberger Y, 2003, FEBS LETT, V538, P53, DOI 10.1016/S0014-5793(03)00124-8; Michikawa Y, 1999, SCIENCE, V286, P774, DOI 10.1126/science.286.5440.774; Mirabella M, 2000, BRAIN, V123, P93, DOI 10.1093/brain/123.1.93; MORRIS RL, 1995, J CELL BIOL, V131, P1315, DOI 10.1083/jcb.131.5.1315; Mozdy AD, 2000, J CELL BIOL, V151, P367, DOI 10.1083/jcb.151.2.367; Nakada K, 2001, NAT MED, V7, P934, DOI 10.1038/90976; Niemann A, 2005, J CELL BIOL, V170, P1067, DOI 10.1083/jcb.200507087; Okamoto K, 2005, ANNU REV GENET, V39, P503, DOI 10.1146/annurev.genet.38.072902.093019; Olichon A, 2003, J BIOL CHEM, V278, P7743, DOI 10.1074/jbc.C200677200; Ono T, 2001, NAT GENET, V28, P272, DOI 10.1038/90116; Payne M, 2004, AM J OPHTHALMOL, V138, P749, DOI 10.1016/j.ajo.2004.06.011; Perfettini JL, 2005, TRENDS CELL BIOL, V15, P179, DOI 10.1016/j.tcb.2005.02.005; Praefcke GJK, 2004, NAT REV MOL CELL BIO, V5, P133, DOI 10.1038/nrm1313; RICHTER C, 1988, P NATL ACAD SCI USA, V85, P6465, DOI 10.1073/pnas.85.17.6465; Schriner SE, 2005, SCIENCE, V308, P1909, DOI 10.1126/science.1106653; Sesaki H, 1999, J CELL BIOL, V147, P699, DOI 10.1083/jcb.147.4.699; Shoubridge E A, 2000, Hum Reprod, V15 Suppl 2, P229; Silva JP, 2000, NAT GENET, V26, P336, DOI 10.1038/81649; Skulachev VP, 2001, TRENDS BIOCHEM SCI, V26, P23, DOI 10.1016/S0968-0004(00)01735-7; Sligh JE, 2000, P NATL ACAD SCI USA, V97, P14461, DOI 10.1073/pnas.250491597; Smirnova E, 2001, MOL BIOL CELL, V12, P2245, DOI 10.1091/mbc.12.8.2245; Stowers RS, 2002, NEURON, V36, P1063, DOI 10.1016/S0896-6273(02)01094-2; Sugioka R, 2004, J BIOL CHEM, V279, P52726, DOI 10.1074/jbc.M408910200; Tieu Q, 2002, J CELL BIOL, V158, P445, DOI 10.1083/jcb.200205031; Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517; TROUNCE I, 1989, LANCET, V1, P637, DOI 10.1016/S0140-6736(89)92143-0; Tyynismaa H, 2005, P NATL ACAD SCI USA, V102, P17687, DOI 10.1073/pnas.0505551102; Verstreken P, 2005, NEURON, V47, P365, DOI 10.1016/j.neuron.2005.06.018; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231; Wilson FH, 2004, SCIENCE, V306, P1190, DOI 10.1126/science.1102521; YONEDA M, 1994, MOL CELL BIOL, V14, P2699, DOI 10.1128/MCB.14.4.2699; Youle RJ, 2005, NAT REV MOL CELL BIO, V6, P657, DOI 10.1038/nrm1697; Zuchner S, 2004, NAT GENET, V36, P449, DOI 10.1038/ng1341; Zuchner S, 2006, ANN NEUROL, V59, P276, DOI 10.1002/ana.20797; Zuchner S, 2005, J MOL MED-JMM, V83, P935, DOI 10.1007/s00109-005-0694-9	89	1448	1508	6	363	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUN 30	2006	125	7					1241	1252		10.1016/j.cell.2006.06.010	http://dx.doi.org/10.1016/j.cell.2006.06.010			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	064QP	16814712	Bronze			2022-12-28	WOS:000239104500009
J	Schwartz, MA; Horwitz, AR				Schwartz, Martin A.; Horwitz, Alan Rick			Integrating adhesion, protrusion, and contraction during cell migration	CELL			English	Editorial Material							NERVE GROWTH; RHO; DYNAMICS; GTPASES	Cell migration is fastest when the strength of the adhesion between the cell and the substrate is neither too strong nor too weak. In this issue of Cell, Gupton and Waterman-Storer (2006) reveal how adhesion and cytoskeletal dynamics are integrated to optimize migration speed.	Univ Virginia, Sch Med, Dept Microbiol, Charlottesville, VA 22908 USA; Univ Virginia, Sch Med, Dept Biomed Engn, Charlottesville, VA 22908 USA; Univ Virginia, Sch Med, Robert M Berne Cardiovasc Res Ctr, Charlottesville, VA 22908 USA; Univ Virginia, Sch Med, Dept Cell Biol, Charlottesville, VA 22908 USA	University of Virginia; University of Virginia; University of Virginia; University of Virginia	Schwartz, MA (corresponding author), Univ Virginia, Sch Med, Dept Microbiol, Charlottesville, VA 22908 USA.	maschwartz@virginia.edu		schwartz, martin/0000-0002-2071-1243				Burridge K, 1996, ANNU REV CELL DEV BI, V12, P463, DOI 10.1146/annurev.cellbio.12.1.463; Cox EA, 2001, MOL BIOL CELL, V12, P265, DOI 10.1091/mbc.12.2.265; Geiger B, 2001, CURR OPIN CELL BIOL, V13, P584, DOI 10.1016/S0955-0674(00)00255-6; GUPTON SL, 2006, CELL; Hall A, 2005, BIOCHEM SOC T, V33, P891, DOI 10.1042/BST0330891; Jay DG, 2000, J NEUROBIOL, V44, P114, DOI 10.1002/1097-4695(200008)44:2<114::AID-NEU3>3.0.CO;2-8; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; MITCHISON T, 1988, NEURON, V1, P761, DOI 10.1016/0896-6273(88)90124-9; Nayal A, 2006, J CELL BIOL, V173, P587, DOI 10.1083/jcb.200509075; Palecek SP, 1997, NATURE, V385, P537, DOI 10.1038/385537a0; Ren XD, 1999, EMBO J, V18, P578, DOI 10.1093/emboj/18.3.578	11	73	77	0	12	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUN 30	2006	125	7					1223	1225		10.1016/j.cell.2006.06.015	http://dx.doi.org/10.1016/j.cell.2006.06.015			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	064QP	16814706	Bronze			2022-12-28	WOS:000239104500003
J	Al-Shahi, R; White, PM; Davenport, RJ; Lindsay, KW				Al-Shahi, Rustam; White, Philip M.; Davenport, Richard J.; Lindsay, Kenneth W.			Subarachnoid haemorrhage	BMJ-BRITISH MEDICAL JOURNAL			English	Review							INTRACRANIAL ANEURYSMS; COMPUTED-TOMOGRAPHY; HEADACHE; HYPERTENSION; SENSITIVITY; MORBIDITY; DIAGNOSIS; RUPTURE; SURGERY; RISK		Univ Edinburgh, Western Gen Hosp, Div Clin Neurosci, Edinburgh EH4 2XU, Midlothian, Scotland; So Gen Hosp, Inst Neurol Sci, Glasgow G51 4TF, Lanark, Scotland	University of Edinburgh; University of Glasgow	Al-Shahi, R (corresponding author), Univ Edinburgh, Western Gen Hosp, Div Clin Neurosci, Edinburgh EH4 2XU, Midlothian, Scotland.	rustam.al-shahi@ed.ac.uk		White, Philip/0000-0001-6007-6013; Al-Shahi Salman, Rustam/0000-0002-2108-9222	MRC [G108/613] Funding Source: UKRI; Medical Research Council [G108/613] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Amaragiri SV, 2000, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD001484; Baltsavias GS, 2000, NEUROSURGERY, V47, P1320, DOI 10.1097/00006123-200012000-00010; Beetham R, 2003, ANN CLIN BIOCHEM, V40, P481; Bromberg JEC, 1996, STROKE, V27, P7, DOI 10.1161/01.STR.27.1.7; DAVENPORT RJ, 2005, PRACT NEUROL, V5, P132, DOI DOI 10.1111/J.1474-7766.2005.00300.X; de Gans K, 2002, NEUROSURGERY, V50, P336, DOI 10.1097/00006123-200202000-00018; DRAKE CG, 1988, J NEUROSURG, V68, P985; Feigin VL, 2005, STROKE, V36, P2773, DOI 10.1161/01.STR.0000190838.02954.e8; Feigin VL, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004583.pub2; Hackett ML, 2000, NEUROLOGY, V55, P658, DOI 10.1212/WNL.55.5.658; Harbour R, 2001, BRIT MED J, V323, P334, DOI 10.1136/bmj.323.7308.334; HEISKANEN O, 1988, ACTA NEUROCHIR, V90, P81, DOI 10.1007/BF01560559; Hillman J, 2002, J NEUROSURG, V97, P771, DOI 10.3171/jns.2002.97.4.0771; Hop JW, 1997, STROKE, V28, P660, DOI 10.1161/01.STR.28.3.660; Huang J, 2002, NEUROSURGERY, V51, P1101, DOI 10.1097/00006123-200211000-00001; Lacut K, 2005, NEUROLOGY, V65, P865, DOI 10.1212/01.wnl.0000176073.80532.a2; Linn FHH, 2005, J NEUROL NEUROSUR PS, V76, P1452, DOI 10.1136/jnnp.2004.051318; Linn FHH, 1996, STROKE, V27, P625, DOI 10.1161/01.STR.27.4.625; LINN FHH, 1994, LANCET, V344, P590, DOI 10.1016/S0140-6736(94)91970-4; Linn FHH, 1998, J NEUROL NEUROSUR PS, V65, P791, DOI 10.1136/jnnp.65.5.791; LOCKSLEY HB, 1966, J NEUROSURG, V25, P321, DOI 10.3171/jns.1966.25.3.0321; Mees SMD, 2003, NEUROLOGY, V61, P1132, DOI 10.1212/01.WNL.0000090466.68866.02; Molyneux AJ, 2005, LANCET, V366, P809, DOI 10.1016/S0140-6736(05)67214-5; Morgenstern LB, 2001, HEADACHE, V41, P537, DOI 10.1046/j.1526-4610.2001.041006537.x; Naidech AM, 2005, CIRCULATION, V112, P2851, DOI 10.1161/CIRCULATIONAHA.105.533620; Oliveira J, 2001, NEUROLOGY, V56, P1299, DOI 10.1212/WNL.56.10.1299; Polmear A, 2003, CEPHALALGIA, V23, P935, DOI 10.1046/j.1468-2982.2003.00596.x; Rinkel GJ, 2004, COCHRANE DB SYST REV, V4; Rinkel GJE, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000277.pub2; Roos YB, 2003, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001245, DOI 10.1002/14651858.CD001245]; Sames TA, 1996, ACAD EMERG MED, V3, P16, DOI 10.1111/j.1553-2712.1996.tb03296.x; Silberstein SD, 2004, CEPHALALGIA, V24, P2, DOI 10.1111/j.1468-2982.2004.00892.x; *SOC BRIT NEUR SUR, 2006, NAT COMP OUTC STUD S; Teasdale GM, 2005, BRAIN, V128, P1677, DOI 10.1093/brain/awh497; Tomer JC, 1981, ANEURYSMAL SUBARACHN, P249; van den Bergh WM, 2005, STROKE, V36, P1011, DOI 10.1161/01.STR.0000160801.96998.57; van den Bergh WM, 2003, NEUROSURGERY, V52, P276, DOI 10.1227/01.NEU.0000043984.42487.0E; van der Schaaf I, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003085.pub2; van Gelder JM, 2003, NEUROSURGERY, V53, P597, DOI 10.1227/01.NEU.0000080060.97293.EE; van Gijn J, 2001, BRAIN, V124, P249, DOI 10.1093/brain/124.2.249; VANDERWEE N, 1995, J NEUROL NEUROSUR PS, V58, P357, DOI 10.1136/jnnp.58.3.357; VANGIJN J, 2005, PRACT NEUROL, V5, P362; Vermeij FH, 1998, STROKE, V29, P924, DOI 10.1161/01.STR.29.5.924; VERMEULEN M, 1990, J NEUROL NEUROSUR PS, V53, P365, DOI 10.1136/jnnp.53.5.365; WARLOW CP, 2001, STROKE PRACTICAL GUI, P376; WARLOW CP, 2001, STROKE PRACTICAL GUI, P518; White PM, 2000, RADIOLOGY, V217, P361, DOI 10.1148/radiology.217.2.r00nv06361; Whitfield PC, 2001, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001697, DOI 10.1002/14651858.CD001697]; WIJDICKS EFM, 1990, CLIN NEUROL NEUROSUR, V92, P111, DOI 10.1016/0303-8467(90)90085-J; WILLIAMS A, 2004, PRACT NEUROL, V4, P174	50	65	66	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 29	2006	333	7561					235	240A		10.1136/bmj.333.7561.235	http://dx.doi.org/10.1136/bmj.333.7561.235			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	070CC	16873858	Green Submitted, Green Published			2022-12-28	WOS:000239496900021
J	Bevan, G				Bevan, Gwyn			Health policy - A third way	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							NHS		Univ London London Sch Econ & Polit Sci, Dept Operat Res, London WC2A 2AE, England	University of London; London School Economics & Political Science	Bevan, G (corresponding author), Univ London London Sch Econ & Polit Sci, Dept Operat Res, Houghton St, London WC2A 2AE, England.	R.G.Bevan@lse.ac.uk						Bevan G, 2006, BMJ-BRIT MED J, V332, P419, DOI 10.1136/bmj.332.7538.419; BEVAN G, IN PRESS PUBLIC ADM; BEVAN G, IN PRESS NATL I EC R; *DEP HLTH, 2005, COMM PAT LED NHS; *DEP HLTH, 2002, SHIFT BAL POW; Ham C, 2006, BRIT MED J, V332, P131, DOI 10.1136/bmj.332.7534.131; HAM C, 2000, POLITICS NHS REFORM, P2; *SECR STAT HLTH, 1997, NEW NHS; *SECR STAT HLTH, 2002, CM5363; *SECR STAT HLTH, 2002, CM5503; *SECR STAT HLTH WA, 1989, WORK PAT; Secretary of State for Health, 2000, NHS PLAN; Tuohy C., 1999, ACCIDENTAL LOGICS DY; *UK CTR MEAS GOV A, 2006, EC TRENDS, V628, P26	14	3	3	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 29	2006	333	7561					252	253		10.1136/bmj.333.7561.252	http://dx.doi.org/10.1136/bmj.333.7561.252			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	070CC	16873864	Green Published			2022-12-28	WOS:000239496900025
J	Savarese, F; Grosschedl, R				Savarese, Fabio; Grosschedl, Rudolf			Blurring cis and trans in gene regulation	CELL			English	Editorial Material							MECHANISM; MOUSE		Max Planck Inst Immunobiol, D-79108 Freiburg, Germany	Max Planck Society	Grosschedl, R (corresponding author), Max Planck Inst Immunobiol, D-79108 Freiburg, Germany.	grosschedl@immunbio.mpg.de						Chakalova L, 2005, NAT REV GENET, V6, P669, DOI 10.1038/nrg1673; Duncan IW, 2002, ANNU REV GENET, V36, P521, DOI 10.1146/annurev.genet.36.060402.100441; Eggan E, 2004, NATURE, V428, P44, DOI 10.1038/nature02375; Lewcock JW, 2004, P NATL ACAD SCI USA, V101, P1069, DOI 10.1073/pnas.0307986100; Ling JQ, 2006, SCIENCE, V312, P269, DOI 10.1126/science.1123191; Mostoslavsky R, 2004, CELL, V118, P539, DOI 10.1016/j.cell.2004.08.023; MULLER HP, 1989, CELL, V58, P767, DOI 10.1016/0092-8674(89)90110-4; Rothman A, 2005, MOL CELL NEUROSCI, V28, P535, DOI 10.1016/j.mcn.2004.11.006; Serizawa S, 2003, SCIENCE, V302, P2088, DOI 10.1126/science.1089122; Shykind BM, 2005, HUM MOL GENET, V14, pR33, DOI 10.1093/hmg/ddi105; Spilianakis CG, 2005, NATURE, V435, P637, DOI 10.1038/nature03574	11	10	10	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 28	2006	126	2					248	250		10.1016/j.cell.2006.07.008	http://dx.doi.org/10.1016/j.cell.2006.07.008			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	070VD	16873057	Bronze			2022-12-28	WOS:000239552600011
J	Binder, HJ				Binder, Henry J.			Causes of chronic diarrhea	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Yale Univ, Sch Med, New Haven, CT 06510 USA	Yale University	Binder, HJ (corresponding author), Yale Univ, Sch Med, 333 Cedar St, New Haven, CT 06510 USA.							BINDER HJ, 2004, HARRISONS PRINCIPLES, P1763; Hogenauer C, 2001, NEW ENGL J MED, V344, P270, DOI 10.1056/NEJM200101253440405; SCHILLER LR, IN PRESS SLEISENGER	3	17	26	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 20	2006	355	3					236	239		10.1056/NEJMp068124	http://dx.doi.org/10.1056/NEJMp068124			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	064NY	16855263				2022-12-28	WOS:000239097600004
J	Singh, SC; Harding, AJ; Kent, GM; Sinha, MC; Combier, V; Bazin, S; Tong, CH; Pye, JW; Barton, PJ; Hobbs, RW; White, RS; Orcutt, JA				Singh, S. C.; Harding, A. J.; Kent, G. M.; Sinha, M. C.; Combier, V.; Bazin, S.; Tong, C. H.; Pye, J. W.; Barton, P. J.; Hobbs, R. W.; White, R. S.; Orcutt, J. A.			Seismic reflection images of the Moho underlying melt sills at the East Pacific Rise	NATURE			English	Article							YOUNG OCEANIC-CRUST; MAGMA CHAMBER; SPREADING CENTER; MIDOCEAN RIDGES; SUPPLY BENEATH; DISCONTINUITIES; PROFILES; CREST; MIGRATION	The determination of melt distribution in the crust and the nature of the crust - mantle boundary ( the 'Moho') is fundamental to the understanding of crustal accretion processes at oceanic spreading centres. Upper-crustal magma chambers have been imaged beneath fast- and intermediate-spreading centres(1-4) but it has been difficult to image structures beneath these magma sills. Using three-dimensional seismic reflection images, here we report the presence of Moho reflections beneath a crustal magma chamber at the 9 degrees 03' N overlapping spreading centre, East Pacific Rise. Our observations highlight the formation of the Moho at zero-aged crust. Over a distance of less than 7 km along the ridge crest, a rapid increase in two-way travel time of seismic waves between the magma chamber and Moho reflections is observed, which we suggest is due to a melt anomaly in the lower crust. The amplitude versus offset variation of reflections from the magma chamber shows a coincident region of higher melt fraction overlying this anomalous region, supporting the conclusion of additional melt at depth.	IPG Paris, Lab Geosci Marine, F-75252 Paris 05, France; Univ Cambridge, Bullard Labs, Cambridge CB3 0EZ, England; Univ Calif San Diego, Cecil H & Ida M Green Inst Geophys & Planetary Ph, La Jolla, CA 92093 USA; Univ Southampton, Sch Ocean & Earth Sci, Southampton SO14 3ZH, Hants, England; Univ Durham, Dept Earth Sci, Durham DH1 3LE, England	UDICE-French Research Universities; Universite Paris Cite; University of Cambridge; University of California System; University of California San Diego; NERC National Oceanography Centre; University of Southampton; Durham University	Singh, SC (corresponding author), IPG Paris, Lab Geosci Marine, F-75252 Paris 05, France.	singh@ipgp.jussieu.fr	Bazin, Sara/AAL-3694-2020; Hobbs, Richard/F-1054-2013; Bazin, Sara/A-5654-2011; White, Robert/B-8453-2015	Bazin, Sara/0000-0001-6478-7760; Hobbs, Richard/0000-0001-5131-9239; Tong, Vincent/0000-0002-2597-5934; Orcutt, John/0000-0001-5508-0050				Barth GA, 1996, J GEOPHYS RES-SOL EA, V101, P17951, DOI 10.1029/96JB00814; Bazin S, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL015137; Boudier F, 1996, EARTH PLANET SC LETT, V144, P239, DOI 10.1016/0012-821X(96)00167-7; Canales JP, 2003, GEOPHYS J INT, V152, P766, DOI 10.1046/j.1365-246X.2003.01885.x; CARBOTTE S, 1992, J GEOPHYS RES-SOL EA, V97, P6959, DOI 10.1029/91JB03065; Carbotte SM, 2004, NATURE, V429, P743, DOI 10.1038/nature02652; COLLIER J, 1990, NATURE, V346, P646, DOI 10.1038/346646a0; Crawford WC, 1999, J GEOPHYS RES-SOL EA, V104, P2923, DOI 10.1029/1998JB900087; Crawford WC, 2002, EARTH PLANET SC LETT, V203, P117, DOI 10.1016/S0012-821X(02)00831-2; DETRICK RS, 1987, NATURE, V326, P35, DOI 10.1038/326035a0; Dunn RA, 1997, NATURE, V388, P259, DOI 10.1038/40831; Dunn RA, 2001, SCIENCE, V291, P1955, DOI 10.1126/science.1057683; Dunn RA, 2000, J GEOPHYS RES-SOL EA, V105, P23537, DOI 10.1029/2000JB900210; GARMANY J, 1989, NATURE, V340, P628, DOI 10.1038/340628a0; HARDING AJ, 1989, J GEOPHYS RES-SOLID, V94, P12163, DOI 10.1029/JB094iB09p12163; HAYMON RM, 1991, EARTH PLANET SC LETT, V104, P513, DOI 10.1016/0012-821X(91)90226-8; Kelemen PB, 1997, EARTH PLANET SC LETT, V146, P475, DOI 10.1016/S0012-821X(96)00235-X; Kent GM, 2000, NATURE, V406, P614, DOI 10.1038/35020543; KENT GM, 1993, J GEOPHYS RES-SOL EA, V98, P13945, DOI 10.1029/93JB00705; Maclennan J, 2004, GEOCHEM GEOPHY GEOSY, V5, DOI 10.1029/2003GC000605; MUTTER JC, 1988, NATURE, V336, P156, DOI 10.1038/336156a0; Nicolas A, 1989, STRUCTURE OPHIOLITES; Singh SC, 1999, GEOLOGY, V27, P219, DOI 10.1130/0091-7613(1999)027<0219:SEFAHL>2.3.CO;2; Singh SC, 1998, NATURE, V394, P874, DOI 10.1038/29740; Taylor MAJ, 2002, GEOPHYS J INT, V149, P15, DOI 10.1046/j.1365-246X.2002.01577.x; TOOMEY DR, 1990, NATURE, V347, P639, DOI 10.1038/347639a0; VERA EE, 1990, J GEOPHYS RES-SOLID, V95, P15529, DOI 10.1029/JB095iB10p15529; Wilcock WSD, 1995, J GEOPHYS RES-SOL EA, V100, P24147, DOI 10.1029/95JB02280; WRIGHT DJ, 1995, J GEOPHYS RES-SOL EA, V100, P6097, DOI 10.1029/94JB02876; Yilmaz O., 2001, SEISMIC DATA ANAL, Vsecond	30	53	54	1	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 20	2006	442	7100					287	290		10.1038/nature04939	http://dx.doi.org/10.1038/nature04939			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064WT	16855587				2022-12-28	WOS:000239122100035
J	Berkowitz, RI; Fujioka, K; Daniels, SR; Hoppin, AG; Owen, S; Perry, AC; Sothern, MS; Renz, CL; Pirner, MA; Walch, JK; Jasinsky, O; Hewkin, AC; Blakesley, VA				Berkowitz, Robert I.; Fujioka, Ken; Daniels, Stephen R.; Hoppin, Alison G.; Owen, Stanford; Perry, Arlette C.; Sothern, Melinda S.; Renz, Cheryl L.; Pirner, Mark A.; Walch, Julia K.; Jasinsky, Olga; Hewkin, Ann C.; Blakesley, Vicky A.		Sibutramine Adolescent Study Grp	Effects of sibutramine treatment in obese adolescents - A randomized trial	ANNALS OF INTERNAL MEDICINE			English	Article							TYPE-2 DIABETES-MELLITUS; FOLLOW-UP; WEIGHT-REDUCTION; US CHILDREN; LIFE-STYLE; OVERWEIGHT; CHILDHOOD; MAINTENANCE; PREVENTION; PREVALENCE	Background: Increased prevalence of adolescent obesity requires effective treatment options beyond behavior therapy. Objective: To see whether sibutramine reduced weight more than placebo in obese adolescents who were receiving a behavior therapy program. Design: 12-month, 3:1 randomized, double-blind trial conducted from July 2000 to February 2002. Setting: 33 U.S. outpatient clinics. Participants: 498 participants 12 to 16 years of age with a body mass index (BMI) that was at least 2 units more than the U.S. weighted mean of the 95th percentile based on age and sex, to the upper limit of 44 kg/m(2). Interventions: Site-specific behavior therapy plus 10 mg of sibutramine or placebo. Blinded study medication dose was uptitrated to 15 mg or placebo at month 6 if initial BMI was not reduced by 10%. Measurements: Body mass index, waist circumference, body weight, fasting lipid and glycemic variables, safety, and tolerability. Results: Seventy-six percent of patients in the sibutramine group and 62% of patients in the placebo group completed the study. The estimated mean treatment group difference at month 12 (linear mixed-effects model) favored sibutramine for change from baseline in BMI (-2.9 kg/m(2) [95% Cl, -3.5 to -2.2 kg/m(2)]) and body weight (-8.4 kg [Cl, -9.7 to -7.2 kg]) (P < 0.001 for both). The sibutramine group had greater improvements in triglyceride levels, high-density lipoprotein cholesterol levels, insulin levels, and insulin sensitivity (P <= 0.001 for all). The rate of tachycardia was greater with sibutramine vs. placebo (12.5% vs. 6.2%; difference, 6.3 percentage points [Cl, 1.0 to 11.7 percentage points]) but did not lead to increased withdrawal (2.4% vs. 1.5%; difference, 0.9 percentage point [Cl, -1.7 to 3.5 percentage points]). Limitations: The 1-year study duration precluded assessment of long-term weight maintenance and putative health benefits and harms, and 24% and 38% of the sibutramine and placebo groups, respectively, did not complete follow-up. Conclusions: Sibutramine added to a behavior therapy program reduced BMI and body weight more than placebo and improved the profile of several metabolic risk factors in obese adolescents.	Childrens Hosp Philadelphia, Behav Hlth Unit, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Philadelphia, PA 19104 USA; Penn Scripps Clin, San Diego, CA USA; Univ Cincinnati, Coll Med, Cincinnati, OH 45221 USA; Childrens Hosp, Med Ctr, Cincinnati, OH 45229 USA; Massachusetts Gen Hosp, Boston, MA 02114 USA; Ctr Hlth Management, Gulfport, MS USA; Univ Miami, Sch Educ, Coral Gables, FL 33124 USA; Louisiana State Univ, Hlth Sci Ctr, New Orleans, LA 70112 USA; Pennington Biomed Res Ctr, New Orleans, LA USA; Abbott Labs, Abbott Pk, IL 60064 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; Harvard University; Massachusetts General Hospital; University of Miami; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; Abbott Laboratories	Berkowitz, RI (corresponding author), Childrens Hosp Philadelphia, Behav Hlth Unit, 3440 Market St,Suite 410, Philadelphia, PA 19104 USA.	berkowitz@email.chop.edu		Renz, Cheryl/0000-0002-7051-1653				*ABB LAB, 2005, MER SIB HYDR MON PAC; Apfelbaum M, 1999, AM J MED, V106, P179, DOI 10.1016/S0002-9343(98)00411-2; Berkowitz RI, 2003, JAMA-J AM MED ASSOC, V289, P1805, DOI 10.1001/jama.289.14.1805; Bray GA, 1999, OBES RES, V7, P189, DOI 10.1002/j.1550-8528.1999.tb00701.x; DATTILO AM, 1992, AM J CLIN NUTR, V56, P320, DOI 10.1093/ajcn/56.2.320; Ehtisham S, 2000, DIABETIC MED, V17, P867, DOI 10.1046/j.1464-5491.2000.00409.x; EPSTEIN LH, 1990, JAMA-J AM MED ASSOC, V264, P2519, DOI 10.1001/jama.264.19.2519; EPSTEIN LH, 1985, PEDIATR CLIN N AM, V32, P363; Flegal KM, 1998, INT J OBESITY, V22, P39, DOI 10.1038/sj.ijo.0800541; Freedman DS, 1999, PEDIATRICS, V103, P1175, DOI 10.1542/peds.103.6.1175; Fujioka K, 2002, OBES RES, V10, p116S, DOI 10.1038/oby.2002.204; Gunnell DJ, 1998, AM J CLIN NUTR, V67, P1111, DOI 10.1093/ajcn/67.6.1111; Guo, 2002, VITAL HLTH STAT, V11, DOI DOI 10.1016/J.BBRC.2015.06.114; HEYTING A, 1992, STAT MED, V11, P2043, DOI 10.1002/sim.4780111603; James WPT, 2000, LANCET, V356, P2119, DOI 10.1016/S0140-6736(00)03491-7; James WPT, 2005, EUR HEART J SUPPL, V7, pL44, DOI 10.1093/eurheartj/sui086; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; McMahon FG, 2000, ARCH INTERN MED, V160, P2185, DOI 10.1001/archinte.160.14.2185; MUST A, 1992, NEW ENGL J MED, V327, P1350, DOI 10.1056/NEJM199211053271904; NIETO FJ, 1992, AM J EPIDEMIOL, V136, P201, DOI 10.1093/oxfordjournals.aje.a116486; *NIH, 1998, NIH PUBL; Ogden CL, 2002, JAMA-J AM MED ASSOC, V288, P1728, DOI 10.1001/jama.288.14.1728; PinhasHamiel O, 1996, J PEDIATR-US, V128, P608, DOI 10.1016/S0022-3476(96)80124-7; Robinson TN, 1999, INT J OBESITY, V23, pS52, DOI 10.1038/sj.ijo.0800860; Rosenbloom AL, 1999, DIABETES CARE, V22, P345, DOI 10.2337/diacare.22.2.345; Rosner B, 1998, J PEDIATR-US, V132, P211, DOI 10.1016/S0022-3476(98)70434-2; SCHLOSSBERGER NM, 1992, J ADOLESCENT HEALTH, V13, P109, DOI 10.1016/1054-139X(92)90075-M; Smith IG, 2001, J FAM PRACTICE, V50, P505; Torgerson JS, 2004, DIABETES CARE, V27, P155, DOI 10.2337/diacare.27.1.155; TUCK ML, 1981, NEW ENGL J MED, V304, P930, DOI 10.1056/NEJM198104163041602; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801	31	155	160	0	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 18	2006	145	2					81	90		10.7326/0003-4819-145-2-200607180-00005	http://dx.doi.org/10.7326/0003-4819-145-2-200607180-00005			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	063WU	16847290				2022-12-28	WOS:000239051400001
J	Baumann, P				Baumann, Peter			Are mouse telomeres going to pot?	CELL			English	Review							DAMAGE RESPONSE; DNA-DAMAGE; END; CHROMOSOME; PROTEIN; LENGTH	Pot1 is a conserved single-stranded DNA binding protein with crucial functions in the protection of telomeres and maintenance of their length. In this issue of Cell, two papers (Hockemeyer et al., 2006; Wu et al., 2006) examine the roles of murine Pot1 homologs and describe intriguing new insights into how cells protect their chromosome ends from DNA-repair activities.	Stowers Inst Med Res, Kansas City, MO 64110 USA; Univ Kansas, Med Ctr, Dept Biochem & Mol Biol, Kansas City, KS 66160 USA	Stowers Institute for Medical Research; University of Kansas; University of Kansas Medical Center	Baumann, P (corresponding author), Stowers Inst Med Res, Kansas City, MO 64110 USA.	peb@stowers-institute.org		Baumann, Peter/0000-0003-4892-1485				Baumann P, 2001, SCIENCE, V292, P1171, DOI 10.1126/science.1060036; Bunch JT, 2005, MOL CELL BIOL, V25, P5567, DOI 10.1128/mcb.25.13.5567-5578.2005; Cech TR, 2004, CELL, V116, P273, DOI 10.1016/S0092-8674(04)00038-8; Celli GB, 2005, NAT CELL BIOL, V7, P712, DOI 10.1038/ncb1275; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; de Lange T, 2004, NAT REV MOL CELL BIO, V5, P323, DOI 10.1038/nrm1359; Downs JA, 2004, NAT REV MOL CELL BIO, V5, P367, DOI 10.1038/nrm1367; Hockemeyer D, 2005, EMBO J, V24, P2667, DOI 10.1038/sj.emboj.7600733; Karlseder J, 2004, PLOS BIOL, V2, P1150, DOI 10.1371/journal.pbio.0020240; Lei M, 2004, NAT STRUCT MOL BIOL, V11, P1223, DOI 10.1038/nsmb867; Loayza D, 2003, NATURE, V423, P1013, DOI 10.1038/nature01688; Skopp R, 1996, CHROMOSOMA, V105, P82, DOI 10.1007/s004120050162; Veldman T, 2004, CURR BIOL, V14, P2264, DOI 10.1016/j.cub.2004.12.031; Verdun RE, 2005, MOL CELL, V20, P551, DOI 10.1016/j.molcel.2005.09.024; Yang Q, 2005, MOL CELL BIOL, V25, P1070, DOI 10.1128/MCB.25.3.1070-1080.2005	15	14	14	1	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 14	2006	126	1					33	36		10.1016/j.cell.2006.06.027	http://dx.doi.org/10.1016/j.cell.2006.06.027			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	066JF	16839874	Bronze			2022-12-28	WOS:000239224800014
J	Huang, L; Quartin, A; Jones, D; Havlir, DV				Huang, Laurence; Quartin, Andew; Jones, Denis; Havlir, Diane V.			Intensive care of patients with HIV infection	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							HUMAN-IMMUNODEFICIENCY-VIRUS; IMMUNE RECONSTITUTION; ANTIRETROVIRAL THERAPY; MEDICINE ASSOCIATION; DISEASES-SOCIETY; RISK-FACTORS; HEPATITIS-B; MANAGEMENT; GUIDELINES; PATTERNS		Univ Calif San Francisco, San Francisco Gen Hosp, Div HIV AIDS, Ward 84, San Francisco, CA 94110 USA; Univ Calif San Francisco, San Francisco Gen Hosp, Div Pulm & Crit Care Med, San Francisco, CA 94110 USA; Univ Miami, Miller Sch Med, Miami Vet Affairs Med Ctr, Div Pulm & Crit Care Med, Miami, FL 33152 USA; Univ Saskatchewan, Dept Med, Regina, SK, Canada	San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; University of Miami; University of Saskatchewan	Huang, L (corresponding author), Univ Calif San Francisco, San Francisco Gen Hosp, Div HIV AIDS, Ward 84, 995 Potrero Ave, San Francisco, CA 94110 USA.	lhuang@php.ucsf.edu	Huang, Laurence/AAZ-7120-2021; Huang, Laurence/AAE-1590-2019	Huang, Laurence/0000-0003-3888-2195; 	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL072117] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI027675, U01AI027663, K24AI051982, U01AI027670] Funding Source: NIH RePORTER	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Aberg JA, 2004, CLIN INFECT DIS, V39, P609, DOI 10.1086/423390; *AC RESP DISTR SYN, 2000, NEW ENGL J MED, V342, P1301, DOI DOI 10.1056/NEJM200005043421801; Alberti A, 2005, J HEPATOL, V43, P1098, DOI 10.1016/j.jhep.2005.10.001; Alberti A, 2005, J HEPATOL, V42, P615, DOI 10.1016/j.jhep.2005.03.003; Centers of Disease Control and Prevention, 2001, MMWR Recomm Rep, V50, P1, DOI 10.1103/PhysRevE.106.055304; [Anonymous], 2005, AM J RESP CRIT CARE, V171, P388, DOI 10.1164/rccm.200405-644ST; Bulterys M, 2004, JAMA-J AM MED ASSOC, V292, P219, DOI 10.1001/jama.292.2.219; Casalino E, 2004, AIDS, V18, P1429, DOI 10.1097/01.aids.0000131301.55204.a7; Dellinger RP, 2004, CRIT CARE MED, V32, P858, DOI 10.1097/01.CCM.0000117317.18092.E4; Dellinger RP, 2004, CRIT CARE MED, V32, P1448; DELORENZO LJ, 1987, CHEST, V91, P323, DOI 10.1378/chest.91.3.323; FEENEY C, 1995, CRIT CARE MED, V23, P1680, DOI 10.1097/00003246-199510000-00012; Franzetti F, 2006, INFECTION, V34, P9, DOI 10.1007/s15010-006-5007-x; Friis-Moller N, 2003, AIDS, V17, P1179, DOI 10.1097/00002030-200305230-00010; FriisMoller N, 2004, NEW ENGL J MED, V350, P955; Goldsack NR, 2003, SEX TRANSM INFECT, V79, P337, DOI 10.1136/sti.79.4.337; Grinspoon S, 2005, NEW ENGL J MED, V352, P48, DOI 10.1056/NEJMra041811; Gupta SK, 2005, CLIN INFECT DIS, V40, P1559, DOI 10.1086/430257; Halpern SD, 2005, JAMA-J AM MED ASSOC, V294, P734, DOI 10.1001/jama.294.6.734; Heyland DK, 1996, INTENS CARE MED, V22, P1339, DOI 10.1007/BF01709548; Hirsch HH, 2004, CLIN INFECT DIS, V38, P1159, DOI 10.1086/383034; Hsue PY, 2004, CIRCULATION, V109, P316, DOI 10.1161/01.CIR.0000114520.38748.AA; Lawn SD, 2005, LANCET INFECT DIS, V5, P361, DOI 10.1016/S1473-3099(05)70140-7; LIN RY, 1993, CHEST, V104, P847, DOI 10.1378/chest.104.3.847; Mimoz O, 1998, INTENS CARE MED, V24, P1047, DOI 10.1007/s001340050714; Morris A, 2003, AIDS, V17, P73, DOI 10.1097/00002030-200301030-00010; Morris A, 2002, AM J RESP CRIT CARE, V166, P262, DOI 10.1164/rccm.2111025; Narasimhan M, 2004, CHEST, V125, P1800, DOI 10.1378/chest.125.5.1800; *NAT HIV AIDS CLIN, DOS FORM MOD REN HEP; Nickas G, 2000, ARCH INTERN MED, V160, P541, DOI 10.1001/archinte.160.4.541; Nunez M, 2005, LANCET INFECT DIS, V5, P374, DOI 10.1016/S1473-3099(05)70141-9; Panel on Antiretroviral Guidelines for Adults and Adolescents, GUID US ANT AG HIV 1; Pastores SM, 1996, AM J MED SCI, V312, P229, DOI 10.1097/00000441-199611000-00008; Petrosillo N, 2005, CURR OPIN PULM MED, V11, P231, DOI 10.1097/01.mcp.0000156993.30376.67; Rani S, 2022, SPAT INF RES, V30, P417, DOI 10.1007/s41324-022-00442-9; Roland ME, 2003, TRANSPLANTATION, V75, P425, DOI 10.1097/01.TP.0000046943.35335.18; American Medical Association, 2004, MMWR Recomm Rep, V53, P1; Tarling MM, 1997, INTENS CARE MED, V23, P256, DOI 10.1007/s001340050325; Trachiotis GD, 2003, ANN THORAC SURG, V76, P1114, DOI 10.1016/S0003-4975(02)04756-2; Vincent B, 2004, INTENS CARE MED, V30, P859, DOI 10.1007/s00134-004-2158-z; WACHTER RM, 1986, AM REV RESPIR DIS, V134, P891, DOI 10.1164/arrd.1986.134.5.891; Wislez M, 2001, AM J RESP CRIT CARE, V164, P847, DOI 10.1164/ajrccm.164.5.2007034; 2005, MMWR MORB MORTAL WKL, V54, P311	43	95	105	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 13	2006	355	2					173	181		10.1056/NEJMra050836	http://dx.doi.org/10.1056/NEJMra050836			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	062UP	16837681	Bronze			2022-12-28	WOS:000238970600009
J	Smellie, WSA				Smellie, W. Stuart A.			Cases in primary care laboratory medicine - Testing pitfalls and summary of guidance in lipid management	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							GENERAL-PRACTICE; CHOLESTEROL; PATHOLOGY; STATINS		Gen Hosp, Clin Lab, Bishop Auckland DL14 6AD, England		Smellie, WSA (corresponding author), Gen Hosp, Clin Lab, Bishop Auckland DL14 6AD, England.	info@smellie.com						Committee on Safety of Medicines/Medicines Control Agency, 2002, CURR PROBL PHARMACOG, V28, P8; *DEP HLTH, 2000, NAT SERV FRAM COR HE; ELDER J, 1990, ANN CLIN BIOCHEM, V27, P110, DOI 10.1177/000456329002700204; EVANS P, 1994, BRIT MED J, V309, P509, DOI 10.1136/bmj.309.6953.509; Law MR, 2003, BRIT MED J, V326, P1423, DOI 10.1136/bmj.326.7404.1423; Pasternak RC, 2002, J AM COLL CARDIOL, V40, P567, DOI 10.1016/S0735-1097(02)02030-2; Reid AE, 2001, GASTROENTEROLOGY, V121, P710, DOI 10.1053/gast.2001.27126; *SCOTT INT GUID NE, 1999, LIP PRIM PREV COR HE, V40; SERIES JJ, 1988, CLIN CHIM ACTA, V172, P217, DOI 10.1016/0009-8981(88)90326-9; Smellie WSA, 2005, J CLIN PATHOL, V58, P1016, DOI 10.1136/jcp.2004.025049; Smellie WSA, 2005, J CLIN PATHOL, V58, P249, DOI 10.1136/jcp.2004.018374; Smellie WSA, 2002, J CLIN PATHOL, V55, P312, DOI 10.1136/jcp.55.4.312; SMELLIE WSA, IN PRESS J CLIN PATH; *U MICH HLTH SYST, 2000, SCREEN MAN LIP	14	8	8	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 8	2006	333	7558					83	86		10.1136/bmj.333.7558.83	http://dx.doi.org/10.1136/bmj.333.7558.83			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	065BA	16825231	Green Published			2022-12-28	WOS:000239133200019
J	Blakely, T; Fawcett, J; Hunt, D; Wilson, N				Blakely, Tony; Fawcett, Jackie; Hunt, Darren; Wilson, Nick			What is the contribution of smoking and socioeconomic position to ethnic inequalities in mortality in New Zealand?	LANCET			English	Article							HEALTH; LINKAGE; TOBACCO; RACISM; RACE	Background Mortality rates for Maori are twice those for non-Maori in New Zealand. We have assessed the contribution of tobacco smoking and socioeconomic position to these inequalities in 45-74-year-old census respondents during 1981-84 and 1996-99 (2.3 and 2.7 million person-years, respectively). Methods We used linked census and mortality cohort datasets with measures of socioeconomic position (household income, highest educational qualification, car access, labour-force status, and neighbourhood deprivation) and smoking (never, ex, current). We used direct standardisation to adjust for smoking and Poisson regression to adjust for socioeconomic position. Findings The apparent contribution of smoking to mortality differences between Maori and non-Maori non-Pacific people was greatest for women in 1996-99 (8% reduction in standardised rate difference); it had increased from 3% in 1981-84. The corresponding reductions in men were 5% in 1996-99 and -1% in 1981-84. The apparent contribution of socioeconomic factors to mortality differences between Maori and non-Maori non-Pacific was greatest for men (39% in 1981-84 and 37% in 1996-99) and increased over time for women (from 23% in 1981-84 to 32% in 1996-99). Interpretation Although small, the contribution of smoking to ethnic inequalities in mortality increased over time and might grow more during the next two decades if differences in smoking between ethnic groups continue to increase. Better measurement of socioeconomic position (eg, lifecourse measures, asset wealth) might increase the proportion of ethnic inequalities attributable to socioeconomic position, perhaps to about half Action to redress socioeconomic gaps and control of tobacco use will both be important in reducing ethnic inequalities in health.	Univ Otago, Wellington Sch Med & Hlth Sci, Dept Publ Hlth, Wellington, New Zealand	University of Otago	Blakely, T (corresponding author), Univ Otago, Wellington Sch Med & Hlth Sci, Dept Publ Hlth, POB 7343, Wellington, New Zealand.	tony.blakely@otago.ac.nz						Ajwani S., 2003, DECADES DISPARITY ET; Anderson I, 2006, LANCET, V367, P1775, DOI 10.1016/S0140-6736(06)68773-4; Belich James, 1996, MAKING PEOPLES HIST, P429; Blakely T, 2002, INT J EPIDEMIOL, V31, P1246, DOI 10.1093/ije/31.6.1246; Blakely T, 2002, INT J EPIDEMIOL, V31, P166, DOI 10.1093/ije/31.1.166; Blakely T, 2000, AUST NZ J PUBL HEAL, V24, P92, DOI 10.1111/j.1467-842X.2000.tb00732.x; Blakely T, 2005, SOC SCI MED, V61, P2233, DOI 10.1016/j.socscimed.2005.02.011; Blakely T, 2002, NZ CENSUS MORTALITY, P258; Bramley Dale, 2004, N Z Med J, V117, pU957; *BRC MARK SOC RES, 2003, EV CULT APPR SMOK CE; Cole SR, 2002, INT J EPIDEMIOL, V31, P163, DOI 10.1093/ije/31.1.163; Cormack D, 2005, ACCESS CANC SERVICES; FAWCETT J, 2006, DECADES DISPARITY, V3; Fawcett J, 2002, 5 NZCMS, P92; Gillespie Julie, 2005, N Z Med J, V118, pU1782; HILL S, 2002, 3 NZCMS U OT WELL SC; Hill SE, 2005, AUST NZ J PUBL HEAL, V29, P279, DOI 10.1111/j.1467-842X.2005.tb00769.x; Howard G, 2000, ANN EPIDEMIOL, V10, P214, DOI 10.1016/S1047-2797(00)00038-7; Hunt D, 2005, INT J EPIDEMIOL, V34, P1020, DOI 10.1093/ije/dyi139; Jeffreys M, 2005, AM J PUBLIC HEALTH, V95, P834, DOI 10.2105/AJPH.2004.053678; Jones CP, 2000, AM J PUBLIC HEALTH, V90, P1212, DOI 10.2105/AJPH.90.8.1212; Karlsen S, 2002, SOCIOL HEALTH ILL, V24, P1, DOI 10.1111/1467-9566.00001; Kaufman JS, 1999, AM J EPIDEMIOL, V150, P113; King M., 2003, PENGUIN HIST NZ; Krieger N., 2000, Discrimination and Health Social Epidemiology, P36, DOI DOI 10.1093/EPIREV/MXP001; Lopez AD, 1994, TOB CONTROL, V3, P242, DOI [DOI 10.1136/TC.3.3.242, 10.1136/tc.3.3.242]; Macintyre S, 1998, J EPIDEMIOL COMMUN H, V52, P657, DOI 10.1136/jech.52.10.657; *MIN HLTH, 1999, TAK PULS 1996 97 NZ; *MIN SOC POL, 2005, SOC REP IND SOC WELL; *MIN SOC POL, 2004, SOC REP IND SOC WELL; Ministry of Health, 2001, INH IN TOB CONTR HLT; Pearce N, 2004, BMJ-BRIT MED J, V328, P1070, DOI 10.1136/bmj.328.7447.1070; PETO R, 1992, LANCET, V339, P1268, DOI 10.1016/0140-6736(92)91600-D; POMARE E, 1995, HAUORA MAORI STANDAR, V3; Reid P., 1991, TE TAONGA MAI TAWHIT; Reid P, 2005, HLTH SOC AOTEAROA NZ; ROBINS JM, 1992, EPIDEMIOLOGY, V3, P143, DOI 10.1097/00001648-199203000-00013; Salmond C, 2001, SOC POLICY J N Z, V17, P82; SMITH GD, 1992, BRIT MED J, V305, P757, DOI 10.1136/bmj.305.6856.757; Smith GD, 2000, AM J PUBLIC HEALTH, V90, P1694, DOI 10.2105/AJPH.90.11.1694; *STAT NZ, 2005, UND WORK ETHN AATA T; *STAT NZ, 2004, NZ LIF TABL 2000 200; Tukuitonga CF, 2002, NEW ZEAL MED J, V115, P179; Victora CG, 1997, INT J EPIDEMIOL, V26, P224, DOI 10.1093/ije/26.1.224; Wardman A E, 2004, Int J Circumpolar Health, V63, P81; Wilson N, 2005, TOB CONTROL, V14, P284, DOI 10.1136/tc.2004.010009	46	102	103	0	11	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 1	2006	368	9529					44	52		10.1016/S0140-6736(06)68813-2	http://dx.doi.org/10.1016/S0140-6736(06)68813-2			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	058TQ	16815379				2022-12-28	WOS:000238687900030
J	Sebire, G				Sebire, G			Transient cerebral arteriopathy in childhood	LANCET			English	Editorial Material							ARTERIAL ISCHEMIC-STROKE; RISK-FACTORS; CHILDREN; VARICELLA		Univ Sherbrooke, Ctr Hosp Univ Sherbrooke, Dept Pediat, Serv Neurol, Sherbrooke, PQ J1H 5N4, Canada	University of Sherbrooke	Sebire, G (corresponding author), Univ Sherbrooke, Ctr Hosp Univ Sherbrooke, Dept Pediat, Serv Neurol, Sherbrooke, PQ J1H 5N4, Canada.	Guillaume.Sebire@Usherbrooke.ca						Benseler SM, 2006, ARTHRITIS RHEUM-US, V54, P1291, DOI 10.1002/art.21766; Chabrier S, 1998, J CHILD NEUROL, V13, P27, DOI 10.1177/088307389801300105; Chabrier S, 2000, J CHILD NEUROL, V15, P290, DOI 10.1177/088307380001500504; Danchaivijitr N, 2006, ANN NEUROL, V59, P620, DOI 10.1002/ana.20800; Ganesan V, 2003, ANN NEUROL, V53, P167, DOI 10.1002/ana.10423; Husson B, 2002, STROKE, V33, P1280, DOI 10.1161/01.STR.0000014504.18199.0D; Sebire G, 2004, CURR OPIN PEDIATR, V16, P617; Sebire G, 1999, ANN NEUROL, V45, P679, DOI 10.1002/1531-8249(199905)45:5<679::AID-ANA22>3.0.CO;2-E; Strater R, 2002, LANCET, V360, P1540, DOI 10.1016/S0140-6736(02)11520-0; Wirrell E, 2004, J PEDIATR-US, V145, P845, DOI 10.1016/j.jpeds.2004.08.005	10	46	48	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 1	2006	368	9529					8	10		10.1016/S0140-6736(06)68944-7	http://dx.doi.org/10.1016/S0140-6736(06)68944-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	058TQ	16815360				2022-12-28	WOS:000238687900007
J	Kitamura, E; Blow, JJ; Tanaka, TU				Kitamura, Etsushi; Blow, J. Julian; Tanaka, Tomoyuki U.			Live-cell imaging reveals replication of individual replicons in eukaryotic replication factories	CELL			English	Article							YEAST SACCHAROMYCES-CEREVISIAE; PREVENT RE-REPLICATION; DNA-REPLICATION; S-PHASE; CHROMOSOME-REPLICATION; SISTER CHROMATIDS; MCM PROTEIN; COMPLEX; POLYMERASE; ORIGINS	Faithful DNA replication ensures genetic integrity in eukaryotic cells, but it is still obscure how replication is organized in space and time within the nucleus. Using timelapse microscopy, we have developed a new assay to analyze the dynamics of DNA replication both spatially and temporally in individual Saccharomyces cerevisiae cells. This allowed us to visualize replication factories, nuclear foci consisting of replication proteins where the bulk of DNA synthesis occurs. We show that the formation of replication factories is a consequence of DNA replication itself. Our analyses of replication at specific DNA sequences support a long-standing hypothesis that sister replication forks generated from the same origin stay associated with each other within a replication factory while the entire replicon is replicated. This assay system allows replication to be studied at extremely high temporal resolution in individual cells, thereby opening a window into how replication dynamics vary from cell to cell.	Univ Dundee, Sch Life Sci, Wellcome Trust Bioctr, Dundee, Scotland	University of Dundee	Kitamura, E (corresponding author), Univ Dundee, Sch Life Sci, Wellcome Trust Bioctr, Dow St, Dundee, Scotland.	t.tanaka@dundee.ac.uk	Kitamura, Etsushi/E-6334-2013; Tanaka, Tomoyuki U/A-4775-2008; Blow, J. Julian/B-3977-2009	Kitamura, Etsushi/0000-0002-3669-2518; Blow, J. Julian/0000-0002-9524-5849; Tanaka, Tomoyuki/0000-0002-9886-5947	Cancer Research UK [A3289, A3135] Funding Source: Medline; Wellcome Trust [062964] Funding Source: Medline	Cancer Research UK(Cancer Research UK); Wellcome Trust(Wellcome TrustEuropean Commission)		Amberg DC., 2005, METHODS YEAST GENETI; Baker TA, 1998, CELL, V92, P295, DOI 10.1016/S0092-8674(00)80923-X; Berezney R, 2000, CHROMOSOMA, V108, P471, DOI 10.1007/s004120050399; Blow JJ, 2005, EMBO REP, V6, P1028, DOI 10.1038/sj.embor.7400557; Blow JJ, 2005, NAT REV MOL CELL BIO, V6, P476, DOI 10.1038/nrm1663; Bressan DA, 2004, J CELL BIOL, V164, P361, DOI 10.1083/jcb.200311063; Bussiere DE, 1999, MOL MICROBIOL, V31, P1611, DOI 10.1046/j.1365-2958.1999.01287.x; DAHMANN C, 1995, CURR BIOL, V5, P1257, DOI 10.1016/S0960-9822(95)00252-1; Dimitrova DS, 1999, J CELL BIOL, V146, P709, DOI 10.1083/jcb.146.4.709; DINGMAN CW, 1974, J THEOR BIOL, V43, P187, DOI 10.1016/S0022-5193(74)80052-4; Falaschi A, 2000, TRENDS GENET, V16, P88, DOI 10.1016/S0168-9525(99)01917-4; Frouin I, 2003, EMBO REP, V4, P666, DOI 10.1038/sj.embor.embor886; HERENDEEN D, 1996, EUKARYOTIC DNA REPLI, P29; Herskowitz I, 1991, METHOD ENZYMOL, P132; Hiraga SI, 2005, GENES CELLS, V10, P297, DOI 10.1111/j.1365-2443.2005.00843.x; HOZAK P, 1993, CELL, V73, P361, DOI 10.1016/0092-8674(93)90235-I; JACKSON PK, 1995, J CELL BIOL, V130, P755, DOI 10.1083/jcb.130.4.755; Jares P, 2000, GENE DEV, V14, P1528; Jensen RB, 2001, EMBO J, V20, P4952, DOI 10.1093/emboj/20.17.4952; Johnson A, 2005, ANNU REV BIOCHEM, V74, P283, DOI 10.1146/annurev.biochem.73.011303.073859; Lau IF, 2003, MOL MICROBIOL, V49, P731, DOI 10.1046/j.1365-2958.2003.03640.x; Lemon KP, 1998, SCIENCE, V282, P1516, DOI 10.1126/science.282.5393.1516; Lemon KP, 2000, MOL CELL, V6, P1321, DOI 10.1016/S1097-2765(00)00130-1; Lengronne A, 2001, NUCLEIC ACIDS RES, V29, P1433, DOI 10.1093/nar/29.7.1433; Leonhardt H, 2000, J CELL BIOL, V149, P271, DOI 10.1083/jcb.149.2.271; Machida YJ, 2005, CELL, V123, P13, DOI 10.1016/j.cell.2005.09.019; Maekawa H, 2003, EMBO J, V22, P438, DOI 10.1093/emboj/cdg063; Meister P, 2005, J CELL BIOL, V168, P537, DOI 10.1083/jcb.200410006; Michaelis C, 1997, CELL, V91, P35, DOI 10.1016/S0092-8674(01)80007-6; Migocki MD, 2004, MOL MICROBIOL, V54, P452, DOI 10.1111/j.1365-2958.2004.04267.x; Mimura S, 2000, GENES CELLS, V5, P439, DOI 10.1046/j.1365-2443.2000.00340.x; NAKAMURA H, 1986, EXP CELL RES, V165, P291, DOI 10.1016/0014-4827(86)90583-5; Newport J, 1996, CURR OPIN CELL BIOL, V8, P365, DOI 10.1016/S0955-0674(96)80011-1; Ohya T, 2002, J BIOL CHEM, V277, P28099, DOI 10.1074/jbc.M111573200; Pasero P, 1997, GENE DEV, V11, P1504, DOI 10.1101/gad.11.12.1504; PIATTI S, 1995, EMBO J, V14, P3788, DOI 10.1002/j.1460-2075.1995.tb00048.x; Piatti S, 1996, GENE DEV, V10, P1516, DOI 10.1101/gad.10.12.1516; Pichler S, 1997, EMBO J, V16, P5988, DOI 10.1093/emboj/16.19.5988; Prein B, 2000, FEBS LETT, V485, P29, DOI 10.1016/S0014-5793(00)02179-7; Raghuraman MK, 2001, SCIENCE, V294, P115, DOI 10.1126/science.294.5540.115; Santocanale C, 1998, NATURE, V395, P615, DOI 10.1038/27001; Schwob E, 2004, CURR OPIN MICROBIOL, V7, P680, DOI 10.1016/j.mib.2004.10.017; SCHWOB E, 1993, GENE DEV, V7, P1160, DOI 10.1101/gad.7.7a.1160; Somanathan S, 2001, J CELL BIOCHEM, V81, P56, DOI 10.1002/1097-4644(20010401)81:1<56::AID-JCB1023>3.0.CO;2-#; Sporbert A, 2002, MOL CELL, V10, P1355, DOI 10.1016/S1097-2765(02)00729-3; Straight AF, 1996, CURR BIOL, V6, P1599, DOI 10.1016/S0960-9822(02)70783-5; SUGINO A, 1995, TRENDS BIOCHEM SCI, V20, P319, DOI 10.1016/S0968-0004(00)89059-3; Tanaka K, 2005, NATURE, V434, P987, DOI 10.1038/nature03483; Tanaka TU, 1998, EMBO J, V17, P5182, DOI 10.1093/emboj/17.17.5182; Tanaka TU, 1997, CELL, V90, P649, DOI 10.1016/S0092-8674(00)80526-7; Uhlmann F, 1998, CURR BIOL, V8, P1095, DOI 10.1016/S0960-9822(98)70463-4; Vernis L, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng121; Waga S, 1998, ANNU REV BIOCHEM, V67, P721, DOI 10.1146/annurev.biochem.67.1.721; WESSEL R, 1992, J VIROL, V66, P804, DOI 10.1128/JVI.66.2.804-815.1992	54	165	167	0	9	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUN 30	2006	125	7					1297	1308		10.1016/j.cell.2006.04.041	http://dx.doi.org/10.1016/j.cell.2006.04.041			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	064QP	16814716	Green Accepted, Bronze			2022-12-28	WOS:000239104500013
J	Yi, P; Han, Z; Li, XM; Olson, EN				Yi, Peng; Han, Zhe; Li, Xiumin; Olson, Eric N.			The mevalonate pathway controls heart formation in Drosophila by isoprenylation of G gamma 1	SCIENCE			English	Article							G-PROTEIN; NETWORK	The early morphogenetic mechanisms involved in heart formation are evolutionarily conserved. A screen for genes that control Drosophila heart development revealed a cardiac defect in which pericardial and cardial cells dissociate, which causes loss of cardiac function and embryonic lethality. This phenotype resulted from mutations in the genes encoding HMG-CoA reductase, downstream enzymes in the mevalonate pathway, and G protein G gamma 1, which is geranylgeranylated, thus representing an end point of isoprenoid biosynthesis. Our findings reveal a cardial cell-autonomous requirement of G gamma 1 geranylgeranylation for heart formation and suggest the involvement of the mevalonate pathway in congenital heart disease.	Univ Texas, SW Med Ctr, Dept Mol Biol, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Han, Z (corresponding author), Univ Texas, SW Med Ctr, Dept Mol Biol, 6000 Harry Hines Blvd, Dallas, TX 75390 USA.	zhe.han@utsouthwestern.edu; eric.olson@utsouthwestern.edu	li, xiu/GXV-1745-2022; Yi, Peng/C-3057-2012	Han, Zhe/0000-0002-5177-7798				Aridor M, 2001, J CELL BIOL, V152, P213, DOI 10.1083/jcb.152.1.213; Clapham DE, 1997, ANNU REV PHARMACOL, V37, P167, DOI 10.1146/annurev.pharmtox.37.1.167; Cripps RM, 2002, DEV BIOL, V246, P14, DOI 10.1006/dbio.2002.0666; Edison RJ, 2005, NEW ENGL J MED, V352, P2759, DOI 10.1056/NEJM200506303522622; Fremion E, 1999, J CELL BIOL, V145, P1063, DOI 10.1083/jcb.145.5.1063; Han Z, 2005, DEVELOPMENT, V132, P3525, DOI 10.1242/dev.01899; Izumi Y, 2004, J CELL BIOL, V164, P729, DOI 10.1083/jcb.200309162; Jamora C, 1997, CELL, V91, P617, DOI 10.1016/S0092-8674(00)80449-3; KINSELLA BT, 1991, P NATL ACAD SCI USA, V88, P8934, DOI 10.1073/pnas.88.20.8934; MUNTZ KH, 1992, MOL BIOL CELL, V3, P49, DOI 10.1091/mbc.3.1.49; OHASHI M, 1994, J BIOL CHEM, V269, P24897; REISS Y, 1991, P NATL ACAD SCI USA, V88, P732, DOI 10.1073/pnas.88.3.732; Van Doren M, 1998, NATURE, V396, P466, DOI 10.1038/24871	13	67	68	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 1	2006	313	5791					1301	1303		10.1126/science.1127704	http://dx.doi.org/10.1126/science.1127704			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	081JI	16857902				2022-12-28	WOS:000240313500045
J	Gotzsche, PC				Gotzsche, Peter C.			Believability of relative risks and odds ratios in abstracts: cross sectional study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							OUTCOME REPORTING BIAS; DOUBLE-BLIND TRIALS; RANDOMIZED-TRIALS; PRIMARY PREVENTION; FRACTURES; EMERGENCY; EFFICACY; DRUGS	Objective To compare the distribution of P values in abstracts of randomised controlled trials with that in observational studies, and to check P values between 0.04 and 0.06. Design Cross sectional study of all 260 abstracts in PubMed of articles published in 2003 that contained "relative risk" or "odds ratio" and reported results from a randomised trial, and random samples of 130 abstracts from cohort studies and 130 from case-control studies. P values were noted or calculated if unreported. Main outcome measures Prevalence of significant P values in abstracts and distribution of P values between 0.04 and 0.06. Results The first result in the abstract was statistically significant in 70% of the trials, 84% of cohort studies, and 84% of case-control studies. Although many of these results were derived from subgroup or secondary analyses, or biased selection of results, they were presented without reservations in 98% of the trials. P values were more extreme in observational studies (P < 0.001) and in cohort studies than in case-control studies (P = 0.04). ne distribution of P values around P = 0.05 was extremely skewed. Only five trials had 0.05 <= P < 0.06, whereas 29 trials had 0.04 <= P < 0.05. I could check the calculations for 27 of these trials. One of four non-significant results was significant. Four of the 23 significant results were wrong, five were doubtful, and four could be discussed. Nine cohort studies and eight case-control studies reported P values between 0.04 and 0.06, but in all 17 cases P < 0.05. Because the analyses had been adjusted for confounders, these results could not be checked. Conclusions Significant results in abstracts are common but should generally be disbelieved.	HS Rigshosp, Nord Cochrane Ctr, DK-2100 Copenhagen O, Denmark	Rigshospitalet	Gotzsche, PC (corresponding author), HS Rigshosp, Nord Cochrane Ctr, DK-2100 Copenhagen O, Denmark.	pcg@cochrane.dk						Arshad SH, 2003, THORAX, V58, P489, DOI 10.1136/thorax.58.6.489; Assmann SF, 2000, LANCET, V355, P1064, DOI 10.1016/S0140-6736(00)02039-0; Basnyat B, 2003, HIGH ALT MED BIOL, V4, P45, DOI 10.1089/152702903321488979; Bishai D, 2003, ACAD EMERG MED, V10, P1371, DOI 10.1197/S1069-6563(03)00540-2; Bland JM, 1996, BMJ-BRIT MED J, V312, P1153; BLAND JM, 1985, BRIT J CLIN PHARMACO, V19, P155, DOI 10.1111/j.1365-2125.1985.tb02626.x; Brassard P, 2003, AM HEART J, V145, DOI 10.1016/S0002-8703(03)00087-5; Chan AW, 2004, CAN MED ASSOC J, V171, P735, DOI 10.1503/cmaj.1041086; Chan AW, 2004, JAMA-J AM MED ASSOC, V291, P2457, DOI 10.1001/jama.291.20.2457; Chan AW, 2005, BMJ-BRIT MED J, V330, P753, DOI 10.1136/bmj.38356.424606.8F; CHAN AW, 2005, 13 COCHR C 22 26 OCT, P166; Fjaertoft H, 2003, STROKE, V34, P2687, DOI 10.1161/01.STR.0000095189.21659.4F; Gaster AL, 2003, HEART, V89, P1043, DOI 10.1136/heart.89.9.1043; George TP, 2003, BIOL PSYCHIAT, V53, P136, DOI 10.1016/S0006-3223(02)01454-3; GOTZSCHE PC, 1989, CONTROL CLIN TRIALS, V10, P31, DOI 10.1016/0197-2456(89)90017-2; Gotzsche PC, 1996, CONTROL CLIN TRIALS, V17, P285, DOI 10.1016/0197-2456(95)00263-4; Greenland S, 1990, Epidemiology, V1, P421, DOI 10.1097/00001648-199011000-00003; Hughes JR, 2003, ALCOHOL CLIN EXP RES, V27, P946, DOI 10.1097/01.ALC.000007142.86555.4D; Kjaergard LL, 2002, J CLIN EPIDEMIOL, V55, P407, DOI 10.1016/S0895-4356(01)00513-3; Leon C, 2003, CRIT CARE MED, V31, P1318, DOI 10.1097/01.CCM.0000026327.58305.22; Lykke N, 2003, J BONE JOINT SURG BR, V85B, P426, DOI 10.1302/0301-620X.85B3.13788; Mion LC, 2003, ANN EMERG MED, V41, P57, DOI 10.1067/mem.2003.3; Mulward S, 1996, DAN MED BULL, V43, P96; Neumann FJ, 2003, JAMA-J AM MED ASSOC, V290, P1593, DOI 10.1001/jama.290.12.1593; Pocock SJ, 2004, BMJ-BRIT MED J, V329, P883, DOI 10.1136/bmj.38250.571088.55; POCOCK SJ, 1987, NEW ENGL J MED, V317, P426, DOI 10.1056/NEJM198708133170706; Sato Y, 2003, NEUROLOGY, V61, P338, DOI 10.1212/01.WNL.0000078892.24356.90; Scherer RW, 2007, COCHRANE DB SYST REV, DOI [10.1002/14651858.MR000005.pub3, 10.1002/14651858.MR000005.pub4]; Sheu BS, 2003, ALIMENT PHARM THER, V17, P1283, DOI 10.1046/j.1365-2036.2003.01527.x; Smith GD, 2002, BMJ-BRIT MED J, V325, P1437; Sterne JAC, 2001, BMJ-BRIT MED J, V322, P226, DOI 10.1136/bmj.322.7280.226; Suter NM, 2003, CANCER EPIDEM BIOMAR, V12, P127; TAUBES G, 1995, SCIENCE, V269, P164, DOI 10.1126/science.7618077; Thies F, 2003, LANCET, V361, P477, DOI 10.1016/S0140-6736(03)12468-3; Trivedi DP, 2003, BMJ-BRIT MED J, V326, P469, DOI 10.1136/bmj.326.7387.469; Tsang JC, 2003, J CARDIAC SURG, V18, P158, DOI 10.1046/j.1540-8191.2003.02009.x; Wood E, 2003, J URBAN HEALTH, V80, P455, DOI 10.1093/jurban/jtg052	37	63	62	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 29	2006	333	7561					231	234B		10.1136/bmj.38895.410451.79	http://dx.doi.org/10.1136/bmj.38895.410451.79			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	070CC	16854948	Green Published, Bronze, Green Submitted			2022-12-28	WOS:000239496900020
J	Doan, T; Mendez, A; Detwiler, PB; Chen, J; Rieke, F				Doan, Thuy; Mendez, Ana; Detwiler, Peter B.; Chen, Jeannie; Rieke, Fred			Multiple phosphorylation sites confer reproducibility of the rod's single-photon responses	SCIENCE			English	Article							MAMMALIAN VOMERONASAL NEURONS; RETINAL RODS; ACTIVATED RHODOPSIN; PHEROMONE DETECTION; G-PROTEIN; IN-VIVO; ARRESTIN; PHOTORECEPTORS; PHOTORESPONSES; VARIABILITY	Although signals controlled by single molecules are expected to be inherently variable, rod photoreceptors generate reproducible responses to single absorbed photons. We show that this unexpected reproducibility - the consistency of amplitude and duration of rhodopsin activity varies in a graded and systematic manner with the number but not the identity of phosphorylation sites on rhodopsin's C terminus. These results indicate that each phosphorylation site provides an independent step in rhodopsin deactivation and that collectively these steps tightly control rhodopsin's active lifetime. Other G protein cascades may exploit a similar mechanism to encode accurately the timing and number of receptor activation.	Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA; Univ Washington, Program Neurobiol, Seattle, WA 98195 USA; Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA; Univ So Calif, Dept Ophthalmol & Cell & Neurobiol, Los Angeles, CA 90089 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Southern California	Chen, J (corresponding author), Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA.	jeannie@usc.edu; rieke@u.washington.edu	Méndez, Ana/F-9729-2016	Méndez, Ana/0000-0001-6393-1644; Detwiler, Peter/0000-0003-3910-2023	NEI NIH HHS [EY-12155, EY-11850, T32EY-07031, EY-02048] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY011850, T32EY007031, R01EY002048, R01EY012155] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		BAYLOR DA, 1979, J PHYSIOL-LONDON, V288, P613; Burns ME, 2002, NEURON, V36, P81, DOI 10.1016/S0896-6273(02)00911-X; Chen CK, 1999, P NATL ACAD SCI USA, V96, P3718, DOI 10.1073/pnas.96.7.3718; CHEN J, 1995, SCIENCE, V267, P374, DOI 10.1126/science.7824934; Field GD, 2002, NEURON, V35, P733, DOI 10.1016/S0896-6273(02)00822-X; Gibson SK, 2000, BIOCHEMISTRY-US, V39, P5738, DOI 10.1021/bi991857f; Gurevich VV, 2004, TRENDS PHARMACOL SCI, V25, P105, DOI 10.1016/j.tips.2003.12.008; Hamer RD, 2003, J GEN PHYSIOL, V122, P419, DOI 10.1085/jgp.200308832; Kennedy MJ, 2001, NEURON, V31, P87, DOI 10.1016/S0896-6273(01)00340-3; KUHN H, 1984, FEBS LETT, V176, P473, DOI 10.1016/0014-5793(84)81221-1; Leinders-Zufall T, 2000, NATURE, V405, P792, DOI 10.1038/35015572; Mendez A, 2000, NEURON, V28, P153, DOI 10.1016/S0896-6273(00)00093-3; Ramanathan S, 2005, BIOPHYS J, V88, P3063, DOI 10.1529/biophysj.103.039321; Rieke F, 1998, BIOPHYS J, V75, P1836, DOI 10.1016/S0006-3495(98)77625-8; Whitlock GG, 1999, NEURON, V23, P337, DOI 10.1016/S0896-6273(00)80784-9; WILDEN U, 1995, BIOCHEMISTRY-US, V34, P1446, DOI 10.1021/bi00004a040; WILDEN U, 1982, BIOCHEMISTRY-US, V21, P3014, DOI 10.1021/bi00541a032; Xu J, 1997, NATURE, V389, P505, DOI 10.1038/39068; Zufall F, 2002, MICROSC RES TECHNIQ, V58, P251, DOI 10.1002/jemt.10152	19	93	97	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 28	2006	313	5786					530	533		10.1126/science.1126612	http://dx.doi.org/10.1126/science.1126612			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067MZ	16873665				2022-12-28	WOS:000239308600065
J	Maharjan, R; Seeto, S; Notley-McRobb, L; Ferenci, T				Maharjan, Ram; Seeto, Shona; Notley-McRobb, Lucinda; Ferenci, Thomas			Clonal adaptive radiation in a constant environment	SCIENCE			English	Article							ESCHERICHIA-COLI; EVOLUTION; POPULATIONS; ADAPTATION; MUTATIONS; EXPRESSION; LIMITATION; SELECTION; PATHWAYS; DYNAMICS	The evolution of new combinations of bacterial properties contributes to biodiversity and the emergence of new diseases. We investigated the capacity for bacterial divergence with a chemostat culture of Escherichia coli. A clonal population radiated into more than five phenotypic clusters within 26 days, with multiple variations in global regulation, metabolic strategies, surface properties, and nutrient permeability pathways. Most isolates belonged to a single ecotype, and neither periodic selection events nor ecological competition for a single niche prevented an adaptive radiation with a single resource. The multidirectional exploration of fitness space is an underestimated ingredient to bacterial success even in unstructured environments.	Univ Sydney, Sch Mol & Microbial Biosci, Sydney, NSW 2006, Australia	University of Sydney	Ferenci, T (corresponding author), Univ Sydney, Sch Mol & Microbial Biosci, Sydney, NSW 2006, Australia.	tferenci@mail.usyd.edu.au	Ferenci, Tom/A-1177-2010	McRobb, Lucinda/0000-0001-5492-1903				ATWOOD KC, 1951, COLD SPRING HARB SYM, V16, P345, DOI 10.1101/SQB.1951.016.01.026; Cohan FM, 2002, ANNU REV MICROBIOL, V56, P457, DOI 10.1146/annurev.micro.56.012302.160634; COHAN FM, 2004, INFEC DIS S, P175; Cooper TF, 2003, P NATL ACAD SCI USA, V100, P1072, DOI 10.1073/pnas.0334340100; DRAKE JW, 1991, P NATL ACAD SCI USA, V88, P7160, DOI 10.1073/pnas.88.16.7160; DYKHUIZEN D, 1981, EVOLUTION, V35, P581, DOI 10.1111/j.1558-5646.1981.tb04919.x; Elena SF, 2003, NAT REV GENET, V4, P457, DOI 10.1038/nrg1088; Feil EJ, 2004, NAT REV MICROBIOL, V2, P483, DOI 10.1038/nrmicro904; Feldgarden M, 2003, ECOLOGY, V84, P1679, DOI 10.1890/0012-9658(2003)084[1679:SDMMSE]2.0.CO;2; Ferenci T, 1996, FEMS MICROBIOL REV, V18, P301, DOI 10.1016/0168-6445(96)00019-8; Friesen ML, 2004, EVOLUTION, V58, P245, DOI 10.1111/j.0014-3820.2004.tb01642.x; HARDIN G, 1960, SCIENCE, V131, P1292, DOI 10.1126/science.131.3409.1292; HELLING RB, 1987, GENETICS, V116, P349; Kassen R, 2004, ANNU REV MICROBIOL, V58, P207, DOI 10.1146/annurev.micro.58.030603.123654; Kerr B, 2002, NATURE, V418, P171, DOI 10.1038/nature00823; King T, 2004, J BACTERIOL, V186, P5614, DOI 10.1128/JB.186.17.5614-5620.2004; Korona R, 1996, GENETICS, V143, P637; Kvint K, 2000, J BIOL CHEM, V275, P14795, DOI 10.1074/jbc.C000128200; LeClerc JE, 1996, SCIENCE, V274, P1208, DOI 10.1126/science.274.5290.1208; Liu XQ, 1998, J BACTERIOL, V180, P3917, DOI 10.1128/JB.180.15.3917-3922.1998; Manche K, 1999, GENETICS, V153, P5; Notley-McRobb L, 2000, GENETICS, V156, P1493; Notley-McRobb L, 2003, P ROY SOC B-BIOL SCI, V270, P843, DOI 10.1098/rspb.2002.2295; Notley-McRobb L, 2002, J BACTERIOL, V184, P806, DOI 10.1128/JB.184.3.806-811.2002; Ochman H, 2000, NATURE, V405, P299, DOI 10.1038/35012500; Papadopoulos D, 1999, P NATL ACAD SCI USA, V96, P3807, DOI 10.1073/pnas.96.7.3807; Pupo GM, 1997, INFECT IMMUN, V65, P2685, DOI 10.1128/IAI.65.7.2685-2692.1997; Rainey PB, 1998, NATURE, V394, P69, DOI 10.1038/27900; Rozen DE, 2000, AM NAT, V155, P24, DOI 10.1086/303299; Rozen DE, 2002, CURR BIOL, V12, P1040, DOI 10.1016/S0960-9822(02)00896-5; RUDD KE, 1985, J BACTERIOL, V163, P534, DOI 10.1128/JB.163.2.534-542.1985; Solnick JV, 2004, P NATL ACAD SCI USA, V101, P2106, DOI 10.1073/pnas.0308573100; Treves DS, 1998, MOL BIOL EVOL, V15, P789, DOI 10.1093/oxfordjournals.molbev.a025984; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Zhang E, 1999, FEMS MICROBIOL LETT, V176, P395, DOI 10.1111/j.1574-6968.1999.tb13689.x	35	123	124	0	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 28	2006	313	5786					514	517		10.1126/science.1129865	http://dx.doi.org/10.1126/science.1129865			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067MZ	16825532				2022-12-28	WOS:000239308600060
J	Klein, R				Klein, Rudolf			The troubled transformation of Britain's National Health Service	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							NHS; REFORM		Univ Bath, Bath BA2 7AY, Avon, England; London Sch Econ, London, England; London Sch Hyg, London, England	University of Bath; University of London; London School Economics & Political Science; University of London; London School of Hygiene & Tropical Medicine	Klein, R (corresponding author), Univ Bath, Bath BA2 7AY, Avon, England.							Appleby J., 2006, SPENDING HLTH CARE M; CLEWS G, 2006, HLTH SERVICE J  0413, P7; Day P., 2005, GOVERNANCE FDN TRUST; *DEP HLTH, 2005, SER DEP HLTH CM, V6524; *DEP HLTH, 2005, CHIEF EX REP NHS DEC; Department of Health, 2005, HLTH REF ENGL UPD NE; Department of Health, 2004, NAT STAND LOC ACT HL; Ham C, 2006, BRIT MED J, V332, P984, DOI 10.1136/bmj.332.7548.984; *HEALTHC COMM, 2005, AC HOSP PORTF AHP RE; *HEALTHC COMM, 2005, STAT HEALTHC REP 200; Klein R., 2006, NEW POLITICS NHS CRE, V5st edition; Maynard A, 2006, BMJ-BRIT MED J, V332, P906, DOI 10.1136/bmj.332.7546.906; Stevens S, 2004, HEALTH AFFAIR, V23, P37, DOI 10.1377/hlthaff.23.3.37	13	24	24	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 27	2006	355	4					409	415		10.1056/NEJMhpr062747	http://dx.doi.org/10.1056/NEJMhpr062747			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	067DT	16870922	Green Published			2022-12-28	WOS:000239282600012
J	Weiss, R; Raz, I				Weiss, Ram; Raz, Itamar			Focus on childhood fitness, not just fatness	LANCET			English	Editorial Material							CARDIOVASCULAR RISK-FACTORS; PHYSICAL-ACTIVITY; METABOLIC SYNDROME; YOUNG-ADULTS; CHILDREN; ADOLESCENCE; YOUTH; FINNS; AGE		Hadassah Hebrew Univ Hosp, Dept Pediat, Jerusalem, Israel; Hadassah Hebrew Univ Hosp, Diabet Unit, Jerusalem, Israel	Hebrew University of Jerusalem; Hadassah University Medical Center; Hebrew University of Jerusalem; Hadassah University Medical Center	Weiss, R (corresponding author), Hadassah Hebrew Univ Hosp, Dept Pediat, Jerusalem, Israel.	weissr@hadassah.org.il	Weiss, Ram/AAC-3964-2020					Andersen LB, 2006, LANCET, V368, P299, DOI 10.1016/S0140-6736(06)69075-2; BAO WH, 1994, ARCH INTERN MED, V154, P1842; Berenson GS, 1998, NEW ENGL J MED, V338, P1650, DOI 10.1056/NEJM199806043382302; Blair SN, 2004, AM J CLIN NUTR, V79, P913; Brage S, 2004, DIABETES CARE, V27, P2141, DOI 10.2337/diacare.27.9.2141; Ferreira I, 2005, ARCH INTERN MED, V165, P42, DOI 10.1001/archinte.165.1.42; Kimm SYS, 2002, NEW ENGL J MED, V347, P709, DOI 10.1056/NEJMoa003277; Raitakari OT, 2003, JAMA-J AM MED ASSOC, V290, P2277, DOI 10.1001/jama.290.17.2277; RAITAKARI OT, 1994, AM J EPIDEMIOL, V140, P195, DOI 10.1093/oxfordjournals.aje.a117239; Strong WB, 2005, J PEDIATR-US, V146, P732, DOI 10.1016/j.jpeds.2005.01.055; Tirosh A, 2005, NEW ENGL J MED, V353, P1454, DOI 10.1056/NEJMoa050080; Weiss R, 2004, NEW ENGL J MED, V350, P2362, DOI 10.1056/NEJMoa031049	12	3	3	1	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 22	2006	368	9532					261	262		10.1016/S0140-6736(06)69051-X	http://dx.doi.org/10.1016/S0140-6736(06)69051-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	067PF	16860679				2022-12-28	WOS:000239314400004
J	Bland-Hawthorn, J; Peebles, PJE				Bland-Hawthorn, Joss; Peebles, P. J. E.			Near-field cosmology	SCIENCE			English	Editorial Material									Anglo Australian Observ, Epping, NSW 2121, Australia; Princeton Univ, Dept Phys, Princeton, NJ 08544 USA	Princeton University	Bland-Hawthorn, J (corresponding author), Anglo Australian Observ, POB 296, Epping, NSW 2121, Australia.	jbh@aaoepp.aao.gov.au	bland-hawthorn, joss/ABE-7646-2020	bland-hawthorn, joss/0000-0001-7516-4016				Beers TC, 2005, ANNU REV ASTRON ASTR, V43, P531, DOI 10.1146/annurev.astro.42.053102.134057; Robertson B, 2005, ASTROPHYS J, V632, P872, DOI 10.1086/452619; Springel V, 2005, NATURE, V435, P629, DOI 10.1038/nature03597; Zentner AR, 2003, ASTROPHYS J, V598, P49, DOI 10.1086/378797; 2006, ASP CTR PHYS WORKSH	5	12	12	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 21	2006	313	5785					311	312		10.1126/science.1127183	http://dx.doi.org/10.1126/science.1127183			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065IV	16857929				2022-12-28	WOS:000239154300031
J	Rosenberg, RN				Rosenberg, Roger N.			Time will be of the essence in treating Alzheimer disease	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							TRANSGENIC MICE; A-BETA; IMMUNIZATION; PROTEIN; TAU; PRESENILIN-1; MEMORY; AGE		Univ Texas, SW Med Ctr, Dept Neurol, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Rosenberg, RN (corresponding author), Univ Texas, SW Med Ctr, Dept Neurol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	archneurol@jama-archives.org						Andreasen N, 2001, ARCH NEUROL-CHICAGO, V58, P373, DOI 10.1001/archneur.58.3.373; Ashe KH, 2005, BIOCHEM SOC T, V33, P591, DOI 10.1042/BST0330591; Bacskai BJ, 2003, P NATL ACAD SCI USA, V100, P12462, DOI 10.1073/pnas.2034101100; Braak H, 1997, NEUROBIOL AGING, V18, P351, DOI 10.1016/S0197-4580(97)00056-0; Duff K, 1996, NATURE, V383, P710, DOI 10.1038/383710a0; Duff Karen, 2004, Briefings in Functional Genomics & Proteomics, V3, P47, DOI 10.1093/bfgp/3.1.47; Galasko D, 1998, ARCH NEUROL-CHICAGO, V55, P937, DOI 10.1001/archneur.55.7.937; Gilman S, 2005, NEUROLOGY, V64, P1553, DOI 10.1212/01.WNL.0000159740.16984.3C; Holcomb L, 1998, NAT MED, V4, P97, DOI 10.1038/nm0198-097; Khachaturian AS, 2004, ARCH GEN PSYCHIAT, V61, P518, DOI 10.1001/archpsyc.61.5.518; Klunk WE, 2004, ANN NEUROL, V55, P306, DOI 10.1002/ana.20009; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Lombardo JA, 2003, J NEUROSCI, V23, P10879, DOI 10.1523/jneurosci.23-34-10879.2003; Masliah E, 2005, NEUROLOGY, V64, P129, DOI 10.1212/01.WNL.0000148590.39911.DF; Noble W, 2005, P NATL ACAD SCI USA, V102, P6990, DOI 10.1073/pnas.0500466102; Orgogozo JM, 2003, NEUROLOGY, V61, P46, DOI 10.1212/01.WNL.0000073623.84147.A8; Peskind ER, 2006, ARCH NEUROL-CHICAGO, V63, P936, DOI 10.1001/archneur.63.7.936; Qu BX, 2006, J NEUROL SCI, V244, P151, DOI 10.1016/j.jns.2006.02.006; Rosenberg RN, 2005, ARCH GEN PSYCHIAT, V62, P1186, DOI 10.1001/archpsyc.62.11.1186; Rosenberg RN, 2005, JAMA-J AM MED ASSOC, V294, P2352, DOI 10.1001/jama.294.18.2352; Santos AP, 2002, J CLIN VIROL, V23, P149, DOI 10.1016/S1386-6532(01)00211-6	21	4	4	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 19	2006	296	3					327	329		10.1001/jama.296.3.327	http://dx.doi.org/10.1001/jama.296.3.327			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	064LA	16862641				2022-12-28	WOS:000239089900025
J	Devauchelle, B; Badet, L; Lengele, B; Morelon, E; Testelin, S; Michallet, M; D'Hauthuille, C; Dubernard, JM				Devauchelle, Bernard; Badet, Lionel; Lengele, Benoit; Morelon, Emmanuel; Testelin, Sylvie; Michallet, Mauricette; D'Hauthuille, Cedric; Dubernard, Jean-Michel			First human face allograft: early report	LANCET			English	Article							DONOR BONE-MARROW; FREE-FLAP; TRANSPLANT RECIPIENTS; SCALP TRANSPLANTATION; IMMUNE-RESPONSES; CELL CHIMERISM; RECONSTRUCTION; TOLERANCE; PANCREAS; ORGAN	Background Extended soft tissue defects of the face are difficult to reconstruct, and autologous tissue transfers usually lead to poor cosmetic and functional outcomes. We judged that composite tissue transplantation could be valuable in facial reconstructive surgery. Methods We transplanted the central and lower face of a brain-dead woman onto a woman aged 38 years who had suffered amputation of distal nose, both lips, chin, and adjacent parts of the cheeks. Transplantation consisted of revascularisation of right and left facial arteries and veins (ischaemic time 4 h), mucosal repair of oral and nasal vestibules, bilateral anastomoses of infraorbital and mental sensitive nerves, joining of mimic muscles with motor nerve suture on mandibular branch of the left facial nerve, and skin closure. Immunosuppressive treatment was with thymoglobulin, tacrolimus, mycophenolate mofetil, and prednisone. Two infusions of donor bone-marrow cells were given. Follow-up included routine tests, biopsies, physiotherapy, and psychological support. Findings The initial postoperative course was uneventful. No surgical complication occurred. Bone-marrow graft and immunosuppression were well tolerated. Mild clinical signs of rejection were seen at day 20. Increased corticoids initially did not reverse rejection, but signs of rejection disappeared after three boluses of prednisone. Anatomical and psychological integration and recovery of sensation were excellent. At the end of the first postoperative week, the patient could eat, and speech improved quickly. Passive transmission of muscle contractions to the graft already exists; physiotherapy is being done to restore dynamic motions around the lips. Interpretation The 4-month outcome demonstrates the feasibility of this procedure. The functional result will be assessed in the future, but this graft can already be deemed successful with respect to appearance, sensitivity, and acceptance by the patient.	Ctr Hosp Univ Amiens, Dept Maxillofacial Surg, Amiens, France; Hosp Edouard Herriot, Ctr Hosp Univ Lyon, Lyon, France; Univ Catholique Louvain, Expt Morphol Dept, B-1200 Brussels, Belgium	Picardie Universites; Universite de Picardie Jules Verne (UPJV); CHU Amiens; bioMerieux; CHU Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Universite Catholique Louvain	Devauchelle, B (corresponding author), Univ Hosp, North Hosp, Dept Maxillofacial Surg, F-80054 Amiens, France.	devauchelle.bernard@chu-amiens.fr						Angrigiani C, 1997, PLAST RECONSTR SURG, V99, P1566, DOI 10.1097/00006534-199705000-00014; Corry RJ, 1999, ANN SURG, V230, P372, DOI 10.1097/00000658-199909000-00010; Delis S, 2006, PANCREAS, V32, P1, DOI 10.1097/01.mpa.0000188307.67420.46; Dubernard JM, 1999, LANCET, V353, P1315, DOI 10.1016/S0140-6736(99)02062-0; FONTES P, 1994, LANCET, V344, P151, DOI 10.1016/S0140-6736(94)92756-1; GarciaMorales R, 1996, TRANSPLANTATION, V62, P1149, DOI 10.1097/00007890-199610270-00021; Kanitakis J, 2005, EUR J DERMATOL, V15, P235; KAWASHIMA T, 1994, PLAST RECONSTR SURG, V94, P944, DOI 10.1097/00006534-199412000-00007; Latifoglu O, 1999, PLAST RECONSTR SURG, V103, P1076, DOI 10.1097/00006534-199903000-00059; Lengele BG, 2004, INT J ORAL MAX SURG, V33, P396, DOI 10.1016/j.ijom.2003.11.004; Mathew JM, 2003, TRANSPL IMMUNOL, V11, P307, DOI 10.1016/S0966-3274(03)00056-X; Mathew JM, 2000, TRANSPLANTATION, V70, P1675, DOI 10.1097/00007890-200012270-00003; Miller J, 1999, TRANSPLANTATION, V68, P1079, DOI 10.1097/00007890-199910270-00001; MONACO AP, 1976, SURGERY, V79, P384; Monaco AP, 2001, TRANSPLANT P, V33, P3837, DOI 10.1016/S0041-1345(01)02625-2; Petruzzo P, 2003, CLIN TRANSPLANT, V17, P455, DOI 10.1034/j.1399-0012.2003.00005.x; Pham SM, 2000, J THORAC CARDIOV SUR, V119, P673, DOI 10.1016/S0022-5223(00)70001-8; Pribaz JJ, 1999, PLAST RECONSTR SURG, V103, P808, DOI 10.1097/00006534-199903000-00006; Prigozhina T, 2004, SPRINGER SEMIN IMMUN, V26, P169, DOI 10.1007/s00281-004-0171-5; Ricordi C, 1997, TRANSPLANTATION, V63, P7, DOI 10.1097/00007890-199701150-00003; Siemionow M, 2005, CLIN PLAST SURG, V32, P401, DOI 10.1016/j.cps.2005.02.003; Siemionow M, 2003, TRANSPLANTATION, V75, P1607, DOI 10.1097/01.TP.0000068870.71053.29; Teot L, 2000, LANCET, V355, P1695, DOI 10.1016/S0140-6736(00)02245-5; Thomas A, 1998, PLAST RECONSTR SURG, V102, P2085, DOI 10.1097/00006534-199811000-00041; Ulusal BG, 2003, PLAST RECONSTR SURG, V112, P1302, DOI 10.1097/01.PRS.0000079823.84984.BB; Unal S, 2005, ANN PLAS SURG, V55, P297, DOI 10.1097/01.sap.0000168693.25306.79; Wilhelmi BJ, 2003, ANN PLAS SURG, V50, P535, DOI 10.1097/01.SAP.0000037875.69379.56	27	445	464	0	31	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 15	2006	368	9531					203	209		10.1016/S0140-6736(06)68935-6	http://dx.doi.org/10.1016/S0140-6736(06)68935-6			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	064MY	16844489				2022-12-28	WOS:000239095000031
J	Crighton, D; Wilkinson, S; O'Prey, J; Syed, N; Smith, P; Harrison, PR; Gasco, M; Garrone, O; Crook, T; Ryan, KM				Crighton, Diane; Wilkinson, Simon; O'Prey, Jim; Syed, Nelofer; Smith, Paul; Harrison, Paul R.; Gasco, Milena; Garrone, Ornella; Crook, Tim; Ryan, Kevin M.			DRAM, a p53-induced modulator of autophagy, is critical for apoptosis	CELL			English	Article							PROGRAMMED CELL-DEATH; DNA-DAMAGE; IN-VIVO; GENE; P53; CANCER; PROTEINS; INACTIVATION; ASSOCIATION; DEGRADATION	Inactivation of cell death is a major step in tumor development, and p53, a tumor suppressor frequently mutated in cancer, is a critical mediator of cell death. While a role for p53 in apoptosis is well established, direct links to other pathways controlling cell death are unknown. Here we describe DRAM (damage-regulated autophagy modulator), a p53 target gene encoding a lysosomal protein that induces macroautophagy, as an effector of p53-mediated death. We show that p53 induces autophagy in a DRAM-dependent manner and, while overexpression of DRAM alone causes minimal cell death, DRAM is essential for p53-mediated apoptosis. Moreover, analysis of DRAM in primary tumors revealed frequent decreased expression often accompanied by retention of wildtype p53. Collectively therefore, these studies not only report a stress-induced regulator of autophagy but also highlight the relationship of DRAM and autophagy to p53 function and damage-induced programmed cell death.	Beatson Inst Canc Res, Canc Res UK Beatson Labs, Tumour Cell Death Lab, Glasgow G61 1BD, Lanark, Scotland; Beatson Inst Canc Res, Canc Res UK Beatson Labs, Oral Canc Mol Genet Lab, Glasgow G61 1BD, Lanark, Scotland; Inst Canc Res, Chester Beatty Labs, Breakthrough toby Robins Breast Canc Res Ctr, London SW3 6JB, England; Osped San Croce & Carle, Dept Med Oncol, Cuneo, Italy	Beatson Institute; Beatson Institute; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK	Ryan, KM (corresponding author), Beatson Inst Canc Res, Canc Res UK Beatson Labs, Tumour Cell Death Lab, Garscube Estate,Switchback Rd, Glasgow G61 1BD, Lanark, Scotland.	k.ryan@beatson.gla.ac.uk	Garrone, Ornella/AAC-5978-2022; Garrone, Ornella/HHS-9402-2022	Garrone, Ornella/0000-0001-7359-5410; Wilkinson, Simon/0000-0003-1082-8218; Ryan, Kevin M./0000-0002-1059-9681	Breast Cancer Now [BREAST CANCER NOW RESEARCH CENTRE] Funding Source: Medline	Breast Cancer Now		Aita VM, 1999, GENOMICS, V59, P59, DOI 10.1006/geno.1999.5851; Baehrecke EH, 2005, NAT REV MOL CELL BIO, V6, P505, DOI 10.1038/nrm1666; Bampton ETW, 2005, AUTOPHAGY, V1, P23, DOI 10.4161/auto.1.1.1495; Beroud C, 2003, HUM MUTAT, V21, P176, DOI 10.1002/humu.10187; Boya P, 2005, MOL CELL BIOL, V25, P1025, DOI 10.1128/MCB.25.3.1025-1040.2005; Crighton D, 2004, BBA-REV CANCER, V1705, P3, DOI 10.1016/j.bbcan.2004.09.001; Edinger AL, 2004, CURR OPIN CELL BIOL, V16, P663, DOI 10.1016/j.ceb.2004.09.011; EDINGTON KG, 1995, MOL CARCINOGEN, V13, P254, DOI 10.1002/mc.2940130408; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Erster S, 2004, MOL CELL BIOL, V24, P6728, DOI 10.1128/MCB.24.15.6728-6741.2004; Feng ZH, 2005, P NATL ACAD SCI USA, V102, P8204, DOI 10.1073/pnas.0502857102; Gasco M, 2002, CANCER RES, V62, P2072; Gozuacik D, 2004, ONCOGENE, V23, P2891, DOI 10.1038/sj.onc.1207521; Grandori C, 1996, EMBO J, V15, P4344, DOI 10.1002/j.1460-2075.1996.tb00808.x; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Herman JG, 2003, NEW ENGL J MED, V349, P2042, DOI 10.1056/NEJMra023075; Hoh J, 2002, P NATL ACAD SCI USA, V99, P8467, DOI 10.1073/pnas.132268899; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Lee CY, 2001, DEVELOPMENT, V128, P1443; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; LITTLEWOOD TD, 1995, NUCLEIC ACIDS RES, V23, P1686, DOI 10.1093/nar/23.10.1686; Lum JJ, 2005, CELL, V120, P237, DOI 10.1016/j.cell.2004.11.046; McGregor F, 2002, CANCER RES, V62, P4757; Mills KR, 2004, P NATL ACAD SCI USA, V101, P3438, DOI 10.1073/pnas.0400443101; Mizushima N, 2001, J CELL BIOL, V152, P657, DOI 10.1083/jcb.152.4.657; Moll UM, 2001, FEBS LETT, V493, P65, DOI 10.1016/S0014-5793(01)02284-0; Nakano K, 2001, MOL CELL, V7, P683, DOI 10.1016/S1097-2765(01)00214-3; Ogier-Denis E, 2003, BBA-REV CANCER, V1603, P113, DOI 10.1016/S0304-419X(03)00004-0; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Rampino N, 1997, SCIENCE, V275, P967, DOI 10.1126/science.275.5302.967; Ryan KM, 2000, NATURE, V404, P892, DOI 10.1038/35009130; Shimizu S, 2004, NAT CELL BIOL, V6, P1221, DOI 10.1038/ncb1192; Soengas MS, 2001, NATURE, V409, P207, DOI 10.1038/35051606; Tanikawa C, 2003, NAT CELL BIOL, V5, P216, DOI 10.1038/ncb943; Wilson A, 1996, J CELL BIOCHEM, V60, P458, DOI 10.1002/(SICI)1097-4644(19960315)60:4<458::AID-JCB3>3.0.CO;2-R; Xue LZ, 1999, MOL CELL NEUROSCI, V14, P180, DOI 10.1006/mcne.1999.0780; Yu J, 2001, MOL CELL, V7, P673, DOI 10.1016/S1097-2765(01)00213-1; Yu L, 2004, SCIENCE, V304, P1500, DOI 10.1126/science.1096645; Yu L, 2006, P NATL ACAD SCI USA, V103, P4952, DOI 10.1073/pnas.0511288103	41	1032	1107	2	84	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUL 14	2006	126	1					121	134		10.1016/j.cell.2006.05.034	http://dx.doi.org/10.1016/j.cell.2006.05.034			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	066JF	16839881	Bronze			2022-12-28	WOS:000239224800021
J	Henschke, CI; Sone, S; Hanaoka, T; Markowitz, S; Miller, A; Klingler, K; Scherer, T; Inderbitzi, R; Zulueta, J; Bastarrika, G; Lozano, MD; Giunta, S; Crecco, M; Pugliese, P; Tockman, M; Shaham, D; Rice, K; Aye, R; Roberts, H; Patsios, D; Bauer, T; Lally, J; Austin, JHM; Pearson, GDN; Naidich, D; McGuinness, G; Rifkin, M; Fiore, E; Kopel, S; Klippenstein, D; Litwin, A; Loud, PA; Kohman, LJ; Scalzetti, EM; Khan, A; Shah, R; Smith, MV; Williams, HT; Lovett, L; Mendelson, DS; Thurer, R; Heelan, RT; Ginsberg, MS; Sullivan, F; Ottinger, M; Vafai, D; Matalon, TAS; Odzer, SL; Liu, XG; Sheppard, B; Cole, E; Wiernik, PH; Ray, D; Pass, H; Endress, C; Mullen, D; Kalafer, M; Grannis, F; Rotter, A; Thorsen, MK; Hansen, R; Camacho, E; Luedke, D; Henschke, CI; Altorki, N; Farooqi, A; Hess, J; Libby, D; McCauley, DI; Miettinen, OS; Ostroff, J; Pasmantier, MW; Reeves, AP; Smith, JP; Vazquez, M; Yankelevitz, DF; Yip, R; Agnello, K; Kramer, A; Carter, D; Brambilla, E; Gazdar, A; Noguchi, M; Travis, WD				Henschke, Claudia I.; Sone, Shusuke; Hanaoka, Takaomi; Markowitz, Steven; Miller, Albert; Klingler, Karl; Scherer, Thomas; Inderbitzi, Rolf; Zulueta, Javier; Bastarrika, Gorka; Lozano, Maria D.; Giunta, Salvatore; Crecco, Marcello; Pugliese, Patrizia; Tockman, Melvyn; Shaham, Dorith; Rice, Kim; Aye, Ralph; Roberts, Heidi; Patsios, Demetris; Bauer, Thomas; Lally, James; Austin, John H. M.; Pearson, Gregory D. N.; Naidich, David; McGuinness, Georgeann; Rifkin, Matthew; Fiore, Edward; Kopel, Samuel; Klippenstein, Donald; Litwin, Alan; Loud, Peter A.; Kohman, Leslie J.; Scalzetti, Ernest M.; Khan, Arfa; Shah, Rakesh; Smith, Michael V.; Williams, Hadyn T.; Lovett, Louis; Mendelson, David S.; Thurer, Richard; Heelan, Robert T.; Ginsberg, Michelle S.; Sullivan, Frank; Ottinger, Marlana; Vafai, Davood; Matalon, Terence A. S.; Odzer, Shari-Lynn; Liu, Xueguo; Sheppard, Barry; Cole, Enser; Wiernik, Peter H.; Ray, Daniel; Pass, Harvey; Endress, Carmen; Mullen, David; Kalafer, Michael; Grannis, Fred; Rotter, Arnold; Thorsen, M. Kristin; Hansen, Richard; Camacho, Elber; Luedke, Dan; Henschke, Claudia I.; Altorki, Nasser; Farooqi, Ali; Hess, Jennifer; Libby, Daniel; McCauley, Dorothy I.; Miettinen, Olli S.; Ostroff, Jamie; Pasmantier, Mark W.; Reeves, Anthony P.; Smith, James P.; Vazquez, Madeline; Yankelevitz, David F.; Yip, Rowena; Agnello, Kimberly; Kramer, Arin; Carter, Darryl; Brambilla, Elizabeth; Gazdar, Adi; Noguchi, Masayuki; Travis, William D.		Int Early Lung Canc Action Program In	Women's susceptibility to tobacco carcinogens and survival after diagnosis of lung cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SEX-ASSOCIATED DIFFERENCES; HISTOLOGIC TYPE; GENDER-DIFFERENCES; CIGARETTE-SMOKING; RISK; RESECTION; STAGE; COUNTY; TREND; MEN	Context It has been hypothesized that women are more susceptible to tobacco carcinogens than men, but after diagnosis of lung cancer, they have better survival rates than men. Objective To add to the evidence on the lung cancer risk of women who smoke and their survival after diagnosis of lung cancer, conditional on other prognostic indicators and compared with men of the same age who smoke. Design, Setting, and Participants Nonexperimental, etiologic study with prospective collection of data based on baseline computed tomographic screening for lung cancer and follow-up of diagnosed cases of lung cancer in North America in 1993-2005. A total of 7498 women and 9427 men were screened, all of whom were asymptomatic, aged at least 40 years, and had a history of cigarette smoking. Main Outcome Measures Comparing women with men, the prevalence odds ratio ( OR) for screen-detectable lung cancer ( conditional on age and smoking history) and the hazard ratio of fatal outcome of lung cancer ( conditional on smoking history, disease stage, tumor cell type, and resection). Results Lung cancer was diagnosed in 156 women and 113 men ( rates of 2.1% and 1.2%, respectively). The prevalence OR comparing women with men was 1.9 (95% confidence interval [CI], 1.5-2.5). The hazard ratio of fatal outcome of lung cancer comparing women with men was 0.48 ( 95% CI, 0.25-0.89). Conclusion Women appear to have increased susceptibility to tobacco carcinogens but have a lower rate of fatal outcome of lung cancer compared with men.	Cornell Univ, Joan & Sanford I Weill Med Coll, Dept Radiol, New York, NY 10021 USA; Cornell Univ, Joan & Sanford I Weill Med Coll, Dept Med, New York, NY 10021 USA; McGill Univ, Fac Med, Dept Med, Montreal, PQ, Canada; McGill Univ, Fac Med, Dept Epidemiol & Biostat, Montreal, PQ, Canada	Cornell University; Cornell University; McGill University; McGill University	Henschke, CI (corresponding author), Cornell Univ, Joan & Sanford I Weill Med Coll, Dept Radiol, 525 E 68th St, New York, NY 10021 USA.	chensch@med.cornell.edu	Brambilla, Elisabeth MP/L-8796-2013; Thurer, Richard/I-1045-2019; Lozano, Maria D/ABD-9613-2020; Zulueta, Javier J/GXZ-5810-2022; Zulueta, Javier J/H-5127-2011	Lozano, Maria D/0000-0002-6796-9380; Zulueta, Javier J/0000-0003-3182-3555				Alexiou C, 2002, EUR J CARDIO-THORAC, V21, P319, DOI 10.1016/S1010-7940(01)01114-9; *AM CANC SOC, 2006, STAT 2006 CANC FACTS; BEARD CM, 1988, J NATL CANCER I, V80, P1404, DOI 10.1093/jnci/80.17.1404; BROWNSON RC, 1992, EPIDEMIOLOGY, V3, P61, DOI 10.1097/00001648-199201000-00012; de Perrot M, 2000, J THORAC CARDIOV SUR, V119, P21, DOI 10.1016/S0022-5223(00)70213-3; Ferguson MK, 2000, ANN THORAC SURG, V69, P245, DOI 10.1016/S0003-4975(99)01078-4; FERGUSON MK, 1990, J CLIN ONCOL, V8, P1402, DOI 10.1200/JCO.1990.8.8.1402; Fu JB, 2005, CHEST, V127, P768, DOI 10.1378/chest.127.3.768; HARRIS RE, 1993, INT J EPIDEMIOL, V22, P592, DOI 10.1093/ije/22.4.592; Henschke CI, 2004, LUNG CANCER, V43, P1, DOI 10.1016/j.lungcan.2003.08.024; Henschke CI, 2002, LUNG CANCER-J IASLC, V35, P143, DOI 10.1016/S0169-5002(01)00416-0; Koyi H, 2002, LUNG CANCER-J IASLC, V36, P9, DOI 10.1016/S0169-5002(01)00451-2; Kreuzer M, 2000, BRIT J CANCER, V82, P227; Levi F, 1997, CANCER, V79, P906, DOI 10.1002/(SICI)1097-0142(19970301)79:5<906::AID-CNCR6>3.0.CO;2-9; LUBIN JH, 1984, JNCI-J NATL CANCER I, V73, P383, DOI 10.1093/jnci/73.2.383; MCDUFFIE HH, 1987, CANCER, V59, P1825, DOI 10.1002/1097-0142(19870515)59:10<1825::AID-CNCR2820591024>3.0.CO;2-2; MIETTINEN O, 1976, AM J EPIDEMIOL, V103, P226, DOI 10.1093/oxfordjournals.aje.a112220; Minami H, 2000, CHEST, V118, P1603, DOI 10.1378/chest.118.6.1603; OSANN KE, 1993, INT J CANCER, V54, P44, DOI 10.1002/ijc.2910540108; Ouellette D, 1998, ANN THORAC SURG, V66, P1140, DOI 10.1016/S0003-4975(98)00557-8; Radzikowska E, 2002, ANN ONCOL, V13, P1087, DOI 10.1093/annonc/mdf187; RISCH HA, 1993, AM J EPIDEMIOL, V138, P281, DOI 10.1093/oxfordjournals.aje.a116857; Shriver SP, 2000, JNCI-J NATL CANCER I, V92, P24, DOI 10.1093/jnci/92.1.24; Thun MJ, 2002, ONCOGENE, V21, P7307, DOI 10.1038/sj.onc.1205807; Travis E, 2004, WHO CLASSIFICATION T; *US PHS, 1989, RED HLTH CONS SMOK 2; Vazquez M, 2003, LUNG CANCER-J IASLC, V39, P231, DOI 10.1016/S0169-5002(02)00452-X; VAZQUEZ M, 2006, EARLY LUNG CANC ACTI; Visbal AL, 2004, ANN THORAC SURG, V78, P209, DOI 10.1016/j.athoracsur.2003.11.021; Wei QY, 2000, J NATL CANCER I, V92, P1764; Yoshino I, 2002, SURGERY, V131, pS242, DOI 10.1067/msy.2002.119796; Zang EA, 1996, JNCI-J NATL CANCER I, V88, P183, DOI 10.1093/jnci/88.3-4.183	32	165	173	0	17	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 12	2006	296	2					180	184						5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	062LP	16835423				2022-12-28	WOS:000238946500023
J	Choudhury, B; Risley, CL; Ghani, AC; Bishop, CJ; Ward, H; Fenton, KA; Ison, CA; Spratt, BG				Choudhury, Bhudipa; Risley, Claire L.; Ghani, Azra C.; Bishop, Cynthia J.; Ward, Helen; Fenton, Kevin A.; Ison, Catherine A.; Spratt, Brian G.			Identification of individuals with gonorrhoea within sexual networks: a population-based study	LANCET			English	Article							NEISSERIA-GONORRHOEAE; EPIDEMIOLOGY; TRANSMISSION; LONDON	Background Molecular typing of Neisseria gonorrhoeae and contact tracing provide a combined approach for analysis of sexual networks in metropolitan areas, although there are some difficulties in application. Our aim was to examine the application of high-throughput molecular approaches that can identify individuals in linked sexual networks. Methods We characterised 2045 isolates of N gonorrhoeae from patients presenting at 13 major sexually transmitted infection clinics in London, UK, between June 1 and Nov 30, 2004. All isolates were assigned a sequence type (strain) on the basis of the sequences of internal fragments of two highly polymorphic loci, par and tbpB. These types were matched to demographic and behavioural data obtained at the clinic for each patient. We assessed the congruence in the demographic and behavioural characteristics of individuals infected with the same strain. Findings We identified 21 prevalent strains in this diverse gonococcal population, each infecting between 20 and 124 individuals. Seven of these strains were predominantly from men who have sex with men; the remaining 14 were predominantly from heterosexual people. No differences were recorded between the strains associated with men who have sex with men in the demographic or behavioural characteristics of infected individuals. By contrast, significant differences in age (p<0.0001), ethnicity (p=0.001), proportion of women (p=0.01), and HIV status (p=0.03) were noted between the 14 prevalent heterosexual-associated strains. Heterosexuals with strains not shared by others in the sample were significantly older (p=0.0005) and more likely to have had sex outside the UK (p<0.0001) than those sharing a strain with at least one other. Interpretation The discriminatory high throughput strain characterisation method applied here identified localised transmission networks and suggests little bridging between networks of men who have sex with men and heterosexual networks.	Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, London, England; London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, London WC1, England; Ctr Dis Control & Prevent, Div Sexually Transmitted Dis Prevent, Atlanta, GA USA; Hlth Protect Agcy, Sexually Transmitted Bacteria Reference Lab, Hlth Protect Agcy Ctr Infect, London, England	Imperial College London; University of London; London School of Hygiene & Tropical Medicine; Centers for Disease Control & Prevention - USA; Health Protection Agency	Spratt, BG (corresponding author), St Marys Hosp, Imperial Coll London, Dept Infect Dis Epidemiol, Norfolk Pl, London W2 1PG, England.	b.spratt@imperial.ac.uk	Choudhury, Bhudipa/D-3863-2011; Ward, Helen/A-1836-2009; Spratt, Brian G/A-1676-2009; Ghani, Azra/B-8560-2009	Choudhury, Bhudipa/0000-0002-1392-6414; Ward, Helen/0000-0001-8238-5036; Ghani, Azra/0000-0002-0007-4910	Wellcome Trust [GR072422] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Aral SO, 2000, SEX TRANSM DIS, V27, P327, DOI 10.1097/00007435-200007000-00005; Aral SO, 2002, SEX TRANSM INFECT, V78, P2, DOI 10.1136/sti.78.1.2; Day S, 1998, SOC SCI MED, V47, P1981, DOI 10.1016/S0277-9536(98)00306-2; Day S, 1998, INT J STD AIDS, V9, P666, DOI 10.1258/0956462981921323; De P, 2004, SEX TRANSM INFECT, V80, P280, DOI 10.1136/sti.2003.007187; Doherty IA, 2005, J INFECT DIS, V191, pS42, DOI 10.1086/425277; Foxman B, 2001, AM J EPIDEMIOL, V153, P1135, DOI 10.1093/aje/153.12.1135; Ghani AC, 1997, SEX TRANSM DIS, V24, P45, DOI 10.1097/00007435-199701000-00009; Ison CA, 1999, SEX TRANSM INFECT, V75, P107, DOI 10.1136/sti.75.2.107; Martin IMC, 2005, J INFECT DIS, V192, P1191, DOI 10.1086/444429; Martin IMC, 2004, J INFECT DIS, V189, P1497, DOI 10.1086/383047; Martin IMC, 2003, J CLIN MICROBIOL, V41, P5609, DOI 10.1128/JCM.41.12.5609-5614.2003; OROURKE M, 1995, MOL MICROBIOL, V17, P865, DOI 10.1111/j.1365-2958.1995.mmi_17050865.x; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; *UK COLL GROUP HIV, 2005, MAPP ISS HIV OTH SEX; Ward H, 2000, LANCET, V356, P1812, DOI 10.1016/S0140-6736(00)03234-7; Ward H, 2004, SEX TRANSM INFECT, V80, P374, DOI 10.1136/sti.2003.009068; White PJ, 2005, J INFECT DIS, V192, P824, DOI 10.1086/432004; Wylie JL, 2005, J INFECT DIS, V191, P899, DOI 10.1086/427661	19	64	66	0	7	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 8	2006	368	9530					139	146		10.1016/S0140-6736(06)69003-X	http://dx.doi.org/10.1016/S0140-6736(06)69003-X			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	062AR	16829298				2022-12-28	WOS:000238917200028
J	Cunningham, D; Allum, WH; Stenning, SP; Thompson, JN; Van de Velde, CJH; Nicolson, M; Scarffe, JH; Lofts, FJ; Falk, SJ; Iveson, TJ; Smith, DB; Langley, RE; Verma, M; Weeden, S; Chua, YJ				Cunningham, David; Allum, William H.; Stenning, Sally P.; Thompson, Jeremy N.; Van de Velde, Cornelis J. H.; Nicolson, Marianne; Scarffe, J. Howard; Lofts, Fiona J.; Falk, Stephen J.; Iveson, Timothy J.; Smith, David B.; Langley, Ruth E.; Verma, Monica; Weeden, Simon; Chua, Yu Jo		MAGIC Trial Participants	Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							LYMPH-NODE DISSECTION; OPERABLE GASTRIC-CANCER; ADJUVANT CHEMOTHERAPY; CURATIVE RESECTION; RANDOMIZED-TRIAL; CISPLATIN; FLUOROURACIL; EPIRUBICIN; METAANALYSIS; ADENOCARCINOMA	Background A regimen of epirubicin, cisplatin, and infused fluorouracil (ECF) improves survival among patients with incurable locally advanced or metastatic gastric adenocarcinoma. We assessed whether the addition of a perioperative regimen of ECF to surgery improves outcomes among patients with potentially curable gastric cancer. Methods We randomly assigned patients with resectable adenocarcinoma of the stomach, esophagogastric junction, or lower esophagus to either perioperative chemotherapy and surgery (250 patients) or surgery alone (253 patients). Chemotherapy consisted of three preoperative and three postoperative cycles of intravenous epirubicin (50 mg per square meter of body-surface area) and cisplatin (60 mg per square meter) on day 1, and a continuous intravenous infusion of fluorouracil (200 mg per square meter per day) for 21 days. The primary end point was overall survival. Results ECF-related adverse effects were similar to those previously reported among patients with advanced gastric cancer. Rates of postoperative complications were similar in the perioperative-chemotherapy group and the surgery group (46 percent and 45 percent, respectively), as were the numbers of deaths within 30 days after surgery. The resected tumors were significantly smaller and less advanced in the perioperative-chemotherapy group. With a median follow-up of four years, 149 patients in the perioperative-chemotherapy group and 170 in the surgery group had died. As compared with the surgery group, the perioperative-chemotherapy group had a higher likelihood of overall survival (hazard ratio for death, 0.75; 95 percent confidence interval, 0.60 to 0.93; P=0.009; five-year survival rate, 36 percent vs. 23 percent) and of progression-free survival (hazard ratio for progression, 0.66; 95 percent confidence interval, 0.53 to 0.81; P<0.001). Conclusions In patients with operable gastric or lower esophageal adenocarcinomas, a perioperative regimen of ECF decreased tumor size and stage and significantly improved progression-free and overall survival.	Royal Marsden Hosp, Dept Med, Sutton SM2 5PT, Surrey, England; Royal Marsden Hosp, Dept Surg, Sutton SM2 5PT, Surrey, England; Royal Marsden Hosp, Dept Med, London SW3 6JJ, England; Royal Marsden Hosp, Dept Surg, London SW3 6JJ, England; MRC, Clin Trials Unit, Canc Grp, London, England; Aberdeen Royal Infirm, Aberdeen, Scotland; Christie Hosp, Dept Med Oncol, Manchester, Lancs, England; St George Hosp, Dept Med Oncol, London, England; Bristol Haematol & Oncol Ctr, Dept Oncol, Bristol, Avon, England; Southampton Gen Hosp, Med Oncol Unit, Southampton SO9 4XY, Hants, England; Clatterbridge Ctr Oncol, Liverpool, Merseyside, England; Leiden Univ, Med Ctr, Dept Surg, Leiden, Netherlands	Royal Marsden NHS Foundation Trust; Royal Marsden NHS Foundation Trust; Royal Marsden NHS Foundation Trust; Royal Marsden NHS Foundation Trust; Medical Research Council Clinical Trials Unit; University of Aberdeen; Christie NHS Foundation Trust; Christie Hospital; St Georges University London; Bristol Haematology & Oncology Centre; University of Southampton; Clatterbridge Cancer Centre; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Cunningham, D (corresponding author), Royal Marsden Hosp, Dept Med, Downs Rd, Sutton SM2 5PT, Surrey, England.	david.cunningham@rmh.nhs.uk	van de Velde, Cornelis/AAY-8360-2020	Cunningham, David/0000-0001-5158-1069; Iveson, Timothy/0000-0002-4681-2712	MRC [MC_U122861327] Funding Source: UKRI; Medical Research Council [MC_U122861327] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		ALLUM W, 2003, P AN M AM SOC CLIN, V22, P249; ALLUM WH, 1989, BRIT J CANCER, V60, P739, DOI 10.1038/bjc.1989.350; ALLUM WH, 1989, LANCET, V1, P571; Bancewicz J, 2002, LANCET, V359, P1727; Bonenkamp JJ, 1999, NEW ENGL J MED, V340, P908, DOI 10.1056/NEJM199903253401202; Cuschieri A, 1999, BRIT J CANCER, V79, P1522, DOI 10.1038/sj.bjc.6690243; Earle CC, 1999, EUR J CANCER, V35, P1059, DOI 10.1016/S0959-8049(99)00076-3; FINDLAY M, 1994, ANN ONCOL, V5, P609, DOI 10.1093/oxfordjournals.annonc.a058932; Hartgrink HH, 2004, EJSO-EUR J SURG ONC, V30, P643, DOI 10.1016/j.ejso.2004.04.013; Hartgrink HH, 2004, J CLIN ONCOL, V22, P2069, DOI 10.1200/JCO.2004.08.026; Hermanek P, 1987, TNM CLASSIFICATION M; HERMANS J, 1993, J CLIN ONCOL, V11, P1441, DOI 10.1200/JCO.1993.11.8.1441; MACDONALD JS, 1995, ANN SURG ONCOL, V2, P488, DOI 10.1007/BF02307081; Macdonald JS, 2001, NEW ENGL J MED, V345, P725, DOI 10.1056/NEJMoa010187; Mari E, 2000, ANN ONCOL, V11, P837, DOI 10.1023/A:1008377101672; McCulloch P, 2004, COCHRANE DB SYST REV, V4; Ross P, 2002, J CLIN ONCOL, V20, P1996, DOI 10.1200/JCO.2002.08.105; Sasako M, 1997, GASTRIC CANCER -BOOK, P223; SIEWERT JR, 1993, BRIT J SURG, V80, P1015, DOI 10.1002/bjs.1800800829; SUELING HM, 1993, BMJ-BRIT MED J, V307, P591, DOI 10.1136/bmj.307.6904.591; Sumpter K, 2005, BRIT J CANCER, V92, P1976, DOI 10.1038/sj.bjc.6602572; Wagner AD, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004064.pub2; Waters JS, 1999, BRIT J CANCER, V80, P269, DOI 10.1038/sj.bjc.6690350; Webb A, 1997, J CLIN ONCOL, V15, P261, DOI 10.1200/JCO.1997.15.1.261	24	4247	4529	7	213	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 6	2006	355	1					11	20		10.1056/NEJMoa055531	http://dx.doi.org/10.1056/NEJMoa055531			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	060DT	16822992				2022-12-28	WOS:000238783200003
J	Tarlinton, RE; Meers, J; Young, PR				Tarlinton, Rachael E.; Meers, Joanne; Young, Paul R.			Retroviral invasion of the koala genome	NATURE			English	Article							GERM-LINE INTEGRATION; ENDOGENOUS RETROVIRUSES; IDENTIFICATION; PROVIRUSES	Endogenous retroviruses are a common ancestral feature of mammalian genomes with most having been inactivated over time through mutation and deletion(1). A group of more intact endogenous retroviruses are considered to have entered the genomes of some species more recently, through infection by exogenous viruses(2), but this event has never been directly proved. We have previously reported koala retrovirus (KoRV) to be a functional virus that is associated with neoplasia(3). Here we show that KoRV also shows features of a recently inserted endogenous retrovirus that is vertically transmitted. The finding that some isolated koala populations have not yet incorporated KoRV into their genomes, combined with its high level of activity and variability in individual koalas, suggests that KoRV is a virus in transition between an exogenous and endogenous element. This ongoing dynamic interaction with a wild species provides an exciting opportunity to study the process and consequences of retroviral endogenization in action, and is an attractive model for studying the evolutionary event in which a retrovirus invades a mammalian genome.	Univ Queensland, Sch Mol & Microbial Sci, St Lucia, Qld 4072, Australia; Univ Queensland, Sch Vet Sci, St Lucia, Qld 4072, Australia	University of Queensland; University of Queensland	Young, PR (corresponding author), Univ Queensland, Sch Mol & Microbial Sci, St Lucia, Qld 4072, Australia.	p.young@uq.edu.au	Meers, Joanne/B-4141-2011; Tarlinton, Rachael/H-1712-2011; Young, Paul R/A-6176-2010	Meers, Joanne/0000-0001-9305-0469; Tarlinton, Rachael/0000-0003-3325-2311; Young, Paul R/0000-0002-2040-5190				BATTINI JL, 1992, J VIROL, V66, P1468, DOI 10.1128/JVI.66.3.1468-1475.1992; Belshaw R, 2004, P NATL ACAD SCI USA, V101, P4894, DOI 10.1073/pnas.0307800101; Boeke J. D., 1997, P343; Bromham L, 2002, TRENDS ECOL EVOL, V17, P91, DOI 10.1016/S0169-5347(01)02394-1; Carlson J, 2003, J VIROL, V77, P9662, DOI 10.1128/JVI.77.17.9662-9668.2003; DELASSUS S, 1989, VIROLOGY, V173, P205, DOI 10.1016/0042-6822(89)90236-5; Fauci A. S., 1997, P587; FRANKEL WN, 1989, J VIROL, V63, P3810, DOI 10.1128/JVI.63.9.3810-3821.1989; Hanger JJ, 2000, J VIROL, V74, P4264, DOI 10.1128/JVI.74.9.4264-4272.2000; Herniou E, 1998, J VIROL, V72, P5955, DOI 10.1128/JVI.72.7.5955-5966.1998; JAENISCH R, 1976, P NATL ACAD SCI USA, V73, P1260, DOI 10.1073/pnas.73.4.1260; Mang R, 2001, J GEN VIROL, V82, P1829, DOI 10.1099/0022-1317-82-8-1829; MARTIN R, 1990, MANAGING KOALAS NEW, P58; Masters P, 2004, WILDLIFE RES, V31, P267, DOI 10.1071/WR03007; O'Neill RJW, 1998, NATURE, V393, P68, DOI 10.1038/29985; RESNICK RM, 1990, J VIROL, V64, P4640, DOI 10.1128/JVI.64.10.4640-4653.1990; SHARP A, 1995, KOALA BOOK; STEFFEN DL, 1982, J VIROL, V42, P165, DOI 10.1128/JVI.42.1.165-175.1982; TAILOR AK, 2003, 15 INT WORKSH RETR P; Tarlinton R, 2005, J GEN VIROL, V86, P783, DOI 10.1099/vir.0.80547-0; Taruscio D, 2004, CYTOGENET GENOME RES, V105, P351, DOI 10.1159/000078208	21	261	269	2	87	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 6	2006	442	7098					79	81		10.1038/nature04841	http://dx.doi.org/10.1038/nature04841			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	059HS	16823453				2022-12-28	WOS:000238724500040
J	Narayanan, V; Mieczkowski, PA; Kim, HM; Petes, TD; Lobachev, KS				Narayanan, Vidhya; Mieczkowski, Piotr A.; Kim, Hyun-Min; Petes, Thomas D.; Lobachev, Kirill S.			The pattern of gene amplification is determined by the chromosomal location of hairpin-capped breaks	CELL			English	Article							DOUBLE-STRAND BREAKS; CHINESE-HAMSTER CELLS; SACCHAROMYCES-CEREVISIAE; FRAGILE SITES; BUDDING YEAST; HUMAN GENOME; CRUCIAL ROLE; RECOMBINATION; REARRANGEMENTS; REPLICATION	DNA palindromes often colocalize in cancer cells with chromosomal regions that are predisposed to gene amplification. The molecular mechanisms by which palindromes can cause gene amplification are largely unknown. Using yeast as a model system, we found that hairpin-capped double-strand breaks (DSBs) occurring at the location of human Alu-quasipalindromes lead to the formation of intrachromosomal amplicons with large inverted repeats (equivalent to homogeneously staining regions in mammalian chromosomes) or extrachromosomal palindromic molecules (equivalent to double minutes [DM] in mammalian cells). We demonstrate that the specific outcomes of gene amplification depend on the applied selection, the nature of the break, and the chromosomal location of the amplified gene relative to the site of the hairpin-capped DSB. The rules for the palindrome-dependent pathway of gene amplification defined in yeast may operate during the formation of amplicons in human tumors.	Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA; Georgia Inst Technol, Inst Bioengn & Biosci, Atlanta, GA 30332 USA; Duke Univ, Dept Mol Genet & Microbiol, Durham, NC 27710 USA	University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; Duke University	Narayanan, V (corresponding author), Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA.	kirill.lobachev@biology.gatech.edu	Kim, Hyun-Min/AAL-2435-2021	Kim, Hyun-Min/0000-0003-4610-3606; Mieczkowski, Piotr/0000-0003-2418-0096	NIGMS NIH HHS [GM52319] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Albertson DG, 2003, NAT GENET, V34, P369, DOI 10.1038/ng1215; Albrecht EB, 2000, MOL BIOL CELL, V11, P873, DOI 10.1091/mbc.11.3.873; Chan SRWL, 2004, PHILOS T R SOC B, V359, P109, DOI 10.1098/rstb.2003.1370; CONTI C, 2001, CURRENT PROTOCOLS CY; Coquelle A, 1997, CELL, V89, P215, DOI 10.1016/S0092-8674(00)80201-9; Coquelle A, 2002, ONCOGENE, V21, P7671, DOI 10.1038/sj.onc.1205880; Debatisse M, 2005, ADV EXP MED BIOL, V570, P343, DOI 10.1007/1-4020-3764-3_12; FLETCHER JA, 2005, PRINCIPLES CLIN CYTO, P365; FRIED M, 1991, BIOCHIM BIOPHYS ACTA, V1090, P143, DOI 10.1016/0167-4781(91)90095-4; HABER JE, 1984, GENETICS, V106, P185; Kaye JA, 2004, CURR BIOL, V14, P2096, DOI 10.1016/j.cub.2004.10.051; Kobayashi T, 2004, CELL, V117, P441, DOI 10.1016/S0092-8674(04)00414-3; KRAMER KM, 1993, GENE DEV, V7, P2345, DOI 10.1101/gad.7.12a.2345; KRAMER KM, 1994, MOL CELL BIOL, V14, P1293, DOI 10.1128/MCB.14.2.1293; Kraus E, 2001, P NATL ACAD SCI USA, V98, P8255, DOI 10.1073/pnas.151008198; Krogh BO, 2004, ANNU REV GENET, V38, P233, DOI 10.1146/annurev.genet.38.072902.091500; KUO MT, 1994, MOL CELL BIOL, V14, P5202, DOI 10.1128/MCB.14.8.5202; Lemoine FJ, 2005, CELL, V120, P587, DOI 10.1016/j.cell.2004.12.039; Lobachev KS, 2000, EMBO J, V19, P3822, DOI 10.1093/emboj/19.14.3822; Lobachev KS, 1998, GENETICS, V148, P1507; Lobachev KS, 2002, CELL, V108, P183, DOI 10.1016/S0092-8674(02)00614-1; MA C, 1993, GENE DEV, V7, P605, DOI 10.1101/gad.7.4.605; Malkova A, 1996, P NATL ACAD SCI USA, V93, P7131, DOI 10.1073/pnas.93.14.7131; Maringele L, 2004, GENE DEV, V18, P2663, DOI 10.1101/gad.316504; McClintock B, 1941, GENETICS, V26, P234; Mondello C, 2001, CANCER RES, V61, P4520; Myung K, 2003, DNA REPAIR, V2, P243, DOI 10.1016/S1568-7864(02)00216-1; Naeem RC, 2005, PRINCIPLES CLIN CYTO, P365; Paulson TG, 1998, MOL CELL BIOL, V18, P3089, DOI 10.1128/MCB.18.5.3089; Pennaneach V, 2006, MOL MICROBIOL, V59, P1357, DOI 10.1111/j.1365-2958.2006.05026.x; Pipiras E, 1998, EMBO J, V17, P325, DOI 10.1093/emboj/17.1.325; Poupon MF, 1996, MOL BIOL CELL, V7, P345, DOI 10.1091/mbc.7.3.345; Putnam CD, 2005, MOL CELL BIOL, V25, P7226, DOI 10.1128/MCB.25.16.7226-7238.2005; Rachidi N, 2000, MOL MICROBIOL, V35, P1421, DOI 10.1046/j.1365-2958.2000.01807.x; Rattray AJ, 2005, GENE DEV, V19, P1390, DOI 10.1101/gad.1315805; RESNICK MA, 1990, CHROMOSOMA, V99, P281, DOI 10.1007/BF01731704; Shimizu N, 2005, EXP CELL RES, V302, P233, DOI 10.1016/j.yexcr.2004.09.001; STARK GR, 1989, CELL, V57, P901, DOI 10.1016/0092-8674(89)90328-0; Stenger JE, 2001, GENOME RES, V11, P12, DOI 10.1101/gr.158801; Sutherland GR, 2003, CYTOGENET GENOME RES, V100, P77, DOI 10.1159/000072840; Tanaka H, 2005, NAT GENET, V37, P320, DOI 10.1038/ng1515; TOLEDO F, 1993, CURR BIOL, V3, P255, DOI 10.1016/0960-9822(93)90175-N; Umezu K, 2002, GENETICS, V160, P97; VandenBerg MA, 1997, YEAST, V13, P551, DOI 10.1002/(SICI)1097-0061(199705)13:6<551::AID-YEA113>3.0.CO;2-0; Wang P, 2005, BIOSTATISTICS, V6, P45, DOI 10.1093/biostatistics/kxh017; Watanabe T, 2005, EMBO J, V24, P190, DOI 10.1038/sj.emboj.7600503; WINDLE BE, 1992, MUTAT RES, V276, P199, DOI 10.1016/0165-1110(92)90009-X; YUNIS JJ, 1987, ONCOGENE, V1, P59; Zhou ZH, 2001, P NATL ACAD SCI USA, V98, P8326, DOI 10.1073/pnas.151008498	49	123	126	0	7	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUN 30	2006	125	7					1283	1296		10.1016/j.cell.2006.04.042	http://dx.doi.org/10.1016/j.cell.2006.04.042			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	064QP	16814715	Bronze			2022-12-28	WOS:000239104500012
J	Novotny, V; Drozd, P; Miller, SE; Kulfan, M; Janda, M; Basset, Y; Weiblen, GD				Novotny, Vojtech; Drozd, Pavel; Miller, Scott E.; Kulfan, Miroslav; Janda, Milan; Basset, Yves; Weiblen, George D.			Why are there so many species of herbivorous insects in tropical rainforests?	SCIENCE			English	Article							HOST-SPECIFICITY; RICHNESS; PLANTS; ABUNDANCE; TREES	Despite recent progress in understanding mechanisms of tree species coexistence in tropical forests, a simple explanation for the even more extensive diversity of insects feeding on these plants has been missing. We compared folivorous insects from temperate and tropical trees to test the hypothesis that herbivore species coexistence in more diverse communities could reflect narrow host specificity relative to less diverse communities. Temperate and tropical tree species of comparable phylogenetic distribution supported similar numbers of folivorous insect species, 29.0 +/- 2.2 and 23.5 +/- 1.8 per 100 square meters of foliage, respectively. Host specificity did not differ significantly between community samples, indicating that food resources are not more finely partitioned among folivorous insects in tropical than in temperate forests. These findings suggest that the latitudinal gradient in insect species richness could be a direct function of plant diversity, which increased sevenfold from our temperate to tropical study sites.	Acad Sci Czech Republ, Inst Entomol, CR-37005 Ceske Budejovice, Czech Republic; Univ S Bohemia, Dept Zool, Ceske Budejovice 37005, Czech Republic; Univ Ostrava, Dept Biol, Ostrava 71000, Czech Republic; Natl Museum Nat Hist, Smithsonian Inst, Washington, DC 20013 USA; Comenius Univ, Dept Zool, Bratislava, Slovakia; Smithsonian Trop Res Inst, Balboa, Ancon, Panama; Univ Minnesota, Dept Plant Biol, St Paul, MN 55108 USA; Univ Minnesota, Bell Museum Nat Hist, St Paul, MN 55108 USA	Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; University of South Bohemia Ceske Budejovice; University of Ostrava; Smithsonian Institution; Smithsonian National Museum of Natural History; Comenius University Bratislava; Smithsonian Institution; Smithsonian Tropical Research Institute; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Novotny, V (corresponding author), Acad Sci Czech Republ, Inst Entomol, Branisovska 31, CR-37005 Ceske Budejovice, Czech Republic.	novotny@entu.cas.cz	Drozd, Pavel/J-3943-2013; Novotny, Vojtech/G-9434-2014; Basset, Yves F/B-6642-2014; Janda, Milan/H-7216-2014	Drozd, Pavel/0000-0002-4602-8856; Novotny, Vojtech/0000-0001-7918-8023; Basset, Yves F/0000-0002-1942-5717; Janda, Milan/0000-0003-3038-0107; Miller, Scott/0000-0002-4138-1378				Barone JA, 1998, J ANIM ECOL, V67, P400, DOI 10.1046/j.1365-2656.1998.00197.x; BARTHLOTT W, 1996, ERDKUNDE, V50, P317, DOI [DOI 10.3112/ERDKUNDE.1996.04.03, 10.1007/s004250050096, DOI 10.1007/S004250050096]; Basset Y, 1996, ECOLOGY, V77, P1906, DOI 10.2307/2265793; BASSET Y, 2003, ARTHROPODS TROPICAL; BEAVER RA, 1979, NATURE, V281, P139, DOI 10.1038/281139a0; Chao A, 2005, ECOL LETT, V8, P148, DOI 10.1111/j.1461-0248.2004.00707.x; DYER LA, 1995, ECOLOGY, V76, P1483, DOI 10.2307/1938150; Fiedler Konrad, 1995, Ecotropica, V1, P51; FUTUYMA DJ, 1979, ECOL MONOGR, V49, P33, DOI 10.2307/1942571; GASTON KJ, 1992, FUNCT ECOL, V6, P243, DOI 10.2307/2389513; JANZEN DH, 1988, BIOTROPICA, V20, P120, DOI 10.2307/2388184; JANZEN DH, 2005, CATERPILLAR REARING; JEANNE RL, 1979, ECOLOGY, V60, P1211, DOI 10.2307/1936968; KARBAN R, 1983, ECOLOGY, V64, P636, DOI 10.2307/1937182; Lewinsohn TM, 2005, ANNU REV ECOL EVOL S, V36, P597, DOI 10.1146/annurev.ecolsys.36.091704.175520; Marquis R.J., 1991, P179; Novotny V, 2005, P ROY SOC B-BIOL SCI, V272, P1083, DOI 10.1098/rspb.2004.3023; Novotny V, 2004, CONSERV BIOL, V18, P227, DOI 10.1111/j.1523-1739.2004.00293.x; Novotny V, 2002, NATURE, V416, P841, DOI 10.1038/416841a; Odegaard F, 2000, J BIOGEOGR, V27, P283, DOI 10.1046/j.1365-2699.2000.00404.x; Price PW, 1995, BIOTROPICA, V27, P468, DOI 10.2307/2388960; SCRIBER JM, 1988, CHEM MEDIATION COEVO, P241; Stireman JO, 2005, P NATL ACAD SCI USA, V102, P17384, DOI 10.1073/pnas.0508839102; Turner I.M., 2001, CAM TROP B, DOI 10.1017/CBO9780511542206; Ward L.K., 1988, British Journal of Entomology and Natural History, V1, P153; WOOD TK, 1983, SOCIOBIOLOGY, V8, P299	26	392	408	8	238	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 25	2006	313	5790					1115	1118		10.1126/science.1129237	http://dx.doi.org/10.1126/science.1129237			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	076ZT	16840659				2022-12-28	WOS:000239998200045
J	Cruts, M; Gijselinck, I; van der Zee, J; Engelborghs, S; Wils, H; Pirici, D; Rademakers, R; Vandenberghe, R; Dermaut, B; Martin, JJ; van Duijn, C; Peeters, K; Sciot, R; Santens, P; De Pooter, T; Mattheijssens, M; Van den Broeck, M; Cuijt, I; Vennekens, K; De Deyn, PP; Kumar-Singh, S; Van Broeckhoven, C				Cruts, Marc; Gijselinck, Ilse; van der Zee, Julie; Engelborghs, Sebastiaan; Wils, Hans; Pirici, Daniel; Rademakers, Rosa; Vandenberghe, Rik; Dermaut, Bart; Martin, Jean-Jacques; van Duijn, Cornelia; Peeters, Karin; Sciot, Raf; Santens, Patrick; De Pooter, Tim; Mattheijssens, Maria; Van den Broeck, Marleen; Cuijt, Ivy; Vennekens, Krist'l; De Deyn, Peter P.; Kumar-Singh, Samir; Van Broeckhoven, Christine			Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21	NATURE			English	Article							VALOSIN-CONTAINING PROTEIN; GROWTH-FACTOR; LOBAR DEGENERATION; PICKS-DISEASE; TAU; INCLUSIONS; EXPRESSION; GRANULIN; FAMILY; GENE	Frontotemporal dementia (FTD) with ubiquitin-immunoreactive neuronal inclusions ( both cytoplasmic and nuclear) of unknown nature has been linked to a chromosome 17q21 region (FTDU-17) containing MAPT (microtubule-associated protein tau)(1-3). FTDU-17 patients have consistently been shown to lack a tau-immunoreactive pathology(1-3), a feature characteristic of FTD with parkinsonism linked to mutations in MAPT (FTDP-17)(4). Furthermore, in FTDU-17 patients, mutations in MAPT and genomic rearrangements in the MAPT region have been excluded by both genomic sequencing(5) and fluorescence in situ hybridization on mechanically stretched chromosomes(6). Here we demonstrate that FTDU-17 is caused by mutations in the gene coding for progranulin (PGRN), a growth factor involved in multiple physiological and pathological processes including tumorigenesis(7). Besides the production of truncated PGRN proteins due to premature stop codons(8), we identified a mutation within the splice donor site of intron 0 (IVS0+5G> C), indicating loss of the mutant transcript by nuclear degradation. The finding was made within an extensively documented Belgian FTDU-17 founder family(3). Transcript and protein analyses confirmed the absence of the mutant allele and a reduction in the expression of PGRN. We also identified a mutation ( c. 3G>A) in the Met1 translation initiation codon, indicating loss of PGRN due to lack of translation of the mutant allele. Our data provide evidence that PGRN haploinsufficiency leads to neurodegeneration because of reduced PGRN-mediated neuronal survival. Furthermore, in a Belgian series of familial FTD patients, PGRN mutations were 3.5 times more frequent than mutations in MAPT, underscoring a principal involvement of PGRN in FTD pathogenesis.	Univ Antwerp VIB, Dept Mol Genet, Neurodegenerat Brain Dis Grp, BE-2610 Antwerp, Belgium; Inst Born Bunge, Neurogenet Lab, BE-2610 Antwerp, Belgium; Inst Born Bunge, Lab Neurochem & Behav, BE-2610 Antwerp, Belgium; Inst Born Bunge, Neuropathol Lab, BE-2610 Antwerp, Belgium; Univ Antwerp, BE-2610 Antwerp, Belgium; Middleheim Gen Hosp, Dept Neurol, Memory Clin, BE-2610 Antwerp, Belgium; Katholieke Univ Leuven, Univ Hosp Gasthuisberg, Dept Pathol, BE-3000 Louvain, Belgium; Katholieke Univ Leuven, Univ Hosp Gasthuisberg, Dept Neurol, BE-3000 Louvain, Belgium; Univ Ghent, State Univ Ghent Hosp, Dept Neurol, BE-9000 Ghent, Belgium; Erasmus MC, Dept Epidemiol & Biostat, Genet Epidemiol Grp, NL-3000 DR Rotterdam, Netherlands	Flanders Institute for Biotechnology (VIB); University of Antwerp; University of Antwerp; KU Leuven; University Hospital Leuven; KU Leuven; University Hospital Leuven; Ghent University; Ghent University Hospital; Erasmus University Rotterdam; Erasmus MC	Van Broeckhoven, C (corresponding author), Univ Antwerp VIB, Dept Mol Genet, Neurodegenerat Brain Dis Grp, Univ Pl 1, BE-2610 Antwerp, Belgium.	christine.vanbroeckhoven@ua.ac.be	Van Broeckhoven, Christine/M-7853-2019; Kumar-Singh, Samir/G-6280-2012; Vandenberghe, Rik/AAR-7485-2020; Vandenberghe, Rik/K-2145-2014; Cruts, Marc/J-6161-2013; Dermaut, Bart/AAM-2483-2020; santens, patrick/O-2505-2013; Van Broeckhoven, Christine/G-8362-2017; Pirici, Daniel/C-5760-2012	Van Broeckhoven, Christine/0000-0003-0183-7665; Kumar-Singh, Samir/0000-0001-9466-6732; Vandenberghe, Rik/0000-0001-6237-2502; Vandenberghe, Rik/0000-0001-6237-2502; Cruts, Marc/0000-0002-1338-992X; Van Broeckhoven, Christine/0000-0003-0183-7665; Pirici, Daniel/0000-0001-9192-7319; Van Duijn, Cornelia/0000-0002-2374-9204; Santens, Patrick/0000-0002-8886-9776; Pirici, Daniel/0000-0002-0196-0949; sciot, raf/0000-0003-2244-5839				Baker CA, 2003, P NATL ACAD SCI USA, V100, P675, DOI 10.1073/pnas.0237313100; BAKER M, 2006, NATURE          0716; Cruts M, 2005, HUM MOL GENET, V14, P1753, DOI 10.1093/hmg/ddi182; CRUTS M, IN PRESS CURR ALZHEI; Daniel R, 2000, J HISTOCHEM CYTOCHEM, V48, P999, DOI 10.1177/002215540004800713; Dermaut B, 2004, ANN NEUROL, V55, P617, DOI 10.1002/ana.20083; Engelborghs S, 2003, J NEUROL NEUROSUR PS, V74, P1148, DOI 10.1136/jnnp.74.8.1148; Forman MS, 2006, ANN NEUROL, V59, P952, DOI 10.1002/ana.20873; GIJSELINCK I, IN PRESS HUM MUTAT; He ZH, 2003, J MOL MED-JMM, V81, P600, DOI 10.1007/s00109-003-0474-3; Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508; Liau LM, 2000, CANCER RES, V60, P1353; Mackenzie IR, 2006, BRAIN, V129, P853, DOI 10.1093/brain/awh724; Malaspina A, 2001, J NEUROCHEM, V77, P132, DOI 10.1046/j.1471-4159.2001.t01-1-00231.x; McKhann GM, 2001, ARCH NEUROL-CHICAGO, V58, P1803, DOI 10.1001/archneur.58.11.1803; Neary D, 1998, NEUROLOGY, V51, P1546, DOI 10.1212/WNL.51.6.1546; Oosthuyse B, 2001, NAT GENET, V28, P131, DOI 10.1038/88842; Pirici D, 2006, J NEUROPATH EXP NEUR, V65, P289, DOI 10.1097/01.jnen.0000205147.39210.c7; Rademakers R, 2002, MOL PSYCHIATR, V7, P1064, DOI 10.1038/sj.mp.4001198; Rosso SM, 2001, BRAIN, V124, P1948, DOI 10.1093/brain/124.10.1948; Rozen S, 2000, Methods Mol Biol, V132, P365; Schroder R, 2005, ANN NEUROL, V57, P457, DOI 10.1002/ana.20407; Suzuki M, 2002, MOL GENET METAB, V75, P31, DOI 10.1006/mgme.2001.3274; Tangkeangsirisin W, 2004, CARCINOGENESIS, V25, P1587, DOI 10.1093/carcin/bgh171; van der Zee J, 2006, BRAIN, V129, P841, DOI 10.1093/brain/awl029; Vinciguerra P, 2004, CURR OPIN CELL BIOL, V16, P285, DOI 10.1016/j.ceb.2004.03.013; Watts GDJ, 2004, NAT GENET, V36, P377, DOI 10.1038/ng1332; Weckx S, 2005, GENOME RES, V15, P436, DOI 10.1101/gr.2754005	28	1122	1148	0	68	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 24	2006	442	7105					920	924		10.1038/nature05017	http://dx.doi.org/10.1038/nature05017			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	076LT	16862115				2022-12-28	WOS:000239960500038
J	Denic, V; Quan, EM; Weissman, JS				Denic, Vladimir; Quan, Erin M.; Weissman, Jonathan S.			A luminal surveillance complex that selects misfolded glycoproteins for ER-associated degradation	CELL			English	Article							RETICULUM-ASSOCIATED DEGRADATION; UNFOLDED PROTEIN RESPONSE; MANNOSIDASE-LIKE PROTEIN; ENDOPLASMIC-RETICULUM; UBIQUITIN-LIGASE; RETRO-TRANSLOCATION; QUALITY-CONTROL; SACCHAROMYCES-CEREVISIAE; MOLECULAR CHAPERONES; IDENTIFIES YOS9P	How the ER-associated degradation (ERAD) machinery accurately identifies terminally misfolded proteins is poorly understood. For luminal ERAD substrates, this recognition depends on their folding and glycosylation status as well as on the conserved ER lectin Yos9p. Here we show that Yos9p is part of a stable complex that organizes key components of ERAD machinery on both sides of the ER membrane, including the transmembrane ubiquitin ligase Hrd1p. We further demonstrate that Yos9p, together with Kar2p and Hrd3p, forms a luminal surveillance complex that both recruits nonnative proteins to the core ERAD machinery and assists a distinct sugar-dependent step necessary to commit substrates for degradation. When Hrd1p is uncoupled from the Yos9p surveillance complex, degradation can occur independently of the requirement for glycosylation. Thus, Yos9p/Kar2p/Hrd3p acts as a gatekeeper, ensuring correct identification of terminally misfolded proteins by recruiting misfolded forms to the ERAD machinery, contributing to the interrogation of substrate sugar status, and preventing glycosylation-independent degradation.	Univ Calif San Francisco, Howard Hughes Med Inst, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; Univ Calif San Francisco, Calif Inst Quantitat Biomed Res, San Francisco, CA 94158 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Weissman, JS (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA.	weissman@cmp.ucsf.edu		Weissman, Jonathan/0000-0003-2445-670X				Adams J, 2002, CURR OPIN CHEM BIOL, V6, P493, DOI 10.1016/S1367-5931(02)00343-5; Bays NW, 2001, NAT CELL BIOL, V3, P24, DOI 10.1038/35050524; Belden WJ, 2001, SCIENCE, V294, P1528, DOI 10.1126/science.1065224; Bhamidipati A, 2005, MOL CELL, V19, P741, DOI 10.1016/j.molcel.2005.07.027; Biederer T, 1997, SCIENCE, V278, P1806, DOI 10.1126/science.278.5344.1806; BONIFACINO JS, 1990, SCIENCE, V247, P79, DOI 10.1126/science.2294595; Buschhorn BA, 2004, FEBS LETT, V577, P422, DOI 10.1016/j.febslet.2004.10.039; Carvalho P, 2006, CELL, V126, P361, DOI 10.1016/j.cell.2006.05.043; Casagrande R, 2000, MOL CELL, V5, P729, DOI 10.1016/S1097-2765(00)80251-8; Deak PM, 2001, J BIOL CHEM, V276, P10663, DOI 10.1074/jbc.M008608200; DRUMM ML, 1991, SCIENCE, V254, P1797, DOI 10.1126/science.1722350; FLOWER AM, 1994, J BACTERIOL, V176, P5607, DOI 10.1128/JB.176.18.5607-5614.1994; Friedlander R, 2000, NAT CELL BIOL, V2, P379, DOI 10.1038/35017001; Friedmann E, 2002, J BIOL CHEM, V277, P35274, DOI 10.1074/jbc.M201044200; Gardner RG, 2001, MOL CELL BIOL, V21, P4276, DOI 10.1128/MCB.21.13.4276-4291.2001; Gardner RG, 2000, J CELL BIOL, V151, P69, DOI 10.1083/jcb.151.1.69; Gauss R, 2006, EMBO J, V25, P1827, DOI 10.1038/sj.emboj.7601088; Helenius A, 2001, SCIENCE, V291, P2364, DOI 10.1126/science.291.5512.2364; Hirao K, 2006, J BIOL CHEM, V281, P9650, DOI 10.1074/jbc.M512191200; HOPFIELD JJ, 1974, P NATL ACAD SCI USA, V71, P4135, DOI 10.1073/pnas.71.10.4135; Jakob CA, 2001, EMBO REP, V2, P423; Jarosch E, 2002, NAT CELL BIOL, V4, P134, DOI 10.1038/ncb746; JENSEN TJ, 1995, CELL, V83, P129, DOI 10.1016/0092-8674(95)90241-4; Jimenez C., 1998, CURRENT PROTOCOLS PR; Kabani M, 2000, MOL CELL BIOL, V20, P6923, DOI 10.1128/MCB.20.18.6923-6934.2000; Kabani M, 2003, MOL BIOL CELL, V14, P3437, DOI 10.1091/mbc.E02-12-0847; Kim W, 2005, MOL CELL, V19, P753, DOI 10.1016/j.molcel.2005.08.010; Knop M, 1996, EMBO J, V15, P753, DOI 10.1002/j.1460-2075.1996.tb00411.x; Kostova Z, 2005, J CELL SCI, V118, P1485, DOI 10.1242/jcs.01740; Lilley BN, 2005, P NATL ACAD SCI USA, V102, P14296, DOI 10.1073/pnas.0505014102; Lilley BN, 2004, NATURE, V429, P834, DOI 10.1038/nature02592; Meusser B, 2005, NAT CELL BIOL, V7, P766, DOI 10.1038/ncb0805-766; Nakatsukasa K, 2001, J BIOL CHEM, V276, P8635, DOI 10.1074/jbc.C100023200; Neuber O, 2005, NAT CELL BIOL, V7, P993, DOI 10.1038/ncb1298; Nishikawa S, 2005, J BIOCHEM, V137, P551, DOI 10.1093/jb/mvi068; Nishikawa S, 2001, J CELL BIOL, V153, P1061, DOI 10.1083/jcb.153.5.1061; Oda Y, 2006, J CELL BIOL, V172, P383, DOI 10.1083/jcb.200507057; Plemper RK, 1999, J CELL SCI, V112, P4123; Richly H, 2005, CELL, V120, P73, DOI 10.1016/j.cell.2004.11.013; Romisch K, 2005, ANNU REV CELL DEV BI, V21, P435, DOI 10.1146/annurev.cellbio.21.012704.133250; Sayeed A, 2005, CRIT REV BIOCHEM MOL, V40, P75, DOI 10.1080/10409230590918685; Schuberth C, 2005, NAT CELL BIOL, V7, P999, DOI 10.1038/ncb1299; Sekijima Y, 2005, CELL, V121, P73, DOI 10.1016/j.cell.2005.01.018; Spear ED, 2005, J CELL BIOL, V169, P73, DOI 10.1083/jcb.200411136; Swanson R, 2001, GENE DEV, V15, P2660, DOI 10.1101/gad.933301; Szathmary R, 2005, MOL CELL, V19, P765, DOI 10.1016/j.molcel.2005.08.015; Taxis C, 2003, J BIOL CHEM, V278, P35903, DOI 10.1074/jbc.M301080200; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; Tsai B, 2002, NAT REV MOL CELL BIO, V3, P246, DOI 10.1038/nrm780; Vashist S, 2004, J CELL BIOL, V165, P41, DOI 10.1083/jcb.200309132; WARD CL, 1995, CELL, V83, P121, DOI 10.1016/0092-8674(95)90240-6; Ye YH, 2001, NATURE, V414, P652, DOI 10.1038/414652a; Ye YH, 2005, P NATL ACAD SCI USA, V102, P14132, DOI 10.1073/pnas.0505006102; Ye YH, 2004, NATURE, V429, P841, DOI 10.1038/nature02656	54	327	334	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 28	2006	126	2					349	359		10.1016/j.cell.2006.05.045	http://dx.doi.org/10.1016/j.cell.2006.05.045			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	070VD	16873065	Bronze			2022-12-28	WOS:000239552600020
J	Reysenbach, AL; Liu, YT; Banta, AB; Beveridge, TJ; Kirshtein, JD; Schouten, S; Tivey, MK; Von Damm, KL; Voytek, MA				Reysenbach, Anna-Louise; Liu, Yitai; Banta, Amy B.; Beveridge, Terry J.; Kirshtein, Julie D.; Schouten, Stefan; Tivey, Margaret K.; Von Damm, Karen L.; Voytek, Mary A.			A ubiquitous thermoacidophilic archaeon from deep-sea hydrothermal vents	NATURE			English	Article							DIVERSITY; MICROORGANISMS; ENVIRONMENTS; SEDIMENTS; BACTERIAL; CHIMNEY; GROWTH; ARC; NOV	Deep-sea hydrothermal vents are important in global biogeochemical cycles, providing biological oases at the sea floor that are supported by the thermal and chemical flux from the Earth's interior. As hot, acidic and reduced hydrothermal fluids mix with cold, alkaline and oxygenated sea water, minerals precipitate to formporous sulphide - sulphate deposits. These structures provide microhabitats for a diversity of prokaryotes that exploit the geochemical and physical gradients in this dynamic ecosystem(1). It has been proposed that fluid pH in the actively venting sulphide structures is generally low( pH < 4.5)(2), yet no extreme thermoacidophile has been isolated from vent deposits. Culture-independent surveys based on ribosomal RNA genes from deep-sea hydrothermal deposits have identified a widespread euryarchaeotal lineage, DHVE2 (deep-sea hydrothermal vent euryarchaeotic 2)(3-6). Despite the ubiquity and apparent deep-sea endemism of DHVE2, cultivation of this group has been unsuccessful and thus its metabolism remains a mystery. Here we report the isolation and cultivation of a member of the DHVE2 group, which is an obligate thermoacidophilic sulphur- or iron-reducing heterotroph capable of growing from pH 3.3 to 5.8 and between 55 and 75 degrees C. In addition, we demonstrate that this isolate constitutes up to 15% of the archaeal population, providing evidence that thermoacidophiles may be key players in the sulphur and iron cycling at deep-sea vents.	Portland State Univ, Dept Biol, Portland, OR 97201 USA; Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada; US Geol Survey, Reston, VA USA; Royal Netherlands Inst Sea Res, Dept Marine Biogeochem & Toxicol, NL-1790 AB Den Burg, Netherlands; Woods Hole Oceanog Inst, Dept Marine Chem & Geochem, Woods Hole, MA 02543 USA; Univ New Hampshire, EOS, Complex Syst Res Ctr, Durham, NH 03824 USA	Portland State University; University of Guelph; United States Department of the Interior; United States Geological Survey; Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ); Woods Hole Oceanographic Institution; University System Of New Hampshire; University of New Hampshire	Reysenbach, AL (corresponding author), Portland State Univ, Dept Biol, Portland, OR 97201 USA.	reysenbacha@pdx.edu		Banta, Amy/0000-0002-1843-5059; Tivey, Margaret/0000-0003-3218-5882				BEVERIDGE TJ, 1999, J BACTERIOL, V7, P253; Hoek J, 2003, GEOBIOLOGY, V1, P119, DOI 10.1046/j.1472-4669.2003.00015.x; Hopmans EC, 2000, RAPID COMMUN MASS SP, V14, P585, DOI 10.1002/(SICI)1097-0231(20000415)14:7<585::AID-RCM913>3.3.CO;2-E; Inagaki F, 2006, P NATL ACAD SCI USA, V103, P2815, DOI 10.1073/pnas.0511033103; Ishibashi J.-I., 2006, EOS T AGU, V87, P13, DOI DOI 10.1029/2006EO020001; KOBAYASHI T, 2001, BERGEYS MANUAL SYSTE, P342; LANGMUIR CH, 2004, EOS, V85; Le Bris N, 2005, DEEP-SEA RES PT I, V52, P1071, DOI 10.1016/j.dsr.2005.01.003; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Macalady JL, 2004, EXTREMOPHILES, V8, P411, DOI 10.1007/s00792-004-0404-5; McCollom TM, 1997, GEOCHIM COSMOCHIM AC, V61, P4375, DOI 10.1016/S0016-7037(97)00241-X; Moussard H, 2006, APPL ENVIRON MICROB, V72, P2268, DOI 10.1128/AEM.72.3.2268-2271.2006; Nakagawa S, 2005, ENVIRON MICROBIOL, V7, P1619, DOI 10.1111/j.1462-2920.2005.00856.x; Nakagawa T, 2006, ENVIRON MICROBIOL, V8, P37, DOI 10.1111/j.1462-2920.2005.00884.x; Nercessian O, 2003, ENVIRON MICROBIOL, V5, P492, DOI 10.1046/j.1462-2920.2003.00437.x; OLSEN GJ, 1994, COMPUT APPL BIOSCI, V10, P41; Prokofeva MI, 2005, EXTREMOPHILES, V9, P437, DOI 10.1007/s00792-005-0461-4; Reysenbach AL, 2000, APPL ENVIRON MICROB, V66, P3798, DOI 10.1128/AEM.66.9.3798-3806.2000; Reysenbach AL, 2002, SCIENCE, V296, P1077, DOI 10.1126/science.1072483; SCHLEPER C, 1995, J BACTERIOL, V177, P7050, DOI 10.1128/jb.177.24.7050-7059.1995; Schrenk MO, 2003, APPL ENVIRON MICROB, V69, P3580, DOI 10.1128/AEM.69.6.3580-3592.2003; SEGERER A, 1988, SYST APPL MICROBIOL, V10, P161, DOI 10.1016/S0723-2020(88)80031-6; Sleytr UB, 1999, TRENDS MICROBIOL, V7, P253, DOI 10.1016/S0966-842X(99)01513-9; Takai K, 2005, INT J SYST EVOL MICR, V55, P183, DOI 10.1099/ijs.0.63330-0; Takai K, 1999, GENETICS, V152, P1285; Takai K, 2001, APPL ENVIRON MICROB, V67, P3618, DOI 10.1128/AEM.67.8.3618-3629.2001; Tivey MK, 2004, GEOPH MONOG SERIES, V144, P137, DOI 10.1029/144GM09; VONDAMM KL, 1995, PHYS CHEM BIOL GEOLO, P222	28	166	180	3	72	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 27	2006	442	7101					444	447		10.1038/nature04921	http://dx.doi.org/10.1038/nature04921			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067CI	16871216	Green Submitted			2022-12-28	WOS:000239278900041
J	Tokano, T; Mckay, CP; Neubauer, FM; Atreya, SK; Ferri, F; Fulchignoni, M; Niemann, HB				Tokano, Tetsuya; McKay, Christopher P.; Neubauer, Fritz M.; Atreya, Sushil K.; Ferri, Francesca; Fulchignoni, Marcello; Niemann, Hasso B.			Methane drizzle on Titan	NATURE			English	Article							MIDLATITUDE CLOUDS; SOUTH-POLE; TROPOSPHERE; ATMOSPHERE; ABUNDANCES; SURFACE; WINDS; RAIN	Saturn's moon Titan shows landscapes with fluvial features(1) suggestive of hydrology based on liquid methane. Recent efforts in understanding Titan's methane hydrological cycle have focused on occasional cloud outbursts near the south pole(2-4) or cloud streaks at southern mid-latitudes(5,6) and the mechanisms of their formation. It is not known, however, if the clouds produce rain or if there are also non-convective clouds, as predicted by several models(7-11). Here we show that the in situ data on the methane concentration and temperature profile in Titan's troposphere point to the presence of layered optically thin stratiform clouds. The data indicate an upper methane ice cloud and a lower, barely visible, liquid methane-nitrogen cloud, with a gap in between. The lower, liquid, cloud produces drizzle that reaches the surface. These non-convective methane clouds are quasi-permanent features supported by the global atmospheric circulation, indicating that methane precipitation occurs wherever there is slow upward motion. This drizzle is a persistent component of Titan's methane hydrological cycle and, by wetting the surface on a global scale, plays an active role in the surface geology of Titan.	Univ Cologne, Inst Geophys & Meteorol, D-50923 Cologne, Germany; NASA, Ames Res Ctr, Moffett Field, CA 94035 USA; Univ Michigan, Dept Atmospher Ocean & Space Sci, Ann Arbor, MI 48109 USA; Univ Padua, CISAS G Colombo, I-35131 Padua, Italy; Observ Paris, LESIA, F-92195 Meudon, France; Univ Paris 07, UFR Phys, F-75006 Paris, France; NASA, Goddard Space Flight Ctr, Greenbelt, MD 20742 USA	University of Cologne; National Aeronautics & Space Administration (NASA); NASA Ames Research Center; University of Michigan System; University of Michigan; University of Padua; UDICE-French Research Universities; PSL Research University Paris; Observatoire de Paris; UDICE-French Research Universities; Universite Paris Cite; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center	Tokano, T (corresponding author), Univ Cologne, Inst Geophys & Meteorol, Albertus Magnus Pl, D-50923 Cologne, Germany.	tokano@geo.uni-koeln.de		Ferri, Francesca/0000-0003-2395-5275				ATREYA SK, IN PRESS PLANET SPAC; Barth EL, 2006, ICARUS, V182, P230, DOI 10.1016/j.icarus.2005.12.017; Bird MK, 2005, NATURE, V438, P800, DOI 10.1038/nature04060; Brown ME, 2002, NATURE, V420, P795, DOI 10.1038/nature01302; COURTIN R, 1995, ICARUS, V114, P144, DOI 10.1006/icar.1995.1050; Fulchignoni M, 2005, NATURE, V438, P785, DOI 10.1038/nature04314; Griffith CA, 2005, SCIENCE, V310, P474, DOI 10.1126/science.1117702; Lemmon MT, 2002, ICARUS, V160, P375, DOI 10.1006/icar.2002.6979; LINDAL GF, 1983, ICARUS, V53, P348, DOI 10.1016/0019-1035(83)90155-0; Lorenz RD, 2002, ICARUS, V158, P557, DOI 10.1006/icar.2002.6880; Lorenz RD, 1996, ICARUS, V122, P79, DOI 10.1006/icar.1996.0110; MAKINEN JTT, UNPUB GEOPHYS RES LE; MAKINEN T, 1996, ADV SPACE RES, V17, P217; McKay CP, 1997, ICARUS, V129, P498, DOI 10.1006/icar.1997.5751; Niemann HB, 2005, NATURE, V438, P779, DOI 10.1038/nature04122; Penteado PF, 2005, ASTROPHYS J, V629, pL53, DOI 10.1086/444353; Porco CC, 2005, NATURE, V434, P159, DOI 10.1038/nature03436; Pruppacher HR, 1997, MICROPHYSICS CLOUDS; Rannou P, 2006, SCIENCE, V311, P201, DOI 10.1126/science.1118424; Roe HG, 2005, SCIENCE, V310, P477, DOI 10.1126/science.1116760; Samuelson RE, 1997, PLANET SPACE SCI, V45, P959, DOI 10.1016/S0032-0633(97)00090-1; Samuelson RE, 1997, PLANET SPACE SCI, V45, P949, DOI 10.1016/S0032-0633(97)00089-5; Schaller EL, 2006, ICARUS, V182, P224, DOI 10.1016/j.icarus.2005.12.021; Sotin C, 2005, NATURE, V435, P786, DOI 10.1038/nature03596; THOMPSON WR, 1992, ICARUS, V97, P187, DOI 10.1016/0019-1035(92)90127-S; Tobie G, 2006, NATURE, V440, P61, DOI 10.1038/nature04497; Tokano T, 2001, ICARUS, V153, P130, DOI 10.1006/icar.2001.6659; Tomasko MG, 2005, NATURE, V438, P765, DOI 10.1038/nature04126; TOON OB, 1988, ICARUS, V75, P255, DOI 10.1016/0019-1035(88)90005-X; Zarnecki JC, 2005, NATURE, V438, P792, DOI 10.1038/nature04211	30	129	129	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 27	2006	442	7101					432	435		10.1038/nature04948	http://dx.doi.org/10.1038/nature04948			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067CI	16871213	Green Published			2022-12-28	WOS:000239278900038
J	Olusanya, BO; Ruben, RJ; Parving, A				Olusanya, Bolajoko O.; Ruben, Robert J.; Parving, Agnete			Reducing the burden of communication disorders in the developing world - An opportunity for the millennium development project	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							SENSORINEURAL HEARING-LOSS; CHRONIC DISEASES; LANGUAGE; PREVALENCE; IMPACT		Inst Child Hlth, London WC1N 1EH, England; Univ Lagos, Coll Med, Inst Child Hlth & Primary Care, Lagos, Nigeria; UCL, Great Ormond St Hosp Children NHS Trust, London, England; Montefiore Med Ctr, Albert Einstein Coll Med, Dept Otorhinolaryngol Head & Neck Surg, Bronx, NY 10467 USA; Bispebjerg Hosp, Dept Audiol, WHO, Collaborating Ctr Prevent Deafness, DK-2400 Copenhagen, Denmark	University of London; University College London; University of Lagos; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; University of Copenhagen; Bispebjerg Hospital; World Health Organization	Olusanya, BO (corresponding author), Inst Child Hlth, 30 Guilford St, London WC1N 1EH, England.	b.olusanya@ich.ucl.ac.uk	Olusanya, Bolajoko O./F-4504-2012	Olusanya, Bolajoko O./0000-0002-3826-0583				Allen T., 1986, DEAF CHILDREN AM, P161, DOI DOI 10.1177/15257401050270010201; [Anonymous], 2005, PREV CHRON DIS VIT I; [Anonymous], 2005, STAT WORLDS CHILDR 2; Bess FH, 1998, EAR HEARING, V19, P339, DOI 10.1097/00003446-199810000-00001; BOYLE CA, 1994, PEDIATRICS, V93, P399; Clegg J, 2005, J CHILD PSYCHOL PSYC, V46, P128, DOI 10.1111/j.1469-7610.2004.00342.x; Elwan A., 1999, 9932 WORLD BANK; Fuster V, 2005, LANCET, V366, P1512, DOI 10.1016/S0140-6736(05)67610-6; Kennedy CR, 2006, NEW ENGL J MED, V354, P2131, DOI 10.1056/NEJMoa054915; Moeller MP, 2000, PEDIATRICS, V106, DOI 10.1542/peds.106.3.e43; Munoz-Baell IM, 2000, J EPIDEMIOL COMMUN H, V54, P40, DOI 10.1136/jech.54.1.40; Olusanya B, 2005, BRIT MED J, V330, P480, DOI 10.1136/bmj.330.7489.480-c; Olusanya BO, 2006, INT J PEDIATR OTORHI, V70, P1495, DOI 10.1016/j.ijporl.2006.04.002; Parving A, 2004, ACTA OTO-LARYNGOL, V124, P416, DOI 10.1080/00016480310000638a; PARVING A, 1993, SCAND AUDIOL, V22, P133, DOI 10.3109/01050399309046029; Ruben RJ, 2000, LARYNGOSCOPE, V110, P241, DOI 10.1097/00005537-200002010-00010; Schuele CM, 2004, MENT RETARD DEV D R, V10, P176, DOI 10.1002/mrdd.20014; Smith RJH, 2005, LANCET, V365, P879, DOI 10.1016/S0140-6736(05)71047-3; *UN DEP PUBL INF, 2005, MILL DEV GOALS REP 2; *WHO, 2005, 58 WORLD HLTH ASS DI; *WHO, 1995, 48 WORLD HLTH ASS PR; *WHO, FACT SHEET DEAFN HEA; *WHO, 2001, GUID HEAR AIDS SERV; *WORLD BANK HUM DE, 2003, ED ALL INCL CHILDR D; Yach D, 2004, JAMA-J AM MED ASSOC, V291, P2616, DOI 10.1001/jama.291.21.2616	25	92	95	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 26	2006	296	4					441	444		10.1001/jama.296.4.441	http://dx.doi.org/10.1001/jama.296.4.441			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	066PN	16868302				2022-12-28	WOS:000239242500030
J	Ross, LF; Zenios, S; Thistlethwaite, JR				Friedman Ross, Lainie; Zenios, Stefanos; Thistlethwaite, J. Richard, Jr.			Shared decision making in deceased-donor transplantation	LANCET			English	Editorial Material							EXPANDED CRITERIA DONORS; CADAVERIC RENAL-TRANSPLANTATION; TERM-FOLLOW-UP; KIDNEY-TRANSPLANTATION; UNITED-STATES; ORGAN DONATION; SCORING SYSTEM; SURVIVAL; ASSOCIATION; NETWORK		Univ Chicago, Dept Pediat, Chicago, IL 60637 USA; Univ Chicago, MacLean Ctr Clin Med Eth, Chicago, IL 60637 USA; Univ Chicago, Dept Surg, Chicago, IL 60637 USA; Univ Chicago, Comm Immunol, Chicago, IL 60637 USA; Stanford Univ, Grad Sch Business, Stanford, CA 94305 USA	University of Chicago; University of Chicago; University of Chicago; University of Chicago; Stanford University	Ross, LF (corresponding author), Univ Chicago, Dept Pediat, 5841S Maryland Ave,MC 6082, Chicago, IL 60637 USA.	Lross@uchicago.edu						Angelico M, 2005, DIGEST LIVER DIS, V37, P461, DOI 10.1016/j.dld.2005.03.006; Baskin-Bey ES, 2005, CLIN TRANSPLANT, V19, P406, DOI 10.1111/j.1399-0012.2005.00365.x; Danovitch GM, 2005, AM J TRANSPLANT, V5, P904, DOI 10.1111/j.1600-6135.2005.00835.x; Delmonico FL, 2005, AM J TRANSPLANT, V5, P862, DOI 10.1111/j.1600-6135.2005.00832.x; Edwards AG, 2005, POSTGRAD MED J, V81, P188, DOI 10.1136/pgmj.2004.024760; ELLIOTT C, 1995, J MED ETHICS, V21, P91, DOI 10.1136/jme.21.2.91; Epstein RM, 2004, JAMA-J AM MED ASSOC, V291, P2359, DOI 10.1001/jama.291.19.2359; Faenza A, 2004, TRANSPL P, V36, P485, DOI 10.1016/j.transproceed.2004.03.070; Gonzalez-Martinez F, 2004, TRANSPL P, V36, P1687, DOI 10.1016/j.transproceed.2004.07.033; HARMON WE, 2004 ANN REPORT US O; Hume D., 1978, TREATISE HUMAN NATUR, V2nd; Jonsen AR, 2002, CLIN ETHICS PRACTICA; Kacar Serdar, 2004, Ann Transplant, V9, P5; Katz J., 1984, SILENT WORLD DOCTOR; Keitel Elizete, 2004, Ann Transplant, V9, P23; Krakauer H, 2004, AM J TRANSPLANT, V4, P1555, DOI 10.1111/j.1600-6143.2004.00577.x; McLaren A, 2001, ANN ROY COLL SURG, V83, P343; MCNUTT RA, 2005, JAMA-J AM MED ASSOC, V292, P2516; Metzger RA, 2003, AM J TRANSPLANT, V3, P114, DOI 10.1034/j.1600-6143.3.s4.11.x; Nyberg SL, 2003, AM J TRANSPLANT, V3, P715, DOI 10.1034/j.1600-6143.2003.00111.x; Nyberg SL, 2001, AM J TRANSPLANT, V1, P162, DOI 10.1034/j.1600-6143.2001.001002162.x; O'Connor AM, 2005, PATIENT EDUC COUNS, V57, P247, DOI 10.1016/j.pec.2005.04.010; OCONNOR A, EFFECTIVENESS DECISI; Ojo AO, 2004, AM J TRANSPLANT, V4, P27, DOI 10.1111/j.1600-6135.2004.00396.x; Port FK, 2002, TRANSPLANTATION, V74, P1281, DOI 10.1097/00007890-200211150-00014; Rocha MB, 2004, TRANSPL P, V36, P914, DOI 10.1016/j.transproceed.2004.03.116; Ross LF, 2002, TRANSPLANTATION, V74, P418; Schnitzler MA, 2003, TRANSPLANTATION, V75, P1940, DOI 10.1097/01.TP.0000076381.16276.1B; Schold JD, 2005, AM J TRANSPLANT, V5, P757, DOI 10.1111/j.1600-6143.2005.00770.x; Stack AG, 2005, AM J KIDNEY DIS, V45, P730, DOI 10.1053/j.ajkd.2004.12.016; Stratta RJ, 2004, ANN SURG, V239, P688, DOI 10.1097/01.sla.0000124296.46712.67; Su XM, 2004, J AM SOC NEPHROL, V15, P1656, DOI 10.1097/01.ASN.0000127866.34592.60; Tan JC, 2004, TRANSPLANTATION, V78, P692, DOI 10.1097/01.tp.0000130452.01521.b1; Wears RL, 1996, ANN EMERG MED, V28, P702; Williams MC, 2004, TRANSPLANTATION, V77, P641, DOI 10.1097/01.TP.0000113232.90613.D5; Wolters HH, 2005, TRANSPLANT INT, V18, P453, DOI 10.1111/j.1432-2277.2004.00068.x; Zaroff Jonathan G., 2002, Circulation, V106, P836, DOI 10.1161/01.CIR.0000025587.40373.75	37	15	15	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 22	2006	368	9532					333	337		10.1016/S0140-6736(06)69078-8	http://dx.doi.org/10.1016/S0140-6736(06)69078-8			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	067PF	16860703				2022-12-28	WOS:000239314400031
J	Baca, HK; Ashley, C; Carnes, E; Lopez, D; Flemming, J; Dunphy, D; Singh, S; Chen, Z; Liu, NG; Fan, HY; Lopez, GP; Brozik, SM; Werner-Washburne, M; Brinker, CJ				Baca, Helen K.; Ashley, Carlee; Carnes, Eric; Lopez, Deanna; Flemming, Jeb; Dunphy, Darren; Singh, Seema; Chen, Zhu; Liu, Nanguo; Fan, Hongyou; Lopez, Gabriel P.; Brozik, Susan M.; Werner-Washburne, Margaret; Brinker, C. Jeffrey			Cell-directed assembly of lipid-silica nanostructures providing extended cell viability	SCIENCE			English	Article							SACCHAROMYCES-CEREVISIAE; LIVING BACTERIA; MICROORGANISMS; ENCAPSULATION; FILMS; DYNAMICS; ARRAYS; ROUTE; STATE; GELS	Amphiphilic phospholipids were used to direct the formation of biocompatible, uniform silica nanostructures in the presence of Saccharomyces cerevisiae and bacterial cell lines. The cell surfaces organize multilayered phospholipid vesicles that interface coherently with the silica host and help relieve drying stresses that develop with conventional templates. These host structures maintain cell accessibility, addressability, and viability in the absence of buffer or an external fluidic architecture. The cell surfaces are accessible and can be used to localize added proteins, plasmids, and nanocrystals. Prolonged cell viability combined with reporter protein expression enabled stand-alone cell-based sensing.	Univ New Mexico, Dept Chem & Nucl Engn, Albuquerque, NM 87185 USA; Sandia Natl Labs, Albuquerque, NM 87185 USA; Los Alamos Natl Lab, Div Chem, Los Alamos, NM 87545 USA; Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA; Univ New Mexico, Dept Mol Genet & Microbiol, Albuquerque, NM 87131 USA	University of New Mexico; United States Department of Energy (DOE); Sandia National Laboratories; United States Department of Energy (DOE); Los Alamos National Laboratory; University of New Mexico; University of New Mexico	Brinker, CJ (corresponding author), Univ New Mexico, Dept Chem & Nucl Engn, Albuquerque, NM 87185 USA.	cjbrink@sandia.gov	Chen, Zhu/M-3834-2015		PHS HHS [206-00139-06] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		[Anonymous], 1992, INTERMOLECULAR SURFA; Bottcher H, 2004, J MATER CHEM, V14, P2176, DOI 10.1039/b401724b; Brinker CJ, 1999, ADV MATER, V11, P579, DOI 10.1002/(SICI)1521-4095(199905)11:7<579::AID-ADMA579>3.0.CO;2-R; Chia SY, 2000, J AM CHEM SOC, V122, P6488, DOI 10.1021/ja0011515; Coiffier A, 2001, J MATER CHEM, V11, P2039, DOI 10.1039/b101308o; Conroy JFT, 2000, J SOL-GEL SCI TECHN, V18, P269, DOI 10.1023/A:1008704208324; deMaranon IM, 1996, BIOCHEM BIOPH RES CO, V227, P519, DOI 10.1006/bbrc.1996.1539; Doshi DA, 2003, J PHYS CHEM B, V107, P7683, DOI 10.1021/jp027214i; Doshi DA, 2003, J AM CHEM SOC, V125, P11646, DOI 10.1021/ja0295523; Fan HY, 2004, SCIENCE, V304, P567, DOI 10.1126/science.1095140; Ferrer ML, 2003, CHEM MATER, V15, P3614, DOI 10.1021/cm034372t; Gill I, 1998, J AM CHEM SOC, V120, P8587, DOI 10.1021/ja9814568; Hauser H, 2000, BBA-BIOMEMBRANES, V1508, P164, DOI 10.1016/S0304-4157(00)00008-3; INAMA L, 1993, J BIOTECHNOL, V30, P197, DOI 10.1016/0168-1656(93)90113-2; Kleinschmidt JH, 2002, BIOPHYS J, V83, P994, DOI 10.1016/S0006-3495(02)75225-9; Klis FM, 2002, FEMS MICROBIOL REV, V26, P239, DOI 10.1016/S0168-6445(02)00087-6; KRESGE CT, 1992, NATURE, V359, P710, DOI 10.1038/359710a0; Langer R, 2004, NATURE, V428, P487, DOI 10.1038/nature02388; Lu YF, 1997, NATURE, V389, P364, DOI 10.1038/38699; Malanoski AP, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.041602; Nagle JF, 2000, BBA-REV BIOMEMBRANES, V1469, P159, DOI 10.1016/S0304-4157(00)00016-2; Nassif N, 2002, NAT MATER, V1, P42, DOI 10.1038/nmat709; POPE EJA, 1995, J SOL-GEL SCI TECHN, V4, P225, DOI 10.1007/BF00488377; Premkumar JR, 2002, CHEM MATER, V14, P2676, DOI 10.1021/cm020020v; Sahai N, 2002, J COLLOID INTERF SCI, V252, P309, DOI 10.1006/jcis.2002.8448; Service RF, 2002, SCIENCE, V297, P962, DOI 10.1126/science.297.5583.962; Sinclair MB, 2004, APPL OPTICS, V43, P2079, DOI 10.1364/AO.43.002079; Smits GJ, 1999, CURR OPIN MICROBIOL, V2, P348; Stevens MM, 2005, SCIENCE, V310, P1135, DOI 10.1126/science.1106587; Tirrell M, 2002, SURF SCI, V500, P61, DOI 10.1016/S0039-6028(01)01548-5; Yang PD, 1998, SCIENCE, V282, P2244, DOI 10.1126/science.282.5397.2244; Zhang SG, 2004, NAT BIOTECHNOL, V22, P151, DOI 10.1038/nbt0204-151	32	133	142	1	81	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 21	2006	313	5785					337	341		10.1126/science.1126590	http://dx.doi.org/10.1126/science.1126590			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065IV	16857936				2022-12-28	WOS:000239154300040
J	Lawler, A				Lawler, Andrew			2007 US budget - NASA budget soars as shuttle lands	SCIENCE			English	News Item																			0	0	0	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 21	2006	313	5785					280	281						2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065IV	16857906				2022-12-28	WOS:000239154300003
J	Garman, K; Hughes, R				Garman, Katharine; Hughes, Robert			Medicine, Medsin, and global health	LANCET			English	Editorial Material							ISSUES		UCL, Int Hlth & Med Educ Ctr, London W4 3DR, England; Univ Birmingham, Fac Med, Birmingham, W Midlands, England; Univ Bristol, Fac Med, Bristol, Avon, England	University of London; University College London; University of Birmingham; University of Bristol	Hughes, R (corresponding author), UCL, Int Hlth & Med Educ Ctr, London W4 3DR, England.	hughes.rob@gmail.com		Hughes, Robert/0000-0002-1345-3063				Bateman C, 2001, LANCET, V358, P1539, DOI 10.1016/S0140-6736(01)06586-2; *INT FED MED STUD, 2005, THINK GLOB; Panosian C, 2006, NEW ENGL J MED, V354, P1771, DOI 10.1056/NEJMp068035; Yudkin JS, 2003, LANCET, V362, P822, DOI 10.1016/S0140-6736(03)14276-6	4	2	2	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL 8	2006	368	9530					103	104		10.1016/S0140-6736(06)68983-6	http://dx.doi.org/10.1016/S0140-6736(06)68983-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	062AR	16829282				2022-12-28	WOS:000238917200008
J	Hoekstra, HE; Hirschmann, RJ; Bundey, RA; Insel, PA; Crossland, JP				Hoekstra, Hopi E.; Hirschmann, Rachel J.; Bundey, Richard A.; Insel, Paul A.; Crossland, Janet P.			A single amino acid mutation contributes to adaptive beach mouse color pattern	SCIENCE			English	Article							MICE PEROMYSCUS-POLIONOTUS; GENETIC-BASIS; EVOLUTION; INTERGRADATION; PIGMENTATION; ADAPTATION; MELANISM; ALLELES; TRAITS	Natural populations of beach mice exhibit a characteristic color pattern, relative to their mainland conspecifics, driven by natural selection for crypsis. We identified a derived, charge-changing amino acid mutation in the melanocortin-1 receptor (Mc1r) in beach mice, which decreases receptor function. In genetic crosses, allelic variation at Mc1r explains 9.8% to 36.4% of the variation in seven pigmentation traits determining color pattern. The derived Mc1r allele is present in Florida's Gulf Coast beach mice but not in Atlantic coast mice with similar light coloration, suggesting that different molecular mechanisms are responsible for convergent phenotypic evolution. Here, we link a single mutation in the coding region of a pigmentation gene to adaptive quantitative variation in the wild.	Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; Univ S Carolina, Dept Biol Sci, Peromyscus Genet Stock Ctr, Columbia, SC 29208 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Hoekstra, HE (corresponding author), Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA.	hoekstra@ucsd.edu	Hoekstra, Hopi E/I-6690-2012	Hoekstra, Hopi E/0000-0003-1431-1769	NATIONAL CENTER FOR RESEARCH RESOURCES [P40RR014279] Funding Source: NIH RePORTER; NCRR NIH HHS [P40-RR14279] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Barsh GS, 1996, TRENDS GENET, V12, P299, DOI 10.1016/0168-9525(96)10031-7; Belk MC, 1996, J MAMMAL, V77, P882, DOI 10.2307/1382694; BOWEN WW, 1977, J MAMMAL, V58, P521, DOI 10.2307/1380000; Carroll SB, 2005, PLOS BIOL, V3, P1159, DOI 10.1371/journal.pbio.0030245; CARROLL SB, 2005, ENDLESS FORMS MOST B; Colosimo PF, 2005, SCIENCE, V307, P1928, DOI 10.1126/science.1107239; Eizirik E, 2003, CURR BIOL, V13, P448, DOI 10.1016/S0960-9822(03)00128-3; JACKSON IJ, 1994, ANNU REV GENET, V28, P189, DOI 10.1146/annurev.ge.28.120194.001201; KAUFMAN DW, 1974, J MAMMAL, V55, P271, DOI 10.2307/1378997; Mackay TFC, 2001, ANNU REV GENET, V35, P303, DOI 10.1146/annurev.genet.35.102401.090633; MCNEIL FS, 1950, US GEOL SURVEY, V221, P59; Mundy NI, 2004, SCIENCE, V303, P1870, DOI 10.1126/science.1093834; Nachman MW, 2003, P NATL ACAD SCI USA, V100, P5268, DOI 10.1073/pnas.0431157100; ORR HA, 1992, AM NAT, V140, P725, DOI 10.1086/285437; Ritland K, 2001, CURR BIOL, V11, P1468, DOI 10.1016/S0960-9822(01)00448-1; ROBBINS LS, 1993, CELL, V72, P827, DOI 10.1016/0092-8674(93)90572-8; Sumner FB, 1929, P NATL ACAD SCI USA, V15, P110, DOI 10.1073/pnas.15.2.110; Sumner FB, 1929, P NATL ACAD SCI USA, V15, P481, DOI 10.1073/pnas.15.6.481; Theron E, 2001, CURR BIOL, V11, P550, DOI 10.1016/S0960-9822(01)00158-0; Van Zant JL, 2003, BIOL CONSERV, V112, P405, DOI 10.1016/S0006-3207(02)00338-5	20	508	517	3	301	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 7	2006	313	5783					101	104		10.1126/science.1126121	http://dx.doi.org/10.1126/science.1126121			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061DA	16825572				2022-12-28	WOS:000238850200041
J	Ron, D				Ron, D			Stressed cells cope with protein overload	SCIENCE			English	Editorial Material							UNFOLDED PROTEIN; ENDOPLASMIC-RETICULUM; MESSENGER-RNA; IRE1; ER		NYU Med Ctr, Skirball Inst, New York, NY 10016 USA	New York University	Ron, D (corresponding author), NYU Med Ctr, Skirball Inst, 540 1st Ave, New York, NY 10016 USA.	ron@saturn.med.nyu.edu		Ron, David/0000-0002-3014-5636				Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Credle JJ, 2005, P NATL ACAD SCI USA, V102, P18773, DOI 10.1073/pnas.0509487102; Harding HP, 2002, ANNU REV CELL DEV BI, V18, P575, DOI 10.1146/annurev.cellbio.18.011402.160624; Hetz C, 2006, SCIENCE, V312, P572, DOI 10.1126/science.1123480; Hollien J, 2006, SCIENCE, V313, P104, DOI 10.1126/science.1129631; Kaufman RJ, 2002, J CLIN INVEST, V110, P1389, DOI 10.1172/JC1200216886; Patil C, 2001, CURR OPIN CELL BIOL, V13, P349, DOI 10.1016/S0955-0674(00)00219-2; Sidrauski C, 1997, CELL, V90, P1031, DOI 10.1016/S0092-8674(00)80369-4; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0	11	16	16	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 7	2006	313	5783					52	53		10.1126/science.1130469	http://dx.doi.org/10.1126/science.1130469			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061DA	16825557				2022-12-28	WOS:000238850200023
J	Ducatez, MF; Olinger, CM; Owoade, AA; De Landtsheer, S; Ammerlaan, W; Niesters, HGM; Osterhaus, ADME; Fouchier, RAM; Muller, CP				Ducatez, M. F.; Olinger, C. M.; Owoade, A. A.; De Landtsheer, S.; Ammerlaan, W.; Niesters, H. G. M.; Osterhaus, A. D. M. E.; Fouchier, R. A. M.; Muller, C. P.			Multiple introductions of H5N1 in Nigeria - Phylogenetic analysis reveals that this deadly virus first arrived in Africa from different sources	NATURE			English	Article									Natl Publ Hlth Lab, Inst Immunol, L-1950 Luxembourg, Luxembourg; Univ Ibadan, Dept Vet Med, Ibadan, Nigeria; Erasmus Med Ctr, Dept Virol, NL-3015 GE Rotterdam, Netherlands	University of Ibadan; Erasmus University Rotterdam; Erasmus MC	Ducatez, MF (corresponding author), Natl Publ Hlth Lab, Inst Immunol, L-1950 Luxembourg, Luxembourg.	claude.muller@lns.etat.lu	Fouchier, Ron A/A-1911-2014; Niesters, Hubert/AAH-6808-2019	Fouchier, Ron A/0000-0001-8095-2869; Niesters, Hubert/0000-0002-1758-0430; De Landtsheer, Sebastien/0000-0002-5421-2338				Munster VJ, 2005, EMERG INFECT DIS, V11, P1545, DOI 10.3201/eid1110.050546; Olsen B, 2006, SCIENCE, V312, P384, DOI 10.1126/science.1122438; Owoade AA, 2006, AVIAN DIS, V50, P222, DOI 10.1637/7412-071505R.1	3	126	129	1	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 6	2006	442	7098					37	37		10.1038/442037a	http://dx.doi.org/10.1038/442037a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	059HS	16823443				2022-12-28	WOS:000238724500028
J	Estruch, R; Martinez-Gonzalez, MA; Corella, D; Salas-Salvado, J; Ruiz-Gutierrez, V; Covas, MI; Fiol, M; Gomez-Gracia, E; Lopez-Sabater, MC; Vinyoles, E; Aros, F; Conde, M; Lahoz, C; Lapetra, J; Saez, G; Ros, E				Estruch, Ramon; Martinez-Gonzalez, Miguel Angel; Corella, Dolores; Salas-Salvado, Jordi; Ruiz-Gutierrez, Valentina; Covas, Maria Isabel; Fiol, Miguel; Gomez-Gracia, Enrique; Lopez-Sabater, Mari Carmen; Vinyoles, Ernest; Aros, Fernando; Conde, Manuel; Lahoz, Carlos; Lapetra, Jose; Saez, Guillermo; Ros, Emilio		PREDIMED Study Investigators	Effects of a Mediterranean-style diet on cardiovascular risk factors - A randomized trial	ANNALS OF INTERNAL MEDICINE			English	Article							MONOUNSATURATED FATTY-ACIDS; CORONARY-HEART-DISEASE; VIRGIN OLIVE OIL; BLOOD-PRESSURE; LINOLENIC ACID; RED WINE; ENDOTHELIAL FUNCTION; NUT CONSUMPTION; SERUM-LIPIDS; HYPERTENSION	Background: The Mediterranean diet has been shown to have beneficial effects on cardiovascular risk factors. Objective: To compare the short-term effects of 2 Mediterranean diets versus those of a low-fat diet on intermediate markers of cardiovascular risk. Design: Substudy of a multicenter, randomized, primary prevention trial of cardiovascular disease (Prevencion con Dieta Mediterranea [PREDIMED) Study). Setting: Primary care centers affiliated with 10 teaching hospitals. Participants: 772 asymptomatic persons 55 to 80 years of age at high cardiovascular risk who were recruited from October 2003 to March 2004. Interventions: Participants were assigned to a low-fat diet (n = 257) or to 1 of 2 Mediterranean diets. Those allocated to Mediterranean diets received nutritional education and either free virgin olive oil, 1 liter per week (n = 257), or free nuts, 30 g/d (n = 258). The authors evaluated outcome changes at 3 months. Measurements: Body weight, blood pressure, lipid profile, glucose levels, and inflammatory molecules. Results: The completion rate was 99.6%. Compared with the low-fat diet, the 2 Mediterranean diets produced beneficial changes in most outcomes. Compared with the low-fat diet, the mean changes in the Mediterranean diet with olive oil group and the Mediterranean diet with nuts group were -0.39 mmol/L (95% Cl, -0.70 to - 0.07 mmol/L) and - 0.30 mmol/L (Cl, -0.58 to - 0.01 mmol/L), respectively, for plasma glucose levels; -5.9 mm Hg (Cl, -8.7 to -3.1 mm Hg) and - 7.1 mm Hg (Cl, -10.0 to -4.1 mm Hg), respectively, for systolic blood pressure; and -0.38 (Cl, -0.55 to - 0.22) and - 0.26 (Cl, -0.42 to -0.10), respectively, for the cholesterol-high-density lipoprotein cholesterol ratio. The Mediterranean diet with olive oil reduced C-reactive protein levels by 0.54 mg/L (Cl, 1.04 to 0.03 mg/L) compared with the low-fat diet. Limitations: This short-term study did not focus on clinical outcomes. Nutritional education about low-fat diet was less intense than education about Mediterranean diets. Conclusion: Compared with a low-fat diet, Mediterranean diets supplemented with olive oil or nuts have beneficial effects on cardiovascular risk factors.	Univ Barcelona, Municipal Inst Med Res IMIM, IDIBAPS, Inst Invest Biomed August Pi Sunyer, Barcelona, Spain; Catalan Inst Hlth, Barcelona, Spain; Univ Valencia, Valencia, Spain; Univ Navarra, Univ Navarra Clin, E-31080 Pamplona, Spain; Univ Rovira & Virgili, E-43201 Reus, Tarragona, Spain; Univ Seville, Hosp Univ Virgen Rocio, CSIC, Inst Grasa, Seville, Spain; San Pablo Hlth Ctr, Seville, Spain; Hosp Son Dureta, Palma de Mallorca, Spain; Univ Malaga, E-29071 Malaga, Spain; Hosp Txangorritxu, Vitoria, Spain; Hosp Carlos III, Madrid, Spain	Institut Hospital del Mar d'Investigacions Mediques (IMIM); University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Valencia; University of Navarra; Universitat Rovira i Virgili; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de la Grasa (IG); University of Sevilla; Virgen del Rocio University Hospital; Hospital Universitari Son Espases; Hospital Universitari Son Dureta; Universidad de Malaga; Hospital Carlos III	Estruch, R (corresponding author), Hosp Clin Barcelona, Dept Internal Med, Villarroel 170, E-08036 Barcelona, Spain.	restruch@clinic.ub.es	Estruch, Ramon/AAZ-3723-2020; Fiol, Miguel/F-6793-2016; IBIS, SALUD PÚBLICA/C-1707-2016; Salas-Salvado, Jordi/C-7229-2017; Vinyoles, Ernest/GRX-4615-2022; Martinez-Gonzalez, Miguel A./AAE-7669-2019; IBIS, ATENCION PRIMARIA/I-3524-2016	Fiol, Miguel/0000-0002-5370-1391; Salas-Salvado, Jordi/0000-0003-2700-7459; Vinyoles, Ernest/0000-0002-8725-9431; Saez, Guillermo/0000-0002-8164-4048; Lahoz, Carlos/0000-0001-5690-7558; Martinez-Gonzalez, Miguel A./0000-0002-3917-9808; Ros, Emilio/0000-0002-2573-1294; Lopez-Sabater, Maria Carmen/0000-0002-8670-7044				Alonso A, 2006, PUBLIC HEALTH NUTR, V9, P251, DOI 10.1079/PHN2005836; Alonso A, 2004, LIPIDS, V39, P1233, DOI 10.1007/s11745-004-1352-x; Appel LJ, 1997, NEW ENGL J MED, V336, P1117, DOI 10.1056/NEJM199704173361601; Appel LJ, 2005, JAMA-J AM MED ASSOC, V294, P2455, DOI 10.1001/jama.294.19.2455; Beauchamp GK, 2005, NATURE, V437, P45, DOI 10.1038/437045a; BERNELMANS WJ, 2002, AM J CLIN NUTR, V75, P221; Carluccio MA, 2003, ARTERIOSCL THROM VAS, V23, P622, DOI 10.1161/01.ATV.0000062884.69432.A0; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Chrysohoou C, 2004, J AM COLL CARDIOL, V44, P152, DOI 10.1016/j.jacc.2004.03.039; Clarke R, 1997, BRIT MED J, V314, P112, DOI 10.1136/bmj.314.7074.112; Djousse L, 2005, HYPERTENSION, V45, P368, DOI 10.1161/01.HYP.0000154679.41568.e6; Djousse L, 2003, AM J CLIN NUTR, V78, P1098, DOI 10.1093/ajcn/78.6.1098; ELOSUA R, 1994, AM J EPIDEMIOL, V139, P1197, DOI 10.1093/oxfordjournals.aje.a116966; Esposito K, 2004, JAMA-J AM MED ASSOC, V292, P1440, DOI 10.1001/jama.292.12.1440; Estruch R, 2004, ATHEROSCLEROSIS, V175, P117, DOI 10.1016/j.atherosclerosis.2004.03.006; EXLER J, 1986, PUBLICATION HNIS; Ferrara LA, 2000, ARCH INTERN MED, V160, P837, DOI 10.1001/archinte.160.6.837; Franz MJ, 2002, DIABETES CARE, V25, P148, DOI 10.2337/diacare.25.1.148; Fuentes F, 2001, ANN INTERN MED, V134, P1115, DOI 10.7326/0003-4819-134-12-200106190-00011; Garcia-Lorda P, 2003, EUR J CLIN NUTR, V57, pS8, DOI 10.1038/sj.ejcn.1601802; Gardner CD, 2005, ANN INTERN MED, V142, P725, DOI 10.7326/0003-4819-142-9-200505030-00007; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Harris WS, 2005, CIRCULATION, V111, P2872, DOI 10.1161/CIRCULATIONAHA.105.545640; Jiang R, 2006, AM J EPIDEMIOL, V163, P222, DOI 10.1093/aje/kwj033; Jiang R, 2002, JAMA-J AM MED ASSOC, V288, P2554, DOI 10.1001/jama.288.20.2554; Katan MB, 1997, NEW ENGL J MED, V337, P563; Keys A, 1997, Nutrition, V13, P250; KNOOPS KT, 2006, EUR J CLIN NUTR; Knoops KTB, 2004, JAMA-J AM MED ASSOC, V292, P1433, DOI 10.1001/jama.292.12.1433; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Krauss RM, 2000, CIRCULATION, V102, P2284; Kris-Etherton PM, 1999, CIRCULATION, V100, P1253, DOI 10.1161/01.CIR.100.11.1253; Kris-Etherton PM, 2001, NUTR REV, V59, P103, DOI 10.1111/j.1753-4887.2001.tb06996.x; Lopez-Garcia E, 2004, AM J CLIN NUTR, V80, P1029, DOI 10.1093/ajcn/80.4.1029; Martinez-Gonzalez MA, 2004, EUR J CLIN NUTR, V58, P1550, DOI 10.1038/sj.ejcn.1602004; Martinez-Gonzalez MA, 2004, EUR J EPIDEMIOL, V19, P9, DOI 10.1023/B:EJEP.0000013351.60227.7b; MARTINMORENO JM, 1993, INT J EPIDEMIOL, V22, P512, DOI 10.1093/ije/22.3.512; Mataix V.J., 2003, TABLA COMPOSICION AL; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; MENOTTI A, 1990, PREV MED, V19, P270, DOI 10.1016/0091-7435(90)90027-H; Mensink RP, 2003, AM J CLIN NUTR, V77, P1146, DOI 10.1093/ajcn/77.5.1146; Miro-Casas E, 2003, EUR J CLIN NUTR, V57, P186, DOI 10.1038/sj.ejcn.1601532; Nigg CR, 1999, GERONTOLOGIST, V39, P473, DOI 10.1093/geront/39.4.473; Obarzanek E, 2001, AM J CLIN NUTR, V74, P80; Perona JS, 2004, CLIN NUTR, V23, P1113, DOI 10.1016/j.clnu.2004.02.004; Psaltopoulou T, 2004, AM J CLIN NUTR, V80, P1012, DOI 10.1093/ajcn/80.4.1012; Ros E, 2004, CIRCULATION, V109, P1609, DOI 10.1161/01.CIR.0000124477.91474.FF; Ros E, 2003, AM J CLIN NUTR, V78, p617S, DOI 10.1093/ajcn/78.3.617S; Sabate J, 2003, AM J CLIN NUTR, V78, p647S, DOI 10.1093/ajcn/78.3.647S; Sacks FM, 2001, NEW ENGL J MED, V344, P3, DOI 10.1056/NEJM200101043440101; STRAZZULLO P, 1986, J HYPERTENS, V4, P407, DOI 10.1097/00004872-198608000-00003; Trichopoulou A, 2003, NEW ENGL J MED, V348, P2599, DOI 10.1056/NEJMoa025039; Tunstall-Pedoe H, 1999, LANCET, V353, P1547, DOI 10.1016/S0140-6736(99)04021-0; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; Visioli F, 2001, Curr Atheroscler Rep, V3, P64, DOI 10.1007/s11883-001-0012-0; Willett W., 1998, NUTR EPIDEMIOLOGY, V30, P321, DOI [DOI 10.1093/AJCN/69.5.1020, DOI 10.1093/acprof:oso/9780195122978.003.13]; WILLETT WC, 1995, AM J CLIN NUTR, V61, p1402S, DOI 10.1093/ajcn/61.6.1402S; Yu-Poth S, 1999, AM J CLIN NUTR, V69, P632; Zambon D, 2000, ANN INTERN MED, V132, P538, DOI 10.7326/0003-4819-132-7-200004040-00039	59	1224	1244	4	415	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 4	2006	145	1					1	11		10.7326/0003-4819-145-1-200607040-00004	http://dx.doi.org/10.7326/0003-4819-145-1-200607040-00004			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	062IS	16818923				2022-12-28	WOS:000238938400001
J	Peeper, D; Berns, A				Peeper, Daniel; Berns, Anton			Cross-species onocogenomics in cancer gene idenfification	CELL			English	Editorial Material							ADDICTION	The complexity of genomic aberrations in most human tumors hampers delineation of the genes that drive the tumorigenic process. In this issue of Cell, Kim et al. (2006) and Zender et al. (2006) demonstrate that cognate mouse tumor models recapitulate these genetic alterations with unexpected fidelity. These results indicate that cross-species genomic analysis is a powerful strategy to identify the responsible genes and assess their oncogenic capacity in the appropriate genetic context.	Netherlands Canc Inst, Div Mol Genet, NL-1066 CX Amsterdam, Netherlands	Netherlands Cancer Institute	Peeper, D (corresponding author), Netherlands Canc Inst, Div Mol Genet, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.	d.peeper@nki.nl; a.berns@nki.nl	Peeper, Daniel/AAA-2430-2020					Bernards R, 2002, NATURE, V418, P823, DOI 10.1038/418823a; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Hess AR, 2005, CANCER RES, V65, P9851, DOI 10.1158/0008-5472.CAN-05-2172; Imoto I, 2001, CANCER RES, V61, P6629; Jonkers J, 2004, CANCER CELL, V6, P535, DOI 10.1016/j.ccr.2004.12.002; KIM M, 2006, CELL; Lucito R, 2003, GENOME RES, V13, P2291, DOI 10.1101/gr.1349003; Rowland BD, 2006, NAT REV CANCER, V6, P11, DOI 10.1038/nrc1780; Weinstein IB, 2002, SCIENCE, V297, P63, DOI 10.1126/science.1073096; Yagi R, 1999, EMBO J, V18, P2551, DOI 10.1093/emboj/18.9.2551; ZENDER L, 2006, CELL	11	19	19	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 30	2006	125	7					1230	1233		10.1016/j.cell.2006.06.018	http://dx.doi.org/10.1016/j.cell.2006.06.018			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	064QP	16814709	Bronze			2022-12-28	WOS:000239104500006
J	Leopold, DA; Bondar, IV; Giese, MA				Leopold, David A.; Bondar, Igor V.; Giese, Martin A.			Norm-based face encoding by single neurons in the monkey inferotemporal cortex	NATURE			English	Article							TEMPORAL CORTEX; DISTINCTIVENESS; RESPONSES; IDENTIFICATION; SELECTIVITY; CARICATURES; IDENTITY	The rich and immediate perception of a familiar face, including its identity, expression and even intent, is one of the most impressive shared faculties of human and non-human primate brains. Many visually responsive neurons in the inferotemporal cortex of macaque monkeys respond selectively to faces(1-4), sometimes to only one or a few individuals(5-7), while showing little sensitivity to scale and other details of the retinal image(8,9). Here we show that face-responsive neurons in the macaque monkey anterior inferotemporal cortex are tuned to a fundamental dimension of face perception. Using a norm-based caricaturization framework previously developed for human psychophysics(10-12), we varied the identity information present in photo-realistic human faces(13), and found that neurons of the anterior inferotemporal cortex were most often tuned around the average, identity-ambiguous face. These observations are consistent with face-selective responses in this area being shaped by a figural comparison, reflecting structural differences between an incoming face and an internal reference or norm. As such, these findings link the tuning of neurons in the inferotemporal cortex to psychological models of face identity perception.	Max Planck Inst Biol Cybernet, D-72076 Tubingen, Germany; Univ Clin Tubingen, Hertie Inst Clin Brain Res, Dept Cognit Neurol, Lab Act Representat & Learning, D-72072 Tubingen, Germany	Max Planck Society; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Leopold, DA (corresponding author), NIMH, Unit Cognit Neurophysiol & Imaging, Neuropsychol Lab, NIH, 49 Convent Dr,Bldg 49,MSC 4400, Bethesda, MD 20892 USA.	leopoldd@mail.nih.gov	Bondar, Igor V/M-6416-2014	Bondar, Igor V/0000-0003-1307-5266; Leopold, David/0000-0002-1345-6360	NATIONAL INSTITUTE OF MENTAL HEALTH [ZIAMH002898, Z01MH002838, Z01MH002898, ZIAMH002838] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Baker CI, 2002, NAT NEUROSCI, V5, P1210, DOI 10.1038/nn960; Blanz V, 1999, COMP GRAPH, P187, DOI 10.1145/311535.311556; GROSS CG, 1994, CEREB CORTEX, V4, P455, DOI 10.1093/cercor/4.5.455; HASSELMO ME, 1989, BEHAV BRAIN RES, V32, P203, DOI 10.1016/S0166-4328(89)80054-3; Kayaert G, 2005, EUR J NEUROSCI, V22, P212, DOI 10.1111/j.1460-9568.2005.04202.x; Kobatake E, 1998, J NEUROPHYSIOL, V80, P324, DOI 10.1152/jn.1998.80.1.324; Lee K, 2000, PSYCHOL SCI, V11, P379, DOI 10.1111/1467-9280.00274; Leopold D.A., 2005, FITTING MIND WORLD A, P189, DOI DOI 10.1093/ACPROF:OSO/9780198529699.003.0008; Leopold DA, 2005, P ROY SOC B-BIOL SCI, V272, P897, DOI 10.1098/rspb.2004.3022; Leopold DA, 2001, NAT NEUROSCI, V4, P89, DOI 10.1038/82947; Lewis MB, 1998, Q J EXP PSYCHOL-A, V51, P321, DOI 10.1080/713755758; Logothetis NK, 1996, ANNU REV NEUROSCI, V19, P577, DOI 10.1146/annurev.ne.19.030196.003045; MAURO R, 1992, MEM COGNITION, V20, P433, DOI 10.3758/BF03210927; PERRETT DI, 1984, HUM NEUROBIOL, V3, P197; PERRETT DI, 1982, EXP BRAIN RES, V47, P329; Persson J, 2002, NEUROREPORT, V13, P2181, DOI 10.1097/00001756-200212030-00004; RHODES G, 1987, COGNITIVE PSYCHOL, V19, P473, DOI 10.1016/0010-0285(87)90016-8; Rhodes G., 2005, FITTING MIND WORLD A, P213, DOI DOI 10.1093/ACPROF:OSO/9780198529699.003.0009; ROLLS ET, 1986, EXP BRAIN RES, V65, P38; Sigala N, 2002, NATURE, V415, P318, DOI 10.1038/415318a; Sugase Y, 1999, NATURE, V400, P869, DOI 10.1038/23703; TOVEE MJ, 1994, J NEUROPHYSIOL, V72, P1049, DOI 10.1152/jn.1994.72.3.1049; Tsao DY, 2006, SCIENCE, V311, P670, DOI 10.1126/science.1119983; Tsao DY, 2003, NAT NEUROSCI, V6, P989, DOI 10.1038/nn1111; VALENTINE T, 1986, PERCEPTION, V15, P525, DOI 10.1068/p150525; VALENTINE T, 1991, Q J EXP PSYCHOL-A, V43, P161, DOI 10.1080/14640749108400966	26	270	270	2	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 3	2006	442	7102					572	575		10.1038/nature04951	http://dx.doi.org/10.1038/nature04951			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069NQ	16862123				2022-12-28	WOS:000239455900045
J	Cramer, P				Cramer, Patrick			Self-correcting messages	SCIENCE			English	Editorial Material							RNA-POLYMERASE-II; STRUCTURAL BASIS; ACTIVE-CENTER; TRANSCRIPTION; MECHANISM; RESOLUTION; FIDELITY; CLEAVAGE		Univ Munich, Gene Ctr Munich, Dept Chem & Biochem, D-81377 Munich, Germany	University of Munich	Cramer, P (corresponding author), Univ Munich, Gene Ctr Munich, Dept Chem & Biochem, Feodor Lynen Str 25, D-81377 Munich, Germany.	cramer@lmb.uni-muenchen.de						BEESE LS, 1991, EMBO J, V10, P25, DOI 10.1002/j.1460-2075.1991.tb07917.x; Cramer Patrick, 2001, Science (Washington D C), V292, P1863, DOI 10.1126/science.1059493; ERIE DA, 1993, SCIENCE, V262, P867, DOI 10.1126/science.8235608; Kettenberger H, 2003, CELL, V114, P347, DOI 10.1016/S0092-8674(03)00598-1; Opalka N, 2003, CELL, V114, P335, DOI 10.1016/S0092-8674(03)00600-7; ORLOVA M, 1995, P NATL ACAD SCI USA, V92, P4596, DOI 10.1073/pnas.92.10.4596; Poole AM, 2005, MOL BIOL EVOL, V22, P1444, DOI 10.1093/molbev/msi132; Sosunov V, 2005, NUCLEIC ACIDS RES, V33, P4202, DOI 10.1093/nar/gki688; Sosunov V, 2003, EMBO J, V22, P2234, DOI 10.1093/emboj/cdg193; Steitz TA, 1998, NATURE, V391, P231, DOI 10.1038/34542; Thomas MJ, 1998, CELL, V93, P627, DOI 10.1016/S0092-8674(00)81191-5; Vassylyev DG, 2002, NATURE, V417, P712, DOI 10.1038/nature752; Westover KD, 2004, CELL, V119, P481, DOI 10.1016/j.cell.2004.10.016; Zenkin N, 2006, SCIENCE, V313, P518, DOI 10.1126/science.1127422	14	7	8	1	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 28	2006	313	5786					447	448		10.1126/science.1131205	http://dx.doi.org/10.1126/science.1131205			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067MZ	16873631	Green Published			2022-12-28	WOS:000239308600023
J	Landsea, CW; Harper, BA; Hoarau, K; Knaff, JA				Landsea, Christopher W.; Harper, Bruce A.; Hoarau, Karl; Knaff, John A.			Can we detect trends in extreme tropical cyclones?	SCIENCE			English	Editorial Material							METEOROLOGY; INTENSITY; HURRICANES		NOAA, Natl Hurricane Ctr, Miami, FL 33165 USA; Syst Engn Australia Pty Ltd, Bridgeman Downs, Qld 4035, Australia; Cergy Pontoise Univ, F-95011 Cergy Pontoise, France; NOAA, Cooperat Inst Res Atmosphere, Ft Collins, CO 80523 USA	National Oceanic Atmospheric Admin (NOAA) - USA; National Hurricane Center, NOAA; CY Cergy Paris Universite; National Oceanic Atmospheric Admin (NOAA) - USA	Landsea, CW (corresponding author), NOAA, Natl Hurricane Ctr, Miami, FL 33165 USA.	chris.landsea@noaa.gov	Knaff, John A./F-5599-2010	Knaff, John A./0000-0003-0427-1409				Chan JCL, 2006, SCIENCE, V311, DOI 10.1126/science.1121522; Chu JH, 2002, NRLMR75400216; Dvorak V, 1984, 11 NOAA NESDIS; DVORAK VF, 1975, MON WEATHER REV, V103, P420, DOI 10.1175/1520-0493(1975)103<0420:TCIAAF>2.0.CO;2; Emanuel K, 2005, NATURE, V436, P686, DOI 10.1038/nature03906; Emanuel K, 2004, HURRICANES AND TYPHOONS: PAST, PRESENT, AND FUTURE, P395; Emanuel K, 2005, NATURE, V438, pE13, DOI 10.1038/nature04427; Emanuel K., 2005, DIVINE WIND HIST SCI; Franklin JL, 2003, WEATHER FORECAST, V18, P32, DOI 10.1175/1520-0434(2003)018<0032:GDWPIH>2.0.CO;2; Hoyos CD, 2006, SCIENCE, V312, P94, DOI 10.1126/science.1123560; Klotzbach PJ, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL025881; KNAFF JA, IN PRESS WEATHER FOR; Knutson TR, 2004, J CLIMATE, V17, P3477, DOI [10.1175/1520-0442(2004)017<3477:IOCWOS>2.0.CO;2, 10.1175/1520-0442(2004)017&lt;3477:IOCWOS&gt;2.0.CO;2]; Landsea CW, 2005, NATURE, V438, pE11, DOI 10.1038/nature04477; Landsea CW, 2004, HURRICANES AND TYPHOONS: PAST, PRESENT, AND FUTURE, P177; Landsea CW, 2004, B AM METEOROL SOC, V85, P1699, DOI 10.1175/BAMS-85-11-1699; LANDSEA CW, 1993, MON WEATHER REV, V121, P1703, DOI 10.1175/1520-0493(1993)121<1703:ACOIMA>2.0.CO;2; Murnane RJ, 2004, HURRICANES AND TYPHOONS: PAST, PRESENT, AND FUTURE, P249; NEUMANN C, 2000, STORMS VOLUME, V1, P164; Pielke RA, 2005, NATURE, V438, pE11, DOI 10.1038/nature04426; VELDEN C, IN PRESS B AM METEOR; Webster PJ, 2006, SCIENCE, V311, DOI 10.1126/science.1121564	23	339	353	3	80	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 28	2006	313	5786					452	454		10.1126/science.1128448	http://dx.doi.org/10.1126/science.1128448			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	067MZ	16873634				2022-12-28	WOS:000239308600027
J	Freeman, D; Price, D				Freeman, Daryl; Price, David			ABC of chronic obstructive pulmonary disease - Primary care and palliative care	BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ Aberdeen, Foresterhill Hlth Ctr, Dept Gen Practice & Primary Care, Aberdeen AB9 1FX, Scotland	University of Aberdeen	Freeman, D (corresponding author), Univ Aberdeen, Foresterhill Hlth Ctr, Dept Gen Practice & Primary Care, Aberdeen AB9 1FX, Scotland.		Price, David/H-2837-2019; Young, John D/M-9756-2016	Price, David/0000-0002-9728-9992; 				Abernethy AP, 2003, BRIT MED J, V327, P523, DOI 10.1136/bmj.327.7414.523; Bellamy David, 2006, Prim Care Respir J, V15, P48, DOI 10.1016/j.pcrj.2005.11.003; Davis CL, 1997, BRIT MED J, V315, P931	3	12	12	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JUL 22	2006	333	7560					188	190		10.1136/bmj.333.7560.188	http://dx.doi.org/10.1136/bmj.333.7560.188			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	068DJ	16858049	Green Published			2022-12-28	WOS:000239352100024
J	Kumada, N; Muraki, K; Hirayama, Y				Kumada, Norio; Muraki, Koji; Hirayama, Yoshiro			Low-frequency spin dynamics in a canted antiferromagnet	SCIENCE			English	Article							QUANTUM HALL SYSTEMS; 2-DIMENSIONAL ELECTRON-GAS; PHASE-TRANSITIONS; DOUBLE-LAYERS; STATES; EXCITATIONS; FERROMAGNETS; RELAXATION; RESISTANCE; INTEGER	Resistively detected nuclear spin relaxation measurements in closely separated two-dimensional electron systems reveal strong low-frequency electron-spin fluctuations in the quantum Hall regime. As the temperature is decreased, the spin fluctuations, manifested by a sharp enhancement of the nuclear spin-lattice relaxation rate 1/T-1, continue to grow down to the lowest temperature of 66 millikelvin. The observed divergent behavior of 1/T-1 signals a gapless spin excitation mode and is a hallmark of canted antiferromagnetic order. Our data demonstrate the realization of a two-dimensional system with planar broken symmetry, in which fluctuations do not freeze out when approaching the zero temperature limit.	NTT Corp, NTT Basic Res Labs, Kanagawa 2430198, Japan; Japan Sci & Technol Agcy, SORST, Kawaguchi, Saitama 3310012, Japan; Tohoku Univ, Dept Phys, Sendai, Miyagi 9808578, Japan	Nippon Telegraph & Telephone Corporation; Japan Science & Technology Agency (JST); Tohoku University	Kumada, N (corresponding author), NTT Corp, NTT Basic Res Labs, 3-1 Morinosato Wakamiya, Kanagawa 2430198, Japan.	kumada@will.brl.ntt.co.jp	Muraki, Koji/M-3468-2016; Hirayama, Yoshiro/AAE-1598-2019; Kumada, Norio/V-9410-2019	Muraki, Koji/0000-0003-0289-5496; Kumada, Norio/0000-0001-7826-6894; Hirayama, Yoshiro/0000-0003-2638-9133				ANDERSON PW, 1984, BASIC CONCEPTS CONDE; BERG A, 1990, PHYS REV LETT, V64, P2563, DOI 10.1103/PhysRevLett.64.2563; Brey L, 1999, PHYS REV LETT, V83, P168, DOI 10.1103/PhysRevLett.83.168; Cote R, 1997, PHYS REV LETT, V78, P4825, DOI 10.1103/PhysRevLett.78.4825; DasSarma S, 1997, PHYS REV LETT, V79, P917, DOI 10.1103/PhysRevLett.79.917; De Poortere EP, 2000, SCIENCE, V290, P1546, DOI 10.1126/science.290.5496.1546; Demler E, 1999, PHYS REV LETT, V82, P3895, DOI 10.1103/PhysRevLett.82.3895; Eisenstein JP, 2004, NATURE, V432, P691, DOI 10.1038/nature03081; Eom J, 2000, SCIENCE, V289, P2320, DOI 10.1126/science.289.5488.2320; Fukuda A, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.165304; Gervais G, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.196803; Girvin SM, 2000, PHYS TODAY, V53, P39, DOI 10.1063/1.1306366; Hashimoto K, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.176601; Jungwirth T, 2001, PHYS REV B, V63, DOI 10.1103/PhysRevB.63.035305; Khrapai VS, 2000, PHYS REV LETT, V84, P725, DOI 10.1103/PhysRevLett.84.725; Kosterlitz JM, 1973, J PHYS C SOLID STATE, V6, P1181, DOI 10.1088/0022-3719/6/7/010; Kumada N, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.155319; Kumada N, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.096802; MacDonald AH, 1999, PHYS REV B, V60, P8817, DOI 10.1103/PhysRevB.60.8817; Maude DK, 1996, PHYS REV LETT, V77, P4604, DOI 10.1103/PhysRevLett.77.4604; MORIYA T, 1963, J PHYS SOC JPN, V18, P516, DOI 10.1143/JPSJ.18.516; Muraki K, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.196801; Pellegrini V, 1997, PHYS REV LETT, V78, P310, DOI 10.1103/PhysRevLett.78.310; Pellegrini V, 1998, SCIENCE, V281, P799, DOI 10.1126/science.281.5378.799; Piazza V, 1999, NATURE, V402, P638, DOI 10.1038/45189; Sawada A, 1998, PHYS REV LETT, V80, P4534, DOI 10.1103/PhysRevLett.80.4534; TYCKO R, 1995, SCIENCE, V268, P1460, DOI 10.1126/science.7539550; VONKLITZING K, 1980, PHYS REV LETT, V45, P494, DOI 10.1103/PhysRevLett.45.494; Zheng L, 1997, PHYS REV LETT, V78, P2453, DOI 10.1103/PhysRevLett.78.2453	31	47	47	1	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 21	2006	313	5785					329	332		10.1126/science.1127094	http://dx.doi.org/10.1126/science.1127094			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065IV	16857933				2022-12-28	WOS:000239154300037
J	Fuyuno, I				Fuyuno, Ichiko			Stuck in the middle	NATURE			English	News Item																			0	1	1	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 20	2006	442	7100					237	237		10.1038/442237a	http://dx.doi.org/10.1038/442237a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064WT	16855561	Bronze			2022-12-28	WOS:000239122100010
J	Kurth, T; Gaziano, JM; Cook, NR; Logroscino, G; Diener, HC; Buring, JE				Kurth, Tobias; Gaziano, J. Michael; Cook, Nancy R.; Logroscino, Giancarlo; Diener, Hans-Christoph; Buring, Julie E.			Migraine and risk of cardiovascular disease in women	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CORONARY-HEART-DISEASE; LOW-DOSE ASPIRIN; PRIMARY PREVENTION; VASCULAR EVENTS; STROKE; PREVALENCE; HEADACHE; ANGINA; ASSOCIATIONS; TOLERABILITY	Context Migraine with aura has been associated with an adverse cardiovascular risk profile and prothrombotic factors that, along with migraine-specific physiology, may increase the risk of vascular events. Although migraine with aura has been associated with increased risk of ischemic stroke, an association with cardiovascular disease (CVD) and, specifically, coronary events remains unclear. Objective To evaluate the association between migraine with and without aura and subsequent risk of overall and specific CVD. Design, Setting, and Participants Prospective cohort study of 27 840 US women aged 45 years or older who were participating in the Women's Health Study, were free of CVD and angina at study entry (1992-1995), and who had information on self-reported migraine and aura status, and lipid measurements. This report is based on follow-up data through March 31, 2004. Main Outcome Measures The primary outcome measure was the combined end point of major CVD (first instance of nonfatal ischemic stroke, nonfatal myocardial infarction, or death due to ischemic CVD); other measures were first ischemic stroke, myocardial infarction, coronary revascularization, angina, and death due to ischemic CVD. Results At baseline, 5125 women (18.4%) reported any history of migraine; of the 3610 with active migraine (migraine in the prior year), 1434 (39.7%) indicated aura symptoms. During a mean of 10 years of follow-up, 580 major CVD events occurred. Compared with women with no migraine history, women who reported active migraine with aura had multivariable-adjusted hazard ratios of 2.15 (95% confidence interval [CI], 1.58-2.92; P<.001) for major CVD, 1.91 (95% CI, 1.17-3.10; P=.01) for ischemic stroke, 2.08 (95% CI, 1.30-3.31; P=.002) for myocardial infarction, 1.74 (95% CI, 1.23-2.46; P=.002) for coronary revascularization, 1.71 (95% CI, 1.16-2.53; P=.007) for angina, and 2.33 (95% CI, 1.21-4.51; P=.01) for ischemic CVD death. After adjusting for age, there were 18 additional major CVD events attributable to migraine with aura per 10 000 women per year. Women who reported active migraine without aura did not have increased risk of any vascular events or angina. Conclusions In this large, prospective cohort of women, active migraine with aura was associated with increased risk of major CVD, myocardial infarction, ischemic stroke, and death due to ischemic CVD, as well as with coronary revascularization and angina. Active migraine without aura was not associated with increased risk of any CVD event.	Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med,Div Prevent Med, Boston, MA 02215 USA; Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med,Div Aging, Boston, MA USA; Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; Boston VA Healthcare Syst, Massachusetts Vet Epidemiol Res & Informat Ctr, Boston, MA USA; Harvard Univ, Sch Med, Dept Ambulatory Care & Prevent, Boston, MA USA; Univ Duisburg Essen, Dept Neurol, Essen, Germany	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; Harvard University; Harvard Medical School; University of Duisburg Essen	Kurth, T (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med,Div Prevent Med, 900 Commonwealth Ave, Boston, MA 02215 USA.	tkurth@rics.bwh.harvard.edu	LOGROSCINO, GIANCARLO/K-5148-2016; Kurth, Tobias/A-9243-2012; Diener, Hans-Christoph/AAF-7275-2019	LOGROSCINO, GIANCARLO/0000-0003-0423-3242; Kurth, Tobias/0000-0001-7169-2620; 	NCI NIH HHS [CA-47988] Funding Source: Medline; NHLBI NIH HHS [HL-43851] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL043851] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		[Anonymous], 1975, JAMA-J AM MED ASSOC, V231, P718; Anzola GP, 1999, NEUROLOGY, V52, P1622, DOI 10.1212/WNL.52.8.1622; Atiya M, 2003, STROKE, V34, P565, DOI 10.1161/01.STR.0000054159.21017.7C; Bednarczyk EM, 1998, NEUROLOGY, V50, P1736, DOI 10.1212/WNL.50.6.1736; Bensenor IM, 2001, CEPHALALGIA, V21, P175, DOI 10.1046/j.0333-1024.2001.00194.x; Cook NR, 2002, HEADACHE, V42, P715, DOI 10.1046/j.1526-4610.2002.02173.x; Dodick DW, 2004, HEADACHE, V44, pS20, DOI 10.1111/j.1526-4610.2004.04105.x; Etminan M, 2005, BMJ-BRIT MED J, V330, P63, DOI 10.1136/bmj.38302.504063.8F; FERRARI MD, 1989, NEUROLOGY, V39, P1239, DOI 10.1212/WNL.39.9.1239; GALLAI V, 1994, ACTA NEUROL SCAND, V89, P47; Goadsby PJ, 2002, NEW ENGL J MED, V346, P257, DOI 10.1056/NEJMra010917; Hall GC, 2004, NEUROLOGY, V62, P563, DOI 10.1212/01.WNL.0000110312.36809.7F; Hargreaves RJ, 1999, CAN J NEUROL SCI, V26, pS12, DOI 10.1017/S0317167100000147; Hering-Hanit R, 2001, CEPHALALGIA, V21, P137, DOI 10.1046/j.1468-2982.2001.00181.x; Kruit MC, 2004, JAMA-J AM MED ASSOC, V291, P427, DOI 10.1001/jama.291.4.427; Kurth T, 2005, NEUROLOGY, V64, P1020, DOI 10.1212/01.WNL.0000154528.21485.3A; Lafitte C, 1996, HEADACHE, V36, P332, DOI 10.1046/j.1526-4610.1996.3605332.x; Launer LJ, 1999, NEUROLOGY, V53, P537, DOI 10.1212/WNL.53.3.537; Lea RA, 2005, MOL BRAIN RES, V136, P112, DOI 10.1016/j.molbrainres.2005.01.006; Lee IM, 2005, JAMA-J AM MED ASSOC, V294, P56, DOI 10.1001/jama.294.1.56; Lipton RB, 2001, HEADACHE, V41, P646, DOI 10.1046/j.1526-4610.2001.041007646.x; Martin VT, 2005, AM J MED, V118, p36S, DOI 10.1016/j.amjmed.2005.01.018; Mitchell P, 1998, AUST NZ J MED, V28, P627, DOI 10.1111/j.1445-5994.1998.tb00659.x; Rexrode KM, 2000, J WOMEN HEALTH GEN-B, V9, P19, DOI 10.1089/152460900318911; Ridker PM, 2005, NEW ENGL J MED, V352, P1293, DOI 10.1056/NEJMoa050613; Rosamond W, 2004, HEADACHE, V44, pS5, DOI 10.1111/j.1526-4610.2004.04103.x; Rose KM, 2004, NEUROLOGY, V63, P2233, DOI 10.1212/01.WNL.0000147289.50605.DC; Rothwell PM, 2005, LANCET, V366, P1773, DOI 10.1016/S0140-6736(05)67702-1; Scher AI, 2006, ANN NEUROL, V59, P372, DOI 10.1002/ana.20755; Scher AI, 2005, NEUROLOGY, V64, P614, DOI 10.1212/01.WNL.0000151857.43225.49; Silberstein SD, 2004, LANCET, V363, P381, DOI 10.1016/S0140-6736(04)15440-8; SORGE F, 1988, CEPHALALGIA, V8, P1, DOI 10.1046/j.1468-2982.1988.0801001.x; Soriani S, 1998, HEADACHE, V38, P779, DOI 10.1046/j.1526-4610.1998.3810779.x; Stang PE, 2005, NEUROLOGY, V64, P1573, DOI 10.1212/01.WNL.0000158326.31368.04; Sternfeld B, 1995, NEUROLOGY, V45, P2135, DOI 10.1212/WNL.45.12.2135; Tietjen GE, 2001, NEUROLOGY, V57, P334, DOI 10.1212/WNL.57.2.334; Uyarel H, 2005, ACTA CARDIOL, V60, P221, DOI 10.2143/AC.60.2.2005036; Vahedi K, 2004, ARCH NEUROL-CHICAGO, V61, P1237, DOI 10.1001/archneur.61.8.1237; Velentgas P, 2004, HEADACHE, V44, P642, DOI 10.1111/j.1526-4610.2004.04122.x; Waeber C, 2005, NEUROLOGY, V64, pS9, DOI 10.1212/WNL.64.10_suppl_2.S9; WATERS WE, 1983, BRIT MED J, V287, P1442, DOI 10.1136/bmj.287.6403.1442	41	398	405	1	16	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 19	2006	296	3					283	291		10.1001/jama.296.3.283	http://dx.doi.org/10.1001/jama.296.3.283			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	064LA	16849661	Bronze			2022-12-28	WOS:000239089900020
J	Mooradian, AD; Bernbaum, M; Albert, SG				Mooradian, Arshag D.; Bernbaum, Marla; Albert, Stewart G.			Narrative review: A rational approach to starting insulin therapy	ANNALS OF INTERNAL MEDICINE			English	Review							BASAL INSULIN; DRUG-THERAPY; TIME-ACTION; ACYLATED INSULINS; GLYCEMIC CONTROL; DOUBLE-BLIND; ORAL-AGENTS; NPH INSULIN; MANAGEMENT; GLARGINE	Background: The emergence of multiple insulin products has provided new opportunities to achieve diabetes control. However, the number of options has raised concerns about the optimal choices of products. Purpose: To briefly review the pharmacologic characteristics of currently available insulin products and to suggest an initial insulin regimen based on common blood glucose profiles among patients with diabetes. Data Sources: Relevant manuscripts were identified through a MEDLINE search (1996 to 25 February 2006) of the English-language literature. The key phrase used was therapeutic use of insulin. The literature search was limited to core clinical journals that have accessible full texts. Study Selection: Clinical trials and authoritative reviews published between 1996 and February 2006 were selected. A total of 420 manuscripts was reviewed. Data Extraction: The authors independently reviewed the relevant available literature. This literature, along with the authors' clinical experience, was used to construct practical suggestions. Data Synthesis: Several new insulin and insulin analogue preparations are now available for clinical use. Used as prandial insulin (for example, insulin lispro, insulin aspart, or insulin glulisine) and basal insulin (for example, insulin glargine or insulin detemir), the analogues simulate physiologic insulin profiles more closely than the older conventional insulins. There is currently no strong rationale favoring glargine, neutral protamine Hagedorn insulin, insulin detemir, or fixed-ratio insulin preparations as the preferred agent for initiating insulin therapy. Limitations: This was a retrospective review of previously published manuscripts chosen at the authors' discretion. Conclusions: The advent of recombinant DNA technology made it possible to overcome limitations in the time-action profiles of conventional insulins. Insulin therapy must be individualized. Nevertheless, certain subgroups of patients with diabetes can be differentiated from each other according to the pattern of blood glucose changes during the day. On the basis of the blood glucose profile, the authors suggest an initial insulin regimen that can be used to evaluate individual responsiveness and plan a long-term regimen.	St Louis Univ, Sch Med, St Louis, MO 63103 USA	Saint Louis University	Mooradian, AD (corresponding author), Univ Florida, Dept Internal Med, LRC, 6531 W 8th St,4th Floor, Jacksonville, FL 32209 USA.	arshag.mooradian@jax.ufl.edu	Albert, Stewart G./AAY-8931-2021	Albert, Stewart G./0000-0003-4621-6897				Am Diabetes Assoc, 2006, DIABETES CARE, V29, pS4; American Diabetes Association, 2001, Diabetes Care, V24, P775; American Diabetes Association, 2004, DIABETES CARE S1, V27, P380, DOI [10.2337/diacare.27.2007.S88, DOI 10.2337/DIACARE.27.2007.S88]; Barlocco Daniela, 2003, Curr Opin Investig Drugs, V4, P1240; Bott U, 2003, DIABETIC MED, V20, P626, DOI 10.1046/j.1464-5491.2003.01010.x; BUSE JB, 2003, WILLIAMS TXB ENDOCRI, P1441; Chapman TM, 2002, DRUGS, V62, P1945, DOI 10.2165/00003495-200262130-00014; Chehade JM, 2000, DRUGS, V60, P95, DOI 10.2165/00003495-200060010-00006; Clement S, 2004, DIABETES CARE, V27, P553, DOI 10.2337/diacare.27.2.553; DeFronzo RA, 1999, ANN INTERN MED, V131, P281, DOI 10.7326/0003-4819-131-4-199908170-00008; DEFRONZO RA, 1995, NEW ENGL J MED, V333, P541, DOI 10.1056/NEJM199508313330902; Dunn CJ, 2003, DRUGS, V63, P1743, DOI 10.2165/00003495-200363160-00007; Edelman SV, 2005, SOUTH MED J, V98, P363, DOI 10.1097/01.SMJ.0000149424.50849.00; Gamson K, 2004, J Matern Fetal Neonatal Med, V15, P26, DOI 10.1080/14767050310001650680; Garg Satish K, 2003, Endocr Pract, V9, P187; Gerich JE, 2004, CURR MED RES OPIN, V20, P31, DOI 10.1185/030079903125002711; Gerich JE, 2002, AM J MED, V113, P308, DOI 10.1016/S0002-9343(02)01176-2; Hamann A, 2003, DIABETES CARE, V26, P1738, DOI 10.2337/diacare.26.6.1738; Heinemann L, 1999, DIABETIC MED, V16, P332, DOI 10.1046/j.1464-5491.1999.00081.x; Heise T, 1998, DIABETES CARE, V21, P800, DOI 10.2337/diacare.21.5.800; HOWEY DC, 1994, DIABETES, V43, P396, DOI 10.2337/diabetes.43.3.396; Inzucchi SE, 2002, JAMA-J AM MED ASSOC, V287, P360, DOI 10.1001/jama.287.3.360; Janka HU, 2005, DIABETES CARE, V28, P254, DOI 10.2337/diacare.28.2.254; Kurtzhals P, 1996, J PHARM SCI, V85, P304, DOI 10.1021/js950412j; Maggs DG, 1998, ANN INTERN MED, V128, P176, DOI 10.7326/0003-4819-128-3-199802010-00002; Malone JK, 2004, CLIN THER, V26, P2034, DOI 10.1016/j.clinthera.2004.12.015; Markussen J, 1996, DIABETOLOGIA, V39, P281; McKeage K, 2001, DRUGS, V61, P1599, DOI 10.2165/00003495-200161110-00007; Metzger BE, 1998, DIABETES CARE, V21, pB161; Mooradian AD, 1999, DRUGS, V57, P19, DOI 10.2165/00003495-199957010-00003; Oiknine R, 2005, DRUGS, V65, P325, DOI 10.2165/00003495-200565030-00003; Oiknine R, 2003, BIOMED PHARMACOTHER, V57, P231, DOI 10.1016/S0753-3322(03)00052-0; Pettitt DJ, 2003, DIABETES CARE, V26, P183, DOI 10.2337/diacare.26.1.183; Pickup J, 2002, BMJ-BRIT MED J, V324, P705, DOI 10.1136/bmj.324.7339.705; Plank J, 2005, DIABETES CARE, V28, P1107, DOI 10.2337/diacare.28.5.1107; Rami B, 1997, EUR J PEDIATR, V156, P838, DOI 10.1007/s004310050724; Raskin P, 2005, DIABETES CARE, V28, P260, DOI 10.2337/diacare.28.2.260; Retnakaran R, 2004, DIABETES CARE, V27, P2590, DOI 10.2337/diacare.27.11.2590; Riddle MC, 2006, DIABETES CARE, V29, P435, DOI 10.2337/diacare.29.02.06.dc05-1267; Riddle MC, 2005, ENDOCRIN METAB CLIN, V34, P77, DOI 10.1016/j.ecl.2004.12.002; Riddle MC, 2003, DIABETES CARE, V26, P3080, DOI 10.2337/diacare.26.11.3080; Ristic Smiljana, 2003, Diabetes Technol Ther, V5, P57, DOI 10.1089/152091503763816472; Roach P, 1999, DIABETES CARE, V22, P1258, DOI 10.2337/diacare.22.8.1258; Rutledge KS, 1997, PEDIATRICS, V100, P968, DOI 10.1542/peds.100.6.968; Sacks DB, 2002, CLIN CHEM, V48, P436; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Simpson KL, 1999, DRUGS, V57, P759, DOI 10.2165/00003495-199957050-00013; Trence DL, 2003, J CLIN ENDOCR METAB, V88, P2430, DOI 10.1210/jc.2003-030347; *UK HLTH CAR, UK INS PROT; Vajo Z, 2001, ENDOCR REV, V22, P706, DOI 10.1210/er.22.5.706; Wang F, 2003, CLIN THER, V25, P1541, DOI 10.1016/S0149-2918(03)80156-X; Weyer C, 1999, J CLIN INVEST, V104, P787, DOI 10.1172/JCI7231; Yki-Jarvinen H, 2000, DIABETES CARE, V23, P1130, DOI 10.2337/diacare.23.8.1130	53	85	98	0	22	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 18	2006	145	2					125	134		10.7326/0003-4819-145-2-200607180-00010	http://dx.doi.org/10.7326/0003-4819-145-2-200607180-00010			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	063WU	16847295	Green Published			2022-12-28	WOS:000239051400006
J	Warnke, PH				Warnke, Patrick H.			Repair of a human face by allotransplantation	LANCET			English	Editorial Material							GRAFT; BONE		Univ Kiel, Dept Oral & Maxillofacial Surg, D-24105 Kiel, Germany	University of Kiel	Warnke, PH (corresponding author), Univ Kiel, Dept Oral & Maxillofacial Surg, D-24105 Kiel, Germany.	warnke@mkg.uni-kiel.de						Atala A, 2006, LANCET, V367, P1241, DOI 10.1016/S0140-6736(06)68438-9; Devauchelle B, 2006, LANCET, V368, P203, DOI 10.1016/S0140-6736(06)68935-6; Harle F, 1993, ATLAS HAUTTUMOREN GE; Kneser U, 2006, J CELL MOL MED, V10, P7, DOI 10.1111/j.1582-4934.2006.tb00287.x; Liu Y, 2000, J THORAC CARDIOV SUR, V120, P108, DOI 10.1067/mtc.2000.106655; Spector M, 1999, TISSUE ENGINEERING, P3; Warnke PH, 2006, BIOMATERIALS, V27, P3163, DOI 10.1016/j.biomaterials.2006.01.050; Warnke PH, 2006, BIOMATERIALS, V27, P1081, DOI 10.1016/j.biomaterials.2005.07.042; Warnke PH, 2004, LANCET, V364, P766, DOI 10.1016/S0140-6736(04)16935-3	9	10	10	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 15	2006	368	9531					181	183		10.1016/S0140-6736(06)68937-X	http://dx.doi.org/10.1016/S0140-6736(06)68937-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	064MY	16844469				2022-12-28	WOS:000239095000006
J	Bulinski, JC				Bulinski, J. Chloe			Cell biology - Actin discrimination	SCIENCE			English	Editorial Material							PROTEIN		Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; Columbia Univ, Dept Pathol & Cell Biol, New York, NY 10027 USA	Columbia University; Columbia University	Bulinski, JC (corresponding author), Columbia Univ, Dept Biol Sci, 1212 Amsterdam Ave, New York, NY 10027 USA.	jcb4@columbia.edu						Das J, 2004, MOL BIOL EVOL, V21, P1572, DOI 10.1093/molbev/msh161; HOLMES KC, 1990, NATURE, V347, P44, DOI 10.1038/347044a0; Karakozova M, 2006, SCIENCE, V313, P192, DOI 10.1126/science.1129344; Kwon YT, 2002, SCIENCE, V297, P96, DOI 10.1126/science.1069531; LAWRENCE JB, 1986, CELL, V45, P407, DOI 10.1016/0092-8674(86)90326-0; OTEY CA, 1987, J CELL BIOCHEM, V34, P113, DOI 10.1002/jcb.240340205; SEGURA M, 1984, J BIOL CHEM, V259, P3949; Shuster CB, 1996, CELL MOTIL CYTOSKEL, V35, P175; VANDEKERCKHOVE J, 1978, J MOL BIOL, V126, P783, DOI 10.1016/0022-2836(78)90020-7; Varshavsky A, 2003, NAT CELL BIOL, V5, P373, DOI 10.1038/ncb0503-373	10	9	10	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 14	2006	313	5784					180	181		10.1126/science.1130813	http://dx.doi.org/10.1126/science.1130813			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	063GZ	16840687				2022-12-28	WOS:000239008000029
J	Green, DR; Chipuk, JE				Green, Douglas R.; Chipuk, Jerry E.			p53 and metabolism: Inside the TIGAR	CELL			English	Editorial Material							CELL-DEATH	The p53 tumor suppressor pathway coordinates DNA repair, cell-cycle arrest, apoptosis, and senescence to preserve genomic stability and prevent tumor formation. The discovery of three new target genes for p53 reveals unexpected functions for this tumor suppressor in the regulation of glucose metabolism and autophagy.	St Jude Childrens Hosp, Dept Immunol, Memphis, TN 38105 USA	St Jude Children's Research Hospital	Green, DR (corresponding author), St Jude Childrens Hosp, Dept Immunol, 332 N Lauderdale St, Memphis, TN 38105 USA.	douglas.green@stjude.org	Green, Douglas R/N-8083-2018	Green, Douglas R/0000-0002-7332-1417; Chipuk, Jerry Edward/0000-0002-1337-842X				Boya P, 2005, MOL CELL BIOL, V25, P1025, DOI 10.1128/MCB.25.3.1025-1040.2005; Jeffers JR, 2003, CANCER CELL, V4, P321, DOI 10.1016/S1535-6108(03)00244-7; Lum JJ, 2005, NAT REV MOL CELL BIO, V6, P439, DOI 10.1038/nrm1660; Matoba S, 2006, SCIENCE, V312, P1650, DOI 10.1126/science.1126863; Nutt LK, 2005, CELL, V123, P89, DOI 10.1016/j.cell.2005.07.032; Sablina AA, 2005, NAT MED, V11, P1306, DOI 10.1038/nm1320; Tanaka H, 2000, NATURE, V404, P42, DOI 10.1038/35003506; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Zaidi AU, 2001, J NEUROPATH EXP NEUR, V60, P937, DOI 10.1093/jnen/60.10.937; Zhang YM, 2003, MOL MICROBIOL, V48, P1317, DOI 10.1046/j.1365-2958.2003.03486.x	10	182	198	1	32	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUL 14	2006	126	1					30	32		10.1016/j.cell.2006.06.032	http://dx.doi.org/10.1016/j.cell.2006.06.032			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	066JF	16839873	Bronze			2022-12-28	WOS:000239224800013
J	Hecht, FM				Hecht, Frederick M.			The CBC	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												rhecht@php.ucsf.edu		Hecht, Frederick/0000-0002-5782-1171					0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 12	2006	296	2					149	150		10.1001/jama.296.2.149	http://dx.doi.org/10.1001/jama.296.2.149			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	062LP	16835410				2022-12-28	WOS:000238946500001
J	Trifilo, MJ; Yajima, T; Gu, YS; Dalton, N; Peterson, KL; Race, RE; Meade-White, K; Portis, JL; Masliah, E; Knowlton, KU; Chesebro, B; Oldstone, MBA				Trifilo, Matthew J.; Yajima, Toshitaka; Gu, Yusu; Dalton, Nancy; Peterson, Kirk L.; Race, Richard E.; Meade-White, Kimberly; Portis, John L.; Masliah, Eliezer; Knowlton, Kirk U.; Chesebro, Bruce; Oldstone, Michael B. A.			Prion-induced amyloid heart disease with high blood infectivity in transgenic mice	SCIENCE			English	Article							CREUTZFELDT-JAKOB-DISEASE; TRANSMISSIBLE SPONGIFORM ENCEPHALOPATHY; DIASTOLIC DYSFUNCTION; SCRAPIE; TRANSFUSION; FAILURE; COMPONENTS; DIAGNOSIS; VARIANT; HUMANS	We investigated extraneural manifestations in scrapie-infected transgenic mice expressing prion protein lacking the glycophosphatydylinositol membrane anchor. In the brain, blood, and heart, both abnormal protease-resistant prion protein (PrPres) and prion infectivity were readily detected by immunoblot and by inoculation into nontransgenic recipients. The titer of infectious scrapie in blood plasma exceeded 10(7) 50% infectious doses per milliliter. The hearts of these transgenic mice contained PrPres-positive amyloid deposits that led to myocardial stiffness and cardiac disease.	Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; Scripps Res Inst, Dept Mol & Integrat Neurosci, Viral Immunobiol Lab, La Jolla, CA 92037 USA; Scripps Res Inst, Dept Infectol, Viral Immunobiol Lab, La Jolla, CA 92037 USA; NIAID, Rocky Mt Labs, Persistent Viral Dis Lab, Hamilton, MT 59840 USA; Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA	University of California System; University of California San Diego; Scripps Research Institute; Scripps Research Institute; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of California System; University of California San Diego; University of California System; University of California San Diego	Knowlton, KU (corresponding author), Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA.	kknowlton@ucsd.edu; bchesebro@niaid.nih.gov; mbaobo@scripps.edu	gu, yu/GSD-4507-2022		NHLBI NIH HHS [5R01HL66424-04] Funding Source: Medline; NIA NIH HHS [P01 AG004342] Funding Source: Medline; NINDS NIH HHS [NS041219-05] Funding Source: Medline; PHS HHS [AGO4342] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL066424] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000937, ZIAAI000086, ZIAAI000937, Z01AI000086] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS041219] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG004342] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Alperovitch A, 1999, LANCET, V353, P1673, DOI 10.1016/S0140-6736(99)01342-2; Ashwath ML, 2005, ARCH INTERN MED, V165, P338, DOI 10.1001/archinte.165.3.338; Bale TL, 2004, P NATL ACAD SCI USA, V101, P3697, DOI 10.1073/pnas.0307324101; Bosque PJ, 2002, P NATL ACAD SCI USA, V99, P3812, DOI 10.1073/pnas.052707499; Brown P, 1999, TRANSFUSION, V39, P1169, DOI 10.1046/j.1537-2995.1999.39111169.x; Brown P, 1998, TRANSFUSION, V38, P810, DOI 10.1046/j.1537-2995.1998.38998408999.x; CASACCIA P, 1989, ARCH VIROL, V108, P145, DOI 10.1007/BF01313752; Castilla J, 2005, NAT MED, V11, P982, DOI 10.1038/nm1286; Cervenakova L, 2003, TRANSFUSION, V43, P1687, DOI 10.1046/j.0041-1132.2003.00586.x; Chesebro B, 2005, SCIENCE, V308, P1435, DOI 10.1126/science.1110837; CLARKE MC, 1967, VET REC, V80, P504, DOI 10.1136/vr.80.16.504; COLLIS SC, 1979, J COMP PATHOL, V89, P389, DOI 10.1016/0021-9975(79)90029-X; FRASER H, 1970, NATURE, V226, P462, DOI 10.1038/226462a0; GAASCH WH, 1994, JAMA-J AM MED ASSOC, V271, P1276; Gajdusek D C, 1968, Res Publ Assoc Res Nerv Ment Dis, V44, P254; GIBBS CJ, 1968, SCIENCE, V161, P388, DOI 10.1126/science.161.3839.388; Heikenwalder M, 2005, SCIENCE, V307, P1107, DOI 10.1126/science.1106460; Herzog C, 2005, J VIROL, V79, P14339, DOI 10.1128/JVI.79.22.14339-14345.2005; Holada K, 2002, J VIROL, V76, P4649, DOI 10.1128/JVI.76.9.4649-4650.2002; Houston F, 2000, LANCET, V356, P999, DOI 10.1016/S0140-6736(00)02719-7; KURODA Y, 1983, INFECT IMMUN, V41, P154, DOI 10.1128/IAI.41.1.154-161.1983; Llewelyn CA, 2004, LANCET, V363, P417, DOI 10.1016/S0140-6736(04)15486-X; Peden AH, 2004, LANCET, V364, P527, DOI 10.1016/S0140-6736(04)16811-6; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Scott MR, 1999, P NATL ACAD SCI USA, V96, P15137, DOI 10.1073/pnas.96.26.15137; TATEISHI J, 1980, ACTA NEUROPATHOL, V51, P127, DOI 10.1007/BF00690454; Zile MR, 2002, CIRCULATION, V105, P1387, DOI 10.1161/hc1102.105289	27	49	51	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 7	2006	313	5783					94	97		10.1126/science.1128635	http://dx.doi.org/10.1126/science.1128635			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061DA	16825571	Green Accepted			2022-12-28	WOS:000238850200039
J	Blumenthal, D				Blumenthal, David			Employer-sponsored health insurance in the United States - Origins and implications	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							CARE; QUALITY		Massachusetts Gen Hosp, Partners Hlth Care Syst, Inst Hlth Policy, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Partners Healthcare System	Blumenthal, D (corresponding author), Massachusetts Gen Hosp, Partners Hlth Care Syst, Inst Hlth Policy, Boston, MA 02114 USA.							Bates DW, 2003, NEW ENGL J MED, V348, P2526, DOI 10.1056/NEJMsa020847; Bodenheimer T, 2005, ANN INTERN MED, V142, P847, DOI 10.7326/0003-4819-142-10-200505170-00010; CHIRBAMARTIN MA, 1994, HEALTH AFFAIR, V13, P142, DOI 10.1377/hlthaff.13.2.142; Christianson JB, 2005, MILBANK Q, V83, P149, DOI 10.1111/j.0887-378X.2005.00339.x; CLAXTON G, 2005, HLTH AFF MILLWOOD S3, V24; COHEN WJ, 1968, COMMUNICATION   1208, P22; CORNING PA, 1969, HIST MEDICARE; *EMPL BEN RES I, 2005, IMP ER RET HLTH BEN; ENTHOVEN AC, 2003, HLTH AFF MILLWOOD S; Foote SM, 2003, HLTH AFF MILLWOOD S, pW; FREUDENHEIM M, 2005, NY TIMES        0725, pC3; FRONSTIN P, SOUCES HLTH INSURANC; Gabel J, 2005, HEALTH AFFAIR, V24, P1273, DOI 10.1377/hlthaff.24.5.1273; Galvin RS, 2005, HEALTH AFFAIR, V24, P1549, DOI 10.1377/hlthaff.24.6.1549; Goetzel RZ, 2005, HEALTH CARE FINANC R, V26, P1; Harris Richard, 1966, SACRED TRUST; Iglehart JK, 2002, NEW ENGL J MED, V347, P956, DOI 10.1056/NEJMhpr022143; *KAIS FAM FDN, 2005, EMPL HLTH BEN 2005 S; Kletke PR, 1996, JAMA-J AM MED ASSOC, V276, P555, DOI 10.1001/jama.276.7.555; Krugman Paul, 2005, NEW YORK TIMES  0405, pA23; Moran DW, 2005, HEALTH AFFAIR, V24, P1415, DOI 10.1377/hlthaff.24.6.1415; NEWHOUSE J, 2005, BOSTON GLOBE    1111, pA23; PETERS JW, 2005, NY TIMES        1018; Robinson JC, 2005, NEW ENGL J MED, V353, P1199, DOI 10.1056/NEJMp058097; ROBINSON JC, 2002, HLTH AFF MILLWOOD S, pW139; Roland M, 2004, NEW ENGL J MED, V351, P1448, DOI 10.1056/NEJMhpr041294; Rosenthal MB, 2004, HEALTH AFFAIR, V23, P127, DOI 10.1377/hlthaff.23.2.127; SCHIEBER SS, 2004, FUTURE RETIREE HLTH; SCHULTZ EE, 2005, WALL STREET J   1019, pD1; SHEILS J, 2004, HLTH AFF MILLWOOD S; Solomon Deborah, 2005, WALL STREET J N 1123, pA1; Starr P, 1982, SOCIAL TRANSFORMATIO; Thomasson MA, 2002, EXPLOR ECON HIST, V39, P233, DOI 10.1006/exeh.2002.0788; Thomasson MA, 2004, EXPLOR ECON HIST, V41, P313, DOI 10.1016/j.eeh.2004.02.001; 2005, NY TIMES        1215, pC4	35	72	72	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 6	2006	355	1					82	88		10.1056/NEJMhpr060703	http://dx.doi.org/10.1056/NEJMhpr060703			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	060DT	16823002				2022-12-28	WOS:000238783200014
J	Farell, B				Farell, B			Psychophysics - Putting plaids in perspective - Reply	NATURE			English	Article									Syracuse Univ, Inst Sensory Res, Syracuse, NY 13244 USA; SUNY Hlth Sci Ctr, Ctr Vis Res, Syracuse, NY 13210 USA	Syracuse University; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Farell, B (corresponding author), Syracuse Univ, Inst Sensory Res, Syracuse, NY 13244 USA.			Farell, Bart/0000-0003-0902-5290				BISHOP PO, 1970, NEUROSCIENCES SECOND, P471; BLAKEMORE C, 1972, J PHYSIOL-LONDON, V225, P437, DOI 10.1113/jphysiol.1972.sp009948; Farell B, 1998, NATURE, V395, P689, DOI 10.1038/27192; Howard I. P., 1982, HUMAN VISUAL ORIENTA; Howard IP, 1995, BINOCULAR VISION STE; Julesz B., 1971, FDN CYCLOPEAN PERCEP; MCKEE SP, 1994, VISION RES, V34, P1047, DOI 10.1016/0042-6989(94)90009-4; Ogle KN, 1962, EYE, P271	8	2	2	0	3	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 23	1999	401	6751					342	343		10.1038/43822	http://dx.doi.org/10.1038/43822			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	240JJ	16862104				2022-12-28	WOS:000082822600039
J	James, AN; Gaston, KJ; Balmford, A				James, AN; Gaston, KJ; Balmford, A			Balancing the Earth's accounts	NATURE			English	Editorial Material									Univ Cambridge, Dept Land Econ, Cambridge CB3 9EP, England; Univ Sheffield, Dept Anim & Plant Sci, Biodivers Macroecol Grp, Sheffield S10 2TN, S Yorkshire, England; Univ Cambridge, Dept Zool, Conservat Biol Grp, Cambridge CB2 3EJ, England	University of Cambridge; University of Sheffield; University of Cambridge	James, AN (corresponding author), Univ Cambridge, Dept Land Econ, 19 Silver St, Cambridge CB3 9EP, England.			Balmford, Andrew/0000-0002-0144-3589				Adams J.S., 1992, MYTH WILD AFRICA CON; Balmford A, 1999, NATURE, V398, P204, DOI 10.1038/18339; Brandon K., 1998, PARKS PERIL PEOPLE P; Costanza R, 1997, NATURE, V387, P253, DOI 10.1038/387253a0; *IUCN, 1993, 4 WORLD C NAT PARKS; *IUCN, 1998, 1997 UN LIST PROT AR; James A. N., 1999, GLOBAL REV PROTECTED; JENKINS TN, 1990, FUTURE HARVESTS EC F; Myers N, 1998, NATURE, V392, P327, DOI 10.1038/32761; PRETTY J, 1999, WHAT PRICE WILDLIFE; *UN, 1993, AG 21 RIO DECL FOR P; van Schaik Carel P., 1997, P64; VANBEERS CP, 1999, ADDICTED SUBSIDIES	13	224	228	0	47	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 23	1999	401	6751					323	324		10.1038/43774	http://dx.doi.org/10.1038/43774			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	240JJ	16862091				2022-12-28	WOS:000082822600024
J	Singleton, P; Wadsworth, M				Singleton, Peter; Wadsworth, Michael			Confidentiality and consent in medical research - Consent for the use of personal medical data in research	BRITISH MEDICAL JOURNAL			English	Editorial Material									UCL, CHIME, London N19 5LW, England; Royal Free & Univ Coll Med Sch, MRC Natl Survey Hlth & Dev, Dept Epidemiol & Publ Hlth, London WC1E 6BT, England	University of London; University College London; University of London; University College London	Singleton, P (corresponding author), UCL, CHIME, London N19 5LW, England.	peter.singleton@chi-group.com						Academy of Medical Sciences, 2006, PERS DAT PUBL GOOD U; Barbone F, 1998, LANCET, V352, P1331, DOI 10.1016/S0140-6736(98)04087-2; *DEP HLTH, 2003, NHS CONF COD PRACT; JICK SS, 1995, BRIT MED J, V310, P215, DOI 10.1136/bmj.310.6974.215; Kalra D, 2006, BRIT MED J, V333, P196, DOI 10.1136/bmj.333.7560.196; LOWRANCE W, 2003, LEARNING EXPERIENCES; *MED RES COUNC, 2003, PERS INF MED RES	7	28	28	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 29	2006	333	7561					255	258		10.1136/bmj.333.7561.255	http://dx.doi.org/10.1136/bmj.333.7561.255			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	070CC	16873867	Green Published			2022-12-28	WOS:000239496900028
J	Dallas, D				Dallas, Duncan			Cafe Scientifique - Deja Vu	CELL			English	Editorial Material									Cafe Sci, Leeds LS7 4PE, W Yorkshire, England		Dallas, D (corresponding author), Cafe Sci, 7 Regent St, Leeds LS7 4PE, W Yorkshire, England.	cafe-sci@dial.pipex.com							0	21	21	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 28	2006	126	2					227	229		10.1016/j.cell.2006.07.006	http://dx.doi.org/10.1016/j.cell.2006.07.006			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	070VD	16873050	Bronze			2022-12-28	WOS:000239552600004
J	Doran, T; Fullwood, C; Gravelle, H; Reeves, D; Kontopantelis, E; Hiroeh, U; Roland, M				Doran, Tim; Fullwood, Catherine; Gravelle, Hugh; Reeves, David; Kontopantelis, Evangelos; Hiroeh, Urara; Roland, Martin			Pay-for-performance programs in family practices in the United Kingdom	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HEALTH-CARE-SYSTEM; QUALITY-OF-CARE; GENERAL-PRACTICE; CLINICAL CARE; ENGLAND; STATES	Background: In 2004, after a series of national initiatives associated with marked improvements in the quality of care, the National Health Service of the United Kingdom introduced a pay-for-performance contract for family practitioners. This contract increases existing income according to performance with respect to 146 quality indicators covering clinical care for 10 chronic diseases, organization of care, and patient experience. Methods: We analyzed data extracted automatically from clinical computing systems for 8105 family practices in England in the first year of the pay-for-performance program (April 2004 through March 2005), data from the U.K. Census, and data on characteristics of individual family practices. We examined the proportion of patients deemed eligible for a clinical quality indicator for whom the indicator was met (reported achievement) and the proportion of the total number of patients with a medical condition for whom a quality indicator was met (population achievement), and we used multiple regression analysis to determine the extent to which practices achieved high scores by classifying patients as ineligible for quality indicators (exception reporting). Results: The median reported achievement in the first year of the new contract was 83.4 percent (interquartile range, 78.2 to 87.0 percent). Sociodemographic characteristics of the patients (age and socioeconomic features) and practices (size of practice, number of patients per practitioner, age of practitioner, and whether the practitioner was medically educated in the United Kingdom) had moderate but significant effects on performance. Exception reporting by practices was not extensive (median rate, 6 percent), but it was the strongest predictor of achievement: a 1 percent increase in the rate of exception reporting was associated with a 0.31 percent increase in reported achievement. Exception reporting was high in a small number of practices: 1 percent of practices excluded more than 15 percent of patients. Conclusions: English family practices attained high levels of achievement in the first year of the new pay-for-performance contract. A small number of practices appear to have achieved high scores by excluding large numbers of patients by exception reporting. More research is needed to determine whether these practices are excluding patients for sound clinical reasons or in order to increase income.	Univ Manchester, Natl Primary Care Res & Dev Ctr, Manchester M13 9PL, Lancs, England	University of Manchester	Doran, T (corresponding author), Univ Manchester, Natl Primary Care Res & Dev Ctr, Williamson Bldg, Manchester M13 9PL, Lancs, England.	tim.doran@manchester.ac.uk	Kontopantelis, Evangelos/H-2966-2019; Greiver, Michelle/N-8764-2015; Reeves, David/H-6203-2014	Kontopantelis, Evangelos/0000-0001-6450-5815; Greiver, Michelle/0000-0001-8957-0285; Reeves, David/0000-0001-6377-6859; Gravelle, Hugh/0000-0002-7753-4233; Fullwood, Catherine/0000-0003-4136-2027	Medical Research Council [MC_PC_13042, MR/K006665/1] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Amick BC, 1995, SOC HLTH, P46; Baker D, 2003, J EPIDEMIOL COMMUN H, V57, P417, DOI 10.1136/jech.57.6.417; *BRIT MED ASS, FOC EXC REP; Campbell S, 2001, BRIT MED J, V322, P1580, DOI 10.1136/bmj.322.7302.1580; Campbell SM, 2005, BMJ-BRIT MED J, V331, P1121, DOI 10.1136/bmj.38632.611123.AE; Campbell SM, 1999, QUAL HEALTH CARE, V8, P6, DOI 10.1136/qshc.8.1.6; Chaix-Couturier C, 2000, INT J QUAL HEALTH C, V12, P133, DOI 10.1093/intqhc/12.2.133; Jha AK, 2005, J GEN INTERN MED, V20, P762, DOI 10.1111/j.1525-1497.2005.0160.x; Kerr EA, 2004, ANN INTERN MED, V141, P272, DOI 10.7326/0003-4819-141-4-200408170-00007; LEATHERMAN S, 2003, QUEST QUALITY NHS; Marmot M G, 1997, J Health Psychol, V2, P283, DOI 10.1177/135910539700200302; McGlynn EA, 2003, NEW ENGL J MED, V348, P2635, DOI 10.1056/NEJMsa022615; Middleton E, 2003, BMJ-BRIT MED J, V326, P854, DOI 10.1136/bmj.326.7394.854; *NAT COMM QUAL ASS, 2005, STAT HLTH CAR QUAL 2; *NHS EMPL, NEW QOF AR IND; *OFF DEP PRIM MIN, 2004, IND DEPR; Roland M, 2004, NEW ENGL J MED, V351, P1448, DOI 10.1056/NEJMhpr041294; Roland M, 2006, PRIM HEALTH CARE RES, V7, P18, DOI DOI 10.1191/1463423606PC2720A; ROLAND MO, 2003, QUEST QUALITY NHS, P203; Rosenthal MB, 2005, JAMA-J AM MED ASSOC, V294, P1788, DOI 10.1001/jama.294.14.1788; Schuster MA, 1998, MILBANK Q, V76, P517, DOI 10.1111/1468-0009.00105; Seddon ME, 2001, QUAL HEALTH CARE, V10, P152, DOI 10.1136/qhc.0100152..; Shekelle P, 2003, BRIT MED J, V326, P457, DOI 10.1136/bmj.326.7387.457; Spooner A, 2001, J Health Serv Res Policy, V6, P145, DOI 10.1258/1355819011927396; Starfield B, 2001, BRIT J GEN PRACT, V51, P303; Timmins N, 2005, BRIT MED J, V331, P800, DOI 10.1136/bmj.331.7520.800	26	542	549	1	46	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 27	2006	355	4					375	384		10.1056/NEJMsa055505	http://dx.doi.org/10.1056/NEJMsa055505			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	067DT	16870916	Bronze			2022-12-28	WOS:000239282600006
J	Carthew, RW				Carthew, Richard W.			A new RNA dimension to genome control	SCIENCE			English	Editorial Material							SPERMATOGENESIS; FAMILY; GENE; PIWI		Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, Evanston, IL 60208 USA	Northwestern University	Carthew, RW (corresponding author), Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, 2153 Sheridan Rd, Evanston, IL 60208 USA.	r-carthew@northwestern.edu			NIGMS NIH HHS [R01 GM068743] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068743] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ARAVIN A, 2006, NATURE; Carmell MA, 2002, GENE DEV, V16, P2733, DOI 10.1101/gad.1026102; Cogoni C, 1999, SCIENCE, V286, P2342, DOI 10.1126/science.286.5448.2342; Deng W, 2002, DEV CELL, V2, P819, DOI 10.1016/S1534-5807(02)00165-X; GIRARD A, NATURE; GRIVNA ST, 2006, GENES DEV; Kuramochi-Miyagawa S, 2004, DEVELOPMENT, V131, P839, DOI 10.1242/dev.00973; Lau NC, 2006, SCIENCE, V313, P363, DOI 10.1126/science.1130164; Matzke MA, 2005, NAT REV GENET, V6, P24, DOI 10.1038/nrg1500; Vagin VV, 2006, SCIENCE, V313, P320, DOI 10.1126/science.1129333; WATANABE T, 2006, GENES DEV       0609	11	31	40	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 21	2006	313	5785					305	306		10.1126/science.1131186	http://dx.doi.org/10.1126/science.1131186			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065IV	16857925				2022-12-28	WOS:000239154300027
J	Dolezal, P; Likic, V; Tachezy, J; Lithgow, T				Dolezal, Pavel; Likic, Vladimir; Tachezy, Jan; Lithgow, Trevor			Evolution of the molecular machines for protein import into mitochondria	SCIENCE			English	Review							BARREL MEMBRANE-PROTEINS; TWIN-PORE TRANSLOCASE; OUTER-MEMBRANE; PREPROTEIN TRANSLOCASE; INNER MEMBRANE; CRYSTAL-STRUCTURE; RECEPTOR TOM20; OMP85 FAMILY; BIOGENESIS; CHAPERONE	In creating mitochondria some 2 billion years ago, the first eukaryotes needed to establish protein import machinery in the membranes of what was a bacterial endosymbiont. Some of the preexisting protein translocation apparatus of the endosymbiont appears to have been commandeered, including molecular chaperones, the signal peptidase, and some components of the protein-targeting machinery. However, the protein translocases that drive protein import into mitochondria have no obvious counterparts in bacteria, making it likely that these machines were created de novo. The presence of similar translocase subunits in all eukaryotic genomes sequenced to date suggests that all eukaryotes can be considered descendants of a single ancestor species that carried an ancestral "protomitochondria."	Univ Melbourne, Dept Biochem & Mol Biol, Parkville, Vic 3010, Australia; Bio21 Mol Sci & Biotechnol Inst, Parkville, Vic 3010, Australia; Charles Univ Prague, Dept Parasitol, CR-12844 Prague 2, Czech Republic	University of Melbourne; Charles University Prague	Lithgow, T (corresponding author), Univ Melbourne, Dept Biochem & Mol Biol, Parkville, Vic 3010, Australia.	t.lithgow@unimelb.edu.au	Dolezal, Pavel/V-1907-2017; Tachezy, Jan/R-4945-2017; Lithgow, Trevor J/H-5925-2017	Dolezal, Pavel/0000-0003-1285-9026; Tachezy, Jan/0000-0001-6976-8446; Lithgow, Trevor J/0000-0002-0102-7884				Abe Y, 2000, CELL, V100, P551, DOI 10.1016/S0092-8674(00)80691-1; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkh121, 10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bauer MF, 1999, FEBS LETT, V464, P41, DOI 10.1016/S0014-5793(99)01665-8; BOORSTEIN WR, 1994, J MOL EVOL, V38, P1; Bozner P, 1997, J PARASITOL, V83, P224, DOI 10.2307/3284444; Chacinska A, 2005, CELL, V120, P817, DOI 10.1016/j.cell.2005.01.011; Chan NC, 2006, J MOL BIOL, V358, P1010, DOI 10.1016/j.jmb.2006.02.062; Dolezal P, 2005, P NATL ACAD SCI USA, V102, P10924, DOI 10.1073/pnas.0500349102; Embley TM, 2006, NATURE, V440, P623, DOI 10.1038/nature04546; Endo T, 2002, BBA-MOL CELL RES, V1592, P3, DOI 10.1016/S0167-4889(02)00259-8; Frazier AE, 2006, J CELL BIOL, V172, P553, DOI 10.1083/jcb.200505060; Gabaldon T, 2003, SCIENCE, V301, P609, DOI 10.1126/science.1085463; Gakh E, 2002, BBA-MOL CELL RES, V1592, P63, DOI 10.1016/S0167-4889(02)00265-3; Gentle I, 2004, J CELL BIOL, V164, P19, DOI 10.1083/jcb.200310092; Gentle IE, 2005, MOL MICROBIOL, V58, P1216, DOI 10.1111/j.1365-2958.2005.04906.x; Gray MW, 1999, SCIENCE, V283, P1476, DOI 10.1126/science.283.5407.1476; Hausler T, 1997, EUR J CELL BIOL, V73, P240; Herrmann JM, 2003, TRENDS MICROBIOL, V11, P74, DOI 10.1016/S0966-842X(02)00033-1; Herrmann JM, 2000, CURR OPIN MICROBIOL, V3, P210, DOI 10.1016/S1369-5274(00)00077-1; Hofmann K, 2000, Brief Bioinform, V1, P167, DOI 10.1093/bib/1.2.167; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Humphries AD, 2005, J BIOL CHEM, V280, P11535, DOI 10.1074/jbc.M413816200; Ishikawa D, 2004, J CELL BIOL, V166, P621, DOI 10.1083/jcb.200405138; Koehler CM, 2004, ANNU REV CELL DEV BI, V20, P309, DOI 10.1146/annurev.cellbio.20.010403.105057; Korndorfer IP, 2004, NAT STRUCT MOL BIOL, V11, P1015, DOI 10.1038/nsmb828; Kozjak V, 2003, J BIOL CHEM, V278, P48520, DOI 10.1074/jbc.C300442200; Kuhn A, 2003, TRENDS CELL BIOL, V13, P510, DOI 10.1016/j.tcb.2003.08.005; Lang BF, 1997, NATURE, V387, P493, DOI 10.1038/387493a0; Likic VA, 2005, J MOL BIOL, V347, P81, DOI 10.1016/j.jmb.2004.12.057; Lucattini R, 2004, MOL BIOL EVOL, V21, P652, DOI 10.1093/molbev/msh058; Macasev D, 2004, MOL BIOL EVOL, V21, P1557, DOI 10.1093/molbev/msh166; Margulis L, 1970, ORIGIN EUKARYOTIC CE; Meinecke M, 2006, SCIENCE, V312, P1523, DOI 10.1126/science.1127628; Meisinger C, 2004, DEV CELL, V7, P61, DOI 10.1016/j.devcel.2004.06.003; Meisinger C, 2001, MOL CELL BIOL, V21, P2337, DOI 10.1128/MCB.21.7.2337-2348.2001; Mokranjac D, 2005, J BIOL CHEM, V280, P23437, DOI 10.1074/jbc.C500135200; Neupert W, 2002, NAT REV MOL CELL BIO, V3, P555, DOI 10.1038/nrm878; Ott M, 2006, EMBO J, V25, P1603, DOI 10.1038/sj.emboj.7601070; Paschen SA, 2003, NATURE, V426, P862, DOI 10.1038/nature02208; Paschen SA, 2005, TRENDS BIOCHEM SCI, V30, P575, DOI 10.1016/j.tibs.2005.08.009; Perry AJ, 2005, CURR BIOL, V15, pR423, DOI 10.1016/j.cub.2005.05.031; Perry AJ, 2006, CURR BIOL, V16, P221, DOI 10.1016/j.cub.2005.12.034; Pfanner N, 2004, NAT STRUCT MOL BIOL, V11, P1044, DOI 10.1038/nsmb852; Rassow J, 1999, J MOL BIOL, V286, P105, DOI 10.1006/jmbi.1998.2455; Regoes A, 2005, J BIOL CHEM, V280, P30557, DOI 10.1074/jbc.M500787200; Rehling P, 2004, NAT REV MOL CELL BIO, V5, P519, DOI 10.1038/nrm1426; Rehling P, 2003, SCIENCE, V299, P1747, DOI 10.1126/science.1080945; Romisch K, 1999, J CELL SCI, V112, P4185; Sickmann A, 2003, P NATL ACAD SCI USA, V100, P13207, DOI 10.1073/pnas.2135385100; *U MONTR, ORG GEN DAT; Waizengger T, 2005, EMBO REP, V6, P57, DOI 10.1038/sj.embor.7400318; Walton TA, 2004, MOL CELL, V15, P367, DOI 10.1016/j.molcel.2004.07.023; Webb CT, 2006, MOL CELL, V21, P123, DOI 10.1016/j.molcel.2005.11.010; Werhahn W, 2001, PLANT PHYSIOL, V125, P943, DOI 10.1104/pp.125.2.943; Wiedemann N, 2003, NATURE, V424, P565, DOI 10.1038/nature01753; Wiedemann N, 2006, MOL CELL, V21, P145, DOI 10.1016/j.molcel.2006.01.001	56	421	432	0	61	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 21	2006	313	5785					314	318		10.1126/science.1127895	http://dx.doi.org/10.1126/science.1127895			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065IV	16857931				2022-12-28	WOS:000239154300033
J	Enemark, EJ; Joshua-Tor, L				Enemark, Eric J.; Joshua-Tor, Leemor			Mechanism of DNA translocation in a replicative hexameric helicase	NATURE			English	Article							SINGLE-STRANDED-DNA; LARGE TUMOR-ANTIGEN; STRUCTURAL-CHANGES; CRYSTAL-STRUCTURE; BINDING DOMAIN; T-ANTIGEN; PROTEIN; E1; PAPILLOMAVIRUS; COMPLEX	The E1 protein of papillomavirus is a hexameric ring helicase belonging to the AAA+ family. The mechanism that couples the ATP cycle to DNA translocation has been unclear. Here we present the crystal structure of the E1 hexamer with single-stranded DNA discretely bound within the hexamer channel and nucleotides at the subunit interfaces. This structure demonstrates that only one strand of DNA passes through the hexamer channel and that the DNA-binding hairpins of each subunit form a spiral 'staircase' that sequentially tracks the oligonucleotide backbone. Consecutively grouped ATP, ADP and apo configurations correlate with the height of the hairpin, suggesting a straightforward DNA translocation mechanism. Each subunit sequentially progresses through ATP, ADP and apo states while the associated DNA-binding hairpin travels from the top staircase position to the bottom, escorting one nucleotide of single-stranded DNA through the channel. These events permute sequentially around the ring from one subunit to the next.	Cold Spring Harbor Lab, WM Keck Struct Biol Lab, Cold Spring Harbor, NY 11724 USA	Cold Spring Harbor Laboratory	Joshua-Tor, L (corresponding author), Cold Spring Harbor Lab, WM Keck Struct Biol Lab, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.	leemor@cshl.edu	Enemark, Eric/N-8086-2018	Joshua-Tor, Leemor/0000-0001-8185-8049	NIAID NIH HHS [R01 AI046724] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI046724] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Abbate EA, 2004, GENE DEV, V18, P1981, DOI 10.1101/gad.1220104; Ahnert P, 1997, J BIOL CHEM, V272, P32267, DOI 10.1074/jbc.272.51.32267; BACON D, 1988, J MOL GRAPHICS, V6, P219, DOI 10.1016/S0263-7855(98)80030-1; Bell SP, 2002, ANNU REV BIOCHEM, V71, P333, DOI 10.1146/annurev.biochem.71.110601.135425; Chen G, 2002, MOL CELL BIOL, V22, P7712, DOI 10.1128/MCB.22.21.7712-7720.2002; Crampton DJ, 2006, MOL CELL, V21, P165, DOI 10.1016/j.molcel.2005.11.027; Davey MJ, 2003, CURR BIOL, V13, pR594, DOI 10.1016/S0960-9822(03)00523-2; EGELMAN EH, 1995, P NATL ACAD SCI USA, V92, P3869, DOI 10.1073/pnas.92.9.3869; Enemark EJ, 2000, MOL CELL, V6, P149, DOI 10.1016/S1097-2765(00)00016-2; Enemark EJ, 2002, EMBO J, V21, P1487, DOI 10.1093/emboj/21.6.1487; Esnouf RM, 1997, J MOL GRAPH MODEL, V15, P132, DOI 10.1016/S1093-3263(97)00021-1; Fouts ET, 1999, J BIOL CHEM, V274, P4447, DOI 10.1074/jbc.274.7.4447; Gai' DH, 2004, CELL, V119, P47, DOI 10.1016/j.cell.2004.09.017; GILLETTE TG, 1994, P NATL ACAD SCI USA, V91, P8846, DOI 10.1073/pnas.91.19.8846; Hickman AB, 2005, CURR OPIN STRUC BIOL, V15, P77, DOI 10.1016/j.sbi.2004.12.001; HINGORANI MM, 1993, BIOCHEMISTRY-US, V32, P12478, DOI 10.1021/bi00097a028; Jeruzalmi D, 2002, CURR OPIN STRUC BIOL, V12, P217, DOI 10.1016/S0959-440X(02)00313-5; Kaplan DL, 2002, MOL CELL, V10, P647, DOI 10.1016/S1097-2765(02)00642-1; Kawaoka J, 2004, NAT STRUCT MOL BIOL, V11, P526, DOI 10.1038/nsmb771; LEBOWITZ JH, 1986, J BIOL CHEM, V261, P4738; Li DW, 2003, NATURE, V423, P512, DOI 10.1038/nature01691; Liao JC, 2005, J MOL BIOL, V350, P452, DOI 10.1016/j.jmb.2005.04.051; Lin BY, 2002, MOL CELL BIOL, V22, P6592, DOI 10.1128/MCB.22.18.6592-6604.2002; Luo XL, 1996, NAT STRUCT BIOL, V3, P1034, DOI 10.1038/nsb1296-1034; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; Messer W, 2002, FEMS MICROBIOL REV, V26, P355, DOI 10.1016/S0168-6445(02)00127-4; Neuwald AF, 1999, GENOME RES, V9, P27; Sanders CM, 1998, EMBO J, V17, P7044, DOI 10.1093/emboj/17.23.7044; Schuck S, 2005, MOL CELL, V20, P377, DOI 10.1016/j.molcel.2005.09.020; Sedman J, 1998, J VIROL, V72, P6893, DOI 10.1128/JVI.72.8.6893-6897.1998; SEO YS, 1993, J BIOL CHEM, V268, P10282; SEO YS, 1993, P NATL ACAD SCI USA, V90, P702, DOI 10.1073/pnas.90.2.702; Singleton MR, 2000, CELL, V101, P589, DOI 10.1016/S0092-8674(00)80871-5; WESSEL R, 1992, J VIROL, V66, P804, DOI 10.1128/JVI.66.2.804-815.1992; YANG L, 1993, P NATL ACAD SCI USA, V90, P5086, DOI 10.1073/pnas.90.11.5086	36	407	411	1	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 20	2006	442	7100					270	275		10.1038/nature04943	http://dx.doi.org/10.1038/nature04943			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064WT	16855583				2022-12-28	WOS:000239122100031
J	Oepkes, D; Seaward, PG; Vandenbussche, FPHA; Windrim, R; Kingdom, J; Beyene, J; Kanhai, HHH; Ohlsson, A; Ryan, G				Oepkes, D; Seaward, PG; Vandenbussche, FPHA; Windrim, R; Kingdom, J; Beyene, J; Kanhai, HHH; Ohlsson, A; Ryan, G		DIAMOND Study Grp	Doppler ultrasonography versus amniocentesis to predict fetal anemia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PEAK SYSTOLIC VELOCITY; MIDDLE CEREBRAL-ARTERY; RED-CELL ALLOIMMUNIZATION; FLUID OPTICAL-DENSITY; HEMOLYTIC-DISEASE; 450 NM; PREGNANCIES; MANAGEMENT; ISOIMMUNIZATION; PROPORTIONS	BACKGROUND Pregnancies complicated by Rh alloimmunization have been evaluated with the use of serial invasive amniocentesis to determine bilirubin levels by measuring in the amniotic fluid the change in optical density at a wavelength of 450 nm (Delta OD450); however, this procedure carries risks. Noninvasive Doppler ultrasonographic measurement of the peak velocity of systolic blood flow in the middle cerebral artery also predicts severe fetal anemia, but this test has not been rigorously evaluated in comparison with amniotic-fluid Delta OD450. METHODS We performed a prospective, international, multicenter study including women with RhD-, Rhc-, RhE-, or Fy(a)-alloimmunized pregnancies with indirect antiglobulin titers of at least 1: 64 and antigen-positive fetuses to assess whether Doppler ultrasonographic measurement of the peak systolic velocity of blood flow in the middle cerebral artery was at least as sensitive and accurate as measurement of amniotic-fluid Delta OD450 for diagnosing severe fetal anemia. The results of the two tests were compared with the incidence of fetal anemia, as determined by measurement of hemoglobin levels in fetal blood. RESULTS Of 165 fetuses, 74 had severe anemia. For the detection of severe fetal anemia, Doppler ultrasonography of the middle cerebral artery had a sensitivity of 88 percent ( 95 percent confidence interval, 78 to 93 percent), a specificity of 82 percent ( 95 percent confidence interval, 73 to 89 percent), and an accuracy of 85 percent ( 95 percent confidence interval, 79 to 90 percent). Amniotic-fluid Delta OD450 had a sensitivity of 76 percent ( 95 percent confidence interval, 65 to 84 percent), a specificity of 77 percent ( 95 percent confidence interval, 67 to 84 percent), and an accuracy of 76 percent ( 95 percent confidence interval, 69 to 82 percent). Doppler ultrasonography was more sensitive, by 12 percentage points ( 95 percent confidence interval, 0.3 to 24.0), and more accurate, by 9 percentage points ( 95 percent confidence interval, 1.1 to 15.9), than measurement of amniotic-fluid Delta OD450. CONCLUSIONS Doppler measurement of the peak velocity of systolic blood flow in the middle cerebral artery can safely replace invasive testing in the management of Rh-alloimmunized pregnancies.	Leiden Univ, Med Ctr, Dept Obstet, Leiden, Netherlands; Mt Sinai Hosp, Dept Obstet & Gynaecol, Fetal Med Unit, Toronto, ON M5G 1X5, Canada; Mt Sinai Hosp, Dept Paediat, Toronto, ON M5G 1X5, Canada; Univ Toronto, Dept Publ Hlth Sci, Toronto, ON, Canada	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto	Oepkes, D (corresponding author), Leiden Univ, Med Ctr, Dept Obstet, Leiden, Netherlands.		Vandenbussche, F.P.H.A./H-8100-2014; Kingdom, John/A-3247-2013; Kingdom, John/AAF-2145-2020; Windrim, Rory/AAC-6038-2020; Windrim, Rory/B-7617-2016; Ryan, Greg/B-7618-2016; Windrim, Rory/ABD-6799-2021; Greg, Ryan/AAG-6134-2020					Agresti A, 1998, AM STAT, V52, P119, DOI 10.2307/2685469; *AM COLL OBST GYN, 1996, ACOG TECHN B, V227; Blessed WB, 2001, AM J OBSTET GYNECOL, V184, P1340, DOI 10.1067/mob.2001.115049; BOWMAN JM, 1985, OBSTET GYNECOL, V66, P749; Bullock R, 2005, ULTRASOUND OBST GYN, V25, P331, DOI 10.1002/uog.1886; CONNOR RJ, 1987, BIOMETRICS, V43, P207, DOI 10.2307/2531961; Dukler D, 2003, AM J OBSTET GYNECOL, V188, P1310, DOI 10.1067/mob.2003.265; Hawass NED, 1997, BRIT J RADIOL, V70, P360, DOI 10.1259/bjr.70.832.9166071; HOLZGREVE W, 1999, FETAL MED BASIC SCI, P417; LILEY AW, 1961, AM J OBSTET GYNECOL, V82, P1359; Liu JP, 2002, STAT MED, V21, P231, DOI 10.1002/sim.1012; Lo YMD, 1998, NEW ENGL J MED, V339, P1734, DOI 10.1056/NEJM199812103392402; Mari G, 2005, J ULTRAS MED, V24, P425, DOI 10.7863/jum.2005.24.4.425; Mari G, 2000, NEW ENGL J MED, V342, P9, DOI 10.1056/NEJM200001063420102; Moise KJ, 2002, OBSTET GYNECOL, V100, P833; MOISE KJ, 1995, AM J OBSTET GYNECOL, V172, P1003, DOI 10.1016/0002-9378(95)90034-9; Newcombe RG, 1998, STAT MED, V17, P857, DOI 10.1002/(SICI)1097-0258(19980430)17:8<857::AID-SIM777>3.0.CO;2-E; NICOLAIDES KH, 1988, AM J OBSTET GYNECOL, V159, P1063, DOI 10.1016/0002-9378(88)90413-9; NICOLAIDES KH, 1986, AM J OBSTET GYNECOL, V155, P90, DOI 10.1016/0002-9378(86)90085-2; NICOLAIDES KH, 1988, LANCET, V1, P1073; Nishie EN, 2003, AM J OBSTET GYNECOL, V188, P214, DOI 10.1067/mob.2003.63; Oepkes D, 2001, AM J OBSTET GYNECOL, V184, P1015, DOI 10.1067/mob.2001.112970; Oepkes D, 2000, EUR J OBSTET GYN R B, V92, P83, DOI 10.1016/S0301-2115(00)00429-2; QUEENAN JT, 1993, AM J OBSTET GYNECOL, V168, P1370, DOI 10.1016/S0002-9378(11)90767-4; Scott F, 1998, PRENATAL DIAG, V18, P1143; Segata M, 2004, CURR OPIN OBSTET GYN, V16, P153, DOI 10.1097/00001703-200404000-00010; Spinnato JA, 1998, OBSTET GYNECOL, V92, P441, DOI 10.1016/S0029-7844(98)00179-3; SPINNATO JA, 1991, AM J OBSTET GYNECOL, V165, P1030, DOI 10.1016/0002-9378(91)90464-3; van Kamp IL, 2001, AM J OBSTET GYNECOL, V185, P668, DOI 10.1067/mob.2001.116690; VAUGHAN JI, 1994, AM J OBSTET GYNECOL, V171, P247, DOI 10.1016/0002-9378(94)90477-4; WEINER CP, 1991, AM J OBSTET GYNECOL, V165, P546, DOI 10.1016/0002-9378(91)90281-U; Zimmermann R, 2002, BJOG-INT J OBSTET GY, V109, P746, DOI 10.1016/S1470-0328(02)01314-9	32	145	163	0	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 13	2006	355	2					156	164		10.1056/NEJMoa052855	http://dx.doi.org/10.1056/NEJMoa052855			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	062UP	16837679				2022-12-28	WOS:000238970600007
J	Thirumurugan, K; Sakamoto, T; Hammer, JA; Sellers, JR; Knight, PJ				Thirumurugan, Kavitha; Sakamoto, Takeshi; Hammer, John A., III; Sellers, James R.; Knight, Peter J.			The cargo-binding domain regulates structure and activity of myosin 5	NATURE			English	Article							ATPASE ACTIVITY; TAIL DOMAIN; CONFORMATION; CALMODULIN; ACTIVATION; MUSCLE; VA	Myosin 5 is a two-headed motor protein that moves cargoes along actin filaments(1,2). Its tail ends in paired globular tail domains (GTDs) thought to bind cargo(3). At nanomolar calcium levels, actin-activated ATPase is low and the molecule is folded. Micromolar calcium concentrations activate ATPase and the molecule unfolds(3-6). Here we describe the structure of folded myosin and the GTD's role in regulating activity. Electron microscopy shows that the two heads lie either side of the tail, contacting the GTDs at a lobe of the motor domain (similar to Pro 117 - Pro 137) that contains conserved acidic side chains, suggesting ionic interactions between motor domain and GTD. Myosin 5 heavy meromyosin, a constitutively active fragment lacking the GTDs, is inhibited and folded by a dimeric GST - GTD fusion protein. Motility assays reveal that at nanomolar calcium levels heavy meromyosin moves robustly on actin filaments whereas few myosins bind or move. These results combine to show that with no cargo, the GTDs bind in an intramolecular manner to the motor domains, producing an inhibited and compact structure that binds weakly to actin and allows the molecule to recycle towards new cargoes.	Univ Leeds, Inst Mol & Cellular Biol, Leeds LS2 9JT, W Yorkshire, England; Univ Leeds, Astbury Ctr Struct Mol Biol, Leeds LS2 9JT, W Yorkshire, England; NHLBI, Lab Mol Physiol, NIH, Bethesda, MD 20892 USA; NHLBI, Cell Biol Lab, NIH, Bethesda, MD 20892 USA	University of Leeds; University of Leeds; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Knight, PJ (corresponding author), Univ Leeds, Inst Mol & Cellular Biol, Leeds LS2 9JT, W Yorkshire, England.	p.j.knight@leeds.ac.uk	Thirumurugan, Kavitha/B-3282-2010	Thirumurugan, Kavitha/0000-0002-4673-4099	Wellcome Trust [076057] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL004229, Z01HL004229, Z01HL000514, ZIAHL000514] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ANKRETT RJ, 1991, J MOL BIOL, V217, P323, DOI 10.1016/0022-2836(91)90546-I; Burgess S, 2002, J CELL BIOL, V159, P983, DOI 10.1083/jcb.200208172; Burgess SA, 2004, J STRUCT BIOL, V147, P247, DOI 10.1016/j.jsb.2004.04.004; CHENEY RE, 1993, CELL, V75, P13, DOI 10.1016/0092-8674(93)90675-G; Cope MJTV, 1996, STRUCTURE, V4, P969, DOI 10.1016/S0969-2126(96)00103-7; Coureux PD, 2004, EMBO J, V23, P4527, DOI 10.1038/sj.emboj.7600458; Forkey JN, 2003, NATURE, V422, P399, DOI 10.1038/nature01529; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Hackney DD, 2000, NAT CELL BIOL, V2, P257, DOI 10.1038/35010525; Houdusse A, 2000, P NATL ACAD SCI USA, V97, P11238, DOI 10.1073/pnas.200376897; Krementsov DN, 2004, J CELL BIOL, V164, P877, DOI 10.1083/jcb.200310065; Li XD, 2005, J BIOL CHEM, V280, P17815, DOI 10.1074/jbc.M413295200; Li XD, 2004, BIOCHEM BIOPH RES CO, V315, P538, DOI 10.1016/j.bbrc.2004.01.084; Nguyen H, 2005, NAT STRUCT MOL BIOL, V12, P127, DOI 10.1038/nsmb894; Pashkova N, 2006, EMBO J, V25, P693, DOI 10.1038/sj.emboj.7600965; Sakamoto T, 2000, BIOCHEM BIOPH RES CO, V272, P586, DOI 10.1006/bbrc.2000.2819; Sakamoto T, 2003, J BIOL CHEM, V278, P29201, DOI 10.1074/jbc.M303662200; Schilstra MJ, 2006, J R SOC INTERFACE, V3, P153, DOI 10.1098/rsif.2005.0098; Sellers J. R., 1999, MYOSINS; Sellers JR, 2006, CURR OPIN CELL BIOL, V18, P68, DOI 10.1016/j.ceb.2005.12.014; Vale RD, 2003, J CELL BIOL, V163, P445, DOI 10.1083/jcb.200308093; Wang F, 2004, J BIOL CHEM, V279, P2333, DOI 10.1074/jbc.C300488200; Wendt T, 2001, P NATL ACAD SCI USA, V98, P4361, DOI 10.1073/pnas.071051098; Yildiz A, 2003, SCIENCE, V300, P2061, DOI 10.1126/science.1084398	24	134	137	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 13	2006	442	7099					212	215		10.1038/nature04865	http://dx.doi.org/10.1038/nature04865			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	062XJ	16838021	Green Accepted			2022-12-28	WOS:000238979700050
J	Brooks, TM; Mittermeier, RA; da Fonseca, GAB; Gerlach, J; Hoffmann, M; Lamoreux, JF; Mittermeier, CG; Pilgrim, JD; Rodrigues, ASL				Brooks, T. M.; Mittermeier, R. A.; da Fonseca, G. A. B.; Gerlach, J.; Hoffmann, M.; Lamoreux, J. F.; Mittermeier, C. G.; Pilgrim, J. D.; Rodrigues, A. S. L.			Global biodiversity conservation priorities	SCIENCE			English	Review							HOTSPOTS; ECOREGIONS; FUTURE; WILDERNESS; EARTHS; AREAS; WORK; TIME	The location of and threats to biodiversity are distributed unevenly, so prioritization is essential to minimize biodiversity loss. To address this need, biodiversity conservation organizations have proposed nine templates of global priorities over the past decade. Here, we review the concepts, methods, results, impacts, and challenges of these prioritizations of conservation practice within the theoretical irreplaceability/vulnerability framework of systematic conservation planning. Most of the templates prioritize highly irreplaceable regions; some are reactive ( prioritizing high vulnerability), and others are proactive ( prioritizing low vulnerability). We hope this synthesis improves understanding of these prioritization approaches and that it results in more efficient allocation of geographically flexible conservation funding.	Conservat Int, Washington, DC 20036 USA; Univ Philippines, ICRAF, World Agroforestry Ctr, Los Banos 4031, Laguna, Philippines; Univ Virginia, Dept Environm Sci, Charlottesville, VA 22904 USA; Univ Fed Minas Gerais, Dept Zool, BR-31270 Belo Horizonte, MG, Brazil; Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England; Nat Protect Trust Seychelles, Victoria, Mahe, Seychelles; BirdLife Int Indochina, Hanoi, Vietnam	Conservation International; CGIAR; World Agroforestry (ICRAF); University of the Philippines System; University of the Philippines Los Banos; University of the Philippines Open University; University of Virginia; Universidade Federal de Minas Gerais; University of Cambridge; BirdLife International	Brooks, TM (corresponding author), Conservat Int, 1919 M St NW, Washington, DC 20036 USA.	t.brooks@conservation.org	Hoffmann, Michael/E-6419-2010; Rodrigues, Ana/GYQ-6273-2022; Rodrigues, Ana S.L./A-5914-2009	Hoffmann, Michael/0000-0003-4785-2254; Rodrigues, Ana S.L./0000-0003-4775-0127; Gerlach, Justin/0000-0002-0157-0449; Brooks, Thomas/0000-0001-8159-3116				BAILLIE JEM, 2004, IUCN RED LIST THREAT; Balmford A, 2005, SCIENCE, V307, P212, DOI 10.1126/science.1106281; Balmford A, 2001, SCIENCE, V291, P2616, DOI 10.1126/science.291.5513.2616; BirdLife International, 2004, STAT WORLDS BIRDS 20; Brummitt N, 2003, CONSERV BIOL, V17, P1442, DOI 10.1046/j.1523-1739.2003.02344.x; Bryant D., 1997, LAST FRONTIER FOREST; Cardillo M, 2006, P NATL ACAD SCI USA, V103, P4157, DOI 10.1073/pnas.0510541103; Cincotta RP, 2000, NATURE, V404, P990, DOI 10.1038/35010105; Cowling RM, 2003, BIOL CONSERV, V112, P191, DOI 10.1016/S0006-3207(02)00425-1; da Fonseca GAB, 2000, NATURE, V405, P393, DOI 10.1038/35013249; Dobson AP, 1997, SCIENCE, V275, P550, DOI 10.1126/science.275.5299.550; Eken G, 2004, BIOSCIENCE, V54, P1110, DOI 10.1641/0006-3568(2004)054[1110:KBAASC]2.0.CO;2; ERWIN TL, 1991, SCIENCE, V253, P750, DOI 10.1126/science.253.5021.750; Ferrier S, 2004, BIOSCIENCE, V54, P1101, DOI 10.1641/0006-3568(2004)054[1101:MMOTBF]2.0.CO;2; Fjeldsa J, 1997, BIODIVERS CONSERV, V6, P325, DOI 10.1023/A:1018356506390; Halpern BS, 2006, CONSERV BIOL, V20, P56, DOI 10.1111/j.1523-1739.2005.00258.x; Hoekstra JM, 2005, ECOL LETT, V8, P23, DOI 10.1111/j.1461-0248.2004.00686.x; HUNTER ML, 1994, CONSERV BIOL, V8, P1163, DOI 10.1046/j.1523-1739.1994.08041163.x; James AN, 1999, NATURE, V401, P323, DOI 10.1038/43774; Jepson P, 2002, CONSERV BIOL, V16, P42, DOI 10.1046/j.1523-1739.2002.01143.x; Kareiva P, 2003, AM SCI, V91, P344, DOI 10.1511/2003.26.869; Krupnick GA, 2003, BIODIVERS CONSERV, V12, P2237, DOI 10.1023/A:1024582529645; Kuper W, 2004, ANN MO BOT GARD, V91, P525; Lamoreux JF, 2006, NATURE, V440, P212, DOI 10.1038/nature04291; Loreau M, 2001, SCIENCE, V294, P804, DOI 10.1126/science.1064088; Mace GM, 2000, NATURE, V405, P393, DOI 10.1038/35013247; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; Millennium Ecosystem Assessment, 2005, ECOSYSTEMS HUMAN WEL; Mittermeier R. A., 1997, MEGADIVERSITY; Mittermeier R.A., 2004, HOTSPOTS REVISITED; Mittermeier RA, 2003, P NATL ACAD SCI USA, V100, P10309, DOI 10.1073/pnas.1732458100; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Myers N, 2003, BIOSCIENCE, V53, P916; Myers N, 1988, Environmentalist, V8, P187, DOI 10.1007/BF02240252; O'Connor C, 2003, ECOL LETT, V6, P706, DOI 10.1046/j.1461-0248.2003.00499.x; Olson DM, 1998, CONSERV BIOL, V12, P502, DOI 10.1046/j.1523-1739.1998.012003502.x; Olson DM, 2002, ANN MO BOT GARD, V89, P199, DOI 10.2307/3298564; Orme CDL, 2005, NATURE, V436, P1016, DOI 10.1038/nature03850; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; PIMM SL, 1995, SCIENCE, V269, P347, DOI 10.1126/science.269.5222.347; Redford KH, 2003, CONSERV BIOL, V17, P116, DOI 10.1046/j.1523-1739.2003.01467.x; Reid WV, 1998, TRENDS ECOL EVOL, V13, P275, DOI 10.1016/S0169-5347(98)01363-9; Ricketts TH, 2005, P NATL ACAD SCI USA, V102, P18497, DOI 10.1073/pnas.0509060102; Roberts CM, 2002, SCIENCE, V295, P1280, DOI 10.1126/science.1067728; Rodrigues ASL, 2004, BIOSCIENCE, V54, P1092, DOI 10.1641/0006-3568(2004)054[1092:GGAPRF]2.0.CO;2; Sanderson EW, 2002, BIOSCIENCE, V52, P891, DOI 10.1641/0006-3568(2002)052[0891:THFATL]2.0.CO;2; Sarkar S, 1999, BIOSCIENCE, V49, P405, DOI 10.2307/1313633; Sechrest W, 2002, P NATL ACAD SCI USA, V99, P2067, DOI 10.1073/pnas.251680798; Smith TB, 1997, SCIENCE, V276, P1855, DOI 10.1126/science.276.5320.1855; Stattersfield Alison J., 1998, Birdlife Conservation Series, V7, P1; Whittaker RJ, 2005, DIVERS DISTRIB, V11, P3, DOI 10.1111/j.1366-9516.2005.00143.x; Wilson K, 2005, ENVIRON MANAGE, V35, P527, DOI 10.1007/s00267-004-0095-9; Wilson KA, 2006, NATURE, V440, P337, DOI 10.1038/nature04366; *WWF IUCN, 1994, CTR PLANT DIV	54	1365	1468	32	1152	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 7	2006	313	5783					58	61		10.1126/science.1127609	http://dx.doi.org/10.1126/science.1127609			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061DA	16825561	Green Submitted			2022-12-28	WOS:000238850200027
J	Wright, AA; Katz, IT				Wright, Alexi A.; Katz, Ingrid T.			Roe versus reality - Abortion and women's health	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Dana Farber Canc Inst, Boston, MA 02115 USA; Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Beth Israel Deaconess Medical Center	Wright, AA (corresponding author), Dana Farber Canc Inst, Boston, MA 02115 USA.		Wright, Alexi/T-5793-2019	Katz, Ingrid/0000-0002-3014-238X				ADLER NE, 1990, SCIENCE, V248, P41, DOI 10.1126/science.2181664; Beral V, 2004, LANCET, V363, P1007, DOI 10.1016/S0140-6736(04)15835-2; Finer LB, 2003, PERSPECT SEX REPRO H, V35, P6, DOI 10.1111/j.1931-2393.2003.tb00079.x; Uttley LJ, 2002, NO STRINGS ATTACHED; 2006, HARPERS MAGAZINE APR	5	17	17	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 6	2006	355	1					1	+		10.1056/NEJMp068083	http://dx.doi.org/10.1056/NEJMp068083			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	060DT	16822990				2022-12-28	WOS:000238783200001
J	Rosenthal, MS				Rosenthal, MS			Cultural competency	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												marjorie.rosenthal@yale.edu						Anderson MR, 2004, PEDIATRICS, V114, P1677, DOI 10.1542/peds.2004-2091; FIELDS J, 2003, AM FAMILY LIVING ARR; Klass P, 2005, NEW ENGL J MED, V353, P2107, DOI 10.1056/NEJMp048155; Schor EL, 2003, PEDIATRICS, V111, P1541; SELLS JM, 1989, PEDIATRICS, V84, P355	5	2	2	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 5	2006	296	1					23	24		10.1001/jama.296.1.23	http://dx.doi.org/10.1001/jama.296.1.23			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	058RU	16820535				2022-12-28	WOS:000238683100001
J	Booth, GL; Kapral, MK; Fung, K; Tu, JV				Booth, Gillian L.; Kapral, Moira K.; Fung, Kinwah; Tu, Jack V.			Relation between age and cardiovascular disease in men and women with diabetes compared with non-diabetic people: a population-based retrospective cohort study	LANCET			English	Article							CORONARY-HEART-DISEASE; LONG-TERM PROGNOSIS; 10-YEAR FOLLOW-UP; MYOCARDIAL-INFARCTION; ARTERY-DISEASE; MORTALITY; IMPACT; RISK; INTERVENTION; MELLITUS	Background Adults with diabetes are thought to have a high risk of cardiovascular disease (CVD), irrespective of their age. The main aim of this study was to find out the age at which people with diabetes develop a high risk of CVD, as defined by: an event rate equivalent to a 10-year risk of 20% or more; or an event rate equivalent to that associated with previous myocardial infarction. Methods We did a population-based retrospective cohort study using provincial health claims to identify all adults with (n=379 003) and (n=9 018 082) without diabetes mellitus living in Ontario, Canada, on April 1, 1994. Individuals were followed up to record CVD events until March 31, 2000. Findings The transition to a high-risk category occurred at a younger age for men and women with diabetes than for those without diabetes (mean difference 14.6 years). For the outcome of acute myocardial infarction (AMI), stroke, or death from any cause, diabetic men and women entered the high-risk category at ages 47.9 and 54.3 years respectively. When we used a broader definition of CVD that also included coronary or carotid revascularisation, the ages were 41.3 and 47.7 years for men and women with diabetes respectively. Interpretation Diabetes confers an equivalent risk to ageing 15 years. However, in general, younger people with diabetes (age 40 or younger) do not seem to be at high risk of CVD. Age should be taken into account in targeting of risk reduction in people with diabetes.	St Michaels Hosp, Dept Med, Div Endocrinol & Metab, Toronto, ON M5C 2T2, Canada; Univ Toronto, Dept Med, Toronto, ON, Canada; Univ Hlth Network, Dept Med, Toronto, ON, Canada; Sunnybrook & Womens Coll Hlth Sci Ctr, Dept Med, Toronto, ON, Canada; Univ Hlth Network Womens Hlth Program, Toronto, ON, Canada; Inst Clin Evaluat Sci, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto	Booth, GL (corresponding author), St Michaels Hosp, Dept Med, Div Endocrinol & Metab, Toronto, ON M5C 2T2, Canada.	boothg@smh.toronto.on.ca		Tu, Jack/0000-0003-0111-722X				[Anonymous], 2005, DIABETES CARE, V28, pS4; Baigent C, 2002, BMJ-BRIT MED J, V324, P71, DOI 10.1136/bmj.324.7329.71; Becker A, 2003, EUR HEART J, V24, P1406, DOI 10.1016/S0195-668X(03)00197-0; BOOTH GL, 2003, DIABETES ONTARIO ICE, P95; Cho E, 2002, J AM COLL CARDIOL, V40, P954, DOI 10.1016/S0735-1097(02)02044-2; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Colhoun HM, 2004, LANCET, V364, P685, DOI 10.1016/S0140-6736(04)16895-5; De Backer G, 2003, EUR J CARDIOV PREV R, V10, pS1, DOI 10.1097/01.hjr.0000087913.96265.e2; Eberly LE, 2003, DIABETES CARE, V26, P848, DOI 10.2337/diacare.26.3.848; Evans JMM, 2002, BRIT MED J, V324, P939, DOI 10.1136/bmj.324.7343.939; Fournier JA, 2004, AM J CARDIOL, V94, P989, DOI 10.1016/j.amjcard.2004.06.051; Fox CS, 2004, DIABETES CARE, V27, P704, DOI 10.2337/diacare.27.3.704; Gaede P, 2003, NEW ENGL J MED, V348, P383, DOI 10.1056/NEJMoa021778; Genest J, 2003, CAN MED ASSOC J, V169, P921; Gerstein HC, 2000, LANCET, V355, P253; Gu K, 1998, DIABETES CARE, V21, P1138, DOI 10.2337/diacare.21.7.1138; Haffner SM, 1998, NEW ENGL J MED, V339, P229, DOI 10.1056/NEJM199807233390404; Harris SB, 2003, CAN FAM PHYSICIAN, V49, P778; Hu FB, 2001, ARCH INTERN MED, V161, P1717, DOI 10.1001/archinte.161.14.1717; Hux JE, 2002, DIABETES CARE, V25, P512, DOI 10.2337/diacare.25.3.512; International diabetes Federation Clinical Guidelines Task Force, GLOB GUID TYP 2 DIAB; Kannel W B, 1979, Diabetes Care, V2, P120, DOI 10.2337/diacare.2.2.120; KAPRAL MK, 2003, DIABETES ONTARIO ICE, P151; Klein BEK, 2004, ARCH INTERN MED, V164, P1917, DOI 10.1001/archinte.164.17.1917; Ko DT, 2004, JAMA-J AM MED ASSOC, V291, P1864, DOI 10.1001/jama.291.15.1864; Lee CD, 2004, CIRCULATION, V109, P855, DOI 10.1161/01.CIR.0000116389.61864.DE; Lee WL, 2000, DIABETES CARE, V23, P962, DOI 10.2337/diacare.23.7.962; Lotufo PA, 2001, ARCH INTERN MED, V161, P242, DOI 10.1001/archinte.161.2.242; Malmberg K, 2000, CIRCULATION, V102, P1014, DOI 10.1161/01.CIR.102.9.1014; Manuel DG, 2004, DIABETES CARE, V27, P407, DOI 10.2337/diacare.27.2.407; Natarajan S, 2003, ARCH INTERN MED, V163, P1735, DOI 10.1001/archinte.163.14.1735; *NIH CLIN EXC, TYP 1 DIAB DIAGN MAN; Orchard TJ, 1998, INT J EPIDEMIOL, V27, P976, DOI 10.1093/ije/27.6.976; Orchard TJ, 2003, DIABETES CARE, V26, P1374, DOI 10.2337/diacare.26.5.1374; Reid RJ, 2001, MED CARE, V39, P86, DOI 10.1097/00005650-200101000-00010; *ROYAL COLL GEN PR, CLIN GUID TYP 2 DIAB; SHAH B, 2003, DIABETES ONTARIO ICE, P51; Stevens RJ, 2001, CLIN SCI, V101, P671, DOI 10.1042/CS20000335; Tu LV, 1999, CAN MED ASSOC J, V161, P1257; Vaccaro O, 2004, ARCH INTERN MED, V164, P1438, DOI 10.1001/archinte.164.13.1438	40	474	489	1	27	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 1	2006	368	9529					29	36		10.1016/S0140-6736(06)68967-8	http://dx.doi.org/10.1016/S0140-6736(06)68967-8			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	058TQ	16815377				2022-12-28	WOS:000238687900028
J	Kellum, J; Palevsky, PM				Kellum, John; Palevsky, Paul M.			Renal support in acute kidney injury	LANCET			English	Editorial Material							CRITICALLY-ILL PATIENTS; REPLACEMENT THERAPY; INTERMITTENT HEMODIALYSIS; DIALYSIS; FAILURE; TRIAL		Univ Pittsburgh, Sch Med, Dept Crit Care Med, Pittsburgh, PA 15261 USA; Univ Pittsburgh, Sch Med, Dept Med, Pittsburgh, PA 15261 USA; VA Pittsburgh Healthcare Syst, Renal Sect, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Pittsburgh Healthcare System	Kellum, J (corresponding author), Univ Pittsburgh, Sch Med, Dept Crit Care Med, Pittsburgh, PA 15261 USA.	kellumja@ccm.upmc.edu	Kellum, John/AAP-3072-2020; Kellum, John A/HCH-2944-2022; Palevsky, Paul M./Q-1491-2019	Kellum, John/0000-0003-1995-2653; Kellum, John A/0000-0003-1995-2653; Palevsky, Paul M./0000-0002-7334-5400				Augustine JJ, 2004, AM J KIDNEY DIS, V44, P1000, DOI 10.1053/j.ajkd.2004.08.022; Dellinger RP, 2004, CRIT CARE MED, V32, P858, DOI 10.1097/01.CCM.0000117317.18092.E4; Evanson JA, 1998, AM J KIDNEY DIS, V32, P731, DOI 10.1016/S0272-6386(98)70127-1; Kellum JA, 2002, INTENS CARE MED, V28, P29, DOI 10.1007/s00134-001-1159-4; Kellum JA, 1998, CRIT CARE MED, V26, P1995, DOI 10.1097/00003246-199812000-00027; Marshall MR, 2001, KIDNEY INT, V60, P777, DOI 10.1046/j.1523-1755.2001.060002777.x; Mehta RL, 1999, AM J NEPHROL, V19, P377, DOI 10.1159/000013481; Mehta RL, 2001, KIDNEY INT, V60, P1154, DOI 10.1046/j.1523-1755.2001.0600031154.x; Ronco C, 2000, LANCET, V356, P26, DOI 10.1016/S0140-6736(00)02430-2; Schiffl H, 2002, NEW ENGL J MED, V346, P305, DOI 10.1056/NEJMoa010877; Schortgen F, 2000, AM J RESP CRIT CARE, V162, P197, DOI 10.1164/ajrccm.162.1.9907098; Uchino S, 2003, INTENS CARE MED, V29, P575, DOI 10.1007/s00134-003-1672-8; Venkataraman R, 2002, J CRIT CARE, V17, P246, DOI 10.1053/jcrc.2002.36757; Vinsonneau C, 2006, LANCET, V368, P379, DOI 10.1016/S0140-6736(06)69111-3	14	14	14	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL-AUG	2006	368	9533					344	345		10.1016/S0140-6736(06)69084-3	http://dx.doi.org/10.1016/S0140-6736(06)69084-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	069JJ	16876645				2022-12-28	WOS:000239441900006
J	Marmot, M				Marmot, Michael			Smoking and inequalities	LANCET			English	Editorial Material							CIVIL-SERVANTS; DEATH RATES; MORTALITY		UCL, Int Inst Soc & Hlth, London WC1E 6BT, England	University of London; University College London	Marmot, M (corresponding author), UCL, Int Inst Soc & Hlth, Mortimer St, London WC1E 6BT, England.	m.marmot@ucl.ac.uk	Marmot, M G/Y-3920-2019	Marmot, M G/0000-0002-2431-6419	Medical Research Council [G0100222, G8802774, G19/35] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Acheson D., 1998, INEQUALITIES HLTH RE; Barker DJP, 1998, MOTHERS BABIES HLTH; Emberson JR, 2004, INT J EPIDEMIOL, V33, P289, DOI 10.1093/ije/dyh006; Jha P, 2006, LANCET, V368, P367, DOI 10.1016/S0140-6736(06)68975-7; Mackenbach JP, 2004, EUR J CANCER, V40, P126, DOI 10.1016/j.ejca.2003.10.018; Marmot M, 2005, LANCET, V365, P1099, DOI 10.1016/S0140-6736(05)74234-3; Marmot M, 2004, STATUS SYNDROME; MARMOT MG, 1991, LANCET, V337, P1387, DOI 10.1016/0140-6736(91)93068-K; Steenland K, 2002, AM J EPIDEMIOL, V156, P11, DOI 10.1093/aje/kwf001; van Rossum CTM, 2000, J EPIDEMIOL COMMUN H, V54, P178, DOI 10.1136/jech.54.3.178; World Health Organization (WHO), 2013, WORLD HLTH REPORT 20	11	44	45	0	9	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL-AUG	2006	368	9533					341	342		10.1016/S0140-6736(06)68976-9	http://dx.doi.org/10.1016/S0140-6736(06)68976-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	069JJ	16876643				2022-12-28	WOS:000239441900004
J	Vial, L; Diatta, G; Tall, A; Ba, EH; Bouganali, H; Durand, P; Sokhna, C; Rogier, C; Renaud, F; Trape, JF				Vial, Laurence; Diatta, Georges; Tall, Adama; Ba, El Hadj; Bouganali, Hilaire; Durand, Patrick; Sokhna, Cheikh; Rogier, Christophe; Renaud, Francois; Trape, Jean-Francois			Incidence of tick-borne relapsing fever in west Africa: longitudinal study	LANCET			English	Article							BORRELIA-CROCIDURAE; FLAGELLIN GENE; HOLOENDEMIC AREA; MALARIA; RODENTS; IMMUNITY; DIELMO	Background The ongoing drought in sub-Saharan countries has led to the colonisation. of west African Savanna by Ornithodoros sonrai; this tick acts as a vector for Borrelia crocidurae, which causes tick-borne relapsing fever (TBRF). Our aim was to ascertain the incidence of TBRF in west Africa. Methods From 1990 to 2003, we monitored the incidence of TBRF in Dielmo, Senegal, by daily clinical surveillance and by blood testing of individuals with a fever. From 2002 to 2005, we investigated the presence of 0 sonrai in 30 villages in Senegal, Mauritania, and Mali, and measured by PCR the prevalence of B crocidurae. Findings The average incidence of TBRF over 14 years was 11 per 100 person-years (range from 4 in 1990 to 25 in 1997). All age-groups presented a high incidence of the disease. In addition to relapses, repeated infections in the same individuals were common, with some affected by up to six distinct infections during the study period. Epidemiological studies indicated that 26 of the 30 studied villages (87%) were colonised by the vector tick 0 sonrai and that the average B crocidurae infection rate of the vector was 31%. Interpretation The incidence of TBRF at the community level is the highest described in Africa for any bacterial disease. The presence of the vector tick in most villages investigated and its high infection rate suggest that TBRF is a common cause of fever in most rural areas of Senegal, Mauritania, and Mali.	Inst Rech Dev, Dakar, Senegal; Inst Pasteur, Dakar, Senegal; Inst Rech Dev, Montpellier, France; Serv Sante Armees, Inst Trop Med, Marseille, France	Institut de Recherche pour le Developpement (IRD); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Dakar; Institut de Recherche pour le Developpement (IRD)	Trape, JF (corresponding author), Inst Rech Dev, BP 1386,CP 18524, Dakar, Senegal.	trape@ird.sn						Barbour AG, 2000, EMERG INFECT DIS, V6, P449, DOI 10.3201/eid0605.000502; BOIRON H., 1949, BULL SOC PATH EXOT, V42, P62; Burman N, 1998, INFECT IMMUN, V66, P815, DOI 10.1128/IAI.66.2.815-819.1998; Camicas J. L., 1998, Les tiques du monde (Acarida, Ixodida): nomenclature, stades decrits, hotes, repartition.; CHARMOT G, 1986, PRESSE MED, V15, P979; Diagne N, 2000, NEW ENGL J MED, V343, P598, DOI 10.1056/NEJM200008313430901; DIATTA G, 1994, T ROY SOC TROP MED H, V88, P423, DOI 10.1016/0035-9203(94)90412-X; FELSENFELD O, 1965, BACTERIOL REV, V29, P46, DOI 10.1128/MMBR.29.1.46-74.1965; Fukunaga M, 2001, VECTOR-BORNE ZOONOT, V1, P331, DOI 10.1089/15303660160025949; GODELUCK B, 1994, AM J TROP MED HYG, V50, P165, DOI 10.4269/ajtmh.1994.50.165; GONNET C, 1942, MED TROP, V2, P895; GOUBAU PF, 1984, ANN SOC BELG MED TR, V64, P335; Horak IG, 2002, EXP APPL ACAROL, V28, P27, DOI 10.1023/A:1025381712339; HUBERT B, 1977, TERRE VIE-REV ECOL A, V31, P33; Hulme M, 2001, CLIM RES, V17, P145, DOI 10.3354/cr017145; Jongen VHWM, 1997, ACTA OBSTET GYN SCAN, V76, P834, DOI 10.3109/00016349709024361; LEGER Andre, 1917, Bulletin de la Societe de Pathologie Exotique, V10, P280; Mathis C., 1934, Ann Inst Pasteur Paris T, V52, P166; Morel PC, 1965, TIQUES AFRIQUE BASSI; NOPPA L, 1995, MICROBIOL-UK, V141, P85, DOI 10.1099/00221287-141-1-85; PICKEN RN, 1992, J CLIN MICROBIOL, V30, P99, DOI 10.1128/JCM.30.1.99-114.1992; Ramos JM, 2004, ANN TROP MED PARASIT, V98, P191, DOI 10.1179/000349804225003136; RODHAIN F, 1976, B I PASTEUR, V74, P173; Rogier C, 1999, AM J TROP MED HYG, V60, P410, DOI 10.4269/ajtmh.1999.60.410; Rogier C, 1996, AM J TROP MED HYG, V54, P613, DOI 10.4269/ajtmh.1996.54.613; SAUTET J., 1944, BULL SOC PATH EXOT, V37, P182; Shamaei-Tousi A, 1999, J INFECT DIS, V180, P1929, DOI 10.1086/315118; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; TRAPE JF, 1994, AM J TROP MED HYG, V51, P123, DOI 10.4269/ajtmh.1994.51.123; Trape JF, 1996, PARASITOL TODAY, V12, P236, DOI 10.1016/0169-4758(96)10015-6; Trape JF, 1996, AM J TROP MED HYG, V54, P289, DOI 10.4269/ajtmh.1996.54.289; TRAPE JF, 1991, LANCET, V337, P473, DOI 10.1016/0140-6736(91)93404-W; *WHO, 2003, 211 WHO; ZEGER SL, 1992, STAT MED, V11, P1825, DOI 10.1002/sim.4780111406	34	119	124	0	7	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 1	2006	368	9529					37	43		10.1016/S0140-6736(06)68968-X	http://dx.doi.org/10.1016/S0140-6736(06)68968-X			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	058TQ	16815378				2022-12-28	WOS:000238687900029
J	Cifelli, RL				Cifelli, RL			Tribosphenic mammal from the North American Early Cretaceous	NATURE			English	Article							EUTHERIAN MAMMALS; MONGOLIA	The main groups of living mammals, marsupials and eutherians, are presumed to have diverged in the Early Cretaceous(1), but their early history and biogeography are poorly understood. Dental remains have suggested that the eutherians may have originated in Asia(2), spreading to North America in the Late Cretaceous, where an endemic radiation of marsupials was already well underway(3). Here I describe a new tribosphenic mammal (a mammal with lower molar heels that are three-cusped and basined) from the Early Cretaceous of North America, based on an unusually complete specimen. The new taxon bears characteristics (molarized last premolar, reduction to three molars) otherwise known only for Eutheria among the tribosphenic mammals. Morphometric analysis and character comparisons show; however, that its molar structure is primitive (and thus phylogenetically uninformative), emphasizing the need for caution in interpretation of isolated teeth. The new mammal is approximately contemporaneous with the oldest known Eutheria from Asia. If it is a eutherian, as is indicated by the available evidence, then this group was far more widely distributed in the Early Cretaceous than previously appreciated. An early presence of Eutheria in North America offers a potential source for the continent's Late Cretaceous radiations, which have, in part, proven difficult to relate to contemporary taxa in Asia.	Univ Oklahoma, Oklahoma Museum Nat Hist, Norman, OK 73019 USA; Univ Oklahoma, Dept Zool, Norman, OK 73019 USA	University of Oklahoma System; University of Oklahoma - Norman; University of Oklahoma System; University of Oklahoma - Norman	Cifelli, RL (corresponding author), Univ Oklahoma, Oklahoma Museum Nat Hist, Norman, OK 73019 USA.							BUTLER PM, 1990, BIOL REV, V65, P529, DOI 10.1111/j.1469-185X.1990.tb01237.x; BUTLER PM, 1990, STRUCTURE FUNCTION E, P125; BUTLER PM, 1978, BREVIORA, V446, P1; Cifelli Richard L., 1999, P219; Cifelli Richard L., 1997, Journal of Mammalian Evolution, V4, P241, DOI 10.1023/A:1027394430433; Clemens W.A., 1986, CONTRIBUTIONS GEOLOG, V3, P55, DOI DOI 10.2113/GSR0CKY.24.SPECIAL_; DASHZEVEG D, 1984, ZOOL J LINN SOC-LOND, V82, P217, DOI 10.1111/j.1096-3642.1984.tb00544.x; FOX RC, 1984, CARNEGIE MUS NAT HIS, V9, P9; Jenkins F.A. Jr, 1988, Journal of Vertebrate Paleontology, V8, P1; Kielan-Jaworowska Z., 1977, Palaeontologia Polonica, V37, P65; KIELANJAWOROWSK.Z, 1982, PALAEONTOLOGY ESSENT, P367; KIELANJAWOROWSKA Z, 1989, ZOOL SCR, V18, P347, DOI 10.1111/j.1463-6409.1989.tb00460.x; LILLEGRAVEN JA, 1987, BIOL J LINN SOC, V32, P281, DOI 10.1111/j.1095-8312.1987.tb00434.x; Lillegraven JA, 1979, MESOZOIC MAMMALS 1 2; Luckett W.P., 1993, MAMMAL PHYLOGENY, V2, P182; LUO ZX, 1994, IN THE SHADOW OF THE DINOSAURS, P98; Nessov Lev A., 1998, Bulletin of Carnegie Museum of Natural History, V34, P40; Nessov Lev A., 1994, Palaeovertebrata (Montpellier), V23, P51; NOVACEK MJ, 1986, B AM MUS NAT HIST, V183, P1; Ostrom JH., 1970, PEABODY MUSEUM B, V35, P1; Rougier GW, 1998, NATURE, V396, P459, DOI 10.1038/24856; SIGOGNEAURUSSELL D, 1992, ZOOL SCR, V21, P205, DOI 10.1111/j.1463-6409.1992.tb00322.x; Slaughter BH, 1971, ZOOL J LINN SOC   S1, V50, P131; Wang Yuanqing, 1995, P221	24	63	66	0	3	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 23	1999	401	6751					363	366		10.1038/43861	http://dx.doi.org/10.1038/43861			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	240JJ	16862109				2022-12-28	WOS:000082822600047
J	Heilbron, JL				Heilbron, JL			From horsehair to lightning rods	NATURE			English	Article									Univ Oxford Worcester Coll, Oxford OX1 2HB, England	University of Oxford	Heilbron, JL (corresponding author), Univ Oxford Worcester Coll, Oxford OX1 2HB, England.								0	0	0	1	2	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 23	1999	401	6751					329	329		10.1038/43791	http://dx.doi.org/10.1038/43791			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	240JJ	16862097	Bronze			2022-12-28	WOS:000082822600029
J	Running, SW				Running, Steven W.			Is global warming causing more, larger wildfires?	SCIENCE			English	Editorial Material									Univ Montana, Numer Terradynam Simulat Grp, Missoula, MT 59812 USA	University of Montana System; University of Montana	Running, SW (corresponding author), Univ Montana, Numer Terradynam Simulat Grp, Missoula, MT 59812 USA.	swr@ntsg.umt.edu						Emanuel K, 2005, NATURE, V436, P686, DOI 10.1038/nature03906; Flannigan MD, 2005, CLIMATIC CHANGE, V72, P1, DOI 10.1007/s10584-005-5935-y; Gillett NP, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020876; Mote PW, 2005, B AM METEOROL SOC, V86, P39, DOI 10.1175/BAMS-86-1-39; Rignot E, 2006, SCIENCE, V311, P986, DOI 10.1126/science.1121381; ROUSTEENOJA K, 2003, 644 FINN ENV I; Stewart IT, 2005, J CLIMATE, V18, P1136, DOI 10.1175/JCLI3321.1; van der Werf GR, 2004, SCIENCE, V303, P73, DOI 10.1126/science.1090753; Westerling AL, 2006, SCIENCE, V313, P940, DOI 10.1126/science.1128834	10	222	252	15	99	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 18	2006	313	5789					927	928		10.1126/science.1130370	http://dx.doi.org/10.1126/science.1130370			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	074MR	16825534				2022-12-28	WOS:000239817000029
J	Mejia, R				Mejia, Robin			Human rights - From accountability to rebuilding	SCIENCE			English	News Item																			0	0	0	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 21	2006	313	5785					289	289		10.1126/science.313.5785.289	http://dx.doi.org/10.1126/science.313.5785.289			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065IV	16857916				2022-12-28	WOS:000239154300013
J	Carlson, CM; Endrizzi, BT; Wu, JH; Ding, XJ; Weinreich, MA; Walsh, ER; Wani, MA; Lingrel, JB; Hogquist, KA; Jameson, SC				Carlson, Corey M.; Endrizzi, Bart T.; Wu, Jinghai; Ding, Xiaojie; Weinreich, Michael A.; Walsh, Elizabeth R.; Wani, Maqsood A.; Lingrel, Jerry B.; Hogquist, Kristin A.; Jameson, Stephen C.			Kruppel-like factor 2 regulates thymocyte and T-cell migration	NATURE			English	Article							TRANSCRIPTION FACTOR; LYMPHOCYTE EGRESS; THYMIC EMIGRANTS; L-SELECTIN; EXPRESSION; LKLF; CD69; SPHINGOSINE-1-PHOSPHATE; IDENTIFICATION; QUIESCENCE	Mammalian Kruppel-like transcription factors are implicated in regulating terminal differentiation of several tissue types(1-3). Deficiency in Kruppel-like factor (KLF) 2 ( also known as LKLF) leads to a massive loss of the peripheral T-cell pool(4), suggesting KLF2 regulates T-cell quiescence and survival(4-7). Here we show, however, that KLF2 is essential for T-cell trafficking. KLF2-deficient (Klf2(-/-)) thymocytes show impaired expression of several receptors required for thymocyte emigration and peripheral trafficking, including the sphingosine-1-phosphate (S1P) receptor S1P(1), CD62L and beta(7) integrin. Furthermore, KLF2 both binds and transactivates the promoter for S1P(1) - a receptor that is critical for thymocyte egress and recirculation through peripheral lymphoid organs. Our findings suggest that KLF2 serves to license mature T cells for trafficking from the thymus and recirculation through secondary lymphoid tissues.	Univ Minnesota, Sch Med, Ctr Immunol, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA; Univ Cincinnati, Dept Mol Genet Biochem & Microbiol, Cincinnati, OH 45267 USA	University of Minnesota System; University of Minnesota Twin Cities; University System of Ohio; University of Cincinnati	Hogquist, KA (corresponding author), Univ Minnesota, Sch Med, Ctr Immunol, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA.	hogqu001@umn.edu; james024@umn.edu	Jameson, Stephen C/D-9892-2013	Jameson, Stephen C/0000-0001-9137-1146; Hogquist, Kristin/0000-0001-9963-5687				Allende ML, 2004, J BIOL CHEM, V279, P15396, DOI 10.1074/jbc.M314291200; ANDERSON KP, 1995, MOL CELL BIOL, V15, P5957; ARBONES ML, 1994, IMMUNITY, V1, P247, DOI 10.1016/1074-7613(94)90076-0; Boursalian TE, 2004, NAT IMMUNOL, V5, P418, DOI 10.1038/ni1049; Buckley AF, 2001, NAT IMMUNOL, V2, P698, DOI 10.1038/90633; Cyster JG, 2005, ANNU REV IMMUNOL, V23, P127, DOI 10.1146/annurev.immunol.23.021704.115628; Dang DT, 2000, INT J BIOCHEM CELL B, V32, P1103, DOI 10.1016/S1357-2725(00)00059-5; Di Santo JP, 2001, NAT IMMUNOL, V2, P667, DOI 10.1038/90598; Feng CG, 2002, INT IMMUNOL, V14, P535, DOI 10.1093/intimm/dxf020; Gabor MJ, 1997, EUR J IMMUNOL, V27, P2010, DOI 10.1002/eji.1830270827; Grayson JM, 2001, J IMMUNOL, V166, P795, DOI 10.4049/jimmunol.166.2.795; Haaland RE, 2005, MOL IMMUNOL, V42, P627, DOI 10.1016/j.molimm.2004.09.012; Kaczynski J, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-206; Kuo CT, 1997, GENE DEV, V11, P2996, DOI 10.1101/gad.11.22.2996; Kuo CT, 1999, ANNU REV IMMUNOL, V17, P149, DOI 10.1146/annurev.immunol.17.1.149; Kuo CT, 1997, SCIENCE, V277, P1986, DOI 10.1126/science.277.5334.1986; Liu YJ, 2000, J CLIN INVEST, V106, P951, DOI 10.1172/JCI10905; Lo CG, 2005, J EXP MED, V201, P291, DOI 10.1084/jem.20041509; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; Mick VE, 2004, J IMMUNOL, V173, P5434, DOI 10.4049/jimmunol.173.9.5434; Nakayama T, 2002, J IMMUNOL, V168, P87, DOI 10.4049/jimmunol.168.1.87; Schober SL, 1999, J IMMUNOL, V163, P3662; Shiow LR, 2006, NATURE, V440, P540, DOI 10.1038/nature04606; Turner J, 1999, TRENDS BIOCHEM SCI, V24, P236, DOI 10.1016/S0968-0004(99)01406-1; Wagner N, 1998, EUR J IMMUNOL, V28, P3832, DOI 10.1002/(SICI)1521-4141(199811)28:11<3832::AID-IMMU3832>3.0.CO;2-J; Wagner N, 1996, NATURE, V382, P366, DOI 10.1038/382366a0; Wani MA, 1998, TRANSGENIC RES, V7, P229, DOI 10.1023/A:1008809809843; Wani MA, 1999, J BIOL CHEM, V274, P21180, DOI 10.1074/jbc.274.30.21180; Wu JH, 2004, ONCOGENE, V23, P8088, DOI 10.1038/sj.onc.1207996; Wu JH, 2005, J IMMUNOL, V175, P3060, DOI 10.4049/jimmunol.175.5.3060	30	405	420	2	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 20	2006	442	7100					299	302		10.1038/nature04882	http://dx.doi.org/10.1038/nature04882			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064WT	16855590	Bronze			2022-12-28	WOS:000239122100038
J	Dellis, O; Dedos, SG; Tovey, SC; Taufiq-Ur-Rahman; Dubel, SJ; Taylor, CW				Dellis, Olivier; Dedos, Skarlatos G.; Tovey, Stephen C.; Taufiq-Ur-Rahman; Dubel, Stefan J.; Taylor, Colin W.			Ca2+ entry through plasma membrane IP3 receptors	SCIENCE			English	Article							INOSITOL 1,4,5-TRISPHOSPHATE RECEPTOR; DT40 B-LYMPHOCYTES; SIGNAL-TRANSDUCTION; CHANNELS; CALCIUM; RELEASE; TRISPHOSPHATE; INHIBITION; RETICULUM; MEDIATE	Inositol 1,4,5-trisphosphate receptors (IP(3)Rs) release calcium ions, Ca2+, from intracellular stores, but their roles in mediating Ca2+ entry are unclear. IP3 stimulated opening of very few (1.9 +/- 0.2 per cell) Ca2+-permeable channels in whole-cell patch-clamp recording of DT40 chicken or mouse B cells. Activation of the B cell receptor (BCR) in perforated-patch recordings evoked the same response. IP3 failed to stimulate intracellular or plasma membrane ( PM) channels in cells lacking IP3 R. Expression of IP3R restored both responses. Mutations within the pore affected the conductances of IP3-activated PM and intracellular channels similarly. An impermeant pore mutant abolished BCR-evoked Ca2+ signals, and PM IP(3)Rs were undetectable. After introduction of an alpha-bungarotoxin binding site near the pore, PM IP(3)Rs were modulated by extracellular alpha-bungarotoxin. IP(3)Rs are unusual among endoplasmic reticulum proteins in being also functionally expressed at the PM, where very few IP(3)Rs contribute substantially to the Ca2+ entry evoked by the BCR.	Dept Pharmacol, Cambridge CB2 1PD, England		Taylor, CW (corresponding author), Dept Pharmacol, Tennis Court Rd, Cambridge CB2 1PD, England.	cwt1000@cam.ac.uk	rahman, taufiq/E-9806-2013; Dedos, Skarlatos G./A-5345-2008; Dellis, Olivier/E-8501-2011; Taylor, Colin/G-2447-2010	rahman, taufiq/0000-0003-3830-5160; Dedos, Skarlatos G./0000-0002-0432-338X; Dellis, Olivier/0000-0003-0377-9163; Taylor, Colin/0000-0001-7771-1044	Biotechnology and Biological Sciences Research Council [BB/C005201/1] Funding Source: Medline; Wellcome Trust Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission)		BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; BEZPROZVANNY I, 1993, NEURON, V10, P1175, DOI 10.1016/0896-6273(93)90065-Y; BEZPROZVANNY I, 1994, J GEN PHYSIOL, V104, P821, DOI 10.1085/jgp.104.5.821; Boehning D, 2001, J BIOL CHEM, V276, P13509, DOI 10.1074/jbc.C100094200; Dalbey R.E., 2002, PROTEIN TARGETING TR; Du GG, 1998, J BIOL CHEM, V273, P31867, DOI 10.1074/jbc.273.48.31867; Echevarria W, 2003, NAT CELL BIOL, V5, P440, DOI 10.1038/ncb980; FADOOL DA, 1992, NEURON, V9, P907, DOI 10.1016/0896-6273(92)90243-7; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; HOTH M, 1993, J PHYSIOL-LONDON, V465, P359, DOI 10.1113/jphysiol.1993.sp019681; KALINOSKI DL, 1992, BIOCHEM J, V281, P449, DOI 10.1042/bj2810449; Kiselyov K, 1999, MOL CELL, V4, P423, DOI 10.1016/S1097-2765(00)80344-5; MARSHALL ICB, 1994, BIOCHEM J, V301, P591, DOI 10.1042/bj3010591; Morita T, 2004, BIOCHEM J, V382, P793, DOI 10.1042/BJ20031970; PALADE P, 1989, MOL PHARMACOL, V36, P664; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Prakriya M, 2001, J PHYSIOL-LONDON, V536, P3, DOI 10.1111/j.1469-7793.2001.t01-1-00003.x; Riley AM, 2004, BIOCONJUGATE CHEM, V15, P278, DOI 10.1021/bc034214s; Sekine-Aizawa Y, 2004, P NATL ACAD SCI USA, V101, P17114, DOI 10.1073/pnas.0407563101; Sugawara H, 1997, EMBO J, V16, P3078, DOI 10.1093/emboj/16.11.3078; TAKAHASHI M, 1994, J BIOL CHEM, V269, P369; Taylor CW, 1999, CELL CALCIUM, V26, P237, DOI 10.1054/ceca.1999.0090; Taylor CW, 2002, CELL CALCIUM, V32, P321, DOI 10.1016/S0143416002001859; Taylor CW, 2002, CELL, V111, P767, DOI 10.1016/S0092-8674(02)01197-2; VACA L, 1995, AM J PHYSIOL-CELL PH, V269, pC733, DOI 10.1152/ajpcell.1995.269.3.C733; van Rossum DB, 2004, P NATL ACAD SCI USA, V101, P2323, DOI 10.1073/pnas.0308565100; Vazquez G, 2002, EMBO J, V21, P4531, DOI 10.1093/emboj/cdf467; ZWEIFACH A, 1993, P NATL ACAD SCI USA, V90, P6295, DOI 10.1073/pnas.90.13.6295	28	149	154	0	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 14	2006	313	5784					229	233		10.1126/science.1125203	http://dx.doi.org/10.1126/science.1125203			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	063GZ	16840702				2022-12-28	WOS:000239008000046
J	Grant, PR; Grant, BR				Grant, Peter R.; Grant, B. Rosemary			Evolution of character displacement in Darwin's finches	SCIENCE			English	Article							ISLA DAPHNE MAJOR; VARIABLE ENVIRONMENT; ADAPTIVE RADIATION; NATURAL-SELECTION; POPULATION; GALAPAGOS; GEOSPIZA; HERITABILITY; DIVERGENCE; RELEASE	Competitor species can have evolutionary effects on each other that result in ecological character displacement; that is, divergence in resource-exploiting traits such as jaws and beaks. Nevertheless, the process of character displacement occurring in nature, from the initial encounter of competitors to the evolutionary change in one or more of them, has not previously been investigated. Here we report that a Darwin's finch species (Geospiza fortis) on an undisturbed Galapagos island diverged in beak size from a competitor species ( G. magnirostris) 22 years after the competitor's arrival, when they jointly and severely depleted the food supply. The observed evolutionary response to natural selection was the strongest recorded in 33 years of study, and close to the value predicted from the high heritability of beak size. These findings support the role of competition in models of community assembly, speciation, and adaptive radiations.	Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA	Princeton University	Grant, PR (corresponding author), Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA.	prgrant@princeton.edu	Grant, Peter/HIR-3733-2022					Adams DC, 2000, P NATL ACAD SCI USA, V97, P4106, DOI 10.1073/pnas.97.8.4106; BENKMAN CW, 1987, ECOL MONOGR, V57, P251, DOI 10.2307/2937083; BOAG PT, 1981, SCIENCE, V214, P82, DOI 10.1126/science.214.4516.82; BOAG PT, 1984, ECOL MONOGR, V54, P463, DOI 10.2307/1942596; BOAG PT, 1983, EVOLUTION, V37, P877, DOI 10.1111/j.1558-5646.1983.tb05618.x; BOAG PT, 1984, BIOL J LINN SOC, V22, P243, DOI 10.1111/j.1095-8312.1984.tb01679.x; BROWN WL, 1956, SYST ZOOL, V5, P49, DOI 10.2307/2411924; GIBBS HL, 1987, J ANIM ECOL, V56, P797, DOI 10.2307/4949; GIBBS HL, 1987, NATURE, V327, P511, DOI 10.1038/327511a0; GRANT P R, 1972, Biological Journal of the Linnean Society, V4, P39, DOI 10.1111/j.1095-8312.1972.tb00690.x; Grant P.R., 1999, RECOGNITION STATES L, V2; Grant Peter R., 1996, P343, DOI 10.1016/B978-012178075-3/50013-1; Grant PR, 2002, SCIENCE, V296, P707, DOI 10.1126/science.1070315; GRANT PR, 1995, EVOLUTION, V49, P229, DOI 10.1111/j.1558-5646.1995.tb02235.x; Grant PR, 2001, GENETICA, V112, P359, DOI 10.1023/A:1013363032724; GRANT PR, 1981, ANIM BEHAV, V29, P785, DOI 10.1016/S0003-3472(81)80012-7; GRANT PR, 1995, EVOLUTION, V49, P241, DOI 10.1111/j.1558-5646.1995.tb02236.x; GRANT PR, 1994, SCIENCE, V266, P802; Keller LF, 2001, HEREDITY, V87, P325, DOI 10.1046/j.1365-2540.2001.00900.x; Kingsolver JG, 2001, AM NAT, V157, P245, DOI 10.1086/319193; Lack D., 1947, DARWINS FINCHES; LANDE R, 1983, EVOLUTION, V37, P1210, DOI 10.2307/2408842; Loso JB, 2000, P NATL ACAD SCI USA, V97, P5693, DOI 10.1073/pnas.97.11.5693; LOSOS JB, 1990, EVOLUTION, V44, P588; Pfennig DW, 2003, ECOLOGY, V84, P1288, DOI 10.1890/0012-9658(2003)084[1288:ATOAHF]2.0.CO;2; PRICE T, 1987, ECOLOGY, V68, P1015, DOI 10.2307/1938373; PRICE TD, 1984, NATURE, V309, P787, DOI 10.1038/309787a0; ROBINSON BW, 1994, AM NAT, V144, P596, DOI 10.1086/285696; Schluter D, 2000, AM NAT, V156, pS4, DOI 10.1086/303412; SCHLUTER D, 1985, SCIENCE, V227, P1056, DOI 10.1126/science.227.4690.1056; SCHLUTER D, 1994, SCIENCE, V266, P798, DOI 10.1126/science.266.5186.798; Schoener T.W., 1984, P254	32	614	632	11	709	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 14	2006	313	5784					224	226		10.1126/science.1128374	http://dx.doi.org/10.1126/science.1128374			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	063GZ	16840700				2022-12-28	WOS:000239008000044
J	Koelle, MR				Koelle, Michael R.			Heterotrimeric G protein signaling: Getting inside the cell	CELL			English	Editorial Material							ALPHA; MONOUBIQUITINATION	Heterotrimeric G proteins have traditionally been thought to transduce signals at the plasma membrane. In this issue, Slessareva et al. (2006) now show that a G protein a subunit acts at the endosome to stimulate a phosphatidylinositol 3-kinase to help yeast respond to mating pheromones.	Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA	Yale University	Koelle, MR (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, POB 6666, New Haven, CT 06520 USA.	michael.koelle@yale.edu						Guo M, 2003, MOL CELL, V12, P517, DOI 10.1016/S1097-2765(03)00307-1; Jamora C, 1999, CELL, V98, P59, DOI 10.1016/S0092-8674(00)80606-6; Le-Niculescu H, 2005, J BIOL CHEM, V280, P22012, DOI 10.1074/jbc.M501833200; Robatzek M, 2001, CURR BIOL, V11, P288, DOI 10.1016/S0960-9822(01)00074-4; Terrell J, 1998, MOL CELL, V1, P193, DOI 10.1016/S1097-2765(00)80020-9; Wang YQ, 2005, J BIOL CHEM, V280, P284, DOI 10.1074/jbc.M411624200; Wilkie TM, 2005, CURR BIOL, V15, pR843, DOI 10.1016/j.cub.2005.10.008	7	28	29	0	6	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUL 14	2006	126	1					25	27		10.1016/j.cell.2006.06.026	http://dx.doi.org/10.1016/j.cell.2006.06.026			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	066JF	16839871	Bronze			2022-12-28	WOS:000239224800011
J	Cash, W				Cash, W			Detection of Earth-like planets around nearby stars using a petal-shaped occulter	NATURE			English	Article							TELESCOPE	Direct observation of Earth-like planets is extremely challenging, because their parent stars are about 10(10) times brighter but lie just a fraction of an arcsecond away(1). In space, the twinkle of the atmosphere that would smear out the light is gone, but the problems of light scatter and diffraction in telescopes remain. The two proposed solutions-a coronagraph internal to a telescope and nulling interferometry from formation-flying telescopes-both require exceedingly clean wavefront control in the optics(2). An attractive variation to the coronagraph is to place an occulting shield outside the telescope, blocking the starlight before it even enters the optical path(3). Diffraction and scatter around or through the occulter, however, have limited effective suppression in practically sized missions(4-6). Here I report an occulter design that would achieve the required suppression and can be built with existing technology. The compact mission architecture of a coronagraph is traded for the inconvenience of two spacecraft, but the daunting optics challenges are replaced with a simple deployable sheet 30 to 50 m in diameter. When such an occulter is flown in formation with a telescope of at least one metre aperture, terrestrial planets could be seen and studied around stars to a distance of ten parsecs.	Univ Colorado, Ctr Astrophys & Space Astron, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder	Cash, W (corresponding author), Univ Colorado, Ctr Astrophys & Space Astron, Campus Box 391, Boulder, CO 80309 USA.	cash@casa.colorado.edu						Cash W., 2005, P SOC PHOTO-OPT INS, V5899, P274; Copi CJ, 2000, ASTROPHYS J, V532, P581, DOI 10.1086/308525; Henry C, 2004, P SOC PHOTO-OPT INS, V5491, P265, DOI 10.1117/12.552345; Jordan IJE, 2004, PROC SPIE, V5487, P1391, DOI 10.1117/12.553029; Kasdin NJ, 2003, ASTROPHYS J, V582, P1147, DOI 10.1086/344751; MARCHAL C, 1985, ACTA ASTRONAUT, V12, P195, DOI 10.1016/0094-5765(85)90061-X; Schultz AB, 2003, P SOC PHOTO-OPT INS, V4860, P54, DOI 10.1117/12.457643; Seager S, 2003, EARTH PLANET SC LETT, V208, P113, DOI 10.1016/S0012-821X(02)01151-2; Vanderbei RJ, 2003, ASTROPHYS J, V599, P686, DOI 10.1086/379238	9	171	176	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 6	2006	442	7098					51	53		10.1038/nature04930	http://dx.doi.org/10.1038/nature04930			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	059HS	16823446				2022-12-28	WOS:000238724500033
J	Detsky, ME; Chiu, L; Shandling, MR; Sproule, ME; Ursell, MR				Detsky, Michael E.; Chiu, Leo; Shandling, Maureen R.; Sproule, Melanie E.; Ursell, Melanie R.			Heading down the wrong path	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							LARGE-CELL LYMPHOMA; CENTRAL-NERVOUS-SYSTEM; INTRAVASCULAR LYMPHOMATOSIS		Mt Sinai Hosp, Dept Med, Toronto, ON M5G 1X5, Canada; Univ Hlth Network, Toronto, ON, Canada; Univ Toronto, Fac Med, Toronto, ON, Canada; St Michaels Hosp, Dept Med, Toronto, ON M5B 1W8, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto	Detsky, ME (corresponding author), Mt Sinai Hosp, Dept Med, Rm 429,600 Univ Ave, Toronto, ON M5G 1X5, Canada.	michael.detsky@utoronto.ca						Beristain X, 2002, ARCH NEUROL-CHICAGO, V59, P439, DOI 10.1001/archneur.59.3.439; Calamia KT, 1999, ADV EXP MED BIOL, V455, P249; DEMIRER T, 1994, CANCER, V73, P1738, DOI 10.1002/1097-0142(19940315)73:6<1738::AID-CNCR2820730631>3.0.CO;2-U; DIGIUSEPPE JA, 1994, J CLIN ONCOL, V12, P2573, DOI 10.1200/JCO.1994.12.12.2573; Imai H, 2004, PATHOL INT, V54, P231, DOI 10.1111/j.1440-1827.2004.01613.x; KAYANO H, 1990, ARCH PATHOL LAB MED, V114, P580; Martin-Duverneuil N, 2002, NEURORADIOLOGY, V44, P749, DOI 10.1007/s00234-002-0808-9; Miyazaki C, 2004, AM J NEURORADIOL, V25, P565; Prayson RA, 1996, PATHOLOGY, V28, P25, DOI 10.1080/00313029600169453; ROUX S, 1995, J NEUROL NEUROSUR PS, V58, P363, DOI 10.1136/jnnp.58.3.363; Schwarz S, 2002, NEURO-ONCOLOGY, V4, P187, DOI 10.1093/neuonc/4.3.187; Song DK, 2002, AM J NEURORADIOL, V23, P239; STROUP RM, 1990, CANCER, V66, P1781, DOI 10.1002/1097-0142(19901015)66:8<1781::AID-CNCR2820660824>3.0.CO;2-5; Waring WS, 1999, CLIN NEUROL NEUROSUR, V101, P275, DOI 10.1016/S0303-8467(99)00063-3; Williams RL, 1998, AM J NEURORADIOL, V19, P427	15	8	9	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 6	2006	355	1					67	74		10.1056/NEJMcps044183	http://dx.doi.org/10.1056/NEJMcps044183			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	060DT	16822998				2022-12-28	WOS:000238783200010
J	Kahn, JM; Goss, CH; Heagerty, PJ; Kramer, AA; O'Brien, CR; Rubenfeld, GD				Kahn, Jeremy M.; Goss, Christopher H.; Heagerty, Patrick J.; Kramer, Andrew A.; O'Brien, Chelsea R.; Rubenfeld, Gordon D.			Hospital volume and the outcomes of mechanical ventilation	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RISK-ADJUSTED MORTALITY; CRITICALLY ILL PATIENTS; INTENSIVE-CARE-UNIT; ACUTE LUNG INJURY; SURGICAL-PROCEDURES; HEALTH-CARE; SURVIVAL; REGIONALIZATION; PATTERNS; DURATION	Background An increased volume of patients is associated with improved survival in numerous high-risk medical and surgical conditions. The relationship between the number of patients admitted (hospital volume) and outcome among patients with critical illnesses is unknown. Methods We analyzed data from 20,241 nonsurgical patients receiving mechanical ventilation at 37 acute care hospitals in the Acute Physiology and Chronic Health Evaluation clinical information system from 2002 through 2003. Multivariate analyses were performed to adjust for the severity of illness and other differences in the case mix. Results An increase in hospital volume was associated with improved survival among patients receiving mechanical ventilation in the intensive care unit (ICU) and in the hospital. Admission to a hospital in the highest quartile according to volume (i.e., >400 patients receiving mechanical ventilation per year) was associated with a 37 percent reduction in the adjusted odds of death in the ICU as compared with admission to hospitals in the lowest quartile (lessthan/equal 150 patients receiving mechanical ventilation per year, P<0.001). In-hospital mortality was similarly reduced (adjusted odds ratio, 0.66; 95 percent confidence interval, 0.52 to 0.83; P<0.001). A typical patient in a hospital in a low-volume quartile would have an adjusted in-hospital mortality of 34.2 percent as compared with 25.5 percent in a hospital in a high-volume quartile. Among survivors, there were no significant trends in the length of stay in the ICU or the hospital. Conclusions Mechanical ventilation of patients in a hospital with a high case volume is associated with reduced mortality. Further research is needed to determine the mechanism of the relationship between volume and outcome among patients with a critical illness.	Univ Washington, Harborview Med Ctr, Div Pulm & Crit Care Med, Seattle, WA 98104 USA; Univ Washington, Dept Biostat, Seattle, WA 98104 USA; Cerner Corp, Kansas City, MO USA	Harborview Medical Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Rubenfeld, GD (corresponding author), Univ Washington, Harborview Med Ctr, Div Pulm & Crit Care Med, Box 359762,325 9tTh Ave, Seattle, WA 98104 USA.	nodrog@u.washington.edu	Kramer, Andrew/AAI-9086-2020	Kramer, Andrew/0000-0002-5681-5781; Goss, Christopher/0000-0001-8602-0309; Kahn, Jeremy/0000-0001-9688-5576	NHLBI NIH HHS [F32 HL080785, F32HL080785, R01HL67939] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL067939, F32HL080785] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Angus DC, 2004, LANCET, V363, P1314, DOI 10.1016/S0140-6736(04)16007-8; Bach PB, 2001, NEW ENGL J MED, V345, P181, DOI 10.1056/NEJM200107193450306; Baker DW, 2003, MED CARE, V41, P729, DOI 10.1097/00005650-200306000-00006; Begg CB, 1998, JAMA-J AM MED ASSOC, V280, P1747, DOI 10.1001/jama.280.20.1747; Behrendt CE, 2000, CHEST, V118, P1100, DOI 10.1378/chest.118.4.1100; Birkmeyer JD, 2001, SURGERY, V130, P415, DOI 10.1067/msy.2001.117139; Brook AD, 1999, CRIT CARE MED, V27, P2609, DOI 10.1097/00003246-199912000-00001; Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801; *CERN CORP, AC PHYS CHRON HLTH E, V4; Cifuentes J, 2002, PEDIATRICS, V109, P745, DOI 10.1542/peds.109.5.745; Durairaj L, 2005, CHEST, V128, P1682, DOI 10.1378/chest.128.3.1682; Ely EW, 1996, NEW ENGL J MED, V335, P1864, DOI 10.1056/NEJM199612193352502; ESCARCE JJ, 1990, JAMA-J AM MED ASSOC, V264, P2389, DOI 10.1001/jama.264.18.2389; Esteban A, 2002, JAMA-J AM MED ASSOC, V287, P345, DOI 10.1001/jama.287.3.345; GROEGER JS, 1992, CRIT CARE MED, V20, P846, DOI 10.1097/00003246-199206000-00024; Halm EA, 2002, ANN INTERN MED, V137, P511, DOI 10.7326/0003-4819-137-6-200209170-00012; HANNAN EL, 1989, JAMA-J AM MED ASSOC, V262, P503, DOI 10.1001/jama.262.4.503; Hannan EL, 2003, CIRCULATION, V108, P795, DOI 10.1161/01.CIR.0000084551.52010.3B; Jones J, 1995, INT J TECHNOL ASSESS, V11, P762, DOI 10.1017/S0266462300009193; KNAUS WA, 1993, ANN INTERN MED, V118, P753, DOI 10.7326/0003-4819-118-10-199305150-00001; KNAUS WA, 1991, CHEST, V100, P1619, DOI 10.1378/chest.100.6.1619; LUFT HS, 1987, HEALTH SERV RES, V22, P157; MILSTEIN A, 2001, EFF CLIN PRACT, V4, P94; Nathens AB, 2001, JAMA-J AM MED ASSOC, V285, P1164, DOI 10.1001/jama.285.9.1164; Pronovost PJ, 2002, JAMA-J AM MED ASSOC, V288, P2151, DOI 10.1001/jama.288.17.2151; Rapoport J, 2000, JAMA-J AM MED ASSOC, V283, P2559, DOI 10.1001/jama.283.19.2559; Rosenberg AL, 2003, ANN INTERN MED, V138, P882, DOI 10.7326/0003-4819-138-11-200306030-00009; Royston P, 1999, INT J EPIDEMIOL, V28, P964, DOI 10.1093/ije/28.5.964; Rubenfeld GD, 2005, NEW ENGL J MED, V353, P1685, DOI 10.1056/NEJMoa050333; Sampalis JS, 1999, J TRAUMA, V46, P565, DOI 10.1097/00005373-199904000-00004; STONE VE, 1992, JAMA-J AM MED ASSOC, V268, P2655, DOI 10.1001/jama.268.19.2655; Tarnow-Mordi WO, 2000, LANCET, V356, P185, DOI 10.1016/S0140-6736(00)02478-8; Thiemann DR, 1999, NEW ENGL J MED, V340, P1640, DOI 10.1056/NEJM199905273402106; THOMPSON DR, 1994, CRIT CARE MED, V22, P1306, DOI 10.1097/00003246-199408000-00015; Van den Berghe G, 2001, NEW ENGL J MED, V345, P1359, DOI 10.1056/NEJMoa011300; Young MP, 1998, INT J QUAL HEALTH C, V10, P15, DOI 10.1093/intqhc/10.1.15; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248	37	379	385	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 6	2006	355	1					41	50		10.1056/NEJMsa053993	http://dx.doi.org/10.1056/NEJMsa053993			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	060DT	16822995				2022-12-28	WOS:000238783200006
J	Melton, DA				Melton, Douglas A.			Reversal of type 1 diabetes in mice	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							NOD MICE; REGENERATION; CELLS		Harvard Univ, Harvard Stem Cell Inst, Dept Mol & Cellular Biol, Boston, MA 02115 USA	Harvard University	Melton, DA (corresponding author), Harvard Univ, Harvard Stem Cell Inst, Dept Mol & Cellular Biol, Boston, MA 02115 USA.		Young, Richard A/F-6495-2012	Young, Richard A/0000-0001-8855-8647				Chong AS, 2006, SCIENCE, V311, P1774, DOI 10.1126/science.1123510; Herold KC, 2002, NEW ENGL J MED, V346, P1692, DOI 10.1056/NEJMoa012864; Huppmann M, 2005, DIABETES CARE, V28, P1204, DOI 10.2337/diacare.28.5.1204; Kodama S, 2004, PEDIATR DIABETES, V5, P38, DOI 10.1111/j.1399-543X.2004.00078.x; Kodama S, 2003, SCIENCE, V302, P1223, DOI 10.1126/science.1088949; Kulkarni RN, 2004, J CLIN INVEST, V114, P828, DOI 10.1172/JCI200421845; Nishio J, 2006, SCIENCE, V311, P1775, DOI 10.1126/science.1124004; SADELAIN MWJ, 1990, DIABETES, V39, P583, DOI 10.2337/diabetes.39.5.583; Suri A, 2006, SCIENCE, V311, P1778, DOI 10.1126/science.1123500; WANG T, 1992, DIABETES, V41, P114, DOI 10.2337/diabetes.41.1.114	10	13	17	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 6	2006	355	1					89	90		10.1056/NEJMcibr062559	http://dx.doi.org/10.1056/NEJMcibr062559			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	060DT	16823003				2022-12-28	WOS:000238783200015
J	Tagg, NT; Tsao, JW				Tagg, N. Troy; Tsao, Jack W.			Abdominal pseudohernia due to herpes zoster	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Walter Reed Army Med Ctr, Washington, DC 20307 USA	United States Department of Defense; United States Army; Walter Reed National Military Medical Center	Tagg, NT (corresponding author), Walter Reed Army Med Ctr, Washington, DC 20307 USA.								0	9	9	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 6	2006	355	1					E1	E1		10.1056/NEJMicm050341	http://dx.doi.org/10.1056/NEJMicm050341			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	060DT	16822989				2022-12-28	WOS:000238783200009
J	Fett, JD; Christie, LG; Murphy, JG				Fett, James D.; Christie, Len G.; Murphy, Joseph G.			Brief communication: Outcomes of subsequent pregnancy after peripartum cardiomyopathy: A case series from Haiti	ANNALS OF INTERNAL MEDICINE			English	Article							ALBERT-SCHWEITZER; PROGNOSIS	Background: Maternal risks with pregnancies after an index diagnosis of periparturn cardiomyopathy (PPCM) are inadequately understood. Objective: To describe the clinical outcomes of subsequent pregnancy in Haitian Women with PPCM. Design: Prospectively identified cases from a defined population base, 2000-2005. Setting: Hopital Albert Schweitzer, Deschapelles, Haiti. Patients: 15 patients with PPCM and subsequent pregnancies among 99 prospectively identified patients with PPCM. Measurements: Clinical and echocardiographic parameters. Results: Fifteen women with PPCM had 16 subsequent pregnancies after the index pregnancies. Eight of these patients experienced worsening heart failure; of these, 1 died and 1 regained normal left ventricular systolic function. Seven patients tolerated pregnancy without Worsening heart failure, and ventricular function recovered in these patients within 30 months after the subsequent pregnancy. Limitations: The results may not apply to non-Haitian women, and power was insufficient to identify factors that might predict recovery (n = 15). Conclusions: Half of the women with subsequent pregnancy after PPCM experienced worsening heart failure and long-term systolic dysfunction, while the other half experienced no deterioration and regained normal left ventricular systolic function.	Mayo Clin & Mayo Fdn, Div Cardiovasc Dis, Rochester, MN 55905 USA; Oregon Hlth & Sci Univ, Portland, OR 97201 USA; Hop Albert Schweitzer, Deschapelles, Haiti	Mayo Clinic; Oregon Health & Science University	Murphy, JG (corresponding author), Mayo Clin & Mayo Fdn, Div Cardiovasc Dis, 200 1st St SW, Rochester, MN 55905 USA.	murphy.joseph@mayo.edu						BARRY M, 1983, ANN INTERN MED, V98, P1018, DOI 10.7326/0003-4819-98-6-1018; DEMAKIS JG, 1971, CIRCULATION, V44, P964, DOI 10.1161/01.CIR.44.5.964; Elkayam U, 2001, NEW ENGL J MED, V344, P1567, DOI 10.1056/NEJM200105243442101; Fett JD, 2005, MAYO CLIN PROC, V80, P1602, DOI 10.4065/80.12.1602; Fett JD, 2003, J HEALTH POPUL NUTR, V21, P1; Fett JD, 2002, AM J OBSTET GYNECOL, V186, P1005, DOI 10.1067/mob.2002.122423; Hibbard JU, 1999, OBSTET GYNECOL, V94, P311, DOI 10.1016/S0029-7844(99)00293-8; KONSTAM MA, 2001, AM J CARDIOL, V93, P1441; Pearson GD, 2000, JAMA-J AM MED ASSOC, V283, P1183, DOI 10.1001/jama.283.9.1183	9	29	30	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 4	2006	145	1					30	34		10.7326/0003-4819-145-1-200607040-00007	http://dx.doi.org/10.7326/0003-4819-145-1-200607040-00007			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	062IS	16818926				2022-12-28	WOS:000238938400004
J	Webber, SA; McCurry, K; Zeevi, A				Webber, Steven A.; McCurry, Kenneth; Zeevi, Adriana			Heart and lung transplantation in children	LANCET			English	Review							PEDIATRIC CARDIAC TRANSPLANTATION; CORONARY-ARTERY-DISEASE; MECHANICAL CIRCULATORY SUPPORT; MONOCLONAL-ANTIBODY RITUXIMAB; SOLID-ORGAN TRANSPLANTATION; VENTRICULAR ASSIST DEVICES; RISK-FACTORS; ALLOGRAFT VASCULOPATHY; ENDOMYOCARDIAL BIOPSY; CALCINEURIN-INHIBITOR	During the past two decades, several advances have resulted in marked improvement in medium-term survival for infants and children undergoing heart transplantation. Unfortunately, progress has been less dramatic in the field of lung and heart-lung transplantation, where there is little evidence of improved outcomes. The procedures remain palliative and all transplant recipients are at risk for the adverse effects of non-specific immunosuppression, including infections, lymphoproliferative disorders, and non-lymphoid malignancies. In addition, current immunosuppressive agents have narrow therapeutic windows and exhibit a wide array of organ toxicities, posing special challenges for the young patient who must endure life-long immunosuppression. New immunosuppressive regimens have lowered the rates of acute rejection but appear to have had relatively little impact on the incidence of chronic rejection, the principal cause of late graft loss. The ultimate goal is to induce a state of donor-specific tolerance, wherein the recipient will accept the allograft indefinitely without the need for long-term immunosuppression. This quest is currently being realised in animal models of solid organ transplantation, and offers great hope for children undergoing heart and lung transplantation in the future.	UPMC Childrens Hosp Pittsburgh, Div Pediat Cardiol, Pittsburgh, PA 15213 USA; Univ Pittsburgh, Sch Med, Dept Pediat, Pittsburgh, PA 15261 USA; Univ Pittsburgh, Sch Med, Dept Surg, Pittsburgh, PA 15261 USA; Univ Pittsburgh, Sch Med, Dept Crit Care Med, Pittsburgh, PA 15261 USA; Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Webber, SA (corresponding author), UPMC Childrens Hosp Pittsburgh, Div Pediat Cardiol, 3705 5th Ave, Pittsburgh, PA 15213 USA.	steve.webber@chp.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL074732] Funding Source: NIH RePORTER; NHLBI NIH HHS [1P50HL74732] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Abarbanell G, 2004, J HEART LUNG TRANSPL, V23, P1334, DOI 10.1016/j.healun.2003.09.019; Aigner C, 2004, TRANSPL P, V36, P2801, DOI 10.1016/j.transproceed.2004.09.066; Allen UD, 2005, PEDIATR TRANSPLANT, V9, P450, DOI 10.1111/j.1399-3046.2005.00318.x; Aris RM, 2001, AM J RESP CRIT CARE, V164, P2102, DOI 10.1164/ajrccm.164.11.2107022; Ashburn DA, 2003, J THORAC CARDIOV SUR, V125, P1070, DOI 10.1067/mtc.2003.183; Awad MR, 2001, J HEART LUNG TRANSPL, V20, P625, DOI 10.1016/S1053-2498(01)00246-7; Baldwin JT, 2006, CIRCULATION, V113, P147, DOI 10.1161/CIRCULATIONAHA.105.571422; Balzer DT, 2002, CIRCULATION, V106, pI76, DOI 10.1161/01.cir.0000032875.55215.cb; Benden C, 2005, PEDIATR PULM, V40, P68, DOI 10.1002/ppul.20234; Bestard O, 2005, TRANSPL P, V37, P3729, DOI 10.1016/j.transproceed.2005.09.129; Billingham M E, 1990, J Heart Transplant, V9, P587; Blume ED, 2006, CIRCULATION, V113, P2313, DOI 10.1161/CIRCULATIONAHA.105.577601; Boucek MM, 2005, J HEART LUNG TRANSPL, V24, P968, DOI 10.1016/j.healun.2005.05.020; Boucek RJ, 2004, CARDIOL YOUNG, V14, P93, DOI 10.1017/S1047951104006377; Boucek RJ, 2002, CURR OPIN PEDIATR, V14, P611, DOI 10.1097/00008480-200210000-00009; Boucek RJ, 1999, J HEART LUNG TRANSPL, V18, P460, DOI 10.1016/S1053-2498(98)00076-X; Bowdish ME, 2004, AM J TRANSPLANT, V4, P1283, DOI 10.1111/j.1600-6143.2004.00514.x; Boyer O, 2005, TRANSPLANTATION, V79, P1405, DOI 10.1097/01.TP.0000156990.11135.60; Bridges ND, 1998, J THORAC CARDIOV SUR, V116, P617, DOI 10.1016/S0022-5223(98)70168-0; Brosig CL, 2003, PEDIATR TRANSPLANT, V7, P390, DOI 10.1034/j.1399-3046.2003.00085.x; Chaparro C, 2001, AM J RESP CRIT CARE, V163, P43, DOI 10.1164/ajrccm.163.1.9811076; Chin C, 2005, TRANSPLANTATION, V80, P477, DOI 10.1097/01.tp.0000168153.50774.30; Chin C, 2004, J HEART LUNG TRANSPL, V23, P178, DOI 10.1016/S1053-2498(03)00059-7; Choong CK, 2006, J THORAC CARDIOV SUR, V131, P198, DOI 10.1016/j.jtcvs.2005.06.053; Choong CK, 2006, J THORAC CARDIOV SUR, V131, P204, DOI 10.1016/j.jtcvs.2005.07.059; Chrisant MRK, 2005, J HEART LUNG TRANSPL, V24, P576, DOI 10.1016/j.healun.2004.01.019; COOPER JD, 1993, J HEART LUNG TRANSPL, V12, P713; Costello JA, 2003, J HEART LUNG TRANSPL, V22, P44, DOI 10.1016/S1053-2498(02)00484-9; Danziger-Isakov LA, 2005, PEDIATR INFECT DIS J, V24, P324, DOI 10.1097/01.inf.0000157089.42020.41; Danziger-Isakov LA, 2003, TRANSPLANTATION, V75, P1538, DOI 10.1097/01.TP.0000061607.07985.BD; Danziger-Isakov LA, 2003, PEDIATR TRANSPLANT, V7, P469, DOI 10.1046/j.1397-3142.2003.00102.x; Date H, 2004, J THORAC CARDIOV SUR, V128, P933, DOI 10.1016/j.jtcvs.2004.07.032; Davis RD, 2003, J THORAC CARDIOV SUR, V125, P533, DOI 10.1067/mtc.2003.166; Deng MC, 2006, AM J TRANSPLANT, V6, P150, DOI 10.1111/j.1600-6143.2005.01175.x; Di Filippo S, 2005, HUM IMMUNOL, V66, P513, DOI 10.1016/j.humimm.2004.12.008; Dobbels F, 2005, PEDIATR TRANSPLANT, V9, P381, DOI 10.1111/j.1399-3046.2005.00356.x; Eisen HJ, 2005, J HEART LUNG TRANSPL, V24, P517, DOI 10.1016/j.healun.2005.02.002; Eisen HJ, 2003, NEW ENGL J MED, V349, P847, DOI 10.1056/NEJMoa022171; ELGAMEL A, 1995, J THORAC CARDIOV SUR, V109, P721, DOI 10.1016/S0022-5223(95)70354-3; English RF, 2002, AM J TRANSPLANT, V2, P769, DOI 10.1034/j.1600-6143.2002.20811.x; Fan XH, 2004, NAT MED, V10, P1227, DOI 10.1038/nm1126; Fenton KN, 2003, ANN THORAC SURG, V76, P843, DOI 10.1016/S0003-4975(03)00659-3; Fiser WP, 2003, J HEART LUNG TRANSPL, V22, P770, DOI 10.1016/S1053-2498(02)00808-2; Ford KA, 2005, J HEART LUNG TRANSPL, V24, P1284, DOI 10.1016/j.healun.2004.08.017; Fortuna R S, 1999, Clin Transpl, P263; Freier MC, 2004, J HEART LUNG TRANSPL, V23, P857, DOI 10.1016/j.healun.2003.08.003; Fricker F J, 1999, Pediatr Transplant, V3, P333, DOI 10.1034/j.1399-3046.1999.00045.x; Gajarski RJ, 2003, J HEART LUNG TRANSPL, V22, P28, DOI 10.1016/S1053-2498(02)00476-X; Garrean S, 2005, CLIN TRANSPLANT, V19, P698, DOI 10.1111/j.1399-0012.2005.00356.x; Goldman AP, 2003, LANCET, V362, P1967, DOI 10.1016/S0140-6736(03)15015-5; Green M, 2003, PEDIATR CLIN N AM, V50, P1471, DOI 10.1016/S0031-3955(03)00127-5; Green M, 2002, AM J TRANSPLANT, V2, P894, DOI 10.1034/j.1600-6143.2002.21003.x; GREEN M, 1999, CURR OPIN ORGAN TRAN, V4, P292; Guenther DA, 2005, PEDIATR TRANSPLANT, V9, P277, DOI 10.1111/j.1399-3046.2005.00308.x; Harmon WE, 2005, AM J TRANSPLANT, V5, P887, DOI 10.1111/j.1600-6135.2005.00834.x; Hathout E, 2006, TRANSPL INT, V19, P184, DOI 10.1111/j.1432-2277.2005.00255.x; Helman DN, 2000, J HEART LUNG TRANSPL, V19, P121, DOI 10.1016/S1053-2498(99)00116-3; Hershberger RE, 2005, NEW ENGL J MED, V352, P2705, DOI 10.1056/NEJMoa032953; Hmiel SP, 2005, AM J TRANSPLANT, V5, P1739, DOI 10.1111/j.1600-6143.2005.00930.x; HSU DT, 1995, J AM COLL CARDIOL, V26, P743, DOI 10.1016/0735-1097(95)00253-Z; Hsu DT, 2005, PEDIATR TRANSPLANT, V9, P697, DOI 10.1111/j.1399-3046.2005.00431.x; Huang J, 2004, J HEART LUNG TRANSPL, V23, P716, DOI 10.1016/j.healun.2003.08.001; HUDDLESTON C, 2006, PEDIAT SOLID ORGAN T; Ibrahim JE, 2002, J HEART LUNG TRANSPL, V21, P311, DOI 10.1016/S1053-2498(01)00395-3; Jacobs JP, 2004, ANN THORAC SURG, V78, P1703, DOI 10.1016/j.athoracsur.2004.03.031; Kaczmarek I, 2005, ASAIO J, V51, P498, DOI 10.1097/01.mat.0000178967.97093.47; KANTROWITZ A, 1968, AM J CARDIOL, V22, P782, DOI 10.1016/0002-9149(68)90173-2; Keogh A, 2004, CIRCULATION, V110, P2694, DOI 10.1161/01.CIR.0000136812.90177.94; Keough WL, 2003, PEDIATR CLIN N AM, V50, P1451, DOI 10.1016/S0031-3955(03)00126-3; Khanna R, 1999, P NATL ACAD SCI USA, V96, P10391, DOI 10.1073/pnas.96.18.10391; Kobashigawa J, 2005, TRANSPL P, V37, P1333, DOI 10.1016/j.transproceed.2004.12.135; Kobashigawa JA, 2006, AM J TRANSPLANT, V6, P1377, DOI 10.1111/j.1600-6143.2006.01290.x; Kobashigawa JA, 2005, J HEART LUNG TRANSPL, V24, P1736, DOI 10.1016/j.healun.2005.02.009; Kobashigawa JA, 2005, J AM COLL CARDIOL, V45, P1532, DOI 10.1016/j.jacc.2005.02.035; Kuhn MA, 2000, J AM COLL CARDIOL, V36, P250, DOI 10.1016/S0735-1097(00)00701-4; Lamour JM, 2004, J HEART LUNG TRANSPL, V23, P948, DOI 10.1016/j.healun.2004.06.012; Law YM, 2006, J HEART LUNG TRANSPL, V25, P276, DOI 10.1016/j.healun.2005.10.006; Leonard GT, 2006, J HEART LUNG TRANSPL, V25, P61, DOI 10.1016/j.healun.2005.01.006; Leonard H, 2003, PEDIATR TRANSPLANT, V7, P59, DOI 10.1034/j.1399-3046.2003.00014.x; Lietz K, 2005, CIRCULATION, V112, P2468, DOI 10.1161/CIRCULATIONAHA.104.485003; Liou TG, 2005, AM J RESP CRIT CARE, V171, P1053, DOI 10.1164/rccm.200407-900OC; Lobach NE, 2005, J HEART LUNG TRANSPL, V24, P184, DOI 10.1016/j.healun.2004.11.005; LOWER R R, 1960, Surg Forum, V11, P18; Mahle WT, 2005, J PEDIATR-US, V147, P739, DOI 10.1016/j.jpeds.2005.07.018; Mahle WT, 2005, J THORAC CARDIOV SUR, V130, P542, DOI 10.1016/j.jtcvs.2005.02.050; Mahle WT, 2005, J HEART LUNG TRANSPL, V24, P63, DOI 10.1016/j.healun.2003.10.013; Mallory GB, 2004, EUR RESPIR J, V24, P839, DOI 10.1183/09031936.04.00064804; Mancini D, 2003, CIRCULATION, V108, P48, DOI 10.1161/01.CIR.0000070421.38604.2B; McOmber D, 2004, J HEART LUNG TRANSPL, V23, P552, DOI 10.1016/S1053-2498(03)00308-5; Meiser B, 2005, AM J TRANSPLANT, V5, P827, DOI 10.1111/j.1600-6143.2005.00757.x; Mendeloff EN, 2002, PEDIATR TRANSPLANT, V6, P270, DOI 10.1034/j.1399-3046.2002.00217.x; Meyers BF, 2005, J THORAC CARDIOV SUR, V129, P1421, DOI 10.1016/j.jtcvs.2005.01.022; Milpied N, 2000, ANN ONCOL, V11, P113, DOI 10.1023/A:1008372814223; Minami Kazutomo, 2005, Ann Thorac Cardiovasc Surg, V11, P307; Nalesnik M A, 2001, Transpl Infect Dis, V3, P88, DOI 10.1034/j.1399-3062.2001.003002088.x; Neuringer IP, 2005, J HEART LUNG TRANSPL, V24, P3, DOI 10.1016/j.healun.2004.01.009; NIXON PA, 1995, CHEST, V107, P1328, DOI 10.1378/chest.107.5.1328; Ozawa Shogo, 2004, Drug Metab Pharmacokinet, V19, P83, DOI 10.2133/dmpk.19.83; Pahl E, 2005, J HEART LUNG TRANSPL, V24, P645, DOI 10.1016/j.healun.2004.03.021; Pahl E, 2001, J HEART LUNG TRANSPL, V20, P279, DOI 10.1016/S1053-2498(00)00228-X; Pearl JP, 2003, PEDIATR CLIN N AM, V50, P1261, DOI 10.1016/S0031-3955(03)00120-2; Pollock-BarZiv SM, 2005, J HEART LUNG TRANSPL, V24, P190, DOI 10.1016/j.healun.2004.11.006; Pophal SG, 1999, J AM COLL CARDIOL, V34, P2105, DOI 10.1016/S0735-1097(99)00452-0; Price JF, 2005, J HEART LUNG TRANSPL, V24, P1798, DOI 10.1016/j.healun.2005.03.013; Qvist E, 2003, PEDIATR CLIN N AM, V50, P1505, DOI 10.1016/S0031-3955(03)00128-7; Reddy Subash C., 2003, Curr Treat Options Cardiovasc Med, V5, P417, DOI 10.1007/s11936-003-0048-2; Reed EF, 2006, J HEART LUNG TRANSPL, V25, P153, DOI 10.1016/j.healun.2005.09.003; Reinhartz O, 2001, J HEART LUNG TRANSPL, V20, P439, DOI 10.1016/S1053-2498(00)00236-9; Rhee EK, 2005, J HEART LUNG TRANSPL, V24, pS63, DOI 10.1016/j.healun.2004.11.089; Ringewald JM, 2001, J PEDIATR-US, V139, P75, DOI 10.1067/mpd.2001.115067; Rosenthal DN, 2004, J HEART LUNG TRANSPL, V23, P323, DOI 10.1016/S1053-2498(03)00209-2; Russo LM, 2004, CURR OPIN CARDIOL, V19, P104, DOI 10.1097/00001573-200403000-00006; Seipelt IM, 2005, J HEART LUNG TRANSPL, V24, P1039, DOI 10.1016/j.healun.2004.07.005; Serrano-Ikkos E, 1998, J HEART LUNG TRANSPL, V17, P1177; Shaddy RE, 2000, PROG PEDIATR CARDIOL, V11, P131, DOI 10.1016/S1058-9813(00)00040-0; Shaddy RE, 2005, PEDIATR TRANSPLANT, V9, P208, DOI 10.1111/j.1399-3046.2005.00262.x; SHAH MB, 1999, TRANSPLANT REV, V13, P83; Sharma MS, 2005, ASAIO J, V51, P490, DOI 10.1097/01.mat.0000177679.55397.e2; Sharples LD, 2002, J HEART LUNG TRANSPL, V21, P271, DOI 10.1016/S1053-2498(01)00360-6; Shirali GS, 2001, NEW ENGL J MED, V344, P1498, DOI 10.1056/NEJM200105173442002; Sindhi R, 2001, TRANSPLANTATION, V72, P851, DOI 10.1097/00007890-200109150-00019; Smith JM, 2003, PEDIATR CLIN N AM, V50, P1283, DOI 10.1016/S0031-3955(03)00121-4; Smith RR, 2005, EUR J CARDIO-THORAC, V27, P790, DOI 10.1016/j.ejcts.2004.12.058; Sritippayawan S, 2003, PEDIATR TRANSPLANT, V7, P200, DOI 10.1034/j.1399-3046.2003.00069.x; Starnes VA, 2004, J THORAC CARDIOV SUR, V127, P114, DOI 10.1016/j.jtcvs.2003.07.042; Stewart S, 2005, J HEART LUNG TRANSPL, V24, P1710, DOI 10.1016/j.healun.2005.03.019; Stiller B, 2003, J HEART LUNG TRANSPL, V22, P1201, DOI 10.1016/S1053-2498(02)01233-0; Sweet SC, 2003, PEDIATR CLIN N AM, V50, P1393, DOI 10.1016/S0031-3955(03)00123-8; Tham EBC, 2005, J HEART LUNG TRANSPL, V24, P769, DOI 10.1016/j.healun.2004.04.009; Tweddell JS, 2002, CIRCULATION, V106, pI82, DOI 10.1161/01.cir.0000032878.55215.bd; *US ORG PROC TRANS, 2005, NETW SCI REG TRANSPL; Valantine H, 2004, J HEART LUNG TRANSPL, V23, pS187, DOI 10.1016/j.healun.2004.03.009; Wagner K, 1997, J HEART LUNG TRANSPL, V16, P275; Ward KM, 2004, J HEART LUNG TRANSPL, V23, P1040, DOI 10.1016/j.healun.2003.08.014; Webber S, 2004, BLOOD, V104, p213A, DOI 10.1182/blood.V104.11.746.746; Webber S A, 1997, Pediatr Transplant, V1, P8; WEBBER SA, 1994, ANN THORAC SURG, V58, P1664, DOI 10.1016/0003-4975(94)91655-1; Webber SA, 2006, LANCET, V367, P233, DOI 10.1016/S0140-6736(06)67933-6; Webber SA, 2003, CARDIOL YOUNG, V13, P64, DOI 10.1017/S104795110300012X; Webber SA, 2003, J HEART LUNG TRANSPL, V22, P869, DOI 10.1016/S1053-2498(02)00819-7; WEBBER SA, 2000, PEDIAT SOLID ORGAN T, P313; West LJ, 2006, J THORAC CARDIOV SUR, V131, P455, DOI 10.1016/j.jtcvs.2005.09.048; West LJ, 2002, TRANSPL IMMUNOL, V9, P149, DOI 10.1016/S0966-3274(02)00044-8; West LJ, 2001, NEW ENGL J MED, V344, P793, DOI 10.1056/NEJM200103153441102; Wray J, 2005, PEDIATR TRANSPLANT, V9, P170, DOI 10.1111/j.1399-3046.2005.00265.x; Yousem SA, 1996, J HEART LUNG TRANSPL, V15, P1; Zheng HX, 2003, AM J TRANSPLANT, V3, P477, DOI 10.1034/j.1600-6143.2003.00077.x; Zheng HX, 2002, HUM IMMUNOL, V63, P765, DOI 10.1016/S0198-8859(02)00426-3	148	24	32	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 1	2006	368	9529					53	69		10.1016/S0140-6736(06)68969-1	http://dx.doi.org/10.1016/S0140-6736(06)68969-1			17	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	058TQ	16815380				2022-12-28	WOS:000238687900031
J	Goddard, A				Goddard, A			How head-hunters track down the winners for science's top jobs	NATURE			English	Article																			0	0	0	0	0	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 23	1999	401	6751					407	409						3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	240JJ	16862114				2022-12-28	WOS:000082822600061
J	Mallett, S; Deeks, JJ; Halligan, S; Hopewell, S; Cornelius, V; Altman, DG				Mallett, Susan; Deeks, Jonathan J.; Halligan, Steve; Hopewell, Sally; Cornelius, Victoria; Altman, Douglas G.			Systematic reviews of diagnostic tests in cancer: review of methods and reporting	BMJ-BRITISH MEDICAL JOURNAL			English	Article							QUALITY; METAANALYSES; ACCURACY; BIAS	Objectives To assess the methods and reporting of systematic reviews of diagnostic tests. Data sources Systematic searches of Medline, Embase, and five other databases identified reviews of tests used in patients with cancer. Of these, 89 satisfied our inclusion criteria of reporting accuracy of the test compared with a reference test, including an electronic search, and published since 1990. Review methods All reviews were assessed for methods and reporting of objectives, search strategy, participants, clinical setting, index and reference tests, study design, study results, graphs, meta-analysis, quality, bias, and procedures in the review. We assessed 25 randomly selected reviews in more detail. Results 75% (67) of the reviews stated inclusion criteria, 49% (44) tabulated characteristics of included studies, 40% (36) reported details of study design, 17% (15) reported on the clinical setting, 17% (15) reported on the severity of disease in participants, and 49% (44) reported on whether the tumours were primary, metastatic, or recurrent. Of the 25 reviews assessed in detail, 68% (17) stated the reference standard used in the review, 36% (9) reported the definition of a positive result for the index test, and 56% (14) reported sensitivity, specificity, and sample sizes for individual studies. Of the 89 reviews, 6 1 No (54) attempted to formally synthesise results of the studies and 32% (29) reported formal assessments of study quality. Conclusions Reliability and relevance of current systematic reviews of diagnostic tests is compromised by poor reporting and review methods.	Univ Oxford Wolfson Coll, Ctr Stat Med, Oxford OX2 6UD, England; Univ Birmingham, Dept Epidemiol & Publ Hlth, Birmingham B15 2TT, W Midlands, England; UK Cochrane Ctr, Oxford OX2 7LG, England; UCL, Dept Specialist Radiol, London NW1 2BU, England; Drug Safety Res Unit, Southampton SO31 1AA, Hants, England	University of Oxford; University of Birmingham; Cochrane Centre; University of London; University College London	Mallett, S (corresponding author), Univ Oxford Wolfson Coll, Ctr Stat Med, Oxford OX2 6UD, England.	susan.mallett@cancer.org.uk	Mallett, Sue/GPS-9933-2022; Halligan, Steve/C-5875-2009; Deeks, Jon/AAV-5745-2020	Halligan, Steve/0000-0003-0632-5108; Deeks, Jon/0000-0002-8850-1971; Mallett, Sue/0000-0002-0596-8200; Cornelius, Victoria/0000-0002-0080-1065; Hopewell, Sally/0000-0002-6881-6984				ARROLF B, 1988, J GEN INTERN MED, V3, P13; ARROLL B, 1988, J GEN INTERN MED, V3, P443, DOI 10.1007/BF02595920; BEGG CB, 1987, STAT MED, V6, P411, DOI 10.1002/sim.4780060402; Bossuyt PM, 2003, ANN INTERN MED, V138, P40, DOI 10.7326/0003-4819-138-1-200301070-00010; DEEKS J, 2004, COCHRANE NEWS    AUG, P31; DEEKS J, 2004, COCHRANE NEWS    AUG; Deeks JJ, 2001, BRIT MED J, V323, P157, DOI 10.1136/bmj.323.7305.157; Deville Walter L, 2002, BMC Med Res Methodol, V2, P9, DOI 10.1186/1471-2288-2-9; Dinnes J, 2005, HEALTH TECHNOL ASSES, V9, P1, DOI 10.3310/hta9120; Egger M, 2002, INT J EPIDEMIOL, V31, P1, DOI 10.1093/ije/31.1.1; Gould MK, 2001, JAMA-J AM MED ASSOC, V285, P914, DOI 10.1001/jama.285.7.914; Harris KM, 1998, HEALTH TECHNOL ASSES, V2, P1; IRWIG L, 1994, ANN INTERN MED, V120, P667, DOI 10.7326/0003-4819-120-8-199404150-00008; Lijmer JG, 1999, JAMA-J AM MED ASSOC, V282, P1061, DOI 10.1001/jama.282.11.1061; LODGE M, 2005, COCHRANE LIB; Moher D, 1999, LANCET, V354, P1896, DOI 10.1016/S0140-6736(99)04149-5; MULROW CD, 1994, BRIT MED J, V309, P597, DOI 10.1136/bmj.309.6954.597; OXMAN AD, 1993, ANN NY ACAD SCI, V703, P125, DOI 10.1111/j.1749-6632.1993.tb26342.x; REID MC, 1995, JAMA-J AM MED ASSOC, V274, P645, DOI 10.1001/jama.274.8.645; Rutjes Anne W S, 2006, CMAJ, V174, P469, DOI 10.1503/cmaj.050090; SCHMID C, 2004, 12 COCHR C OTT 2 6 O; SHEPS SB, 1984, JAMA-J AM MED ASSOC, V252, P2418, DOI 10.1001/jama.252.17.2418; Shojania K G, 2001, Eff Clin Pract, V4, P157; Smidt N, 2005, RADIOLOGY, V235, P347, DOI 10.1148/radiol.2352040507; Tatsioni A, 2005, ANN INTERN MED, V142, P1048, DOI 10.7326/0003-4819-142-12_Part_2-200506211-00004; Whiting P, 2004, HEALTH TECHNOL ASSES, V8, P1, DOI 10.3310/hta8250; Whiting P, 2005, J CLIN EPIDEMIOL, V58, P1, DOI 10.1016/j.jclinepi.2004.04.008; Whiting P, 2004, ANN INTERN MED, V140, P189, DOI 10.7326/0003-4819-140-3-200402030-00010; Whiting Penny, 2003, BMC Med Res Methodol, V3, P25, DOI 10.1186/1471-2288-3-25	29	52	56	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 26	2006	333	7565					413	416A		10.1136/bmj.38895.467130.55	http://dx.doi.org/10.1136/bmj.38895.467130.55			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	081AO	16849365	Green Submitted, Green Published, Bronze			2022-12-28	WOS:000240289800015
J	Smith, DK; Cann, JR; Escartin, J				Smith, Deborah K.; Cann, Johnson R.; Escartin, Javier			Widespread active detachment faulting and core complex formation near 13 degrees N on the Mid-Atlantic Ridge	NATURE			English	Article							15-20 FRACTURE-ZONE; TRANSFORM INTERSECTIONS; ULTRAMAFIC EXPOSURES; MEGAMULLION; TOPOGRAPHY; ORIGIN	Oceanic core complexes are massifs in which lower-crustal and upper-mantle rocks are exposed at the sea floor(1-3). They form at mid-ocean ridges through slip on detachment faults rooted below the spreading axis(2-6). To date, most studies of core complexes have been based on isolated inactive massifs that have spread away from ridge axes. Here we present a survey of the Mid-Atlantic Ridge near 13 degrees N containing a segment in which a number of linked detachment faults extend for 75 km along one flank of the spreading axis. The detachment faults are apparently all currently active and at various stages of development. A field of extinct core complexes extends away from the axis for at least 100 km. Our observations reveal the topographic characteristics of actively forming core complexes and their evolution from initiation within the axial valley floor to maturity and eventual inactivity. Within the surrounding region there is a strong correlation between detachment fault morphology at the ridge axis and high rates of hydroacoustically recorded earthquake seismicity. Preliminary examination of seismicity and seafloor morphology farther north along the Mid-Atlantic Ridge suggests that active detachment faulting is occurring in many segments and that detachment faulting is more important in the generation of ocean crust at this slow-spreading ridge than previously suspected.	Woods Hole Oceanog Inst, Woods Hole, MA 02543 USA; Univ Leeds, Sch Earth Sci, Leeds LS2 9JT, W Yorkshire, England; CNRS, Marine Geosci Grp, F-75252 Paris 05, France	Woods Hole Oceanographic Institution; University of Leeds; Centre National de la Recherche Scientifique (CNRS)	Smith, DK (corresponding author), Woods Hole Oceanog Inst, Woods Hole, MA 02543 USA.	dsmith@whoi.edu	Escartin, Javier/B-3344-2008; ESCARTIN, Javier/A-1043-2010	ESCARTIN, Javier/0000-0002-3416-6856				Blackman DK, 2002, MAR GEOPHYS RES, V23, P443, DOI 10.1023/B:MARI.0000018232.14085.75; Blackman DK, 1998, J GEOPHYS RES-SOL EA, V103, P21315, DOI 10.1029/98JB01756; Bohnenstiehl DR, 2002, TECTONOPHYSICS, V354, P49, DOI 10.1016/S0040-1951(02)00289-5; Cann JR, 1997, NATURE, V385, P329, DOI 10.1038/385329a0; CANNAT M, 1995, GEOLOGY, V23, P49, DOI 10.1130/0091-7613(1995)023<0049:TCUEAR>2.3.CO;2; Christie DM, 1998, NATURE, V394, P637, DOI 10.1038/29226; DICK HJB, 1981, EOS, V62; Escartin J, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017226; Escartin J, 2003, GEOCHEM GEOPHY GEOSY, V4, DOI 10.1029/2002GC000472; Escartin J, 1999, EARTH PLANET SC LETT, V171, P411, DOI 10.1016/S0012-821X(99)00169-7; Fox CG, 2001, J GEOPHYS RES-SOL EA, V106, P4183, DOI 10.1029/2000JB900404; Fujiwara T, 2003, GEOCHEM GEOPHY GEOSY, V4, DOI 10.1029/2002GC000364; KARSON JA, 1983, MAR GEOPHYS RES, V6, P51, DOI 10.1007/BF00300398; MACDONALD C, 1990, CRIT REV BIOTECHNOL, V10, P155, DOI 10.3109/07388559009068265; MacLeod CJ, 2002, GEOLOGY, V30, P879, DOI 10.1130/0091-7613(2002)030<0879:DGEFOD>2.0.CO;2; Ohara Y, 2001, MAR GEOPHYS RES, V22, P47, DOI 10.1023/A:1004818225642; Okino K, 2004, GEOCHEM GEOPHY GEOSY, V5, DOI 10.1029/2004GC000793; Schroeder T, 2004, GEOCHEM GEOPHY GEOSY, V5, DOI 10.1029/2004GC000728; Searle RC, 2003, GEOCHEM GEOPHY GEOSY, V4, DOI 10.1029/2003GC000519; Smith DK, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2002JB001964; Smith DK, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL013912; Smith WHF, 1997, SCIENCE, V277, P1956, DOI 10.1126/science.277.5334.1956; Spencer JE, 1999, GEOLOGY, V27, P327, DOI 10.1130/0091-7613(1999)027<0327:GCCBCA>2.3.CO;2; Sudarikov SM, 2000, J VOLCANOL GEOTH RES, V101, P245, DOI 10.1016/S0377-0273(00)00174-8; Tucholke BE, 1998, J GEOPHYS RES-SOL EA, V103, P9857, DOI 10.1029/98JB00167; Tucholke BE, 2001, J GEOPHYS RES-SOL EA, V106, P16145, DOI 10.1029/2001JB000373	26	208	222	3	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 27	2006	442	7101					440	443		10.1038/nature04950	http://dx.doi.org/10.1038/nature04950			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067CI	16871215				2022-12-28	WOS:000239278900040
J	Gornall, J				Gornall, Jonathan			Child abuse - Royal college rewrites child protection history	BRITISH MEDICAL JOURNAL			English	Editorial Material												Jgornall@mac.com						MEADOW R, 1977, LANCET, V2, P343; *ROYAL COLL PAED C, 2006, CHILD PROT COMP; Shabde N, 1999, ARCH DIS CHILD, V81, P291, DOI 10.1136/adc.81.4.291; Southall DP, 1997, PEDIATRICS, V100, P735, DOI 10.1542/peds.100.5.735	4	5	5	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JUL 22	2006	333	7560					194	196		10.1136/bmj.333.7560.194	http://dx.doi.org/10.1136/bmj.333.7560.194			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	068DJ	16858052	Green Published			2022-12-28	WOS:000239352100025
J	Kalra, D; Gertz, R; Singleton, P; Inskip, HM				Kalra, Dipak; Gertz, Renate; Singleton, Peter; Inskip, Hazel M.			Confidentiality and consent in medical research - Confidentiality of personal health information used for research	BRITISH MEDICAL JOURNAL			English	Editorial Material									UCL, Ctr Hlth Informat & Multiprofess Educ, London N19 5LW, England; Univ Edinburgh, Sch Law, Res Ctr Studies Intellectual Property & Technol L, Edinburgh EH8 9YL, Midlothian, Scotland; Univ Southampton, Southampton Gen Hosp, MRC, Epidemiol Resource Ctr, Southampton SO16 6YD, Hants, England	University of London; University College London; University of Edinburgh; University of Southampton	Kalra, D (corresponding author), UCL, Ctr Hlth Informat & Multiprofess Educ, London N19 5LW, England.	dkalra@chime.ucl.ac.uk	Kalra, D/H-6661-2019; Inskip, Hazel/L-5467-2018	Kalra, D/0000-0001-5254-4067; Inskip, Hazel/0000-0001-8897-1749	Medical Research Council [MC_U147585827, MC_UP_A620_1014] Funding Source: Medline; MRC [MC_U147585827] Funding Source: UKRI; Economic and Social Research Council [RES-145-28-1004] Funding Source: researchfish; Medical Research Council [U1475000001] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		Academy of Medical Sciences, 2006, PERS DAT PUBL GOOD U; Bauchner H, 2001, BMJ-BRIT MED J, V322, P309, DOI 10.1136/bmj.322.7282.309; Department of Health The Caldicott Committee, 1997, REP REV PAT ID INF; Inskip HM, 1996, J ROY STAT SOC A STA, V159, P41, DOI 10.2307/2983467; Kalra D, 2005, METHOD INFORM MED, V44, P193; KALRA D, 2003, THESIS U LONDON LOND; Lowrance WW, 2002, LEARNING EXPERIENCE; *NHS NAT I HLTH RE, 2006, IMPL PLAN 3 1 NAT I	8	39	39	0	6	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 22	2006	333	7560					196	198		10.1136/bmj.333.7560.196	http://dx.doi.org/10.1136/bmj.333.7560.196			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	068DJ	16858053	Green Submitted, Green Published			2022-12-28	WOS:000239352100026
J	Bhatia, RS; Tu, JV; Lee, DS; Austin, PC; Fang, JM; Haouzi, A; Gong, YY; Liu, PP				Bhatia, R. Sacha; Tu, Jack V.; Lee, Douglas S.; Austin, Peter C.; Fang, Jiming; Haouzi, Annick; Gong, Yanyan; Liu, Peter P.			Outcome of heart failure with preserved ejection fraction in a population-based study	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							VENTRICULAR SYSTOLIC FUNCTION; CONVERTING-ENZYME-INHIBITORS; CLINICAL-FEATURES; PROGNOSIS; MORTALITY; DIAGNOSIS; COMMUNITY; TRIAL; AGE; DETERMINANTS	Background: The importance of heart failure with preserved ejection fraction is increasingly recognized. We conducted a study to evaluate the epidemiologic features and outcomes of patients with heart failure with preserved ejection fraction and to compare the findings with those from patients who had heart failure with reduced ejection fraction. Methods: From April 1, 1999, through March 31, 2001, we studied 2802 patients admitted to 103 hospitals in the province of Ontario, Canada, with a discharge diagnosis of heart failure whose ejection fraction had also been assessed. The patients were categorized in three groups: those with an ejection fraction of less than 40 percent (heart failure with reduced ejection fraction), those with an ejection fraction of 40 to 50 percent (heart failure with borderline ejection fraction), and those with an ejection fraction of more than 50 percent (heart failure with preserved ejection fraction). Two groups were studied in detail: those with an ejection fraction of less than 40 percent and those with an ejection fraction of more than 50 percent. The main outcome measures were death within one year and readmission to the hospital for heart failure. Results: Thirty-one percent of the patients had an ejection fraction of more than 50 percent. Patients with heart failure with preserved ejection fraction were more likely to be older and female and to have a history of hypertension and atrial fibrillation. The presenting history and clinical examination findings were similar for the two groups. The unadjusted mortality rates for patients with an ejection fraction of more than 50 percent were not significantly different from those for patients with an ejection fraction of less than 40 percent at 30 days (5 percent vs. 7 percent, P=0.08) and at 1 year (22 percent vs. 26 percent, P=0.07); the adjusted one-year mortality rates were also not significantly different in the two groups (hazard ratio, 1.13; 95 percent confidence interval, 0.94 to 1.36; P=0.18). The rates of readmission for heart failure and of in-hospital complications did not differ between the two groups. Conclusions: Among patients presenting with new-onset heart failure, a substantial proportion had an ejection fraction of more than 50 percent. The survival of patients with heart failure with preserved ejection fraction was similar to that of patients with reduced ejection fraction.	Univ Toronto, Heart & Stroke Richard Lewar Ctr Excellence, Toronto, ON, Canada; Univ Hlth Network, Toronto Gen Hosp, Div Cardiol, Toronto, ON, Canada; Univ Toronto, Sunnybrook & Womens Coll Hlth Sci Ctr, Div Gen Internal Med, Toronto, ON, Canada; NHLBI, Framingham Heart Study, Framingham, MA USA; Inst Clin Evaluat Sci, Toronto, ON, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; Framingham Heart Study; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of Toronto	Liu, PP (corresponding author), Toronto Gen Hosp, Heart & Stroke Richard Lewar Ctr Excellence, NCSB 11-1266,200 Elizabeth St, Toronto, ON M5G 2C4, Canada.	peter.liu@utoronto.ca		Lee, Douglas/0000-0001-7078-745X; Austin, Peter/0000-0003-3337-233X; Tu, Jack/0000-0003-0111-722X				Aurigemma GP, 2004, NEW ENGL J MED, V351, P1097, DOI 10.1056/NEJMcp022709; COHN JN, 1990, CIRCULATION, V81, P48; *DEP HHS, 1988, INT CLASS DIS; Fuster V, 2001, J AM COLL CARDIOL, V38, P1231, DOI 10.1016/S0735-1097(01)01587-X; Gandhi SK, 2001, NEW ENGL J MED, V344, P17, DOI 10.1056/NEJM200101043440103; Gustafsson F, 2003, EUR HEART J, V24, P863, DOI 10.1016/S0195-668X(02)00845-X; Hernandez AF, 2005, ARCH INTERN MED, V165, P2162, DOI 10.1001/archinte.165.18.2162; Hunt SA, 2005, CIRCULATION, V112, pE154, DOI 10.1161/CIRCULATIONAHA.105.167586; Jones RC, 2004, J AM COLL CARDIOL, V44, P1025, DOI 10.1016/j.jacc.2004.05.077; Jong P, 2002, ARCH INTERN MED, V162, P1689, DOI 10.1001/archinte.162.15.1689; Kitzman Dalane W, 2002, Heart Fail Rev, V7, P17; Kitzman DW, 2001, AM J CARDIOL, V87, P413, DOI 10.1016/S0002-9149(00)01393-X; Ko DT, 2005, ARCH INTERN MED, V165, P2486, DOI 10.1001/archinte.165.21.2486; Krumholz HM, 1997, ARCH INTERN MED, V157, P2242, DOI 10.1001/archinte.157.19.2242; Lee DS, 2003, JAMA-J AM MED ASSOC, V290, P2581, DOI 10.1001/jama.290.19.2581; Lenzen MJ, 2004, EUR HEART J, V25, P1214, DOI 10.1016/j.ehj.2004.06.006; Maisel AS, 2003, J AM COLL CARDIOL, V41, P2010, DOI 10.1016/S0735-1097(03)00405-4; Masoudi FA, 2003, J AM COLL CARDIOL, V41, P217, DOI 10.1016/S0735-1097(02)02696-7; McMurray JJV, 2003, LANCET, V362, P767, DOI 10.1016/S0140-6736(03)14283-3; Pernenkil R, 1997, AM J CARDIOL, V79, P216, DOI 10.1016/S0002-9149(96)00719-9; Philbin EF, 2000, AM J MED, V109, P605, DOI 10.1016/S0002-9343(00)00601-X; Redfield MM, 2003, JAMA-J AM MED ASSOC, V289, P194, DOI 10.1001/jama.289.2.194; Senni M, 1998, CIRCULATION, V98, P2282, DOI 10.1161/01.CIR.98.21.2282; Senni M, 2001, J AM COLL CARDIOL, V38, P1277, DOI 10.1016/S0735-1097(01)01567-4; SETARO JF, 1992, AM J CARDIOL, V69, P1212, DOI 10.1016/0002-9149(92)90938-U; Smith GL, 2003, J AM COLL CARDIOL, V41, P1510, DOI 10.1016/S0735-1097(03)00185-2; Steg PG, 2004, CIRCULATION, V109, P494, DOI 10.1161/01.CIR.0000109691.16944.DA; Varadarajan P, 2003, J CARD FAIL, V9, P107, DOI 10.1054/jcaf.2003.13; Vasan RS, 2000, CIRCULATION, V101, P2118, DOI 10.1161/01.CIR.101.17.2118; Vasan RS, 1999, J AM COLL CARDIOL, V33, P1948, DOI 10.1016/S0735-1097(99)00118-7; VASAN RS, 1995, J AM COLL CARDIOL, V26, P1565, DOI 10.1016/0735-1097(95)00381-9; Yusuf S, 2003, LANCET, V362, P777, DOI 10.1016/S0140-6736(03)14285-7; Zile MR, 2001, CIRCULATION, V104, P779, DOI 10.1161/hc3201.094226	33	1397	1474	1	49	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 20	2006	355	3					260	269		10.1056/NEJMoa051530	http://dx.doi.org/10.1056/NEJMoa051530			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	064NY	16855266	Bronze			2022-12-28	WOS:000239097600007
J	Davis, JT				Davis, J. Terrance			Thoughts from the transition zone	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Ohio State Univ, Columbus, OH 43210 USA; Columbus Childrens Hosp, Ctr Heart, Columbus, OH USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital	Davis, JT (corresponding author), Ohio State Univ, Columbus, OH 43210 USA.								0	0	0	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 20	2006	355	3					235	236		10.1056/NEJMp058163	http://dx.doi.org/10.1056/NEJMp058163			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	064NY	16855262				2022-12-28	WOS:000239097600003
J	O'Brien, TJ; Bode, MF; Porcas, RW; Muxlow, TWB; Eyres, SPS; Beswick, RJ; Garrington, ST; Davis, RJ; Evans, A				O'Brien, T. J.; Bode, M. F.; Porcas, R. W.; Muxlow, T. W. B.; Eyres, S. P. S.; Beswick, R. J.; Garrington, S. T.; Davis, R. J.; Evans, A.			An asymmetric shock wave in the 2006 outburst of the recurrent nova RS Ophiuchi	NATURE			English	Article							SYMBIOTIC STARS; MODELS	Nova outbursts(1) take place in binary star systems comprising a white dwarf and either a low-mass Sun-like star or, as in the case of the recurrent nova RS Ophiuchi(2), a red giant. Although the cause of these outbursts is known to be thermonuclear explosion of matter transferred from the companion onto the surface of the white dwarf(3), models of the previous ( 1985) outburst of RS Ophiuchi failed to adequately fit the X-ray evolution(4) and there was controversy over a single-epoch high-resolution radio image, which suggested that the remnant was bipolar(5,6) rather than spherical as modelled. Here we report the detection of spatially resolved structure in RS Ophiuchi from two weeks after its 12 February 2006 outburst. We track an expanding shock wave as it sweeps through the red giant wind, producing a remnant similar to that of a type II supernova but evolving over months rather than millennia(7). As in supernova remnants, the radio emission is non-thermal ( synchrotron emission), but asymmetries and multiple emission components clearly demonstrate that contrary to the assumptions of spherical symmetry in models of the 1985 explosion, the ejection is jet-like, collimated by the central binary whose orientation on the sky can be determined from these observations.	Univ Manchester, Jodrell Bank Observ, Sch Phys & Astron, Macclesfield SK11 9DL, Cheshire, England; Liverpool John Moores Univ, Astrophys Res Inst, Birkenhead CH41 1LD, Merseyside, England; Max Planck Inst Radioastron, D-53121 Bonn, Germany; Univ Cent Lancashire, Ctr Astrophys, Preston PR1 2HE, Lancs, England; Keele Univ, Sch Phys & Geog Sci, Astrophys Grp, Keele ST5 5BG, Staffs, England	University of Manchester; Jodrell Bank Centre for Astrophysics; Liverpool John Moores University; Max Planck Society; University of Central Lancashire; Keele University	O'Brien, TJ (corresponding author), Univ Manchester, Jodrell Bank Observ, Sch Phys & Astron, Macclesfield SK11 9DL, Cheshire, England.	tim.obrien@manchester.ac.uk	Beswick, Robert/AAA-2050-2022; Eyres, Stewart/AAF-6931-2020; Eyres, Stewart/AAF-1660-2020	Eyres, Stewart/0000-0002-6663-7675; Muxlow, Thomas/0000-0001-5797-8796				BODE MF, 1985, MON NOT R ASTRON SOC, V217, P205, DOI 10.1093/mnras/217.1.205; BODE MF, 1989, CLASSICAL NOVAE; BODE MF, 2006, 8675 IAU; BODE MF, 2006, UNPUB ASTROPHYS J; BUIL C, 2006, CENT BUR ELECT TEL, V403; EVANS A, 2006, 8682 IAU; EYRES SPS, 2006, 8678 IAU; HIROSAWA K, 2006, CENT BUR ELECT TEL, V399; HJELLMING RM, 1986, ASTROPHYS J, V305, pL71, DOI 10.1086/184687; Livio M, 2003, ASTROPHYS J, V593, P184, DOI 10.1086/375872; LLOYD HM, 1993, MON NOT R ASTRON SOC, V265, P457, DOI 10.1093/mnras/265.2.457; MARCAIDE JM, 1997, APJ, V486, P31; Mason K.O., 1987, RS OPHIUCHI 1985 REC, P167; MASON KO, 1987, RS OPHIUCHI 1985 REC, P167; NESS JU, 2006, 8683 IAU; OBRIEN TJ, 1992, MON NOT R ASTRON SOC, V255, P683, DOI 10.1093/mnras/255.4.683; OBRIEN TJ, 2006, 8684 IAU; OBRIEN TJ, 2006, 8688 IAU; OSBORNE JP, 2006, ASTRON TEL, V770; OSBORNE JP, 2006, ASTRON TEL, V764; PADIN S, 1985, NATURE, V315, P306, DOI 10.1038/315306a0; PORCAS RW, 1987, RS OPHIUCHI 1985 REC, P203; Shore SN, 1996, ASTROPHYS J, V456, P717, DOI 10.1086/176692; SOKOLOSKI JL, 2006, ASTRON TEL, V754; Starrfield S, 2000, NEW ASTRON REV, V44, P81, DOI 10.1016/S1387-6473(00)00018-X; TAYLOR AR, 1989, MON NOT R ASTRON SOC, V237, P81, DOI 10.1093/mnras/237.1.81	28	132	132	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 20	2006	442	7100					279	281		10.1038/nature04949	http://dx.doi.org/10.1038/nature04949			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064WT	16855585				2022-12-28	WOS:000239122100033
J	Williams, BR; Steinberg, JP				Williams, B. Robinson, III; Steinberg, James P.			Muller's sign	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Emory Crawford Long Hosp, Atlanta, GA 30308 USA		Williams, BR (corresponding author), Emory Crawford Long Hosp, Atlanta, GA 30308 USA.								0	0	0	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 20	2006	355	3					E3	E3		10.1056/NEJMicm050642	http://dx.doi.org/10.1056/NEJMicm050642			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	064NY	16855259				2022-12-28	WOS:000239097600012
J	van Dam, RM; Willett, WC; Manson, JE; Hu, FB				van Dam, Rob M.; Willett, Walter C.; Manson, JoAnn E.; Hu, Frank B.			The relationship between overweight in adolescence and premature death in women	ANNALS OF INTERNAL MEDICINE			English	Article							BODY-MASS INDEX; CORONARY-HEART-DISEASE; FOLLOW-UP; PHYSICAL-ACTIVITY; ADULT MORTALITY; WEIGHT CHANGE; MIDDLE-AGE; OBESITY; COHORT; RISK	Background: The impact of adiposity in adolescence on death during adulthood is uncertain. Objective: To examine the relation between adiposity in adolescence and premature death in women. Design: Prospective cohort study. Setting: United States. Participants: 102400 women from the Nurses' Health Study II who were 24 to 44 years of age and free of cancer at baseline. Ninety percent were of non-Hispanic white ethnicity. Measurements: In 1989, current weight and height and recalled weight at age 18 years were assessed by using validated questionnaires, and body mass index (BMI) was calculated. Hazard ratios for death and 95% Cls were adjusted for potential confounders, including cigarette smoking, alcohol use, and physical activity during adolescence. Results: During 12 years of follow-up, 710 participants died. Compared with a BMI of 18.5 to 21.9 kg/m(2) at age 18 years, the hazard ratio for premature death was 0.98 (95% Cl, 0.78 to 1.23) for a BMI less than 18.5 kg/m(2), 1.18 (Cl, 0.97 to 1.43) for a BMI of 22.0 to 24.9 kg/m(2), 1.66 (Cl, 1.31 to 2.10) for a BMI of 25.0 to 29.9 kg/m(2), and 2.79 (Cl, 2.04 to 3.81) for a BMI of 30 kg/m(2) or greater. Among participants who never smoked, a BMI of 22.0 to 24.9 kg/m2 at age 18 years was also associated with increased premature death (hazard ratio, 1.50 [Cl, 1.16 to 1.94]). Associations between BMI at age 18 years and death could only partly be explained by adult BMI measured in 1989. Limitations: Because of the observational study design, residual confounding by imperfectly measured or unknown confounders may still be present. Conclusion: Moderately higher adiposity at age 18 years is associated with increased premature death in younger and middle-aged U.S. women.	Harvard Univ, Brigham & Womens Hosp, Sch Publ Hlth, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; Vrije Univ Amsterdam, NL-1081 HV Amsterdam, Netherlands	Harvard University; Brigham & Women's Hospital; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School; Vrije Universiteit Amsterdam	van Dam, RM (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Nutr, 665 Huntington Ave,Bodg 2, Boston, MA 02115 USA.	rvandam@hsph.harvard.edu	Hu, Frank/C-1919-2013; van Dam, Rob M/F-9674-2010	van Dam, Rob M/0000-0002-7354-8734	NCI NIH HHS [CA50385] Funding Source: Medline; NIDDK NIH HHS [P30 DK040561-11, P30 DK040561] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA050385] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK040561] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ALLEBECK P, 1992, PUBLIC HEALTH, V106, P375, DOI 10.1016/S0033-3506(05)80186-6; DIPIETRO L, 1994, INT J OBESITY, V18, P585; Eaton DK, 2005, ARCH PEDIAT ADOL MED, V159, P513, DOI 10.1001/archpedi.159.6.513; Engeland A, 2003, AM J EPIDEMIOL, V157, P517, DOI 10.1093/aje/kwf219; Engeland A, 2004, EPIDEMIOLOGY, V15, P79, DOI 10.1097/01.ede.0000100148.40711.59; Falkner NH, 2001, OBES RES, V9, P32, DOI 10.1038/oby.2001.5; Flegal KM, 2005, JAMA-J AM MED ASSOC, V293, P1861, DOI 10.1001/jama.293.15.1861; Flegal KM, 2002, JAMA-J AM MED ASSOC, V288, P1723, DOI 10.1001/jama.288.14.1723; Greenland S, 1996, INT J EPIDEMIOL, V25, P1107, DOI 10.1093/ije/25.6.1107-a; Gunnell DJ, 1998, AM J CLIN NUTR, V67, P1111, DOI 10.1093/ajcn/67.6.1111; HOFFMANS MDAF, 1988, J CLIN EPIDEMIOL, V41, P749, DOI 10.1016/0895-4356(88)90161-8; HOFFMANS MDAF, 1989, J CLIN EPIDEMIOL, V42, P513, DOI 10.1016/0895-4356(89)90147-9; Hu FB, 2004, NEW ENGL J MED, V351, P2694, DOI 10.1056/NEJMoa042135; Huang ZP, 1997, JAMA-J AM MED ASSOC, V278, P1407, DOI 10.1001/jama.278.17.1407; Hunter DJ, 1997, CONTRACEPTION, V56, P373, DOI 10.1016/S0010-7824(97)00172-8; Magnusson PKE, 2006, AM J EPIDEMIOL, V163, P1, DOI 10.1093/aje/kwj002; MANSON JE, 1987, JAMA-J AM MED ASSOC, V257, P353, DOI 10.1001/jama.257.3.353; MANSON JE, 1995, NEW ENGL J MED, V333, P677, DOI 10.1056/NEJM199509143331101; MUELLER WH, 1982, SOC SCI MED, V16, P191, DOI 10.1016/0277-9536(82)90022-3; MUST A, 1992, NEW ENGL J MED, V327, P1350, DOI 10.1056/NEJM199211053271904; Must A, 1999, INT J OBESITY, V23, pS2, DOI 10.1038/sj.ijo.0800852; NIETO FJ, 1992, AM J EPIDEMIOL, V136, P201, DOI 10.1093/oxfordjournals.aje.a116486; Ogden CL, 2002, JAMA-J AM MED ASSOC, V288, P1728, DOI 10.1001/jama.288.14.1728; Popkin BM, 2004, INT J OBESITY, V28, pS2, DOI [10.1038/sj.ijo.0802804, 10.1038/sj.ijo.0802557]; RHOADS GG, 1983, LANCET, V1, P492; RICHEDWARDS JW, 1994, AM J EPIDEMIOL, V140, P1016, DOI 10.1093/oxfordjournals.aje.a117191; Rimm E B, 1990, Epidemiology, V1, P466, DOI 10.1097/00001648-199011000-00009; Rosengren A, 1999, EUR HEART J, V20, P269, DOI 10.1053/euhj.1998.1235; Seidell JC, 1999, MED SCI SPORT EXER, V31, pS597, DOI 10.1097/00005768-199911001-00018; SONNEHOLM S, 1983, BRIT MED J, V287, P795, DOI 10.1136/bmj.287.6395.795; TROY LM, 1995, INT J OBESITY, V19, P570; WILLETT WC, 1995, JAMA-J AM MED ASSOC, V273, P461, DOI 10.1001/jama.273.6.461; Willett WC, 1999, NEW ENGL J MED, V341, P427, DOI 10.1056/NEJM199908053410607; WOLF AM, 1994, INT J EPIDEMIOL, V23, P991, DOI 10.1093/ije/23.5.991; World Health Organization, 1997, WHONUTNCD981; Yarnell JWG, 2000, J EPIDEMIOL COMMUN H, V54, P344, DOI 10.1136/jech.54.5.344	36	131	139	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 18	2006	145	2					91	97		10.7326/0003-4819-145-2-200607180-00006	http://dx.doi.org/10.7326/0003-4819-145-2-200607180-00006			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	063WU	16847291				2022-12-28	WOS:000239051400002
J	Chin, RFM; Neville, BGR; Peckham, C; Bedford, H; Wade, A; Scott, RC				Chin, Richard F. M.; Neville, Brian G. R.; Peckham, Catherine; Bedford, Helen; Wade, Angela; Scott, Rod C.		NLSTEPSS Collaborative Grp	Incidence, cause, and short-term outcome of convulsive status epilepticus in childhood: prospective population-based study	LANCET			English	Article							MORTALITY; EPIDEMIOLOGY; CHILDREN; MANAGEMENT; MINNESOTA; ROCHESTER; EPISODE	Background Convulsive status epilepticus is the most common childhood medical neurological emergency, and is associated with significant morbidity and mortality. Most data for this disorder are from mainly adult populations and might not be relevant to childhood. Thus we undertook the North London Status Epilepticus in Childhood Surveillance Study (NLSTEPSS): a prospective, population-based study of convulsive status epilepticus in childhood, to obtain a uniquely paediatric perspective. Methods Clinical and demographic data for episodes of childhood convulsive status epilepticus that took place in north London were obtained through a clinical network that covered the target population. We obtained these data from anonymised copies of a standardised admission proforma; accident and emergency, nursing, ambulance, and intensive-care unit notes; and interviews with parents, medical, nursing, and paramedic staff. We investigated ascertainment using capture-recapture modelling. Findings Of 226 children enrolled, 176 had a first ever episode of convulsive status epilepticus. We estimated that ascertainment was between 62% and 84%. The ascertainment-adjusted incidence was between 17 and 23 episodes per 100000 per year. 98 (56%, 95% CI 48-63) children were neurologically healthy before their first ever episode and 56 (57%, 47-66) of those children had a prolonged febrile seizure. 11 (12%, 6-18) of children with first ever febrile convulsive status epilepticus had acute bacterial meningitis. Conservative estimation of 1-year recurrence of convulsive status epilepticus was 16% (10-24%). Case fatality was 3% (2-7%). Interpretation Convulsive status epilepticus in childhood is more common, has a different range of causes, and a lower risk of death than that in adults. These paediatric data will help inform management of convulsive status epilepticus and appropriate allocation of resources to reduce the effects of this disorder in childhood.	UCL, Inst Child Hlth, Neurosci Unit, London, England; Great Ormond St Hosp Sick Children, London WC1N 3JH, England; UCL, Inst Child Hlth, Ctr Paediat Epidemiol & Biostat, London, England; UCL, Inst Child Hlth, Radiol & Phys Unit, London, England	University of London; University College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of London; University College London; University of London; University College London	Chin, RFM (corresponding author), Wolfson Ctr Magnet Technol, Mecklenburgh Sq, London WC1N 2AP, England.	r.chin@ich.ucl.ac.uk	Scott, Rod/C-5363-2008; peckham, catherine s/I-6300-2013	Chin, Richard/0000-0002-7256-3027; Scott, Rod/0000-0002-8944-928X	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		AICARDI J, 1970, EPILEPSIA, V11, P187, DOI 10.1111/j.1528-1157.1970.tb03880.x; [Anonymous], 1993, EPILEPSIA, V34, P592; Cascino GD, 1998, EPILEPSIA, V39, P829, DOI 10.1111/j.1528-1157.1998.tb01176.x; Chang JW, 2001, ACTA NEUROCHIR, V143, P297, DOI 10.1007/s007010170110; Chao A, 2001, STAT MED, V20, P3123, DOI 10.1002/sim.996.abs; Chin RFM, 2004, EUR J NEUROL, V11, P800, DOI 10.1111/j.1468-1331.2004.00943.x; Chin RFM, 2005, ARCH DIS CHILD, V90, P66, DOI 10.1136/adc.2003.038844; Chin RFM, 2004, J NEUROL NEUROSUR PS, V75, P1584, DOI 10.1136/jnnp.2003.032797; Coeytaux A, 2000, NEUROLOGY, V55, P693, DOI 10.1212/WNL.55.5.693; DELORENZO RJ, 1995, J CLIN NEUROPHYSIOL, V12, P316; DeLorenzo RJ, 1996, NEUROLOGY, V46, P1029, DOI 10.1212/WNL.46.4.1029; Drislane FW, 2000, EPILEPSY BEHAV, V1, P301, DOI 10.1006/ebeh.2000.0100; Garzon E, 2003, SEIZURE-EUR J EPILEP, V12, P337, DOI 10.1016/S1059-1311(02)00324-2; Hesdorffer DC, 1998, NEUROLOGY, V50, P735, DOI 10.1212/WNL.50.3.735; Holmes GL, 1997, EPILEPSIA, V38, P12, DOI 10.1111/j.1528-1157.1997.tb01074.x; Hook EB, 1995, EPIDEMIOL REV, V17, P243, DOI 10.1093/oxfordjournals.epirev.a036192; Knake S, 2001, EPILEPSIA, V42, P714, DOI 10.1046/j.1528-1157.2001.01101.x; LEPPIK IE, 1985, CLIN THER, V7, P272; Leung Alexander K C, 2005, J Natl Med Assoc, V97, P1708; Logroscino G, 2002, NEUROLOGY, V58, P537, DOI 10.1212/WNL.58.4.537; Logroscino G, 1997, EPILEPSIA, V38, P1344, DOI 10.1111/j.1528-1157.1997.tb00073.x; NELSON KB, 1978, PEDIATRICS, V61, P720; Offringa M, 2001, BRIT MED J, V323, P1111, DOI 10.1136/bmj.323.7321.1111; ROSENBLOOM AL, 1994, PEDIATR ANN, V23, P284, DOI 10.3928/0090-4481-19940601-06; Simondon F, 1999, INT J EPIDEMIOL, V28, P113, DOI 10.1093/ije/28.1.113; Treiman DM, 1996, BAILLIERE CLIN NEUR, V5, P821; TREVATHAN E, 2002, EPILEPSIA S, V43, P75; *UK OFF NAT STAT, 2004, CENS 2001 STAND TABL; Wu YW, 2002, NEUROLOGY, V58, P1070, DOI 10.1212/WNL.58.7.1070; YAGER JY, 1988, CAN J NEUROL SCI, V15, P402, DOI 10.1017/S0317167100028134	30	376	386	0	11	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 15	2006	368	9531					222	229		10.1016/S0140-6736(06)69043-0	http://dx.doi.org/10.1016/S0140-6736(06)69043-0			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	064MY	16844492				2022-12-28	WOS:000239095000034
J	Kates, J; Morrison, JS; Lief, E				Kates, Jennifer; Morrison, J. Stephen; Lief, Eric			Global health funding: a glass half full?	LANCET			English	Editorial Material									Kaiser Family Fdn, Washington, DC 20005 USA; Ctr Strateg & Int Studies, Washington, DC 20006 USA	Centre for Strategic & International Studies	Kates, J (corresponding author), Kaiser Family Fdn, Washington, DC 20005 USA.	jkates@kff.org						KATES J, 2005, FINANCING RESPONSE H; MacKellar L, 2005, POPUL DEV REV, V31, P293, DOI 10.1111/j.1728-4457.2005.00066.x; *OECD, 2000, REC TRENDS OFF DEV A; *OECD, 2003, POV HLTH DAC GUID RE; *OECD CRS, 2006, DAT ONL QUER FEB APR; Owen JW, 2005, GLOBALIZATION HEALTH, V1, DOI 10.1186/1744-8603-1-12; *UNAIDS, 2005, RES NEEDS EXP RESP A; VONSCHIMDING Y, 2005, GLOBAL HLTH, V1; WHO Commission on Macroeconomics and Health, 2001, MACR HLTH INV HLTH E; World Health Organization (WHO), 2006, WORLD HLTH REP 2006	10	15	15	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 15	2006	368	9531					187	188		10.1016/S0140-6736(06)69018-1	http://dx.doi.org/10.1016/S0140-6736(06)69018-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	064MY	16844473				2022-12-28	WOS:000239095000010
J	Portincasa, P; Moschetta, A; Palasciano, G				Portincasa, Piero; Moschetta, Antonio; Palasciano, Giuseppe			Cholesterol gallstone disease	LANCET			English	Review							GALLBLADDER MOTOR FUNCTION; TERT-BUTYL ETHER; SALT EXPORT PUMP; BILE-ACIDS; DEOXYCHOLIC-ACID; NUCLEAR RECEPTOR; BILIARY LIPIDS; CRYSTALLIZATION PATHWAYS; CHOLECYSTOKININ RELEASE; GENETIC EPIDEMIOLOGY	With a prevalence of 10-15% in adults in Europe and the USA, gallstones are the most common digestive disease needing admission to hospital in the West. The interplay between interprandial and postprandial physiological responses to endogenous and dietary lipids underscores the importance of coordinated hepatobiliary and gastrointestinal functions to prevent crystallisation and precipitation of excess biliary cholesterol. Indeed, identifying the metabolic and transcriptional pathways that drive the regulation of biliary lipid secretion has been a major achievement in the field. We highlight scientific advances in protein and gene regulation of cholesterol absorption, synthesis, and catabolism, and biliary lipid secretion with respect to the pathogenesis of cholesterol gallstone disease. We discuss the physical-chemical mechanisms of gallstone formation in bile and the active role of the gallbladder and the intestine. We also discuss gaps in our knowledge of the pathogenesis of gallstone formation and the potential for gene targeting in therapy.	Univ Med Sch, Dept Internal & Publ Hlth, Clin Med Augusto Murri, I-70124 Bari, Italy		Portincasa, P (corresponding author), Univ Med Sch, Dept Internal & Publ Hlth, Clin Med Augusto Murri, I-70124 Bari, Italy.	p.portincasa@semeiotica.uniba.it	Moschetta, Antonio/AAC-5295-2022; Moschetta, Antonio/K-6211-2016	Palasciano, Giuseppe/0000-0002-0396-488X; Moschetta, Antonio/0000-0003-2123-6074; portincasa, piero/0000-0001-5359-1471				ADMIRAND WH, 1968, J CLIN INVEST, V47, P1043, DOI 10.1172/JCI105794; ALLEN MJ, 1985, NEW ENGL J MED, V312, P217, DOI 10.1056/NEJM198501243120406; AMARAL JF, 1985, AM J SURG, V149, P551, DOI 10.1016/S0002-9610(85)80055-6; Ananthanarayanan M, 2001, J BIOL CHEM, V276, P28857, DOI 10.1074/jbc.M011610200; ANDERSEN E, 1979, J LIPID RES, V20, P1020; ANGELICO M, 1988, HEPATOLOGY, V8, P907; [Anonymous], 2002, NIH Consens State Sci Statements, V19, P1; Apstein MD, 1996, EUR J CLIN INVEST, V26, P343, DOI 10.1046/j.1365-2362.1996.148287.x; ASHUR H, 1978, ARCH SURG-CHICAGO, V113, P594; Attili AF, 1997, HEPATOLOGY, V26, P809, DOI 10.1002/hep.510260401; Attili AF, 1998, HEPATOLOGY, V27, P1492, DOI 10.1002/hep.510270605; BARBARA L, 1995, AM J EPIDEMIOL, V141, P158, DOI 10.1093/oxfordjournals.aje.a117403; BENNION LJ, 1978, NEW ENGL J MED, V299, P1221, DOI 10.1056/NEJM197811302992205; Berr F, 1996, GASTROENTEROLOGY, V111, P1611, DOI 10.1016/S0016-5085(96)70024-0; Brink MA, 1999, GASTROENTEROLOGY, V116, P1420, DOI 10.1016/S0016-5085(99)70507-X; BRISGOIUS JH, 1589, ANDER THEIL BUCHER S, P246; CAREY MC, 1978, J LIPID RES, V19, P945; Caroli-bosc FX, 1998, DIGEST DIS SCI, V43, P2131, DOI 10.1023/A:1018879819301; CRAVEN BM, 1976, NATURE, V260, P727, DOI 10.1038/260727a0; Crawford AR, 1997, J CLIN INVEST, V100, P2562, DOI 10.1172/JCI119799; Cuevas A, 2004, J AM COLL NUTR, V23, P187, DOI 10.1080/07315724.2004.10719360; DABNEY WC, 1876, AM J MED SCI, V71, P410; DANZINGER RG, 1972, NEW ENGL J MED, V286, P1, DOI 10.1056/NEJM197201062860101; DENBESTEN L, 1973, SURGERY, V73, P266; DIEHL AK, 1990, AM J MED, V89, P29, DOI 10.1016/0002-9343(90)90094-T; DIEHL AK, 1991, GASTROENTEROL CLIN N, V20, P1; DIMAGNO EP, 1979, DIGEST DIS SCI, V24, P689, DOI 10.1007/BF01314466; Eckel RH, 2005, LANCET, V365, P1415, DOI 10.1016/S0140-6736(05)66378-7; Everhart JE, 1999, GASTROENTEROLOGY, V117, P632, DOI 10.1016/S0016-5085(99)70456-7; Everhart JE, 2002, HEPATOLOGY, V35, P1507, DOI 10.1053/jhep.2002.33336; EVERSON GT, 1980, GASTROENTEROLOGY, V79, P40; Fox JG, 1998, GASTROENTEROLOGY, V114, P755, DOI 10.1016/S0016-5085(98)70589-X; FRIEDMAN GD, 1993, AM J SURG, V165, P399, DOI 10.1016/S0002-9610(05)80930-4; Gebhard RL, 1996, HEPATOLOGY, V24, P544, DOI 10.1002/hep.510240313; Gerloff T, 1998, J BIOL CHEM, V273, P10046, DOI 10.1074/jbc.273.16.10046; GIBNEY EJ, 1990, BRIT J SURG, V77, P368, DOI 10.1002/bjs.1800770405; GILAT T, 1983, GASTROENTEROLOGY, V84, P242; Goldacre MJ, 2005, BRIT J CANCER, V92, P1307, DOI 10.1038/sj.bjc.6602392; Gordon-Taylor G, 1937, BRIT J SURG, V25, P241, DOI 10.1002/bjs.1800259802; Grundy SM, 2004, AM J CLIN NUTR, V80, P1; HEATON KW, 1991, GUT, V32, P316, DOI 10.1136/gut.32.3.316; HEATON KW, 1993, LANCET, V341, P8, DOI 10.1016/0140-6736(93)92479-D; Hellstern A, 1998, DIGEST DIS SCI, V43, P911, DOI 10.1023/A:1018811409538; Hillebrandt S, 2003, EUR J CLIN INVEST, V33, P155, DOI 10.1046/j.1365-2362.2003.01089.x; HOFMANN AF, 1993, NEW ENGL J MED, V328, P1854; Hofmann AF, 1999, ARCH INTERN MED, V159, P2647, DOI 10.1001/archinte.159.22.2647; HOLZBACH RT, 1973, J CLIN INVEST, V52, P1467, DOI 10.1172/JCI107321; HONDA A, 1993, GASTROENTEROL JPN, V28, P406; Huang L, 2003, J BIOL CHEM, V278, P51085, DOI 10.1074/jbc.M308321200; Janowski BA, 1996, NATURE, V383, P728, DOI 10.1038/383728a0; Jirsa M, 2001, FRONT BIOSCI-LANDMRK, V6, pE154, DOI 10.2741/Jirsa; JOHNSTON DE, 1993, NEW ENGL J MED, V328, P412, DOI 10.1056/NEJM199302113280608; Kalimi R, 2001, J AM COLL SURGEONS, V193, P609, DOI 10.1016/S1072-7515(01)01092-4; KALSER SC, 1993, AM J SURG, V165, P390; KHANUJA B, 1995, P NATL ACAD SCI USA, V92, P7729, DOI 10.1073/pnas.92.17.7729; Ko CW, 1999, ANN INTERN MED, V130, P301, DOI 10.7326/0003-4819-130-4-199902160-00016; Konikoff FM, 2000, HEPATOLOGY, V31, P261, DOI 10.1002/hep.510310202; KONIKOFF FM, 1992, J CLIN INVEST, V90, P1155, DOI 10.1172/JCI115935; Lammert F, 2005, NAT CLIN PRACT GASTR, V2, P423, DOI 10.1038/ncpgasthep0257; Lammert Frank, 2005, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V5, P163, DOI 10.2174/1568008054064841; Lamont J T, 1992, Prog Liver Dis, V10, P165; Langenbuch, 1882, BERL KLIN WOCHENSCHR, V19, P725; LEE DWT, 1985, AM J CLIN NUTR, V42, P414, DOI 10.1093/ajcn/42.3.414; LEE SP, 1992, NEW ENGL J MED, V326, P589, DOI 10.1056/NEJM199202273260902; LEOPOLD GR, 1976, RADIOLOGY, V121, P445, DOI 10.1148/121.2.445; LIDDLE RA, 1989, ARCH INTERN MED, V149, P1750, DOI 10.1001/archinte.149.8.1750; LOWENFELS AB, 1985, JNCI-J NATL CANCER I, V75, P77; LOWENFELS AB, 1989, INT J EPIDEMIOL, V18, P50, DOI 10.1093/ije/18.1.50; MACLURE KM, 1989, NEW ENGL J MED, V321, P563, DOI 10.1056/NEJM198908313210902; MAKINO I, 1975, JPN J GASTROENTEROL, V72, P690; Makishima M, 1999, SCIENCE, V284, P1362, DOI 10.1126/science.284.5418.1362; Maurer KJ, 2006, AM J PHYSIOL-GASTR L, V290, pG175, DOI 10.1152/ajpgi.00272.2005; Maurer KJ, 2005, GASTROENTEROLOGY, V128, P1023, DOI 10.1053/j.gastro.2005.01.008; Miquel JF, 1998, GASTROENTEROLOGY, V115, P937, DOI 10.1016/S0016-5085(98)70266-5; Moschetta A, 2004, NAT MED, V10, P1352, DOI 10.1038/nm1138; Moschetta A, 2001, J LIPID RES, V42, P1273; Moschetta A, 2001, ALIMENT PHARM THERAP, V15, P181, DOI 10.1046/j.1365-2036.2001.00924.x; Mouret P, 1990, Chirurgie, V116, P829; NERVI F, 1989, GASTROENTEROLOGY, V96, P825; Paigen B, 2000, PHYSIOL GENOMICS, V4, P59, DOI 10.1152/physiolgenomics.2000.4.1.59; PALASCIANO G, 1989, AM J GASTROENTEROL, V84, P1378; Parks DJ, 1999, SCIENCE, V284, P1365, DOI 10.1126/science.284.5418.1365; Pauletzki J, 1996, GASTROENTEROLOGY, V111, P765, DOI 10.1053/gast.1996.v111.pm8780583; PAUMGARTNER G, 1994, SCAND J GASTROENTERO, V29, P27, DOI 10.3109/00365529409103622; Paumgartner G, 2005, EUR J GASTROEN HEPAT, V17, P525, DOI 10.1097/00042737-200505000-00009; Pereira SP, 2003, ALIMENT PHARM THER, V17, P923, DOI 10.1046/j.1365-2036.2003.01529.x; POKORNY WJ, 1984, AM J SURG, V148, P742, DOI 10.1016/0002-9610(84)90428-8; Portincasa P, 1996, HEPATOLOGY, V24, P580, DOI 10.1053/jhep.1996.v24.pm0008781328; Portincasa P, 2003, DIGEST LIVER DIS, V35, pS56, DOI 10.1016/S1590-8658(03)00096-3; Portincasa P, 2003, J HEPATOL, V39, P864, DOI 10.1016/S0168-8278(03)00294-0; PORTINCASA P, 1994, J HEPATOL, V21, P430, DOI 10.1016/S0168-8278(05)80324-1; Portincasa P, 1996, HEPATOLOGY, V23, P738, DOI 10.1002/hep.510230414; Portincasa Piero, 2004, Curr Gastroenterol Rep, V6, P151, DOI 10.1007/s11894-004-0043-0; Randi G, 2006, INT J CANCER, V118, P1591, DOI 10.1002/ijc.21683; Repa JJ, 2002, J BIOL CHEM, V277, P18793, DOI 10.1074/jbc.M109927200; Rewbridge AG, 1937, SURGERY, V1, P395; ROS E, 1991, GASTROENTEROLOGY, V101, P1701, DOI 10.1016/0016-5085(91)90410-M; Rosmorduc O, 2003, GASTROENTEROLOGY, V125, P452, DOI 10.1016/S0016-5085(03)00898-9; Rosmorduc O, 2001, GASTROENTEROLOGY, V120, P1459, DOI 10.1053/gast.2001.23947; RUSSELL DW, 1992, BIOCHEMISTRY-US, V31, P4737, DOI 10.1021/bi00135a001; Russo MW, 2004, GASTROENTEROLOGY, V126, P1448, DOI 10.1053/j.gastro.2004.01.025; SACKMANN M, 1994, GASTROENTEROLOGY, V106, P225, DOI 10.1016/S0016-5085(94)95581-6; SAMPLINER RE, 1970, NEW ENGL J MED, V283, P1358, DOI 10.1056/NEJM197012172832502; Sandler RS, 2002, GASTROENTEROLOGY, V122, P1500, DOI 10.1053/gast.2002.32978; SARIN SK, 1995, HEPATOLOGY, V22, P138; SAUERBRUCH T, 1986, NEW ENGL J MED, V314, P818, DOI 10.1056/NEJM198603273141304; SCHIFF M, 1873, IMPARZIALE, V13, P97; SCRAGG RKR, 1984, BRIT MED J, V288, P1113, DOI 10.1136/bmj.288.6424.1113; Shaffer Eldon A, 2005, Curr Gastroenterol Rep, V7, P132; SHEHADI WH, 1979, INT SURG, V64, P63; Sherlock S, 2002, DIS LIVER BILIARY SY; SHIEH HS, 1977, NATURE, V267, P287, DOI 10.1038/267287a0; SHODA J, 1995, HEPATOLOGY, V21, P1291, DOI 10.1016/0270-9139(95)90050-0; SITZMANN JV, 1990, SURG GYNECOL OBSTET, V170, P25; SIVAK MV, 1989, AM J SURG, V158, P228, DOI 10.1016/0002-9610(89)90256-0; SMIT JJM, 1993, CELL, V75, P451, DOI 10.1016/0092-8674(93)90380-9; Stolk MFJ, 2001, DIGEST DIS SCI, V46, P1328, DOI 10.1023/A:1010635901414; STOLK MFJ, 1993, AM J PHYSIOL, V264, pG596, DOI 10.1152/ajpgi.1993.264.4.G596; SUGERMAN HJ, 1995, AM J SURG, V169, P91, DOI 10.1016/S0002-9610(99)80115-9; TAIT N, 1995, BMJ-BRIT MED J, V311, P99, DOI 10.1136/bmj.311.6997.99; Thomas LA, 2005, GUT, V54, P630, DOI 10.1136/gut.2003.028431; Thomas LA, 2000, GASTROENTEROLOGY, V119, P806, DOI 10.1053/gast.2000.16495; THUDICHUM JLW, 1983, TREATISE GALLSTONES; Tomida S, 1999, HEPATOLOGY, V30, P6, DOI 10.1002/hep.510300108; Tsai CJ, 2004, ANN INTERN MED, V141, P514, DOI 10.7326/0003-4819-141-7-200410050-00007; Tsunoda K, 2004, HEPATO-GASTROENTEROL, V51, P1271; Van Erpecum KJ, 1999, GUT, V44, P435, DOI 10.1136/gut.44.3.435; van Erpecum KJ, 2001, J HEPATOL, V35, P444, DOI 10.1016/S0168-8278(01)00173-8; Van Erpecum KJ, 2000, ALIMENT PHARM THERAP, V14, P66, DOI 10.1046/j.1365-2036.2000.014s2066.x; VANERPECUM KJ, 1992, J HEPATOL, V14, P194, DOI 10.1016/0168-8278(92)90158-L; Venneman NG, 2005, HEPATOLOGY, V41, P738, DOI 10.1002/hep.20616; Venneman NG, 2006, HEPATOLOGY, V43, P1276, DOI 10.1002/hep.21182; VILLANOVA N, 1989, GASTROENTEROLOGY, V97, P726, DOI 10.1016/0016-5085(89)90644-6; Wang David Q-H, 2004, Curr Gastroenterol Rep, V6, P140, DOI 10.1007/s11894-004-0042-1; Wang DQH, 1996, J LIPID RES, V37, P606; Wang DQH, 2005, BBA-MOL CELL BIOL L, V1733, P90, DOI 10.1016/j.bbalip.2004.12.005; Wang DQH, 2004, J CLIN INVEST, V114, P521, DOI 10.1172/JCI200416801; Wang DQH, 1996, J LIPID RES, V37, P2539; Wang HB, 1999, MOL CELL, V3, P543, DOI 10.1016/S1097-2765(00)80348-2; Wang HH, 2004, GASTROENTEROLOGY, V126, pA15; Xiao ZL, 2005, AM J PHYSIOL-GASTR L, V288, pG525, DOI 10.1152/ajpgi.00261.2004; Yu LQ, 2002, P NATL ACAD SCI USA, V99, P16237, DOI 10.1073/pnas.252582399; Zhang Z, 2001, J LIPID RES, V42, P649	143	421	445	2	54	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 15	2006	368	9531					230	239		10.1016/S0140-6736(06)69044-2	http://dx.doi.org/10.1016/S0140-6736(06)69044-2			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	064MY	16844493				2022-12-28	WOS:000239095000035
J	Nomura, K; DebRoy, S; Lee, YH; Pumplin, N; Jones, J; He, SY				Nomura, Kinya; DebRoy, Sruti; Lee, Yong Hoon; Pumplin, Nathan; Jones, Jonathan; He, Sheng Yang			A bacterial virulence protein suppresses host innate immunity to cause plant disease	SCIENCE			English	Article							III SECRETION SYSTEM; EFFECTOR PROTEINS; CELL-WALL; ARABIDOPSIS; RESISTANCE; PATHOGENS; DEFENSE; MECHANISM; PATHWAY; RIN4	Plants have evolved a powerful immune system to defend against infection by most microbial organisms. However, successful pathogens, such as Pseudomonas syringae, have developed countermeasures and inject virulence proteins into the host plant cell to suppress immunity and cause devastating diseases. Despite intensive research efforts, the molecular targets of bacterial virulence proteins that are important for plant disease development have remained obscure. Here, we show that a conserved P. syringae virulence protein, HopM1, targets an immunity-associated protein, AtMIN7, in Arabidopsis thaliana. HopM1 mediates the destruction of AtMIN7 via the host proteasome. Our results illustrate a strategy by which a bacterial pathogen exploits the host proteasome to subvert host immunity and causes infection in plants.	Michigan State Univ, Dept Plant Biol, Dept Energy, Plant Res Lab, E Lansing, MI 48824 USA; John Innes Ctr Plant Sci Res, Sainsbury Lab, Norwich NR4 7UH, Norfolk, England	Michigan State University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center	He, SY (corresponding author), Michigan State Univ, Dept Plant Biol, Dept Energy, Plant Res Lab, E Lansing, MI 48824 USA.	hes@msu.edu	Lee, Yong Hoon/S-8079-2016; Pumplin, Nathan/F-5539-2016; Jones, Jonathan DG/J-5129-2012	Lee, Yong Hoon/0000-0001-9921-3871; Pumplin, Nathan/0000-0003-4492-5358; Jones, Jonathan DG/0000-0002-4953-261X; He, Sheng Yang/0000-0003-1308-498X				Abramovitch RB, 2004, CURR OPIN PLANT BIOL, V7, P356, DOI 10.1016/j.pbi.2004.05.002; Alfano JR, 2000, P NATL ACAD SCI USA, V97, P4856, DOI 10.1073/pnas.97.9.4856; Alfano JR, 2004, ANNU REV PHYTOPATHOL, V42, P385, DOI 10.1146/annurev.phyto.42.040103.110731; Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Axtell MJ, 2003, CELL, V112, P369, DOI 10.1016/S0092-8674(03)00036-9; Badel JL, 2003, MOL MICROBIOL, V49, P1239, DOI 10.1046/j.1365-2958.2003.03647.x; BESTWICK CS, 1995, PLANT PHYSIOL, V108, P503, DOI 10.1104/pp.108.2.503; Buttner D, 2002, EMBO J, V21, P5313, DOI 10.1093/emboj/cdf536; Chisholm ST, 2006, CELL, V124, P803, DOI 10.1016/j.cell.2006.02.008; Collins NC, 2003, NATURE, V425, P973, DOI 10.1038/nature02076; Cossart P, 2004, SCIENCE, V304, P242, DOI 10.1126/science.1090124; DebRoy S, 2004, P NATL ACAD SCI USA, V101, P9927, DOI 10.1073/pnas.0401601101; He SY, 2004, BBA-MOL CELL RES, V1694, P181, DOI 10.1016/j.bbamcr.2004.03.011; Janjusevic R, 2006, SCIENCE, V311, P222, DOI 10.1126/science.1120131; Kim MG, 2005, CELL, V121, P749, DOI 10.1016/j.cell.2005.03.025; Knodler LA, 2005, MOL BIOL CELL, V16, P4108, DOI 10.1091/mbc.e05-04-0367; Mackey D, 2002, CELL, V108, P743, DOI 10.1016/S0092-8674(02)00661-X; Mossessova E, 2003, MOL CELL, V12, P1403, DOI 10.1016/S1097-2765(03)00475-1; Mudgett MB, 2005, ANNU REV PLANT BIOL, V56, P509, DOI 10.1146/annurev.arplant.56.032604.144218; Nomura K, 2005, CURR OPIN PLANT BIOL, V8, P361, DOI 10.1016/j.pbi.2005.05.005; SANDERFOOT AA, 2002, ARABIDOPSIS BOOK; Shpak ED, 2003, PLANT CELL, V15, P1095, DOI 10.1105/tpc.010413; Steinmann T, 1999, SCIENCE, V286, P316, DOI 10.1126/science.286.5438.316; Wang D, 2005, SCIENCE, V308, P1036, DOI 10.1126/science.1108791; Wang XL, 2005, DEV CELL, V8, P855, DOI 10.1016/j.devcel.2005.05.001; Yuan J, 1996, J BACTERIOL, V178, P6399, DOI 10.1128/jb.178.21.6399-6402.1996	26	368	380	5	81	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 14	2006	313	5784					220	223		10.1126/science.1129523	http://dx.doi.org/10.1126/science.1129523			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	063GZ	16840699				2022-12-28	WOS:000239008000043
J	Antonarakis, ES				Antonarakis, ES			Acquired leukonychia totalis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Johns Hopkins Bayview Med Ctr, Baltimore, MD 21224 USA	Johns Hopkins University; Johns Hopkins Medicine	Antonarakis, ES (corresponding author), Johns Hopkins Bayview Med Ctr, Baltimore, MD 21224 USA.		Antonarakis, Emmanuel S./E-4550-2011	Antonarakis, Emmanuel Stylianos/0000-0003-3531-3851; Antonarakis, Emmanuel S./0000-0003-0031-9655					0	11	11	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 13	2006	355	2					E2	E2		10.1056/NEJMicm050758	http://dx.doi.org/10.1056/NEJMicm050758			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	062UP	16837673				2022-12-28	WOS:000238970600011
J	Barrett-Connor, E; Mosca, L; Collins, P; Geiger, MJ; Grady, D; Kornitzer, M; McNabb, MA; Wenger, NK				Barrett-Connor, Elizabeth; Mosca, Lori; Collins, Peter; Geiger, Mary Jane; Grady, Deborah; Kornitzer, Marcel; McNabb, Michelle A.; Wenger, Nanette K.		RUTH Trial Investigators	Effects of raloxifene on cardiovascular events and breast cancer in postmenopausal women	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ESTROGEN-REPLACEMENT THERAPY; VERTEBRAL FRACTURE RISK; CORONARY-HEART-DISEASE; MULTIPLE OUTCOMES; RANDOMIZED-TRIAL; TAMOXIFEN; REDUCTION; STROKE; OSTEOPOROSIS; PREVENTION	BACKGROUND: The effect of raloxifene, a selective estrogen-receptor modulator, on coronary heart disease (CHD) and breast cancer is not established. METHODS: We randomly assigned 10,101 postmenopausal women (mean age, 67.5 years) with CHD or multiple risk factors for CHD to 60 mg of raloxifene daily or placebo and followed them for a median of 5.6 years. The two primary outcomes were coronary events (i.e., death from coronary causes, myocardial infarction, or hospitalization for an acute coronary syndrome) and invasive breast cancer.) RESULTS: As compared with placebo, raloxifene had no significant effect on the risk of primary coronary events (533 vs. 553 events; hazard ratio, 0.95; 95 percent confidence interval, 0.84 to 1.07), and it reduced the risk of invasive breast cancer (40 vs. 70 events; hazard ratio, 0.56; 95 percent confidence interval, 0.38 to 0.83; absolute risk reduction, 1.2 invasive breast cancers per 1000 women treated for one year); the benefit was primarily due to a reduced risk of estrogen-receptor-positive invasive breast cancers. There was no significant difference in the rates of death from any cause or total stroke according to group assignment, but raloxifene was associated with an increased risk of fatal stroke (59 vs. 39 events; hazard ratio, 1.49; 95 percent confidence interval, 1.00 to 2.24; absolute risk increase, 0.7 per 1000 woman-years) and venous thromboembolism (103 vs. 71 events; hazard ratio, 1.44; 95 percent confidence interval, 1.06 to 1.95; absolute risk increase, 1.2 per 1000 woman-years). Raloxifene reduced the risk of clinical vertebral fractures (64 vs. 97 events; hazard ratio, 0.65; 95 percent confidence interval, 0.47 to 0.89; absolute risk reduction, 1.3 per 1000). CONCLUSIONS: Raloxifene did not significantly affect the risk of CHD. The benefits of raloxifene in reducing the risks of invasive breast cancer and vertebral fracture should be weighed against the increased risks of venous thromboembolism and fatal stroke.	Univ Calif San Diego, Dept Family & Prevent Med, La Jolla, CA 92093 USA; Columbia Univ Coll Phys & Surg, Dept Med, New York, NY 10032 USA; Royal Brompton Hosp, Dept Cardiac Med, London, England; Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London SW7 2AZ, England; Lilly Res Labs, Indianapolis, IN USA; Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Med, San Francisco, CA USA; San Francisco VA Med Ctr, San Francisco, CA USA; Free Univ Brussels, Sch Publ Hlth, Dept Epidemiol & Hlth Promot, Brussels, Belgium; Emory Univ, Sch Med, Atlanta, GA USA	University of California System; University of California San Diego; Columbia University; Royal Brompton Hospital; Imperial College London; Eli Lilly; University of California System; University of California San Francisco; University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center; Universite Libre de Bruxelles; Vrije Universiteit Brussel; Emory University	Barrett-Connor, E (corresponding author), Univ Calif San Diego, Dept Family & Prevent Med, 9500 Gilman Dr, La Jolla, CA 92093 USA.	ebarrettconnor@ucsd.edu	Blas, Juan Ramón Rey/AAB-4064-2021; Arnold, Malcolm/G-2869-2011; Boehm, Bernhard Otto/F-8750-2015	Blas, Juan Ramón Rey/0000-0002-4749-7451; 				Anderson GL, 2004, JAMA-J AM MED ASSOC, V291, P1701, DOI 10.1001/jama.291.14.1701; Anzano MA, 1996, J NATL CANCER I, V88, P123, DOI 10.1093/jnci/88.2.123; Barrett-Connor E, 2002, JAMA-J AM MED ASSOC, V287, P847, DOI 10.1001/jama.287.7.847; Braithwaite RS, 2003, J AM GERIATR SOC, V51, P364, DOI 10.1046/j.1532-5415.2003.51110.x; Brzozowski AM, 1997, NATURE, V389, P753, DOI 10.1038/39645; Bushnell CD, 2004, NEUROLOGY, V63, P1230, DOI 10.1212/01.WNL.0000140491.54664.50; Cauley, 2001, BREAST CANCER RES TR, V67, P191; Cauley JA, 2001, BREAST CANCER RES TR, V65, P125, DOI 10.1023/A:1006478317173; Cirillo DJ, 2005, JAMA-J AM MED ASSOC, V293, P330, DOI 10.1001/jama.293.3.330; Costantino JP, 1999, J NATL CANCER I, V91, P1541, DOI 10.1093/jnci/91.18.1541; Delmas PD, 1997, NEW ENGL J MED, V337, P1641, DOI 10.1056/NEJM199712043372301; Delmas PD, 2002, J CLIN ENDOCR METAB, V87, P3609, DOI 10.1210/jc.87.8.3609; Dignam JJ, 2000, LANCET, V355, P848, DOI 10.1016/S0140-6736(05)72466-1; Ettinger B, 1999, JAMA-J AM MED ASSOC, V282, P2124; Ettinger B, 1999, JAMA-J AM MED ASSOC, V282, P637, DOI 10.1001/jama.282.7.637; Fisher B, 1998, J NATL CANCER I, V90, P1371, DOI 10.1093/jnci/90.18.1371; FUCHSYOUNG R, 1995, ANN NY ACAD SCI, V761, P355, DOI 10.1111/j.1749-6632.1995.tb31392.x; Geiger AM, 2004, JNCI-J NATL CANCER I, V96, P1528, DOI 10.1093/jnci/djh285; GRADY D, 1992, ANN INTERN MED, V117, P1016, DOI 10.7326/0003-4819-117-12-1016; Grady D, 2004, OBSTET GYNECOL, V104, P837, DOI 10.1097/01.AOG.0000137349.79204.b8; Hulley S, 1998, JAMA-J AM MED ASSOC, V280, P605, DOI 10.1001/jama.280.7.605; Martino S, 2004, J NATL CANCER I, V96, P1751, DOI 10.1093/jnci/djh319; Mosca L, 2001, AM J CARDIOL, V88, P392, DOI 10.1016/S0002-9149(01)01685-X; Pasternak RC, 2002, JAMA-J AM MED ASSOC, V288, P3042, DOI 10.1001/jama.288.23.3042; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; STAMPFER MJ, 1991, PREV MED, V20, P47, DOI 10.1016/0091-7435(91)90006-P; Viscoli CM, 2001, NEW ENGL J MED, V345, P1243, DOI 10.1056/NEJMoa010534; Vogel VG, 2006, JAMA-J AM MED ASSOC, V295, P2727, DOI 10.1001/jama.295.23.joc60074; Walsh BW, 1998, JAMA-J AM MED ASSOC, V279, P1445, DOI 10.1001/jama.279.18.1445; Walsh BW, 2000, J CLIN ENDOCR METAB, V85, P214, DOI 10.1210/jc.85.1.214; Wenger NK, 2002, AM J CARDIOL, V90, P1204, DOI 10.1016/S0002-9149(02)02835-7	31	747	778	1	22	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 13	2006	355	2					125	137		10.1056/NEJMoa062462	http://dx.doi.org/10.1056/NEJMoa062462			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	062UP	16837676				2022-12-28	WOS:000238970600004
J	Grimes, DS				Grimes, David S.			Are statins analogues of vitamin D?	LANCET			English	Article							CORONARY-HEART-DISEASE; COD-LIVER OIL; CANCER-MORTALITY; COLON-CANCER; LOWER RISK; PRAVASTATIN; CHOLESTEROL; METABOLITES; CONSUMPTION; PREVENTION	There are many reasons why the dietary-heart-cholesterol hypothesis should be questioned, and why statins might be acting in some other way to reduce the risk of coronary heart disease. Here, I propose that rather than being cholesterol-lowering drugs per se, statins act as vitamin D analogues, and explain why. This proposition is based on published observations that the unexpected and unexplained clinical benefits produced by statins have also been shown to be properties of vitamin D. It seems likely that statins activate vitamin D receptors.	Blackburn Royal Infirm, Blackburn BB6 8HE, Lancs, England		Grimes, DS (corresponding author), Blackburn Royal Infirm, Blackburn BB6 8HE, Lancs, England.	Susan.Rogers@elht.nhs.uk						Andjelkovic Z, 1999, CLIN EXP RHEUMATOL, V17, P453; Apperly FL, 1941, CANCER RES, V1, P191; BURR ML, 1989, LANCET, V2, P757; Coleman MP., 1999, CANC SURVIVAL TRENDS; Edwards CJ, 2000, LANCET, V355, P2218, DOI 10.1016/S0140-6736(00)02408-9; FORETTE B, 1989, LANCET, V1, P868; Freeman DJ, 2001, CIRCULATION, V103, P357; Gjonca A, 1997, LANCET, V350, P1815, DOI 10.1016/S0140-6736(97)08347-5; Grant WB, 2002, CANCER-AM CANCER SOC, V94, P1867, DOI 10.1002/cncr.10427; Grimes DS, 1996, QJM-INT J MED, V89, P579; HANCHETTE CL, 1992, CANCER, V70, P2861, DOI 10.1002/1097-0142(19921215)70:12<2861::AID-CNCR2820701224>3.0.CO;2-G; Hu FB, 2002, JAMA-J AM MED ASSOC, V287, P1815, DOI 10.1001/jama.287.14.1815; Hypponen E, 2001, LANCET, V358, P1500, DOI 10.1016/S0140-6736(01)06580-1; KANE KF, 1994, GUT, V35, pS2; KANNEL WB, 1979, ANN INTERN MED, V90, P85, DOI 10.7326/0003-4819-90-1-85; Katznelson S, 1996, TRANSPLANTATION, V61, P1469, DOI 10.1097/00007890-199605270-00010; KOBASHIGAWA JA, 1995, NEW ENGL J MED, V333, P621, DOI 10.1056/NEJM199509073331003; KROGER H, 1993, SCAND J RHEUMATOL, V22, P172; KROMHOUT D, 1985, NEW ENGL J MED, V312, P1205, DOI 10.1056/NEJM198505093121901; KURTZKE JF, 1975, ACTA NEUROL SCAND, V51, P137; Luscombe CJ, 2001, LANCET, V358, P641, DOI 10.1016/S0140-6736(01)05788-9; MATTHEWS DR, 1990, BRIT MED J, V300, P1012; McCarey DW, 2004, LANCET, V363, P2015, DOI 10.1016/S0140-6736(04)16449-0; MORRIS JN, 1977, BMJ-BRIT MED J, V2, P1307, DOI 10.1136/bmj.2.6098.1307; MORTIMER EA, 1977, NEW ENGL J MED, V296, P581, DOI 10.1056/NEJM197703172961101; Munger KL, 2004, NEUROLOGY, V62, P60, DOI 10.1212/01.WNL.0000101723.79681.38; Packard CJ, 1998, CIRCULATION, V97, P1440; PARKIN DM, 2002, SCI PUBLICATION, V155; PEDERSEN TR, 1994, LANCET, V344, P1383; POYTNER JN, 2005, NEW ENGL J MED, V352, P2184; RENAUD S, 1992, LANCET, V339, P1523, DOI 10.1016/0140-6736(92)91277-F; ROSE G, 1974, LANCET, V1, P181, DOI 10.1016/S0140-6736(74)92492-1; Schatz IJ, 2001, LANCET, V358, P351, DOI 10.1016/S0140-6736(01)05553-2; SHEPHERD J, 1995, NEW ENGL J MED, V333, P1301, DOI 10.1056/NEJM199511163332001; SILMAN AJ, 1991, COMMUNITY MED, V3, P291; Sparen P, 2004, BRIT MED J, V328, P11, DOI 10.1136/bmj.37942.603970.9A; Stene LC, 2000, DIABETOLOGIA, V43, P1093, DOI 10.1007/s001250051499; Stene LC, 2003, AM J CLIN NUTR, V78, P1128, DOI 10.1093/ajcn/78.6.1128; Strandberg TE, 2004, LANCET, V364, P771, DOI 10.1016/S0140-6736(04)16936-5; THOMAS MG, 1992, GUT, V33, P1660, DOI 10.1136/gut.33.12.1660; Vollmer T, 2004, LANCET, V363, P1607, DOI 10.1016/S0140-6736(04)16205-3; VOORS AW, 1979, J CHRON DIS, V32, P157, DOI 10.1016/0021-9681(79)90044-4; ZHOU W, 2005, VITAMIN D PREDICTS O	43	68	74	0	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 1	2006	368	9529					83	86		10.1016/S0140-6736(06)68971-X	http://dx.doi.org/10.1016/S0140-6736(06)68971-X			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	058TQ	16815382				2022-12-28	WOS:000238687900033
J	Jha, P; Peto, R; Zatonski, W; Boreham, J; Jarvis, MJ; Lopez, AD				Jha, Prabhat; Peto, Richard; Zatonski, Witold; Boreham, Jillian; Jarvis, Martin J.; Lopez, Alan D.			Social inequalities in male mortality, and in male mortality from smoking: indirect estimation from national death rates in England and Wales, Poland, and North America	LANCET			English	Article							LUNG-CANCER MORTALITY; UNITED-STATES; ATTRIBUTABLE MORTALITY; EUROPEAN POPULATIONS; HEALTH EXPECTANCY; DISEASE	Background There are substantial social inequalities in adult male mortality in many countries. Smoking is often more prevalent among men of lower social class, education, or income. The contribution of smoking to these social inequalities in mortality remains uncertain. Methods The contribution of smoking to adult mortality in a population can be estimated indirectly from disease-specific death rates in that population (using absolute lung cancer rates to indicate proportions due to smoking of mortality from certain other diseases). We applied these methods to 1996 death rates at ages 35-69 years in men in three different social strata in four countries, based on a total of 0.6 million deaths. The highest and lowest social strata were based on social class (professional vs unskilled manual) in England and Wales, neighbourhood income (top vs bottom quintile) in urban Canada, and completed years of education (more than vs less than 12 years) in the USA and Poland. Results In each country, there was about a two-fold difference between the highest and the lowest social strata in overall risks of dying among men aged 35-69 years (England and Wales 21% vs 43%, USA 20% vs 37%, Canada 21% vs 34%, Poland 26% vs 50%: four-country mean 22% vs 41%, four-country mean absolute difference 19%). More than half of this difference in mortality between the top and bottom social strata involved differences in risks of being killed at age 35-69 years by smoking (England and Wales 4% vs 19%, USA 4% vs 15%, Canada 6% vs 13%, Poland 5% vs 22%: four-country mean 5% vs 17%, four-country mean absolute difference 12%). Smoking-attributed mortality accounted for nearly half of total male mortality in the lowest social stratum of each country. Conclusion In these populations, most, but not all, of the substantial social inequalities in adult male mortality during the 1990s were due to the effects of smoking. Widespread cessation of smoking could eventually halve the absolute differences between these social strata in the risk of premature death.	Univ Toronto, St Michaels Hosp, Ctr Global Hlth Res, Toronto, ON M5C 1N8, Canada; Univ Oxford, Clin Trial Serv Unit, Oxford, England; Univ Oxford, Epidemiol Studies Unit, Oxford, England; Maria Sklodowska Curie Mem Canc Ctr, Warsaw, Poland; Inst Oncol, Warsaw, Poland; UCL, Dept Epidemiol & Publ Hlth, London, England; Univ Queensland, Sch Populat Hlth, Brisbane, Qld, Australia	University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Oxford; University of Oxford; Maria Sklodowska-Curie National Research Institute of Oncology; Maria Sklodowska-Curie National Research Institute of Oncology; University of London; University College London; University of Queensland	Jha, P (corresponding author), Univ Toronto, St Michaels Hosp, Ctr Global Hlth Res, Toronto, ON M5C 1N8, Canada.	prabhat.jha@utoronto.ca	Lopez, Alan D/F-1487-2010; Lopez, Alan/AAA-2734-2022; Jarvis, Martin J/B-1034-2008	Lopez, Alan D/0000-0001-5818-6512; Jarvis, Martin J/0000-0001-9238-8038	FOGARTY INTERNATIONAL CENTER [R01TW005991, R01TW005993] Funding Source: NIH RePORTER; FIC NIH HHS [R01 TW05993-02, R01 TW05991-01] Funding Source: Medline	FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))		Adler NE, 1999, ANN NY ACAD SCI, V896, P3, DOI 10.1111/j.1749-6632.1999.tb08101.x; Banks J, 2006, JAMA-J AM MED ASSOC, V295, P2037, DOI 10.1001/jama.295.17.2037; Bobak M, 2000, TOBACCO CONTROL DEV, VOxford University Press, P41; Bronnum-Hansen H, 2004, J EPIDEMIOL COMMUN H, V58, P604, DOI 10.1136/jech.2003.012955; Bronnum-Hansen H, 2001, TOB CONTROL, V10, P273, DOI 10.1136/tc.10.3.273; *CENTR STAT OFF, 1998, ROCZN STAT DEM; DOLL R, 1981, JNCI-J NATL CANCER I, V66, P1191, DOI 10.1093/jnci/66.6.1192; Ezzati M, 2004, TOB CONTROL, V13, P388, DOI 10.1136/tc.2003.005215; Hart CL, 2001, INT J EPIDEMIOL, V30, P268, DOI 10.1093/ije/30.2.268; Huisman M, 2005, LANCET, V365, P493, DOI 10.1016/S0140-6736(05)17867-2; Jarvis MJ, 2003, BMJ-BRIT MED J, V326, P1061, DOI 10.1136/bmj.326.7398.1061; Jarvis MJ., 2006, SOCIAL DETERMINANTS, P224; Jha P., 2000, TOBACCO CONTROL DEV; JHA P, 1996, DIS CONTROL PRIORITI, P869; Mackenbach JP, 2004, EUR J CANCER, V40, P126, DOI 10.1016/j.ejca.2003.10.018; Malarcher AM, 2000, AM J EPIDEMIOL, V152, P573, DOI 10.1093/aje/152.6.573; *OFF NAT STAT, 1998, MORT STAT GEN DH1; Peters K D, 1998, Natl Vital Stat Rep, V47, P1; PETO R, 1992, LANCET, V339, P1268, DOI 10.1016/0140-6736(92)91600-D; PETO R, MORTALITY SMOKING DE; PETO R, 1994, MORTALITY SMOKING; Steenland K, 2002, AM J EPIDEMIOL, V156, P11, DOI 10.1093/aje/kwf001; Thun MJ, 2000, JAMA-J AM MED ASSOC, V284, P706, DOI 10.1001/jama.284.6.706; Thun MJ., 1997, CHANGES CIGARETTE RE, V8, P305; WILKINS R, TRENDS MORTALITY NEI; World Health Organization, 1978, INT STAT CLASS DIS R	26	308	308	0	15	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL-AUG	2006	368	9533					367	370		10.1016/S0140-6736(06)68975-7	http://dx.doi.org/10.1016/S0140-6736(06)68975-7			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	069JJ	16876664				2022-12-28	WOS:000239441900029
J	Vinsonneau, C; Camus, C; Combes, A; Beauregard, MAC; Klouche, K; Boulain, T; Pallot, JL; Chiche, JD; Taupin, P; Landais, P; Dhainaut, JF				Vinsonneau, Christophe; Camus, Christophe; Combes, Alain; Costa de Beauregard, Marie Alyette; Klouche, Kada; Boulain, Thierry; Pallot, Jean-Louis; Chiche, Jean-Daniel; Taupin, Pierre; Landais, Paul; Dhainaut, Jean-Francois		Hemodiafe Study Grp	Continuous venovenous haemodiafiltration versus intermittent haemodialysis for acute renal failure in patients with multiple-organ dysfunction syndrome: a multicentre randomised trial	LANCET			English	Article							CRITICALLY-ILL PATIENTS; INTENSIVE-CARE-UNIT; REPLACEMENT THERAPY; CONTINUOUS HEMOFILTRATION; ACUTE PHYSIOLOGY; CLINICAL-TRIAL; DIALYSIS; GUIDELINES; REGRESSION; MORTALITY	Background Whether continuous renal replacement therapy is better than intermittent haemodialysis for the treatment of acute renal failure in critically ill patients is controversial. In this study, we compare the effect of intermittent haemodialysis and continuous venovenous haemodiafiltration on survival rates in critically ill patients with acute renal failure as part of multiple-organ dysfunction syndrome. Methods Our prospective, randomised, multicentre study took place between Oct 1, 1999, and March 3, 2003, in 21 medical or multidisciplinary intensive-care units from university or community hospitals in France. Guidelines were provided to achieve optimum haemodynamic tolerance and effectiveness of solute removal in both groups. The two groups were treated with the same polymer membrane and bicarbonate-based buffer. 360 patients were randomised, and the primary endpoint was 60-day survival based on an intention-to-treat analysis. Findings Rate of survival at 60-days did not differ between the groups (32% in the intermittent haemodialysis group versus 33% in the continuous renal replacement therapy group [95 % CI -8.8 to 11.1]), or at any other time. Interpretation These data suggest that, provided strict guidelines to improve tolerance and metabolic control are used, almost all patients with acute renal failure as part of multiple-organ dysfunction syndrome can be treated with intermittent haemodialysis.	Necker Univ Hosp, Dept Biostat, Paris, France; La Source, Dept Intens Care, Orleans, France; Lapeyronie Univ Hosp, Dept Intens Care, Montpellier, France; Tenon Univ Hosp, Dept Intens & Nephrol Care, Paris, France; Pitie Salpetriere Univ Hosp, Dept Intens Care, Paris, France; Pontchaillou Univ Hosp, Dept Infect Dis & Intens Care, Rennes, France; Univ Paris 05, Cochin Port Royal Univ Hosp, Dept Intens Care, Paris, France; Univ Paris 05, Cochin Port Royal Univ Hosp, Dept Emergency Med, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Universite de Montpellier; CHU de Montpellier; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; CHU Rennes; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite	Vinsonneau, C (corresponding author), Hop Cochin, Serv Brules, 27 Rue Faubourg St Jacques, F-75674 Paris, France.	christophe.vinsonneau@cch.aphp.fr	Boulain, Thierry/M-3309-2019; Chiche, Jean-Daniel/P-5220-2017	Boulain, Thierry/0000-0003-4664-3661; Chiche, Jean-Daniel/0000-0002-6433-6254; VINSONNEAU, Christophe/0000-0002-8485-9343				Aegerter P, 1998, REV EPIDEMIOL SANTE, V46, P226; Augustine JJ, 2004, AM J KIDNEY DIS, V44, P1000, DOI 10.1053/j.ajkd.2004.08.022; Bellomo R, 1999, INTENS CARE MED, V25, P781, DOI 10.1007/s001340050953; BELLOMO R, 1995, NEPHRON, V71, P59, DOI 10.1159/000188675; BELLOMO R, 1992, ASAIO J, V38, P654; BONE RC, 1992, CRIT CARE MED, V20, P864, DOI 10.1097/00003246-199206000-00025; Brivet FG, 1996, CRIT CARE MED, V24, P192, DOI 10.1097/00003246-199602000-00003; BUCHARDI H, 1998, KIDNEY INT S, V66, pS120; COX DR, 1972, J R STAT SOC B, V34, P187; DAVENPORT A, 1993, CRIT CARE MED, V21, P328, DOI 10.1097/00003246-199303000-00007; Evanson JA, 1999, KIDNEY INT, V55, P1501, DOI 10.1046/j.1523-1755.1999.00355.x; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; Guerin C, 2000, AM J RESP CRIT CARE, V161, P872, DOI 10.1164/ajrccm.161.3.9809066; Guerin C, 2002, INTENS CARE MED, V28, P1411, DOI 10.1007/s00134-002-1433-0; HertPicciotto I, 1997, BIOMETRICS, V53, P1151, DOI 10.2307/2533573; John S, 2001, NEPHROL DIAL TRANSPL, V16, P320, DOI 10.1093/ndt/16.2.320; Kellum JA, 2002, INTENS CARE MED, V28, P29, DOI 10.1007/s00134-001-1159-4; KIERDORF H, 1991, CONTRIB NEPHROL, V93, P1; KNAUS WA, 1981, CRIT CARE MED, V9, P591, DOI 10.1097/00003246-198108000-00008; KRUCZYNSKI K, 1993, AM SOC ARTIF INTERN, V39, P778; LeGall JR, 1996, JAMA-J AM MED ASSOC, V276, P802, DOI 10.1001/jama.276.10.802; LEGALL JR, 1993, JAMA-J AM MED ASSOC, V270, P2957, DOI 10.1001/jama.270.24.2957; Mehta RL, 2001, KIDNEY INT, V60, P1154, DOI 10.1046/j.1523-1755.2001.0600031154.x; Metnitz PGH, 2002, CRIT CARE MED, V30, P2051, DOI 10.1097/00003246-200209000-00016; Misset B, 1996, INTENS CARE MED, V22, P742, DOI 10.1007/s001340050161; PAGANINI EP, 1996, AM J KIDNEY DIS    S, V28, P81; Ronco C, 2000, LANCET, V356, P26, DOI 10.1016/S0140-6736(00)02430-2; Schiffl H, 2002, NEW ENGL J MED, V346, P305, DOI 10.1056/NEJMoa010877; Schortgen F, 2000, AM J RESP CRIT CARE, V162, P197, DOI 10.1164/ajrccm.162.1.9907098; Silvester W, 2001, CRIT CARE MED, V29, P1910, DOI 10.1097/00003246-200110000-00010; Tonelli M, 2002, AM J KIDNEY DIS, V40, P875, DOI 10.1053/ajkd.2002.36318; Uehlinger DE, 2005, NEPHROL DIAL TRANSPL, V20, P1630, DOI 10.1093/ndt/gfh880; VANBOMMEL EFH, 1995, AM J NEPHROL, V15, P192, DOI 10.1159/000168832	33	405	440	0	16	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL-AUG	2006	368	9533					379	385		10.1016/S0140-6736(06)69111-3	http://dx.doi.org/10.1016/S0140-6736(06)69111-3			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	069JJ	16876666				2022-12-28	WOS:000239441900031
J	Jeong, S; Rokas, A; Carroll, SB				Jeong, Sangyun; Rokas, Antonis; Carroll, Sean B.			Regulation of body pigmentation by the abdominal-B Hox protein and its gain and loss in Drosophila evolution	CELL			English	Article							BITHORAX COMPLEX; GENE-REGULATION; HOMEOTIC GENES; AXIAL MORPHOLOGY; CIS-REGULATION; EXPRESSION; ULTRABITHORAX; PATTERNS; INSECT; ARTHROPODS	Hox genes have been implicated in the evolution of many animal body patterns, but the molecular events underlying trait modification have not been elucidated. Pigmentation of the posterior male abdomen is a recently acquired trait in the Drosophila melanogaster lineage. Here, we show that the Abdominal-B (ABD-B) Hox protein directly activates expression of the yellow pigmentation gene in posterior segments. ABD-B regulation of pigmentation evolved through the gain of ABD-B binding sites in a specific cis-regulatory element of the yellow gene of a common ancestor of sexually dimorphic species. Within the melanogaster species group, male-specific pigmentation has subsequently been lost by at least three different mechanisms, including the mutational inactivation of a key ABD-B binding site in one lineage. These results demonstrate how Hox regulation of traits and target genes is gained and lost at the species level and have general implications for the evolution of body form at higher taxonomic levels.	Univ Wisconsin, Howard Hughes Med Inst, Madison, WI 53706 USA; Univ Wisconsin, Mol Biol Lab, Madison, WI 53706 USA; MIT, Broad Inst, Cambridge, MA 02141 USA; Harvard Univ, Cambridge Ctr 7, Cambridge, MA 02141 USA	Howard Hughes Medical Institute; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University	Jeong, S (corresponding author), Univ Wisconsin, Howard Hughes Med Inst, 1525 Linden Dr, Madison, WI 53706 USA.	sbcarrol@wisc.edu	Rokas, Antonis/A-9775-2008	Rokas, Antonis/0000-0002-7248-6551				Abzhanov A, 1999, EVOL DEV, V1, P77, DOI 10.1046/j.1525-142x.1999.99014.x; Ashburner M., 2004, DROSOPHILA LAB MANUA, V2nd; Averof M, 1997, NATURE, V388, P682, DOI 10.1038/41786; AVEROF M, 1995, NATURE, V376, P420, DOI 10.1038/376420a0; BAKER BS, 1980, GENETICS, V94, P383; Barolo S, 2004, BIOTECHNIQUES, V36, P436, DOI 10.2144/04363ST03; Belting HG, 1998, P NATL ACAD SCI USA, V95, P2355, DOI 10.1073/pnas.95.5.2355; BURKE AC, 1995, DEVELOPMENT, V121, P333; Burtis KC, 1993, CURR OPIN CELL BIOL, V5, P1006, DOI 10.1016/0955-0674(93)90085-5; Carbone MA, 2005, GENETICS, V171, P211, DOI 10.1534/genetics.105.044412; CARROLL SB, 1995, NATURE, V376, P479, DOI 10.1038/376479a0; CARROLL SB, 1995, NATURE, V375, P58, DOI 10.1038/375058a0; Carroll SB, 2000, CELL, V101, P577, DOI 10.1016/S0092-8674(00)80868-5; CARROLL SB, 2005, DNA DIVERSITY MOL GE; CELNIKER SE, 1990, EMBO J, V9, P4277, DOI 10.1002/j.1460-2075.1990.tb07876.x; CELNIKER SE, 1993, P NATL ACAD SCI USA, V90, P1566, DOI 10.1073/pnas.90.4.1566; Cohn MJ, 1999, NATURE, V399, P474, DOI 10.1038/20944; Couderc JL, 2002, DEVELOPMENT, V129, P2419; DUNCAN I, 1987, ANNU REV GENET, V21, P285, DOI 10.1146/annurev.ge.21.120187.001441; EKKER SC, 1994, EMBO J, V13, P3551, DOI 10.1002/j.1460-2075.1994.tb06662.x; FRANGIONI JV, 1993, ANAL BIOCHEM, V210, P179, DOI 10.1006/abio.1993.1170; Garcia-Bellido A, 1975, Ciba Found Symp, V0, P161; GEYER PK, 1987, GENE DEV, V1, P996, DOI 10.1101/gad.1.9.996; Gompel N, 2005, NATURE, V433, P481, DOI 10.1038/nature03235; Gompel N, 2003, NATURE, V424, P931, DOI 10.1038/nature01787; Hersh BM, 2005, DEVELOPMENT, V132, P1567, DOI 10.1242/dev.01737; HOPMANN R, 1995, GENETICS, V139, P815; Kopp A, 2000, NATURE, V408, P553, DOI 10.1038/35046017; Lewis DL, 2000, P NATL ACAD SCI USA, V97, P4504, DOI 10.1073/pnas.97.9.4504; Llopart A, 2002, EVOLUTION, V56, P2262; Lohmann I, 2002, CELL, V110, P457, DOI 10.1016/S0092-8674(02)00871-1; Mahaffey JW, 2005, CURR OPIN GENET DEV, V15, P422, DOI 10.1016/j.gde.2005.06.009; Mahfooz NS, 2004, P NATL ACAD SCI USA, V101, P4877, DOI 10.1073/pnas.0401216101; Pearson JC, 2005, NAT REV GENET, V6, P893, DOI 10.1038/nrg1726; Prud'homme B, 2006, NATURE, V440, P1050, DOI 10.1038/nature04597; Stern DL, 2000, EVOLUTION, V54, P1079, DOI 10.1554/0014-3820(2000)054[1079:PEDBAT]2.0.CO;2; Stern DL, 1998, NATURE, V396, P463, DOI 10.1038/24863; Telford MJ, 1998, P NATL ACAD SCI USA, V95, P10671, DOI 10.1073/pnas.95.18.10671; Tomoyasu Y, 2005, NATURE, V433, P643, DOI 10.1038/nature03272; WARREN RW, 1994, NATURE, V372, P458, DOI 10.1038/372458a0; Weatherbee SD, 1999, CELL, V97, P283, DOI 10.1016/S0092-8674(00)80737-0; Weatherbee SD, 1999, CURR BIOL, V9, P109, DOI 10.1016/S0960-9822(99)80064-5; Wittkopp PJ, 2002, CURR BIOL, V12, P1547, DOI 10.1016/S0960-9822(02)01113-2; Wittkopp PJ, 2002, DEVELOPMENT, V129, P1849	44	163	171	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 30	2006	125	7					1387	1399		10.1016/j.cell.2006.04.043	http://dx.doi.org/10.1016/j.cell.2006.04.043			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	064QP	16814723	Bronze			2022-12-28	WOS:000239104500020
J	Lis, JT; Kraus, WL				Lis, John T.; Kraus, W. Lee			Promoter cleavage: A topoII beta and PARP-1 collaboration	CELL			English	Editorial Material							TOPOISOMERASE-II-BETA; DNA TOPOISOMERASE; PATHWAY	Hormones trigger dramatic changes in the structure and transcriptional activity of specific promoters that lead to exchange of repression complexes for activation complexes. Ju et al. (2006) now show that estrogen-dependent restructuring and transcription of the pS2 promoter require the generation of a DNA double-strand break by a novel protein complex containing two enzymes, topoisomerase II beta and poly(ADP-ribose) polymerase.	Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA	Cornell University	Lis, JT (corresponding author), Cornell Univ, Dept Mol Biol & Genet, Biotechnol Bldg, Ithaca, NY 14853 USA.	jtl10@cornell.edu; wlk5@cornell.edu			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK069710] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01 DK069710] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Austin CA, 1998, BIOESSAYS, V20, P215, DOI 10.1002/(SICI)1521-1878(199803)20:3<215::AID-BIES5>3.0.CO;2-Q; DARBY MK, 1985, EMBO J, V4, P2129, DOI 10.1002/j.1460-2075.1985.tb03903.x; Ju BG, 2004, CELL, V119, P815, DOI 10.1016/j.cell.2004.11.017; Ju BG, 2006, SCIENCE, V312, P1798, DOI 10.1126/science.1127196; Kim MY, 2005, GENE DEV, V19, P1951, DOI 10.1101/gad.1331805; KROEGER PE, 1992, BIOCHEMISTRY-US, V31, P2492, DOI 10.1021/bi00124a008; Lis J, 1998, COLD SPRING HARB SYM, V63, P347, DOI 10.1101/sqb.1998.63.347; Pavri R, 2005, MOL CELL, V18, P83, DOI 10.1016/j.molcel.2005.02.034; Tulin A, 2003, SCIENCE, V299, P560, DOI 10.1126/science.1078764	9	20	20	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 30	2006	125	7					1225	1227		10.1016/j.cell.2006.06.016	http://dx.doi.org/10.1016/j.cell.2006.06.016			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	064QP	16814707	Bronze			2022-12-28	WOS:000239104500004
J	Baker, M; Mackenzie, IR; Pickering-Brown, SM; Gass, J; Rademakers, R; Lindholm, C; Snowden, J; Adamson, J; Sadovnick, AD; Rollinson, S; Cannon, A; Dwosh, E; Neary, D; Melquist, S; Richardson, A; Dickson, D; Berger, Z; Eriksen, J; Robinson, T; Zehr, C; Dickey, CA; Crook, R; McGowan, E; Mann, D; Boeve, B; Feldman, H; Hutton, M				Baker, Matt; Mackenzie, Ian R.; Pickering-Brown, Stuart M.; Gass, Jennifer; Rademakers, Rosa; Lindholm, Caroline; Snowden, Julie; Adamson, Jennifer; Sadovnick, A. Dessa; Rollinson, Sara; Cannon, Ashley; Dwosh, Emily; Neary, David; Melquist, Stacey; Richardson, Anna; Dickson, Dennis; Berger, Zdenek; Eriksen, Jason; Robinson, Todd; Zehr, Cynthia; Dickey, Chad A.; Crook, Richard; McGowan, Eileen; Mann, David; Boeve, Bradley; Feldman, Howard; Hutton, Mike			Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17	NATURE			English	Article							GROWTH-FACTOR; INCLUSIONS; EXPRESSION; DISEASE; FAMILY; 17Q21	Frontotemporal dementia (FTD) is the second most common cause of dementia in people under the age of 65 years(1). A large proportion of FTD patients ( 35 - 50%) have a family history of dementia, consistent with a strong genetic component to the disease(2). In 1998, mutations in the gene encoding the microtubule-associated protein tau ( MAPT) were shown to cause familial FTD with parkinsonism linked to chromosome 17q21 (FTDP- 17)(3). The neuropathology of patients with defined MAPT mutations is characterized by cytoplasmic neurofibrillary inclusions composed of hyperphosphorylated tau(3,4). However, in multiple FTD families with significant evidence for linkage to the same region on chromosome 17q21 (D17S1787 - D17S806), mutations in MAPT have not been found and the patients consistently lack tauimmunoreactive inclusion pathology(5-12). In contrast, these patients have ubiquitin (ub)-immunoreactive neuronal cytoplasmic inclusions and characteristic lentiform ub-immunoreactive neuronal intranuclear inclusions(11-13). Here we demonstrate that in these families, FTD is caused by mutations in progranulin (PGRN) that are likely to create null alleles. PGRN is located 1.7 Mb centromeric of MAPT on chromosome 17q21.31 and encodes a 68.5-kDa secreted growth factor involved in the regulation of multiple processes including development, wound repair and inflammation(14). PGRN has also been strongly linked to tumorigenesis(14). Moreover, PGRN expression is increased in activated microglia in many neurodegenerative diseases including Creutzfeldt - Jakob disease, motor neuron disease and Alzheimer's disease(15,16). Our results identify mutations in PGRN as a cause of neurodegenerative disease and indicate the importance of PGRN function for neuronal survival.	Mayo Clin Coll Med, Dept Neurosci, Jacksonville, FL 32224 USA; Univ British Columbia, Dept Med Genet, Vancouver, BC V6T 2B5, Canada; Univ British Columbia, Dept Pathol, Vancouver, BC V6T 2B5, Canada; Univ British Columbia, Div Neurol, Vancouver, BC V6T 2B5, Canada; Univ Manchester, Dept Med, Div Lab & Regenerat Med, Manchester M13 9PT, Lancs, England; Hope Hosp, Greater Manchester Neurosci Ctr, Ctr Clin Neurosci, Salford M6 8HD, Lancs, England; Mayo Clin Coll Med, Dept Neurol, Rochester, MN 55905 USA	Mayo Clinic; University of British Columbia; University of British Columbia; University of British Columbia; University of Manchester; Mayo Clinic	Hutton, M (corresponding author), Mayo Clin Coll Med, Dept Neurosci, 4500 San Pablo Rd, Jacksonville, FL 32224 USA.	ian.mackenzie@vch.ca; hutton.michael@mayo.edu	Dickey, Chad A/H-4441-2011; Calabrese, Massimiliano/I-6195-2012; Eriksen, Jason/A-8054-2008; Pickering-Brown, Stuart/D-4008-2009	Eriksen, Jason/0000-0003-1549-4165; Pickering-Brown, Stuart/0000-0003-1561-6054; Dickson, Dennis W/0000-0001-7189-7917; Feldman, Howard/0000-0002-9258-4538; Snowden, Julie/0000-0002-3976-4310	Medical Research Council [G0400356] Funding Source: Medline; MRC [G0400356] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Baker CA, 2003, P NATL ACAD SCI USA, V100, P675, DOI 10.1073/pnas.0237313100; Bird TD, 1997, NEUROLOGY, V48, P949, DOI 10.1212/WNL.48.4.949; BRUN A, 1994, J NEUROL NEUROSUR PS, V57, P416; Capsoni S, 2000, P NATL ACAD SCI USA, V97, P6826, DOI 10.1073/pnas.97.12.6826; Chow TW, 1999, ARCH NEUROL-CHICAGO, V56, P817, DOI 10.1001/archneur.56.7.817; Cruts M, 2005, HUM MOL GENET, V14, P1753, DOI 10.1093/hmg/ddi182; CRUTS M, 2006, NATURE          0716, DOI DOI 10.1038/NATURE05017; Daniel R, 2000, J HISTOCHEM CYTOCHEM, V48, P999, DOI 10.1177/002215540004800713; Foster NL, 1997, ANN NEUROL, V41, P706, DOI 10.1002/ana.410410606; Froelich S, 1997, AM J MED GENET, V74, P380, DOI 10.1002/(SICI)1096-8628(19970725)74:4<380::AID-AJMG8>3.0.CO;2-T; Greenway MJ, 2006, NAT GENET, V38, P411, DOI 10.1038/ng1742; He ZH, 2003, J MOL MED-JMM, V81, P600, DOI 10.1007/s00109-003-0474-3; He ZH, 2003, NAT MED, V9, P225, DOI 10.1038/nm816; Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508; Ingram EM, 2002, TRENDS MOL MED, V8, P555, DOI 10.1016/S1471-4914(02)02440-1; Kertesz A, 2000, NEUROLOGY, V54, P818, DOI 10.1212/WNL.54.4.818; Lendon CL, 1998, NEUROLOGY, V50, P1546, DOI 10.1212/WNL.50.6.1546; Lu RQ, 2001, P NATL ACAD SCI USA, V98, P142, DOI 10.1073/pnas.011525198; Mackenzie IR, 2006, BRAIN, V129, P853, DOI 10.1093/brain/awh724; Mackenzie IRA, 2005, J NEUROPATH EXP NEUR, V64, P730, DOI 10.1097/01.jnen.0000174335.27708.0a; Mackenzie IRA, 2003, ACTA NEUROPATHOL, V105, P543, DOI 10.1007/s00401-003-0678-1; Malaspina A, 2001, J NEUROCHEM, V77, P132, DOI 10.1046/j.1471-4159.2001.t01-1-00231.x; Maquat LE, 2004, NAT REV MOL CELL BIO, V5, P89, DOI 10.1038/nrm1310; Neary D, 2000, ANN NY ACAD SCI, V920, P46; Rademakers R, 2005, RES PER ALZ, P117; Rademakers R, 2002, MOL PSYCHIATR, V7, P1064, DOI 10.1038/sj.mp.4001198; Rosso SM, 2001, BRAIN, V124, P1948, DOI 10.1093/brain/124.10.1948; Salehi A, 2004, J NEURAL TRANSM, V111, P323, DOI 10.1007/s00702-003-0091-x; Tangkeangsirisin W, 2004, CARCINOGENESIS, V25, P1587, DOI 10.1093/carcin/bgh171; Trojanowski JQ, 2001, J NEUROPATH EXP NEUR, V60, P1123, DOI 10.1093/jnen/60.12.1123; van der Zee J, 2006, BRAIN, V129, P841, DOI 10.1093/brain/awl029	31	1470	1516	2	89	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 24	2006	442	7105					916	919		10.1038/nature05016	http://dx.doi.org/10.1038/nature05016			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	076LT	16862116				2022-12-28	WOS:000239960500037
J	Everitt, HA; Little, PS; Smith, PWF				Everitt, Hazel A.; Little, Paul S.; Smith, Peter W. F.			A randomised controlled trial of management strategies for acute infective conjunctivitis in general practice	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PRESCRIBING STRATEGIES	Objective To assess different management strategies for acute infective conjunctivitis. Design Open, factorial, randomised controlled trial. Setting 30 general practices in southern England. Participants 307 adults and children with acute infective conjunctivitis. Intervention One of three antibiotic prescribing strategies-immediate antibiotics (chloramphenicol eye drops; n = 104), no antibiotics (controls; n = 94), or delayed antibiotics (n = 109); a patient information leaflet or not; and an eye swab or not. Main outcome measures Severity of symptoms on days 1-3 after consultation, duration of symptoms, and belief in the effectiveness of antibiotics for eye infections. Results Prescribing strategies did not affect the severity of symptoms but duration of moderate symptoms was less with antibiotics: no antibiotics (controls) 4.8 days, immediate antibiotics 3.3 days (risk ratio 0.7, 95% confidence interval 0.6 to 0.8), delayed antibiotics 3.9 days (0.8, 0.7 to 0.9). Compared with no initial offer of antibiotics, antibiotic use was higher in the immediate antibiotic group: controls 30%, immediate antibiotics 99% (odds ratio 185.4, 23.9 to 1439.2), delayed antibiotics 53% (2.9, 1.4 to 5.7), as was belief in the effectiveness of antibiotics: controls 47%, immediate antibiotics 67% (odds ratio 2.4, 1.1 to 5.0), delayed antibiotics 55% (1.4, 0.7 to 3.0), and intention to reattend for eye infections: controls 40%, immediate antibiotics 68% (3.2, 1.6 to 6.4), delayed antibiotics 41% (1.0, 0.5 to 2.0). A patient information leaflet or eye swab had no effect on the main outcomes. Reattendance within two weeks was less in the delayed compared with immediate antibiotic group: 0.3 (0.1 to 1.0) v 0.7 (0.3 to 1.6). Conclusions Delayed prescribing of antibiotics is probably the most appropriate strategy for managing acute conjunctivitis in primary care. It reduces antibiotic use, shows no evidence of medicalisation, provides similar duration and severity of symptoms to immediate prescribing, and reduces reattendance for eye infections.	Univ Southampton, Aldermoor Hlth Ctr, Southampton SO16 5ST, Hants, England; Univ Southampton, Southampton Stat Sci Res Inst, Southampton SO9 5NH, Hants, England	University of Southampton; University of Southampton	Everitt, HA (corresponding author), Univ Southampton, Aldermoor Hlth Ctr, Southampton SO16 5ST, Hants, England.	hael@soton.ac.uk		Everitt, Hazel/0000-0001-7362-8403; Smith, Peter/0000-0003-4423-5410; Little, Paul/0000-0003-3664-1873	Medical Research Council [G84/5610] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Everitt H, 2003, BRIT J GEN PRACT, V53, P36; Little P, 2001, BMJ-BRIT MED J, V322, P336, DOI 10.1136/bmj.322.7282.336; Little P, 2005, JAMA-J AM MED ASSOC, V293, P3029, DOI 10.1001/jama.293.24.3029; Little P, 1997, BMJ-BRIT MED J, V314, P722, DOI 10.1136/bmj.314.7082.722; Rose PW, 2005, LANCET, V366, P37, DOI 10.1016/S0140-6736(05)66709-8; Sheikh A, 2005, BRIT J GEN PRACT, V55, P962; SHEIKH A, 2000, COCHRANE DB SYST REV	7	64	66	0	17	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 12	2006	333	7563					321	324		10.1136/bmj.38891.551088.7C	http://dx.doi.org/10.1136/bmj.38891.551088.7C			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	073VI	16847013	Bronze, Green Published, Green Submitted			2022-12-28	WOS:000239770300013
J	El-Ali, J; Sorger, PK; Jensen, KF				El-Ali, Jamil; Sorger, Peter K.; Jensen, Klavs F.			Cells on chips	NATURE			English	Review							MICROFLUIDIC DEVICE; CHEMICAL-ANALYSIS; ANALYSIS SYSTEMS; ARRAY CHIP; IN-VITRO; SEPARATION; GRADIENT; LYSIS; HEPATOCYTES; EXPRESSION	Microsystems create new opportunities for the spatial and temporal control of cell growth and stimuli by combining surfaces that mimic complex biochemistries and geometries of the extracellular matrix with microfluidic channels that regulate transport of fluids and soluble factors. Further integration with bioanalytic microsystems results in multifunctional platforms for basic biological insights into cells and tissues, as well as for cell-based sensors with biochemical, biomedical and environmental functions. Highly integrated microdevices show great promise for basic biomedical and pharmaceutical research, and robust and portable point-of-care devices could be used in clinical settings, in both the developed and the developing world.	MIT, Dept Chem Engn, Cambridge, MA 02139 USA; MIT, Dept Biol & Biol Engn, Ctr Cell Decis Proc, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Jensen, KF (corresponding author), MIT, Dept Chem Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	kfjensen@mit.edu	Jensen, Klavs F/F-2462-2012; Sano, Michael/E-1715-2011	Jensen, Klavs F/0000-0001-7192-580X; Sorger, Peter/0000-0002-3364-1838				ABHYANAKAR VV, 2004, LAB ON CHIPS CELLOMI, P257; Abhyankar VV, 2006, LAB CHIP, V6, P389, DOI 10.1039/b514133h; Andersson H, 2003, SENSOR ACTUAT B-CHEM, V92, P315, DOI 10.1016/S0925-4005(03)00266-1; Auroux PA, 2004, LAB CHIP, V4, P534, DOI 10.1039/b408850f; Balagadde FK, 2005, SCIENCE, V309, P137, DOI 10.1126/science.1109173; BECKER FF, 1995, P NATL ACAD SCI USA, V92, P860, DOI 10.1073/pnas.92.3.860; Bernard A, 2001, ANAL CHEM, V73, P8, DOI 10.1021/ac0008845; Bhatia SN, 1999, FASEB J, V13, P1883, DOI 10.1096/fasebj.13.14.1883; Bhatia SN, 1997, J BIOMED MATER RES, V34, P189, DOI 10.1002/(SICI)1097-4636(199702)34:2<189::AID-JBM8>3.0.CO;2-M; Blazej RG, 2006, P NATL ACAD SCI USA, V103, P7240, DOI 10.1073/pnas.0602476103; Boccazzi P, 2005, APPL MICROBIOL BIOT, V68, P518, DOI 10.1007/s00253-005-1966-6; Bousse L, 1996, SENSOR ACTUAT B-CHEM, V34, P270, DOI 10.1016/S0925-4005(96)01906-5; Brehm-Stecher BF, 2004, MICROBIOL MOL BIOL R, V68, P538, DOI 10.1128/MMBR.68.3.538-559.2004; Breslauer DN, 2006, MOL BIOSYST, V2, P97, DOI 10.1039/b515632g; BRITLAND S, 1992, EXP CELL RES, V198, P124, DOI 10.1016/0014-4827(92)90157-4; Burg TP, 2003, APPL PHYS LETT, V83, P2698, DOI 10.1063/1.1611625; Burns MA, 1998, SCIENCE, V282, P484, DOI 10.1126/science.282.5388.484; Chang JC, 2001, BIOSENS BIOELECTRON, V16, P527, DOI 10.1016/S0956-5663(01)00166-X; Chang WC, 2005, LAB CHIP, V5, P64, DOI 10.1039/b400455h; Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425; Chung BG, 2005, LAB CHIP, V5, P401, DOI 10.1039/b417651k; Clayton J, 2005, NAT METHODS, V2, P621, DOI 10.1038/nmeth0805-621; DeBusschere BD, 2001, BIOSENS BIOELECTRON, V16, P543, DOI 10.1016/S0956-5663(01)00168-3; Di Carlo D, 2003, LAB CHIP, V3, P287, DOI 10.1039/b305162e; Dittrich PS, 2006, NAT REV DRUG DISCOV, V5, P210, DOI 10.1038/nrd1985; El-Ali J, 2005, ANAL CHEM, V77, P3629, DOI 10.1021/ac050008x; Fertig N, 2002, BIOPHYS J, V82, P3056, DOI 10.1016/S0006-3495(02)75646-4; Folch A, 2000, ANNU REV BIOMED ENG, V2, P227, DOI 10.1146/annurev.bioeng.2.1.227; Fu AY, 2002, ANAL CHEM, V74, P2451, DOI 10.1021/ac0255330; Fu JP, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2149979; Gao J, 2004, LAB CHIP, V4, P47, DOI 10.1039/b310552k; Gascoyne PRC, 2004, P IEEE, V92, P22, DOI 10.1109/JPROC.2003.820535; Geiger B, 2001, NAT REV MOL CELL BIO, V2, P793, DOI 10.1038/35099066; Gottschlich N, 2001, ANAL CHEM, V73, P2669, DOI 10.1021/ac001019n; Groisman A, 2005, NAT METHODS, V2, P685, DOI 10.1038/NMETH784; Gross GW, 1997, BIOSENS BIOELECTRON, V12, P373, DOI 10.1016/S0956-5663(97)00012-2; Gruner G, 2006, ANAL BIOANAL CHEM, V384, P322, DOI 10.1007/s00216-005-3400-4; Gu MB, 2004, ADV BIOCHEM ENG BIOT, V87, P269; GUGUENGUILLOUZO C, 1983, EXP CELL RES, V143, P47, DOI 10.1016/0014-4827(83)90107-6; Han J, 2000, SCIENCE, V288, P1026, DOI 10.1126/science.288.5468.1026; Helmke BP, 2006, P NATL ACAD SCI USA, V103, P6419, DOI 10.1073/pnas.0507304103; Hong JW, 2004, NAT BIOTECHNOL, V22, P435, DOI 10.1038/nbt951; HU X, 1990, BIOCHIM BIOPHYS ACTA, V1021, P191, DOI 10.1016/0005-2736(90)90033-K; Hu XY, 2005, P NATL ACAD SCI USA, V102, P15757, DOI 10.1073/pnas.0507719102; Huang Y, 2002, ANAL CHEM, V74, P3362, DOI 10.1021/ac011273v; Hung PJ, 2005, BIOTECHNOL BIOENG, V89, P1, DOI 10.1002/bit.20289; Jamora C, 2002, NAT CELL BIOL, V4, pE101, DOI 10.1038/ncb0402-e101; Jeon NL, 2002, NAT BIOTECHNOL, V20, P826, DOI 10.1038/nbt712; Kim L, 2006, LAB CHIP, V6, P394, DOI 10.1039/b511718f; Lagally ET, 2004, ANAL CHEM, V76, P3162, DOI 10.1021/ac035310p; Leclerc E, 2006, BIOMATERIALS, V27, P586, DOI 10.1016/j.biomaterials.2005.06.002; Lee PJ, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1938253; Lee SW, 1999, SENSOR ACTUAT A-PHYS, V73, P74, DOI 10.1016/S0924-4247(98)00257-X; Li PCH, 1997, ANAL CHEM, V69, P1564, DOI 10.1021/ac9606564; Li Y, 2004, ANAL CHEM, V76, P742, DOI 10.1021/ac034765b; Liegibel UM, 2004, EXP CLIN ENDOCR DIAB, V112, P356, DOI 10.1055/s-2004-821014; Lin YC, 2001, SENSOR ACTUAT B-CHEM, V79, P137, DOI 10.1016/S0925-4005(01)00859-0; Lion N, 2003, ELECTROPHORESIS, V24, P3533, DOI 10.1002/elps.200305629; Lu H, 2005, LAB CHIP, V5, P23, DOI 10.1039/b406205a; Lu H, 2004, ANAL CHEM, V76, P5705, DOI 10.1021/ac049794g; Lucchetta EM, 2005, NATURE, V434, P1134, DOI 10.1038/nature03509; MANZ A, 1990, SENSOR ACTUAT B-CHEM, V1, P244, DOI 10.1016/0925-4005(90)80209-I; McClain MA, 2003, ANAL CHEM, V75, P5646, DOI 10.1021/ac0346510; Morin F, 2006, BIOSENS BIOELECTRON, V21, P1093, DOI 10.1016/j.bios.2005.04.020; NORTHRUP MA, 1993, TRANSDUCERS 93, P924; Pal R, 2005, LAB CHIP, V5, P1024, DOI 10.1039/b505994a; Pancrazio JJ, 1999, ANN BIOMED ENG, V27, P697, DOI 10.1114/1.225; Pearce TM, 2005, LAB CHIP, V5, P97, DOI 10.1039/b407871c; Powers MJ, 2002, BIOTECHNOL BIOENG, V78, P257, DOI 10.1002/bit.10143; Revzin A, 2005, LAB CHIP, V5, P30, DOI 10.1039/b405557h; Sato K, 2002, ELECTROPHORESIS, V23, P734, DOI 10.1002/1522-2683(200203)23:5<734::AID-ELPS734>3.0.CO;2-W; Schmidt C, 2000, ANGEW CHEM INT EDIT, V39, P3137, DOI 10.1002/1521-3773(20000901)39:17<3137::AID-ANIE3137>3.0.CO;2-D; Seo J, 2004, APPL PHYS LETT, V84, P1973, DOI 10.1063/1.1650035; Sivaraman A, 2005, CURR DRUG METAB, V6, P569, DOI 10.2174/138920005774832632; Song H, 2003, ANGEW CHEM INT EDIT, V42, P768, DOI 10.1002/anie.200390203; Stone HA, 2004, ANNU REV FLUID MECH, V36, P381, DOI 10.1146/annurev.fluid.36.050802.122124; Szita N, 2005, LAB CHIP, V5, P819, DOI 10.1039/b504243g; Takayama S, 2001, NATURE, V411, P1016, DOI 10.1038/35082637; Tan JL, 2003, P NATL ACAD SCI USA, V100, P1484, DOI 10.1073/pnas.0235407100; Thery M, 2005, NAT CELL BIOL, V7, P947, DOI 10.1038/ncb1307; Tsang VL, 2004, ADV DRUG DELIVER REV, V56, P1635, DOI 10.1016/j.addr.2004.05.001; van den Berg A, 1998, TOP CURR CHEM, V194, P21; Verpoorte E, 2003, LAB CHIP, V3, p42N, DOI 10.1039/b307927a; Verpoorte E, 2002, ELECTROPHORESIS, V23, P677, DOI 10.1002/1522-2683(200203)23:5<677::AID-ELPS677>3.0.CO;2-8; Vilkner T, 2004, ANAL CHEM, V76, P3373, DOI 10.1021/ac040063q; Viravaidya K, 2004, BIOTECHNOL PROGR, V20, P316, DOI 10.1021/bp0341996; Voldman J, 2002, ANAL CHEM, V74, P3984, DOI 10.1021/ac0256235; Walker GM, 2005, LAB CHIP, V5, P611, DOI 10.1039/b417245k; Wang MM, 2005, NAT BIOTECHNOL, V23, P83, DOI 10.1038/nbt1050; Wang YC, 2005, ANAL CHEM, V77, P4293, DOI 10.1021/ac050321z; Wang Z, 2004, LAB CHIP, V4, P372, DOI 10.1039/b400663a; Wei CW, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni078; Wheeler AR, 2003, ANAL CHEM, V75, P3581, DOI 10.1021/ac0340758; Wood C, 2004, DRUG DISCOV TODAY, V9, P434, DOI 10.1016/S1359-6446(04)03064-8; Wu HK, 2004, P NATL ACAD SCI USA, V101, P12809, DOI 10.1073/pnas.0405299101; Xia YN, 1998, ANNU REV MATER SCI, V28, P153, DOI 10.1146/annurev.matsci.28.1.153; Yang MS, 2002, ANAL CHEM, V74, P3991, DOI 10.1021/ac025536c; Yin NF, 2005, ANAL CHEM, V77, P527, DOI 10.1021/ac049068d; Zheng GF, 2005, NAT BIOTECHNOL, V23, P1294, DOI 10.1038/nbt1138; Ziegler C, 2004, ANAL BIOANAL CHEM, V379, P946, DOI 10.1007/s00216-004-2694-y	100	1714	1792	22	987	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 27	2006	442	7101					403	411		10.1038/nature05063	http://dx.doi.org/10.1038/nature05063			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067CI	16871208				2022-12-28	WOS:000239278900033
J	Flores, G				Flores, Glenn			Language barriers to health care in the United States	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Ctr Advancement Underserved Children, Milwaukee, WI USA; Med Coll Wisconsin, Milwaukee, WI 53226 USA; Childrens Hosp Wisconsin, Childrens Res Inst, Milwaukee, WI 53201 USA	Medical College of Wisconsin; Children's Hospital of Wisconsin	Flores, G (corresponding author), Ctr Advancement Underserved Children, Milwaukee, WI USA.							Baker DW, 1996, JAMA-J AM MED ASSOC, V275, P783, DOI 10.1001/jama.275.10.783; Flores G, 2000, J PEDIATR-US, V137, P842, DOI 10.1067/mpd.2000.109150; Flores G, 2005, MED CARE RES REV, V62, P255, DOI 10.1177/1077558705275416; Flores G, 2003, PEDIATRICS, V111, P6, DOI 10.1542/peds.111.1.6; YOUDELMAN M, 2001, RACIAL ETHNIC PRIMAR, V2	5	304	305	0	15	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 20	2006	355	3					229	231		10.1056/NEJMp058316	http://dx.doi.org/10.1056/NEJMp058316			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	064NY	16855260				2022-12-28	WOS:000239097600001
J	Owan, TE; Hodge, DO; Herges, RM; Jacobsen, SJ; Roger, VL; Redfield, MM				Owan, Theophilus E.; Hodge, David O.; Herges, Regina M.; Jacobsen, Steven J.; Roger, Veronique L.; Redfield, Margaret M.			Trends in prevalence and outcome of heart failure with preserved ejection fraction	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							VENTRICULAR SYSTOLIC FUNCTION; CLINICAL-FEATURES; NATURAL-HISTORY; MORTALITY; COMMUNITY; SURVIVAL; EPIDEMIOLOGY; PROGNOSIS	Background: The prevalence of heart failure with preserved ejection fraction may be changing as a result of changes in population demographics and in the prevalence and treatment of risk factors for heart failure. Changes in the prevalence of heart failure with preserved ejection fraction may contribute to changes in the natural history of heart failure. We performed a study to define secular trends in the prevalence of heart failure with preserved ejection fraction among patients at a single institution over a 15-year period. Methods: We studied all consecutive patients hospitalized with decompensated heart failure at Mayo Clinic Hospitals in Olmsted County, Minnesota, from 1987 through 2001. We classified patients as having either preserved or reduced ejection fraction. The patients were also classified as community patients (Olmsted County residents) or referral patients. Secular trends in the type of heart failure, associated cardiovascular disease, and survival were defined. Results: A total of 6076 patients with heart failure were discharged over the 15-year period; data on ejection fraction were available for 4596 of these patients (76 percent). Of these, 53 percent had a reduced ejection fraction and 47 percent had a preserved ejection fraction. The proportion of patients with the diagnosis of heart failure with preserved ejection fraction increased over time and was significantly higher among community patients than among referral patients (55 percent vs. 45 percent). The prevalence rates of hypertension, atrial fibrillation, and diabetes among patients with heart failure increased significantly over time. Survival was slightly better among patients with preserved ejection fraction (adjusted hazard ratio for death, 0.96; P=0.01). Survival improved over time for those with reduced ejection fraction but not for those with preserved ejection fraction. Conclusions: The prevalence of heart failure with preserved ejection fraction increased over a 15-year period, while the rate of death from this disorder remained unchanged. These trends underscore the importance of this growing public health problem.	Mayo Clin, Coll Med, Cardiorenal Res Lab, Rochester, MN 55905 USA; Mayo Clin, Coll Med, Div Biostat, Rochester, MN USA; Mayo Clin, Coll Med, Sect Hlth Sci Res, Rochester, MN USA	Mayo Clinic; Mayo Clinic; Mayo Clinic	Redfield, MM (corresponding author), Mayo Clin, Coll Med, Cardiorenal Res Lab, Guggenheim 9,200 1st St SW, Rochester, MN 55905 USA.	redfield.margaret@mayo.edu	Roger, Veronique/AAV-5951-2020	Jacobsen, Steven/0000-0002-8174-8533	NHLBI NIH HHS [HL64112, T32-HL07111-27, HL72435] Funding Source: Medline; NIAMS NIH HHS [AR30582] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL064112, T32HL007111, R01HL072435] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR030582] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Agoston C, 2004, AM J CARDIOL, V94, P1003, DOI 10.1016/j.amjcard.2004.06.054; Banerjee P, 2002, J AM COLL CARDIOL, V39, P138, DOI 10.1016/S0735-1097(01)01704-1; Berry C, 2005, HEART, V91, P907, DOI 10.1136/hrt.2004.041996; Burkhoff D, 2003, CIRCULATION, V107, P656, DOI 10.1161/01.CIR.0000053947.82595.03; Caruana L, 2000, BRIT MED J, V321, P215, DOI 10.1136/bmj.321.7255.215; Chen HH, 2002, J CARD FAIL, V8, P279, DOI 10.1054/jcaf.2002.128871; Curtis JP, 2003, J AM COLL CARDIOL, V42, P736, DOI 10.1016/S0735-1097(03)00789-7; Gustafsson F, 2003, EUR HEART J, V24, P863, DOI 10.1016/S0195-668X(02)00845-X; Hogg K, 2004, J AM COLL CARDIOL, V43, P317, DOI 10.1016/j.jacc.2003.07.046; Hunt SA, ACC AHA 2005 GUIDELI; Kirk V, 2004, EUR J HEART FAIL, V6, P335, DOI 10.1016/j.ejheart.2004.01.002; Lenzen MJ, 2004, EUR HEART J, V25, P1214, DOI 10.1016/j.ehj.2004.06.006; Levy D, 2002, NEW ENGL J MED, V347, P1397, DOI 10.1056/NEJMoa020265; McCullough Peter A, 2005, Congest Heart Fail, V11, P6, DOI 10.1111/j.1527-5299.2005.03731.x; MCKEE PA, 1971, NEW ENGL J MED, V285, P1441, DOI 10.1056/NEJM197112232852601; Melton LJ, 1996, MAYO CLIN PROC, V71, P266, DOI 10.4065/71.3.266; Owan TE, 2005, PROG CARDIOVASC DIS, V47, P320, DOI 10.1016/j.pcad.2005.02.010; Parkash R, 2005, AM HEART J, V150, P701, DOI 10.1016/j.ahj.2004.12.014; Patel JB, 2004, J CARD FAIL, V10, P285, DOI 10.1016/j.cardfail.2003.12.006; Philbin EF, 2000, AM J MED, V109, P605, DOI 10.1016/S0002-9343(00)00601-X; Pocock SJ, 2006, EUR HEART J, V27, P65, DOI 10.1093/eurheartj/ehi555; Redfield MM, 2002, NEW ENGL J MED, V347, P1442, DOI 10.1056/NEJMe020115; Roger VL, 2004, JAMA-J AM MED ASSOC, V292, P344, DOI 10.1001/jama.292.3.344; Senni M, 1998, CIRCULATION, V98, P2282, DOI 10.1161/01.CIR.98.21.2282; Senni M, 2001, J AM COLL CARDIOL, V38, P1277, DOI 10.1016/S0735-1097(01)01567-4; Shahar E, 2004, J CARD FAIL, V10, P374, DOI 10.1016/j.cardfail.2004.02.003; Smith GL, 2003, J AM COLL CARDIOL, V41, P1510, DOI 10.1016/S0735-1097(03)00185-2; Tarantini Luigi, 2002, Ital Heart J, V3, P656; Varadarajan P, 2003, J CARD FAIL, V9, P107, DOI 10.1054/jcaf.2003.13; Vasan RS, 2000, CIRCULATION, V101, P2118, DOI 10.1161/01.CIR.101.17.2118; VASAN RS, 1995, J AM COLL CARDIOL, V26, P1565, DOI 10.1016/0735-1097(95)00381-9; Zile MR, 2003, J AM COLL CARDIOL, V41, P1519, DOI 10.1016/S0735-1097(03)00186-4	32	2910	3083	3	87	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 20	2006	355	3					251	259		10.1056/NEJMoa052256	http://dx.doi.org/10.1056/NEJMoa052256			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	064NY	16855265				2022-12-28	WOS:000239097600006
J	Thanbichler, M; Shapiro, L				Thanbichler, Martin; Shapiro, Lucy			MipZ, a spatial regulator coordinating chromosome segregation with cell division in Caulobacter	CELL			English	Article							BACTERIAL-DNA SEGREGATION; COMPLETE GENOME SEQUENCE; ESCHERICHIA-COLI; PARTITIONING PROTEINS; POLAR LOCALIZATION; BACILLUS-SUBTILIS; PROPER PLACEMENT; MIND PROTEIN; FTSZ; CRESCENTUS	Correct positioning of the division plane is a prerequisite for the generation of daughter cells with a normal chromosome complement. Here, we present a mechanism that coordinates assembly and placement of the FtsZ cytokinetic ring with bipolar localization of the newly duplicated chromosomal origins in Caulobacter. After replication of the polarly located origin region, one copy moves rapidly to the opposite end of the cell in an MreB-dependent manner. A previously uncharacterized essential protein, MipZ, forms a complex with the partitioning protein ParB near the origin of replication and localizes with the duplicated origin regions to the cell poles. MipZ directly interferes with FtsZ polymerization, thereby restricting FtsZ ring formation to midcell, the region of lowest MipZ concentration. The cellular localization of MipZ thus serves the dual function of positioning the FtsZ ring and delaying formation of the cell division apparatus until chromosome segregation has initiated.	Stanford Univ, Sch Med, Beckman Ctr B300, Dept Dev Biol, Stanford, CA 94305 USA	Stanford University	Shapiro, L (corresponding author), Stanford Univ, Sch Med, Beckman Ctr B300, Dept Dev Biol, 279 Campus Dr, Stanford, CA 94305 USA.	shapiro@stanford.edu	Thanbichler, Martin/E-6035-2010		NIGMS NIH HHS [GM51426] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Barilla D, 2005, EMBO J, V24, P1453, DOI 10.1038/sj.emboj.7600619; Ben-Yehuda S, 2002, CELL, V109, P257, DOI 10.1016/S0092-8674(02)00698-0; Bernhardt TG, 2005, MOL CELL, V18, P555, DOI 10.1016/j.molcel.2005.04.012; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; DEBOER PAJ, 1989, CELL, V56, P641, DOI 10.1016/0092-8674(89)90586-2; DEBOER PAJ, 1991, EMBO J, V10, P4371, DOI 10.1002/j.1460-2075.1991.tb05015.x; Easter J, 2002, MOL CELL, V10, P427, DOI 10.1016/S1097-2765(02)00594-4; ELY B, 1991, METHOD ENZYMOL, V204, P372; Figge RM, 2003, MOL MICROBIOL, V47, P1225, DOI 10.1046/j.1365-2958.2003.03367.x; Fu XL, 2001, P NATL ACAD SCI USA, V98, P980, DOI 10.1073/pnas.031549298; Gital Z, 2005, CELL, V120, P329, DOI 10.1016/j.cell.2005.01.007; Goehring NW, 2005, CURR BIOL, V15, pR514, DOI 10.1016/j.cub.2005.06.038; Hale CA, 2001, EMBO J, V20, P1563, DOI 10.1093/emboj/20.7.1563; Hu ZL, 1999, P NATL ACAD SCI USA, V96, P14819, DOI 10.1073/pnas.96.26.14819; Hu ZL, 2001, MOL CELL, V7, P1337, DOI 10.1016/S1097-2765(01)00273-8; Jensen RB, 1999, P NATL ACAD SCI USA, V96, P10661, DOI 10.1073/pnas.96.19.10661; Jensen RB, 2001, EMBO J, V20, P4952, DOI 10.1093/emboj/20.17.4952; Laub MT, 2000, SCIENCE, V290, P2144, DOI 10.1126/science.290.5499.2144; Leipe DD, 2002, J MOL BIOL, V317, P41, DOI 10.1006/jmbi.2001.5378; Leonard TA, 2005, EMBO J, V24, P270, DOI 10.1038/sj.emboj.7600530; Lim GE, 2005, P NATL ACAD SCI USA, V102, P17658, DOI 10.1073/pnas.0507222102; Ma XL, 1996, P NATL ACAD SCI USA, V93, P12998, DOI 10.1073/pnas.93.23.12998; Marston AL, 1998, GENE DEV, V12, P3419, DOI 10.1101/gad.12.21.3419; Martin BR, 2005, NAT BIOTECHNOL, V23, P1308, DOI 10.1038/nbt1136; Mohl DA, 2001, MOL MICROBIOL, V42, P741, DOI 10.1046/j.1365-2958.2001.02643.x; Mohl DA, 1997, CELL, V88, P675, DOI 10.1016/S0092-8674(00)81910-8; Mukherjee A, 1998, EMBO J, V17, P462, DOI 10.1093/emboj/17.2.462; Nierman WC, 2001, P NATL ACAD SCI USA, V98, P4136, DOI 10.1073/pnas.061029298; Quardokus EM, 2002, MOL MICROBIOL, V45, P605, DOI 10.1046/j.1365-2958.2002.03040.x; Quardokus EM, 2001, MOL MICROBIOL, V39, P949, DOI 10.1046/j.1365-2958.2001.02287.x; Raskin DM, 1999, P NATL ACAD SCI USA, V96, P4971, DOI 10.1073/pnas.96.9.4971; Rothfield L, 2005, NAT REV MICROBIOL, V3, P959, DOI 10.1038/nrmicro1290; Thanedar S, 2004, CURR BIOL, V14, P1167, DOI 10.1016/j.cub.2004.06.048; Tran PT, 1997, J STRUCT BIOL, V118, P107, DOI 10.1006/jsbi.1997.3844; Viollier PH, 2004, P NATL ACAD SCI USA, V101, P9257, DOI 10.1073/pnas.0402606101; Wu LJ, 2004, CELL, V117, P915, DOI 10.1016/j.cell.2004.06.002; Yu XC, 1999, MOL MICROBIOL, V32, P315, DOI 10.1046/j.1365-2958.1999.01351.x	37	345	349	0	20	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 14	2006	126	1					147	162		10.1016/j.cell.2006.05.038	http://dx.doi.org/10.1016/j.cell.2006.05.038			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	066JF	16839883	Bronze			2022-12-28	WOS:000239224800023
J	Gewin, V				Gewin, V			Giving it away	NATURE			English	News Item																			0	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 13	2006	442	7099					122	123		10.1038/442122a	http://dx.doi.org/10.1038/442122a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	062XJ	16837990				2022-12-28	WOS:000238979700013
J	Konstantatos, G; Howard, I; Fischer, A; Hoogland, S; Clifford, J; Klem, E; Levina, L; Sargent, EH				Konstantatos, Gerasimos; Howard, Ian; Fischer, Armin; Hoogland, Sjoerd; Clifford, Jason; Klem, Ethan; Levina, Larissa; Sargent, Edward H.			Ultrasensitive solution-cast quantum dot photodetectors	NATURE			English	Article							NANOCRYSTAL SOLIDS; PHOTOCONDUCTIVITY; EMISSION; FILMS	Solution-processed electronic(1) and optoelectronic(2-5) devices offer low cost, large device area, physical flexibility and convenient materials integration compared to conventional epitaxially grown, lattice-matched, crystalline semiconductor devices. Although the electronic or optoelectronic performance of these solution-processed devices is typically inferior to that of those fabricated by conventional routes, this can be tolerated for some applications in view of the other benefits. Here we report the fabrication of solution-processed infrared photodetectors that are superior in their normalized detectivity (D*, the figure of merit for detector sensitivity) to the best epitaxially grown devices operating at room temperature. We produced the devices in a single solution-processing step, overcoating a prefabricated planar electrode array with an unpatterned layer of PbS colloidal quantum dot nanocrystals. The devices showed large photoconductive gains with responsivities greater than 10(3) AW(-1). The best devices exhibited a normalized detectivity D* of 1.8 x 10(13) jones (1 jones = 1 cm Hz(1/2) W-1) at 1.3 mu m at room temperature: today's highest performance infrared photodetectors are photovoltaic devices made from epitaxially grown InGaAs that exhibit peak D* in the 10(12) jones range at room temperature, whereas the previous record for D* from a photoconductive detector lies at 10(11) jones. The tailored selection of absorption onset energy through the quantum size effect, combined with deliberate engineering of the sequence of nanoparticle fusing and surface trap functionalization, underlie the superior performance achieved in this readily fabricated family of devices.	Univ Toronto, Dept Elect & Comp Engn, Toronto, ON M5S 3G4, Canada	University of Toronto	Sargent, EH (corresponding author), Univ Toronto, Dept Elect & Comp Engn, 10 Kings Coll Rd, Toronto, ON M5S 3G4, Canada.	ted.sargent@utoronto.ca	Sargent, Edward H./O-9520-2014; Howard, Ian/A-5253-2010; Hoogland, Sjoerd/ABG-7719-2020	Sargent, Edward H./0000-0003-0396-6495; Howard, Ian/0000-0002-7327-7356; Hoogland, Sjoerd/0000-0002-3099-585X; Konstantatos, Gerasimos/0000-0001-7701-8127				Carbone A, 1998, PHYS REV B, V57, P2454, DOI 10.1103/PhysRevB.57.2454; Ettenberg M. A., 2005, ADV IMAGING, V20, P29; ETTL R, 1991, NATURE, V353, P149, DOI 10.1038/353149a0; Hines MA, 2003, ADV MATER, V15, P1844, DOI 10.1002/adma.200305395; Hoogland S, 2006, OPT EXPRESS, V14, P3273, DOI 10.1364/OE.14.003273; Jarosz MV, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.195327; Kim S, 2004, NAT BIOTECHNOL, V22, P93, DOI 10.1038/nbt920; Konstantatos G, 2005, ADV FUNCT MATER, V15, P1865, DOI 10.1002/adfm.200500379; Leatherdale CA, 2000, PHYS REV B, V62, P2669, DOI 10.1103/PhysRevB.62.2669; LIML YT, 2003, MOL IMAGING, V2, P50; McDonald SA, 2005, NAT MATER, V4, P138, DOI 10.1038/nmat1299; MURRAY CB, 1993, J AM CHEM SOC, V115, P8706, DOI 10.1021/ja00072a025; Oertel DC, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2136227; PETRITZ RL, 1956, PHYS REV, V104, P1508, DOI 10.1103/PhysRev.104.1508; RAHADA RH, 1956, PHYS REV, V102, P1258; Rawlings S, 1996, NATURE, V383, P502, DOI 10.1038/383502a0; Sargent EH, 2005, ADV MATER, V17, P515, DOI 10.1002/adma.200401552; SCHER H, 1975, PHYS REV B, V12, P2455, DOI 10.1103/PhysRevB.12.2455; Schodel R, 2002, NATURE, V419, P694, DOI 10.1038/nature01121; Talapin DV, 2005, SCIENCE, V310, P86, DOI 10.1126/science.1116703; WALKER J, 1975, NATURE, V256, P695, DOI 10.1038/256695b0; Wessels JM, 2004, J AM CHEM SOC, V126, P3349, DOI 10.1021/ja0377605; Yu D, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.216802; Yu D, 2003, SCIENCE, V300, P1277, DOI 10.1126/science.1084424	25	1456	1495	24	949	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 13	2006	442	7099					180	183		10.1038/nature04855	http://dx.doi.org/10.1038/nature04855			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	062XJ	16838017				2022-12-28	WOS:000238979700042
J	Jeffcoate, W				Jeffcoate, W			Mismanagement as a prelude to privatisation of the UK NHS	LANCET			English	Editorial Material									The Lancet, London NW1 7BY, England		Jeffcoate, W (corresponding author), The Lancet, London NW1 7BY, England.							CARVEL J, 2006, GUARDIAN        0123, P1	1	4	4	0	4	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 8	2006	368	9530					98	100		10.1016/S0140-6736(06)68980-0	http://dx.doi.org/10.1016/S0140-6736(06)68980-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	062AR	16829279				2022-12-28	WOS:000238917200005
J	Sasaki, S; Ishiguro, R; Caupin, F; Maris, HJ; Balibar, S				Sasaki, S.; Ishiguro, R.; Caupin, F.; Maris, H. J.; Balibar, S.			Superfluidity of grain boundaries and supersolid behavior	SCIENCE			English	Article							SOLID HE-4; HELIUM; LIQUID	When two communicating vessels are filled to a different height with liquid, the two levels equilibrate because the liquid can flow. We have looked for such equilibration with solid He-4. For crystals with no grain boundaries, we see no flow of mass, whereas for crystals containing several grain boundaries, we detect a mass flow. Our results suggest that the transport of mass is due to the superfluidity of grain boundaries.	Associe Univ Paris 06, Ecole Normale Super, Phys Stat Lab, F-75231 Paris 05, France; Associe Paris 7, F-75231 Paris 05, France; CNRS, F-75231 Paris 05, France; Brown Univ, Dept Phys, Providence, RI 02912 USA	UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); Brown University	Sasaki, S (corresponding author), Associe Univ Paris 06, Ecole Normale Super, Phys Stat Lab, 24 Rue Lhomond, F-75231 Paris 05, France.	ssasaki@lps.ens.fr; balibar@lps.ens.fr	Balibar, Sebastien/B-5546-2013; Caupin, Frédéric/ABG-2589-2021; SASAKI, Satoshi/B-4782-2014; Balibar, Sebastien/P-3328-2019; ishiguro, ryosuke/B-4928-2013	SASAKI, Satoshi/0000-0002-5304-4969; Caupin, Frederic/0000-0002-8892-2514; ishiguro, ryosuke/0000-0002-1355-4913				Anderson PW, 2005, SCIENCE, V310, P1164, DOI 10.1126/science.1118625; ANDREEV AF, 1969, SOV PHYS JETP-USSR, V29, P1107; Balibar S, 2005, REV MOD PHYS, V77, P317, DOI 10.1103/RevModPhys.77.317; BERTMAN B, 1966, PHYS REV, V142, P74, DOI 10.1103/PhysRev.142.74; BONFAIT G, 1989, J PHYS-PARIS, V50, P1997, DOI 10.1051/jphys:0198900500150199700; Boninsegni M, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.105301; Burovski E, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.165301; CHESTER GV, 1970, PHYS REV A, V2, P256, DOI 10.1103/PhysRevA.2.256; Cho A, 2006, SCIENCE, V311, P1693; Clark BK, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.105302; Dash JG, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.235301; Day J, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.035301; Day J, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.105304; Galli DE, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.165301; GILLIS KA, 1989, PHYS REV B, V40, P6684, DOI 10.1103/PhysRevB.40.6684; GRILLY ER, 1973, J LOW TEMP PHYS, V11, P33, DOI 10.1007/BF00655035; HANSON HN, 1976, PHYS REV B, V14, P1911, DOI 10.1103/PhysRevB.14.1911; Ishiguro R, 2006, EUROPHYS LETT, V75, P91, DOI 10.1209/epl/i2006-10075-y; Khairallah SA, 2005, PHYS REV LETT, V95, DOI [10.1103/PhysRevLett.95.185301, 10.1103/PhysRevLett.185301]; Kim E, 2004, SCIENCE, V305, P1941, DOI 10.1126/science.1101501; Kim E, 2004, NATURE, V427, P225, DOI 10.1038/nature02220; LEGGETT AJ, 1970, PHYS REV LETT, V25, P1543, DOI 10.1103/PhysRevLett.25.1543; MARIS HJ, 1982, J LOW TEMP PHYS, V48, P99, DOI 10.1007/BF00681720; SHIRAHAMA K, 2006, AM PHYS SOC BALT MD; TELSCHOW K, 1974, PHYS REV LETT, V32, P1292, DOI 10.1103/PhysRevLett.32.1292	25	141	142	3	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 25	2006	313	5790					1098	1100		10.1126/science.1130879	http://dx.doi.org/10.1126/science.1130879			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	076ZT	16873608	Green Submitted			2022-12-28	WOS:000239998200039
J	Ward, WR; Canup, RM				Ward, William R.; Canup, Robin M.			Forced resonant migration of Pluto's outer satellites by Charon	SCIENCE			English	Article							GIANT IMPACT ORIGIN; KUIPER-BELT; DYNAMICS; BINARY; RINGS	Two small moons of Pluto have been discovered in low-eccentricity orbits exterior to Pluto's large satellite, Charon. All three satellite orbits are nearly coplanar, implying a common origin. It has been argued that Charon formed as a result of a giant impact with primordial Pluto. The orbital periods of the two new moons are nearly integer multiples of Charon's period, suggesting that they were driven outward by resonant interactions with Charon during its tidal orbital expansion. This could have been accomplished if Charon's orbit was eccentric during most of this orbital evolution, with the small moons originating as debris from the collision that produced Charon.	SW Res Inst, Dept Space Studies, Boulder, CO 80302 USA		Ward, WR (corresponding author), SW Res Inst, Dept Space Studies, Boulder, CO 80302 USA.	ward@boulder.swri.edu		Canup, Robin/0000-0002-2342-3458				BROUWER D, 1963, ASTRON J, V68, P152, DOI 10.1086/108932; Buie MW, 2006, ASTRON J, V132, P290, DOI 10.1086/504422; Canup RM, 2005, SCIENCE, V307, P546, DOI 10.1126/science.1106818; Canup RM, 2004, ANNU REV ASTRON ASTR, V42, P441, DOI 10.1146/annurev.astro.41.082201.113457; DERMOTT SF, 1988, ICARUS, V76, P295, DOI 10.1016/0019-1035(88)90074-7; DOBROVOLSKIS AR, 1997, PLUTO CHARON, P193; GOLDREICH P, 1981, ASTROPHYS J, V243, P1062, DOI 10.1086/158671; GOLDREICH P, 1966, ICARUS, V5, P375, DOI 10.1016/0019-1035(66)90051-0; GOLDREICH P, 1986, ASTRON J, V92, P490, DOI 10.1086/114178; LEE MH, 2006, PREPRINT; MCKINNON WB, 1989, ASTROPHYS J, V344, pL41, DOI 10.1086/185526; Murray C.D., 2001, SOLAR SYSTEM DYNAMIC; Namouni F, 2002, NATURE, V417, P45, DOI 10.1038/417045a; Olkin CB, 2003, ICARUS, V164, P254, DOI 10.1016/S0019-1035(03)00136-2; Stern SA, 2006, NATURE, V439, P946, DOI 10.1038/nature04548; Weaver HA, 2006, NATURE, V439, P943, DOI 10.1038/nature04547; Weidenschilling SJ, 2002, ICARUS, V160, P212, DOI 10.1006/icar.2002.6952	18	43	43	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 25	2006	313	5790					1107	1109		10.1126/science.1127293	http://dx.doi.org/10.1126/science.1127293			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	076ZT	16825533				2022-12-28	WOS:000239998200042
J	Barnes, PJ				Barnes, Peter J.			ABC of chronic obstructive pulmonary disease - Future treatments	BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London SW7 2AZ, England	Imperial College London	Barnes, PJ (corresponding author), Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London SW7 2AZ, England.		W, Ackermann P/B-9714-2008	W, Ackermann P/0000-0002-5520-169X; Barnes, Peter/0000-0002-5122-4018				Barnes PJ, 2005, EUR RESPIR J, V25, P1084, DOI 10.1183/09031936.05.00139104; Barnes PJ, 2004, LANCET, V364, P985, DOI 10.1016/S0140-6736(04)17025-6; Rabe KF, 2005, LANCET, V366, P563, DOI 10.1016/S0140-6736(05)67100-0	3	10	13	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JUL 29	2006	333	7561					246	248		10.1136/bmj.333.7561.246	http://dx.doi.org/10.1136/bmj.333.7561.246			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	070CC	16873860	Green Published			2022-12-28	WOS:000239496900023
J	Berwick, DM; Leatherman, S				Berwick, Donald M.; Leatherman, Sheila			Health policy - Steadying the NHS	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Inst Hlth Improvement, Cambridge, MA 02138 USA; Univ N Carolina, Sch Publ Hlth, Chapel Hill, NC 27515 USA	Institute for Healthcare Improvement; University of North Carolina; University of North Carolina Chapel Hill	Berwick, DM (corresponding author), Inst Hlth Improvement, 20 Univ Rd, Cambridge, MA 02138 USA.	dberwick@ihi.org						Department of Health, 1997, NEW NHS; Department of Health, 2005, SHORT GUID NHS FDN T; Department of Health, 2006, NAT PROGR IT NHS; Godlee F, 2006, BRIT MED J, V332, P1, DOI 10.1136/bmj.332.7532.1; LEATHERMAN S, 2005, QUEST QUALITY NHS CH; Leatherman S.T., 2003, QUEST QUALITY NHS MI; Nichols LM, 2004, HEALTH AFFAIR, V23, P8, DOI 10.1377/hlthaff.23.2.8	7	3	3	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 29	2006	333	7561					254	255		10.1136/bmj.333.7561.254	http://dx.doi.org/10.1136/bmj.333.7561.254			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	070CC	16873866	Green Published			2022-12-28	WOS:000239496900027
J	Gabelli, J; Feve, G; Berroir, JM; Placais, B; Cavanna, A; Etienne, B; Jin, Y; Glattli, DC				Gabelli, J.; Feve, G.; Berroir, J. -M.; Placais, B.; Cavanna, A.; Etienne, B.; Jin, Y.; Glattli, D. C.			Violation of Kirchhoff's laws for a coherent RC circuit	SCIENCE			English	Article							COULOMB-BLOCKADE; CONDUCTANCE	What is the complex impedance of a fully coherent quantum resistance-capacitance ( RC) circuit at gigahertz frequencies in which a resistor and a capacitor are connected in series? While Kirchhoff's laws predict addition of capacitor and resistor impedances, we report on observation of a different behavior. The resistance, here associated with charge relaxation, differs from the usual transport resistance given by the Landauer formula. In particular, for a single-mode conductor, the charge-relaxation resistance is half the resistance quantum, regardless of the transmission of the mode. The new mesoscopic effect reported here is relevant for the dynamical regime of all quantum devices.	Ecole Normale Super, Lab Pierre Aigrain, Dept Phys, 24 Rue Lhomond, F-75231 Paris 05, France; CNRS, Lab Photon & Nanostruct, UPR20, CNRS, F-91460 Marcoussis, France; CEA, Serv Phys Etat Condense, CNRS, URA 2464, F-91191 Gif Sur Yvette, France	UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CEA; Centre National de la Recherche Scientifique (CNRS)	Glattli, DC (corresponding author), Ecole Normale Super, Lab Pierre Aigrain, Dept Phys, 24 Rue Lhomond, F-75231 Paris 05, France.	glattli@lpa.ens.fr	Feve, Gwendal/E-2796-2016; GLATTLI, D. Christian/A-3748-2019; Placais, Bernard/E-3014-2016; Placais, Bernard/U-7000-2018; Berroir, Jean-Marc/F-8090-2016	Feve, Gwendal/0000-0001-5587-7537; GLATTLI, D. Christian/0000-0002-1457-0915; Placais, Bernard/0000-0003-2408-7393; Placais, Bernard/0000-0003-2408-7393; Berroir, Jean-Marc/0000-0001-7344-0929; Gabelli, Julien/0000-0002-7574-0228				Aleiner IL, 1998, PHYS REV B, V57, P9608, DOI 10.1103/PhysRevB.57.9608; ANDERSON PW, 1981, PHYS REV B, V23, P4828, DOI 10.1103/PhysRevB.23.4828; ASHOORI RC, 1993, PHYS REV LETT, V71, P613, DOI 10.1103/PhysRevLett.71.613; ASHOORI RC, 1992, PHYS REV LETT, V68, P3088, DOI 10.1103/PhysRevLett.68.3088; Averin D. V., 1992, NATO ASI SER B; Blanter YM, 2000, PHYS REP, V336, P1, DOI 10.1016/S0370-1573(99)00123-4; Brouwer PW, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.075316; Burke PJ, 2003, IEEE T NANOTECHNOL, V2, P55, DOI 10.1109/TNANO.2003.808503; BUTTIKER M, 1985, PHYS REV B, V31, P6207, DOI 10.1103/PhysRevB.31.6207; BUTTIKER M, 1990, PHYS REV B, V41, P7906, DOI 10.1103/PhysRevB.41.7906; BUTTIKER M, 1993, PHYS LETT A, V180, P364, DOI 10.1016/0375-9601(93)91193-9; BUTTIKER M, 1993, PHYS REV LETT, V70, P4114, DOI 10.1103/PhysRevLett.70.4114; BUTTIKER M, 1986, PHYS REV LETT, V57, P1761, DOI 10.1103/PhysRevLett.57.1761; Clerk AA, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.165324; Datta S., 1997, CAMBRIDGE STUDIES SE; GABELLI J, 2006, THESIS P M CURIE PA; Gao B, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.216804; GLATTLI DC, 1993, PHYSICA B, V189, P88, DOI 10.1016/0921-4526(93)90149-Z; Hekking FWJ, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.056603; Imry Y., 1997, INTRO MESOSCOPIC PHY; LANDAUER R, 1957, IBM J RES DEV, V1, P223, DOI 10.1147/rd.13.0223; LANDAUER R, 1970, PHILOS MAG, V21, P863, DOI 10.1080/14786437008238472; MATVEEV KA, 1995, PHYS REV B, V51, P1743, DOI 10.1103/PhysRevB.51.1743; Pilgram S, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.200401; Pretre A, 1996, PHYS REV B, V54, P8130, DOI 10.1103/PhysRevB.54.8130; Seelig G, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.161310	26	291	294	6	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 28	2006	313	5786					499	502		10.1126/science.1126940	http://dx.doi.org/10.1126/science.1126940			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067MZ	16840660	Green Submitted			2022-12-28	WOS:000239308600055
J	Klein, MW; Enkrich, C; Wegener, M; Linden, S				Klein, Matthias W.; Enkrich, Christian; Wegener, Martin; Linden, Stefan			Second-harmonic generation from magnetic metamaterials	SCIENCE			English	Article							SPLIT-RING RESONATORS; OPTICAL FREQUENCIES; NEGATIVE-INDEX; REFRACTION	We observe second-harmonic generation from metamaterials composed of split-ring resonators excited at 1.5-micrometer wavelength. Much larger signals are detected when magnetic-dipole resonances are excited, as compared with purely electric-dipole resonances. The experiments are consistent with calculations based on the magnetic component of the Lorentz force exerted on metal electrons - an intrinsic second-harmonic generation mechanism that plays no role in natural materials. This unusual mechanism becomes relevant in our work as a result of the enhancement and the orientation of the local magnetic fields associated with the magnetic-dipole resonances of the split-ring resonators.	Univ Karlsruhe, Inst Angew Phys, D-76131 Karlsruhe, Germany; Univ Karlsruhe, DFG, Ctr Funct Nanostruct, D-76128 Karlsruhe, Germany; Forschungszentrum Karlsruhe, Inst Nanotechnol, D-76021 Karlsruhe, Germany	Helmholtz Association; Karlsruhe Institute of Technology; German Research Foundation (DFG); Helmholtz Association; Karlsruhe Institute of Technology; Helmholtz Association; Karlsruhe Institute of Technology	Linden, S (corresponding author), Univ Karlsruhe, Inst Angew Phys, Wolfgang Gaede Str 1, D-76131 Karlsruhe, Germany.	stefan.linden@physik.uni-karlsruhe.de	Wegener, Martin/S-5456-2016; Wegener, Martin/ABD-5353-2021	Wegener, Martin/0000-0002-9770-2441; Wegener, Martin/0000-0002-9770-2441				BARLOW HM, 1954, NATURE, V173, P41, DOI 10.1038/173041a0; Chen SY, 1998, NATURE, V396, P653, DOI 10.1038/25303; Dolling G, 2006, SCIENCE, V312, P892, DOI 10.1126/science.1126021; Dolling G, 2006, OPT EXPRESS, V14, P1842, DOI 10.1364/OE.14.001842; Enkrich C, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.203901; Grigorenko AN, 2005, NATURE, V438, P335, DOI 10.1038/nature04242; GUYOTSIONNEST P, 1986, PHYS REV B, V33, P8254, DOI 10.1103/PhysRevB.33.8254; Klein MW, 2006, OPT LETT, V31, P1259, DOI 10.1364/OL.31.001259; Leonhardt U, 2006, SCIENCE, V312, P1777, DOI 10.1126/science.1126493; Linden S, 2004, SCIENCE, V306, P1351, DOI 10.1126/science.1105371; O'Brien S, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.241101; Padilla WJ, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.107401; Pendry JB, 2006, SCIENCE, V312, P1780, DOI 10.1126/science.1125907; Pendry JB, 2000, PHYS REV LETT, V85, P3966, DOI 10.1103/PhysRevLett.85.3966; Pendry JB, 1999, IEEE T MICROW THEORY, V47, P2075, DOI 10.1109/22.798002; Shelby RA, 2001, SCIENCE, V292, P77, DOI 10.1126/science.1058847; Smith DR, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.195104; VESELAGO VG, 1968, SOV PHYS USPEKHI, V10, P509, DOI 10.1070/PU1968v010n04ABEH003699; Wegener M., 2004, EXTREME NONLINEAR OP; Yen TJ, 2004, SCIENCE, V303, P1494, DOI 10.1126/science.1094025; Zhou J, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.223902	21	604	619	15	247	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 28	2006	313	5786					502	504		10.1126/science.1129198	http://dx.doi.org/10.1126/science.1129198			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067MZ	16873661	Green Published			2022-12-28	WOS:000239308600056
J	Fiellin, DA; Pantalon, MV; Chawarski, MC; Moore, BA; Sullivan, LE; O'Connor, PG; Schottenfeld, RS				Fiellin, David A.; Pantalon, Michael V.; Chawarski, Marek C.; Moore, Brent A.; Sullivan, Lynn E.; O'Connor, Patrick G.; Schottenfeld, Richard S.			Counseling plus buprenorphine-naloxone maintenance therapy for opioid dependence	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							OFFICE-BASED TREATMENT; METHADONE-MAINTENANCE; PRIMARY-CARE; HEROIN DEPENDENCE; COCAINE DEPENDENCE; RANDOMIZED-TRIAL; CLINICAL-TRIAL; ABUSE; PSYCHOTHERAPY; PLACEBO	Background: The optimal level of counseling and frequency of attendance for medication distribution has not been established for the primary care, office-based buprenorphine-naloxone treatment of opioid dependence. Methods: We conducted a 24-week randomized, controlled clinical trial with 166 patients assigned to one of three treatments: standard medical management and either once-weekly or thrice-weekly medication dispensing or enhanced medical management and thrice-weekly medication dispensing. Standard medical management was brief, manual-guided, medically focused counseling; enhanced management was similar, but each session was extended. The primary outcomes were the self-reported frequency of illicit opioid use, the percentage of opioid-negative urine specimens, and the maximum number of consecutive weeks of abstinence from illicit opioids. Results: The three treatments had similar efficacies with respect to the mean percentage of opioid-negative urine specimens (standard medical management and once-weekly medication dispensing, 44 percent; standard medical management and thrice-weekly medication dispensing, 40 percent; and enhanced medical management and thrice-weekly medication dispensing, 40 percent; P=0.82) and the maximum number of consecutive weeks during which patients were abstinent from illicit opioids. All three treatments were associated with significant reductions from baseline in the frequency of illicit opioid use, but there were no significant differences among the treatments. The proportion of patients remaining in the study at 24 weeks did not differ significantly among the patients receiving standard medical management and once-weekly medication dispensing (48 percent) or thrice-weekly medication dispensing (43 percent) or enhanced medical management and thrice-weekly medication dispensing (39 percent) (P=0.64). Adherence to buprenorphine-naloxone treatment varied; increased adherence was associated with improved treatment outcomes. Conclusions: Among patients receiving buprenorphine-naloxone in primary care for opioid dependence, the efficacy of brief weekly counseling and once-weekly medication dispensing did not differ significantly from that of extended weekly counseling and thrice-weekly dispensing. Strategies to improve buprenorphine-naloxone adherence are needed. (ClinicalTrials.gov number, NCT00023283.)	Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Psychiat, New Haven, CT 06520 USA	Yale University; Yale University	Fiellin, DA (corresponding author), Yale Univ, Sch Med, Dept Internal Med, 333 Cedar St,POB 208025, New Haven, CT 06520 USA.	david.fiellin@yale.edu	Moore, Brent/O-4867-2015	Moore, Brent/0000-0003-0123-6616; Fiellin, David/0000-0002-4006-010X	NIDA NIH HHS [K23 DA15144, K12 DA00167, K24 DA000445-03, R01 DA009803-07] Funding Source: Medline; NATIONAL INSTITUTE ON DRUG ABUSE [K24DA000445, R01DA009803, K23DA015144, K12DA000167] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		AMASS L, 1994, LIFE SCI, V54, P1215, DOI 10.1016/0024-3205(94)00848-5; Amato L., 2004, COCHRANE DB SYST REV, V4; [Anonymous], 1994, DIAGNOSTIC STAT MANU; Bouchez J, 1998, EUR ADDICT RES, V4, P19, DOI 10.1159/000052037; Carroll KM, 2000, DRUG ALCOHOL DEPEN, V57, P225, DOI 10.1016/S0376-8716(99)00049-6; CARROLL KM, 1994, ARCH GEN PSYCHIAT, V51, P177; Crits-Christoph P, 1999, ARCH GEN PSYCHIAT, V56, P493, DOI 10.1001/archpsyc.56.6.493; Fiellin DA, 2004, AM J ADDICTION, V13, pS67, DOI 10.1080/10550490490440843; Fiellin DA, 2002, ANN INTERN MED, V137, P688, DOI 10.7326/0003-4819-137-8-200210150-00014; Fiellin DA, 2002, AM J DRUG ALCOHOL AB, V28, P231, DOI 10.1081/ADA-120002972; Fiellin DA, 2001, JAMA-J AM MED ASSOC, V286, P1724, DOI 10.1001/jama.286.14.1724; Fudala PJ, 2003, NEW ENGL J MED, V349, P949, DOI 10.1056/NEJMoa022164; George TP, 2000, BIOL PSYCHIAT, V47, P1080, DOI 10.1016/S0006-3223(99)00310-8; HARTEL DM, 1995, AM J PUBLIC HEALTH, V85, P83, DOI 10.2105/AJPH.85.1.83; JOHNSON RE, 1995, DRUG ALCOHOL DEPEN, V40, P17, DOI 10.1016/0376-8716(95)01186-2; Johnson RE, 2000, NEW ENGL J MED, V343, P1290, DOI 10.1056/NEJM200011023431802; KOSTEN TR, 1993, J NERV MENT DIS, V181, P358, DOI 10.1097/00005053-199306000-00004; Ling W, 1996, ARCH GEN PSYCHIAT, V53, P401; Ling W, 1998, ADDICTION, V93, P475, DOI 10.1046/j.1360-0443.1998.9344753.x; MCLELLAN AT, 1993, JAMA-J AM MED ASSOC, V269, P1953, DOI 10.1001/jama.269.15.1953; MERCER D, 1992, GROUP DRUG COUNSELIN; O'Connor PG, 1998, AM J MED, V105, P100, DOI 10.1016/S0002-9343(98)00194-6; OConnor PG, 1996, AM J DRUG ALCOHOL AB, V22, P523, DOI 10.3109/00952999609001678; Pantalon MV, 2004, ADDICTIVE DISORDERS, V3, P71; Schottenfeld RS, 1997, ARCH GEN PSYCHIAT, V54, P713; Sees KL, 2000, JAMA-J AM MED ASSOC, V283, P1303, DOI 10.1001/jama.283.10.1303; Steiner JF, 2000, ANN INTERN MED, V132, P926, DOI 10.7326/0003-4819-132-11-200006060-00026; STOUT RL, 1994, J STUD ALCOHOL, P70, DOI 10.15288/jsas.1994.s12.70; Sullivan LE, 2005, DRUG ALCOHOL DEPEN, V79, P113, DOI 10.1016/j.drugalcdep.2004.12.008; WALSH SL, 1994, CLIN PHARMACOL THER, V55, P569, DOI 10.1038/clpt.1994.71	30	254	257	0	11	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 27	2006	355	4					365	374		10.1056/NEJMoa055255	http://dx.doi.org/10.1056/NEJMoa055255			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	067DT	16870915				2022-12-28	WOS:000239282600005
J	Kitchen, D; Richardella, A; Tang, JM; Flatte, ME; Yazdani, A				Kitchen, Dale; Richardella, Anthony; Tang, Jian-Ming; Flatte, Michael E.; Yazdani, Ali			Atom-by-atom substitution of Mn in GaAs and visualization of their hole-mediated interactions	NATURE			English	Article							FERROMAGNETIC SEMICONDUCTORS; CURIE-TEMPERATURE; GA1-XMNXAS; (GA,MN)AS	The discovery of ferromagnetism in Mn-doped GaAs1 has ignited interest in the development of semiconductor technologies based on electron spin and has led to several proof-of-concept spintronic devices(2-4). A major hurdle for realistic applications of Ga1-xMnxAs, or other dilute magnetic semiconductors, remains that their ferromagnetic transition temperature is below room temperature. Enhancing ferromagnetism in semiconductors requires us to understand the mechanisms for interaction between magnetic dopants, such as Mn, and identify the circumstances in which ferromagnetic interactions are maximized(5). Here we describe an atom-by-atom substitution technique using a scanning tunnelling microscope (STM) and apply it to perform a controlled study at the atomic scale of the interactions between isolated Mn acceptors, which are mediated by holes in GaAs. High-resolution STM measurements are used to visualize the GaAs electronic states that participate in the Mn - Mn interaction and to quantify the interaction strengths as a function of relative position and orientation. Our experimental findings, which can be explained using tight-binding model calculations, reveal a strong dependence of ferromagnetic interaction on crystallographic orientation. This anisotropic interaction can potentially be exploited by growing oriented Ga1-xMnxAs structures to enhance the ferromagnetic transition temperature beyond that achieved in randomly doped samples.	Princeton Univ, Joseph Henry Labs, Dept Phys, Princeton, NJ 08544 USA; Univ Illinois, Dept Phys, Urbana, IL 61801 USA; Univ Iowa, Opt Sci & Technol Ctr, Iowa City, IA 52242 USA; Univ Iowa, Dept Phys & Astron, Iowa City, IA 52242 USA	Princeton University; University of Illinois System; University of Illinois Urbana-Champaign; University of Iowa; University of Iowa	Yazdani, A (corresponding author), Princeton Univ, Joseph Henry Labs, Dept Phys, Princeton, NJ 08544 USA.	yazdani@princeton.edu	Tang, Jian-Ming/B-5534-2011	Tang, Jian-Ming/0000-0001-9033-0350; Flatte, Michael/0000-0001-5093-1549; Yazdani, Ali/0000-0003-4996-8904				BURCH KS, 2006, IMPURITY BAND CONDUC; Chiba D, 2003, APPL PHYS LETT, V82, P3020, DOI 10.1063/1.1571666; Dietl T, 2000, SCIENCE, V287, P1019, DOI 10.1126/science.287.5455.1019; Edmonds KW, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.037201; Edmonds KW, 2002, APPL PHYS LETT, V81, P4991, DOI 10.1063/1.1529079; Eid KF, 2004, APPL PHYS LETT, V85, P1556, DOI 10.1063/1.1787945; FEENSTRA RM, 1987, PHYS REV LETT, V58, P1192, DOI 10.1103/PhysRevLett.58.1192; FEENSTRA RM, 1987, J VAC SCI TECHNOL B, V5, P923, DOI 10.1116/1.583691; Flatte ME, 2000, PHYS REV B, V61, P14810, DOI 10.1103/PhysRevB.61.14810; FU HX, 1995, SURF SCI, V341, P273, DOI 10.1016/0039-6028(95)00735-0; Kane BE, 1998, NATURE, V393, P133, DOI 10.1038/30156; Kitchen D, 2005, J SUPERCOND, V18, P23, DOI 10.1007/s10948-005-2144-x; Ku KC, 2003, APPL PHYS LETT, V82, P2302, DOI 10.1063/1.1564285; Macdonald AH, 2005, NAT MATER, V4, P195, DOI 10.1038/nmat1325; Mahadevan P, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.177201; Mahadevan P, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.115211; Ohno H, 1996, APPL PHYS LETT, V69, P363, DOI 10.1063/1.118061; Ohno H, 2000, NATURE, V408, P944, DOI 10.1038/35050040; Ohno Y, 1999, NATURE, V402, P790, DOI 10.1038/45509; Okabayashi J, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevB.64.125304; Sanvito S, 2002, J SUPERCOND, V15, P85, DOI 10.1023/A:1014083312066; Singley EJ, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.097203; Tang JM, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.161315; Tang JM, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.047201; Timm C, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.155206; Yakunin AM, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.216806; Yakunin AM, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.256402; Zarand G, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.047201	28	235	239	1	79	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 27	2006	442	7101					436	439		10.1038/nature04971	http://dx.doi.org/10.1038/nature04971			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067CI	16871214	Green Submitted			2022-12-28	WOS:000239278900039
J	Psaltis, D; Quake, SR; Yang, CH				Psaltis, Demetri; Quake, Stephen R.; Yang, Changhuei			Developing optofluidic technology through the fusion of microfluidics and optics	NATURE			English	Review							SURFACE-PLASMON RESONANCE; MANIPULATION; FABRICATION; THRESHOLD; SENSORS; SYSTEMS; LASER; EDGE; LENS	We describe devices in which optics and fluidics are used synergistically to synthesize novel functionalities. Fluidic replacement or modification leads to reconfigurable optical systems, whereas the implementation of optics through the microfluidic toolkit gives highly compact and integrated devices. We categorize optofluidics according to three broad categories of interactions: fluid - solid interfaces, purely fluidic interfaces and colloidal suspensions. We describe examples of optofluidic devices in each category.	CALTECH, Dept Elect Engn, Pasadena, CA 91125 USA; Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; Howard Hughes Med Inst, Stanford, CA 94305 USA	California Institute of Technology; Stanford University; Howard Hughes Medical Institute	Psaltis, D (corresponding author), CALTECH, Dept Elect Engn, Pasadena, CA 91125 USA.	psaltis@sunoptics.caltech.edu		Hidayat, Rahmat/0000-0002-3081-4051				Adleman JR, 2006, OPT LETT, V31, P447, DOI 10.1364/OL.31.000447; Aizpurua J, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.057401; Armani AM, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2099529; Atencia J, 2005, NATURE, V437, P648, DOI 10.1038/nature04163; Beebe DJ, 2000, P NATL ACAD SCI USA, V97, P13488, DOI 10.1073/pnas.250273097; Brody JP, 1999, APPL PHYS LETT, V74, P144, DOI 10.1063/1.122977; Campbell K, 2004, APPL PHYS LETT, V85, P6119, DOI 10.1063/1.1839281; Cattaneo F, 2003, J MICROELECTROMECH S, V12, P907, DOI 10.1109/JMEMS.2003.820285; Chiou PY, 2005, NATURE, V436, P370, DOI [10.1038/nature03831, 10.1038/nature0383l]; Domachuk P, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2181204; Domachuk P, 2005, OPT EXPRESS, V13, P7265, DOI 10.1364/OPEX.13.007265; Domachuk P, 2004, APPL PHYS LETT, V84, P1838, DOI 10.1063/1.1667592; DOWLING JP, 1994, J APPL PHYS, V75, P1896, DOI 10.1063/1.356336; Duffy DC, 1998, ANAL CHEM, V70, P4974, DOI 10.1021/ac980656z; Erickson D, 2006, OPT LETT, V31, P59, DOI 10.1364/OL.31.000059; ERICKSON D, 2005, P ICMM JUN 13 15 CAN; Fiorini GS, 2004, ANAL CHEM, V76, P4697, DOI 10.1021/ac0498922; Galas JC, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1968421; Gambin Y, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2194477; Grier DG, 2003, NATURE, V424, P810, DOI 10.1038/nature01935; Grillet C, 2004, OPT EXPRESS, V12, P5440, DOI 10.1364/OPEX.12.005440; Groisman A, 2003, SCIENCE, V300, P955, DOI 10.1126/science.1083694; HAAS WE, 1983, MOL CRYST LIQ CRYST, V94, P1, DOI 10.1080/00268948308084244; Hayes RA, 2003, NATURE, V425, P383, DOI 10.1038/nature01988; Helbo B, 2004, SENSOR ACTUAT A-PHYS, V111, P21, DOI 10.1016/j.sna.2003.10.007; HENG X, UNPUB LAB CHIP; Homola J, 1999, SENSOR ACTUAT B-CHEM, V54, P3, DOI 10.1016/S0925-4005(98)00321-9; Hong JW, 2003, NAT BIOTECHNOL, V21, P1179, DOI 10.1038/nbt871; Joannopoulos J. D., 1995, PHOTONIC CRYSTALS; Knight JC, 1998, SCIENCE, V282, P1476, DOI 10.1126/science.282.5393.1476; Kuiper S, 2004, APPL PHYS LETT, V85, P1128, DOI 10.1063/1.1779954; Levene MJ, 2003, SCIENCE, V299, P682, DOI 10.1126/science.1079700; Levy U, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2182111; Li ZY, 2006, OPT EXPRESS, V14, P696, DOI 10.1364/OPEX.14.000696; Liang W, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1904716; Liu GL, 2006, NAT MATER, V5, P27, DOI 10.1038/nmat1528; Lu Y, 2005, NANO LETT, V5, P119, DOI 10.1021/nl048232+; Mach P, 2002, APPL PHYS LETT, V80, P4294, DOI 10.1063/1.1483384; Maune B, 2004, APPL PHYS LETT, V85, P360, DOI 10.1063/1.1772869; McDonald JC, 2000, ELECTROPHORESIS, V21, P27, DOI 10.1002/(SICI)1522-2683(20000101)21:1<27::AID-ELPS27>3.0.CO;2-C; Mookherjea S, 2002, IEEE J SEL TOP QUANT, V8, P448, DOI 10.1109/JSTQE.2002.1016347; Mugele F, 2005, J PHYS-CONDENS MAT, V17, pR705, DOI 10.1088/0953-8984/17/28/R01; Neuman KC, 2004, REV SCI INSTRUM, V75, P2787, DOI 10.1063/1.1785844; Painter O, 1999, SCIENCE, V284, P1819, DOI 10.1126/science.284.5421.1819; Pang L, 2005, OPT EXPRESS, V13, P9003, DOI 10.1364/OPEX.13.009003; Quake SR, 2000, SCIENCE, V290, P1536, DOI 10.1126/science.290.5496.1536; Rolland JP, 2004, J AM CHEM SOC, V126, P2322, DOI 10.1021/ja031657y; Ronchi V, 1969, Physis Riv Int Stor Sci, V11, P520; Schuck P, 1997, ANNU REV BIOPH BIOM, V26, P541, DOI 10.1146/annurev.biophys.26.1.541; Shinn A, 2005, SENSOR ACTUAT B-CHEM, V105, P360, DOI 10.1016/j.snb.2004.06.024; Squires TM, 2005, REV MOD PHYS, V77, P977, DOI 10.1103/RevModPhys.77.977; Stone HA, 2004, ANNU REV FLUID MECH, V36, P381, DOI 10.1146/annurev.fluid.36.050802.122124; Sudarsan AP, 2005, ANAL CHEM, V77, P5167, DOI 10.1021/ac050448o; Thorsen T, 2002, SCIENCE, V298, P580, DOI 10.1126/science.1076996; Trindade T, 2001, CHEM MATER, V13, P3843, DOI 10.1021/cm000843p; Van der Hulst H. C., 1957, LIGHT SCATTERING SMA; Vezenov DV, 2005, J AM CHEM SOC, V127, P8952, DOI 10.1021/ja0517421; Vezenov DV, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1850610; Vo-Dinh T, 1998, TRAC-TREND ANAL CHEM, V17, P557, DOI 10.1016/S0165-9936(98)00069-7; Wang X, 2000, APPL OPTICS, V39, P6545, DOI 10.1364/AO.39.006545; WHITESIDES G, 2004, P NATL ACAD SCI USA, V34, P12434; Wolfe DB, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2119412; Wolfe DB, 2004, P NATL ACAD SCI USA, V101, P12434, DOI 10.1073/pnas.0404423101; Wood RW, 1909, ASTROPHYS J, V29, P164, DOI 10.1086/141639; Xia YN, 1996, SCIENCE, V273, P347, DOI 10.1126/science.273.5273.347; Xu F, 1995, OPT LETT, V20, P2457, DOI 10.1364/OL.20.002457; Zhang DY, 2004, APPL PHYS LETT, V84, P4194, DOI 10.1063/1.1756679	67	1395	1486	36	922	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 27	2006	442	7101					381	386		10.1038/nature05060	http://dx.doi.org/10.1038/nature05060			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067CI	16871205	Green Published			2022-12-28	WOS:000239278900030
J	Harnden, A; Grant, C; Harrison, T; Perera, R; Brueggemann, AB; Mayon-White, R; Mant, D				Harnden, Anthony; Grant, Cameron; Harrison, Timothy; Perera, Rafael; Brueggemann, Angela B.; Mayon-White, Richard; Mant, David			Whooping cough in school age children with persistent cough: prospective cohort study in primary care	BRITISH MEDICAL JOURNAL			English	Article							BORDETELLA-PERTUSSIS INFECTION; ADULTS; OUTBREAK	Objective To estimate the proportion of school age children with a persistent cough who have evidence of a recent Bordetella pertussis infection. Design Prospective cohort study (October 2001 to March 2005). Setting General practices in Oxfordshire, England. Participants 172 children aged 5-16 years who presented to their general practitioner with a cough lasting 14 days or more who consented to have a blood test. Main outcome measures Serological evidence of a recent Bordetella pertussis infection; symptoms at presentation; duration and severity of cough; sleep disturbance (parents and child). Results 64 (37.2%, 95% confidence interval 30.0% to 44.4%) children had serological evidence of a recent Bordetella pertussis infection; 55 (85.9%) of these children had been fully immunised. At presentation, children with whooping cough were more likely than others to have whooping (odds ratio 2.85, 95% confidence interval 1.39 to 5.82), vomiting (4.35, 2.04 to 9.25), and sputum production (2.39, 1.14 to 5.02). Children with whooping cough were also more likely to still be coughing two months after the start of their illness (85% v 48%; P = 0.001), continue to have more than five coughing episodes a day (P = 0.049), and cause sleep disturbance for their parents (P = 0.003). Conclusions For school age children presenting to primary care with a cough lasting two weeks or more, a diagnosis of whooping cough should be considered even if the child has been immunised. Making a secure diagnosis of whooping cough may prevent inappropriate investigations and treatment.	Univ Oxford, Dept Primary Hlth Care, Oxford OX3 7LF, England; Univ Auckland, Starship Childrens Hosp, Dept Paediat, Auckland 1, New Zealand; Hlth Protect Agcy, Ctr Infect, Resp & Systemat Infect Lab, London NW9 5HT, England	University of Oxford; Starship Children's Hospital; University of Auckland; Health Protection Agency	Harnden, A (corresponding author), Univ Oxford, Dept Primary Hlth Care, Oxford OX3 7LF, England.	anthony.harnden@dphpc.ox.ac.uk	Mant, David CA/C-7763-2009	Grant, Cameron/0000-0002-4032-7230; Brueggemann, Angela/0000-0002-2329-1934; Perera, Rafael/0000-0003-2418-2091	Medical Research Council [G0000340] Funding Source: Medline; MRC [G0000340] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		BIELLIK RJ, 1988, J INFECT DIS, V157, P1134, DOI 10.1093/infdis/157.6.1134; de Melker HE, 2000, J CLIN MICROBIOL, V38, P800, DOI 10.1128/JCM.38.2.800-806.2000; Faniran AO, 1998, ARCH DIS CHILD, V79, P411, DOI 10.1136/adc.79.5.411; Gilberg S, 2002, J INFECT DIS, V186, P415, DOI 10.1086/341511; LAMBERT HJ, 1965, PUBLIC HEALTH REP, V80, P365, DOI 10.2307/4592424; ROBERTSON PW, 1987, MED J AUSTRALIA, V146, P522, DOI 10.5694/j.1326-5377.1987.tb120392.x; SCHMITTGROHE S, 1995, CLIN INFECT DIS, V21, P860, DOI 10.1093/clinids/21.4.860; Senzilet LD, 2001, CLIN INFECT DIS, V32, P1691, DOI 10.1086/320754; Van Buynder PG, 1999, EPIDEMIOL INFECT, V123, P403, DOI 10.1017/S0950268899003052; WRIGHT SW, 1995, JAMA-J AM MED ASSOC, V273, P1044, DOI 10.1001/jama.273.13.1044	10	74	76	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JUL 22	2006	333	7560					174	177		10.1136/bmj.38870.655405.AE	http://dx.doi.org/10.1136/bmj.38870.655405.AE			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	068DJ	16829538	Green Submitted, Bronze, Green Published			2022-12-28	WOS:000239352100020
J	Laing, C; Hamour, S; Sheaff, M; Miller, R; Woolfson, R				Laing, Chris; Hamour, Sally; Sheaff, Michael; Miller, Ron; Woolfson, Robin			Chinese herbal uropathy and nephropathy	LANCET			English	Editorial Material									Whittington Hosp, Dept Nephrol, London N19 5NF, England; Whittington Hosp, Dept Urol, London N19 5NF, England; Royal London Hosp, Barts & London NHS Trust, Dept Histopathol, London E1 1BB, England	University of London; University College London; University of London; University College London; Barts Health NHS Trust; Royal London Hospital	Hamour, S (corresponding author), Whittington Hosp, Dept Nephrol, London N19 5NF, England.	sallyhamour@hotmail.com						CHUNG O, 2004, STANDARD        0317; DEPIERREUX M, 1994, AM J KIDNEY DIS, V24, P172, DOI 10.1016/S0272-6386(12)80178-8; Gold LS, 2003, NEW ENGL J MED, V349, P1576, DOI 10.1056/NEJM200310163491619; Nortier JL, 2000, NEW ENGL J MED, V342, P1686, DOI 10.1056/NEJM200006083422301; VANHERWEGHEM JL, 1993, LANCET, V341, P387, DOI 10.1016/0140-6736(93)92984-2	5	46	50	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 22	2006	368	9532					338	338		10.1016/S0140-6736(06)69079-X	http://dx.doi.org/10.1016/S0140-6736(06)69079-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	067PF	16860704				2022-12-28	WOS:000239314400032
J	Hasin, T; Davidovitch, N; Cohen, R; Dagan, T; Romem, A; Orr, N; Klement, E; Lubezky, N; Kayouf, R; Sela, T; Keller, N; Derazne, E; Halperin, T; Yavzori, M; Grotto, I; Cohen, D				Hasin, T; Davidovitch, N; Cohen, R; Dagan, T; Romem, A; Orr, N; Klement, E; Lubezky, N; Kayouf, R; Sela, T; Keller, N; Derazne, E; Halperin, T; Yavzori, M; Grotto, I; Cohen, D			Postexposure treatment with doxycycline for the prevention of tick-borne relapsing fever	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GLYCEROPHOSPHODIESTER PHOSPHODIESTERASE GLPQ; JARISCH-HERXHEIMER REACTION; SINGLE-DOSE DOXYCYCLINE; BORRELIA-RECURRENTIS; LYME-DISEASE; TETRACYCLINE	BACKGROUND: Tick-borne relapsing fever (TBRF) is an acute febrile illness. In Israel, TBRF is caused by Borrelia persica and is transmitted by Ornithodoros tholozani ticks. We examined the safety and efficacy of postexposure treatment to prevent TBRF. METHODS: In a double-blind, placebo-controlled trial, 93 healthy subjects with suspected tick exposure (52 with signs of tick bites and 41 close contacts -- those without signs but with a similar risk of contact with ticks) were randomly assigned to receive either doxycycline (Dexxon, in a dose of 200 mg the first day and then 100 mg per day for four days) or placebo after presumed exposure to TBRF. Cases of TBRF were defined by fever and a positive blood smear. Serologic analysis for cross-reactivity to Borrelia burgdorferi and polymerase chain reaction (PCR) for the borrelia glpQ gene were also performed. RESULTS: After randomization, 47 subjects (26 with signs of tick bites and 21 close contacts) received doxycycline. Forty-six other subjects (26 with signs of tick bites and 20 close contacts) received placebo. All 10 cases of TBRF identified by a positive blood smear were in the placebo group of subjects with signs of a tick bite (P<0.001). These findings suggested a 100 percent efficacy of preemptive treatment (95 percent confidence interval, 46 to 100 percent). PCR for the borrelia glpQ gene was negative at baseline for all subjects and subsequently positive in all subjects with fever and a positive blood smear. Seroconversion was detected in eight of nine cases of TBRF. PCR and serum samples were negative for all of the other subjects tested. No major treatment-associated adverse effects were identified. CONCLUSIONS: Treatment with doxycycline is safe and efficacious in preventing TBRF after suspected exposure to ticks in a high-risk environment.	Israel Def Forces, Med Corps, Mil Post 02149, Tel Hashomer, Israel; Israel Def Forces, AF Acad, Tel Hashomer, Israel; Israel Def Forces, AF, Tel Hashomer, Israel; Haim Sheba Med Ctr, Bacteriol Lab, Tel Hashomer, Israel; Tel Aviv Univ, Sackler Fac Med, Sch Publ Hlth, Dept Epidemiol & Prevent Med, IL-69978 Tel Aviv, Israel	Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine	Hasin, T (corresponding author), 16A Koboby St, IL-96757 Jerusalem, Israel.	hasintal@zahav.net.il	Grotto, Itamar/F-2028-2012; Klement, Eyal/H-8388-2019	Klement, Eyal/0000-0002-2384-2345; Cohen, Daniel/0000-0003-2664-2303; Grotto, Itamar/0000-0002-3363-3715				BaradaranDilmaghani R, 1996, INFECTION, V24, P60, DOI 10.1007/BF01780660; BARBER DH, 1999, TROPICAL INFECT DIS, P535; BURGDORFER W, 1967, ANNU REV ENTOMOL, V12, P347, DOI 10.1146/annurev.en.12.010167.002023; Cadavid D, 1998, CLIN INFECT DIS, V26, P151, DOI 10.1086/516276; DECLERCQ AG, 1975, E AFR MED J, V52, P428; DENNIS DT, 1998, HARRISONS PRINCIPLES, P1038; Dworkin MS, 1998, CLIN INFECT DIS, V26, P122, DOI 10.1086/516273; EGOZ N, 1978, HAREFUAH, V95, P367; GALUN E, 1984, J INFECT DIS, V150, P617, DOI 10.1093/infdis/150.4.617; GRACIA L, 2003, MANUAL CLIN MICROBIO, P1934; Halperin T, 2006, ACTA TROP, V98, P189, DOI 10.1016/j.actatropica.2006.04.004; JOHNSON WD, 2000, MANDELL DOUGLAS BENN, P2502; Korenberg EI, 1996, INFECTION, V24, P187, DOI 10.1007/BF01713337; LERMAN Y, 1978, HAREFUAH, V95, P365; LILES WC, 1993, WESTERN J MED, V158, P200; Megiddo D, 1984, Harefuah, V107, P142; Nadelman RB, 2001, NEW ENGL J MED, V345, P79, DOI 10.1056/NEJM200107123450201; NEGUSSIE Y, 1992, J EXP MED, V175, P1207, DOI 10.1084/jem.175.5.1207; Porcella SF, 2000, J CLIN MICROBIOL, V38, P3561, DOI 10.1128/JCM.38.10.3561-3571.2000; RAZ R, 1987, ISRAEL J MED SCI, V23, P221; ROSA PA, 1989, J INFECT DIS, V160, P1018, DOI 10.1093/infdis/160.6.1018; TEKLU B, 1983, LANCET, V1, P835; van Dam AP, 1999, J CLIN MICROBIOL, V37, P2027, DOI 10.1128/JCM.37.6.2027-2030.1999; WARRELL DA, 1983, J INFECT DIS, V147, P898, DOI 10.1093/infdis/147.5.898; WILSKE B, 2003, MANUAL CLIN MICROBIO, P941	25	30	34	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 13	2006	355	2					148	155		10.1056/NEJMoa053884	http://dx.doi.org/10.1056/NEJMoa053884			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	062UP	16837678				2022-12-28	WOS:000238970600006
J	Mulch, A; Graham, SA; Chamberlain, CP				Mulch, Andreas; Graham, Stephan A.; Chamberlain, C. Page			Hydrogen isotopes in Eocene river gravels and paleoelevation of the Sierra Nevada	SCIENCE			English	Article							UPLIFT; CALIFORNIA; TECTONICS; EVOLUTION; TOPOGRAPHY; HIMALAYA; BENEATH; ORIGIN; BASIN	We determine paleoelevation of the Sierra Nevada, California, by tracking the effect of topography on precipitation, as recorded in hydrogen isotopes of kaolinite exposed in gold-bearing river deposits from the Eocene Yuba River. The data, compared with the modern isotopic composition of precipitation, show that about 40 to 50 million years ago the Sierra Nevada stood tall ( >= 2200 meters), a result in conflict with proposed young surface uplift by tectonic and climatic forcing but consistent with the Sierra Nevada representing the edge of a pre-Eocene continental plateau.	Stanford Univ, Stanford, CA 94305 USA	Stanford University	Mulch, A (corresponding author), Stanford Univ, 450 Serra Mall,Bldg 320, Stanford, CA 94305 USA.	mulch@pangea.stanford.edu	Mulch, Andreas/A-1324-2013					Beaumont C, 2001, NATURE, V414, P738, DOI 10.1038/414738a; Clark M.K., 2005, GEOLOGICAL SOC AM TO, V15, P4, DOI [10:1130/1052-5173(2005)0152.0.CO;2, 10.1130/1052-5173(2005)015[4:TNLOTS]2.0.CO;2, DOI 10.1130/1052-5173(2005)015[4:TNLOTS]2.0.CO;2]; DeCelles PG, 2004, AM J SCI, V304, P105, DOI 10.2475/ajs.304.2.105; DICKINSON WR, 1979, GEOLOGICAL SOC AM B, V0090, P01458, DOI DOI 10.1130/GSAB-P2-90-1458; Ducea MN, 1998, CONTRIB MINERAL PETR, V133, P169, DOI 10.1007/s004100050445; Garzione CN, 2000, EARTH PLANET SC LETT, V183, P215, DOI 10.1016/S0012-821X(00)00252-1; Henry CD, 2001, GEOLOGY, V29, P719, DOI 10.1130/0091-7613(2001)029<0719:SNBART>2.0.CO;2; House MA, 1998, NATURE, V396, P66, DOI 10.1038/23926; INGRAHAM NL, 1991, WATER RESOUR RES, V27, P77, DOI 10.1029/90WR01708; Jones CH, 2004, GEOL SOC AM BULL, V116, P1408, DOI 10.1130/B25397.1; LINDGREN W, 1911, US GEOL SURV PROF PA, V73; MOLNAR P, 1990, NATURE, V346, P29, DOI 10.1038/346029a0; Mulch A, 2004, GEOLOGY, V32, P525, DOI 10.1130/G20394.1; Poage MA, 2002, TECTONICS, V21, DOI 10.1029/2001TC001303; Poage MA, 2001, AM J SCI, V301, P1, DOI 10.2475/ajs.301.1.1; Rowley DB, 2001, EARTH PLANET SC LETT, V188, P253, DOI 10.1016/S0012-821X(01)00324-7; Saleeby J, 2003, TECTONICS, V22, DOI 10.1029/2002TC001374; SMALL EE, 1995, SCIENCE, V270, P277, DOI 10.1126/science.270.5234.277; Stock GM, 2005, EARTH SURF PROC LAND, V30, P985, DOI 10.1002/esp.1258; UNRUH JR, 1991, GEOL SOC AM BULL, V103, P1395, DOI 10.1130/0016-7606(1991)103<1395:TUOTSN>2.3.CO;2; Wakabayashi J, 2001, J GEOL, V109, P539, DOI 10.1086/321962; Wernicke B, 1996, SCIENCE, V271, P190, DOI 10.1126/science.271.5246.190; YEEND WH, 1974, US GEOL SURV PROF PA, V722; Zandt G, 2004, NATURE, V431, P41, DOI 10.1038/nature02847	24	150	156	1	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 7	2006	313	5783					87	89		10.1126/science.1125986	http://dx.doi.org/10.1126/science.1125986			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061DA	16825568				2022-12-28	WOS:000238850200036
J	Waterhouse, PM; Fusaro, AF				Waterhouse, Peter M.; Fusaro, Adriana F.			Viruses face a double defense by plant small RNAs	SCIENCE			English	Editorial Material							DICER-LIKE PROTEINS; SUPPRESSION; INDUCTION; IMMUNITY; BINDING		CSIRO Plant Ind, Canberra, ACT 2601, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Waterhouse, PM (corresponding author), CSIRO Plant Ind, Canberra, ACT 2601, Australia.	peter.waterhouse@csiro.au	Fusaro, Adriana F./CAF-8495-2022; Fusaro, Adriana F/J-9986-2013	Fusaro, Adriana F./0000-0001-7192-556X; Fusaro, Adriana F/0000-0001-7192-556X; Waterhouse, Peter/0000-0002-2812-3753				Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Cullen BR, 2006, NAT IMMUNOL, V7, P563, DOI 10.1038/ni1352; Deleris A, 2006, SCIENCE, V313, P68, DOI 10.1126/science.1128214; Hamilton AJ, 1999, SCIENCE, V286, P950, DOI 10.1126/science.286.5441.950; Hiraguri A, 2005, PLANT MOL BIOL, V57, P173, DOI 10.1007/s11103-004-6853-5; LAKATOS L, 2006, EMBO J; Li HW, 2002, SCIENCE, V296, P1319, DOI 10.1126/science.1070948; Lu R, 2004, P NATL ACAD SCI USA, V101, P15742, DOI 10.1073/pnas.0404940101; Margis R, 2006, FEBS LETT, V580, P2442, DOI 10.1016/j.febslet.2006.03.072; Merai Z, 2006, J VIROL, V80, P5747, DOI 10.1128/JVI.01963-05; Pazhouhandeh M, 2006, P NATL ACAD SCI USA, V103, P1994, DOI 10.1073/pnas.0510784103; Tomari Y, 2005, GENE DEV, V19, P517, DOI 10.1101/gad.1284105; Voinnet O, 2005, NAT REV GENET, V6, P206, DOI 10.1038/nrg1555; Wang XH, 2006, SCIENCE, V312, P452, DOI 10.1126/science.1125694; Xie ZX, 2004, PLOS BIOL, V2, P642, DOI 10.1371/journal.pbio.0020104	15	40	54	1	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 7	2006	313	5783					54	55		10.1126/science.1130818	http://dx.doi.org/10.1126/science.1130818			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061DA	16825558				2022-12-28	WOS:000238850200024
J	Augustin, N; Wessely, R; Porner, M; Schomig, A; Lange, R				Augustin, N.; Wessely, Rainer; Poerner, Michael; Schoemig, Albert; Lange, Ruediger			Giant coronary aneurysm obstructing the right heart	LANCET			English	Editorial Material									Tech Univ Munich, Dept Cardiovasc Surg, German Heart Ctr, D-80636 Munich, Germany; Tech Univ Munich, Dept Cardiol, German Heart Ctr, D-80636 Munich, Germany; Tech Univ Munich, Inst Radiol & Nucl Med, German Heart Ctr, D-80636 Munich, Germany	German Heart Centre Munich; Technical University of Munich; German Heart Centre Munich; Technical University of Munich; German Heart Centre Munich; Technical University of Munich	Augustin, N (corresponding author), Tech Univ Munich, Dept Cardiovasc Surg, German Heart Ctr, D-80636 Munich, Germany.	n.augustin@freenet.de							0	12	12	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL-AUG	2006	368	9533					386	386		10.1016/S0140-6736(06)69112-5	http://dx.doi.org/10.1016/S0140-6736(06)69112-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	069JJ	16876667	Bronze			2022-12-28	WOS:000239441900032
J	Brook, NR; Nicholson, ML				Brook, Nicholas R.; Nicholson, Michael L.			Non-directed live kidney donation	LANCET			English	Editorial Material							DONOR NEPHRECTOMY; EXPERIENCE; CENTERS		Univ Leicester, Dept Cardiovasc Sci, Div Transplant Surg, Leicester LE5 4PW, Leics, England	University of Leicester	Brook, NR (corresponding author), Univ Leicester, Dept Cardiovasc Sci, Div Transplant Surg, Leicester LE5 4PW, Leics, England.	nicholasbrook@fastmail.fm						Brook NR, 2004, BJU INT, V93, P1027, DOI 10.1111/j.1464-410X.2003.04775.x; Delmonico FL, 2004, AM J TRANSPLANT, V4, P1628, DOI 10.1111/j.1600-6143.2004.00572.x; Jacobs CL, 2004, AM J TRANSPLANT, V4, P1110, DOI 10.1111/j.1600-6143.2004.00478.x; Kahn JP, 2003, KENNEDY INST ETHIC J, V13, P45, DOI 10.1353/ken.2003.0005; Montgomery RA, 2006, LANCET, V368, P419, DOI 10.1016/S0140-6736(06)69115-0; *ORG PROC TRANSPL, 2005, DON REC US DON TYP; Ratner LE, 2000, TRANSPLANTATION, V69, P2319, DOI 10.1097/00007890-200006150-00016; Ratner LE, 1999, NEPHROL DIAL TRANSPL, V14, P2090, DOI 10.1093/ndt/14.9.2090; Stegall MD, 2004, TRANSPLANTATION, V78, P635, DOI 10.1097/01.tp.0000136263.46262.0d; *UK TRANSPL STAT A, 2005, MOR TRANSPL NEW LIV; *UN ORG SHAR, 2006, LIV DON KIDN NUMB TR	11	1	4	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL-AUG	2006	368	9533					346	347		10.1016/S0140-6736(06)69085-5	http://dx.doi.org/10.1016/S0140-6736(06)69085-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	069JJ	16876646				2022-12-28	WOS:000239441900007
J	Meister, P; Taddei, A; Gasser, SM				Meister, Peter; Taddei, Angela; Gasser, Susan M.			In and out of the replication factory	CELL			English	Editorial Material							DNA-REPLICATION; S-PHASE; ORGANIZATION; CELLS	In this issue of Cell, Kitamura et al. (2006) use live-fluorescence microscopy to monitor individual genomic loci as they replicate in budding yeast. They confirm that DNA is recruited to replication factories and show that sister replication forks initiated from the same origin are held together within a single replication factory.	Friedrich Miescher Inst Biomed Res, CH-4058 Basel, Switzerland; Inst Curie, UMR 218, Sect Rech, F-75231 Paris, France	Friedrich Miescher Institute for Biomedical Research; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS)	Meister, P (corresponding author), Friedrich Miescher Inst Biomed Res, Maulbeerstr 66, CH-4058 Basel, Switzerland.	susan.gasser@fmi.ch	Meister, Peter/B-4770-2010; taddei, angela/AAL-2413-2021	Meister, Peter/0000-0002-6230-4216; taddei, angela/0000-0002-3217-0739; Gasser, Susan/0000-0003-3610-9123				Cook PR, 1999, SCIENCE, V284, P1790, DOI 10.1126/science.284.5421.1790; Jackson DA, 1998, J CELL BIOL, V140, P1285, DOI 10.1083/jcb.140.6.1285; Lemon KP, 2001, GENE DEV, V15, P2031, DOI 10.1101/gad.913301; Lengronne A, 2001, NUCLEIC ACIDS RES, V29, P1433, DOI 10.1093/nar/29.7.1433; McNairn AJ, 2003, BIOESSAYS, V25, P647, DOI 10.1002/bies.10305; PARDOLL DM, 1980, CELL, V19, P527, DOI 10.1016/0092-8674(80)90527-9; Raghuraman MK, 2001, SCIENCE, V294, P115, DOI 10.1126/science.294.5540.115; TUBO RA, 1987, J BIOL CHEM, V262, P5857	8	18	18	0	4	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUN 30	2006	125	7					1233	1235		10.1016/j.cell.2006.06.014	http://dx.doi.org/10.1016/j.cell.2006.06.014			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	064QP	16814710	Bronze			2022-12-28	WOS:000239104500007
J	Wen, WQ; Shu, XO; Gao, YT; Yang, G; Li, Q; Li, HL; Zheng, W				Wen, Wanqing; Shu, Xiao Ou; Gao, Yu-Tang; Yang, Gong; Li, Qi; Li, Honglan; Zheng, Wei			Environmental tobacco smoke and mortality in Chinese women who have never smoked: prospective cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CORONARY-HEART-DISEASE; PASSIVE SMOKING; RISK; REGRESSION; EXPOSURE; CANCER; STROKE	Objective To evaluate the association of environmental exposure to tobacco smoke from husbands and from work, as well as from family members in early life, with all cause mortality and mortality due to cancer or cardiovascular disease in Chinese women. Design Ongoing prospective cohort study in Shanghai, China. Participants Of 72 829 women who had never smoked, 65 180 women provided information on smoking by their husbands, and 66 520 women provided information on exposure to tobacco smoke at work and in early life from family members. Main outcome measures All cause mortality and cause specific mortality with the main focus on cancer and cardiovascular disease. Cumulative mortality according to exposure status, and hazard ratios. Results Exposure to tobacco smoke from husbands (mainly current exposure) was significantly associated with increased all cause mortality (hazard ratio 1.15, 95% confidence interval 1.01 to 1.31) and with increased mortality due to cardiovascular disease (1.37, 1.06 to 1.78). Exposure to tobacco smoke at work was associated with increased mortality due to cancer (1.19, 0.94 to 1.50), especially lung cancer (1.79, 1.09 to 2.93). Exposure in early life was associated with increased mortality due to cardiovascular disease (1.26, 0.94 to 1.69). Conclusions In Chinese women, exposure to environmental tobacco smoke is related to moderately increased risk of all cause mortality and mortality due to lung cancer and cardiovascular disease.	Vanderbilt Univ, Sch Med, Vanderbilt Ingram Canc Ctr, Dept Med, Nashville, TN 37232 USA; Shanghai Canc Inst, Dept Epidemiol, Shanghai 20032, Peoples R China	Vanderbilt University	Wen, WQ (corresponding author), Vanderbilt Univ, Sch Med, Vanderbilt Ingram Canc Ctr, Dept Med, 221 Kirkland Hall, Nashville, TN 37232 USA.	wanqing.wen@vanderbilt.edu	Zheng, Wei/O-3351-2013; Gao, Yu/HGE-1937-2022; zhang, weihua/GXV-1334-2022	Zheng, Wei/0000-0003-1226-070X; 	NCI NIH HHS [R01CA70867] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA070867] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		COX DR, 1972, J R STAT SOC B, V34, P187; Enstrom JE, 2003, BMJ-BRIT MED J, V326, P1057, DOI 10.1136/bmj.326.7398.1057; Glaser JH, 2003, BRIT MED J, V327, P502, DOI 10.1136/bmj.327.7413.502; He J, 1999, NEW ENGL J MED, V340, P920, DOI 10.1056/NEJM199903253401204; Hill SE, 2004, BMJ-BRIT MED J, V328, P988, DOI 10.1136/bmj.38070.503009.EE; IARC, 2004, IARC MON EV CARC RIS, V83; Johnson KC, 2005, INT J CANCER, V117, P619, DOI 10.1002/ijc.21150; Kaur S, 2004, J WOMENS HEALTH, V13, P888, DOI 10.1089/jwh.2004.13.888; Kawachi I, 1996, AM J EPIDEMIOL, V144, P909; Korn EL, 1997, AM J EPIDEMIOL, V145, P72; Law MR, 1997, BMJ-BRIT MED J, V315, P973, DOI 10.1136/bmj.315.7114.973; LUNN M, 1995, BIOMETRICS, V51, P524, DOI 10.2307/2532940; McGhee SM, 2005, BMJ-BRIT MED J, V330, P287, DOI 10.1136/bmj.38342.706748.47; Milne E, 2003, BRIT MED J, V327, P502, DOI 10.1136/bmj.327.7413.502-b; Rani S, 2022, SPAT INF RES, V30, P417, DOI 10.1007/s41324-022-00442-9; TAYLOR AE, 1992, CIRCULATION, V86, P1; Thun M, 1999, ENVIRON HEALTH PERSP, V107, P841, DOI 10.2307/3434563; Tonks A, 2003, BRIT MED J, V327, P505, DOI 10.1136/bmj.327.7413.505; Vaidya JS, 2003, BRIT MED J, V327, P501, DOI 10.1136/bmj.327.7413.501; Vineis P, 2005, BRIT MED J, V330, P277, DOI 10.1136/bmj.38327.648472.82; Wells AJ, 1999, NEW ENGL J MED, V341, P697; Whincup PH, 2004, BRIT MED J, V329, P200, DOI 10.1136/bmj.38146.427188.55; WHINCUP PH, 2001, BMJ-BRIT MED J, V329, P200; Zhang XL, 2005, AM J EPIDEMIOL, V161, P213, DOI 10.1093/aje/kwi028; Zheng W, 2005, AM J EPIDEMIOL, V162, P1123, DOI 10.1093/aje/kwi322	25	70	75	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 19	2006	333	7564					376	379		10.1136/bmj.38834.522894.2F	http://dx.doi.org/10.1136/bmj.38834.522894.2F			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	078OD	16837487	Green Published, Bronze, Green Submitted			2022-12-28	WOS:000240112200017
J	Palframan, WJ; Meehl, JB; Jaspersen, SL; Winey, M; Murray, AW				Palframan, William J.; Meehl, Janet B.; Jaspersen, Sue L.; Winey, Mark; Murray, Andrew W.			Anaphase inactivation of the spindle checkpoint	SCIENCE			English	Article							POLE BODY DUPLICATION; BUDDING YEAST; SACCHAROMYCES-CEREVISIAE; ASSEMBLY CHECKPOINT; KINETOCHORE ATTACHMENT; MITOTIC CHECKPOINT; MITOSIS; KINASE; INHIBITOR; PATHWAY	The spindle checkpoint delays cell cycle progression unfit microtubules attach each pair of sister chromosomes to opposite poles of the mitotic spindle. Following sister chromatid separation, however, the checkpoint ignores chromosomes whose kinetochores are attached to only one spindle pole, a state that activates the checkpoint prior to, metaphase. We demonstrate that, in budding yeast, mutual inhibition between the anaphase-promoting complex (APC) and Mps1, an essential component of the checkpoint, leads to sustained inactivation of the spindle checkpoint. Mps1 protein abundance decreases in anaphase, and Mps1 is a target of the APC. Furthermore, expression of Mps1 in anaphase, or repression of the APC in anaphase, reactivates the spindle checkpoint. This APC-Mps1 feedback circuit allows cells to irreversibly inactivate the checkpoint during anaphase.	Harvard Univ, Dept Mol & Cellular Biol, Biol Labs, Cambridge, MA 02138 USA; Univ Colorado, Boulder, CO 80309 USA; Stowers Inst Med Res, Kansas City, MO 64110 USA	Harvard University; University of Colorado System; University of Colorado Boulder; Stowers Institute for Medical Research	Murray, AW (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, Biol Labs, 16 Divin Ave, Cambridge, MA 02138 USA.	amurray@mcb.harvard.edu			NIGMS NIH HHS [R37 GM043987, GM51312, GM43987] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM043987, R01GM051312, R37GM043987] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ball CA, 2000, NUCLEIC ACIDS RES, V28, P77, DOI 10.1093/nar/28.1.77; Biggins S, 2001, GENETICS, V159, P453; Buvelot S, 2003, J CELL BIOL, V160, P329, DOI 10.1083/jcb.200209018; Cohen-Fix O, 1997, P NATL ACAD SCI USA, V94, P14361, DOI 10.1073/pnas.94.26.14361; Cohen-Fix O, 1999, GENE DEV, V13, P1950, DOI 10.1101/gad.13.15.1950; CohenFix O, 1996, GENE DEV, V10, P3081, DOI 10.1101/gad.10.24.3081; GLOTZER M, 1991, NATURE, V349, P132, DOI 10.1038/349132a0; HARDWICK KG, 1995, J CELL BIOL, V131, P709, DOI 10.1083/jcb.131.3.709; Hardwick KG, 1996, SCIENCE, V273, P953, DOI 10.1126/science.273.5277.953; Higuchi T, 2005, NATURE, V433, P171, DOI 10.1038/nature03240; HOYT MA, 1991, CELL, V66, P507, DOI 10.1016/0092-8674(81)90014-3; Hwang LH, 1998, SCIENCE, V279, P1041, DOI 10.1126/science.279.5353.1041; Jaspersen SL, 2004, DEV CELL, V7, P263, DOI 10.1016/j.devcel.2004.07.006; Jaspersen SL, 1998, MOL BIOL CELL, V9, P2803, DOI 10.1091/mbc.9.10.2803; Jones MH, 2005, CURR BIOL, V15, P160, DOI 10.1016/j.cub.2005.01.010; Li R, 1999, P NATL ACAD SCI USA, V96, P4989, DOI 10.1073/pnas.96.9.4989; LI R, 1991, CELL, V66, P519, DOI 10.1016/0092-8674(81)90015-5; LI XT, 1995, NATURE, V373, P630, DOI 10.1038/373630a0; Musacchio A, 2002, NAT REV MOL CELL BIO, V3, P731, DOI 10.1038/nrm929; Nasmyth K, 2002, SCIENCE, V297, P559, DOI 10.1126/science.1074757; NICKLAS RB, 1969, J CELL BIOL, V43, P40, DOI 10.1083/jcb.43.1.40; Pan J, 2004, GENE DEV, V18, P1439, DOI 10.1101/gad.1184204; Pereira G, 2003, SCIENCE, V302, P2120, DOI 10.1126/science.1091936; Pinsky BA, 2006, NAT CELL BIOL, V8, P78, DOI 10.1038/ncb1341; RIEDER CL, 1994, J CELL BIOL, V127, P1301, DOI 10.1083/jcb.127.5.1301; Shirayama M, 1999, NATURE, V402, P203, DOI 10.1038/46080; Vagnarelli P, 2004, CHROMOSOMA, V113, P211, DOI 10.1007/s00412-004-0307-3; Weiss E, 1996, J CELL BIOL, V132, P111, DOI 10.1083/jcb.132.1.111; Wells WAE, 1996, J CELL BIOL, V133, P75, DOI 10.1083/jcb.133.1.75; Yeong FM, 2000, MOL CELL, V5, P501, DOI 10.1016/S1097-2765(00)80444-X	30	97	106	1	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 4	2006	313	5787					680	684		10.1126/science.1127205	http://dx.doi.org/10.1126/science.1127205			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072IQ	16825537				2022-12-28	WOS:000239667500047
J	Dykxhoorn, DM; Lieberman, J				Dykxhoorn, Derek M.; Lieberman, Judy			Knocking down disease with siRNAs	CELL			English	Editorial Material							SMALL INTERFERING RNA; FAS PROTECTS MICE; IN-VIVO; GENE; INHIBITION; EXPRESSION; MICRORNAS		Harvard Univ, Sch Med, CBR Inst Biomed Res, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Harvard Medical School	Lieberman, J (corresponding author), Harvard Univ, Sch Med, CBR Inst Biomed Res, Boston, MA 02115 USA.	lieberman@cbr.med.harvard.edu	Lieberman, Judy/A-2717-2015; Dykxhoorn, Derek M/D-1357-2015		NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI056900] Funding Source: NIH RePORTER; NIAID NIH HHS [U19 AI056900] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bitko V, 2005, NAT MED, V11, P50, DOI 10.1038/nm1164; Croce CM, 2005, CELL, V122, P6, DOI 10.1016/j.cell.2005.06.036; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Grimm D, 2006, NATURE, V441, P537, DOI 10.1038/nature04791; Hamar P, 2004, P NATL ACAD SCI USA, V101, P14883, DOI 10.1073/pnas.0406421101; Hammond SM, 2006, CURR OPIN GENET DEV, V16, P4, DOI 10.1016/j.gde.2005.12.005; Jackson AL, 2006, RNA, V12, P1197, DOI 10.1261/rna.30706; Jackson AL, 2006, RNA, V12, P1179, DOI 10.1261/rna.25706; Jackson AL, 2003, NAT BIOTECHNOL, V21, P635, DOI 10.1038/nbt831; Judge AD, 2005, NAT BIOTECHNOL, V23, P457, DOI 10.1038/nbt1081; Kim DH, 2005, NAT BIOTECHNOL, V23, P222, DOI 10.1038/nbt1051; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Li BJ, 2005, NAT MED, V11, P944, DOI 10.1038/nm1280; Lu SH, 2004, J VIROL, V78, P12868, DOI 10.1128/JVI.78.23.12868-12876.2004; McCaffrey AP, 2002, NATURE, V418, P38, DOI 10.1038/418038a; Morrissey DV, 2005, NAT BIOTECHNOL, V23, P1002, DOI 10.1038/nbt1122; Palliser D, 2006, NATURE, V439, P89, DOI 10.1038/nature04263; Sledz CA, 2003, NAT CELL BIOL, V5, P834, DOI 10.1038/ncb1038; Song EW, 2005, NAT BIOTECHNOL, V23, P709, DOI 10.1038/nbt1101; Song EW, 2003, J VIROL, V77, P7174, DOI 10.1128/JVI.77.13.7174-7181.2003; Song EW, 2003, NAT MED, V9, P347, DOI 10.1038/nm828; Soutschek J, 2004, NATURE, V432, P173, DOI 10.1038/nature03121; Zimmermann TS, 2006, NATURE, V441, P111, DOI 10.1038/nature04688	23	169	179	0	9	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUL 28	2006	126	2					231	235		10.1016/j.cell.2006.07.007	http://dx.doi.org/10.1016/j.cell.2006.07.007			5	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	070VD	16873051	Green Published, Bronze			2022-12-28	WOS:000239552600005
J	Kleppner, D				Kleppner, Daniel			A more precise fine structure constant	SCIENCE			English	Editorial Material							ELECTRON		MIT, Dept Phys, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Kleppner, D (corresponding author), MIT, Dept Phys, Cambridge, MA 02139 USA.	kleppner@mit.edu						Dirac PAM, 1928, P R SOC LOND A-CONTA, V118, P351, DOI 10.1098/rspa.1928.0056; Dirac PAM, 1928, P R SOC LOND A-CONTA, V117, P610, DOI 10.1098/rspa.1928.0023; Gabrielse G, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.030802; Kinoshita T, 2006, PHYS REV D, V73, DOI 10.1103/PhysRevD.73.013003; KUSCH P, 1948, PHYS REV, V74, P250, DOI 10.1103/PhysRev.74.250; Laporta S, 1996, PHYS LETT B, V379, P283, DOI 10.1016/0370-2693(96)00439-X; Odom B, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.030801; SCHWEBER SS, 1994, QED MEN MADE IT DYSO; VANDYCK RS, 1987, PHYS REV LETT, V59, P26, DOI 10.1103/PhysRevLett.59.26	9	1	1	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 28	2006	313	5786					448	449		10.1126/science.1131834	http://dx.doi.org/10.1126/science.1131834			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067MZ	16873632				2022-12-28	WOS:000239308600024
J	Garber, AM				Garber, Alan M.			The price of growth in the medical-device industry	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA 94304 USA; Stanford Univ, Ctr Hlth Policy, Stanford, CA 94305 USA; Stanford Univ, Ctr Hlth Care Evaluat, Stanford, CA 94305 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford University; Stanford University	Garber, AM (corresponding author), Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA 94304 USA.		Garber, Alan M/F-1476-2010						0	4	5	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 27	2006	355	4					337	339		10.1056/NEJMp068085	http://dx.doi.org/10.1056/NEJMp068085			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	067DT	16870911	Green Published			2022-12-28	WOS:000239282600001
J	Hueso, R; Sanchez-Lavega, A				Hueso, R.; Sanchez-Lavega, A.			Methane storms on Saturn's moon Titan	NATURE			English	Article							3-DIMENSIONAL MODEL; MIDLATITUDE CLOUDS; MOIST CONVECTION; HUYGENS PROBE; GIANT PLANETS; SOUTH-POLE; ATMOSPHERE; SURFACE; ABUNDANCES; DESCENT	The presence of dry fluvial river channels and the intense cloud activity in the south pole of Titan over the past few years(1-3) suggest the presence of methane rain. The nitrogen atmosphere of Titan therefore appears to support a methane meteorological cycle that sculptures the surface and controls its properties(1,4). Titan and Earth are the only worlds in the Solar System where rain reaches the surface, although the atmospheric cycles of water and methane are expected to be very different(5). Here we report three-dimensional dynamical calculations showing that severe methane convective storms accompanied by intense precipitation may occur in Titan under the right environmental conditions. The strongest storms grow when the methane relative humidity in the middle troposphere is above 80 per cent, producing updrafts with maximum velocities of 20 m s(-1), able to reach altitudes of 30 km before dissipating in 5 - 8 h. Raindrops of 1 - 5 mm in radius produce precipitation rainfalls on the surface as high as 110 kg m(-2) and are comparable to flash flood events on Earth(6).	Univ Basque Country, Dept Fis Aplicada 1, ETS Ingn, Bilbao 48013, Spain	University of Basque Country	Hueso, R (corresponding author), Univ Basque Country, Dept Fis Aplicada 1, ETS Ingn, Alameda Urquijo S-N, Bilbao 48013, Spain.	wubhualr@lg.ehu.es; agustin.sanchez@ehu.es	Sanchez-Lavega, Agustin/Z-3639-2019; Hueso, Ricardo/Z-3277-2019	Hueso, Ricardo/0000-0003-0169-123X; Sanchez-Lavega, Agustin/0000-0001-7355-1522; Sanchez-Lavega, Agustin/0000-0001-7234-7634				AWAL M, 1994, GEOPHYS RES LETT, V21, P2491, DOI 10.1029/94GL01707; Brown ME, 2002, NATURE, V420, P795, DOI 10.1038/nature01302; Elachi C, 2005, SCIENCE, V308, P970, DOI 10.1126/science.1109919; Fulchignoni M, 2005, NATURE, V438, P785, DOI 10.1038/nature04314; Griffith CA, 2000, SCIENCE, V290, P509, DOI 10.1126/science.290.5491.509; Griffith CA, 2005, SCIENCE, V310, P474, DOI 10.1126/science.1117702; Griffith CA, 1998, NATURE, V395, P575, DOI 10.1038/26920; HOUZE R, 1994, CLOUD DYNAMICS, pCH3; Hueso R, 2004, ICARUS, V172, P255, DOI 10.1016/j.icarus.2004.06.010; Hueso R, 2001, ICARUS, V151, P257, DOI 10.1006/icar.2000.6606; Lebreton JP, 2005, NATURE, V438, P758, DOI 10.1038/nature04347; LELLOUCH E, 1989, ICARUS, V79, P328, DOI 10.1016/0019-1035(89)90081-X; LORENZ RD, 1993, PLANET SPACE SCI, V41, P647, DOI 10.1016/0032-0633(93)90048-7; Lorenz RD, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL021415; Lorenz RD, 1997, SCIENCE, V275, P642, DOI 10.1126/science.275.5300.642; MADDOX RA, 1980, B AM METEOROL SOC, V61, P1374, DOI 10.1175/1520-0477(1980)061<1374:MCC>2.0.CO;2; Niemann HB, 2005, NATURE, V438, P779, DOI 10.1038/nature04122; Porco CC, 2005, NATURE, V434, P159, DOI 10.1038/nature03436; PRESS WH, 1992, NUMERICAL RECIPES, P829; Rannou P, 2006, SCIENCE, V311, P201, DOI 10.1126/science.1118424; Roe HG, 2005, SCIENCE, V310, P477, DOI 10.1126/science.1116760; Roe HG, 2002, ASTROPHYS J, V581, P1399, DOI 10.1086/344403; Samuelson RE, 1997, PLANET SPACE SCI, V45, P959, DOI 10.1016/S0032-0633(97)00090-1; Schaller EL, 2006, ICARUS, V182, P224, DOI 10.1016/j.icarus.2005.12.021; Tao WK, 2003, METEOROL ATMOS PHYS, V82, P97, DOI 10.1007/s00703-001-0594-7; THOMPSON WR, 1992, ICARUS, V97, P187, DOI 10.1016/0019-1035(92)90127-S; Tokano T, 2005, ICARUS, V173, P222, DOI 10.1016/j.icarus.2004.08.019; Tomasko MG, 2005, NATURE, V438, P765, DOI 10.1038/nature04126	28	86	86	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 27	2006	442	7101					428	431		10.1038/nature04933	http://dx.doi.org/10.1038/nature04933			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067CI	16871212				2022-12-28	WOS:000239278900037
J	Coffey, DS; Getzenberg, RH; DeWeese, TL				Coffey, Donald S.; Getzenberg, Robert H.; DeWeese, Theodore L.			Hyperthermic biology and cancer therapies a hypothesis for the "Lance Armstrong effect"	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							NUCLEAR-MATRIX PROTEINS; PROSTATE-CANCER; DNA ORGANIZATION; FEVER; IDENTIFICATION; RADIATION; CELLS; SEX		Johns Hopkins Univ, Sch Med, James Buchanan Brady Urol Inst, Dept Urol, Baltimore, MD 21287 USA; Johns Hopkins Univ, Sch Med, Dept Radiat Oncol & Mol Radiat Sci, Baltimore, MD 21287 USA; Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21287 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine	Getzenberg, RH (corresponding author), Johns Hopkins Univ, Sch Med, James Buchanan Brady Urol Inst, Dept Urol, Marburg 121,600 N Wolfe St, Baltimore, MD 21287 USA.	rgetzen1@jhmi.edu						Barone JG, 2000, UROLOGY, V56, P1068, DOI 10.1016/S0090-4295(00)00788-3; Brizel DM, 1996, CANCER RES, V56, P5347; Chen Q, 2006, CANCER IMMUNOL IMMUN, V55, P299, DOI 10.1007/s00262-005-0022-9; CIEJEK EM, 1983, NATURE, V306, P607, DOI 10.1038/306607a0; Dewhirst MW, 2005, INT J HYPERTHER, V21, P779, DOI 10.1080/02656730500271668; di Pietro A, 2005, INT J BIOCHEM CELL B, V37, P2437, DOI 10.1016/j.biocel.2005.06.014; Dynlacht JR, 2000, RADIAT RES, V154, P515, DOI 10.1667/0033-7587(2000)154[0515:DPODFA]2.0.CO;2; Farokhzad OC, 2004, CANCER RES, V64, P7668, DOI 10.1158/0008-5472.CAN-04-2550; FERGUSON MWJ, 1982, NATURE, V296, P850, DOI 10.1038/296850a0; GETZENBERG RH, 1991, CANCER RES, V51, P6514; GETZENBERG RH, 1990, MOL ENDOCRINOL, V4, P1336, DOI 10.1210/mend-4-9-1336; Greisman LA, 2002, CURR OPIN INFECT DIS, V15, P241, DOI 10.1097/00001432-200206000-00005; Guan K, 2006, NATURE, V440, P1199, DOI 10.1038/nature04697; HAHN GM, 1975, P NATL ACAD SCI USA, V72, P937, DOI 10.1073/pnas.72.3.937; Horwich A, 2006, LANCET, V367, P754, DOI 10.1016/S0140-6736(06)68305-0; Ito A, 2006, CANCER IMMUNOL IMMUN, V55, P320, DOI 10.1007/s00262-005-0049-y; KLUGER MJ, 1975, SCIENCE, V188, P166, DOI 10.1126/science.1114347; Lepock JR, 2001, CELL STRESS CHAPERON, V6, P136, DOI 10.1379/1466-1268(2001)006<0136:TNMIAT>2.0.CO;2; Lupold SE, 2002, CANCER RES, V62, P4029; Paul B, 2005, CANCER RES, V65, P4097, DOI 10.1158/0008-5472.CAN-04-4523; PIENTA KJ, 1989, CANCER RES, V49, P2525; Roti JLR, 1998, CELL STRESS CHAPERON, V3, P245, DOI 10.1379/1466-1268(1998)003<0245:NMAATF>2.3.CO;2; Rylander MN, 2005, ANN NY ACAD SCI, V1066, P222, DOI 10.1196/annals.1363.009; Takaha N, 2002, CANCER RES, V62, P647; Vertrees RA, 2000, ANN THORAC SURG, V69, P1675, DOI 10.1016/S0003-4975(00)01421-1; VOGELSTEIN B, 1980, CELL, V22, P79, DOI 10.1016/0092-8674(80)90156-7; Westermann AM, 2005, CANCER, V104, P763, DOI 10.1002/cncr.21128	27	71	73	0	17	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 26	2006	296	4					445	448		10.1001/jama.296.4.445	http://dx.doi.org/10.1001/jama.296.4.445			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	066PN	16868303				2022-12-28	WOS:000239242500031
J	Biesmeijer, JC; Roberts, SPM; Reemer, M; Ohlemuller, R; Edwards, M; Peeters, T; Schaffers, AP; Potts, SG; Kleukers, R; Thomas, CD; Settele, J; Kunin, WE				Biesmeijer, J. C.; Roberts, S. P. M.; Reemer, M.; Ohlemueller, R.; Edwards, M.; Peeters, T.; Schaffers, A. P.; Potts, S. G.; Kleukers, R.; Thomas, C. D.; Settele, J.; Kunin, W. E.			Parallel declines in pollinators and insect-pollinated plants in Britain and the Netherlands	SCIENCE			English	Article							BRITISH BUTTERFLIES; CLIMATE	Despite widespread concern about declines in pollination services, little is known about the patterns of change in most pollinator assemblages. By studying bee and hoverfly assemblages in Britain and the Netherlands, we found evidence of declines (pre- versus post-1980) in local bee diversity in both countries; however, divergent trends were observed in hoverflies. Depending on the assemblage and location, pollinator declines were most frequent in habitat and flower specialists, in univoltine species, and/or in nonmigrants. In conjunction with this evidence, outcrossing plant species that are reliant on the declining pollinators have themselves declined relative to other plant species. Taken together, these findings strongly suggest a causal connection between local extinctions of functionally linked plant and pollinator species.	Univ Leeds, Inst Integrat & Comparat Biol, Leeds LS2 9JT, W Yorkshire, England; Univ Leeds, Earth & Biosphere Inst, Leeds LS2 9JT, W Yorkshire, England; Univ Reading, Ctr Agrienvironm Res, Reading RG6 6AR, Berks, England; Natl Museum Nat Hist Naturalis, European Invertebrate Survey Netherlands, NL-2300 RA Leiden, Netherlands; Univ York, Dept Biol, York YO10 5YW, N Yorkshire, England; Lea Side, Midhurst GU29 9LB, W Sussex, England; Radboud Univ Nijmegen, Bargerveen Fdn, Dept Anim Ecol, NL-6500 GL Nijmegen, Netherlands; Univ Wageningen & Res Ctr, Nat Conservat & Plant Ecol Grp, NL-6708 PD Wageningen, Netherlands; Umweltforschungszentrum Ctr Environm Res Leipzig, D-06120 Halle, Germany	University of Leeds; University of Leeds; University of Reading; Naturalis Biodiversity Center; University of York - UK; Radboud University Nijmegen; Wageningen University & Research; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ)	Biesmeijer, JC (corresponding author), Univ Leeds, Inst Integrat & Comparat Biol, Leeds LS2 9JT, W Yorkshire, England.	j.c.biesmeijer@leeds.ac.uk	Settele, Josef/A-6371-2009; Thomas, Chris D/A-1460-2014; Potts, Simon/ABF-9221-2020; Potts, Simon G/C-7250-2008; Thomas, Chris D/A-1894-2012	Settele, Josef/0000-0002-8624-4983; Thomas, Chris D/0000-0003-2822-1334; Potts, Simon/0000-0002-2045-980X; Potts, Simon G/0000-0002-2045-980X; Thomas, Chris D/0000-0003-2822-1334; Biesmeijer, Koos/0000-0003-0328-0573; Ohlemuller, Ralf/0000-0001-9102-6481				Banaszak J., 1995, CHANGES FAUNA WILD B; *CENTR BUR VOORD, 2003, BIOB 2003; Chapin FS, 1997, SCIENCE, V277, P500, DOI 10.1126/science.277.5325.500; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; Fontaine C, 2006, PLOS BIOL, V4, P129, DOI 10.1371/journal.pbio.0040001; Ghazoul J, 2005, TRENDS ECOL EVOL, V20, P367, DOI 10.1016/j.tree.2005.04.026; Hassan R., 2005, ECOSYSTEMS HUMAN WEL, V1, P297, DOI DOI 10.1021/JF020083Y; KEVAN P G, 1975, Biological Conservation, V7, P301, DOI 10.1016/0006-3207(75)90045-2; Klotz S., 2002, BIOLFLOR DATABASE BI; Memmott J, 2004, P ROY SOC B-BIOL SCI, V271, P2605, DOI 10.1098/rspb.2004.2909; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; PIMM SL, 1995, SCIENCE, V269, P347, DOI 10.1126/science.269.5222.347; Preston C, 2002, NEW ATLAS BRIT IRISH; Settele J, 2005, GAIA, V14, P69, DOI 10.14512/gaia.14.1.20; SPEIGHT M, 2004, SYRPH NET CD ISSUE 2; Stang M, 2006, OIKOS, V112, P111, DOI 10.1111/j.0030-1299.2006.14199.x; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Thomas JA, 2004, SCIENCE, V303, P1879, DOI 10.1126/science.1095046; Warren MS, 2001, NATURE, V414, P65, DOI 10.1038/35102054	19	1880	1980	44	1547	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 21	2006	313	5785					351	354		10.1126/science.1127863	http://dx.doi.org/10.1126/science.1127863			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065IV	16857940				2022-12-28	WOS:000239154300044
J	Frei, H				Frei, Heinz			Selective hydrocarbon oxidation in zeolites	SCIENCE			English	Editorial Material							ROOM-TEMPERATURE; CHARGE-TRANSFER; Y-ZEOLITE; PHOTOOXIDATION; PROPANE; OXYGEN; IR		Univ Calif Berkeley, Lawrence Berkeley Lab, Phys Biosci Div, Berkeley, CA 94720 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Frei, H (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Lab, Phys Biosci Div, Berkeley, CA 94720 USA.	hmfrei@lbl.gov						BERG O, 2005, VANM C LEID NETH MAY; Blatter F, 1998, CATAL TODAY, V41, P297, DOI 10.1016/S0920-5861(98)00021-2; BLATTER F, 1993, J AM CHEM SOC, V115, P7501, DOI 10.1021/ja00069a059; Breck D.W., 1974, ZEOLITE MOL SIEVES; Centi G, 1998, CATAL TODAY, V41, P287, DOI 10.1016/S0920-5861(98)00020-0; EVANS DF, 1953, J CHEM SOC, P345, DOI 10.1039/jr9530000345; Pidko EA, 2006, J PHYS CHEM B, V110, P2963, DOI 10.1021/jp0547562; Sheldon R A., 1981, METAL CATALYZED OXID; TSUBOMURA H, 1960, J AM CHEM SOC, V82, P5966, DOI 10.1021/ja01508a002; Vanoppen DL, 1997, STUD SURF SCI CATAL, V105, P1045; Xiang Y, 1999, J AM CHEM SOC, V121, P5063, DOI 10.1021/ja984477a; Xu J, 2005, J PHYS CHEM B, V109, P18361, DOI 10.1021/jp052941+; Xu J, 2004, J PHYS CHEM B, V108, P15728, DOI 10.1021/jp048656s; Yeom YH, 2003, J PHYS CHEM B, V107, P6286, DOI 10.1021/jp022394h; Yeom YH, 2004, IN SITU SPECTROSCOPY, P32	15	58	60	2	73	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 21	2006	313	5785					309	310		10.1126/science.1128981	http://dx.doi.org/10.1126/science.1128981			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065IV	16857928				2022-12-28	WOS:000239154300030
J	Jarcho, JA				Jarcho, John A.			Biventricular pacing	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CARDIAC-RESYNCHRONIZATION THERAPY; CHRONIC HEART-FAILURE; BUNDLE-BRANCH-BLOCK; IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR; INTRAVENTRICULAR-CONDUCTION DELAY; CHRONIC ATRIAL-FIBRILLATION; LEFT-VENTRICULAR FUNCTION; DILATED CARDIOMYOPATHY; SINUS RHYTHM; QRS DURATION		Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; Brigham & Womens Hosp, Div Cardiol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Jarcho, JA (corresponding author), Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA.							Abraham WT, 2003, CIRCULATION, V108, P2596, DOI 10.1161/01.CIR.0000096580.26969.9A; Abraham WT, 2004, CIRCULATION, V110, P2864, DOI 10.1161/01.CIR.0000146336.92331.D1; Abraham WT, 2002, NEW ENGL J MED, V346, P1845, DOI 10.1056/NEJMoa013168; Auricchio A, 2002, J AM COLL CARDIOL, V39, P2026, DOI 10.1016/S0735-1097(02)01895-8; Auricchio A, 2004, CIRCULATION, V109, P300, DOI 10.1161/01.CIR.0000115583.20268.E1; Baldasseroni S, 2002, AM HEART J, V143, P398, DOI 10.1067/mhj.2002.121264; Bardy GH, 2005, NEW ENGL J MED, V352, P2146; Bardy GH, 2005, NEW ENGL J MED, V352, P225, DOI 10.1056/NEJMoa043399; Bax JJ, 2004, J AM COLL CARDIOL, V44, P1, DOI 10.1016/j.jacc.2004.02.055; Bax JJ, 2004, J AM COLL CARDIOL, V44, P1834, DOI 10.1016/j.jacc.2004.08.016; Breithardt OA, 2003, J AM COLL CARDIOL, V41, P765, DOI 10.1016/S0735-1097(02)02937-6; Breithardt OA, 2003, J AM COLL CARDIOL, V41, P1853, DOI 10.1016/S0735-1097(03)00552-7; Bristow MR, 2004, NEW ENGL J MED, V350, P2140, DOI 10.1056/NEJMoa032423; Cazeau S, 2001, NEW ENGL J MED, V344, P873, DOI 10.1056/NEJM200103223441202; Cazeau S, 1996, PACE, V19, P1748, DOI 10.1111/j.1540-8159.1996.tb03218.x; Cleland JGF, 2005, NEW ENGL J MED, V352, P1539, DOI 10.1056/NEJMoa050496; Garrigue S, 2002, HEART, V87, P529, DOI 10.1136/heart.87.6.529; Ghali JK, 2003, J AM COLL CARDIOL, V42, P2128, DOI 10.1016/j.jacc.2003.05.012; Goldschlager N, 2001, ARCH INTERN MED, V161, P649, DOI 10.1001/archinte.161.5.649; Gregoratos Gabriel, 2002, Circulation, V106, P2145, DOI 10.1161/01.CIR.0000035996.46455.09; GRINES CL, 1989, CIRCULATION, V79, P845, DOI 10.1161/01.CIR.79.4.845; Higgins SL, 2003, J AM COLL CARDIOL, V42, P1454, DOI 10.1016/S0735-1097(03)01042-8; Iuliano S, 2002, AM HEART J, V143, P1085, DOI 10.1067/mhj.2002.122516; Kasravi B, 2005, PACE, V28, P51, DOI 10.1111/j.1540-8159.2005.09353.x; Kass DA, 1999, CIRCULATION, V99, P1567, DOI 10.1161/01.CIR.99.12.1567; Knight BP, 2004, J AM COLL CARDIOL, V44, P72, DOI 10.1016/j.jacc.2004.03.054; Leclercq C, 2000, AM J CARDIOL, V85, P1154, DOI 10.1016/S0002-9149(00)00716-5; Leclercq C, 2002, EUR HEART J, V23, P1780, DOI 10.1053/euhj.2002.3232; Leclercq C, 1998, J AM COLL CARDIOL, V32, P1825, DOI 10.1016/S0735-1097(98)00492-6; Leon AR, 2002, J AM COLL CARDIOL, V39, P1258, DOI 10.1016/S0735-1097(02)01779-5; McAlister FA, 2005, ANN INTERN MED, V142, P311; McAlister FA, 2004, ANN INTERN MED, V141, P381, DOI 10.7326/0003-4819-141-5-200409070-00101; Molhoek SG, 2004, AM J CARDIOL, V94, P1506, DOI 10.1016/j.amjcard.2004.08.028; Moss AJ, 2002, NEW ENGL J MED, V346, P877, DOI 10.1056/NEJMoa013474; Navia JL, 2005, ANN THORAC SURG, V79, P1536, DOI 10.1016/j.athoracsur.2004.10.041; Nelson GS, 2000, CIRCULATION, V102, P3053; Penicka M, 2004, CIRCULATION, V109, P978, DOI 10.1161/01.CIR.0000116765.43251.D7; Pinski SL, 2002, PACE, V25, P1496, DOI 10.1046/j.1460-9592.2002.01496.x; Pinski SL, 2002, PACE, V25, P1367, DOI 10.1046/j.1460-9592.2002.01367.x; Pitzalis MV, 2005, J AM COLL CARDIOL, V45, P65, DOI 10.1016/j.jacc.2004.09.058; Ricci R, 2002, J INTERV CARD ELECTR, V6, P279, DOI 10.1023/A:1019570022647; Saxon LA, 2003, CIRCULATION, V108, P1044, DOI 10.1161/01.CIR.0000085656.57918.B1; Shamim W, 1999, INT J CARDIOL, V70, P171, DOI 10.1016/S0167-5273(99)00077-7; Strickberger SA, 2005, CIRCULATION, V111, P2146, DOI 10.1161/01.CIR.0000161276.09685.4A; Sundell J, 2004, J AM COLL CARDIOL, V43, P1027, DOI 10.1016/j.jacc.2003.10.044; Sutton MGS, 2003, CIRCULATION, V107, P1985, DOI 10.1161/01.CIR.0000065226.24159.E9; Swedberg K, 2005, EUR HEART J, V26, P1115, DOI 10.1093/eurheartj/ehi204; TANG AS, 2005, CAN J CARDIOL SA, V21; Turner MS, 2004, CIRCULATION, V109, P2544, DOI 10.1161/01.CIR.0000131184.40893.40; Tyers GFO, 2003, PACE, V26, P524; Wyman BT, 1999, AM J PHYSIOL-HEART C, V276, pH881, DOI 10.1152/ajpheart.1999.276.3.H881; WYNDHAM CRC, 1980, CIRCULATION, V61, P696, DOI 10.1161/01.CIR.61.4.696; Yong P, 2000, PACE, V23, P1735; Young JB, 2003, JAMA-J AM MED ASSOC, V289, P2685, DOI 10.1001/jama.289.20.2685; Zhang Q, 2006, EUR HEART J, V27, P1423, DOI 10.1093/eurheartj/ehi885	55	24	27	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 20	2006	355	3					288	294		10.1056/NEJMct055185	http://dx.doi.org/10.1056/NEJMct055185			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	064NY	16855269				2022-12-28	WOS:000239097600010
J	Ferner, RE; Aronson, JK				Ferner, R. E.; Aronson, J. K.			Drugs - Communicating information about drug safety	BRITISH MEDICAL JOURNAL			English	Editorial Material									City Hosp, W Midlands Ctr Adverse Drug React Reporting, Birmingham B18 7QH, W Midlands, England; Radcliffe Infirm, Univ Dept Clin Pharmacol, Oxford OX2 6HE, England	University of Birmingham; Radcliffe Infirmary; University of Oxford	Ferner, RE (corresponding author), City Hosp, W Midlands Ctr Adverse Drug React Reporting, Birmingham B18 7QH, W Midlands, England.	r.e.ferner@bham.ac.uk		Ferner, Robin/0000-0003-3769-1346				Aronson JK, 2004, BRIT J CLIN PHARMACO, V58, P343, DOI 10.1111/j.1365-2125.2004.02244.x; Aronson JK, 2003, BRIT MED J, V327, P1222, DOI 10.1136/bmj.327.7425.1222; Aronson JK, 2002, FUND CLIN PHARMACOL, V16, P49, DOI 10.1046/j.1472-8206.2002.00066.x; Baxter K, 2005, STOCKLEYS DRUG INTER; Ferner RE, 2004, BRIT MED J, V328, P1172, DOI 10.1136/bmj.328.7449.1172; HANTSEN PD, 2005, DRUG INTERACTIONS AN; Hawkey CJ, 2005, CURR OPIN GASTROEN, V21, P660; Loke YK, 2006, BMJ-BRIT MED J, V332, P335, DOI 10.1136/bmj.38701.399942.63; Weingart SN, 2003, ARCH INTERN MED, V163, P2625, DOI 10.1001/archinte.163.21.2625	9	43	44	1	4	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JUL 15	2006	333	7559					143	145		10.1136/bmj.333.7559.143	http://dx.doi.org/10.1136/bmj.333.7559.143			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	065JK	16840480	Green Published			2022-12-28	WOS:000239155900031
J	Nordstrom, A				Nordstroem, Anders			What's next for WHO?	LANCET			English	Editorial Material									WHO, CH-1202 Geneva, Switzerland	World Health Organization	Nordstrom, A (corresponding author), WHO, CH-1202 Geneva, Switzerland.	nordstroma@who.int						[Anonymous], 2005, PREV CHRON DIS VIT I; *GLOB POL ER IN, 2006, GLOB POL ER IN ANN R; *WHO, 2004, REPR HLTH; WHO, 2006, PREV CONTR SEX TRANS; *WHO, 2005, APPL INT HLTH REG; World Health Organization (WHO), 2005, MULT STUD WOM HLTH D; World Health Organization (WHO), 2006, WORLD HLTH REP 2006; *WORLD HLTH ASS, 2006, 11 GEN PROGR WORK 20	8	0	0	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 15	2006	368	9531					177	179		10.1016/S0140-6736(06)69014-4	http://dx.doi.org/10.1016/S0140-6736(06)69014-4			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	064MY	16844467				2022-12-28	WOS:000239095000004
J	Fairchild, AL				Fairchild, Amy L.			Public health - Diabetes and disease surveillance	SCIENCE			English	Editorial Material									Columbia Univ, Mailman Sch Publ Hlth, Ctr Hist & Eth Publ Hlth, New York, NY 10502 USA	Columbia University	Fairchild, AL (corresponding author), Columbia Univ, Mailman Sch Publ Hlth, Ctr Hist & Eth Publ Hlth, New York, NY 10502 USA.	alf4@columbia.edu	Fairchild, Amy/F-1811-2018	Fairchild, Amy/0000-0002-1292-7212				BREWIN B, 2005, GOV HLTH IT     0713; CARDWELL D, 2006, NY TIMES        0615, P83; FAIRCHILD AL, IN PRESS SEARCHING E; FRIEDEN T, 2006, COMMUNICATION   0306; Gudbjornsdottir S, 2003, DIABETES CARE, V26, P1270, DOI 10.2337/diacare.26.4.1270; KAZON PM, 2005, COMMUNICATION   0816; KLEINFIELD NR, 2006, NY TIMES        0109; KLEINFIELD NR, 2006, NY TIMES        0110; MACLEAN CD, 2004, CLIN TRIALS, V1, P534; *MED SOC STAT NEW, 2005, UPDATE NEW YORK STAT, V5, P28; *NEW YORK CIT DEP, DIAB PREV CONTR PROG; Piwernetz K, 2001, INT CLIN PSYCHOPHARM, V16, pS5, DOI 10.1097/00004850-200104003-00002; SCHLAFLY A, 2005, COMMUNICATION   0817; Spero M, 1998, Eff Clin Pract, V1, P90; STEIN R, 2006, WASHINGTON POST 0111, pA3	15	13	13	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 14	2006	313	5784					175	176		10.1126/science.1127610	http://dx.doi.org/10.1126/science.1127610			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	063GZ	16840684				2022-12-28	WOS:000239008000026
J	Savina, A; Jancic, C; Hugues, S; Guermonprez, P; Vargas, P; Moura, IC; Lennon-Dumenil, AM; Seabra, MC; Raposo, G; Amigorena, S				Savina, Ariel; Jancic, Carolina; Hugues, Stephanie; Guermonprez, Pierre; Vargas, Pablo; Moura, Ivan Cruz; Lennon-Dumenil, Ana-Maria; Seabra, Miguel C.; Raposo, Graca; Amigorena, Sebastian			NOX2 controls phagosomal pH to regulate antigen processing during crosspresentation by dendritic cells	CELL			English	Article							RESPIRATORY BURST OXIDASE; NADPH OXIDASE; CROSS-PRESENTATION; PRESENTING CELLS; ACTIVATION; NEUTROPHILS; PHAGOCYTES; STIMULATION; GENERATION; ENDOSOMES	To initiate adaptative cytotoxic immune responses, proteolytic peptides derived from phagocytosed antigens are presented by dendritic cells (DCs) to CD8(+) T lymphocytes through a process called antigen "crosspresentation." The partial degradation of antigens mediated by lysosomal proteases in an acidic environment must be tightly controlled to prevent destruction of potential peptides for T cell recognition. We now describe a specialization of the phagocytic pathway of DCs that allows a fine control of antigen processing. The NADPH oxidase NOX2 is recruited to the DC's early phagosomes and mediates the sustained production of low levels of reactive oxygen species, causing active and maintained alkalinization of the phagosomal lumen. DCs lacking NOX2 show enhanced phagosomal acidification and increased antigen degradation, resulting in impaired crosspresentation. Therefore, NOX2 plays a critical role in conferring DCs the ability to function as specialized phagocytes adapted to process antigens rather than kill pathogens.	Inst Curie, INSERM, U653, F-75248 Paris 05, France; Univ London Imperial Coll Sci Technol & Med, Div Biomed Sci, London SW7 2AZ, England; Inst Curie, INSERM, U520, F-75248 Paris 05, France; Inst Curie, CNRS, UMR144, F-75248 Paris 05, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Imperial College London; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Sorbonne Universite	Amigorena, S (corresponding author), Inst Curie, INSERM, U653, 26 Rue Ulm, F-75248 Paris 05, France.	sebastian.amigorena@curie.fr	Guermonprez, Pierre/ABE-7718-2020; Seabra, Miguel/AAC-3099-2019; Lennon-Dumenil, Ana-Maria/I-6716-2016; Seabra, Miguel C/M-3280-2013; Moura, Ivan C/A-9510-2013; Vargas, Pablo/L-9858-2017; VARGAS, Pablo/HHM-4543-2022; Cruz Moura, Ivan/A-9510-2013	Guermonprez, Pierre/0000-0001-5621-2262; Seabra, Miguel C/0000-0002-6404-4892; Moura, Ivan C/0000-0002-2977-0354; Vargas, Pablo/0000-0002-6475-494X; VARGAS, Pablo/0000-0002-6475-494X; hugues, stephanie/0000-0002-1031-5909; Cruz Moura, Ivan/0000-0002-8418-2803; Amigorena, Sebastian/0000-0001-8583-8416; Raposo, graca/0000-0001-9590-1298	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Accapezzato D, 2005, J EXP MED, V202, P817, DOI 10.1084/jem.20051106; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; BENAROCH P, 1995, EMBO J, V14, P37, DOI 10.1002/j.1460-2075.1995.tb06973.x; Bonifaz L, 2002, J EXP MED, V196, P1627, DOI 10.1084/jem.20021598; CALAFAT J, 1993, BLOOD, V81, P3122; Claus V, 1998, J BIOL CHEM, V273, P9842, DOI 10.1074/jbc.273.16.9842; Cresswell P, 2005, IMMUNOL REV, V207, P5, DOI 10.1111/j.0105-2896.2005.00320.x; CROSS AR, 2004, BIOCHIM BIOPHYS ACTA, V1654, P1; DeCoursey TE, 2003, NATURE, V422, P531, DOI 10.1038/nature01523; DeCoursey TE, 2001, J BIOL CHEM, V276, P36063, DOI 10.1074/jbc.C100352200; Delamarre L, 2005, SCIENCE, V307, P1630, DOI 10.1126/science.1108003; El-Benna J, 2005, ARCH IMMUNOL THER EX, V53, P199; ELBENNA J, 1994, J BIOL CHEM, V269, P23431; Elsen S, 2004, J CELL SCI, V117, P2215, DOI 10.1242/jcs.01085; Forman HJ, 2002, AM J RESP CRIT CARE, V166, pS4, DOI 10.1164/rccm.2206007; Guermonprez P, 2002, ANNU REV IMMUNOL, V20, P621, DOI 10.1146/annurev.immunol.20.100301.064828; Guermonprez P, 2005, SPRINGER SEMIN IMMUN, V26, P257, DOI 10.1007/s00281-004-0176-0; Guermonprez P, 2003, NATURE, V425, P397, DOI 10.1038/nature01911; Hackam DJ, 1998, J EXP MED, V188, P351, DOI 10.1084/jem.188.2.351; Heath WR, 2004, IMMUNOL REV, V199, P9, DOI 10.1111/j.0105-2896.2004.00142.x; Houde M, 2003, NATURE, V425, P402, DOI 10.1038/nature01912; Jiang Q, 1997, CHEM RES TOXICOL, V10, P1080, DOI 10.1021/tx9700984; KARTTUNEN J, 1992, P NATL ACAD SCI USA, V89, P6020, DOI 10.1073/pnas.89.13.6020; Kjeken R, 2004, MOL BIOL CELL, V15, P345, DOI 10.1091/mbc.e03-05-0334; Lee WL, 2003, MICROBES INFECT, V5, P1299, DOI 10.1016/j.micinf.2003.09.014; Lennon-Dumenil AM, 2002, J EXP MED, V196, P529, DOI 10.1084/jem.20020327; Manoury B, 1998, NATURE, V396, P695, DOI 10.1038/25379; Matsue H, 2003, J IMMUNOL, V171, P3010, DOI 10.4049/jimmunol.171.6.3010; Mellman I, 2001, CELL, V106, P255, DOI 10.1016/S0092-8674(01)00449-4; NANDA A, 1994, J CLIN INVEST, V93, P1770, DOI 10.1172/JCI117162; Pierre P, 1997, NATURE, V388, P787, DOI 10.1038/42039; RAPOSO G, 1997, HDB EXPT IMMUNOLOGY, P1; Reeves EP, 2002, NATURE, V416, P291, DOI 10.1038/416291a; Segal AW, 2005, ANNU REV IMMUNOL, V23, P197, DOI 10.1146/annurev.immunol.23.021704.115653; SEGAL AW, 1978, BIOCHEM BIOPH RES CO, V84, P611, DOI 10.1016/0006-291X(78)90749-0; SEGAL AW, 1981, NATURE, V290, P406, DOI 10.1038/290406a0; Trombetta ES, 2003, SCIENCE, V299, P1400, DOI 10.1126/science.1080106; VOWELLS SJ, 1995, J IMMUNOL METHODS, V178, P89, DOI 10.1016/0022-1759(94)00247-T; Vulcano M, 2004, J IMMUNOL, V173, P5749, DOI 10.4049/jimmunol.173.9.5749; Winzler C, 1997, J EXP MED, V185, P317, DOI 10.1084/jem.185.2.317; Yates RM, 2005, IMMUNITY, V23, P409, DOI 10.1016/j.immuni.2005.09.007; YILLA M, 1993, J BIOL CHEM, V268, P19092	42	617	627	0	36	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 14	2006	126	1					205	218		10.1016/j.cell.2006.05.035	http://dx.doi.org/10.1016/j.cell.2006.05.035			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	066JF	16839887	Bronze			2022-12-28	WOS:000239224800027
J	Goldmann, D				Goldmann, D			System failure versus personal accountability - The case for clean hands	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Inst Healthcare Improvement, Cambridge, MA USA; Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA	Institute for Healthcare Improvement; Harvard University; Harvard Medical School	Goldmann, D (corresponding author), Inst Healthcare Improvement, Cambridge, MA USA.							[Anonymous], 2002, MMWR Recomm Rep, V51, P1; *I HEALTHC IMPR, 2006, GUID IMPR HAND HYG; Lankford MG, 2003, EMERG INFECT DIS, V9, P217; Pittet D, 1999, ANN INTERN MED, V130, P126, DOI 10.7326/0003-4819-130-2-199901190-00006; World Health Organization, 2005, WHO GUID HAND HYG HL	5	81	82	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 13	2006	355	2					121	123		10.1056/NEJMp068118	http://dx.doi.org/10.1056/NEJMp068118			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	062UP	16837675				2022-12-28	WOS:000238970600003
J	Percec, V; Ungar, G; Peterca, M				Percec, V; Ungar, G; Peterca, M			Self-assembly in action	SCIENCE			English	Editorial Material							POLYMERIZATION; MOLECULES; LATTICE		Univ Penn, Dept Chem, Roy & Diana Vagelos Labs, Philadelphia, PA 19104 USA; Univ Sheffield, Dept Mat Engn, Sheffield S1 3JD, S Yorkshire, England	University of Pennsylvania; University of Sheffield	Percec, V (corresponding author), Univ Penn, Dept Chem, Roy & Diana Vagelos Labs, Philadelphia, PA 19104 USA.	percec@sas.upenn.edu; g.ungar@shef.ac.uk; peterca@sas.upenn.edu	Peterca, Mihai/C-9504-2009; Percec, Virgil/H-6316-2014	Peterca, Mihai/0000-0002-7247-4008; Percec, Virgil/0000-0001-5926-0489; Ungar, Goran/0000-0002-9743-2656				Aizenberg J, 1999, NATURE, V398, P495, DOI 10.1038/19047; Arnaud A, 2004, ANGEW CHEM INT EDIT, V43, P1718, DOI 10.1002/anie.200353434; Bayley H, 2001, NATURE, V413, P226, DOI 10.1038/35093038; CAHN RW, 1986, NATURE, V323, P668, DOI 10.1038/323668a0; Douglas T, 2006, SCIENCE, V312, P873, DOI 10.1126/science.1123223; Dudowicz J, 2000, J CHEM PHYS, V113, P434, DOI 10.1063/1.481808; Engelkamp H, 1999, SCIENCE, V284, P785, DOI 10.1126/science.284.5415.785; GULIKKRZYWICKI T, 1993, P NATL ACAD SCI USA, V90, P163, DOI 10.1073/pnas.90.1.163; Ivin KJ, 2000, J POLYM SCI POL CHEM, V38, P2137, DOI 10.1002/(SICI)1099-0518(20000615)38:12<2137::AID-POLA20>3.0.CO;2-D; Jonkheijm P, 2006, SCIENCE, V313, P80, DOI 10.1126/science.1127884; KLUG A, 1983, ANGEW CHEM INT EDIT, V22, P565, DOI 10.1002/anie.198305653; LEHN JM, 1988, ANGEW CHEM INT EDIT, V27, P89, DOI 10.1002/anie.198800891; Percec V, 2004, NATURE, V430, P764, DOI 10.1038/nature02770; Ungar G, 2003, SCIENCE, V299, P1208, DOI 10.1126/science.1078849; Van Workum K, 2005, MACROMOL SYMP, V227, P1, DOI 10.1002/masy.200550901	15	83	83	3	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 7	2006	313	5783					55	56		10.1126/science.1129512	http://dx.doi.org/10.1126/science.1129512			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061DA	16825559				2022-12-28	WOS:000238850200025
J	Prattico, F; Perfetti, P				Prattico, Francesco; Perfetti, Paola			Frey's syndrome	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Osped Civile, Azienda Osped Verona, I-37126 Verona, Italy	University of Verona; Azienda Ospedaliera Universitaria Integrata Verona	Prattico, F (corresponding author), Osped Civile, Azienda Osped Verona, Piazzale Stefani 1, I-37126 Verona, Italy.								0	9	10	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 6	2006	355	1					66	66		10.1056/NEJMicm040462	http://dx.doi.org/10.1056/NEJMicm040462			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	060DT	16822997				2022-12-28	WOS:000238783200008
J	O'Reilly, J; Lowson, K; Young, J; Forster, A; Green, J; Small, N				O'Reilly, Jacqueline; Lowson, Karin; Young, John; Forster, Anne; Green, John; Small, Neil			A cost effectiveness analysis within a randomised controlled trial of post-acute care of older people in a community hospital	BMJ-BRITISH MEDICAL JOURNAL			English	Article							OXFORDSHIRE; BEDS	Objective To assess the cost effectiveness of post-acute care for older people in a locality based community hospital compared with a department for care of elderly people in a district general hospital, which admits patients aged over 76 years with acute medical conditions. Design Cost effectiveness analysis within a randomised controlled trial. Setting Community hospital and district general hospital in Yorkshire, England. Participants 220 patients needing rehabilitation after an acute illness for which they required admission to hospital. Interventions Multidisciplinary care in the district general hospital or prompt transfer to the community hospital. Main outcome measures EuroQol EQ-5D scores transformed into quality adjusted life years (QALYs), and health and social service costs over six months from randomisation. Results The mean QALY score for the community hospital group was marginally non-significantly higher than that for the district general hospital group (0.38 v 0.35) at six months after recruitment. The mean (standard deviation) costs per patient of the health and social services resources used were similar for both groups: community hospital group 7233 pound (E10 567; $13 341) (5031) pound, district general hospital group 7351 pound (6229) pound, and these findings were robust to several sensitivity analyses. The incremental cost effectiveness ratio for community hospital care dominated. A cost effectiveness acceptability curve, based on bootstrapped simulations, suggests that at a willingness to pay threshold of 10 pound 000 per QALY, 51% of community hospital cases will be cost effective, which rises to 53% of cases when the threshold is 30 pound 000 per QALY. Conclusion Post-acute care for older people in a locality based community hospital is of similar cost effectiveness to that of an elderly care department in a district general hospital.	Univ York, York Hlth Econ Consortium, York YO10 5NH, N Yorkshire, England; St Lukes Hosp, Acad Unit Elderly Care & Rehabil, Bradford BD5 0NA, W Yorkshire, England; Univ Bradford, Sch Hlth Studies, Bradford BD7 1DP, W Yorkshire, England	University of York - UK; University of Bradford	Lowson, K (corresponding author), Univ York, York Hlth Econ Consortium, York YO10 5NH, N Yorkshire, England.	kvl2@york.ac.uk		young, john/0000-0003-4085-9306; Forster, Anne/0000-0001-7466-4414				BAKER JE, 1986, J EPIDEMIOL COMMUN H, V40, P117, DOI 10.1136/jech.40.2.117; Briggs AH, 1997, HEALTH ECON, V6, P327, DOI 10.1002/(SICI)1099-1050(199707)6:4<327::AID-HEC282>3.0.CO;2-W; Briggs AH, 1999, STAT MED, V18, P3245, DOI 10.1002/(SICI)1097-0258(19991215)18:23<3245::AID-SIM314>3.0.CO;2-2; *CIPFA, 2002, HLTH SERV FIN DAT CO; Cook PJ, 1998, AGE AGEING, V27, P357, DOI 10.1093/ageing/27.3.357; *DEP HLTH, 2002, REF COSTS 2002; *DEP HLTH, 2006, CM6737; *DEP HLTH, 2000, NHS PLAN; Green J, 2005, BMJ-BRIT MED J, V331, P317, DOI 10.1136/bmj.38498.387569.8F; Hine C, 1996, J ROY SOC MED, V89, P681, DOI 10.1177/014107689608901207; Meads G, 2001, BRIT J GEN PRACT, V51, P91; NETTEN A, 2002, UNIT COSTS HLTH SOCI; Seamark D, 2001, BRIT J GEN PRACT, V51, P125; 1996, EUROQOL EQ 5D USER G	14	13	13	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 29	2006	333	7561					228	231		10.1136/bmj.38887.558576.7C	http://dx.doi.org/10.1136/bmj.38887.558576.7C			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	070CC	16861254	Green Published, Bronze, Green Submitted			2022-12-28	WOS:000239496900019
J	Rudensky, AY; Gavin, M; Zheng, Y				Rudensky, Alexander Y.; Gavin, Marc; Zheng, Ye			FOXP3 and NFAT: Partners in tolerance	CELL			English	Review							REGULATORY T-CELLS; IMMUNE-RESPONSE; KAPPA-B; INTERLEUKIN-2; COSTIMULATION; TRANSCRIPTION; EXPRESSION; LINEAGE; SELF; DNA		Univ Washington, Howard Hughes Med Inst, Sch Med, Seattle, WA 98195 USA; Univ Washington, Dept Immunol, Sch Med, Seattle, WA 98195 USA	Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Rudensky, AY (corresponding author), Univ Washington, Howard Hughes Med Inst, Sch Med, Seattle, WA 98195 USA.	aruden@u.washington.edu						Bettelli E, 2005, P NATL ACAD SCI USA, V102, P5138, DOI 10.1073/pnas.0501675102; Fontenot JD, 2005, NAT IMMUNOL, V6, P1142, DOI 10.1038/ni1263; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Grant C, 2006, PLOS PATHOG, V2, P303, DOI 10.1371/journal.ppat.0020033; Hsieh CS, 2006, NAT IMMUNOL, V7, P401, DOI 10.1038/ni1318; JANEWAY CA, 1989, COLD SPRING HARB SYM, V54, P1; Kretschmer K, 2005, NAT IMMUNOL, V6, P1219, DOI 10.1038/ni1265; Li SR, 2004, MOL CELL BIOL, V24, P809, DOI 10.1128/MCB.24.2.809-822.2004; Macian F, 2002, CELL, V109, P719, DOI 10.1016/S0092-8674(02)00767-5; Medzhitov R, 1999, COLD SPRING HARB SYM, V64, P429, DOI 10.1101/sqb.1999.64.429; Ochs HD, 2005, IMMUNOL REV, V203, P156, DOI 10.1111/j.0105-2896.2005.00231.x; Ramsdell F, 2003, IMMUNITY, V19, P165, DOI 10.1016/S1074-7613(03)00207-3; Sakaguchi S, 2005, NAT IMMUNOL, V6, P345, DOI 10.1038/ni1178; Salomon B, 2000, IMMUNITY, V12, P431, DOI 10.1016/S1074-7613(00)80195-8; Stroud JC, 2006, STRUCTURE, V14, P159, DOI 10.1016/j.str.2005.10.005; Suffia IJ, 2006, J EXP MED, V203, P777, DOI 10.1084/jem.20052056; Tai XG, 2005, NAT IMMUNOL, V6, P152, DOI 10.1038/ni1160; Ziegler SF, 2006, ANNU REV IMMUNOL, V24, P209, DOI 10.1146/annurev.immunol.24.021605.090547	18	82	98	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 28	2006	126	2					253	256		10.1016/j.cell.2006.07.005	http://dx.doi.org/10.1016/j.cell.2006.07.005			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	070VD	16873058	Bronze			2022-12-28	WOS:000239552600012
J	Turkington, JRA; McAteer, E				Turkington, J. R. A.; McAteer, E.			A medical mystery: Abnormal chest X-ray film	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Craigavon Area Hosp, Portadown BT63 5QQ, North Ireland		Turkington, JRA (corresponding author), Craigavon Area Hosp, Portadown BT63 5QQ, North Ireland.								0	1	1	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 27	2006	355	4					393	393		10.1056/NEJMicm050764	http://dx.doi.org/10.1056/NEJMicm050764			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	067DT	16870918				2022-12-28	WOS:000239282600008
J	Yager, P; Edwards, T; Fu, E; Helton, K; Nelson, K; Tam, MR; Weigl, BH				Yager, Paul; Edwards, Thayne; Fu, Elain; Helton, Kristen; Nelson, Kjell; Tam, Milton R.; Weigl, Bernhard H.			Microfluidic diagnostic technologies for global public health	NATURE			English	Review							FIELD-FLOW-FRACTIONATION; IMMUNOCHROMATOGRAPHIC STRIP TEST; PLASMODIUM-FALCIPARUM MALARIA; POLYMERASE-CHAIN-REACTION; FLUORESCENCE DETECTION; RESONANCE MICROSCOPE; PARTICLE SEPARATION; INFECTIOUS-DISEASES; ENZYME-IMMUNOASSAY; MU-TAS	The developing world does not have access to many of the best medical diagnostic technologies; they were designed for air-conditioned laboratories, refrigerated storage of chemicals, a constant supply of calibrators and reagents, stable electrical power, highly trained personnel and rapid transportation of samples. Microfluidic systems allow miniaturization and integration of complex functions, which could move sophisticated diagnostic tools out of the developed-world laboratory. These systems must be inexpensive, but also accurate, reliable, rugged and well suited to the medical and social contexts of the developing world.	Univ Washington, Dept Bioengn, Seattle, WA 98195 USA; PATH, Seattle, WA 98107 USA	University of Washington; University of Washington Seattle	Yager, P (corresponding author), Univ Washington, Dept Bioengn, Box 355061, Seattle, WA 98195 USA.	yagerp@u.washington.edu						[Anonymous], 1996, GLOBAL BURDEN DIS CO; Becker GS, 2005, AM ECON REV, V95, P277, DOI 10.1257/0002828053828563; Black RE, 2003, LANCET, V361, P2226, DOI 10.1016/S0140-6736(03)13779-8; Boel CHE, 2005, J CLIN MICROBIOL, V43, P2231, DOI 10.1128/JCM.43.5.2231-2235.2005; Brody JP, 1996, SENSOR ACTUAT A-PHYS, V54, P704, DOI 10.1016/S0924-4247(97)80042-8; Brody JP, 1996, BIOPHYS J, V71, P3430, DOI 10.1016/S0006-3495(96)79538-3; Brody JP, 1997, SENSOR ACTUAT A-PHYS, V58, P13, DOI 10.1016/S0924-4247(97)80219-1; Cabrera CR, 2001, ELECTROPHORESIS, V22, P355, DOI 10.1002/1522-2683(200101)22:2<355::AID-ELPS355>3.0.CO;2-C; CABRERA CR, 2000, IEEE 1 ANN C MICR ME; CATES W, 2003, NETWORK, V23; Cayemittes M, 1993, IDRC Rep, V21, P27; Cheng SB, 2001, ANAL CHEM, V73, P1472, DOI 10.1021/ac0007938; CHINOWSKY T, UNPUB BIOSENS BIOELE; Conroy J., 2006, IVD TECHNOL, V12, P37; Dittrich PS, 2005, ANAL BIOANAL CHEM, V382, P1771, DOI 10.1007/s00216-005-3335-9; Dupuy AM, 2005, CLIN CHEM LAB MED, V43, P1291, DOI 10.1515/CCL,.2005.223; Eickhoff Meike, 2003, Clin Lab, V49, P217; Engler KH, 2002, J CLIN MICROBIOL, V40, P80, DOI 10.1128/JCM.40.1.80-83.2002; Fauci AS, 2001, CLIN INFECT DIS, V32, P675, DOI 10.1086/319235; Fu E, 2004, REV SCI INSTRUM, V75, P2300, DOI 10.1063/1.1764608; Fu E, 2003, REV SCI INSTRUM, V74, P3182, DOI 10.1063/1.1574603; Garcia E, 2004, LAB CHIP, V4, P78, DOI 10.1039/b308914b; GARCIA E, 2003, MICRO TOTAL ANAL SYS, P551; Gascoyne P, 2002, LAB CHIP, V2, P70, DOI [10.1039/b110990c, 10.1039/b110090c]; Gascoyne PRC, 2002, ELECTROPHORESIS, V23, P1973, DOI 10.1002/1522-2683(200207)23:13<1973::AID-ELPS1973>3.0.CO;2-1; Guerrant RL, 2001, CLIN INFECT DIS, V32, P331, DOI 10.1086/318514; Hawkins KR, 2003, LAB CHIP, V3, P248, DOI 10.1039/b307772c; Hix J, 2004, AM J CLIN NUTR, V79, P93; Hughes MP, 2000, NANOTECHNOLOGY, V11, P124, DOI 10.1088/0957-4484/11/2/314; Jalal H, 2006, SEX TRANSM INFECT, V82, P37, DOI 10.1136/sti.2005.015362; Kaur H, 2000, Indian J Med Sci, V54, P432; Labbe AC, 2001, ANN TROP MED PARASIT, V95, P671, DOI 10.1080/00034980120103243; Loutfy MR, 1998, J INFECT DIS, V178, P1852, DOI 10.1086/314524; Macounova K, 2001, ANAL CHEM, V73, P1627, DOI 10.1021/ac001013y; Mills CD, 1999, B WORLD HEALTH ORGAN, V77, P553; Morens DM, 2004, NATURE, V430, P242, DOI 10.1038/nature02759; Muller T, 2000, J LIQ CHROMATOGR R T, V23, P47, DOI 10.1081/JLC-100101435; *NAT RES COUNC COM, 2006, FUND ROL SCI TECHN I; Parkes R, 2001, CAN J MICROBIOL, V47, P903; Patterson K, 2002, J CLIN MICROBIOL, V40, P3694, DOI 10.1128/JCM.40.10.3694-3702.2002; Perkins MD, 2002, B WORLD HEALTH ORGAN, V80, P512; Price CP, 2001, BMJ-BRIT MED J, V322, P1285, DOI 10.1136/bmj.322.7297.1285; Raj A A, 2001, Indian J Pathol Microbiol, V44, P413; Rodriguez WR, 2005, PLOS MED, V2, P663, DOI 10.1371/journal.pmed.0020182; Rousselet J, 1998, COLLOID SURFACE A, V140, P209, DOI 10.1016/S0927-7757(97)00279-3; Stroock AD, 2002, SCIENCE, V295, P647, DOI 10.1126/science.1066238; Talbot EA, 2004, CLIN INFECT DIS, V39, pE1, DOI 10.1086/421388; TAM MR, 1991, UPSALA J MED SCI, P22; TAM MR, 1999, SEXUALLY TRANSMITTED, P1409; Toner M, 2005, ANNU REV BIOMED ENG, V7, P77, DOI 10.1146/annurev.bioeng.7.011205.135108; *UK DEP INT DEV, 2005, CHALL TB MAL CONTR; Vickerman Peter, 2005, Mol Diagn, V9, P175, DOI 10.2165/00066982-200509040-00002; von Lode P, 2005, CLIN BIOCHEM, V38, P591, DOI 10.1016/j.clinbiochem.2005.03.008; Wang XB, 2000, ANAL CHEM, V72, P832, DOI 10.1021/ac990922o; WEIGL BH, 2006, P SPIE INT SOC OPT E, V6112, P1; *WORLD BANK, 1993, WORLD BANK WORLD DEV; World Health Organization (WHO), 2013, WORLD HLTH REPORT 20; YAGER P, 1998, MICRO TOTAL ANAL SYS, P207; Zarakolu P, 2002, J CLIN MICROBIOL, V40, P3064, DOI 10.1128/JCM.40.8.3064-3065.2002	59	1464	1571	12	805	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 27	2006	442	7101					412	418		10.1038/nature05064	http://dx.doi.org/10.1038/nature05064			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067CI	16871209	Bronze			2022-12-28	WOS:000239278900034
J	Shojania, KG; Ranji, SR; McDonald, KM; Grimshaw, JM; Sundaram, V; Rushakoff, RJ; Owens, DK				Shojania, Kaveh G.; Ranji, Sumant R.; McDonald, Kathryn M.; Grimshaw, Jeremy M.; Sundaram, Vandana; Rushakoff, Robert J.; Owens, Douglas K.			Effects of quality improvement strategies for type 2 diabetes on glycemic control - A meta-regression analysis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							RANDOMIZED CONTROLLED-TRIAL; NURSE FOLLOW-UP; HEALTH MAINTENANCE ORGANIZATION; DISEASE MANAGEMENT PROGRAMS; CARDIOVASCULAR RISK-FACTORS; NO MAGIC BULLETS; PRIMARY-CARE; GENERAL-PRACTICE; AUTOMATED CALLS; MULTIFACTORIAL INTERVENTION	Context There have been numerous reports of interventions designed to improve the care of patients with diabetes, but the effectiveness of such interventions is unclear. Objective To assess the impact on glycemic control of 11 distinct strategies for quality improvement (QI) in adults with type 2 diabetes. Data Sources and Study Selection MEDLINE (1966-April 2006) and the Cochrane Collaboration's Effective Practice and Organisation of Care Group database, which covers multiple bibliographic databases. Eligible studies included randomized or quasi-randomized controlled trials and controlled before-after studies that evaluated a QI intervention targeting some aspect of clinician behavior or organizational change and reported changes in glycosylated hemoglobin (HbA(1c)) values. Data Extraction Postintervention difference in HbA1c values were estimated using a meta-regression model that included baseline glycemic control and other key intervention and study features as predictors. Data Synthesis Fifty randomized controlled trials, 3 quasi-randomized trials, and 13 controlled before-after trials met all inclusion criteria. Across these 66 trials, interventions reduced HbA1c values by a mean of 0.42% (95% confidence interval [CI], 0.29%-0.54%) over a median of 13 months of follow-up. Trials with fewer patients than the median for all included trials reported significantly greater effects than did larger trials (0.61% vs 0.27%, P=. 004), strongly suggesting publication bias. Trials with mean baseline HbA1c values of 8.0% or greater also reported significantly larger effects (0.54% vs 0.20%, P=. 005). Adjusting for these effects, 2 of the 11 categories of QI strategies were associated with reductions in HbA1c values of at least 0.50%: team changes (0.67%; 95% CI, 0.43%-0.91%; n=26 trials) and case management (0.52%; 95% CI, 0.31%-0.73%; n=26 trials); these also represented the only 2 strategies conferring significant incremental reductions in HbA1c values. Interventions involving team changes reduced values by 0.33% more ( 95% CI, 0.12%-0.54%; P=. 004) than those without this strategy, and those involving case management reduced values by 0.22% more ( 95% CI, 0.00%-0.44%; P=. 04) than those without case management. Interventions in which nurse or pharmacist case managers could make medication adjustments without awaiting physician authorization reduced values by 0.80% ( 95% CI, 0.51%-1.10%), vs only 0.32% ( 95% CI, 0.14%-0.49%) for all other interventions ( P=. 002). Conclusions Most QI strategies produced small to modest improvements in glycemic control. Team changes and case management showed more robust improvements, especially for interventions in which case managers could adjust medications without awaiting physician approval. Estimates of the effectiveness of other specific QI strategies may have been limited by difficulty in classifying complex interventions, insufficient numbers of studies, and publication bias.	Univ Ottawa, Ottawa Hlth Res Inst, Ottawa, ON, Canada; Univ Ottawa, Dept Med, Ottawa, ON, Canada; Univ Ottawa, Inst Populat Hlth, Ottawa, ON, Canada; Univ Calif San Francisco, Dept Med, San Francisco, CA USA; Univ Calif San Francisco, Div Endocrinol, San Francisco, CA USA; Stanford Univ, Ctr Primary Care & Outcomes Res, Palo Alto, CA 94304 USA; VA Palo Alto Hlth Care Syst, Palo Alto, CA USA	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; University of Ottawa; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Shojania, KG (corresponding author), Ottawa Hosp, Civic Campus,1053 Carling Ave,Room C403,Box 693, Ottawa, ON K1Y 4E9, Canada.	kshojania@ohri.ca	McDowell, Joan R S/H-3159-2014; Young, Alexander/A-1523-2009; Grimshaw, Jeremy/D-8726-2013	Young, Alexander/0000-0002-9367-9213; Grimshaw, Jeremy/0000-0001-8015-8243	PHS HHS [290-02-0017] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		AHRING KK, 1992, DIABETES CARE, V15, P971, DOI 10.2337/diacare.15.8.971; Armour Carol L, 2004, J Am Pharm Assoc (2003), V44, P455, DOI 10.1331/1544345041475625; Aubert RE, 1998, ANN INTERN MED, V129, P605, DOI 10.7326/0003-4819-129-8-199810150-00004; Balas EA, 2004, MED CARE, V42, P610, DOI 10.1097/01.mlr.0000128008.12117.f8; Benjamin EM, 1999, DIABETES CARE, V22, P1672, DOI 10.2337/diacare.22.10.1672; BOUCHER BJ, 1987, DIABETIC MED, V4, P480, DOI 10.1111/j.1464-5491.1987.tb00913.x; Cagliero E, 1999, DIABETES CARE, V22, P1785, DOI 10.2337/diacare.22.11.1785; Campbell M, 2000, J Health Serv Res Policy, V5, P12; Campbell MK, 2001, STAT MED, V20, P391, DOI 10.1002/1097-0258(20010215)20:3<391::AID-SIM800>3.0.CO;2-Z; Chaix-Couturier C, 2000, INT J QUAL HEALTH C, V12, P133, DOI 10.1093/intqhc/12.2.133; Chang JT, 2004, BRIT MED J, V328, P680, DOI 10.1136/bmj.328.7441.680; Choe HM, 2005, AM J MANAG CARE, V11, P253; Clifford RM, 2002, INT J PHARM PRACT, V10, P85; *COCHR EFF PRACT O, 2002, EPOC REG        1104; Cochrane Effective Practice and Organisation of Care Group (EPOC), 2002, EPOC DAT COLL CHECKL; Davidoff F, 2005, QUAL SAF HEALTH CARE, V14, P319, DOI 10.1136/qshc.2005.014787; DERAMOMELKUS GA, 1992, DIABETES CARE, V15, P864, DOI 10.2337/diacare.15.7.864; deSonnaville JJJ, 1997, DIABETOLOGIA, V40, P1334, DOI 10.1007/s001250050829; Dijkstra RF, 2006, DIABETIC MED, V23, P164, DOI 10.1111/j.1464-5491.2005.01751.x; Dijkstra RF, 2005, DIABETES RES CLIN PR, V68, P126, DOI 10.1016/j.diabres.2004.09.020; Donner A, 2002, STAT MED, V21, P2971, DOI 10.1002/sim.1301; Dudley RA, 2005, JAMA-J AM MED ASSOC, V294, P1821, DOI 10.1001/jama.294.14.1821; Eccles M, 2002, BMC HEALTH SERV RES, V2, DOI 10.1186/1472-6963-2-5; Ellis SE, 2004, PATIENT EDUC COUNS, V52, P97, DOI 10.1016/S0738-3991(03)00016-8; Engelgau MM, 2004, ANN INTERN MED, V140, P945, DOI 10.7326/0003-4819-140-11-200406010-00035; FRANZ MJ, 1995, J AM DIET ASSOC, V95, P1009, DOI 10.1016/S0002-8223(95)00276-6; Gabbay RA, 2006, DIABETES RES CLIN PR, V71, P28, DOI 10.1016/j.diabres.2005.05.002; Gaede P, 1999, LANCET, V353, P617, DOI 10.1016/S0140-6736(98)07368-1; Gaede P, 2003, NEW ENGL J MED, V348, P383, DOI 10.1056/NEJMoa021778; Gary TL, 2003, PREV MED, V37, P23, DOI 10.1016/S0091-7435(03)00040-9; Gary TL, 2003, DIABETES EDUCATOR, V29, P488, DOI 10.1177/014572170302900313; GINSBERG BH, 1996, JCOM, V3, P45; Glasgow RE, 2005, DIABETES CARE, V28, P33, DOI 10.2337/diacare.28.1.33; Glasgow RE, 1996, DIABETES CARE, V19, P835, DOI 10.2337/diacare.19.8.835; Goldberg H. I., 2004, JOINT COMM J QUAL IM, V30, p[629, 589]; Goldberg Harold I, 2004, Jt Comm J Qual Saf, V30, P629; Grant RW, 2004, DIABETES CARE, V27, P2299, DOI 10.2337/diacare.27.10.2299; Grimshaw J, 2003, QUAL SAF HEALTH CARE, V12, P298, DOI 10.1136/qhc.12.4.298; Grimshaw JM, 2004, HEALTH TECHNOL ASSES, V8, P1, DOI 10.3310/hta8060; GRIMSHAW JM, 2001, MED CARE S2, V39, P2, DOI DOI 10.1097/00005650-200108002-00002; Groeneveld Y, 2001, SCAND J PRIM HEALTH, V19, P25, DOI 10.1080/028134301300034585; HAYES TM, 1984, BRIT MED J, V289, P728, DOI 10.1136/bmj.289.6447.728; Hetlevik I, 2000, INT J TECHNOL ASSESS, V16, P210, DOI 10.1017/S0266462300161185; Hirsch IB, 2002, DIABETES RES CLIN PR, V58, P27, DOI 10.1016/S0168-8227(02)00100-6; HOSKINS PL, 1993, DIABETIC MED, V10, P81, DOI 10.1111/j.1464-5491.1993.tb02001.x; HURWITZ B, 1993, BRIT MED J, V306, P624, DOI 10.1136/bmj.306.6878.624; Ilag LL, 2003, DIABETES CARE, V26, P2722, DOI 10.2337/diacare.26.10.2722; Jaber LA, 1996, ANN PHARMACOTHER, V30, P238, DOI 10.1177/106002809603000305; Jamtvedt G, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000259.pub2; Jovanovic L, 2004, DIABETES CARE, V27, P95; Kerry SM, 1998, BRIT MED J, V316, P1455, DOI 10.1136/bmj.316.7142.1455; Kim HS, 2003, J ADV NURS, V44, P256, DOI 10.1046/j.1365-2648.2003.02800.x; Kinmonth AL, 1998, BMJ-BRIT MED J, V317, P1202, DOI 10.1136/bmj.317.7167.1202; Knight K, 2005, AM J MANAG CARE, V11, P242; Krein SL, 2004, AM J MED, V116, P732, DOI 10.1016/j.amjmed.2003.11.028; Kwon HS, 2004, DIABETES CARE, V27, P478, DOI 10.2337/diacare.27.2.478; LEGORRETA AP, 1996, AM J MANAG CARE, V2, P1024; Levetan CS, 2002, DIABETES CARE, V25, P2, DOI 10.2337/diacare.25.1.2; Litaker David, 2003, J Interprof Care, V17, P223, DOI 10.1080/1356182031000122852; Maislos M, 2004, ACTA DIABETOL, V41, P44, DOI 10.1007/s00592-004-0143-1; Majumdar SR, 2003, DIABETES CARE, V26, P3061, DOI 10.2337/diacare.26.11.3061; MAZZUCA SA, 1986, DIABETES CARE, V9, P1, DOI 10.2337/diacare.9.1.1; McAlister FA, 2001, AM J MED, V110, P378, DOI 10.1016/S0002-9343(00)00743-9; McFarlane SI, 2002, DIABETES CARE, V25, P718, DOI 10.2337/diacare.25.4.718; McMahon GT, 2005, DIABETES CARE, V28, P1624, DOI 10.2337/diacare.28.7.1624; Meigs JB, 2003, DIABETES CARE, V26, P750, DOI 10.2337/diacare.26.3.750; Narayan KMV, 2003, JAMA-J AM MED ASSOC, V290, P1884, DOI 10.1001/jama.290.14.1884; Narayan V, 2004, ANN INTERN MED, V140, P958, DOI 10.7326/0003-4819-140-11-200406010-00037; Normand SLT, 1999, STAT MED, V18, P321, DOI 10.1002/(SICI)1097-0258(19990215)18:3<321::AID-SIM28>3.0.CO;2-P; Norris SL, 2002, AM J PREV MED, V22, P15, DOI 10.1016/S0749-3797(02)00423-3; Norris SL, 2002, DIABETES CARE, V25, P1159, DOI 10.2337/diacare.25.7.1159; O'Connor PJ, 2005, ANN FAM MED, V3, P300, DOI 10.1370/afm.327; O'Connor PJ, 2005, DIABETES CARE, V28, P1890, DOI 10.2337/diacare.28.8.1890; O'Hare JP, 2004, DIABETIC MED, V21, P1357, DOI 10.1111/j.1464-5491.2004.01373.x; OConnor PJ, 1996, ARCH FAM MED, V5, P502, DOI 10.1001/archfami.5.9.502; Oh JA, 2003, YONSEI MED J, V44, P1, DOI 10.3349/ymj.2003.44.1.1; OXMAN AD, 1995, CAN MED ASSOC J, V153, P1423; Phillips LS, 2005, DIABETES CARE, V28, P2352, DOI 10.2337/diacare.28.10.2352; Piette JD, 2000, MED CARE, V38, P218, DOI 10.1097/00005650-200002000-00011; Piette JD, 2000, AM J MED, V108, P20, DOI 10.1016/S0002-9343(99)00298-3; Piette JD, 2001, DIABETES CARE, V24, P202, DOI 10.2337/diacare.24.2.202; Polonsky WH, 2003, DIABETES CARE, V26, P3048, DOI 10.2337/diacare.26.11.3048; Pouwer F, 2001, DIABETES CARE, V24, P1929, DOI 10.2337/diacare.24.11.1929; Renders CM, 2001, COCHRANE DB SYST REV, DOI [10.1002/14651858, DOI 10.1002/14651858.CD001481]; Rothman RL, 2005, AM J MED, V118, P276, DOI 10.1016/j.amjmed.2004.09.017; Saaddine JB, 2002, ANN INTERN MED, V136, P565, DOI 10.7326/0003-4819-136-8-200204160-00005; Sadur CN, 1999, DIABETES CARE, V22, P2011, DOI 10.2337/diacare.22.12.2011; Sarkisian CA, 2003, DIABETES EDUCATOR, V29, P467, DOI 10.1177/014572170302900311; Shea S, 2006, J AM MED INFORM ASSN, V13, P40, DOI 10.1197/jamia.M1917; Shojania KG, 2004, AM J MED, V116, P778, DOI 10.1016/j.amjmed.2004.03.003; Shojania KG, 2005, HEALTH AFFAIR, V24, P138, DOI 10.1377/hlthaff.24.1.138; SHOJANIA KG, 2004, AHRQ PUBLICATION, V2; Shojania KG, 2004, AHRQ PUBLICATION, V1; Smith S, 2004, FAM PRACT, V21, P39, DOI 10.1093/fampra/cmh109; Smith SA, 1998, DIABETES CARE, V21, P972, DOI 10.2337/diacare.21.6.972; Stone EG, 2002, ANN INTERN MED, V136, P641, DOI 10.7326/0003-4819-136-9-200205070-00006; Taylor Katherine I, 2005, Biol Res Nurs, V6, P207, DOI 10.1177/1099800404272223; Terrin N, 2003, STAT MED, V22, P2113, DOI 10.1002/sim.1461; Thompson DM, 1999, CAN MED ASSOC J, V161, P959; Ubink-Vetmaat LJ, 2005, NETH J MED, V63, P103; van Houwelingen HC, 2002, STAT MED, V21, P589, DOI 10.1002/sim.1040; van Zyl DG, 2004, SAMJ S AFR MED J, V94, P455; Varroud-Vial M, 2004, DIABETIC MED, V21, P592, DOI 10.1111/j.1464-5491.2004.01207.x; Wagner EH, 2001, DIABETES CARE, V24, P695, DOI 10.2337/diacare.24.4.695; Walsh JME, 2006, MED CARE, V44, P646, DOI 10.1097/01.mlr.0000220260.30768.32; Warsi A, 2004, ARCH INTERN MED, V164, P1641, DOI 10.1001/archinte.164.15.1641; WEINBERER M, 1995, J GEN INTERN MED, V10, P59, DOI 10.1007/BF02600227; Weingarten SR, 2002, BRIT MED J, V325, P925, DOI 10.1136/bmj.325.7370.925; Welschen LMC, 2005, DIABETES CARE, V28, P1510, DOI 10.2337/diacare.28.6.1510	109	514	547	0	46	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 26	2006	296	4					427	440		10.1001/jama.296.4.427	http://dx.doi.org/10.1001/jama.296.4.427			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	066PN	16868301				2022-12-28	WOS:000239242500029
J	Smyth, RL; Openshaw, PJM				Smyth, Rosalind L.; Openshaw, Peter J. M.			Bronchiolitis	LANCET			English	Review							RESPIRATORY-SYNCYTIAL-VIRUS; NONSTRUCTURAL PROTEINS NS1; EVIDENCE-BASED GUIDELINE; HUMAN METAPNEUMOVIRUS; PERIPHERAL-BLOOD; DISEASE SEVERITY; YOUNG-CHILDREN; EMERGENCY-DEPARTMENTS; EPITHELIAL-CELLS; VIRAL-INFECTION	Bronchiolitis is a distressing, potentially life-threatening respiratory condition that affects young babies. Around 2-3% of all infants younger than 1 year are admitted to hospital with bronchiolitis, usually during the seasonal epidemic. The majority of these infants are infected with respiratory syncytial virus and all have an intense inflammatory response in their airways. Although most infants recover, they have an increased risk of recurrent wheezing. Although bronchiolitis is common, little is known about what causes infants to be susceptible. Diagnostic interventions have little effect on clinical outcome, and apart from supportive measures, there is no specific treatment. Bronchiolitis therefore presents an intriguing clinical conundrum and a major challenge to researchers. High quality clinical studies are needed to clarify assessment of disease severity and criteria for hospital admission, particularly the use of pulse oximetry and chest radiography. Careful mapping of the inflammatory pathways in the pathogenesis of bronchiolitis should lead to development of new therapies to alleviate symptoms.	Univ Liverpool, Alder Hey Childrens Hosp, Sch Reprod & Dev Med, Div Child Hlth, Liverpool L12 2AP, Merseyside, England; Imperial Coll, Natl Heart & Lung Inst, Sect Resp Infect, London, England	Alder Hey Children's NHS Foundation Trust; Alder Hey Children's Hospital; University of Liverpool; Imperial College London	Smyth, RL (corresponding author), Univ Liverpool, Alder Hey Childrens Hosp, Sch Reprod & Dev Med, Div Child Hlth, Liverpool L12 2AP, Merseyside, England.	r.l.smyth@liv.ac.uk	Openshaw, Peter/AAL-9442-2020	Openshaw, Peter/0000-0002-7220-2555				Aberle JH, 2005, PEDIATR INFECT DIS J, V24, P605, DOI 10.1097/01.inf.0000168741.59747.2d; Arbiza J, 2006, J CLIN VIROL, V35, P41, DOI 10.1016/j.jcv.2005.03.009; Beyer M, 2004, J ALLERGY CLIN IMMUN, V113, P127, DOI 10.1016/j.jaci.2003.10.057; Bitko V, 2005, NAT MED, V11, P50, DOI 10.1038/nm1164; Boivin G, 2003, EMERG INFECT DIS, V9, P634; Bont L, 1999, EUR RESPIR J, V14, P144, DOI 10.1034/j.1399-3003.1999.14a24.x; Bont L, 2000, Paediatr Respir Rev, V1, P221, DOI 10.1053/prrv.2000.0052; Bordley WC, 2004, ARCH PEDIAT ADOL MED, V158, P119, DOI 10.1001/archpedi.158.2.119; Bosis S, 2005, J MED VIROL, V75, P101, DOI 10.1002/jmv.20243; Bossert B, 2003, J VIROL, V77, P8661, DOI 10.1128/JVI.77.16.8661-8668.2003; Bossert B, 2002, J VIROL, V76, P4287, DOI 10.1128/JVI.76.9.4287-4293.2002; Bramley AM, 1999, EUR RESPIR J, V14, P1061, DOI 10.1183/09031936.99.14510619; Broughton S, 2006, ARCH DIS CHILD, V91, P26, DOI 10.1136/adc.2005.087270; Christakis DA, 2005, PEDIATRICS, V115, P878, DOI 10.1542/peds.2004-1299; Chung HL, 2002, ANN ALLERG ASTHMA IM, V88, P463, DOI 10.1016/S1081-1206(10)62383-6; Creery David, 2005, Int J Circumpolar Health, V64, P38; Culley FJ, 2002, J EXP MED, V196, P1381, DOI 10.1084/jem.20020943; Davison Caroline, 2004, Pediatr Crit Care Med, V5, P482, DOI 10.1097/01.PCC.0000128891.54799.67; Dayan PS, 2004, CLIN PEDIAT EMERG ME, V5, P41; de Bilderling G, 2003, ACTA CLIN BELG, V58, P98; Elphick HE, 2004, ARCH DIS CHILD, V89, P1059, DOI 10.1136/adc.2003.046458; Esper F, 2004, J INFECT DIS, V189, P1388, DOI 10.1086/382482; Falsey AR, 2006, J CLIN VIROL, V35, P46, DOI 10.1016/j.jcv.2005.04.004; Feltes TF, 2003, J PEDIATR-US, V143, P532, DOI 10.1067/S0022-3476(03)00454-2; Fitzgerald DA, 2004, MED J AUSTRALIA, V180, P399, DOI 10.5694/j.1326-5377.2004.tb05993.x; Fleming DM, 2005, J EPIDEMIOL COMMUN H, V59, P586, DOI 10.1136/jech.2004.026450; Gagro A, 2004, CLIN EXP IMMUNOL, V135, P267, DOI 10.1111/j.1365-2249.2004.02364.x; Gilca R, 2006, J INFECT DIS, V193, P54, DOI 10.1086/498526; Gill MA, 2005, J INFECT DIS, V191, P1105, DOI 10.1086/428589; Gomez R, 2004, ANN ALLERG ASTHMA IM, V93, P447, DOI 10.1016/S1081-1206(10)61411-1; HALL CB, 1986, NEW ENGL J MED, V315, P77, DOI 10.1056/NEJM198607103150201; Hanna S, 2003, ACTA PAEDIATR, V92, P430, DOI 10.1111/j.1651-2227.2003.tb00573.x; Hartling L, 2011, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD003123.pub2, DOI 10.1002/14651858.CD003123.PUB2]; Henderson J, 2005, PEDIAT ALLERG IMM-UK, V16, P386, DOI 10.1111/j.1399-3038.2005.00298.x; Henrickson KJ, 2004, PEDIATR INFECT DIS J, V23, pS11, DOI 10.1097/01.inf.0000108188.37237.48; Hirschheimer Mário, 2002, Braz J Infect Dis, V6, P146, DOI 10.1590/S1413-86702002000300009; Hoebee B, 2004, J INFECT DIS, V189, P239, DOI 10.1086/380908; Hoebee B, 2003, J INFECT DIS, V187, P2, DOI 10.1086/345859; Holman RC, 2004, PEDIATRICS, V114, pE437, DOI 10.1542/peds.2004-0049; Holman RC, 2003, PEDIATR INFECT DIS J, V22, P483, DOI 10.1097/00006454-200306000-00001; Hull J, 2003, J INFECT DIS, V188, P904, DOI 10.1086/377587; Illi S, 2001, BMJ-BRIT MED J, V322, P390, DOI 10.1136/bmj.322.7283.390; Joffe S, 1999, PEDIATRICS, V104, P419, DOI 10.1542/peds.104.3.419; JOHNSTON SL, 1995, BRIT MED J, V310, P1225, DOI 10.1136/bmj.310.6989.1225; Kabir M L, 2003, Mymensingh Med J, V12, P128; Kafetzis DA, 2003, CLIN MICROBIOL INFEC, V9, P1006, DOI 10.1046/j.1469-0691.2003.00715.x; Kamal-Bahl S, 2002, ARCH PEDIAT ADOL MED, V156, P1034, DOI 10.1001/archpedi.156.10.1034; Kellner JD, 2000, COCHRANE DB SYST REV, V2, DOI [10.1002/14651858.CD001266, DOI 10.1002/14651858.CD001266]; Kho N, 2004, J CHILD NEUROL, V19, P859, DOI 10.1177/08830738040190110301; King VJ, 2004, ARCH PEDIAT ADOL MED, V158, P127, DOI 10.1001/archpedi.158.2.127; Korppi M, 2004, PEDIATR INFECT DIS J, V23, P995, DOI 10.1097/01.inf.0000143642.72480.53; Korppi M, 2004, PEDIATR PULM, V38, P155, DOI 10.1002/ppul.20058; Kurt-Jones EA, 2000, NAT IMMUNOL, V1, P398, DOI 10.1038/80833; LAHAM FR, J INFECT DIS A, V189, P2047; Langley JM, 2003, J INFECT DIS, V188, P1764, DOI 10.1086/379740; Leader S, 2003, J PEDIATR-US, V143, pS127, DOI 10.1067/S0022-3476(03)00510-9; Legg JP, 2003, AM J RESP CRIT CARE, V168, P633, DOI 10.1164/rccm.200210-1148OC; Levine DA, 2004, PEDIATRICS, V113, P1728, DOI 10.1542/peds.113.6.1728; Li XQ, 2006, J VIROL, V80, P537, DOI 10.1128/JVI.80.1.537-540.2006; Macfarlane P, 2005, ARCH DIS CHILD, V90, P634, DOI 10.1136/adc.2004.065144; Mallory MD, 2003, PEDIATRICS, V111, DOI 10.1542/peds.111.1.e45; Mansbach JM, 2005, PEDIATR EMERG CARE, V21, P242, DOI 10.1097/01.pec.0000161469.19841.86; Massie RJH, 1999, J PAEDIATR CHILD H, V35, P497, DOI 10.1046/j.1440-1754.1999.355369.x; McNamara PS, 2005, J INFECT DIS, V191, P1225, DOI 10.1086/428855; McNamara PS, 2004, LANCET, V363, P1031, DOI 10.1016/S0140-6736(04)15838-8; McNamara PS, 2003, ARCH DIS CHILD, V88, P922, DOI 10.1136/adc.88.10.922; Melendez E, 2003, PEDIATR INFECT DIS J, V22, P1053, DOI 10.1097/01.inf.0000101296.68993.4d; Monick MM, 2003, J BIOL CHEM, V278, P53035, DOI 10.1074/jbc.M308093200; MULHOLLAND EK, 1990, LANCET, V335, P1259, DOI 10.1016/0140-6736(90)91314-Z; Mullins JA, 2003, PEDIATR INFECT DIS J, V22, P857, DOI 10.1097/01.inf.0000090921.21313.d3; O'Donnell DR, 1998, J PEDIATR-US, V133, P272, DOI 10.1016/S0022-3476(98)70234-3; Openshaw PJM, 2005, CLIN MICROBIOL REV, V18, P541, DOI 10.1128/CMR.18.3.541-555.2005; Panickar JR, 2005, THORAX, V60, P1035, DOI 10.1136/thx.2005.044750; Papadopoulos NG, 2002, AM J RESP CRIT CARE, V165, P1285, DOI 10.1164/rccm.200112-118BC; Patel H., 2004, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858.CD004878; Peiris JSM, 2003, EMERG INFECT DIS, V9, P628; Perlstein PH, 1999, PEDIATRICS, V104, P1334, DOI 10.1542/peds.104.6.1334; Perlstein PH, 2000, ARCH PEDIAT ADOL MED, V154, P1001, DOI 10.1001/archpedi.154.10.1001; PERROTTA C, 2005, COCHRANE DB SYST REV, V2; Pitrez PMC, 2004, ANN ALLERG ASTHMA IM, V92, P659, DOI 10.1016/S1081-1206(10)61433-0; Plint AC, 2004, ACAD EMERG MED, V11, P353, DOI 10.1197/j.aem.2003.12.003; Purcell K, 2004, PEDIATR INFECT DIS J, V23, P418, DOI 10.1097/01.inf.0000126273.27123.33; Purcell K, 2004, PEDIATR INFECT DIS J, V23, P267, DOI 10.1097/01.inf.0000116759.21252.29; Puthothu B, 2006, J INFECT DIS, V193, P438, DOI 10.1086/499316; Scarfone RJ, 2005, CURR OPIN PEDIATR, V17, P62, DOI 10.1097/01.mop.0000149604.98591.9a; Schauer U, 2004, CLIN EXP IMMUNOL, V138, P102, DOI 10.1111/j.1365-2249.2004.02582.x; Schlender J, 2000, J VIROL, V74, P8234, DOI 10.1128/JVI.74.18.8234-8242.2000; Schwarze J, 2004, AM J RESP CRIT CARE, V169, P801, DOI 10.1164/rccm.200308-1203OC; Scott PD, 2006, J INFECT DIS, V193, P59, DOI 10.1086/498246; Semple MG, 2005, J INFECT DIS, V191, P382, DOI 10.1086/426457; Sigurs N, 2005, AM J RESP CRIT CARE, V171, P137, DOI 10.1164/rccm.200406-730OC; Simoes EAF, 2003, PEDIATR INFECT DIS J, V22, pS13, DOI 10.1097/00006454-200302001-00003; Smyth RL, 2002, PEDIATR PULM, V33, P339, DOI 10.1002/ppul.10080; Smyth RL, 1999, LANCET, V354, P1997, DOI 10.1016/S0140-6736(05)76769-6; Spann KM, 2004, J VIROL, V78, P4363, DOI 10.1128/JVI.78.8.4363-4369.2004; Stein R, 1999, LANCET, V354, P541, DOI 10.1016/S0140-6736(98)10321-5; Struck A, 2004, PEDIATR INFECT DIS J, V23, P1000, DOI [10.1097/01.inf.0000143652.86242.1c, 10.1097/01.inf.0000145531.65979.cf]; Sweetman LL, 2005, PEDIATR NEUROL, V32, P307, DOI 10.1016/j.pediatrneurol.2005.01.010; Swingler GH, 1998, LANCET, V351, P404, DOI 10.1016/S0140-6736(97)07013-X; Tal G, 2004, J INFECT DIS, V189, P2057, DOI 10.1086/420830; Tekkanat KK, 2002, EUR J IMMUNOL, V32, P3276, DOI 10.1002/1521-4141(200211)32:11<3276::AID-IMMU3276>3.0.CO;2-5; Tripp RA, 2001, NAT IMMUNOL, V2, P732, DOI 10.1038/90675; TRISTRAM DA, 1988, AM J DIS CHILD, V142, P834, DOI 10.1001/archpedi.1988.02150080040017; Valarcher JF, 2001, VIROLOGY, V291, P55, DOI 10.1006/viro.2001.1083; van den Hoogen BG, 2001, NAT MED, V7, P719, DOI 10.1038/89098; van Woensel JBM, 2003, THORAX, V58, P383, DOI 10.1136/thorax.58.5.383; Ventre K., 2004, COCHRANE DB SYST REV, V4; Vogel AM, 2003, J PAEDIATR CHILD H, V39, P40, DOI 10.1046/j.1440-1754.2003.00069.x; Wegner S, 2004, PEDIATRICS, V114, P1612, DOI 10.1542/peds.2004-0959; Wenzel SE, 2002, AM J MED, V112, P627, DOI 10.1016/S0002-9343(02)01095-1; Williams JV, 2004, NEW ENGL J MED, V350, P443, DOI 10.1056/NEJMoa025472; Willson DF, 2003, J PEDIATR-US, V143, pS142, DOI 10.1067/S0022-3476(03)00514-6; Willson DF, 2001, PEDIATRICS, V108, P851, DOI 10.1542/peds.108.4.851; Wong JYW, 2005, THORAX, V60, P582, DOI 10.1136/thx.2004.024638; Yount LE, 2004, PEDIATRICS, V114, P1606, DOI 10.1542/peds.2004-0224; Zhang WD, 2005, NAT MED, V11, P56, DOI 10.1038/nm1174	117	307	322	0	21	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 22	2006	368	9532					312	322		10.1016/S0140-6736(06)69077-6	http://dx.doi.org/10.1016/S0140-6736(06)69077-6			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	067PF	16860701				2022-12-28	WOS:000239314400029
J	Fox, M; Young, A; Anggiansah, R; Anggiansah, A; Sanderson, J				Fox, Mark; Young, Alasdair; Anggiansah, Roy; Anggiansah, Angela; Sanderson, Jeremy			Interactive case report - A 22 year old man with persistent regurgitation and vomiting: case outcome	BRITISH MEDICAL JOURNAL			English	Editorial Material							RUMINATION SYNDROME; DISORDERS; DIAGNOSIS		St Thomas Hosp, Oesophageal Lab, London SE1 7EH, England; St Thomas Hosp, Dept Gastroenterol, London SE1 7EH, England	Guy's & St Thomas' NHS Foundation Trust; Guy's & St Thomas' NHS Foundation Trust	Fox, M (corresponding author), St Thomas Hosp, Oesophageal Lab, London SE1 7EH, England.	markfox@doctors.org.uk						AMARNATH RP, 1986, ANN INTERN MED, V105, P513, DOI 10.7326/0003-4819-105-4-513; Chial HJ, 2003, PEDIATRICS, V111, P158, DOI 10.1542/peds.111.1.158; Clouse RE, 1999, GUT, V45, P31; OBRIEN MD, 1995, GASTROENTEROLOGY, V108, P1024, DOI 10.1016/0016-5085(95)90199-X; Rasquin-Weber A, 1999, GUT, V45, P60, DOI 10.1136/gut.45.2008.ii60; Thumshirn M, 1998, AM J PHYSIOL-GASTR L, V275, pG314, DOI 10.1152/ajpgi.1998.275.2.G314	6	7	7	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JUL 15	2006	333	7559					133	133		10.1136/bmj.333.7559.133	http://dx.doi.org/10.1136/bmj.333.7559.133			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	065JK	16840471	Green Published			2022-12-28	WOS:000239155900019
J	Healy, D				Healy, David			Drug regulation - Did regulators fail over selective serotonin reuptake inhibitors?	BRITISH MEDICAL JOURNAL			English	Editorial Material							ANTIDEPRESSANT CLINICAL-TRIALS; RANDOMIZED CONTROLLED-TRIALS; SUICIDE RISK; ADMINISTRATION DATABASE; SYMPTOM REDUCTION; PLACEBO; DEPRESSION; METAANALYSIS; FLUOXETINE; SSRIS		Cardiff Univ, N Wales Dept Psychol Med, Bangor LL57 2PW, Gwynedd, Wales	Cardiff University	Healy, D (corresponding author), Cardiff Univ, N Wales Dept Psychol Med, Bangor LL57 2PW, Gwynedd, Wales.	healy_hergest@compuserve.com						[Anonymous], 2004, REPORT CSM EXPERT WO; BEASLEY CM, 1991, BMJ-BRIT MED J, V303, P685, DOI 10.1136/bmj.303.6804.685; BRECHER M, 1991, 20031 DEP HHS CTR DR; BURNSIDE R, 1990, COMMUNICATION   1031; Fergusson D, 2005, BMJ-BRIT MED J, V330, P396, DOI 10.1136/bmj.330.7488.396; *GLAX, 2004, SER ART 31 CONS RESP; Gunnell D, 2005, BMJ-BRIT MED J, V330, P385, DOI 10.1136/bmj.330.7488.385; HAMMAD T, 2003, PHARMACOEPIDEM DR S, V12, pS156; Healy D, 2003, J PSYCHIATR NEUROSCI, V28, P331; Healy D, 2002, BRIT J PSYCHIAT, V180, P547, DOI 10.1192/bjp.180.6.547; Khan A, 2003, AM J PSYCHIAT, V160, P790, DOI 10.1176/appi.ajp.160.4.790; Khan A, 2000, ARCH GEN PSYCHIAT, V57, P311, DOI 10.1001/archpsyc.57.4.311; Khan A, 2001, INT J NEUROPSYCHOPH, V4, P113, DOI 10.1017/S1461145701002322; Laughren TP, 2001, EUR PSYCHIAT, V16, P418, DOI 10.1016/S0924-9338(01)00600-9; LEE H, 1991, STAT REV SERTRALINE; MONTGOMERY SA, 1995, EUR NEUROPSYCHOPHARM, V5, P5, DOI 10.1016/0924-977X(94)00131-T; Newman TB, 2004, NEW ENGL J MED, V351, P1595; *PFIZ GLOB RES DEV, 2004, COMMUNICATION   0706; POOLE C, 1987, AM J PUBLIC HEALTH, V77, P195, DOI 10.2105/AJPH.77.2.195; Power N, 2002, BRIT J PSYCHIAT, V180, P547, DOI 10.1192/S0007125000161185; Rockhold F, 2002, BRIT J PSYCHIAT, V180, P548, DOI 10.1192/S0007125000161197; *SMITHKL BEECH REG, 1990, REC TEL CONV M BRECH; Storosum JG, 2001, AM J PSYCHIAT, V158, P1271, DOI 10.1176/appi.ajp.158.8.1271; TEICHER MH, 1990, AM J PSYCHIAT, V147, P207	24	47	48	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JUL 8	2006	333	7558					92	95		10.1136/bmj.333.7558.92	http://dx.doi.org/10.1136/bmj.333.7558.92			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	065BA	16825234	Green Published			2022-12-28	WOS:000239133200022
J	Rompler, H; Rohland, N; Lalueza-Fox, C; Willerslev, E; Kuznetsova, T; Rabeder, G; Bertranpetit, J; Schoneberg, T; Hofreiter, M				Roempler, Holger; Rohland, Nadin; Lalueza-Fox, Carles; Willerslev, Eske; Kuznetsova, Tatyana; Rabeder, Gernot; Bertranpetit, Jaume; Schoeneberg, Torsten; Hofreiter, Michael			Nuclear gene indicates coat-color polymorphism in mammoths	SCIENCE			English	Article							DNA-SEQUENCES		Max Planck Inst Evolutionary Anthropol, Dept Evolutionary Genet, D-04103 Leipzig, Germany; Univ Leipzig, Fac Med, Inst Biochem, D-04103 Leipzig, Germany; Univ Barcelona, Fac Biol, Dept Biol Anim, E-08028 Barcelona, Spain; Niels Bohr Inst, Ctr Ancient Genet, Ancient DNA & Evolut Grp, DK-2100 Copenhagen, Denmark; Univ Copenhagen, Inst Biol, DK-2100 Copenhagen, Denmark; Moscow MV Lomonosov State Univ, Fac Geol, Dept Paleontol, Moscow 119992, Russia; Univ Vienna, Dept Paleontol, A-1090 Vienna, Austria; Univ Pompeu Fabra, Fac Ciencies Salut & Vida, Unitat Biol Evolut, Barcelona 08003, Spain	Max Planck Society; Leipzig University; University of Barcelona; University of Copenhagen; Niels Bohr Institute; University of Copenhagen; Lomonosov Moscow State University; University of Vienna; Pompeu Fabra University	Hofreiter, M (corresponding author), Max Planck Inst Evolutionary Anthropol, Dept Evolutionary Genet, D-04103 Leipzig, Germany.	hofreite@eva.mpg.de	Willerslev, Eske/AAA-5686-2019; Bertranpetit, Jaume/F-8550-2012; LALUEZA-FOX, CARLES/AAG-5341-2020; Willerslev, Eske/A-9619-2011; Hofreiter, Michael/A-3996-2017; Kuznetsova, Tatyana/J-4806-2013	Bertranpetit, Jaume/0000-0003-0100-0590; LALUEZA-FOX, CARLES/0000-0002-1730-5914; Willerslev, Eske/0000-0002-7081-6748; Hofreiter, Michael/0000-0003-0441-4705; Kuznetsova, Tatyana/0000-0003-4302-9607				Greenwood AD, 1999, MOL BIOL EVOL, V16, P1466, DOI 10.1093/oxfordjournals.molbev.a026058; Hoekstra HE, 2006, SCIENCE, V313, P101, DOI 10.1126/science.1126121; Hofreiter M, 2001, NUCLEIC ACIDS RES, V29, P4793, DOI 10.1093/nar/29.23.4793; Poinar HN, 2006, SCIENCE, V311, P392, DOI 10.1126/science.1123360; Rees JL, 2003, ANNU REV GENET, V37, P67, DOI 10.1146/annurev.genet.37.110801.143233; Thornton JW, 2004, NAT REV GENET, V5, P366, DOI 10.1038/nrg1324	6	118	122	0	70	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 7	2006	313	5783					62	62		10.1126/science.1128994	http://dx.doi.org/10.1126/science.1128994			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061DA	16825562	Green Accepted			2022-12-28	WOS:000238850200028
J	Mulcair, MD; Schaeffer, PM; Oakley, AJ; Cross, HF; Neylon, C; Hill, TM; Dixon, NE				Mulcair, Mark D.; Schaeffer, Patrick M.; Oakley, Aaron J.; Cross, Hannah F.; Neylon, Cameron; Hill, Thomas M.; Dixon, Nicholas E.			A molecular mousetrap determines polarity of termination of DNA replication in E-coli	CELL			English	Article							TUS-TER COMPLEX; BINDING PROTEIN; CRYSTAL-STRUCTURES; ANTIGEN HELICASE; IN-VITRO; SEQUENCE; MECHANISM; ARREST; IDENTIFICATION; EQUILIBRIUM	During chromosome synthesis in Escherichia coli, replication forks are blocked by Tus bound Ter sites on approach from one direction but not the other. To study the basis of this polarity, we measured the rates of dissociation of Tus from forked TerB oligonucleotides, such as would be produced by the replicative DnaB helicase at both the fork-blocking (nonpermissive) and permissive ends of the Ter site. Strand separation of a few nucleotides at the permissive end was sufficient to force rapid dissociation of Tus to allow fork progression. In contrast, strand separation extending to and including the strictly conserved G-C(6) base pair at the nonpermissive end led to formation of a stable locked complex. Lock formation specifically requires the cytosine residue, C(6). The crystal structure of the locked complex showed that C(6) moves 14 angstrom from its normal position to bind in acytosine-specific pocket on the surface of Tus.	Australian Natl Univ, Res Sch Chem, Canberra, ACT 0200, Australia; Univ Southampton, Sch Chem, Southampton SO17 1BJ, Hants, England; Univ N Dakota, Dept Microbiol & Immunol, Sch Med & Hlth Sci, Grand Forks, ND 58202 USA	Australian National University; University of Southampton; University of North Dakota Grand Forks	Mulcair, MD (corresponding author), Australian Natl Univ, Res Sch Chem, Canberra, ACT 0200, Australia.	dixon@rsc.anu.edu.au	Schaeffer, Patrick/C-3807-2012; Oakley, Aaron/A-9464-2013; Dixon, Nicholas E/A-1226-2008; Neylon, Cameron/B-6265-2008	Schaeffer, Patrick/0000-0002-0717-5984; Oakley, Aaron/0000-0002-4764-014X; Dixon, Nicholas E/0000-0002-5958-6945; Neylon, Cameron/0000-0002-0068-716X				BEDROSIAN CL, 1991, P NATL ACAD SCI USA, V88, P2618, DOI 10.1073/pnas.88.7.2618; Cheng XD, 2001, NUCLEIC ACIDS RES, V29, P3784, DOI 10.1093/nar/29.18.3784; COSKUNARI FF, 1994, J BIOL CHEM, V269, P4027; CoskunAri FF, 1997, J BIOL CHEM, V272, P26448, DOI 10.1074/jbc.272.42.26448; Duggan LJ, 1996, BIOCHEMISTRY-US, V35, P15391, DOI 10.1021/bi962208w; GOTTLIEB PA, 1992, J BIOL CHEM, V267, P7434; Henderson TA, 2001, MOL GENET GENOMICS, V265, P941; HIDAKA M, 1989, J BIOL CHEM, V264, P21031; HIDAKA M, 1992, J BIOL CHEM, V267, P5361; HILL TM, 1987, P NATL ACAD SCI USA, V84, P1754, DOI 10.1073/pnas.84.7.1754; HILL TM, 1989, P NATL ACAD SCI USA, V86, P1593, DOI 10.1073/pnas.86.5.1593; HILL TM, 1992, ANNU REV MICROBIOL, V46, P603, DOI 10.1146/annurev.micro.46.1.603; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kamada K, 1996, NATURE, V383, P598, DOI 10.1038/383598a0; KHATRI GS, 1989, CELL, V59, P667, DOI 10.1016/0092-8674(89)90012-3; Korolev S, 1997, CELL, V90, P635, DOI 10.1016/S0092-8674(00)80525-5; LEE EH, 1992, J BIOL CHEM, V267, P8778; LEE EH, 1989, P NATL ACAD SCI USA, V86, P9104, DOI 10.1073/pnas.86.23.9104; Mohanty BK, 1998, J BIOL CHEM, V273, P3051, DOI 10.1074/jbc.273.5.3051; Mulugu S, 2001, P NATL ACAD SCI USA, V98, P9569, DOI 10.1073/pnas.171065898; Murakami KS, 2003, CURR OPIN STRUC BIOL, V13, P31, DOI 10.1016/S0959-440X(02)00005-2; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Neylon C, 2000, BIOCHEMISTRY-US, V39, P11989, DOI 10.1021/bi001174w; Neylon C, 2005, MICROBIOL MOL BIOL R, V69, P501, DOI 10.1128/MMBR.69.3.501-526.2005; Neylon C, 2004, NUCLEIC ACIDS RES, V32, P1448, DOI 10.1093/nar/gkh315; Otwinowski Z., 1993, P CCP4 STUD WEEK DAT, P56; Patel SS, 2000, ANNU REV BIOCHEM, V69, P651, DOI 10.1146/annurev.biochem.69.1.651; RECORD MT, 1991, METHOD ENZYMOL, V208, P291; SAHOO T, 1995, J BIOL CHEM, V270, P29138, DOI 10.1074/jbc.270.49.29138; Schaeffer PM, 2005, IUBMB LIFE, V57, P5, DOI 10.1080/15216540500058956; Skokotas A, 1995, J BIOL CHEM, V270, P30941, DOI 10.1074/jbc.270.52.30941; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Velankar SS, 1999, CELL, V97, P75, DOI 10.1016/S0092-8674(00)80716-3	34	95	97	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 30	2006	125	7					1309	1319		10.1016/j.cell.2006.04.040	http://dx.doi.org/10.1016/j.cell.2006.04.040			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	064QP	16814717	Bronze			2022-12-28	WOS:000239104500014
J	Gross, O; Gewies, A; Finger, K; Schafer, M; Sparwasser, T; Peschel, C; Forster, I; Ruland, J				Gross, Olaf; Gewies, Andreas; Finger, Katrin; Schaefer, Martin; Sparwasser, Tim; Peschel, Christian; Forster, Irmgard; Ruland, Juergen			Card9 controls a non-TLR signalling pathway for innate anti-fungal immunity	NATURE			English	Article							NF-KAPPA-B; TOLL-LIKE RECEPTOR-2; BETA-GLUCANS; MYD88-DEFICIENT MICE; T-CELL; ACTIVATION; CARMA1; RECOGNITION; MALT1; INDUCTION	Fungal infections are increasing worldwide due to the marked rise in immunodeficiencies including AIDS; however, immune responses to fungi are poorly understood. Dectin- 1 is the major mammalian pattern recognition receptor for the fungal component zymosan. Dectin- 1 represents the prototype of innate non- Toll- like receptors ( TLRs) containing immunoreceptor tyrosine- based activation motifs ( ITAMs) related to those of adaptive antigen receptors. Here we identify Card9 as a key transducer of Dectin- 1 signalling. Although being dispensable for TLR/ MyD88- induced responses, Card9 controls Dectin- 1- mediated myeloid cell activation, cytokine production and innate anti- fungal immunity. Card9 couples to Bcl10 and regulates Bcl10 - Malt1- mediated NF- kappa B activation induced by zymosan. Yet, Card9 is dispensable for antigen receptor signalling that uses Carma1 as a link to Bcl10 - Malt1. Thus, our results define a novel innate immune pathway and indicate that evolutionarily distinct ITAM receptors in innate and adaptive immune cells use diverse adaptor proteins to engage selectively the conserved Bcl10 - Malt1 module.	Tech Univ Munich, Klinikum Rechts Isar, Med Klin 3, D-81675 Munich, Germany; Tech Univ Munich, Inst Med Mikrobiol Immunol & Hyg, D-81675 Munich, Germany	Technical University of Munich; Technical University of Munich	Ruland, J (corresponding author), Tech Univ Munich, Klinikum Rechts Isar, Med Klin 3, Ismaninger Str 22, D-81675 Munich, Germany.	jruland@lrz.tum.de	Ruland, Jürgen/Q-6680-2018; Sparwasser, Tim D/AAA-4306-2022; Gross, Olaf/E-4570-2010; Sparwasser, Tim/AAF-7085-2019; Förster, Irmgard/P-8545-2016	Ruland, Jürgen/0000-0002-8381-3597; Gross, Olaf/0000-0001-8660-3619; Sparwasser, Tim/0000-0001-5645-902X; Förster, Irmgard/0000-0002-7644-5642; Gewies, Andreas/0000-0002-7606-6482				Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Aliprantis AO, 1999, SCIENCE, V285, P736, DOI 10.1126/science.285.5428.736; Bertin J, 2000, J BIOL CHEM, V275, P41082, DOI 10.1074/jbc.C000726200; Bonizzi G, 2004, TRENDS IMMUNOL, V25, P280, DOI 10.1016/j.it.2004.03.008; Brown GD, 2003, J EXP MED, V197, P1119, DOI 10.1084/jem.20021890; Brown GD, 2006, NAT REV IMMUNOL, V6, P33, DOI 10.1038/nri1745; Brown GD, 2001, NATURE, V413, P36, DOI 10.1038/35092620; Brown GD, 2003, IMMUNITY, V19, P311, DOI 10.1016/S1074-7613(03)00233-4; DICARLO FJ, 1958, SCIENCE, V127, P756, DOI 10.1126/science.127.3301.756-a; Eliopoulos AG, 2006, J BIOL CHEM, V281, P1371, DOI 10.1074/jbc.M506790200; Gantner BN, 2003, J EXP MED, V197, P1107, DOI 10.1084/jem.20021787; Gordon S, 2002, CELL, V111, P927, DOI 10.1016/S0092-8674(02)01201-1; Hammer M, 2005, EUR J IMMUNOL, V35, P2991, DOI 10.1002/eji.200526192; Inohara N, 2003, NAT REV IMMUNOL, V3, P371, DOI 10.1038/nri1086; Kawai T, 1999, IMMUNITY, V11, P115, DOI 10.1016/S1074-7613(00)80086-2; Klemm S, 2006, J EXP MED, V203, P337, DOI 10.1084/jem.20051982; Lin X, 2004, SEMIN IMMUNOL, V16, P429, DOI 10.1016/j.smim.2004.08.022; Matsumoto R, 2005, IMMUNITY, V23, P575, DOI 10.1016/j.immuni.2005.10.007; McAllister-Lucas LM, 2001, J BIOL CHEM, V276, P30589, DOI 10.1074/jbc.M103824200; Rogers NC, 2005, IMMUNITY, V22, P507, DOI 10.1016/j.immuni.2005.03.004; Ruland J, 2003, IMMUNITY, V19, P749, DOI 10.1016/S1074-7613(03)00293-0; Ruland J, 2001, CELL, V104, P33, DOI 10.1016/S0092-8674(01)00189-1; Sommer K, 2005, IMMUNITY, V23, P561, DOI 10.1016/j.immuni.2005.09.014; Sparwasser T, 1998, EUR J IMMUNOL, V28, P2045, DOI 10.1002/(SICI)1521-4141(199806)28:06<2045::AID-IMMU2045>3.0.CO;2-8; Takeuchi O, 2000, J IMMUNOL, V165, P5392, DOI 10.4049/jimmunol.165.10.5392; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Thome M, 2004, NAT REV IMMUNOL, V4, P348, DOI 10.1038/nri1352; Thome M, 2003, TRENDS IMMUNOL, V24, P419, DOI 10.1016/S1471-4906(03)00177-7; Underhill DM, 1999, NATURE, V401, P811, DOI 10.1038/44605; Villamon E, 2004, MICROBES INFECT, V6, P1, DOI 10.1016/j.micinf.2003.09.020	30	640	675	3	56	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 10	2006	442	7103					651	656		10.1038/nature04926	http://dx.doi.org/10.1038/nature04926			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071UU	16862125				2022-12-28	WOS:000239630200037
J	Lisse, CM; VanCleve, J; Adams, AC; A'Hearn, MF; Fernandez, YR; Farnham, TL; Armus, L; Grillmair, CJ; Ingalls, J; Belton, MJS; Groussin, O; McFadden, LA; Meech, KJ; Schultz, PH; Clark, BC; Feaga, LM; Sunshine, JM				Lisse, C. M.; VanCleve, J.; Adams, A. C.; A'Hearn, M. F.; Fernandez, Y. R.; Farnham, T. L.; Armus, L.; Grillmair, C. J.; Ingalls, J.; Belton, M. J. S.; Groussin, O.; McFadden, L. A.; Meech, K. J.; Schultz, P. H.; Clark, B. C.; Feaga, L. M.; Sunshine, J. M.			Spitzer spectral observations of the Deep Impact ejecta	SCIENCE			English	Article							COMET HALE-BOPP; CHEMICAL HETEROGENEITY; CRYSTALLINE SILICATES; SULFIDE GRAINS; WATER ICE; DUST; NUCLEUS; SPECTROSCOPY; MINERALOGY; EVOLUTION	Spitzer Space Telescope imaging spectrometer observations of comet 9P/Tempel 1 during the Deep Impact encounter returned detailed, highly structured, 5- to 35-micrometer spectra of the ejecta. Emission signatures due to amorphous and crystalline silicates, amorphous carbon, carbonates, phyllositicates, polycyclic aromatic hydrocarbons, water gas and ice, and sulfides were found. Good agreement is seen between the ejecta spectra and the material emitted from comet C/1995 O1 (Hale-Bopp) and the circumstellar material around the young stellar object HD100546. The atomic abundance of the observed material is consistent with solar and C1 chondritic abundances, and the dust-to-gas ratio was determined to be greater than or equal to 1.3. The presence of the observed mix of materials requires efficient methods of annealing amorphous silicates and mixing of high- and low-temperature phases over large distances in the early protosolar nebula.	Johns Hopkins Univ, Appl Phys Lab, Dept Space, Planetary Explorat Grp, Laurel, MD 20723 USA; Univ Maryland, Dept Astron, College Pk, MD 20742 USA; Ball Aerosp & Technol Corp, Boulder, CO 80306 USA; Univ Cent Florida, Dept Phys, Orlando, FL 32816 USA; CALTECH, Spitzer Space Sci Ctr, Pasadena, CA 91125 USA; Belton Space Explorat Initiat, Tucson, AZ 85716 USA; Univ Hawaii, Inst Astron, Honolulu, HI 96822 USA; Brown Univ, Dept Geol Sci, Providence, RI 02912 USA; Lockheed Martin, Space Explorat Syst, Denver, CO 80201 USA	Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory; University System of Maryland; University of Maryland College Park; Ball Aerospace & Technologies; State University System of Florida; University of Central Florida; California Institute of Technology; University of Hawaii System; Brown University; Lockheed Martin	Lisse, CM (corresponding author), Johns Hopkins Univ, Appl Phys Lab, Dept Space, Planetary Explorat Grp, 11100 Johns Hopkins Rd, Laurel, MD 20723 USA.		Ingalls, James/AAK-6875-2021; McFadden, Lucy-Ann/I-4902-2013; Meech, Karen/CAH-1412-2022; Lisse, Carey M/B-7772-2016	Ingalls, James/0000-0003-4714-1364; McFadden, Lucy-Ann/0000-0002-0537-9975; Lisse, Carey M/0000-0002-9548-1526; Meech, Karen/0000-0002-2058-5670; Fernandez, Yanga/0000-0003-1156-9721; Armus, Lee/0000-0003-3498-2973; Sunshine, Jessica/0000-0002-9413-8785; Feaga, Lori/0000-0002-4230-6759; Grillmair, Carl/0000-0003-4072-169X				A'Hearn MF, 2005, SCIENCE, V310, P258, DOI 10.1126/science.1118923; AHearn MF, 1995, ICARUS, V118, P223, DOI 10.1006/icar.1995.1190; ANDERS E, 1989, GEOCHIM COSMOCHIM AC, V53, P197, DOI 10.1016/0016-7037(89)90286-X; BOCKELEEMORVAN D, 1995, ICARUS, V116, P18, DOI 10.1006/icar.1995.1111; Boss AP, 2004, ASTROPHYS J, V616, P1265, DOI 10.1086/425118; Bradley J, 2003, LECT NOTES PHYS, V609, P217; BRADLEY JP, COMMUNICATION; BREGMAN JD, 1987, ASTRON ASTROPHYS, V187, P616; BROWNLEE D, COMMUNICATION; Ceccarelli C, 2002, ASTRON ASTROPHYS, V395, pL29, DOI 10.1051/0004-6361:20021490; Cheng AF, 2004, ADV SPACE RES, V33, P1558, DOI 10.1016/S0273-1177(03)00452-6; Chiavassa A, 2005, ASTRON ASTROPHYS, V432, P547, DOI 10.1051/0004-6361:20041891; CLARK BC, 1987, ASTRON ASTROPHYS, V187, P779; Crovisier J, 1997, SCIENCE, V275, P1904, DOI 10.1126/science.275.5308.1904; CROVISIER J, COMMUNICATION; DEUTSCH LK, 1995, ASTROPHYS SPACE SCI, V224, P89, DOI 10.1007/BF00667828; FLYNN GJ, 2005, LUNAR PLANETARY I CO, V1280, P48; FOMENKOVA MN, 1992, SCIENCE, V258, P266, DOI 10.1126/science.11538058; Gail HP, 2004, ASTRON ASTROPHYS, V413, P571, DOI 10.1051/0004-6361:20031554; Hanner MS, 1998, ASTROPHYS J, V502, P871, DOI 10.1086/305939; Harker DE, 2005, SCIENCE, V310, P278, DOI 10.1126/science.1119143; Hony S, 2002, ASTRON ASTROPHYS, V393, pL103, DOI 10.1051/0004-6361:20021260; Houck JR, 2004, ASTROPHYS J SUPPL S, V154, P18, DOI 10.1086/423134; JESSBERGER EK, 1988, NATURE, V332, P691, DOI 10.1038/332691a0; Keller LP, 2002, NATURE, V417, P148, DOI 10.1038/417148a; KELLER LP, 2000, LUN PLAN SCI C, V31; Kemper F, 2004, ASTROPHYS J, V609, P826, DOI 10.1086/421339; Kimura Y, 2005, ASTRON ASTROPHYS, V442, P507, DOI 10.1051/0004-6361:20052757; Lederer SM, 2002, EARTH MOON PLANETS, V90, P381, DOI 10.1023/A:1021542619078; Lellouch E, 1998, ASTRON ASTROPHYS, V339, pL9; LI A, IN PRESS ASTROPHYS J; Licandro J, 2003, ASTRON ASTROPHYS, V398, pL45, DOI 10.1051/0004-6361:20030009; Lisse CM, 2005, SPACE SCI REV, V117, P161, DOI 10.1007/s11214-005-3384-6; Lisse CM, 2005, ASTROPHYS J, V625, pL139, DOI 10.1086/431238; Malfait K, 1998, ASTRON ASTROPHYS, V332, pL25; Melosh H. J, 1989, OXFORD MONOGRAPHS GE, V11; Nuth JA, 2006, ICARUS, V180, P243, DOI 10.1016/j.icarus.2005.09.003; Nuth JA, 2000, NATURE, V406, P275, DOI 10.1038/35018516; RIETMEIJER FJM, 1991, EARTH PLANET SC LETT, V102, P148, DOI 10.1016/0012-821X(91)90004-2; SANDFORD SA, 1986, SCIENCE, V231, P1540, DOI 10.1126/science.231.4745.1540; Sarid G, 2005, PUBL ASTRON SOC PAC, V117, P796, DOI 10.1086/431657; SCHULZE H, 1992, METEORITICS, V27, P286; Soderblom LA, 2004, ICARUS, V167, P100, DOI 10.1016/j.icarus.2003.08.019; STOFFLER D, 1975, J GEOPHYS RES, V80, P4062, DOI 10.1029/JB080i029p04062; Sunshine JM, 2006, SCIENCE, V311, P1453, DOI 10.1126/science.1123632; TOMEOKA K, 1986, SCIENCE, V231, P1544, DOI 10.1126/science.231.4745.1544; Toppani A, 2005, NATURE, V437, P1121, DOI 10.1038/nature04128; Wilson JK, 1998, GEOPHYS RES LETT, V25, P225, DOI 10.1029/97GL03704; Wooden DH, 1999, ASTROPHYS J, V517, P1034, DOI 10.1086/307206	50	266	269	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 4	2006	313	5787					635	640		10.1126/science.1124694	http://dx.doi.org/10.1126/science.1124694			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072IQ	16840662				2022-12-28	WOS:000239667500034
J	Bugreev, DV; Mazina, OM; Mazin, AV				Bugreev, Dmitry V.; Mazina, Olga M.; Mazin, Alexander V.			Rad54 protein promotes branch migration of Holliday junctions	NATURE			English	Article							SACCHAROMYCES-CEREVISIAE; ESCHERICHIA-COLI; GENETIC-RECOMBINATION; MAMMALIAN-CELLS; RUVB PROTEINS; DNA; CHROMATIN; ATPASE; YEAST; CONVERSION	Homologous recombination has a crucial function in the repair of DNA double-strand breaks and in faithful chromosome segregation(1-3). The mechanism of homologous recombination involves the search for homology and invasion of the ends of a broken DNA molecule into homologous duplex DNA to form a cross-stranded structure, a Holliday junction (HJ)(4-7). A HJ is able to undergo branch migration along DNA, generating increasing or decreasing lengths of heteroduplex. In both prokaryotes and eukaryotes, the physical evidence for HJs, the key intermediate in homologous recombination, was provided by electron microscopy(8). In bacteria there are specialized enzymes that promote branch migration of HJs(7). However, in eukaryotes the identity of homologous recombination branch-migration protein(s) has remained elusive. Here we show that Rad54, a Swi2/Snf2 protein(9), binds HJ-like structures with high specificity and promotes their bidirectional branch migration in an ATPase-dependent manner. The activity seemed to be conserved in human and yeast Rad54 orthologues. In vitro, Rad54 has been shown to stimulate DNA pairing of Rad51, a key homologous recombination protein(10-12). However, genetic data indicate that Rad54 protein might also act at later stages of homologous recombination, after Rad51 (ref. 13). Novel DNA branch-migration activity is fully consistent with this late homologous recombination function of Rad54 protein.	Drexel Univ, Coll Med, Dept Biochem & Mol Biol, Philadelphia, PA 19102 USA; Russian Acad Sci, Inst Chem Biol & Fundamental Med, Siberian Branch, Novosibirsk 630090, Russia	Drexel University; Institute of Chemical Biology & Fundamental Medicine, Siberian Branch of the RAS; Russian Academy of Sciences	Mazin, AV (corresponding author), Drexel Univ, Coll Med, Dept Biochem & Mol Biol, Philadelphia, PA 19102 USA.	amazin@drexelmed.edu						Bianco P. R., 1998, FRONT BIOSCI, V3, pD570; Bugreev DV, 2004, P NATL ACAD SCI USA, V101, P9988, DOI 10.1073/pnas.0402105101; Constantinou A, 2001, CELL, V104, P259, DOI 10.1016/S0092-8674(01)00210-0; DRESSLER D, 1982, ANNU REV BIOCHEM, V51, P727, DOI 10.1146/annurev.bi.51.070182.003455; Eggleston AK, 1997, CELL, V89, P607, DOI 10.1016/S0092-8674(00)80242-1; Essers J, 1997, CELL, V89, P195, DOI 10.1016/S0092-8674(00)80199-3; HOLLIDAY R, 1964, GENET RES, V5, P282, DOI 10.1017/S0016672300001233; Interthal H, 2000, MOL GEN GENET, V263, P812, DOI 10.1007/s004380000241; Jaskelioff M, 2003, J BIOL CHEM, V278, P9212, DOI 10.1074/jbc.M211545200; Kim PM, 2002, NUCLEIC ACIDS RES, V30, P2727, DOI 10.1093/nar/gkf413; Krogh BO, 2004, ANNU REV GENET, V38, P233, DOI 10.1146/annurev.genet.38.072902.091500; Liu YL, 2004, NAT REV MOL CELL BIO, V5, P937, DOI 10.1038/nrm1502; Liu YL, 2004, SCIENCE, V303, P243, DOI 10.1126/science.1093037; Lusser A, 2003, BIOESSAYS, V25, P1192, DOI 10.1002/bies.10359; Mazin AV, 2000, MOL CELL, V6, P583, DOI 10.1016/S1097-2765(00)00057-5; Mazina OM, 2004, J BIOL CHEM, V279, P52042, DOI 10.1074/jbc.M410244200; PANYUTIN IG, 1993, J MOL BIOL, V230, P413, DOI 10.1006/jmbi.1993.1159; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; PARSONS CA, 1992, P NATL ACAD SCI USA, V89, P5452, DOI 10.1073/pnas.89.12.5452; Petukhova G, 1998, NATURE, V393, P91, DOI 10.1038/30037; Ristic D, 2001, P NATL ACAD SCI USA, V98, P8454, DOI 10.1073/pnas.151056798; Shinohara M, 1997, GENETICS, V147, P1545; Sung P, 2003, J BIOL CHEM, V278, P42729, DOI 10.1074/jbc.R300027200; SUSLOVA N G, 1970, Genetika, V6, P158; Swagemakers SMA, 1998, J BIOL CHEM, V273, P28292, DOI 10.1074/jbc.273.43.28292; Thoma NH, 2005, NAT STRUCT MOL BIOL, V12, P350, DOI 10.1038/nsmb919; TSANEVA IR, 1992, CELL, V69, P1171, DOI 10.1016/0092-8674(92)90638-S; van Brabant AJ, 2000, BIOCHEMISTRY-US, V39, P14617, DOI 10.1021/bi0018640; West SC, 1997, ANNU REV GENET, V31, P213, DOI 10.1146/annurev.genet.31.1.213; Wyman C, 2004, DNA REPAIR, V3, P827, DOI 10.1016/j.dnarep.2004.03.037	30	141	144	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 3	2006	442	7102					590	593		10.1038/nature04889	http://dx.doi.org/10.1038/nature04889			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069NQ	16862129				2022-12-28	WOS:000239455900049
J	Otero, V; Finkelstein, N; McCray, R; Pollock, S				Otero, Valerie; Finkelstein, Noah; McCray, Richard; Pollock, Steven			Who is responsible for preparing science teachers?	SCIENCE			English	Editorial Material									Univ Colorado, Sch Educ, Boulder, CO 80309 USA; Univ Colorado, Dept Phys, Boulder, CO 80309 USA; Univ Colorado, Dept Astrophys & Planetary Sci, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder	Otero, V (corresponding author), Univ Colorado, Sch Educ, Boulder, CO 80309 USA.	valerie.otero@colorado.edu		OTERO, VALERIE/0000-0001-6890-4880				*COL COMM HIGH ED, 2006, REP GOV GEN ASS TEAC; Ding L, 2006, PHYS REV SPEC TOP-PH, V2, DOI 10.1103/PhysRevSTPER.2.010105; Finkelstein ND, 2005, PHYS REV SPEC TOP-PH, V1, DOI 10.1103/PhysRevSTPER.1.010101; FINKELSTEIN ND, 2004, J SCHOLARSHIP TEACHI, V4, P1; Hake RR, 1998, AM J PHYS, V66, P64, DOI 10.1119/1.18809; Handelsman J, 2004, SCIENCE, V306, P229; Handelsman J, 2004, SCIENCE, V304, P521, DOI 10.1126/science.1096022; Knight Jennifer K, 2005, Cell Biol Educ, V4, P298, DOI 10.1187/05-06-0082; Mazur E., 1997, PEER INSTRUCTION USE; MCDERMOTT L, 2002, PHYS ED GROUP TUTORI; Moin LJ, 2005, SCI EDUC, V89, P980, DOI 10.1002/sce.20088; *NAT SCI BOARD, 2006, SCI ENG IND 2006, V2; *NAT SCI BOARD, 2006, SCI ENG IND 2006, V1; National Research Council [ NRC ], 2005, RIS GATH STORM EN EM; NELSON M, 2005, THESIS U COLORADO BO; NEUSCHATZ M, 2003, BROADENING BASE HIGH; NEUSCHATZ M, COMMUNICATION; OTERO V, 2005, AAAS ANN M WASH DC 1; Shulman LS., 1986, EDUC RESEARCHER, V15, P4, DOI [10.3102/0013189X015002004, 10.3102%2F0013189X015002004, DOI 10.3102/0013189X015002004]; Thornton RK, 1998, AM J PHYS, V66, P338, DOI 10.1119/1.18863; U.S. Department of Education, 2002, M HIGHL QUAL TEACH C	21	85	85	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 28	2006	313	5786					445	446		10.1126/science.1129648	http://dx.doi.org/10.1126/science.1129648			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	067MZ	16873630				2022-12-28	WOS:000239308600022
J	Paillard, D				Paillard, Didier			What drives the Ice Age cycle?	SCIENCE			English	Editorial Material							CLIMATE		UVSQ, CNRS, CEA, Inst Pierre Simon Laplace,Lab Sci Climat & Enviro, F-91191 Gif Sur Yvette, France	UDICE-French Research Universities; Universite Paris Cite; Universite Paris Saclay; CEA; Centre National de la Recherche Scientifique (CNRS)	Paillard, D (corresponding author), UVSQ, CNRS, CEA, Inst Pierre Simon Laplace,Lab Sci Climat & Enviro, F-91191 Gif Sur Yvette, France.	didier.paillard@cea.fr	Paillard, Didier/G-4776-2012	Paillard, Didier/0000-0002-9995-2794				Archer D, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002625; Archer D, 2005, GEOCHEM GEOPHY GEOSY, V6, DOI 10.1029/2004GC000891; Bard E, 2004, CR GEOSCI, V336, P603, DOI 10.1016/j.crte.2004.02.005; DOWSETT H, 1994, GLOBAL PLANET CHANGE, V9, P169, DOI 10.1016/0921-8181(94)90015-9; Huybers P, 2006, SCIENCE, V313, P508, DOI 10.1126/science.1125249; Lisiecki LE, 2005, PALEOCEANOGRAPHY, V20, DOI 10.1029/2005PA001164; Paillard D, 2004, EARTH PLANET SC LETT, V227, P263, DOI 10.1016/j.epsl.2004.08.023; Raymo ME, 2006, SCIENCE, V313, P492, DOI 10.1126/science.1123296; Siegenthaler U, 2005, SCIENCE, V310, P1313, DOI 10.1126/science.1120130	9	16	16	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 28	2006	313	5786					455	456		10.1126/science.1131297	http://dx.doi.org/10.1126/science.1131297			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067MZ	16873636				2022-12-28	WOS:000239308600029
J	Janasek, D; Franzke, J; Manz, A				Janasek, Dirk; Franzke, Joachim; Manz, Andreas			Scaling and the design of miniaturized chemical-analysis systems	NATURE			English	Review							FREE-FLOW ELECTROPHORESIS; VOLATILE ORGANIC-COMPOUNDS; TRAP MASS-SPECTROMETER; CAPILLARY-ELECTROPHORESIS; SEPARATION; MICROCHIP; CHROMATOGRAPHY; PERFORMANCE; RESOLUTION; DEVICE	Micrometre-scale analytical devices are more attractive than their macroscale counterparts for various reasons. For example, they use smaller volumes of reagents and are therefore cheaper, quicker and less hazardous to use, and more environmentally appealing. Scaling laws compare the relative performance of a system as the dimensions of the system change, and can predict the operational success of miniaturized chemical separation, reaction and detection devices before they are fabricated. Some devices designed using basic principles of scaling are now commercially available, and opportunities for miniaturizing new and challenging analytical systems continue to arise.	ISAS, Inst Analyt Sci, D-44139 Dortmund, Germany	Dortmund University of Technology; Leibniz Institut fur Analytische Wissenschaften (ISAS)	Janasek, D (corresponding author), ISAS, Inst Analyt Sci, Bunsen Kirchhoff Str 11, D-44139 Dortmund, Germany.	d.janasek@ansci.de	Janasek, Dirk/G-4902-2010; Manz, Andreas/C-4483-2008	Janasek, Dirk/0000-0002-4231-1224; Manz, Andreas/0000-0001-9712-711X; Franzke, Joachim/0000-0003-0419-1898				ALBRECHT J, 2005, 9 INT C MIN SYST CHE, P1537; Backhouse CJ, 2003, ELECTROPHORESIS, V24, P1777, DOI 10.1002/elps.200305398; Badman ER, 2000, ANAL CHEM, V72, P5079, DOI 10.1021/ac000377n; Berkout VD, 2001, J AM SOC MASS SPECTR, V12, P641, DOI 10.1016/S1044-0305(01)00250-1; Bessoth FG, 1999, ANAL COMMUN, V36, P213, DOI 10.1039/a902237f; Blain MG, 2004, INT J MASS SPECTROM, V236, P91, DOI 10.1016/j.ijms.2004.06.011; Boumsellek S, 2001, J AM SOC MASS SPECTR, V12, P633, DOI 10.1016/S1044-0305(01)00248-3; BRUIN GJM, 1990, J CHROMATOGR, V517, P557, DOI 10.1016/S0021-9673(01)95747-4; Carr WR, 1903, PHILOS T R SOC LOND, V201, P403, DOI 10.1098/rsta.1903.0020; Cornish TJ, 2000, RAPID COMMUN MASS SP, V14, P2408, DOI 10.1002/1097-0231(20001230)14:24<2408::AID-RCM181>3.0.CO;2-K; de la Rue W., 1880, PHILOS T ROY SOC LON, V171, P65; de Mello AJ, 2003, LAB CHIP, V3, p29N, DOI 10.1039/b304585b; Desmet G, 1999, J CHROMATOGR A, V855, P57, DOI 10.1016/S0021-9673(99)00652-4; Desmet G, 2000, ANAL CHEM, V72, P2160, DOI 10.1021/ac991254+; Diaz JA, 2002, TRAC-TREND ANAL CHEM, V21, P498, DOI 10.1016/S0165-9936(02)00704-5; Diaz JA, 2001, J AM SOC MASS SPECTR, V12, P619, DOI 10.1016/S1044-0305(01)00245-8; Diaz JA, 2001, FIELD ANAL CHEM TECH, V5, P156, DOI 10.1002/fact.1016; Dittrich PS, 2005, ANAL BIOANAL CHEM, V382, P1771, DOI 10.1007/s00216-005-3335-9; Drexler K.E., 1992, NANOSYSTEMS MOL MACH; Eijkel JCT, 2006, ELECTROPHORESIS, V27, P677, DOI 10.1002/elps.200500727; Eijkel JCT, 2005, MICROFLUID NANOFLUID, V1, P249, DOI 10.1007/s10404-004-0012-9; FLUGGE S, 1956, ENCY PHYS, V22, P1; FODOR SPA, 1991, SCIENCE, V251, P767, DOI 10.1126/science.1990438; Fonslow BR, 2005, ANAL CHEM, V77, P5706, DOI 10.1021/ac050766n; Franzke J, 2006, APPL SPECTROSC, V60, p80A, DOI 10.1366/000370206776342689; Franzke J, 2003, J ANAL ATOM SPECTROM, V18, P802, DOI 10.1039/b300193h; FULFORD GD, 1968, IND ENG CHEM, V60, P71, DOI 10.1021/ie50699a009; GOLAY MJE, 1957, ANAL CHEM, V29, P928, DOI 10.1021/ac60126a019; HARRISON DJ, 1993, SCIENCE, V261, P895, DOI 10.1126/science.261.5123.895; Holm R, 1924, PHYS Z, V25, P497; Janasek D, 2006, ANAL CHEM, V78, P3815, DOI 10.1021/ac060063l; Jenkins G, 2005, LAB CHIP, V5, P711, DOI 10.1039/b501467k; JONES FL, 1951, P PHYS SOC LOND B, V64, P560, DOI 10.1088/0370-1301/64/7/303; Keller RA, 2002, ANAL CHEM, V74, p316a, DOI 10.1021/ac022035i; Kitamori T, 2004, ANAL CHEM, V76, p52A, DOI 10.1021/ac041508d; KNOX JH, 1979, J CHROMATOGR, V186, P405, DOI 10.1016/S0021-9673(00)95263-4; Kobayashi H, 2003, J CHROMATOGR A, V990, P169, DOI 10.1016/S0021-9673(02)01964-7; Kohlheyer D, 2006, LAB CHIP, V6, P374, DOI 10.1039/b514731j; Lakowitz J., 1999, PRINCIPLES FLUORESCE; Lee CC, 2005, SCIENCE, V310, P1793, DOI 10.1126/science.1118919; Lipshutz RJ, 1999, NAT GENET, V21, P20, DOI 10.1038/4447; Ludwig M, 2003, ELECTROPHORESIS, V24, P3233, DOI 10.1002/elps.200305427; MANZ A, 1990, SENSOR ACTUAT B-CHEM, V1, P244, DOI 10.1016/0925-4005(90)80209-I; MANZ A, 1992, J CHROMATOGR, V593, P253, DOI 10.1016/0021-9673(92)80293-4; MARGENAU H, 1948, PHYS REV, V73, P326, DOI 10.1103/PhysRev.73.326; Mazereeuw M, 2000, ANAL CHEM, V72, P3881, DOI 10.1021/ac991202k; Miclea M, 2004, J ANAL ATOM SPECTROM, V19, P990, DOI 10.1039/b401319k; Moxom J, 2003, ANAL CHEM, V75, P3739, DOI 10.1021/ac034043k; Orient OJ, 2002, REV SCI INSTRUM, V73, P2157, DOI 10.1063/1.1469675; Palmer PT, 2001, J AM SOC MASS SPECTR, V12, P656, DOI 10.1016/S1044-0305(01)00249-5; Paschen F., 1889, WIED ANN, V37, P69; Patterson GE, 2002, ANAL CHEM, V74, P6145, DOI 10.1021/ac020494d; Pollack L, 1999, P NATL ACAD SCI USA, V96, P10115, DOI 10.1073/pnas.96.18.10115; Prieto MC, 2002, J MASS SPECTROM, V37, P1158, DOI 10.1002/jms.386; Riter LS, 2002, ANAL CHEM, V74, P6154, DOI 10.1021/ac0204956; Riter LS, 2002, RAPID COMMUN MASS SP, V16, P2370, DOI 10.1002/rcm.841; Short RT, 1999, MEAS SCI TECHNOL, V10, P1195, DOI 10.1088/0957-0233/10/12/311; Song H, 2003, APPL PHYS LETT, V83, P4664, DOI 10.1063/1.1630378; Stroock AD, 2002, SCIENCE, V295, P647, DOI 10.1126/science.1066238; Tas NR, 2003, NANO LETT, V3, P1537, DOI 10.1021/nl034676e; TOWNSEND JS, 1915, ELECT GASES, P365; TRIMMER WSN, 1989, SENSOR ACTUATOR, V19, P267, DOI 10.1016/0250-6874(89)87079-9; VANDEEMTER JJ, 1956, CHEM ENG SCI, V5, P271, DOI 10.1016/0009-2509(56)80003-1; VONENGEL A, 1934, ELEKT GASENTLADJUNGE, V2; Xu Y, 2003, LAB CHIP, V3, P224, DOI 10.1039/b308476k; Zhang CX, 2003, ANAL CHEM, V75, P5759, DOI 10.1021/ac0345190	67	547	563	3	250	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 27	2006	442	7101					374	380		10.1038/nature05059	http://dx.doi.org/10.1038/nature05059			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067CI	16871204				2022-12-28	WOS:000239278900029
J	Whitesides, GM				Whitesides, George M.			The origins and the future of microfluidics	NATURE			English	Editorial Material							SINGLE-MOLECULE; SYSTEMS; DEVICES; CHANNELS; FLOW; SEPARATION; POLY(DIMETHYLSILOXANE); ELECTROPHORESIS; TECHNOLOGIES; DIFFUSION	The manipulation of fluids in channels with dimensions of tens of micrometres - microfluidics - has emerged as a distinct new field. Microfluidics has the potential to influence subject areas from chemical synthesis and biological analysis to optics and information technology. But the field is still at an early stage of development. Even as the basic science and technological demonstrations develop, other problems must be addressed: choosing and focusing on initial applications, and developing strategies to complete the cycle of development, including commercialization. The solutions to these problems will require imagination and ingenuity.	Harvard Univ, Dept Chem & Biol Chem, Cambridge, MA 02138 USA	Harvard University	Whitesides, GM (corresponding author), Harvard Univ, Dept Chem & Biol Chem, Cambridge, MA 02138 USA.	gwhitesides@gmwgroup.harvard.edu						Anna SL, 2003, APPL PHYS LETT, V82, P364, DOI 10.1063/1.1537519; Auroux PA, 2004, LAB CHIP, V4, P534, DOI 10.1039/b408850f; Balagadde FK, 2005, SCIENCE, V309, P137, DOI 10.1126/science.1109173; Balslev S, 2005, OPT EXPRESS, V13, P344, DOI 10.1364/OPEX.13.000344; Beebe DJ, 2002, ANNU REV BIOMED ENG, V4, P261, DOI 10.1146/annurev.bioeng.4.112601.125916; Breslauer DN, 2006, MOL BIOSYST, V2, P97, DOI 10.1039/b515632g; Campbell K, 2004, APPL PHYS LETT, V85, P6119, DOI 10.1063/1.1839281; Cho BS, 2003, ANAL CHEM, V75, P1671, DOI 10.1021/ac020579e; Chung BG, 2005, LAB CHIP, V5, P401, DOI 10.1039/b417651k; Czaplewski DA, 2003, APPL PHYS LETT, V83, P4836, DOI 10.1063/1.1633008; Datta A, 2003, IEEE SENS J, V3, P788, DOI 10.1109/JSEN.2003.820343; Dittrich PS, 2005, ANAL BIOANAL CHEM, V382, P1771, DOI 10.1007/s00216-005-3335-9; Dittrich PS, 2006, NAT REV DRUG DISCOV, V5, P210, DOI 10.1038/nrd1985; Ganan-Calvo AM, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.274501; Garstecki P, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1946902; Garstecki P, 2004, APPL PHYS LETT, V85, P2649, DOI 10.1063/1.1796526; Glasgow IK, 2001, IEEE T BIO-MED ENG, V48, P570, DOI 10.1109/10.918596; Gunther A, 2005, LANGMUIR, V21, P1547, DOI 10.1021/la0482406; Hansen CL, 2002, P NATL ACAD SCI USA, V99, P16531, DOI 10.1073/pnas.262485199; Hong JW, 2003, NAT BIOTECHNOL, V21, P1179, DOI 10.1038/nbt871; Huh D, 2005, PHYSIOL MEAS, V26, pR73, DOI 10.1088/0967-3334/26/3/R02; Hung PJ, 2005, BIOTECHNOL BIOENG, V89, P1, DOI 10.1002/bit.20289; Jensen KF, 2006, MRS BULL, V31, P101, DOI 10.1557/mrs2006.23; Karnik R, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2186967; Kerbage C, 2003, APPL PHYS LETT, V82, P1338, DOI 10.1063/1.1557334; Laser DJ, 2004, J MICROMECH MICROENG, V14, pR35, DOI 10.1088/0960-1317/14/6/R01; Lee CC, 2005, SCIENCE, V310, P1793, DOI 10.1126/science.1118919; Lee JN, 2003, ANAL CHEM, V75, P6544, DOI 10.1021/ac0346712; Link DR, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.054503; Lowe H, 1999, ELECTROCHIM ACTA, V44, P3679, DOI 10.1016/S0013-4686(99)00071-7; Lu H, 2004, ANAL CHEM, V76, P5257, DOI 10.1021/ac049837t; Lucchetta EM, 2005, NATURE, V434, P1134, DOI 10.1038/nature03509; MANZ A, 1992, J CHROMATOGR, V593, P253, DOI 10.1016/0021-9673(92)80293-4; McClain MA, 2003, ANAL CHEM, V75, P5646, DOI 10.1021/ac0346510; McDonald JC, 2000, ELECTROPHORESIS, V21, P27, DOI 10.1002/(SICI)1522-2683(20000101)21:1<27::AID-ELPS27>3.0.CO;2-C; Mijatovic D, 2005, LAB CHIP, V5, P492, DOI 10.1039/b416951d; Ng JMK, 2002, ELECTROPHORESIS, V23, P3461, DOI 10.1002/1522-2683(200210)23:20<3461::AID-ELPS3461>3.0.CO;2-8; Nguyen NT, 2005, J MICROMECH MICROENG, V15, pR1, DOI 10.1088/0960-1317/15/2/R01; Pihl J, 2005, DRUG DISCOV TODAY, V10, P1377, DOI 10.1016/S1359-6446(05)03571-3; Ramsey RS, 1997, ANAL CHEM, V69, P1174, DOI 10.1021/ac9610671; Rolland JP, 2004, J AM CHEM SOC, V126, P2322, DOI 10.1021/ja031657y; Santiago JG, 2001, ANAL CHEM, V73, P2353, DOI 10.1021/ac0101398; SHIM JU, UNPUB J AM CHEM SOC; Sia SK, 2003, ELECTROPHORESIS, V24, P3563, DOI 10.1002/elps.200305584; Snyder DA, 2005, HELV CHIM ACTA, V88, P1, DOI 10.1002/hlca.200490304; Squires TM, 2005, REV MOD PHYS, V77, P977, DOI 10.1103/RevModPhys.77.977; Stavis SM, 2005, LAB CHIP, V5, P337, DOI 10.1039/b416161k; Stone HA, 2004, ANNU REV FLUID MECH, V36, P381, DOI 10.1146/annurev.fluid.36.050802.122124; Suh R, 2005, J ANDROL, V26, P664, DOI 10.2164/jandrol.05119; Takayama S, 2003, CHEM BIOL, V10, P123, DOI 10.1016/S1074-5521(03)00019-X; Tan YC, 2004, LAB CHIP, V4, P292, DOI 10.1039/b403280m; Taylor AM, 2003, LANGMUIR, V19, P1551, DOI 10.1021/la026417v; Thorsen T, 2001, PHYS REV LETT, V86, P4163, DOI 10.1103/PhysRevLett.86.4163; Thorsen T, 2002, SCIENCE, V298, P580, DOI 10.1126/science.1076996; Vezenov DV, 2005, J AM CHEM SOC, V127, P8952, DOI 10.1021/ja0517421; Wainright A, 2003, ELECTROPHORESIS, V24, P3784, DOI 10.1002/elps.200305594; Walker GM, 2005, LAB CHIP, V5, P611, DOI 10.1039/b417245k; Walters EM, 2004, METH MOL B, V254, P375; Weibel DB, 2005, ANAL CHEM, V77, P4726, DOI 10.1021/ac048303p; Werdich AA, 2004, LAB CHIP, V4, P357, DOI 10.1039/B315648F; Wheeler AR, 2003, ANAL CHEM, V75, P3581, DOI 10.1021/ac0340758; Whitesides GM, 2001, PHYS TODAY, V54, P42, DOI 10.1063/1.1387591; Wolfe DB, 2004, P NATL ACAD SCI USA, V101, P12434, DOI 10.1073/pnas.0404423101; Xu SQ, 2005, ANGEW CHEM INT EDIT, V44, P724, DOI 10.1002/anie.200462226; Zheng B, 2004, ANGEW CHEM INT EDIT, V43, P2508, DOI 10.1002/anie.200453974	65	6203	6529	158	3612	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 27	2006	442	7101					368	373		10.1038/nature05058	http://dx.doi.org/10.1038/nature05058			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067CI	16871203				2022-12-28	WOS:000239278900028
J	Oakeshott, P; Hay, P				Oakeshott, Pippa; Hay, Phillip			Improving women's experience during speculum examinations at routine gynaecological visits: randomised clinical trial - Commentary: Best practice in primary care	BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ London St Georges Hosp, London SW17 0RE, England	St Georges University London	Oakeshott, P (corresponding author), Univ London St Georges Hosp, London SW17 0RE, England.	oakeshot@sgul.ac.uk		Oakeshott, Pippa/0000-0003-2568-8211				Coldicott Y, 2003, BRIT MED J, V326, P97, DOI 10.1136/bmj.326.7380.97; MAJEED FA, 1994, BRIT MED J, V308, P1272, DOI 10.1136/bmj.308.6939.1272; *ROYAL COLL OBST G, 2002, GYNAEC EX GUID SPEC; Sandelowski M, 2000, J Obstet Gynecol Neonatal Nurs, V29, P73, DOI 10.1111/j.1552-6909.2000.tb02759.x; Seehusen DA, 2006, BMJ-BRIT MED J, V333, P171, DOI 10.1136/bmj.38888.588519.55; Wright D, 2005, J CLIN NURS, V14, P1098, DOI 10.1111/j.1365-2702.2005.01205.x	6	3	3	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JUL 22	2006	333	7560					173	174		10.1136/bmj.333.7560.173	http://dx.doi.org/10.1136/bmj.333.7560.173			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	068DJ	16858046	Green Submitted, Green Published, Bronze			2022-12-28	WOS:000239352100019
J	Chu, BJ; Zhou, X; Ren, KL; Neese, B; Lin, MR; Wang, Q; Bauer, F; Zhang, QM				Chu, Baojin; Zhou, Xin; Ren, Kailiang; Neese, Bret; Lin, Minren; Wang, Qing; Bauer, F.; Zhang, Q. M.			A dielectric polymer with high electric energy density and fast discharge speed	SCIENCE			English	Article							CAPACITORS; FUTURE	Dielectric polymers with high dipole density have the potential to achieve very high energy density, which is required in many modern electronics and electric systems. We demonstrate that a very high energy density with fast discharge speed and low loss can be obtained in defect-modified poly(vinylidene fluoride) polymers. This is achieved by combining nonpolar and polar molecular structural changes of the polymer with the proper dielectric constants, to avoid the electric displacement saturation at electric fields well below the breakdown field. The results indicate that a very high dielectric constant may not be desirable to reach a very high energy density.	Penn State Univ, Dept Mat Sci & Engn, University Pk, PA 16802 USA; Penn State Univ, Mat Res Inst, University Pk, PA 16802 USA; Dept Elect Engn, F-68300 St Louis, France; Inst Franco Allemand Rech, F-68300 St Louis, France	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Zhang, QM (corresponding author), Penn State Univ, Dept Mat Sci & Engn, University Pk, PA 16802 USA.	qxz1@psu.edu	Chu, Baojin/A-7623-2009; Wang, Qing/B-5034-2015; Ren, Kailiang/B-2531-2015	Ren, Kailiang/0000-0002-6469-799X; Wang, Qing/0000-0002-5968-3235				Bobnar V, 2003, MACROMOLECULES, V36, P4436, DOI 10.1021/ma034149h; Bune AV, 1998, NATURE, V391, P874, DOI 10.1038/36069; Cao Y, 2004, IEEE T DIELECT EL IN, V11, P797; Kepler R. G., 1995, FERROELECTRIC POLYM; LOVINGER AJ, 1983, SCIENCE, V220, P1115, DOI 10.1126/science.220.4602.1115; Nalwa H. S., 1999, HDB LOW HIGH DIELECT, V2; Nalwa H.S., 1995, FERROELECTRIC POLYM; Rabuffi M, 2002, IEEE T PLASMA SCI, V30, P1939, DOI 10.1109/TPS.2002.805318; Sarjeant WJ, 1998, IEEE T PLASMA SCI, V26, P1368, DOI 10.1109/27.736020; SARJEANT WJ, 1999, HDB LOW HIGH DIELECT, V2, pCH9; SINHA JK, 1965, J SCI INSTRUM, V42, P696, DOI 10.1088/0950-7671/42/9/308; Su HB, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.064101; Tortai JH, 2005, J APPL PHYS, V97, DOI 10.1063/1.1858872; WANG TT, 1988, APL FERROELECTRIC PO; Zhang Q.M., 2002, ENCY SMART MAT, V2; Zhang QM, 1998, SCIENCE, V280, P2101, DOI 10.1126/science.280.5372.2101; ZHANG QM, 2004, ELECTROACTIVE POLYM, pCH4	17	1718	1767	56	1086	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 21	2006	313	5785					334	336		10.1126/science.1127798	http://dx.doi.org/10.1126/science.1127798			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065IV	16857935				2022-12-28	WOS:000239154300039
J	Stankovich, S; Dikin, DA; Dommett, GHB; Kohlhaas, KM; Zimney, EJ; Stach, EA; Piner, RD; Nguyen, ST; Ruoff, RS				Stankovich, Sasha; Dikin, Dmitriy A.; Dommett, Geoffrey H. B.; Kohlhaas, Kevin M.; Zimney, Eric J.; Stach, Eric A.; Piner, Richard D.; Nguyen, SonBinh T.; Ruoff, Rodney S.			Graphene-based composite materials	NATURE			English	Article							THIN-FILM PARTICLES; GRAPHITE OXIDE; ELECTRICAL APPLICATIONS; CARBON NANOTUBES; NANOPLATELETS; POLYMERS; GAS	Graphene sheets - one- atom-thick two-dimensional layers of sp(2)-bonded carbon - are predicted to have a range of unusual properties. Their thermal conductivity and mechanical stiffness may rival the remarkable in-plane values for graphite (similar to 3,000 W m(-1) K-1 and 1,060 GPa, respectively); their fracture strength should be comparable to that of carbon nanotubes for similar types of defects(1-3); and recent studies have shown that individual graphene sheets have extraordinary electronic transport properties(4-8). One possible route to harnessing these properties for applications would be to incorporate graphene sheets in a composite material. The manufacturing of such composites requires not only that graphene sheets be produced on a sufficient scale but that they also be incorporated, and homogeneously distributed, into various matrices. Graphite, inexpensive and available in large quantity, unfortunately does not readily exfoliate to yield individual graphene sheets. Here we present a general approach for the preparation of graphene-polymer composites via complete exfoliation of graphite(9) and molecular-level dispersion of individual, chemically modified graphene sheets within polymer hosts. A polystyrene - graphene composite formed by this route exhibits a percolation threshold(10) of similar to 0.1 volume per cent for room-temperature electrical conductivity, the lowest reported value for any carbon-based composite except for those involving carbon nanotubes(11); at only 1 volume per cent, this composite has a conductivity of similar to 0.1 S m(-1), sufficient for many electrical applications(12). Our bottom-up chemical approach of tuning the graphene sheet properties provides a path to a broad new class of graphene-based materials and their use in a variety of applications.	Northwestern Univ, Dept Mech Engn, Evanston, IL 60208 USA; Northwestern Univ, Dept Chem, Evanston, IL 60208 USA; Purdue Univ, Sch Mat Engn, W Lafayette, IN 47907 USA; Purdue Univ, Birck Nanotechnol Ctr, W Lafayette, IN 47907 USA	Northwestern University; Northwestern University; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Nguyen, ST (corresponding author), Northwestern Univ, Dept Mech Engn, 2145 Sheridan Rd, Evanston, IL 60208 USA.	stn@northwestern.edu; r-ruoff@northwestern.edu	Dikin, Dmitriy/B-7592-2009; Ruoff, Rodney/ABE-6532-2020; Piner, Richard/Y-2520-2019; Ruoff, Rodney S/B-7605-2009; Nguyen, SonBinh/C-1682-2014; Dikin, Dmitriy/A-1086-2010; Stach, Eric Andrew/M-6455-2019; Stach, Eric A/D-8545-2011; Zhu, Huazhang/O-7601-2016; Dikin, Dmitriy/B-4649-2014	Ruoff, Rodney/0000-0002-6599-6764; Ruoff, Rodney S/0000-0002-6599-6764; Nguyen, SonBinh/0000-0002-6977-3445; Dikin, Dmitriy/0000-0001-8100-4502; Stach, Eric Andrew/0000-0002-3366-2153; Stach, Eric A/0000-0002-3366-2153; Dikin, Dmitriy/0000-0001-8100-4502				Berger C, 2004, J PHYS CHEM B, V108, P19912, DOI 10.1021/jp040650f; Cassagneau T, 2000, LANGMUIR, V16, P7318, DOI 10.1021/la000442o; Chen GH, 2003, EUR POLYM J, V39, P2329, DOI 10.1016/j.eurpolymj.2003.08.005; Chung DDL, 2004, J MATER SCI, V39, P2645, DOI 10.1023/B:JMSC.0000021439.18202.ea; Dresselhaus MS, 2002, ADV PHYS, V51, P1, DOI [10.1080/00018730110113644, 10.1080/00018738100101367]; Du XS, 2004, SYNTHETIC MET, V143, P129, DOI 10.1016/j.synthmet.2003.10.023; GARBOCZI EJ, 1995, PHYS REV E, V52, P819, DOI 10.1103/PhysRevE.52.819; Grossiord N, 2005, J MATER CHEM, V15, P2349, DOI 10.1039/b501805f; He HY, 1998, CHEM PHYS LETT, V287, P53, DOI 10.1016/S0009-2614(98)00144-4; Hirata M, 2005, CARBON, V43, P503, DOI 10.1016/j.carbon.2004.10.009; Hirata M, 2004, CARBON, V42, P2929, DOI 10.1016/j.carbon.2004.07.003; Kotov NA, 1996, ADV MATER, V8, P637, DOI 10.1002/adma.19960080806; Kovtyukhova NI, 1999, CHEM MATER, V11, P771, DOI 10.1021/cm981085u; Lerf A, 1998, J PHYS CHEM B, V102, P4477, DOI 10.1021/jp9731821; Liu PG, 1999, CARBON, V37, P706, DOI 10.1016/S0008-6223(99)00037-8; McLachlan DS, 2005, J POLYM SCI POL PHYS, V43, P3273, DOI 10.1002/polb.20597; Novoselov KS, 2005, NATURE, V438, P197, DOI 10.1038/nature04233; Novoselov KS, 2004, SCIENCE, V306, P666, DOI 10.1126/science.1102896; Olson D.W., 2006, USGS MINERAL COMMODI; Ounaies Z, 2003, COMPOS SCI TECHNOL, V63, P1637, DOI 10.1016/S0266-3538(03)00067-8; Ramasubramaniam R, 2003, APPL PHYS LETT, V83, P2928, DOI 10.1063/1.1616976; Stankovich S, 2006, J MATER CHEM, V16, P155, DOI 10.1039/b512799h; STANKOVICH S, IN PRESS CARBON; Stauffer D., 1991, INTRO PERCOLATION TH; Szabo T, 2005, CARBON, V43, P87, DOI 10.1016/j.carbon.2004.08.025; TITELMAN GI, 2005, METHOD MANUFACTURING, pP1391; Vaia RA, 2004, MATER TODAY, V7, P32, DOI 10.1016/S1369-7021(04)00506-1; Yu MF, 2000, SCIENCE, V287, P637, DOI 10.1126/science.287.5453.637; Zhang YB, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.176803; Zhang YB, 2005, NATURE, V438, P201, DOI 10.1038/nature04235	30	10692	11157	258	11592	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 20	2006	442	7100					282	286		10.1038/nature04969	http://dx.doi.org/10.1038/nature04969			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064WT	16855586				2022-12-28	WOS:000239122100034
J	Thornton, A; McAuliffe, K				Thornton, Alex; McAuliffe, Katherine			Teaching in wild meerkats	SCIENCE			English	Article							SURICATA-SURICATTA; ANIMALS	Despite the obvious benefits of directed mechanisms that facilitate the efficient transfer of skills, there is little critical evidence for teaching in nonhuman animals. Using observational and experimental data, we show that wild meerkats (Suricata suricatta) teach pups prey-handling skills by providing them with opportunities to interact with live prey. In response to changing pup begging calls, helpers alter their prey-provisioning methods as pups grow older, thus accelerating learning without the use of complex cognition. The lack of evidence for teaching in species other than humans may reflect problems in producing unequivocal support for the occurrence of teaching, rather than the absence of teaching.	Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England	University of Cambridge	Thornton, A (corresponding author), Univ Cambridge, Dept Zool, Downing St, Cambridge CB2 3EJ, England.	jant2@cam.ac.uk		Thornton, Alex/0000-0002-1607-2047				BOESCH C, 1991, ANIM BEHAV, V41, P530, DOI 10.1016/S0003-3472(05)80857-7; Boyd R., 1985, CULTURE EVOLUTIONARY; Caro T., 1994, CHEETAHS SERENGETI P; CARO TM, 1992, Q REV BIOL, V67, P151, DOI 10.1086/417553; Cheney D. L., 1990, MONKEYS SEE WORLD IN; Clutton-Brock TH, 2001, SCIENCE, V291, P478, DOI 10.1126/science.291.5503.478; Doolan SP, 1996, J ZOOL, V239, P697, DOI 10.1111/j.1469-7998.1996.tb05472.x; EWER RF, 1969, NATURE, V222, P698, DOI 10.1038/222698a0; Fragaszy D.M., 2003, BIOL TRADITIONS MODE; Franks NR, 2006, NATURE, V439, P153, DOI 10.1038/439153a; Galef BG, 2005, ANIM BEHAV, V70, P91, DOI 10.1016/j.anbehav.2004.12.004; Heyes CM., 1996, SOCIAL LEARNING ANIM; Leeming J, 2003, SCORPIONS SO AFRICA; MAESTRIPIERI D, 1995, HUM NATURE-INT BIOS, V6, P361, DOI 10.1007/BF02734206; Manser MB, 2000, BEHAV ECOL SOCIOBIOL, V48, P429, DOI 10.1007/s002650000248; Pearson A, 1989, TEACHER THEORY PRACT; Rendell L, 2001, BEHAV BRAIN SCI, V24, P309, DOI 10.1017/S0140525X0100396X; TOMASELLO M, 1993, BEHAV BRAIN SCI, V16, P495, DOI 10.1017/S0140525X0003123X; White SM, 2001, THESIS U CAMBRIDGE C	19	222	224	4	173	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 14	2006	313	5784					227	229		10.1126/science.1128727	http://dx.doi.org/10.1126/science.1128727			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	063GZ	16840701				2022-12-28	WOS:000239008000045
J	Tillett, RL; Saxby, PJ; Stone, CA; Morgan, MS				Tillett, Rachel L.; Saxby, Peter J.; Stone, Christopher A.; Morgan, Marina S.			Group A streptococcal necrotising fasciitis masquerading as mastitis	LANCET			English	Editorial Material							TOXIC-SHOCK-SYNDROME; THERAPY		Royal Devon & Exeter Hosp, Dept Plast & Reconstruct Surg, Exeter EX2 5DW, Devon, England; Royal Devon & Exeter Hosp, Dept Med Microbiol, Exeter EX2 5DW, Devon, England	University of Exeter; University of Exeter	Tillett, RL (corresponding author), Royal Devon & Exeter Hosp, Dept Plast & Reconstruct Surg, Exeter EX2 5DW, Devon, England.	racheltillet@doctors.org.uk		morgan, marina/0000-0002-9336-481X				BREIMAN RF, 1993, JAMA-J AM MED ASSOC, V269, P390, DOI 10.1001/jama.1993.03500030088038; Coyle EA, 2003, PHARMACOTHERAPY, V23, P638, DOI 10.1592/phco.23.5.638.32191; Darenberg J, 2003, CLIN INFECT DIS, V37, P333, DOI 10.1086/376630; Kaul R, 1999, CLIN INFECT DIS, V28, P800, DOI 10.1086/515199; Stevens DL, 2000, ANNU REV MED, V51, P271, DOI 10.1146/annurev.med.51.1.271	5	7	7	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 8	2006	368	9530					174	174		10.1016/S0140-6736(06)69007-7	http://dx.doi.org/10.1016/S0140-6736(06)69007-7			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	062AR	16829302				2022-12-28	WOS:000238917200032
J	Saa, P; Castilla, J; Soto, C				Saa, Paula; Castilla, Joaquin; Soto, Claudio			Presymptomatic detection of prions in blood	SCIENCE			English	Article							CREUTZFELDT-JAKOB-DISEASE; CYCLIC AMPLIFICATION; TRANSMISSION; TRANSFUSION; PROTEIN; PATHOGENESIS; BSE; SCRAPIE; INFECTIVITY; DISORDERS	Prions are thought to be the proteinaceous infectious agents responsible for transmissible spongiform encephalopathies (TSEs). PrPSc, the main component of the infectious agent, is also the only validated surrogate marker for the disease, and its sensitive detection is critical for minimizing the spread of the disease. We detected PrPSc biochemically in the blood of hamsters infected with scrapie during most of the presymptomatic phase of the disease. At early stages of the incubation period, PrPSc detected in blood was likely to be from the peripheral replication of prions, whereas at the symptomatic phase, PrPSc in blood was more likely to have leaked from the brain. The ability to detect prions biochemically in the blood of infected but not clinically sick animals offers a great promise for the noninvasive early diagnosis of TSEs.	Univ Texas, Med Branch, George & Cynthia Mitchell Ctr Alzheimers Dis Res, Dept Neurol, Galveston, TX 77555 USA; Univ Texas, Med Branch, George & Cynthia Mitchell Ctr Alzheimers Dis Res, Dept Neurosci & Cell Biol, Galveston, TX 77555 USA; Univ Texas, Med Branch, George & Cynthia Mitchell Ctr Alzheimers Dis Res, Dept Biochem & Mol Biol, Galveston, TX 77555 USA; Univ Autonoma Madrid, Ctr Biol Mol, E-28049 Madrid, Spain	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; Autonomous University of Madrid	Soto, C (corresponding author), Univ Texas, Med Branch, George & Cynthia Mitchell Ctr Alzheimers Dis Res, Dept Neurol, 301 Univ Blvd, Galveston, TX 77555 USA.	clsoto@utmb.edu	Castilla, Joaquin/D-5261-2011; Castilla, Joaquín/J-8414-2019; Saa, Paula/AAB-6607-2019	Castilla, Joaquin/0000-0002-2216-1361; Castilla, Joaquín/0000-0002-2216-1361; Saa, Paula/0000-0001-6077-4532	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS049173] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG002246] Funding Source: NIH RePORTER; NIA NIH HHS [AG0224642] Funding Source: Medline; NINDS NIH HHS [NS049173] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Banks WA, 1999, J NEUROVIROL, V5, P538, DOI 10.3109/13550289909021284; Bishop MT, 2006, LANCET NEUROL, V5, P393, DOI 10.1016/S1474-4422(06)70413-6; Bradley Ray, 2004, Folia Neuropathol, V42 Suppl A, P55; Brown P, 2001, J LAB CLIN MED, V137, P5, DOI 10.1067/mlc.2001.111951; Brown P, 2005, VOX SANG, V89, P63, DOI 10.1111/j.1423-0410.2005.00683.x; Bruce ME, 1997, NATURE, V389, P498, DOI 10.1038/39057; Castilla J, 2005, NAT MED, V11, P982, DOI 10.1038/nm1286; Castilla J, 2004, CURR MOL MED, V4, P397, DOI 10.2174/1566524043360654; Collinge J, 1999, LANCET, V354, P317, DOI 10.1016/S0140-6736(99)05128-4; Cousens SN, 1997, NATURE, V385, P197, DOI 10.1038/385197a0; Glatzel M, 2000, MICROBES INFECT, V2, P613, DOI 10.1016/S1286-4579(00)00364-6; Houston F, 2000, LANCET, V356, P999, DOI 10.1016/S0140-6736(00)02719-7; Hunter N, 2003, BRIT MED BULL, V66, P171, DOI 10.1093/bmb/66.1.171; Hunter N, 2002, J GEN VIROL, V83, P2897, DOI 10.1099/0022-1317-83-11-2897; Ingrosso L, 2002, TRENDS MOL MED, V8, P273, DOI 10.1016/S1471-4914(02)02358-4; Ironside JW, 2006, HAEMOPHILIA, V12, P8, DOI 10.1111/j.1365-2516.2006.01195.x; KIMBERLIN RH, 1986, J GEN VIROL, V67, P255, DOI 10.1099/0022-1317-67-2-255; KIMBERLIN RH, 1979, J COMP PATHOL, V89, P551, DOI 10.1016/0021-9975(79)90046-X; Llewelyn CA, 2004, LANCET, V363, P417, DOI 10.1016/S0140-6736(04)15486-X; Peden AH, 2004, LANCET, V364, P527, DOI 10.1016/S0140-6736(04)16811-6; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Saborio GP, 2001, NATURE, V411, P810, DOI 10.1038/35081095; Schiermeier Q, 2001, NATURE, V409, P658, DOI 10.1038/35055646; Silveira JR, 2005, NATURE, V437, P257, DOI 10.1038/nature03989; Soto C, 2004, NAT REV MICROBIOL, V2, P809, DOI 10.1038/nrmicro1003; Soto C, 2005, FEBS LETT, V579, P638, DOI 10.1016/j.febslet.2004.12.035; Soto C, 2002, TRENDS NEUROSCI, V25, P390, DOI 10.1016/S0166-2236(02)02195-1	27	170	179	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 7	2006	313	5783					92	94		10.1126/science.1129051	http://dx.doi.org/10.1126/science.1129051			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061DA	16825570				2022-12-28	WOS:000238850200038
J	Segall, P; Desmarais, EK; Shelly, D; Miklius, A; Cervelli, P				Segall, Paul; Desmarais, Emily K.; Shelly, David; Miklius, Asta; Cervelli, Peter			Earthquakes triggered by silent slip events on Kilauea volcano, Hawaii	NATURE			English	Article							1975 KALAPANA; SOUTH FLANK; SUBDUCTION ZONE; FAULT; DEFORMATION; BENEATH	Slow-slip events, or 'silent earthquakes', have recently been discovered in a number of subduction zones including the Nankai trough(1-3) in Japan, Cascadia(4,5), and Guerrero(6) in Mexico, but the depths of these events have been difficult to determine from surface deformation measurements. Although it is assumed that these silent earthquakes are located along the plate megathrust, this has not been proved. Slow slip in some subduction zones is associated with non-volcanic tremor(7,8), but tremor is difficult to locate and may be distributed over a broad depth range(9). Except for some events on the San Andreas fault(10), slow-slip events have not yet been associated with high-frequency earthquakes, which are easily located. Here we report on swarms of high-frequency earthquakes that accompany otherwise silent slips on Kilauea volcano, Hawaii. For the most energetic event, in January 2005, the slow slip began before the increase in seismicity. The temporal evolution of earthquakes is well explained by increased stressing caused by slow slip, implying that the earthquakes are triggered. The earthquakes, located at depths of 7-8 km, constrain the slow slip to be at comparable depths, because they must fall in zones of positive Coulomb stress change. Triggered earthquakes accompanying slow-slip events elsewhere might go undetected if background seismicity rates are low. Detection of such events would help constrain the depth of slow slip, and could lead to a method for quantifying the increased hazard during slow-slip events, because triggered events have the potential to grow into destructive earthquakes.	Stanford Univ, Dept Geophys, Stanford, CA 94305 USA; USGS Hawaii Volcano Observ, Hawaii Natl Pk, HI 96718 USA; USGS Alaska Volcano Observ, Anchorage, AK 99508 USA	Stanford University; United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Geological Survey	Segall, P (corresponding author), Stanford Univ, Dept Geophys, Stanford, CA 94305 USA.	segall@stanford.edu		Cervelli, Peter/0000-0001-6765-1009; Shelly, David/0000-0003-2783-5158				BROOKS B, 2005, T AGU S, V86; Cervelli P, 2002, NATURE, V415, P1014, DOI 10.1038/4151014a; Cervelli P, 2001, J GEOPHYS RES-SOL EA, V106, P11217, DOI 10.1029/2000JB900399; Delaney PT, 1998, J GEOPHYS RES-SOL EA, V103, P18003, DOI 10.1029/98JB01665; DIETERICH J, 1994, J GEOPHYS RES-SOL EA, V99, P2601, DOI 10.1029/93JB02581; Dragert H, 2001, SCIENCE, V292, P1525, DOI 10.1126/science.1060152; Got J.-L., 2003, Journal of Geophysical Research, V108, pESE5, DOI 10.1029/2002JB002060; GOT JL, 1994, J GEOPHYS RES-SOL EA, V99, P15375, DOI 10.1029/94JB00577; Hansen S, 2004, B SEISMOL SOC AM, V94, P1430, DOI 10.1785/012003154; Hirose H, 1999, GEOPHYS RES LETT, V26, P3237, DOI 10.1029/1999GL010999; Kao H, 2005, NATURE, V436, P841, DOI 10.1038/nature03903; Kato N, 2004, J GEOPHYS RES-SOL EA, V109, DOI 10.1029/2004JB003001; Kostoglodov V, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017219; Linde AT, 1996, NATURE, V383, P65, DOI 10.1038/383065a0; Liu YJ, 2005, J GEOPHYS RES-SOL EA, V110, DOI 10.1029/2004JB003424; Ma KF, 1999, J GEOPHYS RES-SOL EA, V104, P13153, DOI 10.1029/1999JB900073; Miller MM, 2002, SCIENCE, V295, P2423, DOI 10.1126/science.1071193; Miyazaki S, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2001JB000456; Nettles M, 2004, B SEISMOL SOC AM, V94, P422, DOI 10.1785/0120030090; Obara K, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020848; Owen S, 2000, J GEOPHYS RES-SOL EA, V105, P18983, DOI 10.1029/2000JB900109; Owen SE, 2006, J VOLCANOL GEOTH RES, V150, P163, DOI 10.1016/j.jvolgeores.2005.07.012; Ozawa S, 2002, SCIENCE, V298, P1009, DOI 10.1126/science.1076780; Rogers G, 2003, SCIENCE, V300, P1942, DOI 10.1126/science.1084783; SEGALL P, 2002, EOS T S, V83; SEGALL P, 2005, T AGU S, V86; Waldhauser F, 2000, B SEISMOL SOC AM, V90, P1353, DOI 10.1785/0120000006	27	146	148	0	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 6	2006	442	7098					71	74		10.1038/nature04938	http://dx.doi.org/10.1038/nature04938			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	059HS	16823451				2022-12-28	WOS:000238724500038
J	Lloyd-Jones, DM; Liu, K; Tian, L; Greenland, P				Lloyd-Jones, Donald M.; Liu, Kiang; Tian, Lu; Greenland, Philip			Narrative review: Assessment of C-reactive protein in risk prediction for cardiovascular disease	ANNALS OF INTERNAL MEDICINE			English	Review							CORONARY-HEART-DISEASE; INFLAMMATORY MARKERS; METABOLIC SYNDROME; FRAMINGHAM SCORE; NATIONAL-HEALTH; STATIN THERAPY; CHOLESTEROL; PREVENTION; MORTALITY; STANDARD	Some experts propose C-reactive protein (CRP) as a screening tool for prediction of cardiovascular disease (CM. Many epidemiologic studies show positive associations between elevated CRP levels and incident CVD. Assessment of the value of new prognostic tests, however, must rely on understanding of test characteristics rather than on associations measured by relative risks. In the case of CRP, test characteristics must be judged in the context of currently available CVD risk prediction algorithms. In this review of literature published before January 2006, the authors describe what is known about the additional utility of CRP in risk prediction. They find no definitive evidence that, for most individuals, CRP adds substantial predictive value above that provided by risk estimation using traditional risk factors for CVD. Use of CRP may add to risk estimation in a limited subset of individuals who are at intermediate predicted risk according to the Framingham risk score. The authors propose that many questions still must be addressed before CRP is incorporated into risk prediction algorithms and before universal screening with CRP can be recommended.	Northwestern Univ, Feinberg Sch Med, Dept Prevent Med, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Lloyd-Jones, DM (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Prevent Med, 680 N Lake Shore Dr,Suite 1102, Chicago, IL 60611 USA.	dlj@northwestern.edu	Lloyd-Jones, Donald M/C-5899-2009; Greenland, Philip/ABD-5528-2021	Lloyd-Jones, Donald/0000-0003-0847-6110				Albert MA, 2004, AM J CARDIOL, V93, P1238, DOI 10.1016/j.amjcard.2004.01.067; Albert MA, 2003, CIRCULATION, V108, P161, DOI 10.1161/01.CIR.0000080289.72166.CF; Anand SS, 2004, ARTERIOSCL THROM VAS, V24, P1509, DOI 10.1161/01.ATV.0000135845.95890.4e; Assmann G, 2002, CIRCULATION, V105, P310, DOI 10.1161/hc0302.102575; Bermudez EA, 2002, ARTERIOSCL THROM VAS, V22, P1668, DOI 10.1161/01.ATV.0000029781.31325.66; Conroy RM, 2003, EUR HEART J, V24, P987, DOI 10.1016/S0195-668X(03)00114-3; Danesh J, 2004, NEW ENGL J MED, V350, P1387, DOI 10.1056/NEJMoa032804; FOREMAN J, 2002, BOSTON GLOBE    1119, pC1; Futterman L G, 1998, Am J Crit Care, V7, P240; Greenland P, 2004, JAMA-J AM MED ASSOC, V291, P210, DOI 10.1001/jama.291.2.210; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Harb TS, 2003, AM J CARDIOL, V91, P1120, DOI 10.1016/S0002-9149(03)00162-0; Hawthorne V, 2002, HEART, V88, P222; HILDEN J, 1991, MED DECIS MAKING, V11, P95, DOI 10.1177/0272989X9101100204; HOPKINS PN, 1981, ATHEROSCLEROSIS, V40, P1, DOI 10.1016/0021-9150(81)90122-2; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Khera A, 2005, J AM COLL CARDIOL, V46, P464, DOI 10.1016/j.jacc.2005.04.051; Kinjo K, 2003, AM J CARDIOL, V91, P931, DOI 10.1016/S0002-9149(03)00106-1; Klingman D, 2005, AM HEART J, V150, P595, DOI 10.1016/j.ahj.2004.09.039; Koenig W, 2004, CIRCULATION, V109, P1349, DOI 10.1161/01.CIR.0000120707.98922.E3; Lagrand WK, 1999, CIRCULATION, V100, P96, DOI 10.1161/01.CIR.100.1.96; Lefkowitz RJ, 2001, JAMA-J AM MED ASSOC, V285, P581, DOI 10.1001/jama.285.5.581; LEMONICK MD, 2005, TIME            0117, P34; Magnus P, 2001, ARCH INTERN MED, V161, P2657, DOI 10.1001/archinte.161.22.2657; Miller M, 2005, ARCH INTERN MED, V165, P2063, DOI 10.1001/archinte.165.18.2063; Nieto FJ, 1999, AM J PUBLIC HEALTH, V89, P292, DOI 10.2105/AJPH.89.3.292; Pai JK, 2004, NEW ENGL J MED, V351, P2599, DOI 10.1056/NEJMoa040967; Pasceri V, 2000, CIRCULATION, V102, P2165; Patel VB, 2001, CLEV CLIN J MED, V68, P521, DOI 10.3949/ccjm.68.6.521; Pearson TA, 2003, CIRCULATION, V107, P499, DOI 10.1161/01.CIR.0000052939.59093.45; Pepe MS, 2004, AM J EPIDEMIOL, V159, P882, DOI 10.1093/aje/kwh101; Ray KK, 2005, J AM COLL CARDIOL, V46, P1417, DOI 10.1016/j.jacc.2005.08.024; Ridker PM, 2005, JAMA-J AM MED ASSOC, V294, P326, DOI 10.1001/jama.294.3.326; Ridker PM, 2004, CIRCULATION, V109, P2818, DOI 10.1161/01.CIR.0000132467.45278.59; Ridker PM, 2003, CIRCULATION, V107, P363, DOI 10.1161/01.CIR.0000053730.47739.3C; Ridker PM, 2001, NEW ENGL J MED, V344, P1959, DOI 10.1056/NEJM200106283442601; Ridker PM, 2004, CIRCULATION, V109, P1955, DOI 10.1161/01.CIR.0000125690.80303.A8; Ridker PM, 2005, NEW ENGL J MED, V352, P20, DOI 10.1056/NEJMoa042378; Ridker PM, 2002, NEW ENGL J MED, V347, P1557, DOI 10.1056/NEJMoa021993; Rutter MK, 2004, CIRCULATION, V110, P380, DOI 10.1161/01.CIR.0000136581.59584.0E; Sanchis J, 2004, AM J CARDIOL, V94, P766, DOI 10.1016/j.amjcard.2004.05.062; Shlipak MG, 2005, JAMA-J AM MED ASSOC, V293, P1737, DOI 10.1001/jama.293.14.1737; Torzewski M, 2000, ARTERIOSCL THROM VAS, V20, P2094, DOI 10.1161/01.ATV.20.9.2094; van der Meer IM, 2003, ARCH INTERN MED, V163, P1323, DOI 10.1001/archinte.163.11.1323; Wilson PWF, 2005, ARCH INTERN MED, V165, P2473, DOI 10.1001/archinte.165.21.2473; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; Yeh ETH, 2003, CIRCULATION, V107, P370, DOI 10.1161/01.CIR.0000053731.05365.5A; 2002, NY TIMES        1117, pA10; 2005, NY TIMES        0111, pA18	49	186	192	0	8	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 4	2006	145	1					35	42		10.7326/0003-4819-145-1-200607040-00129	http://dx.doi.org/10.7326/0003-4819-145-1-200607040-00129			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	062IS	16818927				2022-12-28	WOS:000238938400005
J	Carbotte, JP; Schachinger, E; Basov, DN				Carbotte, JP; Schachinger, E; Basov, DN			Coupling strength of charge carriers to spin fluctuations in high-temperature superconductors	NATURE			English	Article							T-C SUPERCONDUCTORS; NEUTRON-SCATTERING; CONDUCTIVITY; YBA2CU3O7; STATE; PSEUDOGAP; COHERENCE; YBCO	In conventional superconductors, the most direct evidence of the mechanism responsible for superconductivity comes from tunnelling experiments, which provide a clear picture of the underlying electron-phonon interactions(1,2), As the coherence length in conventional superconductors is large, the tunnelling process probes several atomic layers into the bulk of the material; the observed structure in the current-voltage characteristics at the phonon energies gives(1), through inversion of the Eliashberg equations, the electron-phonon spectral density alpha(2)F(omega). The situation is different for the high-temperature copper oxide superconductors, where the coherence length (particularly for c-axis tunnelling) can be very short. Because of this, methods such as optical spectroscopy and neutron scattering provide a better route for investigating the underlying, mechanism, as they probe bulk properties. Accurate reflection measurements at infrared wavelengths and precise polarized neutron-scattering data are now available for a variety of the copper oxides(3-5), and here we shaw that the conducting carriers (probed by infrared spectroscopy) are strongly coupled to a resonance structure in the spectrum of spin fluctuations (measured by neutron scattering). The coupling strength inferred from those results is sufficient to account for the high transition temperatures of the copper oxides, highlighting a prominent role for spin fluctuations in driving superconductivity in these materials.	Graz Univ Technol, Inst Theoret Phys, A-8010 Graz, Austria; McMaster Univ, Dept Phys & Astron, Hamilton, ON L8S 4M1, Canada; Univ Calif San Diego, Dept Phys, La Jolla, CA 92093 USA	Graz University of Technology; McMaster University; University of California System; University of California San Diego	Schachinger, E (corresponding author), Graz Univ Technol, Inst Theoret Phys, A-8010 Graz, Austria.	Schachinger@itp.tu-graz.ac.at						Basov DN, 1996, PHYS REV LETT, V77, P4090, DOI 10.1103/PhysRevLett.77.4090; Bourges P, 1998, NATO ADV SCI I B-PHY, V371, P349; BOURGES P, CONDMAT9902067; Bulut N, 1996, PHYS REV B, V53, P5149, DOI 10.1103/PhysRevB.53.5149; CARBOTTE JP, 1990, REV MOD PHYS, V62, P1027, DOI 10.1103/RevModPhys.62.1027; COLLINS RT, 1989, PHYS REV B, V39, P6571, DOI 10.1103/PhysRevB.39.6571; DEMLER E, 1995, PHYS REV LETT, V75, P4126, DOI 10.1103/PhysRevLett.75.4126; DeWilde Y, 1998, PHYS REV LETT, V80, P153, DOI 10.1103/PhysRevLett.80.153; Fong HF, 1999, NATURE, V398, P588, DOI 10.1038/19255; Fong HF, 1997, PHYS REV LETT, V78, P713, DOI 10.1103/PhysRevLett.78.713; Marsiglio F, 1998, PHYS LETT A, V245, P172, DOI 10.1016/S0375-9601(98)00373-9; MCMILLAN WL, 1965, PHYS REV LETT, V14, P108, DOI 10.1103/PhysRevLett.14.108; MONTHOUX P, 1993, PHYS REV B, V47, P6069, DOI 10.1103/PhysRevB.47.6069; NUSS MC, 1991, PHYS REV LETT, V66, P3305, DOI 10.1103/PhysRevLett.66.3305; PONOMAREV YG, 1995, PHYSICA C, V243, P167, DOI 10.1016/0921-4534(94)02452-9; Puchkov AV, 1996, J PHYS-CONDENS MAT, V8, P10049, DOI 10.1088/0953-8984/8/48/023; SCALAPINO DJ, 1986, PHYS REV B, V34, P8190, DOI 10.1103/PhysRevB.34.8190; Schachinger E, 1997, PHYS REV B, V56, P2738, DOI 10.1103/PhysRevB.56.2738; TSUEI CC, 1994, PHYS REV LETT, V73, P593, DOI 10.1103/PhysRevLett.73.593; VARMA CM, 1989, PHYS REV LETT, V63, P1996, DOI 10.1103/PhysRevLett.63.1996; WOLLMAN DA, 1993, PHYS REV LETT, V71, P2134, DOI 10.1103/PhysRevLett.71.2134	21	193	194	2	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 23	1999	401	6751					354	356		10.1038/43843	http://dx.doi.org/10.1038/43843			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	240JJ	16862106	Green Submitted			2022-12-28	WOS:000082822600044
J	Jenkins, N; Saam, JR; Mango, SE				Jenkins, Noah; Saam, Jennifer R.; Mango, Susan E.			CYK-4/GAP provides a localized cue to initiate anteroposterior polarity upon fertilization	SCIENCE			English	Article							ANTERIOR-POSTERIOR POLARITY; C-ELEGANS EMBRYOS; CAENORHABDITIS-ELEGANS; CELL POLARITY; PAR PROTEINS; CYTOKINESIS; ESTABLISHMENT; MORPHOGENESIS; POLARIZATION; ZYGOTE	The Caenorhabditis elegans anteroposterior axis is established in response to fertilization by sperm. Here we present evidence that RhoA, the guanine nucleotide-exchange factor ECT-2, and the Rho guanosine triphosphatase-activating protein CYK-4 modulate myosin light-chain activity to create a gradient of actomyosin, which establishes the anterior domain. CYK-4 is enriched within sperm, and paternally donated CYK-4 is required for polarity. These data suggest that CYK-4 provides a molecular link between fertilization and polarity establishment in the one-cell embryo. Orthologs of CYK-4 are expressed in sperm of other species, which suggests that this cue may be evolutionarily conserved.	Univ Utah, Huntsman Canc Inst, Dept Oncol Sci, Salt Lake City, UT 84112 USA	Huntsman Cancer Institute; Utah System of Higher Education; University of Utah	Mango, SE (corresponding author), Univ Utah, Huntsman Canc Inst, Dept Oncol Sci, Salt Lake City, UT 84112 USA.	susan.mango@hci.utah.edu		Mango, Susan/0000-0002-2146-3237	NATIONAL CANCER INSTITUTE [P30CA042014] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK002966] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056264] Funding Source: NIH RePORTER; NCI NIH HHS [2P30CA42014] Funding Source: Medline; NIDDK NIH HHS [K01DK02966-2] Funding Source: Medline; NIGMS NIH HHS [R01 GM056264, R01 GM056264-10, R01 GM056264-09] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AGNEL M, 1992, MOL CELL BIOL, V12, P5111, DOI 10.1128/MCB.12.11.5111; Cheeks RJ, 2004, CURR BIOL, V14, P851, DOI 10.1016/j.cub.2004.05.022; Cowan CR, 2004, NATURE, V431, P92, DOI 10.1038/nature02825; Cowan CR, 2004, ANNU REV CELL DEV BI, V20, P427, DOI 10.1146/annurev.cellbio.19.111301.113823; Cuenca AA, 2003, DEVELOPMENT, V130, P1255, DOI 10.1242/dev.00284; Encalada SE, 2005, MOL BIOL CELL, V16, P1056, DOI 10.1091/mbc.E04-08-0712; Glotzer M, 2005, SCIENCE, V307, P1735, DOI 10.1126/science.1096896; Goldstein B, 1996, DEVELOPMENT, V122, P1467; Gotta M, 2001, CURR BIOL, V11, P482, DOI 10.1016/S0960-9822(01)00142-7; Jantsch-Plunger V, 2000, J CELL BIOL, V149, P1391, DOI 10.1083/jcb.149.7.1391; L'Hernault SW, 1997, C ELEGANS, P271; Lundquist EA, 2001, DEVELOPMENT, V128, P4475; Munro E, 2004, DEV CELL, V7, P413, DOI 10.1016/j.devcel.2004.08.001; OKAMOTO H, 1985, J NEUROSCI, V5, P643; Portereiko MF, 2004, CURR BIOL, V14, P932, DOI 10.1016/j.cub.2004.05.052; Portereiko MF, 2001, DEV BIOL, V233, P482, DOI 10.1006/dbio.2001.0235; Prodon F, 2004, M S-MED SCI, V20, P526, DOI 10.1051/medsci/2004205526; Riento K, 2003, NAT REV MOL CELL BIO, V4, P446, DOI 10.1038/nrm1128; Sadler PL, 2000, DEVELOPMENT, V127, P355; Schneider SQ, 2003, ANNU REV GENET, V37, P221, DOI 10.1146/annurev.genet.37.110801.142443; Shelton CA, 1999, J CELL BIOL, V146, P439, DOI 10.1083/jcb.146.2.439; Toure A, 2001, J BIOL CHEM, V276, P20309, DOI 10.1074/jbc.M011740200; Verbrugghe KJC, 2004, CURR BIOL, V14, P1755, DOI 10.1016/j.cub.2004.09.055; Zernicka-Goetz MZ, 2005, NAT REV MOL CELL BIO, V6, P919, DOI 10.1038/nrm1782	24	98	103	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 1	2006	313	5791					1298	1301		10.1126/science.1130291	http://dx.doi.org/10.1126/science.1130291			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	081JI	16873611				2022-12-28	WOS:000240313500044
J	Armatas, GS; Kanatzidis, MG				Armatas, Gerasimos S.; Kanatzidis, Mercouri G.			Hexagonal mesoporous germanium	SCIENCE			English	Article							METAL	The blending of mesoporosity with the properties of semiconductors promises new types of multifunctional nanomaterials. It would be particularly interesting to combine the shape selectivity of a mesoporous oxide with the electronic and photonic characteristics of a useful semiconductor. We demonstrated the synthesis of a mesoporous germanium semiconductor using liquid-crystals-templated chemistry. The template removal was achieved by a two-step ion-exchange thermal procedure. This semiconductive mesoporous form of germanium possesses hexagonal pore ordering with very high surface area and exhibits strongly size-dependent optical properties as well as photoluminescence.	Michigan State Univ, Dept Chem, E Lansing, MI 48824 USA	Michigan State University	Kanatzidis, MG (corresponding author), Michigan State Univ, Dept Chem, E Lansing, MI 48824 USA.	kanatzid@cem.msu.edu	Armatas, Gerasimos/F-4753-2011	Armatas, Gerasimos/0000-0001-9475-1929				Armatas GS, 2006, NATURE, V441, P1122, DOI 10.1038/nature04833; Attard GS, 1997, SCIENCE, V278, P838, DOI 10.1126/science.278.5339.838; Billinge SJL, 2004, CHEM COMMUN, P749, DOI 10.1039/b309577k; Carreon MA, 2005, EUR J INORG CHEM, P27, DOI 10.1002/ejic.200400675; Gao F, 2003, ADV MATER, V15, P739, DOI 10.1002/adma.200304758; He X, 2002, ANGEW CHEM INT EDIT, V41, P214, DOI 10.1002/1521-3773(20020118)41:2<214::AID-ANIE214>3.0.CO;2-D; Jun S, 2000, J AM CHEM SOC, V122, P10712, DOI 10.1021/ja002261e; Li HL, 1999, SCIENCE, V283, P1145, DOI 10.1126/science.283.5405.1145; MacLachlan MJ, 1999, NATURE, V397, P681, DOI 10.1038/17776; Mohanan JL, 2005, SCIENCE, V307, P397, DOI 10.1126/science.1106525; Moss T.S., 1973, SEMICONDUCTOR OPTO E; Nandhakumar IS, 2004, CHEM COMMUN, P1374, DOI 10.1039/b403423f; Rangan KK, 2000, J AM CHEM SOC, V122, P10230, DOI 10.1021/ja002362c; Riley AE, 2003, J AM CHEM SOC, V125, P4551, DOI 10.1021/ja0275919; Schlecht S, 2003, Z ANORG ALLG CHEM, V629, P2521, DOI 10.1002/zaac.200300288; Sun D, 2006, NATURE, V441, P1126, DOI 10.1038/nature04891; Taylor BR, 1999, CHEM MATER, V11, P2493, DOI 10.1021/cm990203q; Thommes M, 2004, NANOPOROUS MAT SCI E; Trikalitis PN, 2002, J AM CHEM SOC, V124, P2604, DOI 10.1021/ja017245b; Trikalitis PN, 2001, NATURE, V410, P671, DOI 10.1038/35070533; TURTON R, 1995, QUANTUM DOT; Wang YQ, 2005, ADV MATER, V17, P53, DOI 10.1002/adma.200400777	22	136	142	1	96	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 11	2006	313	5788					817	820		10.1126/science.1130101	http://dx.doi.org/10.1126/science.1130101			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072KC	16857901				2022-12-28	WOS:000239671300054
J	Whitty, CJM; Lalloo, D; Ustianowski, A				Whitty, Christopher J. M.; Lalloo, David; Ustianowski, Andrew			BMJ learning - Malaria: an update on treatment of adults in non-endemic countries	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PLASMODIUM-FALCIPARUM MALARIA; ARTESUNATE; THERAPY		Hosp Trop Dis, London WC1E 6AU, England; Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England; N Manchester Grp Hosp, Monsall Unit, Manchester M8 5RB, Lancs, England	University College London Hospitals NHS Foundation Trust; University of London; London School of Hygiene & Tropical Medicine; Liverpool School of Tropical Medicine; University of Liverpool	Whitty, CJM (corresponding author), Hosp Trop Dis, Mortimer Market, London WC1E 6AU, England.	christopher.whitty@lshtm.ac.uk	Whitty, Christopher/C-7740-2012	Ustianowski, Andrew/0000-0002-6134-7855; Lalloo, David/0000-0001-7680-2200; Whitty, Christopher/0000-0002-6076-5027				Baird JK, 2004, CLIN INFECT DIS, V39, P1336, DOI 10.1086/424663; Faiz MA, 2005, LANCET, V366, P717; Lesi A, 2004, COCHRANE DB SYST REV, V2004, DOI [10.1002/14651858.CD003341, DOI 10.1002/14651858.CD003341]; Marra F, 2003, ANN PHARMACOTHER, V37, P1266, DOI 10.1345/aph.1C473; McIntosh H M, 2000, Cochrane Database Syst Rev, pCD000527, DOI 10.1002/14651858.CD000527; MEREMIKWU M, 1982, COCHRANE DB SYST REV; Newton CRJC, 1997, ARCH DIS CHILD, V76, P219, DOI 10.1136/adc.76.3.219; Newton PN, 2003, CLIN INFECT DIS, V37, P7, DOI 10.1086/375059; Okoromah CA, 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD004615.PUB2; Omari AAA, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005564; PRASAD K, 2000, COCHRANE DATABASE SY; Riddle MS, 2002, CLIN INFECT DIS, V34, P1192, DOI 10.1086/339810; Stepniewska K, 2001, T ROY SOC TROP MED H, V95, P637, DOI 10.1016/S0035-9203(01)90104-X; Stohrer JM, 2004, TROP MED INT HEALTH, V9, P1175, DOI 10.1111/j.1365-3156.2004.01320.x	14	10	10	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 29	2006	333	7561					241	245		10.1136/bmj.333.7561.241	http://dx.doi.org/10.1136/bmj.333.7561.241			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	070CC	16873859	Green Published, Green Submitted			2022-12-28	WOS:000239496900022
J	Longo, VD; Kennedy, BK				Longo, Valter D.; Kennedy, Brian K.			Sirtuins in aging and age-related disease	CELL			English	Review							REPLICATIVE LIFE-SPAN; POSITION-EFFECT VARIEGATION; FOXO TRANSCRIPTION FACTORS; PROMOTES CELL-SURVIVAL; CALORIE RESTRICTION; SACCHAROMYCES-CEREVISIAE; CAENORHABDITIS-ELEGANS; LONGEVITY REGULATION; DIETARY RESTRICTION; INSULIN-SECRETION		Univ So Calif, Dept Mol & Computat Biol, Ethel Percy Andrus Gerontol Ctr, Los Angeles, CA 90089 USA; Univ Washington, Dept Biochem, Seattle, WA 98195 USA	University of Southern California; University of Washington; University of Washington Seattle	Longo, VD (corresponding author), Univ So Calif, Dept Mol & Computat Biol, Ethel Percy Andrus Gerontol Ctr, Los Angeles, CA 90089 USA.	vlongo@usc.edu; bkenn@u.washington.edu		Kennedy, Brian/0000-0002-5754-1874	NATIONAL INSTITUTE ON AGING [R01AG020642] Funding Source: NIH RePORTER; NIA NIH HHS [AG20642, AG01028] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Aguilaniu H, 2003, SCIENCE, V299, P1751, DOI 10.1126/science.1080418; Anderson RM, 2003, SCIENCE, V302, P2124, DOI 10.1126/science.1088697; Araki T, 2004, SCIENCE, V305, P1010, DOI 10.1126/science.1098014; Berdichevsky A, 2006, CELL, V125, P1165, DOI 10.1016/j.cell.2006.04.036; Bitterman KJ, 2003, MICROBIOL MOL BIOL R, V67, P376, DOI 10.1128/MMBR.67.3.376-399.2003; Bitterman KJ, 2002, J BIOL CHEM, V277, P45099, DOI 10.1074/jbc.M205670200; Blander G, 2004, ANNU REV BIOCHEM, V73, P417, DOI 10.1146/annurev.biochem.73.011303.073651; Bluher M, 2003, SCIENCE, V299, P572, DOI 10.1126/science.1078223; Bordone L, 2006, PLOS BIOL, V4, P210, DOI 10.1371/journal.pbio.0040031; Borra MT, 2005, J BIOL CHEM, V280, P17187, DOI 10.1074/jbc.M501250200; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Chen D, 2005, SCIENCE, V310, P1641, DOI 10.1126/science.1118357; Chen J, 2005, J BIOL CHEM, V280, P40364, DOI 10.1074/jbc.M509329200; Cheng HL, 2003, P NATL ACAD SCI USA, V100, P10794, DOI 10.1073/pnas.1934713100; Chua KF, 2005, CELL METAB, V2, P67, DOI 10.1016/j.cmet.2005.06.007; Clancy DJ, 2002, SCIENCE, V296, P319, DOI 10.1126/science.1069366; Cohen HY, 2004, SCIENCE, V305, P390, DOI 10.1126/science.1099196; Defossez PA, 1999, MOL CELL, V3, P447, DOI 10.1016/S1097-2765(00)80472-4; Denu JM, 2003, TRENDS BIOCHEM SCI, V28, P41, DOI 10.1016/S0968-0004(02)00005-1; Fabrizio P, 2005, CELL, V123, P655, DOI 10.1016/j.cell.2005.08.042; Fabrizio P, 2004, J CELL BIOL, V166, P1055, DOI 10.1083/jcb.200404002; Fabrizio P, 2004, FEBS LETT, V557, P136, DOI 10.1016/S0014-5793(03)01462-5; Fabrizio P, 2003, GENETICS, V163, P35; Fabrizio P, 2001, SCIENCE, V292, P288, DOI 10.1126/science.1059497; Ford J, 2005, CANCER RES, V65, P10457, DOI 10.1158/0008-5472.CAN-05-1923; Gao L, 2002, J BIOL CHEM, V277, P25748, DOI 10.1074/jbc.M111871200; Garigan D, 2002, GENETICS, V161, P1101; Greer EL, 2005, ONCOGENE, V24, P7410, DOI 10.1038/sj.onc.1209086; Gu Wei, 2004, Novartis Found Symp, V259, P197; Guarente L, 2005, MECH AGEING DEV, V126, P923, DOI 10.1016/j.mad.2005.03.013; Guarente L, 2005, CELL, V120, P473, DOI 10.1016/j.cell.2005.01.029; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Jedrusik MA, 2003, MOL CELL BIOL, V23, P3681, DOI 10.1128/MCB.23.10.3681-3691.2003; Jiang JC, 2002, EXP GERONTOL, V37, P1023, DOI 10.1016/S0531-5565(02)00064-5; Kaeberlein M, 2005, J BIOL CHEM, V280, P17038, DOI 10.1074/jbc.M500655200; Kaeberlein M, 2005, PLOS GENET, V1, P614, DOI 10.1371/journal.pgen.0010069; Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570; Kaeberlein M, 2005, MECH AGEING DEV, V126, P491, DOI 10.1016/j.mad.2004.10.007; Kaeberlein M, 2004, PLOS BIOL, V2, P1381, DOI 10.1371/journal.pbio.0020296; Kaeberlein M, 2005, SCIENCE, V310, P1193, DOI 10.1126/science.1115535; Kaeberlein M, 2006, PLOS GENET, V2, P376, DOI 10.1371/journal.pgen.0020034; Kaeberlein M, 2006, SCIENCE, V312, DOI 10.1126/science.1124608; Kamel C, 2006, AGING CELL, V5, P81, DOI 10.1111/j.1474-9726.2006.00191.x; Kennedy BK, 2005, CELL, V123, P548, DOI 10.1016/j.cell.2005.11.002; Kennedy BK, 1997, CELL, V89, P381, DOI 10.1016/S0092-8674(00)80219-6; KENNEDY BK, 1995, CELL, V80, P485, DOI 10.1016/0092-8674(95)90499-9; Kenyon C, 2005, CELL, V120, P449, DOI 10.1016/j.cell.2005.02.002; Kobayashi T, 1996, GENES CELLS, V1, P465, DOI 10.1046/j.1365-2443.1996.d01-256.x; Lakowski B, 1998, P NATL ACAD SCI USA, V95, P13091, DOI 10.1073/pnas.95.22.13091; Lamming DW, 2006, SCIENCE, V312, DOI 10.1126/science.1124767; Lamming DW, 2005, SCIENCE, V309, P1861, DOI 10.1126/science.1113611; Langley E, 2002, EMBO J, V21, P2383, DOI 10.1093/emboj/21.10.2383; Lee SE, 1999, CURR BIOL, V9, P767, DOI 10.1016/S0960-9822(99)80339-X; Lim CS, 2006, MECH AGEING DEV, V127, P511, DOI 10.1016/j.mad.2006.02.001; Lin SJ, 2004, GENE DEV, V18, P12, DOI 10.1101/gad.1164804; Lin SJ, 2000, SCIENCE, V289, P2126, DOI 10.1126/science.289.5487.2126; Lin SJ, 2002, NATURE, V418, P344, DOI 10.1038/nature00829; Lin SJ, 2006, PLOS GENET, V2, P376, DOI 10.1371/journal.pgen.0020033; Liszt G, 2005, J BIOL CHEM, V280, P21313, DOI 10.1074/jbc.M413296200; Longo VD, 2003, SCIENCE, V299, P1342, DOI 10.1126/science.1077991; Longo VD, 1997, J CELL BIOL, V137, P1581, DOI 10.1083/jcb.137.7.1581; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; McBurney MW, 2003, MOL CELL BIOL, V23, P38, DOI 10.1128/MCB.23.1.38-54.2003; MORTIMER RK, 1959, NATURE, V183, P1751, DOI 10.1038/1831751a0; Mostoslavsky R, 2006, CELL, V124, P315, DOI 10.1016/J.CEL.2005.11.044; Moynihan KA, 2005, CELL METAB, V2, P105, DOI 10.1016/j.cmet.2005.07.001; Newman BL, 2002, GENETICS, V162, P1675; Ota H, 2006, ONCOGENE, V25, P176, DOI 10.1038/sj.onc.1209049; Parker JA, 2005, NAT GENET, V37, P349, DOI 10.1038/ng1534; Perrod S, 2001, EMBO J, V20, P197, DOI 10.1093/emboj/20.1.197; Picard F, 2004, NATURE, V429, P771, DOI 10.1038/nature02583; Powers RW, 2006, GENE DEV, V20, P174, DOI 10.1101/gad.1381406; Pruitt K, 2006, PLOS GENET, V2, P344, DOI 10.1371/journal.pgen.0020040; Prusty R, 2004, MOL GENET GENOMICS, V272, P264, DOI 10.1007/s00438-004-1049-x; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Rogina B, 2004, P NATL ACAD SCI USA, V101, P15998, DOI 10.1073/pnas.0404184101; Rogina B, 2002, SCIENCE, V298, P1745, DOI 10.1126/science.1078986; Rosenberg MI, 2002, CELL, V109, P447, DOI 10.1016/S0092-8674(02)00732-8; Roth SY, 2001, ANNU REV BIOCHEM, V70, P81, DOI 10.1146/annurev.biochem.70.1.81; Rusche LN, 2003, ANNU REV BIOCHEM, V72, P481, DOI 10.1146/annurev.biochem.72.121801.161547; Sengupta N, 2004, J CELL BIOCHEM, V93, P57, DOI 10.1002/jcb.20179; Shi T, 2005, J BIOL CHEM, V280, P13560, DOI 10.1074/jbc.M414670200; Sinclair DA, 1997, CELL, V91, P1033, DOI 10.1016/S0092-8674(00)80493-6; Solomon JM, 2006, MOL CELL BIOL, V26, P28, DOI 10.1128/MCB.26.1.28-38.2006; Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Viswanathan M, 2005, DEV CELL, V9, P605, DOI 10.1016/j.devcel.2005.09.017; Walker G, 2005, MECH AGEING DEV, V126, P929, DOI 10.1016/j.mad.2005.03.014; Wang J, 2005, J CELL BIOL, V170, P349, DOI 10.1083/jcb.200504028; Wang Y, 2006, MECH AGEING DEV, V127, P741, DOI 10.1016/j.mad.2006.05.005; Wang YM, 2006, MECH AGEING DEV, V127, P48, DOI 10.1016/j.mad.2005.09.005; Wood JG, 2004, NATURE, V430, P686, DOI 10.1038/nature02789; Yeung F, 2004, EMBO J, V23, P2369, DOI 10.1038/sj.emboj.7600244	94	487	516	1	51	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 28	2006	126	2					257	268		10.1016/j.cell.2006.07.002	http://dx.doi.org/10.1016/j.cell.2006.07.002			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	070VD	16873059	Bronze			2022-12-28	WOS:000239552600013
J	Reck-Peterson, SL; Yildiz, A; Carter, AP; Gennerich, A; Zhang, N; Vale, RD				Reck-Peterson, Samara L.; Yildiz, Ahmet; Carter, Andrew P.; Gennerich, Arne; Zhang, Nan; Vale, Ronald D.			Single-molecule analysis of dynein processivity and stepping behavior	CELL			English	Article							HAND-OVER-HAND; CYTOPLASMIC DYNEIN; NUCLEOTIDE-BINDING; IN-VIVO; KINESIN; DOMAIN; ATP; SITES; COMMUNICATION; HYDROLYSIS	Cytoplasmic dynein, the 1.2 MDa motor driving minus-end-directed motility, has been reported to move processively along microtubules, but its mechanism of motility remains poorly understood. Here, using S. cerevisiae to produce recombinant dynein with a chemically controlled dimerization switch, we show by structural and single-molecule analysis that processivity requires two dynein motor domains but not dynein's tail domain or any associated subunits. Dynein advances most frequently in 8 nm steps, although longer as well as side and backward steps are observed. Individual motor domains show a different stepping pattern, which is best explained by the two motor domains shuffling in an alternating manner between rear and forward positions. Our results suggest that cytoplasmic dynein moves processively through the coordination of its two motor domains, but its variable step size and direction suggest a considerable diffusional component to its step, which differs from Kinesin-1 and is more akin to myosin VI.	Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco	Vale, RD (corresponding author), Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA.	vale@cmp.ucsf.edu	Yildiz, Ahmet/E-6167-2015; Gennerich, Arne/W-5488-2019; Zhang, Nan/GXH-0361-2022	Yildiz, Ahmet/0000-0003-4792-174X; Reck-Peterson, Samara/0000-0002-1553-465X; Carter, Andrew/0000-0001-7292-5430	Howard Hughes Medical Institute Funding Source: Medline; NIAMS NIH HHS [P01-AR42895, P01 AR042895-130005, P01 AR042895] Funding Source: Medline; NIGMS NIH HHS [F32-GM67403-02, F32 GM067403] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P01AR042895] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM067403] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adames NR, 2000, J CELL BIOL, V149, P863, DOI 10.1083/jcb.149.4.863; Banaszynski LA, 2005, J AM CHEM SOC, V127, P4715, DOI 10.1021/ja043277y; Burgess SA, 2003, NATURE, V421, P715, DOI 10.1038/nature01377; Case RB, 1997, CELL, V90, P959, DOI 10.1016/S0092-8674(00)80360-8; Cashikar AG, 2002, MOL CELL, V9, P751, DOI 10.1016/S1097-2765(02)00499-9; Churchman LS, 2005, P NATL ACAD SCI USA, V102, P1419, DOI 10.1073/pnas.0409487102; DeLaBarre B, 2003, NAT STRUCT BIOL, V10, P856, DOI 10.1038/nsb972; Fletcher RJ, 2003, NAT STRUCT BIOL, V10, P160, DOI 10.1038/nsb893; Gee MA, 1997, NATURE, V390, P636, DOI 10.1038/37663; Gerdes JM, 2005, CELL MOL LIFE SCI, V62, P1556, DOI 10.1007/s00018-005-5007-5; GIBBONS IR, 1987, J BIOL CHEM, V262, P2780; GIBBONS IR, 1991, NATURE, V352, P640, DOI 10.1038/352640a0; GOODENOUGH U, 1984, J MOL BIOL, V180, P1083, DOI 10.1016/0022-2836(84)90272-9; Ho SN, 1996, NATURE, V382, P822, DOI 10.1038/382822a0; Hook P, 2005, J BIOL CHEM, V280, P33045, DOI 10.1074/jbc.M504693200; Hua W, 2002, SCIENCE, V295, P844, DOI 10.1126/science.1063089; KARKI S, 1995, J BIOL CHEM, V270, P28806, DOI 10.1074/jbc.270.48.28806; KERSSEMAKERS JWJ, 2006, IN PRESS NATURE 0625, DOI DOI 10.1038/NATURE04928; King SJ, 2000, NAT CELL BIOL, V2, P20, DOI 10.1038/71338; Kon T, 2005, NAT STRUCT MOL BIOL, V12, P513, DOI 10.1038/nsmb930; Kon T, 2004, BIOCHEMISTRY-US, V43, P11266, DOI 10.1021/bi048985a; Koonce MP, 1997, J BIOL CHEM, V272, P19714, DOI 10.1074/jbc.272.32.19714; Koonce MP, 1996, MOL BIOL CELL, V7, P935, DOI 10.1091/mbc.7.6.935; Kural C, 2005, SCIENCE, V308, P1469, DOI 10.1126/science.1108408; Li J, 2005, NAT CELL BIOL, V7, P686, DOI 10.1038/ncb1273; Lo KWH, 2001, J BIOL CHEM, V276, P14059, DOI 10.1074/jbc.M010320200; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Lupetti P, 2005, CELL MOTIL CYTOSKEL, V62, P69, DOI 10.1002/cm.20084; Mallik R, 2005, CURR BIOL, V15, P2075, DOI 10.1016/j.cub.2005.10.039; Mallik R, 2004, NATURE, V427, P649, DOI 10.1038/nature02293; Neuwald AF, 1999, GENOME RES, V9, P27; Nicastro D, 2005, P NATL ACAD SCI USA, V102, P15889, DOI 10.1073/pnas.0508274102; Nishiura M, 2004, J BIOL CHEM, V279, P22799, DOI 10.1074/jbc.M313362200; Reck-Peterson SL, 2004, P NATL ACAD SCI USA, V101, P1491, DOI 10.1073/pnas.2637011100; Rock RS, 2005, MOL CELL, V17, P603, DOI 10.1016/j.molcel.2005.01.015; Sakakibara H, 1999, NATURE, V400, P586, DOI 10.1038/23066; Samso M, 2004, J MOL BIOL, V340, P1059, DOI 10.1016/j.jmb.2004.05.063; Silvanovich A, 2003, MOL BIOL CELL, V14, P1355, DOI 10.1091/mbc.E02-10-0675; Takahashi Y, 2004, P NATL ACAD SCI USA, V101, P12865, DOI 10.1073/pnas.0403429101; Toba S, 2006, P NATL ACAD SCI USA, V103, P5741, DOI 10.1073/pnas.0508511103; Vale RD, 2000, SCIENCE, V288, P88, DOI 10.1126/science.288.5463.88; Vallee RB, 2004, J NEUROBIOL, V58, P189, DOI 10.1002/neu.10314; Wang ZH, 1995, BIOPHYS J, V69, P2011, DOI 10.1016/S0006-3495(95)80071-8; Warshaw DM, 2005, BIOPHYS J, V88, pL30, DOI 10.1529/biophysj.105.061903; Yildiz A, 2004, SCIENCE, V303, P676, DOI 10.1126/science.1093753; Yildiz A, 2005, ACCOUNTS CHEM RES, V38, P574, DOI 10.1021/ar040136s; Yildiz A, 2003, SCIENCE, V300, P2061, DOI 10.1126/science.1084398	47	461	468	0	53	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 28	2006	126	2					335	348		10.1016/j.cell.2006.05.046	http://dx.doi.org/10.1016/j.cell.2006.05.046			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	070VD	16873064	Green Accepted, Bronze			2022-12-28	WOS:000239552600019
J	Moser, M; Setaro, JF				Moser, Marvin; Setaro, John F.			Resistant or difficult-to-control hypertension	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							AMBULATORY BLOOD-PRESSURE; HIGH PREVALENCE; SLEEP-APNEA; MANAGEMENT; METAANALYSIS; VERAPAMIL; THERAPY		Yale Univ, Sch Med, Sect Cardiovasc Med, New Haven, CT 06520 USA; Yale Univ, Sch Med, Cardiovasc Dis Prevent Ctr, Dept Internal Med, New Haven, CT 06520 USA	Yale University; Yale University	Moser, M (corresponding author), Yale Univ, Sch Med, Sect Cardiovasc Med, Box 208017,333 Cedar St, New Haven, CT 06520 USA.							*ALLHAT OFF COORD, 2002, JAMA-J AM MED ASSOC, V288, P1981; ANDERSON GH, 1994, J HYPERTENS, V12, P609, DOI 10.1097/00004872-199405000-00015; Berlowitz DR, 1998, NEW ENGL J MED, V339, P1957, DOI 10.1056/NEJM199812313392701; Black HR, 2003, JAMA-J AM MED ASSOC, V289, P2073, DOI 10.1001/jama.289.16.2073; Bramlage P, 2004, AM J HYPERTENS, V17, P904, DOI 10.1016/j.amjhyper.2004.05.017; Burnier M, 2001, J HYPERTENS, V19, P335, DOI 10.1097/00004872-200102000-00022; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Cuspidi C, 2001, J HYPERTENS, V19, P2063, DOI 10.1097/00004872-200111000-00018; FINNERTY FA, 1977, ANGIOLOGY, V28, P125, DOI 10.1177/000331977702800209; Garg JP, 2005, AM J HYPERTENS, V18, P619, DOI 10.1016/j.amjhyper.2004.11.021; GRAVES JW, 1989, AM J MED SCI, V298, P361, DOI 10.1097/00000441-198912000-00001; Hajjar I, 2003, JAMA-J AM MED ASSOC, V290, P199, DOI 10.1001/jama.290.2.199; Hill MN, 1996, CIRCULATION, V93, P4, DOI 10.1161/01.CIR.93.1.4; Hyman DJ, 2001, NEW ENGL J MED, V345, P479, DOI 10.1056/NEJMoa010273; HYMAN DJ, 2002, NEW ENGL J MED, V346, P544; Jee SH, 1999, HYPERTENSION, V33, P647, DOI 10.1161/01.HYP.33.2.647; Kaplan NM, 1998, CLIN HYPERTENSION; Logan AG, 2001, J HYPERTENS, V19, P2271, DOI 10.1097/00004872-200112000-00022; MESSERLI FH, 1985, NEW ENGL J MED, V312, P1548, DOI 10.1056/NEJM198506133122405; MODAN M, 1991, HYPERTENSION, V17, P565, DOI 10.1161/01.HYP.17.4.565; Mogensen CE, 2000, BRIT MED J, V321, P1440, DOI 10.1136/bmj.321.7274.1440; Moser M, 1997, AM FAM PHYSICIAN, V56, P1275; Nishizaka Mari K, 2004, J Clin Hypertens (Greenwich), V6, P458, DOI 10.1111/j.1524-6175.2004.03412.x; O'Rorke JE, 2001, BRIT MED J, V322, P1229, DOI 10.1136/bmj.322.7296.1229; Omvik Per, 1996, Blood Pressure, V5, P71, DOI 10.3109/08037059609062111; Pepperell JCT, 2002, LANCET, V359, P204, DOI 10.1016/S0140-6736(02)07445-7; Saseen JJ, 1996, HYPERTENSION, V28, P109, DOI 10.1161/01.HYP.28.1.109; SETARO JF, 1992, NEW ENGL J MED, V327, P543; Singer GA, 2002, HYPERTENSION, V40, P464, DOI 10.1161/01.HYP.0000035858.04434.03; Sowers JR, 2005, ARCH INTERN MED, V165, P551; Sowers JR, 2005, ARCH INTERN MED, V165, P161, DOI 10.1001/archinte.165.2.161; Staessen JA, 2004, JAMA-J AM MED ASSOC, V291, P955, DOI 10.1001/jama.291.8.955; Taler SJ, 2002, HYPERTENSION, V39, P982, DOI 10.1161/01.HYP.0000016176.16042.2F; The AO, 2002, JAMA-J AM MED ASSOC, V288, P2981, DOI DOI 10.1001/JAMA.288.23.2981; van Jaarsveld BC, 2000, NEW ENGL J MED, V342, P1007, DOI 10.1056/NEJM200004063421403; Veglio F, 2001, CLIN EXP HYPERTENS, V23, P203, DOI 10.1081/CEH-100102660; Weinberger MH, 1996, HYPERTENSION, V27, P481, DOI 10.1161/01.HYP.27.3.481; Whelton A, 2001, Am J Ther, V8, P85, DOI 10.1097/00045391-200103000-00003; WHELTON A, 2001, AM J THER, V8, P220; Wofford Marion R., 2000, J Clin Hypertens (Greenwich), V2, P124; Xin X, 2001, HYPERTENSION, V38, P1112, DOI 10.1161/hy1101.093424	41	142	158	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 27	2006	355	4					385	392		10.1056/NEJMcp041698	http://dx.doi.org/10.1056/NEJMcp041698			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	067DT	16870917				2022-12-28	WOS:000239282600007
J	Currat, M; Excoffier, L; Maddison, W; Otto, SP; Ray, N; Whitlock, MC; Yeaman, S				Currat, Mathias; Excoffier, Laurent; Maddison, Wayne; Otto, Sarah P.; Ray, Nicolas; Whitlock, Michael C.; Yeaman, Sam			Comment on "Ongoing adaptive evolution of ASPM, a brain size determinant in homo sapiens" and "microcephalin, a gene regulating brain size, continues to evolve adaptively in humans"	SCIENCE			English	Editorial Material							MUTATIONS; WAVE		Univ British Columbia, Dept Zool, Vancouver, BC V6T 1Z4, Canada; Univ Bern, Inst Zool, CH-3012 Bern, Switzerland	University of British Columbia; University of Bern	Otto, SP (corresponding author), Univ British Columbia, Dept Zool, 6270 Univ Blvd, Vancouver, BC V6T 1Z4, Canada.	otto@zoology.ubc.ca	Ray, Nicolas/C-8988-2009; Whitlock, Michael C/G-1900-2012; Excoffier, Laurent/D-3498-2013; Ray, Nicolas/AFG-2968-2022; Yeaman, Sam/C-7778-2011; Otto, Sarah Perin/K-5625-2012	Ray, Nicolas/0000-0002-4696-5313; Excoffier, Laurent/0000-0002-7507-6494; Ray, Nicolas/0000-0002-4696-5313; Yeaman, Sam/0000-0002-1706-8699; Otto, Sarah Perin/0000-0003-3042-0818; Whitlock, Michael/0000-0002-0782-1843				Edmonds CA, 2004, P NATL ACAD SCI USA, V101, P975, DOI 10.1073/pnas.0308064100; Evans PD, 2005, SCIENCE, V309, P1717, DOI 10.1126/science.1113722; Hudson RR, 2002, BIOINFORMATICS, V18, P337, DOI 10.1093/bioinformatics/18.2.337; Klopfstein S, 2006, MOL BIOL EVOL, V23, P482, DOI 10.1093/molbev/msj057; Mekel-Bobrov N, 2005, SCIENCE, V309, P1720, DOI 10.1126/science.1116815; Ramachandran S, 2005, P NATL ACAD SCI USA, V102, P15942, DOI 10.1073/pnas.0507611102; Ray N, 2005, GENOME RES, V15, P1161, DOI 10.1101/gr.3708505	7	101	103	1	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 14	2006	313	5784					172	172		10.1126/science.1122712	http://dx.doi.org/10.1126/science.1122712			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	063GZ	16840683				2022-12-28	WOS:000239008000022
J	Li, CF; Pontes, O; El-Shami, M; Henderson, IR; Bernatavichute, YV; Chan, SWL; Lagrange, T; Pikaard, CS; Jacobsen, SE				Li, Carey Fei; Pontes, Olga; El-Shami, Mahmoud; Henderson, Ian R.; Bernatavichute, Yana V.; Chan, Simon W. -L.; Lagrange, Thierry; Pikaard, Craig S.; Jacobsen, Steven E.			An ARGONAUTE4-containing nuclear processing center colocalized with Cajal bodies in Arabidopsis thaliana	CELL			English	Article							RNA-POLYMERASE-II; DIRECTED DNA METHYLATION; H3 LYSINE-9 METHYLATION; LIVING PLANT-CELLS; HETEROCHROMATIN FORMATION; HISTONE METHYLATION; FLUORESCENT PROTEIN; TERMINAL DOMAIN; SIRNA; CHROMATIN	ARGONAUTE4 (AGO4) and RNA polymerase IV (Pol IV) are required for DNA methylation guided by 24 nucleotide small interfering RNAs (siRNAs) in Arabidopsis thaliana. Here we show that AGO4 localizes to nucleolus-associated bodies along with the Pol IV subunit NRPD1b; the small nuclear RNA (snRNA) binding protein SmD3; and two markers of Cajal bodies, trimethylguanosine-capped snRNAs and the U2 snRNA binding protein U2B". AGO4 interacts with the C-terminal domain of NRPD1b, and AGO(4) protein stability depends on upstream factors that synthesize siRNAs. AGO(4) is also found, along with the DNA methyltransferase DRM2, throughout the nucleus at presumed DNA methylation target sites. Cajal bodies are conserved sites for the maturation of ribonucleoprotein complexes. Our results suggest a function for Cajal bodies as a center for the assembly of an AGO(4)/NRPD1b/siRNA complex, facilitating its function in RNA-directed gene silencing at target loci.	Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Howard Hughes Med Inst, Los Angeles, CA 90095 USA; Washington Univ, Dept Biol, St Louis, MO 63130 USA; Univ Perpignan, UMR 5096, LGDP, F-66860 Perpignan, France	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Howard Hughes Medical Institute; University of California System; University of California Los Angeles; Washington University (WUSTL); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite Perpignan Via Domitia	Jacobsen, SE (corresponding author), Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA.	jacobsen@ucla.edu	Pontes, Olga MF/F-9768-2011; Henderson, Ian/A-2174-2012; Pikaard, Craig S/K-8772-2012	Pontes, Olga MF/0000-0003-3316-1145; Pikaard, Craig S/0000-0001-8204-7459; Henderson, Ian/0000-0001-5066-1489; Lagrange, Thierry/0000-0003-3090-0918; Henderson, Ian/0000-0002-9954-4977	NIGMS NIH HHS [GM07185, GM07104, R01GM077590, GM60398, R01 GM077590, R01GM60380] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060380, R37GM060398, R01GM060398, R01GM077590] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Barilla D, 2001, P NATL ACAD SCI USA, V98, P445, DOI 10.1073/pnas.021545298; Bechtold N, 1998, METH MOL B, V82, P259; BEVEN AF, 1995, J CELL SCI, V108, P509; Boudonck K, 1998, J CELL SCI, V111, P3687; Boudonck K, 1999, MOL BIOL CELL, V10, P2297, DOI 10.1091/mbc.10.7.2297; Cao XF, 2002, CURR BIOL, V12, P1138, DOI 10.1016/S0960-9822(02)00925-9; Carmell MA, 2002, GENE DEV, V16, P2733, DOI 10.1101/gad.1026102; CHAMBERLAND H, 1993, CHROMOSOMA, V102, P220, DOI 10.1007/BF00352395; Chan SWL, 2005, NAT REV GENET, V6, P351, DOI 10.1038/nrg1601; Chan SWL, 2004, SCIENCE, V303, P1336, DOI 10.1126/science.1095989; Chanvivattana Y, 2004, DEVELOPMENT, V131, P5263, DOI 10.1242/dev.01400; Cioce M, 2005, ANNU REV CELL DEV BI, V21, P105, DOI 10.1146/annurev.cellbio.20.010403.103738; Dahmus ME, 1996, J BIOL CHEM, V271, P19009, DOI 10.1074/jbc.271.32.19009; Docquier S, 2004, CHROMOSOMA, V112, P255, DOI 10.1007/s00412-003-0271-3; Fagard M, 2000, P NATL ACAD SCI USA, V97, P11650, DOI 10.1073/pnas.200217597; Fransz P, 2002, P NATL ACAD SCI USA, V99, P14584, DOI 10.1073/pnas.212325299; Fu D, 2006, GENE DEV, V20, P531, DOI 10.1101/gad.1390306; Gall JG, 2003, NAT REV MOL CELL BIO, V4, P975, DOI 10.1038/nrm1262; Grummt I, 2003, NAT REV MOL CELL BIO, V4, P641, DOI 10.1038/nrm1171; Hampsey M, 2003, CELL, V113, P429, DOI 10.1016/S0092-8674(03)00360-X; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; Herr AJ, 2005, SCIENCE, V308, P118, DOI 10.1126/science.1106910; Jabri E, 2005, NAT STRUCT MOL BIOL, V12, P564, DOI 10.1038/nsmb0705-564; Jacobsen SE, 2000, CURR BIOL, V10, P179, DOI 10.1016/S0960-9822(00)00324-9; Jacobsen SE, 1997, SCIENCE, V277, P1100, DOI 10.1126/science.277.5329.1100; Jasencakova Z, 2003, PLANT J, V33, P471, DOI 10.1046/j.1365-313X.2003.01638.x; Johnson J., 2002, EUR CELLS MATER, V3, P12; Kanno T, 2005, NAT GENET, V37, P761, DOI 10.1038/ng1580; Khusial P, 2005, TRENDS BIOCHEM SCI, V30, P522, DOI 10.1016/j.tibs.2005.07.006; Li JJ, 2005, CURR BIOL, V15, P1501, DOI 10.1016/j.cub.2005.07.029; Lin CT, 1996, PLANT J, V10, P893, DOI 10.1046/j.1365-313X.1996.10050893.x; Lindroth AM, 2004, EMBO J, V23, P4146, DOI 10.1038/sj.emboj.7600430; Lorkovic ZJ, 2004, MOL BIOL CELL, V15, P3233, DOI 10.1091/mbc.E04-01-0055; Mathieu O, 2005, EMBO J, V24, P2783, DOI 10.1038/sj.emboj.7600743; MATTAJ IW, 1986, CELL, V46, P905, DOI 10.1016/0092-8674(86)90072-3; Meister G, 2004, NATURE, V431, P343, DOI 10.1038/nature02873; Onodera Y, 2005, CELL, V120, P613, DOI 10.1016/j.cell.2005.02.007; Pendle AF, 2005, MOL BIOL CELL, V16, P260, DOI 10.1091/mbc.E04-09-0791; Pontes O, 2003, P NATL ACAD SCI USA, V100, P11418, DOI 10.1073/pnas.1932522100; Pontes O, 2006, CELL, V126, P79, DOI 10.1016/j.cell.2006.05.031; Pontier D, 2005, GENE DEV, V19, P2030, DOI 10.1101/gad.348405; Schauer SE, 2002, TRENDS PLANT SCI, V7, P487, DOI 10.1016/S1360-1385(02)02355-5; Shaw PJ, 2004, CURR OPIN PLANT BIOL, V7, P614, DOI 10.1016/j.pbi.2004.09.011; Soppe WJJ, 2002, EMBO J, V21, P6549, DOI 10.1093/emboj/cdf657; Tijsterman M, 2002, ANNU REV GENET, V36, P489, DOI 10.1146/annurev.genet.36.043002.091619; Tran RK, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-11-r90; VANKAN P, 1988, EMBO J, V7, P791, DOI 10.1002/j.1460-2075.1988.tb02877.x; Verdel A, 2004, SCIENCE, V303, P672, DOI 10.1126/science.1093686; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; Wassenegger M, 2005, CELL, V122, P13, DOI 10.1016/j.cell.2005.06.034; Xie ZX, 2004, PLOS BIOL, V2, P642, DOI 10.1371/journal.pbio.0020104; Zilberman D, 2003, SCIENCE, V299, P716, DOI 10.1126/science.1079695; Zilberman D, 2004, CURR BIOL, V14, P1214, DOI 10.1016/j.cub.2004.06.055	53	291	311	0	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 14	2006	126	1					93	106		10.1016/j.cell.2006.05.032	http://dx.doi.org/10.1016/j.cell.2006.05.032			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	066JF	16839879	Bronze			2022-12-28	WOS:000239224800019
J	Valenzuela, SO; Tinkham, M				Valenzuela, SO; Tinkham, M			Direct electronic measurement of the spin Hall effect	NATURE			English	Article							ROOM-TEMPERATURE; SEMICONDUCTORS; INJECTION; CHARGE; POLARIZATION; DIFFUSION; CURRENTS; VALVES	The generation, manipulation and detection of spin-polarized electrons in nanostructures define the main challenges of spin-ased electronics(1). Among the different approaches for spin generation and manipulation, spin - orbit coupling - which couples the spin of an electron to its momentum - is attracting considerable interest. In a spin - orbit-coupled system, a non-zero spin current is predicted in a direction perpendicular to the applied electric field, giving rise to a spin Hall effect(2-4). Consistent with this effect, electrically induced spin polarization was recently detected by optical techniques at the edges of a semiconductor channel(5) and in two-dimensional electron gases in semiconductor heterostructures(6,7). Here we report electrical measurements of the spin Hall effect in a diffusive metallic conductor, using a ferromagnetic electrode in combination with a tunnel barrier to inject a spin-polarized current. In our devices, we observe an induced voltage that results exclusively from the conversion of the injected spin current into charge imbalance through the spin Hall effect. Such a voltage is proportional to the component of the injected spins that is perpendicular to the plane defined by the spin current direction and the voltage probes. These experiments reveal opportunities for efficient spin detection without the need for magnetic materials, which could lead to useful spintronics devices that integrate information processing and data storage.	Harvard Univ, Dept Phys, Cambridge, MA 02138 USA	Harvard University	Valenzuela, SO (corresponding author), MIT, Francis Bitter Natl Magnet Lab, Cambridge, MA 02139 USA.	sov@mit.edu	Valenzuela, Sergio/A-1169-2007	Valenzuela, Sergio/0000-0002-4632-8891				DYAKONOV MI, 1971, PHYS LETT A, VA 35, P459, DOI 10.1016/0375-9601(71)90196-4; DYAKONOV MI, 1971, JETP LETT-USSR, V13, P467; Engel HA, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.166605; Hirsch JE, 1999, PHYS REV LETT, V83, P1834, DOI 10.1103/PhysRevLett.83.1834; Jedema FJ, 2002, NATURE, V416, P713, DOI 10.1038/416713a; Ji Y, 2004, APPL PHYS LETT, V85, P6218, DOI 10.1063/1.1841455; JOHNSON M, 1988, PHYS REV B, V37, P5326, DOI 10.1103/PhysRevB.37.5326; JOHNSON M, 1985, PHYS REV LETT, V55, P1790, DOI 10.1103/PhysRevLett.55.1790; JOHNSON M, 1988, PHYS REV B, V37, P5312, DOI 10.1103/PhysRevB.37.5312; Kato YK, 2004, SCIENCE, V306, P1910, DOI 10.1126/science.1105514; Monsma DJ, 2000, APPL PHYS LETT, V77, P720, DOI 10.1063/1.127097; Murakami S, 2003, SCIENCE, V301, P1348, DOI 10.1126/science.1087128; O'Handley R. C., 2000, MODERN MAGNETIC MAT; PAPACONSTANTOPO.DA, 1986, HDB BAND STRUCTURE E; Qi Y, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.052407; Shchelushkin RV, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.045123; Shchelushkin RV, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.073110; Sih V, 2005, NAT PHYS, V1, P31, DOI 10.1038/nphys009; Sinova J, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.126603; Tse WK, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.056601; Urech M, 2006, NANO LETT, V6, P871, DOI 10.1021/nl052075c; Valenzuela SO, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.196601; Valenzuela SO, 2004, APPL PHYS LETT, V85, P5914, DOI 10.1063/1.1830685; Wolf SA, 2001, SCIENCE, V294, P1488, DOI 10.1126/science.1065389; Wunderlich J, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.047204; Zhang SF, 2001, J APPL PHYS, V89, P7564, DOI 10.1063/1.1357125; Zhang SF, 2000, PHYS REV LETT, V85, P393, DOI 10.1103/PhysRevLett.85.393	27	1122	1135	9	387	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 13	2006	442	7099					176	179		10.1038/nature04937	http://dx.doi.org/10.1038/nature04937			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	062XJ	16838016	Green Submitted			2022-12-28	WOS:000238979700041
J	Kulkarni, N; Pierse, N; Rushton, L; Grigg, J				Kulkarni, Neeta; Pierse, Nevil; Rushton, Lesley; Grigg, Jonathan			Carbon in airway macrophages and lung function in children	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							FINE-PARTICLE DEPOSITION; INDUCED SPUTUM; ALVEOLAR MACROPHAGES; PHYSICAL-ACTIVITY; POLLUTION; INHALATION; RETENTION; EXPOSURE; COTININE; SMOKING	Background Epidemiologic studies indirectly suggest that the inhalation of carbonaceous particulate matter impairs lung function in children. Using the carbon content of airway macrophages as a marker of individual exposure to particulate matter derived from fossil fuel, we sought direct evidence of this association. Methods Airway macrophages were obtained from healthy children through sputum induction, and the area of airway macrophages occupied by carbon was measured. Lung function was measured with the use of spirometry. We modeled the exposure to primary particulate matter ( PM) that is less than 10 mu m in aerodynamic diameter (PM10) at or near each child's home address. Linear regression was used to evaluate associations between carbon content of alveolar macrophages and variables that may affect individual exposure. To determine whether lung function that is reduced for other reasons is associated with an increase in the carbon content of airway macrophages, we also studied children with severe asthma. Results We were able to assess the carbon content of airway macrophages in 64 of 114 healthy children (56 percent). Each increase in primary PM10 of 1.0 mu g per cubic meter was associated with an increase of 0.10 mu m(2) (95 percent confidence interval, 0.01 to 0.18) in the carbon content of airway macrophages, and each increase of 1.0 mu m(2) in carbon content was associated with a reduction of 17 percent (95 percent confidence interval, 5.6 to 28.4 percent) in forced expiratory volume in one second, of 12.9 percent (95 percent confidence interval, 0.9 to 24.8 percent) in forced vital capacity, and of 34.7 percent ( 95 percent confidence interval, 11.3 to 58.1 percent) in the forced expiratory flow between 25 and 75 percent of the forced vital capacity. The carbon content of airway macrophages was lower in children with asthma than in healthy children. Conclusions There is a dose-dependent inverse association between the carbon content of airway macrophages and lung function in children. We found no evidence that reduced lung function itself causes an increase in carbon content.	Univ Leicester, Dept Infect Immun & Inflammat, Div Child Hlth, Leicester, Leics, England; Univ Leicester, Inst Environm & Hlth, Leicester, Leics, England	University of Leicester; University of Leicester	Grigg, J (corresponding author), Barts & London Queen Marys Sch Med & Dent, Inst Cell & Mol Sci, London E1 2AT, England.	j.grigg@qmul.ac.uk		Grigg, Jonathan/0000-0003-3109-6028; Pierse, Nevil/0000-0002-2726-8141				AARON DJ, 1993, MED SCI SPORT EXER, V25, P847, DOI 10.1249/00005768-199307000-00014; Alexis NE, 2001, AM J RESP CRIT CARE, V164, P1964, DOI 10.1164/ajrccm.164.10.2104051; Alexis NE, 2001, AM J PHYSIOL-LUNG C, V280, pL369; [Anonymous], 1995, AM J RESP CRIT CARE, V152, P1107, DOI 10.1164/ajrccm.152.3.7663792; Artinano B, 2004, SCI TOTAL ENVIRON, V334, P111, DOI 10.1016/j.scitotenv.2004.04.032; Avol Edward, 2005, NEW ENGL J MED, V352, P1276; Bennett WD, 2004, J APPL PHYSIOL, V97, P821, DOI 10.1152/japplphysiol.01403.2003; Bennett WD, 1996, AM J RESP CRIT CARE, V153, P1641, DOI 10.1164/ajrccm.153.5.8630615; Brainard JS, 2002, ENVIRON PLANN A, V34, P695, DOI 10.1068/a34184; Brauer M, 2001, ENVIRON HEALTH PERSP, V109, P1039, DOI 10.2307/3454959; Brichtling CE, 2000, AM J RESP CRIT CARE, V162, P878, DOI 10.1164/ajrccm.162.3.9909064; Bunn HJ, 2001, THORAX, V56, P932, DOI 10.1136/thorax.56.12.932; Cataldo D, 2001, CHEST, V120, P1815, DOI 10.1378/chest.120.6.1815; Daigle CC, 2003, INHAL TOXICOL, V15, P539, DOI 10.1080/08958370304468; FEYERABEND C, 1990, J PHARM PHARMACOL, V42, P450, DOI 10.1111/j.2042-7158.1990.tb06592.x; Finch GL, 2002, INHAL TOXICOL, V14, P1017, DOI 10.1080/08958370290084764; Fireman E, 1999, CHEST, V115, P1720, DOI 10.1378/chest.115.6.1720; FIREMAN E, 1999, CHEST, V116, P588; Fireman EM, 2004, ENVIRON HEALTH PERSP, V112, P1564, DOI 10.1289/ehp.7233; Gauderman WJ, 2004, NEW ENGL J MED, V351, P1057, DOI 10.1056/NEJMoa040610; Gibson PG, 2003, THORAX, V58, P116, DOI 10.1136/thorax.58.2.116; HE QC, 1993, ARCH ENVIRON HEALTH, V48, P382, DOI 10.1080/00039896.1993.10545959; Horak F, 2002, EUR RESPIR J, V19, P838, DOI 10.1183/09031936.02.00512001; JARVIS MJ, 1992, AM J PUBLIC HEALTH, V82, P1225, DOI 10.2105/AJPH.82.9.1225; KNUDSON RJ, 1983, AM REV RESPIR DIS, V127, P725; KRISKA AM, 1990, DIABETES CARE, V13, P401, DOI 10.2337/diacare.13.4.401; Kulkarni NS, 2005, SCI TOTAL ENVIRON, V345, P23, DOI 10.1016/j.scitotenv.2004.10.016; Lay JC, 1998, AM J RESP CELL MOL, V18, P687, DOI 10.1165/ajrcmb.18.5.2948; *LEIC CIT COUNC PO, 2000, REV ASS AIR QUAL LEI; MCNEILL AD, 1987, BRIT J ADDICT, V82, P1355; Pavord ID, 1997, THORAX, V52, P498, DOI 10.1136/thx.52.6.498; Pierse N, 2006, THORAX, V61, P216, DOI 10.1136/thx.2004.036418; PILLING M, 2005, PARTICULATE MATTER U, P29; PILLING M, 2005, PARTICULATE MATTER U, P6; POLGAR G, 1979, AM REV RESPIR DIS, V120, P625; QUANJER PH, 1993, EUR RESPIR J, V6, P5, DOI 10.1183/09041950.005s1693; ROSENTHAL M, 1993, THORAX, V48, P794, DOI 10.1136/thx.48.8.794; STROM KA, 1990, J TOXICOL ENV HEALTH, V29, P377, DOI 10.1080/15287399009531399	38	176	186	0	29	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 6	2006	355	1					21	30		10.1056/NEJMoa052972	http://dx.doi.org/10.1056/NEJMoa052972			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	060DT	16822993	Green Published			2022-12-28	WOS:000238783200004
J	Jorenby, DE; Hays, JT; Rigotti, NA; Azoulay, S; Watsky, EJ; Williams, KE; Billing, CB; Gong, J; Reeves, KR				Jorenby, Douglas E.; Hays, J. Taylor; Rigotti, Nancy A.; Azoulay, Salomon; Watsky, Eric J.; Williams, Kathryn E.; Billing, Clare B.; Gong, Jason; Reeves, Karen R.		Varenicline Phase 3 Study Grp	Efficacy of varenicline, an alpha 4 beta 2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation - A randomized controlled trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							TOLERANCE; SMOKERS; PATCH	Context Varenicline, a partial agonist at the alpha 4 beta 2 nicotinic acetylcholine receptor, has the potential to aid smoking cessation by relieving nicotine withdrawal symptoms and reducing the rewarding properties of nicotine. Objective To determine the efficacy and safety of varenicline for smoking cessation compared with placebo or sustained-release bupropion (bupropion SR). Design, Setting, and Participants A randomized, double-blind, placebo-controlled trial conducted between June 2003 and March 2005 at 14 research centers with a 12-week treatment period and follow-up of smoking status to week 52. Of 1413 adult smokers who volunteered for the study, 1027 were enrolled; 65% of randomized participants completed the study. Intervention Varenicline titrated to 1 mg twice daily (n= 344) or bupropion SR titrated to 150 mg twice daily (n= 342) or placebo (n= 341) for 12 weeks, plus weekly brief smoking cessation counseling. Main Outcome Measures Continuous abstinence from smoking during the last 4 weeks of treatment (weeks 9-12; primary end point) and through the follow-up period (weeks 9-24 and 9-52). Results During the last 4 weeks of treatment (weeks 9-12), 43.9% of participants in the varenicline group were continuously abstinent from smoking compared with 17.6% in the placebo group(odds ratio [OR], 3.85; 95% confidence interval [CI], 2.69-5.50; P<.001) and 29.8% in the bupropion SR group (OR, 1.90; 95% CI, 1.38-2.62; P<.001). For weeks 9 through 24, 29.7% of participants in the varenicline group were continuously abstinent compared with 13.2% in the placebo group (OR, 2.83; 95% CI, 1.91-4.19; P<.001) and 20.2% in the bupropion group (OR, 1.69; 95% CI, 1.19-2.42; P=.003). For weeks 9 through 52, 23% of participants in the varenicline group were continuously abstinent compared with 10.3% in the placebo group (OR, 2.66; 95% CI, 1.72-4.11; P<.001) and 14.6% in the bupropion SR group (OR, 1.77; 95% CI, 1.19-2.63; P=.004). Treatment was discontinued due to adverse events by 10.5% of participants in the varenicline group, 12.6% in the bupropion SR group, and 7.3% in the placebo group. The most common adverse event with varenicline was nausea, which occurred in 101 participants (29.4%). Conclusions Varenicline is an efficacious, safe, and well-tolerated smoking cessation pharmacotherapy. Varenicline's short-term and long-term efficacy exceeded that of both placebo and bupropion SR.	Univ Wisconsin, Sch Med & Publ Hlth, Ctr Tobacco Res & Intervent, Madison, WI 53711 USA; Mayo Clin Coll Med, Div Gen Internal Med, Rochester, MN USA; Harvard Univ, Sch Med, Boston, MA USA; Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; Pfizer Global Res & Dev, Groton, CT USA	University of Wisconsin System; University of Wisconsin Madison; Mayo Clinic; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Pfizer	Jorenby, DE (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Ctr Tobacco Res & Intervent, Suite 200,1930 Monroe St, Madison, WI 53711 USA.	dej@ctri.medicine.wisc.edu						Armour B. S., 2005, Morbidity and Mortality Weekly Report, V54, P625; Cappelleri JC, 2005, VALUE HEALTH, V8, P334, DOI 10.1016/S1098-3015(10)62877-X; Cox L S, 2001, Nicotine Tob Res, V3, P7, DOI 10.1080/14622200020032051; FIORE MC, 2000, TREATING TOBACCO USE; Gonzales DH, 2001, CLIN PHARMACOL THER, V69, P438, DOI 10.1067/mcp.2001.115750; Hays JT, 2001, ANN INTERN MED, V135, P423, DOI 10.7326/0003-4819-135-6-200109180-00011; HEATHERTON TF, 1991, BRIT J ADDICT, V86, P1119; HUGHES JR, 1986, ARCH GEN PSYCHIAT, V43, P289; HUGHES JR, 2006, COCHRANE LIB; Hurt RD, 1997, NEW ENGL J MED, V337, P1195, DOI 10.1056/NEJM199710233371703; *INT C HARM WEB SI, ICH PROC HARM GUID; Jorenby DE, 1999, NEW ENGL J MED, V340, P685, DOI 10.1056/NEJM199903043400903; NIDES M, IN PRESS ARCH INTERN; Obach RS, 2006, DRUG METAB DISPOS, V34, P121, DOI 10.1124/dmd.105.006767; ROSE JE, 1994, CLIN PHARMACOL THER, V56, P86, DOI 10.1038/clpt.1994.105; Solberg LI, 2001, MAYO CLIN PROC, V76, P138; Tapper AR, 2004, SCIENCE, V306, P1029, DOI 10.1126/science.1099420; Thorndike AN, 1998, JAMA-J AM MED ASSOC, V279, P604, DOI 10.1001/jama.279.8.604; TONNESEN P, 1993, ADDICTION, V88, P533, DOI 10.1111/j.1360-0443.1993.tb02060.x; *US DEP HHS, 1998, DHHS PUBL; *WORLD MED ASS WEB, DECL HELS ETH PRINC	21	1044	1082	1	71	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 5	2006	296	1					56	63		10.1001/jama.296.1.56	http://dx.doi.org/10.1001/jama.296.1.56			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	058RU	16820547	Bronze			2022-12-28	WOS:000238683100022
